GO:0006600;creatine metabolic process;4085;1830;GO:0006094
GO:0006601;creatine biosynthetic process;4022;106;GO:0009065
GO:0006611;protein export from nucleus;19260;2370;GO:0006887
GO:0006612;protein targeting to membrane;343226;2840;GO:0055085
GO:0006610;ribosomal protein import into nucleus;198;366;GO:0005740
GO:0006604;phosphoarginine metabolic process;0;6;GO:0006569
GO:0006605;protein targeting;826536;4800;GO:0006613
GO:0006602;creatinine catabolic process;993;3;GO:0007567
GO:0006603;phosphocreatine metabolic process;24309;8;GO:0006094
GO:0006606;protein import into nucleus;63593;3420;GO:0009405
GO:0006607;NLS-bearing protein import into nucleus;1338;1830;GO:0005730
GO:0018626;2-chlorobenzoate 1,2-dioxygenase activity;606;4;GO:0004497
GO:0018625;naphthalene 1,2-dioxygenase activity;156;3;GO:0004497
GO:0018628;terephthalate 1,2-dioxygenase activity;119;3;GO:0004497
GO:0018627;2-aminobenzenesulfonate 2,3-dioxygenase activity;40;4;GO:0004497
GO:0018629;2-hydroxyquinoline 5,6-dioxygenase activity;0;4;GO:0004497
GO:0006640;monoacylglycerol biosynthetic process;421;167;GO:0006661
GO:0006641;triglyceride metabolic process;37583;1950;GO:0006629
GO:0006644;phospholipid metabolic process;2443468;3020;GO:0006631
GO:0006642;triglyceride mobilization;297;244;GO:0006629
GO:0006643;membrane lipid metabolic process;858535;1250;GO:0006629
GO:0006637;acyl-CoA metabolic process;423484;1600;GO:0006631
GO:0006638;neutral lipid metabolic process;40771;1470;GO:0006629
GO:0006635;fatty acid beta-oxidation;127331;4620;GO:0006635
GO:0006636;unsaturated fatty acid biosynthetic process;21804;1180;GO:0006631
GO:0006639;acylglycerol metabolic process;40608;1100;GO:0006631
GO:0018631;phenylacetate hydroxylase activity;1;3;GO:0046395
GO:0018630;3,5-xylenol methylhydroxylase activity;0;2;GO:0004497
GO:0018633;dimethyl sulfide monooxygenase activity;1;2;GO:0004497
GO:0018632;4-nitrophenol 4-monooxygenase activity;29;4;GO:0004497
GO:0018635;(R)-limonene 1,2-monooxygenase activity;4124;0;GO:0004497
GO:0018634;alpha-pinene monooxygenase [NADH] activity;0;3;GO:0004497
GO:0018615;2-indanone monooxygenase activity;0;3;GO:0004497
GO:0018614;ethylbenzene dioxygenase activity;0;3;GO:0004497
GO:0018617;4-aminobenzenesulfonate 3,4-dioxygenase (deaminating) activity;0;3;GO:0004497
GO:0018616;trihydroxytoluene dioxygenase activity;0;1;GO:0004497
GO:0018619;benzene 1,2-dioxygenase activity;167;5;GO:0004497
GO:0018618;anthranilate 1,2-dioxygenase (deaminating, decarboxylating) activity;1145;4;GO:0004497
GO:0006651;diacylglycerol biosynthetic process;524;97;GO:0006661
GO:0006650;glycerophospholipid metabolic process;583166;1860;GO:0006631
GO:0006655;phosphatidylglycerol biosynthetic process;64543;377;GO:0006631
GO:0006656;phosphatidylcholine biosynthetic process;33504;1010;GO:0006633
GO:0006653;1,2-diacyl-sn-glycero-3-phosphocholine metabolic process;1;2;GO:0006631
GO:0006654;phosphatidic acid biosynthetic process;19524;1320;GO:0006661
GO:0006648;dihydrosphingosine-1-P pathway;4;2;GO:0006631
GO:0006649;phospholipid transfer to membrane;77;22;GO:0006633
GO:0006646;phosphatidylethanolamine biosynthetic process;47298;880;GO:0006633
GO:0006647;phosphatidyl-N-monomethylethanolamine biosynthetic process;0;2;GO:0006631
GO:0018620;phthalate 4,5-dioxygenase activity;403;4;GO:0004497
GO:0018622;4-chlorophenylacetate 3,4-dioxygenase activity;0;3;GO:0004497
GO:0018621;4-sulfobenzoate 3,4-dioxygenase activity;0;3;GO:0004497
GO:0018624;toluene dioxygenase activity;18;3;GO:0004497
GO:0018623;benzoate 1,2-dioxygenase activity;1506;3;GO:0004497
GO:0018604;4-aminobenzoate 3,4-dioxygenase (deaminating) activity;0;3;GO:0004479
GO:0018603;nitrobenzene 1,2-dioxygenase activity;0;3;GO:0004497
GO:0018606;benzenesulfonate dioxygenase activity;0;3;GO:0004497
GO:0018608;1-indanone dioxygenase activity;0;3;GO:0004497
GO:0018607;1-indanone monooxygenase activity;0;3;GO:0004497
GO:0018609;chlorobenzene dioxygenase activity;0;1;GO:0004497
GO:0006622;protein targeting to lysosome;2637;548;GO:0005764
GO:0006623;protein targeting to vacuole;24278;1660;GO:0005764
GO:0006620;post-translational protein targeting to endoplasmic reticulum membrane;5170;155;GO:0006612
GO:0006621;protein retention in ER lumen;9297;2050;GO:0005789
GO:0006615;SRP-dependent cotranslational protein targeting to membrane, docking;0;5;GO:0006614
GO:0006616;SRP-dependent cotranslational protein targeting to membrane, translocation;4107;503;GO:0006412
GO:0006613;cotranslational protein targeting to membrane;242032;3000;GO:0006614
GO:0006614;SRP-dependent cotranslational protein targeting to membrane;241826;6050;GO:0006412
GO:0006617;SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition;86021;210;GO:0006412
GO:0006618;SRP-dependent cotranslational protein targeting to membrane, signal sequence processing;0;7;GO:0006412
GO:0018611;toluate dioxygenase activity;0;2;GO:0004497
GO:0018610;dibenzofuran 4,4a-dioxygenase activity;0;1;GO:0004497
GO:0018613;9-fluorenone dioxygenase activity;0;2;GO:0004497
GO:0018612;dibenzothiophene dioxygenase activity;0;3;GO:0004497
GO:0006633;fatty acid biosynthetic process;2033895;7010;GO:0006631
GO:0006634;hexadecanal biosynthetic process;0;2;GO:0006631
GO:0006631;fatty acid metabolic process;3165248;7790;GO:0006631
GO:0006626;protein targeting to mitochondrion;51056;3210;GO:0005739
GO:0006627;protein processing involved in protein targeting to mitochondrion;3956;521;GO:0006613
GO:0006624;vacuolar protein processing;477;92;GO:0006414
GO:0006625;protein targeting to peroxisome;40158;700;GO:0006629
GO:0006629;lipid metabolic process;10993544;19900;GO:0006629
GO:0018600;alpha-pinene dehydrogenase activity;0;6;GO:0004497
GO:0018602;2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity;2;4;GO:0004497
GO:0018601;4-nitrophenol 2-monooxygenase activity;106;6;GO:0004497
GO:0016007;mitochondrial derivative;139;2;GO:0005739
GO:0043626;PCNA complex;341;217;GO:0005839
GO:0016008;major mitochondrial derivative;11;1;GO:0005739
GO:0018669;3-hydroxybenzoate 6-monooxygenase activity;1514;5;GO:0004497
GO:0043625;delta DNA polymerase complex;7565;414;GO:0005737
GO:0016009;minor mitochondrial derivative;0;1;GO:0005743
GO:0043628;regulatory ncRNA 3'-end processing;1801;2;GO:0010467
GO:0043627;response to estrogen;3138;2810;GO:0009725
GO:0006680;glucosylceramide catabolic process;3306;40;GO:0006032
GO:0006681;galactosylceramide metabolic process;3701;25;GO:0006029
GO:0004021;L-alanine:2-oxoglutarate aminotransferase activity;5106;29;GO:0004073
GO:0006684;sphingomyelin metabolic process;7374;323;GO:0006633
GO:0004020;adenylylsulfate kinase activity;101845;719;GO:0004723
GO:0006685;sphingomyelin catabolic process;6491;471;GO:0006633
GO:0004023;alcohol dehydrogenase activity, metal ion-independent;0;5;GO:0004746
GO:0006682;galactosylceramide biosynthetic process;362;148;GO:0006029
GO:0043620;regulation of DNA-templated transcription in response to stress;4086;584;GO:0045944
GO:0004022;alcohol dehydrogenase (NAD+) activity;77578;792;GO:0004089
GO:0006683;galactosylceramide catabolic process;3296;28;GO:0009044
GO:0004025;alcohol dehydrogenase activity, iron-dependent;2;5;GO:0006730
GO:0006688;glycosphingolipid biosynthetic process;2434;693;GO:0006631
GO:0043622;cortical microtubule organization;3336;276;GO:0097190
GO:0004024;alcohol dehydrogenase activity, zinc-dependent;741;442;GO:0004746
GO:0006689;ganglioside catabolic process;2582;450;GO:0008610
GO:0043621;protein self-association;7642;1580;GO:0042803
GO:0004027;alcohol sulfotransferase activity;195;31;GO:0004746
GO:0006686;sphingomyelin biosynthetic process;707;300;GO:0006633
GO:0004026;alcohol O-acetyltransferase activity;84;9;GO:0006022
GO:0006687;glycosphingolipid metabolic process;12627;1070;GO:0006032
GO:0004018;N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity;116212;0;GO:0009065
GO:0031637;regulation of neuronal synaptic plasticity in response to neurotrophin;12;4;GO:0048666
GO:0004017;adenylate kinase activity;208953;1220;GO:0004721
GO:0031638;zymogen activation;6572;947;GO:0008544
GO:0006679;glucosylceramide biosynthetic process;342;113;GO:0006029
GO:0031635;adenylate cyclase-inhibiting opioid receptor signaling pathway;72;8;GO:0007218
GO:0004019;adenylosuccinate synthase activity;183296;1080;GO:0004723
GO:0018671;4-hydroxybenzoate 3-monooxygenase [NAD(P)H] activity;60;2;GO:0004089
GO:0031639;plasminogen activation;4119;486;GO:0007596
GO:0018670;4-aminobenzoate 1-monooxygenase activity;1;3;GO:0004497
GO:0016010;dystrophin-associated glycoprotein complex;14135;713;GO:0005576
GO:0018673;anthraniloyl-CoA monooxygenase activity;195;3;GO:0004497
GO:0016011;dystroglycan complex;8850;48;GO:0005925
GO:0018672;anthranilate 3-monooxygenase (deaminating) activity;0;4;GO:0004497
GO:0031630;regulation of synaptic vesicle fusion to presynaptic active zone membrane;773;8;GO:0007416
GO:0016012;sarcoglycan complex;8549;287;GO:0005576
GO:0018675;(S)-limonene 6-monooxygenase activity;172;0;GO:0004497
GO:0016013;syntrophin complex;24;65;GO:0005576
GO:0018674;(S)-limonene 3-monooxygenase activity;10;0;GO:0004497
GO:0016014;dystrobrevin complex;17;4;GO:0005576
GO:0018677;pentachlorophenol monooxygenase activity;803;3;GO:0004497
GO:0031633;xanthophore;0;2;GO:0008544
GO:0016015;morphogen activity;608;167;GO:0003700
GO:0018676;(S)-limonene 7-monooxygenase activity;6;0;GO:0004497
GO:0031634;replication fork barrier binding;18;2;GO:0003690
GO:0018679;dibenzothiophene-5,5-dioxide monooxygenase activity;0;4;GO:0004497
GO:0031631;negative regulation of synaptic vesicle fusion to presynaptic active zone membrane;13;1;GO:0048608
GO:0018678;4-hydroxybenzoate 1-hydroxylase activity;1;3;GO:0004073
GO:0031632;positive regulation of synaptic vesicle fusion to presynaptic active zone membrane;404;2;GO:0048608
GO:0018659;4-hydroxybenzoate 3-monooxygenase activity;9435;8;GO:0004497
GO:0043637;puromycin metabolic process;0;4;GO:0009044
GO:0018658;salicylate 1-monooxygenase activity;1193;7;GO:0004497
GO:0043636;bisphenol A catabolic process;0;3;GO:0046274
GO:0043639;benzoate catabolic process;5443;3;GO:0006066
GO:0043638;puromycin biosynthetic process;0;2;GO:0009032
GO:0006691;leukotriene metabolic process;7044;1030;GO:0006631
GO:0006692;prostanoid metabolic process;20627;233;GO:0004415
GO:0004030;aldehyde dehydrogenase [NAD(P)+] activity;95942;0;GO:0004073
GO:0006690;icosanoid metabolic process;35312;643;GO:0006631
GO:0004032;alditol:NADP+ 1-oxidoreductase activity;2463;573;GO:0006066
GO:0006695;cholesterol biosynthetic process;18902;3000;GO:0016125
GO:0004031;aldehyde oxidase activity;1040;47;GO:0004041
GO:0006696;ergosterol biosynthetic process;2844;930;GO:0016126
GO:0004034;aldose 1-epimerase activity;38093;145;GO:0004073
GO:0006693;prostaglandin metabolic process;20573;790;GO:0006631
GO:0004033;aldo-keto reductase (NADP) activity;9774;353;GO:0004041
GO:0006694;steroid biosynthetic process;146062;5290;GO:0008202
GO:0006699;bile acid biosynthetic process;3681;1550;GO:0006741
GO:0043633;polyadenylation-dependent RNA catabolic process;4614;48;GO:0010467
GO:0004035;alkaline phosphatase activity;19066;607;GO:0004721
GO:0043632;modification-dependent macromolecule catabolic process;461622;1900;GO:0043161
GO:0004038;allantoinase activity;14669;138;GO:0006032
GO:0006697;ecdysone biosynthetic process;121;140;GO:0046274
GO:0043635;methylnaphthalene catabolic process;0;3;GO:0046148
GO:0004037;allantoicase activity;24121;208;GO:0005576
GO:0043634;polyadenylation-dependent ncRNA catabolic process;4487;27;GO:0010467
GO:0004029;aldehyde dehydrogenase (NAD+) activity;76906;679;GO:0004073
GO:0031626;beta-endorphin binding;2;7;GO:0005515
GO:0004028;3-chloroallyl aldehyde dehydrogenase activity;145;197;GO:0004067
GO:0031627;telomeric loop formation;204;23;GO:0007030
GO:0031624;ubiquitin conjugating enzyme binding;3102;1070;GO:0005515
GO:0031625;ubiquitin protein ligase binding;52758;5850;GO:0005515
GO:0031628;opioid receptor binding;1096;54;GO:0005509
GO:0031629;synaptic vesicle fusion to presynaptic active zone membrane;1173;196;GO:0008026
GO:0018662;phenol 2-monooxygenase activity;2275;7;GO:0004497
GO:0018661;orcinol 2-monooxygenase activity;0;4;GO:0004497
GO:0018664;benzoate 4-monooxygenase activity;5;3;GO:0004497
GO:0016002;sulfite reductase activity;34746;233;GO:0004067
GO:0018663;2,6-dihydroxypyridine 3-monooxygenase activity;33;4;GO:0004497
GO:0018666;2,4-dichlorophenol 6-monooxygenase activity;382;2;GO:0004497
GO:0031622;positive regulation of fever generation;238;494;GO:0048407
GO:0016004;phospholipase activator activity;529;415;GO:0005576
GO:0018665;4-hydroxyphenylacetate 1-monooxygenase activity;3;3;GO:0004497
GO:0031623;receptor internalization;7674;1330;GO:0004872
GO:0016005;phospholipase A2 activator activity;52;190;GO:0004866
GO:0018668;3-hydroxybenzoate 4-monooxygenase activity;39;4;GO:0004497
GO:0031620;regulation of fever generation;293;1040;GO:0009987
GO:0016006;Nebenkern;115;53;GO:0005576
GO:0018667;cyclohexanone monooxygenase activity;588;3;GO:0004497
GO:0031621;negative regulation of fever generation;0;4;GO:0010467
GO:0018648;methanesulfonate monooxygenase activity;52;3;GO:0004497
GO:0043648;dicarboxylic acid metabolic process;2555425;1220;GO:0006066
GO:0018647;phenanthrene 1,2-monooxygenase activity;0;1;GO:0004497
GO:0043647;inositol phosphate metabolic process;21080;718;GO:0006765
GO:0018649;tetrahydrofuran hydroxylase activity;0;3;GO:0004497
GO:0043649;dicarboxylic acid catabolic process;64652;148;GO:0006066
GO:0006662;glycerol ether metabolic process;4574;2800;GO:0046395
GO:0043640;benzoate catabolic process via hydroxylation;18;5;GO:0046148
GO:0006663;platelet activating factor biosynthetic process;174;71;GO:0006631
GO:0004001;adenosine kinase activity;16566;214;GO:0004721
GO:0006660;phosphatidylserine catabolic process;286;32;GO:0006631
GO:0043642;novobiocin biosynthetic process;13;4;GO:0009405
GO:0004000;adenosine deaminase activity;209909;766;GO:0004553
GO:0006661;phosphatidylinositol biosynthetic process;181169;1200;GO:0006631
GO:0043641;novobiocin metabolic process;13;8;GO:0009065
GO:0006666;3-keto-sphinganine metabolic process;4510;10;GO:0006631
GO:0043644;tetracycline biosynthetic process;0;2;GO:0009181
GO:0006667;sphinganine metabolic process;142;10;GO:0006633
GO:0043643;tetracycline metabolic process;0;4;GO:0006725
GO:0006664;glycolipid metabolic process;683980;531;GO:0006631
GO:0043646;cephalosporin biosynthetic process;0;3;GO:0009181
GO:0006665;sphingolipid metabolic process;185640;1900;GO:0006631
GO:0043645;cephalosporin metabolic process;1;4;GO:0009065
GO:0006659;phosphatidylserine biosynthetic process;13195;327;GO:0006633
GO:0031615;cytosolic proteasome regulatory particle, lid subcomplex;0;0;GO:0005829
GO:0031616;spindle pole centrosome;876;347;GO:0005819
GO:0006657;CDP-choline pathway;15120;260;GO:0006066
GO:0031613;nuclear proteasome regulatory particle, lid subcomplex;0;0;GO:0005829
GO:0006658;phosphatidylserine metabolic process;14193;562;GO:0006633
GO:0031619;homologous chromosome orientation in meiotic metaphase I;11;2;GO:0000976
GO:0018651;toluene-4-sulfonate monooxygenase activity;0;2;GO:0004497
GO:0018650;styrene monooxygenase activity;0;2;GO:0004497
GO:0018653;3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity;0;3;GO:0004497
GO:0018652;toluene-sulfonate methyl-monooxygenase activity;2;3;GO:0004497
GO:0018655;2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity;0;2;GO:0004497
GO:0018654;2-hydroxy-phenylacetate hydroxylase activity;0;3;GO:0046395
GO:0031612;cytosolic proteasome regulatory particle, base subcomplex;0;0;GO:0005840
GO:0018657;toluene 3-monooxygenase activity;0;1;GO:0004497
GO:0018656;phenanthrene 3,4-monooxygenase activity;0;3;GO:0004497
GO:0031610;nuclear proteasome regulatory particle, base subcomplex;0;1;GO:0005829
GO:0018637;1-hydroxy-2-naphthoate hydroxylase activity;0;4;GO:0004497
GO:0043659;symbiosome;136;4;GO:0009579
GO:0018636;phenanthrene 9,10-monooxygenase activity;70;119;GO:0004497
GO:0043658;host symbiosome;0;0;GO:0048309
GO:0018639;xylene monooxygenase activity;0;2;GO:0004497
GO:0018638;toluene 4-monooxygenase activity;0;2;GO:0004497
GO:0006670;sphingosine metabolic process;4808;502;GO:0006633
GO:0006673;inositol phosphoceramide metabolic process;1501;6;GO:0006631
GO:0043651;linoleic acid metabolic process;1448;1130;GO:0006633
GO:0043650;dicarboxylic acid biosynthetic process;1152472;1340;GO:0006066
GO:0006671;phytosphingosine metabolic process;116;5;GO:0008610
GO:0043653;mitochondrial fragmentation involved in apoptotic process;527;419;GO:0043066
GO:0006672;ceramide metabolic process;60806;814;GO:0006631
GO:0043652;engulfment of apoptotic cell;1034;563;GO:0006915
GO:0004014;adenosylmethionine decarboxylase activity;57279;463;GO:0006067
GO:0006677;glycosylceramide metabolic process;7598;259;GO:0006032
GO:0043655;host extracellular space;22879;7;GO:0005615
GO:0004013;adenosylhomocysteinase activity;49753;1560;GO:0004497
GO:0006678;glucosylceramide metabolic process;3769;20;GO:0006029
GO:0043654;recognition of apoptotic cell;308;121;GO:0008630
GO:0004016;adenylate cyclase activity;197461;1020;GO:0004721
GO:0006675;mannosyl-inositol phosphorylceramide metabolic process;152;6;GO:0006631
GO:0043657;host cell;7940090;515;GO:0044464
GO:0004015;adenosylmethionine-8-amino-7-oxononanoate transaminase activity;74151;326;GO:0004497
GO:0006676;mannosyl diphosphorylinositol ceramide metabolic process;13;3;GO:0006629
GO:0043656;host intracellular region;5017787;8;GO:0005622
GO:0031604;nuclear proteasome core complex, alpha-subunit complex;0;0;GO:0005829
GO:0006668;sphinganine-1-phosphate metabolic process;156;28;GO:0006633
GO:0006669;sphinganine-1-phosphate biosynthetic process;107;138;GO:0006633
GO:0031603;cytosolic proteasome core complex;0;0;GO:0005829
GO:0031609;cytosolic proteasome core complex, beta-subunit complex;0;0;GO:0005829
GO:0031606;cytosolic proteasome core complex, alpha-subunit complex;0;1;GO:0005829
GO:0043660;bacteroid-containing symbiosome;134;3;GO:0044421
GO:0031607;nuclear proteasome core complex, beta-subunit complex;0;0;GO:0005829
GO:0018640;dibenzothiophene monooxygenase activity;53;2;GO:0004497
GO:0018642;chlorophenol 4-monooxygenase activity;0;2;GO:0004497
GO:0018641;6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity;0;3;GO:0004497
GO:0018644;toluene 2-monooxygenase activity;0;3;GO:0004497
GO:0031600;cytosolic proteasome regulatory particle;0;1;GO:0005840
GO:0018643;carbon disulfide oxygenase activity;0;2;GO:0004497
GO:0031601;nuclear proteasome core complex;0;1;GO:0000746
GO:0018646;1-hydroxy-2-oxolimonene 1,2-monooxygenase activity;0;3;GO:0004497
GO:0018645;alkene monooxygenase activity;10;3;GO:0046148
GO:0004061;arylformamidase activity;63054;38;GO:0004465
GO:0031680;G-protein beta/gamma-subunit complex;26;8;GO:0005581
GO:0004060;arylamine N-acetyltransferase activity;3988;160;GO:0004073
GO:0031681;G-protein beta-subunit binding;10588;309;GO:0005516
GO:0004063;aryldialkylphosphatase activity;267;318;GO:0004721
GO:0004062;aryl sulfotransferase activity;10665;175;GO:0004725
GO:0004065;arylsulfatase activity;15854;369;GO:0004553
GO:0004064;arylesterase activity;6872;376;GO:0004497
GO:0004067;asparaginase activity;118116;428;GO:0004553
GO:0004066;asparagine synthase (glutamine-hydrolyzing) activity;106225;1340;GO:0009065
GO:0004069;L-aspartate:2-oxoglutarate aminotransferase activity;26772;283;GO:0004073
GO:0004068;aspartate 1-decarboxylase activity;81325;447;GO:0006066
GO:0031679;NADH dehydrogenase (plastoquinone) activity;0;4;GO:0004747
GO:0016050;vesicle organization;57281;1900;GO:0030141
GO:0016051;carbohydrate biosynthetic process;2403638;3540;GO:0005976
GO:0016052;carbohydrate catabolic process;3448159;3190;GO:0005975
GO:0016053;organic acid biosynthetic process;19730392;2840;GO:0006082
GO:0016054;organic acid catabolic process;2179185;2940;GO:0006066
GO:0031673;H zone;54;51;GO:0005576
GO:0016055;Wnt signaling pathway;260438;5890;GO:0016055
GO:0031674;I band;17924;1170;GO:0005578
GO:0016056;rhodopsin mediated signaling pathway;1013;840;GO:0007186
GO:0031671;primary cell septum biogenesis;39;6;GO:0006021
GO:0016057;regulation of membrane potential in photoreceptor cell;74;17;GO:0048407
GO:0031672;A band;3800;689;GO:0005576
GO:0016058;maintenance of membrane potential in photoreceptor cell by rhodopsin mediated signaling;1;3;GO:0048407
GO:0016059;deactivation of rhodopsin mediated signaling;173;63;GO:0007186
GO:0031676;plasma membrane-derived thylakoid membrane;75311;5;GO:0009986
GO:0004070;aspartate carbamoyltransferase activity;151495;899;GO:0004073
GO:0004072;aspartate kinase activity;228269;585;GO:0004721
GO:0004071;aspartate-ammonia ligase activity;23809;36;GO:0004061
GO:0031670;cellular response to nutrient;3467;629;GO:0009719
GO:0004074;biliverdin reductase (NAD(P)+) activity;1953;0;GO:0004067
GO:0004073;aspartate-semialdehyde dehydrogenase activity;139702;656;GO:0004073
GO:0004076;biotin synthase activity;94681;609;GO:0004497
GO:0004075;biotin carboxylase activity;66005;732;GO:0004073
GO:0004078;biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity;36;0;GO:0006081
GO:0004077;biotin-[acetyl-CoA-carboxylase] ligase activity;99359;1;GO:0006081
GO:0004079;biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity;89;0;GO:0006081
GO:0031668;cellular response to extracellular stimulus;786812;2290;GO:0009611
GO:0031669;cellular response to nutrient levels;112946;1970;GO:0042592
GO:0016040;glutamate synthase (NADH) activity;3776;30;GO:0003824
GO:0016041;glutamate synthase (ferredoxin) activity;1897;8;GO:0003824
GO:0016042;lipid catabolic process;762405;6450;GO:0006631
GO:0016043;cellular component organization;13177693;6470;GO:0043234
GO:0031663;lipopolysaccharide-mediated signaling pathway;3304;2240;GO:0002237
GO:0016045;detection of bacterium;741;1850;GO:0044421
GO:0016046;detection of fungus;110;14;GO:0050832
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;632;210;GO:0043408
GO:0016048;detection of temperature stimulus;1044;543;GO:0009416
GO:0031667;response to nutrient levels;269591;3360;GO:0009719
GO:0016049;cell growth;44522;6630;GO:0016049
GO:0031664;regulation of lipopolysaccharide-mediated signaling pathway;1252;47;GO:0043407
GO:0031665;negative regulation of lipopolysaccharide-mediated signaling pathway;484;733;GO:0050727
GO:0016029;subrhabdomeral cisterna;36;9;GO:0005730
GO:0043604;amide biosynthetic process;28709946;1830;GO:0006520
GO:0102505;apigeninidin 5-O-glucosyltransferase activity;0;0;GO:0006073
GO:0043603;amide metabolic process;29729404;2140;GO:0006520
GO:0102504;luteolinidin 5-O-glucosyltransferase activity;0;0;GO:0006073
GO:0043606;formamide metabolic process;100080;51;GO:0006066
GO:0102507;cyanidin 3-O-glucoside 7-O-glucosyltransferase (hydroxybenzoly-glucose dependent) activity;2;1;GO:0006073
GO:0043605;amide catabolic process;448042;242;GO:0006512
GO:0102506;cyanidin 3-O-glucoside 5-O-glucosyltransferase (acyl-glucose dependent) activity;3;1;GO:0006073
GO:0043608;formamide catabolic process;0;2;GO:0006559
GO:0102501;D-fructuronate reductase activity;0;0;GO:0004067
GO:0043607;formamide biosynthetic process;0;4;GO:0006066
GO:0102500;beta-maltose 4-alpha-glucanotransferase activity;24783;3;GO:0006031
GO:0004040;amidase activity;58872;1110;GO:0004553
GO:0043609;regulation of carbon utilization;84;5;GO:0045735
GO:0102502;ADP-glucose-starch glucosyltransferase activity;22;3;GO:0006096
GO:0004043;L-aminoadipate-semialdehyde dehydrogenase activity;2642;37;GO:0009065
GO:0004042;acetyl-CoA:L-glutamate N-acetyltransferase activity;115028;87;GO:0004067
GO:0004045;aminoacyl-tRNA hydrolase activity;185492;1140;GO:0006412
GO:0004044;amidophosphoribosyltransferase activity;141697;537;GO:0004061
GO:0004047;aminomethyltransferase activity;113354;659;GO:0004061
GO:0043600;cytoplasmic replisome;0;1;GO:0005840
GO:0102509;cyanidin 3,5-diglucoside glucosidase activity;0;0;GO:0004553
GO:0004046;aminoacylase activity;6617;270;GO:0004553
GO:0102508;cyanidin 3,7-diglucoside glucosidase activity;0;0;GO:0004553
GO:0004049;anthranilate synthase activity;90945;428;GO:0004497
GO:0043602;nitrate catabolic process;4;9;GO:0006569
GO:0004048;anthranilate phosphoribosyltransferase activity;141389;600;GO:0004061
GO:0043601;nuclear replisome;13983;232;GO:0005840
GO:0004039;allophanate hydrolase activity;3008;14;GO:0004553
GO:0018690;4-methoxybenzoate monooxygenase (O-demethylating) activity;26;5;GO:0004497
GO:0018693;ethylbenzene hydroxylase activity;1;4;GO:0046148
GO:0016031;tRNA import into mitochondrion;108;8;GO:0005743
GO:0016032;viral process;9345379;5840;GO:0043169
GO:0018695;4-cresol dehydrogenase (hydroxylating) activity;102;4;GO:0004497
GO:0031651;negative regulation of heat generation;53;6;GO:0010467
GO:0018694;p-cymene methyl hydroxylase activity;0;4;GO:0046395
GO:0031652;positive regulation of heat generation;316;387;GO:0010467
GO:0016034;maleylacetoacetate isomerase activity;5270;32;GO:0006099
GO:0018697;carbonyl sulfide nitrogenase activity;16995;5;GO:0006091
GO:0102510;pelargonidin 3-O-glucoside 5-O-glucosyltransferase (acyl-glucose dependent) activity;3;1;GO:0006073
GO:0016035;zeta DNA polymerase complex;5307;133;GO:0005730
GO:0031650;regulation of heat generation;424;236;GO:0042060
GO:0016036;cellular response to phosphate starvation;9697;1190;GO:0009739
GO:0018699;1,1,1-trichloroethane reductive dehalogenase activity;0;3;GO:0004497
GO:0031655;negative regulation of heat dissipation;0;2;GO:0010426
GO:0016037;light absorption;6431;10;GO:0009765
GO:0018698;vinyl chloride reductive dehalogenase activity;0;3;GO:0004497
GO:0031656;positive regulation of heat dissipation;0;2;GO:0010467
GO:0016038;absorption of visible light;398;18;GO:0046148
GO:0031653;heat dissipation;0;9;GO:0009415
GO:0016039;absorption of UV light;65;5;GO:0009579
GO:0031654;regulation of heat dissipation;0;3;GO:0010467
GO:0016018;cyclosporin A binding;1949;525;GO:0005515
GO:0043615;astrocyte cell migration;296;59;GO:0016477
GO:0102516;delphinidin 3-O-glucoside 7-O-glucosyltransferase (feruloyl-glucose dependent) activity;0;0;GO:0006073
GO:0016019;peptidoglycan immune receptor activity;232;20;GO:0002237
GO:0043614;multi-eIF complex;591;50;GO:0005840
GO:0102515;pelargonidin 3-O-glucoside 7-O-glucosyltransferase (feruloyl-glucose dependent) activity;0;0;GO:0006073
GO:0043617;cellular response to sucrose starvation;41;87;GO:0009416
GO:0102518;(11Z)-eicosenoate 14-hydroxylase activity;1;0;GO:0004073
GO:0043616;keratinocyte proliferation;3685;1240;GO:0042127
GO:0102517;oleate 12-hydroxylase activity;1;0;GO:0004497
GO:0043619;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;312;717;GO:0045944
GO:0102512;delphinidin 3-O-glucoside 5-O-glucosyltransferase (acyl-glucose dependent) activity;3;1;GO:0006073
GO:0043618;regulation of transcription from RNA polymerase II promoter in response to stress;3809;882;GO:0045944
GO:0102511;pelargonidin 3-O-glucoside 7-O-glucosyltransferase (acyl-glucose dependent) activity;2;1;GO:0006073
GO:0004052;arachidonate 12(S)-lipoxygenase activity;393;0;GO:0004497
GO:0102514;cyanidin 3-O-glucoside 7-O-glucosyltransferase (feruloyl-glucose dependent) activity;2;1;GO:0006073
GO:0004051;arachidonate 5-lipoxygenase activity;227;148;GO:0004497
GO:0102513;delphinidin 3-O-glucoside 5-O-glucosyltransferase (vanilloyl-glucose dependent) activity;0;0;GO:0006073
GO:0004054;arginine kinase activity;20844;10;GO:0004721
GO:0004053;arginase activity;30030;266;GO:0004723
GO:0004056;argininosuccinate lyase activity;149382;474;GO:0006030
GO:0004055;argininosuccinate synthase activity;137289;859;GO:0006030
GO:0004058;aromatic-L-amino-acid decarboxylase activity;2834;26;GO:0009065
GO:0043611;isoprene metabolic process;1;3;GO:0006096
GO:0004057;arginyl-tRNA--protein transferase activity;35001;0;GO:0006418
GO:0043610;regulation of carbohydrate utilization;13;10;GO:0005975
GO:0043613;isoprene catabolic process;0;2;GO:0006096
GO:0004059;aralkylamine N-acetyltransferase activity;420;210;GO:0004041
GO:0043612;isoprene biosynthetic process;1;2;GO:0006096
GO:0031648;protein destabilization;2691;886;GO:0006464
GO:0031649;heat generation;2279;153;GO:0006096
GO:0031646;positive regulation of nervous system process;1184;337;GO:0050877
GO:0031647;regulation of protein stability;46971;1990;GO:0006457
GO:0018680;deethylatrazine monooxygenase activity;0;3;GO:0004497
GO:0018682;atrazine N-dealkylase activity;0;3;GO:0004497
GO:0016020;membrane;147248956;80000;GO:0016020
GO:0018681;deisopropylatrazine monooxygenase activity;0;2;GO:0004497
GO:0018684;2,5-diketocamphane 1,2-monooxygenase;14;2;GO:0004497
GO:0031640;killing of cells of another organism;101408;533;GO:0097190
GO:0018683;camphor 5-monooxygenase activity;72;2;GO:0004497
GO:0031641;regulation of myelination;2521;925;GO:0048010
GO:0018686;6-hydroxy pseudo-oxynicotine monooxygenase activity;0;3;GO:0004497
GO:0102521;tRNA-4-demethylwyosine synthase activity;5171;3;GO:0006457
GO:0016024;CDP-diacylglycerol biosynthetic process;61959;536;GO:0006633
GO:0018685;alkane 1-monooxygenase activity;1344;153;GO:0004497
GO:0102520;L-threonine O-3-phosphate phosphatase activity;0;0;GO:0006066
GO:0018688;DDT 2,3-dioxygenase activity;0;4;GO:0004497
GO:0031644;regulation of nervous system process;4317;392;GO:0050789
GO:0018687;biphenyl 2,3-dioxygenase activity;407;3;GO:0004497
GO:0031645;negative regulation of nervous system process;480;8;GO:0050789
GO:0016027;inaD signaling complex;106;9;GO:0009913
GO:0031642;negative regulation of myelination;342;227;GO:0048771
GO:0016028;rhabdomere;613;63;GO:0005576
GO:0018689;naphthalene disulfonate 1,2-dioxygenase activity;0;2;GO:0004497
GO:0031643;positive regulation of myelination;579;608;GO:0048010
GO:0102527;8-demethylnovobiocate synthase activity;25;2;GO:0004497
GO:0102526;8-demethylnovobiocic acid C8-methyltransferase activity;18;3;GO:0004497
GO:0102529;apigenin 7-O-methyltransferase activity;0;1;GO:0004725
GO:0102528;7,8,4'-trihydroxyflavone methyltransferase activity;0;0;GO:0004497
GO:0102523;2-chloroacrylate reductase activity;400;2;GO:0004067
GO:0102522;tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity;3143;4;GO:0003729
GO:0102525;2-oxoglutarate, L-arginine oxygenase (succinate-forming) activity;6;2;GO:0004091
GO:0102524;tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity;73;0;GO:0006061
GO:0043585;nose morphogenesis;61;9;GO:0009952
GO:0043584;nose development;912;53;GO:0008544
GO:0043587;tongue morphogenesis;544;46;GO:0048731
GO:0043586;tongue development;1078;566;GO:0009952
GO:0043589;skin morphogenesis;854;1530;GO:0008544
GO:0043588;skin development;19501;2470;GO:0008544
GO:0043590;bacterial nucleoid;36755;10;GO:0005829
GO:0043592;exosporium;279;2;GO:0046395
GO:0043591;endospore external encapsulating structure;289;1;GO:0048304
GO:0043594;outer endospore membrane;5;3;GO:0005576
GO:0043593;endospore coat;1;1;GO:0005576
GO:0102530;aclacinomycin T methylesterase activity;117;2;GO:0004497
GO:0031597;cytosolic proteasome complex;83058;281;GO:0005829
GO:0031594;neuromuscular junction;13490;2150;GO:0008092
GO:0102532;genkwanin 6-hydroxylase activity;0;0;GO:0004497
GO:0031595;nuclear proteasome complex;55;114;GO:0005839
GO:0102531;ecdysteroid-phosphate phosphatase activity;3;1;GO:0004730
GO:0031598;nuclear proteasome regulatory particle;0;0;GO:0005829
GO:0102538;UDP-N-acetyl-alpha-D-quinovosamine dehydrogenase activity;0;0;GO:0009065
GO:0102537;ecdysone-phosphate phosphatase activity;0;0;GO:0004722
GO:0102539;UDP-N-acetyl-alpha-D-fucosamine dehydrogenase activity;0;0;GO:0006032
GO:0031592;centrosomal corona;26;33;GO:0005819
GO:0102534;apigenin-7,4'-dimethyl ether 6-hydroxylase activity;0;0;GO:0004497
GO:0031593;polyubiquitin modification-dependent protein binding;21009;144;GO:0016567
GO:0102533;genkwanin 4'-O-methyltransferase activity;0;0;GO:0004725
GO:0031590;wybutosine metabolic process;1843;5;GO:0009065
GO:0102536;sakuranetin 6-hydroxylase activity;0;0;GO:0004497
GO:0031591;wybutosine biosynthetic process;1843;217;GO:0009065
GO:0102535;ladanein 6-O-methyltransferase activity;0;0;GO:0004730
GO:0043596;nuclear replication fork;28726;698;GO:0006260
GO:0043595;endospore cortex;4;2;GO:0005576
GO:0043598;cytoplasmic DNA replication factor C complex;0;1;GO:0005739
GO:0043597;cytoplasmic replication fork;1;2;GO:0003688
GO:0043599;nuclear DNA replication factor C complex;6;2;GO:0005730
GO:0031585;regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;13;326;GO:0008092
GO:0102541;D-galactose 6-phosphate 1-epimerase activity;0;0;GO:0006066
GO:0031586;negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;2;3;GO:0008092
GO:0102540;D-mannose 6-phosphate 1-epimerase activity;0;0;GO:0006032
GO:0031583;phospholipase D-activating G protein-coupled receptor signaling pathway;59;6;GO:0007186
GO:0102543;epsilon-rhodomycinone methylesterase activity;115;1;GO:0046395
GO:0031584;activation of phospholipase D activity;23;100;GO:0048193
GO:0102542;aclacinomycin A methylesterase activity;115;1;GO:0004497
GO:0031589;cell-substrate adhesion;45780;2580;GO:0007155
GO:0031587;positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;9;315;GO:0008092
GO:0031588;nucleotide-activated protein kinase complex;1369;235;GO:0005524
GO:0102549;1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity;27;2;GO:0008610
GO:0031581;hemidesmosome assembly;701;2180;GO:0009986
GO:0102545;phosphatidyl phospholipase B activity;10993;9;GO:0004631
GO:0031582;replication fork arrest at rDNA repeats;20;7;GO:0007050
GO:0102544;ornaline synthase activity;0;0;GO:0004073
GO:0102547;glucosylglycerate hydrolase activity;2;1;GO:0004553
GO:0031580;membrane raft distribution;60776;42;GO:0070062
GO:0102546;mannosylglycerate hydrolase activity;1;1;GO:0006032
GO:0102551;homogentisate geranylgeranyl transferase activity;14;2;GO:0004073
GO:0031573;mitotic intra-S DNA damage checkpoint signaling;1547;65;GO:0000724
GO:0031578;mitotic spindle orientation checkpoint signaling;141;6;GO:0048285
GO:0031579;membrane raft organization;66359;688;GO:0070062
GO:0102550;2-methyl-6-geranylgeranyl-1,4-benzoquinol methyltransferase activity;87;3;GO:0004714
GO:0031577;spindle checkpoint signaling;18725;4;GO:0007067
GO:0102559;protein-(glutamine-N5) methyltransferase activity;58064;0;GO:0003723
GO:0031570;DNA integrity checkpoint signaling;43498;114;GO:0000086
GO:0102556;dammarenediol 12-hydroxylase activity;2;2;GO:0004497
GO:0031571;mitotic G1 DNA damage checkpoint signaling;1321;127;GO:0007050
GO:0102557;protopanaxadiol 6-hydroxylase activity;9;2;GO:0004497
GO:0031569;mitotic G2 cell size control checkpoint signaling;24;4;GO:0043408
GO:0031563;mating projection tip polarisome;0;0;GO:0048305
GO:0102563;aurachin C monooxygenase activity;0;0;GO:0004497
GO:0031564;transcription antitermination;278804;643;GO:0003700
GO:0102562;hydroxyproline O-arbinofuranose transferase activity;7;1;GO:0006030
GO:0031561;cellular bud tip polarisome;2;2;GO:0048285
GO:0031562;hyphal tip polarisome;4;1;GO:0048309
GO:0102564;aurachin C epoxide hydrolase/isomerase activity;0;1;GO:0005576
GO:0031567;mitotic cell size control checkpoint signaling;62;0;GO:0045727
GO:0031568;mitotic G1 cell size control checkpoint signaling;32;4;GO:0045727
GO:0102561;D-ribose 2,5-bisphosphate 2-phosphohydrolase activity;64;2;GO:0004553
GO:0031566;actomyosin contractile ring maturation;90;1;GO:0007049
GO:0102560;5-phospho-alpha-D-ribose 1,2-cyclic phosphate 1-phosphohydrolase activity;64;2;GO:0004553
GO:0043549;regulation of kinase activity;2256;1710;GO:0016310
GO:0043548;phosphatidylinositol 3-kinase binding;5605;755;GO:0048193
GO:0102566;1-acyl dihydroxyacetone phosphate reductase activity;20;4;GO:0006066
GO:0102569;FR-33289 synthase activity;0;0;GO:0004497
GO:0043541;UDP-N-acetylglucosamine transferase complex;343;109;GO:0005576
GO:0043540;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex;80;13;GO:0005975
GO:0043543;protein acylation;6871;588;GO:0006464
GO:0043542;endothelial cell migration;15821;1580;GO:0030900
GO:0043545;molybdopterin cofactor metabolic process;786779;440;GO:0006096
GO:0043544;lipoamide binding;2;5;GO:0005525
GO:0043547;positive regulation of GTPase activity;817;4660;GO:0007264
GO:0043546;molybdopterin cofactor binding;173249;1060;GO:0005525
GO:0043550;regulation of lipid kinase activity;23;563;GO:0046394
GO:0102574;3-oxo-myristoyl-ACP hydrolase activity;0;1;GO:0008029
GO:0102573;aminodeoxyfutalosine synthase activity;8660;3;GO:0006030
GO:0102576;3-oxo-palmitoyl-ACP hydrolase activity;0;0;GO:0004734
GO:0102575;3-oxo-dodecanoyl-ACP hydrolase activity;0;1;GO:0004497
GO:0102570;tyrosine:phenylpyruvate aminotransferase activity;0;1;GO:0004073
GO:0102572;N-glutamylanilide hydrolase activity;0;1;GO:0004721
GO:0102571;[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity;259;0;GO:0004553
GO:0043559;insulin binding;317;549;GO:0005520
GO:0102577;3-oxo-palmitate decarboxylase activity;25;1;GO:0006081
GO:0043554;aerobic respiration, using arsenite as electron donor;0;2;GO:0009060
GO:0043556;regulation of translation in response to oxidative stress;2;3;GO:0006979
GO:0043555;regulation of translation in response to stress;4877;294;GO:0006414
GO:0043558;regulation of translational initiation in response to stress;3968;51;GO:0006414
GO:0043557;regulation of translation in response to osmotic stress;0;2;GO:0045944
GO:0043561;regulation of translational initiation in response to osmotic stress;0;2;GO:0006414
GO:0043560;insulin receptor substrate binding;4216;457;GO:0048193
GO:0102585;cyanidin 3-O-[2''-O-(xylosyl)-6''-O-(p-coumaroyl) glucoside] 5-O-glucoside malonyltransferase activity;0;0;GO:0006073
GO:0102584;cyanidin 3-O-[2''-O-(xylosyl)-6''-O-(p-coumaroyl) glucoside] 5-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102587;cyanidin 3-O-[2''-O-(2''-O-(sinapoyl) xylosyl) 6''-O-(p-O-(glucosyl)-p-coumaroyl) glucoside] 5-O-[6''-O-(malonyl) glucoside] sinapoylglucose glucosyltransferase activity;0;0;GO:0006073
GO:0102586;cyanidin 3-O-[2''-O-(2''-O-(sinapoyl) xylosyl) 6''-O-(p-coumaroyl) glucoside] 5-O-[6''-O-(malonyl) glucoside] sinapoyltransferase activity;0;0;GO:0006073
GO:0102581;cyanidin 3-O-glucoside-p-coumaroyltransferase activity;0;0;GO:0006073
GO:0102580;cyanidin 3-O-glucoside 2-O''-xylosyltransferase activity;9;0;GO:0006073
GO:0102583;cyanidin 3-O-glucoside-(2''-O-xyloside) 6''-O-acyltransferase activity;0;0;GO:0006073
GO:0102582;cyanidin 3-O-p-coumaroylglucoside 2-O''-xylosyltransferase activity;0;0;GO:0006073
GO:0102589;cyanidin 3-O-glucoside 3'',6''-O-dimalonyltransferase activity;0;0;GO:0006073
GO:0102588;cyanidin 3-O-glucoside 6''-O-malonyltransferase activity;5;1;GO:0006073
GO:0043562;cellular response to nitrogen levels;3045;204;GO:0045735
GO:0043565;sequence-specific DNA binding;2132383;22700;GO:0003677
GO:0043564;Ku70:Ku80 complex;7578;117;GO:0007040
GO:0043567;regulation of insulin-like growth factor receptor signaling pathway;1127;784;GO:0030516
GO:0043569;negative regulation of insulin-like growth factor receptor signaling pathway;394;220;GO:0030516
GO:0043568;positive regulation of insulin-like growth factor receptor signaling pathway;463;395;GO:0030516
GO:0102590;delphinidin 3-O-rutinoside 7-O-glucosyltransferase (acyl-glucose dependent) activity;0;0;GO:0006073
GO:0043570;maintenance of DNA repeat elements;103562;253;GO:0010467
GO:0043572;plastid fission;2528;11;GO:0048471
GO:0043571;maintenance of CRISPR repeat elements;102564;255;GO:0048316
GO:0102596;cytochrome P450 dependent ent-sandaracopimaradiene 3-hydroxylase activity;2;2;GO:0004497
GO:0102595;cyanidin 7-O-(6-O-(4-O-(glucosyl)-oxybenzoyl)-glucoside) acyltransferase (acyl-glucose dependent) activity;0;0;GO:0006073
GO:0102598;3alpha-hydroxy-ent-sandaracopimardiene 7-beta-monooxygenase activity;2;2;GO:0004497
GO:0102597;3alpha-hydroxy-ent-sandaracopimardiene 9-beta-monooxygenase activity;16;2;GO:0004497
GO:0102592;delphinidin 7-O-(6-O-(4-O-(glucosyl)-oxybenzoyl)-glucoside) acyltransferase (acyl-glucose dependent activity;0;0;GO:0005576
GO:0102591;delphinidin 7-O-glucoside acyltransferase (acyl-glucose dependent) activity;0;0;GO:0006081
GO:0102594;cyanidin 7-O-glucoside acyltransferase(acyl-glucose dependent) activity;0;0;GO:0006081
GO:0102593;UDP-glucose: N-methylanthranilate glucosyltransferase activity;0;0;GO:0006022
GO:0102599;cytochrome P450 dependent beta-amyrin 12,13beta-epoxidase activity;0;0;GO:0004601
GO:0043574;peroxisomal transport;42141;77;GO:0006635
GO:0043573;leucoplast fission;0;2;GO:0006935
GO:0043576;regulation of respiratory gaseous exchange;1087;496;GO:0050789
GO:0043575;detection of osmotic stimulus;1;5;GO:0009416
GO:0043578;nuclear matrix organization;162;24;GO:0005634
GO:0043577;chemotropism;21;5;GO:0009954
GO:0043579;elaioplast organization;0;2;GO:0009986
GO:0043580;periplasmic space organization;2079;6;GO:0008544
GO:0043583;ear development;24801;1320;GO:0009952
GO:0043582;sporangium development;0;2;GO:0048285
GO:0018703;2,4-dichlorophenoxyacetate dehalogenase activity;0;2;GO:0004497
GO:0018702;1,1-dichloro-2,2-bis(4-chlorophenyl)ethene dehalogenase activity;0;3;GO:0004497
GO:0018705;1,2-dichloroethene reductive dehalogenase activity;0;0;GO:0004497
GO:0018707;1-phenanthrol methyltransferase activity;0;3;GO:0004497
GO:0018706;pyrogallol hydroxytransferase activity;85;4;GO:0004073
GO:0018708;thiol S-methyltransferase activity;79;6;GO:0004725
GO:0006721;terpenoid metabolic process;576894;906;GO:0006073
GO:0006722;triterpenoid metabolic process;17889;187;GO:0006073
GO:0006720;isoprenoid metabolic process;1574121;1160;GO:0006720
GO:0006714;sesquiterpenoid metabolic process;3495;33;GO:0006721
GO:0006715;farnesol biosynthetic process;2;1;GO:0006721
GO:0006712;mineralocorticoid catabolic process;0;3;GO:0046395
GO:0006713;glucocorticoid catabolic process;48;25;GO:0009062
GO:0006718;juvenile hormone biosynthetic process;28;10;GO:0006720
GO:0006719;juvenile hormone catabolic process;67;4;GO:0046274
GO:0006716;juvenile hormone metabolic process;107;4;GO:0006720
GO:0018710;acetone carboxylase activity;627;3;GO:0006099
GO:0018712;3-hydroxybutyryl-CoA thiolase activity;0;3;GO:0006066
GO:0018711;benzoyl acetate-CoA thiolase activity;0;2;GO:0006081
GO:0006730;one-carbon metabolic process;803694;4320;GO:0006749
GO:0006725;cellular aromatic compound metabolic process;103480380;4720;GO:0006725
GO:0006726;eye pigment biosynthetic process;666;58;GO:0004073
GO:0006723;cuticle hydrocarbon biosynthetic process;145;309;GO:0006021
GO:0006729;tetrahydrobiopterin biosynthetic process;45027;553;GO:0006783
GO:0006727;ommochrome biosynthetic process;383;17;GO:0006021
GO:0006728;pteridine biosynthetic process;55;105;GO:0006749
GO:0018701;2,5-dichlorohydroquinone reductive dehalogenase activity;0;2;GO:0004497
GO:0018700;2-chloro-N-isopropylacetanilide reductive dehalogenase activity;0;2;GO:0004497
GO:0006700;C21-steroid hormone biosynthetic process;844;287;GO:0046649
GO:0006710;androgen catabolic process;175;46;GO:0009062
GO:0006711;estrogen catabolic process;51;9;GO:0046274
GO:0006703;estrogen biosynthetic process;2207;588;GO:0006685
GO:0006704;glucocorticoid biosynthetic process;747;582;GO:0009060
GO:0006701;progesterone biosynthetic process;180;96;GO:0006955
GO:0006702;androgen biosynthetic process;1256;424;GO:0006685
GO:0006707;cholesterol catabolic process;3132;402;GO:0006629
GO:0006708;ecdysone catabolic process;0;3;GO:0046274
GO:0006705;mineralocorticoid biosynthetic process;493;45;GO:0046323
GO:0006706;steroid catabolic process;3960;345;GO:0006725
GO:0006709;progesterone catabolic process;8;4;GO:0046274
GO:0018747;phenanthrene-1,2-epoxide hydrolase activity;0;2;GO:0004497
GO:0018746;phenanthrene-3,4-epoxide hydrolase activity;0;2;GO:0004497
GO:0018749;(3,5-dichlorophenylurea)acetate amidohydrolase activity;0;3;GO:0004479
GO:0018748;iprodione amidohydrolase activity;0;2;GO:0004721
GO:0006761;dihydrofolate biosynthetic process;33539;3;GO:0006790
GO:0004100;chitin synthase activity;40085;45;GO:0004553
GO:0090096;positive regulation of metanephric cap mesenchymal cell proliferation;4;26;GO:0048608
GO:0006760;folic acid-containing compound metabolic process;1281682;875;GO:0006796
GO:0004102;choline O-acetyltransferase activity;167;25;GO:0004073
GO:0090094;metanephric cap mesenchymal cell proliferation involved in metanephros development;57;8;GO:0048608
GO:0006766;vitamin metabolic process;4407657;1320;GO:0006796
GO:0090095;regulation of metanephric cap mesenchymal cell proliferation;4;9;GO:0048608
GO:0004104;cholinesterase activity;13158;222;GO:0004497
GO:0090092;regulation of transmembrane receptor protein serine/threonine kinase signaling pathway;23615;284;GO:0007186
GO:0004103;choline kinase activity;725;128;GO:0004722
GO:0090093;regulation of fungal-type cell wall beta-glucan biosynthetic process;12;0;GO:0046364
GO:0031714;C5a anaphylatoxin chemotactic receptor binding;48;4;GO:0004866
GO:0031715;C5L2 anaphylatoxin chemotactic receptor binding;44;7;GO:0004866
GO:0006756;AMP phosphorylation;2;313;GO:0006468
GO:0031712;B1 bradykinin receptor binding;4;1;GO:0005126
GO:0031713;B2 bradykinin receptor binding;7;2;GO:0005126
GO:0031718;type 1 cannabinoid receptor binding;89;2;GO:0005125
GO:0031719;type 2 cannabinoid receptor binding;0;1;GO:0005125
GO:0031716;calcitonin receptor binding;105;7;GO:0005509
GO:0031717;cannabinoid receptor binding;89;1;GO:0005125
GO:0018750;biuret amidohydrolase activity;165;5;GO:0004553
GO:0018752;epsilon-caprolactam lactamase activity;0;2;GO:0004746
GO:0018751;3,5-dichlorophenylcarboximide hydrolase activity;0;2;GO:0004553
GO:0018754;ammelide aminohydrolase activity;0;1;GO:0004730
GO:0031710;neuromedin B receptor binding;20;2;GO:0005509
GO:0018753;cyanuric acid amidohydrolase activity;1104;5;GO:0004730
GO:0031711;bradykinin receptor binding;117;28;GO:0005509
GO:0018756;ammeline aminohydrolase activity;2;1;GO:0004553
GO:0018755;2-chloro-4-hydroxy-6-amino-1,3,5-triazine aminohydrolase activity;0;1;GO:0004725
GO:0018736;6-oxo-2-hydroxycyclohexane-1-carboxyl-CoA hydrolase activity;0;2;GO:0006066
GO:0018738;S-formylglutathione hydrolase activity;42139;199;GO:0004746
GO:0018737;2-ketocyclohexane-1-carboxyl-CoA hydrolase activity;0;1;GO:0006081
GO:0018739;4-hydroxybenzoyl-CoA thioesterase activity;352;4;GO:0006081
GO:0006772;thiamine metabolic process;713610;998;GO:0006749
GO:0004111;creatine kinase activity;27812;370;GO:0004721
GO:0031709;gastrin-releasing peptide receptor binding;0;1;GO:0005509
GO:0004110;corticosteroid side-chain-isomerase activity;0;3;GO:0004722
GO:0006771;riboflavin metabolic process;649352;517;GO:0006749
GO:0004113;2',3'-cyclic-nucleotide 3'-phosphodiesterase activity;28178;3;GO:0004721
GO:0006776;vitamin A metabolic process;359;554;GO:0006797
GO:0004112;cyclic-nucleotide phosphodiesterase activity;151466;587;GO:0004721
GO:0006777;Mo-molybdopterin cofactor biosynthetic process;643375;1490;GO:0006099
GO:0004115;3',5'-cyclic-AMP phosphodiesterase activity;34210;63;GO:0004721
GO:0004114;3',5'-cyclic-nucleotide phosphodiesterase activity;91051;183;GO:0004721
GO:0006775;fat-soluble vitamin metabolic process;16414;349;GO:0006749
GO:0004106;chorismate mutase activity;137704;176;GO:0006032
GO:0006769;nicotinamide metabolic process;109;221;GO:0006749
GO:0031703;type 2 angiotensin receptor binding;64;7;GO:0004930
GO:0004105;choline-phosphate cytidylyltransferase activity;6767;156;GO:0004734
GO:0031704;apelin receptor binding;759;8;GO:0005126
GO:0004108;citrate (Si)-synthase activity;31825;0;GO:0006099
GO:0006767;water-soluble vitamin metabolic process;4390961;799;GO:0006796
GO:0031701;angiotensin receptor binding;323;246;GO:0005126
GO:0004107;chorismate synthase activity;156349;451;GO:0004497
GO:0006768;biotin metabolic process;415793;710;GO:0006730
GO:0031702;type 1 angiotensin receptor binding;135;226;GO:0004930
GO:0031707;endothelin A receptor binding;149;8;GO:0005126
GO:0004109;coproporphyrinogen oxidase activity;120481;697;GO:0004073
GO:0031708;endothelin B receptor binding;225;246;GO:0005126
GO:0031705;bombesin receptor binding;395;8;GO:0005509
GO:0031706;subtype 3 bombesin receptor binding;0;1;GO:0005509
GO:0018741;linear primary-alkylsulfatase activity;8186;5;GO:0005525
GO:0018740;2'-hydroxybiphenyl-2-sulfinate desulfinase activity;87;2;GO:0004497
GO:0018743;phenanthrene-9,10-epoxide hydrolase (9R,10R-forming) activity;0;3;GO:0008021
GO:0018742;epoxide hydrolase B activity;3;1;GO:0004553
GO:0031700;adrenomedullin receptor binding;70;6;GO:0005125
GO:0018745;epoxide hydrolase A activity;0;4;GO:0004553
GO:0018744;limonene-1,2-epoxide hydrolase activity;134;6;GO:0004553
GO:0018725;trans-3,4-dihydrodiolphenanthrene sulfotransferase activity;0;1;GO:0004497
GO:0018724;4-phenanthrol sulfotransferase activity;0;1;GO:0004497
GO:0018727;2-phenanthrol sulfotransferase activity;0;1;GO:0004497
GO:0018726;9-phenanthrol sulfotransferase activity;0;2;GO:0004497
GO:0018729;propionate CoA-transferase activity;159;4;GO:0004067
GO:0090078;smooth muscle derived foam cell differentiation;0;1;GO:0048608
GO:0090079;translation regulator activity, nucleic acid binding;2344480;97;GO:0003735
GO:0090076;relaxation of skeletal muscle;212;52;GO:0007517
GO:0006740;NADPH regeneration;502358;795;GO:0006749
GO:0090077;foam cell differentiation;1448;168;GO:0002576
GO:0090074;negative regulation of protein homodimerization activity;3;50;GO:0048193
GO:0090075;relaxation of muscle;2112;128;GO:0007599
GO:0006743;ubiquinone metabolic process;527561;784;GO:0006749
GO:0006744;ubiquinone biosynthetic process;527427;2540;GO:0006749
GO:0090073;positive regulation of protein homodimerization activity;1;381;GO:0042302
GO:0006741;NADP biosynthetic process;153443;701;GO:0006749
GO:0090070;positive regulation of ribosome biogenesis;115;48;GO:0045944
GO:0006742;NADP catabolic process;229;291;GO:0006749
GO:0090071;negative regulation of ribosome biogenesis;38734;46;GO:0045944
GO:0090080;positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway;227;86;GO:0048010
GO:0006734;NADH metabolic process;922;2060;GO:0006096
GO:0006735;NADH regeneration;647;349;GO:0015986
GO:0006738;nicotinamide riboside catabolic process;48;405;GO:0046395
GO:0006739;NADP metabolic process;660565;814;GO:0006749
GO:0018730;glutaconate CoA-transferase activity;709;4;GO:0004067
GO:0018732;sulfolactone hydrolase activity;195;4;GO:0004553
GO:0018731;1-oxa-2-oxocycloheptane lactonase activity;0;4;GO:0004730
GO:0018734;butyrolactone hydrolase activity;0;4;GO:0010401
GO:0018733;3,4-dihydrocoumarin hydrolase activity;4;10;GO:0004497
GO:0018713;3-ketopimelyl-CoA thiolase activity;0;2;GO:0006081
GO:0018716;1-phenanthrol glycosyltransferase activity;0;4;GO:0006022
GO:0018715;9-phenanthrol UDP-glucuronosyltransferase activity;0;4;GO:0004497
GO:0018718;1,2-dihydroxy-phenanthrene glycosyltransferase activity;0;4;GO:0006022
GO:0018717;9-phenanthrol glycosyltransferase activity;0;3;GO:0006022
GO:0090089;regulation of dipeptide transport;143;2;GO:0006865
GO:0018719;6-aminohexanoate transaminase activity;0;2;GO:0009065
GO:0006750;glutathione biosynthetic process;287276;2270;GO:0006749
GO:0090087;regulation of peptide transport;11303;228;GO:0006916
GO:0006751;glutathione catabolic process;109332;501;GO:0006749
GO:0090088;regulation of oligopeptide transport;143;1;GO:0006865
GO:0090085;regulation of protein deubiquitination;680;35;GO:0016567
GO:0090086;negative regulation of protein deubiquitination;199;46;GO:0016567
GO:0006754;ATP biosynthetic process;2502228;3690;GO:0006091
GO:0090083;regulation of inclusion body assembly;706;696;GO:0048193
GO:0090084;negative regulation of inclusion body assembly;431;891;GO:0048193
GO:0090081;regulation of heart induction by regulation of canonical Wnt signaling pathway;153;6;GO:0048704
GO:0006753;nucleoside phosphate metabolic process;15274814;1870;GO:0006796
GO:0090082;positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway;153;7;GO:0048704
GO:0006747;FAD biosynthetic process;83680;80;GO:0006635
GO:0090090;negative regulation of canonical Wnt signaling pathway;14714;2650;GO:0045765
GO:0006748;lipoamide metabolic process;0;5;GO:0006066
GO:0090091;positive regulation of extracellular matrix disassembly;318;72;GO:0032989
GO:0006746;FADH2 metabolic process;0;2;GO:0006749
GO:0006749;glutathione metabolic process;493374;3680;GO:0006749
GO:0018721;trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity;0;2;GO:0004497
GO:0018720;phenol kinase activity;0;4;GO:0004721
GO:0018723;3-phenanthrol sulfotransferase activity;0;1;GO:0004497
GO:0018722;1-phenanthrol sulfotransferase activity;0;1;GO:0004497
GO:0016128;phytosteroid metabolic process;4935;49;GO:0006725
GO:0016129;phytosteroid biosynthetic process;4747;34;GO:0016125
GO:0043749;phenol, water dikinase activity;0;3;GO:0004721
GO:0043748;O-succinylbenzoate synthase activity;11326;3;GO:0006081
GO:0004140;dephospho-CoA kinase activity;153621;730;GO:0004721
GO:0004142;diacylglycerol cholinephosphotransferase activity;284;42;GO:0004722
GO:0004141;dethiobiotin synthase activity;87029;501;GO:0004449
GO:0004144;diacylglycerol O-acyltransferase activity;56376;427;GO:0008610
GO:0043741;alpha-aminoadipate acetyltransferase activity;1;2;GO:0004073
GO:0004143;ATP-dependent diacylglycerol kinase activity;84889;26;GO:0008092
GO:0043740;GTP cyclohydrolase IIa activity;2365;4;GO:0006032
GO:0004146;dihydrofolate reductase activity;123919;301;GO:0003824
GO:0043743;LPPG:FO 2-phospho-L-lactate transferase activity;33307;7;GO:0006099
GO:0004145;diamine N-acetyltransferase activity;3916;45;GO:0004073
GO:0004148;dihydrolipoyl dehydrogenase activity;162054;791;GO:0005524
GO:0043744;N2-acetyl-L-aminoadipate kinase activity;772;2;GO:0004721
GO:0004139;deoxyribose-phosphate aldolase activity;105337;459;GO:0004073
GO:0031758;Edg-5 sphingosine 1-phosphate receptor binding;0;1;GO:0005509
GO:0004138;deoxyguanosine kinase activity;954;7;GO:0004725
GO:0031759;Edg-6 sphingosine 1-phosphate receptor binding;0;1;GO:0005126
GO:0031756;Edg-3 sphingosine 1-phosphate receptor binding;0;0;GO:0030198
GO:0031757;Edg-4 lysophosphatidic acid receptor binding;0;1;GO:0005549
GO:0018792;bis(4-chlorophenyl)acetate decarboxylase activity;0;1;GO:0006073
GO:0016130;phytosteroid catabolic process;0;5;GO:0046274
GO:0018791;2-hydroxy-3-carboxy-6-oxo-7-methylocta-2,4-dienoate decarboxylase activity;0;2;GO:0006073
GO:0016131;brassinosteroid metabolic process;2055;96;GO:0006725
GO:0018794;2-hydroxyisobutyrate decarboxylase activity;0;2;GO:0006099
GO:0031750;D3 dopamine receptor binding;61;9;GO:0048167
GO:0016132;brassinosteroid biosynthetic process;1903;562;GO:0009813
GO:0018793;3,5-dibromo-4-hydroxybenzoate decarboxylase activity;0;2;GO:0006073
GO:0031751;D4 dopamine receptor binding;15;9;GO:0005509
GO:0016133;brassinosteroid catabolic process;0;2;GO:0046274
GO:0018796;4,5-dihydroxyphthalate decarboxylase activity;293;3;GO:0006073
GO:0016134;saponin metabolic process;122;9;GO:0046274
GO:0018795;2-hydroxy-2-methyl-1,3-dicarbonate decarboxylase activity;0;2;GO:0006066
GO:0016135;saponin biosynthetic process;26;9;GO:0008037
GO:0018798;gallate decarboxylase activity;5;4;GO:0006073
GO:0031754;Edg-1 sphingosine 1-phosphate receptor binding;0;0;GO:0005126
GO:0016136;saponin catabolic process;60;2;GO:0046274
GO:0031755;Edg-2 lysophosphatidic acid receptor binding;122;4;GO:0005549
GO:0016137;glycoside metabolic process;73855;387;GO:0005975
GO:0031752;D5 dopamine receptor binding;59;52;GO:0005509
GO:0016138;glycoside biosynthetic process;40402;132;GO:0005976
GO:0018799;4-hydroxybenzoate decarboxylase activity;224;3;GO:0006099
GO:0031753;endothelial differentiation G protein-coupled receptor binding;122;0;GO:0005096
GO:0016117;carotenoid biosynthetic process;95147;884;GO:0009744
GO:0043758;acetate-CoA ligase (ADP-forming) activity;22116;8;GO:0006099
GO:0016118;carotenoid catabolic process;90;4;GO:0009813
GO:0043757;adenosylcobinamide-phosphate synthase activity;354;2;GO:0006030
GO:0016119;carotene metabolic process;14164;79;GO:0006725
GO:0043759;methylbutanoate-CoA ligase activity;8;3;GO:0006081
GO:0004151;dihydroorotase activity;141161;640;GO:0004730
GO:0004150;dihydroneopterin aldolase activity;111893;819;GO:0004067
GO:0004153;dihydropterin deaminase activity;11;2;GO:0004723
GO:0043750;phosphatidylinositol alpha-mannosyltransferase activity;1256;3;GO:0006029
GO:0004152;dihydroorotate dehydrogenase activity;157740;556;GO:0004061
GO:0004155;6,7-dihydropteridine reductase activity;1471;37;GO:0004073
GO:0043752;adenosylcobinamide kinase activity;66626;10;GO:0004721
GO:0004154;dihydropterin oxidase activity;0;2;GO:0004725
GO:0043751;polyphosphate:AMP phosphotransferase activity;3633;5;GO:0005524
GO:0004157;dihydropyrimidinase activity;5425;58;GO:0004553
GO:0043754;dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity;307;8;GO:0004364
GO:0004156;dihydropteroate synthase activity;139724;626;GO:0004497
GO:0004159;dihydropyrimidine dehydrogenase (NAD+) activity;1110;0;GO:0009065
GO:0043756;adenosylcobinamide hydrolase activity;138;4;GO:0006032
GO:0043755;alpha-ribazole phosphatase activity;5938;19;GO:0004721
GO:0031747;type 2 cysteinyl leukotriene receptor binding;0;0;GO:0005126
GO:0004149;dihydrolipoyllysine-residue succinyltransferase activity;82579;796;GO:0004866
GO:0031748;D1 dopamine receptor binding;204;38;GO:0005509
GO:0031745;cysteinyl leukotriene receptor binding;0;0;GO:0005126
GO:0031746;type 1 cysteinyl leukotriene receptor binding;0;1;GO:0005126
GO:0018781;S-triazine hydrolase activity;0;0;GO:0004553
GO:0031749;D2 dopamine receptor binding;34;135;GO:0005509
GO:0018780;dichloroacetate halidohydrolase activity;0;1;GO:0004730
GO:0016120;carotene biosynthetic process;11154;24;GO:0009744
GO:0018783;deisopropyldeethylatrazine hydrolase activity;0;1;GO:0004497
GO:0016121;carotene catabolic process;2748;187;GO:0009615
GO:0018782;cis-chloroacrylic acid dehalogenase activity;0;1;GO:0004721
GO:0031740;type A cholecystokinin receptor binding;0;1;GO:0005126
GO:0016122;xanthophyll metabolic process;1847;140;GO:0009579
GO:0018785;haloacetate dehalogenase activity;1258;3;GO:0004497
GO:0016123;xanthophyll biosynthetic process;446;336;GO:0009579
GO:0018784;(S)-2-haloacid dehalogenase activity;12859;0;GO:0004721
GO:0016124;xanthophyll catabolic process;75;62;GO:0009813
GO:0018787;4-chlorobenzoyl-CoA dehalogenase activity;335;3;GO:0004497
GO:0016125;sterol metabolic process;122399;2210;GO:0016125
GO:0018786;haloalkane dehalogenase activity;7615;9;GO:0046395
GO:0016126;sterol biosynthetic process;73766;3960;GO:0016125
GO:0018789;cyclamate sulfohydrolase activity;0;4;GO:0004730
GO:0031741;type B gastrin/cholecystokinin receptor binding;45;0;GO:0005126
GO:0016127;sterol catabolic process;3170;330;GO:0016125
GO:0018788;atrazine chlorohydrolase activity;328;3;GO:0004721
GO:0016106;sesquiterpenoid biosynthetic process;3113;109;GO:0046274
GO:0018769;2-hydroxy-6-oxoocta-2,4-dienoate hydrolase activity;0;2;GO:0004497
GO:0043769;Tpg-containing telomere binding complex;0;1;GO:0005576
GO:0016107;sesquiterpenoid catabolic process;186;7;GO:0046274
GO:0018768;2-hydroxy-6-oxo-6-(2'-aminophenyl)hexa-2,4-dienoate hydrolase activity;164;0;GO:0004466
GO:0043768;S-ribosylhomocysteine lyase activity;35860;21;GO:0006073
GO:0016108;tetraterpenoid metabolic process;103391;30;GO:0006721
GO:0016109;tetraterpenoid biosynthetic process;95147;21;GO:0006073
GO:0006780;uroporphyrinogen III biosynthetic process;54224;67;GO:0009065
GO:0004120;photoreceptor cyclic-nucleotide phosphodiesterase activity;0;2;GO:0008021
GO:0006783;heme biosynthetic process;864102;2390;GO:0009055
GO:0043761;archaetidylserine synthase activity;64;2;GO:0004073
GO:0006784;heme A biosynthetic process;45432;317;GO:0009055
GO:0043760;acetyldiaminopimelate aminotransferase activity;0;1;GO:0004449
GO:0004122;cystathionine beta-synthase activity;20623;50;GO:0004067
GO:0006781;succinyl-CoA pathway;1;216;GO:0006094
GO:0043763;UTP:glucose-1-phosphate uridylyltransferase regulator activity;1;2;GO:0005524
GO:0004121;cystathionine beta-lyase activity;25622;43;GO:0004067
GO:0006782;protoporphyrinogen IX biosynthetic process;279969;1170;GO:0009065
GO:0004124;cysteine synthase activity;146803;1770;GO:0006457
GO:0006787;porphyrin-containing compound catabolic process;21877;123;GO:0046395
GO:0043765;T/G mismatch-specific endonuclease activity;76;5;GO:0004518
GO:0004123;cystathionine gamma-lyase activity;4295;50;GO:0004067
GO:0006788;heme oxidation;15267;742;GO:0006879
GO:0004126;cytidine deaminase activity;86066;751;GO:0004518
GO:0006785;heme B biosynthetic process;4529;8;GO:0009405
GO:0043767;pyrrolysyl-tRNA synthetase activity;145;3;GO:0006418
GO:0004125;L-seryl-tRNA(Sec) selenium transferase activity;45872;5;GO:0006413
GO:0006786;heme C biosynthetic process;0;5;GO:0006749
GO:0043766;Sep-tRNA:Cys-tRNA synthase activity;2096;6;GO:0003735
GO:0004117;calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity;233;3;GO:0004721
GO:0031736;CCR11 chemokine receptor binding;0;2;GO:0005125
GO:0031737;CX3C chemokine receptor binding;176;3;GO:0005125
GO:0004119;cGMP-inhibited cyclic-nucleotide phosphodiesterase activity;57;30;GO:0004721
GO:0006778;porphyrin-containing compound metabolic process;1876216;688;GO:0006721
GO:0031734;CCR9 chemokine receptor binding;0;1;GO:0005125
GO:0004118;cGMP-stimulated cyclic-nucleotide phosphodiesterase activity;206;71;GO:0008026
GO:0006779;porphyrin-containing compound biosynthetic process;1842951;3140;GO:0006721
GO:0031735;CCR10 chemokine receptor binding;114;36;GO:0005125
GO:0018770;6-oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8-trichloroocta-2E,4E,7-trienoate hydrolase activity;0;0;GO:0004721
GO:0031738;XCR1 chemokine receptor binding;0;1;GO:0004872
GO:0043770;demethylmenaquinone methyltransferase activity;29124;3;GO:0004725
GO:0031739;cholecystokinin receptor binding;51;1;GO:0005125
GO:0018772;trioxoheptanoate hydrolase activity;0;2;GO:0006081
GO:0016110;tetraterpenoid catabolic process;90;1;GO:0006081
GO:0018771;2-hydroxy-6-oxonona-2,4-dienedioate hydrolase activity;2152;6;GO:0004467
GO:0016111;polyterpenoid metabolic process;0;2;GO:0006073
GO:0018774;2,6-dioxo-6-phenylhexa-3-enoate hydrolase activity;629;3;GO:0046395
GO:0016112;polyterpenoid biosynthetic process;0;4;GO:0046274
GO:0018773;acetylpyruvate hydrolase activity;217;7;GO:0006081
GO:0016113;polyterpenoid catabolic process;0;2;GO:0046274
GO:0018776;trans-chloroacrylic acid dehalogenase activity;0;2;GO:0004497
GO:0031732;CCR7 chemokine receptor binding;8;10;GO:0004872
GO:0016114;terpenoid biosynthetic process;552431;1980;GO:0006721
GO:0018775;2-hydroxymuconate-semialdehyde hydrolase activity;365;2;GO:0006032
GO:0031733;CCR8 chemokine receptor binding;0;2;GO:0005125
GO:0016115;terpenoid catabolic process;1053;192;GO:0046274
GO:0018778;DL-2 haloacid dehalogenase activity;10;3;GO:0004721
GO:0031730;CCR5 chemokine receptor binding;107;464;GO:0004872
GO:0016116;carotenoid metabolic process;103391;381;GO:0006725
GO:0018777;1,3,4,6-tetrachloro-1,4-cyclohexadiene halidohydrolase activity;0;1;GO:0004553
GO:0031731;CCR6 chemokine receptor binding;284;148;GO:0005125
GO:0018758;2,4-dihydroxy-6-(N'-ethyl)amino-1,3,5-triazine aminohydrolase activity;0;0;GO:0004553
GO:0018757;deisopropylhydroxyatrazine aminohydrolase activity;0;2;GO:0004497
GO:0043779;cobalt-precorrin-5A acetaldehyde-lyase activity;1141;3;GO:0006073
GO:0018759;methenyltetrahydromethanopterin cyclohydrolase activity;10367;7;GO:0004497
GO:0006790;sulfur compound metabolic process;4834462;3220;GO:0006720
GO:0006791;sulfur utilization;16;35;GO:0009063
GO:0004131;cytosine deaminase activity;5026;10;GO:0004518
GO:0006794;phosphorus utilization;0;26;GO:0009432
GO:0043772;acyl-phosphate glycerol-3-phosphate acyltransferase activity;69913;9;GO:0008610
GO:0004130;cytochrome-c peroxidase activity;2568;8;GO:0004601
GO:0006795;regulation of phosphorus utilization;0;2;GO:0045735
GO:0043771;cytidine kinase activity;9913;5;GO:0004721
GO:0004133;glycogen debranching enzyme activity;25505;194;GO:0005976
GO:0006792;regulation of sulfur utilization;9;6;GO:0009065
GO:0043774;coenzyme F420-2 alpha-glutamyl ligase activity;90;8;GO:0006067
GO:0004132;dCMP deaminase activity;18966;30;GO:0004723
GO:0006793;phosphorus metabolic process;32148654;4180;GO:0006793
GO:0043773;coenzyme F420-0 gamma-glutamyl ligase activity;21006;9;GO:0006081
GO:0004135;amylo-alpha-1,6-glucosidase activity;13052;30;GO:0004553
GO:0006798;polyphosphate catabolic process;151;34;GO:0006032
GO:0043776;cobalt-precorrin-6B C5-methyltransferase activity;329;3;GO:0003676
GO:0004134;4-alpha-glucanotransferase activity;65723;446;GO:0005986
GO:0006799;polyphosphate biosynthetic process;69633;116;GO:0006796
GO:0004137;deoxycytidine kinase activity;444;250;GO:0004725
GO:0006796;phosphate-containing compound metabolic process;31399691;3130;GO:0006793
GO:0043778;cobalt-precorrin-8 methylmutase activity;857;3;GO:0005524
GO:0004136;deoxyadenosine kinase activity;621;7;GO:0004721
GO:0006797;polyphosphate metabolic process;85193;44;GO:0006796
GO:0043777;cobalt-precorrin-7 C15-methyltransferase activity;4;3;GO:0003676
GO:0004128;cytochrome-b5 reductase activity, acting on NAD(P)H;12749;88;GO:0004091
GO:0031725;CXCR6 chemokine receptor binding;0;1;GO:0005125
GO:0031371;ubiquitin conjugating enzyme complex;907;20;GO:0005829
GO:0102359;daphnetin 4-O-beta-glucosyltransferase activity;5;1;GO:0006073
GO:0043332;mating projection tip;3927;130;GO:0048305
GO:0045995;regulation of embryonic development;9423;976;GO:0048608
GO:0043331;response to dsRNA;2677;167;GO:0032259
GO:0043334;2-hexaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;214;6;GO:0004091
GO:0045993;negative regulation of translational initiation by iron;1;3;GO:0006417
GO:0043333;2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity;15792;4;GO:0004497
GO:0045994;positive regulation of translational initiation by iron;61;60;GO:0006417
GO:0043336;site-specific telomere resolvase activity;0;3;GO:0003677
GO:0045999;negative regulation of ecdysteroid secretion;0;2;GO:0048608
GO:0043335;protein unfolding;35264;413;GO:0006457
GO:0043338;CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity;2599;5;GO:0004721
GO:0045997;negative regulation of ecdysteroid biosynthetic process;0;2;GO:0010468
GO:0043337;cardiolipin synthase (CMP-forming);523;3;GO:0006631
GO:0045998;positive regulation of ecdysteroid biosynthetic process;60;1;GO:0010468
GO:0031365;N-terminal protein amino acid modification;408;470;GO:0006464
GO:0102365;taxusin 2-alpha-hydroxylase activity;0;0;GO:0004073
GO:0031366;N-terminal peptidyl-asparagine deamination;0;4;GO:0006464
GO:0070930;trans-translation-dependent protein tagging;1;2;GO:0006464
GO:0031363;N-terminal protein amino acid deamination;0;4;GO:0006457
GO:0102367;2-alpha-hydroxytaxusin 7-beta-hydroxylase activity;0;0;GO:0004073
GO:0031364;N-terminal protein amino acid deamination, from side chain;0;4;GO:0006470
GO:0102366;7-beta-hydroxytaxusin 2-alpha-hydroxylase activity;0;0;GO:0004073
GO:0031369;translation initiation factor binding;22667;1090;GO:0003735
GO:0070933;histone H4 deacetylation;0;643;GO:0016569
GO:0102361;esculetin 4-O-beta-glucosyltransferase activity;5;1;GO:0004553
GO:0070934;CRD-mediated mRNA stabilization;622;424;GO:0006414
GO:0102360;daphnetin 3-O-glucosyltransferase activity;90;1;GO:0006073
GO:0031367;N-terminal peptidyl-glutamine deamination;0;3;GO:0006486
GO:0070931;Golgi-associated vesicle lumen;4;9;GO:0005764
GO:0102363;isoscopoletin-O-methyltransferase activity;0;1;GO:0004497
GO:0070932;histone H3 deacetylation;7;619;GO:0016569
GO:0102362;esculetin 3-O-glucosyltransferase activity;0;0;GO:0004553
GO:0102369;11alpha-30-dihydroxy beta-amyrin dehydrogenase activity;0;0;GO:0006073
GO:0102368;beta-amyrin 30-monooxygenase activity;0;0;GO:0004497
GO:0102370;lupeol 28-monooxygenase activity;0;0;GO:0004497
GO:0102376;lupeol 28-oxidase activity;0;0;GO:0004601
GO:0102375;11-oxo-beta-amyrin 30-oxidase activity;73;2;GO:0004601
GO:0102378;steviolmonoside glucosyltransferase activity;0;0;GO:0006073
GO:0102377;steviol 13-O glucosyltransferase activity;0;0;GO:0006073
GO:0102372;alpha-amyrin 28-monooxygenase activity;0;0;GO:0004497
GO:0102371;betulin dehydrogenase activity;0;0;GO:0004073
GO:0102374;ursolic aldehyde 28-monooxygenase activity;18;1;GO:0004497
GO:0102373;uvaol dehydrogenase activity;18;1;GO:0004497
GO:0102379;steviolbioside glucosyltransferase activity (stevioside forming);0;1;GO:0006073
GO:0102381;stevioside glucosyltransferase activity (rebaudioside A forming);0;1;GO:0006073
GO:0102380;steviolbioside glucosyltransferase activity (rebaudioside B forming);0;0;GO:0006073
GO:0102387;2-phenylethanol acetyltransferase activity;7;1;GO:0004089
GO:0102386;phenylacetaldehyde reductase activity;0;0;GO:0046395
GO:0102389;polyprenol reductase activity;5593;5;GO:0004067
GO:0102388;UDP-N,N'-diacetylbacillosamine 2-epimerase activity;251;0;GO:0006022
GO:0102383;steviol 19-O glucosyltransferase activity;0;0;GO:0006073
GO:0102382;rebaudioside B glucosyltransferase activity;0;0;GO:0006073
GO:0102385;patchoulol synthase activity;0;0;GO:0004497
GO:0102384;19-O-beta-glucopyranosyl-steviol glucosyltransferase activity;0;0;GO:0006073
GO:0102390;mycophenolic acid acyl-glucuronide esterase activity;13;4;GO:0008021
GO:0102392;decanoate-[HmqF protein] ligase activity;0;0;GO:0005524
GO:0102391;decanoate-CoA ligase activity;80;35;GO:0004497
GO:0102398;dTDP-3-amino-4-oxo-2,3,6-trideoxy-alpha-D-glucose N-methyltransferase activity;0;0;GO:0006030
GO:0102399;dTDP-3-N-methylamino-4-oxo-2,3,6-trideoxy-alpha-D-glucose N-methyltransferase activity;0;0;GO:0006030
GO:0102394;4-hydroxy-L-isoleucine dehydrogenase activity;0;0;GO:0009065
GO:0102393;decanoyl-[acp] 2-dehydrogenase activity;0;0;GO:0004497
GO:0102396;9-cis-10'-apo-beta-carotenal cleavage oxygenase activity;7;2;GO:0004497
GO:0102395;9-cis-beta-carotene 9',10'-cleavage oxygenase activity;6;1;GO:0004497
GO:0043387;mycotoxin catabolic process;14;173;GO:0046274
GO:0043386;mycotoxin biosynthetic process;20296;47;GO:0046274
GO:0043388;positive regulation of DNA binding;200;1130;GO:0030528
GO:0043392;negative regulation of DNA binding;184;1180;GO:0030528
GO:0043394;proteoglycan binding;1667;724;GO:0005539
GO:0043393;regulation of protein binding;383;904;GO:0030528
GO:0043396;corticotropin-releasing hormone secretion;101;69;GO:0004930
GO:0043395;heparan sulfate proteoglycan binding;702;822;GO:0005539
GO:0043398;HLH domain binding;192;47;GO:0042302
GO:0043397;regulation of corticotropin-releasing hormone secretion;101;9;GO:0048167
GO:0043399;tRNA A64-2'-O-ribosylphosphate transferase activity;2042;1;GO:0006418
GO:0070991;medium-chain-acyl-CoA dehydrogenase activity;11927;84;GO:0004089
GO:0070992;translation initiation complex;27;2;GO:0006413
GO:0070990;snRNP binding;379;15;GO:0003723
GO:0070995;NADPH oxidation;196;133;GO:0006749
GO:0070996;type 1 melanocortin receptor binding;214;90;GO:0004872
GO:0070993;translation preinitiation complex;73718;118;GO:0006413
GO:0070994;detection of oxidative stress;104;9;GO:0006979
GO:0070999;detection of mechanical stimulus involved in sensory perception of gravity;0;1;GO:0007600
GO:0070998;sensory perception of gravity;0;1;GO:0007600
GO:0018505;cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase activity;9;4;GO:0004073
GO:0018504;cis-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;6;2;GO:0004073
GO:0018507;cis-3,4-dihydrophenanthrene-3,4-diol dehydrogenase activity;3;4;GO:0003824
GO:0018506;maleylacetate reductase activity;5463;2;GO:0004067
GO:0018509;cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase activity;125;2;GO:0004073
GO:0018508;cis-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylate dehydrogenase activity;0;0;GO:0004067
GO:0006520;amino acid metabolic process;23819619;8370;GO:0006520
GO:0006523;alanine biosynthetic process;62644;252;GO:0006559
GO:0006524;alanine catabolic process;45450;45;GO:0006559
GO:0006521;regulation of cellular amino acid metabolic process;15408;2310;GO:0006520
GO:0006522;alanine metabolic process;209428;231;GO:0006541
GO:0006516;glycoprotein catabolic process;3314;468;GO:0006518
GO:0006517;protein deglycosylation;140;257;GO:0006486
GO:0006515;protein quality control for misfolded or incompletely synthesized proteins;55010;483;GO:0006457
GO:0006518;peptide metabolic process;27349695;3840;GO:0006519
GO:0018510;phloroglucinol reductase activity;2;3;GO:0004091
GO:0018511;2,3-dihydroxy-2,3-dihydro-p-cumate dehydrogenase activity;15;4;GO:0004073
GO:0018513;dibenzothiophene dihydrodiol dehydrogenase activity;5;4;GO:0004067
GO:0006530;asparagine catabolic process;1075;35;GO:0006559
GO:0006531;aspartate metabolic process;8482;384;GO:0006544
GO:0006534;cysteine metabolic process;749310;2490;GO:0006520
GO:0006535;cysteine biosynthetic process from serine;158179;1440;GO:0006520
GO:0006532;aspartate biosynthetic process;192;119;GO:0006544
GO:0006533;aspartate catabolic process;195;406;GO:0006544
GO:0006527;arginine catabolic process;117884;1360;GO:0006541
GO:0006528;asparagine metabolic process;174509;195;GO:0006559
GO:0006525;arginine metabolic process;1499399;2430;GO:0006576
GO:0006526;arginine biosynthetic process;1222012;1600;GO:0006569
GO:0006529;asparagine biosynthetic process;155388;1740;GO:0006559
GO:0018501;cis-chlorobenzene dihydrodiol dehydrogenase activity;0;3;GO:0004067
GO:0018500;trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity;0;4;GO:0004497
GO:0018503;trans-1,2-dihydrodiolphenanthrene dehydrogenase activity;0;4;GO:0004497
GO:0018502;2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity;4;4;GO:0004091
GO:0006501;C-terminal protein lipidation;19;388;GO:0006631
GO:0006500;N-terminal protein palmitoylation;91;9;GO:0006464
GO:0006513;protein monoubiquitination;444;1080;GO:0043687
GO:0006511;ubiquitin-dependent protein catabolic process;413665;10500;GO:0006511
GO:0006505;GPI anchor metabolic process;17332;862;GO:0006631
GO:0006506;GPI anchor biosynthetic process;16934;1750;GO:0008610
GO:0006509;membrane protein ectodomain proteolysis;3047;1590;GO:0004867
GO:0006507;GPI anchor release;148;15;GO:0005576
GO:0006508;proteolysis;8785700;22900;GO:0006508
GO:0018549;methanethiol oxidase activity;3683;3;GO:0004497
GO:0043505;CENP-A containing nucleosome;206;59;GO:0000786
GO:0018548;pentaerythritol trinitrate reductase activity;2706;3;GO:0004067
GO:0043504;mitochondrial DNA repair;1081;77;GO:0006364
GO:0043507;positive regulation of JUN kinase activity;95;1250;GO:0043406
GO:0043506;regulation of JUN kinase activity;148;168;GO:0043406
GO:0043509;activin A complex;76;4;GO:0005581
GO:0006560;proline metabolic process;691544;2150;GO:0006565
GO:0043508;negative regulation of JUN kinase activity;51;528;GO:0043406
GO:0006563;L-serine metabolic process;488817;2460;GO:0006538
GO:0006564;L-serine biosynthetic process;208975;2420;GO:0006538
GO:0006561;proline biosynthetic process;523649;2810;GO:0006565
GO:0006562;proline catabolic process;137393;597;GO:0006559
GO:0006567;threonine catabolic process;90277;347;GO:0006559
GO:0043501;skeletal muscle adaptation;968;686;GO:0048193
GO:0006568;tryptophan metabolic process;1626167;3960;GO:0006565
GO:0043500;muscle adaptation;4817;548;GO:0048193
GO:0006565;L-serine catabolic process;873;158;GO:0006559
GO:0043503;skeletal muscle fiber adaptation;190;201;GO:0048193
GO:0006566;threonine metabolic process;580478;414;GO:0006565
GO:0043502;regulation of muscle adaptation;3468;91;GO:0048193
GO:0031516;far-red light photoreceptor activity;7;2;GO:0009579
GO:0031517;red light photoreceptor activity;7;1;GO:0009579
GO:0006558;L-phenylalanine metabolic process;239829;2300;GO:0006559
GO:0031514;motile cilium;83493;1640;GO:0005929
GO:0006559;L-phenylalanine catabolic process;109448;3270;GO:0009065
GO:0031515;tRNA (m1A) methyltransferase complex;27831;27;GO:0005737
GO:0018550;tetrachloro-p-hydroquinone reductive dehalogenase activity;0;2;GO:0004497
GO:0031518;CBF3 complex;78;10;GO:0005829
GO:0031519;PcG protein complex;8645;1310;GO:0016570
GO:0018551;dissimilatory sulfite reductase activity;7546;7;GO:0009067
GO:0018554;1,2-dihydroxynaphthalene dioxygenase activity;24;3;GO:0004497
GO:0018553;3-(2,3-dihydroxyphenyl)propionate 1,2-dioxygenase activity;0;0;GO:0004497
GO:0018556;2,2',3-trihydroxybiphenyl dioxygenase activity;0;3;GO:0004497
GO:0018555;phenanthrene dioxygenase activity;0;4;GO:0046395
GO:0018558;5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity;0;3;GO:0004497
GO:0031510;SUMO activating enzyme complex;2941;231;GO:0008031
GO:0018557;1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity;0;3;GO:0004497
GO:0031511;Mis6-Sim4 complex;947;7;GO:0048285
GO:0018538;epoxide carboxylase activity;0;0;GO:0006720
GO:0043516;regulation of DNA damage response, signal transduction by p53 class mediator;3277;334;GO:0006974
GO:0018537;coenzyme F420-dependent N5,N10-methenyltetrahydromethanopterin reductase activity;3602;5;GO:0006749
GO:0043515;kinetochore binding;970;240;GO:0005524
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;953;420;GO:0030528
GO:0043517;positive regulation of DNA damage response, signal transduction by p53 class mediator;1940;393;GO:0030528
GO:0006570;tyrosine metabolic process;163315;1310;GO:0006559
GO:0006571;tyrosine biosynthetic process;101806;867;GO:0006559
GO:0043519;regulation of myosin II filament organization;189;6;GO:0048608
GO:0006574;valine catabolic process;18920;259;GO:0009062
GO:0006575;cellular modified amino acid metabolic process;2053313;1380;GO:0006520
GO:0006572;tyrosine catabolic process;39698;541;GO:0006559
GO:0043510;activin B complex;0;0;GO:0048608
GO:0006573;valine metabolic process;357135;1010;GO:0006576
GO:0006578;amino-acid betaine biosynthetic process;102548;24;GO:0006520
GO:0043512;inhibin A complex;146;48;GO:0005576
GO:0006579;amino-acid betaine catabolic process;3886;20;GO:0009062
GO:0043511;inhibin complex;150;104;GO:0005576
GO:0006576;biogenic amine metabolic process;2075002;1440;GO:0006560
GO:0043514;interleukin-12 complex;195;9;GO:0002764
GO:0006577;amino-acid betaine metabolic process;124886;858;GO:0006520
GO:0043513;inhibin B complex;4;4;GO:0048608
GO:0031505;fungal-type cell wall organization;7461;566;GO:0072555
GO:0031506;cell wall glycoprotein biosynthetic process;363;5;GO:0005976
GO:0006569;tryptophan catabolic process;176897;2290;GO:0006559
GO:0031503;protein-containing complex localization;56329;320;GO:0043005
GO:0031504;peptidoglycan-based cell wall organization;0;5;GO:0070062
GO:0031509;subtelomeric heterochromatin formation;6060;64;GO:0048285
GO:0031507;heterochromatin formation;27451;153;GO:0000786
GO:0031508;pericentric heterochromatin formation;449;202;GO:0000786
GO:0018541;p-benzoquinone reductase (NADPH) activity;11;4;GO:0004067
GO:0018543;4-amino-2-nitroso-6-nitrotoluene reductase activity;0;1;GO:0004067
GO:0018542;2,3-dihydroxy DDT 1,2-dioxygenase activity;0;4;GO:0004497
GO:0018545;NAD(P)H nitroreductase activity;15;2;GO:0004784
GO:0031501;mannosyltransferase complex;965;34;GO:0005524
GO:0018544;4-carboxy-4'-sulfoazobenzene reductase activity;0;0;GO:0004067
GO:0031502;dolichyl-phosphate-mannose-protein mannosyltransferase complex;68;3;GO:0005524
GO:0018547;nitroglycerin reductase activity;58;2;GO:0004067
GO:0018546;nitrobenzene nitroreductase activity;52;2;GO:0004746
GO:0031500;Tea1 cell-end complex;1;1;GO:0005634
GO:0018527;cyclohexylamine oxidase activity;0;4;GO:0004497
GO:0043527;tRNA methyltransferase complex;28706;36;GO:0005737
GO:0018526;2-aminobenzoyl-CoA reductase activity;0;2;GO:0004497
GO:0018529;nitrilotriacetate monooxygenase activity;835;3;GO:0004497
GO:0043529;GET complex;1951;23;GO:0005667
GO:0018528;iminodiacetate dehydrogenase activity;0;2;GO:0004723
GO:0043528;tRNA (m2G10) methyltransferase complex;121;2;GO:0005737
GO:0006541;glutamine metabolic process;1273440;2570;GO:0006541
GO:0006542;glutamine biosynthetic process;112854;1420;GO:0006541
GO:0043521;regulation of myosin II filament disassembly;6;3;GO:0048608
GO:0006540;glutamate decarboxylation to succinate;45;103;GO:0006099
GO:0043520;regulation of myosin II filament assembly;49;5;GO:0048608
GO:0006545;glycine biosynthetic process;204618;236;GO:0006541
GO:0043523;regulation of neuron apoptotic process;12681;932;GO:0010941
GO:0006546;glycine catabolic process;254250;1310;GO:0006541
GO:0043522;leucine zipper domain binding;529;308;GO:0003700
GO:0006543;glutamine catabolic process;13244;278;GO:0006541
GO:0043525;positive regulation of neuron apoptotic process;1958;1670;GO:0010941
GO:0006544;glycine metabolic process;515930;1740;GO:0006541
GO:0043524;negative regulation of neuron apoptotic process;9569;2530;GO:0043066
GO:0006538;glutamate catabolic process;22510;636;GO:0006541
GO:0006539;glutamate catabolic process via 2-oxoglutarate;69;6;GO:0006541
GO:0006536;glutamate metabolic process;458340;2020;GO:0006541
GO:0006537;glutamate biosynthetic process;145891;1270;GO:0006541
GO:0018530;(R)-6-hydroxynicotine oxidase activity;272;0;GO:0004746
GO:0018532;5,10-methenyl-5,6,7,8-tetrahydromethanopterin dehydrogenase activity;0;2;GO:0004497
GO:0018531;(S)-6-hydroxynicotine oxidase activity;3;0;GO:0004746
GO:0018534;nitrilotriacetate dehydrogenase activity;0;3;GO:0009065
GO:0018533;peptidyl-cysteine acetylation;0;4;GO:0006464
GO:0018535;nicotine dehydrogenase activity;12;2;GO:0009081
GO:0018516;2,4-dichlorobenzoyl-CoA reductase activity;0;4;GO:0004497
GO:0043538;regulation of actin phosphorylation;51;6;GO:0045944
GO:0018515;pimeloyl-CoA dehydrogenase activity;130;4;GO:0009086
GO:0043537;negative regulation of blood vessel endothelial cell migration;1872;746;GO:0016477
GO:0018518;5,6-dihydroxy-3-methyl-2-oxo-1,2,5,6-tetrahydroquinoline dehydrogenase activity;0;4;GO:0004497
GO:0018517;phthalate 4,5-cis-dihydrodiol dehydrogenase activity;25;4;GO:0009065
GO:0043539;protein serine/threonine kinase activator activity;17443;617;GO:0030528
GO:0018519;cis-dihydroethylcatechol dehydrogenase activity;0;3;GO:0004067
GO:0006552;leucine catabolic process;6470;308;GO:0006544
GO:0043530;adenosine 5'-monophosphoramidase activity;290;3;GO:0004553
GO:0006553;lysine metabolic process;1260391;1140;GO:0006541
GO:0006550;isoleucine catabolic process;327;133;GO:0009062
GO:0043532;angiostatin binding;214;72;GO:0005578
GO:0006551;leucine metabolic process;716340;183;GO:0006565
GO:0043531;ADP binding;153794;4210;GO:0043531
GO:0006556;S-adenosylmethionine biosynthetic process;113115;1300;GO:0009065
GO:0043534;blood vessel endothelial cell migration;7516;780;GO:0030574
GO:0043533;inositol 1,3,4,5 tetrakisphosphate binding;117;43;GO:0097183
GO:0006554;lysine catabolic process;46639;1680;GO:0006541
GO:0043536;positive regulation of blood vessel endothelial cell migration;3136;1530;GO:0016477
GO:0006555;methionine metabolic process;931179;1220;GO:0006541
GO:0043535;regulation of blood vessel endothelial cell migration;5444;342;GO:0016477
GO:0006549;isoleucine metabolic process;520452;544;GO:0006576
GO:0006547;histidine metabolic process;1860841;982;GO:0006565
GO:0006548;histidine catabolic process;249948;410;GO:0006559
GO:0018521;1,2-dihydroxy-6-methylcyclohexa-3,5-dienecarboxylate dehydrogenase activity;0;4;GO:0004091
GO:0018520;cis-1,2-dihydroxy-4-methylcyclohexa-3,5-diene-1-carboxylate dehydrogenase activity;0;3;GO:0004067
GO:0018523;quinoline 2-oxidoreductase activity;6;5;GO:0004497
GO:0018522;benzoyl-CoA reductase activity;870;4;GO:0004449
GO:0018525;4-hydroxybenzoyl-CoA reductase activity;8;4;GO:0004091
GO:0018524;acetophenone carboxylase activity;0;2;GO:0004497
GO:0031560;cellular bud neck polarisome;2;1;GO:0005929
GO:0018590;methylsilanetriol hydroxylase activity;0;4;GO:0046395
GO:0031559;oxidosqualene cyclase activity;3057;9;GO:0004714
GO:0018592;4-nitrocatechol 4-monooxygenase activity;62;4;GO:0004497
GO:0018591;methyl tertiary butyl ether 3-monooxygenase activity;0;2;GO:0004497
GO:0018594;tert-butanol 2-monooxygenase activity;0;2;GO:0004497
GO:0018593;4-chlorophenoxyacetate monooxygenase activity;0;3;GO:0004497
GO:0018596;dimethylsilanediol hydroxylase activity;0;4;GO:0046395
GO:0031552;negative regulation of brain-derived neurotrophic factor-activated receptor activity;1;5;GO:0048608
GO:0018595;alpha-pinene monooxygenase activity;0;5;GO:0004497
GO:0031553;positive regulation of brain-derived neurotrophic factor-activated receptor activity;0;5;GO:0048608
GO:0018598;hydroxymethylsilanetriol oxidase activity;0;3;GO:0004091
GO:0031550;positive regulation of brain-derived neurotrophic factor receptor signaling pathway;7;4;GO:0048169
GO:0018597;ammonia monooxygenase activity;3222;6;GO:0004497
GO:0031551;regulation of brain-derived neurotrophic factor-activated receptor activity;1;3;GO:0048608
GO:0031556;transcriptional attenuation by ribosome;1895;8;GO:0003723
GO:0018599;2-hydroxyisobutyrate 3-monooxygenase activity;0;3;GO:0004497
GO:0031554;regulation of termination of DNA-templated transcription;330051;8;GO:0006355
GO:0031555;transcriptional attenuation;1903;4;GO:0003700
GO:0031549;negative regulation of brain-derived neurotrophic factor receptor signaling pathway;46;5;GO:0048169
GO:0031547;brain-derived neurotrophic factor receptor signaling pathway;410;55;GO:0007179
GO:0031548;regulation of brain-derived neurotrophic factor receptor signaling pathway;53;10;GO:0048169
GO:0018581;hydroxyquinol 1,2-dioxygenase activity;353;4;GO:0004497
GO:0018580;nitronate monooxygenase activity;75552;388;GO:0004497
GO:0018583;biphenyl-2,3-diol 1,2-dioxygenase activity;698;4;GO:0004497
GO:0018582;1-hydroxy-2-naphthoate 1,2-dioxygenase activity;16;4;GO:0004497
GO:0018585;fluorene oxygenase activity;0;5;GO:0004497
GO:0031541;negative regulation of anthocyanin biosynthetic process;0;1;GO:0010468
GO:0018584;2,4,5-trichlorophenoxyacetic acid oxygenase activity;0;3;GO:0004497
GO:0031542;positive regulation of anthocyanin biosynthetic process;29;3;GO:0046354
GO:0018586;mono-butyltin dioxygenase activity;0;3;GO:0004497
GO:0031540;regulation of anthocyanin biosynthetic process;183;71;GO:0010468
GO:0018589;di-n-butyltin dioxygenase activity;0;3;GO:0004497
GO:0031545;peptidyl-proline 4-dioxygenase activity;13668;55;GO:0004866
GO:0018588;tri-n-butyltin dioxygenase activity;0;4;GO:0004497
GO:0031546;brain-derived neurotrophic factor receptor binding;0;1;GO:0005509
GO:0031543;peptidyl-proline dioxygenase activity;18438;67;GO:0004867
GO:0031544;peptidyl-proline 3-dioxygenase activity;2171;2;GO:0004866
GO:0006581;acetylcholine catabolic process;640;161;GO:0006518
GO:0006582;melanin metabolic process;17512;435;GO:0006073
GO:0006580;ethanolamine metabolic process;33436;16;GO:0006553
GO:0006585;dopamine biosynthetic process from tyrosine;124;62;GO:0006511
GO:0006586;indolalkylamine metabolic process;1626169;2290;GO:0009065
GO:0006583;melanin biosynthetic process from tyrosine;278;70;GO:0006073
GO:0006584;catecholamine metabolic process;11089;666;GO:0006725
GO:0006589;octopamine biosynthetic process;138;39;GO:0006749
GO:0006587;serotonin biosynthetic process from tryptophan;102;9;GO:0006575
GO:0031538;negative regulation of anthocyanin metabolic process;177;7;GO:0010468
GO:0031539;positive regulation of anthocyanin metabolic process;34;38;GO:0046148
GO:0031536;positive regulation of exit from mitosis;349;219;GO:0048285
GO:0031537;regulation of anthocyanin metabolic process;428;203;GO:0010468
GO:0018570;p-cumate 2,3-dioxygenase activity;8;5;GO:0004497
GO:0018572;3,5-dichlorocatechol 1,2-dioxygenase activity;0;3;GO:0004497
GO:0018571;2,3-dihydroxy-p-cumate dioxygenase activity;0;4;GO:0004497
GO:0018574;2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity;0;2;GO:0004497
GO:0031530;gonadotropin-releasing hormone receptor binding;29;4;GO:0005509
GO:0018573;2-aminophenol 1,6-dioxygenase activity;0;4;GO:0004497
GO:0031531;thyrotropin-releasing hormone receptor binding;186;43;GO:0004872
GO:0018576;catechol 1,2-dioxygenase activity;16589;16;GO:0004497
GO:0018575;chlorocatechol 1,2-dioxygenase activity;130;4;GO:0004497
GO:0018578;protocatechuate 3,4-dioxygenase activity;21536;10;GO:0004497
GO:0031534;minus-end directed microtubule sliding;49;3;GO:0008028
GO:0018577;catechol 2,3-dioxygenase activity;5677;5;GO:0004497
GO:0031535;plus-end directed microtubule sliding;48;7;GO:0008028
GO:0018579;protocatechuate 4,5-dioxygenase activity;1736;4;GO:0004497
GO:0031533;mRNA cap methyltransferase complex;2522;10;GO:0005840
GO:0018559;1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity;0;0;GO:0004497
GO:0006592;ornithine biosynthetic process;335;435;GO:0006541
GO:0006593;ornithine catabolic process;970;9;GO:0006541
GO:0006590;thyroid hormone generation;3380;601;GO:0048193
GO:0006591;ornithine metabolic process;336548;233;GO:0006541
GO:0006596;polyamine biosynthetic process;381499;1500;GO:0009065
GO:0006597;spermine biosynthetic process;7405;328;GO:0009065
GO:0006595;polyamine metabolic process;395796;667;GO:0006569
GO:0006598;polyamine catabolic process;11393;262;GO:0006569
GO:0006599;phosphagen metabolic process;24309;9;GO:0006096
GO:0031527;filopodium membrane;3216;397;GO:0048471
GO:0031528;microvillus membrane;4804;1150;GO:0005886
GO:0031525;menthol biosynthetic process;2;3;GO:0006073
GO:0031526;brush border membrane;2252;1210;GO:0005886
GO:0018561;2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity;0;0;GO:0004497
GO:0031529;ruffle organization;2536;392;GO:0005934
GO:0018560;protocatechuate 3,4-dioxygenase type II activity;0;3;GO:0004497
GO:0018563;2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity;0;3;GO:0004497
GO:0018562;3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity;0;4;GO:0004497
GO:0031520;plasma membrane of cell tip;113;100;GO:0009986
GO:0018565;dihydroxydibenzothiophene dioxygenase activity;0;4;GO:0004497
GO:0018564;carbazole 1,9a-dioxygenase activity;2;4;GO:0004497
GO:0018567;styrene dioxygenase activity;0;4;GO:0004497
GO:0031523;Myb complex;268;72;GO:0048305
GO:0018566;1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity;0;3;GO:0004497
GO:0031524;menthol metabolic process;2;2;GO:0006073
GO:0018569;hydroquinone 1,2-dioxygenase activity;0;4;GO:0004497
GO:0031521;spitzenkorper;19;2;GO:0005576
GO:0018568;3,4-dihydroxyphenanthrene dioxygenase activity;0;3;GO:0004497
GO:0031522;cell envelope Sec protein transport complex;93;308;GO:0005737
GO:0031482;myosin XII complex;0;0;GO:0048309
GO:0031483;myosin XIII complex;0;1;GO:0048608
GO:0031480;myosin X complex;0;0;GO:0005524
GO:0031481;myosin XI complex;0;1;GO:0048309
GO:0043464;malolactic fermentation;1244;3;GO:0006099
GO:0043463;regulation of rhamnose catabolic process;0;2;GO:0046395
GO:0043466;pyrimidine nucleobase fermentation;0;2;GO:0006099
GO:0043465;regulation of fermentation;211;5;GO:0046395
GO:0043468;regulation of fucose catabolic process;1;2;GO:0006032
GO:0043467;regulation of generation of precursor metabolites and energy;28296;404;GO:0006091
GO:0043469;regulation of D-xylose catabolic process;1;2;GO:0046395
GO:0043470;regulation of carbohydrate catabolic process;3899;243;GO:0005975
GO:0043473;pigmentation;15697;2990;GO:0008544
GO:0043472;IgD binding;0;1;GO:0002227
GO:0031475;myosin V complex;86;6;GO:0005524
GO:0031476;myosin VI complex;14;2;GO:0005524
GO:0031473;myosin III binding;1;3;GO:0005524
GO:0031474;myosin IV complex;0;0;GO:0048193
GO:0031479;myosin IX complex;0;1;GO:0048608
GO:0031477;myosin VII complex;24;6;GO:0048608
GO:0031478;myosin VIII complex;0;1;GO:0048193
GO:0031471;ethanolamine degradation polyhedral organelle;15032;4;GO:0005768
GO:0031472;propanediol degradation polyhedral organelle;24;1;GO:0005737
GO:0031470;carboxysome;55948;8;GO:0005764
GO:0043475;pigment metabolic process involved in pigment accumulation;3;2;GO:0046148
GO:0043474;pigment metabolic process involved in pigmentation;917;10;GO:0043473
GO:0043477;pigment biosynthetic process involved in pigment accumulation;3;6;GO:0046148
GO:0043476;pigment accumulation;805;35;GO:0048646
GO:0043479;pigment accumulation in tissues in response to UV light;62;1;GO:0046148
GO:0043478;pigment accumulation in response to UV light;62;3;GO:0046148
GO:0043480;pigment accumulation in tissues;68;10;GO:0048405
GO:0043482;cellular pigment accumulation;704;98;GO:0046148
GO:0043481;anthocyanin accumulation in tissues in response to UV light;62;130;GO:0009908
GO:0043484;regulation of RNA splicing;37373;1620;GO:0008380
GO:0043483;anthocyanin biosynthetic process involved in anthocyanin accumulation in response to UV light;0;3;GO:0009908
GO:0031464;Cul4A-RING E3 ubiquitin ligase complex;3013;382;GO:0005634
GO:0031465;Cul4B-RING E3 ubiquitin ligase complex;405;222;GO:0005634
GO:0031462;Cul2-RING ubiquitin ligase complex;1586;372;GO:0005829
GO:0031463;Cul3-RING ubiquitin ligase complex;4349;1700;GO:0005829
GO:0031468;nuclear membrane reassembly;1939;212;GO:0007030
GO:0031469;bacterial microcompartment;233185;18;GO:0005576
GO:0031466;Cul5-RING ubiquitin ligase complex;634;265;GO:0005829
GO:0031467;Cul7-RING ubiquitin ligase complex;332;103;GO:0005829
GO:0031460;glycine betaine transport;23573;21;GO:0006826
GO:0031461;cullin-RING ubiquitin ligase complex;86122;1170;GO:0005829
GO:0043485;endosome to pigment granule transport;561;447;GO:0006897
GO:0043488;regulation of mRNA stability;102833;2050;GO:0010467
GO:0043487;regulation of RNA stability;104145;712;GO:0010467
GO:0043489;RNA stabilization;8477;672;GO:0006413
GO:0018491;2-oxobutyrate synthase activity;3171;5;GO:0004497
GO:0031459;ABC-type glycine betaine transporter activity;9;3;GO:0005215
GO:0043491;phosphatidylinositol 3-kinase/protein kinase B signal transduction;12048;39;GO:0007242
GO:0018490;4-hydroxyphenylpyruvate oxidase activity;0;4;GO:0004091
GO:0043490;malate-aspartate shuttle;336;92;GO:0006096
GO:0018493;formylmethanofuran dehydrogenase activity;6305;9;GO:0004497
GO:0043493;viral terminase complex;1817;0;GO:0005737
GO:0018492;carbon-monoxide dehydrogenase (acceptor) activity;18385;32;GO:0004746
GO:0018495;2-hydroxycyclohexane-1-carboxyl-CoA dehydrogenase activity;0;1;GO:0009065
GO:0043495;protein-membrane adaptor activity;7286;85;GO:0004872
GO:0018494;carvone reductase activity;0;3;GO:0004497
GO:0043494;CLRC complex;29;4;GO:0005829
GO:0018497;1-chloro-2,2-bis(4-chlorophenyl)ethane dehydrogenase activity;0;2;GO:0004073
GO:0031453;positive regulation of heterochromatin formation;1016;8;GO:0016570
GO:0018496;2,6-dihydroxycyclohexane-1-carboxyl-CoA dehydrogenase activity;0;2;GO:0004091
GO:0018499;cis-2,3-dihydrodiol DDT dehydrogenase activity;0;4;GO:0004497
GO:0031451;positive regulation of slow-twitch skeletal muscle fiber contraction;0;2;GO:0048407
GO:0018498;2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity;226;6;GO:0004091
GO:0031452;negative regulation of heterochromatin formation;556;7;GO:0016569
GO:0031457;glycine betaine catabolic process;11;3;GO:0006559
GO:0031458;ABC-type betaine transporter activity;0;1;GO:0005215
GO:0031455;glycine betaine metabolic process;47477;140;GO:0006570
GO:0031456;glycine betaine biosynthetic process;47466;35;GO:0009065
GO:0031450;negative regulation of slow-twitch skeletal muscle fiber contraction;0;2;GO:0048407
GO:0043497;regulation of protein heterodimerization activity;1;390;GO:0048193
GO:0043496;regulation of protein homodimerization activity;4;326;GO:0042302
GO:0018480;5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase activity;4946;10;GO:0004073
GO:0031448;positive regulation of fast-twitch skeletal muscle fiber contraction;114;31;GO:0048193
GO:0031449;regulation of slow-twitch skeletal muscle fiber contraction;155;27;GO:0048407
GO:0018482;4-formylbenzenesulfonate dehydrogenase activity;535;4;GO:0004067
GO:0018481;4-hydroxymuconic-semialdehyde dehydrogenase activity;4;3;GO:0004067
GO:0018484;4-hydroxybenzaldehyde dehydrogenase activity;12;5;GO:0004073
GO:0018483;6-oxohexanoate dehydrogenase activity;3;4;GO:0009081
GO:0018486;2-butanone oxidase activity;0;2;GO:0004497
GO:0031442;positive regulation of mRNA 3'-end processing;337;4;GO:0010467
GO:0102200;N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity;481;4;GO:0004721
GO:0018485;salicylaldehyde dehydrogenase activity;70;3;GO:0004073
GO:0031443;fast-twitch skeletal muscle fiber contraction;165;28;GO:0006936
GO:0018488;aryl-aldehyde oxidase activity;58;6;GO:0004041
GO:0031440;regulation of mRNA 3'-end processing;5811;7;GO:0003743
GO:0102202;soladodine glucosyltransferase activity;1222;3;GO:0006073
GO:0018487;vanillate O-demethylase (anaerobic) activity;0;1;GO:0046395
GO:0031441;negative regulation of mRNA 3'-end processing;4620;1;GO:0008380
GO:0102201;(+)-2-epi-prezizaene synthase activity;0;0;GO:0004497
GO:0031446;regulation of fast-twitch skeletal muscle fiber contraction;114;10;GO:0006936
GO:0018489;vanillate monooxygenase activity;776;4;GO:0004497
GO:0031447;negative regulation of fast-twitch skeletal muscle fiber contraction;0;2;GO:0048407
GO:0031444;slow-twitch skeletal muscle fiber contraction;194;124;GO:0006936
GO:0031445;regulation of heterochromatin formation;1951;5;GO:0016570
GO:0043428;2-heptaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;0;2;GO:0004091
GO:0102208;2-polyprenyl-6-hydroxyphenol methylase activity;9233;2;GO:0004091
GO:0043427;carbon fixation by 3-hydroxypropionate cycle;12;4;GO:0006099
GO:0043429;2-nonaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;8;3;GO:0004497
GO:0102209;trans-permethrin hydrolase activity;228;3;GO:0004553
GO:0102203;brassicasterol glucosyltransferase activity;1220;4;GO:0006073
GO:0102205;cholesterol alpha-glucosyltransferase activity;1223;2;GO:0006081
GO:0043420;anthranilate metabolic process;23984;32;GO:0009060
GO:0043422;protein kinase B binding;481;234;GO:0043402
GO:0043421;anthranilate catabolic process;2;2;GO:0009065
GO:0043424;protein histidine kinase binding;8609;32;GO:0043169
GO:0043423;3-phosphoinositide-dependent protein kinase binding;9;42;GO:0019901
GO:0043426;MRF binding;265;151;GO:0048471
GO:0043425;bHLH transcription factor binding;1911;696;GO:0030528
GO:0102211;unsaturated rhamnogalacturonyl hydrolase activity;835;2;GO:0004553
GO:0102210;rhamnogalacturonan endolyase activity;4080;5;GO:0004553
GO:0102213;in-chain hydroxy fatty acyl-CoA synthetase activity;0;0;GO:0006081
GO:0102212;unsaturated chondroitin disaccharide hydrolase activity;242;2;GO:0004553
GO:0102219;phosphogluco-amylopectin water dikinase activity;52;1;GO:0006096
GO:0043438;acetoacetic acid metabolic process;43;57;GO:0006066
GO:0102218;starch, H2O dikinase activity;68;1;GO:0005976
GO:0102215;thiocyanate methyltransferase activity;3;1;GO:0004725
GO:0102214;omega-hydroxy fatty acyl-CoA synthetase activity;0;1;GO:0006081
GO:0102217;6-phosphoglucan, water dikinase activity;54;2;GO:0006096
GO:0102216;maltodextrin water dikinase;68;1;GO:0005524
GO:0043431;2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone methyltransferase activity;1;2;GO:0004725
GO:0043430;2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;17;5;GO:0004091
GO:0043433;negative regulation of DNA-binding transcription factor activity;566;1220;GO:0030528
GO:0043435;response to corticotropin-releasing hormone;445;57;GO:0004971
GO:0043434;response to peptide hormone;36864;2210;GO:0009719
GO:0043436;oxoacid metabolic process;33934204;4700;GO:0006066
GO:0102224;GDP-2,4-diacetamido-2,4,6-trideoxy-alpha-D-glucopyranose hydrolase/2-epimerase activity;1;1;GO:0004553
GO:0102223;4,4'-diapophytoene desaturase (4,4'-diaponeurosporene-forming);375;0;GO:0006749
GO:0102220;hydrogenase activity (NAD+, ferredoxin);3;2;GO:0008061
GO:0043449;cellular alkene metabolic process;3673;112;GO:0006629
GO:0102229;amylopectin maltohydrolase activity;3946;4;GO:0004553
GO:0043442;acetoacetic acid catabolic process;2;2;GO:0006066
GO:0043441;acetoacetic acid biosynthetic process;0;3;GO:0006099
GO:0043446;cellular alkane metabolic process;92956;4;GO:0006631
GO:0043448;alkane catabolic process;1321;3;GO:0006073
GO:0043447;alkane biosynthetic process;91553;118;GO:0006073
GO:0043451;alkene catabolic process;4;1;GO:0006073
GO:0043450;alkene biosynthetic process;3665;118;GO:0006629
GO:0102233;crotonaldehyde redutase activity;0;0;GO:0004497
GO:0102232;acrolein reductase activity;0;0;GO:0004067
GO:0031495;negative regulation of mating type switching;0;2;GO:0048285
GO:0102235;1-penten-3-one reductase activity;0;0;GO:0004091
GO:0031496;positive regulation of mating type switching;61;5;GO:0048285
GO:0102234;but-1-en-3-one reductase activity;0;0;GO:0004091
GO:0031499;TRAMP complex;479;27;GO:0005737
GO:0031490;chromatin DNA binding;14599;2890;GO:0003677
GO:0102237;ATP:farnesol kinase activity;1;1;GO:0005524
GO:0031494;regulation of mating type switching;67;5;GO:0048285
GO:0102236;trans-4-hexen-3-one reductase activity;0;0;GO:0004497
GO:0031491;nucleosome binding;13772;1540;GO:0003682
GO:0031492;nucleosomal DNA binding;5434;1350;GO:0003677
GO:0102238;geraniol kinase activity (ATP-dependent) activity;0;0;GO:0004721
GO:0043453;alkyne biosynthetic process;0;3;GO:0046394
GO:0043452;cellular alkyne metabolic process;0;3;GO:0006066
GO:0043455;regulation of secondary metabolic process;5854;211;GO:0019748
GO:0043454;alkyne catabolic process;0;2;GO:0046395
GO:0043457;regulation of cellular respiration;4245;458;GO:0015986
GO:0043456;regulation of pentose-phosphate shunt;332;57;GO:0006096
GO:0043462;regulation of ATP-dependent activity;433;20;GO:0008528
GO:0043461;proton-transporting ATP synthase complex assembly;10213;112;GO:0005737
GO:0031486;myosin XVI complex;0;1;GO:0005524
GO:0102244;3-aminopropanal dehydrogenase activity;0;0;GO:0004067
GO:0031487;myosin XVII complex;0;1;GO:0048608
GO:0102243;ATP:geranylgeraniol phosphotransferase activity;4;2;GO:0004721
GO:0031484;myosin XIV complex;0;1;GO:0005524
GO:0102246;6-amino-6-deoxyfutalosine hydrolase activity;18;3;GO:0005524
GO:0031485;myosin XV complex;0;1;GO:0048608
GO:0102245;lupan-3beta,20-diol synthase activity;2;2;GO:0004497
GO:0102240;soyasapogenol B glucuronide galactosyltransferase activity;28;2;GO:0004553
GO:0031488;myosin XVIII complex;0;1;GO:0048608
GO:0031489;myosin V binding;963;361;GO:0005524
GO:0102241;soyasaponin III rhamnosyltransferase activity;49;2;GO:0006021
GO:0102248;diacylglycerol transacylase activity;0;0;GO:0008610
GO:0102247;malonyl-malonyl acyl carrier protein-condensing enzyme activity;0;0;GO:0006081
GO:0102249;phosphatidylcholine:diacylglycerol cholinephosphotransferase activity;0;0;GO:0004734
GO:0102255;neo-lambda-carrahexaose hydrolase activity;20;1;GO:0004553
GO:0102254;neoagarotetraose 1,3-alpha-3,6-anhydro-L-galactosidase activity;3;1;GO:0004553
GO:0102257;1-16:0-2-18:2-phosphatidylcholine sn-1 acylhydrolase activity;0;0;GO:0005576
GO:0102256;neoagarohexaose 1,3-alpha-3,6-anhydro-L-galactosidase activity;3;1;GO:0004553
GO:0102251;all-trans-beta-apo-10'-carotenal cleavage oxygenase activity;8;2;GO:0004497
GO:0102250;linear malto-oligosaccharide phosphorylase activity;29912;8;GO:0006032
GO:0102253;neoagarobiose 1,3-alpha-3,6-anhydro-L-galactosidase activity;3;1;GO:0004553
GO:0102252;cellulose 1,4-beta-cellobiosidase activity (reducing end);121;1;GO:0004553
GO:0102259;1,2-diacylglycerol acylhydrolase activity;7;1;GO:0008610
GO:0102258;1,3-diacylglycerol acylhydrolase activity;7;0;GO:0008610
GO:0102266;tRNA-dihydrouridine20a synthase activity;17524;3;GO:0003906
GO:0102265;tRNA-dihydrouridine47 synthase activity;2737;1;GO:0003906
GO:0102267;tRNA-dihydrouridine20b synthase activity;34;3;GO:0003906
GO:0102262;tRNA-dihydrouridine16 synthase activity;7658;3;GO:0003735
GO:0102261;8-hydroxy-5-deazaflavin:NADPH oxidoreductase activity;91;2;GO:0004091
GO:0102264;tRNA-dihydrouridine20 synthase activity;10960;1;GO:0003735
GO:0102263;tRNA-dihydrouridine17 synthase activity;60;2;GO:0003906
GO:0102277;2-acetamido-4-O-(2-amino-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-D-glucose exo-beta-D-glucosaminidase activity;0;0;GO:0004553
GO:0102276;2-oxoglutarate oxygenase/decarboxylase (ethylene-forming) activity;2048;2;GO:0006096
GO:0102279;lecithin:11-cis retinol acyltransferase activity;11;3;GO:0004073
GO:0102278;N,N'-diacetylchitobiose synthase activity;0;1;GO:0006021
GO:0102273;homophytochelatin synthase (dimmer forming) activity;0;0;GO:0004867
GO:0102272;homophytochelatin synthase activity (polymer-forming);0;0;GO:0004867
GO:0102275;cysteine-S-conjugate N-malonyl transferase activity;0;1;GO:0004041
GO:0102274;glutathione S-conjugate carboxypeptidase activity;0;1;GO:0008029
GO:0102280;choline monooxygenase activity (NADP-dependent);0;0;GO:0004497
GO:0102281;formylaminopyrimidine deformylase activity;0;0;GO:0003735
GO:0102287;4-coumaroylhexanoylmethane synthase activity;0;0;GO:0004497
GO:0102289;beta-amyrin 11-oxidase activity;21;2;GO:0004601
GO:0102286;ornithine N-delta-acetyltransferase activity;0;0;GO:0004073
GO:0102285;1-deoxy-11-oxopentalenate oxygenase activity;33;2;GO:0004497
GO:0102291;11alpha-hydroxy-beta-amyrin dehydrogenase activity;21;2;GO:0004073
GO:0102290;beta-amyrin monooxygenase activity;21;2;GO:0004497
GO:0102293;pheophytinase b activity;582;4;GO:0006032
GO:0102292;30-hydroxy-beta-amyrin 11-hydroxylase activity;0;0;GO:0004073
GO:0102299;linolenate 9R-lipoxygenase activity;7;2;GO:0004497
GO:0102298;selenocystathione synthase activity;0;0;GO:0004705
GO:0102295;4-methylumbelliferyl glucoside 6'-O-malonyltransferase activity;0;0;GO:0006022
GO:0102294;cholesterol dehydrogenase activity;101;3;GO:0004601
GO:0102297;selenate adenylyltransferase activity;0;0;GO:0004730
GO:0102296;4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase activity;458;2;GO:0004497
GO:0016403;dimethylargininase activity;2595;62;GO:0004467
GO:0016404;15-hydroxyprostaglandin dehydrogenase (NAD+) activity;190;0;GO:0004497
GO:0016405;CoA-ligase activity;265344;220;GO:0004497
GO:0016406;carnitine O-acyltransferase activity;3605;27;GO:0006631
GO:0016407;acetyltransferase activity;1139370;1900;GO:0016567
GO:0016408;C-acyltransferase activity;207444;41;GO:0004734
GO:0016409;palmitoyltransferase activity;129060;623;GO:0004722
GO:0004421;hydroxymethylglutaryl-CoA synthase activity;19197;308;GO:0004041
GO:0004420;hydroxymethylglutaryl-CoA reductase (NADPH) activity;30711;337;GO:0004091
GO:0004423;iduronate-2-sulfatase activity;9784;82;GO:0005576
GO:0004422;hypoxanthine phosphoribosyltransferase activity;83871;38;GO:0004067
GO:0004414;homoserine O-acetyltransferase activity;46880;8;GO:0004067
GO:0004413;homoserine kinase activity;112019;539;GO:0004721
GO:0004416;hydroxyacylglutathione hydrolase activity;53867;449;GO:0004746
GO:0004415;hyalurononglucosaminidase activity;20935;161;GO:0005576
GO:0004418;hydroxymethylbilane synthase activity;170685;1410;GO:0004041
GO:0004417;hydroxyethylthiazole kinase activity;51503;603;GO:0004721
GO:0004419;hydroxymethylglutaryl-CoA lyase activity;17151;143;GO:0004067
GO:0016410;N-acyltransferase activity;888513;1250;GO:0004867
GO:0016411;acylglycerol O-acyltransferase activity;127212;180;GO:0008610
GO:0016412;serine O-acyltransferase activity;121548;8;GO:0004081
GO:0016413;O-acetyltransferase activity;177227;191;GO:0004089
GO:0004430;1-phosphatidylinositol 4-kinase activity;14391;352;GO:0004721
GO:0004425;indole-3-glycerol-phosphate synthase activity;140079;325;GO:0004497
GO:0004424;imidazoleglycerol-phosphate dehydratase activity;128103;300;GO:0006067
GO:0004427;inorganic diphosphate phosphatase activity;194834;293;GO:0004723
GO:0016401;palmitoyl-CoA oxidase activity;128;221;GO:0004601
GO:0016402;pristanoyl-CoA oxidase activity;49;364;GO:0004067
GO:0004401;histidinol-phosphatase activity;92412;60;GO:0004723
GO:0004400;histidinol-phosphate transaminase activity;168005;413;GO:0004467
GO:0004410;homocitrate synthase activity;8511;25;GO:0006099
GO:0004412;homoserine dehydrogenase activity;127213;286;GO:0004067
GO:0004411;homogentisate 1,2-dioxygenase activity;57364;155;GO:0004497
GO:0004402;histone acetyltransferase activity;110028;2890;GO:0016570
GO:0004407;histone deacetylase activity;80910;1250;GO:0016570
GO:0004409;homoaconitate hydratase activity;5656;7;GO:0006067
GO:0004408;holocytochrome-c synthase activity;11601;132;GO:0003824
GO:0016447;somatic recombination of immunoglobulin gene segments;4154;509;GO:0002776
GO:0004461;lactose synthase activity;498;55;GO:0004553
GO:0004460;L-lactate dehydrogenase (cytochrome) activity;2772;4;GO:0004746
GO:0004463;leukotriene-A4 hydrolase activity;11486;65;GO:0004497
GO:0004462;lactoylglutathione lyase activity;68565;643;GO:0004730
GO:0004465;lipoprotein lipase activity;4663;191;GO:0006629
GO:0004464;leukotriene-C4 synthase activity;315;270;GO:0004449
GO:0004467;long-chain fatty acid-CoA ligase activity;34007;1420;GO:0006081
GO:0004466;long-chain-acyl-CoA dehydrogenase activity;10730;385;GO:0006631
GO:0004458;D-lactate dehydrogenase (cytochrome) activity;1458;22;GO:0003854
GO:0004457;lactate dehydrogenase activity;64686;38;GO:0004746
GO:0004459;L-lactate dehydrogenase activity;53004;737;GO:0004746
GO:0016453;C-acetyltransferase activity;156125;38;GO:0004867
GO:0016454;C-palmitoyltransferase activity;1720;70;GO:0004722
GO:0016456;X chromosome located dosage compensation complex, transcription activating;32;12;GO:0003677
GO:0016436;rRNA (uridine) methyltransferase activity;37572;10;GO:0003729
GO:0016438;tRNA-queuosine beta-mannosyltransferase activity;0;3;GO:0006021
GO:0004470;malic enzyme activity;163114;562;GO:0006066
GO:0004471;malate dehydrogenase (decarboxylating) (NAD+) activity;80227;0;GO:0003824
GO:0004474;malate synthase activity;78789;180;GO:0006099
GO:0004473;malate dehydrogenase (decarboxylating) (NADP+) activity;9118;0;GO:0004073
GO:0004476;mannose-6-phosphate isomerase activity;84036;590;GO:0006032
GO:0004475;mannose-1-phosphate guanylyltransferase (GTP) activity;30218;8;GO:0006022
GO:0004478;methionine adenosyltransferase activity;179023;2240;GO:0004497
GO:0004477;methenyltetrahydrofolate cyclohydrolase activity;122693;92;GO:0004497
GO:0004468;lysine N-acetyltransferase activity, acting on acetyl phosphate as donor;343;155;GO:0004723
GO:0016441;post-transcriptional gene silencing;110860;156;GO:0034470
GO:0016442;RISC complex;87320;1290;GO:0005840
GO:0016443;bidentate ribonuclease III activity;47;9;GO:0004518
GO:0016444;somatic cell DNA recombination;96044;513;GO:0000746
GO:0016445;somatic diversification of immunoglobulins;4917;151;GO:0002776
GO:0016446;somatic hypermutation of immunoglobulin genes;600;1940;GO:0002474
GO:0102901;isopimaradienol hydroxylase activity;0;0;GO:0046395
GO:0016426;tRNA (adenine) methyltransferase activity;80982;7;GO:0003729
GO:0102900;dehydroabietadienal hydroxylase activity;0;0;GO:0046395
GO:0016427;tRNA (cytosine) methyltransferase activity;17521;9;GO:0003729
GO:0102903;gamma-terpinene synthase activity;14;2;GO:0004497
GO:0016428;tRNA (cytosine-5-)-methyltransferase activity;5247;0;GO:0003729
GO:0102902;isopimaradienal hydroxylase activity;0;0;GO:0004497
GO:0016429;tRNA (adenine-N1-)-methyltransferase activity;31002;0;GO:0003735
GO:0004441;inositol-1,4-bisphosphate 1-phosphatase activity;162;117;GO:0004721
GO:0102905;valencene synthase activity;11;3;GO:0004497
GO:0102904;germacrene C synthase activity;4;2;GO:0004714
GO:0004445;inositol-polyphosphate 5-phosphatase activity;12358;322;GO:0005524
GO:0102907;sesquisabinene synthase activity;0;0;GO:0004497
GO:0102906;7-epi-alpha-selinene synthase activity;2;2;GO:0004497
GO:0004436;phosphatidylinositol diacylglycerol-lyase activity;2388;3;GO:0004734
GO:0004435;phosphatidylinositol phospholipase C activity;73631;1100;GO:0004721
GO:0004438;phosphatidylinositol-3-phosphate phosphatase activity;15742;10;GO:0004721
GO:0004439;phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;6464;264;GO:0004721
GO:0016430;tRNA (adenine-N6-)-methyltransferase activity;11933;0;GO:0003735
GO:0016432;tRNA-uridine aminocarboxypropyltransferase activity;10640;8;GO:0003906
GO:0016433;rRNA (adenine) methyltransferase activity;353849;318;GO:0003729
GO:0016434;rRNA (cytosine) methyltransferase activity;91759;489;GO:0003729
GO:0016435;rRNA (guanine) methyltransferase activity;157619;31;GO:0003729
GO:0016414;O-octanoyltransferase activity;180;4;GO:0004734
GO:0102912;(-)-lactol dehydrogenase activity;0;0;GO:0004730
GO:0016415;octanoyltransferase activity;117706;15;GO:0004081
GO:0102911;(-)-secoisolariciresinol dehydrogenase activity;5;0;GO:0004497
GO:0016416;O-palmitoyltransferase activity;3314;22;GO:0004722
GO:0102914;N-methyl-3-aminomethylindole N-methyltransferase activity;0;1;GO:0004497
GO:0016417;S-acyltransferase activity;334187;146;GO:0004734
GO:0102913;3-aminomethylindole N-methyltransferase activity;1;1;GO:0004497
GO:0016418;S-acetyltransferase activity;72401;186;GO:0004723
GO:0016419;S-malonyltransferase activity;111481;136;GO:0004734
GO:0102910;dirigent protein activity;1;2;GO:0003700
GO:0004450;isocitrate dehydrogenase (NADP+) activity;132600;1;GO:0003824
GO:0102919;5,6-dimethylbenzimidazole synthase activity;2364;3;GO:0004497
GO:0004452;isopentenyl-diphosphate delta-isomerase activity;70582;506;GO:0003906
GO:0004451;isocitrate lyase activity;59210;182;GO:0004067
GO:0004454;ketohexokinase activity;1533;159;GO:0006096
GO:0102916;sesamin synthase activity;0;1;GO:0006033
GO:0004453;juvenile-hormone esterase activity;18;7;GO:0008544
GO:0102915;piperitol synthase activity;0;2;GO:0006030
GO:0004456;phosphogluconate dehydratase activity;37660;75;GO:0006067
GO:0102918;(R)-reticuline 7-O-methyltransferase activity;3;0;GO:0004725
GO:0004455;ketol-acid reductoisomerase activity;168156;324;GO:0009065
GO:0102917;(S)-reticuline 7-O-methyltransferase activity;3;0;GO:0004497
GO:0004447;iodide peroxidase activity;961;155;GO:0004601
GO:0004446;inositol-hexakisphosphate phosphatase activity;1917;8;GO:0004723
GO:0004449;isocitrate dehydrogenase (NAD+) activity;3910;1;GO:0003824
GO:0004448;isocitrate dehydrogenase [NAD(P)+] activity;136510;0;GO:0003824
GO:0016420;malonyltransferase activity;111535;6;GO:0004081
GO:0016421;CoA carboxylase activity;200515;55;GO:0004497
GO:0016422;mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity;3154;0;GO:0003729
GO:0016423;tRNA (guanine) methyltransferase activity;348636;157;GO:0003729
GO:0102923;3'-N-debenzoyl-2'-deoxytaxol N-benzoyltransferase activity;12247;0;GO:0006073
GO:0102922;phenylpropanoyltransferase activity;1;1;GO:0004073
GO:0102925;solanine UDP-galactose galactosyltransferase activity;0;0;GO:0008800
GO:0102924;gibberellin A44,2-oxoglutarate:oxygen oxidoreductase activity;24;0;GO:0004091
GO:0102921;mannosylglycerate synthase activity;6;2;GO:0006030
GO:0102920;acyl coenzyme A: isopenicillin N acyltransferase activity;37;1;GO:0004041
GO:0102927;beta-chaconine rhamnosyltransferase activity;0;0;GO:0006073
GO:0102926;solanidine glucosyltransferase activity;0;0;GO:0006073
GO:0102929;lachrymatory factor synthase activity;0;0;GO:0004449
GO:0102928;beta-solanine rhamnosyltransferase activity;0;0;GO:0006073
GO:0016490;structural constituent of peritrophic membrane;8;4;GO:0043169
GO:0016491;oxidoreductase activity;48144424;29500;GO:0016491
GO:0016492;G protein-coupled neurotensin receptor activity;996;6;GO:0004930
GO:0016493;C-C chemokine receptor activity;5249;693;GO:0005031
GO:0016494;C-X-C chemokine receptor activity;2498;304;GO:0005031
GO:0016495;C-X3-C chemokine receptor activity;290;54;GO:0005031
GO:0016496;substance P receptor activity;81;1;GO:0004930
GO:0016497;substance K receptor activity;20;2;GO:0004930
GO:0016498;neuromedin K receptor activity;0;1;GO:0004930
GO:0016499;orexin receptor activity;1170;95;GO:0004930
GO:0102934;costunolide synthase activity;43;2;GO:0004497
GO:0102933;GDP-4-dehydro-6-deoxy-D-mannose-4-aminotransferase activity;245;2;GO:0006022
GO:0102936;gypsogenate-UDP-glucosyltransferase activity;0;0;GO:0004553
GO:0102935;gypsogenin-UDP-glucosyltransferase activity;0;1;GO:0006029
GO:0102930;4-hydroxybenzoate geranyltransferase activity;5;2;GO:0004073
GO:0102932;pterocarpan reductase activity;0;0;GO:0004497
GO:0102931;(Z,E)-alpha- farnesene synthase activity;0;0;GO:0004497
GO:0102938;orcinol O-methyltransferase activity;1338;3;GO:0004497
GO:0102937;16-alpha-hydroxygypsogenate-UDP-glucosyltransferase activity;0;0;GO:0004553
GO:0102939;3-methoxy-5-hydroxytoluene O-methyltransferase activity;0;1;GO:0004497
GO:0016480;negative regulation of transcription by RNA polymerase III;6238;98;GO:0045944
GO:0016482;cytosolic transport;69176;634;GO:0006810
GO:0016483;tryptophan hydroxylase activator activity;0;1;GO:0004867
GO:0016485;protein processing;485300;3370;GO:0006412
GO:0016486;peptide hormone processing;2676;1160;GO:0004867
GO:0016487;farnesol metabolic process;106;6;GO:0006722
GO:0016488;farnesol catabolic process;52;9;GO:0009062
GO:0016469;proton-transporting two-sector ATPase complex;1381813;1150;GO:0008026
GO:0102945;soyasapogenol B UDP-glucosyl transferase activity;0;0;GO:0006073
GO:1905200;gibberellic acid transmembrane transport;9;4;GO:0006869
GO:0102944;medicagenate UDP-glucosyltransferase activity;0;0;GO:0004553
GO:0102947;(+)-delta-cadinene-8-hydroxylase activity;0;0;GO:0004497
GO:0102946;soyasapogenol E UDP-glucosyltransferase activity;0;0;GO:0006073
GO:0102941;3,5-dihydroxyanisole O-methyltransferase activity;0;0;GO:0004497
GO:1905204;negative regulation of connective tissue replacement;55;5;GO:0048407
GO:0102940;phloroglucinol O-methyltransferase activity;0;0;GO:0004497
GO:1905203;regulation of connective tissue replacement;230;4;GO:0048407
GO:0004481;methylene-fatty-acyl-phospholipid synthase activity;3;4;GO:0008610
GO:0102943;trans-2,3-dihydro-3-hydroxy-anthranilate isomerase activity;633;2;GO:0004497
GO:1905202;methylcrotonoyl-CoA carboxylase complex;359;79;GO:0006099
GO:0102942;3,5-dimethoxyphenol O-methyltransferase activity;0;0;GO:0004497
GO:1905201;gibberellin transmembrane transporter activity;7;0;GO:0005525
GO:0004483;mRNA (nucleoside-2'-O-)-methyltransferase activity;20983;0;GO:0003729
GO:1905208;negative regulation of cardiocyte differentiation;658;185;GO:0048608
GO:0004482;mRNA 5'-cap (guanine-N7-)-methyltransferase activity;49543;0;GO:0003729
GO:1905207;regulation of cardiocyte differentiation;1516;40;GO:0048608
GO:0004485;methylcrotonoyl-CoA carboxylase activity;2347;292;GO:0004497
GO:0004484;mRNA guanylyltransferase activity;17586;270;GO:0003743
GO:1905205;positive regulation of connective tissue replacement;137;198;GO:0048407
GO:0004487;methylenetetrahydrofolate dehydrogenase (NAD+) activity;287;0;GO:0006749
GO:0102949;1,2-rhamnosyltransferase activity;0;0;GO:0006022
GO:0004486;methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;224432;0;GO:0006749
GO:0102948;luteolin C-glucosyltransferase activity;0;0;GO:0006073
GO:0004489;methylenetetrahydrofolate reductase (NAD(P)H) activity;159581;373;GO:0006749
GO:0004488;methylenetetrahydrofolate dehydrogenase (NADP+) activity;183628;1;GO:0006749
GO:1905209;positive regulation of cardiocyte differentiation;718;37;GO:0048608
GO:0004479;methionyl-tRNA formyltransferase activity;160918;599;GO:0006413
GO:0016471;vacuolar proton-transporting V-type ATPase complex;26311;1020;GO:0005764
GO:0016472;sodium ion-transporting two-sector ATPase complex;0;2;GO:0008026
GO:0016473;sodium ion-transporting F-type ATPase complex;0;1;GO:0008565
GO:0016474;sodium ion-transporting V-type ATPase complex;0;1;GO:0008026
GO:0102950;indole-3-acetyl-valine synthetase activity;0;1;GO:0006073
GO:0016475;detection of nuclear:cytoplasmic ratio;0;3;GO:0008565
GO:0016476;regulation of embryonic cell shape;412;34;GO:0048608
GO:0016477;cell migration;199399;8590;GO:0016477
GO:0016479;negative regulation of transcription by RNA polymerase I;644;206;GO:0045944
GO:0102956;UDP-glucose:sinapaldehyde 4-beta-D-glucosyltransferase activity;3;1;GO:0006022
GO:1905211;negative regulation of fibroblast chemotaxis;0;0;GO:0050921
GO:0016459;myosin complex;214300;3040;GO:0005575
GO:0102955;S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity;29124;2;GO:0004725
GO:1905210;regulation of fibroblast chemotaxis;0;0;GO:0050900
GO:0004490;methylglutaconyl-CoA hydratase activity;613;141;GO:0006081
GO:0102952;UDP-glucose:coniferaldehyde 4-beta-D-glucosyltransferase activity;3;1;GO:0006022
GO:1905215;negative regulation of RNA binding;1;0;GO:0010468
GO:0102951;indole-3-acetyl-phenylalanine synthetase activity;0;1;GO:0006073
GO:1905214;regulation of RNA binding;21;73;GO:0030528
GO:0004492;methyl/ethyl malonyl-CoA decarboxylase activity;30;3;GO:0006081
GO:0102954;dalcochinase activity;0;0;GO:0006029
GO:1905213;negative regulation of mitotic chromosome condensation;117;4;GO:0048285
GO:0004491;methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity;48803;6;GO:0004067
GO:0102953;hypoglycin A gamma-glutamyl transpeptidase activity;0;7;GO:0008544
GO:1905212;positive regulation of fibroblast chemotaxis;0;0;GO:0050921
GO:0004494;methylmalonyl-CoA mutase activity;54988;176;GO:0006066
GO:1905219;regulation of platelet formation;48;1;GO:0050877
GO:0004493;methylmalonyl-CoA epimerase activity;6049;6;GO:0006099
GO:1905218;cellular response to astaxanthin;1;0;GO:0006954
GO:0004496;mevalonate kinase activity;25303;173;GO:0004714
GO:1905217;response to astaxanthin;6;1;GO:0009725
GO:0004495;mevaldate reductase activity;0;5;GO:0004497
GO:1905216;positive regulation of RNA binding;19;26;GO:0010467
GO:0004498;calcidiol 1-monooxygenase activity;146;10;GO:0004497
GO:0004497;monooxygenase activity;2233579;7470;GO:0004497
GO:0004499;N,N-dimethylaniline monooxygenase activity;71461;733;GO:0004497
GO:0016460;myosin II complex;1256;475;GO:0035095
GO:0016461;unconventional myosin complex;302;205;GO:0005525
GO:0016462;pyrophosphatase activity;11130545;3660;GO:0004723
GO:0016463;P-type zinc transporter activity;85;2;GO:0005215
GO:0016464;chloroplast protein-transporting ATPase activity;879;1;GO:0008544
GO:0102960;momilactone-A synthase activity;7;2;GO:0004497
GO:0016465;chaperonin ATPase complex;55;5;GO:0005737
GO:0102967;10-hydroxygeraniol oxidoreductase activity;0;1;GO:0004091
GO:0102966;arachidoyl-CoA:1-dodecanol O-acyltransferase activity;87;4;GO:0008610
GO:0102969;10-oxogeraniol oxidoreductase activity;0;1;GO:0004497
GO:0102968;10-hydroxygeranial oxidoreductase activity;0;1;GO:0004091
GO:0102963;(S)-corytuberine synthase activity;2;0;GO:0004497
GO:0102965;alcohol-forming long-chain fatty acyl-CoA reductase activity;13152;5;GO:0006066
GO:0102964;S-adenosyl-L-methionine:(S)-corytuberine-N-methyltransferase activity;1;0;GO:0004497
GO:0102970;7-deoxyloganetic acid glucosyltransferase activity;10;2;GO:0006073
GO:0102972;gibberellin A12,2-oxoglutarate:oxygen oxidoreductase activity (gibberellin A110-forming);0;0;GO:0004497
GO:0102971;phosphinothricin N-acetyltransferase activity;1800;2;GO:0004073
GO:0102978;furaneol oxidoreductase activity;25;2;GO:0004497
GO:0102977;nitrilotriacetate monooxygenase activity (FMN-dependent);836;3;GO:0004497
GO:0102979;homofuraneol oxidoreductase activity;0;1;GO:0004091
GO:0102974;hydroxyversicolorone reductase activity;4;2;GO:0004091
GO:0102973;norsolorinate anthrone synthase activity;8;2;GO:0006081
GO:0102976;versiconal reductase activity;4;2;GO:0004067
GO:0102975;versiconal hemiacetal acetate reductase activity;4;2;GO:0006081
GO:0102981;4-hydroxy-5-methyl-2-propyl-3(2H)-furanone oxidoreductase activity;0;0;GO:0004091
GO:0102980;2-butyl-4-hydroxy-5-methyl-3(2H)-furanoneoxidoreductase activity;0;0;GO:0004497
GO:0102983;xylogalacturonan beta-1,3-xylosyltransferase activity;130;1;GO:0004553
GO:0102982;UDP-3-dehydro-alpha-D-glucose dehydrogenase activity;1;1;GO:0006066
GO:0102989;5-pentadecatrienylresorcinol synthase activity;0;0;GO:0006073
GO:0102988;9,12-cis-hexadecadienoic acid delta 15 desaturase activity;0;1;GO:0008610
GO:0102985;delta12-fatty-acid desaturase activity;163;2;GO:0008610
GO:0102984;sulfoacetaldehyde dehydrogenase activity;172;2;GO:0004067
GO:0102987;palmitoleic acid delta 12 desaturase activity;8;1;GO:0006631
GO:0102986;trehalose synthase activity;315;3;GO:0006030
GO:0102992;2-methylbutyronitrile hydroxylase activity;0;1;GO:0046395
GO:0102991;myristoyl-CoA hydrolase activity;663;7;GO:0004721
GO:0102993;linolenate delta15 desaturase activity;3;1;GO:0008610
GO:0102990;5-n-alk(en)ylresorcinol O-methyltransferase activity;1;1;GO:0004723
GO:0102999;UDP-glucose:2-hydroxylamino-4,6-dinitrotoluene-O-glucosyltransferase activity;0;0;GO:0006022
GO:0102996;beta,beta digalactosyldiacylglycerol galactosyltransferase activity;6;1;GO:0004553
GO:0102995;angelicin synthase activity;3;2;GO:0006033
GO:0102998;4-sulfomuconolactone hydrolase activity;199;2;GO:0004553
GO:0102997;progesterone 5beta- reductase activity;0;0;GO:0004629
GO:0090337;regulation of formin-nucleated actin cable assembly;113;4;GO:0048193
GO:1905145;cellular response to acetylcholine;23788;106;GO:0006929
GO:0090338;positive regulation of formin-nucleated actin cable assembly;82;5;GO:0048193
GO:1905144;response to acetylcholine;23919;76;GO:0007631
GO:0090335;regulation of brown fat cell differentiation;1084;45;GO:0045595
GO:1905143;eukaryotic translation initiation factor 2 complex assembly;37;1;GO:0003735
GO:0090336;positive regulation of brown fat cell differentiation;630;193;GO:0045595
GO:1905142;positive regulation of apical ectodermal ridge formation;0;0;GO:0048704
GO:0090333;regulation of stomatal closure;1552;131;GO:0010468
GO:1905149;positive regulation of smooth muscle hypertrophy;4;1;GO:0048608
GO:0090334;regulation of cell wall (1->3)-beta-D-glucan biosynthetic process;46;1;GO:0009405
GO:1905148;negative regulation of smooth muscle hypertrophy;0;2;GO:0048608
GO:0090331;negative regulation of platelet aggregation;520;100;GO:0042592
GO:1905147;regulation of smooth muscle hypertrophy;4;2;GO:0048608
GO:0090332;stomatal closure;1727;135;GO:0009579
GO:1905146;lysosomal protein catabolic process;917;105;GO:0006914
GO:0090330;regulation of platelet aggregation;1214;386;GO:0042330
GO:1905141;negative regulation of apical ectodermal ridge formation;0;0;GO:0048704
GO:1905140;regulation of apical ectodermal ridge formation;0;0;GO:0048704
GO:0090339;negative regulation of formin-nucleated actin cable assembly;5;3;GO:0048193
GO:0090348;regulation of cellular organofluorine metabolic process;26;3;GO:0010468
GO:1905156;negative regulation of photosynthesis;217;4;GO:0015979
GO:0090349;negative regulation of cellular organohalogen metabolic process;26;4;GO:0046686
GO:1905155;positive regulation of membrane invagination;666;38;GO:0048193
GO:0090346;cellular organofluorine metabolic process;73;8;GO:0006721
GO:1905154;negative regulation of membrane invagination;79;10;GO:0048193
GO:0090347;regulation of cellular organohalogen metabolic process;27;4;GO:0010468
GO:1905153;regulation of membrane invagination;802;16;GO:0048193
GO:0090345;cellular organohalogen metabolic process;74;10;GO:0006725
GO:1905157;positive regulation of photosynthesis;26;3;GO:0015979
GO:0090340;positive regulation of secretion of lysosomal enzymes;51;6;GO:0048193
GO:0090341;negative regulation of secretion of lysosomal enzymes;66;209;GO:0048193
GO:1905152;positive regulation of voltage-gated sodium channel activity;12;1;GO:0048169
GO:1905151;negative regulation of voltage-gated sodium channel activity;11;0;GO:0048169
GO:1905150;regulation of voltage-gated sodium channel activity;28;59;GO:0048169
GO:0090315;negative regulation of protein targeting to membrane;250;64;GO:0048193
GO:1905167;positive regulation of lysosomal protein catabolic process;162;57;GO:0048193
GO:0090316;positive regulation of intracellular protein transport;9909;1110;GO:0010467
GO:1905166;negative regulation of lysosomal protein catabolic process;133;10;GO:0048193
GO:0090313;regulation of protein targeting to membrane;4203;10;GO:0016021
GO:1905165;regulation of lysosomal protein catabolic process;453;19;GO:0048193
GO:0090314;positive regulation of protein targeting to membrane;3863;484;GO:0048193
GO:1905164;positive regulation of phagosome maturation;4;2;GO:0048661
GO:0090311;regulation of protein deacetylation;1849;40;GO:0016567
GO:0090312;positive regulation of protein deacetylation;620;331;GO:0010468
GO:1905169;regulation of protein localization to phagocytic vesicle;129;5;GO:0048193
GO:0090310;negative regulation of DNA methylation-dependent heterochromatin formation;211;3;GO:0045944
GO:1905168;positive regulation of double-strand break repair via homologous recombination;1890;105;GO:0045727
GO:0090319;positive regulation of chylomicron remodeling;1;6;GO:0048193
GO:1905163;negative regulation of phagosome maturation;0;0;GO:0048661
GO:1905162;regulation of phagosome maturation;73;3;GO:0048661
GO:0090317;negative regulation of intracellular protein transport;2064;54;GO:0010467
GO:1905161;protein localization to phagocytic vesicle;135;4;GO:0006909
GO:0090318;regulation of chylomicron remodeling;1;3;GO:0048193
GO:0090326;positive regulation of locomotion involved in locomotory behavior;120;6;GO:0040011
GO:1905178;regulation of cardiac muscle tissue regeneration;201;6;GO:0048407
GO:0090327;negative regulation of locomotion involved in locomotory behavior;101;8;GO:0040011
GO:1905177;tracheary element differentiation;154;4;GO:0048468
GO:0090324;negative regulation of oxidative phosphorylation;260;166;GO:0050789
GO:1905176;positive regulation of vascular associated smooth muscle cell dedifferentiation;60;4;GO:0048608
GO:0090325;regulation of locomotion involved in locomotory behavior;294;55;GO:0040011
GO:1905175;negative regulation of vascular associated smooth muscle cell dedifferentiation;4;0;GO:0010717
GO:0090322;regulation of superoxide metabolic process;1014;211;GO:0050789
GO:0090323;prostaglandin secretion involved in immune response;0;3;GO:0002684
GO:0090320;regulation of chylomicron remnant clearance;6;3;GO:0048193
GO:0090321;positive regulation of chylomicron remnant clearance;5;4;GO:0048193
GO:1905179;negative regulation of cardiac muscle tissue regeneration;155;47;GO:0048405
GO:1905170;negative regulation of protein localization to phagocytic vesicle;1;1;GO:0048193
GO:1905174;regulation of vascular associated smooth muscle cell dedifferentiation;69;1;GO:0048608
GO:1905173;eukaryotic translation initiation factor 2B complex assembly;0;0;GO:0003735
GO:0090328;regulation of olfactory learning;78;15;GO:0007612
GO:1905172;RISC complex binding;213;8;GO:0003700
GO:0090329;regulation of DNA-templated DNA replication;33407;6;GO:0006281
GO:1905171;positive regulation of protein localization to phagocytic vesicle;123;6;GO:0048193
GO:1905101;negative regulation of apoptosome assembly;2;1;GO:0008631
GO:1905100;regulation of apoptosome assembly;2;0;GO:0008631
GO:1905102;positive regulation of apoptosome assembly;0;0;GO:0008631
GO:1905109;regulation of pulmonary blood vessel remodeling;12;1;GO:0010717
GO:1905108;guanosine binding;4;0;GO:0005525
GO:0090304;nucleic acid metabolic process;75096064;3350;GO:0006139
GO:0090305;nucleic acid phosphodiester bond hydrolysis;29778;3060;GO:0004518
GO:1905111;positive regulation of pulmonary blood vessel remodeling;10;9;GO:0010717
GO:1905110;negative regulation of pulmonary blood vessel remodeling;0;0;GO:0010717
GO:0090303;positive regulation of wound healing;3520;591;GO:0010717
GO:0090300;positive regulation of neural crest formation;2;2;GO:0048704
GO:1905116;positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore;45;0;GO:0048285
GO:0090301;negative regulation of neural crest formation;6;6;GO:0048704
GO:1905115;regulation of lateral attachment of mitotic spindle microtubules to kinetochore;45;0;GO:0048285
GO:0051369;peptidyl-threonine decanoylation;0;2;GO:0006464
GO:1905552;positive regulation of protein localization to endoplasmic reticulum;171;7;GO:0048193
GO:1905551;negative regulation of protein localization to endoplasmic reticulum;37;3;GO:0010468
GO:1905550;regulation of protein localization to endoplasmic reticulum;210;2;GO:0006986
GO:1905556;ciliary vesicle assembly;0;2;GO:0005576
GO:1905555;positive regulation of blood vessel branching;152;8;GO:0050727
GO:1905554;negative regulation of vessel branching;0;2;GO:0050727
GO:1905553;regulation of blood vessel branching;204;5;GO:0050727
GO:0051381;histamine binding;83;109;GO:0005509
GO:0051382;kinetochore assembly;11194;2210;GO:0000786
GO:1905559;positive regulation of mitotic nuclear envelope disassembly;0;1;GO:0048285
GO:1905558;negative regulation of mitotic nuclear envelope disassembly;0;0;GO:0048285
GO:0051380;norepinephrine binding;251;61;GO:0031622
GO:1905557;regulation of mitotic nuclear envelope disassembly;8;2;GO:0048285
GO:0051378;serotonin binding;705;719;GO:0005509
GO:0075323;positive regulation of oomycete sporangium development;0;1;GO:0048405
GO:0051379;epinephrine binding;317;187;GO:0004867
GO:0075324;negative regulation of oomycete sporangium development;0;1;GO:0048405
GO:0075325;spore dispersal;0;4;GO:0048305
GO:0051377;mannose-ethanolamine phosphotransferase activity;16817;61;GO:0004733
GO:0075320;negative regulation of ascus development;0;1;GO:0048285
GO:0075321;oomycete sporangium development;0;1;GO:0048309
GO:0051373;FATZ binding;235;189;GO:0003700
GO:0075322;regulation of oomycete sporangium development;0;1;GO:0048309
GO:0075328;formation of arbuscule for nutrient acquisition;0;0;GO:0046274
GO:0075329;regulation of arbuscule formation for nutrient acquisition from host;0;1;GO:0046394
GO:1905563;negative regulation of vascular endothelial cell proliferation;223;50;GO:0050727
GO:1905562;regulation of vascular endothelial cell proliferation;1161;9;GO:0050727
GO:1905561;positive regulation of kinetochore assembly;64;2;GO:0048285
GO:1905560;negative regulation of kinetochore assembly;1;1;GO:0007062
GO:1905564;positive regulation of vascular endothelial cell proliferation;768;222;GO:0045766
GO:0051392;tRNA N-acetyltransferase activity;8734;9;GO:0006418
GO:0051393;alpha-actinin binding;1329;651;GO:0005525
GO:1905569;negative regulation of ferrichrome biosynthetic process;3;2;GO:0046395
GO:0051391;tRNA acetylation;11874;17;GO:0006418
GO:1905568;regulation of ferrichrome biosynthetic process;3;1;GO:0046395
GO:0051387;negative regulation of neurotrophin TRK receptor signaling pathway;210;90;GO:0048608
GO:0051388;positive regulation of neurotrophin TRK receptor signaling pathway;205;202;GO:0048608
GO:0051385;response to mineralocorticoid;615;593;GO:0009719
GO:0051386;regulation of neurotrophin TRK receptor signaling pathway;575;49;GO:0048608
GO:0051383;kinetochore organization;11477;2840;GO:0000786
GO:0051384;response to glucocorticoid;6027;2980;GO:0032496
GO:1905574;ganglioside GM2 binding;50;2;GO:0005525
GO:1905573;ganglioside GM1 binding;155;2;GO:0005515
GO:1905572;ganglioside GM1 transport to membrane;50;5;GO:0006869
GO:1905571;interleukin-10 receptor complex;0;1;GO:0005125
GO:1905578;regulation of ERBB3 signaling pathway;47;0;GO:0030518
GO:1905577;ganglioside GP1c binding;50;2;GO:0005515
GO:1905576;ganglioside GT1b binding;154;7;GO:0005525
GO:1905575;ganglioside GM3 binding;50;2;GO:0005525
GO:1905579;negative regulation of ERBB3 signaling pathway;0;0;GO:0030518
GO:0051396;positive regulation of nerve growth factor receptor activity;0;3;GO:0048608
GO:0075341;host cell PML body;3;8;GO:0005634
GO:0075342;symbiont-mediated disruption of host cell PML body;14;0;GO:0048608
GO:0051394;regulation of nerve growth factor receptor activity;1;6;GO:0048608
GO:0075343;modulation by symbiont of abscisic acid levels in host;0;1;GO:0046686
GO:0051395;negative regulation of nerve growth factor receptor activity;0;2;GO:0048405
GO:1905570;positive regulation of ferrichrome biosynthetic process;0;1;GO:0046395
GO:1905505;positive regulation of motile cilium assembly;68;1;GO:0048193
GO:1905504;negative regulation of motile cilium assembly;0;1;GO:0048193
GO:1905503;regulation of motile cilium assembly;82;1;GO:0048193
GO:1905502;acetyl-CoA binding;146;4;GO:0097159
GO:1905509;protein localization to interphase microtubule organizing center;0;0;GO:0005813
GO:1905508;protein localization to microtubule organizing center;7245;6;GO:0005840
GO:1905506;gerontoplast stroma;0;0;GO:0048608
GO:0051323;metaphase;0;9;GO:0000278
GO:0051324;prophase;0;22;GO:0000786
GO:0051321;meiotic cell cycle;133356;6020;GO:0000279
GO:0051322;anaphase;0;122;GO:0000910
GO:0051320;S phase;0;94;GO:0007049
GO:0051329;mitotic interphase;0;23;GO:0000278
GO:0051327;meiotic M phase;0;2;GO:0000910
GO:0051328;meiotic interphase;0;1;GO:0000786
GO:0051325;interphase;0;1240;GO:0000279
GO:0051326;telophase;0;6;GO:0007067
GO:1905512;regulation of short-term synaptic potentiation;45;1;GO:0048167
GO:1905511;positive regulation of myosin II filament assembly;7;0;GO:0048608
GO:1905510;negative regulation of myosin II filament assembly;0;0;GO:0048608
GO:1905516;positive regulation of fertilization;260;14;GO:0048608
GO:1905515;non-motile cilium assembly;11733;495;GO:0005986
GO:1905514;positive regulation of short-term synaptic potentiation;0;0;GO:0048167
GO:1905513;negative regulation of short-term synaptic potentiation;45;2;GO:0048167
GO:0110001;toxin-antitoxin complex;35243;8;GO:0048304
GO:1905519;negative regulation of presynaptic active zone assembly;23;1;GO:0048608
GO:1905518;regulation of presynaptic active zone assembly;27;0;GO:0048608
GO:1905517;macrophage migration;2979;251;GO:0002548
GO:0051334;meiosis I nuclear membrane reassembly;0;0;GO:0007067
GO:0051335;meiosis II nuclear membrane reassembly;0;0;GO:0007067
GO:0051332;meiotic S phase;0;1;GO:0000786
GO:0051333;meiotic nuclear membrane reassembly;0;1;GO:0007067
GO:0051330;meiotic G1 phase;0;2;GO:0000786
GO:0051331;meiotic G2 phase;0;1;GO:0000279
GO:0051338;regulation of transferase activity;3511;1880;GO:0010468
GO:0051339;regulation of lyase activity;215;164;GO:0010468
GO:0051336;regulation of hydrolase activity;3388;2040;GO:0010467
GO:0051337;amitosis;0;4;GO:0006944
GO:1905523;positive regulation of macrophage migration;1185;36;GO:0050921
GO:1905522;negative regulation of macrophage migration;445;9;GO:0050900
GO:1905521;regulation of macrophage migration;2031;128;GO:0050900
GO:1905520;positive regulation of presynaptic active zone assembly;4;2;GO:0048608
GO:1905527;negative regulation of Golgi lumen acidification;0;0;GO:0048193
GO:1905526;regulation of Golgi lumen acidification;98;1;GO:0006897
GO:1905524;negative regulation of protein autoubiquitination;77;4;GO:0016567
GO:0110011;regulation of basement membrane organization;306;3;GO:0030198
GO:0110012;protein localization to P-body;55;7;GO:0005730
GO:1905529;regulation of uracil import across plasma membrane;4;0;GO:0006873
GO:0110010;basolateral protein secretion;56;1;GO:0006986
GO:1905528;positive regulation of Golgi lumen acidification;35;0;GO:0048193
GO:0051345;positive regulation of hydrolase activity;2088;1670;GO:0010467
GO:0075312;negative regulation of sporangium development;0;1;GO:0048405
GO:0110004;positive regulation of tRNA methylation;0;0;GO:0045944
GO:0051346;negative regulation of hydrolase activity;800;1080;GO:0010467
GO:0075313;basidium development;0;1;GO:0048305
GO:0110005;positive regulation of tRNA C5-cytosine methylation;0;0;GO:0045944
GO:0051343;positive regulation of cyclic-nucleotide phosphodiesterase activity;5;42;GO:0010401
GO:0075314;regulation of basidium development;0;0;GO:0048405
GO:0110002;regulation of tRNA methylation;53;5;GO:0045944
GO:0051344;negative regulation of cyclic-nucleotide phosphodiesterase activity;11;109;GO:0010401
GO:0075315;positive regulation of basidium development;0;1;GO:0048405
GO:0110003;regulation of tRNA C5-cytosine methylation;0;0;GO:0045944
GO:0051341;regulation of oxidoreductase activity;292;554;GO:0016705
GO:0110008;ncRNA deadenylation;57;3;GO:0009081
GO:0051342;regulation of cyclic-nucleotide phosphodiesterase activity;16;63;GO:0008033
GO:0110009;formin-nucleated actin cable organization;460;1;GO:0048285
GO:0075310;regulation of sporangium development;0;1;GO:0048285
GO:0051340;regulation of ligase activity;27;464;GO:0004842
GO:0075311;positive regulation of sporangium development;0;1;GO:0048285
GO:0051349;positive regulation of lyase activity;173;270;GO:0010468
GO:0075316;negative regulation of basidium development;0;2;GO:0048405
GO:0075317;ascus development;40;4;GO:0048285
GO:0051347;positive regulation of transferase activity;2387;1210;GO:0010468
GO:0075318;regulation of ascus development;40;1;GO:0048285
GO:0051348;negative regulation of transferase activity;810;1180;GO:0010468
GO:0075319;positive regulation of ascus development;40;2;GO:0048285
GO:1905530;negative regulation of uracil import across plasma membrane;4;2;GO:0006873
GO:1905534;positive regulation of leucine import across plasma membrane;14;1;GO:0048193
GO:1905533;negative regulation of leucine import across plasma membrane;125;4;GO:0048193
GO:1905532;regulation of leucine import across plasma membrane;139;2;GO:0006810
GO:1905531;positive regulation of uracil import across plasma membrane;0;0;GO:0048285
GO:1905538;polysome binding;357;178;GO:0005840
GO:1905537;positive regulation of eukaryotic translation initiation factor 4F complex assembly;56;3;GO:0007049
GO:1905536;negative regulation of eukaryotic translation initiation factor 4F complex assembly;30;0;GO:0007049
GO:1905535;regulation of eukaryotic translation initiation factor 4F complex assembly;86;0;GO:0003712
GO:0110022;regulation of cardiac muscle myoblast proliferation;200;1;GO:0048608
GO:0110023;negative regulation of cardiac muscle myoblast proliferation;39;3;GO:0048405
GO:0110020;regulation of actomyosin structure organization;8399;38;GO:0048608
GO:0110021;cardiac muscle myoblast proliferation;275;2;GO:0048608
GO:1905539;regulation of postsynapse to nucleus signaling pathway;60;2;GO:0048608
GO:0051356;visual perception involved in equilibrioception;0;2;GO:0007600
GO:0110015;positive regulation of elastin catabolic process;2;3;GO:0048608
GO:0075302;regulation of basidiospore formation;0;2;GO:0048285
GO:0110016;B-WICH complex;380;6;GO:0005840
GO:0051354;negative regulation of oxidoreductase activity;82;148;GO:0046395
GO:0075303;positive regulation of basidiospore formation;0;2;GO:0048285
GO:0110013;positive regulation of aggregation involved in sorocarp development;2;1;GO:0048608
GO:0051355;proprioception involved in equilibrioception;37;5;GO:0007600
GO:0075304;negative regulation of basidiospore formation;0;2;GO:0048285
GO:0110014;negative regulation of aggregation involved in sorocarp development;1;1;GO:0048405
GO:0051352;negative regulation of ligase activity;2;1800;GO:0010468
GO:0110019;IRES-dependent translational initiation of circular RNA;0;0;GO:0006412
GO:0051353;positive regulation of oxidoreductase activity;158;467;GO:0046395
GO:0051350;negative regulation of lyase activity;28;52;GO:0010468
GO:0110017;cap-independent translational initiation of linear mRNA;57;1;GO:0006413
GO:0051351;positive regulation of ligase activity;25;779;GO:0010468
GO:0075300;negative regulation of zygospore formation;0;1;GO:0048285
GO:0110018;cap-independent translational initiation of circular RNA;0;0;GO:0006417
GO:0075306;regulation of conidium formation;57;6;GO:0010467
GO:0075307;positive regulation of conidium formation;27;4;GO:0046365
GO:0075308;negative regulation of conidium formation;15;3;GO:0046274
GO:0110030;regulation of G2/MI transition of meiotic cell cycle;197;1;GO:0048285
GO:0110033;regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway;15;0;GO:0007186
GO:0110034;negative regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway;15;5;GO:0048010
GO:0110031;negative regulation of G2/MI transition of meiotic cell cycle;73;2;GO:0048285
GO:0110032;positive regulation of G2/MI transition of meiotic cell cycle;121;4;GO:0048285
GO:0110026;regulation of DNA strand resection involved in replication fork processing;80;3;GO:0048285
GO:0110027;negative regulation of DNA strand resection involved in replication fork processing;1;1;GO:0048285
GO:0110024;positive regulation of cardiac muscle myoblast proliferation;161;5;GO:0048405
GO:0110025;DNA strand resection involved in replication fork processing;221;9;GO:0007067
GO:0075297;negative regulation of ascospore formation;59;5;GO:0048285
GO:0075298;regulation of zygospore formation;0;1;GO:0048285
GO:0075299;positive regulation of zygospore formation;0;1;GO:0048285
GO:0110028;positive regulation of mitotic spindle organization;8;1;GO:0048285
GO:0110029;negative regulation of meiosis I;10;0;GO:0048285
GO:0075293;response to host pH environment;3;0;GO:0097169
GO:0110040;nematode pharynx morphogenesis;8;0;GO:0009952
GO:0075294;positive regulation by symbiont of entry into host;649;9;GO:0046686
GO:0110041;regulation of nematode pharynx morphogenesis;3;0;GO:0048608
GO:0075296;positive regulation of ascospore formation;34;3;GO:0048285
GO:0110044;regulation of cell cycle switching, mitotic to meiotic cell cycle;81;7;GO:0048285
GO:0075290;regulation of aplanospore formation;0;1;GO:0048285
GO:0110045;negative regulation of cell cycle switching, mitotic to meiotic cell cycle;47;4;GO:0048285
GO:0075291;positive regulation of aplanospore formation;0;0;GO:0048285
GO:0110042;negative regulation of nematode pharynx morphogenesis;0;0;GO:0048706
GO:0075292;negative regulation of aplanospore formation;0;1;GO:0048285
GO:0110043;positive regulation of nematode pharynx morphogenesis;3;0;GO:0048608
GO:0110037;regulation of nematode male tail tip morphogenesis;173;0;GO:0048706
GO:0110038;negative regulation of nematode male tail tip morphogenesis;0;0;GO:0048706
GO:0110035;rDNA spacer replication fork barrier binding, bending;5;1;GO:0003676
GO:0110036;C2 domain binding;0;0;GO:0005515
GO:0075286;regulation of sporangiospore formation;0;1;GO:0048285
GO:0075287;positive regulation of sporangiospore formation;0;1;GO:0048285
GO:0075288;negative regulation of sporangiospore formation;0;1;GO:0048285
GO:0110039;positive regulation of nematode male tail tip morphogenesis;144;1;GO:0048608
GO:0075289;aplanospore formation;0;2;GO:0048304
GO:0110051;metabolite repair;215;3;GO:0046686
GO:0110052;toxic metabolite repair;4;1;GO:0046686
GO:0110050;deaminated glutathione amidase activity;211;3;GO:0004723
GO:0110055;negative regulation of actin filament annealing;0;0;GO:0048285
GO:0110056;positive regulation of actin filament annealing;0;2;GO:0048285
GO:0110053;regulation of actin filament organization;109569;419;GO:0050921
GO:0110054;regulation of actin filament annealing;0;0;GO:0048285
GO:0110046;signal transduction involved in cell cycle switching, mitotic to meiotic cell cycle;16;5;GO:0007346
GO:0110062;negative regulation of angiotensin-activated signaling pathway;55;2;GO:0050727
GO:0110063;positive regulation of angiotensin-activated signaling pathway;53;0;GO:0030518
GO:0110061;regulation of angiotensin-activated signaling pathway;159;4;GO:0030518
GO:0110066;negative regulation of interphase mitotic telomere clustering;0;1;GO:0048285
GO:0110067;ammonium transmembrane transporter complex;10;0;GO:0008544
GO:0110064;lncRNA catabolic process;145;3;GO:0010467
GO:0110065;regulation of interphase mitotic telomere clustering;0;0;GO:0048285
GO:0110059;negative regulation of blood vessel endothelial cell differentiation;58;2;GO:0050727
GO:0110057;regulation of blood vessel endothelial cell differentiation;59;0;GO:0001944
GO:0110058;positive regulation of blood vessel endothelial cell differentiation;1;2;GO:0050727
GO:1905464;positive regulation of DNA duplex unwinding;2;2;GO:0003676
GO:1905463;negative regulation of DNA duplex unwinding;102;7;GO:0003676
GO:1905462;regulation of DNA duplex unwinding;105;3;GO:0003676
GO:1905461;positive regulation of vascular associated smooth muscle cell apoptotic process;337;10;GO:0043066
GO:0110070;cellularization cleavage furrow;125;5;GO:0008544
GO:1905467;positive regulation of G-quadruplex DNA unwinding;0;2;GO:0048285
GO:1905466;negative regulation of G-quadruplex DNA unwinding;0;3;GO:0007049
GO:1905465;regulation of G-quadruplex DNA unwinding;0;3;GO:0003677
GO:0051293;establishment of spindle localization;7796;212;GO:0051321
GO:0075260;regulation of spore-bearing organ development;83;3;GO:0048285
GO:0110073;regulation of apical constriction involved in ventral furrow formation;23;0;GO:0048285
GO:0051294;establishment of spindle orientation;5634;490;GO:0048285
GO:0075261;positive regulation of spore-bearing organ development;58;2;GO:0048366
GO:0110074;positive regulation of apical constriction involved in ventral furrow formation;23;1;GO:0048285
GO:0051291;protein heterooligomerization;1501;1100;GO:0046983
GO:0075262;negative regulation of spore-bearing organ development;19;1;GO:0048285
GO:0110071;cellularization cleavage furrow invagination front;40;0;GO:0008544
GO:0051292;nuclear pore complex assembly;864;2530;GO:0005730
GO:0075263;oogonium development;0;1;GO:0048608
GO:0110072;apical constriction involved in ventral furrow formation;39;0;GO:0009952
GO:0110077;vesicle-mediated intercellular transport;23;7;GO:0006903
GO:0051290;protein heterotetramerization;733;1040;GO:0046982
GO:0110078;TTT complex;222;2;GO:0005819
GO:0110075;regulation of ferroptosis;290;4;GO:1901363
GO:0110076;negative regulation of ferroptosis;178;5;GO:0046395
GO:0075257;positive regulation of teliospore formation;0;1;GO:0048285
GO:0075258;negative regulation of teliospore formation;0;1;GO:0048285
GO:0075259;spore-bearing structure development;170;2;GO:0048305
GO:0110068;glucosylglycerate phosphorylase activity;2;1;GO:0006081
GO:0051289;protein homotetramerization;7464;1820;GO:0008092
GO:0110069;syncytial embryo cellularization;59;2;GO:0008544
GO:0051286;cell tip;6681;709;GO:0009987
GO:0075253;positive regulation of uredospore formation;0;1;GO:0048285
GO:0051287;NAD binding;1630702;6690;GO:0043169
GO:0075254;negative regulation of uredospore formation;0;1;GO:0048285
GO:0051284;positive regulation of sequestering of calcium ion;303;8;GO:0048407
GO:0075255;teliospore formation;0;0;GO:0048305
GO:0051285;cell cortex of cell tip;860;34;GO:0009987
GO:0075256;regulation of teliospore formation;0;1;GO:0048285
GO:1905460;negative regulation of vascular associated smooth muscle cell apoptotic process;108;182;GO:0043066
GO:1905475;regulation of protein localization to membrane;73736;145;GO:0016021
GO:1905474;canonical Wnt signaling pathway involved in stem cell proliferation;54;4;GO:0048407
GO:0110080;positive regulation of placenta blood vessel development;0;0;GO:0001944
GO:0110081;negative regulation of placenta blood vessel development;1;0;GO:0048706
GO:1905477;positive regulation of protein localization to membrane;69340;66;GO:0048193
GO:1905476;negative regulation of protein localization to membrane;1695;10;GO:0048193
GO:0110084;negative regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly;0;1;GO:0048285
GO:0075250;negative regulation of aeciospore formation;0;2;GO:0048285
GO:0110085;mitotic actomyosin contractile ring;1003;25;GO:0007067
GO:0075251;uredospore formation;0;1;GO:0048304
GO:0110082;regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly;16;1;GO:0007067
GO:0075252;regulation of uredospore formation;0;1;GO:0048285
GO:0110083;positive regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly;16;1;GO:0048285
GO:0110088;hippocampal neuron apoptotic process;240;1;GO:0010941
GO:0099243;extrinsic component of synaptic membrane;580;5;GO:0048167
GO:0110089;regulation of hippocampal neuron apoptotic process;162;10;GO:0010941
GO:0110086;meiotic actomyosin contractile ring;0;2;GO:0007067
GO:0075246;negative regulation of oospore formation;0;1;GO:0048285
GO:0075247;aeciospore formation;0;1;GO:0048304
GO:0004900;erythropoietin receptor activity;76;10;GO:0004872
GO:0051299;centrosome separation;1634;178;GO:0007088
GO:0075248;regulation of aeciospore formation;0;1;GO:0048285
GO:0110079;regulation of placenta blood vessel development;1;0;GO:0001944
GO:0075249;positive regulation of aeciospore formation;0;1;GO:0048285
GO:0004902;granulocyte colony-stimulating factor receptor activity;0;1;GO:0004974
GO:0075242;negative regulation of zoospore formation;0;1;GO:0048405
GO:0004901;granulocyte macrophage colony-stimulating factor receptor activity;1;2;GO:0004974
GO:0051298;centrosome duplication;17405;1950;GO:0000922
GO:0075243;oospore formation;0;1;GO:0048304
GO:0004904;interferon receptor activity;513;91;GO:0004872
GO:0051295;establishment of meiotic spindle localization;514;116;GO:0055088
GO:0075244;regulation of oospore formation;0;1;GO:0048285
GO:0004903;growth hormone receptor activity;31;9;GO:0004930
GO:0051296;establishment of meiotic spindle orientation;98;9;GO:0007018
GO:0075245;positive regulation of oospore formation;0;1;GO:0048285
GO:0004906;type II interferon receptor activity;102;6;GO:0002768
GO:0004905;type I interferon receptor activity;269;49;GO:0002768
GO:0004908;interleukin-1 receptor activity;6783;281;GO:0005125
GO:0004909;interleukin-1, type I, activating receptor activity;1157;85;GO:0004896
GO:1905486;regulation of anterior/posterior axon guidance;79;2;GO:0048608
GO:1905485;positive regulation of motor neuron migration;119;0;GO:0048704
GO:1905484;negative regulation of motor neuron migration;12;0;GO:0048704
GO:1905483;regulation of motor neuron migration;153;0;GO:0048704
GO:0110091;negative regulation of hippocampal neuron apoptotic process;114;7;GO:0010941
GO:0110092;nucleus leading edge;21;3;GO:0005634
GO:1905489;regulation of sensory neuron axon guidance;65;2;GO:0048608
GO:1905488;positive regulation of anterior/posterior axon guidance;79;1;GO:0048608
GO:0110090;positive regulation of hippocampal neuron apoptotic process;9;2;GO:0048608
GO:1905487;negative regulation of anterior/posterior axon guidance;0;1;GO:0048608
GO:0075282;negative regulation of uredinium development;0;2;GO:0048405
GO:0110095;cellular detoxification of aldehyde;27284;102;GO:0006979
GO:0075283;sporulation resulting in formation of a multicellular or syncytial spore;0;0;GO:0048304
GO:0110096;cellular response to aldehyde;27602;124;GO:0050832
GO:0075284;asexual sporulation resulting in formation of a multicellular or syncytial spore;0;1;GO:0048304
GO:0110093;nucleus lagging edge;0;1;GO:0005634
GO:0075285;sexual sporulation resulting in formation of a multicellular or syncytial spore;0;0;GO:0048304
GO:0110094;polyphosphate-mediated signaling;18;3;GO:0007218
GO:0110099;negative regulation of calcium import into the mitochondrion;53;3;GO:0006836
GO:0075280;regulation of uredinium development;0;2;GO:0048405
GO:0110097;regulation of calcium import into the mitochondrion;112;0;GO:0006836
GO:0075281;positive regulation of uredinium development;0;1;GO:0048405
GO:0110098;positive regulation of calcium import into the mitochondrion;0;0;GO:0006836
GO:0075279;uredinium development;0;1;GO:0048405
GO:0075275;telium development;0;1;GO:0048608
GO:0075276;regulation of telium development;0;1;GO:0048608
GO:0075277;positive regulation of telium development;0;0;GO:0048608
GO:0075278;negative regulation of telium development;0;0;GO:0048608
GO:1905497;negative regulation of triplex DNA binding;0;2;GO:0048285
GO:1905496;regulation of triplex DNA binding;0;1;GO:0045944
GO:1905495;positive regulation of G-quadruplex DNA binding;0;2;GO:0045944
GO:1905494;negative regulation of G-quadruplex DNA binding;0;2;GO:0048285
GO:1905499;trichome papilla formation;106;7;GO:0048305
GO:1905498;positive regulation of triplex DNA binding;0;2;GO:0045944
GO:0075271;zygosporangium development;0;1;GO:0048309
GO:0075272;regulation of zygosporangium development;0;1;GO:0048285
GO:0075273;positive regulation of zygosporangium development;0;1;GO:0048285
GO:0075274;negative regulation of zygosporangium development;0;1;GO:0048285
GO:0075270;negative regulation of aecium development;0;3;GO:0048285
GO:0075268;regulation of aecium development;0;3;GO:0048608
GO:0075269;positive regulation of aecium development;0;3;GO:0048704
GO:0075264;regulation of oogonium development;0;1;GO:0048608
GO:0075265;positive regulation of oogonium development;0;1;GO:0048608
GO:0075266;negative regulation of oogonium development;0;1;GO:0048608
GO:0075267;aecium development;0;3;GO:0048285
GO:1905493;regulation of G-quadruplex DNA binding;0;1;GO:0045944
GO:1905492;positive regulation of branching morphogenesis of a nerve;65;2;GO:0048704
GO:1905491;positive regulation of sensory neuron axon guidance;32;0;GO:0048608
GO:1905490;negative regulation of sensory neuron axon guidance;12;1;GO:0048704
GO:0016920;pyroglutamyl-peptidase activity;23756;15;GO:0004721
GO:0016922;nuclear receptor binding;15126;966;GO:0030528
GO:0016925;protein sumoylation;26355;1800;GO:0016567
GO:0016926;protein desumoylation;205;477;GO:0016567
GO:0016929;deSUMOylase activity;985;5;GO:0004842
GO:0004940;beta1-adrenergic receptor activity;952;8;GO:0004930
GO:0004931;extracellularly ATP-gated monoatomic cation channel activity;10578;15;GO:0008026
GO:0004930;G protein-coupled receptor activity;1364159;10300;GO:0004930
GO:0004933;mating-type a-factor pheromone receptor activity;649;2;GO:0003700
GO:0004932;mating-type factor pheromone receptor activity;6342;30;GO:0004930
GO:0004935;adrenergic receptor activity;15355;447;GO:0004871
GO:0004934;mating-type alpha-factor pheromone receptor activity;802;2;GO:0003700
GO:0004937;alpha1-adrenergic receptor activity;2200;149;GO:0004930
GO:0004936;alpha-adrenergic receptor activity;4921;99;GO:0004930
GO:0004939;beta-adrenergic receptor activity;2705;169;GO:0004872
GO:0004938;alpha2-adrenergic receptor activity;2719;77;GO:0004930
GO:0016913;follicle-stimulating hormone activity;255;7;GO:0003714
GO:0016914;follicle-stimulating hormone complex;228;7;GO:0002526
GO:0016917;GABA receptor activity;28642;469;GO:0004930
GO:0016918;retinal binding;1231;219;GO:0005576
GO:0004951;cholecystokinin receptor activity;705;41;GO:0004930
GO:0004950;chemokine receptor activity;21222;874;GO:0004872
GO:0004941;beta2-adrenergic receptor activity;1378;17;GO:0004930
GO:0004946;bombesin receptor activity;1022;25;GO:0004930
GO:0004945;angiotensin type II receptor activity;2299;182;GO:0004930
GO:0004948;calcitonin receptor activity;4454;232;GO:0004872
GO:0004947;bradykinin receptor activity;1793;59;GO:0004872
GO:0004949;cannabinoid receptor activity;2438;120;GO:0004930
GO:0016900;oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor;0;10;GO:0004601
GO:0016901;oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor;225886;340;GO:0004497
GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors;2389652;1010;GO:0004497
GO:0016905;myosin heavy chain kinase activity;272;334;GO:0008092
GO:0016906;sterol 3-beta-glucosyltransferase activity;9514;9;GO:0006073
GO:0016907;G protein-coupled acetylcholine receptor activity;10759;313;GO:0004930
GO:0004911;interleukin-2 receptor activity;787;228;GO:0004872
GO:0004910;interleukin-1, type II, blocking receptor activity;770;8;GO:0004896
GO:0004913;interleukin-4 receptor activity;48;43;GO:0004896
GO:0004912;interleukin-3 receptor activity;18;10;GO:0004872
GO:0004915;interleukin-6 receptor activity;140;98;GO:0004896
GO:0004914;interleukin-5 receptor activity;61;71;GO:0005125
GO:0004917;interleukin-7 receptor activity;2;43;GO:0004984
GO:0004919;interleukin-9 receptor activity;63;6;GO:0004930
GO:0004918;interleukin-8 receptor activity;45;38;GO:0005125
GO:0004920;interleukin-10 receptor activity;84;52;GO:0005125
GO:0004921;interleukin-11 receptor activity;106;24;GO:0005125
GO:0004924;oncostatin-M receptor activity;195;66;GO:0030518
GO:0004923;leukemia inhibitory factor receptor activity;123;254;GO:0004872
GO:0004925;prolactin receptor activity;123;118;GO:0004867
GO:0016964;alpha-2 macroglobulin receptor activity;48;46;GO:0004872
GO:0016966;nitric oxide reductase activity;2452;8;GO:0004784
GO:0004980;melanocyte-stimulating hormone receptor activity;5058;90;GO:0004930
GO:0004982;N-formyl peptide receptor activity;113;189;GO:0004930
GO:0002320;lymphoid progenitor cell differentiation;1299;344;GO:0045595
GO:0002321;natural killer cell progenitor differentiation;0;5;GO:0045765
GO:0004984;olfactory receptor activity;188192;5360;GO:0004984
GO:0002322;B cell proliferation involved in immune response;605;65;GO:0042113
GO:0004983;neuropeptide Y receptor activity;13319;384;GO:0004930
GO:0002312;B cell activation involved in immune response;5545;838;GO:0002449
GO:0002313;mature B cell differentiation involved in immune response;1567;767;GO:0002504
GO:0004974;leukotriene receptor activity;2929;66;GO:0004930
GO:0002314;germinal center B cell differentiation;381;130;GO:0002504
GO:0004977;melanocortin receptor activity;15031;63;GO:0004930
GO:0002315;marginal zone B cell differentiation;416;218;GO:0002504
GO:0002316;follicular B cell differentiation;155;65;GO:0042113
GO:0004979;beta-endorphin receptor activity;1211;24;GO:0004866
GO:0002317;plasma cell differentiation;483;150;GO:0042113
GO:0004978;corticotropin receptor activity;550;4;GO:0004930
GO:0002318;myeloid progenitor cell differentiation;468;119;GO:0030097
GO:0002319;memory B cell differentiation;53;6;GO:0042113
GO:0016971;flavin-dependent sulfhydryl oxidase activity;10139;8;GO:0004067
GO:0016972;thiol oxidase activity;38326;418;GO:0004601
GO:0016973;poly(A)+ mRNA export from nucleus;11399;1;GO:0006413
GO:0004991;parathyroid hormone receptor activity;1693;73;GO:0004930
GO:0004990;oxytocin receptor activity;1314;9;GO:0004930
GO:0002330;pre-B cell receptor expression;0;4;GO:0042127
GO:0004993;G protein-coupled serotonin receptor activity;13604;809;GO:0004930
GO:0002331;pre-B cell allelic exclusion;191;198;GO:0048193
GO:0004992;platelet activating factor receptor activity;875;262;GO:0004866
GO:0002332;transitional stage B cell differentiation;101;2;GO:0042113
GO:0004995;tachykinin receptor activity;4613;174;GO:0004930
GO:0002333;transitional one stage B cell differentiation;51;20;GO:0042113
GO:0004994;somatostatin receptor activity;4450;194;GO:0004930
GO:0002323;natural killer cell activation involved in immune response;752;443;GO:0002449
GO:0002324;natural killer cell proliferation involved in immune response;0;3;GO:0042113
GO:0004985;G protein-coupled opioid receptor activity;8124;10;GO:0004930
GO:0002325;natural killer cell differentiation involved in immune response;123;10;GO:0002273
GO:0002326;B cell lineage commitment;217;281;GO:0042113
GO:0002327;immature B cell differentiation;705;141;GO:0042113
GO:0002328;pro-B cell differentiation;575;116;GO:0042113
GO:0004989;octopamine receptor activity;570;62;GO:0004930
GO:0002329;pre-B cell differentiation;341;72;GO:0042127
GO:0016942;insulin-like growth factor binding protein complex;273;84;GO:0048608
GO:0004960;thromboxane receptor activity;1461;92;GO:0004930
GO:0004962;endothelin receptor activity;3017;76;GO:0004872
GO:0002300;CD8-positive, alpha-beta intraepithelial T cell differentiation;60;8;GO:0002277
GO:0004961;thromboxane A2 receptor activity;2;7;GO:0004930
GO:0004953;icosanoid receptor activity;11445;96;GO:0004930
GO:0004952;dopamine neurotransmitter receptor activity;5424;152;GO:0004872
GO:0004955;prostaglandin receptor activity;7025;154;GO:0004930
GO:0004954;prostanoid receptor activity;8516;24;GO:0004930
GO:0004957;prostaglandin E receptor activity;3758;118;GO:0004930
GO:0004956;prostaglandin D receptor activity;355;8;GO:0004930
GO:0004958;prostaglandin F receptor activity;837;184;GO:0004930
GO:0016933;extracellularly glycine-gated ion channel activity;3358;7;GO:0005216
GO:0016934;extracellularly glycine-gated chloride channel activity;3210;5;GO:0004930
GO:0016935;glycine-gated chloride channel complex;134;97;GO:0008026
GO:0016936;galactoside binding;234;84;GO:0042330
GO:0016937;short-chain-acyl-CoA dehydrogenase activity;13719;4;GO:0004089
GO:0016938;kinesin I complex;19;10;GO:0008021
GO:0016939;kinesin II complex;304;105;GO:0005524
GO:0004971;AMPA glutamate receptor activity;462;48;GO:0048167
GO:0004970;ionotropic glutamate receptor activity;42636;1810;GO:0004930
GO:0002310;alpha-beta T cell proliferation involved in immune response;0;2;GO:0042113
GO:0002311;gamma-delta T cell proliferation involved in immune response;0;3;GO:0042113
GO:0004972;NMDA glutamate receptor activity;903;117;GO:0048167
GO:0002301;CD4-positive, alpha-beta intraepithelial T cell differentiation;0;3;GO:0002277
GO:0004964;luteinizing hormone receptor activity;1064;8;GO:0004872
GO:0002302;CD8-positive, alpha-beta T cell differentiation involved in immune response;96;88;GO:0002227
GO:0004963;follicle-stimulating hormone receptor activity;1008;9;GO:0004930
GO:0002303;gamma-delta T cell differentiation involved in immune response;0;2;GO:0046649
GO:0004966;galanin receptor activity;1535;68;GO:0004930
GO:0002304;gamma-delta intraepithelial T cell differentiation;132;9;GO:0042127
GO:0004965;G protein-coupled GABA receptor activity;8062;129;GO:0004930
GO:0002305;CD8-positive, gamma-delta intraepithelial T cell differentiation;132;62;GO:0042127
GO:0004968;gonadotropin-releasing hormone receptor activity;141;23;GO:0004930
GO:0002306;CD4-positive gamma-delta intraepithelial T cell differentiation;0;2;GO:0046649
GO:0004967;glucagon receptor activity;1651;55;GO:0004930
GO:0002307;CD8-positive, alpha-beta regulatory T cell differentiation;0;3;GO:0002757
GO:0002308;CD8-positive, alpha-beta cytotoxic T cell differentiation;0;2;GO:0002279
GO:0004969;histamine receptor activity;3707;248;GO:0004930
GO:0002309;T cell proliferation involved in immune response;369;132;GO:0002821
GO:0016941;natriuretic peptide receptor activity;286;203;GO:0004930
GO:0016645;oxidoreductase activity, acting on the CH-NH group of donors;1149215;326;GO:0016616
GO:0016646;oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor;883577;401;GO:0004497
GO:0016647;oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor;47037;56;GO:0016616
GO:0016648;oxidoreductase activity, acting on the CH-NH group of donors, disulfide as acceptor;21;6;GO:0003824
GO:0016649;oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor;184524;33;GO:0004497
GO:0004661;protein geranylgeranyltransferase activity;20976;10;GO:0004842
GO:0004660;protein farnesyltransferase activity;7993;216;GO:0003749
GO:0002000;detection of renal blood flow;0;4;GO:0010721
GO:0004663;Rab geranylgeranyltransferase activity;16556;92;GO:0003924
GO:0002001;renin secretion into blood stream;288;93;GO:0007596
GO:0004662;CAAX-protein geranylgeranyltransferase activity;1451;90;GO:0004842
GO:0002002;regulation of angiotensin levels in blood;433;262;GO:0048608
GO:0004665;prephenate dehydrogenase (NADP+) activity;46994;0;GO:0006067
GO:0002003;angiotensin maturation;322;716;GO:0007596
GO:0004664;prephenate dehydratase activity;98441;441;GO:0006067
GO:0004656;procollagen-proline 4-dioxygenase activity;13435;285;GO:0004866
GO:0004655;porphobilinogen synthase activity;100951;534;GO:0004073
GO:0004658;propionyl-CoA carboxylase activity;15853;27;GO:0006099
GO:0004657;proline dehydrogenase activity;116589;419;GO:0004721
GO:0004659;prenyltransferase activity;597814;871;GO:0004061
GO:0016651;oxidoreductase activity, acting on NAD(P)H;2669513;1720;GO:0003954
GO:0016652;oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor;79788;135;GO:0003954
GO:0016653;oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;74153;72;GO:0003954
GO:0016655;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;2084606;1450;GO:0003954
GO:0016634;oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor;191928;69;GO:0016616
GO:0016635;oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor;51359;153;GO:0004497
GO:0016636;oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor;18250;6;GO:0003824
GO:0016638;oxidoreductase activity, acting on the CH-NH2 group of donors;1034779;630;GO:0016616
GO:0016639;oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor;246710;577;GO:0004497
GO:0004672;protein kinase activity;7107723;20500;GO:0004713
GO:0002010;excitation of vasomotor center by baroreceptor signaling;0;5;GO:0002881
GO:0004671;protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity;27755;117;GO:0003723
GO:0002011;morphogenesis of an epithelial sheet;6962;644;GO:0030216
GO:0004674;protein serine/threonine kinase activity;1864490;19900;GO:0004674
GO:0002012;vasoconstriction of artery involved in chemoreceptor response to lowering of systemic arterial blood pressure;0;6;GO:0002873
GO:0004673;protein histidine kinase activity;2420392;1280;GO:0004721
GO:0002013;detection of carbon dioxide by vasomotor center;0;2;GO:0007623
GO:0004676;3-phosphoinositide-dependent protein kinase activity;101;38;GO:0004721
GO:0002014;vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure;2;7;GO:0002072
GO:0004675;transmembrane receptor protein serine/threonine kinase activity;40135;970;GO:0004713
GO:0002004;secretion of vasopressin involved in fast regulation of systemic arterial blood pressure;0;3;GO:0006953
GO:0004667;prostaglandin-D synthase activity;438;77;GO:0004497
GO:0004666;prostaglandin-endoperoxide synthase activity;2104;130;GO:0004497
GO:0002006;vasoconstriction by vasopressin involved in systemic arterial blood pressure control;0;4;GO:0002072
GO:0002007;detection of hypoxic conditions in blood by chemoreceptor signaling;41;5;GO:0009416
GO:0004668;protein-arginine deiminase activity;30139;212;GO:0004721
GO:0002008;excitation of vasomotor center by chemoreceptor signaling;0;7;GO:0007623
GO:0002009;morphogenesis of an epithelium;73073;2660;GO:0030216
GO:0016640;oxidoreductase activity, acting on the CH-NH2 group of donors, cytochrome as acceptor;0;2;GO:0016616
GO:0016641;oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor;273381;271;GO:0016616
GO:0016642;oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor;138696;1;GO:0004601
GO:0016643;oxidoreductase activity, acting on the CH-NH2 group of donors, iron-sulfur protein as acceptor;1897;2;GO:0004497
GO:0016623;oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor;3809;10;GO:0004497
GO:0016624;oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor;370560;555;GO:0004497
GO:0016625;oxidoreductase activity, acting on the aldehyde or oxo group of donors, iron-sulfur protein as acceptor;102067;16;GO:0004497
GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;2398117;2420;GO:0004497
GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;799710;1230;GO:0003824
GO:0016629;12-oxophytodienoate reductase activity;423;8;GO:0004497
GO:0004641;phosphoribosylformylglycinamidine cyclo-ligase activity;146659;523;GO:0004061
GO:0004640;phosphoribosylanthranilate isomerase activity;137361;311;GO:0004067
GO:0004643;phosphoribosylaminoimidazolecarboxamide formyltransferase activity;148688;558;GO:0004061
GO:0004642;phosphoribosylformylglycinamidine synthase activity;258610;688;GO:0004061
GO:0004634;phosphopyruvate hydratase activity;199743;2130;GO:0006099
GO:0004633;phosphopantothenoylcysteine decarboxylase activity;132369;522;GO:0006073
GO:0004636;phosphoribosyl-ATP diphosphatase activity;117963;229;GO:0005524
GO:0004635;phosphoribosyl-AMP cyclohydrolase activity;132715;501;GO:0004061
GO:0004638;phosphoribosylaminoimidazole carboxylase activity;69582;648;GO:0004061
GO:0004637;phosphoribosylamine-glycine ligase activity;162272;900;GO:0004067
GO:0004639;phosphoribosylaminoimidazolesuccinocarboxamide synthase activity;154844;512;GO:0006064
GO:0016630;protochlorophyllide reductase activity;3984;47;GO:0009813
GO:0016631;enoyl-[acyl-carrier-protein] reductase activity;107768;0;GO:0004091
GO:0016632;oxidoreductase activity, acting on the CH-CH group of donors, cytochrome as acceptor;572;2;GO:0004497
GO:0016633;galactonolactone dehydrogenase activity;547;7;GO:0006067
GO:0016612;molybdenum-iron nitrogenase complex;5632;23;GO:0009536
GO:0016613;vanadium-iron nitrogenase complex;65;7;GO:0009536
GO:0016614;oxidoreductase activity, acting on CH-OH group of donors;5375032;2540;GO:0016616
GO:0016615;malate dehydrogenase activity;376373;530;GO:0003824
GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;4572463;4860;GO:0003824
GO:0016617;4-oxoproline reductase activity;7;4;GO:0004067
GO:0016618;hydroxypyruvate reductase activity;11901;164;GO:0004067
GO:0004650;polygalacturonase activity;55067;1060;GO:0004553
GO:0004651;polynucleotide 5'-phosphatase activity;9207;8;GO:0004553
GO:0004654;polyribonucleotide nucleotidyltransferase activity;154406;567;GO:0004518
GO:0004653;polypeptide N-acetylgalactosaminyltransferase activity;11952;697;GO:0006029
GO:0004645;1,4-alpha-oligoglucan phosphorylase activity;161277;34;GO:0004553
GO:0004644;phosphoribosylglycinamide formyltransferase activity;146426;605;GO:0004067
GO:0004649;poly(ADP-ribose) glycohydrolase activity;11076;91;GO:0004721
GO:0004648;O-phospho-L-serine:2-oxoglutarate aminotransferase activity;113582;594;GO:0006066
GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;1782193;2760;GO:0004497
GO:0016621;cinnamoyl-CoA reductase activity;164;207;GO:0004076
GO:0016622;oxidoreductase activity, acting on the aldehyde or oxo group of donors, cytochrome as acceptor;7693;3;GO:0004497
GO:0016689;manganese peroxidase activity;19;3;GO:0004601
GO:0014025;neural keel formation;1;4;GO:0008544
GO:0014023;neural rod formation;1;1;GO:0048666
GO:0014022;neural plate elongation;115;150;GO:0048704
GO:0014021;secondary neural tube formation;0;4;GO:0048704
GO:0014020;primary neural tube formation;6902;181;GO:0007423
GO:0002040;sprouting angiogenesis;10451;1380;GO:0001525
GO:0002041;intussusceptive angiogenesis;62;69;GO:0048608
GO:0002042;cell migration involved in sprouting angiogenesis;3420;1040;GO:0030900
GO:0002043;blood vessel endothelial cell proliferation involved in sprouting angiogenesis;1283;84;GO:0048608
GO:0002044;blood vessel endothelial cell migration involved in intussusceptive angiogenesis;4;3;GO:0048608
GO:0002045;regulation of cell adhesion involved in intussusceptive angiogenesis;0;5;GO:0048010
GO:0002046;opsin binding;203;55;GO:0005515
GO:0002047;phenazine biosynthetic process;51;5;GO:0046271
GO:0002037;negative regulation of L-glutamate import across plasma membrane;71;7;GO:0048169
GO:0002038;positive regulation of L-glutamate import across plasma membrane;179;10;GO:0048169
GO:0004699;diacylglycerol-dependent, calcium-independent serine/threonine kinase activity;182;2;GO:0004721
GO:0002039;p53 binding;13442;1800;GO:0003677
GO:0016690;diarylpropane peroxidase activity;25;4;GO:0004601
GO:0016691;chloride peroxidase activity;1993;3;GO:0004601
GO:0016692;NADH peroxidase activity;1423;5;GO:0004601
GO:0016695;oxidoreductase activity, acting on hydrogen as donor;56464;3;GO:0016616
GO:0014019;neuroblast development;249;142;GO:0048699
GO:0016696;oxidoreductase activity, acting on hydrogen as donor, NAD or NADP as acceptor;3337;2;GO:0003954
GO:0014018;neuroblast fate specification;77;5;GO:0048699
GO:0016697;oxidoreductase activity, acting on hydrogen as donor, cytochrome as acceptor;426;1;GO:0016616
GO:0014017;neuroblast fate commitment;416;43;GO:0048704
GO:0014016;neuroblast differentiation;940;60;GO:0048667
GO:0016699;oxidoreductase activity, acting on hydrogen as donor, iron-sulfur protein as acceptor;43082;3;GO:0003954
GO:0014037;Schwann cell differentiation;2568;350;GO:0048667
GO:0014036;neural crest cell fate specification;245;22;GO:0009952
GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;250006;276;GO:0016616
GO:0014035;neural crest cell fate determination;0;3;GO:0009952
GO:0014034;neural crest cell fate commitment;428;25;GO:0009952
GO:0014033;neural crest cell differentiation;10187;606;GO:0045595
GO:0014032;neural crest cell development;8817;955;GO:0009952
GO:0014031;mesenchymal cell development;295;1110;GO:0030509
GO:0002050;pyoverdine catabolic process;0;4;GO:0046274
GO:0014030;mesenchymal cell fate commitment;2;2;GO:0030183
GO:0002051;osteoblast fate commitment;180;97;GO:0048193
GO:0002052;positive regulation of neuroblast proliferation;1658;1060;GO:0048666
GO:0002053;positive regulation of mesenchymal cell proliferation;1119;1320;GO:0045765
GO:0002054;nucleobase binding;314;156;GO:0003676
GO:0002055;adenine binding;120;7;GO:0005524
GO:0002056;cytosine binding;0;2;GO:0003676
GO:0002057;guanine binding;2;2;GO:0005524
GO:0002058;uracil binding;89;10;GO:0005524
GO:0002048;pyoverdine metabolic process;0;4;GO:0006743
GO:0002049;pyoverdine biosynthetic process;54;5;GO:0009405
GO:0016680;oxidoreductase activity, acting on diphenols and related substances as donors, NAD or NADP as acceptor;0;2;GO:0004497
GO:0016682;oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor;71669;651;GO:0016616
GO:0016684;oxidoreductase activity, acting on peroxide as acceptor;1149789;1620;GO:0004601
GO:0014029;neural crest formation;1145;244;GO:0007517
GO:0014028;notochord formation;301;157;GO:0002041
GO:0016688;L-ascorbate peroxidase activity;2587;75;GO:0004601
GO:0014004;microglia differentiation;725;34;GO:0042113
GO:0016667;oxidoreductase activity, acting on a sulfur group of donors;1572617;496;GO:0004746
GO:0014003;oligodendrocyte development;2481;999;GO:0048667
GO:0016668;oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor;609662;331;GO:0004746
GO:0014002;astrocyte development;1541;865;GO:0048667
GO:0016669;oxidoreductase activity, acting on a sulfur group of donors, cytochrome as acceptor;9568;9;GO:0004746
GO:0014001;sclerenchyma cell differentiation;4;2;GO:0048468
GO:0002020;protease binding;8665;3030;GO:0050840
GO:0004683;calmodulin-dependent protein kinase activity;35344;1270;GO:0004725
GO:0002021;response to dietary excess;1579;778;GO:0007586
GO:0002022;detection of dietary excess;0;5;GO:0007586
GO:0002023;reduction of food intake in response to dietary excess;298;288;GO:0007586
GO:0002024;diet induced thermogenesis;459;230;GO:0007566
GO:0004687;myosin light chain kinase activity;1829;450;GO:0004721
GO:0002025;norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure;200;91;GO:0007623
GO:0004686;elongation factor-2 kinase activity;3724;21;GO:0008061
GO:0002015;regulation of systemic arterial blood pressure by atrial baroreceptor feedback;0;2;GO:0002074
GO:0002016;regulation of blood volume by renin-angiotensin;251;58;GO:0048193
GO:0004677;DNA-dependent protein kinase activity;1705;412;GO:0004725
GO:0002017;regulation of blood volume by renal aldosterone;14;26;GO:0048193
GO:0002018;renin-angiotensin regulation of aldosterone production;70;211;GO:0048193
GO:0004679;AMP-activated protein kinase activity;6160;164;GO:0003774
GO:0002019;regulation of renal output by angiotensin;14;48;GO:0050727
GO:0016670;oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor;52216;204;GO:0004497
GO:0016671;oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor;548912;488;GO:0004746
GO:0016672;oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor;19249;159;GO:0004497
GO:0016673;oxidoreductase activity, acting on a sulfur group of donors, iron-sulfur protein as acceptor;12547;1;GO:0004601
GO:0016675;oxidoreductase activity, acting on a heme group of donors;5113076;81;GO:0016616
GO:0016677;oxidoreductase activity, acting on a heme group of donors, nitrogenous group as acceptor;6556;1;GO:0016616
GO:0014015;positive regulation of gliogenesis;2612;177;GO:0045766
GO:0016656;monodehydroascorbate reductase (NADH) activity;269;23;GO:0004073
GO:0014014;negative regulation of gliogenesis;1827;116;GO:0045595
GO:0016657;oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor;6762;25;GO:0003824
GO:0014013;regulation of gliogenesis;4606;518;GO:0048667
GO:0014012;peripheral nervous system axon regeneration;152;139;GO:0048666
GO:0014011;Schwann cell proliferation involved in axon regeneration;9;8;GO:0048608
GO:0014010;Schwann cell proliferation;430;178;GO:0042127
GO:0004690;cyclic nucleotide-dependent protein kinase activity;21753;38;GO:0004721
GO:0004692;cGMP-dependent protein kinase activity;8209;109;GO:0004725
GO:0002030;inhibitory G protein-coupled receptor phosphorylation;64;95;GO:0004872
GO:0004691;cAMP-dependent protein kinase activity;13544;467;GO:0004721
GO:0002031;G protein-coupled receptor internalization;643;490;GO:0006874
GO:0004694;eukaryotic translation initiation factor 2alpha kinase activity;3160;124;GO:0006413
GO:0002032;desensitization of G protein-coupled receptor signaling pathway by arrestin;33;10;GO:0007186
GO:0004693;cyclin-dependent protein serine/threonine kinase activity;67669;1720;GO:0004721
GO:0002033;angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure;16;7;GO:0002026
GO:0002034;maintenance of blood vessel diameter homeostasis by renin-angiotensin;248;8;GO:0048193
GO:0002035;brain renin-angiotensin system;109;62;GO:0006811
GO:0004698;calcium,diacylglycerol-dependent serine/threonine kinase activity;16035;0;GO:0004721
GO:0002036;regulation of L-glutamate import across plasma membrane;258;1;GO:0006836
GO:0004697;diacylglycerol-dependent serine/threonine kinase activity;46717;7;GO:0004721
GO:0002026;regulation of the force of heart contraction;1245;1210;GO:0002028
GO:0004689;phosphorylase kinase activity;4130;187;GO:0004721
GO:0002027;regulation of heart rate;5281;1540;GO:0002074
GO:0002028;regulation of sodium ion transport;6617;870;GO:0050890
GO:0002029;desensitization of G protein-coupled receptor signaling pathway;940;9;GO:0007186
GO:0016661;oxidoreductase activity, acting on other nitrogenous compounds as donors;360642;213;GO:0004497
GO:0014009;glial cell proliferation;2841;829;GO:0042127
GO:0016662;oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor;58925;10;GO:0004497
GO:0014008;positive regulation of microglia differentiation;65;7;GO:0045580
GO:0016663;oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor;14007;4;GO:0004497
GO:0014007;negative regulation of microglia differentiation;0;3;GO:0045580
GO:0016664;oxidoreductase activity, acting on other nitrogenous compounds as donors, iron-sulfur protein as acceptor;882;4;GO:0004497
GO:0014006;regulation of microglia differentiation;65;4;GO:0045580
GO:0014005;microglia development;269;39;GO:0048699
GO:0038037;G protein-coupled receptor dimeric complex;758;69;GO:0005516
GO:0090612;cAMP deaminase activity;4;3;GO:0004721
GO:1905420;vascular associated smooth muscle cell differentiation involved in phenotypic switching;104;1;GO:0048608
GO:0014069;postsynaptic density;25971;4370;GO:0048666
GO:0038036;sphingosine-1-phosphate receptor activity;3853;141;GO:0004930
GO:0090613;5'-deoxyadenosine deaminase activity;930;0;GO:0004518
GO:0038039;G protein-coupled receptor heterodimeric complex;315;127;GO:0005516
GO:0090610;bundle sheath cell fate specification;146;4;GO:0048468
GO:0038038;G protein-coupled receptor homodimeric complex;71;103;GO:0004872
GO:0090611;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;247;33;GO:0006626
GO:0002080;acrosomal membrane;1962;424;GO:0008544
GO:0038033;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;279;140;GO:0050727
GO:1905424;regulation of Wnt-mediated midbrain dopaminergic neuron differentiation;5;1;GO:0048704
GO:0002081;outer acrosomal membrane;63;31;GO:0005576
GO:0038032;termination of G protein-coupled receptor signaling pathway;2;135;GO:0007186
GO:1905423;positive regulation of plant organ morphogenesis;0;0;GO:0048316
GO:0002082;regulation of oxidative phosphorylation;1185;447;GO:0015986
GO:0014064;positive regulation of serotonin secretion;8;22;GO:0048608
GO:0038035;G protein-coupled receptor signaling in absence of ligand;0;1;GO:0007186
GO:1905422;negative regulation of plant organ morphogenesis;0;0;GO:0048316
GO:0002083;4-hydroxybenzoate decaprenyltransferase activity;15040;10;GO:0004073
GO:0014063;negative regulation of serotonin secretion;254;38;GO:0048608
GO:0038034;signal transduction in absence of ligand;3401;44;GO:0007165
GO:1905421;regulation of plant organ morphogenesis;2325;8;GO:0048468
GO:0002084;protein depalmitoylation;48;263;GO:0006464
GO:0014062;regulation of serotonin secretion;306;19;GO:0048608
GO:1905428;regulation of plant organ formation;645;3;GO:0048468
GO:0002085;inhibition of neuroepithelial cell differentiation;293;20;GO:0048704
GO:0014061;regulation of norepinephrine secretion;109;209;GO:0048608
GO:1905427;intracellular signal transduction involved in positive regulation of cell growth;0;1;GO:0007179
GO:0002086;diaphragm contraction;106;106;GO:0006936
GO:0014060;regulation of epinephrine secretion;136;14;GO:0048608
GO:0038031;non-canonical Wnt signaling pathway via JNK cascade;271;89;GO:0043406
GO:1905426;positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation;5;6;GO:0048704
GO:0002087;regulation of respiratory gaseous exchange by nervous system process;482;22;GO:0050890
GO:1905425;negative regulation of Wnt-mediated midbrain dopaminergic neuron differentiation;0;2;GO:0048704
GO:0002088;lens development in camera-type eye;5835;789;GO:0007530
GO:0002089;lens morphogenesis in camera-type eye;1479;483;GO:0048407
GO:1905429;response to glycine;54;4;GO:0009631
GO:0051004;regulation of lipoprotein lipase activity;32;169;GO:0010467
GO:0051005;negative regulation of lipoprotein lipase activity;16;218;GO:0010467
GO:0051002;ligase activity, forming nitrogen-metal bonds;37759;4;GO:0004812
GO:0051003;ligase activity, forming nitrogen-metal bonds, forming coordination complexes;37759;2;GO:0004812
GO:0051000;positive regulation of nitric-oxide synthase activity;40;551;GO:0046323
GO:0051001;negative regulation of nitric-oxide synthase activity;38;579;GO:0010467
GO:0090618;DNA clamp unloading;4280;4;GO:0005524
GO:0090619;meiotic spindle pole;192;5;GO:0007062
GO:0051008;Hsp27 protein binding;57;3;GO:0043161
GO:0090616;mitochondrial mRNA 3'-end processing;2;0;GO:0008033
GO:0051009;O-acetylhomoserine sulfhydrylase activity;11;1;GO:0004067
GO:0090617;mitochondrial mRNA 5'-end processing;21;0;GO:0008033
GO:0051006;positive regulation of lipoprotein lipase activity;16;1260;GO:0048608
GO:0090614;5'-methylthioadenosine deaminase activity;17320;0;GO:0006066
GO:0051007;squalene-hopene cyclase activity;2357;5;GO:0004730
GO:0090615;mitochondrial mRNA processing;292;9;GO:0006364
GO:0038026;reelin-mediated signaling pathway;464;38;GO:0048608
GO:1905431;microcystin transport;2;1;GO:0006810
GO:0038025;reelin receptor activity;106;23;GO:0004872
GO:0090624;endoribonuclease activity, cleaving miRNA-paired mRNA;125;6;GO:0004518
GO:1905430;cellular response to glycine;14;2;GO:0006941
GO:0002090;regulation of receptor internalization;2929;288;GO:0004872
GO:0038027;apolipoprotein A-I-mediated signaling pathway;369;59;GO:0006954
GO:0002091;negative regulation of receptor internalization;656;165;GO:0048193
GO:0038022;G protein-coupled olfactory receptor activity;348;3;GO:0004984
GO:0002092;positive regulation of receptor internalization;1273;607;GO:0048193
GO:0014076;response to fluoxetine;0;4;GO:0006950
GO:0038021;leptin receptor activity;112;4;GO:0004872
GO:1905434;positive regulation of retrograde trans-synaptic signaling by neuropeptide;0;1;GO:0048608
GO:0002093;auditory receptor cell morphogenesis;1279;27;GO:0048704
GO:0014075;response to amine;1098;581;GO:0042221
GO:0038024;cargo receptor activity;25140;529;GO:0004872
GO:1905433;negative regulation of retrograde trans-synaptic signaling by neuropeptide;15;0;GO:0048608
GO:0002094;polyprenyltransferase activity;120145;176;GO:0004073
GO:0014074;response to purine-containing compound;12818;491;GO:0042592
GO:0038023;signaling receptor activity;3016259;5600;GO:0004872
GO:1905432;regulation of retrograde trans-synaptic signaling by neuropeptide;15;1;GO:0048608
GO:0002095;caveolar macromolecular signaling complex;112;36;GO:0005764
GO:0014073;response to tropane;0;17;GO:0048608
GO:1905439;response to chondroitin 6'-sulfate;0;0;GO:0005581
GO:0002096;polkadots;102;6;GO:0048706
GO:0014072;response to isoquinoline alkaloid;631;44;GO:0046686
GO:1905438;non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;51;3;GO:0048704
GO:0002097;tRNA wobble base modification;225959;67;GO:0006519
GO:0014071;response to cycloalkane;0;2;GO:0010033
GO:0038020;insulin receptor recycling;238;5;GO:0006974
GO:0002098;tRNA wobble uridine modification;124493;1230;GO:0008544
GO:0014070;response to organic cyclic compound;164881;4660;GO:0010033
GO:0002099;tRNA wobble guanine modification;80;3;GO:0006418
GO:0051015;actin filament binding;116120;5200;GO:0003779
GO:0051016;barbed-end actin filament capping;22627;2110;GO:0005524
GO:0051013;microtubule severing;13320;886;GO:0006029
GO:0051014;actin filament severing;6352;462;GO:0008037
GO:0051011;microtubule minus-end binding;1780;267;GO:0005524
GO:0051012;microtubule sliding;2719;54;GO:0007088
GO:0051010;microtubule plus-end binding;7598;667;GO:0005524
GO:0090629;lagging strand initiation;0;2;GO:0006260
GO:0038019;Wnt receptor recycling;0;1;GO:0006874
GO:0051019;mitogen-activated protein kinase binding;1459;646;GO:0043407
GO:0090627;plant epidermal cell differentiation;7784;24;GO:0009908
GO:0038018;Wnt receptor catabolic process;148;47;GO:0004870
GO:0090628;plant epidermal cell fate specification;38;1;GO:0048316
GO:0051017;actin filament bundle assembly;17925;1700;GO:0007049
GO:0090625;siRNA-mediated gene silencing by mRNA destabilization;137;7;GO:0030941
GO:0051018;protein kinase A binding;6595;520;GO:0043402
GO:0090626;plant epidermis morphogenesis;9296;6;GO:0048316
GO:0014048;regulation of glutamate secretion;291;655;GO:0048169
GO:0038015;positive regulation of insulin receptor signaling pathway by insulin receptor internalization;0;2;GO:0048193
GO:1905442;cellular response to chondroitin 4'-sulfate;0;1;GO:0002526
GO:0014047;glutamate secretion;640;2790;GO:0007631
GO:0038014;negative regulation of insulin receptor signaling pathway by insulin receptor internalization;0;6;GO:0048193
GO:1905441;response to chondroitin 4'-sulfate;0;0;GO:0005581
GO:0014046;dopamine secretion;1962;47;GO:0007601
GO:0038017;Wnt receptor internalization;0;2;GO:0008544
GO:1905440;cellular response to chondroitin 6'-sulfate;0;1;GO:0002526
GO:0014045;establishment of endothelial blood-brain barrier;85;12;GO:0048308
GO:0038016;insulin receptor internalization;119;8;GO:0002596
GO:0014044;Schwann cell development;2084;179;GO:0048667
GO:0038011;negative regulation of signal transduction by receptor internalization;0;2;GO:0048193
GO:1905446;regulation of mitochondrial ATP synthesis coupled electron transport;201;5;GO:0015986
GO:0014043;negative regulation of neuron maturation;168;49;GO:0048666
GO:0038010;positive regulation of signal transduction by receptor internalization;1;1;GO:0048193
GO:1905445;positive regulation of clathrin coat assembly;62;2;GO:0048193
GO:0002060;purine nucleobase binding;222;43;GO:0097367
GO:0014042;positive regulation of neuron maturation;243;300;GO:0048666
GO:0038013;positive regulation of Wnt signaling pathway by Wnt receptor internalization;0;3;GO:0048407
GO:1905444;negative regulation of clathrin coat assembly;2;1;GO:0048193
GO:0002061;pyrimidine nucleobase binding;92;1;GO:0003676
GO:0014041;regulation of neuron maturation;577;272;GO:0048666
GO:0038012;negative regulation of Wnt signaling pathway by Wnt receptor internalization;0;3;GO:0048405
GO:1905443;regulation of clathrin coat assembly;64;0;GO:0048193
GO:0002062;chondrocyte differentiation;11372;1540;GO:0045595
GO:0014040;positive regulation of Schwann cell differentiation;71;27;GO:0048661
GO:0002063;chondrocyte development;4500;1090;GO:0048667
GO:0051030;snRNA transport;4815;180;GO:0030529
GO:1905449;regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;180;1;GO:0050729
GO:0002064;epithelial cell development;19426;2490;GO:0030216
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;143;9;GO:0015986
GO:0002065;columnar/cuboidal epithelial cell differentiation;10012;447;GO:0030216
GO:1905447;negative regulation of mitochondrial ATP synthesis coupled electron transport;50;4;GO:0015986
GO:0002066;columnar/cuboidal epithelial cell development;3359;325;GO:0030216
GO:0002067;glandular epithelial cell differentiation;6320;531;GO:0030216
GO:0002068;glandular epithelial cell development;2251;408;GO:0030216
GO:0002069;columnar/cuboidal epithelial cell maturation;711;27;GO:0048608
GO:0002059;thymine binding;3;3;GO:0003676
GO:0051026;chiasma assembly;788;465;GO:0007030
GO:0051027;DNA transport;1600;6;GO:0006351
GO:0051022;Rho GDP-dissociation inhibitor binding;60;45;GO:0005524
GO:0051020;GTPase binding;147730;1390;GO:0005524
GO:0051021;GDP-dissociation inhibitor binding;66;10;GO:0005524
GO:0038008;TRAF-mediated signal transduction;84;2;GO:0007165
GO:0038007;netrin-activated signaling pathway;22815;51;GO:0048608
GO:0014039;negative regulation of Schwann cell differentiation;0;2;GO:0048661
GO:0051028;mRNA transport;175719;3180;GO:0015031
GO:0014038;regulation of Schwann cell differentiation;72;133;GO:0048704
GO:0038009;regulation of signal transduction by receptor internalization;61;6;GO:0007165
GO:0051029;rRNA transport;688;64;GO:0006413
GO:0014059;regulation of dopamine secretion;1723;939;GO:0048167
GO:0038004;epidermal growth factor receptor ligand maturation;180;9;GO:0002520
GO:0090601;enucleation;19;2;GO:0007067
GO:1905453;regulation of myeloid progenitor cell differentiation;172;4;GO:0045595
GO:0014058;negative regulation of acetylcholine secretion, neurotransmission;2;4;GO:0048666
GO:0038003;G protein-coupled opioid receptor signaling pathway;15677;9;GO:0007186
GO:0090602;sieve element enucleation;7;3;GO:0009986
GO:0014057;positive regulation of acetylcholine secretion, neurotransmission;73;113;GO:0048666
GO:0038006;netrin receptor activity involved in chemoattraction;2;2;GO:0005021
GO:1905451;positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;120;8;GO:0032989
GO:0014056;regulation of acetylcholine secretion, neurotransmission;82;32;GO:0048666
GO:0090600;alpha-1,3-glucosidase activity;233;0;GO:0004553
GO:1905450;negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;58;4;GO:0050729
GO:0014055;acetylcholine secretion, neurotransmission;90;7;GO:0007218
GO:1905457;negative regulation of lymphoid progenitor cell differentiation;213;2;GO:0045595
GO:0002070;epithelial cell maturation;1317;262;GO:0030216
GO:0014054;positive regulation of gamma-aminobutyric acid secretion;66;53;GO:0048167
GO:1905456;regulation of lymphoid progenitor cell differentiation;610;4;GO:0045595
GO:0002071;glandular epithelial cell maturation;434;30;GO:0007517
GO:0014053;negative regulation of gamma-aminobutyric acid secretion;22;83;GO:0048167
GO:0038002;endocrine signaling;56;6;GO:0007218
GO:1905455;positive regulation of myeloid progenitor cell differentiation;58;1;GO:0045595
GO:0002072;optic cup morphogenesis involved in camera-type eye development;2561;34;GO:0048704
GO:0014052;regulation of gamma-aminobutyric acid secretion;92;10;GO:0048167
GO:0038001;paracrine signaling;374;25;GO:0009913
GO:1905454;negative regulation of myeloid progenitor cell differentiation;50;1;GO:0045595
GO:0014051;gamma-aminobutyric acid secretion;318;42;GO:0008037
GO:0051040;regulation of calcium-independent cell-cell adhesion;104;5;GO:0050877
GO:0002074;extraocular skeletal muscle development;129;49;GO:0048704
GO:0014050;negative regulation of glutamate secretion;60;269;GO:0048169
GO:0051041;positive regulation of calcium-independent cell-cell adhesion;42;4;GO:0048608
GO:0002075;somitomeric trunk muscle development;37;3;GO:0048704
GO:1905459;regulation of vascular associated smooth muscle cell apoptotic process;493;4;GO:0043066
GO:0002076;osteoblast development;782;915;GO:0048609
GO:1905458;positive regulation of lymphoid progenitor cell differentiation;124;1;GO:0045595
GO:0002077;acrosome matrix dispersal;5;9;GO:0008037
GO:0002078;membrane fusion involved in acrosome reaction;0;4;GO:0006974
GO:0002079;inner acrosomal membrane;688;59;GO:0005576
GO:0051037;regulation of transcription involved in meiotic cell cycle;387;10;GO:0048285
GO:0051038;negative regulation of transcription involved in meiotic cell cycle;65;5;GO:0048285
GO:0051035;DNA transmembrane transporter activity;0;1;GO:0005524
GO:0051036;regulation of endosome size;337;34;GO:0048193
GO:0051033;RNA transmembrane transporter activity;69;284;GO:0003723
GO:0051034;tRNA transmembrane transporter activity;0;1;GO:0003735
GO:0051031;tRNA transport;12296;23;GO:0006413
GO:0051032;nucleic acid transmembrane transporter activity;123;9;GO:0008529
GO:0090609;single-species submerged biofilm formation;2762;3;GO:0046278
GO:0090605;submerged biofilm formation;8003;4;GO:0048565
GO:0090606;single-species surface biofilm formation;64;4;GO:0046278
GO:0051039;positive regulation of transcription involved in meiotic cell cycle;253;7;GO:0048285
GO:0090603;sieve element differentiation;47;4;GO:0048704
GO:0014049;positive regulation of glutamate secretion;134;433;GO:0048167
GO:0090604;surface biofilm formation;66;0;GO:0046278
GO:0102728;campest-4-en-3-one,NADPH:steroid 5alpha-reductase activity;1;1;GO:0004722
GO:0043822;ribonuclease M5 activity;13577;9;GO:0004518
GO:0043821;propionyl-CoA:succinate CoA-transferase activity;2;1;GO:0004091
GO:0016290;palmitoyl-CoA hydrolase activity;1245;411;GO:0046395
GO:0016295;myristoyl-[acyl-carrier-protein] hydrolase activity;4552;0;GO:0004721
GO:0016296;palmitoyl-[acyl-carrier-protein] hydrolase activity;4554;0;GO:0004734
GO:0016297;acyl-[acyl-carrier-protein] hydrolase activity;27915;0;GO:0005576
GO:0016298;lipase activity;457170;1570;GO:0004553
GO:0102730;cathasterone hydroxylase activity;0;0;GO:0004497
GO:0043834;trimethylamine methyltransferase activity;314;4;GO:0004497
GO:0102735;trihydroxybenzophenone synthase activity;4;2;GO:0004073
GO:0043837;valine dehydrogenase (NAD) activity;1102;3;GO:0009065
GO:0102738;(gibberellin-14), 2-oxoglutarate:oxygen oxidoreductase activity;0;1;GO:0004091
GO:0043836;xanthine hydrolase activity;0;1;GO:0004725
GO:0102737;p-coumaroyltriacetic acid synthase activity;0;0;GO:0004497
GO:0043839;lipid A phosphate methyltransferase activity;0;1;GO:0003906
GO:0102732;myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity;456;1;GO:0004721
GO:0043838;phosphatidylethanolamine:Kdo2-lipid A phosphoethanolamine transferase activity;4;1;GO:0004734
GO:0102731;D-myo-inositol (1,3,4,6)-tetrakisphosphate 2-kinase activity;0;0;GO:0004721
GO:0102734;brassinolide synthase activity;3;0;GO:0004497
GO:0102733;typhasterol C-23 hydroxylase activity;0;1;GO:0046395
GO:0043831;thiosulfate dehydrogenase (quinone) activity;181;3;GO:0004746
GO:0043830;thiol-driven fumarate reductase activity;0;3;GO:0009065
GO:0102739;(gibberellin-36), 2-oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0043833;[methyl-Co(III) methylamine-specific corrinoid protein]:coenzyme M methyltransferase activity;36;0;GO:0003676
GO:0016281;eukaryotic translation initiation factor 4F complex;1098;741;GO:0003743
GO:0016282;eukaryotic 43S preinitiation complex;37091;797;GO:0005840
GO:0016286;small conductance calcium-activated potassium channel activity;7791;457;GO:0008092
GO:0016287;glycerone-phosphate O-acyltransferase activity;1836;140;GO:0008610
GO:0102741;paraxanthine:S-adenosyl-L-methionine 3-N-methyltransferase activity;20;2;GO:0004725
GO:0102740;theobromine:S-adenosyl-L-methionine 1-N-methyltransferase activity;20;3;GO:0004722
GO:0016289;CoA hydrolase activity;193323;78;GO:0016829
GO:0043846;DNA polymerase III, clamp loader complex;7;4;GO:0005524
GO:0102747;chlorophyllide-a:geranyl-geranyl diphosphate geranyl-geranyl transferase activity;0;0;GO:0004725
GO:0043845;DNA polymerase III, proofreading complex;0;1;GO:0003964
GO:0102746;tetrahydrogeranylgeranyl-PP reductase activity;0;0;GO:0004091
GO:0102749;dihydrogeranylgeranyl-chlorophyll a reductase activity;0;0;GO:0008629
GO:0043847;DNA polymerase III, clamp loader chi/psi subcomplex;0;1;GO:0005524
GO:0102748;geranylgeranyl-chlorophyll a reductase activity;0;0;GO:0006096
GO:0102743;eriodictyol,NADPH:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0043849;Ras palmitoyltransferase activity;65;9;GO:0004721
GO:0102742;R(+)-3,4-dihydroxyphenyllactate:NADP+ oxidoreductase activity;18;0;GO:0004091
GO:0102745;dihydrogeranylgeranyl-PP reductase activity;0;0;GO:0004091
GO:0102744;all-trans-geranyl-geranyl diphosphate reductase activity;0;0;GO:0004091
GO:0043840;branched-chain amino acid:2-keto-4-methylthiobutyrate aminotransferase activity;0;1;GO:0009065
GO:0043842;Kdo transferase activity;22423;4;GO:0004332
GO:0043841;(S)-lactate 2-kinase activity;1;0;GO:0004721
GO:0043844;ADP-specific phosphofructokinase activity;321;2;GO:0006099
GO:0043843;ADP-specific glucokinase activity;362;6;GO:0006096
GO:0031899;chromoplast inner membrane;0;1;GO:0009909
GO:0016270;O-glycan processing, core 4;0;2;GO:0008544
GO:0016272;prefoldin complex;37314;1160;GO:0005737
GO:0016273;arginine N-methyltransferase activity;44277;46;GO:0004725
GO:0016274;protein-arginine N-methyltransferase activity;44236;482;GO:0003723
GO:0031893;vasopressin receptor binding;91;7;GO:0004872
GO:0102750;tetrahydrogeranylgeranyl-chlorophyll a reductase activity;0;0;GO:0008631
GO:0031894;V1A vasopressin receptor binding;82;7;GO:0004872
GO:0031891;type 1 vasoactive intestinal polypeptide receptor binding;0;1;GO:0004930
GO:0102752;1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis);28621;3;GO:0005976
GO:0031892;type 2 vasoactive intestinal polypeptide receptor binding;0;0;GO:0004930
GO:0102751;UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity;141;4;GO:0006029
GO:0016278;lysine N-methyltransferase activity;134476;182;GO:0004725
GO:0031897;Tic complex;3;6;GO:0005840
GO:0016279;protein-lysine N-methyltransferase activity;134231;1080;GO:0004723
GO:0031898;chromoplast envelope;2;1;GO:0009579
GO:0031895;V1B vasopressin receptor binding;6;5;GO:0004872
GO:0031896;V2 vasopressin receptor binding;3;6;GO:0004867
GO:0043857;N-acetylornithine carbamoyltransferase activity;2576;5;GO:0006081
GO:0102758;very-long-chain enoyl-CoA reductase activity;924;5;GO:0004091
GO:0043856;anti-sigma factor antagonist activity;47656;22;GO:0003712
GO:0102757;NADPH phosphatase activity;69;5;GO:0004725
GO:0043858;arginine:ornithine antiporter activity;2868;9;GO:0009065
GO:0102759;campestanol hydroxylase activity;0;0;GO:0004497
GO:0102754;chlorophyllide-b:phytyl-diphosphate phytyltransferase activity;0;0;GO:0003824
GO:0031890;vasoactive intestinal polypeptide receptor binding;0;0;GO:0004867
GO:0102753;chlorophyllide b:geranyl-geranyl diphosphate geranyl-geranyltransferase activity;0;0;GO:0004725
GO:0102755;gibberellin-15(closed lactone form),2-oxoglutarate:oxygen oxidoreductase (3beta-hydroxylating) activity;0;0;GO:0004091
GO:0004298;threonine-type endopeptidase activity;87736;2360;GO:0004175
GO:0043850;RecFOR complex;0;1;GO:0005576
GO:0043853;methanol-CoM methyltransferase complex;0;0;GO:0005524
GO:0043852;monomethylamine methyltransferase activity;366;4;GO:0004497
GO:0043855;cyclic nucleotide-gated monoatomic ion channel activity;1003;0;GO:0005216
GO:0043854;cyclic nucleotide-gated mechanosensitive monoatomic ion channel activity;0;1;GO:0005216
GO:0031889;urotensin receptor binding;0;1;GO:0005509
GO:0016260;selenocysteine biosynthetic process;50593;173;GO:0009064
GO:0016261;selenocysteine catabolic process;9;4;GO:0009062
GO:0016262;protein N-acetylglucosaminyltransferase activity;175;49;GO:0006029
GO:0016263;glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity;2446;37;GO:0008544
GO:0031882;type 5 somatostatin receptor binding;0;1;GO:0005509
GO:0102761;eriodictyol 3'-O-methyltransferase activity;0;0;GO:0004497
GO:0016264;gap junction assembly;848;987;GO:0005929
GO:0031883;taste receptor binding;71;3;GO:0005509
GO:0102760;6-deoxocathasterone hydroxylase activity;0;0;GO:0004497
GO:0031880;type 3 somatostatin receptor binding;0;1;GO:0005509
GO:0102763;phytyl-P kinase activity;1;1;GO:0004721
GO:0016266;O-glycan processing;236;1780;GO:0008544
GO:0031881;type 4 somatostatin receptor binding;0;0;GO:0005509
GO:0102762;eriodictyol 4'-O-methyltransferase activity;0;0;GO:0004497
GO:0016267;O-glycan processing, core 1;10;27;GO:0008544
GO:0031886;type 1 member 3 taste receptor binding;0;0;GO:0005509
GO:0016268;O-glycan processing, core 2;4;4;GO:0008021
GO:0031887;lipid droplet transport along microtubule;78;3;GO:0048193
GO:0016269;O-glycan processing, core 3;1;6;GO:0008021
GO:0031884;type 1 member 1 taste receptor binding;0;1;GO:0005509
GO:0031885;type 1 member 2 taste receptor binding;0;1;GO:0005509
GO:0102769;dihydroceramide glucosyltransferase activity;2757;3;GO:0006029
GO:0102768;anthocyanidin synthase activity;0;1;GO:0004497
GO:0102765;UDP-D-apiose synthase activity;0;0;GO:0006032
GO:0102764;6-deoxotyphasterol C-23 hydroxylase activity;0;0;GO:0004497
GO:0102767;flavanone 4'-O-methyltransferase activity;2;0;GO:0004497
GO:0102766;naringenin 7-O-methyltransferase activity;2;3;GO:0004725
GO:0102772;sphingolipid long-chain base 4-hydroxylase activity;0;0;GO:0004073
GO:0102771;sphingolipid very long chain fatty acid alpha-hydroxylase activity;3;1;GO:0004073
GO:0102774;p-coumaroyltriacetic acid lactone synthase activity;0;0;GO:0004497
GO:0102773;dihydroceramide kinase activity;48;2;GO:0004721
GO:0102770;inositol phosphorylceramide synthase activity;1;0;GO:0006030
GO:0090106;pancreatic E cell fate commitment;0;2;GO:0048704
GO:0090107;regulation of high-density lipoprotein particle assembly;154;10;GO:0048193
GO:0102779;cannabidiolate synthase activity;6;2;GO:0004497
GO:0090104;pancreatic epsilon cell differentiation;139;5;GO:0048608
GO:0090105;pancreatic E cell development;0;3;GO:0007596
GO:0090102;cochlea development;1943;1040;GO:0007586
GO:0102776;UDP-D-glucose:pelargonidin-3-O-beta-D-glucoside 5-O-glucosyltransferase activity;0;0;GO:0006022
GO:0090103;cochlea morphogenesis;986;764;GO:0048704
GO:0102775;6-(4-methyl-2-oxopentyl)-4-hydroxy-2-pyrone synthase activity;0;0;GO:0004497
GO:0090100;positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway;5989;163;GO:0007186
GO:0102778;delta9-tetrahydrocannabinolate synthase activity;4;2;GO:0004497
GO:0090101;negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway;15499;417;GO:0048010
GO:0102777;caffeoyl-CoA:pelargonidin-3,5-diglucoside 5-O-glucoside-6-O-hydroxycinnamoyltransferase activity;11;1;GO:0006073
GO:0102783;beta-carotene oxygenase activity;0;0;GO:0004497
GO:0102782;cholestanol hydroxylase activity;0;0;GO:0004784
GO:0102785;violaxanthin oxygenase activity;0;0;GO:0004073
GO:0102784;lutein oxygenase activity;0;0;GO:0004497
GO:0090108;positive regulation of high-density lipoprotein particle assembly;99;10;GO:0048193
GO:0102781;isofucosterol hydroxylase activity;0;0;GO:0004073
GO:0090109;regulation of cell-substrate junction assembly;2775;66;GO:0048010
GO:0102780;sitosterol hydroxylase activity;0;1;GO:0004497
GO:0102787;caffeoyl-CoA:pelargonidin-3-O-beta-D-glucoside-6''-O-acyltransferase activity;0;0;GO:0006073
GO:0102786;stearoyl-[acp] desaturase activity;1186;1;GO:0008610
GO:0102789;UDP-D-glucose:cyanidin 5-O-beta-D-glucosyltransferase activity;0;1;GO:0006029
GO:0102788;4-coumaroyl-CoA:pelargonidin-3-O-beta-D-glucoside-6''-O-acyltransferase activity;0;0;GO:0006073
GO:0016191;synaptic vesicle uncoating;226;53;GO:0008030
GO:0016192;vesicle-mediated transport;2207413;11900;GO:0008092
GO:0016197;endosomal transport;97273;2170;GO:0006897
GO:0102794;cinnamaldehyde:oxygen oxidoreductase activity;6;1;GO:0004497
GO:0016198;axon choice point recognition;2467;170;GO:0008076
GO:0102793;soyasapogenol B glucuronosyltransferase activity;0;2;GO:0004497
GO:0016199;axon midline choice point recognition;2324;324;GO:0008021
GO:0102796;protocatechualdehyde:oxygen oxidoreductase activity;6;1;GO:0004497
GO:0102795;1-naphthaldehyde:oxygen oxidoreductase activity;6;1;GO:0004497
GO:0102790;cyanidin 5,3-O-glycosyltransferase activity;0;0;GO:0004553
GO:0102792;sinapaldehyde:NAD(P)+ oxidoreductase activity;0;0;GO:0004089
GO:0102791;sulfuretin synthase activity;3;1;GO:0004730
GO:0102799;glucosinolate glucohydrolase activity;728;1;GO:0004553
GO:0016180;snRNA processing;22074;669;GO:0006364
GO:0016182;synaptic vesicle budding from endosome;122;7;GO:0008030
GO:0016183;synaptic vesicle coating;15;26;GO:0008026
GO:0016185;synaptic vesicle budding from presynaptic endocytic zone membrane;140;57;GO:0008029
GO:0016188;synaptic vesicle maturation;1283;2120;GO:0008026
GO:0016189;synaptic vesicle to endosome fusion;86;8;GO:0006986
GO:0043783;oxidoreductase activity, acting on metal ions, flavin as acceptor;0;1;GO:0004601
GO:0043782;cobalt-precorrin-3 C17-methyltransferase activity;0;3;GO:0003676
GO:0043785;cinnamoyl-CoA:phenyllactate CoA-transferase activity;308;5;GO:0006081
GO:0043786;cinnamate reductase activity;0;2;GO:0004067
GO:0043792;enamidase activity;139;3;GO:0004553
GO:0043791;dimethylamine methyltransferase activity;347;4;GO:0004497
GO:0043794;formate dehydrogenase (coenzyme F420) activity;2;1;GO:0009065
GO:0043793;beta-ribofuranosylaminobenzene 5'-phosphate synthase activity;0;1;GO:0006030
GO:0043796;glyceraldehyde dehydrogenase (NADP) activity;13;3;GO:0006066
GO:0043795;glyceraldehyde oxidoreductase activity;94;115;GO:0004067
GO:0043798;glycerate 2-kinase activity;1197;7;GO:0004721
GO:0043797;glyceraldehyde-3-phosphate dehydrogenase (ferredoxin) activity;33;4;GO:0003824
GO:0043799;glycine oxidase activity;4136;1;GO:0004067
GO:0090179;planar cell polarity pathway involved in neural tube closure;561;1440;GO:0009952
GO:0090177;establishment of planar polarity involved in neural tube closure;673;37;GO:0007610
GO:0090178;regulation of establishment of planar polarity involved in neural tube closure;620;1350;GO:0048704
GO:0090175;regulation of establishment of planar polarity;3426;958;GO:0048608
GO:0090176;microtubule cytoskeleton organization involved in establishment of planar polarity;189;137;GO:0048471
GO:0090173;regulation of synaptonemal complex assembly;1711;2;GO:0048704
GO:0090174;organelle membrane fusion;20745;179;GO:0005743
GO:0090171;chondrocyte morphogenesis;118;12;GO:0048608
GO:0090172;microtubule cytoskeleton organization involved in homologous chromosome segregation;54;7;GO:0007059
GO:0090170;regulation of Golgi inheritance;676;25;GO:0048193
GO:0090188;negative regulation of pancreatic juice secretion;199;186;GO:0048407
GO:0090189;regulation of branching involved in ureteric bud morphogenesis;1066;33;GO:0048608
GO:0090186;regulation of pancreatic juice secretion;266;7;GO:0048407
GO:0090187;positive regulation of pancreatic juice secretion;67;10;GO:0048407
GO:0090184;positive regulation of kidney development;462;232;GO:0048704
GO:0090185;negative regulation of kidney development;248;198;GO:0048706
GO:0090182;regulation of secretion of lysosomal enzymes;122;1;GO:0048193
GO:0090183;regulation of kidney development;2029;173;GO:0048316
GO:0090180;positive regulation of thiamine biosynthetic process;19;4;GO:0046395
GO:0090181;regulation of cholesterol metabolic process;1994;898;GO:0045944
GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis;873;423;GO:0048608
GO:0090159;sphingolipid biosynthesis involved in endoplasmic reticulum membrane organization;0;2;GO:0006629
GO:0090158;endoplasmic reticulum membrane organization;1478;109;GO:0007030
GO:0090155;negative regulation of sphingolipid biosynthetic process;372;37;GO:0046356
GO:0090156;intracellular sphingolipid homeostasis;389;2;GO:0006629
GO:0090153;regulation of sphingolipid biosynthetic process;3532;31;GO:0046394
GO:0090154;positive regulation of sphingolipid biosynthetic process;287;40;GO:0046394
GO:0090151;establishment of protein localization to mitochondrial membrane;17208;1820;GO:0005743
GO:0090152;establishment of protein localization to mitochondrial membrane involved in mitochondrial fission;59;4;GO:0005740
GO:0090150;establishment of protein localization to membrane;559513;1350;GO:0051604
GO:0090168;Golgi reassembly;165;76;GO:0006631
GO:0090169;regulation of spindle assembly;2257;37;GO:0048285
GO:0090166;Golgi disassembly;216;52;GO:0005766
GO:0090167;Golgi distribution to daughter cells;0;1;GO:0005764
GO:0090164;asymmetric Golgi ribbon formation;94;7;GO:0008544
GO:0090165;regulation of secretion by asymmetric Golgi ribbon formation;0;2;GO:0048193
GO:0090162;establishment of epithelial cell polarity;7852;406;GO:0030154
GO:0090163;establishment of epithelial cell planar polarity;31;6;GO:0048316
GO:0090160;Golgi to lysosome transport;722;57;GO:0006897
GO:0090161;Golgi ribbon formation;1840;82;GO:0009986
GO:0090139;mitochondrial chromosome packaging;3;2;GO:0005739
GO:0090137;epithelial cell-cell adhesion involved in epithelium migration;3;2;GO:0007155
GO:0090138;regulation of actin cytoskeleton organization by cell-cell adhesion;66;87;GO:0030198
GO:0090135;actin filament branching;76;48;GO:0003779
GO:0090136;epithelial cell-cell adhesion;1034;1380;GO:0007155
GO:0090133;mesendoderm migration;133;1;GO:0048704
GO:0090134;cell migration involved in mesendoderm migration;127;4;GO:0048608
GO:0090131;mesenchyme migration;285;154;GO:0030900
GO:0090132;epithelium migration;23772;606;GO:0030900
GO:0090130;tissue migration;24303;529;GO:0030900
GO:0090148;membrane fission;2132;244;GO:0007050
GO:0090149;mitochondrial membrane fission;1636;67;GO:0007047
GO:0090144;mitochondrial nucleoid organization;42;2;GO:0005739
GO:0090143;nucleoid organization;155;5;GO:0005829
GO:0090140;regulation of mitochondrial fission;4522;258;GO:0048471
GO:0090141;positive regulation of mitochondrial fission;3960;805;GO:0048285
GO:0006810;transport;66070311;32700;GO:0006810
GO:0006801;superoxide metabolic process;511425;1770;GO:0006879
GO:0006807;nitrogen compound metabolic process;167398843;8830;GO:0006519
GO:0006805;xenobiotic metabolic process;96614;3430;GO:0006725
GO:0006808;regulation of nitrogen utilization;87187;1130;GO:0046394
GO:0006809;nitric oxide biosynthetic process;11547;2030;GO:1901363
GO:0090117;endosome to lysosome transport of low-density lipoprotein particle;112;4;GO:0006897
GO:0090118;receptor-mediated endocytosis involved in cholesterol transport;393;133;GO:0006897
GO:0090116;C-5 methylation of cytosine;134203;83;GO:0004553
GO:0090114;COPII-coated vesicle budding;17444;128;GO:0008029
GO:0090111;regulation of COPII vesicle uncoating;0;0;GO:0006626
GO:0090112;COPII vesicle uncoating;0;1;GO:0008029
GO:0090110;COPII-coated vesicle cargo loading;1671;81;GO:0008023
GO:0090119;vesicle-mediated cholesterol transport;396;25;GO:0006897
GO:0090128;regulation of synapse maturation;936;873;GO:0048167
GO:0090129;positive regulation of synapse maturation;359;2780;GO:0048167
GO:0090126;protein-containing complex assembly involved in synapse maturation;5;0;GO:0048167
GO:0090127;positive regulation of synapse maturation by synaptic transmission;0;1;GO:0048167
GO:0090124;N-4 methylation of cytosine;68861;3;GO:0045944
GO:0090125;cell-cell adhesion involved in synapse maturation;14;4;GO:0030062
GO:0090122;cholesterol ester hydrolysis involved in cholesterol transport;1;4;GO:0006629
GO:0090123;lysosomal glycocalyx;0;2;GO:0005764
GO:0090120;lysosome to ER cholesterol transport;0;0;GO:0006629
GO:0090121;low-density lipoprotein particle disassembly involved in cholesterol transport;0;1;GO:0006869
GO:0018945;organosilicon metabolic process;0;4;GO:0006790
GO:0018944;tri-n-butyltin metabolic process;0;2;GO:0046395
GO:0018947;anaerobic organosilicon metabolic process;0;2;GO:0009062
GO:0043903;regulation of biological process involved in symbiotic interaction;2942;211;GO:0045734
GO:0018946;aerobic organosilicon metabolic process;0;2;GO:0006091
GO:0018949;m-xylene metabolic process;0;1;GO:0046148
GO:0043905;L-seryl-tRNA(Thr) hydrolase activity;0;0;GO:0008544
GO:0018948;xylene metabolic process;6;2;GO:0046365
GO:0043904;isochorismate pyruvate lyase activity;122;3;GO:0006099
GO:0043907;Cys-tRNA(Pro) hydrolase activity;2;1;GO:0006457
GO:0043906;Ala-tRNA(Pro) hydrolase activity;6;2;GO:0008544
GO:0031918;positive regulation of synaptic metaplasticity;0;1;GO:0048167
GO:0031919;vitamin B6 transport;303;4;GO:0006869
GO:0004300;enoyl-CoA hydratase activity;86195;642;GO:0004497
GO:0006963;positive regulation of antibacterial peptide biosynthetic process;429;201;GO:0046274
GO:0006964;positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria;92;9;GO:0046274
GO:0004301;epoxide hydrolase activity;3575;419;GO:0004497
GO:0006962;male-specific antibacterial humoral response;10;4;GO:0002757
GO:0006956;complement activation;26910;4650;GO:0006958
GO:0031912;oral apparatus;1;1;GO:0009566
GO:0006957;complement activation, alternative pathway;2478;2010;GO:0006958
GO:0031913;contractile vacuole pore;0;2;GO:0005576
GO:0006954;inflammatory response;99745;20000;GO:0006954
GO:0031910;cytostome;5;3;GO:0005576
GO:0006955;immune response;1157429;28500;GO:0006955
GO:0031911;cytoproct;0;3;GO:0005576
GO:0031916;regulation of synaptic metaplasticity;0;2;GO:0048167
GO:0031917;negative regulation of synaptic metaplasticity;0;1;GO:0048167
GO:0006958;complement activation, classical pathway;8752;3770;GO:0006958
GO:0031914;negative regulation of synaptic plasticity;131;137;GO:0048167
GO:0006959;humoral immune response;38675;5040;GO:0006955
GO:0031915;positive regulation of synaptic plasticity;393;130;GO:0048167
GO:0043909;N-acetylcitrulline deacetylase activity;227;3;GO:0004723
GO:0043908;Ser(Gly)-tRNA(Ala) hydrolase activity;31260;0;GO:0008544
GO:0018950;o-xylene metabolic process;0;2;GO:0046148
GO:0018952;parathion metabolic process;0;5;GO:0006749
GO:0018951;p-xylene metabolic process;0;1;GO:0046365
GO:0018954;pentaerythritol tetranitrate metabolic process;0;3;GO:0006749
GO:0018953;p-cymene metabolic process;0;2;GO:0006749
GO:0018934;nitrilotriacetate metabolic process;0;2;GO:0006559
GO:0043912;D-lysine oxidase activity;0;2;GO:0004725
GO:0018933;nicotine metabolic process;373;3;GO:0009062
GO:0043911;D-lysine transaminase activity;0;1;GO:0004449
GO:0018936;anaerobic nitrilotriacetate metabolic process;0;2;GO:0009061
GO:0043914;NADPH:sulfur oxidoreductase activity;3;10;GO:0004091
GO:0018935;aerobic nitrilotriacetate metabolic process;0;2;GO:0009065
GO:0018938;2-nitropropane metabolic process;0;3;GO:0006569
GO:0043916;DNA-7-methylguanine glycosylase activity;4727;54;GO:0004518
GO:0018937;nitroglycerin metabolic process;1;1;GO:0006749
GO:0043915;L-seryl-tRNA(Sec) kinase activity;107;5;GO:0006413
GO:0043918;cadaverine aminopropyltransferase activity;34;1;GO:0006029
GO:0018939;n-octane metabolic process;0;3;GO:0006749
GO:0043917;ribose 1,5-bisphosphate isomerase activity;2961;5;GO:0006096
GO:0006970;response to osmotic stress;32969;4540;GO:0006970
GO:0006971;hypotonic response;884;7;GO:0006970
GO:0031907;microbody lumen;9510;307;GO:0005829
GO:0031908;glyoxysomal lumen;0;2;GO:0005764
GO:0004311;farnesyltranstransferase activity;174448;144;GO:0003749
GO:0006974;DNA damage response;8806241;4940;GO:0006974
GO:0004310;farnesyl-diphosphate farnesyltransferase activity;11398;93;GO:0003743
GO:0004313;[acyl-carrier-protein] S-acetyltransferase activity;4559;232;GO:0004089
GO:0006972;hyperosmotic response;5347;883;GO:0006970
GO:0043910;ATP:coenzyme F420 adenylyltransferase activity;0;2;GO:0006091
GO:0004312;fatty acid synthase activity;20136;1270;GO:0004613
GO:0006973;intracellular accumulation of glycerol;13;5;GO:0006633
GO:0004304;estrone sulfotransferase activity;69;123;GO:0004730
GO:0006967;positive regulation of antifungal peptide biosynthetic process;44;25;GO:0046274
GO:0031901;early endosome membrane;51319;1770;GO:0005768
GO:0004303;estradiol 17-beta-dehydrogenase [NAD(P)] activity;3351;0;GO:0004497
GO:0006968;cellular defense response;6022;2090;GO:0006952
GO:0031902;late endosome membrane;53895;1500;GO:0005768
GO:0004306;ethanolamine-phosphate cytidylyltransferase activity;15097;45;GO:0006067
GO:0006965;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;84;153;GO:0046274
GO:0004305;ethanolamine kinase activity;707;218;GO:0004721
GO:0031900;chromoplast outer membrane;0;1;GO:0009941
GO:0004308;exo-alpha-sialidase activity;1078528;107;GO:0004553
GO:0031905;early endosome lumen;25;212;GO:0005768
GO:0004307;ethanolaminephosphotransferase activity;295;208;GO:0004723
GO:0031906;late endosome lumen;33;26;GO:0005768
GO:0031903;microbody membrane;75590;240;GO:0005886
GO:0004309;exopolyphosphatase activity;24100;47;GO:0004721
GO:0031904;endosome lumen;299;479;GO:0005768
GO:0043919;agmatine aminopropyltransferase activity;34;2;GO:0004073
GO:0018941;organomercury metabolic process;2744;2;GO:0006725
GO:0018940;orcinol metabolic process;2;4;GO:0006032
GO:0018943;organotin metabolic process;0;2;GO:0006725
GO:0018942;organometal metabolic process;2744;4;GO:0006730
GO:0018923;limonene metabolic process;10;3;GO:0006073
GO:0043923;positive regulation by host of viral transcription;912;1010;GO:0010467
GO:0018922;iprodione metabolic process;0;4;GO:0006725
GO:0043922;negative regulation by host of viral transcription;582;473;GO:0010467
GO:0018925;m-cresol metabolic process;0;2;GO:0006066
GO:0018924;mandelate metabolic process;14;5;GO:0006073
GO:0043924;suramin binding;52;6;GO:0043169
GO:0018926;methanesulfonic acid metabolic process;0;3;GO:0006066
GO:0018929;methyl fluoride metabolic process;0;2;GO:0046395
GO:0043929;primary ovarian follicle growth involved in double layer follicle stage;0;2;GO:0048608
GO:0018928;methyl ethyl ketone metabolic process;0;3;GO:0046274
GO:0043928;exonucleolytic catabolism of deadenylated mRNA;1391;26;GO:0006512
GO:0006941;striated muscle contraction;14003;2180;GO:0006936
GO:0006942;regulation of striated muscle contraction;6488;1310;GO:0048407
GO:0043921;modulation by host of viral transcription;86;220;GO:0010467
GO:0006940;regulation of smooth muscle contraction;6338;976;GO:0048010
GO:0043920;aminopropylagmatine ureohydrolase activity;171;2;GO:0004441
GO:0006934;substrate-bound cell migration, adhesion receptor recycling;0;2;GO:0048608
GO:0006935;chemotaxis;983266;9260;GO:0042330
GO:0006932;substrate-dependent cell migration, cell contraction;1;2;GO:0048608
GO:0006933;negative regulation of cell adhesion involved in substrate-bound cell migration;140;113;GO:0022610
GO:0006939;smooth muscle contraction;15362;1070;GO:0006936
GO:0006936;muscle contraction;42616;7100;GO:0006936
GO:0006937;regulation of muscle contraction;22410;1580;GO:0006936
GO:0018930;3-methylquinoline metabolic process;0;2;GO:0006749
GO:0018912;1,4-dichlorobenzene metabolic process;0;3;GO:0006725
GO:0043934;sporulation;189598;667;GO:0000976
GO:0018911;1,2,4-trichlorobenzene metabolic process;0;2;GO:0006725
GO:0043933;protein-containing complex organization;4676166;128;GO:0043234
GO:0018914;chlorobenzene metabolic process;0;3;GO:0006725
GO:0043936;asexual sporulation resulting in formation of a cellular spore;108;6;GO:0048304
GO:0018913;anaerobic ethylbenzene metabolic process;1;2;GO:0006066
GO:0043935;sexual sporulation resulting in formation of a cellular spore;2137;317;GO:0048304
GO:0018916;nitrobenzene metabolic process;94;225;GO:0006749
GO:0043938;positive regulation of sporulation;1594;6;GO:0046395
GO:0018915;ethylbenzene metabolic process;1;2;GO:0046148
GO:0043937;regulation of sporulation;40471;192;GO:0048304
GO:0043939;negative regulation of sporulation;5535;2;GO:0048304
GO:0018919;gamma-1,2,3,4,5,6-hexachlorocyclohexane metabolic process;0;2;GO:0046148
GO:0006952;defense response;1792208;18200;GO:0006952
GO:0043930;primary ovarian follicle growth involved in primary follicle stage;0;2;GO:0048608
GO:0006953;acute-phase response;9799;3130;GO:0006953
GO:0006950;response to stress;12333651;23500;GO:0006950
GO:0043932;ossification involved in bone remodeling;110;46;GO:0007599
GO:0043931;ossification involved in bone maturation;1144;244;GO:0007518
GO:0006949;syncytium formation;4972;641;GO:0048608
GO:0006948;induction by virus of host cell-cell fusion;231;10;GO:0048193
GO:0018921;3-hydroxybenzyl alcohol metabolic process;0;2;GO:0046148
GO:0018920;glyphosate metabolic process;0;179;GO:0006569
GO:0018989;apolysis;0;4;GO:0006936
GO:0016327;apicolateral plasma membrane;1099;1070;GO:0009986
GO:0016328;lateral plasma membrane;22817;1770;GO:0005886
GO:0004340;glucokinase activity;69465;911;GO:0004723
GO:0004342;glucosamine-6-phosphate deaminase activity;75210;710;GO:0006032
GO:0004341;gluconolactonase activity;3797;4;GO:0004553
GO:0004344;glucose dehydrogenase activity;23733;9;GO:0006066
GO:0004343;glucosamine 6-phosphate N-acetyltransferase activity;10554;24;GO:0006073
GO:0004346;glucose-6-phosphatase activity;4510;202;GO:0006066
GO:0004345;glucose-6-phosphate dehydrogenase activity;181719;1260;GO:0004067
GO:0004337;geranyltranstransferase activity;18252;147;GO:0004497
GO:0031956;medium-chain fatty acid-CoA ligase activity;741;35;GO:0006081
GO:0004336;galactosylceramidase activity;5068;40;GO:0008544
GO:0031957;very long-chain fatty acid-CoA ligase activity;721;458;GO:0006081
GO:0004339;glucan 1,4-alpha-glucosidase activity;6099;26;GO:0004553
GO:0006998;nuclear envelope organization;9066;1150;GO:0005634
GO:0031954;positive regulation of protein autophosphorylation;1418;594;GO:0043406
GO:0004338;glucan exo-1,3-beta-glucosidase activity;340;9;GO:0004553
GO:0006999;nuclear pore organization;1465;2180;GO:0005829
GO:0031955;short-chain fatty acid-CoA ligase activity;2;1;GO:0006081
GO:0018990;ecdysis, chitin-based cuticle;696;22;GO:0009650
GO:0031958;corticosteroid receptor signaling pathway;3345;277;GO:0004725
GO:0031959;mineralocorticoid receptor signaling pathway;5;21;GO:0030518
GO:0018992;germ-line sex determination;359;24;GO:0007548
GO:0016330;second mitotic wave involved in compound eye morphogenesis;88;16;GO:0048608
GO:0018991;egg-laying behavior;968;6;GO:0007631
GO:0016331;morphogenesis of embryonic epithelium;15538;952;GO:0030216
GO:0016332;establishment or maintenance of polarity of embryonic epithelium;133;76;GO:0048608
GO:0018993;somatic sex determination;246;14;GO:0007548
GO:0016333;morphogenesis of follicular epithelium;599;24;GO:0030216
GO:0018996;molting cycle, collagen and cuticulin-based cuticle;2024;38;GO:0008544
GO:0031952;regulation of protein autophosphorylation;2149;144;GO:0010468
GO:0016334;establishment or maintenance of polarity of follicular epithelium;319;29;GO:0048608
GO:0018995;host cellular component;7962972;90;GO:0005622
GO:0031953;negative regulation of protein autophosphorylation;563;545;GO:0010468
GO:0016335;morphogenesis of larval imaginal disc epithelium;71;7;GO:0048608
GO:0031950;negative regulation of glucocorticoid catabolic process;0;4;GO:0045944
GO:0016336;establishment or maintenance of polarity of larval imaginal disc epithelium;42;10;GO:0048608
GO:0031951;positive regulation of glucocorticoid catabolic process;0;4;GO:0010467
GO:0018978;anaerobic 1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process;0;0;GO:0006790
GO:0016316;phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity;8245;48;GO:0004721
GO:0018977;1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process;0;0;GO:0046148
GO:0016318;ommatidial rotation;328;124;GO:0007528
GO:0018979;trichloroethylene metabolic process;3;3;GO:0006725
GO:0016319;mushroom body development;1515;188;GO:0007399
GO:0004351;glutamate decarboxylase activity;25270;704;GO:0004930
GO:0004350;glutamate-5-semialdehyde dehydrogenase activity;137565;508;GO:0004067
GO:0004353;glutamate dehydrogenase [NAD(P)+] activity;87055;0;GO:0004746
GO:0004352;glutamate dehydrogenase (NAD+) activity;38903;0;GO:0004723
GO:0004355;glutamate synthase (NADPH) activity;27416;10;GO:0004061
GO:0004354;glutamate dehydrogenase (NADP+) activity;4334;0;GO:0004723
GO:0004357;glutamate-cysteine ligase activity;134010;633;GO:0004364
GO:0004356;glutamine synthetase activity;195220;10;GO:0003824
GO:0004348;glucosylceramidase activity;25968;336;GO:0004553
GO:0031945;positive regulation of glucocorticoid metabolic process;48;3;GO:0045944
GO:0004347;glucose-6-phosphate isomerase activity;183392;850;GO:0006066
GO:0031946;regulation of glucocorticoid biosynthetic process;488;8;GO:0045944
GO:0031943;regulation of glucocorticoid metabolic process;546;30;GO:0010468
GO:0004349;glutamate 5-kinase activity;130278;727;GO:0004725
GO:0031944;negative regulation of glucocorticoid metabolic process;274;5;GO:0045944
GO:0031949;regulation of glucocorticoid catabolic process;0;2;GO:0042470
GO:0031947;negative regulation of glucocorticoid biosynthetic process;274;10;GO:0045944
GO:0031948;positive regulation of glucocorticoid biosynthetic process;48;3;GO:0045944
GO:0018980;2,4,5-trichlorophenoxyacetic acid metabolic process;2;2;GO:0006725
GO:0016320;endoplasmic reticulum membrane fusion;281;46;GO:0006986
GO:0018983;Z-phenylacetaldoxime metabolic process;0;2;GO:0006066
GO:0016321;female meiosis chromosome segregation;459;138;GO:0007059
GO:0018982;vanillin metabolic process;5;3;GO:0006066
GO:0016322;neuron remodeling;1333;1040;GO:0048666
GO:0018985;pronuclear envelope synthesis;2;4;GO:0005764
GO:0031941;filamentous actin;1165;949;GO:0003779
GO:0016323;basolateral plasma membrane;32906;4300;GO:0005886
GO:0018984;naphthalenesulfonate metabolic process;1;4;GO:0006749
GO:0031942;i-AAA complex;78;6;GO:0005737
GO:0016324;apical plasma membrane;194890;5560;GO:0009986
GO:0016325;oocyte microtubule cytoskeleton organization;359;24;GO:0007018
GO:0018967;tetrachloroethylene metabolic process;0;2;GO:0006749
GO:0018966;styrene metabolic process;5;2;GO:0006066
GO:0018969;thiocyanate metabolic process;143;7;GO:0006749
GO:0018968;tetrahydrofuran metabolic process;0;5;GO:0006096
GO:0016308;1-phosphatidylinositol-4-phosphate 5-kinase activity;9839;411;GO:0004721
GO:0016309;1-phosphatidylinositol-5-phosphate 4-kinase activity;191;43;GO:0004721
GO:0006982;response to lipid hydroperoxide;119;277;GO:0046686
GO:0004320;oleoyl-[acyl-carrier-protein] hydrolase activity;4619;0;GO:0004734
GO:0004322;ferroxidase activity;35077;967;GO:0004601
GO:0004321;fatty-acyl-CoA synthase activity;2071;130;GO:0004497
GO:0006986;response to unfolded protein;36591;3940;GO:0006986
GO:0004324;ferredoxin-NADP+ reductase activity;78558;118;GO:0003824
GO:0006983;ER overload response;586;1060;GO:0006986
GO:0006984;ER-nucleus signaling pathway;9749;1120;GO:0007165
GO:0004315;3-oxoacyl-[acyl-carrier-protein] synthase activity;300174;3;GO:0004497
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;875;554;GO:0006974
GO:0031934;mating-type region heterochromatin;245;22;GO:0007049
GO:0004314;[acyl-carrier-protein] S-malonyltransferase activity;74070;700;GO:0006081
GO:0006979;response to oxidative stress;854860;15600;GO:0006979
GO:0004317;(3R)-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity;2111;0;GO:0006081
GO:0031932;TORC2 complex;20814;515;GO:0005515
GO:0004316;3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity;158169;0;GO:0004041
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;542;3070;GO:0006974
GO:0004319;enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity;1024;0;GO:0004091
GO:0004318;enoyl-[acyl-carrier-protein] reductase (NADH) activity;104906;0;GO:0004089
GO:0018970;toluene metabolic process;62;3;GO:0006725
GO:0018972;toluene-4-sulfonate metabolic process;0;3;GO:0006749
GO:0016310;phosphorylation;11148868;18300;GO:0006468
GO:0018971;anaerobic toluene metabolic process;0;1;GO:0009062
GO:0016311;dephosphorylation;330694;5390;GO:0016310
GO:0018974;2,4,6-trinitrotoluene metabolic process;21;3;GO:0006749
GO:0031930;mitochondria-nucleus signaling pathway;369;54;GO:0007242
GO:0016312;inositol bisphosphate phosphatase activity;340;137;GO:0004721
GO:0018973;trinitrotoluene metabolic process;21;3;GO:0006749
GO:0031931;TORC1 complex;14920;314;GO:0005737
GO:0018976;1,2,3-tribromopropane metabolic process;0;2;GO:0046395
GO:0016314;phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity;4381;113;GO:0004721
GO:0018975;anaerobic 2,4,6-trinitrotoluene metabolic process;0;2;GO:0006749
GO:0018956;phenanthrene catabolic process via trans-9(R),10(R)-dihydrodiolphenanthrene;0;0;GO:0046356
GO:0018955;phenanthrene metabolic process;4;2;GO:0006725
GO:0018958;phenol-containing compound metabolic process;140764;605;GO:0046148
GO:0018957;phenanthrene catabolic process via trans-9(S),10(S)-dihydrodiolphenanthrene;0;0;GO:0046356
GO:0018959;aerobic phenol-containing compound metabolic process;4;2;GO:0019438
GO:0004331;fructose-2,6-bisphosphate 2-phosphatase activity;6824;233;GO:0006066
GO:0031929;TOR signaling;61737;984;GO:0007049
GO:0006991;response to sterol depletion;8256;247;GO:0006869
GO:0004333;fumarate hydratase activity;223421;431;GO:0003954
GO:0006996;organelle organization;5371416;5600;GO:0005737
GO:0004332;fructose-bisphosphate aldolase activity;143381;1440;GO:0004073
GO:0006997;nucleus organization;24979;2010;GO:0051301
GO:0004335;galactokinase activity;57599;623;GO:0004721
GO:0004334;fumarylacetoacetase activity;33644;251;GO:0006066
GO:0006995;cellular response to nitrogen starvation;2902;796;GO:0009737
GO:0004326;tetrahydrofolylpolyglutamate synthase activity;104542;682;GO:0006099
GO:0031923;pyridoxine transport;255;10;GO:0006836
GO:0004325;ferrochelatase activity;159220;761;GO:0006779
GO:0031924;vitamin B6 transmembrane transporter activity;0;0;GO:0005085
GO:0004328;formamidase activity;8586;10;GO:0004553
GO:0031921;pyridoxal phosphate transport;28;4;GO:0006836
GO:0031922;pyridoxamine transport;10;4;GO:0006836
GO:0031927;pyridoxamine transmembrane transporter activity;5;3;GO:0005525
GO:0004329;formate-tetrahydrofolate ligase activity;85275;533;GO:0004497
GO:0031928;pyridoxine transmembrane transporter activity;5;3;GO:0005215
GO:0031925;pyridoxal transmembrane transporter activity;5;3;GO:0005215
GO:0031926;pyridoxal phosphate transmembrane transporter activity;0;2;GO:0005215
GO:0018961;pentachlorophenol metabolic process;3;4;GO:0006725
GO:0018960;4-nitrophenol metabolic process;57;3;GO:0006749
GO:0016300;tRNA (uracil) methyltransferase activity;51419;241;GO:0003729
GO:0018963;phthalate metabolic process;26;42;GO:0006725
GO:0016301;kinase activity;19470503;18400;GO:0004721
GO:0018962;3-phenylpropionate metabolic process;4846;2;GO:0006081
GO:0031920;pyridoxal transport;10;4;GO:0006836
GO:0018965;s-triazine compound metabolic process;1129;5;GO:0006725
GO:0016303;1-phosphatidylinositol-3-kinase activity;17300;1110;GO:0004721
GO:0018964;propylene metabolic process;7;8;GO:0006073
GO:0004380;glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity;59;10;GO:0004553
GO:0004382;GDP phosphatase activity;678;5;GO:0004721
GO:0004381;fucosylgalactoside 3-alpha-galactosyltransferase activity;90;10;GO:0008544
GO:0043981;histone H4-K5 acetylation;8;633;GO:0016569
GO:0004383;guanylate cyclase activity;30960;713;GO:0004567
GO:0043980;histone H2B-K12 acetylation;0;4;GO:0016569
GO:0004386;helicase activity;3458885;8230;GO:0003697
GO:0043983;histone H4-K12 acetylation;1;457;GO:0016569
GO:0004385;guanylate kinase activity;143851;1110;GO:0004721
GO:0043982;histone H4-K8 acetylation;1;656;GO:0016569
GO:0043985;histone H4-R3 methylation;10;96;GO:0016569
GO:0043984;histone H4-K16 acetylation;1;597;GO:0016569
GO:0031998;regulation of fatty acid beta-oxidation;1196;978;GO:0006631
GO:0031999;negative regulation of fatty acid beta-oxidation;305;56;GO:0045944
GO:0031992;energy transducer activity;22155;9;GO:0003700
GO:0031993;light transducer activity;0;1;GO:0009521
GO:0031990;mRNA export from nucleus in response to heat stress;128;213;GO:0006413
GO:0031991;regulation of actomyosin contractile ring contraction;194;5;GO:0048285
GO:0031996;thioesterase binding;538;468;GO:0019904
GO:0031994;insulin-like growth factor I binding;813;704;GO:0008151
GO:0031995;insulin-like growth factor II binding;436;284;GO:0008151
GO:0043999;histone H2AK5 acetyltransferase activity;52;0;GO:0016569
GO:0004392;heme oxygenase (decyclizing) activity;20261;631;GO:0046395
GO:0004395;hexaprenyldihydroxybenzoate methyltransferase activity;2295;8;GO:0004497
GO:0043992;histone H3K9 acetyltransferase activity;243;1;GO:0016569
GO:0004394;heparan sulfate 2-O-sulfotransferase activity;117;6;GO:0004719
GO:0004397;histidine ammonia-lyase activity;68611;188;GO:0004497
GO:0043994;histone H3K23 acetyltransferase activity;68;0;GO:0016569
GO:0004396;hexokinase activity;117733;1030;GO:0006096
GO:0043993;histone H3K18 acetyltransferase activity;121;1;GO:0016569
GO:0004399;histidinol dehydrogenase activity;138255;390;GO:0004073
GO:0043996;histone H4K8 acetyltransferase activity;599;9;GO:0016570
GO:0004398;histidine decarboxylase activity;2109;28;GO:0004067
GO:0043995;histone H4K5 acetyltransferase activity;606;8;GO:0016569
GO:0043998;histone H2A acetyltransferase activity;3762;4;GO:0005515
GO:0043997;histone H4K12 acetyltransferase activity;657;4;GO:0016569
GO:0031989;bombesin receptor signaling pathway;2042;10;GO:0007186
GO:0031987;locomotion involved in locomotory behavior;633;178;GO:0040011
GO:0016360;sensory organ precursor cell fate determination;264;40;GO:0048699
GO:0016361;activin receptor activity, type I;367;437;GO:0004872
GO:0016362;activin receptor activity, type II;26;7;GO:0004870
GO:0031981;nuclear lumen;1492439;3170;GO:0005634
GO:0016363;nuclear matrix;7106;2620;GO:0005634
GO:0031982;vesicle;1385953;8760;GO:0030141
GO:0031985;Golgi cisterna;50541;296;GO:0005783
GO:0031986;proteinoplast;0;2;GO:0005737
GO:0031983;vesicle lumen;6389;1330;GO:0030141
GO:0031984;organelle subcompartment;1120250;647;GO:0005737
GO:0016348;imaginal disc-derived leg joint morphogenesis;194;22;GO:0048608
GO:0004360;glutamine-fructose-6-phosphate transaminase (isomerizing) activity;167906;794;GO:0006099
GO:0004362;glutathione-disulfide reductase (NADP) activity;30243;10;GO:0004746
GO:0004361;glutaryl-CoA dehydrogenase activity;1360;10;GO:0004073
GO:0004364;glutathione transferase activity;87303;2830;GO:0004364
GO:0004363;glutathione synthase activity;79175;285;GO:0004364
GO:0004366;glycerol-3-phosphate O-acyltransferase activity;30807;226;GO:0004089
GO:0004365;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity;35768;0;GO:0004073
GO:0004368;glycerol-3-phosphate dehydrogenase (quinone) activity;150320;311;GO:0004067
GO:0004359;glutaminase activity;311610;720;GO:0004723
GO:0031978;plastid thylakoid lumen;2221;94;GO:0009536
GO:0004358;glutamate N-acetyltransferase activity;108625;222;GO:0004073
GO:0031979;plasma membrane-derived thylakoid lumen;2225;2;GO:0009536
GO:0031976;plastid thylakoid;1055266;288;GO:0009579
GO:0031977;thylakoid lumen;7071;233;GO:0009536
GO:0031970;organelle envelope lumen;55046;346;GO:0005737
GO:0031974;membrane-enclosed lumen;1805284;2740;GO:0005615
GO:0031975;envelope;9994494;2440;GO:0005576
GO:0031972;chloroplast intermembrane space;54;3;GO:0009536
GO:0016358;dendrite development;13628;1880;GO:0048667
GO:0031973;chromoplast intermembrane space;0;0;GO:0009986
GO:0016338;calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules;347;857;GO:0007155
GO:0016339;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;1475;966;GO:0007156
GO:0004371;glycerone kinase activity;56550;353;GO:0004721
GO:0004370;glycerol kinase activity;121534;543;GO:0004721
GO:0004373;glycogen (starch) synthase activity;42122;698;GO:0005976
GO:0004372;glycine hydroxymethyltransferase activity;204657;725;GO:0004067
GO:0004375;glycine dehydrogenase (decarboxylating) activity;138696;607;GO:0009065
GO:0004377;GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity;13391;8;GO:0006022
GO:0004376;glycolipid mannosyltransferase activity;39745;34;GO:0006022
GO:0004379;glycylpeptide N-tetradecanoyltransferase activity;13552;78;GO:0006021
GO:0004378;GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity;11346;6;GO:0006022
GO:0031967;organelle envelope;7426492;1700;GO:0005737
GO:0004369;glycerol-3-phosphate oxidase activity;1248;5;GO:0004601
GO:0031968;organelle outer membrane;1282574;493;GO:0005737
GO:0031965;nuclear membrane;80151;3950;GO:0005634
GO:0031966;mitochondrial membrane;5811161;5510;GO:0005739
GO:0031969;chloroplast membrane;63507;355;GO:0009536
GO:0016340;calcium-dependent cell-matrix adhesion;57;59;GO:0007156
GO:0031960;response to corticosteroid;6542;1110;GO:0032496
GO:0016342;catenin complex;1213;1100;GO:0005637
GO:0016344;meiotic chromosome movement towards spindle pole;202;167;GO:0007067
GO:0031963;nuclear cortisol receptor activity;4;1;GO:0004872
GO:0016345;female meiotic chromosome movement towards spindle pole;0;2;GO:0007062
GO:0031964;beta-alanyl-histamine hydrolase activity;8;2;GO:0004867
GO:0016346;male meiotic chromosome movement towards spindle pole;16;2;GO:0007067
GO:0031961;nuclear cortisol receptor binding;0;0;GO:0004872
GO:0031962;nuclear mineralocorticoid receptor binding;59;2;GO:0004871
GO:0043945;positive regulation of asexual sporulation resulting in formation of a cellular spore;14;2;GO:0048304
GO:0043944;negative regulation of asexual sporulation resulting in formation of a cellular spore;8;4;GO:0048304
GO:0102603;12-demethyl-elloramycin C12a O-methyltransferase activity;0;0;GO:0004497
GO:0102606;octat-9-en-7-ol 5-monooxygenase activity;0;1;GO:0004497
GO:0102605;cyclooctat-9-en-5,7-diol C18-monooxygenase activity;0;1;GO:0004497
GO:0043949;regulation of cAMP-mediated signaling;1067;628;GO:0007186
GO:0102600;cytochrome P450 dependent 12,13beta-epoxy-beta-amyrin hydroxylase activity;0;0;GO:0004601
GO:0102602;cytochrome P450 dependent 16beta-hydroxy-beta-amyrin epoxidase activity;0;0;GO:0004601
GO:0102601;cytochrome P450 dependent beta-amyrin 16beta-hydroxylase activity;0;2;GO:0004601
GO:0043941;positive regulation of sexual sporulation resulting in formation of a cellular spore;45;2;GO:0048304
GO:0102608;tetracenomycin B3 8-O-methyl transferase activity;0;0;GO:0004497
GO:0043940;regulation of sexual sporulation resulting in formation of a cellular spore;127;1;GO:0048304
GO:0102607;3beta-hydroxy-12,15-cassadiene-11-one 2-hydroxylase activity;0;0;GO:0004497
GO:0043943;regulation of asexual sporulation resulting in formation of a cellular spore;26;3;GO:0048304
GO:0043942;negative regulation of sexual sporulation resulting in formation of a cellular spore;74;2;GO:0048304
GO:0043956;3-hydroxypropionyl-CoA dehydratase activity;189;4;GO:0006081
GO:0102615;ent-cassadiene-C2-hydroxylase activity;0;1;GO:0004497
GO:0043955;3-hydroxypropionyl-CoA synthetase activity;63;4;GO:0006081
GO:0102614;germacrene A acid 8beta-hydroxylase activity;3;0;GO:0006073
GO:0043958;acryloyl-CoA reductase (NADH) activity;1923;2;GO:0006066
GO:0043957;acryloyl-CoA reductase (NADP+) activity;559;0;GO:0006066
GO:0102611;(+)-secoisolariciresinol monoglucoside glucosyltransferase activity;0;0;GO:0006073
GO:0043959;L-erythro-3-methylmalyl-CoA lyase activity;633;2;GO:0006081
GO:0102610;(+)-secoisolariciresinol glucosyltransferase activity;0;0;GO:0006073
GO:0102613;trimethyluric acid monooxygenase activity;0;1;GO:0004497
GO:0102612;syn-pimaradiene 6beta-hydroxylase activity;0;0;GO:0006081
GO:0043950;positive regulation of cAMP-mediated signaling;398;1100;GO:0030516
GO:0043952;protein transport by the Sec complex;147818;1050;GO:0006413
GO:0043951;negative regulation of cAMP-mediated signaling;587;492;GO:0010468
GO:0043954;cellular component maintenance;7394;55;GO:0048471
GO:0043953;protein transport by the Tat complex;163702;31;GO:0015031
GO:0102620;3-geranylgeranylindole NADPH:oxygen oxidoreductase (10,11-epoxidizing) activity;0;0;GO:0004091
GO:0043967;histone H4 acetylation;107;1140;GO:0016569
GO:0102626;parthenolide synthase activity;1;0;GO:0004497
GO:0043966;histone H3 acetylation;176;973;GO:0016569
GO:0102625;cirsimaritin 4'-O-methyltransferase activity;0;0;GO:0004497
GO:0043969;histone H2B acetylation;0;9;GO:0016569
GO:0102628;costunolide 3beta-hydroxylase activity;1;0;GO:0004497
GO:0043968;histone H2A acetylation;0;2060;GO:0016569
GO:0102627;parthenolide 3beta-hydroxylase activity;1;0;GO:0004073
GO:0102622;linuron hydrolase activity;0;0;GO:0004553
GO:0102621;emindole-SB NADPH:oxygen oxidoreductase (14,15-epoxidizing) activity;0;0;GO:0004746
GO:0102624;scutellarein 7-methyl ether 4'-O-methyltransferase activity;0;0;GO:0004497
GO:0102623;scutellarein 7-methyl ether 6-O-methyltransferase activity;0;0;GO:0004497
GO:0043961;succinyl-CoA:(R)-citramalate CoA-transferase activity;35;0;GO:0006081
GO:0043960;L-erythro-3-methylmalyl-CoA dehydratase activity;0;0;GO:0006066
GO:0043963;perturbation of host adenylate cyclase-mediated signal transduction;1;2;GO:0006954
GO:0102629;patuletin 3'-O-methyltransferase activity;0;0;GO:0004497
GO:0043965;symbiont-mediated suppression of host adenylate cyclase-mediated signal transduction;0;0;GO:0009909
GO:0102631;caffeoylglucose 3-O-methyltransferase activity;0;0;GO:0006073
GO:0102630;gossypetin 8-methyl ester 3'-O-methyltransferase activity;0;1;GO:0004497
GO:0102637;5-aminolevulinate-CoA ligase activity;0;0;GO:0006066
GO:0043977;histone H2A-K5 acetylation;0;3;GO:0016569
GO:0102639;paspalicine synthase activity;0;0;GO:0006021
GO:0043979;histone H2B-K5 acetylation;0;4;GO:0016569
GO:0102638;[1-(2-amino-7-methyl-4-oxo-7,8-dihydro-3H-pteridin-6-yl)]ethyl-4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase activity;126;0;GO:0003824
GO:0102633;flaviolin monooxygenase activity;0;0;GO:0004497
GO:0102632;(S)-nandinine synthase activity;6;0;GO:0004497
GO:0102635;11-deoxycorticosterone reductase activity;1;1;GO:0004721
GO:0102634;1,3,6,8-tetrahydroxynaphthalene monooxygenase (quinone-forming) activity;0;0;GO:0004497
GO:0043970;histone H3-K9 acetylation;134;261;GO:0016569
GO:0043972;histone H3-K23 acetylation;4;6;GO:0016569
GO:0043971;histone H3-K18 acetylation;2;9;GO:0016569
GO:0043974;histone H3-K27 acetylation;1;41;GO:0016569
GO:0043973;histone H3-K4 acetylation;0;8;GO:0016569
GO:0102640;paspalinine synthase activity;0;0;GO:0006030
GO:0102641;(R)-lactaldehyde dehydrogenase activity;0;0;GO:0004073
GO:0102648;D-ribose 5-phosphate:D-fructose 6-phosphate transaldolase activity;0;1;GO:0006096
GO:0102647;D-ribose 5-phosphate:D-sedoheptulose 7-phosphate transaldolase activity;0;1;GO:0006099
GO:0090214;spongiotrophoblast layer developmental growth;74;8;GO:0048608
GO:0102649;acetoacetyl-ACP synthase activity;0;0;GO:0006099
GO:0090212;negative regulation of establishment of blood-brain barrier;18;9;GO:0048168
GO:0102644;monocyclic sesterterpenediol synthase activity;0;0;GO:0004497
GO:0090213;regulation of radial pattern formation;35;3;GO:0048608
GO:0102643;scalarane-17alpha-19-diol synthase activity;0;0;GO:0004497
GO:0090210;regulation of establishment of blood-brain barrier;132;99;GO:0048168
GO:0102646;14betaH-scalarane-17alpha-19-diol synthase activity;0;0;GO:0004497
GO:0090211;positive regulation of establishment of blood-brain barrier;0;3;GO:0048168
GO:0102645;17(E)-cheilanthenediol synthase activity;0;0;GO:0004497
GO:0102650;cyclo-acetoacetyl-L-tryptophan synthetase activity;0;0;GO:0006030
GO:0102653;gibberellin A51,2-oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0102652;gibberellin A9,2-oxoglutarate:oxygen oxidoreductase activity;24;0;GO:0004091
GO:0090218;positive regulation of lipid kinase activity;4;67;GO:0046394
GO:0090219;negative regulation of lipid kinase activity;1;27;GO:0010468
GO:0090227;regulation of red or far-red light signaling pathway;521;4;GO:0046274
GO:0102659;UDP-glucose: 4-methylthiobutylhydroximate S-glucosyltransferase activity;7;1;GO:0006022
GO:0090228;positive regulation of red or far-red light signaling pathway;464;3;GO:0045734
GO:0102658;2-oxo-5-methylthiopentanoate aminotransferase activity;0;0;GO:0004073
GO:0090226;regulation of microtubule nucleation by Ran protein signal transduction;54;5;GO:0048285
GO:0090223;chromatin-templated microtubule nucleation;0;2;GO:0007049
GO:0102655;1-18:1-2-trans-16:1-phosphatidylglycerol desaturase activity;7;2;GO:0008610
GO:0090224;regulation of spindle organization;7499;1050;GO:0048285
GO:0102654;1-18:1-2-16:0-phosphatidylglycerol trans-3 desaturase activity;6;2;GO:0008610
GO:0090221;mitotic spindle-templated microtubule nucleation;0;2;GO:0000922
GO:0102657;1-18:1-2-16:0-monogalactosyldiacylglycerol palmitoyl-lipid 7-desaturase activity;1;1;GO:0008610
GO:0090222;centrosome-templated microtubule nucleation;2067;6;GO:0007088
GO:0102656;1-18:2-2-trans-16:1-phosphatidylglycerol desaturase activity;0;0;GO:0008610
GO:0090220;chromosome localization to nuclear envelope involved in homologous chromosome segregation;2805;9;GO:0007062
GO:0102661;homogentisate solanyltransferase activity;21;2;GO:0004073
GO:0100001;regulation of skeletal muscle contraction by action potential;129;2;GO:0006936
GO:0102664;indole-3-acetyl-leucine synthetase activity;0;1;GO:0004497
GO:0102663;gibberellin A34,2-oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0090229;negative regulation of red or far-red light signaling pathway;29;2;GO:0010033
GO:0102660;caffeoyl-CoA:shikimate O-(hydroxycinnamoyl)transferase activity;0;0;GO:0006073
GO:0100008;regulation of fever generation by prostaglandin biosynthetic process;0;3;GO:0048608
GO:0102669;isoflavone-7-O-glucoside beta-glucosidase activity;0;1;GO:0004553
GO:0100009;regulation of fever generation by prostaglandin secretion;0;4;GO:0048608
GO:0102666;indole-3-acetyl-beta-4-D-glucose hydrolase activity;0;1;GO:0004553
GO:0102665;indole-3-acetyl-glutamate synthetase activity;0;1;GO:0006099
GO:0102667;indole-3-acetyl-beta-1-D-glucose hydrolase activity;0;1;GO:0004553
GO:0100010;positive regulation of fever generation by prostaglandin biosynthetic process;0;1;GO:0048608
GO:0102673;fatty aldehyde dehydrogenase activity;0;0;GO:0004076
GO:0100011;positive regulation of fever generation by prostaglandin secretion;0;1;GO:0048608
GO:0102672;fatty acid alpha-oxygenase activity;13;2;GO:0004601
GO:0100012;regulation of heart induction by canonical Wnt signaling pathway;156;5;GO:0048704
GO:0102671;6a-hydroxymaackiain-3-O-methyltransferase activity;4;2;GO:0004497
GO:0102670;2,7,4'-trihydroxyisoflavanone-4'-O-methyltransferase activity;9;0;GO:0004497
GO:0090205;positive regulation of cholesterol metabolic process;659;34;GO:0045944
GO:0090206;negative regulation of cholesterol metabolic process;281;134;GO:0045927
GO:0090204;protein localization to nuclear pore;87;40;GO:0005829
GO:0090201;negative regulation of release of cytochrome c from mitochondria;871;505;GO:0048304
GO:0102677;campesterol,NADPH:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0102676;avenasterol-desaturase activity;0;0;GO:0004497
GO:0102679;(5alpha)-campestan-3-one hydroxylase activity;0;0;GO:0004497
GO:0090200;positive regulation of release of cytochrome c from mitochondria;1412;966;GO:0048304
GO:0102678;22-alpha-hydroxy-campest-4-en-3-one,NADPH:steroid 5alpha-reductase activity;0;0;GO:0004041
GO:0102684;L-phenylalanine N-monooxygenase activity;6;2;GO:0004497
GO:0102686;UDP-glucose:trans-zeatin 9-N-glucosyltransferase;0;0;GO:0006073
GO:0102685;UDP-glucose:trans-zeatin 7-N-glucosyltransferase activity;0;0;GO:0006029
GO:0090209;negative regulation of triglyceride metabolic process;491;198;GO:0045944
GO:0102680;campest-4-en-3-one hydroxylase activity;0;0;GO:0004497
GO:0090207;regulation of triglyceride metabolic process;3577;252;GO:0045944
GO:0102682;N6-(Delta2-isopentenyl)-adenosine 5'-monophosphate phosphoribohydrolase activity;6995;0;GO:0004721
GO:0090208;positive regulation of triglyceride metabolic process;2454;370;GO:0045944
GO:0102681;isoamylase (maltodextrin-releasing) activity;0;0;GO:0004553
GO:0102688;dihydrozeatin UDP glycosyltransferase activity;0;0;GO:0006073
GO:0102687;UDP-glucose:dihydrozeatin 7-N-glucosyltransferase activity;0;0;GO:0006029
GO:0102689;UDP-glucose:isopentenyladenine 7-N-glucosyltransferase activity;0;0;GO:0006073
GO:0102695;UDP-glucose:cis-zeatin 7-N-glucosyltransferase activity;0;0;GO:0006029
GO:0102694;kinetin UDP glycosyltransferase activity;0;0;GO:0004553
GO:0102697;trans-zeatin-O-glucoside UDP glycosyltransferase activity;0;0;GO:0006073
GO:0102696;cis-zeatin UDP glycosyltransferase activity;0;0;GO:0004725
GO:0102691;UDP-glucose:benzyladenine 7-N-glucosyltransferase activity;0;0;GO:0006029
GO:0102690;isopentenyladenine UDP glycosyltransferase activity;0;0;GO:0006073
GO:0102693;UDP-glucose:kinetin 7-N-glucosyltransferase activity;0;0;GO:0006022
GO:0102692;benzyladenine UDP glycosyltransferase activity;0;0;GO:0006022
GO:0102699;2-methylpropionitrile hydroxylase activity;0;1;GO:0046395
GO:0102698;5-epi-aristolochene synthase activity;20;3;GO:0004497
GO:0100067;positive regulation of spinal cord association neuron differentiation by canonical Wnt signaling pathway;0;0;GO:0048704
GO:0090298;negative regulation of mitochondrial DNA replication;60;133;GO:0010467
GO:0090299;regulation of neural crest formation;19;6;GO:0048704
GO:0090296;regulation of mitochondrial DNA replication;273;6;GO:0006260
GO:0090297;positive regulation of mitochondrial DNA replication;156;10;GO:0045944
GO:0090294;nitrogen catabolite activation of transcription;104;9;GO:0045944
GO:0090295;nitrogen catabolite repression of transcription;11;2;GO:0010468
GO:0090292;nuclear matrix anchoring at nuclear membrane;156;51;GO:0005615
GO:0090293;nitrogen catabolite regulation of transcription;119;21;GO:0010468
GO:0090290;positive regulation of osteoclast proliferation;172;9;GO:0045944
GO:0090291;negative regulation of osteoclast proliferation;43;30;GO:0045595
GO:0090278;negative regulation of peptide hormone secretion;2280;126;GO:0048608
GO:0090279;regulation of calcium ion import;1214;644;GO:0006836
GO:0090276;regulation of peptide hormone secretion;10996;317;GO:0048608
GO:0090277;positive regulation of peptide hormone secretion;5213;480;GO:0048608
GO:0090274;positive regulation of somatostatin secretion;24;10;GO:0048608
GO:0090275;negative regulation of somatostatin secretion;58;3;GO:0048608
GO:0090272;negative regulation of fibroblast growth factor production;107;21;GO:0048608
GO:0090273;regulation of somatostatin secretion;84;6;GO:0048608
GO:0090270;regulation of fibroblast growth factor production;228;20;GO:0048608
GO:0090271;positive regulation of fibroblast growth factor production;118;76;GO:0048608
GO:0090289;regulation of osteoclast proliferation;215;8;GO:0045944
GO:0090287;regulation of cellular response to growth factor stimulus;26355;581;GO:0048407
GO:0090288;negative regulation of cellular response to growth factor stimulus;10096;238;GO:0045727
GO:0090281;negative regulation of calcium ion import;224;191;GO:0006836
GO:0090282;positive regulation of transcription involved in G2/M transition of mitotic cell cycle;21;16;GO:0045786
GO:0090280;positive regulation of calcium ion import;505;559;GO:0048407
GO:0018901;2,4-dichlorophenoxyacetic acid metabolic process;12;2;GO:0006725
GO:0018900;dichloromethane metabolic process;3;4;GO:0006559
GO:0018903;1,3-dichloropropene metabolic process;0;1;GO:0006749
GO:0090258;negative regulation of mitochondrial fission;140;69;GO:0048285
GO:0090259;regulation of retinal ganglion cell axon guidance;293;122;GO:0048608
GO:0018905;dimethyl ether metabolic process;0;2;GO:0046395
GO:0090256;regulation of cell proliferation involved in imaginal disc-derived wing morphogenesis;33;7;GO:0048608
GO:0018904;ether metabolic process;5937;688;GO:0046395
GO:0090257;regulation of muscle system process;26598;655;GO:0050789
GO:0004127;cytidylate kinase activity;151900;1050;GO:0004721
GO:0031726;CCR1 chemokine receptor binding;91;262;GO:0005125
GO:0006789;bilirubin conjugation;4;92;GO:0006749
GO:0031723;CXCR4 chemokine receptor binding;13;5;GO:0005125
GO:0004129;cytochrome-c oxidase activity;5076859;3430;GO:0005746
GO:0031724;CXCR5 chemokine receptor binding;53;7;GO:0005125
GO:0031729;CCR4 chemokine receptor binding;3;10;GO:0004872
GO:0031727;CCR2 chemokine receptor binding;129;63;GO:0005125
GO:0043781;cobalt-factor II C20-methyltransferase activity;2663;3;GO:0003729
GO:0031728;CCR3 chemokine receptor binding;219;46;GO:0005125
GO:0043780;cobalt-precorrin-5B C1-methyltransferase activity;6550;3;GO:0004073
GO:0018761;bromoxynil nitrilase activity;0;3;GO:0004479
GO:0018760;thiocyanate hydrolase activity;201;4;GO:0004553
GO:0016100;monoterpenoid catabolic process;9;2;GO:0046274
GO:0018763;hydroxydechloroatrazine ethylaminohydrolase activity;326;3;GO:0004725
GO:0016101;diterpenoid metabolic process;27720;973;GO:0046274
GO:0018762;aliphatic nitrilase activity;682;4;GO:0004497
GO:0016102;diterpenoid biosynthetic process;12777;506;GO:0046274
GO:0018765;2-hydroxy-6-oxohepta-2,4-dienoate hydrolase activity;1;3;GO:0004497
GO:0031721;hemoglobin alpha binding;71;33;GO:0019899
GO:0016103;diterpenoid catabolic process;650;126;GO:0046274
GO:0018764;N-isopropylammelide isopropylaminohydrolase activity;319;3;GO:0004553
GO:0031722;hemoglobin beta binding;6;4;GO:0019901
GO:0016104;triterpenoid biosynthetic process;17867;116;GO:0009813
GO:0018767;2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase activity;0;2;GO:0004497
GO:0016105;triterpenoid catabolic process;2;1;GO:0009062
GO:0018766;dihydrophloroglucinol hydrolase activity;0;2;GO:0004553
GO:0031720;haptoglobin binding;220;197;GO:0043161
GO:0043703;photoreceptor cell fate determination;145;2;GO:0048608
GO:0043702;carotenoid vesicle;0;1;GO:0009579
GO:0004180;carboxypeptidase activity;979899;1990;GO:0004721
GO:0043705;cyanophycin metabolic process;0;5;GO:0006032
GO:0043704;photoreceptor cell fate specification;279;4;GO:0048608
GO:0043707;cell adhesion involved in single-species biofilm formation in or on host organism;2;2;GO:0022610
GO:0004181;metallocarboxypeptidase activity;122170;1430;GO:0004721
GO:0043709;cell adhesion involved in single-species biofilm formation;2486;22;GO:0022610
GO:0043708;cell adhesion involved in biofilm formation;7715;8;GO:0022610
GO:0004185;serine-type carboxypeptidase activity;331632;1530;GO:0004723
GO:0043701;cyanosome;0;2;GO:0005730
GO:0043700;pterinosome;0;2;GO:0005730
GO:0016170;interleukin-15 receptor binding;54;3;GO:0005125
GO:0016174;NAD(P)H oxidase H2O2-forming activity;4642;53;GO:0004601
GO:0016175;superoxide-generating NAD(P)H oxidase activity;2671;85;GO:0004784
GO:0016176;superoxide-generating NADPH oxidase activator activity;3556;171;GO:0004722
GO:0031795;G protein-coupled GABA receptor binding;0;1;GO:0004930
GO:0031798;type 1 metabotropic glutamate receptor binding;6;7;GO:0005509
GO:0031799;type 2 metabotropic glutamate receptor binding;55;1;GO:0005509
GO:0031796;type 1 metabotropic GABA receptor binding;0;1;GO:0004930
GO:0031797;type 2 metabotropic GABA receptor binding;0;1;GO:0004930
GO:0043714;(R)-citramalate synthase activity;1608;0;GO:0006099
GO:0043713;(R)-2-hydroxyisocaproate dehydrogenase activity;0;0;GO:0004067
GO:0043716;2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity;6792;9;GO:0004723
GO:0004190;aspartic-type endopeptidase activity;1193666;4610;GO:0004175
GO:0043715;2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity;8038;8;GO:0006099
GO:0043718;2-hydroxymethylglutarate dehydrogenase activity;653;3;GO:0006066
GO:0043717;2-hydroxyglutaryl-CoA dehydratase activity;2;2;GO:0006067
GO:0043719;2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity;93;2;GO:0004497
GO:0004197;cysteine-type endopeptidase activity;221510;3990;GO:0004175
GO:0004198;calcium-dependent cysteine-type endopeptidase activity;35767;996;GO:0004222
GO:0043710;cell adhesion involved in multi-species biofilm formation;17;1;GO:0022610
GO:0043712;2-hydroxyisocaproate CoA-transferase activity;0;1;GO:0006081
GO:0043711;pilus organization;76790;49;GO:0043403
GO:0031789;G protein-coupled acetylcholine receptor binding;4;1;GO:0005509
GO:0016160;amylase activity;70916;247;GO:0004553
GO:0016161;beta-amylase activity;9124;267;GO:0004553
GO:0016162;cellulose 1,4-beta-cellobiosidase activity;927;278;GO:0004553
GO:0016163;nitrogenase activity;50654;39;GO:0009579
GO:0031783;type 5 melanocortin receptor binding;114;10;GO:0004930
GO:0016165;linoleate 13S-lipoxygenase activity;372;181;GO:0004497
GO:0031784;melatonin receptor binding;1;1;GO:0005509
GO:0016166;phytoene dehydrogenase activity;4061;24;GO:0009813
GO:0031781;type 3 melanocortin receptor binding;210;307;GO:0004930
GO:0016167;glial cell-derived neurotrophic factor receptor activity;130;53;GO:0004872
GO:0031782;type 4 melanocortin receptor binding;301;99;GO:0004930
GO:0016168;chlorophyll binding;231244;1230;GO:0042803
GO:0031787;H9 melatonin receptor binding;0;1;GO:0004930
GO:0016169;bacteriochlorophyll c binding;0;1;GO:0043161
GO:0031788;motilin receptor binding;56;2;GO:0005509
GO:0031785;type 1A melatonin receptor binding;0;1;GO:0004930
GO:0031786;type 1B melatonin receptor binding;0;0;GO:0004930
GO:0043724;2-keto-3-deoxygalactonate aldolase activity;0;1;GO:0006099
GO:0043727;5-amino-4-imidazole carboxylate lyase activity;5416;4;GO:0006067
GO:0043726;5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity;12;0;GO:0004721
GO:0004160;dihydroxy-acid dehydratase activity;122916;445;GO:0006066
GO:0043729;2-amino-5-formylamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one formate-lyase activity;180;0;GO:0006099
GO:0031780;corticotropin hormone receptor binding;114;10;GO:0004930
GO:0043728;2-keto-4-methylthiobutyrate aminotransferase activity;0;2;GO:0004073
GO:0004162;dimethylnitrosamine demethylase activity;0;1;GO:0046395
GO:0004161;dimethylallyltranstransferase activity;4182;296;GO:0004497
GO:0004164;diphthine synthase activity;11533;128;GO:0004497
GO:0004163;diphosphomevalonate decarboxylase activity;18504;194;GO:0006096
GO:0004166;dolichyl-phosphate alpha-N-acetylglucosaminyltransferase activity;31;2;GO:0006029
GO:0004165;delta(3)-delta(2)-enoyl-CoA isomerase activity;17226;0;GO:0004497
GO:0004168;dolichol kinase activity;2343;10;GO:0003924
GO:0043721;4-hydroxybutanoyl-CoA dehydratase activity;267;2;GO:0006081
GO:0004167;dopachrome isomerase activity;206;169;GO:0004073
GO:0043720;3-keto-5-aminohexanoate cleavage activity;23960;5;GO:0006081
GO:0043723;2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity;1;0;GO:0006067
GO:0004169;dolichyl-phosphate-mannose-protein mannosyltransferase activity;32076;173;GO:0006029
GO:0043722;4-hydroxyphenylacetate decarboxylase activity;994;4;GO:0006096
GO:0031778;type 2 melanin-concentrating hormone receptor binding;0;1;GO:0004930
GO:0031779;melanocortin receptor binding;1013;25;GO:0005509
GO:0016150;translation release factor activity, codon nonspecific;144;7;GO:0003746
GO:0016151;nickel cation binding;295788;1370;GO:0043169
GO:0016152;mercury (II) reductase activity;14579;10;GO:0008047
GO:0016153;urocanate hydratase activity;81566;33;GO:0004497
GO:0031772;type 2 orexin receptor binding;20;1;GO:0005509
GO:0016154;pyrimidine-nucleoside phosphorylase activity;39649;118;GO:0006029
GO:0031773;kisspeptin receptor binding;21;2;GO:0048608
GO:0016155;formyltetrahydrofolate dehydrogenase activity;7213;136;GO:0009065
GO:0031770;growth hormone-releasing hormone receptor binding;112;4;GO:0004930
GO:0016156;fumarate reductase (NADH) activity;1176;8;GO:0003954
GO:0031771;type 1 orexin receptor binding;20;1;GO:0005509
GO:0016157;sucrose synthase activity;14727;217;GO:0005975
GO:0031776;melanin-concentrating hormone receptor binding;26;1;GO:0005509
GO:0016158;3-phytase activity;9282;6;GO:0004553
GO:0031777;type 1 melanin-concentrating hormone receptor binding;26;2;GO:0004930
GO:0016159;muconolactone delta-isomerase activity;6060;6;GO:0006067
GO:0031774;leukotriene receptor binding;2;1;GO:0005126
GO:0031775;lutropin-choriogonadotropic hormone receptor binding;15;9;GO:0004872
GO:0016139;glycoside catabolic process;685;198;GO:0005975
GO:0043738;reduced coenzyme F420 dehydrogenase activity;0;3;GO:0009065
GO:0043737;deoxyribonuclease V activity;15555;4;GO:0004518
GO:0004170;dUTP diphosphatase activity;133126;417;GO:0004553
GO:0043739;G/U mismatch-specific uracil-DNA glycosylase activity;1780;20;GO:0004518
GO:0004173;ecdysone O-acyltransferase activity;0;3;GO:0004722
GO:0004175;endopeptidase activity;4689371;5230;GO:0004175
GO:0004174;electron-transferring-flavoprotein dehydrogenase activity;67935;133;GO:0004746
GO:0004177;aminopeptidase activity;1179220;3270;GO:0004723
GO:0043730;5-ureido-4-imidazole carboxylate hydrolase activity;0;1;GO:0004723
GO:0004176;ATP-dependent peptidase activity;403017;1670;GO:0016787
GO:0043732;6-hydroxynicotinate dehydrogenase activity;0;2;GO:0009065
GO:0043731;6-hydroxynicotinate 3-monooxygenase activity;482;2;GO:0004497
GO:0043734;DNA-N1-methyladenine dioxygenase activity;324;211;GO:0006066
GO:0043733;DNA-3-methylbase glycosylase activity;51067;5;GO:0004518
GO:0031769;glucagon receptor binding;64;24;GO:0004930
GO:0031767;gastric inhibitory polypeptide receptor binding;46;1;GO:0005125
GO:0031768;ghrelin receptor binding;391;10;GO:0005509
GO:0031761;fMet-Leu-Phe receptor binding;0;1;GO:0004872
GO:0016143;S-glycoside metabolic process;643;37;GO:0005975
GO:0031762;follicle-stimulating hormone receptor binding;38;9;GO:0004872
GO:0016144;S-glycoside biosynthetic process;256;59;GO:0005976
GO:0102400;dTDP-3-amino-4-oxo-2,3,6-trideoxy-alpha-D-glucose N,N-dimethyltransferase activity;0;0;GO:0006061
GO:0016145;S-glycoside catabolic process;194;6;GO:0005975
GO:0031760;Edg-7 lysophosphatidic acid receptor binding;0;1;GO:0005549
GO:0031765;type 2 galanin receptor binding;58;2;GO:0004930
GO:0031766;type 3 galanin receptor binding;58;3;GO:0004930
GO:0031763;galanin receptor binding;186;2;GO:0005509
GO:0016149;translation release factor activity, codon specific;190656;580;GO:0003746
GO:0031764;type 1 galanin receptor binding;51;4;GO:0004930
GO:0102406;omega-hydroxypalmitate O-sinapoyl transferase activity;50;3;GO:0006081
GO:0102405;(+)-taxifolin 5'-hydroxylase activity;0;0;GO:0004497
GO:0102402;2-phenylethyl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside glucosidase (Yabukita) activity;7;1;GO:0004553
GO:0102404;linalyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside glucosidase (Yabukita) activity;7;1;GO:0004553
GO:0016090;prenol metabolic process;0;6;GO:0006091
GO:0016091;prenol biosynthetic process;0;3;GO:0009112
GO:0016092;prenol catabolic process;0;2;GO:0006631
GO:0016093;polyprenol metabolic process;48024;8;GO:0006073
GO:0016094;polyprenol biosynthetic process;6788;246;GO:0006021
GO:0016095;polyprenol catabolic process;3374;20;GO:0006073
GO:0016098;monoterpenoid metabolic process;241;294;GO:0006721
GO:0016099;monoterpenoid biosynthetic process;78;7;GO:0046148
GO:0102411;quercetin-3,4'-O-glucosyltransferase activity;0;0;GO:0004553
GO:0102410;quercetin-4',3-O-glucosyltransferase activity;0;0;GO:0006073
GO:0065007;biological regulation;50805352;21700;GO:0065007
GO:0102417;apigenin-7-O-glucoside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0065008;regulation of biological quality;3402398;4570;GO:0010468
GO:0102416;quercetin gentiotrioside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0065005;protein-lipid complex assembly;1405;1340;GO:0043234
GO:0102418;luteolin-7-O-glucoside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0065003;protein-containing complex assembly;2092662;1830;GO:0043234
GO:0102413;6-O-methyl-deacetylisoipecoside beta-glucosidase activity;0;0;GO:0004553
GO:0065004;protein-DNA complex assembly;113401;1920;GO:0043234
GO:0102412;valerena-4,7(11)-diene synthase activity;2;0;GO:0004497
GO:0065001;specification of axis polarity;2709;32;GO:0048608
GO:0102415;quercetin gentiobioside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0065002;intracellular protein transmembrane transport;273560;821;GO:0015031
GO:0102414;quercetin-3-O-glucoside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0065009;regulation of molecular function;11997;2500;GO:0050789
GO:0016080;synaptic vesicle targeting;160;48;GO:0008030
GO:0016081;synaptic vesicle docking;344;2480;GO:0008092
GO:0016082;synaptic vesicle priming;1053;310;GO:0008026
GO:0016084;myostimulatory hormone activity;26;2;GO:0008021
GO:0016085;myoinhibitory hormone activity;12;2;GO:0004872
GO:0016087;ecdysiostatic hormone activity;0;2;GO:0003714
GO:0065010;extracellular membrane-bounded organelle;8944;575;GO:0005783
GO:0102420;sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;10333;3;GO:0008610
GO:0102422;curcumin-4'-O-beta-D-gentiotrioside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0102421;curcumin-4'-O-beta-D-gentiobioside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0102428;kaempferol-3-O-glucoside 1,6-glucosyltransferase activity;0;1;GO:0006073
GO:0102427;allocryptopine 6-hydroxylase activity;0;0;GO:0006081
GO:0004081;bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity;3152;0;GO:0005525
GO:0004080;biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity;99;0;GO:0004812
GO:0102429;genistein-3-O-glucoside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0102424;sesaminol-2-O-gentiobioside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0004082;bisphosphoglycerate mutase activity;2307;404;GO:0006066
GO:0102423;(+)-sesaminol 2-O-glucosyltransferase activity;0;0;GO:0006073
GO:0004085;butyryl-CoA dehydrogenase activity;6857;41;GO:0004089
GO:0102426;myricetin-3-O-glucoside 1,6-glucosyltransferase activity;0;0;GO:0006073
GO:0004084;branched-chain-amino-acid transaminase activity;290719;1350;GO:0004449
GO:0102425;myricetin 3-O-glucosyltransferase activity;90;1;GO:0006073
GO:0004087;carbamoyl-phosphate synthase (ammonia) activity;477;128;GO:0006099
GO:0004089;carbonate dehydratase activity;263724;2940;GO:0006099
GO:0004088;carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity;261196;929;GO:0004061
GO:0016070;RNA metabolic process;53064122;7590;GO:0010467
GO:0016071;mRNA metabolic process;2508127;4990;GO:0022613
GO:0016072;rRNA metabolic process;3443107;4190;GO:0006364
GO:0016073;snRNA metabolic process;25706;294;GO:0006364
GO:0016074;sno(s)RNA metabolic process;2495;10;GO:0016071
GO:0016075;rRNA catabolic process;31162;1270;GO:0006364
GO:0016076;snRNA catabolic process;263;7;GO:0006364
GO:0031695;alpha-2B adrenergic receptor binding;70;3;GO:0005126
GO:0102431;acyl-lipid omega-(9-4) desaturase activity;4;0;GO:0008610
GO:0016077;sno(s)RNA catabolic process;344;7;GO:0010401
GO:0031696;alpha-2C adrenergic receptor binding;116;6;GO:0005126
GO:0016078;tRNA catabolic process;2473;34;GO:0006413
GO:0031693;alpha-1D adrenergic receptor binding;0;1;GO:0005126
GO:0102433;phenylalanine 4-hydroxylase (N10-formyl-tetrahydrofolate dependent) activity;0;0;GO:0006022
GO:0016079;synaptic vesicle exocytosis;14197;3070;GO:0008026
GO:0031694;alpha-2A adrenergic receptor binding;187;46;GO:0005126
GO:0102432;quercetin 7-O-methyltransferase activity;1;0;GO:0004725
GO:0031699;beta-3 adrenergic receptor binding;115;19;GO:0005126
GO:0031697;beta-1 adrenergic receptor binding;85;26;GO:0005126
GO:0031698;beta-2 adrenergic receptor binding;160;61;GO:0005126
GO:0004090;carbonyl reductase (NADPH) activity;1456;139;GO:0004076
GO:0102439;3',4',5'-trimethylmyricetin 7-O-methyltransferase activity;1;0;GO:0004497
GO:0102438;laricitrin 4'-O-methyltransferase activity;0;0;GO:0004497
GO:0004092;carnitine O-acetyltransferase activity;275;21;GO:0004073
GO:0031691;alpha-1A adrenergic receptor binding;4;6;GO:0005126
GO:0102435;myricetin 7-O-methyltransferase activity;1;0;GO:0004725
GO:0031692;alpha-1B adrenergic receptor binding;6;6;GO:0005126
GO:0102434;pterin-4alpha-carbinolamine dehydratase activity;0;0;GO:0004067
GO:0004096;catalase activity;185283;1260;GO:0004601
GO:0004095;carnitine O-palmitoyltransferase activity;3154;50;GO:0004722
GO:0031690;adrenergic receptor binding;749;152;GO:0005126
GO:0102436;7-methylmyricetin 4'-O-methyltransferase activity;0;0;GO:0004497
GO:0004098;cerebroside-sulfatase activity;110;6;GO:0005576
GO:0004097;catechol oxidase activity;2918;253;GO:0004497
GO:0004099;chitin deacetylase activity;2322;21;GO:0004553
GO:0016060;metarhodopsin inactivation;30;95;GO:0005525
GO:0016061;regulation of light-activated channel activity;1;3;GO:0009416
GO:0016062;adaptation of rhodopsin mediated signaling;214;43;GO:0007600
GO:0016063;rhodopsin biosynthetic process;193;105;GO:0006836
GO:0016064;immunoglobulin mediated immune response;15175;2760;GO:0002449
GO:0102442;syringetin 3-O-methyltransferase activity;0;0;GO:0004497
GO:0031685;adenosine receptor binding;204;413;GO:0005126
GO:0102441;syringetin 7-O-methyltransferase activity;1;0;GO:0004725
GO:0031682;G-protein gamma-subunit binding;78;7;GO:0005525
GO:0102444;isorhamnetin 3-O-methyltransferase activity;0;0;GO:0004725
GO:0016068;type I hypersensitivity;70;57;GO:0002237
GO:0031683;G-protein beta/gamma-subunit complex binding;35012;905;GO:0005516
GO:0102443;L-2-hydroxycarboxylate dehydrogenase (NAD+) activity;30;0;GO:0004067
GO:0031688;A2B adenosine receptor binding;0;3;GO:0005126
GO:0031689;A3 adenosine receptor binding;0;2;GO:0005126
GO:0031686;A1 adenosine receptor binding;45;62;GO:0005126
GO:0102440;3',4',5'-trimethylmyricetin 3-O-methyltransferase activity;1;0;GO:0004497
GO:0031687;A2A adenosine receptor binding;52;7;GO:0005126
GO:0043669;ectexine;0;2;GO:0005576
GO:0102449;kaempferol 3-O-methyltransferase activity;2;2;GO:0004497
GO:0102446;rhamnetin 3-O-methyltransferase activity;0;0;GO:0004725
GO:0102445;3-methylquercetin 3'-O-methyltransferase activity;0;0;GO:0004497
GO:0102448;rhamnetin 4'-O-methyltransferase activity;1;1;GO:0004497
GO:0102447;rhamnetin 3'-O-methyltransferase activity;1;0;GO:0004497
GO:0043662;peribacteroid fluid;5;4;GO:0009986
GO:0043661;peribacteroid membrane;13;6;GO:0009941
GO:0043664;host peribacteroid membrane;0;3;GO:0009941
GO:0043663;host bacteroid-containing symbiosome;0;3;GO:0046148
GO:0043666;regulation of phosphoprotein phosphatase activity;156;1010;GO:0010468
GO:0043665;host peribacteroid fluid;0;1;GO:0009579
GO:0043668;exine;35;6;GO:0048305
GO:0043667;pollen wall;89;4;GO:0005618
GO:0043671;endexine;0;2;GO:0005576
GO:0043670;foot layer;0;1;GO:0005615
GO:0102453;anthocyanidin 3-O-glucoside 6''-O-acyltransferase activity;4;0;GO:0005976
GO:0102452;bisdemethoxycurcumin synthase activity;2;2;GO:0004497
GO:0102455;anthocyanidin 3-O-glucoside 2''-O-glucosyltransferase activity;35;0;GO:0005976
GO:0102454;cyanidin 3-O-galactosyltransferase activity;5;2;GO:0004553
GO:0102451;kaempferide 3-O-methyltransferase activity;0;1;GO:0004497
GO:0102450;kaempferide 7-O-methyltransferase activity;1;0;GO:0004497
GO:0102457;cyanidin 3-O-glucoside 7-O-glucosyltransferase (vanilloyl-glucose dependent) activity;3;2;GO:0006073
GO:0102456;cyanidin 3-O-glucoside 5-O-glucosyltransferase (sinapoyl-glucose dependent) activity;0;0;GO:0005983
GO:0102459;8-oxo-dADP diphosphate phosphatase activity;0;0;GO:0004723
GO:0102458;cyanidin 3-O-glucoside 5-O glucosyltransferase (vanilloyl-glucose dependent) activity;3;1;GO:0006073
GO:0043673;sexine;8;1;GO:0005576
GO:0043672;nexine;0;1;GO:0005576
GO:0043675;sculpture element;0;1;GO:0048608
GO:0043674;columella;8;3;GO:0009953
GO:0043676;tectum;0;4;GO:0007399
GO:0043679;axon terminus;4439;1230;GO:0043005
GO:0043678;intine;1;1;GO:0005576
GO:0043680;filiform apparatus;16;5;GO:0048704
GO:0043682;P-type divalent copper transporter activity;445;29;GO:0008565
GO:0102464;zeaxanthin 2-beta-hydroxylase activity;0;0;GO:0004497
GO:0102463;quercetin 3-gentiobioside 7-O-rhamnosyltransferase activity;0;0;GO:0006073
GO:0102466;beta-carotene 2,2'-beta-hydroxylase activity;0;0;GO:0004497
GO:0102465;zeaxanthin 2,2'-beta-hydroxylase activity;0;0;GO:0004497
GO:0102460;kaempferol 3-gentiobioside 7-O-rhamnosyltransferase activity;0;0;GO:0006073
GO:0102462;quercetin 3-sophoroside 7-O-rhamnosyltransferase activity;0;0;GO:0006073
GO:0102461;kaempferol 3-sophoroside 7-O-rhamnosyltransferase activity;0;0;GO:0006073
GO:0102468;wogonin 7-O-glucuronosyltransferase activity;1;2;GO:0008021
GO:0102467;scutellarein 7-O-glucuronosyltransferase activity;1;2;GO:0004553
GO:0102469;naringenin 2-hydroxylase activity;2;1;GO:0004497
GO:0043684;type IV secretion system complex;7898;6;GO:0042746
GO:0043683;type IV pilus assembly;30877;38;GO:0030154
GO:0043686;co-translational protein modification;272;487;GO:0006464
GO:0043685;conversion of glutamyl-tRNA to glutaminyl-tRNA;0;3;GO:0006413
GO:0043688;conversion of aspartyl-tRNA to asparaginyl-tRNA;0;3;GO:0006418
GO:0043687;post-translational protein modification;659867;3460;GO:0006464
GO:0043691;reverse cholesterol transport;1572;2180;GO:0006825
GO:0043693;monoterpene biosynthetic process;73;87;GO:0046274
GO:0043692;monoterpene metabolic process;88;6;GO:0046274
GO:0102475;2-hydroxyeriodictyol 6C-glucoside dehydratase activity;0;0;GO:0006073
GO:0102474;eriodictyol dibenzoylmethane tautomer 6C-glucosyltransferase activity;0;0;GO:0006073
GO:0102477;2,5,7-trihydroxyflavanone 6C-glucoside dehydratase activity;0;0;GO:0006073
GO:0102476;pinocembrin 2-hydroxylase activity;0;1;GO:0004497
GO:0102471;2-hydroxynaringenin-6C-glucoside dehydratase activity;0;0;GO:0006073
GO:0102470;6C-naringenin dibenzoylmethane tautomer glucosyltransferase activity;0;0;GO:0006073
GO:0102473;eriodictyol dibenzoylmethane tautomer 8C-glucosyltransferase activity;0;0;GO:0006073
GO:0102472;eriodictyol 2-hydroxylase activity;1;1;GO:0004497
GO:0102479;quercetin 3-O-beta:-D-galactosyltransferase activity;1;0;GO:0004553
GO:0102478;beta-L-arabinofuranosidase activity;406;2;GO:0004553
GO:0043695;detection of pheromone;103;4;GO:0009536
GO:0043694;monoterpene catabolic process;4;1;GO:0046274
GO:0043697;cell dedifferentiation;1032;384;GO:0045595
GO:0043696;dedifferentiation;1032;17;GO:0045595
GO:0043699;leucosome;0;2;GO:0005764
GO:0043698;iridosome;0;2;GO:0005576
GO:0102480;5-fluorocytosine deaminase activity;4987;1;GO:0004497
GO:0102482;5-deoxy-D-glucuronate isomerase activity;3099;2;GO:0006066
GO:0102481;3D-(3,5/4)-trihydroxycyclohexane-1,2-dione hydrolase activity;3765;0;GO:0004553
GO:0102484;esculetin glucosyltransferase activity;0;0;GO:0006073
GO:0102483;scopolin beta-glucosidase activity;33583;48;GO:0004553
GO:0090058;metaxylem development;38;4;GO:0048468
GO:0090059;protoxylem development;26;3;GO:0048309
GO:0090056;regulation of chlorophyll metabolic process;299;2;GO:0010468
GO:0090057;root radial pattern formation;30;7;GO:0048608
GO:0090054;regulation of silent mating-type cassette heterochromatin formation;101;2;GO:0048285
GO:0090055;positive regulation of silent mating-type cassette heterochromatin formation;3;0;GO:0048285
GO:0090052;regulation of pericentric heterochromatin formation;96;0;GO:0045731
GO:0090053;positive regulation of pericentric heterochromatin formation;81;1;GO:0045727
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;1266;750;GO:0048608
GO:0090051;negative regulation of cell migration involved in sprouting angiogenesis;837;473;GO:0045766
GO:0102497;scyllo-inositol dehydrogenase (NADP+) activity;229;0;GO:0006067
GO:0102496;GA5 2,3 epoxidase activity;0;0;GO:0004497
GO:0102499;SHG alpha-glucan phosphorylase activity;49328;9;GO:0005976
GO:0102498;maltose glucosidase activity;0;0;GO:0006032
GO:0102493;wogonin 7-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102495;GA5 3beta-hydroxylase activity;0;1;GO:0004497
GO:0102494;GA20 2,3-desaturase activity;0;0;GO:0004497
GO:0090069;regulation of ribosome biogenesis;38977;6;GO:0022627
GO:0090067;regulation of thalamus size;90;7;GO:0048666
GO:0090068;positive regulation of cell cycle process;27622;1090;GO:0042127
GO:0090066;regulation of anatomical structure size;158692;1210;GO:0048513
GO:0090063;positive regulation of microtubule nucleation;383;296;GO:0048285
GO:0090064;activation of microtubule nucleation;0;1;GO:0048285
GO:0090062;regulation of trehalose metabolic process;53;5;GO:0046274
GO:0090060;regulation of metaxylem development;0;2;GO:0048608
GO:0090038;negative regulation of protein kinase C signaling;233;143;GO:0043403
GO:0090036;regulation of protein kinase C signaling;1978;38;GO:0043406
GO:0090037;positive regulation of protein kinase C signaling;413;644;GO:0043406
GO:0090034;regulation of chaperone-mediated protein complex assembly;53;6;GO:0016570
GO:0090035;positive regulation of chaperone-mediated protein complex assembly;53;71;GO:0048193
GO:0090032;negative regulation of steroid hormone biosynthetic process;562;5;GO:0045944
GO:0090033;positive regulation of filamentous growth;762;5;GO:0048870
GO:0090030;regulation of steroid hormone biosynthetic process;1105;9;GO:0030522
GO:0090031;positive regulation of steroid hormone biosynthetic process;233;56;GO:0045944
GO:0090049;regulation of cell migration involved in sprouting angiogenesis;2226;119;GO:0048608
GO:0090045;positive regulation of deacetylase activity;4;33;GO:0016567
GO:0090043;regulation of tubulin deacetylation;1088;211;GO:0010467
GO:0090044;positive regulation of tubulin deacetylation;47;7;GO:0010467
GO:0090042;tubulin deacetylation;1110;133;GO:0006066
GO:0090018;posterior neural plate formation;0;2;GO:0007423
GO:0090016;regulation of leaflet formation;0;1;GO:0010468
GO:0090017;anterior neural plate formation;2;1;GO:0007423
GO:0090014;leaflet formation;0;1;GO:0009987
GO:0090015;positive regulation of leaflet formation by auxin mediated signaling pathway;0;0;GO:0010033
GO:0090011;Wnt signaling pathway involved in primitive streak formation;0;1;GO:0009952
GO:0090029;negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion;23;3;GO:0048285
GO:0090027;negative regulation of monocyte chemotaxis;186;100;GO:0050900
GO:0090028;positive regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion;0;1;GO:0048285
GO:0090025;regulation of monocyte chemotaxis;2212;266;GO:0050900
GO:0090026;positive regulation of monocyte chemotaxis;1963;1820;GO:0050900
GO:0090023;positive regulation of neutrophil chemotaxis;1182;803;GO:0050921
GO:0090024;negative regulation of neutrophil chemotaxis;256;29;GO:0050921
GO:0090021;positive regulation of posterior neural plate formation by Wnt signaling pathway;0;4;GO:0048704
GO:0090022;regulation of neutrophil chemotaxis;1796;145;GO:0050921
GO:0090008;hypoblast development;65;3;GO:0048608
GO:0090006;regulation of linear element assembly;22;2;GO:0048646
GO:0090001;replication fork arrest at tRNA locus;3;1;GO:0007050
GO:0090009;primitive streak formation;431;539;GO:0009952
GO:0006402;mRNA catabolic process;417942;3300;GO:0022626
GO:0006403;RNA localization;201380;3020;GO:0051270
GO:0006400;tRNA modification;3168271;3700;GO:0006418
GO:0006401;RNA catabolic process;737957;4150;GO:0006364
GO:0006413;translational initiation;2121587;9120;GO:0006413
GO:0006414;translational elongation;2311097;11400;GO:0006414
GO:0006412;translation;26724838;33500;GO:0006412
GO:0006406;mRNA export from nucleus;47391;3020;GO:0006413
GO:0006407;rRNA export from nucleus;432;636;GO:0006631
GO:0006404;RNA import into nucleus;2994;187;GO:0006403
GO:0006405;RNA export from nucleus;64288;2140;GO:0006413
GO:0006408;snRNA export from nucleus;2130;88;GO:0006460
GO:0006409;tRNA export from nucleus;12100;464;GO:0006413
GO:0018428;copper incorporation into copper-sulfur cluster;0;3;GO:0009065
GO:0018427;copper incorporation into metallo-sulfur cluster;0;3;GO:0009065
GO:0018429;copper incorporation into copper-sulfur cluster via heptakis-L-histidino tetracopper mu4-sulfide hydroxide;0;5;GO:0009986
GO:0006446;regulation of translational initiation;43405;2460;GO:0006414
GO:0006447;regulation of translational initiation by iron;63;101;GO:0006412
GO:0006437;tyrosyl-tRNA aminoacylation;98659;724;GO:0006418
GO:0006438;valyl-tRNA aminoacylation;106984;1150;GO:0006418
GO:0018417;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl L-cysteine persulfido L-glutamato L-histidino L-serinyl nickel triiron disulfide trioxide;0;7;GO:0005737
GO:0018416;nickel incorporation into iron-sulfur cluster via tris-L-cysteinyl L-cysteine persulfido bis-L-glutamato L-histidino nickel triiron disulfide trioxide;0;7;GO:0009086
GO:0018419;protein catenane formation;0;1;GO:0008021
GO:0018418;nickel incorporation into iron-sulfur cluster via tris-L-cysteinyl L-cysteine persulfido L-glutamato L-histidino L-serinyl nickel triiron disulfide trioxide;0;6;GO:0009086
GO:0006450;regulation of translational fidelity;1092080;1770;GO:0006414
GO:0006451;translational readthrough;42217;110;GO:0006415
GO:0006452;translational frameshifting;483;336;GO:0006414
GO:0006457;protein folding;1980504;18700;GO:0006457
GO:0006458;'de novo' protein folding;14675;2050;GO:0006457
GO:0006448;regulation of translational elongation;68257;1280;GO:0006414
GO:0006449;regulation of translational termination;39847;1330;GO:0006414
GO:0018422;GDP-mannose:serine-protein mannose-1-phosphotransferase activity;0;1;GO:0006022
GO:0018421;UDP-N-acetylglucosamine:serine-protein N-acetylglucosamine-1-phosphotransferase activity;0;0;GO:0006032
GO:0018423;protein C-terminal leucine carboxyl O-methyltransferase activity;66;5;GO:0003723
GO:0018426;O3-(phosphoglycosyl-D-mannose-1-phosphoryl)-L-serine biosynthetic process;0;0;GO:0006021
GO:0018425;O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process;0;0;GO:0006032
GO:0018406;protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;3;5;GO:0006486
GO:0043406;positive regulation of MAP kinase activity;327;2290;GO:0043406
GO:0018405;protein-keratan sulfate linkage via keratan sulfate D-glucuronyl-D-galactosyl-D-galactosyl-D-xylosyl-L-threonine;0;4;GO:0005576
GO:0043405;regulation of MAP kinase activity;521;1150;GO:0043406
GO:0043408;regulation of MAPK cascade;66748;2280;GO:0043406
GO:0043407;negative regulation of MAP kinase activity;156;2250;GO:0043406
GO:0043409;negative regulation of MAPK cascade;8352;846;GO:0043407
GO:0006420;arginyl-tRNA aminoacylation;131405;1030;GO:0006418
GO:0006421;asparaginyl-tRNA aminoacylation;48669;714;GO:0006418
GO:0043400;cortisol secretion;291;19;GO:0007596
GO:0006424;glutamyl-tRNA aminoacylation;141208;1420;GO:0006418
GO:0043402;glucocorticoid mediated signaling pathway;2779;89;GO:0009719
GO:0006425;glutaminyl-tRNA aminoacylation;26425;348;GO:0006418
GO:0043401;steroid hormone mediated signaling pathway;66449;1950;GO:0009725
GO:0006422;aspartyl-tRNA aminoacylation;62039;583;GO:0006418
GO:0043404;corticotropin-releasing hormone receptor activity;11;7;GO:0004930
GO:0006423;cysteinyl-tRNA aminoacylation;105823;1350;GO:0006418
GO:0043403;skeletal muscle tissue regeneration;2484;588;GO:0048771
GO:0006417;regulation of translation;3197578;6200;GO:0006414
GO:0006418;tRNA aminoacylation for protein translation;3466020;6430;GO:0006418
GO:0006415;translational termination;661094;5750;GO:0006413
GO:0006419;alanyl-tRNA aminoacylation;127943;964;GO:0006418
GO:0018411;protein glucuronidation;0;3;GO:0006081
GO:0018410;C-terminal protein amino acid modification;65;227;GO:0006464
GO:0018413;peptidyl-serine O-glucuronidation;0;2;GO:0009086
GO:0018412;protein O-glucuronidation;0;2;GO:0009065
GO:0018415;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl L-cysteine persulfido bis-L-glutamato L-histidino nickel triiron disulfide trioxide;0;6;GO:0005737
GO:0018414;nickel incorporation into metallo-sulfur cluster;1;5;GO:0009065
GO:0043417;negative regulation of skeletal muscle tissue regeneration;61;8;GO:0048771
GO:0043416;regulation of skeletal muscle tissue regeneration;447;123;GO:0048771
GO:0043419;urea catabolic process;78159;102;GO:0006569
GO:0043418;homocysteine catabolic process;161;33;GO:0006541
GO:0006431;methionyl-tRNA aminoacylation;107193;1160;GO:0006418
GO:0006432;phenylalanyl-tRNA aminoacylation;250565;1080;GO:0006418
GO:0006430;lysyl-tRNA aminoacylation;116354;1060;GO:0006418
GO:0043410;positive regulation of MAPK cascade;49675;3620;GO:0043406
GO:0006435;threonyl-tRNA aminoacylation;107195;1370;GO:0006418
GO:0043413;macromolecule glycosylation;78236;1100;GO:0005539
GO:0006436;tryptophanyl-tRNA aminoacylation;96399;795;GO:0006418
GO:0043412;macromolecule modification;12040240;2300;GO:0006464
GO:0006433;prolyl-tRNA aminoacylation;108015;1330;GO:0006418
GO:0043415;positive regulation of skeletal muscle tissue regeneration;272;219;GO:0048771
GO:0006434;seryl-tRNA aminoacylation;94724;1140;GO:0006418
GO:0043414;macromolecule methylation;4245774;948;GO:0004553
GO:0006428;isoleucyl-tRNA aminoacylation;102489;1020;GO:0006418
GO:0006429;leucyl-tRNA aminoacylation;110145;716;GO:0006418
GO:0006426;glycyl-tRNA aminoacylation;139759;959;GO:0006418
GO:0006427;histidyl-tRNA aminoacylation;95209;637;GO:0006418
GO:0018400;peptidyl-proline hydroxylation to 3-hydroxy-L-proline;0;4;GO:0006457
GO:0018402;protein-chondroitin sulfate linkage via chondroitin sulfate D-glucuronyl-D-galactosyl-D-galactosyl-D-xylosyl-L-serine;0;3;GO:0005581
GO:0018401;peptidyl-proline hydroxylation to 4-hydroxy-L-proline;27;358;GO:0006457
GO:0018404;protein-heparan sulfate linkage via heparan sulfate D-glucuronyl-D-galactosyl-D-galactosyl-D-xylosyl-L-serine;0;3;GO:0005539
GO:0018403;protein-dermatan sulfate linkage via dermatan 4-sulfate D-glucuronyl-D-galactosyl-D-galactosyl-D-xylosyl-L-serine;0;2;GO:0005581
GO:0006482;protein demethylation;42;540;GO:0043548
GO:0006480;N-terminal protein amino acid methylation;44;61;GO:0006468
GO:0006481;C-terminal protein methylation;7;284;GO:0016567
GO:0006486;protein glycosylation;78195;4830;GO:0006493
GO:0006487;protein N-linked glycosylation;33506;1900;GO:0008203
GO:0006488;dolichol-linked oligosaccharide biosynthetic process;29705;704;GO:0006021
GO:0006489;dolichyl diphosphate biosynthetic process;125;70;GO:0006064
GO:0018471;4-chlorobenzaldehyde oxidase activity;0;3;GO:0004497
GO:0018470;4-hydroxybutaraldehyde dehydrogenase activity;0;1;GO:0004067
GO:0018473;cis-2-methyl-5-isopropylhexa-2,5-dienal dehydrogenase activity;0;3;GO:0004497
GO:0018472;1-hydroxy-2-naphthaldehyde dehydrogenase activity;0;2;GO:0004073
GO:0018475;trans-2-methyl-5-isopropylhexa-2,5-dienal dehydrogenase activity;0;3;GO:0004497
GO:0031431;Dbf4-dependent protein kinase complex;206;7;GO:0005524
GO:0018474;2-carboxybenzaldehyde dehydrogenase activity;1;2;GO:0004067
GO:0031432;titin binding;564;446;GO:0005544
GO:0018477;benzaldehyde dehydrogenase (NADP+) activity;13;0;GO:0004067
GO:0031430;M band;1118;821;GO:0005524
GO:0018479;benzaldehyde dehydrogenase (NAD+) activity;605;1;GO:0004067
GO:0031435;mitogen-activated protein kinase kinase kinase binding;663;393;GO:0043406
GO:0018478;malonate-semialdehyde dehydrogenase (acetylating) activity;3905;6;GO:0004067
GO:0031436;BRCA1-BARD1 complex;718;50;GO:0005515
GO:0031433;telethonin binding;374;334;GO:0005515
GO:0031434;mitogen-activated protein kinase kinase binding;464;198;GO:0043406
GO:0006490;oligosaccharide-lipid intermediate biosynthetic process;35753;107;GO:0006021
GO:0006493;protein O-linked glycosylation;42653;1580;GO:0008201
GO:0006491;N-glycan processing;1636;1210;GO:0008544
GO:0006497;protein lipidation;18132;1180;GO:0042578
GO:0006498;N-terminal protein lipidation;130;17;GO:0006464
GO:0006499;N-terminal protein myristoylation;39;400;GO:0006469
GO:0031428;box C/D RNP complex;13050;31;GO:0022613
GO:0031429;box H/ACA snoRNP complex;827;165;GO:0005840
GO:0031426;polycistronic mRNA processing;108;6;GO:0000976
GO:0031427;response to methotrexate;567;640;GO:0097169
GO:0018460;cyclohexanol dehydrogenase activity;6;3;GO:0004497
GO:0018462;4-(hydroxymethyl)benzenesulfonate dehydrogenase activity;19;0;GO:0004067
GO:0018461;fluoren-9-ol dehydrogenase activity;2;2;GO:0004497
GO:0018464;3-hydroxypimeloyl-CoA dehydrogenase activity;0;3;GO:0006066
GO:0031420;alkali metal ion binding;126782;243;GO:0043169
GO:0018463;6-hydroxyhexanoate dehydrogenase activity;2;3;GO:0004091
GO:0031421;invertasome;2;1;GO:0005840
GO:0018466;limonene-1,2-diol dehydrogenase activity;0;2;GO:0004091
GO:0018465;vanillyl-alcohol oxidase activity;20;3;GO:0004497
GO:0031424;keratinization;1978;4590;GO:0008544
GO:0018467;formaldehyde dehydrogenase activity;1668;6;GO:0004497
GO:0031425;chloroplast RNA processing;1286;78;GO:0006364
GO:0031422;RecQ family helicase-topoisomerase III complex;346;13;GO:0005524
GO:0018469;myrtenal dehydrogenase activity;0;2;GO:0004497
GO:0031423;hexon binding;712;3;GO:0005515
GO:0018449;1-phenylethanol dehydrogenase activity;0;5;GO:0004073
GO:0006465;signal peptide processing;147400;2640;GO:0006412
GO:0006463;steroid hormone receptor complex assembly;18;18;GO:0005665
GO:0006468;protein phosphorylation;2490602;22600;GO:0006468
GO:0006469;negative regulation of protein kinase activity;652;3110;GO:0010468
GO:0031417;NatC complex;6862;84;GO:0005737
GO:0031418;L-ascorbic acid binding;88110;1010;GO:0005576
GO:0031415;NatA complex;6771;84;GO:0005737
GO:0031416;NatB complex;390;9;GO:0005737
GO:0018451;epoxide dehydrogenase activity;0;6;GO:0006721
GO:0031419;cobalamin binding;400253;639;GO:0043169
GO:0018450;myrtenol dehydrogenase activity;0;5;GO:0004497
GO:0018453;2-hydroxytetrahydrofuran dehydrogenase activity;0;6;GO:0004067
GO:0018452;5-exo-hydroxycamphor dehydrogenase activity;51;8;GO:0004067
GO:0031410;cytoplasmic vesicle;1353074;7250;GO:0005789
GO:0018455;alcohol dehydrogenase [NAD(P)+] activity;79007;0;GO:0004089
GO:0018454;acetoacetyl-CoA reductase activity;14777;60;GO:0009062
GO:0018457;perillyl-alcohol dehydrogenase activity;91;4;GO:0004073
GO:0031413;regulation of buoyancy;41;3;GO:0050877
GO:0018456;aryl-alcohol dehydrogenase (NAD+) activity;624;0;GO:0004089
GO:0031414;N-terminal protein acetyltransferase complex;14023;8;GO:0008029
GO:0018459;carveol dehydrogenase activity;95;4;GO:0004067
GO:0031411;gas vesicle;47167;36;GO:0005576
GO:0018458;isopiperitenol dehydrogenase activity;3;4;GO:0004067
GO:0031412;gas vesicle organization;14121;20;GO:0009986
GO:0006470;protein dephosphorylation;5146;4410;GO:0006468
GO:0006475;internal protein amino acid acetylation;5060;901;GO:0006464
GO:0006476;protein deacetylation;2051;639;GO:0016570
GO:0006473;protein acetylation;6312;977;GO:0016525
GO:0006474;N-terminal protein amino acid acetylation;219;867;GO:0006464
GO:0006479;protein methylation;2443;1520;GO:0016567
GO:0006477;protein sulfation;25;72;GO:0004715
GO:0006478;peptidyl-tyrosine sulfation;20;48;GO:0004719
GO:0031406;carboxylic acid binding;615179;1250;GO:0097159
GO:0031407;oxylipin metabolic process;15816;215;GO:0046274
GO:0031404;chloride ion binding;1946;341;GO:0043169
GO:0031405;lipoic acid binding;182;141;GO:0097159
GO:0031408;oxylipin biosynthetic process;15753;519;GO:0046274
GO:0031409;pigment binding;1977;185;GO:0042605
GO:0018441;iron incorporation into iron-sulfur cluster via hexakis-L-cysteinyl L-serinyl octairon heptasulfide;0;6;GO:0009086
GO:0018444;translation release factor complex;710;52;GO:0005840
GO:0018446;pinocarveol dehydrogenase activity;0;4;GO:0004073
GO:0031402;sodium ion binding;30169;866;GO:0043169
GO:0018445;prothoracicotrophic hormone activity;20;9;GO:0005524
GO:0031403;lithium ion binding;111;105;GO:0005509
GO:0018448;hydroxymethylmethylsilanediol oxidase activity;0;4;GO:0004497
GO:0031400;negative regulation of protein modification process;31768;809;GO:0043687
GO:0018447;chloral hydrate dehydrogenase activity;0;3;GO:0004730
GO:0031401;positive regulation of protein modification process;43753;1570;GO:0016567
GO:0070968;pyrroloquinoline quinone binding;4;5;GO:0097159
GO:0018392;glycoprotein 3-alpha-L-fucosyltransferase activity;165;7;GO:0004553
GO:0018394;peptidyl-lysine acetylation;5582;587;GO:0016525
GO:0018393;internal peptidyl-lysine acetylation;5055;945;GO:0006464
GO:0018396;peptidyl-lysine hydroxylation to 4-hydroxy-L-lysine;0;3;GO:0006468
GO:0018395;peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine;13;7;GO:0006468
GO:0070962;positive regulation of neutrophil mediated killing of bacterium;55;2;GO:0042742
GO:0070963;positive regulation of neutrophil mediated killing of gram-negative bacterium;55;9;GO:0045087
GO:0070960;positive regulation of neutrophil mediated cytotoxicity;112;2;GO:0046649
GO:0070961;positive regulation of neutrophil mediated killing of symbiont cell;112;4;GO:0046655
GO:0070966;nuclear-transcribed mRNA catabolic process, no-go decay;7454;292;GO:0022613
GO:0070967;coenzyme F420 binding;6782;10;GO:0097159
GO:0070964;positive regulation of neutrophil mediated killing of gram-positive bacterium;0;1;GO:0042742
GO:0070965;positive regulation of neutrophil mediated killing of fungus;57;9;GO:0045087
GO:0070959;negative regulation of neutrophil mediated killing of fungus;0;1;GO:0045087
GO:0070957;negative regulation of neutrophil mediated killing of gram-negative bacterium;0;1;GO:0045080
GO:0070958;negative regulation of neutrophil mediated killing of gram-positive bacterium;0;1;GO:0042742
GO:0043354;enucleate erythrocyte maturation;12;1;GO:0008023
GO:0043353;enucleate erythrocyte differentiation;384;297;GO:0008023
GO:0031349;positive regulation of defense response;70880;1630;GO:0042742
GO:0043363;nucleate erythrocyte differentiation;252;4;GO:0002576
GO:0043362;nucleate erythrocyte maturation;83;2;GO:0008544
GO:0018387;N-terminal peptidyl-amino acid deamination to pyruvic acid;0;3;GO:0006457
GO:0031343;positive regulation of cell killing;4699;438;GO:0046330
GO:0070951;regulation of neutrophil mediated killing of gram-negative bacterium;65;3;GO:0002684
GO:0018386;N-terminal peptidyl-cysteine condensation with pyruvate to form N-pyruvic acid 2-iminyl-L-cysteine;0;4;GO:0006483
GO:0031344;regulation of cell projection organization;63454;949;GO:0032989
GO:0070952;regulation of neutrophil mediated killing of gram-positive bacterium;0;1;GO:0042742
GO:0018389;N-terminal peptidyl-valine deamination;0;2;GO:0006486
GO:0031341;regulation of cell killing;12246;503;GO:0010941
GO:0102301;gamma-linolenate elongase activity;0;0;GO:0004073
GO:0018388;N-terminal peptidyl-valine condensation with pyruvate to form N-pyruvic acid 2-iminyl-L-valine;0;4;GO:0006486
GO:0031342;negative regulation of cell killing;1241;1620;GO:0043066
GO:0070950;regulation of neutrophil mediated killing of bacterium;65;1;GO:0042742
GO:0102300;linoleate 9R-lipoxygenase activity;5;2;GO:0004497
GO:0031347;regulation of defense response;659094;2450;GO:0006952
GO:0070955;negative regulation of neutrophil mediated killing of symbiont cell;0;4;GO:0046649
GO:0031348;negative regulation of defense response;555069;1630;GO:0050832
GO:0070956;negative regulation of neutrophil mediated killing of bacterium;0;1;GO:0045087
GO:0031345;negative regulation of cell projection organization;13575;453;GO:0048608
GO:0070953;regulation of neutrophil mediated killing of fungus;57;1;GO:0045087
GO:0031346;positive regulation of cell projection organization;16253;902;GO:0048608
GO:0070954;negative regulation of neutrophil mediated cytotoxicity;0;1;GO:0045087
GO:0102307;erythromycin C 3''-o-methyltransferase activity;119;0;GO:0004497
GO:0102306;benzil reductase [(S)-benzoin-forming] activity;285;0;GO:0004067
GO:0102308;erythromycin D 3''-o-methyltransferase activity;119;0;GO:0004497
GO:0006383;transcription by RNA polymerase III;60945;500;GO:0006364
GO:0102303;resveratrol 3,5-O-dimethyltransferase activity;27;3;GO:0004497
GO:0006384;transcription initiation at RNA polymerase III promoter;16361;116;GO:0006366
GO:0031340;positive regulation of vesicle fusion;934;498;GO:0008092
GO:0102302;mycinamicin VI 2''-O-methyltransferase activity;28;1;GO:0004721
GO:0102305;(13E)-labda-7,13-dien-15-ol synthase activity;2;0;GO:0004497
GO:0006382;adenosine to inosine editing;81593;54;GO:0008490
GO:0102304;sesquithujene synthase activity;2;2;GO:0004497
GO:0043365;[formate-C-acetyltransferase]-activating enzyme activity;47847;0;GO:0004497
GO:0006388;tRNA splicing, via endonucleolytic cleavage and ligation;33504;2060;GO:0000786
GO:0043364;glycyl-radical enzyme activating activity;47849;5;GO:0003954
GO:0006385;transcription elongation by RNA polymerase III;4;0;GO:0006364
GO:0043367;CD4-positive, alpha-beta T cell differentiation;6447;340;GO:0002376
GO:0006386;termination of RNA polymerase III transcription;821;1100;GO:0006364
GO:0043366;beta selection;131;45;GO:0007049
GO:0043369;CD4-positive or CD8-positive, alpha-beta T cell lineage commitment;2023;246;GO:0002213
GO:0043368;positive T cell selection;2875;1530;GO:0002449
GO:0031338;regulation of vesicle fusion;1658;1760;GO:0006906
GO:0043370;regulation of CD4-positive, alpha-beta T cell differentiation;2642;247;GO:0045595
GO:0031339;negative regulation of vesicle fusion;211;32;GO:0006903
GO:0043372;positive regulation of CD4-positive, alpha-beta T cell differentiation;1317;465;GO:0045595
GO:0070980;biphenyl catabolic process;8;154;GO:0046395
GO:0043371;negative regulation of CD4-positive, alpha-beta T cell differentiation;1092;1110;GO:0045595
GO:0070981;L-asparagine biosynthetic process;6838;103;GO:0006559
GO:0043374;CD8-positive, alpha-beta T cell differentiation;765;92;GO:0002277
GO:0043373;CD4-positive, alpha-beta T cell lineage commitment;1777;35;GO:0002213
GO:0031332;RNAi effector complex;88416;66;GO:0005737
GO:0033995;anhydrosialidase activity;1;1;GO:0004553
GO:0070984;SET domain binding;18;22;GO:0003682
GO:0102310;dTDP-(2R,6S)-6-hydroxy-2-methyl-3-oxo-3,6-dihydro-2H-pyran-4-olate 3-ketoreductase (dTDP-4-dehydro-2,6-dideoxy-alpha-D-allose-forming) activity;0;0;GO:0006073
GO:0031333;negative regulation of protein-containing complex assembly;79811;156;GO:0048193
GO:0033994;glucuronan lyase activity;1;2;GO:0004553
GO:0070985;transcription factor TFIIK complex;4952;8;GO:0005634
GO:0018378;cytochrome c-heme linkage via heme-L-cysteine;0;3;GO:0005525
GO:0031330;negative regulation of cellular catabolic process;16853;986;GO:0042330
GO:0033993;response to lipid;169724;3170;GO:0006629
GO:0070982;L-asparagine metabolic process;6893;14;GO:0006559
GO:0102312;4-coumaroyl 2'-hydroxylase activity;12;0;GO:0004497
GO:0018377;protein myristoylation;39;126;GO:0006449
GO:0031331;positive regulation of cellular catabolic process;128809;1200;GO:0050789
GO:0033992;1,5-anhydro-D-fructose dehydratase activity;1;3;GO:0006067
GO:0070983;dendrite guidance;274;31;GO:0048608
GO:0102311;8-hydroxygeraniol dehydrogenase activity;15;2;GO:0004067
GO:0031336;negative regulation of sulfur amino acid metabolic process;122;4;GO:0046395
GO:0033999;chondroitin B lyase activity;68;2;GO:0004553
GO:0070988;demethylation;34834;345;GO:0043565
GO:0018379;cytochrome c-heme linkage via heme-bis-L-cysteine;0;3;GO:0005525
GO:0031337;positive regulation of sulfur amino acid metabolic process;17;9;GO:0046394
GO:0033998;inulin fructotransferase (DFA-III-forming) activity;4;2;GO:0004553
GO:0070989;oxidative demethylation;3531;877;GO:0016570
GO:0031334;positive regulation of protein-containing complex assembly;11547;293;GO:0048193
GO:0033997;inulin fructotransferase (DFA-I-forming) activity;67;1;GO:0004553
GO:0070986;left/right axis specification;703;1100;GO:0048608
GO:0031335;regulation of sulfur amino acid metabolic process;312;274;GO:0006559
GO:0033996;levan fructotransferase (DFA-IV-forming) activity;0;2;GO:0004553
GO:0070987;error-free translesion synthesis;5002;262;GO:0007049
GO:0006390;mitochondrial transcription;2757;463;GO:0005741
GO:0102318;2-deoxystreptamine glucosyltransferase activity;251;3;GO:0006029
GO:0006391;transcription initiation at mitochondrial promoter;303;10;GO:0005730
GO:0102317;4-methylaminobutyrate oxidase (demethylating) activity;840;2;GO:0004497
GO:0070979;protein K11-linked ubiquitination;128;1510;GO:0042775
GO:0102319;2-deoxystreptamine N-acetyl-D-glucosaminyltransferase activity;70;3;GO:0004553
GO:0033991;aldos-2-ulose dehydratase activity;3;3;GO:0006067
GO:0033990;ectoine synthase activity;13922;5;GO:0004730
GO:0102313;1,8-cineole synthase activity;21;3;GO:0004497
GO:0006392;transcription elongation by mitochondrial RNA polymerase;777;3;GO:0006364
GO:0006393;termination of mitochondrial transcription;149;13;GO:0006364
GO:0006398;mRNA 3'-end processing by stem-loop binding and cleavage;2262;10;GO:0003743
GO:0043376;regulation of CD8-positive, alpha-beta T cell differentiation;267;64;GO:0045595
GO:0006399;tRNA metabolic process;10565690;3060;GO:0006364
GO:0043375;CD8-positive, alpha-beta T cell lineage commitment;110;34;GO:0002213
GO:0006396;RNA processing;12875361;13300;GO:0006396
GO:0043378;positive regulation of CD8-positive, alpha-beta T cell differentiation;111;102;GO:0048011
GO:0006397;mRNA processing;1998552;12700;GO:0006364
GO:0043377;negative regulation of CD8-positive, alpha-beta T cell differentiation;107;5;GO:0048011
GO:0043379;memory T cell differentiation;413;20;GO:0042127
GO:0031329;regulation of cellular catabolic process;201356;2140;GO:0042330
GO:0031327;negative regulation of cellular biosynthetic process;2661708;2350;GO:0045944
GO:0043381;negative regulation of memory T cell differentiation;80;10;GO:0048364
GO:0031328;positive regulation of cellular biosynthetic process;1271469;3380;GO:0010468
GO:0033989;3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity;127;25;GO:0004497
GO:0043380;regulation of memory T cell differentiation;355;478;GO:0048011
GO:0018361;peptidyl-glutamine 2-methylation;0;3;GO:0046395
GO:0043383;negative T cell selection;614;1660;GO:0002821
GO:0018360;protein-heme P460 linkage via heme P460-bis-L-cysteine-L-lysine;0;3;GO:0005525
GO:0043382;positive regulation of memory T cell differentiation;217;157;GO:0048011
GO:0018363;peroxidase-heme linkage via dihydroxyheme-L-aspartyl ester-L-glutamyl ester-L-methionine sulfonium;0;4;GO:0004601
GO:0043385;mycotoxin metabolic process;20375;157;GO:0046274
GO:0018362;peroxidase-heme linkage via dihydroxyheme-L-aspartyl ester-L-glutamyl ester;0;5;GO:0004601
GO:0043384;pre-T cell receptor complex;0;1;GO:0002776
GO:0018365;protein-serine epimerase activity;2;3;GO:0006412
GO:0031321;ascospore-type prospore assembly;1105;9;GO:0048304
GO:0033984;indole-3-glycerol-phosphate lyase activity;31;3;GO:0006073
GO:0070973;protein localization to endoplasmic reticulum exit site;6910;139;GO:0006688
GO:0102321;2,2'-hydroxybiphenyl monooxygenase activity;2;0;GO:0004497
GO:0018364;peptidyl-glutamine methylation;13;856;GO:0046395
GO:0031322;ascospore-type prospore-specific spindle pole body remodeling;67;6;GO:0048285
GO:0033983;diaminobutyrate decarboxylase activity;1143;3;GO:0009065
GO:0070974;POU domain binding;2053;10;GO:0043169
GO:0102320;1,8-cineole 2-exo-monooxygenase activity;2;4;GO:0004497
GO:0033982;3-dehydro-L-gulonate-6-phosphate decarboxylase activity;1845;4;GO:0006066
GO:0070971;endoplasmic reticulum exit site;7290;609;GO:0005783
GO:0102323;2-isopropylphenol monooxygenase activity;0;1;GO:0004497
GO:0018366;chiral amino acid racemization;1;2;GO:0006457
GO:0031320;hexitol dehydrogenase activity;590;3;GO:0006032
GO:0033981;D-dopachrome decarboxylase activity;32;9;GO:0004073
GO:0070972;protein localization to endoplasmic reticulum;271524;1880;GO:0005783
GO:0102322;2-propylphenol monooxygenase activity;0;1;GO:0004497
GO:0031325;positive regulation of cellular metabolic process;1459575;2990;GO:0050789
GO:0033988;bile-acid 7alpha-dehydratase activity;197;5;GO:0006066
GO:0070977;bone maturation;1217;148;GO:0007518
GO:0031326;regulation of cellular biosynthetic process;28250782;4580;GO:0010468
GO:0033987;2-hydroxyisoflavanone dehydratase activity;80;3;GO:0006073
GO:0070978;voltage-gated calcium channel complex assembly;40;1;GO:0008092
GO:0031323;regulation of cellular metabolic process;28817210;3910;GO:0050789
GO:0033986;response to methanol;46;4;GO:0046395
GO:0070975;FHA domain binding;55;5;GO:0005515
GO:0031324;negative regulation of cellular metabolic process;2798856;2800;GO:0050789
GO:0033985;acidocalcisome lumen;0;3;GO:0005829
GO:0070976;TIR domain binding;1895;14;GO:0043169
GO:0043307;eosinophil activation;329;18;GO:0002273
GO:0070926;regulation of ATP:ADP antiporter activity;1;6;GO:0009060
GO:0043306;positive regulation of mast cell degranulation;569;952;GO:0042430
GO:0070927;negative regulation of ATP:ADP antiporter activity;0;1;GO:0009086
GO:0102328;3-oxoacid decarboxylase activity;0;0;GO:0006066
GO:0043309;regulation of eosinophil degranulation;149;10;GO:0050729
GO:0045968;negative regulation of juvenile hormone biosynthetic process;8;5;GO:0048608
GO:0043308;eosinophil degranulation;305;30;GO:0002376
GO:0045969;positive regulation of juvenile hormone biosynthetic process;1;2;GO:0048608
GO:0070925;organelle assembly;638133;1660;GO:0005739
GO:0102325;2,2',3-trihydroxybiphenyl monooxygenase activity;0;1;GO:0004497
GO:0102324;2-hydroxy-6-oxo-nona-2,4-dienoate hydrolase activity;0;0;GO:0004497
GO:0102327;3-oxoacyl-CoA hydrolase activity;0;0;GO:0004497
GO:0070929;trans-translation;41190;8;GO:0006412
GO:0102326;2-hydroxy-6-oxo-6-(2,3-dihydroxyphenyl)-hexa-2,4-dienoate hydrolase activity;0;0;GO:0046395
GO:0045962;positive regulation of development, heterochronic;17;41;GO:0048731
GO:0045963;negative regulation of dopamine metabolic process;30;318;GO:0043403
GO:0043301;negative regulation of leukocyte degranulation;398;267;GO:0042742
GO:0045960;positive regulation of complement activation, classical pathway;39;71;GO:0006958
GO:0043300;regulation of leukocyte degranulation;1721;797;GO:0042742
GO:0045961;negative regulation of development, heterochronic;0;2;GO:0048731
GO:0043303;mast cell degranulation;2036;1010;GO:0002520
GO:0045966;positive regulation of ecdysteroid metabolic process;60;2;GO:0010468
GO:0043302;positive regulation of leukocyte degranulation;892;486;GO:0042742
GO:0045967;negative regulation of growth rate;84;170;GO:0048589
GO:0043305;negative regulation of mast cell degranulation;192;126;GO:0042430
GO:0045964;positive regulation of dopamine metabolic process;184;180;GO:0045935
GO:0043304;regulation of mast cell degranulation;1117;1350;GO:0042470
GO:0045965;negative regulation of ecdysteroid metabolic process;0;1;GO:0010468
GO:0045970;negative regulation of juvenile hormone catabolic process;0;3;GO:0010468
GO:0031398;positive regulation of protein ubiquitination;6623;2290;GO:0016567
GO:0102332;fatty-acyl-[acp] elongase/decarboxylase activity;0;0;GO:0004497
GO:0031399;regulation of protein modification process;96370;2340;GO:0016567
GO:0102331;heptadecanoyl-[acp] elongase/decarboxylase activity;0;0;GO:0004444
GO:0031396;regulation of protein ubiquitination;12298;1120;GO:0016567
GO:0102334;N,N'-diacetylbacilliosaminyl-1-phosphate transferase activity;472;0;GO:0004553
GO:0031397;negative regulation of protein ubiquitination;3443;1560;GO:0016567
GO:0102333;stearoyl-[acp] elongase/decarboxylase activity;0;0;GO:0004784
GO:0070922;RISC complex assembly;2000;67;GO:0003712
GO:0070920;regulation of regulatory ncRNA processing;2092;9;GO:0010467
GO:0102330;palmitoyl-[acp] elongase/decarboxylase activity;0;0;GO:0004722
GO:0070921;regulation of siRNA processing;479;2;GO:0010467
GO:0031390;Ctf18 RFC-like complex;6574;164;GO:0005576
GO:0043318;negative regulation of cytotoxic T cell degranulation;61;15;GO:0045087
GO:0070915;lysophosphatidic acid receptor activity;2697;119;GO:0004930
GO:0031391;Elg1 RFC-like complex;4460;226;GO:0005524
GO:0043317;regulation of cytotoxic T cell degranulation;61;10;GO:0002687
GO:0070916;inositol phosphoceramide synthase complex;71;5;GO:0005576
GO:0045979;positive regulation of nucleoside metabolic process;0;4;GO:0045944
GO:0070913;Ddb1-Wdr21 complex;7;2;GO:0043161
GO:0043319;positive regulation of cytotoxic T cell degranulation;0;3;GO:0045087
GO:0070914;UV-damage excision repair;1315;537;GO:0006281
GO:0031394;positive regulation of prostaglandin biosynthetic process;296;242;GO:0050731
GO:0031395;bursicon neuropeptide hormone complex;319;8;GO:0005576
GO:0102335;N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase activity;387;0;GO:0006030
GO:0031392;regulation of prostaglandin biosynthetic process;443;64;GO:0045944
GO:0070917;inositol phosphoceramide synthase regulator activity;1219;3;GO:0005524
GO:0031393;negative regulation of prostaglandin biosynthetic process;114;51;GO:0050731
GO:0070918;regulatory ncRNA processing;21673;10;GO:0010467
GO:0043310;negative regulation of eosinophil degranulation;38;125;GO:0050729
GO:0045973;positive regulation of juvenile hormone secretion;0;1;GO:0048608
GO:0045974;regulation of translation, ncRNA-mediated;590;1210;GO:0010467
GO:0043312;neutrophil degranulation;515;4830;GO:0002684
GO:0045971;positive regulation of juvenile hormone catabolic process;0;4;GO:0010468
GO:0043311;positive regulation of eosinophil degranulation;111;132;GO:0050729
GO:0045972;negative regulation of juvenile hormone secretion;0;1;GO:0048608
GO:0043314;negative regulation of neutrophil degranulation;91;42;GO:0042330
GO:0045977;positive regulation of mitotic cell cycle, embryonic;100;44;GO:0048285
GO:0043313;regulation of neutrophil degranulation;248;114;GO:0042330
GO:0045978;negative regulation of nucleoside metabolic process;0;7;GO:0045944
GO:0043316;cytotoxic T cell degranulation;120;54;GO:0006954
GO:0045975;positive regulation of translation, ncRNA-mediated;446;9;GO:0010467
GO:0043315;positive regulation of neutrophil degranulation;82;38;GO:0042330
GO:0045976;negative regulation of mitotic cell cycle, embryonic;123;44;GO:0048285
GO:0045980;negative regulation of nucleotide metabolic process;543;96;GO:0045944
GO:0045981;positive regulation of nucleotide metabolic process;622;317;GO:0045944
GO:0031387;MPF complex;0;2;GO:0005524
GO:0031388;organic acid phosphorylation;50904;26;GO:0006464
GO:0031385;regulation of termination of mating projection growth;4;4;GO:0048285
GO:0031386;protein tag activity;11320;260;GO:0003700
GO:0070911;global genome nucleotide-excision repair;65;152;GO:0006281
GO:0070912;Ddb1-Ckn1 complex;9;2;GO:0043161
GO:0031389;Rad17 RFC-like complex;1067;10;GO:0005576
GO:0070910;cell wall macromolecule catabolic process involved in cell wall disassembly;6;3;GO:0046274
GO:0070948;regulation of neutrophil mediated cytotoxicity;242;139;GO:0002687
GO:0031380;nuclear RNA-directed RNA polymerase complex;449;6;GO:0005634
GO:0043328;protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;11395;200;GO:0006914
GO:0070949;regulation of neutrophil mediated killing of symbiont cell;122;5;GO:0046649
GO:0070946;neutrophil-mediated killing of gram-positive bacterium;66;6;GO:0002376
GO:0070947;neutrophil-mediated killing of fungus;96;35;GO:0045087
GO:0031383;regulation of mating projection assembly;19;2;GO:0048608
GO:0031384;regulation of initiation of mating projection growth;4;5;GO:0048285
GO:0031381;viral RNA-directed RNA polymerase complex;0;1;GO:0009570
GO:0031382;mating projection formation;30;2;GO:0048608
GO:0043321;regulation of natural killer cell degranulation;146;22;GO:0045087
GO:0045984;negative regulation of pyrimidine nucleobase metabolic process;4;1;GO:0045941
GO:0043320;natural killer cell degranulation;373;65;GO:0002756
GO:0045985;positive regulation of pyrimidine nucleobase metabolic process;0;1;GO:0045941
GO:0043323;positive regulation of natural killer cell degranulation;130;134;GO:0045087
GO:0045982;negative regulation of purine nucleobase metabolic process;3980;58;GO:0045941
GO:0043322;negative regulation of natural killer cell degranulation;16;5;GO:0045087
GO:0045983;positive regulation of purine nucleobase metabolic process;0;2;GO:0045944
GO:0043325;phosphatidylinositol-3,4-bisphosphate binding;1499;358;GO:0097367
GO:0045988;negative regulation of striated muscle contraction;296;93;GO:0048407
GO:0043324;pigment metabolic process involved in developmental pigmentation;747;7;GO:0046148
GO:0045989;positive regulation of striated muscle contraction;446;108;GO:0048407
GO:0043327;chemotaxis to cAMP;310;27;GO:0007626
GO:0045986;negative regulation of smooth muscle contraction;595;268;GO:0048010
GO:0043326;chemotaxis to folate;62;6;GO:0007626
GO:0045987;positive regulation of smooth muscle contraction;1650;536;GO:0048010
GO:0045991;carbon catabolite activation of transcription;634;8;GO:0003700
GO:0045992;negative regulation of embryonic development;119;215;GO:0048608
GO:0043330;response to exogenous dsRNA;2358;751;GO:0032496
GO:0045990;carbon catabolite regulation of transcription;1636;8;GO:0010468
GO:0102354;11-cis-retinol dehydrogenase activity;8;4;GO:0004073
GO:0070941;eisosome assembly;91;49;GO:0009986
GO:0102356;isoitalicene synthase activity;0;0;GO:0004497
GO:0102355;2-oxo-3-(5-oxofuran-2-ylidene)propanoate lactonase activity;4;0;GO:0046274
GO:0070944;neutrophil-mediated killing of bacterium;458;37;GO:0045087
GO:0070945;neutrophil-mediated killing of gram-negative bacterium;232;72;GO:0002379
GO:0070942;neutrophil mediated cytotoxicity;674;66;GO:0006954
GO:0102352;phosphatidate kinase activity;0;0;GO:0004721
GO:0031379;RNA-directed RNA polymerase complex;559;25;GO:0009536
GO:0070943;neutrophil-mediated killing of symbiont cell;554;125;GO:0046649
GO:0102351;gamma-aminobutyrate transaminase (glyoxylate dependent) activity;123;2;GO:0006081
GO:0070937;CRD-mediated mRNA stability complex;357;479;GO:0008033
GO:0070938;contractile ring;2002;197;GO:0007088
GO:0070935;3'-UTR-mediated mRNA stabilization;1133;571;GO:0006414
GO:0070936;protein K48-linked ubiquitination;550;1070;GO:0006486
GO:0031372;UBC13-MMS2 complex;87;56;GO:0005524
GO:0102358;daphnetin-8-O-methyltransferase activity;1;0;GO:0004497
GO:0102357;mithramycin dehydrogenase activity;0;0;GO:0006067
GO:0031370;eukaryotic initiation factor 4G binding;529;39;GO:0005515
GO:0070939;Dsl1/NZR complex;4544;95;GO:0005524
GO:1905815;regulation of dorsal/ventral axon guidance;56;4;GO:0048608
GO:1905814;positive regulation of motor neuron axon guidance;0;0;GO:0048704
GO:1905809;negative regulation of synapse organization;975;37;GO:0048167
GO:1905808;positive regulation of synapse pruning;120;4;GO:0048167
GO:1905807;negative regulation of synapse pruning;4;1;GO:0048608
GO:1903241;U2-type prespliceosome assembly;212;10;GO:0007049
GO:1903242;regulation of cardiac muscle hypertrophy in response to stress;383;21;GO:0048407
GO:1903243;negative regulation of cardiac muscle hypertrophy in response to stress;188;35;GO:0048405
GO:1903244;positive regulation of cardiac muscle hypertrophy in response to stress;130;30;GO:0048407
GO:0051491;positive regulation of filopodium assembly;1462;1210;GO:0048193
GO:1903249;negative regulation of citrulline biosynthetic process;52;8;GO:0046394
GO:0051492;regulation of stress fiber assembly;4563;447;GO:0048608
GO:0051490;negative regulation of filopodium assembly;156;78;GO:0048193
GO:1903248;regulation of citrulline biosynthetic process;52;10;GO:0006569
GO:0051489;regulation of filopodium assembly;2568;470;GO:0048608
GO:0051486;isopentenyl diphosphate biosynthetic process, mevalonate pathway involved in terpenoid biosynthetic process;0;3;GO:0006096
GO:0051484;isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process;101;4;GO:0006073
GO:0051485;terpenoid biosynthetic process, mevalonate-dependent;1;3;GO:0006685
GO:0051483;terpenoid biosynthetic process, mevalonate-independent;103;1;GO:0006685
GO:1903252;hercynylcysteine sulfoxide metabolic process;4;1;GO:0046395
GO:1903253;hercynylcysteine sulfoxide biosynthetic process;4;3;GO:0046395
GO:1903250;positive regulation of citrulline biosynthetic process;0;0;GO:0046394
GO:1903251;multi-ciliated epithelial cell differentiation;433;35;GO:0048608
GO:1903256;selenoneine metabolic process;8;0;GO:0006749
GO:1903257;selenoneine biosynthetic process;8;3;GO:0009065
GO:1903254;hercynylselenocysteine metabolic process;4;1;GO:0009064
GO:1903255;hercynylselenocysteine biosynthetic process;4;1;GO:0009065
GO:1903258;sorbose import across plasma membrane;0;0;GO:0006814
GO:1903259;exon-exon junction complex disassembly;3066;6;GO:0008312
GO:0051499;D-aminoacyl-tRNA deacylase activity;128927;37;GO:0004867
GO:0051497;negative regulation of stress fiber assembly;1361;561;GO:0048285
GO:0051498;syn-copalyl diphosphate synthase activity;11;3;GO:0006032
GO:0051495;positive regulation of cytoskeleton organization;14745;936;GO:0051015
GO:0051496;positive regulation of stress fiber assembly;2465;1150;GO:0048608
GO:0051493;regulation of cytoskeleton organization;158665;2340;GO:0051012
GO:0051494;negative regulation of cytoskeleton organization;84122;982;GO:0051015
GO:1903264;nitrate reductase activity involved in anaerobic electron transport chain;1;2;GO:0009065
GO:1903267;negative regulation of ornithine catabolic process;0;1;GO:0046395
GO:1903268;positive regulation of ornithine catabolic process;0;0;GO:0046395
GO:1903265;positive regulation of tumor necrosis factor-mediated signaling pathway;518;121;GO:0032724
GO:1903266;regulation of ornithine catabolic process;0;0;GO:0046395
GO:1903269;ornithine carbamoyltransferase inhibitor complex;65;0;GO:0005524
GO:0099400;caveola neck;58;7;GO:0005576
GO:0099401;caveola bulb;0;1;GO:0008021
GO:0099404;mitotic sister chromatid cohesion, telomeric;103;5;GO:0007030
GO:0099402;plant organ development;51219;157;GO:0048513
GO:0099403;maintenance of mitotic sister chromatid cohesion, telomeric;103;3;GO:0007050
GO:1903260;protein localization to mating projection tip;9;2;GO:0005737
GO:1903272;positive regulation of cytoplasmic translational elongation through polyproline stretches;2;0;GO:0045944
GO:1903278;positive regulation of sodium ion export across plasma membrane;206;7;GO:0048193
GO:1903279;regulation of calcium:sodium antiporter activity;5;8;GO:0006836
GO:1903276;regulation of sodium ion export across plasma membrane;208;2;GO:0048407
GO:1903277;negative regulation of sodium ion export across plasma membrane;2;1;GO:0048193
GO:1903270;regulation of cytoplasmic translational elongation through polyproline stretches;2;0;GO:0006414
GO:1903271;negative regulation of cytoplasmic translational elongation through polyproline stretches;0;0;GO:0010467
GO:1905860;positive regulation of heparan sulfate proteoglycan binding;1;5;GO:0048407
GO:1905864;regulation of Atg1/ULK1 kinase complex assembly;16;0;GO:1901563
GO:1905862;ferroxidase complex;18814;1;GO:0005576
GO:1903200;positive regulation of L-dopa decarboxylase activity;2;6;GO:0010468
GO:1905861;intranuclear rod assembly;10;4;GO:0048706
GO:1905868;regulation of 3'-UTR-mediated mRNA stabilization;238;2;GO:0010467
GO:1905867;epididymis development;72;5;GO:0007517
GO:1905866;positive regulation of Atg1/ULK1 kinase complex assembly;16;3;GO:1901563
GO:1905865;negative regulation of Atg1/ULK1 kinase complex assembly;0;0;GO:1901563
GO:1905869;negative regulation of 3'-UTR-mediated mRNA stabilization;55;4;GO:0010467
GO:0051444;negative regulation of ubiquitin-protein transferase activity;76;1580;GO:0004842
GO:0051445;regulation of meiotic cell cycle;6420;488;GO:0048285
GO:0051443;positive regulation of ubiquitin-protein transferase activity;828;1670;GO:0004842
GO:0051448;gonadotropin-releasing hormone binding;0;2;GO:0004867
GO:0051449;thyrotropin-releasing hormone binding;0;2;GO:0004930
GO:0051446;positive regulation of meiotic cell cycle;1784;370;GO:0048285
GO:0051447;negative regulation of meiotic cell cycle;3627;311;GO:0048285
GO:1905871;regulation of protein localization to cell leading edge;115;3;GO:0048193
GO:1905870;positive regulation of 3'-UTR-mediated mRNA stabilization;165;4;GO:0010468
GO:1903212;protein localization to mating-type region heterochromatin;0;0;GO:0007049
GO:1905875;negative regulation of postsynaptic density organization;3;0;GO:0048608
GO:1903213;protein localization to subtelomeric heterochromatin;0;0;GO:0007031
GO:1905874;regulation of postsynaptic density organization;570;3;GO:0048608
GO:1903210;podocyte apoptotic process;190;5;GO:0043066
GO:1905873;positive regulation of protein localization to cell leading edge;2;0;GO:0048193
GO:1905872;negative regulation of protein localization to cell leading edge;49;2;GO:0048193
GO:1903216;regulation of protein processing involved in protein targeting to mitochondrion;7;4;GO:0006613
GO:1905879;regulation of oogenesis;257;7;GO:0048608
GO:1903217;negative regulation of protein processing involved in protein targeting to mitochondrion;7;6;GO:0006457
GO:1903214;regulation of protein targeting to mitochondrion;849;307;GO:0006613
GO:1903215;negative regulation of protein targeting to mitochondrion;231;49;GO:0006613
GO:1905876;positive regulation of postsynaptic density organization;0;0;GO:0048608
GO:1903218;regulation of malate dehydrogenase (decarboxylating) (NADP+) activity;17;0;GO:0010467
GO:1903219;negative regulation of malate dehydrogenase (decarboxylating) (NADP+) activity;0;0;GO:0010467
GO:0051455;spindle attachment to meiosis I kinetochore;309;7;GO:0007062
GO:0051456;attachment of meiotic spindle microtubules to meiosis II kinetochore;8;1;GO:0007062
GO:0051453;regulation of intracellular pH;11381;939;GO:0045735
GO:0051454;intracellular pH elevation;593;122;GO:0006874
GO:0051451;myoblast migration;847;324;GO:0048471
GO:0051452;intracellular pH reduction;3379;257;GO:0006874
GO:0051450;myoblast proliferation;1544;125;GO:0042127
GO:0051459;regulation of corticotropin secretion;321;10;GO:0048608
GO:0051457;maintenance of protein location in nucleus;1432;515;GO:0034660
GO:0051458;corticotropin secretion;403;16;GO:0002768
GO:1903220;positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity;17;0;GO:0046394
GO:1905881;positive regulation of oogenesis;29;5;GO:0048608
GO:1905880;negative regulation of oogenesis;0;2;GO:0048608
GO:1903224;regulation of endodermal cell differentiation;747;59;GO:0045595
GO:1905885;positive regulation of triglyceride transport;151;4;GO:0010467
GO:1903221;regulation of mitotic recombination-dependent replication fork processing;4;1;GO:0048285
GO:1905884;negative regulation of triglyceride transport;1;0;GO:0010467
GO:1903222;quinolinic acid transmembrane transport;4;6;GO:0006836
GO:1905883;regulation of triglyceride transport;152;0;GO:0006869
GO:1903227;xanthosine metabolic process;5;0;GO:0006073
GO:0051470;ectoine transport;3838;8;GO:0006826
GO:1903228;xanthosine catabolic process;1;1;GO:0009065
GO:1905889;positive regulation of cellular response to very-low-density lipoprotein particle stimulus;0;0;GO:0045944
GO:1903225;negative regulation of endodermal cell differentiation;367;110;GO:0045595
GO:1905888;negative regulation of cellular response to very-low-density lipoprotein particle stimulus;0;0;GO:0010467
GO:1903226;positive regulation of endodermal cell differentiation;141;5;GO:0045595
GO:1905887;autoinducer AI-2 transmembrane transport;908;86;GO:0008544
GO:1903229;xanthosine biosynthetic process;4;0;GO:0009065
GO:0051466;positive regulation of corticotropin-releasing hormone secretion;61;23;GO:0048167
GO:0051467;detection of steroid hormone stimulus;0;2;GO:0009719
GO:0051464;positive regulation of cortisol secretion;208;23;GO:0010817
GO:0051465;negative regulation of corticotropin-releasing hormone secretion;0;1;GO:0048167
GO:0051462;regulation of cortisol secretion;271;9;GO:0010817
GO:0051463;negative regulation of cortisol secretion;63;4;GO:0010817
GO:0051460;negative regulation of corticotropin secretion;90;6;GO:0048608
GO:0051461;positive regulation of corticotropin secretion;162;229;GO:0048608
GO:0051468;detection of glucocorticoid hormone stimulus;0;2;GO:0009719
GO:0051469;vesicle fusion with vacuole;83;4;GO:0005764
GO:1903231;mRNA base-pairing translational repressor activity;2081;628;GO:0003735
GO:1905890;regulation of cellular response to very-low-density lipoprotein particle stimulus;49;10;GO:0045944
GO:1903234;negative regulation of calcium ion-dependent exocytosis of neurotransmitter;0;1;GO:0048608
GO:1905897;regulation of response to endoplasmic reticulum stress;8724;367;GO:0034976
GO:1903235;positive regulation of calcium ion-dependent exocytosis of neurotransmitter;56;1;GO:0048167
GO:1903232;melanosome assembly;357;48;GO:0005576
GO:1903233;regulation of calcium ion-dependent exocytosis of neurotransmitter;237;20;GO:0007416
GO:0051480;regulation of cytosolic calcium ion concentration;3899;1630;GO:0006873
GO:1903238;positive regulation of leukocyte tethering or rolling;448;72;GO:0048011
GO:0051481;negative regulation of cytosolic calcium ion concentration;513;1780;GO:0048407
GO:1903236;regulation of leukocyte tethering or rolling;734;4;GO:0030168
GO:1905899;regulation of smooth muscle tissue development;54;0;GO:0048731
GO:1903237;negative regulation of leukocyte tethering or rolling;163;473;GO:0048011
GO:1905898;positive regulation of response to endoplasmic reticulum stress;5286;72;GO:0034976
GO:0051477;mannosylglycerate transmembrane transporter activity;0;0;GO:0005525
GO:0051478;mannosylglycerate metabolic process;4158;7;GO:0006032
GO:0051475;glucosylglycerol transmembrane transport;1;1;GO:0008544
GO:0051476;phosphoenolpyruvate-dependent mannosylglycerate phosphotransferase system;3;1;GO:0005975
GO:0051473;glucosylglycerol biosynthetic process;943;3;GO:0006021
GO:0051474;glucosylglycerol transmembrane transporter activity;0;0;GO:0005576
GO:0051472;glucosylglycerol metabolic process;944;4;GO:0006073
GO:0051479;mannosylglycerate biosynthetic process;4157;5;GO:0006021
GO:1903165;response to polycyclic arene;14;3;GO:0046686
GO:1903168;positive regulation of pyrroline-5-carboxylate reductase activity;2;6;GO:0046395
GO:1903169;regulation of calcium ion transmembrane transport;5691;501;GO:0006873
GO:1903166;cellular response to polycyclic arene;7;0;GO:0043407
GO:1903167;regulation of pyrroline-5-carboxylate reductase activity;2;0;GO:0009065
GO:1903175;fatty alcohol biosynthetic process;58;1;GO:0006631
GO:1903176;regulation of tyrosine 3-monooxygenase activity;2;0;GO:0046395
GO:1903173;fatty alcohol metabolic process;191;4;GO:0006631
GO:1903174;fatty alcohol catabolic process;0;1;GO:0006631
GO:1903179;regulation of dopamine biosynthetic process;115;5;GO:0043403
GO:1903177;negative regulation of tyrosine 3-monooxygenase activity;0;0;GO:0010468
GO:1903178;positive regulation of tyrosine 3-monooxygenase activity;2;6;GO:0046356
GO:1903170;negative regulation of calcium ion transmembrane transport;803;265;GO:0048407
GO:1903186;regulation of vitellogenesis;83;1;GO:0048608
GO:1903187;negative regulation of vitellogenesis;7;0;GO:0048608
GO:1903184;L-dopa metabolic process;52;1;GO:0006797
GO:1903185;L-dopa biosynthetic process;48;5;GO:0006783
GO:1903188;positive regulation of vitellogenesis;35;4;GO:0048608
GO:1903189;glyoxal metabolic process;367;5;GO:0006066
GO:1903182;regulation of SUMO transferase activity;1;3;GO:0004842
GO:1903183;negative regulation of SUMO transferase activity;0;1;GO:0048193
GO:1903180;negative regulation of dopamine biosynthetic process;0;0;GO:0045935
GO:1903181;positive regulation of dopamine biosynthetic process;65;8;GO:0045935
GO:1903197;positive regulation of L-dopa biosynthetic process;48;8;GO:0046356
GO:1903198;regulation of L-dopa decarboxylase activity;2;0;GO:0010468
GO:1903195;regulation of L-dopa biosynthetic process;48;0;GO:0046356
GO:1903196;negative regulation of L-dopa biosynthetic process;0;0;GO:0010468
GO:1903199;negative regulation of L-dopa decarboxylase activity;0;0;GO:0010468
GO:1903190;glyoxal catabolic process;106;2;GO:0006569
GO:1903193;sesquarterpene biosynthetic process;0;0;GO:0046274
GO:1903191;glyoxal biosynthetic process;0;0;GO:0006066
GO:1903192;sesquarterpene metabolic process;0;1;GO:0006721
GO:0002410;plasmacytoid dendritic cell chemotaxis;2;3;GO:0002504
GO:0002400;tolerance induction in nasopharyngeal-associated lymphoid tissue;0;3;GO:0002273
GO:0002401;tolerance induction in mucosal-associated lymphoid tissue;0;3;GO:0002576
GO:0002402;B cell tolerance induction in mucosal-associated lymphoid tissue;0;3;GO:0002429
GO:0002403;T cell tolerance induction in mucosal-associated lymphoid tissue;0;2;GO:0002821
GO:0002404;antigen sampling in mucosal-associated lymphoid tissue;5;8;GO:0002576
GO:0002405;antigen sampling by dendritic cells in mucosal-associated lymphoid tissue;0;3;GO:0002449
GO:0002406;antigen sampling by M cells in mucosal-associated lymphoid tissue;5;3;GO:0002449
GO:0002407;dendritic cell chemotaxis;868;1310;GO:0002526
GO:0002408;myeloid dendritic cell chemotaxis;249;201;GO:0050900
GO:0002409;Langerhans cell chemotaxis;0;4;GO:0002504
GO:0002440;production of molecular mediator of immune response;15304;471;GO:0002429
GO:0002441;histamine secretion involved in inflammatory response;447;10;GO:0002684
GO:0002442;serotonin secretion involved in inflammatory response;167;57;GO:0002768
GO:0002443;leukocyte mediated immunity;32362;2570;GO:0002443
GO:0002433;immune response-regulating cell surface receptor signaling pathway involved in phagocytosis;291;90;GO:0002449
GO:0002434;immune complex clearance;158;24;GO:0002504
GO:0002435;immune complex clearance by erythrocytes;1;5;GO:0002576
GO:0002436;immune complex clearance by monocytes and macrophages;95;14;GO:0002429
GO:0002437;inflammatory response to antigenic stimulus;2697;578;GO:0002684
GO:0002438;acute inflammatory response to antigenic stimulus;1001;158;GO:0002684
GO:0002439;chronic inflammatory response to antigenic stimulus;321;143;GO:0002682
GO:0002450;B cell antigen processing and presentation;46;6;GO:0019882
GO:0002451;peripheral B cell tolerance induction;12;7;GO:0002429
GO:0002452;B cell receptor editing;0;7;GO:0002774
GO:0002453;peripheral B cell anergy;0;5;GO:0002449
GO:0002454;peripheral B cell deletion;0;4;GO:0002704
GO:0002444;myeloid leukocyte mediated immunity;4776;1370;GO:0002449
GO:0002445;type II hypersensitivity;226;156;GO:0002237
GO:0002446;neutrophil mediated immunity;1629;2800;GO:0002376
GO:0002447;eosinophil mediated immunity;355;24;GO:0002449
GO:0002448;mast cell mediated immunity;2154;306;GO:0002429
GO:0002449;lymphocyte mediated immunity;26873;1510;GO:0002449
GO:0002420;natural killer cell mediated cytotoxicity directed against tumor cell target;421;12;GO:0002221
GO:0002421;B cell antigen processing and presentation following pinocytosis;0;4;GO:0002474
GO:0002411;T cell tolerance induction to tumor cell;0;2;GO:0002821
GO:0002412;antigen transcytosis by M cells in mucosal-associated lymphoid tissue;5;7;GO:0002449
GO:0002413;tolerance induction to tumor cell;55;3;GO:0002526
GO:0002414;immunoglobulin transcytosis in epithelial cells;134;44;GO:0006929
GO:0002415;immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor;122;137;GO:0002504
GO:0002416;IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor;1;8;GO:0008021
GO:0002417;B cell antigen processing and presentation mediated by B cell receptor uptake of antigen;0;3;GO:0002474
GO:0002418;immune response to tumor cell;1122;53;GO:0002449
GO:0002419;T cell mediated cytotoxicity directed against tumor cell target;96;10;GO:0006956
GO:0002430;complement receptor mediated signaling pathway;3415;282;GO:0006954
GO:0002431;Fc receptor mediated stimulatory signaling pathway;487;375;GO:0002768
GO:0002432;granuloma formation;65;30;GO:0050921
GO:0002423;natural killer cell mediated immune response to tumor cell;450;6;GO:0002449
GO:0002424;T cell mediated immune response to tumor cell;350;47;GO:0002449
GO:0002425;tolerance induction in urogenital tract;0;3;GO:0002596
GO:0002426;immunoglobulin production in mucosal tissue;41;33;GO:0002729
GO:0002427;mucosal tolerance induction;0;2;GO:0002576
GO:0002428;antigen processing and presentation of peptide antigen via MHC class Ib;804;198;GO:0002474
GO:0002429;immune response-activating cell surface receptor signaling pathway;23546;965;GO:0002449
GO:1905703;negative regulation of inhibitory synapse assembly;58;2;GO:0048608
GO:1905702;regulation of inhibitory synapse assembly;228;5;GO:0048608
GO:1905701;positive regulation of xenobiotic detoxification by transmembrane export across the plasma membrane;0;1;GO:0046356
GO:1905700;negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane;13;7;GO:0046686
GO:1905707;negative regulation of mitochondrial ATP synthesis coupled proton transport;0;4;GO:0015986
GO:1905706;regulation of mitochondrial ATP synthesis coupled proton transport;220;3;GO:0015986
GO:1905704;positive regulation of inhibitory synapse assembly;119;3;GO:0048608
GO:0002598;regulation of antigen processing and presentation of lipid antigen via MHC class Ib;0;2;GO:0002449
GO:0051521;termination of monopolar cell growth;0;2;GO:0048608
GO:0002599;negative regulation of antigen processing and presentation of lipid antigen via MHC class Ib;0;2;GO:0002449
GO:0051522;activation of monopolar cell growth;0;1;GO:0048608
GO:0051520;termination of bipolar cell growth;0;1;GO:0048608
GO:0051525;NFAT protein binding;221;279;GO:0043169
GO:0051523;cell growth mode switching, monopolar to bipolar;31;3;GO:0048285
GO:0051524;cell growth mode switching, bipolar to monopolar;0;0;GO:0048285
GO:1905710;positive regulation of membrane permeability;2487;37;GO:0048169
GO:1905712;cellular response to phosphatidylethanolamine;0;0;GO:0006936
GO:1905711;response to phosphatidylethanolamine;4;2;GO:0006631
GO:1905717;positive regulation of cornification;0;3;GO:0048305
GO:1905716;negative regulation of cornification;4;3;GO:0048305
GO:1905715;regulation of cornification;4;2;GO:0046330
GO:1905709;negative regulation of membrane permeability;1216;5;GO:0048169
GO:1905708;regulation of cell morphogenesis involved in conjugation with cellular fusion;0;0;GO:0048285
GO:0051538;3 iron, 4 sulfur cluster binding;114593;576;GO:0005525
GO:0051539;4 iron, 4 sulfur cluster binding;3312918;5320;GO:0005525
GO:0051536;iron-sulfur cluster binding;9563588;4800;GO:0005737
GO:0051537;2 iron, 2 sulfur cluster binding;1074527;3940;GO:0005525
GO:1905721;mitotic spindle astral microtubule end;159;4;GO:0007088
GO:1905720;cytoplasmic microtubule bundle;55;3;GO:0005929
GO:1905725;protein localization to microtubule end;158;1;GO:0007049
GO:0002580;regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;44650;8;GO:0002474
GO:1905724;positive regulation of trypanothione biosynthetic process;1;0;GO:0046395
GO:0002581;negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;44546;53;GO:0002449
GO:1905723;negative regulation of trypanothione biosynthetic process;0;2;GO:0046395
GO:0002582;positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;104;127;GO:0002449
GO:1905722;regulation of trypanothione biosynthetic process;1;0;GO:0046395
GO:0002583;regulation of antigen processing and presentation of peptide antigen;44683;6;GO:0002474
GO:0002584;negative regulation of antigen processing and presentation of peptide antigen;44577;7;GO:0002449
GO:0002585;positive regulation of antigen processing and presentation of peptide antigen;106;8;GO:0019882
GO:0002586;regulation of antigen processing and presentation of peptide antigen via MHC class II;44590;7;GO:0002474
GO:0002576;platelet degranulation;385;3040;GO:0002576
GO:0051543;regulation of elastin biosynthetic process;6;1;GO:0048608
GO:0075510;macropinocytosis involved in viral entry into host cell;0;1;GO:0006897
GO:0002577;regulation of antigen processing and presentation;45280;1110;GO:0008632
GO:0051544;positive regulation of elastin biosynthetic process;1;1;GO:0048608
GO:0075511;macropinosome lysis involved in viral entry into host cell;0;0;GO:0006979
GO:0002578;negative regulation of antigen processing and presentation;44818;45;GO:0019882
GO:0051541;elastin metabolic process;263;32;GO:0008544
GO:0075512;clathrin-dependent endocytosis of virus by host cell;441471;9;GO:0006897
GO:0002579;positive regulation of antigen processing and presentation;398;824;GO:0019882
GO:0051542;elastin biosynthetic process;9;8;GO:0008544
GO:0075513;caveolin-mediated endocytosis of virus by host cell;8165;5;GO:0006897
GO:1905719;protein localization to perinuclear region of cytoplasm;490;34;GO:0005737
GO:0051540;metal cluster binding;9565306;889;GO:0046872
GO:0075519;microtubule-dependent intracellular transport of viral material;31251;3;GO:0048193
GO:0051549;positive regulation of keratinocyte migration;536;275;GO:0048010
GO:0051547;regulation of keratinocyte migration;574;38;GO:0016477
GO:0075514;endosome lysis involved in viral entry into host cell;0;0;GO:0006897
GO:0051548;negative regulation of keratinocyte migration;38;9;GO:0048010
GO:0051545;negative regulation of elastin biosynthetic process;5;4;GO:0010401
GO:0051546;keratinocyte migration;896;153;GO:0030900
GO:0002590;negative regulation of antigen processing and presentation of peptide antigen via MHC class I;91;34;GO:0002449
GO:1905736;negative regulation of L-proline import across plasma membrane;0;0;GO:0046395
GO:0002591;positive regulation of antigen processing and presentation of peptide antigen via MHC class I;2;7;GO:0002474
GO:1905735;regulation of L-proline import across plasma membrane;115;1;GO:0006865
GO:0002592;regulation of antigen processing and presentation via MHC class Ib;0;1;GO:0002449
GO:0002593;negative regulation of antigen processing and presentation via MHC class Ib;0;2;GO:0002449
GO:0002594;positive regulation of antigen processing and presentation via MHC class Ib;0;2;GO:0019882
GO:0002595;regulation of antigen processing and presentation of peptide antigen via MHC class Ib;0;1;GO:0002449
GO:0002596;negative regulation of antigen processing and presentation of peptide antigen via MHC class Ib;0;2;GO:0002449
GO:0002597;positive regulation of antigen processing and presentation of peptide antigen via MHC class Ib;0;2;GO:0019882
GO:1905737;positive regulation of L-proline import across plasma membrane;115;5;GO:0046395
GO:0002587;negative regulation of antigen processing and presentation of peptide antigen via MHC class II;44486;8;GO:0002449
GO:0051554;flavonol metabolic process;389;9;GO:0009813
GO:0002588;positive regulation of antigen processing and presentation of peptide antigen via MHC class II;104;32;GO:0002449
GO:0051555;flavonol biosynthetic process;387;81;GO:0009813
GO:0002589;regulation of antigen processing and presentation of peptide antigen via MHC class I;93;10;GO:0002474
GO:0051552;flavone metabolic process;568;125;GO:0009813
GO:0051553;flavone biosynthetic process;467;31;GO:0009813
GO:0075502;endosome membrane permeabilization involved in viral entry into host cell;0;0;GO:0006974
GO:0051550;aurone metabolic process;0;3;GO:0006032
GO:0051551;aurone biosynthetic process;0;5;GO:0009813
GO:0075507;entry of viral genome into host nucleus via docking of viral capsid to the nuclear pore complex and injection of viral genome;0;1;GO:0005740
GO:0075508;entry of viral genome into host nucleus via retainment of capsid in nuclear pore complex and release of genome into nucleoplasm;0;1;GO:0009579
GO:0075509;endocytosis involved in viral entry into host cell;911077;139;GO:0006897
GO:0051558;phlobaphene metabolic process;3;2;GO:0006749
GO:0075503;fusion of virus membrane with host macropinosome membrane;0;1;GO:0048193
GO:0051559;phlobaphene biosynthetic process;3;3;GO:0046395
GO:0075504;macropinosomal membrane permeabilization involved in viral entry into host cell;0;0;GO:0048193
GO:0051556;leucoanthocyanidin metabolic process;0;4;GO:0009813
GO:0075505;entry of intact viral capsid into host nucleus through nuclear pore complex;0;1;GO:0009986
GO:0051557;leucoanthocyanidin biosynthetic process;0;3;GO:0009813
GO:0075506;entry of viral genome into host nucleus through nuclear pore complex via importin;152;5;GO:0005730
GO:0051509;tomatidine UDP-glucosyltransferase activity;3;2;GO:0006081
GO:0051500;D-tyrosyl-tRNA(Tyr) deacylase activity;218;72;GO:0006413
GO:0051507;beta-sitosterol UDP-glucosyltransferase activity;13;3;GO:0006081
GO:0051508;stigmasterol UDP-glucosyltransferase activity;3;3;GO:0004553
GO:0051506;ergosterol UDP-glucosyltransferase activity;29;2;GO:0006029
GO:0051503;adenine nucleotide transport;86570;231;GO:0006873
GO:0051504;diterpene phytoalexin precursor biosynthetic process pathway;0;2;GO:0046274
GO:0051501;diterpene phytoalexin metabolic process;25;6;GO:0009617
GO:0051502;diterpene phytoalexin biosynthetic process;25;2;GO:0009640
GO:0051510;regulation of unidimensional cell growth;2462;81;GO:0042127
GO:0051511;negative regulation of unidimensional cell growth;121;150;GO:0045944
GO:0051518;positive regulation of bipolar cell growth;14;0;GO:0048608
GO:0051519;activation of bipolar cell growth;13;5;GO:0048407
GO:0051516;regulation of bipolar cell growth;43;1;GO:0048608
GO:0051517;negative regulation of bipolar cell growth;4;3;GO:0048405
GO:0051514;negative regulation of monopolar cell growth;0;3;GO:0048706
GO:0051515;positive regulation of monopolar cell growth;3;2;GO:0048608
GO:0051512;positive regulation of unidimensional cell growth;69;5;GO:0045944
GO:0051513;regulation of monopolar cell growth;1880;75;GO:0048608
GO:1903120;protein localization to actin filament bundle;0;0;GO:0003779
GO:1903121;regulation of TRAIL-activated apoptotic signaling pathway;207;8;GO:0046330
GO:1905782;positive regulation of phosphatidylserine exposure on apoptotic cell surface;71;0;GO:0048193
GO:1905781;negative regulation of phosphatidylserine exposure on apoptotic cell surface;0;1;GO:0048193
GO:1905780;regulation of phosphatidylserine exposure on apoptotic cell surface;71;0;GO:0048193
GO:1903124;negative regulation of thioredoxin peroxidase activity;1;0;GO:0046209
GO:1905787;regulation of detection of mechanical stimulus involved in sensory perception of touch;88;1;GO:0007600
GO:1903125;negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation;1;5;GO:0046209
GO:1905786;positive regulation of anaphase-promoting complex-dependent catabolic process;560;7;GO:0048285
GO:1903122;negative regulation of TRAIL-activated apoptotic signaling pathway;52;14;GO:0043066
GO:1905785;negative regulation of anaphase-promoting complex-dependent catabolic process;15;2;GO:0048285
GO:1903123;regulation of thioredoxin peroxidase activity;2;0;GO:0004601
GO:1905784;regulation of anaphase-promoting complex-dependent catabolic process;577;3;GO:0007049
GO:1903126;negative regulation of centriole-centriole cohesion;65;1;GO:0048193
GO:1905789;positive regulation of detection of mechanical stimulus involved in sensory perception of touch;86;2;GO:0050890
GO:1903127;positive regulation of centriole-centriole cohesion;0;0;GO:0048193
GO:1905788;negative regulation of detection of mechanical stimulus involved in sensory perception of touch;2;0;GO:0050890
GO:0099550;trans-synaptic signaling, modulating synaptic transmission;579;7;GO:0007213
GO:0099551;trans-synaptic signaling by neuropeptide, modulating synaptic transmission;69;9;GO:0007218
GO:0099543;trans-synaptic signaling by soluble gas;118;9;GO:0007213
GO:0099544;perisynaptic space;59;7;GO:0005789
GO:0099541;trans-synaptic signaling by lipid;448;9;GO:0048169
GO:0099542;trans-synaptic signaling by endocannabinoid;448;5;GO:0007213
GO:0099547;regulation of translation at synapse, modulating synaptic transmission;166;9;GO:0048167
GO:0099548;trans-synaptic signaling by nitric oxide;118;4;GO:0007218
GO:0099545;trans-synaptic signaling by trans-synaptic complex;354;127;GO:0008021
GO:0099546;protein catabolic process, modulating synaptic transmission;6;1;GO:0048167
GO:0099549;trans-synaptic signaling by carbon monoxide;0;0;GO:0008021
GO:1903131;mononuclear cell differentiation;112201;135;GO:0045595
GO:1905794;response to puromycin;4;0;GO:0006929
GO:1903132;regulation of tube lumen cavitation;2;0;GO:0048608
GO:1905793;protein localization to pericentriolar material;121;3;GO:0005788
GO:1905792;positive regulation of mechanosensory behavior;93;1;GO:0050729
GO:1905791;negative regulation of mechanosensory behavior;0;1;GO:0050729
GO:1903135;cupric ion binding;166;156;GO:0043169
GO:1905798;positive regulation of intraciliary anterograde transport;9;1;GO:0048193
GO:1903136;cuprous ion binding;395;53;GO:0043169
GO:1905797;negative regulation of intraciliary anterograde transport;0;1;GO:0048193
GO:1903133;negative regulation of tube lumen cavitation;2;2;GO:0048193
GO:1905796;regulation of intraciliary anterograde transport;9;0;GO:0048193
GO:1905795;cellular response to puromycin;4;1;GO:0006974
GO:1903139;positive regulation of cell wall integrity MAPK cascade;1;2;GO:0043406
GO:1903137;regulation of cell wall integrity MAPK cascade;125;0;GO:0007165
GO:1903138;negative regulation of cell wall integrity MAPK cascade;124;4;GO:0043407
GO:1905799;regulation of intraciliary retrograde transport;118;3;GO:0048193
GO:0099561;synaptic membrane adhesion to extracellular matrix;1;1;GO:0030199
GO:0099562;maintenance of postsynaptic density structure;524;7;GO:0048471
GO:0099560;synaptic membrane adhesion;1681;109;GO:0048608
GO:0099554;trans-synaptic signaling by soluble gas, modulating synaptic transmission;99;0;GO:0007218
GO:0099555;trans-synaptic signaling by nitric oxide, modulating synaptic transmission;99;2;GO:0008066
GO:0099552;trans-synaptic signaling by lipid, modulating synaptic transmission;128;4;GO:0007218
GO:0099553;trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;128;7;GO:0007218
GO:0099558;maintenance of synapse structure;2034;198;GO:0048167
GO:0099559;maintenance of alignment of postsynaptic density and presynaptic active zone;10;1;GO:0048608
GO:0099556;trans-synaptic signaling by carbon monoxide, modulating synaptic transmission;0;0;GO:0008076
GO:0099557;trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission;113;7;GO:0008021
GO:1905790;regulation of mechanosensory behavior;158;1;GO:0007610
GO:1903142;positive regulation of establishment of endothelial barrier;324;99;GO:0050727
GO:1903143;adrenomedullin receptor complex;164;6;GO:0005576
GO:1903140;regulation of establishment of endothelial barrier;907;100;GO:0050731
GO:1903141;negative regulation of establishment of endothelial barrier;100;4;GO:0050727
GO:1903146;regulation of autophagy of mitochondrion;1588;293;GO:0006914
GO:1903147;negative regulation of autophagy of mitochondrion;314;4;GO:0006914
GO:1903144;actomyosin contractile ring actin filament;20;5;GO:0005524
GO:1903145;actin filament of cell cortex of cell tip;0;1;GO:0009987
GO:0099521;ATPase coupled ion transmembrane transporter activity involved in regulation of presynaptic membrane potential;0;1;GO:0048169
GO:0099522;cytosolic region;1357;2;GO:0005737
GO:0099520;monoatomic ion antiporter activity involved in regulation of presynaptic membrane potential;0;1;GO:0008026
GO:0099525;presynaptic dense core vesicle exocytosis;396;43;GO:0008026
GO:0099526;presynapse to nucleus signaling pathway;76;7;GO:0007268
GO:0099523;presynaptic cytosol;794;31;GO:0005737
GO:0099524;postsynaptic cytosol;563;38;GO:0005667
GO:0099529;neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential;29348;67;GO:0004871
GO:0099527;postsynapse to nucleus signaling pathway;294;28;GO:0048471
GO:0099528;G protein-coupled neurotransmitter receptor activity;10990;104;GO:0004930
GO:0099540;trans-synaptic signaling by neuropeptide;103;8;GO:0007218
GO:0099532;synaptic vesicle endosomal processing;495;6;GO:0007066
GO:0099533;positive regulation of presynaptic cytosolic calcium concentration;16;2;GO:0048608
GO:0099530;G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential;179;9;GO:0007616
GO:0099531;presynaptic process involved in chemical synaptic transmission;0;35;GO:0007268
GO:0099536;synaptic signaling;233845;1490;GO:0007268
GO:0099537;trans-synaptic signaling;220184;674;GO:0007213
GO:0099534;calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration;116;1;GO:0008092
GO:0099535;synapse-associated extracellular matrix;659;3;GO:0031982
GO:0099538;synaptic signaling via neuropeptide;230;8;GO:0007186
GO:0099539;neuropeptide secretion from presynapse;0;0;GO:0008021
GO:1905743;calcium import into the mitochondrion involved in negative regulation of presynaptic cytosolic calcium concentration;0;0;GO:0006836
GO:1905742;Ras guanyl-nucleotide exchange factor complex;18;1;GO:0005524
GO:1905741;calcium export from the mitochondrion involved in positive regulation of presynaptic cytosolic calcium concentration;0;1;GO:0048193
GO:1905747;negative regulation of saliva secretion;96;7;GO:0048608
GO:1905746;positive regulation of mRNA cis splicing, via spliceosome;6;0;GO:0008380
GO:1905745;negative regulation of mRNA cis splicing, via spliceosome;0;1;GO:0003712
GO:1905744;regulation of mRNA cis splicing, via spliceosome;72;2;GO:0008380
GO:1905749;regulation of endosome to plasma membrane protein transport;207;0;GO:0006897
GO:1905748;hard palate morphogenesis;172;4;GO:0009952
GO:0051565;negative regulation of smooth endoplasmic reticulum calcium ion concentration;0;0;GO:0008629
GO:0051566;anthocyanidin-3-glucoside rhamnosyltransferase activity;1;1;GO:0005976
GO:0099500;vesicle fusion to plasma membrane;1217;53;GO:0008021
GO:0051563;smooth endoplasmic reticulum calcium ion homeostasis;129;103;GO:0006836
GO:0051564;positive regulation of smooth endoplasmic reticulum calcium ion concentration;0;0;GO:0048193
GO:0051561;positive regulation of mitochondrial calcium ion concentration;670;592;GO:0048193
GO:0099503;secretory vesicle;69584;628;GO:0005764
GO:0051562;negative regulation of mitochondrial calcium ion concentration;181;10;GO:0048169
GO:0099504;synaptic vesicle cycle;20968;592;GO:0007029
GO:0075530;establishment of latency as a linear episome;0;0;GO:0048608
GO:0099501;exocytic vesicle membrane;16198;81;GO:0005768
GO:0051560;mitochondrial calcium ion homeostasis;16954;289;GO:0006836
GO:0099502;calcium-dependent activation of synaptic vesicle fusion;403;7;GO:0008026
GO:0099507;ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential;831;5;GO:0008026
GO:0099508;voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential;310;9;GO:0048169
GO:0099505;regulation of presynaptic membrane potential;2513;9;GO:0048169
GO:0099506;synaptic vesicle transport along actin filament;0;1;GO:0006936
GO:0051569;regulation of histone H3-K4 methylation;667;735;GO:0045944
GO:0051567;histone H3-K9 methylation;789;1300;GO:0016569
GO:0099509;regulation of presynaptic cytosolic calcium ion concentration;987;93;GO:0048608
GO:0051568;histone H3-K4 methylation;719;1620;GO:0045944
GO:1905750;negative regulation of endosome to plasma membrane protein transport;0;1;GO:0048193
GO:1905754;ascospore-type prospore nucleus;58;2;GO:0048305
GO:1905751;positive regulation of endosome to plasma membrane protein transport;65;1;GO:0048193
GO:1905758;positive regulation of primary cell septum biogenesis;9;2;GO:0048285
GO:0051580;regulation of neurotransmitter uptake;801;906;GO:0006836
GO:1905757;negative regulation of primary cell septum biogenesis;13;1;GO:0048285
GO:1905756;regulation of primary cell septum biogenesis;22;0;GO:0048285
GO:1905755;protein localization to cytoplasmic microtubule;116;0;GO:0005737
GO:1905759;post-anaphase array microtubule;8;3;GO:0048285
GO:0075521;microtubule-dependent intracellular transport of viral material towards nucleus;30403;9;GO:0048193
GO:0099510;calcium ion binding involved in regulation of cytosolic calcium ion concentration;174;1;GO:0005524
GO:0075522;IRES-dependent viral translational initiation;572;62;GO:0006412
GO:0099511;voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels;195;3;GO:0008092
GO:0051574;positive regulation of histone H3-K9 methylation;648;180;GO:0045944
GO:0075523;viral translational frameshifting;88;5;GO:0006414
GO:0051575;5'-deoxyribose-5-phosphate lyase activity;396;10;GO:0006061
GO:0075524;ribosomal skipping;0;2;GO:0006414
GO:0051572;negative regulation of histone H3-K4 methylation;4;45;GO:0045944
GO:0099514;synaptic vesicle cytoskeletal transport;915;96;GO:0006929
GO:0051573;negative regulation of histone H3-K9 methylation;7;383;GO:0045944
GO:0099515;actin filament-based transport;1486;169;GO:0006810
GO:0051570;regulation of histone H3-K9 methylation;762;1270;GO:0045944
GO:0099512;supramolecular fiber;707024;604;GO:0005576
GO:0051571;positive regulation of histone H3-K4 methylation;662;922;GO:0045944
GO:0075520;actin-dependent intracellular transport of virus;9;3;GO:0048193
GO:0099513;polymeric cytoskeletal fiber;641618;433;GO:0015629
GO:0075529;establishment of latency as a circular episome;0;0;GO:0048305
GO:0099518;vesicle cytoskeletal trafficking;3701;135;GO:0006906
GO:0099519;dense core granule cytoskeletal transport;152;7;GO:0005929
GO:0099517;synaptic vesicle transport along microtubule;915;24;GO:0006936
GO:0075525;viral translational termination-reinitiation;274;50;GO:0006415
GO:0075526;cap snatching;253818;7;GO:0002379
GO:0075527;viral RNA editing;0;4;GO:0006418
GO:0075528;perturbation by virus of host immune response;671230;2;GO:0043207
GO:1905761;SCF ubiquitin ligase complex binding;655;0;GO:0005515
GO:1905760;post-anaphase array microtubule end;0;2;GO:0048285
GO:1903102;1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate biosynthetic process;0;1;GO:0006631
GO:1905765;negative regulation of protection from non-homologous end joining at telomere;168;7;GO:0048285
GO:1903103;potassium:proton antiporter complex;8;1;GO:0008023
GO:1905764;regulation of protection from non-homologous end joining at telomere;168;1;GO:0007050
GO:1903100;1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process;58;2;GO:0006631
GO:1905763;MTREC complex binding;0;0;GO:0005515
GO:1903101;1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate catabolic process;0;0;GO:0006631
GO:1905762;CCR4-NOT complex binding;210;5;GO:0005840
GO:0051590;positive regulation of neurotransmitter transport;969;739;GO:0048167
GO:1905769;positive regulation of double-stranded telomeric DNA binding;0;1;GO:0045944
GO:0051591;response to cAMP;2671;3700;GO:0007623
GO:1905768;negative regulation of double-stranded telomeric DNA binding;1;3;GO:0048285
GO:1905767;regulation of double-stranded telomeric DNA binding;1;1;GO:0003677
GO:1905766;positive regulation of protection from non-homologous end joining at telomere;0;0;GO:0048285
GO:1903108;regulation of mitochondrial transcription;335;4;GO:0045944
GO:1903109;positive regulation of mitochondrial transcription;95;2;GO:0045944
GO:0051587;inhibition of dopamine uptake involved in synaptic transmission;0;0;GO:0007601
GO:0051588;regulation of neurotransmitter transport;4503;1240;GO:0006836
GO:0051585;negative regulation of dopamine uptake involved in synaptic transmission;48;98;GO:0048167
GO:0051586;positive regulation of dopamine uptake involved in synaptic transmission;120;47;GO:0048167
GO:0051583;dopamine uptake involved in synaptic transmission;561;67;GO:0007611
GO:0051584;regulation of dopamine uptake involved in synaptic transmission;356;289;GO:0007612
GO:0051581;negative regulation of neurotransmitter uptake;119;10;GO:0048167
GO:0051582;positive regulation of neurotransmitter uptake;252;7;GO:0048167
GO:0051589;negative regulation of neurotransmitter transport;398;7;GO:0048167
GO:1905772;positive regulation of mesodermal cell differentiation;170;3;GO:0045595
GO:1903110;regulation of single-strand break repair via homologous recombination;15;1;GO:0006281
GO:1905771;negative regulation of mesodermal cell differentiation;205;2;GO:0045595
GO:1905770;regulation of mesodermal cell differentiation;732;6;GO:0045595
GO:1903113;copper ion transmembrane transporter complex;0;0;GO:0005576
GO:1905776;positive regulation of DNA helicase activity;2;5;GO:0005524
GO:1903114;silver ion transmembrane transporter complex;0;0;GO:0005576
GO:1905775;negative regulation of DNA helicase activity;1;10;GO:0006350
GO:1903111;negative regulation of single-strand break repair via homologous recombination;0;2;GO:0043161
GO:1905774;regulation of DNA helicase activity;4;3;GO:0003677
GO:1903112;positive regulation of single-strand break repair via homologous recombination;15;0;GO:0043405
GO:1905773;8-hydroxy-2'-deoxyguanosine DNA binding;163;8;GO:0003677
GO:1905779;positive regulation of exonuclease activity;12;3;GO:0003723
GO:1903115;regulation of actin filament-based movement;1614;559;GO:0048608
GO:1905778;negative regulation of exonuclease activity;3;2;GO:0005524
GO:1903116;positive regulation of actin filament-based movement;49;4;GO:0048608
GO:1905777;regulation of exonuclease activity;15;2;GO:0004518
GO:1903119;protein localization to actin cytoskeleton;58;2;GO:0003779
GO:0051598;meiotic recombination checkpoint signaling;450;58;GO:0007050
GO:0051599;response to hydrostatic pressure;225;275;GO:0006950
GO:0051596;methylglyoxal catabolic process;25781;118;GO:0006559
GO:0051597;response to methylmercury;324;509;GO:0042180
GO:0051594;detection of glucose;28;94;GO:0006096
GO:0051595;response to methylglyoxal;1517;9;GO:0046395
GO:0051592;response to calcium ion;8743;3080;GO:0009719
GO:0051593;response to folic acid;393;230;GO:0009719
GO:1903087;mitotic spindle pole body duplication;22;5;GO:0000904
GO:1903088;5-amino-1-ribofuranosylimidazole-4-carboxamide transmembrane transport;6;5;GO:0008565
GO:1903085;regulation of sinapate ester biosynthetic process;5;0;GO:0046274
GO:1903086;negative regulation of sinapate ester biosynthetic process;5;1;GO:0046274
GO:1903089;5-amino-1-ribofuranosylimidazole-4-carboxamide transmembrane transporter activity;3;2;GO:0005215
GO:1903080;regulation of C-C chemokine receptor CCR7 signaling pathway;50;1;GO:0050921
GO:1903083;protein localization to condensed chromosome;6263;1;GO:0007049
GO:1903084;protein localization to condensed nuclear chromosome;0;0;GO:0005829
GO:1903081;negative regulation of C-C chemokine receptor CCR7 signaling pathway;0;0;GO:0045765
GO:1903082;positive regulation of C-C chemokine receptor CCR7 signaling pathway;50;7;GO:0045765
GO:1903096;protein localization to meiotic spindle midzone;50;1;GO:0007062
GO:1903090;pyridoxal transmembrane transport;10;2;GO:0006836
GO:1903091;pyridoxamine transmembrane transport;10;2;GO:0006836
GO:1903094;negative regulation of protein K48-linked deubiquitination;147;55;GO:0016567
GO:1903095;ribonuclease III complex;2177;7;GO:0005576
GO:1903092;pyridoxine transmembrane transport;10;2;GO:0006836
GO:1903093;regulation of protein K48-linked deubiquitination;225;8;GO:0016567
GO:1903043;positive regulation of chondrocyte hypertrophy;47;3;GO:0048608
GO:1903044;protein localization to membrane raft;480;8;GO:0016021
GO:1903041;regulation of chondrocyte hypertrophy;59;0;GO:0048608
GO:1903042;negative regulation of chondrocyte hypertrophy;3;2;GO:0048608
GO:1903047;mitotic cell cycle process;199982;3920;GO:0007049
GO:1903048;regulation of acetylcholine-gated cation channel activity;13;20;GO:0008026
GO:1903045;neural crest cell migration involved in sympathetic nervous system development;5;6;GO:0048704
GO:1903046;meiotic cell cycle process;90387;2550;GO:0000279
GO:1903049;negative regulation of acetylcholine-gated cation channel activity;11;4;GO:0048666
GO:1903040;exon-exon junction complex assembly;12;2;GO:0005618
GO:1903054;negative regulation of extracellular matrix organization;585;26;GO:0032963
GO:1903055;positive regulation of extracellular matrix organization;1331;596;GO:0032989
GO:1903052;positive regulation of proteolysis involved in protein catabolic process;52670;6;GO:0048193
GO:1903053;regulation of extracellular matrix organization;2988;607;GO:0030198
GO:1903058;positive regulation of melanosome organization;0;0;GO:0048193
GO:1903059;regulation of protein lipidation;782;10;GO:0016567
GO:1903056;regulation of melanosome organization;16;159;GO:0048193
GO:1903057;negative regulation of melanosome organization;0;0;GO:0048193
GO:1903050;regulation of proteolysis involved in protein catabolic process;65051;3;GO:0016567
GO:1903051;negative regulation of proteolysis involved in protein catabolic process;3523;7;GO:0010467
GO:1903066;regulation of protein localization to cell tip;14;2;GO:0048471
GO:1903063;negative regulation of reverse cholesterol transport;6;0;GO:0032963
GO:1903064;positive regulation of reverse cholesterol transport;56;0;GO:0032989
GO:1903069;regulation of ER-associated ubiquitin-dependent protein catabolic process;655;8;GO:0006986
GO:1903067;negative regulation of protein localization to cell tip;10;4;GO:0048285
GO:1903068;positive regulation of protein localization to cell tip;3;3;GO:0048285
GO:1903061;positive regulation of protein lipidation;232;100;GO:0016567
GO:1903062;regulation of reverse cholesterol transport;62;0;GO:0045595
GO:1903060;negative regulation of protein lipidation;95;4;GO:0010468
GO:1903076;regulation of protein localization to plasma membrane;7059;455;GO:0048471
GO:1903077;negative regulation of protein localization to plasma membrane;1332;765;GO:0048193
GO:1903074;TRAIL death-inducing signaling complex assembly;0;1;GO:0008631
GO:1903075;pyridoxine import across plasma membrane;0;0;GO:0006836
GO:1903078;positive regulation of protein localization to plasma membrane;4223;937;GO:0048193
GO:1903072;regulation of death-inducing signaling complex assembly;4;1;GO:0043066
GO:1903073;negative regulation of death-inducing signaling complex assembly;4;10;GO:0043066
GO:1903070;negative regulation of ER-associated ubiquitin-dependent protein catabolic process;205;204;GO:0042787
GO:1903071;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;335;189;GO:0042787
GO:0002520;immune system development;107416;2100;GO:0002520
GO:0002510;central B cell tolerance induction;59;3;GO:0002429
GO:0002511;central B cell receptor editing;0;2;GO:0002774
GO:0002512;central T cell tolerance induction;0;3;GO:0002821
GO:0002513;tolerance induction to self antigen;339;255;GO:0002449
GO:0002514;B cell tolerance induction;124;10;GO:0002429
GO:0002515;B cell anergy;0;5;GO:0002449
GO:0002516;B cell deletion;0;5;GO:0002713
GO:0002517;T cell tolerance induction;861;42;GO:0002821
GO:0002518;lymphocyte chemotaxis across high endothelial venule;24;10;GO:0002687
GO:0002519;natural killer cell tolerance induction;147;46;GO:0002821
GO:0002530;regulation of systemic arterial blood pressure involved in acute-phase response;0;6;GO:0002757
GO:0002531;regulation of heart contraction involved in acute-phase response;0;6;GO:0032989
GO:0002521;leukocyte differentiation;127579;1870;GO:0002521
GO:0002522;leukocyte migration involved in immune response;161;51;GO:0002684
GO:0002523;leukocyte migration involved in inflammatory response;932;1380;GO:0002687
GO:0002524;hypersensitivity;635;305;GO:0002237
GO:0002525;acute inflammatory response to non-antigenic stimulus;91;138;GO:0002682
GO:0002526;acute inflammatory response;12196;3600;GO:0006954
GO:0002527;vasodilation involved in acute inflammatory response;0;3;GO:0002687
GO:0002528;regulation of vascular permeability involved in acute inflammatory response;117;218;GO:0002706
GO:0002529;regulation of plasma kallikrein-kinin cascade;0;3;GO:0048193
GO:0002500;proteolysis within lysosome associated with antigen processing and presentation;0;4;GO:0002504
GO:0002501;peptide antigen assembly with MHC protein complex;735;93;GO:0002474
GO:0002502;peptide antigen assembly with MHC class I protein complex;246;22;GO:0002474
GO:0002503;peptide antigen assembly with MHC class II protein complex;489;101;GO:0002474
GO:0002504;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;63379;1170;GO:0002474
GO:0002505;antigen processing and presentation of polysaccharide antigen via MHC class II;47;4;GO:0002474
GO:0002507;tolerance induction;2007;1230;GO:0002821
GO:0002508;central tolerance induction;181;9;GO:0002821
GO:0002509;central tolerance induction to self antigen;63;4;GO:0002429
GO:0002560;basophil mediated immunity;2;3;GO:0002449
GO:0002561;basophil degranulation;2;4;GO:0002576
GO:0002562;somatic diversification of immune receptors via germline recombination within a single locus;95742;192;GO:0002758
GO:0002563;somatic diversification of immune receptors via alternate splicing;0;1;GO:0002768
GO:0002564;alternate splicing of immunoglobulin genes;0;2;GO:0007586
GO:0002554;serotonin secretion by platelet;110;31;GO:0007596
GO:0002555;histamine secretion by platelet;0;3;GO:0002576
GO:0002556;serotonin secretion by basophil;0;2;GO:0002768
GO:0002557;histamine secretion by basophil;0;3;GO:0002768
GO:0002558;type I hypersensitivity mediated by mast cells;0;2;GO:0002526
GO:0002559;type I hypersensitivity mediated by basophils;0;2;GO:0002449
GO:0002570;somatic diversification of immunoglobulin genes by N region addition;0;3;GO:0002774
GO:0002571;somatic diversification of T cell receptor genes by N region addition;0;1;GO:0002776
GO:0002572;pro-T cell differentiation;157;36;GO:0045595
GO:0002573;myeloid leukocyte differentiation;18129;950;GO:0002521
GO:0002574;thrombocyte differentiation;358;9;GO:0002576
GO:0002575;basophil chemotaxis;2;7;GO:0002687
GO:0002565;somatic diversification of immune receptors via gene conversion;3;3;GO:0002757
GO:0002566;somatic diversification of immune receptors via somatic mutation;652;1010;GO:0002713
GO:0002567;somatic diversification of FREP-based immune receptors;0;1;GO:0002757
GO:0002568;somatic diversification of T cell receptor genes;235;7;GO:0002213
GO:0002569;somatic diversification of immune receptors by N region addition;0;2;GO:0002449
GO:0002540;leukotriene production involved in inflammatory response;146;340;GO:0002237
GO:0002541;activation of plasma proteins involved in acute inflammatory response;67;451;GO:0002687
GO:0002542;Factor XII activation;55;20;GO:0007596
GO:0002532;production of molecular mediator involved in inflammatory response;5346;1310;GO:0002526
GO:0002533;lysosomal enzyme secretion involved in inflammatory response;0;2;GO:0006954
GO:0002534;cytokine production involved in inflammatory response;3078;111;GO:0002687
GO:0002536;respiratory burst involved in inflammatory response;341;62;GO:0002684
GO:0002537;nitric oxide production involved in inflammatory response;58;93;GO:0002684
GO:0002538;arachidonic acid metabolite production involved in inflammatory response;148;5;GO:0046649
GO:0002539;prostaglandin production involved in inflammatory response;2;4;GO:0030530
GO:0002550;positive regulation of plasma kallikrein-kinin cascade;0;3;GO:0048193
GO:0002551;mast cell chemotaxis;499;392;GO:0002548
GO:0002552;serotonin secretion by mast cell;57;10;GO:0002504
GO:0002553;histamine secretion by mast cell;412;90;GO:0002504
GO:0002543;activation of blood coagulation via clotting cascade;66;25;GO:0007596
GO:0002544;chronic inflammatory response;859;813;GO:0006954
GO:0002545;chronic inflammatory response to non-antigenic stimulus;39;8;GO:0002682
GO:0002546;negative regulation of tissue kallikrein-kinin cascade;0;3;GO:0048193
GO:0002547;positive regulation of tissue kallikrein-kinin cascade;0;3;GO:0048193
GO:0002548;monocyte chemotaxis;3298;1950;GO:0002548
GO:0002549;negative regulation of plasma kallikrein-kinin cascade;0;3;GO:0048193
GO:0035165;embryonic crystal cell differentiation;35;10;GO:0048608
GO:0060121;vestibular receptor cell stereocilium organization;62;2;GO:0008544
GO:0035166;post-embryonic hemopoiesis;1180;107;GO:0007596
GO:0060122;inner ear receptor cell stereocilium organization;2499;578;GO:0005576
GO:1903880;17alpha-hydroxyprogesterone binding;1;0;GO:0005525
GO:0035167;larval lymph gland hemopoiesis;920;17;GO:0002520
GO:0060123;regulation of growth hormone secretion;543;66;GO:0048608
GO:0035168;larval lymph gland hemocyte differentiation;266;12;GO:0002520
GO:0060124;positive regulation of growth hormone secretion;387;201;GO:0048608
GO:0035161;imaginal disc lineage restriction;14;7;GO:0048608
GO:1901220;negative regulation of cardiac chamber morphogenesis;0;0;GO:0048608
GO:1903883;positive regulation of interleukin-17-mediated signaling pathway;52;4;GO:0050729
GO:2000120;positive regulation of sodium-dependent phosphate transport;102;7;GO:0045765
GO:0035162;embryonic hemopoiesis;6577;938;GO:0007565
GO:1903884;regulation of chemokine (C-C motif) ligand 20 production;52;0;GO:0050729
GO:0035163;embryonic hemocyte differentiation;44;9;GO:0002526
GO:1901222;regulation of non-canonical NF-kappaB signal transduction;6046;6;GO:0030528
GO:1903881;regulation of interleukin-17-mediated signaling pathway;53;1;GO:0050729
GO:0035164;embryonic plasmatocyte differentiation;0;2;GO:0002526
GO:0060120;inner ear receptor cell fate commitment;336;21;GO:0008544
GO:1901221;positive regulation of cardiac chamber morphogenesis;1;0;GO:0048608
GO:1903882;negative regulation of interleukin-17-mediated signaling pathway;1;2;GO:0050729
GO:0060129;thyroid-stimulating hormone-secreting cell differentiation;288;36;GO:0048193
GO:1901224;positive regulation of non-canonical NF-kappaB signal transduction;3351;10;GO:0045944
GO:1901223;negative regulation of non-canonical NF-kappaB signal transduction;1392;5;GO:0045944
GO:1903888;regulation of plant epidermal cell differentiation;34;1;GO:0048316
GO:0047149;thetin-homocysteine S-methyltransferase activity;1;3;GO:0006457
GO:1903885;negative regulation of chemokine (C-C motif) ligand 20 production;0;1;GO:0050729
GO:0035160;maintenance of epithelial integrity, open tracheal system;139;76;GO:0022610
GO:0047148;methylamine-glutamate N-methyltransferase activity;40;4;GO:0004067
GO:1903886;positive regulation of chemokine (C-C motif) ligand 20 production;52;5;GO:0050729
GO:0060125;negative regulation of growth hormone secretion;87;30;GO:0048608
GO:0060126;somatotropin secreting cell differentiation;165;10;GO:0048608
GO:0060127;prolactin secreting cell differentiation;57;78;GO:0048608
GO:1903889;negative regulation of plant epidermal cell differentiation;27;0;GO:0010468
GO:0060128;corticotropin hormone secreting cell differentiation;144;9;GO:0048608
GO:1901229;regulation of non-canonical Wnt signaling pathway via JNK cascade;52;0;GO:0043406
GO:0047154;methylmalonyl-CoA carboxytransferase activity;2020;5;GO:0006099
GO:0050795;regulation of behavior;10783;635;GO:0050789
GO:0047153;deoxycytidylate 5-hydroxymethyltransferase activity;270;3;GO:0004067
GO:0050796;regulation of insulin secretion;8991;2550;GO:0048193
GO:0098730;male germline stem cell symmetric division;85;2;GO:0048608
GO:0047152;methanol-5-hydroxybenzimidazolylcobamide Co-methyltransferase activity;20;4;GO:0006022
GO:0050793;regulation of developmental process;1628569;2970;GO:0032502
GO:2000119;negative regulation of sodium-dependent phosphate transport;57;4;GO:0045765
GO:0047151;methylenetetrahydrofolate-tRNA-(uracil-5-)-methyltransferase (FADH2-oxidizing) activity;30526;0;GO:0003735
GO:0050794;regulation of cellular process;46494769;7990;GO:0050794
GO:2000118;regulation of sodium-dependent phosphate transport;217;162;GO:0045765
GO:0047158;sinapoylglucose-sinapoylglucose O-sinapoyltransferase activity;18;4;GO:0006073
GO:0072103;glomerulus vasculature morphogenesis;226;9;GO:0048771
GO:0098733;hemidesmosome associated protein complex;11;1;GO:0048193
GO:0047157;myelin-proteolipid O-palmitoyltransferase activity;0;2;GO:0004872
GO:0050792;regulation of viral process;38862;818;GO:0016032
GO:0072102;glomerulus morphogenesis;545;99;GO:0048666
GO:0098734;macromolecule depalmitoylation;14865;33;GO:0005576
GO:0047156;acetoin-ribose-5-phosphate transaldolase activity;0;3;GO:0006099
GO:0098731;skeletal muscle satellite stem cell maintenance involved in skeletal muscle regeneration;0;2;GO:0048771
GO:0047155;3-hydroxymethylcephem carbamoyltransferase activity;20;2;GO:0004497
GO:0050790;regulation of catalytic activity;7777;5620;GO:0050789
GO:0072100;specification of ureteric bud anterior/posterior symmetry;0;8;GO:0048704
GO:0098732;macromolecule deacylation;57188;27;GO:0004553
GO:0072107;positive regulation of ureteric bud formation;224;60;GO:0048608
GO:0098737;protein insertion into plasma membrane;44;1;GO:0005886
GO:0072106;regulation of ureteric bud formation;226;5;GO:0048608
GO:0072105;ureteric peristalsis;102;3;GO:0007599
GO:0098735;positive regulation of the force of heart contraction;162;165;GO:0048407
GO:2000111;positive regulation of macrophage apoptotic process;57;25;GO:0043066
GO:0072104;glomerular capillary formation;226;27;GO:0001944
GO:0098736;negative regulation of the force of heart contraction;52;9;GO:0048407
GO:2000110;negative regulation of macrophage apoptotic process;143;62;GO:0043066
GO:0035158;regulation of tube diameter, open tracheal system;153;81;GO:0048646
GO:0047150;betaine-homocysteine S-methyltransferase activity;730;114;GO:0004067
GO:0050799;cocaine biosynthetic process;0;0;GO:0009809
GO:2000117;negative regulation of cysteine-type endopeptidase activity;235;592;GO:0048193
GO:0035159;regulation of tube length, open tracheal system;442;54;GO:0048646
GO:2000116;regulation of cysteine-type endopeptidase activity;975;360;GO:0004867
GO:0050797;thymidylate synthase (FAD) activity;53568;227;GO:0004723
GO:0072109;glomerular mesangium development;547;9;GO:0048771
GO:0098739;import across plasma membrane;533841;73;GO:0009986
GO:2000115;regulation of maintenance of bipolar cell polarity regulating cell shape;0;0;GO:0048608
GO:0050798;activated T cell proliferation;2093;1290;GO:0042127
GO:0072108;positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;133;10;GO:0048704
GO:2000114;regulation of establishment of cell polarity;61966;839;GO:0048608
GO:0035154;terminal cell fate specification, open tracheal system;31;6;GO:0048608
GO:0060110;basal layer of collagen and cuticulin-based cuticle extracellular matrix;0;1;GO:0048407
GO:1903890;positive regulation of plant epidermal cell differentiation;7;0;GO:0046316
GO:0035155;negative regulation of terminal cell fate specification, open tracheal system;24;10;GO:0048704
GO:0060111;alae of collagen and cuticulin-based cuticle extracellular matrix;8;3;GO:0005578
GO:1903891;regulation of ATF6-mediated unfolded protein response;162;3;GO:0034976
GO:0035156;fusion cell fate specification;38;4;GO:0048704
GO:0060112;generation of ovulation cycle rhythm;29;8;GO:0048608
GO:0035157;negative regulation of fusion cell fate specification;27;10;GO:0048706
GO:0060113;inner ear receptor cell differentiation;6241;304;GO:0007601
GO:0035150;regulation of tube size;40497;383;GO:0048608
GO:1901231;positive regulation of non-canonical Wnt signaling pathway via JNK cascade;52;2;GO:0043406
GO:1903894;regulation of IRE1-mediated unfolded protein response;518;27;GO:0034976
GO:2000131;regulation of tyramine signaling pathway;0;0;GO:0043403
GO:0035151;regulation of tube size, open tracheal system;943;78;GO:0048646
GO:1901230;negative regulation of non-canonical Wnt signaling pathway via JNK cascade;0;1;GO:0043406
GO:1903895;negative regulation of IRE1-mediated unfolded protein response;261;126;GO:0034976
GO:2000130;positive regulation of octopamine signaling pathway;24;1;GO:0048608
GO:0035152;regulation of tube architecture, open tracheal system;1575;217;GO:0048608
GO:1901233;negative regulation of convergent extension involved in axis elongation;52;3;GO:0048704
GO:1903892;negative regulation of ATF6-mediated unfolded protein response;113;5;GO:0010468
GO:0035153;epithelial cell type specification, open tracheal system;122;10;GO:0048667
GO:1901232;regulation of convergent extension involved in axis elongation;114;1;GO:0048704
GO:1903893;positive regulation of ATF6-mediated unfolded protein response;48;2;GO:0010468
GO:0060118;vestibular receptor cell development;315;3;GO:0048704
GO:1901235;(R)-carnitine transmembrane transporter activity;1451;0;GO:0005215
GO:1903898;negative regulation of PERK-mediated unfolded protein response;320;31;GO:0034976
GO:0060119;inner ear receptor cell development;4145;322;GO:0007610
GO:1901234;positive regulation of convergent extension involved in axis elongation;0;0;GO:0048704
GO:1903899;positive regulation of PERK-mediated unfolded protein response;210;22;GO:0034976
GO:1903896;positive regulation of IRE1-mediated unfolded protein response;125;60;GO:0034976
GO:0047159;1-alkenylglycerophosphocholine O-acyltransferase activity;80;3;GO:0008631
GO:1901236;4-(trimethylammonio)butanoate transmembrane transporter activity;1283;0;GO:0008544
GO:1903897;regulation of PERK-mediated unfolded protein response;531;7;GO:0034976
GO:0060114;vestibular receptor cell differentiation;315;2;GO:0008544
GO:1901239;malonate(1-) transmembrane transporter activity;2185;0;GO:0005215
GO:0060115;vestibular receptor cell fate commitment;0;1;GO:0048704
GO:1901238;ABC-type tungstate transporter activity;17;5;GO:0005215
GO:0060116;vestibular receptor cell morphogenesis;109;1;GO:0048704
GO:0060117;auditory receptor cell development;1790;44;GO:0008590
GO:0047165;flavonol-3-O-beta-glucoside O-malonyltransferase activity;5;5;GO:0005982
GO:0047164;isoflavone-7-O-beta-glucoside 6''-O-malonyltransferase activity;37;0;GO:0006073
GO:0047163;3,4-dichloroaniline N-malonyltransferase activity;0;2;GO:0006081
GO:0047162;17-O-deacetylvindoline O-acetyltransferase activity;9;2;GO:0004497
GO:2000129;negative regulation of octopamine signaling pathway;0;0;GO:0048608
GO:0047169;galactarate O-hydroxycinnamoyltransferase activity;1;3;GO:0006081
GO:0098744;1-phosphatidylinositol 4-kinase activator activity;1;1;GO:0005524
GO:0047168;isocitrate O-dihydroxycinnamoyltransferase activity;0;2;GO:0006099
GO:0098745;RNA decapping complex;36;2;GO:0005743
GO:0047167;1-alkyl-2-acetylglycerol O-acyltransferase activity;0;2;GO:0008631
GO:0098742;cell-cell adhesion via plasma-membrane adhesion molecules;144450;1200;GO:0007155
GO:0047166;1-alkenylglycerophosphoethanolamine O-acyltransferase activity;60;3;GO:0008610
GO:0098743;cell aggregation;17064;195;GO:0030199
GO:2000124;regulation of endocannabinoid signaling pathway;66;55;GO:0030521
GO:0098749;cerebellar neuron development;157;7;GO:0048699
GO:2000123;positive regulation of stomatal complex development;443;4;GO:0048366
GO:0098746;fast, calcium ion-dependent exocytosis of neurotransmitter;57;43;GO:0007416
GO:2000122;negative regulation of stomatal complex development;43;0;GO:0010468
GO:0098747;slow, calcium ion-dependent exocytosis of neurotransmitter;0;1;GO:0007416
GO:2000121;regulation of removal of superoxide radicals;211;58;GO:0046395
GO:0035147;branch fusion, open tracheal system;358;102;GO:0048706
GO:0047161;tartronate O-hydroxycinnamoyltransferase activity;0;3;GO:0006081
GO:2000128;regulation of octopamine signaling pathway;24;0;GO:0048608
GO:0035148;tube formation;12555;503;GO:0001944
GO:0047160;alkylglycerophosphate 2-O-acetyltransferase activity;0;3;GO:0004073
GO:2000127;positive regulation of octopamine or tyramine signaling pathway;24;0;GO:0048608
GO:0035149;lumen formation, open tracheal system;416;41;GO:0008544
GO:2000126;negative regulation of octopamine or tyramine signaling pathway;0;0;GO:0048608
GO:2000125;regulation of octopamine or tyramine signaling pathway;24;0;GO:0048608
GO:0035143;caudal fin morphogenesis;204;4;GO:0048706
GO:0060143;positive regulation of syncytium formation by plasma membrane fusion;1362;485;GO:0048193
GO:0035144;anal fin morphogenesis;3;2;GO:0048706
GO:0035145;exon-exon junction complex;9595;413;GO:0005615
GO:0035146;tube fusion;359;7;GO:0048193
GO:1901242;ABC-type doxorubicin transporter activity;0;1;GO:0005215
GO:2000142;regulation of DNA-templated transcription initiation;1947721;592;GO:0006355
GO:0060140;modulation by virus of syncytium formation via plasma membrane fusion;231;1;GO:0048193
GO:1901241;4-hydroxyphenylacetate transmembrane transporter activity;1058;9;GO:0005525
GO:2000141;positive regulation of octopamine signaling pathway involved in response to food;0;1;GO:0048608
GO:0035141;medial fin morphogenesis;313;4;GO:0009952
GO:0060141;positive regulation of syncytium formation by virus;231;5;GO:0048608
GO:2000140;negative regulation of octopamine signaling pathway involved in response to food;0;0;GO:0048608
GO:0035142;dorsal fin morphogenesis;1;3;GO:0008544
GO:0060142;regulation of syncytium formation by plasma membrane fusion;1818;625;GO:0048193
GO:1901246;regulation of lung ciliated cell differentiation;115;0;GO:0050730
GO:1901245;positive regulation of toll-like receptor 9 signaling pathway by B cell receptor internalization;0;0;GO:0046649
GO:1901248;positive regulation of lung ciliated cell differentiation;112;4;GO:0048661
GO:1901247;negative regulation of lung ciliated cell differentiation;3;2;GO:0010467
GO:0060147;regulation of post-transcriptional gene silencing;5802;5;GO:0034470
GO:0060148;positive regulation of post-transcriptional gene silencing;940;4;GO:0034470
GO:1901249;regulation of lung goblet cell differentiation;11;2;GO:0050729
GO:0060149;negative regulation of post-transcriptional gene silencing;979;4;GO:0010468
GO:0047176;beta-glucogallin-tetrakisgalloylglucose O-galloyltransferase activity;0;3;GO:0006073
GO:0072121;head kidney maturation;0;1;GO:0048407
GO:0047175;galactosylacylglycerol O-acyltransferase activity;0;3;GO:0008610
GO:0072120;pronephros maturation;0;0;GO:0007565
GO:0047174;putrescine N-hydroxycinnamoyltransferase activity;0;2;GO:0004725
GO:0047173;phosphatidylcholine-retinol O-acyltransferase activity;1196;7;GO:0008610
GO:0072125;negative regulation of glomerular mesangial cell proliferation;144;10;GO:0048193
GO:0098711;iron ion import across plasma membrane;291;27;GO:0006826
GO:0047179;platelet-activating factor acetyltransferase activity;171;38;GO:0004041
GO:0072124;regulation of glomerular mesangial cell proliferation;287;16;GO:0048010
GO:0098712;L-glutamate import across plasma membrane;1052;223;GO:0006836
GO:0047178;glycerophospholipid acyltransferase (CoA-dependent) activity;1;2;GO:0008610
GO:0072123;intraglomerular mesangial cell proliferation;0;0;GO:0048193
GO:0047177;glycerophospholipid arachidonoyl-transferase (CoA-independent) activity;0;2;GO:0008610
GO:0072122;extraglomerular mesangial cell proliferation;0;3;GO:0048608
GO:0098710;guanine import across plasma membrane;38;4;GO:0006865
GO:0072129;renal capsule formation;25;0;GO:0048193
GO:0098715;malonic acid import across plasma membrane;4;1;GO:0006836
GO:0072128;renal capsule morphogenesis;25;1;GO:0048608
GO:0098716;nickel cation import across plasma membrane;8;0;GO:0006826
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;3546;1350;GO:0051726
GO:0072127;renal capsule development;50;4;GO:0048608
GO:0098713;leucine import across plasma membrane;542;5;GO:0006810
GO:2000133;positive regulation of tyramine signaling pathway;0;0;GO:0043408
GO:0072126;positive regulation of glomerular mesangial cell proliferation;137;26;GO:0048010
GO:0098714;malate import across plasma membrane;6;1;GO:0006836
GO:2000132;negative regulation of tyramine signaling pathway;0;0;GO:0048608
GO:0035136;forelimb morphogenesis;2359;427;GO:0009952
GO:0047172;shikimate O-hydroxycinnamoyltransferase activity;238;7;GO:0006073
GO:0098719;sodium ion import across plasma membrane;1578;352;GO:0006836
GO:2000139;regulation of octopamine signaling pathway involved in response to food;0;1;GO:0048608
GO:0035137;hindlimb morphogenesis;2151;383;GO:0048704
GO:0047171;glucarolactone O-hydroxycinnamoyltransferase activity;0;2;GO:0006081
GO:2000138;positive regulation of cell proliferation involved in heart morphogenesis;281;216;GO:0048608
GO:0035138;pectoral fin morphogenesis;691;7;GO:0048608
GO:0047170;glucarate O-hydroxycinnamoyltransferase activity;1;3;GO:0006081
GO:0098717;pantothenate import across plasma membrane;55;0;GO:0006836
GO:2000137;negative regulation of cell proliferation involved in heart morphogenesis;158;14;GO:0048608
GO:0035139;pelvic fin morphogenesis;40;2;GO:0048706
GO:0098718;serine import across plasma membrane;130;2;GO:0006836
GO:2000136;regulation of cell proliferation involved in heart morphogenesis;1035;7;GO:0048608
GO:0035132;post-embryonic medial fin morphogenesis;0;1;GO:0048608
GO:0060132;prolactin secreting cell development;0;1;GO:0048608
GO:0035133;post-embryonic caudal fin morphogenesis;0;1;GO:0048608
GO:0060133;somatotropin secreting cell development;54;276;GO:0048608
GO:0035134;post-embryonic dorsal fin morphogenesis;0;2;GO:0048608
GO:0060134;prepulse inhibition;405;1060;GO:0007610
GO:1901251;positive regulation of lung goblet cell differentiation;1;2;GO:0050729
GO:0035135;post-embryonic anal fin morphogenesis;0;1;GO:0048706
GO:0060135;maternal process involved in female pregnancy;1971;456;GO:0007565
GO:1901250;negative regulation of lung goblet cell differentiation;4;3;GO:0050729
GO:1901253;negative regulation of intracellular transport of viral material;69;10;GO:0048193
GO:1901252;regulation of intracellular transport of viral material;122;9;GO:0016021
GO:2000152;regulation of ubiquitin-specific protease activity;8;5;GO:0004842
GO:0035130;post-embryonic pectoral fin morphogenesis;0;2;GO:0048608
GO:0060130;thyroid-stimulating hormone-secreting cell development;0;2;GO:0048608
GO:1901255;nucleotide-excision repair involved in interstrand cross-link repair;310;7;GO:0006281
GO:2000151;negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis;2;2;GO:0048704
GO:0035131;post-embryonic pelvic fin morphogenesis;0;2;GO:0048706
GO:0060131;corticotropin hormone secreting cell development;0;0;GO:0048608
GO:1901254;positive regulation of intracellular transport of viral material;53;8;GO:0048193
GO:2000150;regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis;2;1;GO:0048704
GO:1901257;negative regulation of macrophage colony-stimulating factor production;43;1;GO:0048169
GO:0038066;p38MAPK cascade;5374;172;GO:0007165
GO:0038065;collagen-activated signaling pathway;3949;187;GO:0007179
GO:0038062;protein tyrosine kinase collagen receptor activity;221;283;GO:0004713
GO:0038061;non-canonical NF-kappaB signal transduction;7612;6;GO:0043409
GO:0038064;collagen receptor activity;397;31;GO:0004872
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;3482;597;GO:0007169
GO:0038060;nitric oxide-cGMP-mediated signaling pathway;244;90;GO:0007186
GO:0038059;IKKalpha-IKKalpha complex;0;0;GO:0043408
GO:0038058;TNFSF11 receptor activity;0;1;GO:0004896
GO:0038055;BMP secretion;62;2;GO:0007518
GO:1905402;regulation of activated CD8-positive, alpha-beta T cell apoptotic process;164;3;GO:0043066
GO:0038054;G protein-coupled estrogen receptor activity;49;3;GO:0004930
GO:1905401;positive regulation of activated CD4-positive, alpha-beta T cell apoptotic process;0;0;GO:0043066
GO:0038057;TNFSF11 binding;0;0;GO:0048308
GO:1905400;negative regulation of activated CD4-positive, alpha-beta T cell apoptotic process;0;4;GO:0043066
GO:1905406;positive regulation of mitotic cohesin loading;1;2;GO:0048285
GO:1905405;regulation of mitotic cohesin loading;10;1;GO:0048285
GO:1905404;positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process;52;3;GO:0043066
GO:1905403;negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process;112;6;GO:0043066
GO:1905409;positive regulation of creatine transmembrane transporter activity;0;0;GO:0010468
GO:1905408;negative regulation of creatine transmembrane transporter activity;2;0;GO:0010468
GO:1905407;regulation of creatine transmembrane transporter activity;2;1;GO:0005215
GO:0038048;dynorphin receptor activity;744;8;GO:0004866
GO:0038047;morphine receptor activity;83;10;GO:0004872
GO:1905413;regulation of dense core granule exocytosis;225;2;GO:0048608
GO:0038043;interleukin-5-mediated signaling pathway;372;27;GO:0007186
GO:1905412;negative regulation of mitotic cohesin loading;9;1;GO:0048285
GO:0038046;G protein-coupled enkephalin receptor activity;689;4;GO:0004930
GO:1905411;positive regulation of mitotic cohesin unloading;0;0;GO:0048285
GO:0038045;large latent transforming growth factor-beta complex;2;8;GO:0048407
GO:1905410;regulation of mitotic cohesin unloading;0;1;GO:0048285
GO:1905417;negative regulation of amoeboid sperm motility;0;1;GO:0048193
GO:1905416;regulation of amoeboid sperm motility;7;0;GO:0048608
GO:1905415;positive regulation of dense core granule exocytosis;15;1;GO:0048193
GO:0038041;cross-receptor inhibition within G protein-coupled receptor heterodimer;2;7;GO:0004872
GO:1905414;negative regulation of dense core granule exocytosis;3;0;GO:0048193
GO:1905418;positive regulation of amoeboid sperm motility;7;1;GO:0048193
GO:1905387;response to beta-carotene;0;0;GO:0009813
GO:1905386;positive regulation of protein localization to presynapse;3;2;GO:0048169
GO:0090577;RNA polymerase IV transcription regulator complex;1;1;GO:0000976
GO:1905385;negative regulation of protein localization to presynapse;0;2;GO:0048608
GO:0090578;RNA polymerase V transcription regulator complex;0;1;GO:0003700
GO:1905384;regulation of protein localization to presynapse;3;1;GO:0048608
GO:0090575;RNA polymerase II transcription regulator complex;139748;627;GO:0000976
GO:0090576;RNA polymerase III transcription regulator complex;12638;2;GO:0000976
GO:0090573;RNA polymerase IV transcription repressor complex;0;2;GO:0000976
GO:1905389;response to leukotriene B4;0;0;GO:0002237
GO:0090574;RNA polymerase V transcription repressor complex;0;2;GO:0000976
GO:1905388;cellular response to beta-carotene;0;0;GO:0071346
GO:0090571;RNA polymerase II transcription repressor complex;5238;61;GO:0000976
GO:0090572;RNA polymerase III transcription repressor complex;0;1;GO:0000976
GO:0090570;RNA polymerase I transcription repressor complex;0;2;GO:0000976
GO:1905383;protein localization to presynapse;187;5;GO:0048169
GO:1905382;positive regulation of snRNA transcription by RNA polymerase II;201;6;GO:0045944
GO:1905381;negative regulation of snRNA transcription by RNA polymerase II;53;1;GO:0045944
GO:1905380;regulation of snRNA transcription by RNA polymerase II;254;1;GO:0006351
GO:1905398;activated CD4-positive, alpha-beta T cell apoptotic process;2;0;GO:0043066
GO:1905397;activated CD8-positive, alpha-beta T cell apoptotic process;164;1;GO:0042981
GO:0090588;protein-phosphocysteine-N-acetylmuramate phosphotransferase system transporter activity;8;0;GO:0008565
GO:1905396;cellular response to flavonoid;63;0;GO:0046340
GO:0090589;protein-phosphocysteine-trehalose phosphotransferase system transporter activity;26;2;GO:0008565
GO:1905395;response to flavonoid;95;3;GO:0009813
GO:0090586;protein-phosphocysteine-N-acetylglucosamine phosphotransferase system transporter activity;2;0;GO:0008565
GO:0090587;protein-phosphocysteine-glucosamine phosphotransferase system transporter activity;0;0;GO:0008565
GO:0090584;protein-phosphocysteine-galactitol-phosphotransferase system transporter activity;4;1;GO:0008544
GO:0090585;protein-phosphocysteine-L-ascorbate-phosphotransferase system transporter activity;4;1;GO:0008544
GO:1905399;regulation of activated CD4-positive, alpha-beta T cell apoptotic process;2;4;GO:0043066
GO:0090582;protein-phosphocysteine-D-fructose-phosphotransferase system transporter activity;16;3;GO:0008565
GO:0090583;protein-phosphocysteine-D-sorbitol-phosphotransferase system transporter activity;0;1;GO:0008544
GO:0090580;phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands;93;0;GO:0004518
GO:0090581;protein-phosphocysteine-mannosylglycerate-phosphotransferase system transporter activity;1;0;GO:0008565
GO:1905390;cellular response to leukotriene B4;0;0;GO:0006954
GO:1905394;retromer complex binding;426;15;GO:0005576
GO:1905393;plant organ formation;2457;47;GO:0048468
GO:1905392;plant organ morphogenesis;11587;139;GO:0048468
GO:1905391;regulation of protein localization to cell division site involved in cell separation after cytokinesis;4;1;GO:0007049
GO:0090557;establishment of endothelial intestinal barrier;401;99;GO:0009986
GO:0090558;plant epidermis development;20731;187;GO:0009908
GO:0090555;phosphatidylethanolamine flippase activity;4746;8;GO:0005525
GO:0090556;phosphatidylserine floppase activity;164;5;GO:0005525
GO:0090553;unicellular trichome tip;0;1;GO:0048305
GO:0090554;phosphatidylcholine floppase activity;325;9;GO:0005525
GO:0090551;response to manganese starvation;0;0;GO:0009739
GO:0090552;unicellular trichome apex;0;2;GO:0048305
GO:0090550;response to molybdenum starvation;0;1;GO:0046395
GO:0090559;regulation of membrane permeability;4217;273;GO:0016021
GO:0090566;protein-phosphocysteine-N,N'-diacetylchitobiose phosphotransferase system transporter activity;6;0;GO:0008565
GO:0090567;reproductive shoot system development;27132;232;GO:0048468
GO:0090564;protein-phosphocysteine-glucose phosphotransferase system transporter activity;8;3;GO:0008544
GO:0090565;protein-phosphocysteine-mannitol phosphotransferase system transporter activity;2;2;GO:0005525
GO:0090562;protein-N(PI)-phosphohistidine-N,N'-diacetylchitobiose phosphotransferase system transporter activity;0;0;GO:0008565
GO:0090563;protein-phosphocysteine-sugar phosphotransferase activity;166;8;GO:0005524
GO:0090560;2-(3-amino-3-carboxypropyl)histidine synthase activity;26564;0;GO:0006066
GO:0090561;nuclear migration during mitotic telophase;16;1;GO:0007067
GO:0090535;WICH complex;1824;2;GO:0005515
GO:1905343;regulation of cohesin unloading;0;0;GO:0048285
GO:0090536;NoRC complex;57;1;GO:0005819
GO:1905342;positive regulation of protein localization to kinetochore;165;6;GO:0048285
GO:0090533;cation-transporting ATPase complex;7984;140;GO:0008026
GO:1905341;negative regulation of protein localization to kinetochore;11;3;GO:0048285
GO:0090534;calcium ion-transporting ATPase complex;62;7;GO:0008047
GO:1905340;regulation of protein localization to kinetochore;176;3;GO:0048285
GO:0090531;L-ascorbic acid biosynthetic process via GDP-alpha-D-mannose;0;0;GO:0006022
GO:1905347;endodeoxyribonuclease complex;282336;4;GO:0005576
GO:0090532;L-ascorbic acid biosynthetic process via UDP-alpha-D-glucuronate;0;1;GO:0006096
GO:1905346;protein localization to cleavage furrow rim;0;0;GO:0007067
GO:1905345;protein localization to cleavage furrow;42;0;GO:0007067
GO:1905344;prostaglandin catabolic process;264;5;GO:0007596
GO:1905349;ciliary transition zone assembly;107;8;GO:0048704
GO:1905348;endonuclease complex;442203;20;GO:0003676
GO:0090539;peptide pheromone export by transmembrane transport;2;0;GO:0008544
GO:0090537;CERF complex;1634;49;GO:0005829
GO:0090538;peptide pheromone secretion;0;0;GO:0005576
GO:0090546;chlorophyll fluorescence;0;1;GO:0009579
GO:1905354;exoribonuclease complex;75127;8;GO:0005737
GO:0090547;response to low humidity;26;0;GO:0009415
GO:1905353;ciliary transition fiber assembly;0;0;GO:0005576
GO:1905352;ciliary necklace assembly;0;0;GO:0048706
GO:0090545;CHD-type complex;3414;116;GO:0005576
GO:1905351;pericyte cell migration;5;1;GO:0030900
GO:0090542;ELYC domain binding;0;1;GO:0005515
GO:1905358;positive regulation of snRNA pseudouridine synthesis;0;1;GO:0010467
GO:0090543;Flemming body;1885;432;GO:0005829
GO:1905357;negative regulation of snRNA pseudouridine synthesis;0;1;GO:0010467
GO:0090540;bacterial cellulose biosynthetic process;3;1;GO:0009405
GO:1905356;regulation of snRNA pseudouridine synthesis;5;3;GO:0010467
GO:0090541;MIT domain binding;129;37;GO:0005515
GO:1905355;spine apparatus assembly;15;2;GO:0048704
GO:1905359;protein localization to meiotic spindle;50;0;GO:0051321
GO:1905350;Y-shaped link assembly;1;0;GO:0048285
GO:0090548;response to nitrate starvation;68;5;GO:0046274
GO:0090549;response to carbon starvation;41;3;GO:0006950
GO:0090513;L-histidine transmembrane import into vacuole;57;1;GO:0005576
GO:1905365;regulation of intralumenal vesicle formation;45;1;GO:0008030
GO:0090514;L-tyrosine transmembrane import into vacuole;54;0;GO:0005576
GO:1905364;regulation of endosomal vesicle fusion;57;5;GO:0006906
GO:0090511;periclinal cell division;0;1;GO:0048285
GO:1905363;positive regulation of endosomal vesicle fusion;0;0;GO:0048193
GO:0090512;eisosome membrane domain/MCC;9;2;GO:0005737
GO:1905362;negative regulation of endosomal vesicle fusion;2;0;GO:0048193
GO:1905369;endopeptidase complex;599519;156;GO:0005576
GO:0090510;anticlinal cell division;0;0;GO:0048285
GO:1905368;peptidase complex;649644;267;GO:0005576
GO:1905367;positive regulation of intralumenal vesicle formation;0;0;GO:0048193
GO:1905366;negative regulation of intralumenal vesicle formation;45;5;GO:0048193
GO:0090519;anoxia protection;0;0;GO:0006979
GO:0090517;L-lysine transmembrane import into vacuole;119;1;GO:0005576
GO:0090518;L-arginine transmembrane import into vacuole;57;1;GO:0006836
GO:1905360;GTPase complex;18270;156;GO:0005840
GO:0090515;L-glutamate transmembrane import into vacuole;54;0;GO:0006836
GO:0090516;L-serine transmembrane import into vacuole;54;0;GO:0006836
GO:0090524;cytochrome-b5 reductase activity, acting on NADH;0;0;GO:0004091
GO:1905376;negative regulation of cytochrome-c oxidase activity;0;1;GO:0048167
GO:1905375;cellular response to homocysteine;1;0;GO:0071356
GO:0090522;vesicle tethering involved in exocytosis;20175;27;GO:0008092
GO:1905374;response to homocysteine;1;0;GO:0042303
GO:0090523;cytochrome-b5 reductase activity, acting on NADPH;0;1;GO:0004091
GO:1905373;ceramide phosphoethanolamine biosynthetic process;132;5;GO:0006631
GO:0090520;sphingolipid mediated signaling pathway;8301;86;GO:0007267
GO:0090521;podocyte cell migration;425;8;GO:0030900
GO:1905379;beta-N-acetylhexosaminidase complex;118;10;GO:0005975
GO:1905378;cellular response to D-galactose;0;0;GO:0009719
GO:1905377;response to D-galactose;2;2;GO:0009719
GO:0090528;smooth septate junction assembly;32;3;GO:0008544
GO:1905372;ceramide phosphoethanolamine catabolic process;0;0;GO:0009062
GO:0090529;cell septum assembly;375737;256;GO:0007067
GO:1905371;ceramide phosphoethanolamine metabolic process;132;3;GO:0006631
GO:1905370;serine-type endopeptidase complex;452;10;GO:0005576
GO:0016601;Rac protein signal transduction;2151;790;GO:0007165
GO:0016602;CCAAT-binding factor complex;14017;476;GO:0003700
GO:0016603;glutaminyl-peptide cyclotransferase activity;16958;45;GO:0006029
GO:0016604;nuclear body;109184;3980;GO:0005634
GO:0016605;PML body;16118;2630;GO:0031424
GO:0016606;LYSP100-associated nuclear domain;0;3;GO:0005634
GO:0016607;nuclear speck;54154;4960;GO:0005829
GO:0016608;growth hormone-releasing hormone activity;1181;24;GO:0004966
GO:0004621;glycosylphosphatidylinositol phospholipase D activity;1248;14;GO:0008021
GO:0004620;phospholipase activity;339345;1150;GO:0004601
GO:0004612;phosphoenolpyruvate carboxykinase (ATP) activity;83297;272;GO:0006099
GO:0004611;phosphoenolpyruvate carboxykinase activity;294965;686;GO:0006099
GO:0004614;phosphoglucomutase activity;39588;342;GO:0005524
GO:0004613;phosphoenolpyruvate carboxykinase (GTP) activity;48101;97;GO:0006099
GO:0004616;phosphogluconate dehydrogenase (decarboxylating) activity;85318;1120;GO:0006096
GO:0004615;phosphomannomutase activity;21565;183;GO:0008869
GO:0004618;phosphoglycerate kinase activity;185611;777;GO:0003824
GO:0004617;phosphoglycerate dehydrogenase activity;71797;303;GO:0006096
GO:0004619;phosphoglycerate mutase activity;180130;1100;GO:0006096
GO:0016610;nitrogenase complex;5698;5;GO:0009536
GO:0016611;iron-iron nitrogenase complex;0;6;GO:0009536
GO:0004630;phospholipase D activity;31683;592;GO:0004626
GO:0004632;phosphopantothenate--cysteine ligase activity;131896;2;GO:0006457
GO:0004631;phosphomevalonate kinase activity;10486;119;GO:0004721
GO:0004623;phospholipase A2 activity;52444;1170;GO:0004601
GO:0004622;lysophospholipase activity;22012;644;GO:0004734
GO:0004629;phospholipase C activity;102826;1840;GO:0004626
GO:0016600;flotillin complex;1033;931;GO:0005829
GO:0090599;alpha-glucosidase activity;51433;86;GO:0005975
GO:0090597;nematode male tail mating organ morphogenesis;136;2;GO:0048608
GO:0090598;male anatomical structure morphogenesis;1079;9;GO:0048608
GO:0090595;acetyl-CoA:L-lysine N6-acetyltransferase;0;1;GO:0009065
GO:0090596;sensory organ morphogenesis;35659;299;GO:0009952
GO:0090593;peptidyl-histidine autophosphorylation;0;3;GO:0004672
GO:0090594;inflammatory response to wounding;1851;116;GO:0009611
GO:0090591;protein-N(PI)-phosphohistidine-N-acetyl-mannosamine phosphotransferase system transporter activity;0;0;GO:0008565
GO:0090592;DNA synthesis involved in DNA replication;94;3;GO:0006260
GO:0090590;protein-N(PI)-phosphohistidine-D-glucosamine phosphotransferase system transporter activity;0;0;GO:0008565
GO:0004610;phosphoacetylglucosamine mutase activity;10415;159;GO:0006032
GO:0004601;peroxidase activity;1135302;6820;GO:0004601
GO:0004603;phenylethanolamine N-methyltransferase activity;146;14;GO:0004465
GO:0004602;glutathione peroxidase activity;55274;1540;GO:0004601
GO:0004605;phosphatidate cytidylyltransferase activity;75945;568;GO:0004734
GO:0004604;phosphoadenylyl-sulfate reductase (thioredoxin) activity;62912;87;GO:0004723
GO:0004607;phosphatidylcholine-sterol O-acyltransferase activity;374;138;GO:0008610
GO:0004609;phosphatidylserine decarboxylase activity;118301;456;GO:0004722
GO:0004608;phosphatidylethanolamine N-methyltransferase activity;7880;160;GO:0004734
GO:0016767;geranylgeranyl-diphosphate geranylgeranyltransferase activity;9581;19;GO:0003906
GO:0016768;spermine synthase activity;1608;61;GO:0004033
GO:0016769;transferase activity, transferring nitrogenous groups;2675112;735;GO:0003824
GO:0004780;sulfate adenylyltransferase (ADP) activity;37;4;GO:0004734
GO:0004782;sulfinoalanine decarboxylase activity;105;39;GO:0009065
GO:0004781;sulfate adenylyltransferase (ATP) activity;139394;609;GO:0003824
GO:0002121;inter-male aggressive behavior;236;114;GO:0050921
GO:0004784;superoxide dismutase activity;164508;1640;GO:0004784
GO:0002122;fear-induced aggressive behavior;0;4;GO:0007610
GO:0004783;sulfite reductase (NADPH) activity;34280;169;GO:0004067
GO:0002123;irritable aggressive behavior;0;4;GO:0007610
GO:0002124;territorial aggressive behavior;4;8;GO:0048608
GO:0002114;interleukin-33 receptor activity;95;21;GO:0005125
GO:0004777;succinate-semialdehyde dehydrogenase (NAD+) activity;6219;0;GO:0004073
GO:0002115;store-operated calcium entry;3630;329;GO:0006873
GO:0004776;succinate-CoA ligase (GDP-forming) activity;45396;38;GO:0006099
GO:0002116;semaphorin receptor complex;260;138;GO:0008021
GO:0004779;sulfate adenylyltransferase activity;139432;38;GO:0004734
GO:0002117;amphibian larval development;0;4;GO:0008565
GO:0004778;succinyl-CoA hydrolase activity;45;7;GO:0004721
GO:0002118;aggressive behavior;440;472;GO:0007626
GO:0002119;nematode larval development;3447;550;GO:0007548
GO:0016772;transferase activity, transferring phosphorus-containing groups;33901399;5080;GO:0008528
GO:0016773;phosphotransferase activity, alcohol group as acceptor;10709758;5160;GO:0016772
GO:0016774;phosphotransferase activity, carboxyl group as acceptor;842527;88;GO:0016791
GO:0016775;phosphotransferase activity, nitrogenous group as acceptor;2556442;278;GO:0004725
GO:0016776;phosphotransferase activity, phosphate group as acceptor;1514153;786;GO:0016791
GO:0016755;aminoacyltransferase activity;932438;10;GO:0006413
GO:0016756;glutathione gamma-glutamylcysteinyltransferase activity;5585;27;GO:0004364
GO:0016757;glycosyltransferase activity;7650784;3460;GO:0004553
GO:0016758;hexosyltransferase activity;2047635;525;GO:0004553
GO:0016759;cellulose synthase activity;38038;311;GO:0004553
GO:0004791;thioredoxin-disulfide reductase (NADP) activity;204704;155;GO:0004747
GO:0004790;thioether S-methyltransferase activity;19;5;GO:0004784
GO:0002130;wobble position ribose methylation;327;10;GO:0097194
GO:0004793;threonine aldolase activity;18203;43;GO:0006073
GO:0002131;wobble position cytosine ribose methylation;74;2;GO:0004518
GO:0004792;thiosulfate sulfurtransferase activity;79669;348;GO:0004734
GO:0002132;wobble position uridine ribose methylation;69;3;GO:0045944
GO:0004795;threonine synthase activity;64075;469;GO:0006468
GO:0002133;polycystin complex;157;48;GO:0005576
GO:0004794;L-threonine ammonia-lyase activity;124073;628;GO:0009061
GO:0002134;UTP binding;845;111;GO:0005524
GO:0004797;thymidine kinase activity;89735;458;GO:0004721
GO:0002135;CTP binding;30;30;GO:0005524
GO:0004796;thromboxane-A synthase activity;193;52;GO:0004722
GO:0002125;maternal aggressive behavior;19;47;GO:0007586
GO:0004788;thiamine diphosphokinase activity;53372;179;GO:0004721
GO:0002126;instrumental aggressive behavior;0;4;GO:0007610
GO:0004787;thiamine diphosphate phosphatase activity;6846;2;GO:0004723
GO:0002127;tRNA wobble base cytosine methylation;108;4;GO:0006519
GO:0002128;tRNA nucleoside ribose methylation;14140;68;GO:0009063
GO:0004789;thiamine-phosphate diphosphorylase activity;127775;290;GO:0006066
GO:0002129;wobble position guanine ribose methylation;5;3;GO:0045944
GO:0016760;cellulose synthase (UDP-forming) activity;30887;653;GO:0004553
GO:0016761;cellulose synthase (GDP-forming) activity;0;4;GO:0004553
GO:0016762;xyloglucan:xyloglucosyl transferase activity;17696;1520;GO:0004553
GO:0016763;pentosyltransferase activity;2254695;616;GO:0006022
GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;3316624;1970;GO:0016746
GO:0016744;transketolase or transaldolase activity;779485;7;GO:0006096
GO:0016746;acyltransferase activity;9882197;2890;GO:0004089
GO:0016747;acyltransferase activity, transferring groups other than amino-acyl groups;5171504;948;GO:0004041
GO:0016748;succinyltransferase activity;232342;8;GO:0004721
GO:0016749;N-succinyltransferase activity;110653;8;GO:0004721
GO:0004760;serine-pyruvate transaminase activity;1817;25;GO:0004089
GO:0002100;tRNA wobble adenosine to inosine editing;80980;245;GO:0009061
GO:0002101;tRNA wobble cytosine modification;12717;76;GO:0006519
GO:0004764;shikimate 3-dehydrogenase (NADP+) activity;163390;0;GO:0006099
GO:0002102;podosome;4944;1510;GO:0030198
GO:0004755;saccharopine dehydrogenase (NADP+, L-glutamate-forming) activity;122;9;GO:0009065
GO:0004754;saccharopine dehydrogenase (NAD+, L-lysine-forming) activity;8847;7;GO:0009065
GO:0004757;sepiapterin reductase activity;1994;18;GO:0004067
GO:0004756;selenide, water dikinase activity;52496;133;GO:0004730
GO:0004758;serine C-palmitoyltransferase activity;1720;266;GO:0004722
GO:0016750;O-succinyltransferase activity;39109;3;GO:0004723
GO:0016751;S-succinyltransferase activity;82579;2;GO:0004723
GO:0016752;sinapoyltransferase activity;33;1;GO:0004497
GO:0016753;O-sinapoyltransferase activity;31;1;GO:0008061
GO:0016754;sinapoylglucose-malate O-sinapoyltransferase activity;4;5;GO:0006073
GO:0016737;oxidoreductase activity, acting on reduced flavodoxin as donor;1;2;GO:0003954
GO:0016738;oxidoreductase activity, acting on reduced flavodoxin as donor, dinitrogen as acceptor;1;1;GO:0003824
GO:0004771;sterol esterase activity;438;143;GO:0004746
GO:0002110;cotranscriptional mitochondrial rRNA nucleotide insertion;0;3;GO:0006091
GO:0004773;steryl-sulfatase activity;70;5;GO:0004721
GO:0002111;BRCA2-BRAF35 complex;1;5;GO:0005515
GO:0004772;sterol O-acyltransferase activity;1657;105;GO:0004714
GO:0002112;interleukin-33 receptor binding;26;3;GO:0005125
GO:0004775;succinate-CoA ligase (ADP-forming) activity;181511;254;GO:0006099
GO:0002113;interleukin-33 binding;56;91;GO:0042592
GO:0004774;succinate-CoA ligase activity;226924;91;GO:0006094
GO:0002103;endonucleolytic cleavage of tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA);1;3;GO:0006364
GO:0004766;spermidine synthase activity;53212;233;GO:0004497
GO:0002104;endonucleolytic cleaveage between 4.5S rRNA and 5S rRNA of tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA);0;3;GO:0003735
GO:0004765;shikimate kinase activity;153501;181;GO:0004721
GO:0002105;endonucleolytic cleaveage between LSU-rRNA and 4.5S rRNA of tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA);0;3;GO:0003735
GO:0004768;stearoyl-CoA 9-desaturase activity;9211;366;GO:0006631
GO:0002106;endonucleolytic cleaveage between SSU-rRNA and LSU-rRNA of tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA);0;3;GO:0006364
GO:0004767;sphingomyelin phosphodiesterase activity;22731;461;GO:0008030
GO:0002107;generation of mature 3'-end of 5S rRNA generated by RNA polymerase III;4;0;GO:0006032
GO:0002108;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA,5S);0;3;GO:0006412
GO:0004769;steroid delta-isomerase activity;628;83;GO:0004722
GO:0002109;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA,5S);3;7;GO:0006470
GO:0016740;transferase activity;97054567;23800;GO:0016740
GO:0016741;transferase activity, transferring one-carbon groups;13936422;902;GO:0003824
GO:0016742;hydroxymethyl-, formyl- and related transferase activity;953704;844;GO:0004497
GO:0016743;carboxyl- or carbamoyltransferase activity;580799;205;GO:0004061
GO:0038114;interleukin-21-mediated signaling pathway;2;113;GO:0007186
GO:0038113;interleukin-9-mediated signaling pathway;425;262;GO:0007186
GO:0038116;chemokine (C-C motif) ligand 21 signaling pathway;218;5;GO:0007186
GO:0038115;chemokine (C-C motif) ligand 19 signaling pathway;160;2;GO:0007186
GO:0038110;interleukin-2-mediated signaling pathway;1908;327;GO:0007249
GO:0038112;interleukin-8-mediated signaling pathway;89;75;GO:0007186
GO:0002160;desmosome maintenance;0;3;GO:0007030
GO:0038111;interleukin-7-mediated signaling pathway;4;530;GO:0007249
GO:0002161;aminoacyl-tRNA editing activity;556342;1380;GO:0006470
GO:0002162;dystroglycan binding;389;288;GO:0005576
GO:0002164;larval development;6112;182;GO:0007631
GO:0002165;instar larval or pupal development;9951;169;GO:0048608
GO:0002167;VRK3/VHR/ERK complex;0;2;GO:0005515
GO:0002168;instar larval development;885;103;GO:0048608
GO:0002158;osteoclast proliferation;469;40;GO:0048193
GO:0002159;desmosome assembly;293;59;GO:0005929
GO:0038106;choriogonadotropin hormone binding;56;1;GO:0005520
GO:0038109;Kit signaling pathway;2001;235;GO:0007186
GO:0038108;negative regulation of appetite by leptin-mediated signaling pathway;211;36;GO:0048608
GO:0016799;hydrolase activity, hydrolyzing N-glycosyl compounds;982688;797;GO:0004553
GO:0038102;activin receptor antagonist activity;102;4;GO:0004870
GO:0038105;sequestering of TGFbeta from receptor via TGFbeta binding;0;1;GO:0004842
GO:0038104;nodal receptor complex;0;0;GO:0009952
GO:0002170;high-affinity IgA receptor activity;0;2;GO:0002729
GO:0038101;sequestering of nodal from receptor via nodal binding;38;1;GO:0005515
GO:0002171;low-affinity IgA receptor activity;0;2;GO:0002729
GO:0038100;nodal binding;135;9;GO:0009952
GO:0002172;high-affinity IgM receptor activity;0;2;GO:0002768
GO:0002173;low-affinity IgM receptor activity;0;1;GO:0002768
GO:0002174;mammary stem cell proliferation;42;2;GO:0048699
GO:0002175;protein localization to paranode region of axon;149;128;GO:0048771
GO:0002176;male germ cell proliferation;356;8;GO:1901363
GO:0002177;manchette;884;94;GO:0008544
GO:0002178;palmitoyltransferase complex;1173;38;GO:0005576
GO:0002179;homodimeric serine palmitoyltransferase complex;0;1;GO:0005576
GO:0002169;3-methylcrotonyl-CoA carboxylase complex, mitochondrial;121;18;GO:0005739
GO:0016788;hydrolase activity, acting on ester bonds;15459320;4030;GO:0016787
GO:0002140;stereocilia tip link;11;1;GO:0005525
GO:0002141;stereocilia ankle link;370;16;GO:0005525
GO:0002142;stereocilia ankle link complex;215;23;GO:0005576
GO:0002143;tRNA wobble position uridine thiolation;13375;217;GO:0006418
GO:0002144;cytosolic tRNA wobble base thiouridylase complex;194;6;GO:0005737
GO:0002145;4-amino-5-hydroxymethyl-2-methylpyrimidine diphosphatase activity;474;5;GO:0004723
GO:0002136;tRNA wobble base lysidine biosynthesis;1;0;GO:0009065
GO:0004799;thymidylate synthase activity;120424;952;GO:0004723
GO:0004798;thymidylate kinase activity;160276;1260;GO:0004723
GO:0002138;retinoic acid biosynthetic process;893;430;GO:0009063
GO:0002139;stereocilia coupling link;381;20;GO:0005986
GO:0016790;thiolester hydrolase activity;456889;890;GO:0004721
GO:0016791;phosphatase activity;3098757;4620;GO:0004721
GO:0016793;triphosphoric monoester hydrolase activity;40444;8;GO:0016840
GO:0016794;diphosphoric monoester hydrolase activity;8054;6;GO:0016840
GO:0016795;phosphoric triester hydrolase activity;3230;4;GO:0016840
GO:0016796;exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters;715796;1;GO:0004518
GO:0016797;exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters;2;0;GO:0004518
GO:0016798;hydrolase activity, acting on glycosyl bonds;6577633;4080;GO:0004553
GO:0016778;diphosphotransferase activity;329254;37;GO:0005524
GO:0016779;nucleotidyltransferase activity;10377294;4120;GO:0004518
GO:0002150;hypochlorous acid catabolic process;0;3;GO:0046395
GO:0002151;G-quadruplex RNA binding;7745;70;GO:0003723
GO:0002152;bile acid conjugation;54;7;GO:0007566
GO:0002153;steroid receptor RNA activator RNA binding;112;10;GO:0003712
GO:0002154;thyroid hormone mediated signaling pathway;467;29;GO:0030522
GO:0002155;regulation of thyroid hormone mediated signaling pathway;356;32;GO:0030522
GO:0002156;negative regulation of thyroid hormone mediated signaling pathway;0;2;GO:0030518
GO:0002157;positive regulation of thyroid hormone mediated signaling pathway;120;9;GO:0030518
GO:0002148;hypochlorous acid metabolic process;46;9;GO:0006779
GO:0002149;hypochlorous acid biosynthetic process;46;176;GO:0006779
GO:0016780;phosphotransferase activity, for other substituted phosphate groups;1141278;1240;GO:0016791
GO:0016781;phosphotransferase activity, paired acceptors;190895;70;GO:0016791
GO:0016782;transferase activity, transferring sulphur-containing groups;1385549;487;GO:0004332
GO:0016783;sulfurtransferase activity;832602;874;GO:0004723
GO:0016784;3-mercaptopyruvate sulfurtransferase activity;2880;19;GO:0004067
GO:0016785;selenotransferase activity;67409;4;GO:0004732
GO:0016787;hydrolase activity;75062942;26800;GO:0016787
GO:0038158;granulocyte colony-stimulating factor signaling pathway;155;6;GO:0007155
GO:0090733;tenascin complex;213;3;GO:0005578
GO:0038157;granulocyte-macrophage colony-stimulating factor signaling pathway;176;9;GO:0045727
GO:0090734;site of DNA damage;8317;188;GO:0006974
GO:0090731;cellular response to very-low-density lipoprotein particle stimulus;49;2;GO:0006986
GO:0038159;C-X-C chemokine receptor CXCR4 signaling pathway;282;6;GO:0007186
GO:0090732;cofilin-actin rod;2;1;GO:0003735
GO:0038154;interleukin-11-mediated signaling pathway;368;9;GO:0007179
GO:1905303;positive regulation of macropinocytosis;137;3;GO:0048193
GO:0038153;CCL2-activated CCR4 signaling pathway;0;2;GO:0046649
GO:0090730;Las1 complex;4123;9;GO:0048285
GO:1905302;negative regulation of macropinocytosis;5;1;GO:0048193
GO:0038156;interleukin-3-mediated signaling pathway;261;21;GO:0007186
GO:1905301;regulation of macropinocytosis;170;1;GO:0050727
GO:0038155;interleukin-23-mediated signaling pathway;188;152;GO:0007186
GO:1905300;positive regulation of intestinal epithelial cell development;46;2;GO:0048660
GO:0038150;C-C chemokine receptor CCR2 signaling pathway;0;2;GO:0007186
GO:1905307;response to miconazole;0;0;GO:0046686
GO:1905306;positive regulation of cardiac myofibril assembly;10;0;GO:0048407
GO:0038152;C-C chemokine receptor CCR4 signaling pathway;0;2;GO:0007186
GO:1905305;negative regulation of cardiac myofibril assembly;62;4;GO:0048407
GO:0038151;CCL2-activated CCR2 signaling pathway;0;2;GO:0050921
GO:1905304;regulation of cardiac myofibril assembly;74;0;GO:0048407
GO:1905309;positive regulation of cohesin loading;1;0;GO:0048285
GO:1905308;cellular response to miconazole;0;0;GO:0050829
GO:0051125;regulation of actin nucleation;3891;33;GO:0048285
GO:0051126;negative regulation of actin nucleation;1248;185;GO:0048285
GO:0051123;RNA polymerase II preinitiation complex assembly;7263;69;GO:0000976
GO:0051124;synaptic assembly at neuromuscular junction;2358;10;GO:0008092
GO:0051121;hepoxilin metabolic process;332;16;GO:0046323
GO:0051122;hepoxilin biosynthetic process;332;85;GO:0046395
GO:0051120;hepoxilin A3 synthase activity;120;19;GO:0004722
GO:0051129;negative regulation of cellular component organization;424551;2400;GO:0022627
GO:0090737;telomere maintenance via telomere trimming;888;6;GO:0007050
GO:0051127;positive regulation of actin nucleation;970;97;GO:0048285
GO:0090735;DNA repair complex assembly;2344;1;GO:0007031
GO:0051128;regulation of cellular component organization;891871;3530;GO:0051128
GO:0090736;MATH domain binding;4;0;GO:0005524
GO:0038147;C-X-C motif chemokine 12 receptor activity;73;7;GO:0005096
GO:1905310;regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis;162;3;GO:0048704
GO:0038146;chemokine (C-X-C motif) ligand 12 signaling pathway;434;6;GO:0007186
GO:0038149;C-C motif chemokine 2 receptor activity;0;2;GO:0004872
GO:0038148;chemokine (C-C motif) ligand 2 signaling pathway;0;3;GO:0007186
GO:0038143;ERBB3:ERBB2 complex;106;6;GO:0048285
GO:1905314;semi-lunar valve development;2653;177;GO:0007565
GO:0038142;EGFR:ERBB2 complex;0;0;GO:0048193
GO:0090741;pigment granule membrane;9981;5;GO:0030130
GO:0038145;macrophage colony-stimulating factor signaling pathway;482;143;GO:0045727
GO:1905312;positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis;155;5;GO:0048704
GO:0038144;ERBB4:ERBB2 complex;0;0;GO:0048285
GO:1905311;negative regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis;0;0;GO:0048704
GO:1905318;meiosis I spindle assembly checkpoint signaling;8;1;GO:0007067
GO:0051140;regulation of NK T cell proliferation;406;8;GO:0046649
GO:1905317;inferior endocardial cushion morphogenesis;53;3;GO:0048706
GO:0038141;ERBB4-ERBB4 complex;0;0;GO:0005515
GO:1905316;superior endocardial cushion morphogenesis;3;3;GO:0048704
GO:0038140;ERBB4-ERBB3 complex;0;0;GO:0005515
GO:1905315;cell proliferation involved in endocardial cushion morphogenesis;3;3;GO:0048608
GO:1905319;mesenchymal stem cell migration;156;2;GO:0030900
GO:0051136;regulation of NK T cell differentiation;270;8;GO:0046649
GO:0051137;negative regulation of NK T cell differentiation;0;1;GO:0046649
GO:0051134;negative regulation of NK T cell activation;74;7;GO:0046649
GO:0051135;positive regulation of NK T cell activation;542;83;GO:0046649
GO:0051132;NK T cell activation;710;7;GO:0002449
GO:0051133;regulation of NK T cell activation;616;23;GO:0046649
GO:0051130;positive regulation of cellular component organization;165377;2470;GO:0050789
GO:0051131;chaperone-mediated protein complex assembly;16362;1540;GO:0006457
GO:0038139;ERBB4-EGFR complex;0;0;GO:0048193
GO:0051138;positive regulation of NK T cell differentiation;206;262;GO:0046649
GO:0051139;metal cation:proton antiporter activity;111572;180;GO:0005215
GO:0038136;ERBB3-ERBB4 signaling pathway;0;1;GO:0007169
GO:0089722;phosphoenolpyruvate transmembrane transport;278;2;GO:0006836
GO:0090711;FMN hydrolase activity;1;1;GO:0004067
GO:1905321;negative regulation of mesenchymal stem cell migration;0;0;GO:0045766
GO:0038135;ERBB2-ERBB4 signaling pathway;262;6;GO:0007179
GO:0090712;basal pole of outer hair cell;0;0;GO:0005576
GO:1905320;regulation of mesenchymal stem cell migration;111;1;GO:0016477
GO:0038138;ERBB4-ERBB4 signaling pathway;334;8;GO:0007169
GO:0038137;ERBB4-EGFR signaling pathway;0;2;GO:0007169
GO:0090710;phosphomevalonate decarboxylase activity;0;2;GO:0006096
GO:0038132;neuregulin binding;297;92;GO:0048608
GO:1905325;regulation of meiosis I spindle assembly checkpoint;0;0;GO:0048285
GO:0002180;5-lipoxygenase complex;0;2;GO:0005576
GO:0038131;neuregulin receptor activity;159;8;GO:0004872
GO:1905324;telomere-telomerase complex assembly;7;4;GO:0007031
GO:0002181;cytoplasmic translation;99946;3760;GO:0006412
GO:0038134;ERBB2-EGFR signaling pathway;558;71;GO:0007169
GO:0089720;caspase binding;511;51;GO:0005576
GO:1905323;telomerase holoenzyme complex assembly;577;89;GO:0005737
GO:0002182;cytoplasmic translational elongation;5626;33;GO:0006414
GO:0038133;ERBB2-ERBB3 signaling pathway;209;9;GO:0007179
GO:0089721;phosphoenolpyruvate transmembrane transporter activity;139;3;GO:0005525
GO:1905322;positive regulation of mesenchymal stem cell migration;111;7;GO:0045766
GO:0002183;cytoplasmic translational initiation;83331;260;GO:0006413
GO:0051150;regulation of smooth muscle cell differentiation;1486;170;GO:0048608
GO:1905329;sphingoid long-chain base transport;7;5;GO:0006836
GO:0002184;cytoplasmic translational termination;344;119;GO:0006414
GO:0051151;negative regulation of smooth muscle cell differentiation;805;330;GO:0048608
GO:1905328;plant septum development;6;1;GO:0048522
GO:0002185;creatine kinase complex;0;1;GO:0005840
GO:0038130;ERBB4 signaling pathway;819;6;GO:0007179
GO:1905327;tracheoesophageal septum formation;40;3;GO:0002041
GO:0002186;cytosolic creatine kinase complex;0;0;GO:0005737
GO:0075120;symbiont-mediated suppression of host G protein-coupled receptor signal transduction;0;1;GO:0009909
GO:1905326;positive regulation of meiosis I spindle assembly checkpoint;0;1;GO:0048285
GO:0002187;mitochondrial creatine kinase complex;0;3;GO:0005740
GO:0002188;translation reinitiation;354;59;GO:0006413
GO:0002189;ribose phosphate diphosphokinase complex;3440;72;GO:0005524
GO:0051147;regulation of muscle cell differentiation;7053;372;GO:0045595
GO:0075114;symbiont-mediated suppression of host transmembrane receptor-mediated signal transduction;1;0;GO:0009913
GO:0051148;negative regulation of muscle cell differentiation;2539;162;GO:0045595
GO:0051145;smooth muscle cell differentiation;3564;806;GO:0048608
GO:0051146;striated muscle cell differentiation;24771;1330;GO:0045595
GO:0051143;propanediol metabolic process;6577;4;GO:0006073
GO:0051144;propanediol catabolic process;6576;6;GO:0006066
GO:0075111;symbiont-mediated suppression of host receptor-mediated signal transduction;119616;0;GO:0009913
GO:0051141;negative regulation of NK T cell proliferation;50;1;GO:0046649
GO:0075112;perturbation of host transmembrane receptor-mediated signal transduction;1;0;GO:0007186
GO:0051142;positive regulation of NK T cell proliferation;356;94;GO:0046649
GO:0090719;adaptive immune effector response involving T cells and B lineage cells;0;1;GO:0002449
GO:0090717;adaptive immune memory response involving T cells and B cells;50;2;GO:0002449
GO:0090718;adaptive immune effector response;0;2;GO:0002684
GO:0038129;ERBB3 signaling pathway;303;143;GO:0007179
GO:0075118;perturbation of host G protein-coupled receptor signal transduction pathway;0;1;GO:0007186
GO:0090715;immunological memory formation process;466;1;GO:0002449
GO:0038128;ERBB2 signaling pathway;1172;705;GO:0007179
GO:0090716;adaptive immune memory response;153;1;GO:0002449
GO:0051149;positive regulation of muscle cell differentiation;3246;870;GO:0045595
GO:0090713;immunological memory process;619;5;GO:0002449
GO:0090714;innate immunity memory response;0;2;GO:0002443
GO:0090722;receptor-receptor interaction;205;10;GO:0004872
GO:1905332;positive regulation of morphogenesis of an epithelium;2198;92;GO:0032989
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;91;360;GO:0002237
GO:1905331;negative regulation of morphogenesis of an epithelium;521;28;GO:0032989
GO:0038127;ERBB signaling pathway;16951;569;GO:0007179
GO:0090720;primary adaptive immune response;60;3;GO:0006955
GO:1905330;regulation of morphogenesis of an epithelium;4654;134;GO:0030574
GO:0090721;primary adaptive immune response involving T cells and B cells;58;6;GO:0002449
GO:0002190;cap-independent translational initiation;265;21;GO:0006413
GO:0038121;C-C motif chemokine 21 receptor activity;63;6;GO:0004872
GO:1905336;negative regulation of aggrephagy;0;1;GO:0048193
GO:0002191;cap-dependent translational initiation;2865;147;GO:0006413
GO:0038120;CCL21-activated CCR7 signaling pathway;0;1;GO:0046649
GO:1905335;regulation of aggrephagy;171;2;GO:0048193
GO:0002192;IRES-dependent translational initiation of linear mRNA;57;4;GO:0006413
GO:0038123;toll-like receptor TLR1:TLR2 signaling pathway;35;148;GO:0002224
GO:1905334;Swi5-Sfr1 complex binding;58;2;GO:0048285
GO:0002193;MAML1-RBP-Jkappa- ICN1 complex;189;82;GO:0048704
GO:0038122;C-C motif chemokine 5 receptor activity;0;1;GO:0004872
GO:1905333;regulation of gastric motility;43;4;GO:0048608
GO:0002194;hepatocyte cell migration;56;32;GO:0030900
GO:0051161;arabitol metabolic process;8;1;GO:0006067
GO:0002195;2-methylthio-N-6-(cis-hydroxy)isopentenyl adenosine-tRNA biosynthesis;19290;0;GO:0006418
GO:0051162;L-arabitol metabolic process;0;0;GO:0006066
GO:1905339;positive regulation of cohesin unloading;0;0;GO:0048285
GO:0002196;Ser-tRNA(Ala) hydrolase activity;162;6;GO:0008544
GO:1905338;negative regulation of cohesin unloading;0;1;GO:0048285
GO:0002197;xanthine dehydrogenase complex;4;0;GO:0008023
GO:0051160;L-xylitol catabolic process;57;6;GO:0006067
GO:1905337;positive regulation of aggrephagy;171;10;GO:0048193
GO:0002199;zona pellucida receptor complex;384;506;GO:0008021
GO:0051158;L-arabitol catabolic process;0;1;GO:0006067
GO:0051159;D-arabitol catabolic process;1;1;GO:0006067
GO:0051156;glucose 6-phosphate metabolic process;599540;974;GO:0006096
GO:0051157;arabitol catabolic process;2;1;GO:0006067
GO:0051154;negative regulation of striated muscle cell differentiation;1323;154;GO:0048193
GO:0051155;positive regulation of striated muscle cell differentiation;2276;319;GO:0048407
GO:0051152;positive regulation of smooth muscle cell differentiation;553;99;GO:0048608
GO:0051153;regulation of striated muscle cell differentiation;4362;157;GO:0048731
GO:0090728;negative regulation of brood size;0;0;GO:0045730
GO:0090729;toxin activity;118241;292;GO:0046686
GO:0038118;C-C chemokine receptor CCR7 signaling pathway;50;3;GO:0007186
GO:0090726;cortical dynamic polarity patch;137;5;GO:0048608
GO:0038117;C-C motif chemokine 19 receptor activity;80;5;GO:0050921
GO:0090727;positive regulation of brood size;55;2;GO:0045766
GO:0075109;perturbation of host receptor-mediated signal transduction;119616;0;GO:0007186
GO:0090724;central region of growth cone;25;10;GO:0048608
GO:0038119;CCL19-activated CCR7 signaling pathway;0;1;GO:0046649
GO:0090725;peripheral region of growth cone;16;3;GO:0048608
GO:0089700;protein kinase D signaling;229;157;GO:0007165
GO:0089701;U2AF complex;7970;7;GO:0003735
GO:0089702;undecaprenyl-phosphate glucose phosphotransferase activity;9;0;GO:0006030
GO:0089703;L-aspartate transmembrane export from vacuole;0;0;GO:0006836
GO:0038198;auxin receptor activity;6;4;GO:0009734
GO:0038197;type I interferon receptor complex;0;0;GO:0005125
GO:0038199;ethylene receptor activity;2297;45;GO:0009725
GO:0038194;thyroid-stimulating hormone signaling pathway;3289;26;GO:0007186
GO:0089708;L-histidine transmembrane export from vacuole;98;1;GO:0008544
GO:0038193;thromboxane A2 signaling pathway;4;7;GO:0007186
GO:0089709;L-histidine transmembrane transport;1113;9;GO:0006810
GO:0038196;type III interferon-mediated signaling pathway;178;51;GO:0060337
GO:0038195;urokinase plasminogen activator signaling pathway;49;81;GO:0007186
GO:0038190;VEGF-activated neuropilin signaling pathway;105;35;GO:0048010
GO:0089704;L-glutamate transmembrane export from vacuole;0;0;GO:0006836
GO:0089705;protein localization to outer membrane;21;4;GO:0015986
GO:0038192;gastric inhibitory peptide signaling pathway;1681;4;GO:0008021
GO:0089706;L-ornithine transmembrane export from vacuole;0;0;GO:0006836
GO:0038191;neuropilin binding;448;302;GO:0008092
GO:0089707;L-lysine transmembrane export from vacuole;52;1;GO:0008544
GO:0090700;maintenance of plant organ identity;31;2;GO:0048316
GO:0090701;specification of plant organ identity;307;4;GO:0048562
GO:0089713;Cbf1-Met4-Met28 complex;19;3;GO:0048285
GO:0089714;UDP-N-acetyl-D-mannosamine dehydrogenase activity;8484;10;GO:0006029
GO:0038187;pattern recognition receptor activity;1977;298;GO:0004872
GO:0038186;lithocholic acid receptor activity;54;2;GO:0004984
GO:0038189;neuropilin signaling pathway;293;50;GO:0007186
GO:0038188;cholecystokinin signaling pathway;1321;10;GO:0007186
GO:0089710;endocytic targeting sequence binding;0;0;GO:0005576
GO:0038183;bile acid signaling pathway;1724;65;GO:0032989
GO:0089719;RHG protein domain binding;0;1;GO:0042802
GO:0038182;G protein-coupled bile acid receptor activity;60;3;GO:0004930
GO:0038185;intracellular bile acid receptor signaling pathway;62;10;GO:0048193
GO:0038184;cell surface bile acid receptor signaling pathway;110;3;GO:0048193
GO:0089715;tRNA m6t6A37 methyltransferase activity;63;2;GO:0003729
GO:0089716;Pip2-Oaf1 complex;6;3;GO:0048193
GO:0038181;bile acid receptor activity;238;31;GO:0004984
GO:0038180;nerve growth factor signaling pathway;512;676;GO:0007186
GO:0089718;amino acid import across plasma membrane;4627;252;GO:0006865
GO:0090708;specification of plant organ axis polarity;1716;2;GO:0048316
GO:0090709;regulation of timing of plant organ formation;43;0;GO:0048608
GO:0090706;specification of plant organ position;5;0;GO:0048316
GO:0090707;establishment of plant organ orientation;4;0;GO:0048316
GO:0090704;nicotinate-O-glucosyltransferase activity;11;0;GO:0006073
GO:0090705;trichome papilla;0;0;GO:0009913
GO:0038179;neurotrophin signaling pathway;8215;303;GO:0007268
GO:0038176;positive regulation of SREBP signaling pathway in response to decreased oxygen levels;0;2;GO:0045944
GO:0038175;negative regulation of SREBP signaling pathway in response to increased oxygen levels;0;1;GO:0010468
GO:0038178;complement component C5a signaling pathway;232;66;GO:0006954
GO:0038177;death receptor agonist activity;89;6;GO:0048608
GO:0038172;interleukin-33-mediated signaling pathway;224;53;GO:0007267
GO:0038171;cannabinoid signaling pathway;4983;31;GO:0007186
GO:0038174;interleukin-17A receptor activity;0;1;GO:0005125
GO:0038173;interleukin-17A-mediated signaling pathway;368;8;GO:0007186
GO:0038170;somatostatin signaling pathway;8900;125;GO:0007259
GO:0051103;DNA ligation involved in DNA repair;5973;326;GO:0006281
GO:0051104;DNA-dependent DNA replication DNA ligation;0;0;GO:0006260
GO:0051101;regulation of DNA binding;433;1040;GO:0030528
GO:0051102;DNA ligation involved in DNA recombination;53;8;GO:0006310
GO:0051100;negative regulation of binding;437;449;GO:0010468
GO:0051109;crotonobetaine-CoA ligase activity;1044;2;GO:0006081
GO:0051107;negative regulation of DNA ligation;2;1;GO:0010468
GO:0051108;carnitine-CoA ligase activity;875;2;GO:0004866
GO:0051105;regulation of DNA ligation;171;8;GO:0006360
GO:0051106;positive regulation of DNA ligation;169;172;GO:0045944
GO:0038169;somatostatin receptor signaling pathway;8900;6;GO:0007259
GO:0038165;oncostatin-M-mediated signaling pathway;579;43;GO:0007179
GO:0038164;thrombopoietin receptor activity;61;2;GO:0004896
GO:0038166;angiotensin-activated signaling pathway;8184;697;GO:0007186
GO:0038161;prolactin signaling pathway;244;42;GO:0007186
GO:0038160;CXCL12-activated CXCR4 signaling pathway;224;18;GO:0048608
GO:0038163;thrombopoietin-mediated signaling pathway;392;43;GO:0007179
GO:0038162;erythropoietin-mediated signaling pathway;333;46;GO:0007186
GO:0051114;peptidyl-histidine uridylylation;0;3;GO:0043405
GO:0051112;peptidyl-histidine adenylylation, to form peptidyl-1'-(phospho-5'-adenosine)-L-histidine;0;0;GO:0046395
GO:0051110;peptidyl-histidine uridylylation, to form peptidyl-1'-(phospho-5'-uridine)-L-histidine;0;0;GO:0006464
GO:0051111;peptidyl-histidine adenylylation;0;5;GO:0043405
GO:0051118;glucan endo-1,3-alpha-glucosidase activity;4236;6;GO:0004553
GO:0051119;sugar transmembrane transporter activity;115385;597;GO:0008544
GO:0051116;cobaltochelatase activity;14763;239;GO:0006096
GO:0051117;ATPase binding;5536;1520;GO:0005524
GO:1905266;blasticidin S biosynthetic process;0;0;GO:0009065
GO:1905265;blasticidin S catabolic process;0;0;GO:0046395
GO:0090698;post-embryonic plant morphogenesis;8001;28;GO:0048468
GO:1905264;blasticidin S metabolic process;0;0;GO:0009064
GO:1905263;positive regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination;66;2;GO:0000922
GO:0090696;post-embryonic plant organ development;3405;9;GO:0048468
GO:0090697;post-embryonic plant organ morphogenesis;1784;8;GO:0048468
GO:1905269;positive regulation of chromatin organization;1071;38;GO:0045727
GO:0090694;Scc2-Scc4 cohesin loading complex;220;5;GO:0005524
GO:1905268;negative regulation of chromatin organization;575;41;GO:0016568
GO:0090695;Wpl/Pds5 cohesin loading/unloading complex;2;1;GO:0005524
GO:0051095;regulation of helicase activity;29;753;GO:0003677
GO:0090692;mitochondrial membrane scission site;0;2;GO:0005743
GO:0051096;positive regulation of helicase activity;23;233;GO:0005524
GO:0090693;plant organ senescence;7289;45;GO:0048608
GO:0051093;negative regulation of developmental process;79715;1730;GO:0048589
GO:0051094;positive regulation of developmental process;113774;2210;GO:0048856
GO:0090691;formation of plant organ boundary;104;8;GO:0097367
GO:0051091;positive regulation of DNA-binding transcription factor activity;1049;1760;GO:0030528
GO:0051092;positive regulation of NF-kappaB transcription factor activity;587;4280;GO:0045944
GO:0051090;regulation of DNA-binding transcription factor activity;1671;1340;GO:0030528
GO:0099024;plasma membrane invagination;3455;158;GO:0009986
GO:0075055;positive regulation of penetration peg formation;0;1;GO:0048285
GO:0051089;constitutive protein ectodomain proteolysis;55;6;GO:0004867
GO:0051086;chaperone mediated protein folding independent of cofactor;1646;40;GO:0006457
GO:0051087;protein-folding chaperone binding;134505;495;GO:0008023
GO:1905262;negative regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination;4;1;GO:0000922
GO:1905261;regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination;74;1;GO:0000786
GO:1905260;positive regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway;0;1;GO:1901363
GO:1905277;negative regulation of epithelial tube formation;0;0;GO:0048706
GO:1905276;regulation of epithelial tube formation;426;59;GO:0030574
GO:1905275;Rohon-Beard neuron differentiation;0;2;GO:0048699
GO:1905274;regulation of modification of postsynaptic actin cytoskeleton;138;9;GO:0048608
GO:1905279;regulation of retrograde transport, endosome to Golgi;312;9;GO:0006836
GO:1905278;positive regulation of epithelial tube formation;424;8;GO:0048608
GO:0099040;ceramide translocation;162;8;GO:0006629
GO:0099041;vesicle tethering to Golgi;1480;7;GO:0006626
GO:0075053;penetration peg formation;0;2;GO:0048285
GO:0075054;modulation of penetration peg formation;0;1;GO:0048706
GO:0099044;vesicle tethering to endoplasmic reticulum;156;3;GO:0008023
GO:0099045;viral extrusion;31;5;GO:0016032
GO:0099043;cargo loading involved in clathrin-dependent endocytosis;0;1;GO:0006897
GO:0099038;ceramide floppase activity;75;5;GO:0005576
GO:0051099;positive regulation of binding;416;986;GO:0050789
GO:0075045;regulation of formation by symbiont of haustorium for nutrient acquisition from host;0;4;GO:0046148
GO:0051097;negative regulation of helicase activity;4;74;GO:0006364
GO:0075046;positive regulation of formation by symbiont of haustorium for nutrient acquisition from host;0;2;GO:0045734
GO:0099039;sphingolipid translocation;329;2;GO:0006629
GO:0051098;regulation of binding;1011;1490;GO:0050789
GO:0075047;negative regulation of formation by symbiont of haustorium for nutrient acquisition from host;0;3;GO:0045734
GO:1905273;positive regulation of proton-transporting ATP synthase activity, rotational mechanism;8;2;GO:0015986
GO:1905272;negative regulation of proton-transporting ATP synthase activity, rotational mechanism;0;1;GO:0015986
GO:1905271;regulation of proton-transporting ATP synthase activity, rotational mechanism;8;1;GO:0008544
GO:1905270;Meynert cell differentiation;0;0;GO:0048667
GO:0090678;cell dedifferentiation involved in phenotypic switching;69;10;GO:0045595
GO:1905288;vascular associated smooth muscle cell apoptotic process;535;5;GO:0043066
GO:0090679;cell differentiation involved in phenotypic switching;104;0;GO:0030154
GO:1905287;positive regulation of G2/M transition of mitotic cell cycle involved in cellular response to nitrogen starvation;11;1;GO:0042127
GO:0090676;calcium ion transmembrane transport via low voltage-gated calcium channel;59;4;GO:0006811
GO:1905286;serine-type peptidase complex;559;8;GO:0005576
GO:0090677;reversible differentiation;211;8;GO:0045595
GO:1905285;fibrous ring of heart morphogenesis;54;6;GO:0048608
GO:0038099;nodal receptor complex assembly;4;1;GO:0048704
GO:0090674;endothelial cell-matrix adhesion via fibronectin;291;3;GO:0048010
GO:0038098;sequestering of BMP from receptor via BMP binding;160;39;GO:0048407
GO:0090675;intermicrovillar adhesion;89;37;GO:0048308
GO:0090672;telomerase RNA localization;490;12;GO:0005930
GO:0090673;endothelial cell-matrix adhesion;295;7;GO:0007155
GO:1905289;regulation of CAMKK-AMPK signaling cascade;156;6;GO:0043406
GO:0038095;Fc-epsilon receptor signaling pathway;1388;1490;GO:0007186
GO:0090670;RNA localization to Cajal body;763;9;GO:0005840
GO:0038094;Fc-gamma receptor signaling pathway;616;443;GO:0007186
GO:0090671;telomerase RNA localization to Cajal body;490;33;GO:0005730
GO:0038097;positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway;4;5;GO:0048002
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;258;1420;GO:0002449
GO:0038091;positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway;179;36;GO:0048010
GO:0099011;neuronal dense core vesicle exocytosis;429;0;GO:0008030
GO:0038090;positive regulation of cell migration by VEGF-activated platelet derived growth factor receptor signaling pathway;0;2;GO:0048010
GO:0099012;neuronal dense core vesicle membrane;157;3;GO:0005768
GO:0038093;Fc receptor signaling pathway;4465;352;GO:0007186
GO:0038092;nodal signaling pathway;878;542;GO:0007179
GO:0099010;modification of postsynaptic structure;978;9;GO:0048608
GO:0099004;calmodulin dependent kinase signaling pathway;562;5;GO:0007186
GO:0099005;extrinsic component of postsynaptic recycling endosome membrane;0;0;GO:0005768
GO:0099002;viral genome ejection through host cell envelope, short tail mechanism;3210;4;GO:0016021
GO:0099003;vesicle-mediated transport in synapse;22510;778;GO:0008021
GO:0099008;viral entry via permeabilization of inner membrane;9858;3;GO:0016032
GO:0099009;viral genome circularization;7;4;GO:0016032
GO:0099006;viral entry via permeabilization of endosomal membrane;0;0;GO:0006897
GO:0099007;extrinsic component of presynaptic endosome membrane;0;0;GO:0005768
GO:1905280;negative regulation of retrograde transport, endosome to Golgi;60;2;GO:0048193
GO:1905284;positive regulation of epidermal growth factor receptor signaling pathway involved in heart process;0;0;GO:0048010
GO:1905283;negative regulation of epidermal growth factor receptor signaling pathway involved in heart process;1;0;GO:0048010
GO:1905282;regulation of epidermal growth factor receptor signaling pathway involved in heart process;1;0;GO:0048010
GO:1905281;positive regulation of retrograde transport, endosome to Golgi;67;2;GO:0048193
GO:0090689;cleavage furrow leading edge;5;3;GO:0007067
GO:1905299;negative regulation of intestinal epithelial cell development;2;1;GO:0048660
GO:1905298;regulation of intestinal epithelial cell development;87;0;GO:0030900
GO:0090687;activation of meiosis I spindle assembly checkpoint;0;0;GO:0007067
GO:1905297;positive regulation of neural crest cell fate specification;0;0;GO:0048704
GO:0090688;cleavage furrow rim;0;1;GO:0007067
GO:1905296;negative regulation of neural crest cell fate specification;0;0;GO:0048704
GO:0038088;VEGF-activated platelet-derived growth factor receptor-beta signaling pathway;0;1;GO:0048010
GO:0090685;RNA localization to nucleus;763;8;GO:0003676
GO:0038087;VEGF-activated platelet-derived growth factor receptor-alpha signaling pathway;0;1;GO:0048010
GO:0090686;glycine betaine-activated nonselective monoatomic cation channel activity;0;0;GO:0005216
GO:0090683;GPCR sweet taste receptor activity;0;0;GO:0004930
GO:0038089;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;396;47;GO:0048010
GO:0090684;contact chemoreceptor activity;0;1;GO:0003700
GO:0038084;vascular endothelial growth factor signaling pathway;16206;1400;GO:0048010
GO:0090681;GPCR taste receptor activity;0;2;GO:0004930
GO:0038083;peptidyl-tyrosine autophosphorylation;371;1400;GO:0006468
GO:0090682;GPCR bitter taste receptor activity;0;0;GO:0004930
GO:0038086;VEGF-activated platelet-derived growth factor receptor signaling pathway;179;9;GO:0048010
GO:0038085;vascular endothelial growth factor binding;293;364;GO:0048010
GO:0090680;viral release via disruption of host outer membrane;3;1;GO:0016032
GO:0099022;vesicle tethering;21947;23;GO:0008021
GO:0075070;adhesion of symbiont hyphopodium to host;0;1;GO:0048193
GO:0099023;vesicle tethering complex;139026;6;GO:0005766
GO:0075071;symbiont-mediated perturbation of host autophagy;23299;1;GO:0048193
GO:0099020;perinuclear endoplasmic reticulum lumen;122;6;GO:0005783
GO:0099021;cortical endoplasmic reticulum lumen;61;5;GO:0005789
GO:0099015;degradation of host chromosome by virus;405;3;GO:0048285
GO:0099016;evasion by virus of DNA end degradation;6;2;GO:0048285
GO:0099013;neuronal dense core vesicle lumen;60;3;GO:0005768
GO:0099014;neuronal dense core vesicle organization;0;0;GO:0008030
GO:0099019;maintenance of protein localization at growing cell tip;0;0;GO:0048471
GO:0099017;maintenance of protein localization at cell tip;0;0;GO:0048471
GO:0075069;adhesion of symbiont infection cushion to host;0;1;GO:0048193
GO:0099018;evasion by virus of host restriction-modification system;816;3;GO:0045730
GO:1905291;positive regulation of CAMKK-AMPK signaling cascade;39;25;GO:0043406
GO:1905290;negative regulation of CAMKK-AMPK signaling cascade;2;0;GO:0043403
GO:1905295;regulation of neural crest cell fate specification;3;0;GO:0048704
GO:1905294;positive regulation of neural crest cell differentiation;0;3;GO:0048704
GO:1905293;negative regulation of neural crest cell differentiation;0;1;GO:0048704
GO:1905292;regulation of neural crest cell differentiation;10;3;GO:0048704
GO:0090656;t-circle formation;779;145;GO:0048285
GO:1905222;atrioventricular canal morphogenesis;284;6;GO:0007565
GO:0090657;telomeric loop disassembly;756;10;GO:0007062
GO:1905221;positive regulation of platelet formation;46;6;GO:0050877
GO:0090654;basolateral recycling endosome;0;2;GO:0006867
GO:1905220;negative regulation of platelet formation;2;1;GO:0050727
GO:0090655;double-stranded/single-stranded junction telomeric DNA binding;3;1;GO:0003677
GO:0090652;basolateral cytoplasm;0;1;GO:0005737
GO:0090653;apical recycling endosome;0;2;GO:0007041
GO:1905225;response to thyrotropin-releasing hormone;18;3;GO:0004930
GO:0090650;cellular response to oxygen-glucose deprivation;109;70;GO:0070941
GO:0090651;apical cytoplasm;160;5;GO:0005737
GO:1905223;epicardium morphogenesis;89;6;GO:0048608
GO:0051051;negative regulation of transport;28603;1190;GO:0055085
GO:0051052;regulation of DNA metabolic process;289519;3210;GO:0006259
GO:1905229;cellular response to thyrotropin-releasing hormone;13;7;GO:0006954
GO:0051050;positive regulation of transport;60889;1340;GO:0055085
GO:0051048;negative regulation of secretion;11540;482;GO:0032989
GO:0075015;formation of infection structure;12;4;GO:0044421
GO:0051049;regulation of transport;275792;2440;GO:0055085
GO:0075016;appressorium formation;11;5;GO:0048305
GO:0051046;regulation of secretion;43166;1510;GO:0055085
GO:0075017;regulation of appressorium formation;6;2;GO:0046274
GO:0051047;positive regulation of secretion;16312;1170;GO:0050832
GO:0075018;positive regulation of appressorium formation;6;2;GO:0046365
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;812;1070;GO:0048193
GO:0075011;positive regulation of germ tube formation;0;2;GO:0048285
GO:0051045;negative regulation of membrane protein ectodomain proteolysis;417;151;GO:0048193
GO:0075012;negative regulation of germ tube formation;0;1;GO:0048285
GO:0051042;negative regulation of calcium-independent cell-cell adhesion;62;6;GO:0048193
GO:0051043;regulation of membrane protein ectodomain proteolysis;1229;585;GO:0042596
GO:0075019;negative regulation of appressorium formation;0;1;GO:0046274
GO:0090658;cone matrix sheath;22;1;GO:0005576
GO:0090659;walking behavior;1725;9;GO:0040011
GO:0090667;cell chemotaxis to vascular endothelial growth factor;59;2;GO:0006935
GO:1905233;response to codeine;6;6;GO:0043161
GO:0090668;endothelial cell chemotaxis to vascular endothelial growth factor;59;1;GO:0030599
GO:1905232;cellular response to L-glutamate;38;10;GO:0006986
GO:0090665;glycoprotein complex;14302;485;GO:0044445
GO:1905231;cellular response to borneol;6;6;GO:0050829
GO:0090666;scaRNA localization to Cajal body;273;45;GO:0005840
GO:1905230;response to borneol;6;0;GO:0046686
GO:0090663;galanin-activated signaling pathway;90;2;GO:0007186
GO:1905237;response to cyclosporin A;9;7;GO:0009631
GO:0090664;response to high population density;3;3;GO:0010033
GO:1905236;cellular response to quercetin;0;0;GO:0071346
GO:0090661;box H/ACA telomerase RNP complex;198;305;GO:0005737
GO:1905235;response to quercetin;9;6;GO:0006979
GO:1905234;cellular response to codeine;0;0;GO:0006950
GO:0051062;UDP reductase activity;0;2;GO:0004089
GO:0051063;CDP reductase activity;17;2;GO:0003824
GO:0090660;cerebrospinal fluid circulation;756;19;GO:0007565
GO:0051060;pullulanase activity;8959;25;GO:0005986
GO:1905239;regulation of canonical Wnt signaling pathway involved in osteoblast differentiation;113;0;GO:0048608
GO:0051061;ADP reductase activity;0;3;GO:0003824
GO:0075010;regulation of germ tube formation;0;1;GO:0048285
GO:1905238;cellular response to cyclosporin A;0;0;GO:0006955
GO:0099000;viral genome ejection through host cell envelope, contractile tail mechanism;2852;3;GO:0016021
GO:0099001;viral genome ejection through host cell envelope, long flexible tail mechanism;73;5;GO:0016021
GO:0051059;NF-kappaB binding;1616;787;GO:0043066
GO:0075004;adhesion of symbiont spore to host;2;4;GO:0048193
GO:0051057;positive regulation of small GTPase mediated signal transduction;5517;615;GO:0043403
GO:0051058;negative regulation of small GTPase mediated signal transduction;6648;315;GO:0043403
GO:0051055;negative regulation of lipid biosynthetic process;8794;155;GO:0045944
GO:0075000;response to host osmotic environment;0;0;GO:0009415
GO:0051056;regulation of small GTPase mediated signal transduction;91547;3370;GO:0007264
GO:0075001;adhesion of symbiont infection structure to host;0;5;GO:0044421
GO:0051053;negative regulation of DNA metabolic process;48670;478;GO:0006281
GO:0075002;adhesion of symbiont germination tube to host;0;0;GO:0048193
GO:0051054;positive regulation of DNA metabolic process;23925;708;GO:0006281
GO:0075003;adhesion of symbiont appressorium to host;0;0;GO:0048305
GO:0075009;germ tube formation;0;1;GO:0007507
GO:0090669;telomerase RNA stabilization;217;45;GO:0005524
GO:0090634;microglial cell mediated cytotoxicity;140;4;GO:0006954
GO:1905244;regulation of modification of synaptic structure;606;223;GO:0048167
GO:0090635;extracellular core region of desmosome;0;1;GO:0005576
GO:1905243;cellular response to 3,3',5-triiodo-L-thyronine;11;1;GO:0009719
GO:0090632;N-glycolylneuraminic acid (Neu5Gc) cytidylyltransferase activity;5;1;GO:0004721
GO:1905242;response to 3,3',5-triiodo-L-thyronine;26;4;GO:0048608
GO:0090633;keto-deoxynonulosonic acid (KDN) cytidylyltransferase activity;7;1;GO:0006067
GO:1905241;positive regulation of canonical Wnt signaling pathway involved in osteoblast differentiation;3;2;GO:0048704
GO:0090630;activation of GTPase activity;198;1140;GO:0005524
GO:1905247;positive regulation of aspartic-type peptidase activity;20;251;GO:0048608
GO:1905246;negative regulation of aspartic-type peptidase activity;6;70;GO:0010401
GO:1905245;regulation of aspartic-type peptidase activity;29;8;GO:0010468
GO:0051073;adenosylcobinamide-GDP ribazoletransferase activity;80110;9;GO:0003954
GO:0051071;4,6-pyruvylated galactose residue metabolic process;0;1;GO:0006073
GO:0051072;4,6-pyruvylated galactose residue biosynthetic process;23;1;GO:0006022
GO:0075043;melanization of appressorium wall;0;1;GO:0009636
GO:0051070;galactomannan biosynthetic process;4;1;GO:1901363
GO:0051068;dihydrolipoamide metabolic process;2;558;GO:0006066
GO:0075039;establishment of turgor in appressorium;1;0;GO:0048305
GO:0051069;galactomannan metabolic process;22;1;GO:0006073
GO:0051066;dihydrobiopterin metabolic process;54591;35;GO:0006749
GO:0051067;dihydropteridine metabolic process;11;2;GO:0006765
GO:0051064;TTP reductase activity;0;2;GO:0003954
GO:0075035;appressorium maturation;1;2;GO:0048305
GO:0051065;CTP reductase activity;1;2;GO:0003954
GO:0090638;phosphatidylcholine biosynthesis from phosphatidylethanolamine;0;2;GO:0006633
GO:1905240;negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation;110;5;GO:0045944
GO:0090639;phosphatidylcholine biosynthesis from choline and CDP-diacylglycerol;0;2;GO:0006633
GO:0090636;outer dense plaque of desmosome;223;78;GO:0005576
GO:0090637;inner dense plaque of desmosome;218;96;GO:0005576
GO:1905255;regulation of RNA binding transcription factor activity;1;1;GO:0030528
GO:0090646;mitochondrial tRNA processing;1479;27;GO:0006519
GO:0090643;inflorescence phyllotactic patterning;0;0;GO:0048704
GO:0090644;age-related resistance;4;1;GO:0006979
GO:0090641;microsporidian-type endospore;0;0;GO:0048304
GO:1905259;negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway;78;7;GO:1901169
GO:0090642;microsporidian-type exospore;0;0;GO:0048304
GO:1905258;regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway;78;3;GO:1901363
GO:1905257;positive regulation of RNA binding transcription factor activity;0;0;GO:0010468
GO:0090640;phosphatidylcholine biosynthesis from sn-glycero-3-phosphocholine;0;5;GO:0006633
GO:1905256;negative regulation of RNA binding transcription factor activity;0;1;GO:0010468
GO:0051084;'de novo' post-translational protein folding;8492;9;GO:0006457
GO:0051085;chaperone cofactor-dependent protein refolding;6791;1090;GO:0006457
GO:0075030;modulation of formation of symbiont germ tube hook structure for appressorium development;0;1;GO:0048309
GO:0051082;unfolded protein binding;692510;9310;GO:0008023
GO:0075031;positive regulation of formation of symbiont germ tube hook structure for appressorium development;0;1;GO:0048309
GO:0051083;'de novo' cotranslational protein folding;4928;772;GO:0006457
GO:0075032;negative regulation of formation of symbiont germ tube hook structure for appressorium development;0;0;GO:0048405
GO:0051080;meiosis II nuclear membrane disassembly;0;0;GO:0007067
GO:0051081;nuclear membrane disassembly;282;8;GO:0006979
GO:0051079;meiosis I nuclear membrane disassembly;0;0;GO:0007067
GO:0075029;formation of appressorium germ tube hook structure;0;0;GO:0048309
GO:0051077;secondary cell septum;0;3;GO:0048471
GO:0051078;meiotic nuclear membrane disassembly;20;1;GO:0007062
GO:0051075;S-adenosylmethionine:tRNA ribosyltransferase-isomerase activity;51145;24;GO:0003735
GO:0075025;initiation of appressorium formation;0;0;GO:0048305
GO:0090649;response to oxygen-glucose deprivation;188;33;GO:0097194
GO:1905251;epidermal growth factor receptor signaling pathway involved in heart process;1;0;GO:0007179
GO:0090648;response to environmental enrichment;42;4;GO:0042221
GO:0004704;NF-kappaB-inducing kinase activity;150;179;GO:0043406
GO:0004703;G protein-coupled receptor kinase activity;11051;117;GO:0004713
GO:0004706;JUN kinase kinase kinase activity;373;101;GO:0043406
GO:0004705;JUN kinase activity;701;194;GO:0043406
GO:0004708;MAP kinase kinase activity;1859;846;GO:0043406
GO:0004707;MAP kinase activity;68336;1990;GO:0043565
GO:0004709;MAP kinase kinase kinase activity;17891;1270;GO:0043406
GO:0099091;postsynaptic specialization, intracellular component;673;10;GO:0048666
GO:0099092;postsynaptic density, intracellular component;581;78;GO:0043005
GO:0099095;ligand-gated monoatomic anion channel activity;5496;1;GO:0005216
GO:0099096;vestibular calyx terminal;0;1;GO:0008544
GO:0099093;calcium export from the mitochondrion;257;7;GO:0006836
GO:0099094;ligand-gated monoatomic cation channel activity;93354;4;GO:0005216
GO:0099099;G-protein gated monoatomic ion channel activity;0;1;GO:0005216
GO:0099098;microtubule polymerization based movement;88;1;GO:0007049
GO:0016722;oxidoreductase activity, acting on metal ions;89847;170;GO:0004601
GO:0016723;oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor;16621;6;GO:0004601
GO:0016724;oxidoreductase activity, acting on metal ions, oxygen as acceptor;35079;3;GO:0004601
GO:0016725;oxidoreductase activity, acting on CH or CH2 groups;496299;60;GO:0016616
GO:0016726;oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor;166223;8;GO:0004497
GO:0016727;oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor;988;5;GO:0016616
GO:0099070;static microtubule bundle;27;5;GO:0007049
GO:0016728;oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor;247488;42;GO:0004601
GO:0099073;mitochondrion-derived vesicle;148;9;GO:0005741
GO:0099074;mitochondrion to lysosome transport;157;8;GO:0006986
GO:0099071;dynamic microtubule bundle;0;0;GO:0007049
GO:0099072;regulation of postsynaptic membrane neurotransmitter receptor levels;4724;55;GO:0048666
GO:0004740;pyruvate dehydrogenase (acetyl-transferring) kinase activity;576;106;GO:0004723
GO:0099077;histone-dependent DNA binding;3;3;GO:0003677
GO:0099078;BORC complex;705;8;GO:0000976
GO:0004742;dihydrolipoyllysine-residue acetyltransferase activity;67842;373;GO:0005524
GO:0099075;mitochondrion-derived vesicle mediated transport;157;0;GO:0008023
GO:0004741;[pyruvate dehydrogenase (lipoamide)] phosphatase activity;264;0;GO:0004723
GO:0099076;mitochondrion to peroxisome transport;0;0;GO:0006986
GO:0004733;pyridoxamine phosphate oxidase activity;91172;638;GO:0004730
GO:0004732;pyridoxal oxidase activity;13;4;GO:0004746
GO:0004735;pyrroline-5-carboxylate reductase activity;165490;1050;GO:0004067
GO:0099068;postsynapse assembly;1958;21;GO:0048608
GO:0004734;pyrimidodiazepine synthase activity;21;9;GO:0004721
GO:0099069;synaptic vesicle tethering involved in synaptic vesicle exocytosis;5;0;GO:0008092
GO:0004737;pyruvate decarboxylase activity;7061;226;GO:0006099
GO:0004736;pyruvate carboxylase activity;56390;167;GO:0006099
GO:0004739;pyruvate dehydrogenase (acetyl-transferring) activity;159280;812;GO:0004089
GO:0004738;pyruvate dehydrogenase activity;161864;835;GO:0004723
GO:0016730;oxidoreductase activity, acting on iron-sulfur proteins as donors;174465;56;GO:0004091
GO:0016731;oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor;89128;45;GO:0003954
GO:0016732;oxidoreductase activity, acting on iron-sulfur proteins as donors, dinitrogen as acceptor;67649;2;GO:0003954
GO:0016711;flavonoid 3'-monooxygenase activity;60;2;GO:0004497
GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;91114;706;GO:0004601
GO:0016713;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen;7159;48;GO:0004601
GO:0016714;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen;41745;50;GO:0004601
GO:0016715;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen;28334;108;GO:0004601
GO:0099080;supramolecular complex;909634;612;GO:0043234
GO:0016716;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen;3603;9;GO:0016616
GO:0099081;supramolecular polymer;707604;505;GO:0043169
GO:0016717;oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water;72469;467;GO:0016616
GO:0016719;carotene 7,8-desaturase activity;2881;67;GO:0004497
GO:0099084;postsynaptic specialization organization;2727;68;GO:0048666
GO:0099085;DIF dechlorinase activity;2;1;GO:0004497
GO:0099082;retrograde trans-synaptic signaling by neuropeptide;17;0;GO:0007218
GO:0099083;retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission;2;2;GO:0007218
GO:0004751;ribose-5-phosphate isomerase activity;97099;996;GO:0004067
GO:0099088;axonal transport of messenger ribonucleoprotein complex;23;1;GO:0006936
GO:0004750;D-ribulose-phosphate 3-epimerase activity;155930;1060;GO:0006096
GO:0099089;establishment of endoplasmic reticulum localization to postsynapse;7;2;GO:0008544
GO:0004753;saccharopine dehydrogenase activity;12477;19;GO:0006067
GO:0099086;synaptonemal structure;8022;6;GO:0008021
GO:0099087;anterograde axonal transport of messenger ribonucleoprotein complex;0;0;GO:0006903
GO:0004743;pyruvate kinase activity;121801;1560;GO:0004721
GO:0004746;riboflavin synthase activity;17962;33;GO:0004067
GO:0099079;actin body;123;3;GO:0035023
GO:0004745;NAD-retinol dehydrogenase activity;1327;208;GO:0006749
GO:0004748;ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;203471;887;GO:0003824
GO:0004747;ribokinase activity;150347;482;GO:0003824
GO:0004749;ribose phosphate diphosphokinase activity;166612;1700;GO:0004061
GO:0016720;delta12-fatty acid dehydrogenase activity;39;6;GO:0006631
GO:0016721;oxidoreductase activity, acting on superoxide radicals as acceptor;167611;142;GO:0004497
GO:0016701;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen;593394;1220;GO:0004601
GO:0016702;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;447630;1620;GO:0004601
GO:0016703;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases);88055;5;GO:0004497
GO:0016705;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;1624187;5330;GO:0016616
GO:0016706;2-oxoglutarate-dependent dioxygenase activity;106120;306;GO:0004497
GO:0016707;gibberellin 3-beta-dioxygenase activity;248;43;GO:0004497
GO:0016708;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor;28790;9;GO:0004601
GO:0099051;vesicle scission involved in endocytosis;0;1;GO:0008021
GO:0016709;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;219291;1600;GO:0004601
GO:0099052;vesicle scission involved in clathrin-mediated endocytosis;0;1;GO:0008021
GO:0099050;vesicle scission;29;3;GO:0008030
GO:0004720;protein-lysine 6-oxidase activity;12237;143;GO:0004784
GO:0099053;activating signal cointegrator 1 complex;175;7;GO:0003712
GO:0099054;presynapse assembly;7959;62;GO:0048608
GO:0004711;ribosomal protein S6 kinase activity;1071;73;GO:0006468
GO:0099048;CRISPR-cas system;21;5;GO:0008061
GO:0099049;clathrin coat assembly involved in endocytosis;0;1;GO:0006897
GO:0004713;protein tyrosine kinase activity;544235;6970;GO:0004713
GO:0099046;clearance of foreign intracellular nucleic acids;274613;1;GO:0097194
GO:0004712;protein serine/threonine/tyrosine kinase activity;31146;1360;GO:0004713
GO:0099047;clearance of foreign intracellular RNA;0;0;GO:0034660
GO:0004715;non-membrane spanning protein tyrosine kinase activity;67946;3050;GO:0004713
GO:0004714;transmembrane receptor protein tyrosine kinase activity;121679;2990;GO:0004713
GO:0004719;protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;116258;509;GO:0004812
GO:0016710;trans-cinnamate 4-monooxygenase activity;146;22;GO:0004497
GO:0004731;purine-nucleoside phosphorylase activity;225903;671;GO:0004073
GO:0004730;pseudouridylate synthase activity;34895;508;GO:0004497
GO:0004722;protein serine/threonine phosphatase activity;430907;2950;GO:0004721
GO:0004721;phosphoprotein phosphatase activity;1242241;5010;GO:0004721
GO:0004723;calcium-dependent protein serine/threonine phosphatase activity;21369;79;GO:0004721
GO:0004726;non-membrane spanning protein tyrosine phosphatase activity;7356;440;GO:0004722
GO:0004725;protein tyrosine phosphatase activity;302771;4160;GO:0004723
GO:0004727;prenylated protein tyrosine phosphatase activity;3;63;GO:0004723
GO:0004729;oxygen-dependent protoporphyrinogen oxidase activity;37718;59;GO:0004073
GO:0036012;cyanelle inner membrane;1;1;GO:0005737
GO:0036013;cyanelle outer membrane;0;2;GO:0005576
GO:0036014;cyanelle intermembrane space;0;1;GO:0005746
GO:0036015;response to interleukin-3;206;6;GO:0045765
GO:0036010;protein localization to endosome;1375;1260;GO:0005768
GO:0036011;imaginal disc-derived leg segmentation;306;7;GO:0008544
GO:1903403;negative regulation of renal phosphate excretion;61;6;GO:0010468
GO:1903404;positive regulation of renal phosphate excretion;0;0;GO:0010468
GO:1903401;L-lysine transmembrane transport;16324;68;GO:0008544
GO:1903402;regulation of renal phosphate excretion;113;1;GO:0042254
GO:1903407;negative regulation of P-type sodium:potassium-exchanging transporter activity;14;3;GO:0010468
GO:1903408;positive regulation of P-type sodium:potassium-exchanging transporter activity;115;7;GO:0010468
GO:1903405;protein localization to nuclear body;188;22;GO:0005634
GO:1903406;regulation of P-type sodium:potassium-exchanging transporter activity;130;0;GO:0005215
GO:0048001;erythrose-4-phosphate dehydrogenase activity;9179;9;GO:0006096
GO:0051642;centrosome localization;1954;782;GO:0005815
GO:0048000;isoflavone 3'-hydroxylase activity;4;1;GO:0004497
GO:0051643;endoplasmic reticulum localization;9182;85;GO:0005783
GO:0051640;organelle localization;150224;2270;GO:0005737
GO:0000064;L-ornithine transmembrane transporter activity;2472;95;GO:0005215
GO:0051641;cellular localization;7523508;2770;GO:0005575
GO:0000062;fatty-acyl-CoA binding;27568;1510;GO:0097367
GO:0048003;antigen processing and presentation of lipid antigen via MHC class Ib;250;170;GO:0002474
GO:0048002;antigen processing and presentation of peptide antigen;51774;1050;GO:0019882
GO:0036009;protein-glutamine N-methyltransferase activity;41432;26;GO:0004723
GO:0051648;vesicle localization;44855;365;GO:0008021
GO:0051649;establishment of localization in cell;2728430;3510;GO:0051604
GO:0036005;response to macrophage colony-stimulating factor;956;59;GO:0002504
GO:0051646;mitochondrion localization;5385;956;GO:0005739
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus;940;129;GO:0002684
GO:0051647;nucleus localization;3256;519;GO:0005634
GO:0036007;scintillon;0;1;GO:0009952
GO:0051644;plastid localization;1484;9;GO:0009536
GO:0036008;sucrose catabolic process to fructose-6-phosphate and glucose-6-phosphate;0;3;GO:0005975
GO:0051645;Golgi localization;958;298;GO:0005764
GO:0036001;'de novo' pyridoxal 5'-phosphate biosynthetic process;11;0;GO:0009065
GO:0036002;pre-mRNA binding;71423;468;GO:0003723
GO:0036003;positive regulation of transcription from RNA polymerase II promoter in response to stress;1714;365;GO:0045944
GO:0036004;GAF domain binding;61;6;GO:0005515
GO:0036000;mucocyst;0;2;GO:0005576
GO:0048009;insulin-like growth factor receptor signaling pathway;2891;1440;GO:0007179
GO:0048008;platelet-derived growth factor receptor signaling pathway;6590;1270;GO:0007179
GO:1903415;flavonoid transport from endoplasmic reticulum to plant-type vacuole;57;3;GO:0006869
GO:0048007;antigen processing and presentation, exogenous lipid antigen via MHC class Ib;158;193;GO:0002474
GO:1903412;response to bile acid;290;8;GO:0042605
GO:0048006;antigen processing and presentation, endogenous lipid antigen via MHC class Ib;92;49;GO:0002474
GO:1903413;cellular response to bile acid;158;23;GO:0072562
GO:1903418;protein localization to plasma membrane of cell tip;0;0;GO:0009986
GO:1903419;protein localization to cortical endoplasmic reticulum;0;0;GO:0005789
GO:1903416;response to glycoside;126;160;GO:0009813
GO:0048012;hepatocyte growth factor receptor signaling pathway;894;251;GO:0007179
GO:0051653;spindle localization;8064;301;GO:0051321
GO:0000077;DNA damage checkpoint signaling;33791;522;GO:0000086
GO:0048011;neurotrophin TRK receptor signaling pathway;1869;955;GO:0007169
GO:0051654;establishment of mitochondrion localization;1783;1370;GO:0005743
GO:0000076;DNA replication checkpoint signaling;9506;222;GO:0007050
GO:0048010;vascular endothelial growth factor receptor signaling pathway;6310;2690;GO:0048010
GO:0051651;maintenance of location in cell;58811;831;GO:0051649
GO:1903409;reactive oxygen species biosynthetic process;2645;648;GO:0006879
GO:0000075;cell cycle checkpoint signaling;63745;252;GO:0007049
GO:0051652;maintenance of chromosome location;0;0;GO:0051276
GO:0000073;initial mitotic spindle pole body separation;167;6;GO:0000922
GO:0048015;phosphatidylinositol-mediated signaling;37554;3360;GO:0007186
GO:0051650;establishment of vesicle localization;43369;860;GO:0006626
GO:0048014;Tie signaling pathway;296;65;GO:0007165
GO:0048013;ephrin receptor signaling pathway;42618;2030;GO:0007169
GO:0000070;mitotic sister chromatid segregation;64606;5440;GO:0007059
GO:0075606;transport of viral material towards nucleus;45889;3;GO:0048193
GO:0051659;maintenance of mitochondrion location;152;260;GO:0005739
GO:0051657;maintenance of organelle location;885;8;GO:0007049
GO:0051658;maintenance of nucleus location;49;2;GO:0007050
GO:0051655;maintenance of vesicle location;0;1;GO:0007049
GO:0051656;establishment of organelle localization;111147;1660;GO:0005783
GO:1903421;regulation of synaptic vesicle recycling;1122;123;GO:0048608
GO:1903422;negative regulation of synaptic vesicle recycling;58;8;GO:0048608
GO:1903420;protein localization to endoplasmic reticulum tubular network;13;4;GO:0005783
GO:1903425;fluoride transmembrane transporter activity;89568;22;GO:0005215
GO:0048019;receptor antagonist activity;2125;159;GO:0004872
GO:1903426;regulation of reactive oxygen species biosynthetic process;1974;228;GO:0046686
GO:0048018;receptor ligand activity;399209;1740;GO:0004872
GO:1903423;positive regulation of synaptic vesicle recycling;255;114;GO:0048608
GO:1903424;fluoride transmembrane transport;136747;6;GO:0006826
GO:0000038;very long-chain fatty acid metabolic process;10250;1700;GO:0006631
GO:1903429;regulation of cell maturation;1280;9;GO:0048608
GO:0000036;acyl carrier activity;50358;604;GO:0004721
GO:1903427;negative regulation of reactive oxygen species biosynthetic process;487;65;GO:0046686
GO:0000035;acyl binding;366;145;GO:0097159
GO:1903428;positive regulation of reactive oxygen species biosynthetic process;698;240;GO:0046686
GO:0000045;autophagosome assembly;30203;1220;GO:0007049
GO:0002697;regulation of immune effector process;32795;2330;GO:0002684
GO:0048023;positive regulation of melanin biosynthetic process;494;32;GO:0046148
GO:0051664;nuclear pore localization;358;22;GO:0005577
GO:0002698;negative regulation of immune effector process;6415;516;GO:0002684
GO:0048022;negative regulation of melanin biosynthetic process;215;30;GO:0046148
GO:0051665;membrane raft localization;60900;89;GO:0072562
GO:0002699;positive regulation of immune effector process;17721;702;GO:0002684
GO:0048021;regulation of melanin biosynthetic process;907;65;GO:0046148
GO:0048020;CCR chemokine receptor binding;1426;649;GO:0005576
GO:0051663;oocyte nucleus localization involved in oocyte dorsal/ventral axis specification;58;6;GO:0008544
GO:0000041;transition metal ion transport;1495735;1710;GO:0006810
GO:0048027;mRNA 5'-UTR binding;23030;240;GO:0003729
GO:0051660;establishment of centrosome localization;381;65;GO:0048471
GO:0048026;positive regulation of mRNA splicing, via spliceosome;1380;689;GO:0000398
GO:0051661;maintenance of centrosome location;419;30;GO:0048471
GO:0048025;negative regulation of mRNA splicing, via spliceosome;1233;1680;GO:0000398
GO:0048024;regulation of mRNA splicing, via spliceosome;24522;1020;GO:0000398
GO:0051668;localization within membrane;771356;669;GO:0005576
GO:0051669;fructan beta-fructosidase activity;474;7;GO:0005986
GO:0051666;actin cortical patch localization;6047;119;GO:0005911
GO:0051667;establishment of plastid localization;1351;4;GO:0009536
GO:1903432;regulation of TORC1 signaling;11955;85;GO:1901363
GO:1903433;regulation of constitutive secretory pathway;121;4;GO:0003723
GO:1903430;negative regulation of cell maturation;518;2;GO:0048608
GO:1903431;positive regulation of cell maturation;466;7;GO:0048608
GO:1903436;regulation of mitotic cytokinetic process;630;69;GO:0000910
GO:1903437;negative regulation of mitotic cytokinetic process;46;0;GO:0048285
GO:0048029;monosaccharide binding;159033;942;GO:0008152
GO:1903434;negative regulation of constitutive secretory pathway;59;2;GO:0010467
GO:0048028;galacturonan binding;1;5;GO:0005576
GO:1903435;positive regulation of constitutive secretory pathway;62;55;GO:0032989
GO:0000049;tRNA binding;1677436;3480;GO:0003735
GO:0000048;peptidyltransferase activity;74;31;GO:0004812
GO:1903438;positive regulation of mitotic cytokinetic process;508;127;GO:0048285
GO:1903439;calcitonin family receptor complex;564;8;GO:0005576
GO:0000056;ribosomal small subunit export from nucleus;4479;390;GO:0006631
GO:0048034;heme O biosynthetic process;60238;348;GO:0006749
GO:0051675;isopullulanase activity;2;2;GO:0004553
GO:0000055;ribosomal large subunit export from nucleus;13167;900;GO:0006631
GO:0048033;heme O metabolic process;60238;5;GO:0006796
GO:0051676;pullulan metabolic process;2;2;GO:0006032
GO:0000054;ribosomal subunit export from nucleus;20043;1120;GO:0005740
GO:0048032;galacturonate binding;2;3;GO:0005576
GO:0051673;disruption of plasma membrane integrity in another organism;162345;6;GO:0006979
GO:0000053;argininosuccinate metabolic process;205;147;GO:0009062
GO:0048031;trisaccharide binding;1;1;GO:0042379
GO:0051674;localization of cell;295;2130;GO:0051649
GO:0000052;citrulline metabolic process;632;444;GO:0006576
GO:0048038;quinone binding;754338;1460;GO:0019901
GO:0000050;urea cycle;15832;3920;GO:0006099
GO:0048036;central complex development;117;15;GO:0048608
GO:0048035;heme O catabolic process;0;3;GO:0006865
GO:0051670;inulinase activity;27;5;GO:0004553
GO:0048030;disaccharide binding;267;108;GO:0005576
GO:0051679;6-alpha-maltosylglucose metabolic process;0;2;GO:0006032
GO:0051677;pullulan biosynthetic process;0;2;GO:0006032
GO:0051678;pullulan catabolic process;2;5;GO:0006032
GO:0036056;filtration diaphragm;301;70;GO:0048193
GO:0036057;slit diaphragm;255;300;GO:0009986
GO:0036058;filtration diaphragm assembly;169;28;GO:0048193
GO:0036059;nephrocyte diaphragm assembly;54;10;GO:0048193
GO:0036052;protein localization to uropod;3;1;GO:0005576
GO:0036053;glomerular endothelium fenestra;18;7;GO:0005576
GO:0036054;protein-malonyllysine demalonylase activity;17676;10;GO:0006081
GO:0051608;histamine transport;988;32;GO:0006874
GO:0036055;protein-succinyllysine desuccinylase activity;40000;56;GO:0006081
GO:0051609;inhibition of neurotransmitter uptake;0;7;GO:0006836
GO:0036050;peptidyl-lysine succinylation;0;3;GO:0006464
GO:0036051;protein localization to trailing edge;9;2;GO:0005576
GO:0051606;detection of stimulus;571019;1050;GO:0009583
GO:0051607;defense response to virus;248681;6680;GO:0050832
GO:0051604;protein maturation;2653130;3080;GO:0006464
GO:0036049;peptidyl-lysine desuccinylation;40012;7;GO:0006468
GO:0051602;response to electrical stimulus;743;634;GO:0009611
GO:0051603;proteolysis involved in protein catabolic process;737147;1410;GO:0006508
GO:0051600;regulation of endocytosis by exocyst localization;4;1;GO:0009986
GO:0051601;exocyst localization;326;174;GO:0007030
GO:0036046;protein demalonylation;19;2;GO:0006468
GO:0036047;peptidyl-lysine demalonylation;11;6;GO:0006468
GO:0036048;protein desuccinylation;40035;5;GO:0006464
GO:0036041;long-chain fatty acid binding;1127;379;GO:0030198
GO:0036042;long-chain fatty acyl-CoA binding;246;115;GO:0097367
GO:0051619;inhibition of histamine uptake;0;1;GO:0002218
GO:0036040;curcumin catabolic process;0;2;GO:0046274
GO:0051610;serotonin uptake;3497;182;GO:0006836
GO:0051617;negative regulation of histamine uptake;0;1;GO:0048608
GO:0051618;positive regulation of histamine uptake;0;1;GO:0048608
GO:0051615;histamine uptake;279;8;GO:0006849
GO:0051616;regulation of histamine uptake;0;1;GO:0002218
GO:0036038;MKS complex;3157;131;GO:0005524
GO:0051613;positive regulation of serotonin uptake;0;1;GO:0048608
GO:0036039;curcumin metabolic process;0;1;GO:0006725
GO:0051614;inhibition of serotonin uptake;0;1;GO:0006836
GO:0051611;regulation of serotonin uptake;120;10;GO:0004976
GO:0051612;negative regulation of serotonin uptake;71;295;GO:0048608
GO:0036034;mediator complex assembly;49;8;GO:0005829
GO:0036035;osteoclast development;1075;126;GO:0007596
GO:0036036;cardiac neural crest cell delamination;0;1;GO:0007517
GO:0036037;CD8-positive, alpha-beta T cell activation;1617;584;GO:0002449
GO:0036030;protein C inhibitor-plasma kallikrein complex;47;57;GO:0005576
GO:0036031;recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex;35;4;GO:0003723
GO:0036032;neural crest cell delamination;11;1;GO:0007517
GO:0036033;mediator complex binding;775;158;GO:0005829
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;208;3070;GO:0005524
GO:0000089;mitotic metaphase;0;461;GO:0000278
GO:0051620;norepinephrine uptake;621;35;GO:0006836
GO:0000088;mitotic prophase;0;125;GO:0000278
GO:0051621;regulation of norepinephrine uptake;152;35;GO:0006836
GO:0000087;mitotic M phase;0;84;GO:0000278
GO:0000086;G2/M transition of mitotic cell cycle;19429;3930;GO:0000070
GO:0000085;mitotic G2 phase;0;220;GO:0000278
GO:0000084;mitotic S phase;0;84;GO:0000278
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;4658;2340;GO:0000082
GO:0000082;G1/S transition of mitotic cell cycle;15509;5750;GO:0000082
GO:0051628;positive regulation of epinephrine uptake;0;1;GO:0048608
GO:0000080;mitotic G1 phase;0;180;GO:0000278
GO:0051629;inhibition of epinephrine uptake;0;0;GO:0006836
GO:0051626;regulation of epinephrine uptake;0;1;GO:0002686
GO:0051627;negative regulation of epinephrine uptake;0;1;GO:0048608
GO:0036027;protein C inhibitor-PLAU complex;48;9;GO:0005576
GO:0051624;inhibition of norepinephrine uptake;0;1;GO:0006836
GO:0036028;protein C inhibitor-thrombin complex;46;59;GO:0005576
GO:0051625;epinephrine uptake;104;4;GO:0006836
GO:0036029;protein C inhibitor-KLK3 complex;46;9;GO:0048193
GO:0051622;negative regulation of norepinephrine uptake;48;38;GO:0048608
GO:0051623;positive regulation of norepinephrine uptake;1;6;GO:0048167
GO:0036023;embryonic skeletal limb joint morphogenesis;162;77;GO:0048704
GO:0036024;protein C inhibitor-TMPRSS7 complex;46;9;GO:0043405
GO:0036025;protein C inhibitor-TMPRSS11E complex;46;9;GO:0048193
GO:0036026;protein C inhibitor-PLAT complex;46;9;GO:0005581
GO:0036020;endolysosome membrane;534;134;GO:0005764
GO:0036021;endolysosome lumen;6;61;GO:0005764
GO:0036022;limb joint morphogenesis;252;20;GO:0048608
GO:0051631;regulation of acetylcholine uptake;62;2;GO:0006890
GO:0000099;sulfur amino acid transmembrane transporter activity;22429;98;GO:0008544
GO:0051632;negative regulation of acetylcholine uptake;0;1;GO:0048608
GO:0000098;sulfur amino acid catabolic process;14025;1380;GO:0009062
GO:0000097;sulfur amino acid biosynthetic process;1461045;747;GO:0009063
GO:0051630;acetylcholine uptake;124;1;GO:0006836
GO:0000096;sulfur amino acid metabolic process;1741631;1350;GO:0006541
GO:0000095;S-adenosyl-L-methionine transmembrane transporter activity;514;8;GO:0008565
GO:0000093;mitotic telophase;0;7;GO:0000910
GO:0000092;mitotic anaphase B;0;6;GO:0000910
GO:0051639;actin filament network formation;526;608;GO:0030054
GO:0000091;mitotic anaphase A;0;6;GO:0000910
GO:0000090;mitotic anaphase;0;86;GO:0000910
GO:0051638;barbed-end actin filament uncapping;47;2;GO:0008544
GO:0036016;cellular response to interleukin-3;206;35;GO:0050727
GO:0036017;response to erythropoietin;419;76;GO:0048193
GO:0036018;cellular response to erythropoietin;412;181;GO:0006954
GO:0051633;positive regulation of acetylcholine uptake;0;1;GO:0048608
GO:0036019;endolysosome;851;303;GO:0005764
GO:0051634;inhibition of acetylcholine uptake;0;1;GO:0006890
GO:0061056;sclerotome development;261;47;GO:0007517
GO:0061057;peptidoglycan recognition protein signaling pathway;726;59;GO:0009664
GO:0061058;regulation of peptidoglycan recognition protein signaling pathway;451;3;GO:0043161
GO:0061059;positive regulation of peptidoglycan recognition protein signaling pathway;135;8;GO:0043161
GO:0061052;negative regulation of cell growth involved in cardiac muscle cell development;148;258;GO:0045944
GO:1903487;regulation of lactation;185;10;GO:0010468
GO:0061053;somite development;8186;1470;GO:0007530
GO:1903488;negative regulation of lactation;11;4;GO:0010468
GO:0036098;male germ-line stem cell population maintenance;229;6;GO:0048608
GO:0061054;dermatome development;228;6;GO:0007517
GO:0036099;female germ-line stem cell population maintenance;382;33;GO:0048699
GO:0061055;myotome development;401;27;GO:0048704
GO:0085026;tubovesicular membrane network;1;0;GO:0072562
GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process;61084;1270;GO:0006631
GO:0036093;germ cell proliferation;550;27;GO:0048608
GO:0036094;small molecule binding;74401431;3750;GO:0097159
GO:0085029;extracellular matrix assembly;2965;718;GO:0043062
GO:1903489;positive regulation of lactation;133;54;GO:0010468
GO:0036090;cleavage furrow ingression;178;23;GO:0007067
GO:0097010;eukaryotic translation initiation factor 4F complex assembly;95;28;GO:0003735
GO:0036091;positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress;62;43;GO:0045944
GO:0048089;regulation of female pigmentation;1;2;GO:0030522
GO:0097001;ceramide binding;1532;163;GO:0048193
GO:0048088;regulation of male pigmentation;1;3;GO:0030522
GO:0048087;positive regulation of developmental pigmentation;510;263;GO:0048608
GO:0097003;adipokinetic hormone receptor activity;275;19;GO:0004930
GO:0048086;negative regulation of developmental pigmentation;163;10;GO:0048608
GO:0097002;mitochondrial inner boundary membrane;141;7;GO:0005743
GO:0097005;adipokinetic hormone receptor binding;11;3;GO:0004930
GO:0097004;adipokinetic hormone binding;139;3;GO:0005515
GO:0097007;4,8,12-trimethyltrideca-1,3,7,11-tetraene synthase activity;12;2;GO:0004497
GO:0097006;regulation of plasma lipoprotein particle levels;7383;214;GO:0048146
GO:0048081;positive regulation of cuticle pigmentation;40;8;GO:0048305
GO:0097009;energy homeostasis;3948;817;GO:0007586
GO:0048080;negative regulation of cuticle pigmentation;0;2;GO:0048405
GO:0061060;negative regulation of peptidoglycan recognition protein signaling pathway;316;17;GO:0043403
GO:0097008;(3E)-4,8-dimethyl-1,3,7-nonatriene synthase activity;9;0;GO:0004497
GO:0061061;muscle structure development;78002;2250;GO:0007517
GO:0061062;regulation of nematode larval development;931;7;GO:0048608
GO:0048085;adult chitin-containing cuticle pigmentation;251;10;GO:0008544
GO:0085030;symbiotic process benefiting host;10;2;GO:0009617
GO:0048084;positive regulation of adult chitin-containing cuticle pigmentation;0;2;GO:0048405
GO:0048083;negative regulation of adult chitin-containing cuticle pigmentation;0;3;GO:0048405
GO:0048082;regulation of adult chitin-containing cuticle pigmentation;191;8;GO:0048405
GO:0036089;cleavage furrow formation;568;132;GO:0007067
GO:0061045;negative regulation of wound healing;6335;686;GO:0010717
GO:0085034;symbiont-mediated suppression of host canonical NF-kappaB cascade;9118;0;GO:0046649
GO:1903494;response to dehydroepiandrosterone;41;52;GO:0007596
GO:0061046;regulation of branching involved in lung morphogenesis;400;28;GO:0048608
GO:0085035;haustorium;12;4;GO:0005929
GO:1903495;cellular response to dehydroepiandrosterone;3;0;GO:0009719
GO:0061047;positive regulation of branching involved in lung morphogenesis;109;9;GO:0048608
GO:0085032;pertubation of host canonical NF-kappaB cascade;23834;0;GO:0043123
GO:1903492;response to acetylsalicylate;0;1;GO:0010033
GO:0061048;negative regulation of branching involved in lung morphogenesis;61;45;GO:0048706
GO:0085033;induction of host canonical NF-kappaB signal transduction;14715;1;GO:0043409
GO:1903493;response to clopidogrel;0;1;GO:0042759
GO:0036085;GDP-fucose import into Golgi lumen;119;5;GO:0005929
GO:0061041;regulation of wound healing;10075;941;GO:0010717
GO:1903498;bundle sheath cell differentiation;0;0;GO:0048468
GO:0036086;positive regulation of transcription from RNA polymerase II promoter in response to iron ion starvation;332;2;GO:0045944
GO:0061042;vascular wound healing;835;119;GO:0007596
GO:0085039;hyphal membrane;3;4;GO:0005576
GO:1903499;regulation of mitotic actomyosin contractile ring assembly;150;2;GO:0048285
GO:0036087;glutathione synthase complex;4;1;GO:0008021
GO:0061043;regulation of vascular wound healing;351;100;GO:0010717
GO:0085036;extrahaustorial matrix;0;3;GO:0005576
GO:1903496;response to 11-deoxycorticosterone;40;56;GO:0009725
GO:0036088;D-serine catabolic process;118;6;GO:0009065
GO:0061044;negative regulation of vascular wound healing;210;86;GO:0010717
GO:0085037;extrahaustorial membrane;0;3;GO:0005576
GO:1903497;cellular response to 11-deoxycorticosterone;0;0;GO:0009719
GO:0036081;extracellular ammonia-gated monoatomic ion channel activity;11;0;GO:0005216
GO:0036082;extracellular phenylacetaldehyde-gated monoatomic ion channel activity;25;0;GO:0005216
GO:0036084;GDP-fucose import into endoplasmic reticulum lumen;1;2;GO:0008544
GO:0061049;cell growth involved in cardiac muscle cell development;444;351;GO:0048608
GO:0097021;lymphocyte migration into lymphoid organs;382;167;GO:0002526
GO:0036080;purine nucleotide-sugar transmembrane transporter activity;627;8;GO:0005031
GO:0097020;COPII receptor activity;2463;6;GO:0003700
GO:0097012;response to granulocyte macrophage colony-stimulating factor;439;7;GO:0045766
GO:0048099;anterior/posterior lineage restriction, imaginal disc;5;8;GO:0002040
GO:0097011;cellular response to granulocyte macrophage colony-stimulating factor stimulus;438;85;GO:0009615
GO:0048098;antennal joint development;92;5;GO:0008544
GO:0097014;ciliary plasm;37994;189;GO:0005576
GO:0097013;phagocytic vesicle lumen;16;42;GO:0005764
GO:0097016;L27 domain binding;1709;65;GO:0005515
GO:0097018;renal albumin absorption;277;47;GO:0006890
GO:0097017;renal protein absorption;398;8;GO:0006867
GO:0048092;negative regulation of male pigmentation;1;6;GO:0048608
GO:0048091;positive regulation of female pigmentation;1;3;GO:0048608
GO:0048090;negative regulation of female pigmentation;0;2;GO:0048608
GO:0061050;regulation of cell growth involved in cardiac muscle cell development;330;5;GO:0048608
GO:0061051;positive regulation of cell growth involved in cardiac muscle cell development;179;34;GO:0048608
GO:0085041;arbuscule;0;1;GO:0046395
GO:1903490;positive regulation of mitotic cytokinesis;642;106;GO:0048285
GO:0048095;female pigmentation;1;2;GO:0008544
GO:0085042;periarbuscular membrane;9;2;GO:0009941
GO:1903491;response to simvastatin;0;2;GO:0030518
GO:0048094;male pigmentation;13;5;GO:0008544
GO:0048093;positive regulation of male pigmentation;0;3;GO:0048608
GO:0036078;minus-end specific microtubule depolymerization;0;3;GO:0008037
GO:0061078;positive regulation of prostaglandin secretion involved in immune response;31;2;GO:0050729
GO:0085001;formation of stylet for nutrient acquisition;0;0;GO:0048305
GO:0061079;left horn of sinus venosus development;0;3;GO:0008544
GO:0036074;metaplastic ossification;0;3;GO:0002041
GO:0061074;regulation of neural retina development;360;23;GO:0048666
GO:0036075;replacement ossification;1678;233;GO:0002041
GO:0061075;positive regulation of neural retina development;82;21;GO:0048666
GO:0036076;ligamentous ossification;63;5;GO:0007518
GO:0061076;negative regulation of neural retina development;0;5;GO:0048666
GO:0036077;intratendonous ossification;3;2;GO:0002086
GO:0061077;chaperone-mediated protein folding;53749;1750;GO:0006457
GO:0036070;light-independent bacteriochlorophyll biosynthetic process;3479;1;GO:0009579
GO:0036071;N-glycan fucosylation;4250;269;GO:0008544
GO:0036072;direct ossification;372;43;GO:0048609
GO:0036073;perichondral ossification;4;3;GO:0002041
GO:0099642;retrograde axonal protein transport;7;1;GO:0006903
GO:0099643;signal release from synapse;23118;141;GO:0007611
GO:0099640;axo-dendritic protein transport;200;51;GO:0048193
GO:0099641;anterograde axonal protein transport;172;9;GO:0048193
GO:0099646;neurotransmitter receptor transport, plasma membrane to endosome;0;1;GO:0006836
GO:0099644;protein localization to presynaptic membrane;0;0;GO:0048169
GO:0099645;neurotransmitter receptor localization to postsynaptic specialization membrane;1384;37;GO:0048666
GO:0061081;positive regulation of myeloid leukocyte cytokine production involved in immune response;1517;157;GO:0050729
GO:0061082;myeloid leukocyte cytokine production;2422;25;GO:0050729
GO:0061083;regulation of protein refolding;21;7;GO:0006457
GO:0061084;negative regulation of protein refolding;12;47;GO:0006457
GO:0061080;right horn of sinus venosus development;0;1;GO:0048704
GO:0036067;light-dependent chlorophyll biosynthetic process;3;2;GO:0019637
GO:0061067;negative regulation of dauer larval development;86;2;GO:0048608
GO:0036068;light-independent chlorophyll biosynthetic process;10220;3;GO:0019699
GO:0061068;urethra development;0;0;GO:0007599
GO:0036069;light-dependent bacteriochlorophyll biosynthetic process;1;1;GO:0009579
GO:0061069;male urethra development;0;0;GO:0007565
GO:0036063;acroblast;60;3;GO:0005576
GO:0061063;positive regulation of nematode larval development;112;4;GO:0048608
GO:0085016;dormancy exit of symbiont in host;4;2;GO:0048285
GO:0036064;ciliary basal body;16019;1180;GO:0005929
GO:0061064;negative regulation of nematode larval development;621;2;GO:0048608
GO:0085017;entry into host cell by a symbiont-containing vacuole;15;3;GO:0048193
GO:0036065;fucosylation;18272;343;GO:0002576
GO:0061065;regulation of dauer larval development;282;3;GO:0048608
GO:0085014;dormancy entry of symbiont in host;2;2;GO:0048285
GO:0036066;protein O-linked fucosylation;7405;81;GO:0006493
GO:0061066;positive regulation of dauer larval development;59;1;GO:0048608
GO:0085015;dormancy maintenance of symbiont in host;1;3;GO:0048285
GO:0036060;slit diaphragm assembly;110;53;GO:0009986
GO:0036061;muscle cell chemotaxis toward tendon cell;16;2;GO:0048608
GO:0036062;presynaptic periactive zone;85;11;GO:0005730
GO:0085019;formation of tubovesicular network for nutrient acquisition;0;0;GO:0006897
GO:0061070;female urethra development;0;1;GO:0007565
GO:0061071;urethra epithelium development;0;2;GO:0030216
GO:0061072;iris morphogenesis;402;52;GO:0048316
GO:0061073;ciliary body morphogenesis;207;46;GO:0048608
GO:0085020;protein K6-linked ubiquitination;45;1210;GO:0006464
GO:0061013;regulation of mRNA catabolic process;125479;290;GO:0010467
GO:1903440;amylin receptor complex;294;129;GO:0005576
GO:0061014;positive regulation of mRNA catabolic process;87037;743;GO:0010467
GO:0061015;snRNA import into nucleus;2685;228;GO:0006460
GO:1903443;cellular response to lipoic acid;0;1;GO:0006950
GO:1903444;negative regulation of brown fat cell differentiation;224;2;GO:0045944
GO:0061010;gallbladder development;111;3;GO:0007517
GO:1903441;protein localization to ciliary membrane;575;21;GO:0005576
GO:0061011;hepatic duct development;14;5;GO:0042127
GO:1903442;response to lipoic acid;4;4;GO:0008299
GO:1903447;geraniol catabolic process;0;0;GO:0006081
GO:1903448;geraniol biosynthetic process;6;0;GO:0046274
GO:1903445;protein transport from ciliary membrane to plasma membrane;118;39;GO:0006810
GO:0048039;ubiquinone binding;22523;221;GO:0097159
GO:1903446;geraniol metabolic process;6;0;GO:0006073
GO:0061016;snRNA localization to Cajal body;0;0;GO:0005840
GO:0061017;hepatoblast differentiation;141;43;GO:0042127
GO:1903449;androst-4-ene-3,17-dione biosynthetic process;39;2;GO:0006629
GO:0051686;establishment of ER localization;20;5;GO:0008544
GO:0099620;UDP-4-amino-4-deoxy-L-arabinose aminotransferase;4452;2;GO:0006066
GO:0051687;maintenance of spindle location;0;1;GO:0048285
GO:0099621;undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase activity;4451;3;GO:0006021
GO:0051684;maintenance of Golgi location;199;27;GO:0005829
GO:0051685;maintenance of ER location;66;18;GO:0007049
GO:0051682;galactomannan catabolic process;16;2;GO:0006032
GO:0099624;atrial cardiac muscle cell membrane repolarization;434;38;GO:0048407
GO:0048048;embryonic eye morphogenesis;4590;463;GO:0008544
GO:0051683;establishment of Golgi localization;321;98;GO:0005764
GO:0099625;ventricular cardiac muscle cell membrane repolarization;1964;9;GO:0048407
GO:0048047;mating behavior, sex discrimination;92;24;GO:0007586
GO:0051680;6-alpha-maltosylglucose biosynthetic process;0;2;GO:0006021
GO:0099622;cardiac muscle cell membrane repolarization;3259;95;GO:0048407
GO:0048046;apoplast;106974;2810;GO:0009536
GO:0051681;6-alpha-maltosylglucose catabolic process;0;0;GO:0006032
GO:0099623;regulation of cardiac muscle cell membrane repolarization;1294;18;GO:0048407
GO:0099628;neurotransmitter receptor diffusion trapping;300;9;GO:0006836
GO:0099629;postsynaptic specialization of symmetric synapse;43;2;GO:0048666
GO:0099626;voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;193;6;GO:0008092
GO:0099627;neurotransmitter receptor cycle;69;3;GO:0007612
GO:0048041;focal adhesion assembly;3933;1450;GO:0048010
GO:0048040;UDP-glucuronate decarboxylase activity;73161;34;GO:0006096
GO:0051688;maintenance of plastid location;0;1;GO:0009936
GO:0061001;regulation of dendritic spine morphogenesis;1300;2330;GO:0048608
GO:1903450;regulation of G1 to G0 transition;279;66;GO:0045786
GO:0061002;negative regulation of dendritic spine morphogenesis;126;112;GO:0048608
GO:1903451;negative regulation of G1 to G0 transition;59;7;GO:0045746
GO:0061003;positive regulation of dendritic spine morphogenesis;561;2530;GO:0048608
GO:0061004;pattern specification involved in kidney development;662;124;GO:0048316
GO:1903454;regulation of androst-4-ene-3,17-dione biosynthetic process;2;0;GO:0010468
GO:1903455;negative regulation of androst-4-ene-3,17-dione biosynthetic process;0;0;GO:0010468
GO:1903452;positive regulation of G1 to G0 transition;41;9;GO:0045944
GO:0061000;negative regulation of dendritic spine development;275;41;GO:0048608
GO:0061009;common bile duct development;604;10;GO:0042127
GO:1903459;mitotic DNA replication lagging strand elongation;62;3;GO:0007067
GO:1903456;positive regulation of androst-4-ene-3,17-dione biosynthetic process;2;1;GO:0010468
GO:1903457;lactate catabolic process;256;4;GO:0006096
GO:0061005;cell differentiation involved in kidney development;4069;264;GO:0042127
GO:0061006;regulation of cell proliferation involved in kidney morphogenesis;55;4;GO:0042127
GO:0061007;hepaticobiliary system process;39;4;GO:0042127
GO:0061008;hepaticobiliary system development;11053;207;GO:0048513
GO:0048056;R3/R4 cell differentiation;161;5;GO:0045595
GO:0051697;protein delipidation;29;160;GO:0006631
GO:0099631;postsynaptic endocytic zone cytoplasmic component;50;5;GO:0048471
GO:0048055;R2/R5 development;0;2;GO:0048731
GO:0051698;saccharopine oxidase activity;19;1;GO:0006067
GO:0099632;protein transport within plasma membrane;0;5;GO:0006810
GO:0048054;R2/R5 cell differentiation;21;3;GO:0045595
GO:0051695;actin filament uncapping;102;3;GO:0006096
GO:0048053;R1/R6 development;9;5;GO:0048731
GO:0051696;pointed-end actin filament uncapping;0;2;GO:0005524
GO:0099630;postsynaptic neurotransmitter receptor cycle;11;5;GO:0007612
GO:0051693;actin filament capping;60191;908;GO:0003779
GO:0099635;voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;1;4;GO:0048407
GO:0051694;pointed-end actin filament capping;7846;92;GO:0005524
GO:0099636;cytoplasmic streaming;11;2;GO:0006928
GO:0048058;compound eye corneal lens development;24;10;GO:0007530
GO:0099633;protein localization to postsynaptic specialization membrane;1384;4;GO:0048608
GO:0048057;R3/R4 development;1;4;GO:0048731
GO:0099634;postsynaptic specialization membrane;7519;82;GO:0048666
GO:0099639;neurotransmitter receptor transport, endosome to plasma membrane;634;9;GO:0006836
GO:0099637;neurotransmitter receptor transport;1504;9;GO:0006836
GO:0099638;endosome to plasma membrane protein transport;1079;10;GO:0006897
GO:0048052;R1/R6 cell differentiation;61;6;GO:0045595
GO:0048050;post-embryonic eye morphogenesis;387;116;GO:0007548
GO:0061034;olfactory bulb mitral cell layer development;106;22;GO:0048608
GO:1903461;Okazaki fragment processing involved in mitotic DNA replication;107;8;GO:0007067
GO:0061035;regulation of cartilage development;6500;378;GO:0048608
GO:0061036;positive regulation of cartilage development;2252;521;GO:0048608
GO:0061037;negative regulation of cartilage development;1578;447;GO:0048608
GO:1903460;mitotic DNA replication leading strand elongation;56;3;GO:0007067
GO:0061030;epithelial cell differentiation involved in mammary gland alveolus development;156;41;GO:0030216
GO:1903465;positive regulation of mitotic cell cycle DNA replication;74;67;GO:0051726
GO:0061031;endodermal digestive tract morphogenesis;165;35;GO:0007517
GO:1903466;regulation of mitotic DNA replication initiation;103;1;GO:0000086
GO:0061032;visceral serous pericardium development;245;109;GO:0048704
GO:1903463;regulation of mitotic cell cycle DNA replication;169;8;GO:0000086
GO:0061033;secretion by lung epithelial cell involved in lung growth;199;8;GO:0048193
GO:1903464;negative regulation of mitotic cell cycle DNA replication;33;9;GO:0051726
GO:1903469;removal of RNA primer involved in mitotic DNA replication;39;2;GO:0007067
GO:1903467;negative regulation of mitotic DNA replication initiation;25;2;GO:0045727
GO:1903468;positive regulation of DNA replication initiation;71;2;GO:0045727
GO:0061038;uterus morphogenesis;324;30;GO:0048589
GO:0048067;cuticle pigmentation;390;128;GO:0008544
GO:0048066;developmental pigmentation;7519;919;GO:0008544
GO:0048065;male courtship behavior, veined wing extension;153;124;GO:0007530
GO:0099602;neurotransmitter receptor regulator activity;3737;40;GO:0004871
GO:0048069;eye pigmentation;1290;25;GO:0008544
GO:0099601;regulation of neurotransmitter receptor activity;225;138;GO:0004872
GO:0099606;microtubule plus-end directed mitotic chromosome migration;43;6;GO:0048285
GO:0099607;lateral attachment of mitotic spindle microtubules to kinetochore;88;3;GO:0007062
GO:0099604;ligand-gated calcium channel activity;20957;234;GO:0005509
GO:0061040;female gonad morphogenesis;70;5;GO:0008544
GO:0099605;regulation of action potential firing rate;3;0;GO:0048666
GO:0048061;positive gravitaxis;0;2;GO:0007623
GO:0099608;regulation of action potential firing pattern;48;2;GO:0048666
GO:0048060;negative gravitaxis;59;77;GO:0007623
GO:0099609;microtubule lateral binding;55;59;GO:0005524
GO:1903472;negative regulation of mitotic actomyosin contractile ring contraction;1;2;GO:0048285
GO:0061024;membrane organization;1015911;3810;GO:0016020
GO:1903473;positive regulation of mitotic actomyosin contractile ring contraction;117;4;GO:0048285
GO:0061025;membrane fusion;397757;1440;GO:0006903
GO:0061026;cardiac muscle tissue regeneration;668;27;GO:0048407
GO:1903471;regulation of mitotic actomyosin contractile ring contraction;138;5;GO:0048285
GO:1903476;protein localization to cell division site involved in mitotic actomyosin contractile ring assembly;28;1;GO:0007067
GO:1903477;mitotic contractile ring actin filament bundle assembly;0;0;GO:0007088
GO:1903475;mitotic actomyosin contractile ring assembly;815;10;GO:0007088
GO:1903479;mitotic actomyosin contractile ring assembly actin filament organization;90;3;GO:0007088
GO:0061027;umbilical cord development;55;1;GO:0048589
GO:0061028;establishment of endothelial barrier;2435;537;GO:0030098
GO:0061029;eyelid development in camera-type eye;548;396;GO:0007530
GO:0048078;positive regulation of compound eye pigmentation;29;5;GO:0048608
GO:0048077;negative regulation of compound eye pigmentation;0;2;GO:0048405
GO:0099610;action potential initiation;145;8;GO:0007631
GO:0048076;regulation of compound eye pigmentation;125;5;GO:0048608
GO:0048075;positive regulation of eye pigmentation;30;136;GO:0048608
GO:0099613;protein localization to cell wall;0;0;GO:0005618
GO:0099614;protein localization to spore cell wall;2;0;GO:0048305
GO:0099611;regulation of action potential firing threshold;55;3;GO:0048666
GO:0048079;regulation of cuticle pigmentation;231;4;GO:0009913
GO:0099612;protein localization to axon;465;99;GO:0048471
GO:0048070;regulation of developmental pigmentation;1353;127;GO:0048608
GO:0099617;matrix side of mitochondrial inner membrane;272;74;GO:0005746
GO:0099618;UDP-glucuronic acid dehydrogenase activity;3104;2;GO:0006066
GO:0099615;(D)-2-hydroxyglutarate-pyruvate transhydrogenase activity;4;0;GO:0006096
GO:0099616;extrinsic component of matrix side of mitochondrial inner membrane;6;1;GO:0005743
GO:0048074;negative regulation of eye pigmentation;46;5;GO:0048405
GO:0048073;regulation of eye pigmentation;217;116;GO:0009913
GO:0048072;compound eye pigmentation;268;10;GO:0005524
GO:0099619;UDP-4-amino-4-deoxy-L-arabinose formyltransferase activity;3098;3;GO:0004497
GO:0048071;sex-specific pigmentation;19;9;GO:0008544
GO:0099590;neurotransmitter receptor internalization;1241;65;GO:0006836
GO:0099592;endocytosed synaptic vesicle processing via endosome;0;2;GO:0006897
GO:0099593;endocytosed synaptic vesicle to endosome fusion;0;0;GO:0006897
GO:0099587;inorganic ion import across plasma membrane;10148;39;GO:0006810
GO:0099588;positive regulation of postsynaptic cytosolic calcium concentration;0;1;GO:0048608
GO:0099585;release of sequestered calcium ion into presynaptic cytosol;0;3;GO:0008066
GO:0099586;release of sequestered calcium ion into postsynaptic cytosol;0;2;GO:0008092
GO:0099589;serotonin receptor activity;13965;39;GO:0004930
GO:0002600;positive regulation of antigen processing and presentation of lipid antigen via MHC class Ib;0;2;GO:0019882
GO:0002601;regulation of antigen processing and presentation of polysaccharide antigen via MHC class II;0;2;GO:0002474
GO:0002602;negative regulation of antigen processing and presentation of polysaccharide antigen via MHC class II;0;2;GO:0002449
GO:0002603;positive regulation of antigen processing and presentation of polysaccharide antigen via MHC class II;0;3;GO:0002449
GO:0002604;regulation of dendritic cell antigen processing and presentation;396;1290;GO:0002449
GO:0002605;negative regulation of dendritic cell antigen processing and presentation;122;463;GO:0002449
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;274;98;GO:0048002
GO:0002607;regulation of myeloid dendritic cell antigen processing and presentation;0;1;GO:0002429
GO:0002608;negative regulation of myeloid dendritic cell antigen processing and presentation;0;3;GO:0002449
GO:0002609;positive regulation of myeloid dendritic cell antigen processing and presentation;0;1;GO:0048002
GO:0099572;postsynaptic specialization;28160;362;GO:0048666
GO:0099573;glutamatergic postsynaptic density;2;3;GO:0048666
GO:0099571;postsynaptic cytoskeleton;908;9;GO:0043005
GO:0099565;chemical synaptic transmission, postsynaptic;109013;155;GO:0007268
GO:0099566;regulation of postsynaptic cytosolic calcium ion concentration;955;264;GO:0048608
GO:0099563;modification of synaptic structure;1337;58;GO:0048666
GO:0099564;modification of synaptic structure, modulating synaptic transmission;0;0;GO:0048167
GO:0099569;presynaptic cytoskeleton;471;7;GO:0043005
GO:0099567;calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration;58;1;GO:0008092
GO:0099568;cytoplasmic region;52316;191;GO:0005737
GO:0099580;monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential;33;1;GO:0008092
GO:0099583;neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration;261;185;GO:0004871
GO:0099581;ATPase coupled ion transmembrane transporter activity involved in regulation of postsynaptic membrane potential;0;2;GO:0008026
GO:0099582;neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration;0;2;GO:0004871
GO:0099576;regulation of protein catabolic process at postsynapse, modulating synaptic transmission;158;7;GO:0048608
GO:0099577;regulation of translation at presynapse, modulating synaptic transmission;20;4;GO:0048608
GO:0099574;regulation of protein catabolic process at synapse, modulating synaptic transmission;0;2;GO:0048167
GO:0099575;regulation of protein catabolic process at presynapse, modulating synaptic transmission;66;5;GO:0048608
GO:0099578;regulation of translation at postsynapse, modulating synaptic transmission;118;8;GO:0048608
GO:0099579;G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential;87;6;GO:0004890
GO:0002631;regulation of granuloma formation;10;5;GO:0050921
GO:0002632;negative regulation of granuloma formation;1;8;GO:0050727
GO:0002633;positive regulation of granuloma formation;3;1;GO:0050729
GO:0002634;regulation of germinal center formation;398;907;GO:0048308
GO:0002635;negative regulation of germinal center formation;117;10;GO:0048308
GO:0002636;positive regulation of germinal center formation;110;154;GO:0048308
GO:0002637;regulation of immunoglobulin production;4105;373;GO:0050729
GO:0002638;negative regulation of immunoglobulin production;500;294;GO:0050729
GO:0002639;positive regulation of immunoglobulin production;2837;799;GO:0050729
GO:0002650;negative regulation of tolerance induction to self antigen;0;3;GO:0043066
GO:0002651;positive regulation of tolerance induction to self antigen;53;6;GO:0043066
GO:0002652;regulation of tolerance induction dependent upon immune response;140;127;GO:0002768
GO:0002643;regulation of tolerance induction;962;807;GO:0050890
GO:0002644;negative regulation of tolerance induction;12;25;GO:0048646
GO:0002645;positive regulation of tolerance induction;673;455;GO:0048646
GO:0002646;regulation of central tolerance induction;59;4;GO:0050729
GO:0002647;negative regulation of central tolerance induction;0;2;GO:0048364
GO:0002648;positive regulation of central tolerance induction;59;2;GO:0050729
GO:0002649;regulation of tolerance induction to self antigen;54;4;GO:0048407
GO:0002610;regulation of plasmacytoid dendritic cell antigen processing and presentation;0;1;GO:0002449
GO:0002611;negative regulation of plasmacytoid dendritic cell antigen processing and presentation;0;2;GO:0048002
GO:0002612;positive regulation of plasmacytoid dendritic cell antigen processing and presentation;0;2;GO:0048002
GO:0002613;regulation of monocyte antigen processing and presentation;0;2;GO:0002687
GO:0002614;negative regulation of monocyte antigen processing and presentation;0;2;GO:0002696
GO:0002615;positive regulation of monocyte antigen processing and presentation;0;2;GO:0048002
GO:0002616;regulation of macrophage antigen processing and presentation;57;3;GO:0002684
GO:0002617;negative regulation of macrophage antigen processing and presentation;57;9;GO:0002696
GO:0002618;positive regulation of macrophage antigen processing and presentation;0;2;GO:0002687
GO:0002619;regulation of non-professional antigen presenting cell antigen processing and presentation;0;2;GO:0002449
GO:0002630;positive regulation of proteolysis associated with antigen processing and presentation;0;4;GO:0048608
GO:0002620;negative regulation of non-professional antigen presenting cell antigen processing and presentation;0;2;GO:0002449
GO:0002621;positive regulation of non-professional antigen presenting cell antigen processing and presentation;0;1;GO:0002449
GO:0002622;regulation of B cell antigen processing and presentation;1;5;GO:0008632
GO:0002623;negative regulation of B cell antigen processing and presentation;0;1;GO:0002449
GO:0002624;positive regulation of B cell antigen processing and presentation;0;2;GO:0019882
GO:0002625;regulation of T cell antigen processing and presentation;54;185;GO:0008631
GO:0002626;negative regulation of T cell antigen processing and presentation;0;5;GO:0002449
GO:0002627;positive regulation of T cell antigen processing and presentation;0;3;GO:0019882
GO:0002628;regulation of proteolysis associated with antigen processing and presentation;0;2;GO:0002755
GO:0002629;negative regulation of proteolysis associated with antigen processing and presentation;0;2;GO:0002755
GO:0000019;regulation of mitotic recombination;758;69;GO:0000746
GO:0000018;regulation of DNA recombination;32671;653;GO:0006281
GO:0002680;pro-T cell lineage commitment;0;2;GO:0042127
GO:0000017;alpha-glucoside transport;230;15;GO:0006865
GO:0002681;somatic recombination of T cell receptor gene segments;235;7;GO:0002776
GO:0000016;lactase activity;100;74;GO:0004553
GO:0002682;regulation of immune system process;870347;4410;GO:0002682
GO:0000015;phosphopyruvate hydratase complex;69382;1400;GO:0005737
GO:0002683;negative regulation of immune system process;235095;1530;GO:0002682
GO:0000014;single-stranded DNA endodeoxyribonuclease activity;8991;382;GO:0004518
GO:0002684;positive regulation of immune system process;217480;3520;GO:0002684
GO:0002685;regulation of leukocyte migration;16425;977;GO:0050900
GO:0000023;maltose metabolic process;15455;722;GO:0006066
GO:0002675;positive regulation of acute inflammatory response;835;666;GO:0050729
GO:0000022;mitotic spindle elongation;1251;815;GO:0007088
GO:0002676;regulation of chronic inflammatory response;421;213;GO:0050729
GO:0002677;negative regulation of chronic inflammatory response;225;158;GO:0050729
GO:0002678;positive regulation of chronic inflammatory response;189;47;GO:0050729
GO:0002679;respiratory burst involved in defense response;682;699;GO:0006979
GO:0002690;positive regulation of leukocyte chemotaxis;6231;927;GO:0050900
GO:0002691;regulation of cellular extravasation;1923;232;GO:0050900
GO:0000028;ribosomal small subunit assembly;6329;4670;GO:0005840
GO:0002692;negative regulation of cellular extravasation;412;31;GO:0010817
GO:0000027;ribosomal large subunit assembly;131405;2620;GO:0000786
GO:0002693;positive regulation of cellular extravasation;841;269;GO:0050900
GO:0000026;alpha-1,2-mannosyltransferase activity;19601;58;GO:0006022
GO:0002694;regulation of leukocyte activation;110506;1860;GO:0002684
GO:0000025;maltose catabolic process;171;31;GO:0006066
GO:0002695;negative regulation of leukocyte activation;15235;529;GO:0002684
GO:0000024;maltose biosynthetic process;4;77;GO:0006066
GO:0002696;positive regulation of leukocyte activation;85561;1360;GO:0050729
GO:0000034;adenine deaminase activity;88445;52;GO:0003929
GO:0002686;negative regulation of leukocyte migration;2447;334;GO:0050900
GO:0000033;alpha-1,3-mannosyltransferase activity;3566;61;GO:0004553
GO:0002687;positive regulation of leukocyte migration;10172;1060;GO:0050900
GO:0000032;cell wall mannoprotein biosynthetic process;361;66;GO:0005976
GO:0002688;regulation of leukocyte chemotaxis;8016;549;GO:0002684
GO:0000031;mannosylphosphate transferase activity;4;3;GO:0006029
GO:0002689;negative regulation of leukocyte chemotaxis;1016;364;GO:0050900
GO:0000030;mannosyltransferase activity;188726;969;GO:0006029
GO:0002660;positive regulation of peripheral tolerance induction;103;3;GO:0048246
GO:0002661;regulation of B cell tolerance induction;112;10;GO:0042430
GO:0002662;negative regulation of B cell tolerance induction;0;1;GO:0042430
GO:0002663;positive regulation of B cell tolerance induction;112;46;GO:0042430
GO:0000001;mitochondrion inheritance;2072;833;GO:0005740
GO:0002653;negative regulation of tolerance induction dependent upon immune response;0;3;GO:0050829
GO:0002654;positive regulation of tolerance induction dependent upon immune response;106;6;GO:0050829
GO:0002655;regulation of tolerance induction to nonself antigen;3;3;GO:0046649
GO:0002656;negative regulation of tolerance induction to nonself antigen;0;2;GO:0048407
GO:0002657;positive regulation of tolerance induction to nonself antigen;3;2;GO:0048407
GO:0002658;regulation of peripheral tolerance induction;103;5;GO:0002821
GO:0002659;negative regulation of peripheral tolerance induction;0;2;GO:0002821
GO:0000009;alpha-1,6-mannosyltransferase activity;18105;70;GO:0004553
GO:0000007;low-affinity zinc ion transmembrane transporter activity;65;34;GO:0005215
GO:0000006;high-affinity zinc transmembrane transporter activity;66;9;GO:0008544
GO:0002670;regulation of B cell anergy;0;3;GO:0042430
GO:0002671;negative regulation of B cell anergy;0;2;GO:0042430
GO:0002672;positive regulation of B cell anergy;0;2;GO:0042430
GO:0000003;reproduction;637380;22800;GO:0000003
GO:0002673;regulation of acute inflammatory response;1522;911;GO:0002682
GO:0000002;mitochondrial genome maintenance;18815;2660;GO:0005740
GO:0002674;negative regulation of acute inflammatory response;257;957;GO:0002682
GO:0000012;single strand break repair;3317;1350;GO:0006281
GO:0002664;regulation of T cell tolerance induction;552;941;GO:0002821
GO:0000011;vacuole inheritance;1260;48;GO:0007049
GO:0002665;negative regulation of T cell tolerance induction;3;4;GO:0048011
GO:0000010;trans-hexaprenyltranstransferase activity;1814;54;GO:0004073
GO:0002666;positive regulation of T cell tolerance induction;390;98;GO:0048011
GO:0002667;regulation of T cell anergy;314;155;GO:0042110
GO:0002668;negative regulation of T cell anergy;3;3;GO:0042110
GO:0002669;positive regulation of T cell anergy;196;192;GO:0042110
GO:0036133;11-hydroxythromboxane B2 dehydrogenase activity;0;3;GO:0008021
GO:0036134;12-hydroxyheptadecatrienoic acid synthase activity;44;7;GO:0004497
GO:0036135;Schwann cell migration;326;10;GO:0030900
GO:0036136;kynurenine-oxaloacetate transaminase activity;0;0;GO:0009065
GO:1905941;positive regulation of gonad development;927;3;GO:0048608
GO:0036130;prostaglandin H2 endoperoxidase reductase activity;14;4;GO:0004722
GO:1905940;negative regulation of gonad development;171;0;GO:0048608
GO:0036131;prostaglandin D2 11-ketoreductase activity;87;4;GO:0046323
GO:0036132;13-prostaglandin reductase activity;2177;60;GO:0046395
GO:1905945;regulation of response to calcium ion;3;6;GO:0010467
GO:1905944;positive regulation of formation of growth cone in injured axon;5;0;GO:0048706
GO:1905943;negative regulation of formation of growth cone in injured axon;0;3;GO:0048706
GO:1905942;regulation of formation of growth cone in injured axon;5;0;GO:0048706
GO:1905949;negative regulation of calcium ion import across plasma membrane;79;2;GO:0006836
GO:1905948;ABC-type 3',5'-cyclic GMP transmembrane transporter activity;11;3;GO:0005215
GO:0000179;rRNA (adenine-N6,N6-)-dimethyltransferase activity;190167;0;GO:0003735
GO:1905947;positive regulation of response to calcium ion;0;1;GO:0050832
GO:0000178;exosome (RNase complex);70966;738;GO:0005740
GO:1905946;negative regulation of response to calcium ion;0;1;GO:0048407
GO:0051763;sesquiterpene catabolic process;0;2;GO:0046274
GO:0051764;actin crosslink formation;588;430;GO:0005923
GO:0051761;sesquiterpene metabolic process;2092;8;GO:0046274
GO:0075732;viral penetration into host nucleus;182624;17;GO:0048706
GO:0051762;sesquiterpene biosynthetic process;2087;47;GO:0046274
GO:0075733;intracellular transport of virus;229890;621;GO:0016192
GO:1905939;regulation of gonad development;1264;6;GO:0048608
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;52577;3700;GO:0006412
GO:0000183;rDNA heterochromatin formation;2081;212;GO:0000786
GO:0051760;meiotic sister chromatid cohesion, arms;0;0;GO:0007070
GO:0000182;rDNA binding;966;92;GO:0003676
GO:0051769;regulation of nitric-oxide synthase biosynthetic process;574;406;GO:0046323
GO:1901256;regulation of macrophage colony-stimulating factor production;305;8;GO:0048010
GO:1901259;chloroplast rRNA processing;1061;34;GO:0006364
GO:1901258;positive regulation of macrophage colony-stimulating factor production;202;10;GO:0046649
GO:0060136;embryonic process involved in female pregnancy;303;1140;GO:0007565
GO:0060137;maternal process involved in parturition;164;238;GO:0042330
GO:0060138;fetal process involved in parturition;1;3;GO:0043467
GO:0047187;deacetyl-[citrate-(pro-3S)-lyase] S-acetyltransferase activity;0;0;GO:0006066
GO:0072110;glomerular mesangial cell proliferation;299;8;GO:0048608
GO:0047186;N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;91;0;GO:0004073
GO:0047185;N-acetylneuraminate 4-O-acetyltransferase activity;0;3;GO:0004734
GO:0047184;1-acylglycerophosphocholine O-acyltransferase activity;2842;61;GO:0008610
GO:0072114;pronephros morphogenesis;610;6;GO:0048608
GO:0098722;asymmetric stem cell division;497;9;GO:0048608
GO:0072113;head kidney development;0;1;GO:0008544
GO:0098723;skeletal muscle myofibril;21;8;GO:0005576
GO:0047189;2,3-diaminopropionate N-oxalyltransferase activity;0;3;GO:0006067
GO:0072112;podocyte differentiation;1505;8;GO:0048856
GO:0098720;succinate import across plasma membrane;4;2;GO:0006836
GO:0047188;aromatic-hydroxylamine O-acetyltransferase activity;0;3;GO:0004073
GO:0072111;cell proliferation involved in kidney development;980;291;GO:0042127
GO:0098721;uracil import across plasma membrane;49;5;GO:0006873
GO:0035129;post-embryonic hindlimb morphogenesis;14;5;GO:0048608
GO:0072118;pronephros structural organization;7;1;GO:0048704
GO:0098726;symmetric division of skeletal muscle satellite stem cell;0;0;GO:0048771
GO:0106008;2-oxoglutaramate amidase activity;628;3;GO:0006066
GO:2000146;negative regulation of cell motility;19357;713;GO:0010467
GO:0072117;head kidney formation;0;1;GO:0048608
GO:0098727;maintenance of cell number;16463;95;GO:0042127
GO:0106007;microtubule anchoring at cell cortex of cell tip;0;0;GO:0005929
GO:2000145;regulation of cell motility;82861;2960;GO:0016477
GO:0072116;pronephros formation;45;3;GO:0048608
GO:0098724;symmetric stem cell division;94;0;GO:0048608
GO:0106006;cytoskeletal protein-membrane anchor activity;150;20;GO:0048471
GO:2000144;positive regulation of DNA-templated transcription initiation;7560;576;GO:0006355
GO:0072115;head kidney morphogenesis;0;0;GO:0048608
GO:0098725;symmetric cell division;152;1;GO:0051301
GO:0106005;RNA 5'-cap (guanine-N7)-methylation;100112;0;GO:0045944
GO:2000143;negative regulation of DNA-templated transcription initiation;525;10;GO:0006355
GO:0035125;embryonic anal fin morphogenesis;3;2;GO:0008544
GO:0047183;anthocyanin 5-aromatic acyltransferase activity;12;4;GO:0005576
GO:0106004;tRNA (guanine-N7)-methylation;274677;0;GO:0006418
GO:0035126;post-embryonic genitalia morphogenesis;219;2;GO:0048608
GO:0047182;alcohol O-cinnamoyltransferase activity;0;3;GO:0006081
GO:0106003;amyloid-beta complex;56;6;GO:0042605
GO:2000149;negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis;2;0;GO:0048704
GO:0035127;post-embryonic limb morphogenesis;120;6;GO:0048704
GO:0047181;tetrahydroxybenzophenone synthase activity;6;3;GO:0004089
GO:0098728;germline stem cell asymmetric division;448;21;GO:0048608
GO:0106002;mCRD-mediated mRNA stability complex;253;4;GO:0008033
GO:2000148;regulation of planar cell polarity pathway involved in ventricular septum morphogenesis;2;0;GO:0048704
GO:0035128;post-embryonic forelimb morphogenesis;106;21;GO:0048704
GO:0047180;salutaridinol 7-O-acetyltransferase activity;52;3;GO:0004497
GO:0072119;head kidney structural organization;0;1;GO:0032989
GO:0098729;germline stem cell symmetric division;85;0;GO:0048608
GO:0106001;intestinal hexose absorption;165;3;GO:0005985
GO:2000147;positive regulation of cell motility;37305;1860;GO:0016477
GO:2000160;negative regulation of planar cell polarity pathway involved in heart morphogenesis;10;0;GO:0048704
GO:2000164;negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis;2;0;GO:0048704
GO:1903840;response to arsenite(3-);63;0;GO:0046686
GO:2000163;regulation of planar cell polarity pathway involved in outflow tract morphogenesis;2;0;GO:0048704
GO:2000162;negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis;2;0;GO:0048704
GO:0106009;(4S)-4-hydroxy-2-oxoglutarate aldolase activity;741;0;GO:0004073
GO:2000161;regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis;2;0;GO:0048704
GO:0047107;gamma-guanidinobutyraldehyde dehydrogenase activity;66;3;GO:0004067
GO:1903843;cellular response to arsenite ion;244;4;GO:0043407
GO:0047106;4-hydroxyphenylacetaldehyde dehydrogenase activity;1;3;GO:0004073
GO:1903844;regulation of cellular response to transforming growth factor beta stimulus;9843;153;GO:0048010
GO:0047105;4-trimethylammoniobutyraldehyde dehydrogenase activity;124;6;GO:0004073
GO:1903841;cellular response to arsenite(3-);63;3;GO:0043407
GO:0047104;hexadecanal dehydrogenase (acylating) activity;7;5;GO:0004497
GO:1903842;response to arsenite ion;250;1;GO:0046686
GO:1903847;regulation of aorta morphogenesis;92;7;GO:0048608
GO:1903848;negative regulation of aorta morphogenesis;0;1;GO:0048706
GO:0047109;(S)-3-hydroxyacid-ester dehydrogenase activity;0;0;GO:0004089
GO:1903845;negative regulation of cellular response to transforming growth factor beta stimulus;111;78;GO:0010468
GO:0047108;(R)-3-hydroxyacid-ester dehydrogenase activity;0;0;GO:0004073
GO:1903846;positive regulation of cellular response to transforming growth factor beta stimulus;1618;84;GO:0048010
GO:0047110;phenylglyoxylate dehydrogenase (acylating) activity;504;3;GO:0006081
GO:0106011;regulation of protein localization to medial cortex;2;0;GO:0048608
GO:1903838;negative regulation of mRNA 3'-UTR binding;0;1;GO:0010468
GO:0050750;low-density lipoprotein particle receptor binding;2743;732;GO:0004872
GO:1903839;positive regulation of mRNA 3'-UTR binding;0;1;GO:0010468
GO:0047114;kynurenate-7,8-dihydrodiol dehydrogenase activity;0;3;GO:0004721
GO:0047113;aldehyde dehydrogenase (quinone) activity;177;2;GO:0004041
GO:0047112;pyruvate oxidase activity;2623;8;GO:0004091
GO:0047111;formate dehydrogenase (cytochrome-c-553) activity;7026;7;GO:0009065
GO:0106019;phosphatidylinositol-4,5-bisphosphate phosphatase activity;11309;7;GO:0004721
GO:2000157;negative regulation of ubiquitin-specific protease activity;3;65;GO:0048193
GO:0106018;phosphatidylinositol-3,5-bisphosphate phosphatase activity;11084;9;GO:0004721
GO:2000156;regulation of retrograde vesicle-mediated transport, Golgi to ER;134;6;GO:0006986
GO:0106017;phosphatidylinositol-3,4-bisphosphate phosphatase activity;10236;0;GO:0004721
GO:2000155;positive regulation of cilium-dependent cell motility;607;3;GO:0048193
GO:0106016;positive regulation of inflammatory response to wounding;66;7;GO:0050729
GO:0106015;negative regulation of inflammatory response to wounding;541;8;GO:0050727
GO:0106014;regulation of inflammatory response to wounding;689;8;GO:0002684
GO:0106013;negative regulation of protein localization to cell cortex of cell tip;0;0;GO:0048285
GO:2000159;regulation of planar cell polarity pathway involved in heart morphogenesis;10;0;GO:0048704
GO:0106012;positive regulation of protein localization to medial cortex;1;0;GO:0048193
GO:2000158;positive regulation of ubiquitin-specific protease activity;3;102;GO:0048193
GO:0035198;miRNA binding;7127;955;GO:0003729
GO:2000171;negative regulation of dendrite development;141;1070;GO:0048608
GO:0035199;salt aversion;47;8;GO:0007610
GO:2000170;positive regulation of peptidyl-cysteine S-nitrosylation;80;16;GO:0046395
GO:0035194;regulatory ncRNA-mediated post-transcriptional gene silencing;106826;48;GO:0010468
GO:1903850;regulation of cristae formation;235;5;GO:0048285
GO:2000175;negative regulation of pro-T cell differentiation;0;0;GO:0045595
GO:0035195;miRNA-mediated post-transcriptional gene silencing;99993;488;GO:0034440
GO:1903851;negative regulation of cristae formation;0;1;GO:0048193
GO:2000174;regulation of pro-T cell differentiation;58;7;GO:0045595
GO:0035196;miRNA processing;13269;410;GO:0006397
GO:2000173;negative regulation of branching morphogenesis of a nerve;16;9;GO:0048704
GO:0035197;siRNA binding;2737;293;GO:0003723
GO:2000172;regulation of branching morphogenesis of a nerve;241;140;GO:0048704
GO:0035190;syncytial nuclear migration;100;31;GO:0007062
GO:0047118;2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate reductase activity;0;3;GO:0004091
GO:1903854;negative regulation of stress response to copper ion;10;1;GO:0010468
GO:0035191;nuclear axial expansion;54;7;GO:0005634
GO:0047117;enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity;1773;0;GO:0004091
GO:1903855;positive regulation of stress response to copper ion;0;0;GO:0010468
GO:0035192;nuclear cortical migration;8;1;GO:0048706
GO:0047116;1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate dehydrogenase activity;1246;2;GO:0006066
GO:1903852;positive regulation of cristae formation;171;6;GO:0048193
GO:0035193;larval central nervous system remodeling;39;16;GO:0048704
GO:0047115;trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;227;167;GO:0004073
GO:1903853;regulation of stress response to copper ion;10;1;GO:0006979
GO:1903858;protein localization to old growing cell tip;0;0;GO:0007049
GO:1903859;regulation of dendrite extension;1131;36;GO:0048608
GO:1903856;regulation of cytokinin dehydrogenase activity;1;0;GO:0046395
GO:1903857;negative regulation of cytokinin dehydrogenase activity;1;0;GO:0046395
GO:0047121;isoquinoline 1-oxidoreductase activity;2861;3;GO:0004497
GO:0050762;depsipeptide catabolic process;0;2;GO:0046274
GO:0106022;positive regulation of vesicle docking;4;1;GO:0048193
GO:0047120;(3S,4R)-3,4-dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate dehydrogenase activity;19;0;GO:0006066
GO:0050763;depsipeptide biosynthetic process;12;3;GO:0046394
GO:0106021;negative regulation of vesicle docking;0;1;GO:0048193
GO:0106020;regulation of vesicle docking;47;3;GO:0008092
GO:1903849;positive regulation of aorta morphogenesis;86;17;GO:0048608
GO:0050761;depsipeptide metabolic process;12;2;GO:0009065
GO:0047125;delta1-piperideine-2-carboxylate reductase activity;137;3;GO:0004497
GO:0098700;neurotransmitter loading into synaptic vesicle;434;40;GO:0007416
GO:0047124;L-erythro-3,5-diaminohexanoate dehydrogenase activity;136;3;GO:0004073
GO:0047123;quinoline-4-carboxylate 2-oxidoreductase activity;0;3;GO:0004497
GO:0047122;quinaldate 4-oxidoreductase activity;0;3;GO:0004497
GO:0098704;carbohydrate import across plasma membrane;516476;9;GO:0005929
GO:2000168;negative regulation of planar cell polarity pathway involved in neural tube closure;2;1;GO:0048704
GO:0098705;copper ion import across plasma membrane;79;5;GO:0006810
GO:0106029;tRNA pseudouridine synthase activity;127982;61;GO:0003906
GO:2000167;regulation of planar cell polarity pathway involved in neural tube closure;3;2;GO:0048704
GO:0050768;negative regulation of neurogenesis;6777;1520;GO:0048699
GO:0098702;adenine import across plasma membrane;36;5;GO:0006873
GO:0106028;neuron projection retraction;58;8;GO:0043005
GO:2000166;negative regulation of planar cell polarity pathway involved in pericardium morphogenesis;2;0;GO:0048704
GO:0050769;positive regulation of neurogenesis;13109;1360;GO:0048667
GO:0098703;calcium ion import across plasma membrane;2707;450;GO:0006810
GO:0106027;neuron projection organization;3636;99;GO:0043005
GO:2000165;regulation of planar cell polarity pathway involved in pericardium morphogenesis;2;0;GO:0048704
GO:0050766;positive regulation of phagocytosis;4682;1660;GO:0050832
GO:0098708;glucose import across plasma membrane;248;10;GO:0006865
GO:0106026;Gly-tRNA(Ala) hydrolase activity;31314;3;GO:0008544
GO:0050767;regulation of neurogenesis;22438;2580;GO:0048699
GO:0098709;glutathione import across plasma membrane;7;1;GO:0006879
GO:0106025;positive regulation of pupariation;0;1;GO:0048608
GO:0050764;regulation of phagocytosis;6230;1050;GO:0045727
GO:0098706;iron ion import across cell outer membrane;8;2;GO:0006826
GO:0106024;negative regulation of pupariation;19;1;GO:0048405
GO:0050765;negative regulation of phagocytosis;852;1420;GO:0048661
GO:0106023;regulation of pupariation;20;2;GO:0048608
GO:2000169;regulation of peptidyl-cysteine S-nitrosylation;326;7;GO:0046395
GO:0035187;hatching behavior;44;9;GO:0007631
GO:2000182;regulation of progesterone biosynthetic process;117;17;GO:0045944
GO:0035188;hatching;1275;143;GO:0007565
GO:0060100;positive regulation of phagocytosis, engulfment;666;97;GO:0048661
GO:2000181;negative regulation of blood vessel morphogenesis;11075;122;GO:0050727
GO:0035189;Rb-E2F complex;344;56;GO:0007049
GO:0060101;negative regulation of phagocytosis, engulfment;77;7;GO:0048661
GO:2000180;negative regulation of androgen biosynthetic process;49;0;GO:0045944
GO:0060102;collagen and cuticulin-based cuticle extracellular matrix;97;8;GO:0005578
GO:0035183;female germline ring canal inner rim;39;5;GO:0005576
GO:1903861;positive regulation of dendrite extension;944;233;GO:0048608
GO:2000186;negative regulation of phosphate transmembrane transport;37;2;GO:0045735
GO:1903862;positive regulation of oxidative phosphorylation;213;55;GO:0015986
GO:2000185;regulation of phosphate transmembrane transport;109;4;GO:0006874
GO:0035185;preblastoderm mitotic cell cycle;96;9;GO:0000278
GO:1901200;negative regulation of calcium ion transport into cytosol involved in cellular response to salt stress;0;0;GO:0010468
GO:2000184;positive regulation of progesterone biosynthetic process;7;6;GO:0045944
GO:0035186;syncytial blastoderm mitotic cell cycle;270;8;GO:0000278
GO:1903860;negative regulation of dendrite extension;89;8;GO:0048608
GO:2000183;negative regulation of progesterone biosynthetic process;1;0;GO:0010468
GO:0047129;opine dehydrogenase activity;264;3;GO:0004746
GO:0060107;annuli extracellular matrix;7;3;GO:0044421
GO:1901202;negative regulation of extracellular matrix assembly;68;7;GO:0032963
GO:1903865;sigma factor antagonist complex;11;3;GO:0048285
GO:0035180;larval wandering behavior;36;7;GO:0007626
GO:0047128;1,2-dehydroreticulinium reductase (NADPH) activity;2;3;GO:0006067
GO:0060108;annular furrow extracellular matrix;9;1;GO:0048407
GO:1901201;regulation of extracellular matrix assembly;837;100;GO:0032963
GO:1903866;palisade mesophyll development;47;2;GO:0048316
GO:0035181;larval burrowing behavior;0;3;GO:0007626
GO:0047127;thiomorpholine-carboxylate dehydrogenase activity;858;5;GO:0004497
GO:0060109;medial layer of collagen and cuticulin-based cuticle extracellular matrix;5;1;GO:0005576
GO:1903863;P granule assembly;106;3;GO:0030182
GO:0035182;female germline ring canal outer rim;14;3;GO:0005576
GO:0047126;N5-(carboxyethyl)ornithine synthase activity;1365;0;GO:0004465
GO:1901203;positive regulation of extracellular matrix assembly;561;213;GO:0032989
GO:1903864;P granule disassembly;7;0;GO:0048608
GO:1903869;negative regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity;0;0;GO:0010468
GO:0060104;surface coat of collagen and cuticulin-based cuticle extracellular matrix;0;1;GO:0005576
GO:0060105;epicuticle of collagen and cuticulin-based cuticle extracellular matrix;0;2;GO:0005576
GO:1901208;negative regulation of heart looping;54;5;GO:0048704
GO:1903867;extraembryonic membrane development;550;5;GO:0009952
GO:0060106;cortical layer of collagen and cuticulin-based cuticle extracellular matrix;17;2;GO:0005576
GO:1901207;regulation of heart looping;261;8;GO:0048608
GO:1903868;regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity;0;0;GO:0010468
GO:0047132;dihydrobenzophenanthridine oxidase activity;0;3;GO:0004497
GO:0050773;regulation of dendrite development;4384;831;GO:0048699
GO:0106033;spine synapse;4;1;GO:0008092
GO:0047131;saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity;1723;138;GO:0009065
GO:0050774;negative regulation of dendrite morphogenesis;353;1070;GO:0048608
GO:0106032;snRNA pseudouridine synthase activity;1;0;GO:0004723
GO:0047130;saccharopine dehydrogenase (NADP+, L-lysine-forming) activity;1654;10;GO:0009065
GO:0050771;negative regulation of axonogenesis;2526;886;GO:0048706
GO:0050772;positive regulation of axonogenesis;3055;1560;GO:0048704
GO:0106030;neuron projection fasciculation;1203;72;GO:0043005
GO:0047136;4-(dimethylamino)phenylazoxybenzene reductase activity;0;0;GO:0004067
GO:0047135;bis-gamma-glutamylcystine reductase activity;7;2;GO:0004067
GO:0050770;regulation of axonogenesis;7426;1420;GO:0048699
GO:0047134;protein-disulfide reductase (NAD(P)) activity;29687;0;GO:0004746
GO:0047133;dimethylamine dehydrogenase activity;33;5;GO:0046395
GO:2000179;positive regulation of neural precursor cell proliferation;3152;762;GO:0048699
GO:2000178;negative regulation of neural precursor cell proliferation;1331;543;GO:0048699
GO:0050779;RNA destabilization;65420;684;GO:0006364
GO:2000177;regulation of neural precursor cell proliferation;5549;467;GO:0048699
GO:2000176;positive regulation of pro-T cell differentiation;58;9;GO:0045595
GO:0050777;negative regulation of immune response;205141;932;GO:0002682
GO:0106037;apicomedial cortex;87;1;GO:0043005
GO:0050778;positive regulation of immune response;115631;3810;GO:0002684
GO:0106036;assembly of apicomedial cortex actomyosin;9;4;GO:0048608
GO:0050775;positive regulation of dendrite morphogenesis;1398;717;GO:0048608
GO:0106035;protein maturation by [4Fe-4S] cluster transfer;5432;23;GO:0008544
GO:0050776;regulation of immune response;722761;7000;GO:0002682
GO:0106034;protein maturation by [2Fe-2S] cluster transfer;281;9;GO:0008544
GO:0035176;social behavior;2300;1700;GO:0007610
GO:2000193;positive regulation of fatty acid transport;687;62;GO:0045735
GO:0035177;larval foraging behavior;32;6;GO:0007623
GO:2000192;negative regulation of fatty acid transport;291;7;GO:0006631
GO:0035178;turning behavior;33;8;GO:0007626
GO:2000191;regulation of fatty acid transport;1144;339;GO:0006631
GO:0035179;larval turning behavior;33;4;GO:0007600
GO:0035172;hemocyte proliferation;400;108;GO:0042127
GO:1903872;regulation of DNA recombinase mediator complex assembly;1;0;GO:0048285
GO:2000197;regulation of ribonucleoprotein complex localization;601;15;GO:0022613
GO:0035173;histone kinase activity;5002;484;GO:0016567
GO:1903873;negative regulation of DNA recombinase mediator complex assembly;1;1;GO:0048285
GO:2000196;positive regulation of female gonad development;51;5;GO:0048608
GO:1901211;negative regulation of cardiac chamber formation;54;3;GO:0048608
GO:1903870;positive regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity;0;0;GO:0010468
GO:2000195;negative regulation of female gonad development;120;41;GO:0048608
GO:0035175;histone H3S10 kinase activity;308;4;GO:0004721
GO:1901210;regulation of cardiac chamber formation;82;0;GO:0048608
GO:1903871;DNA recombinase mediator complex assembly;1;1;GO:0005576
GO:2000194;regulation of female gonad development;288;7;GO:0030518
GO:1903876;11-deoxycortisol binding;1;0;GO:0005525
GO:0047139;glutathione-homocystine transhydrogenase activity;4;5;GO:0004784
GO:1901212;positive regulation of cardiac chamber formation;0;0;GO:0048608
GO:1903877;21-deoxycortisol binding;1;0;GO:0005525
GO:0035170;lymph gland crystal cell differentiation;75;20;GO:0048703
GO:0035171;lamellocyte differentiation;125;109;GO:0048405
GO:0047137;N-hydroxy-2-acetamidofluorene reductase activity;0;2;GO:0004067
GO:1903875;corticosterone binding;2;0;GO:0005525
GO:1901219;regulation of cardiac chamber morphogenesis;1;0;GO:0048608
GO:1903878;11-deoxycorticosterone binding;1;0;GO:0043169
GO:1903879;11beta-hydroxyprogesterone binding;1;0;GO:0043169
GO:0047143;chlorate reductase activity;4;4;GO:0008629
GO:0050784;cocaine catabolic process;1;2;GO:0009062
GO:0106044;guanine deglycation;162;2;GO:0009065
GO:0047142;enzyme-thiol transhydrogenase (glutathione-disulfide) activity;1;3;GO:0004723
GO:0050785;advanced glycation end-product receptor activity;4;3;GO:0005096
GO:1901209;positive regulation of heart looping;0;2;GO:0048704
GO:0047141;glutathione-cystine transhydrogenase activity;0;3;GO:0004746
GO:0050782;galactose uniporter activity;0;1;GO:0008544
GO:0106042;negative regulation of GABA-A receptor activity;0;1;GO:0048169
GO:0047140;glutathione-CoA-glutathione transhydrogenase activity;0;3;GO:0004746
GO:0050783;cocaine metabolic process;2;6;GO:0009060
GO:0106041;positive regulation of GABA-A receptor activity;0;2;GO:0048169
GO:0047147;trimethylsulfonium-tetrahydrofolate N-methyltransferase activity;0;3;GO:0006790
GO:0050780;dopamine receptor binding;444;236;GO:0005509
GO:0106040;regulation of GABA-A receptor activity;2;1;GO:0048169
GO:0047146;sterigmatocystin 7-O-methyltransferase activity;18;4;GO:0004721
GO:0050781;ortho-trichlorophenol reductive dehalogenase activity;1;2;GO:0004497
GO:0047145;demethylsterigmatocystin 6-O-methyltransferase activity;11;4;GO:0004497
GO:0047144;2-acylglycerol-3-phosphate O-acyltransferase activity;17;38;GO:0008610
GO:0106049;regulation of cellular response to osmotic stress;649;9;GO:0050832
GO:2000187;positive regulation of phosphate transmembrane transport;5;3;GO:0045735
GO:0035169;lymph gland plasmatocyte differentiation;46;3;GO:0002504
GO:0050788;sequestering of mercury;0;1;GO:0046686
GO:0106048;spermidine deacetylation;95;2;GO:0010401
GO:0050789;regulation of biological process;49039012;9080;GO:0050789
GO:0106047;polyamine deacetylation;190;4;GO:0046395
GO:0050786;RAGE receptor binding;314;829;GO:0005509
GO:0106046;guanine deglycation, glyoxal removal;54;4;GO:0009065
GO:0050787;detoxification of mercury ion;35859;37;GO:0046686
GO:0106045;guanine deglycation, methylglyoxal removal;52;3;GO:0009065
GO:0072190;ureter urothelium development;106;7;GO:0030216
GO:0072194;kidney smooth muscle tissue development;195;7;GO:0048513
GO:0072193;ureter smooth muscle cell differentiation;193;24;GO:0048608
GO:0072192;ureter epithelial cell differentiation;1;10;GO:0030216
GO:0072191;ureter smooth muscle development;193;4;GO:0048608
GO:0072187;metanephric cap formation;0;1;GO:0048608
GO:0106055;mannosyl-oligosaccharide 1,2-alpha-mannosidase complex;13;2;GO:0009570
GO:0072186;metanephric cap morphogenesis;57;5;GO:0048608
GO:0106054;tRNA U34 sulfurtransferase activity;4;0;GO:0006457
GO:0072185;metanephric cap development;57;5;GO:0048608
GO:0072184;renal vesicle progenitor cell differentiation;54;2;GO:0048706
GO:0106050;tRNA 2'-O-methyltransferase activity;29010;3;GO:0003729
GO:0072189;ureter development;1364;241;GO:0048513
GO:0072188;metanephric cap specification;0;1;GO:0048704
GO:2000199;positive regulation of ribonucleoprotein complex localization;55;1;GO:0030529
GO:2000198;negative regulation of ribonucleoprotein complex localization;6;1;GO:0030529
GO:0106059;tRNA (cytidine 56-2'-O)-methyltransferase activity;3367;0;GO:0003729
GO:0106058;positive regulation of calcineurin-mediated signaling;938;8;GO:0043406
GO:0106057;negative regulation of calcineurin-mediated signaling;951;5;GO:0048010
GO:0106056;regulation of calcineurin-mediated signaling;2195;4;GO:0043406
GO:0060198;clathrin-sculpted vesicle;81;21;GO:0008021
GO:0060199;clathrin-sculpted glutamate transport vesicle;22;46;GO:0008029
GO:0060194;regulation of antisense RNA transcription;71;4;GO:0010467
GO:0060195;negative regulation of antisense RNA transcription;62;9;GO:0010467
GO:0060196;positive regulation of antisense RNA transcription;9;5;GO:0010467
GO:0060197;cloacal septation;118;25;GO:0002041
GO:0072183;negative regulation of nephron tubule epithelial cell differentiation;72;5;GO:0048193
GO:0072182;regulation of nephron tubule epithelial cell differentiation;546;171;GO:0048193
GO:0072181;mesonephric duct formation;93;17;GO:0048704
GO:0072180;mesonephric duct morphogenesis;191;89;GO:0048706
GO:0072176;nephric duct development;1382;85;GO:0008544
GO:0072175;epithelial tube formation;11117;373;GO:0030574
GO:0072174;metanephric tubule formation;218;10;GO:0048608
GO:0106064;regulation of cobalamin metabolic process;172;3;GO:0045941
GO:0072173;metanephric tubule morphogenesis;403;3;GO:0048608
GO:0106063;G protein-coupled folate receptor activity;3;2;GO:0004930
GO:0106062;positive regulation of exit from meiosis;0;0;GO:0048285
GO:0072179;nephric duct formation;265;21;GO:0048704
GO:0106061;negative regulation of exit from meiosis;3;0;GO:0048285
GO:0072178;nephric duct morphogenesis;868;132;GO:0048704
GO:0106060;regulation of exit from meiosis;3;0;GO:0048285
GO:0072177;mesonephric duct development;445;30;GO:0048704
GO:0106069;synapsis initiation complex;4;2;GO:0000786
GO:0106068;SUMO ligase complex;23923;9;GO:0008031
GO:0098795;global gene silencing by mRNA cleavage;946;15;GO:0010467
GO:0106077;histone succinylation;27;7;GO:0016570
GO:0098796;membrane protein complex;4926976;1190;GO:0044424
GO:0106076;peptide-lysine-N-succinyltransferase activity;0;1;GO:0004867
GO:0098793;presynapse;126687;1980;GO:0008021
GO:0106075;peptide N-succinyltransferase activity;54;1;GO:0006081
GO:0098794;postsynapse;416648;1420;GO:0048666
GO:0106074;aminoacyl-tRNA metabolism involved in translational fidelity;1043103;9;GO:0006418
GO:0098799;outer mitochondrial membrane protein complex;26201;36;GO:0005743
GO:0106073;dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity;8599;9;GO:0006029
GO:0106072;negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;445;8;GO:0048010
GO:0098797;plasma membrane protein complex;1672023;774;GO:0016021
GO:0106071;positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;209;7;GO:0007186
GO:0098798;mitochondrial protein-containing complex;256302;231;GO:0005739
GO:0106070;regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;777;15;GO:0007186
GO:0106078;histone succinyltransferase activity;54;3;GO:0003729
GO:0106080;GATOR1 complex binding;0;0;GO:0005524
GO:0072198;mesenchymal cell proliferation involved in ureter development;227;10;GO:0048608
GO:0106088;regulation of cell adhesion involved in sprouting angiogenesis;60;3;GO:0048010
GO:0072197;ureter morphogenesis;386;50;GO:0048513
GO:0072196;proximal/distal pattern formation involved in pronephric nephron development;12;2;GO:0048704
GO:0072195;kidney smooth muscle cell differentiation;86;1;GO:0048608
GO:0106084;mitotic nuclear membrane microtubule tethering complex;2;1;GO:0005576
GO:0106083;nuclear membrane protein complex;1755;3;GO:0048471
GO:0106082;sucrose import across plasma membrane;6;0;GO:0006814
GO:0072199;regulation of mesenchymal cell proliferation involved in ureter development;167;6;GO:0048608
GO:0106081;maltose import across plasma membrane;6;0;GO:0005576
GO:0106089;negative regulation of cell adhesion involved in sprouting angiogenesis;59;4;GO:0048010
GO:0060165;regulation of timing of subpallium neuron differentiation;41;4;GO:0048608
GO:1901260;peptidyl-lysine hydroxylation involved in bacterial-type EF-P lysine modification;0;0;GO:0008544
GO:0060166;olfactory pit development;164;107;GO:0007576
GO:0060167;regulation of adenosine receptor signaling pathway;268;6;GO:0030518
GO:1901262;negative regulation of sorocarp spore cell differentiation;3;0;GO:0048285
GO:0060168;positive regulation of adenosine receptor signaling pathway;177;29;GO:0030518
GO:1901261;regulation of sorocarp spore cell differentiation;60;1;GO:0048285
GO:0060161;positive regulation of dopamine receptor signaling pathway;266;48;GO:0048167
GO:1901264;carbohydrate derivative transport;570053;455;GO:0006810
GO:0060162;negative regulation of phospholipase C-activating dopamine receptor signaling pathway;0;2;GO:0048608
GO:1901263;positive regulation of sorocarp spore cell differentiation;6;1;GO:0048285
GO:0060163;subpallium neuron fate commitment;92;7;GO:0048704
GO:1901266;cephalosporin C metabolic process;1;2;GO:0009065
GO:0060164;regulation of timing of neuron differentiation;149;47;GO:0048608
GO:1901265;nucleoside phosphate binding;70544693;1970;GO:0097159
GO:0106091;glial cell projection elongation;55;4;GO:0043005
GO:1901268;cephalosporin C biosynthetic process;0;1;GO:0009181
GO:0106090;positive regulation of cell adhesion involved in sprouting angiogenesis;1;2;GO:0048010
GO:1901267;cephalosporin C catabolic process;0;1;GO:0009987
GO:1901269;lipooligosaccharide metabolic process;579581;3;GO:0008610
GO:0060169;negative regulation of adenosine receptor signaling pathway;91;10;GO:0048608
GO:0072150;juxtaglomerulus cell fate commitment;0;2;GO:0048704
GO:0098780;response to mitochondrial depolarisation;1178;32;GO:0006952
GO:0098781;ncRNA transcription;13339;48;GO:0006351
GO:0047198;cysteine-S-conjugate N-acetyltransferase activity;25;6;GO:0004041
GO:0072143;mesangial cell development;246;9;GO:0001558
GO:0098773;skin epidermis development;7147;69;GO:0008544
GO:0106099;2-keto-3-deoxy-L-rhamnonate aldolase activity;758;2;GO:0006099
GO:0047197;triglyceride-sterol O-acyltransferase activity;0;3;GO:0004784
GO:0072142;juxtaglomerulus cell development;0;0;GO:0048608
GO:0098774;curli;0;1;GO:0005576
GO:0106098;NAGS/NAGK complex;4;2;GO:0005576
GO:0047196;long-chain-alcohol O-fatty-acyltransferase activity;175;13;GO:0004089
GO:0072141;renal interstitial fibroblast development;105;8;GO:0048608
GO:0098771;inorganic ion homeostasis;501875;832;GO:0006874
GO:0106097;cellular response to ceramide;32;0;GO:0046686
GO:0047195;diacylglycerol-sterol O-acyltransferase activity;0;2;GO:0008610
GO:0072140;DCT cell development;0;1;GO:0048699
GO:0098772;molecular function regulator activity;2377442;1230;GO:0030528
GO:0106096;response to ceramide;2;0;GO:0006954
GO:0072147;glomerular parietal epithelial cell fate commitment;0;3;GO:0048608
GO:0098777;protein secretion by the type VIII secretion system;6;1;GO:0055085
GO:0106095;m7G(5')pppN diphosphatase complex;3;0;GO:0005524
GO:0072146;DCT cell fate commitment;0;0;GO:0048608
GO:0098778;curli subunit secretion coupled to curli assembly;0;0;GO:0008037
GO:0106094;nuclear membrane microtubule tethering complex;1719;2;GO:0005576
GO:0072145;proximal convoluted tubule segment 1 cell development;0;0;GO:0042127
GO:0098775;curli assembly;8;2;GO:0048193
GO:0106093;EDS1 disease-resistance complex;47;1;GO:0009631
GO:0047199;phosphatidylcholine-dolichol O-acyltransferase activity;0;2;GO:0008610
GO:0072144;glomerular mesangial cell development;192;227;GO:0048771
GO:0098776;protein transport across the cell outer membrane;157992;1;GO:0006810
GO:0106092;glial cell projection elongation involved in axon ensheathment;0;0;GO:0048666
GO:0047190;2-acylglycerophosphocholine O-acyltransferase activity;62;3;GO:0008610
GO:0060170;ciliary membrane;14822;1010;GO:0005576
GO:0072149;podocyte cell fate commitment;107;3;GO:0030154
GO:0098779;positive regulation of mitophagy in response to mitochondrial depolarization;575;262;GO:0048285
GO:0060171;stereocilium membrane;71;22;GO:0005576
GO:0072148;epithelial cell fate commitment;1241;136;GO:0030154
GO:0047194;indoleacetylglucose-inositol O-acyltransferase activity;7;3;GO:0006021
GO:0047192;1-alkylglycerophosphocholine O-acetyltransferase activity;198;9;GO:0008033
GO:0047191;1-alkylglycerophosphocholine O-acyltransferase activity;45;4;GO:0008631
GO:1901271;lipooligosaccharide biosynthetic process;575362;3;GO:0009405
GO:0060155;platelet dense granule organization;317;1120;GO:0030168
GO:1901270;lipooligosaccharide catabolic process;0;1;GO:0009062
GO:0060156;milk ejection reflex;10;4;GO:0002526
GO:1901273;2-dehydro-3-deoxy-D-gluconic acid catabolic process;0;0;GO:0006066
GO:0060157;urinary bladder development;192;172;GO:0048513
GO:1901272;2-dehydro-3-deoxy-D-gluconic acid metabolic process;0;3;GO:0006066
GO:1901275;tartrate metabolic process;4;0;GO:0006066
GO:0060151;peroxisome localization;133;34;GO:0005764
GO:1901274;2-dehydro-3-deoxy-D-gluconic acid biosynthetic process;0;0;GO:0006066
GO:0060152;microtubule-based peroxisome localization;113;10;GO:0005840
GO:1901277;tartrate biosynthetic process;0;0;GO:0006066
GO:0060153;perturbation by virus of host cell cycle progression;74058;4;GO:0048285
GO:1901276;tartrate catabolic process;3;1;GO:0006066
GO:1901279;D-ribose 5-phosphate catabolic process;0;0;GO:0006066
GO:1901278;D-ribose 5-phosphate metabolic process;0;2;GO:0006066
GO:0060158;phospholipase C-activating dopamine receptor signaling pathway;472;614;GO:0048608
GO:0098791;Golgi apparatus subcompartment;106927;133;GO:0005829
GO:0060159;regulation of dopamine receptor signaling pathway;514;76;GO:0048167
GO:0098792;xenophagy;873;65;GO:0006914
GO:0098790;ncRNA transcription associated with protein coding gene TSS/TES;0;0;GO:0045944
GO:0072132;mesenchyme morphogenesis;3829;522;GO:0048731
GO:0098784;biofilm matrix organization;51;2;GO:0043234
GO:0072131;kidney mesenchyme morphogenesis;336;3;GO:0048704
GO:0098785;biofilm matrix assembly;4;0;GO:0043279
GO:0072130;renal capsule specification;25;1;GO:0048704
GO:0098782;mechanosensitived potassium channel activity;60;2;GO:0008092
GO:0072136;metanephric mesenchymal cell proliferation involved in metanephros development;112;5;GO:0048608
GO:0098788;dendritic knob;6;1;GO:0048608
GO:0072135;kidney mesenchymal cell proliferation;112;1;GO:0042127
GO:0072134;nephrogenic mesenchyme morphogenesis;113;5;GO:0048704
GO:0098786;biofilm matrix disassembly;47;5;GO:0048308
GO:0072133;metanephric mesenchyme morphogenesis;223;7;GO:0048704
GO:0072139;glomerular parietal epithelial cell differentiation;136;152;GO:0048193
GO:0072138;mesenchymal cell proliferation involved in ureteric bud development;97;30;GO:0048608
GO:0060160;negative regulation of dopamine receptor signaling pathway;118;48;GO:0048167
GO:0072137;condensed mesenchymal cell proliferation;171;143;GO:0048608
GO:0060187;cell pole;6848;163;GO:0005634
GO:1901282;fructoselysine biosynthetic process;0;1;GO:0006066
GO:0060188;regulation of protein desumoylation;125;7;GO:0006464
GO:1901281;fructoselysine catabolic process;1;0;GO:0006066
GO:0060189;positive regulation of protein desumoylation;11;0;GO:0016567
GO:1901284;5,6,7,8-tetrahydromethanopterin catabolic process;0;0;GO:0006067
GO:1901283;5,6,7,8-tetrahydromethanopterin metabolic process;265;1;GO:0006790
GO:0060183;apelin receptor signaling pathway;782;2;GO:0007186
GO:1901286;iron-sulfur-molybdenum cofactor metabolic process;0;1;GO:0006732
GO:0060184;cell cycle switching;369;6;GO:0007049
GO:1901285;5,6,7,8-tetrahydromethanopterin biosynthetic process;265;2;GO:0006790
GO:0060185;outer ear unfolding;0;1;GO:0008544
GO:1901288;iron-sulfur-molybdenum cofactor biosynthetic process;0;1;GO:0009061
GO:0060186;outer ear emergence;0;1;GO:0008544
GO:1901287;iron-sulfur-molybdenum cofactor catabolic process;0;1;GO:0009062
GO:1901289;succinyl-CoA catabolic process;128;8;GO:0006066
GO:0072172;mesonephric tubule formation;851;9;GO:0048608
GO:0072171;mesonephric tubule morphogenesis;4717;25;GO:0048608
GO:0072170;metanephric tubule development;1583;110;GO:0048608
GO:0072165;anterior mesonephric tubule development;54;1;GO:0048608
GO:0098751;bone cell development;1075;58;GO:0048667
GO:0072164;mesonephric tubule development;7518;220;GO:0048608
GO:0072163;mesonephric epithelium development;7598;100;GO:0030216
GO:0072162;metanephric mesenchymal cell differentiation;144;150;GO:0045595
GO:0098750;FYXD domain binding;4;1;GO:0005515
GO:0072169;specification of posterior mesonephric tubule identity;54;3;GO:0048704
GO:0098755;maintenance of seed dormancy by absisic acid;44;1;GO:0009835
GO:0072168;specification of anterior mesonephric tubule identity;54;2;GO:0048704
GO:0098756;response to interleukin-21;2;1;GO:0045727
GO:0072167;specification of mesonephric tubule identity;108;1;GO:0048704
GO:0072166;posterior mesonephric tubule development;120;153;GO:0048608
GO:0098754;detoxification;3784935;866;GO:0006979
GO:0060190;negative regulation of protein desumoylation;0;1;GO:0016567
GO:0098759;cellular response to interleukin-8;158;28;GO:0071346
GO:0060191;regulation of lipase activity;239;331;GO:0004613
GO:0060192;negative regulation of lipase activity;32;1030;GO:0010401
GO:0098757;cellular response to interleukin-21;2;7;GO:0071346
GO:0060193;positive regulation of lipase activity;203;179;GO:0010401
GO:0098758;response to interleukin-8;158;62;GO:0050921
GO:1901280;D-ribose 5-phosphate biosynthetic process;0;0;GO:0006066
GO:0060176;regulation of aggregation involved in sorocarp development;133;2;GO:0048608
GO:1901293;nucleoside phosphate biosynthetic process;13062938;1490;GO:0006790
GO:0060177;regulation of angiotensin metabolic process;101;46;GO:0010468
GO:1901292;nucleoside phosphate catabolic process;349501;1050;GO:0009061
GO:0060178;regulation of exocyst localization;121;31;GO:0048193
GO:1901295;regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment;112;4;GO:0048704
GO:0060179;male mating behavior;1473;563;GO:0007548
GO:0060172;astral microtubule depolymerization;14;4;GO:0007049
GO:1901297;positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment;49;29;GO:0048704
GO:0060173;limb development;17512;2090;GO:0009952
GO:1901296;negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment;61;3;GO:0048704
GO:0060174;limb bud formation;461;1210;GO:0048704
GO:1901299;negative regulation of hydrogen peroxide-mediated programmed cell death;486;174;GO:0043524
GO:0060175;brain-derived neurotrophic factor receptor activity;133;1;GO:0004872
GO:1901298;regulation of hydrogen peroxide-mediated programmed cell death;546;4;GO:0010941
GO:0072161;mesenchymal cell differentiation involved in kidney development;234;259;GO:0030509
GO:0072160;nephron tubule epithelial cell differentiation;724;99;GO:0048667
GO:0098770;FBXO family protein binding;125;103;GO:0005515
GO:0072154;proximal convoluted tubule segment 1 cell fate commitment;0;1;GO:0048608
GO:0098762;meiotic cell cycle phase;0;17;GO:0000279
GO:0072153;renal interstitial fibroblast fate commitment;0;1;GO:0048608
GO:0098763;mitotic cell cycle phase;0;26;GO:0000278
GO:0072152;glomerular mesangial cell fate commitment;0;1;GO:0048193
GO:0098760;response to interleukin-7;599;83;GO:0045727
GO:0072151;mesangial cell fate commitment;0;2;GO:0048608
GO:0098761;cellular response to interleukin-7;542;95;GO:0071346
GO:0072158;proximal tubule morphogenesis;12;2;GO:0048193
GO:0072157;epithelial cell migration involved in distal tubule morphogenesis;0;2;GO:0048608
GO:0072156;distal tubule morphogenesis;145;8;GO:0048608
GO:0098764;meiosis I cell cycle phase;0;8;GO:0000086
GO:0072155;epithelial cell migration involved in nephron tubule morphogenesis;0;1;GO:0048608
GO:0098765;meiosis II cell cycle phase;0;1;GO:0051321
GO:0060180;female mating behavior;707;275;GO:0007548
GO:0098768;meiotic prometaphase I;0;1;GO:0000965
GO:0060182;apelin receptor activity;136;3;GO:0004872
GO:0072159;epithelial cell migration involved in proximal tubule morphogenesis;0;0;GO:0048608
GO:0098769;TIMP family protein binding;1;3;GO:0048407
GO:1901291;negative regulation of double-strand break repair via single-strand annealing;55;5;GO:0048285
GO:1901290;succinyl-CoA biosynthetic process;51;3;GO:0006094
GO:0180011;cytoplasmic polyadenylation;209;4;GO:0003743
GO:0180010;co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway;467;1;GO:0000976
GO:0180013;lysophosphatidylserine flippase activity;11;1;GO:0005525
GO:0180012;co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway;469;2;GO:0000976
GO:0001700;embryonic development via the syncytial blastoderm;2825;138;GO:0007498
GO:0001701;in utero embryonic development;20912;6590;GO:0008544
GO:0001702;gastrulation with mouth forming second;2449;1250;GO:0008544
GO:0001703;gastrulation with mouth forming first;708;15;GO:0008544
GO:0001704;formation of primary germ layer;9740;651;GO:0031012
GO:0180019;Knl1/Spc105 complex;96;2;GO:0048285
GO:0001705;ectoderm formation;339;19;GO:0009952
GO:0180018;cytoplasmic polyadenylation-dependent RNA catabolic process;0;1;GO:0022627
GO:0001706;endoderm formation;4093;912;GO:0032502
GO:0001707;mesoderm formation;5243;2020;GO:0007530
GO:0001708;cell fate specification;18529;1620;GO:0032502
GO:0180015;nucleoside import across plasma membrane;50;0;GO:0006865
GO:0001709;cell fate determination;4361;1230;GO:0032502
GO:0180014;protein-tRNA adaptor activity;1;0;GO:0003735
GO:0180017;K11-linked deubiquitinase activity;0;0;GO:0004867
GO:0180016;SUMO ligase regulator activity;1;1;GO:0004842
GO:0180000;histone methyltransferase inhibitor activity;14;1;GO:0016567
GO:0180002;renal zinc excretion;1;1;GO:0006836
GO:0001710;mesodermal cell fate commitment;1489;44;GO:0030182
GO:0180001;cyclic-di-AMP binding;0;2;GO:0005524
GO:0001711;endodermal cell fate commitment;1204;237;GO:0032502
GO:0001712;ectodermal cell fate commitment;269;29;GO:0030182
GO:0001713;ectodermal cell fate determination;20;5;GO:0009952
GO:0001714;endodermal cell fate specification;775;192;GO:0032502
GO:0001715;ectodermal cell fate specification;174;7;GO:0009952
GO:0180008;RNA polymerase II CTD heptapeptide repeat S7 phosphatase activity;0;0;GO:0006031
GO:0001716;L-amino-acid oxidase activity;83233;40;GO:0004401
GO:0180007;RNA polymerase II CTD heptapeptide repeat S5 phosphatase activity;0;0;GO:0006031
GO:0001717;conversion of seryl-tRNAsec to selenocys-tRNAsec;3507;8;GO:0006413
GO:0180009;broad specificity neutral L-amino acid:basic L-amino acid antiporter activity;58;1;GO:0005215
GO:0180004;RNA polymerase II CTD heptapeptide repeat Y1 phosphatase activity;0;0;GO:0006073
GO:0180003;S-adenosyl-L-methionine:S-adenosyl-L-homocysteine antiporter activity;60;3;GO:0009065
GO:0180006;RNA polymerase II CTD heptapeptide repeat S2 phosphatase activity;0;0;GO:0006073
GO:0180005;RNA polymerase II CTD heptapeptide repeat T4 phosphatase activity;1;2;GO:0006073
GO:0001750;photoreceptor outer segment;9650;1250;GO:0005576
GO:0001740;Barr body;339;136;GO:0005819
GO:0001741;XY body;672;314;GO:0005615
GO:0001742;oenocyte differentiation;147;3;GO:0008544
GO:0001743;lens placode formation;197;0;GO:0007530
GO:0001744;insect visual primordium formation;44;0;GO:0008544
GO:0001745;compound eye morphogenesis;5744;324;GO:0009952
GO:0001746;Bolwig's organ morphogenesis;88;20;GO:0048608
GO:0001748;insect visual primordium development;114;0;GO:0008544
GO:0001760;aminocarboxymuconate-semialdehyde decarboxylase activity;3082;7;GO:0009065
GO:0001761;beta-alanine transmembrane transporter activity;45;10;GO:0005215
GO:0001751;compound eye photoreceptor cell differentiation;3181;70;GO:0048608
GO:0072099;anterior/posterior pattern specification involved in ureteric bud development;0;8;GO:0009952
GO:0001752;compound eye photoreceptor fate commitment;1117;9;GO:0009952
GO:0072098;anterior/posterior pattern specification involved in kidney development;197;6;GO:0009952
GO:0001754;eye photoreceptor cell differentiation;7862;967;GO:0007566
GO:0072096;negative regulation of branch elongation involved in ureteric bud branching;0;8;GO:0048608
GO:0001755;neural crest cell migration;5931;1640;GO:0048704
GO:0001756;somitogenesis;5702;2160;GO:0007275
GO:0001757;somite specification;402;116;GO:0002041
GO:0001758;retinal dehydrogenase activity;565;477;GO:0004497
GO:0001759;organ induction;1181;973;GO:0048731
GO:0001720;conversion of lysyl-tRNA to pyrrolysyl-tRNA;0;3;GO:0006413
GO:0001725;stress fiber;3584;2110;GO:0005925
GO:0001726;ruffle;27703;2640;GO:0005578
GO:0001727;lipid kinase activity;180996;165;GO:0016791
GO:0001729;ceramide kinase activity;441;28;GO:0004721
GO:0001730;2'-5'-oligoadenylate synthetase activity;1199;160;GO:0005524
GO:0180021;snRNA 2'-O-ribose methyltransferase activity;0;0;GO:0003729
GO:0001731;formation of translation preinitiation complex;5363;2220;GO:0006413
GO:0001732;formation of cytoplasmic translation initiation complex;36874;256;GO:0006413
GO:0001733;galactosylceramide sulfotransferase activity;5466;53;GO:0004730
GO:0001734;mRNA (N6-adenosine)-methyltransferase activity;443;1;GO:0003729
GO:0001735;prenylcysteine oxidase activity;5100;231;GO:0004730
GO:0180020;membrane bending activity;0;0;GO:0003774
GO:0001736;establishment of planar polarity;9945;1800;GO:0048608
GO:0001737;establishment of imaginal disc-derived wing hair orientation;219;26;GO:0048608
GO:0001738;morphogenesis of a polarized epithelium;11767;647;GO:0030216
GO:0001739;sex chromatin;253;256;GO:0007049
GO:1903800;positive regulation of miRNA processing;336;7;GO:0010467
GO:0001790;polymeric immunoglobulin binding;0;3;GO:0042803
GO:0001791;IgM binding;37;7;GO:0044421
GO:1903803;L-glutamine import across plasma membrane;114;5;GO:0006874
GO:0001792;polymeric immunoglobulin receptor activity;52;4;GO:0002768
GO:1903804;glycine import across plasma membrane;219;0;GO:0006836
GO:0001793;IgM receptor activity;0;2;GO:0002430
GO:1903801;L-leucine import across plasma membrane;345;4;GO:0006836
GO:0001794;type IIa hypersensitivity;226;9;GO:0002237
GO:0001784;phosphotyrosine residue binding;13891;324;GO:0042802
GO:0001785;prostaglandin J receptor activity;49;8;GO:0004930
GO:0001786;phosphatidylserine binding;2641;1230;GO:0048193
GO:0001787;natural killer cell proliferation;790;500;GO:0042127
GO:0001788;antibody-dependent cellular cytotoxicity;165;70;GO:0002449
GO:0050714;positive regulation of protein secretion;6827;1880;GO:0050832
GO:0050728;negative regulation of inflammatory response;8055;2340;GO:0050729
GO:0050729;positive regulation of inflammatory response;6965;2940;GO:0050729
GO:1903810;L-histidine import across plasma membrane;128;3;GO:0006836
GO:1903811;L-asparagine import across plasma membrane;8;1;GO:0006865
GO:1903814;regulation of collecting lymphatic vessel constriction;4;2;GO:0048207
GO:1903815;negative regulation of collecting lymphatic vessel constriction;2;1;GO:0048207
GO:1903812;L-serine import across plasma membrane;74;3;GO:0006874
GO:0001795;type IIb hypersensitivity;0;2;GO:0002237
GO:1903807;L-threonine import across plasma membrane;0;0;GO:0006865
GO:0001796;regulation of type IIa hypersensitivity;162;90;GO:0048316
GO:1903808;L-tyrosine import across plasma membrane;1;0;GO:0006836
GO:0001797;negative regulation of type IIa hypersensitivity;1;3;GO:0048002
GO:1903805;L-valine import across plasma membrane;33;0;GO:0006865
GO:0001798;positive regulation of type IIa hypersensitivity;160;151;GO:0048002
GO:1903806;L-isoleucine import across plasma membrane;54;1;GO:0006869
GO:0001799;regulation of type IIb hypersensitivity;0;3;GO:0048002
GO:0050727;regulation of inflammatory response;21626;5330;GO:0002682
GO:0050739;peptide cross-linking via S-[5'-(L-tryptoph-6'-yl)-L-tyrosin-3'-yl]-L-methionin-S-ium;0;0;GO:0048608
GO:1903825;organic acid transmembrane transport;1180465;322;GO:0015075
GO:0001770;establishment of natural killer cell polarity;1;5;GO:0048308
GO:1903826;L-arginine transmembrane transport;15598;67;GO:0006865
GO:0001771;immunological synapse formation;625;524;GO:0002227
GO:1903823;telomere single strand break repair;0;10;GO:0007049
GO:0001772;immunological synapse;2652;1540;GO:0002227
GO:1903824;negative regulation of telomere single strand break repair;1;9;GO:0048285
GO:0001762;beta-alanine transport;100;9;GO:0006865
GO:1903818;positive regulation of voltage-gated potassium channel activity;46;33;GO:0048169
GO:0001763;morphogenesis of a branching structure;19349;1690;GO:0048468
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;10528;1170;GO:0043406
GO:0001764;neuron migration;16855;3860;GO:0048608
GO:1903816;positive regulation of collecting lymphatic vessel constriction;2;0;GO:0048010
GO:0001765;membrane raft assembly;5091;307;GO:0048193
GO:1903817;negative regulation of voltage-gated potassium channel activity;64;165;GO:0048608
GO:0001766;membrane raft polarization;60576;99;GO:0048193
GO:0001767;establishment of lymphocyte polarity;61169;53;GO:0048308
GO:0001768;establishment of T cell polarity;61168;339;GO:0048308
GO:0001769;establishment of B cell polarity;0;5;GO:0048308
GO:0050737;O-hydroxycinnamoyltransferase activity;270;3;GO:0004073
GO:0050738;fructosyltransferase activity;55;1;GO:0004553
GO:0050735;N-malonyltransferase activity;0;1;GO:0004734
GO:0050736;O-malonyltransferase activity;52;5;GO:0004734
GO:0050733;RS domain binding;117;98;GO:0005515
GO:0050734;hydroxycinnamoyltransferase activity;2326;8;GO:0004073
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;7509;3880;GO:0043406
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;1629;354;GO:0043406
GO:1903832;regulation of cellular response to amino acid starvation;288;1;GO:0009063
GO:1903833;positive regulation of cellular response to amino acid starvation;281;8;GO:0045735
GO:1903830;magnesium ion transmembrane transport;273818;69;GO:0006836
GO:1903831;signal transduction involved in cellular response to ammonium ion;2;5;GO:0006811
GO:0001780;neutrophil homeostasis;1335;304;GO:0002682
GO:0001781;neutrophil apoptotic process;360;43;GO:0043066
GO:1903837;regulation of mRNA 3'-UTR binding;0;1;GO:0010467
GO:0001782;B cell homeostasis;1580;1150;GO:0002449
GO:0001783;B cell apoptotic process;1887;720;GO:0042981
GO:0001773;myeloid dendritic cell activation;1540;1720;GO:0002456
GO:1903829;positive regulation of protein localization;89874;444;GO:0010468
GO:0001774;microglial cell activation;1800;3480;GO:0002442
GO:0001775;cell activation;246820;5360;GO:0042110
GO:0001776;leukocyte homeostasis;6851;714;GO:0002526
GO:1903828;negative regulation of protein localization;18058;108;GO:0010468
GO:0001777;T cell homeostatic proliferation;167;123;GO:0042127
GO:0047103;3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity;115;2;GO:0004497
GO:0001778;plasma membrane repair;2166;1950;GO:0048471
GO:0047102;aminomuconate-semialdehyde dehydrogenase activity;301;6;GO:0004067
GO:0001779;natural killer cell differentiation;1398;889;GO:0002273
GO:0047101;2-oxoisovalerate dehydrogenase (acylating) activity;18;4;GO:0004089
GO:0047100;glyceraldehyde-3-phosphate dehydrogenase (NADP+) (phosphorylating) activity;1365;0;GO:0004073
GO:0050748;negative regulation of lipoprotein metabolic process;313;77;GO:0045944
GO:0050746;regulation of lipoprotein metabolic process;1159;172;GO:0019216
GO:0050747;positive regulation of lipoprotein metabolic process;234;8;GO:0045944
GO:0050745;peptide cross-linking via L-cysteinyl-5-imidazolinone glycine;0;1;GO:0048193
GO:0035122;embryonic medial fin morphogenesis;110;2;GO:0009952
GO:0035123;embryonic dorsal fin morphogenesis;0;2;GO:0008544
GO:0035124;embryonic caudal fin morphogenesis;84;3;GO:0048608
GO:0035120;post-embryonic appendage morphogenesis;5773;33;GO:0048608
GO:0035118;embryonic pectoral fin morphogenesis;464;6;GO:0009952
GO:0035119;embryonic pelvic fin morphogenesis;40;2;GO:0048706
GO:0035114;imaginal disc-derived appendage morphogenesis;6043;150;GO:0048608
GO:0035115;embryonic forelimb morphogenesis;1641;1160;GO:0009952
GO:0035116;embryonic hindlimb morphogenesis;1606;1020;GO:0002040
GO:0035112;genitalia morphogenesis;1072;737;GO:0009952
GO:0035113;embryonic appendage morphogenesis;9898;691;GO:0009952
GO:2000209;regulation of anoikis;1171;68;GO:0010942
GO:2000208;positive regulation of ribosomal small subunit export from nucleus;55;3;GO:0045934
GO:2000207;negative regulation of ribosomal small subunit export from nucleus;0;1;GO:0022627
GO:2000206;regulation of ribosomal small subunit export from nucleus;55;1;GO:0022627
GO:0035107;appendage morphogenesis;20178;1380;GO:0048608
GO:2000201;negative regulation of ribosomal subunit export from nucleus;5;2;GO:0045944
GO:0035108;limb morphogenesis;12774;1560;GO:0048704
GO:2000200;regulation of ribosomal subunit export from nucleus;124;4;GO:0022627
GO:2000205;positive regulation of ribosomal large subunit export from nucleus;0;3;GO:0045934
GO:2000204;negative regulation of ribosomal large subunit export from nucleus;5;1;GO:0022627
GO:2000203;regulation of ribosomal large subunit export from nucleus;60;5;GO:0022627
GO:0035106;operant conditioning;97;190;GO:0007612
GO:2000202;positive regulation of ribosomal subunit export from nucleus;55;4;GO:0045934
GO:0035100;ecdysone binding;932;9;GO:0005524
GO:0035101;FACT complex;9493;105;GO:0000786
GO:0035102;PRC1 complex;3307;369;GO:0048608
GO:2000219;positive regulation of invasive growth in response to glucose limitation;82;5;GO:0046278
GO:2000218;negative regulation of invasive growth in response to glucose limitation;5;3;GO:0046365
GO:2000217;regulation of invasive growth in response to glucose limitation;193;5;GO:0010468
GO:2000212;negative regulation of glutamate metabolic process;61;0;GO:0046394
GO:2000211;regulation of glutamate metabolic process;262;10;GO:0045727
GO:2000210;positive regulation of anoikis;267;83;GO:0048608
GO:2000216;positive regulation of proline metabolic process;12;0;GO:0045944
GO:2000215;negative regulation of proline metabolic process;3;0;GO:0046365
GO:2000214;regulation of proline metabolic process;72;2;GO:0046274
GO:2000213;positive regulation of glutamate metabolic process;142;19;GO:0046394
GO:0050708;regulation of protein secretion;17907;983;GO:0051603
GO:2000230;negative regulation of pancreatic stellate cell proliferation;4;9;GO:0048010
GO:0050709;negative regulation of protein secretion;7196;597;GO:0032989
GO:2000229;regulation of pancreatic stellate cell proliferation;7;4;GO:0048010
GO:2000228;positive regulation of pancreatic A cell differentiation;23;0;GO:0048608
GO:2000222;positive regulation of pseudohyphal growth;200;6;GO:0046330
GO:2000221;negative regulation of pseudohyphal growth;34;7;GO:0048285
GO:2000220;regulation of pseudohyphal growth;317;4;GO:0048285
GO:0050700;CARD domain binding;638;289;GO:0004846
GO:2000227;negative regulation of pancreatic A cell differentiation;94;4;GO:0048706
GO:2000226;regulation of pancreatic A cell differentiation;117;0;GO:0048608
GO:2000225;negative regulation of testosterone biosynthetic process;129;3;GO:0045944
GO:2000224;regulation of testosterone biosynthetic process;270;7;GO:0043434
GO:0060242;contact inhibition;373;51;GO:0048608
GO:0035287;head segmentation;170;8;GO:0048704
GO:0060243;negative regulation of cell growth involved in contact inhibition;52;3;GO:0048285
GO:0035288;anterior head segmentation;23;18;GO:0008544
GO:0060244;negative regulation of cell proliferation involved in contact inhibition;200;37;GO:0042127
GO:0035289;posterior head segmentation;78;10;GO:0048704
GO:0060245;detection of cell density;64485;3;GO:0048608
GO:0035282;segmentation;12740;862;GO:0048608
GO:1903762;positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;8;6;GO:0048407
GO:0035283;central nervous system segmentation;321;24;GO:0007423
GO:1903763;gap junction channel activity involved in cell communication by electrical coupling;593;26;GO:0008021
GO:0035284;brain segmentation;277;331;GO:0007319
GO:0060240;negative regulation of signal transduction involved in conjugation with cellular fusion;23;1;GO:0048285
GO:1901101;gramicidin S metabolic process;0;0;GO:0009064
GO:1903760;regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;10;6;GO:0048407
GO:0035285;appendage segmentation;306;4;GO:0009952
GO:0060241;lysozyme inhibitor activity;10;1;GO:0048305
GO:1903761;negative regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;0;0;GO:0048407
GO:1901103;gramicidin S biosynthetic process;0;0;GO:0009181
GO:1903766;positive regulation of potassium ion export across plasma membrane;122;6;GO:0048405
GO:1901102;gramicidin S catabolic process;0;1;GO:0046395
GO:1903767;sweet taste receptor complex;107;5;GO:0005929
GO:1901105;tetracenomycin C catabolic process;0;1;GO:0046395
GO:1903764;regulation of potassium ion export across plasma membrane;355;79;GO:0048407
GO:0035281;pre-miRNA export from nucleus;57;73;GO:0022627
GO:0047269;poly(ribitol-phosphate) N-acetylglucosaminyltransferase activity;3;3;GO:0006029
GO:1901104;tetracenomycin C metabolic process;0;1;GO:0006033
GO:1903765;negative regulation of potassium ion export across plasma membrane;137;6;GO:0048405
GO:1901107;granaticin metabolic process;0;0;GO:0006073
GO:1901106;tetracenomycin C biosynthetic process;0;3;GO:0046395
GO:1901109;granaticin biosynthetic process;0;1;GO:0046271
GO:1903768;taste receptor complex;107;2;GO:0005929
GO:0060249;anatomical structure homeostasis;16957;843;GO:0042592
GO:1901108;granaticin catabolic process;0;0;GO:0046274
GO:1903769;negative regulation of cell proliferation in bone marrow;6;4;GO:0045727
GO:0047275;glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity;71;153;GO:0006029
GO:0072220;metanephric descending thin limb development;40;3;GO:0002041
GO:0098850;extrinsic component of synaptic vesicle membrane;237;5;GO:0008026
GO:0047274;galactinol-sucrose galactosyltransferase activity;790;4;GO:0006033
GO:0098851;double-stranded miRNA binding;0;3;GO:0003723
GO:0047273;galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity;13;18;GO:0006029
GO:0047272;phosphopolyprenol glucosyltransferase activity;11;1;GO:0006021
GO:0047279;sn-glycerol-3-phosphate 1-galactosyltransferase activity;0;3;GO:0008800
GO:0072224;metanephric glomerulus development;665;9;GO:0048608
GO:0098854;podocyte primary projection;0;1;GO:0043005
GO:0047278;bilirubin-glucuronoside glucuronosyltransferase activity;0;2;GO:0006081
GO:0072223;metanephric glomerular mesangium development;87;5;GO:0048193
GO:0098855;HCN channel complex;431;35;GO:0048608
GO:0047277;globoside alpha-N-acetylgalactosaminyltransferase activity;33;8;GO:0006022
GO:0072222;metanephric early distal convoluted tubule development;0;1;GO:0048608
GO:0098852;lytic vacuole membrane;105523;293;GO:0005737
GO:0047276;N-acetyllactosaminide 3-alpha-galactosyltransferase activity;61;4;GO:0004553
GO:0072221;metanephric distal convoluted tubule development;187;430;GO:0048608
GO:0098853;endoplasmic reticulum-vacuole membrane contact site;1;3;GO:0005743
GO:0072228;metanephric prebend segment development;0;1;GO:0048704
GO:0098858;actin-based cell projection;41250;140;GO:0042995
GO:0072227;metanephric macula densa development;28;2;GO:0048608
GO:0098859;actin filament bundle of actin-based cell projection;4;0;GO:0050921
GO:0072226;metanephric long descending thin limb bend development;0;0;GO:0048704
GO:0098856;intestinal lipid absorption;1170;32;GO:0007586
GO:0072225;metanephric late distal convoluted tubule development;0;1;GO:0048608
GO:0098857;membrane microdomain;48408;1340;GO:0016021
GO:0035279;miRNA-mediated gene silencing by mRNA destabilization;1428;58;GO:0030968
GO:0047271;glycosaminoglycan galactosyltransferase activity;0;1;GO:0004553
GO:0047270;lipopolysaccharide glucosyltransferase II activity;18;3;GO:0004553
GO:0072229;metanephric proximal convoluted tubule development;44;39;GO:0048608
GO:0035275;dibutyl phthalate binding;17;6;GO:0042393
GO:0060231;mesenchymal to epithelial transition;853;299;GO:0030509
GO:0035276;ethanol binding;57;147;GO:0043169
GO:0060232;delamination;810;55;GO:0048661
GO:1903770;negative regulation of beta-galactosidase activity;2;10;GO:0010467
GO:0035277;spiracle morphogenesis, open tracheal system;271;47;GO:0009952
GO:0060233;oenocyte delamination;22;3;GO:0009955
GO:0035278;miRNA-mediated gene silencing by inhibition of translation;3835;286;GO:0034440
GO:0060234;neuroblast delamination;60;0;GO:0048704
GO:0035271;ring gland development;41;8;GO:0048608
GO:1901110;actinorhodin metabolic process;1;1;GO:0006073
GO:1903773;negative regulation of viral budding via host ESCRT complex;0;0;GO:0048193
GO:2000010;positive regulation of protein localization to cell surface;949;154;GO:0048193
GO:0035272;exocrine system development;5379;331;GO:0007517
GO:1903774;positive regulation of viral budding via host ESCRT complex;151;10;GO:0048193
GO:0035273;phthalate binding;0;2;GO:0046936
GO:1901112;actinorhodin biosynthetic process;1;0;GO:0009405
GO:1903771;positive regulation of beta-galactosidase activity;1;4;GO:0010467
GO:0035274;diphenyl phthalate binding;8;5;GO:0097159
GO:0060230;lipoprotein lipase activator activity;179;238;GO:0005576
GO:1901111;actinorhodin catabolic process;0;0;GO:0046274
GO:1903772;regulation of viral budding via host ESCRT complex;151;17;GO:0048193
GO:0060239;positive regulation of signal transduction involved in conjugation with cellular fusion;0;1;GO:0048285
GO:1901114;erythromycin catabolic process;0;0;GO:0046395
GO:1903777;melibiose binding;17;4;GO:0042379
GO:1901113;erythromycin metabolic process;1;0;GO:0006796
GO:1903778;protein localization to vacuolar membrane;204;48;GO:0005737
GO:1901116;cephamycin C metabolic process;0;0;GO:0009064
GO:1903775;regulation of DNA double-strand break processing;122;3;GO:0000086
GO:0035270;endocrine system development;12384;543;GO:0007530
GO:1901115;erythromycin biosynthetic process;1;0;GO:0009405
GO:1903776;regulation of double-strand break repair via single-strand annealing, removal of nonhomologous ends;0;0;GO:0006281
GO:0060235;lens induction in camera-type eye;162;298;GO:0007548
GO:1901118;cephamycin C biosynthetic process;0;0;GO:0009181
GO:0060236;regulation of mitotic spindle organization;7078;1750;GO:0048285
GO:1901117;cephamycin C catabolic process;0;0;GO:0046274
GO:0060237;regulation of fungal-type cell wall organization;358;9;GO:0032989
GO:1903779;regulation of cardiac conduction;690;448;GO:0048407
GO:0060238;regulation of signal transduction involved in conjugation with cellular fusion;32;2;GO:0007165
GO:1901119;tobramycin metabolic process;1;4;GO:0009064
GO:0047286;NAD+-diphthamide ADP-ribosyltransferase activity;234;0;GO:0004867
GO:0098861;actin filament bundle of filopodium;0;1;GO:0005913
GO:0047285;flavonol-3-O-glycoside xylosyltransferase activity;0;3;GO:0004553
GO:0098862;cluster of actin-based cell projections;12066;167;GO:0030054
GO:0047284;dolichyl-xylosyl-phosphate-protein xylosyltransferase activity;0;4;GO:0004073
GO:2000009;negative regulation of protein localization to cell surface;618;8070;GO:0048193
GO:0047283;dolichyl-phosphate D-xylosyltransferase activity;0;2;GO:0004073
GO:0098860;actin filament bundle of stereocilium;0;1;GO:0005576
GO:2000008;regulation of protein localization to cell surface;3089;15800;GO:0051649
GO:0072213;metanephric capsule development;50;2;GO:0048608
GO:0098865;symbiont-mediated perturbation of host tight cell-cell junction;2;0;GO:0048316
GO:0047289;galactosyldiacylglycerol alpha-2,3-sialyltransferase activity;0;3;GO:0004553
GO:0098866;multivesicular body fusion to apical plasma membrane;2;0;GO:0007088
GO:0047288;beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase;136;0;GO:0005581
GO:0072211;metanephric pyramids development;0;3;GO:0048608
GO:0098863;nuclear migration by microtubule mediated pushing forces;77;7;GO:0007049
GO:0072210;metanephric nephron development;2356;223;GO:0048316
GO:0098864;symbiont-mediated stabilization of host tight cell-cell junction;1;0;GO:0009986
GO:0072217;negative regulation of metanephros development;64;2;GO:0048706
GO:0098869;cellular oxidant detoxification;3583948;1810;GO:0006979
GO:2000003;positive regulation of DNA damage checkpoint;127;5970;GO:0045727
GO:0072216;positive regulation of metanephros development;63;10;GO:0048704
GO:2000002;negative regulation of DNA damage checkpoint;341;217;GO:0045727
GO:0072215;regulation of metanephros development;141;10;GO:0048706
GO:0098867;intramembranous bone growth;2;1;GO:0002040
GO:2000001;regulation of DNA damage checkpoint;1084;1200;GO:0000086
GO:0072214;metanephric cortex development;55;4;GO:0007420
GO:0098868;bone growth;2085;71;GO:0007518
GO:0035268;protein mannosylation;32992;286;GO:0006486
GO:0047282;dTDP-dihydrostreptose-streptidine-6-phosphate dihydrostreptosyltransferase activity;4;3;GO:0006030
GO:2000007;negative regulation of metanephric comma-shaped body morphogenesis;68;110;GO:0048706
GO:0035269;protein O-linked mannosylation;32900;689;GO:0006486
GO:0047281;dioxotetrahydropyrimidine phosphoribosyltransferase activity;0;3;GO:0004061
GO:2000006;regulation of metanephric comma-shaped body morphogenesis;68;9;GO:0048608
GO:0047280;nicotinamide phosphoribosyltransferase activity;2338;29;GO:0004073
GO:0072219;metanephric cortical collecting duct development;55;4;GO:0048608
GO:2000005;negative regulation of metanephric S-shaped body morphogenesis;68;51;GO:0048706
GO:0072218;metanephric ascending thin limb development;169;50;GO:0048704
GO:2000004;regulation of metanephric S-shaped body morphogenesis;68;6;GO:0048608
GO:0035264;multicellular organism growth;11176;1850;GO:0048870
GO:0060264;regulation of respiratory burst involved in inflammatory response;259;83;GO:0046649
GO:1903780;negative regulation of cardiac conduction;28;3;GO:0048407
GO:0035265;organ growth;12666;1010;GO:0048731
GO:0060265;positive regulation of respiratory burst involved in inflammatory response;71;49;GO:0046649
GO:1903781;positive regulation of cardiac conduction;51;6;GO:0048407
GO:0035266;meristem growth;2219;35;GO:0048316
GO:0060266;negative regulation of respiratory burst involved in inflammatory response;184;167;GO:0050729
GO:0035267;NuA4 histone acetyltransferase complex;32890;1070;GO:0016569
GO:0060267;positive regulation of respiratory burst;359;412;GO:0046649
GO:0035260;internal genitalia morphogenesis;26;4;GO:0007548
GO:0060260;regulation of transcription initiation by RNA polymerase II;7919;5;GO:0006351
GO:1901121;tobramycin biosynthetic process;1;1;GO:0009405
GO:1903784;positive regulation of sodium ion import across plasma membrane;0;1;GO:0048193
GO:0035261;external genitalia morphogenesis;76;9;GO:0009952
GO:0060261;positive regulation of transcription initiation by RNA polymerase II;7180;187;GO:0006355
GO:1901120;tobramycin catabolic process;0;1;GO:0046395
GO:1903785;L-valine transmembrane transport;323;2;GO:0008544
GO:2000020;positive regulation of male gonad development;404;612;GO:0048608
GO:0035262;gonad morphogenesis;427;127;GO:0048608
GO:0060262;negative regulation of N-terminal protein palmitoylation;74;5;GO:0010425
GO:1901123;bacitracin A catabolic process;0;0;GO:0009065
GO:1903782;regulation of sodium ion import across plasma membrane;2;1;GO:0048407
GO:0035263;genital disc sexually dimorphic development;93;8;GO:0007565
GO:0060263;regulation of respiratory burst;729;225;GO:0046649
GO:1901122;bacitracin A metabolic process;0;0;GO:0006066
GO:1903783;negative regulation of sodium ion import across plasma membrane;2;1;GO:0048193
GO:1901125;candicidin metabolic process;0;0;GO:0006032
GO:1903788;positive regulation of glutathione biosynthetic process;53;70;GO:0046394
GO:1901124;bacitracin A biosynthetic process;0;0;GO:0009405
GO:1903789;regulation of amino acid transmembrane transport;4514;6;GO:0006865
GO:1901127;candicidin biosynthetic process;0;0;GO:0046395
GO:1903786;regulation of glutathione biosynthetic process;101;223;GO:0046394
GO:1901126;candicidin catabolic process;0;0;GO:0006032
GO:1903787;negative regulation of glutathione biosynthetic process;0;1;GO:0046394
GO:0060268;negative regulation of respiratory burst;228;119;GO:0046649
GO:0018907;dimethyl sulfoxide metabolic process;4;3;GO:0006790
GO:0090254;cell elongation involved in imaginal disc-derived wing morphogenesis;138;15;GO:0048608
GO:0018906;methyl tert-butyl ether metabolic process;0;2;GO:0046395
GO:0090255;cell proliferation involved in imaginal disc-derived wing morphogenesis;656;1;GO:0042127
GO:0018909;dodecyl sulfate metabolic process;8185;6;GO:0006631
GO:0090252;epithelium migration involved in imaginal disc-derived wing morphogenesis;0;0;GO:0048608
GO:0018908;organosulfide cycle;0;2;GO:0006099
GO:0090253;convergent extension involved in imaginal disc-derived wing morphogenesis;0;1;GO:0048608
GO:0090250;cell-cell adhesion involved in establishment of planar polarity;0;3;GO:0007155
GO:0090251;protein localization involved in establishment of planar polarity;157;5;GO:0005576
GO:0006913;nucleocytoplasmic transport;347663;4800;GO:0006909
GO:0006910;phagocytosis, recognition;754;1250;GO:0006908
GO:0006911;phagocytosis, engulfment;2709;1850;GO:0006909
GO:0006914;autophagy;306769;8340;GO:0006914
GO:0006915;apoptotic process;381261;20400;GO:0006915
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;370;2850;GO:0046330
GO:0018910;benzene metabolic process;1;5;GO:0006725
GO:0090269;fibroblast growth factor production;234;9;GO:0048608
GO:0090267;positive regulation of mitotic cell cycle spindle assembly checkpoint;619;298;GO:0045786
GO:0090268;activation of mitotic cell cycle spindle assembly checkpoint;9;2;GO:0007067
GO:0090265;positive regulation of immune complex clearance by monocytes and macrophages;93;37;GO:0002449
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;2772;879;GO:0000819
GO:0090263;positive regulation of canonical Wnt signaling pathway;6910;1630;GO:0048216
GO:0090264;regulation of immune complex clearance by monocytes and macrophages;94;7;GO:0002449
GO:0090261;positive regulation of inclusion body assembly;83;113;GO:0048193
GO:0090262;regulation of transcription-coupled nucleotide-excision repair;111;7;GO:0006281
GO:0006930;substrate-dependent cell migration, cell extension;293;262;GO:0048608
GO:0006931;substrate-dependent cell migration, cell attachment to substrate;179;39;GO:0022610
GO:0090260;negative regulation of retinal ganglion cell axon guidance;55;10;GO:0048706
GO:0006924;activation-induced cell death of T cells;462;149;GO:0006915
GO:0006921;cellular component disassembly involved in execution phase of apoptosis;3056;457;GO:0043066
GO:0006925;inflammatory cell apoptotic process;705;65;GO:0043066
GO:0006929;substrate-dependent cell migration;1043;714;GO:0016477
GO:0090238;positive regulation of arachidonic acid secretion;187;59;GO:0030520
GO:0090239;regulation of histone H4 acetylation;79;66;GO:0045944
GO:0090237;regulation of arachidonic acid secretion;245;8;GO:0030518
GO:0090234;regulation of kinetochore assembly;241;124;GO:0007062
GO:0090235;regulation of metaphase plate congression;861;306;GO:0048608
GO:0090232;positive regulation of spindle checkpoint;619;135;GO:0045786
GO:0090233;negative regulation of spindle checkpoint;260;3;GO:0048285
GO:0090230;regulation of centromere complex assembly;286;162;GO:0007062
GO:0090231;regulation of spindle checkpoint;2772;487;GO:0051726
GO:0090249;regulation of cell migration involved in somitogenic axis elongation;13;1;GO:0048608
GO:0090248;cell migration involved in somitogenic axis elongation;14;2;GO:0048608
GO:0090245;axis elongation involved in somitogenesis;241;23;GO:0048704
GO:0090246;convergent extension involved in somitogenesis;44;6;GO:0002064
GO:0090243;fibroblast growth factor receptor signaling pathway involved in somitogenesis;4;3;GO:0048608
GO:0090244;Wnt signaling pathway involved in somitogenesis;161;57;GO:0007219
GO:0090241;negative regulation of histone H4 acetylation;7;19;GO:0045944
GO:0090242;retinoic acid receptor signaling pathway involved in somitogenesis;55;3;GO:0030501
GO:0090240;positive regulation of histone H4 acetylation;54;50;GO:0045944
GO:0006901;vesicle coating;10268;591;GO:0008026
GO:0006900;vesicle budding from membrane;20411;263;GO:0008029
GO:0006906;vesicle fusion;18494;1240;GO:0008026
GO:0006903;vesicle targeting;34016;500;GO:0008023
GO:0006904;vesicle docking involved in exocytosis;5268;1780;GO:0008092
GO:0006909;phagocytosis;21421;4600;GO:0006909
GO:0006907;pinocytosis;2001;1390;GO:0006897
GO:0016887;ATP hydrolysis activity;6561027;5530;GO:0003924
GO:0016888;endodeoxyribonuclease activity, producing 5'-phosphomonoesters;181895;7;GO:0004518
GO:0016889;DNA endonuclease activity, producing 3'-phosphomonoesters;89442;1;GO:0004518
GO:0002240;response to molecule of oomycetes origin;30;10;GO:0009617
GO:0002241;response to parasitic plant;2;2;GO:0046274
GO:0002242;defense response to parasitic plant;2;5;GO:0050832
GO:0002243;detection of parasitic plant;0;4;GO:0048309
GO:0002244;hematopoietic progenitor cell differentiation;10341;1650;GO:0030097
GO:0002235;detection of unfolded protein;4;7;GO:0006457
GO:0002236;detection of misfolded protein;0;4;GO:0006457
GO:0004897;ciliary neurotrophic factor receptor activity;394;137;GO:0004872
GO:0002237;response to molecule of bacterial origin;19633;2780;GO:0002237
GO:0002238;response to molecule of fungal origin;4394;220;GO:0009617
GO:0002239;response to oomycetes;1801;175;GO:0046686
GO:0016890;site-specific endodeoxyribonuclease activity, specific for altered base;161;7;GO:0004518
GO:0016891;RNA endonuclease activity, producing 5'-phosphomonoesters;937902;5;GO:0004518
GO:0016892;RNA endonuclease activity, producing 3'-phosphomonoesters;21920;5;GO:0004518
GO:0016893;endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters;1119797;5;GO:0004518
GO:0016894;endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters;113064;3;GO:0004518
GO:0016895;DNA exonuclease activity, producing 5'-phosphomonoesters;396271;0;GO:0004518
GO:0016896;RNA exonuclease activity, producing 5'-phosphomonoesters;319525;2;GO:0003907
GO:0016897;RNA exonuclease activity, producing 3'-phosphomonoesters;0;0;GO:0003907
GO:0016877;ligase activity, forming carbon-sulfur bonds;709161;163;GO:0004812
GO:0016878;acid-thiol ligase activity;527869;131;GO:0004867
GO:0016879;ligase activity, forming carbon-nitrogen bonds;5633265;2350;GO:0004812
GO:0002250;adaptive immune response;102257;7710;GO:0006955
GO:0002251;organ or tissue specific immune response;1436;355;GO:0002376
GO:0002252;immune effector process;71967;4380;GO:0002684
GO:0002253;activation of immune response;94469;3310;GO:0002684
GO:0002254;kinin cascade;158;22;GO:0006954
GO:0002255;tissue kallikrein-kinin cascade;2;4;GO:0006958
GO:0002256;regulation of kinin cascade;0;3;GO:0002768
GO:0002246;wound healing involved in inflammatory response;380;51;GO:0009611
GO:0002247;clearance of damaged tissue involved in inflammatory response wound healing;0;4;GO:0002526
GO:0002248;connective tissue replacement involved in inflammatory response wound healing;263;52;GO:0010717
GO:0002249;lymphocyte anergy;500;19;GO:0002821
GO:0016880;acid-ammonia (or amide) ligase activity;336870;312;GO:0003954
GO:0016881;acid-amino acid ligase activity;2107137;1810;GO:0004867
GO:0016882;cyclo-ligase activity;291372;15;GO:0003824
GO:0016884;carbon-nitrogen ligase activity, with glutamine as amido-N-donor;1477694;1400;GO:0003824
GO:0016885;ligase activity, forming carbon-carbon bonds;258199;193;GO:0004812
GO:0016886;ligase activity, forming phosphoric ester bonds;385262;54;GO:0004723
GO:0016866;intramolecular transferase activity;2448574;1210;GO:0004871
GO:0016867;intramolecular transferase activity, transferring acyl groups;21247;3;GO:0004812
GO:0016868;intramolecular transferase activity, phosphotransferases;766129;1020;GO:0004723
GO:0016869;intramolecular transferase activity, transferring amino groups;116438;6;GO:0004812
GO:1905600;regulation of receptor-mediated endocytosis involved in cholesterol transport;203;1;GO:0006897
GO:1905604;negative regulation of blood-brain barrier permeability;108;5;GO:0048168
GO:1905603;regulation of blood-brain barrier permeability;346;4;GO:0048168
GO:1905602;positive regulation of receptor-mediated endocytosis involved in cholesterol transport;129;9;GO:0048193
GO:1905601;negative regulation of receptor-mediated endocytosis involved in cholesterol transport;74;5;GO:0048193
GO:0002220;innate immune response activating cell surface receptor signaling pathway;4692;128;GO:0002764
GO:0004883;nuclear glucocorticoid receptor activity;1438;7;GO:0004872
GO:1905608;positive regulation of presynapse assembly;23;4;GO:0048608
GO:0002221;pattern recognition receptor signaling pathway;42657;823;GO:0002224
GO:1905607;negative regulation of presynapse assembly;41;0;GO:0048608
GO:0002222;stimulatory killer cell immunoglobulin-like receptor signaling pathway;46;10;GO:0002449
GO:1905606;regulation of presynapse assembly;6802;123;GO:0048608
GO:0002223;stimulatory C-type lectin receptor signaling pathway;411;945;GO:0002449
GO:1905605;positive regulation of blood-brain barrier permeability;228;6;GO:0048168
GO:0002213;defense response to insect;387;549;GO:0009620
GO:0004876;complement component C3a receptor activity;289;9;GO:0004866
GO:0004875;complement receptor activity;1774;179;GO:0004872
GO:0002215;defense response to nematode;131;337;GO:0009620
GO:0004878;complement component C5a receptor activity;143;46;GO:0004866
GO:0004877;complement component C3b receptor activity;4;6;GO:0006956
GO:0002218;activation of innate immune response;48510;2330;GO:0002224
GO:0004879;nuclear receptor activity;40125;2890;GO:0003700
GO:0016871;cycloartenol synthase activity;89;9;GO:0004497
GO:0016872;intramolecular lyase activity;88647;746;GO:0004867
GO:0016874;ligase activity;18632022;9170;GO:0004842
GO:0016875;ligase activity, forming carbon-oxygen bonds;6278563;364;GO:0003824
GO:0016854;racemase and epimerase activity;1637945;288;GO:0003824
GO:0016855;racemase and epimerase activity, acting on amino acids and derivatives;690741;55;GO:0004497
GO:0016856;racemase and epimerase activity, acting on hydroxy acids and derivatives;38894;5;GO:0004497
GO:0016857;racemase and epimerase activity, acting on carbohydrates and derivatives;739852;592;GO:0006032
GO:1905611;negative regulation of mRNA cap binding;0;1;GO:0010467
GO:0016859;cis-trans isomerase activity;1576575;336;GO:0003824
GO:1905610;regulation of mRNA cap binding;1;1;GO:0010467
GO:0004890;GABA-A receptor activity;19632;937;GO:0005509
GO:1905615;positive regulation of developmental vegetative growth;41;0;GO:0048731
GO:1905614;negative regulation of developmental vegetative growth;48;3;GO:0048731
GO:1905613;regulation of developmental vegetative growth;111;0;GO:0048731
GO:0002230;positive regulation of defense response to virus by host;2109;1740;GO:0050832
GO:1905612;positive regulation of mRNA cap binding;1;2;GO:0010467
GO:0002231;detection of oomycetes;0;3;GO:0046355
GO:1905619;regulation of alpha-(1->3)-fucosyltransferase activity;2;0;GO:0003723
GO:0002232;leukocyte chemotaxis involved in inflammatory response;418;103;GO:0002687
GO:0002233;leukocyte chemotaxis involved in immune response;36;5;GO:0002684
GO:0004896;cytokine receptor activity;58907;2700;GO:0004872
GO:0002234;detection of endoplasmic reticulum overloading;0;2;GO:0006986
GO:0004895;cell adhesion receptor activity;15;3;GO:0048608
GO:0002224;toll-like receptor signaling pathway;26014;3080;GO:0032496
GO:0002225;positive regulation of antimicrobial peptide production;1141;192;GO:0046323
GO:0002227;innate immune response in mucosa;761;1010;GO:0002237
GO:0004888;transmembrane signaling receptor activity;2243818;4940;GO:0004872
GO:1905609;positive regulation of smooth muscle cell-matrix adhesion;66;3;GO:0048010
GO:0002228;natural killer cell mediated immunity;5764;1020;GO:0002227
GO:0002229;defense response to oomycetes;1633;167;GO:0009617
GO:0016860;intramolecular oxidoreductase activity;1444142;410;GO:0004872
GO:0016861;intramolecular oxidoreductase activity, interconverting aldoses and ketoses;1209077;402;GO:0006096
GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;9885;119;GO:0003824
GO:0016863;intramolecular oxidoreductase activity, transposing C=C bonds;134170;76;GO:0004872
GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;30958;322;GO:0004872
GO:0002280;monocyte activation involved in immune response;98;10;GO:0002684
GO:0002281;macrophage activation involved in immune response;1084;1620;GO:0002684
GO:0002282;microglial cell activation involved in immune response;107;358;GO:0002443
GO:0002283;neutrophil activation involved in immune response;855;3610;GO:0002684
GO:0002284;myeloid dendritic cell differentiation involved in immune response;0;6;GO:0002443
GO:0002285;lymphocyte activation involved in immune response;13484;365;GO:0002684
GO:0002286;T cell activation involved in immune response;7128;1340;GO:0002684
GO:0002287;alpha-beta T cell activation involved in immune response;5197;286;GO:0002449
GO:0002288;NK T cell activation involved in immune response;0;3;GO:0002449
GO:0002289;NK T cell proliferation involved in immune response;0;3;GO:0042113
GO:0002279;mast cell activation involved in immune response;2273;406;GO:0002443
GO:0002290;gamma-delta T cell activation involved in immune response;5;9;GO:0002449
GO:0002291;T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;421;132;GO:0002449
GO:0002292;T cell differentiation involved in immune response;5725;407;GO:0002376
GO:0002293;alpha-beta T cell differentiation involved in immune response;5189;293;GO:0002449
GO:0002294;CD4-positive, alpha-beta T cell differentiation involved in immune response;5093;774;GO:0002376
GO:0002295;T-helper cell lineage commitment;1659;42;GO:0042113
GO:0002296;T-helper 1 cell lineage commitment;187;42;GO:0046649
GO:0002297;T-helper 2 cell lineage commitment;0;4;GO:0046649
GO:0002298;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response;70;3;GO:0002764
GO:0002299;alpha-beta intraepithelial T cell differentiation;60;2;GO:0002227
GO:0002260;lymphocyte homeostasis;4623;933;GO:0002526
GO:0002261;mucosal lymphocyte homeostasis;0;3;GO:0050900
GO:0002262;myeloid cell homeostasis;15445;1270;GO:0050729
GO:0002263;cell activation involved in immune response;18716;988;GO:0002684
GO:0002264;endothelial cell activation involved in immune response;78;8;GO:0002687
GO:0002265;astrocyte activation involved in immune response;124;132;GO:0002684
GO:0002266;follicular dendritic cell activation;98;32;GO:0002449
GO:0002267;follicular dendritic cell activation involved in immune response;0;6;GO:0002449
GO:0002257;negative regulation of kinin cascade;0;4;GO:0048193
GO:0002258;positive regulation of kinin cascade;0;4;GO:0048193
GO:0002259;endothelial cell activation within high endothelial venule involved in immune response;0;3;GO:0002576
GO:0016898;oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor;5729;6;GO:0016616
GO:0038202;TORC1 signaling;12582;435;GO:0007049
GO:0016899;oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor;61952;261;GO:0016616
GO:0038201;TOR complex;35734;93;GO:0005737
GO:0038203;TORC2 signaling;1064;112;GO:0009986
GO:0038200;ethylene receptor histidine kinase activity;0;0;GO:0004721
GO:0002270;plasmacytoid dendritic cell activation;168;50;GO:0002456
GO:0002271;plasmacytoid dendritic cell activation involved in immune response;0;6;GO:0002449
GO:0002272;plasmacytoid dendritic cell differentiation involved in immune response;0;2;GO:0002443
GO:0002273;plasmacytoid dendritic cell differentiation;106;10;GO:0046649
GO:0002274;myeloid leukocyte activation;14113;2330;GO:0002684
GO:0002275;myeloid cell activation involved in immune response;4901;3050;GO:0002684
GO:0002276;basophil activation involved in immune response;131;19;GO:0002237
GO:0002277;myeloid dendritic cell activation involved in immune response;152;562;GO:0002449
GO:0002278;eosinophil activation involved in immune response;305;30;GO:0002684
GO:0002268;follicular dendritic cell differentiation;97;280;GO:0002504
GO:0002269;leukocyte activation involved in inflammatory response;1964;154;GO:0002684
GO:1905662;negative regulation of telomerase RNA reverse transcriptase activity;1;0;GO:0010468
GO:1903000;regulation of lipid transport across blood-brain barrier;51;6;GO:0006869
GO:1905661;regulation of telomerase RNA reverse transcriptase activity;5;2;GO:0002273
GO:1905660;mitotic checkpoint complex assembly;0;1;GO:0000724
GO:1903003;positive regulation of protein deubiquitination;348;67;GO:0016567
GO:1905666;regulation of protein localization to endosome;696;5;GO:0048193
GO:1903004;regulation of protein K63-linked deubiquitination;122;1;GO:0048193
GO:1905665;positive regulation of calcium ion import across plasma membrane;314;7;GO:0048407
GO:1905664;regulation of calcium ion import across plasma membrane;494;8;GO:0006811
GO:1903002;positive regulation of lipid transport across blood-brain barrier;49;105;GO:0050921
GO:1905663;positive regulation of telomerase RNA reverse transcriptase activity;4;6;GO:0045944
GO:1903007;positive regulation of Lys63-specific deubiquitinase activity;1;27;GO:0048193
GO:0051250;negative regulation of lymphocyte activation;11605;762;GO:0042110
GO:1903008;organelle disassembly;28942;505;GO:0048471
GO:1905669;TORC1 complex assembly;47;3;GO:0005840
GO:1903005;negative regulation of protein K63-linked deubiquitination;0;0;GO:0048193
GO:1905668;positive regulation of protein localization to endosome;640;7;GO:0048193
GO:1903006;positive regulation of protein K63-linked deubiquitination;122;136;GO:0048193
GO:1905667;negative regulation of protein localization to endosome;56;3;GO:0048193
GO:1903009;proteasome complex disassembly;0;2;GO:0000502
GO:0051246;regulation of protein metabolic process;3405824;3210;GO:0019538
GO:0051247;positive regulation of protein metabolic process;205627;2200;GO:0019538
GO:0075214;spore encystment;0;4;GO:0048305
GO:0075215;modulation of spore encystment on host;0;2;GO:0048405
GO:0051245;negative regulation of cellular defense response;27;1;GO:0045087
GO:0075216;positive regulation of spore encystment on host;0;1;GO:0048405
GO:0075210;symbiont-mediated suppression of host cAMP-mediated signal transduction;0;0;GO:0009909
GO:0051240;positive regulation of multicellular organismal process;224891;1930;GO:0050896
GO:0051241;negative regulation of multicellular organismal process;102373;1450;GO:0048523
GO:0075217;negative regulation of spore encystment on host;0;0;GO:0048405
GO:0075218;zoospore encystment on host;0;3;GO:0048405
GO:0051248;negative regulation of protein metabolic process;268681;1590;GO:0019538
GO:0075219;modulation of zoospore encystment on host;0;1;GO:0048405
GO:0051249;regulation of lymphocyte activation;103516;1860;GO:0046649
GO:1903010;regulation of bone development;487;40;GO:0048608
GO:1905673;positive regulation of lysosome organization;181;3;GO:0048193
GO:1903011;negative regulation of bone development;50;15;GO:0048609
GO:1905672;negative regulation of lysosome organization;172;5;GO:0048193
GO:1905671;regulation of lysosome organization;468;6;GO:0048193
GO:1905670;TORC2 complex disassembly;0;1;GO:0005515
GO:1903014;cellular response to differentiation-inducing factor 1;5;3;GO:0045766
GO:1905677;regulation of adaptive immune effector response;0;0;GO:0002684
GO:1903015;regulation of exo-alpha-sialidase activity;3;2;GO:0008037
GO:1905676;positive regulation of adaptive immune memory response;45;2;GO:0045727
GO:1903012;positive regulation of bone development;85;73;GO:0048608
GO:1905675;negative regulation of adaptive immune memory response;56;7;GO:0045727
GO:1903013;response to differentiation-inducing factor 1;43;2;GO:0045765
GO:1905674;regulation of adaptive immune memory response;101;0;GO:0019724
GO:0051260;protein homooligomerization;83111;3910;GO:0046983
GO:1903018;regulation of glycoprotein metabolic process;2237;24;GO:0010467
GO:0051261;protein depolymerization;79265;710;GO:0010467
GO:1903019;negative regulation of glycoprotein metabolic process;698;62;GO:0010467
GO:1903016;negative regulation of exo-alpha-sialidase activity;2;5;GO:0048193
GO:1905679;positive regulation of adaptive immune effector response;0;0;GO:0050821
GO:1903017;positive regulation of exo-alpha-sialidase activity;1;3;GO:0048193
GO:1905678;negative regulation of adaptive immune effector response;0;1;GO:0050821
GO:0051257;meiotic spindle midzone assembly;149;46;GO:0007062
GO:0075202;regulation of penetration hypha formation;0;0;GO:0046395
GO:0051258;protein polymerization;210368;3710;GO:0043234
GO:0075203;positive regulation of penetration hypha formation;0;0;GO:0046365
GO:0051255;spindle midzone assembly;1266;59;GO:0007067
GO:0051256;mitotic spindle midzone assembly;604;256;GO:0007067
GO:0051253;negative regulation of RNA metabolic process;1151016;1870;GO:0010467
GO:0051254;positive regulation of RNA metabolic process;866648;2640;GO:0010467
GO:0051251;positive regulation of lymphocyte activation;83200;1180;GO:0046649
GO:0051252;regulation of RNA metabolic process;23545046;4250;GO:0010467
GO:0075201;penetration hypha formation;1;0;GO:0048285
GO:0051259;protein complex oligomerization;309916;572;GO:0043234
GO:1903021;regulation of phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands;0;0;GO:0004553
GO:1905684;regulation of plasma membrane repair;246;4;GO:0048285
GO:1903022;positive regulation of phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands;0;0;GO:0010468
GO:1905683;peroxisome disassembly;0;0;GO:0006626
GO:1905682;positive regulation of innate immunity memory response;0;1;GO:0046649
GO:1903020;positive regulation of glycoprotein metabolic process;1052;51;GO:0010467
GO:1905681;negative regulation of innate immunity memory response;0;2;GO:0046649
GO:1903025;regulation of RNA polymerase II regulatory region sequence-specific DNA binding;22;28;GO:0045944
GO:1905688;negative regulation of diacylglycerol kinase activity;0;1;GO:0010467
GO:1903026;negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding;10;31;GO:0045944
GO:1905687;regulation of diacylglycerol kinase activity;2;0;GO:0008033
GO:1903023;regulation of ascospore-type prospore membrane formation;25;0;GO:0048285
GO:1905686;positive regulation of plasma membrane repair;68;2;GO:0048285
GO:1903024;positive regulation of ascospore-type prospore membrane formation;25;5;GO:0048285
GO:1905685;negative regulation of plasma membrane repair;0;1;GO:0048285
GO:0075240;regulation of zoospore formation;0;1;GO:0048405
GO:1903027;regulation of opsonization;396;24;GO:0002376
GO:0075241;positive regulation of zoospore formation;0;1;GO:0048405
GO:1903028;positive regulation of opsonization;314;131;GO:0045087
GO:1905689;positive regulation of diacylglycerol kinase activity;2;3;GO:0010468
GO:0051268;alpha-keto amide reductase activity;4;4;GO:0004067
GO:0051269;alpha-keto ester reductase activity;4;4;GO:0004067
GO:0051266;sirohydrochlorin ferrochelatase activity;22727;9;GO:0006096
GO:0051267;CP2 mannose-ethanolamine phosphotransferase activity;171;4;GO:0005525
GO:0051264;mono-olein transacylation activity;161;6;GO:0006631
GO:0051265;diolein transacylation activity;161;5;GO:0003774
GO:0051262;protein tetramerization;37112;2360;GO:0006457
GO:0075239;zoospore formation;0;2;GO:0048503
GO:1905680;regulation of innate immunity memory response;0;2;GO:0046649
GO:1903032;negative regulation of microtubule plus-end binding;0;0;GO:0048285
GO:1905695;positive regulation of phosphatidic acid biosynthetic process;60;2;GO:0045944
GO:1903033;positive regulation of microtubule plus-end binding;1;53;GO:0048285
GO:1905694;negative regulation of phosphatidic acid biosynthetic process;0;0;GO:0010468
GO:1905693;regulation of phosphatidic acid biosynthetic process;62;2;GO:0045944
GO:1903031;regulation of microtubule plus-end binding;1;215;GO:0048285
GO:1905692;endoplasmic reticulum disassembly;0;0;GO:0006464
GO:1903036;positive regulation of response to wounding;4092;205;GO:0050817
GO:1905699;regulation of xenobiotic detoxification by transmembrane export across the plasma membrane;13;1;GO:0046686
GO:1903037;regulation of leukocyte cell-cell adhesion;87066;756;GO:0030155
GO:1905698;positive regulation of polysome binding;5;2;GO:0045944
GO:1903034;regulation of response to wounding;12449;853;GO:0050817
GO:1905697;negative regulation of polysome binding;0;0;GO:0045944
GO:1903035;negative regulation of response to wounding;7569;652;GO:0050832
GO:1905696;regulation of polysome binding;6;4;GO:0022613
GO:0051282;regulation of sequestering of calcium ion;39483;221;GO:0048407
GO:0051283;negative regulation of sequestering of calcium ion;39227;115;GO:0048407
GO:0051280;negative regulation of release of sequestered calcium ion into cytosol;110;10;GO:0048407
GO:1903038;negative regulation of leukocyte cell-cell adhesion;9625;149;GO:0050900
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;1343;1540;GO:0048407
GO:1903039;positive regulation of leukocyte cell-cell adhesion;77040;756;GO:0050921
GO:0110100;spindle pole body separation;172;1;GO:0000976
GO:0051279;regulation of release of sequestered calcium ion into cytosol;3446;1190;GO:0048407
GO:0075224;positive regulation of sporangium germination;0;0;GO:0048285
GO:0075225;negative regulation of sporangium germination;0;0;GO:0048285
GO:0075226;encysted zoospore germination;0;4;GO:0048405
GO:0051278;fungal-type cell wall polysaccharide biosynthetic process;405;20;GO:0009405
GO:0075227;regulation of encysted zoospore germination;0;1;GO:0048405
GO:0051275;beta-glucan catabolic process;108757;27;GO:0006073
GO:0075220;positive regulation of zoospore encystment on host;0;0;GO:0048405
GO:0051276;chromosome organization;2934691;9490;GO:0006325
GO:0075221;negative regulation of zoospore encystment on host;0;2;GO:0048405
GO:0051273;beta-glucan metabolic process;167106;65;GO:0006073
GO:0075222;sporangium germination;0;0;GO:0048305
GO:0051274;beta-glucan biosynthetic process;58262;65;GO:0009405
GO:0075223;regulation of sporangium germination;0;0;GO:0048285
GO:0075228;positive regulation of encysted zoospore germination;0;1;GO:0048405
GO:1905691;lipid droplet disassembly;364;6;GO:0006631
GO:0075229;negative regulation of encysted zoospore germination;0;1;GO:0048405
GO:1905690;nucleus disassembly;0;1;GO:0008340
GO:1905622;negative regulation of leaf development;9;3;GO:0048316
GO:1905621;positive regulation of alpha-(1->3)-fucosyltransferase activity;0;0;GO:0003723
GO:1905620;negative regulation of alpha-(1->3)-fucosyltransferase activity;0;0;GO:0003723
GO:1905626;positive regulation of L-methionine import across plasma membrane;4;0;GO:0046395
GO:1905625;negative regulation of L-methionine import across plasma membrane;0;2;GO:0046395
GO:1905624;regulation of L-methionine import across plasma membrane;4;0;GO:0006873
GO:1905623;positive regulation of leaf development;1;2;GO:0048731
GO:0110110;positive regulation of animal organ morphogenesis;1911;287;GO:0048731
GO:0110111;negative regulation of animal organ morphogenesis;117;8;GO:0048731
GO:1905629;positive regulation of serotonin biosynthetic process;0;0;GO:0045944
GO:1905628;negative regulation of serotonin biosynthetic process;0;2;GO:0045944
GO:1905627;regulation of serotonin biosynthetic process;52;1;GO:0045944
GO:0051202;phytochromobilin metabolic process;2606;1;GO:0006749
GO:0110103;RNA polymerase II termination complex;38;0;GO:0000976
GO:0051203;peptidyl-aspartic acid reduction to form L-aspartyl aldehyde;0;2;GO:0006457
GO:0110104;mRNA alternative polyadenylation;419;7;GO:0006415
GO:0110101;L-valine transmembrane import into vacuole;3;1;GO:0008544
GO:0110102;ribulose bisphosphate carboxylase complex assembly;8124;7;GO:0005975
GO:0110107;regulation of imaginal disc-derived wing vein specification;42;0;GO:0048608
GO:0110108;positive regulation of imaginal disc-derived wing vein specification;0;0;GO:0048608
GO:0110105;mRNA cleavage and polyadenylation specificity factor complex assembly;0;0;GO:0000976
GO:0051208;sequestering of calcium ion;39678;320;GO:0006836
GO:0110109;negative regulation of imaginal disc-derived wing vein specification;21;0;GO:0048405
GO:0051209;release of sequestered calcium ion into cytosol;39167;1420;GO:0006836
GO:0051206;silicate metabolic process;0;4;GO:0006073
GO:0051204;protein insertion into mitochondrial membrane;16159;67;GO:0005743
GO:0051205;protein insertion into membrane;81862;968;GO:0016021
GO:1905633;establishment of protein localization to euchromatin;0;1;GO:0016570
GO:1905632;protein localization to euchromatin;33;1;GO:0005819
GO:1905631;cellular response to glyceraldehyde;4;0;GO:0006974
GO:1905630;response to glyceraldehyde;4;0;GO:0006974
GO:1905637;regulation of mitochondrial mRNA catabolic process;6;0;GO:0010467
GO:1905636;positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding;11;5;GO:0045944
GO:1905635;FACT complex assembly;17;1;GO:0000786
GO:1905634;regulation of protein localization to chromatin;787;8;GO:0016568
GO:0110121;gamma-tubulin complex localization to cytoplasmic side of mitotic spindle pole body;2;1;GO:0005815
GO:0110122;myotube cell migration;76;2;GO:0048608
GO:1905639;positive regulation of mitochondrial mRNA catabolic process;6;1;GO:0045944
GO:0110120;gamma-tubulin complex localization to nuclear side of mitotic spindle pole body;3;0;GO:0005819
GO:1905638;negative regulation of mitochondrial mRNA catabolic process;0;0;GO:0045944
GO:0051213;dioxygenase activity;1271352;2460;GO:0004497
GO:0110114;negative regulation of lipid transporter activity;5;3;GO:0010468
GO:0051214;RNAi-mediated antiviral immunity against RNA virus;47;1;GO:1902492
GO:0110115;Cdr2 medial cortical node complex;22;2;GO:0048193
GO:0051211;anisotropic cell growth;1453;77;GO:0048285
GO:0110112;regulation of lipid transporter activity;29;4;GO:0006629
GO:0051212;vanadium ion binding;94;3;GO:0097159
GO:0110113;positive regulation of lipid transporter activity;23;3;GO:0045765
GO:0110118;negative regulation of compound eye photoreceptor cell differentiation;130;0;GO:0048405
GO:0051210;isotropic cell growth;0;1;GO:0048285
GO:0110119;positive regulation of very-low-density lipoprotein particle clearance;2;0;GO:0048193
GO:0110116;regulation of compound eye photoreceptor cell differentiation;263;0;GO:0048608
GO:0110117;positive regulation of compound eye photoreceptor cell differentiation;25;0;GO:0048608
GO:0051219;phosphoprotein binding;16908;1080;GO:0019901
GO:0051217;molybdenum incorporation via L-aspartyl molybdenum bis(molybdopterin guanine dinucleotide);0;1;GO:0009065
GO:0051218;tungsten incorporation via L-selenocysteinyl tungsten bis(molybdopterin guanine dinucleotide);0;2;GO:0006873
GO:0051215;RNAi-mediated antiviral immunity against DNA virus;0;1;GO:0009615
GO:0051216;cartilage development;29206;3250;GO:0007518
GO:1905640;response to acetaldehyde;0;0;GO:0042127
GO:1905644;regulation of FACT complex assembly;17;0;GO:0048285
GO:1905643;positive regulation of DNA methylation;195;9;GO:0045944
GO:1905642;negative regulation of DNA methylation;135;9;GO:0045944
GO:1905641;cellular response to acetaldehyde;0;0;GO:0043408
GO:1905648;regulation of shell calcification;0;0;GO:0010468
GO:1905647;proline import across plasma membrane;253;0;GO:0006836
GO:1905646;positive regulation of FACT complex assembly;17;1;GO:0048285
GO:1905645;negative regulation of FACT complex assembly;0;0;GO:0048285
GO:0110130;ribitol-5-phosphatase activity;18;2;GO:0006032
GO:0110131;Aim21-Tda2 complex;6;1;GO:0005576
GO:1905649;negative regulation of shell calcification;0;0;GO:0010468
GO:0051224;negative regulation of protein transport;13559;327;GO:0015031
GO:0110125;negative regulation of myotube cell migration;21;1;GO:0048608
GO:0051225;spindle assembly;23402;2090;GO:0007059
GO:0110126;phloem loading;59;3;GO:0009908
GO:0051222;positive regulation of protein transport;18464;775;GO:0015031
GO:0110123;regulation of myotube cell migration;21;0;GO:0048608
GO:0051223;regulation of protein transport;37926;1490;GO:0015031
GO:0110124;positive regulation of myotube cell migration;0;1;GO:0048608
GO:0051220;cytoplasmic sequestering of protein;527;188;GO:0005737
GO:0110129;SHREC2 complex;63;3;GO:0005576
GO:0051221;tungsten incorporation into metallo-sulfur cluster;0;2;GO:0009986
GO:0110127;phloem unloading;9;0;GO:0009986
GO:0110128;phloem sucrose unloading;9;1;GO:0009909
GO:0051228;mitotic spindle disassembly;382;43;GO:0000910
GO:0051229;meiotic spindle disassembly;66;2;GO:0007062
GO:1905651;regulation of artery morphogenesis;201;3;GO:0048608
GO:1905650;positive regulation of shell calcification;0;0;GO:0048407
GO:1905655;negative regulation of artery smooth muscle contraction;4;0;GO:0048010
GO:1905654;regulation of artery smooth muscle contraction;6;0;GO:0048010
GO:1905653;positive regulation of artery morphogenesis;183;9;GO:0048608
GO:1905652;negative regulation of artery morphogenesis;10;1;GO:0048608
GO:0110140;flagellum attachment zone organization;3;1;GO:0007043
GO:1905656;positive regulation of artery smooth muscle contraction;2;0;GO:0048010
GO:0110143;magnetosome;387;3;GO:0048471
GO:0110141;L-glutamate import into mitochondrion;1;2;GO:0006836
GO:0110142;ubiquinone biosynthesis complex;325;1;GO:0005746
GO:0051235;maintenance of location;84444;1020;GO:0051604
GO:0110136;protein-RNA complex remodeling;121;3;GO:0030529
GO:0051236;establishment of RNA localization;197555;912;GO:0051276
GO:0110137;regulation of imaginal disc-derived leg joint morphogenesis;1;1;GO:0048608
GO:0051233;spindle midzone;3603;961;GO:0007067
GO:0110134;meiotic drive;181;7;GO:0007049
GO:0051234;establishment of localization;66408784;5780;GO:0051234
GO:0110135;Norrin signaling pathway;387;5;GO:0007224
GO:0051231;spindle elongation;1826;54;GO:0048471
GO:0051232;meiotic spindle elongation;24;3;GO:0007062
GO:0110138;positive regulation of imaginal disc-derived leg joint morphogenesis;0;0;GO:0048608
GO:0051230;spindle disassembly;448;2;GO:0007062
GO:0110139;negative regulation of imaginal disc-derived leg joint morphogenesis;0;0;GO:0048608
GO:0051239;regulation of multicellular organismal process;489809;3600;GO:0030154
GO:0051237;maintenance of RNA location;34;8;GO:0048471
GO:0051238;sequestering of metal ion;1186;681;GO:0006879
GO:0075183;infection cushion formation;0;3;GO:0048285
GO:0099150;regulation of postsynaptic specialization assembly;639;7;GO:0048608
GO:0075184;regulation of infection cushion formation;0;2;GO:0048285
GO:0099151;regulation of postsynaptic density assembly;473;46;GO:0048608
GO:0075185;positive regulation of infection cushion formation;0;1;GO:0048285
GO:0075186;negative regulation of infection cushion formation;0;1;GO:0048285
GO:0099154;serotonergic synapse;76;12;GO:0032595
GO:0110154;RNA decapping;28497;4;GO:0006032
GO:0099155;synaptic transmission, noradrenergic;0;1;GO:0007268
GO:0110155;NAD-cap decapping;362;6;GO:0006099
GO:0099152;regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane;142;4;GO:0048608
GO:0110152;RNA NAD-cap (NAD-forming) hydrolase activity;66;2;GO:0003964
GO:0099153;synaptic transmission, serotonergic;5;2;GO:0007268
GO:0110153;RNA NAD-cap (NMN-forming) hydrolase activity;2138;1;GO:0003906
GO:0099147;extrinsic component of postsynaptic density membrane;122;3;GO:0048471
GO:0110147;protein maturation by nickel ion transfer;5;1;GO:0006457
GO:0099148;regulation of synaptic vesicle docking;35;1;GO:0048608
GO:0099145;regulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane;45;2;GO:0048608
GO:0110145;magnetosome lumen;1;1;GO:0005576
GO:0110146;magnetosome membrane;206;2;GO:0048471
GO:0099149;regulation of postsynaptic neurotransmitter receptor internalization;716;10;GO:0048608
GO:0099161;regulation of presynaptic dense core granule exocytosis;131;3;GO:0048608
GO:0110161;positive regulation of mitotic spindle formation (spindle phase one);4;1;GO:0048285
GO:0099162;regulation of neurotransmitter loading into synaptic vesicle;12;0;GO:0007612
GO:0110162;regulation of mitotic spindle elongation (spindle phase three);24;1;GO:0048285
GO:0099160;postsynaptic intermediate filament cytoskeleton;347;9;GO:0043005
GO:0110160;negative regulation of mitotic spindle formation (spindle phase one);0;0;GO:0048285
GO:0099165;postsynaptic specialization of symmetric synapse, intracellular component;0;0;GO:0048666
GO:0110165;cellular anatomical entity;274356756;3200;GO:0005576
GO:0110166;DNA synthesis involved in mitochondrial DNA replication;12;0;GO:0006260
GO:0099163;synaptic signaling by nitric oxide;141;5;GO:0007268
GO:0110163;negative regulation of mitotic spindle elongation (spindle phase three);0;0;GO:0048285
GO:0099164;postsynaptic specialization membrane of symmetric synapse;0;1;GO:0048167
GO:0110164;positive regulation of mitotic spindle elongation (spindle phase three);0;0;GO:0048285
GO:0099158;regulation of recycling endosome localization within postsynapse;34;2;GO:0048193
GO:0110158;calpain complex;128;4;GO:0005576
GO:0099159;regulation of modification of postsynaptic structure;391;5;GO:0048608
GO:0110159;regulation of mitotic spindle formation (spindle phase one);4;0;GO:0048285
GO:0099156;cell-cell signaling via exosome;67;2;GO:0070062
GO:0110156;methylguanosine-cap decapping;27996;5;GO:0006613
GO:0099157;trans-synaptic signaling via exosome;16;1;GO:0048169
GO:0110157;reelin complex;51;3;GO:0048608
GO:0099130;estrogen binding;60;1;GO:0005515
GO:0099125;PAK family kinase-Sog2 complex;0;0;GO:0005515
GO:0099126;transforming growth factor beta complex;4;4;GO:0030516
GO:0099123;somato-dendritic dopamine secretion;5;2;GO:0007601
GO:0099124;axonal dopamine secretion;0;1;GO:0008092
GO:0075198;modulation of symbiont haustorium neck formation for entry into host;0;2;GO:0048309
GO:0099129;cochlear outer hair cell electromotile response;2;0;GO:0008021
GO:0075199;positive regulation of symbiont haustorium neck formation for entry into host;0;2;GO:0048309
GO:0099128;mitochondrial iron-sulfur cluster assembly complex;347;5;GO:0005739
GO:0075194;positive regulation of haustorium mother cell formation;0;2;GO:0048285
GO:0075195;negative regulation of haustorium mother cell formation;0;1;GO:0048285
GO:0099140;presynaptic actin cytoskeleton organization;83;4;GO:0050921
GO:0075196;adhesion of symbiont haustorium mother cell to host;0;4;GO:0048305
GO:0075197;haustorium neck formation;0;1;GO:0048706
GO:0075190;negative regulation of hyphopodium formation;0;1;GO:0048706
GO:0099143;presynaptic actin cytoskeleton;9;3;GO:0048608
GO:0075192;haustorium mother cell formation;0;6;GO:0048285
GO:0099141;cellular response to protozoan;0;0;GO:0050829
GO:0075193;regulation of haustorium mother cell formation;0;1;GO:0048285
GO:0099142;intracellularly ATP-gated ion channel activity;1248;1;GO:0008026
GO:0099136;chimeric non-reproductive fruiting body development;38;2;GO:0048285
GO:0099137;altruistic, chimeric, non-reproductive fruiting body development;4;0;GO:0048285
GO:0099134;chimeric sorocarp development;38;3;GO:0048706
GO:0099135;chimeric colonial development;38;1;GO:0048405
GO:0075187;hyphopodium formation;0;2;GO:0048706
GO:0075188;regulation of hyphopodium formation;0;1;GO:0048608
GO:0075189;positive regulation of hyphopodium formation;0;1;GO:0048608
GO:0099138;altruistic, chimeric sorocarp development;4;2;GO:0048608
GO:0099139;cheating during chimeric sorocarp development;34;2;GO:0048285
GO:1905585;regulation of outer hair cell apoptotic process;52;2;GO:0010941
GO:1905584;outer hair cell apoptotic process;212;1;GO:0010941
GO:1905583;cellular response to mannose;0;0;GO:0002548
GO:1905582;response to mannose;31;1;GO:0009611
GO:1905589;positive regulation of L-arginine import across plasma membrane;40;3;GO:0048193
GO:1905588;plant-type cell wall modification involved in stomatal movement;0;0;GO:0009813
GO:1905587;positive regulation of outer hair cell apoptotic process;0;1;GO:0010942
GO:1905586;negative regulation of outer hair cell apoptotic process;52;1;GO:0043066
GO:0051172;negative regulation of nitrogen compound metabolic process;1475376;2630;GO:0045735
GO:0051173;positive regulation of nitrogen compound metabolic process;1101724;3790;GO:0045735
GO:0051170;import into nucleus;86585;869;GO:0005634
GO:0051171;regulation of nitrogen compound metabolic process;27209192;3730;GO:0046394
GO:0099110;microtubule polymerization based protein transport to cell tip cortex;0;0;GO:0048285
GO:0099111;microtubule-based transport;35401;51;GO:0006810
GO:0051169;nuclear transport;355146;2010;GO:0009405
GO:0075136;response to host;1179498;1020;GO:0009615
GO:0099103;channel activator activity;461;4;GO:0097458
GO:0075137;response to host redox environment;1;1;GO:0006979
GO:0099104;potassium channel activator activity;396;9;GO:0048608
GO:0051167;xylulose 5-phosphate metabolic process;34835;6;GO:0006094
GO:0075138;response to host oxygen tension environment;0;0;GO:0009432
GO:0099101;G-protein gated potassium channel activity;0;0;GO:0048010
GO:0051168;nuclear export;133573;1350;GO:0006953
GO:0075139;response to host iron concentration;24;2;GO:0006879
GO:0099102;G-protein gated potassium channel activity involved in regulation of postsynaptic membrane potential;0;2;GO:0048666
GO:0051165;2,5-dihydroxypyridine metabolic process;0;3;GO:0006749
GO:0099107;ion channel regulator activity involved in G protein-coupled receptor signaling pathway;4;1;GO:0004930
GO:0051166;2,5-dihydroxypyridine catabolic process;0;1;GO:0009062
GO:0075133;perturbation of host calcium or calmodulin-mediated signal transduction;2;0;GO:0006936
GO:0099108;potassium channel activator activity involved in G protein-coupled receptor signaling pathway;0;0;GO:0004930
GO:0051163;D-arabitol metabolic process;1;1;GO:0006066
GO:0099105;ion channel modulating, G protein-coupled receptor signaling pathway;350;6;GO:0007186
GO:0051164;L-xylitol metabolic process;112;6;GO:0006066
GO:0075135;symbiont-mediated suppression of host calcium or calmodulin-mediated signal transduction;2;0;GO:0009909
GO:0099106;ion channel regulator activity;29921;40;GO:0048407
GO:0099109;potassium channel activating, G protein-coupled receptor signaling pathway;49;0;GO:0007186
GO:1905581;positive regulation of low-density lipoprotein particle clearance;166;7;GO:0032963
GO:1905580;positive regulation of ERBB3 signaling pathway;47;4;GO:0030518
GO:1905596;negative regulation of low-density lipoprotein particle receptor binding;3;3;GO:0048193
GO:1905595;regulation of low-density lipoprotein particle receptor binding;7;1;GO:0048193
GO:1905594;resveratrol binding;108;2;GO:0046907
GO:1905593;positive regulation of optical nerve axon regeneration;0;1;GO:0048704
GO:1905599;positive regulation of low-density lipoprotein receptor activity;9;93;GO:0048193
GO:1905598;negative regulation of low-density lipoprotein receptor activity;15;27;GO:0048193
GO:1905597;positive regulation of low-density lipoprotein particle receptor binding;4;7;GO:0048193
GO:0099121;fungal sorus development;0;0;GO:0048309
GO:0051180;vitamin transport;304556;885;GO:0006865
GO:0099122;RNA polymerase II C-terminal domain binding;5310;18;GO:0003700
GO:0099120;socially cooperative development;1647;4;GO:0048608
GO:0099115;chromosome, subtelomeric region;350;21;GO:0000786
GO:0099112;microtubule polymerization based protein transport;0;2;GO:0048193
GO:0051179;localization;66825364;11600;GO:0051179
GO:0099113;negative regulation of presynaptic cytosolic calcium concentration;0;0;GO:0048608
GO:0051176;positive regulation of sulfur metabolic process;599;10;GO:0045735
GO:0099118;microtubule-based protein transport;450;8;GO:0048193
GO:0051177;meiotic sister chromatid cohesion;3628;38;GO:0007030
GO:0099119;3-demethylubiquinol-8 3-O-methyltransferase activity;1;0;GO:0004497
GO:0051174;regulation of phosphorus metabolic process;125361;2030;GO:0045735
GO:0099116;tRNA 5'-end processing;96973;1;GO:0006364
GO:0051175;negative regulation of sulfur metabolic process;197;0;GO:0045735
GO:0099117;protein transport along microtubule to cell tip;6;1;GO:0048285
GO:1905592;negative regulation of optical nerve axon regeneration;1;0;GO:0048704
GO:1905591;regulation of optical nerve axon regeneration;1;0;GO:0048666
GO:1905590;fibronectin fibril organization;177;7;GO:0030199
GO:0051192;prosthetic group binding;50359;9;GO:0019899
GO:0051190;prosthetic group catabolic process;0;5;GO:0046274
GO:0051191;prosthetic group biosynthetic process;3794;31;GO:0043169
GO:0051189;prosthetic group metabolic process;790573;43;GO:0019748
GO:0099100;G-protein gated monoatomic cation channel activity;0;1;GO:0005216
GO:0016801;hydrolase activity, acting on ether bonds;40015;55;GO:0016829
GO:0016802;trialkylsulfonium hydrolase activity;346;124;GO:0008021
GO:0016803;ether hydrolase activity;39669;23;GO:0016829
GO:0016805;dipeptidase activity;209645;857;GO:0004723
GO:0016807;cysteine-type carboxypeptidase activity;277;10;GO:0004721
GO:0004810;CCA tRNA nucleotidyltransferase activity;75535;9;GO:0003729
GO:0004812;aminoacyl-tRNA ligase activity;6278562;4710;GO:0004812
GO:0004814;arginine-tRNA ligase activity;209620;955;GO:0006418
GO:0004813;alanine-tRNA ligase activity;212193;928;GO:0006418
GO:0004816;asparagine-tRNA ligase activity;83628;423;GO:0006414
GO:0004815;aspartate-tRNA ligase activity;95992;718;GO:0006418
GO:0004818;glutamate-tRNA ligase activity;197291;1100;GO:0004812
GO:0004817;cysteine-tRNA ligase activity;183237;1390;GO:0006418
GO:0004819;glutamine-tRNA ligase activity;74191;742;GO:0006418
GO:0004830;tryptophan-tRNA ligase activity;168795;1210;GO:0006413
GO:0004821;histidine-tRNA ligase activity;167997;882;GO:0003735
GO:0004820;glycine-tRNA ligase activity;247534;1120;GO:0003735
GO:0004823;leucine-tRNA ligase activity;190889;1110;GO:0004812
GO:0004822;isoleucine-tRNA ligase activity;187335;844;GO:0004812
GO:0004825;methionine-tRNA ligase activity;188749;1640;GO:0003735
GO:0004824;lysine-tRNA ligase activity;195717;810;GO:0004812
GO:0004827;proline-tRNA ligase activity;188040;996;GO:0006414
GO:0004826;phenylalanine-tRNA ligase activity;356041;1110;GO:0006413
GO:0004829;threonine-tRNA ligase activity;189445;743;GO:0006413
GO:0004828;serine-tRNA ligase activity;164163;1140;GO:0006418
GO:0004801;transaldolase activity;143447;203;GO:0006099
GO:0004800;thyroxine 5'-deiodinase activity;4519;9;GO:0004730
GO:0004803;transposase activity;442449;1790;GO:0004803
GO:0004802;transketolase activity;100268;828;GO:0006096
GO:0004805;trehalose-phosphatase activity;40906;521;GO:0006032
GO:0004807;triose-phosphate isomerase activity;197358;878;GO:0006096
GO:0004806;triglyceride lipase activity;53766;2170;GO:0004784
GO:0004809;tRNA (guanine-N2-)-methyltransferase activity;20824;0;GO:0003735
GO:0004808;tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity;26193;0;GO:0003729
GO:0016843;amine-lyase activity;76837;199;GO:0004497
GO:0016844;strictosidine synthase activity;10229;219;GO:0004497
GO:0016846;carbon-sulfur lyase activity;254069;623;GO:0004723
GO:0016847;1-aminocyclopropane-1-carboxylate synthase activity;408;250;GO:0004497
GO:0099190;postsynaptic spectrin-associated cytoskeleton organization;5;1;GO:0048608
GO:0016848;carbon-halide lyase activity;147;8;GO:0046395
GO:0099191;trans-synaptic signaling by BDNF;209;5;GO:0048167
GO:0016849;phosphorus-oxygen lyase activity;497000;654;GO:0004723
GO:0099192;cerebellar Golgi cell to granule cell synapse;99;1;GO:0048666
GO:0004861;cyclin-dependent protein serine/threonine kinase inhibitor activity;8491;1320;GO:0048285
GO:0004860;protein kinase inhibitor activity;94897;1380;GO:0030414
GO:0002200;somatic diversification of immune receptors;96557;375;GO:0002449
GO:0002201;somatic diversification of DSCAM-based immune receptors;0;2;GO:0002224
GO:0004862;cAMP-dependent protein kinase inhibitor activity;4150;266;GO:0004866
GO:0004854;xanthine dehydrogenase activity;20984;171;GO:0004073
GO:0004853;uroporphyrinogen decarboxylase activity;147902;528;GO:0006096
GO:0004856;xylulokinase activity;70403;341;GO:0004721
GO:0099189;postsynaptic spectrin-associated cytoskeleton;115;2;GO:0048471
GO:0004855;xanthine oxidase activity;935;58;GO:0004721
GO:0004858;dUTP pyrophosphatase inhibitor activity;0;1;GO:0004867
GO:0004857;enzyme inhibitor activity;579023;4260;GO:0030414
GO:0004859;phospholipase inhibitor activity;5413;821;GO:0046674
GO:0016851;magnesium chelatase activity;22996;233;GO:0004792
GO:0016852;sirohydrochlorin cobaltochelatase activity;10307;13;GO:0004723
GO:0016853;isomerase activity;12497175;5110;GO:0003824
GO:0016832;aldehyde-lyase activity;576885;1180;GO:0004497
GO:0016833;oxo-acid-lyase activity;440646;273;GO:0046395
GO:0016835;carbon-oxygen lyase activity;5017312;846;GO:0004497
GO:0016836;hydro-lyase activity;4120742;2300;GO:0016829
GO:0016837;carbon-oxygen lyase activity, acting on polysaccharides;229199;86;GO:0005976
GO:0016838;carbon-oxygen lyase activity, acting on phosphates;470974;292;GO:0004723
GO:0002210;behavioral response to wounding;0;8;GO:0007611
GO:0002211;behavioral defense response to insect;0;8;GO:0009611
GO:0002212;behavioral defense response to nematode;0;8;GO:0009611
GO:0004873;asialoglycoprotein receptor activity;7;233;GO:0005529
GO:0002202;somatic diversification of variable lymphocyte receptors of jawless fish;0;2;GO:0002768
GO:0004865;protein serine/threonine phosphatase inhibitor activity;16214;330;GO:0004721
GO:0002203;proteolysis by cytosolic proteases associated with antigen processing and presentation;0;4;GO:0002576
GO:0004864;protein phosphatase inhibitor activity;48937;1280;GO:0004721
GO:0002204;somatic recombination of immunoglobulin genes involved in immune response;3433;483;GO:0002449
GO:0004867;serine-type endopeptidase inhibitor activity;164349;6110;GO:0004867
GO:0002205;somatic hypermutation of immunoglobulin genes involved in immune response;0;3;GO:0002449
GO:0004866;endopeptidase inhibitor activity;267104;3540;GO:0004867
GO:0002206;gene conversion of immunoglobulin genes;3;5;GO:0002729
GO:0004869;cysteine-type endopeptidase inhibitor activity;29037;1650;GO:0004867
GO:0002207;gene conversion of immunoglobulin genes involved in immune response;0;4;GO:0002449
GO:0002208;somatic diversification of immunoglobulins involved in immune response;3443;565;GO:0002449
GO:0002209;behavioral defense response;1779;752;GO:0009611
GO:0016840;carbon-nitrogen lyase activity;1076111;132;GO:0006091
GO:0016841;ammonia-lyase activity;505587;331;GO:0004474
GO:0016842;amidine-lyase activity;436980;7;GO:0004497
GO:0016822;hydrolase activity, acting on acid carbon-carbon bonds;119404;8;GO:0016787
GO:0016823;hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances;119206;112;GO:0016787
GO:0016824;hydrolase activity, acting on acid halide bonds;40237;4;GO:0016787
GO:0016825;hydrolase activity, acting on acid phosphorus-nitrogen bonds;8584;54;GO:0016787
GO:0016826;hydrolase activity, acting on acid sulfur-nitrogen bonds;267;5;GO:0016787
GO:0016827;hydrolase activity, acting on acid carbon-phosphorus bonds;19510;6;GO:0016787
GO:0016828;hydrolase activity, acting on acid sulfur-sulfur bonds;0;1;GO:0004553
GO:0016829;lyase activity;16554335;6540;GO:0016829
GO:0099172;presynapse organization;8867;158;GO:0048666
GO:0099173;postsynapse organization;11546;141;GO:0048608
GO:0099170;postsynaptic modulation of chemical synaptic transmission;1102;34;GO:0007611
GO:0099171;presynaptic modulation of chemical synaptic transmission;1632;39;GO:0008092
GO:0099176;regulation of retrograde trans-synaptic signaling by trans-synaptic protein complex;0;1;GO:0048608
GO:0099177;regulation of trans-synaptic signaling;41074;535;GO:0048167
GO:0099174;regulation of presynapse organization;7295;4;GO:0048608
GO:0099175;regulation of postsynapse organization;4064;234;GO:0048608
GO:0004832;valine-tRNA ligase activity;182977;928;GO:0004812
GO:0004831;tyrosine-tRNA ligase activity;184439;602;GO:0004812
GO:0004834;tryptophan synthase activity;321931;734;GO:0006559
GO:0004833;tryptophan 2,3-dioxygenase activity;57107;89;GO:0004866
GO:0004836;tyramine-beta hydroxylase activity;5;1;GO:0004073
GO:0004835;tubulin-tyrosine ligase activity;291;47;GO:0008061
GO:0004838;L-tyrosine:2-oxoglutarate aminotransferase activity;4808;31;GO:0004073
GO:0004837;tyrosine decarboxylase activity;1373;8;GO:0004061
GO:0004839;ubiquitin activating enzyme activity;2353;370;GO:0004842
GO:0016830;carbon-carbon lyase activity;4381276;870;GO:0004497
GO:0016831;carboxy-lyase activity;2959555;2350;GO:0004497
GO:0016810;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;5383278;2300;GO:0016787
GO:0016811;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides;2135310;1190;GO:0016787
GO:0016812;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides;548422;411;GO:0016829
GO:0016813;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines;359085;359;GO:0016829
GO:0016814;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;1488597;498;GO:0016829
GO:0016815;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles;18617;5;GO:0016829
GO:0099180;zinc ion import into synaptic vesicle;80;3;GO:0006836
GO:0016817;hydrolase activity, acting on acid anhydrides;11332161;1980;GO:0016787
GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;11283176;2570;GO:0016829
GO:0099183;trans-synaptic signaling by BDNF, modulating synaptic transmission;170;5;GO:0048666
GO:0016819;hydrolase activity, acting on acid anhydrides, in sulfonyl-containing anhydrides;2546;3;GO:0016829
GO:0099184;structural constituent of postsynaptic intermediate filament cytoskeleton;183;9;GO:0030475
GO:0099181;structural constituent of presynapse;17;5;GO:0048608
GO:0099182;presynaptic intermediate filament cytoskeleton;116;6;GO:0048471
GO:0004850;uridine phosphorylase activity;26731;75;GO:0004553
GO:0099187;presynaptic cytoskeleton organization;83;4;GO:0048471
GO:0099188;postsynaptic cytoskeleton organization;1129;18;GO:0048608
GO:0004852;uroporphyrinogen-III synthase activity;136595;404;GO:0006096
GO:0099185;postsynaptic intermediate filament cytoskeleton organization;366;5;GO:0048471
GO:0004851;uroporphyrin-III C-methyltransferase activity;60037;523;GO:0004721
GO:0099186;structural constituent of postsynapse;845;6;GO:0048608
GO:0004843;cysteine-type deubiquitinase activity;271413;582;GO:0004867
GO:0004842;ubiquitin-protein transferase activity;661909;8820;GO:0004842
GO:0004845;uracil phosphoribosyltransferase activity;134921;359;GO:0004061
GO:0099178;regulation of retrograde trans-synaptic signaling by endocanabinoid;145;4;GO:0048608
GO:0004844;uracil DNA N-glycosylase activity;217144;1270;GO:0004518
GO:0099179;regulation of synaptic membrane adhesion;156;7;GO:0048608
GO:0004847;urea carboxylase activity;1362;9;GO:0004061
GO:0004846;urate oxidase activity;13746;127;GO:0003954
GO:0004849;uridine kinase activity;44094;603;GO:0004721
GO:0004848;ureidoglycolate hydrolase activity;11459;8;GO:0004553
GO:0002360;T cell lineage commitment;2425;304;GO:0042113
GO:0002361;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;575;76;GO:0002764
GO:0002362;CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment;55;25;GO:0002763
GO:0002363;alpha-beta T cell lineage commitment;1983;29;GO:0042127
GO:0002364;NK T cell lineage commitment;52;5;GO:0046649
GO:0002365;gamma-delta T cell lineage commitment;3;4;GO:0042127
GO:0002366;leukocyte activation involved in immune response;18501;917;GO:0002684
GO:0002356;peripheral B cell negative selection;0;3;GO:0002429
GO:0002357;defense response to tumor cell;598;43;GO:0009615
GO:0002358;B cell homeostatic proliferation;97;30;GO:0042113
GO:0002359;B-1 B cell proliferation;0;4;GO:0042127
GO:0016997;alpha-sialidase activity;1078772;133;GO:0004553
GO:0016998;cell wall macromolecule catabolic process;159617;2650;GO:0009279
GO:0016999;antibiotic metabolic process;274563;698;GO:0046275
GO:0002370;natural killer cell cytokine production;989;38;GO:0002729
GO:0002371;dendritic cell cytokine production;615;116;GO:0002440
GO:0002372;myeloid dendritic cell cytokine production;249;8;GO:0046649
GO:0002373;plasmacytoid dendritic cell cytokine production;22;7;GO:0046649
GO:0002376;immune system process;1740851;21800;GO:0002376
GO:0002377;immunoglobulin production;6975;1040;GO:0002429
GO:0002367;cytokine production involved in immune response;6684;390;GO:0002687
GO:0002368;B cell cytokine production;1;172;GO:0045640
GO:0002369;T cell cytokine production;1738;50;GO:0045640
GO:0016987;sigma factor activity;970540;1540;GO:0003700
GO:0016989;sigma factor antagonist activity;13776;10;GO:0048285
GO:0002340;central B cell selection;0;3;GO:0002449
GO:0002341;central B cell anergy;0;5;GO:0002449
GO:0002342;central B cell deletion;0;4;GO:0002704
GO:0002343;peripheral B cell selection;126;6;GO:0002429
GO:0002344;B cell affinity maturation;126;33;GO:0002449
GO:0002334;transitional two stage B cell differentiation;50;7;GO:0042113
GO:0004997;thyrotropin-releasing hormone receptor activity;2478;10;GO:0004930
GO:0051301;cell division;2639173;17900;GO:0051301
GO:0002335;mature B cell differentiation;1863;419;GO:0042113
GO:0004996;thyroid-stimulating hormone receptor activity;1656;56;GO:0004930
GO:0051302;regulation of cell division;60269;2440;GO:0051301
GO:0002336;B-1 B cell lineage commitment;3;5;GO:0042113
GO:0004999;vasoactive intestinal polypeptide receptor activity;5535;225;GO:0004930
GO:0002337;B-1a B cell differentiation;99;119;GO:0042113
GO:0004998;transferrin receptor activity;2387;143;GO:0006896
GO:0051300;spindle pole body organization;549;35;GO:0000976
GO:0002338;B-1b B cell differentiation;0;3;GO:0042113
GO:0002339;B cell selection;210;54;GO:0002449
GO:0051309;female meiosis chromosome separation;60;2;GO:0007062
GO:0016990;arginine deiminase activity;36487;48;GO:0004725
GO:0051307;meiotic chromosome separation;895;275;GO:0000910
GO:0016992;lipoate synthase activity;139746;696;GO:0004497
GO:0051308;male meiosis chromosome separation;85;1;GO:0007067
GO:0016993;precorrin-8X methylmutase activity;20389;7;GO:0003676
GO:0051305;chromosome movement towards spindle pole;657;97;GO:0007049
GO:0016994;precorrin-6A reductase activity;16083;10;GO:0006032
GO:0051306;mitotic sister chromatid separation;21501;174;GO:0000786
GO:0016995;cholesterol oxidase activity;857;3;GO:0004601
GO:0051303;establishment of chromosome localization;30828;1400;GO:0051276
GO:0016996;endo-alpha-(2,8)-sialidase activity;117;0;GO:0004553
GO:0051304;chromosome separation;62077;427;GO:0000910
GO:0016977;chitosanase activity;8381;56;GO:0004553
GO:0016979;lipoate-protein ligase activity;26259;182;GO:0004812
GO:0002350;peripheral B cell positive selection;0;3;GO:0002429
GO:0002351;serotonin production involved in inflammatory response;167;95;GO:0002687
GO:0002352;B cell negative selection;84;65;GO:0002713
GO:0002353;plasma kallikrein-kinin cascade;156;35;GO:0006956
GO:0002354;central B cell negative selection;0;3;GO:0002449
GO:0002355;detection of tumor cell;125;8;GO:0048699
GO:0002345;peripheral B cell receptor editing;0;3;GO:0002729
GO:0002346;B cell positive selection;0;5;GO:0002729
GO:0002347;response to tumor cell;2951;105;GO:0042127
GO:0051310;metaphase chromosome alignment;27894;5;GO:0000976
GO:0002348;central B cell positive selection;0;3;GO:0002449
GO:0051311;meiotic metaphase chromosome alignment;521;2;GO:0000922
GO:0002349;histamine production involved in inflammatory response;447;82;GO:0002684
GO:0016980;creatinase activity;1267;4;GO:0004721
GO:0051318;G1 phase;0;55;GO:0000070
GO:0051319;G2 phase;0;16;GO:0000070
GO:0051316;attachment of meiotic spindle microtubules to kinetochore;373;2;GO:0007062
GO:0016984;ribulose-bisphosphate carboxylase activity;496222;350;GO:0006096
GO:0016985;mannan endo-1,4-beta-mannosidase activity;19918;70;GO:0004553
GO:0051315;attachment of mitotic spindle microtubules to kinetochore;9464;346;GO:0007062
GO:0002381;immunoglobulin production involved in immunoglobulin-mediated immune response;3611;146;GO:0002440
GO:0002382;regulation of tissue kallikrein-kinin cascade;0;3;GO:0048193
GO:0002383;immune response in brain or nervous system;31;9;GO:0002376
GO:0002384;hepatic immune response;46;273;GO:0006955
GO:0002385;mucosal immune response;1277;371;GO:0002376
GO:0002387;immune response in gut-associated lymphoid tissue;124;5;GO:0002376
GO:0002388;immune response in Peyer's patch;0;2;GO:0002376
GO:0002391;platelet activating factor production involved in inflammatory response;0;4;GO:0046330
GO:0002393;lysosomal enzyme production involved in inflammatory response;0;2;GO:0006954
GO:0002394;tolerance induction in gut-associated lymphoid tissue;0;2;GO:0002273
GO:0002395;immune response in nasopharyngeal-associated lymphoid tissue;121;6;GO:0002684
GO:0002396;MHC protein complex assembly;860;98;GO:0042612
GO:0002397;MHC class I protein complex assembly;253;41;GO:0042612
GO:0002398;MHC class Ib protein complex assembly;48;7;GO:0042612
GO:0002399;MHC class II protein complex assembly;559;80;GO:0042612
GO:0002389;tolerance induction in Peyer's patch;0;3;GO:0002768
GO:1905541;regulation of L-arginine import across plasma membrane;44;1;GO:0006865
GO:1905540;interleukin-7 receptor complex;0;0;GO:0004872
GO:1905544;L-methionine import across plasma membrane;4;0;GO:0006836
GO:1905543;interleukin-15 receptor complex;0;1;GO:0004872
GO:1905542;negative regulation of L-arginine import across plasma membrane;0;2;GO:0006865
GO:0051371;muscle alpha-actinin binding;513;1010;GO:0005525
GO:1905546;cellular response to phenylpropanoid;22;2;GO:0046340
GO:0051367;peptidyl-serine decanoylation;0;2;GO:0006464
GO:0051368;peptidyl-threonine octanoylation;0;1;GO:0006464
GO:0051365;cellular response to potassium ion starvation;169;41;GO:0009416
GO:0051366;protein decanoylation;1;4;GO:0016567
GO:0051363;peptidoglycan-protein cross-linking via L-alanyl-pentaglycyl-murein;0;2;GO:0005576
GO:0075330;positive regulation of arbuscule formation for nutrient acquisition from host;0;1;GO:0046394
GO:0051364;N-terminal peptidyl-proline N-formylation;0;2;GO:0006464
GO:0075331;negative regulation of arbuscule formation for nutrient acquisition from host;0;1;GO:0046274
GO:0099703;induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration;2;5;GO:0048608
GO:0036126;sperm flagellum;12298;696;GO:0005576
GO:0051767;nitric-oxide synthase biosynthetic process;574;70;GO:0009072
GO:0036127;3-sulfino-L-alanine binding;0;1;GO:0043169
GO:0036128;CatSper complex;3831;68;GO:0008026
GO:0051765;inositol tetrakisphosphate kinase activity;9104;10;GO:0004721
GO:0051766;inositol trisphosphate kinase activity;20078;10;GO:0004721
GO:0036122;BMP binding;1243;196;GO:0048407
GO:0036123;histone H3-K9 dimethylation;664;92;GO:0016569
GO:0036124;histone H3-K9 trimethylation;2;175;GO:0045944
GO:0036125;fatty acid beta-oxidation multienzyme complex;7059;9;GO:0006631
GO:1905952;regulation of lipid localization;10875;100;GO:0048193
GO:1905951;mitochondrion DNA recombination;0;1;GO:0006364
GO:0036120;cellular response to platelet-derived growth factor stimulus;1797;641;GO:0048010
GO:0036121;double-stranded DNA helicase activity;135;6;GO:0003690
GO:1905956;positive regulation of endothelial tube morphogenesis;37;6;GO:0048010
GO:1905955;negative regulation of endothelial tube morphogenesis;2;4;GO:0050727
GO:1905954;positive regulation of lipid localization;6117;182;GO:0048193
GO:1905953;negative regulation of lipid localization;2812;374;GO:0048193
GO:1905959;positive regulation of cellular response to alcohol;1;3;GO:0050727
GO:1905958;negative regulation of cellular response to alcohol;3731;2;GO:0050727
GO:1905957;regulation of cellular response to alcohol;4930;1;GO:0050789
GO:0048133;male germ-line stem cell asymmetric division;249;318;GO:0048608
GO:0048132;female germ-line stem cell asymmetric division;199;33;GO:0048608
GO:0051775;response to redox state;16347;1030;GO:0006979
GO:0075720;establishment of episomal latency;0;0;GO:009743
GO:0000196;cell wall integrity MAPK cascade;287;9;GO:0009813
GO:0048137;spermatocyte division;293;20;GO:0000904
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;412;1290;GO:0045944
GO:0048136;male germ-line cyst formation;24;3;GO:0048608
GO:0051771;negative regulation of nitric-oxide synthase biosynthetic process;162;157;GO:0010467
GO:0048135;female germ-line cyst formation;293;8;GO:0008544
GO:0048134;germ-line cyst formation;356;26;GO:0048305
GO:0036119;response to platelet-derived growth factor;1907;30;GO:0048010
GO:0036115;fatty-acyl-CoA catabolic process;504;9;GO:0006631
GO:0051778;ent-7-alpha-hydroxykaurenoate oxidase activity;0;1;GO:0004497
GO:0036116;long-chain fatty-acyl-CoA catabolic process;34;7;GO:0006631
GO:0051779;gibberellin 12-aldehyde oxidase activity;0;1;GO:0004497
GO:0036117;hyaluranon cable;117;104;GO:0005576
GO:0051776;detection of redox state;58;7;GO:0006879
GO:0036118;hyaluranon cable assembly;172;10;GO:0005576
GO:0051777;ent-kaurenoate oxidase activity;163;6;GO:0004497
GO:0036111;very long-chain fatty-acyl-CoA metabolic process;106;46;GO:0006631
GO:0061111;epithelial-mesenchymal cell signaling involved in lung development;0;2;GO:0048704
GO:0036112;medium-chain fatty-acyl-CoA metabolic process;211;20;GO:0006631
GO:0061112;negative regulation of bud outgrowth involved in lung branching;0;3;GO:0048608
GO:0036113;very long-chain fatty-acyl-CoA catabolic process;52;1;GO:0006631
GO:0061113;pancreas morphogenesis;271;104;GO:0048704
GO:0036114;medium-chain fatty-acyl-CoA catabolic process;154;34;GO:0006631
GO:0061114;branching involved in pancreas morphogenesis;95;91;GO:0048704
GO:1903300;negative regulation of hexokinase activity;11;31;GO:0010467
GO:1903301;positive regulation of hexokinase activity;8;24;GO:0010467
GO:1905962;glutamatergic neuron differentiation;1148;4;GO:0048666
GO:1905961;protein-cysteine S-palmitoyltransferase complex;0;1;GO:0005737
GO:0036110;cellular response to inositol starvation;0;1;GO:0006974
GO:0061110;dense core granule biogenesis;61;10;GO:0048471
GO:1905960;response to differentiation-inducing factor 2;0;1;GO:0045765
GO:0061119;regulation of positive chemotaxis to cAMP by chlorinated alkylphenone;10;3;GO:0046686
GO:1903304;positive regulation of pyruvate kinase activity;0;0;GO:0010468
GO:1903305;regulation of regulated secretory pathway;5687;502;GO:0010467
GO:0048139;female germ-line cyst encapsulation;103;3;GO:0008565
GO:1903302;regulation of pyruvate kinase activity;3;2;GO:0010468
GO:0048138;germ-line cyst encapsulation;209;4;GO:0008565
GO:1903303;negative regulation of pyruvate kinase activity;0;1;GO:0010468
GO:0000159;protein phosphatase type 2A complex;50222;1810;GO:0000981
GO:0061115;lung proximal/distal axis specification;56;3;GO:0048704
GO:0061116;ductus venosus closure;0;1;GO:0007565
GO:0061117;negative regulation of heart growth;581;10;GO:0048608
GO:1903306;negative regulation of regulated secretory pathway;867;85;GO:0010467
GO:0000156;phosphorelay response regulator activity;158546;958;GO:0004721
GO:0061118;regulation of positive chemotaxis to cAMP;32;2;GO:0050921
GO:1903307;positive regulation of regulated secretory pathway;1794;199;GO:0010467
GO:0000166;nucleotide binding;70544630;39200;GO:0003676
GO:0048144;fibroblast proliferation;5766;353;GO:0042127
GO:0051785;positive regulation of nuclear division;3873;81;GO:0051301
GO:0000165;MAPK cascade;261038;5310;GO:0007165
GO:0048143;astrocyte activation;818;355;GO:0048169
GO:0051786;all-trans-retinol 13,14-reductase activity;175;8;GO:0004073
GO:0000164;protein phosphatase type 1 complex;1344;1110;GO:0000502
GO:0048142;germarium-derived cystoblast division;109;8;GO:0048285
GO:0051783;regulation of nuclear division;29491;1670;GO:0051301
GO:0051784;negative regulation of nuclear division;21742;760;GO:0051321
GO:0000162;tryptophan biosynthetic process;1206953;1300;GO:0006565
GO:0048148;behavioral response to cocaine;601;1720;GO:0007610
GO:0051781;positive regulation of cell division;22843;2380;GO:0051301
GO:0000161;osmosensory signaling MAPK cascade;56;7;GO:0007186
GO:0048147;negative regulation of fibroblast proliferation;1494;785;GO:0048010
GO:0051782;negative regulation of cell division;9726;787;GO:0051301
GO:0000160;phosphorelay signal transduction system;5344082;3900;GO:0007218
GO:0048146;positive regulation of fibroblast proliferation;2463;2440;GO:0048010
GO:0048145;regulation of fibroblast proliferation;4029;535;GO:0048010
GO:0051780;behavioral response to nutrient;141;59;GO:0007589
GO:0036108;4-amino-4-deoxy-alpha-L-arabinopyranosyl undecaprenyl phosphate biosynthetic process;3857;5;GO:0006073
GO:0036109;alpha-linolenic acid metabolic process;19;2050;GO:0006633
GO:0036104;Kdo2-lipid A biosynthetic process;32791;26;GO:0009405
GO:0048140;male germ-line cyst encapsulation;106;5;GO:0008565
GO:0036105;peroxisome membrane class-1 targeting sequence binding;51;7;GO:0005576
GO:0036106;peroxisome membrane class-2 targeting sequence binding;0;0;GO:0005576
GO:0051787;misfolded protein binding;1586;818;GO:0005576
GO:0036107;4-amino-4-deoxy-alpha-L-arabinopyranosyl undecaprenyl phosphate metabolic process;3857;4;GO:0006073
GO:0051788;response to misfolded protein;5813;827;GO:0006457
GO:0036100;leukotriene catabolic process;258;8;GO:0006559
GO:0061100;lung neuroendocrine cell differentiation;41;1;GO:0048608
GO:0036101;leukotriene B4 catabolic process;142;43;GO:0006559
GO:0061101;neuroendocrine cell differentiation;1135;22;GO:0048608
GO:0036102;leukotriene B4 metabolic process;154;9;GO:0006631
GO:0061102;stomach neuroendocrine cell differentiation;143;3;GO:0048608
GO:0036103;Kdo2-lipid A metabolic process;32791;5;GO:0006631
GO:0061103;carotid body glomus cell differentiation;41;2;GO:0048608
GO:1903311;regulation of mRNA metabolic process;273613;608;GO:0010467
GO:1903312;negative regulation of mRNA metabolic process;130542;409;GO:0022627
GO:0061108;seminal vesicle epithelium development;48;4;GO:0048513
GO:1903315;negative regulation of nitrogen cycle metabolic process;0;3;GO:0046274
GO:0061109;dense core granule organization;0;2;GO:0048471
GO:1903316;positive regulation of nitrogen cycle metabolic process;8;1;GO:0046394
GO:1903313;positive regulation of mRNA metabolic process;88758;307;GO:0022613
GO:0048149;behavioral response to ethanol;1044;1300;GO:0007610
GO:1903314;regulation of nitrogen cycle metabolic process;112;8;GO:0019538
GO:0061104;adrenal chromaffin cell differentiation;73;5;GO:0048608
GO:1903319;positive regulation of protein maturation;2397;155;GO:0010467
GO:0061105;regulation of stomach neuroendocrine cell differentiation;51;1;GO:0048608
GO:0061106;negative regulation of stomach neuroendocrine cell differentiation;51;5;GO:0048608
GO:1903317;regulation of protein maturation;3980;152;GO:0016567
GO:0061107;seminal vesicle development;64;75;GO:0007548
GO:1903318;negative regulation of protein maturation;942;339;GO:0010467
GO:0000177;cytoplasmic exosome (RNase complex);2726;281;GO:0005740
GO:0051796;negative regulation of timing of catagen;47;0;GO:0048608
GO:0000176;nuclear exosome (RNase complex);13087;1050;GO:0005829
GO:0051797;regulation of hair follicle development;1069;298;GO:0048608
GO:0000175;3'-5'-RNA exonuclease activity;120786;60;GO:0003905
GO:0051794;regulation of timing of catagen;294;2;GO:0048608
GO:0051795;positive regulation of timing of catagen;176;136;GO:0048608
GO:0048159;primary oocyte stage;0;2;GO:0008544
GO:0051792;medium-chain fatty acid biosynthetic process;285;148;GO:0006021
GO:0000172;ribonuclease MRP complex;15386;191;GO:0005737
GO:0048158;oogonium stage;0;2;GO:0048608
GO:0051793;medium-chain fatty acid catabolic process;235;26;GO:0009062
GO:0000171;ribonuclease MRP activity;2175;165;GO:0004518
GO:0051790;short-chain fatty acid biosynthetic process;712;9;GO:0006066
GO:0000170;sphingosine hydroxylase activity;124;17;GO:0046395
GO:0048156;tau protein binding;824;892;GO:0005515
GO:0051791;medium-chain fatty acid metabolic process;891;96;GO:0006096
GO:0048150;behavioral response to ether;2;10;GO:0007610
GO:0051798;positive regulation of hair follicle development;638;290;GO:0048608
GO:0051799;negative regulation of hair follicle development;303;6;GO:0048608
GO:0036177;filamentous growth of a population of unicellular organisms in response to pH;121;4;GO:0048285
GO:0036178;filamentous growth of a population of unicellular organisms in response to neutral pH;89;6;GO:0048285
GO:0036179;osteoclast maturation;17;7;GO:0004723
GO:0036173;thiosulfate binding;3;0;GO:0005576
GO:0036174;butane monooxygenase activity;0;0;GO:0004497
GO:0036175;ribonucleoside-diphosphate reductase activity, glutaredoxin disulfide as acceptor;4;1;GO:0003906
GO:0051729;germline cell cycle switching, mitotic to meiotic cell cycle;196;7;GO:0007067
GO:0036176;response to neutral pH;150;1;GO:0045735
GO:1905901;positive regulation of smooth muscle tissue development;0;0;GO:0048608
GO:0036170;filamentous growth of a population of unicellular organisms in response to starvation;332;125;GO:0048285
GO:1905900;negative regulation of smooth muscle tissue development;0;0;GO:0048608
GO:0036171;filamentous growth of a population of unicellular organisms in response to chemical stimulus;68;6;GO:0048285
GO:0036172;thiamine salvage;47;4;GO:0009065
GO:1905905;nematode pharyngeal gland morphogenesis;51;0;GO:0048309
GO:1905904;positive regulation of mesoderm formation;2;1;GO:0048704
GO:1905903;negative regulation of mesoderm formation;0;2;GO:0048704
GO:1905902;regulation of mesoderm formation;2;5;GO:0048704
GO:0051720;DNA (cytosine-5-)-methyltransferase activity, acting on CpNpG substrates;0;0;GO:0003729
GO:0051728;cell cycle switching, mitotic to meiotic cell cycle;351;4;GO:0007067
GO:0051725;protein de-ADP-ribosylation;38;115;GO:0006468
GO:0051726;regulation of cell cycle;366808;11800;GO:0051726
GO:0051723;protein methylesterase activity;117148;10;GO:0016829
GO:0051724;NAD transmembrane transporter activity;403;5;GO:0005215
GO:0051721;protein phosphatase 2A binding;1182;847;GO:0048407
GO:0051722;protein C-terminal methylesterase activity;67;4;GO:0004723
GO:0036166;phenotypic switching;413;10;GO:0032502
GO:0036167;phenotypic switching in response to host;0;1;GO:0045087
GO:0036168;filamentous growth of a population of unicellular organisms in response to heat;30;9;GO:0048285
GO:0036169;3-methoxy-4-hydroxy-5-decaprenylbenzoic acid decarboxylase activity;0;1;GO:0006073
GO:0036162;oxytocin production;44;1;GO:0007565
GO:0036163;3-hexaprenyl-4-hydroxy-5-methoxybenzoic acid decarboxylase activity;0;1;GO:0006073
GO:0036164;cell-abiotic substrate adhesion;16;5;GO:0022610
GO:0036165;invasive growth in response to heat;1;3;GO:0048285
GO:1905912;regulation of calcium ion export across plasma membrane;133;0;GO:0006836
GO:1905911;positive regulation of dauer entry;15;1;GO:0048608
GO:0036160;melanocyte-stimulating hormone secretion;0;1;GO:0002504
GO:1905910;negative regulation of dauer entry;31;1;GO:0048608
GO:0036161;calcitonin secretion;2;3;GO:0007596
GO:1905916;negative regulation of cell differentiation involved in phenotypic switching;48;0;GO:0045595
GO:1905915;regulation of cell differentiation involved in phenotypic switching;104;1;GO:0045595
GO:1905914;positive regulation of calcium ion export across plasma membrane;0;0;GO:0048407
GO:1905913;negative regulation of calcium ion export across plasma membrane;130;5;GO:0006836
GO:0051730;GTP-dependent polyribonucleotide 5'-hydroxyl-kinase activity;993;0;GO:0005524
GO:1905909;regulation of dauer entry;87;3;GO:0030528
GO:0051731;polynucleotide 5'-hydroxyl-kinase activity;13325;3;GO:0004721
GO:1905908;positive regulation of amyloid fibril formation;178;120;GO:0048169
GO:1905907;negative regulation of amyloid fibril formation;656;111;GO:0010467
GO:1905906;regulation of amyloid fibril formation;911;191;GO:0043161
GO:0051738;xanthophyll binding;1;3;GO:0042169
GO:0051736;ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity;734;0;GO:0008061
GO:0051737;GTP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity;0;0;GO:0005524
GO:0036159;inner dynein arm assembly;3142;392;GO:0005524
GO:0051734;ATP-dependent polynucleotide 5'-hydroxyl-kinase activity;3196;0;GO:0003964
GO:0051735;GTP-dependent polynucleotide 5'-hydroxyl-kinase activity;993;0;GO:0003954
GO:0036155;acylglycerol acyl-chain remodeling;53;32;GO:0006631
GO:0036156;inner dynein arm;306;44;GO:0005524
GO:0036157;outer dynein arm;1689;136;GO:0005524
GO:0036158;outer dynein arm assembly;3633;898;GO:0005524
GO:0036151;phosphatidylcholine acyl-chain remodeling;730;292;GO:0006631
GO:0036152;phosphatidylethanolamine acyl-chain remodeling;409;354;GO:0046394
GO:0036153;triglyceride acyl-chain remodeling;49;8;GO:0006631
GO:0036154;diacylglycerol acyl-chain remodeling;0;2;GO:0006631
GO:1905923;positive regulation of acetylcholine biosynthetic process;0;2;GO:0050729
GO:1905922;negative regulation of acetylcholine biosynthetic process;0;2;GO:0048608
GO:1905921;regulation of acetylcholine biosynthetic process;0;1;GO:0010467
GO:0036150;phosphatidylserine acyl-chain remodeling;348;830;GO:0006633
GO:1905920;positive regulation of CoA-transferase activity;10;5;GO:0010468
GO:0048100;wing disc anterior/posterior pattern formation;127;99;GO:0009952
GO:0051741;2-methyl-6-phytyl-1,4-benzoquinone methyltransferase activity;1417;5;GO:0004497
GO:0051742;2-methyl-6-solanyl-1,4-benzoquinone methyltransferase activity;5;2;GO:0004497
GO:1905919;negative regulation of CoA-transferase activity;2;0;GO:0010468
GO:1905918;regulation of CoA-transferase activity;12;0;GO:0006732
GO:0051740;ethylene binding;3990;48;GO:0009719
GO:1905917;positive regulation of cell differentiation involved in phenotypic switching;56;1;GO:0045595
GO:0048104;establishment of body hair or bristle planar orientation;226;24;GO:0048608
GO:0048103;somatic stem cell division;526;656;GO:0048285
GO:0048102;autophagic cell death;798;762;GO:0043066
GO:0048101;calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity;145;0;GO:0008026
GO:0051749;indole acetic acid carboxyl methyltransferase activity;27;4;GO:0004497
GO:0051747;cytosine C-5 DNA demethylase activity;203;10;GO:0003676
GO:0051748;UTP-monosaccharide-1-phosphate uridylyltransferase activity;110813;67;GO:0006067
GO:0036148;phosphatidylglycerol acyl-chain remodeling;125;324;GO:0006631
GO:0051745;4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity;107118;452;GO:0004091
GO:0036149;phosphatidylinositol acyl-chain remodeling;231;995;GO:0006631
GO:0051746;thalianol synthase activity;4;3;GO:0004497
GO:0075713;establishment of integrated proviral latency;357994;1990;GO:009743
GO:0051743;red chlorophyll catabolite reductase activity;912;4;GO:0006081
GO:0051744;3,8-divinyl protochlorophyllide a 8-vinyl reductase activity;56;3;GO:0006749
GO:0036145;dendritic cell homeostasis;114;10;GO:0045727
GO:0036146;cellular response to mycotoxin;51;16;GO:0046686
GO:0036147;rumination;0;1;GO:0007586
GO:0036140;[protein]-asparagine 3-dioxygenase activity;94;0;GO:0004497
GO:1905930;regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching;104;1;GO:0048608
GO:0036141;L-phenylalanine-oxaloacetate transaminase activity;0;0;GO:0004475
GO:0036143;kringle domain binding;60;4;GO:0005515
GO:0048108;peptide cross-linking via 4-amino-3-isothiazolidinone;0;3;GO:0046395
GO:1905934;negative regulation of cell fate determination;53;3;GO:0045595
GO:0048107;4-amino-3-isothiazolidinone biosynthetic process;0;2;GO:1901363
GO:1905933;regulation of cell fate determination;119;2;GO:0030154
GO:0048106;establishment of thoracic bristle planar orientation;16;3;GO:0048704
GO:1905932;positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching;56;2;GO:0048608
GO:0048105;establishment of body hair planar orientation;158;28;GO:0048608
GO:1905931;negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching;48;1;GO:0048608
GO:1905938;positive regulation of germ cell proliferation;82;1;GO:0048608
GO:1905937;negative regulation of germ cell proliferation;146;2;GO:0048608
GO:1905936;regulation of germ cell proliferation;328;4;GO:0048608
GO:0048109;peptide cross-linking via 2-amino-3-isothiazolidinone-L-serine;0;3;GO:0048193
GO:1905935;positive regulation of cell fate determination;6;0;GO:0045595
GO:0051752;phosphoglucan, water dikinase activity;159;5;GO:0004553
GO:0051753;mannan synthase activity;1059;107;GO:0006029
GO:0051750;delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity;140;0;GO:0004497
GO:0051751;alpha-1,4-mannosyltransferase activity;3739;3;GO:0004553
GO:0051758;homologous chromosome movement towards spindle pole in meiosis I anaphase;11;1;GO:0007049
GO:0051759;sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation;30;2;GO:0007067
GO:0036137;kynurenine aminotransferase activity;2195;8;GO:0004073
GO:0051756;meiotic sister chromatid centromere separation;0;0;GO:0000922
GO:0036138;peptidyl-histidine hydroxylation;0;8;GO:0046148
GO:0051757;meiotic sister chromatid separation;7;3;GO:0007067
GO:0036139;peptidyl-histidine dioxygenase activity;191;4;GO:0004721
GO:0051754;meiotic sister chromatid cohesion, centromeric;1113;77;GO:0007070
GO:0051755;meiotic sister chromatid arm separation;4;2;GO:0000922
GO:0061177;type Is terminal bouton;90;10;GO:0008092
GO:0061178;regulation of insulin secretion involved in cellular response to glucose stimulus;2517;354;GO:0048193
GO:0061179;negative regulation of insulin secretion involved in cellular response to glucose stimulus;310;92;GO:0010467
GO:1903360;protein localization to lateral cortical node;45;0;GO:0005737
GO:1903361;protein localization to basolateral plasma membrane;158;58;GO:0005576
GO:0061173;positive regulation of establishment of bipolar cell polarity;6;3;GO:0048704
GO:1903366;negative regulation of fear response;2;0;GO:0007610
GO:0061174;type I terminal bouton;418;9;GO:0008092
GO:1903367;positive regulation of fear response;134;6;GO:0007610
GO:0061175;type II terminal bouton;21;2;GO:0048608
GO:0061176;type Ib terminal bouton;90;10;GO:0008021
GO:1903365;regulation of fear response;228;6;GO:0007610
GO:1903368;regulation of foraging behavior;0;1;GO:0007610
GO:1903369;negative regulation of foraging behavior;0;0;GO:0050789
GO:0097131;cyclin D1-CDK6 complex;0;1;GO:0005524
GO:0097130;cyclin D3-CDK4 complex;109;4;GO:0005524
GO:0097122;cyclin A2-CDK1 complex;97;2;GO:0005524
GO:0097121;cyclin A1-CDK1 complex;0;1;GO:0005819
GO:0097124;cyclin A2-CDK2 complex;286;66;GO:0005524
GO:0097123;cyclin A1-CDK2 complex;101;51;GO:0005524
GO:0097126;cyclin B2-CDK1 complex;0;0;GO:0007067
GO:0097125;cyclin B1-CDK1 complex;118;47;GO:0007031
GO:0097128;cyclin D1-CDK4 complex;211;6;GO:0005524
GO:0097127;cyclin B3-CDK2 complex;0;0;GO:0005524
GO:0061180;mammary gland epithelium development;4497;655;GO:0030216
GO:0061181;regulation of chondrocyte development;1838;149;GO:0045595
GO:0097129;cyclin D2-CDK4 complex;257;140;GO:0005524
GO:0061182;negative regulation of chondrocyte development;176;4;GO:0045595
GO:0061183;regulation of dermatome development;227;6;GO:0048704
GO:1903373;positive regulation of endoplasmic reticulum tubular network organization;3313;9;GO:0048193
GO:0061168;regulation of hair follicle placode formation;50;1;GO:0048608
GO:1903371;regulation of endoplasmic reticulum tubular network organization;3411;58;GO:0048193
GO:0061169;positive regulation of hair placode formation;0;0;GO:0048608
GO:1903372;negative regulation of endoplasmic reticulum tubular network organization;0;0;GO:0048193
GO:0061162;establishment of monopolar cell polarity;1470;711;GO:0048608
GO:1903377;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;863;65;GO:0097188
GO:0061163;endoplasmic reticulum polarization;88;8;GO:0006986
GO:1903378;positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;222;24;GO:0043407
GO:1903375;facioacoustic ganglion development;72;9;GO:0048704
GO:1903376;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;1181;151;GO:0097190
GO:1903379;regulation of mitotic chromosome condensation;177;0;GO:0048285
GO:0097140;BIM-BCL-xl complex;2;4;GO:0042981
GO:0097142;PUMA-BCL-2 complex;0;1;GO:0043066
GO:0097141;BIM-BCL-2 complex;2;4;GO:0043069
GO:0097133;cyclin D3-CDK6 complex;0;0;GO:0005524
GO:0097132;cyclin D2-CDK6 complex;13;2;GO:0005524
GO:0097135;cyclin E2-CDK2 complex;125;31;GO:0005524
GO:0097134;cyclin E1-CDK2 complex;162;309;GO:0005524
GO:0097137;BAD-BCL-xl complex;0;1;GO:0005634
GO:0097136;Bcl-2 family protein complex;1058;209;GO:0042981
GO:0097139;BID-BCL-2 complex;0;0;GO:0043066
GO:0097138;BAD-BCL-2 complex;102;2;GO:0005737
GO:0061170;negative regulation of hair follicle placode formation;50;2;GO:0048608
GO:0061171;establishment of bipolar cell polarity;198;5;GO:0048704
GO:0061172;regulation of establishment of bipolar cell polarity;56;5;GO:0048704
GO:1903370;positive regulation of foraging behavior;0;0;GO:0050921
GO:0036199;cholest-4-en-3-one 26-monooxygenase activity;179;2;GO:0004497
GO:0061199;striated muscle contraction involved in embryonic body morphogenesis;11;2;GO:0048608
GO:1903384;negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway;145;46;GO:0043407
GO:1903385;regulation of homophilic cell adhesion;76;10;GO:0050921
GO:1903382;negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway;97;9;GO:0046686
GO:1903383;regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway;145;5;GO:0043407
GO:0036195;muscle cell projection membrane;151;275;GO:0048471
GO:0061195;taste bud formation;75;1;GO:0007586
GO:1903388;regulation of synaptic vesicle uncoating;0;0;GO:0048608
GO:0036196;zymosterol metabolic process;1;2;GO:0006767
GO:0061196;fungiform papilla development;264;8;GO:0048608
GO:1903389;negative regulation of synaptic vesicle uncoating;0;0;GO:0048608
GO:0036197;zymosterol biosynthetic process;1;2;GO:0006631
GO:0061197;fungiform papilla morphogenesis;207;7;GO:0048608
GO:1903386;negative regulation of homophilic cell adhesion;1;3;GO:0050921
GO:0036198;dTMP salvage;1;1;GO:0006796
GO:0061198;fungiform papilla formation;101;50;GO:0048608
GO:1903387;positive regulation of homophilic cell adhesion;51;1;GO:0048608
GO:0036191;indolin-2-one monooxygenase activity;2;2;GO:0046395
GO:0036192;3-hydroxyindolin-2-one monooxygenase activity;9;2;GO:0004497
GO:0036193;2-hydroxy-1,4-benzoxazin-3-one monooxygenase activity;0;2;GO:0004497
GO:0036194;muscle cell projection;173;125;GO:0043005
GO:0036190;indole-2-monooxygenase activity;2;2;GO:0004497
GO:0097100;supercoiled DNA binding;271;290;GO:0003677
GO:0097102;endothelial tip cell fate specification;45;425;GO:0048608
GO:0097101;blood vessel endothelial cell fate specification;98;5;GO:0001944
GO:0097104;postsynaptic membrane assembly;479;64;GO:0048608
GO:0097103;endothelial stalk cell fate specification;0;2;GO:0048706
GO:0097106;postsynaptic density organization;2281;53;GO:0030054
GO:0097105;presynaptic membrane assembly;423;2370;GO:0048608
GO:0097108;hedgehog family protein binding;327;38;GO:0005515
GO:0097107;postsynaptic density assembly;919;69;GO:0048471
GO:0097109;neuroligin family protein binding;145;131;GO:0005539
GO:1903380;positive regulation of mitotic chromosome condensation;55;3;GO:0048285
GO:1903381;regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway;104;9;GO:0046686
GO:0036188;abieta-7,13-dien-18-al dehydrogenase activity;0;2;GO:0004497
GO:0061188;negative regulation of rDNA heterochromatin formation;203;9;GO:0045944
GO:1903395;regulation of secondary cell septum biogenesis;9;2;GO:0048285
GO:0036189;abieta-7,13-diene hydroxylase activity;0;2;GO:0046395
GO:0061189;positive regulation of sclerotome development;43;3;GO:0048608
GO:1903396;negative regulation of secondary cell septum biogenesis;0;0;GO:0048285
GO:1903393;positive regulation of adherens junction organization;112;447;GO:0048010
GO:1903394;protein localization to kinetochore involved in kinetochore assembly;43;1;GO:0007062
GO:0036184;asperthecin biosynthetic process;11;3;GO:0046395
GO:0061184;positive regulation of dermatome development;166;15;GO:0048704
GO:0036185;13-lipoxin reductase activity;8;1;GO:0004076
GO:0061185;negative regulation of dermatome development;61;5;GO:0048704
GO:0036186;early phagosome membrane;68;4;GO:0005768
GO:0061186;negative regulation of silent mating-type cassette heterochromatin formation;95;7;GO:0048285
GO:1903397;positive regulation of secondary cell septum biogenesis;0;0;GO:0048285
GO:0036187;cell growth mode switching, budding to filamentous;17;4;GO:0048285
GO:0061187;regulation of rDNA heterochromatin formation;230;2;GO:0045944
GO:0036180;filamentous growth of a population of unicellular organisms in response to biotic stimulus;760;23;GO:0048285
GO:0036181;protein localization to linear element;0;1;GO:0005576
GO:0036182;asperthecin metabolic process;12;1;GO:0006032
GO:0036183;asperthecin catabolic process;0;1;GO:0046274
GO:0097120;receptor localization to synapse;3404;303;GO:0048169
GO:0097111;endoplasmic reticulum-Golgi intermediate compartment organization;71;4;GO:0007031
GO:0097110;scaffold protein binding;2898;1310;GO:0005515
GO:0097113;AMPA glutamate receptor clustering;437;86;GO:0048167
GO:0097112;gamma-aminobutyric acid receptor clustering;290;23;GO:0048169
GO:0097115;neurexin clustering involved in presynaptic membrane assembly;54;5;GO:0048608
GO:0097114;NMDA glutamate receptor clustering;134;223;GO:0048169
GO:0097117;guanylate kinase-associated protein clustering;34;8;GO:0005524
GO:0097116;gephyrin clustering involved in postsynaptic density assembly;214;37;GO:0048608
GO:0061191;positive regulation of vacuole fusion, non-autophagic;7;2;GO:0048193
GO:0097119;postsynaptic density protein 95 clustering;359;201;GO:0030182
GO:0061192;negative regulation of vacuole fusion, non-autophagic;4;1;GO:0048193
GO:0097118;neuroligin clustering involved in postsynaptic membrane assembly;114;41;GO:0048608
GO:0061193;taste bud development;116;133;GO:0007586
GO:0061194;taste bud morphogenesis;75;3;GO:0007586
GO:1903391;regulation of adherens junction organization;367;101;GO:0030198
GO:1903392;negative regulation of adherens junction organization;198;61;GO:0048010
GO:0061190;regulation of sclerotome development;43;2;GO:0048704
GO:1903390;positive regulation of synaptic vesicle uncoating;0;0;GO:0048608
GO:0061133;endopeptidase activator activity;1081;570;GO:0004870
GO:0061134;peptidase regulator activity;356360;976;GO:0030528
GO:0061135;endopeptidase regulator activity;268273;858;GO:0030528
GO:0061136;regulation of proteasomal protein catabolic process;62513;853;GO:0043161
GO:1903322;positive regulation of protein modification by small protein conjugation or removal;8885;46;GO:0016567
GO:0061130;pancreatic bud formation;39;1;GO:0048704
GO:1903323;regulation of snoRNA metabolic process;0;0;GO:0010467
GO:0061131;pancreas field specification;38;2;GO:0048704
GO:1903320;regulation of protein modification by small protein conjugation or removal;16697;404;GO:0043687
GO:0061132;pancreas induction;0;2;GO:0048704
GO:1903321;negative regulation of protein modification by small protein conjugation or removal;4879;49;GO:0043687
GO:1903326;regulation of tRNA metabolic process;315;3;GO:0006519
GO:1903327;negative regulation of tRNA metabolic process;179;1;GO:0006519
GO:1903324;negative regulation of snoRNA metabolic process;0;0;GO:0045944
GO:1903325;positive regulation of snoRNA metabolic process;0;0;GO:0045944
GO:0061137;bud dilation;59;2;GO:0048285
GO:0061138;morphogenesis of a branching epithelium;16794;539;GO:0030216
GO:0061139;bud field specification;0;1;GO:0048316
GO:1903328;positive regulation of tRNA metabolic process;16;1;GO:0045934
GO:1903329;regulation of iron-sulfur cluster assembly;168;2;GO:0009086
GO:0048166;mature follicle stage;0;1;GO:0008544
GO:0048165;fused antrum stage;255;273;GO:0008544
GO:0048164;distinct antral spaces stage;0;2;GO:0048608
GO:0048163;scattered antral spaces stage;0;2;GO:0048608
GO:0048169;regulation of long-term neuronal synaptic plasticity;881;2150;GO:0048167
GO:0048168;regulation of neuronal synaptic plasticity;3927;2280;GO:0048167
GO:0048167;regulation of synaptic plasticity;12223;2950;GO:0048167
GO:0048162;multi-layer follicle stage;94;8;GO:0048608
GO:0048161;double layer follicle stage;0;2;GO:0008544
GO:0048160;primary follicle stage;34;3;GO:0008544
GO:0061122;positive regulation of positive chemotaxis to cAMP;13;3;GO:0045765
GO:0061123;negative regulation of positive chemotaxis to cAMP;5;2;GO:0048646
GO:1903330;negative regulation of iron-sulfur cluster assembly;0;1;GO:0008631
GO:0061124;positive regulation of positive chemotaxis to cAMP by chlorinated alkylphenone;8;1;GO:0046356
GO:0061125;negative regulation of positive chemotaxis to cAMP by chlorinated alkylphenone;0;1;GO:0048646
GO:1903333;negative regulation of protein folding;144;8;GO:0006457
GO:1903334;positive regulation of protein folding;69;76;GO:0006457
GO:0061120;regulation of positive chemotaxis to cAMP by DIF-1;2;0;GO:0046395
GO:1903331;positive regulation of iron-sulfur cluster assembly;108;3;GO:0046395
GO:0061121;regulation of positive chemotaxis to cAMP by DIF-2;8;0;GO:0048646
GO:1903332;regulation of protein folding;279;7;GO:0006457
GO:1903337;positive regulation of vacuolar transport;3;4;GO:0048193
GO:1903338;regulation of cell wall organization or biogenesis;951;8;GO:0071555
GO:1903335;regulation of vacuolar transport;140;10;GO:0006897
GO:1903336;negative regulation of vacuolar transport;57;64;GO:0048193
GO:0061126;positive regulation of positive chemotaxis to cAMP by DIF-1;0;2;GO:0048608
GO:0061127;negative regulation of positive chemotaxis to cAMP by DIF-1;0;2;GO:0048646
GO:0061128;positive regulation of chemotaxis to cAMP by DIF-2;8;3;GO:0030518
GO:1903339;negative regulation of cell wall organization or biogenesis;19;4;GO:0010467
GO:0061129;negative regulation of positive chemotaxis to cAMP by DIF-2;0;1;GO:0048646
GO:0048174;negative regulation of short-term neuronal synaptic plasticity;15;7;GO:0048167
GO:0048179;activin receptor complex;338;78;GO:0005581
GO:0048173;positive regulation of short-term neuronal synaptic plasticity;0;4;GO:0048167
GO:0048172;regulation of short-term neuronal synaptic plasticity;638;2600;GO:0048167
GO:0048171;negative regulation of long-term neuronal synaptic plasticity;0;5;GO:0048167
GO:0048170;positive regulation of long-term neuronal synaptic plasticity;161;82;GO:0048167
GO:0061155;pulmonary artery endothelial tube morphogenesis;2;20;GO:0048589
GO:1903340;positive regulation of cell wall organization or biogenesis;26;2;GO:0010467
GO:0061156;pulmonary artery morphogenesis;311;183;GO:0048608
GO:1903341;regulation of meiotic DNA double-strand break formation;244;5;GO:0007040
GO:0061157;mRNA destabilization;65204;342;GO:0006364
GO:0061158;3'-UTR-mediated mRNA destabilization;3375;78;GO:0006414
GO:1903344;regulation of protein polyglycylation;28;1;GO:0010468
GO:0061152;trachea submucosa development;99;21;GO:0030900
GO:1903345;negative regulation of protein polyglycylation;2;0;GO:0010468
GO:0061153;trachea gland development;99;36;GO:0008544
GO:1903342;negative regulation of meiotic DNA double-strand break formation;76;4;GO:0048706
GO:0061154;endothelial tube morphogenesis;996;507;GO:0048514
GO:1903343;positive regulation of meiotic DNA double-strand break formation;152;3;GO:0048285
GO:1903348;positive regulation of bicellular tight junction assembly;300;25;GO:0048193
GO:1903349;omegasome membrane;255;20;GO:0005789
GO:1903346;positive regulation of protein polyglycylation;26;0;GO:0010468
GO:1903347;negative regulation of bicellular tight junction assembly;218;41;GO:0048193
GO:0061159;establishment of bipolar cell polarity involved in cell morphogenesis;105;4;GO:0048608
GO:0048188;Set1C/COMPASS complex;20528;665;GO:0000786
GO:0048185;activin binding;788;414;GO:0005539
GO:0048189;Lid2 complex;49;2;GO:0048193
GO:0048180;activin complex;76;3;GO:0005581
GO:0061160;regulation of establishment of bipolar cell polarity regulating cell shape;1;0;GO:0048608
GO:0061161;positive regulation of establishment of bipolar cell polarity regulating cell shape;1;0;GO:0048608
GO:0048183;activin AB complex;0;1;GO:0030516
GO:0061144;alveolar secondary septum development;106;74;GO:0048608
GO:1903351;cellular response to dopamine;41447;276;GO:0007601
GO:0061145;lung smooth muscle development;109;24;GO:0042692
GO:1903352;L-ornithine transmembrane transport;5101;25;GO:0006836
GO:0061146;Peyer's patch morphogenesis;114;44;GO:0030900
GO:0061147;endocardial endothelium development;0;3;GO:0001944
GO:1903350;response to dopamine;41455;91;GO:0048167
GO:0061140;lung secretory cell differentiation;533;5;GO:0032989
GO:1903355;negative regulation of distal tip cell migration;20;1;GO:0048608
GO:0061141;lung ciliated cell differentiation;177;10;GO:0030216
GO:1903356;positive regulation of distal tip cell migration;73;2;GO:0048608
GO:0061142;mesothelial-mesenchymal cell signaling involved in early lung development;0;1;GO:0048704
GO:1903353;regulation of nucleus organization;40;3;GO:0051276
GO:0061143;alveolar primary septum development;56;8;GO:0048706
GO:1903354;regulation of distal tip cell migration;142;3;GO:0048608
GO:1903359;lateral cortical node assembly;45;1;GO:0048704
GO:1903357;regulation of transcription initiation by RNA polymerase I;0;1;GO:0006351
GO:1903358;regulation of Golgi organization;1356;175;GO:0048193
GO:0061148;extracellular matrix organization involved in endocardium development;0;4;GO:0043062
GO:0048199;vesicle targeting, to, from or within Golgi;11713;178;GO:0005764
GO:0048198;Golgi vesicle bud deformation and release;0;2;GO:0006986
GO:0048197;Golgi membrane coat protein complex assembly;1;1;GO:0005829
GO:0099738;cell cortex region;4545;128;GO:0005618
GO:0048190;wing disc dorsal/ventral pattern formation;597;58;GO:0009952
GO:0061150;renal system segmentation;0;9;GO:0048193
GO:0048195;Golgi membrane priming complex assembly;0;2;GO:0048193
GO:0048194;Golgi vesicle budding;563;575;GO:0007088
GO:0048193;Golgi vesicle transport;279290;3040;GO:0006897
GO:0097090;presynaptic membrane organization;541;1760;GO:0048471
GO:0097092;polyacyltrehalose metabolic process;0;3;GO:0006021
GO:0097091;synaptic vesicle clustering;730;165;GO:0008026
GO:0097094;craniofacial suture morphogenesis;861;587;GO:0007518
GO:0097093;polyacyltrehalose biosynthetic process;0;1;GO:0006021
GO:0097096;facial suture morphogenesis;0;1;GO:0007518
GO:0097095;frontonasal suture morphogenesis;5;0;GO:0048704
GO:0097098;DNA/RNA hybrid annealing activity;1;0;GO:0003676
GO:0097097;nasal suture morphogenesis;0;1;GO:0009952
GO:0097089;methyl-branched fatty acid metabolic process;283;115;GO:0006631
GO:0097088;interleukin-17F production;0;1;GO:0046649
GO:0097099;structural constituent of albumen;2;1;GO:0042302
GO:0097070;ductus arteriosus closure;285;120;GO:0007596
GO:0097072;interferon regulatory factor 3 complex;0;0;GO:0005634
GO:0097071;interferon regulatory factor complex;0;0;GO:0005665
GO:0097074;interferon regulatory factor 7 complex;0;0;GO:0005665
GO:0097073;interferon regulatory factor 5 complex;0;0;GO:0005665
GO:0097076;transforming growth factor beta activated kinase 1 complex;0;0;GO:0016301
GO:0097075;interferon regulatory factor 3-interferon regulatory factor 7 complex;0;0;GO:0005665
GO:0097067;cellular response to thyroid hormone stimulus;656;702;GO:0048193
GO:0097066;response to thyroid hormone;821;385;GO:0009719
GO:0097069;cellular response to thyroxine stimulus;10;44;GO:0009719
GO:0097068;response to thyroxine;31;75;GO:0009728
GO:0097081;vascular associated smooth muscle cell fate commitment;0;0;GO:0048608
GO:0097080;plasma membrane selenite transport;144;2;GO:0006836
GO:0097083;vascular associated smooth muscle cell fate determination;0;0;GO:0048608
GO:0097082;vascular associated smooth muscle cell fate specification;0;0;GO:0048608
GO:0097085;interferon regulatory factor 3-interferon regulatory factor 5 complex;0;0;GO:0005665
GO:0097084;vascular associated smooth muscle cell development;664;7;GO:0048608
GO:0097087;interleukin-17A production;8;1;GO:0046649
GO:0097086;amniotic stem cell differentiation;45;0;GO:0045737
GO:0097078;FAL1-SGD1 complex;17;5;GO:0005524
GO:0097077;copper ion sensor activity;1;1;GO:0003700
GO:0097079;selenite:proton symporter activity;25;3;GO:0008565
GO:1903285;positive regulation of hydrogen peroxide catabolic process;57;108;GO:0046395
GO:1903286;regulation of potassium ion import;341;232;GO:0045735
GO:1903283;negative regulation of glutathione peroxidase activity;0;1;GO:0046329
GO:1903284;positive regulation of glutathione peroxidase activity;1;31;GO:0046394
GO:0061096;negative regulation of turning behavior involved in mating;47;2;GO:0048608
GO:0061097;regulation of protein tyrosine kinase activity;243;115;GO:0042169
GO:0061098;positive regulation of protein tyrosine kinase activity;122;562;GO:0042169
GO:1903287;negative regulation of potassium ion import across plasma membrane;1;1;GO:0048405
GO:0061099;negative regulation of protein tyrosine kinase activity;104;499;GO:0046330
GO:1903288;positive regulation of potassium ion import across plasma membrane;274;104;GO:0048169
GO:0097050;type B pancreatic cell apoptotic process;589;38;GO:0010941
GO:0097052;L-kynurenine metabolic process;17918;10;GO:0006583
GO:0097051;establishment of protein localization to endoplasmic reticulum membrane;184;35;GO:0006612
GO:0097054;L-glutamate biosynthetic process;2363;9;GO:0006576
GO:0097053;L-kynurenine catabolic process;15259;10;GO:0006583
GO:0097045;phosphatidylserine exposure on blood platelet;61;14;GO:0002376
GO:0002710;negative regulation of T cell mediated immunity;973;1170;GO:0042110
GO:0097047;DNA replication termination region;16;2;GO:0000786
GO:0002711;positive regulation of T cell mediated immunity;2849;356;GO:0050776
GO:0097046;replication fork progression beyond termination site;21;1;GO:0007067
GO:0002712;regulation of B cell mediated immunity;3249;339;GO:0002449
GO:0097049;motor neuron apoptotic process;1460;9;GO:0043066
GO:0002713;negative regulation of B cell mediated immunity;577;6;GO:0002704
GO:0097048;dendritic cell apoptotic process;576;22;GO:0042127
GO:0002714;positive regulation of B cell mediated immunity;2364;693;GO:0046649
GO:0002715;regulation of natural killer cell mediated immunity;4656;522;GO:0002821
GO:0002716;negative regulation of natural killer cell mediated immunity;673;40;GO:0002821
GO:0002717;positive regulation of natural killer cell mediated immunity;3728;254;GO:0002821
GO:0002718;regulation of cytokine production involved in immune response;6684;493;GO:0050727
GO:0002719;negative regulation of cytokine production involved in immune response;1591;1100;GO:0050727
GO:1903281;positive regulation of calcium:sodium antiporter activity;3;24;GO:0048407
GO:1903282;regulation of glutathione peroxidase activity;1;23;GO:0008629
GO:1903280;negative regulation of calcium:sodium antiporter activity;2;10;GO:0006836
GO:1903296;positive regulation of glutamate secretion, neurotransmission;46;7;GO:0048167
GO:1903297;regulation of hypoxia-induced intrinsic apoptotic signaling pathway;233;2;GO:0010941
GO:1903294;regulation of glutamate secretion, neurotransmission;93;5;GO:0048167
GO:1903295;negative regulation of glutamate secretion, neurotransmission;2;2;GO:0048167
GO:0061085;regulation of histone H3-K27 methylation;103;10;GO:0045944
GO:0061086;negative regulation of histone H3-K27 methylation;49;54;GO:0045944
GO:0061087;positive regulation of histone H3-K27 methylation;53;72;GO:0045944
GO:1903298;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;233;53;GO:0010941
GO:1903299;regulation of hexokinase activity;19;7;GO:0010467
GO:0097061;dendritic spine organization;2958;951;GO:0097403
GO:0097060;synaptic membrane;377578;2190;GO:0048666
GO:0097063;cadmium ion sensor activity;10;1;GO:0003700
GO:0097062;dendritic spine maintenance;721;182;GO:0048608
GO:0097065;anterior head development;414;53;GO:0008544
GO:0097064;ncRNA export from nucleus;14666;7;GO:0022627
GO:0002720;positive regulation of cytokine production involved in immune response;4512;612;GO:0050727
GO:0097055;agmatine biosynthetic process;2;2;GO:0009065
GO:0002721;regulation of B cell cytokine production;1;8;GO:0050727
GO:0097058;CRLF-CLCF1 complex;136;50;GO:0048193
GO:0002722;negative regulation of B cell cytokine production;0;3;GO:0050729
GO:0097057;TRAF2-GSTP1 complex;87;43;GO:0005576
GO:0002723;positive regulation of B cell cytokine production;0;1;GO:0050729
GO:0014709;positive regulation of somitomeric trunk muscle development;37;3;GO:0048704
GO:0002724;regulation of T cell cytokine production;1738;338;GO:0050727
GO:0014708;regulation of somitomeric trunk muscle development;37;2;GO:0048704
GO:0097059;CNTFR-CLCF1 complex;122;43;GO:0005576
GO:0002725;negative regulation of T cell cytokine production;351;107;GO:0042110
GO:0014707;branchiomeric skeletal muscle development;264;44;GO:0048704
GO:0002726;positive regulation of T cell cytokine production;1228;421;GO:0050727
GO:0014706;striated muscle tissue development;18226;1530;GO:0007517
GO:0002727;regulation of natural killer cell cytokine production;989;9;GO:0050727
GO:0014705;C zone;2;8;GO:0005576
GO:0061092;positive regulation of phospholipid translocation;250;249;GO:0048193
GO:0002728;negative regulation of natural killer cell cytokine production;51;10;GO:0045087
GO:0014704;intercalated disc;2391;1540;GO:0030199
GO:0061093;negative regulation of phospholipid translocation;6;3;GO:0048193
GO:0002729;positive regulation of natural killer cell cytokine production;938;144;GO:0050727
GO:0014703;oscillatory muscle contraction;7;2;GO:0006936
GO:0061094;regulation of turning behavior involved in mating;47;2;GO:0048608
GO:0014702;free sarcoplasmic reticulum membrane;0;1;GO:0005789
GO:0061095;positive regulation of turning behavior involved in mating;0;1;GO:0048608
GO:0014701;junctional sarcoplasmic reticulum membrane;87;188;GO:0005789
GO:1903292;protein localization to Golgi membrane;369;8;GO:0005764
GO:1903293;phosphatase complex;62566;47;GO:0005524
GO:0061091;regulation of phospholipid translocation;273;34;GO:0016021
GO:0085044;symbiont-mediated disruption of host cuticle;0;0;GO:0042127
GO:0097030;CENP-A containing nucleosome binding;6;1;GO:0005524
GO:0097023;fructose 6-phosphate aldolase activity;2463;5;GO:0006066
GO:0097022;lymphocyte migration into lymph node;143;7;GO:0002526
GO:0097025;MPP7-DLG1-LIN7 complex;1677;74;GO:0048471
GO:0097027;ubiquitin-protein transferase activator activity;13149;116;GO:0004842
GO:0097026;dendritic cell dendrite assembly;18;10;GO:0048703
GO:0097029;mature conventional dendritic cell differentiation;216;43;GO:0046649
GO:0097028;dendritic cell differentiation;2411;749;GO:0030182
GO:0097041;phenolic phthiocerol biosynthetic process;12;3;GO:0006073
GO:0097040;phthiocerol biosynthetic process;14;2;GO:0006732
GO:0097043;histone H3-K56 acetylation;6;3;GO:0016569
GO:0097036;regulation of plasma membrane sterol distribution;3421;9;GO:0048193
GO:0002700;regulation of production of molecular mediator of immune response;12288;323;GO:0002684
GO:0097035;regulation of membrane lipid distribution;163638;241;GO:0048193
GO:0002701;negative regulation of production of molecular mediator of immune response;2263;43;GO:0050727
GO:0097038;perinuclear endoplasmic reticulum;1592;427;GO:0005783
GO:0002702;positive regulation of production of molecular mediator of immune response;8594;181;GO:0050727
GO:0097037;heme export;137;8;GO:0046395
GO:0002703;regulation of leukocyte mediated immunity;14628;711;GO:0002684
GO:0002704;negative regulation of leukocyte mediated immunity;2583;1420;GO:0002684
GO:0097039;protein linear polyubiquitination;193;113;GO:0006511
GO:0002705;positive regulation of leukocyte mediated immunity;9808;654;GO:0002684
GO:0002706;regulation of lymphocyte mediated immunity;12111;457;GO:0002821
GO:0002707;negative regulation of lymphocyte mediated immunity;2223;929;GO:0002821
GO:0002708;positive regulation of lymphocyte mediated immunity;8941;328;GO:0050729
GO:0002709;regulation of T cell mediated immunity;4206;474;GO:0002821
GO:0014741;negative regulation of muscle hypertrophy;966;165;GO:0048193
GO:0014740;negative regulation of muscle hyperplasia;29;63;GO:0048405
GO:0002760;positive regulation of antimicrobial humoral response;1207;57;GO:0050829
GO:0002761;regulation of myeloid leukocyte differentiation;7413;421;GO:0045580
GO:0002762;negative regulation of myeloid leukocyte differentiation;2756;230;GO:0045580
GO:0000100;S-methylmethionine transmembrane transporter activity;2;5;GO:0005215
GO:0002752;cell surface pattern recognition receptor signaling pathway;4228;68;GO:0002443
GO:0002753;cytosolic pattern recognition receptor signaling pathway;11051;140;GO:0002224
GO:0002754;endosomal pattern recognition receptor signaling pathway;0;1;GO:0002224
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;2333;1490;GO:0032496
GO:0002756;MyD88-independent toll-like receptor signaling pathway;3802;694;GO:0007165
GO:0002757;immune response-activating signaling pathway;62174;5;GO:0002764
GO:0002758;innate immune response-activating signaling pathway;43248;7;GO:0002755
GO:0002759;regulation of antimicrobial humoral response;1586;73;GO:0050829
GO:0014739;positive regulation of muscle hyperplasia;3;7;GO:0048771
GO:0014738;regulation of muscle hyperplasia;68;10;GO:0048608
GO:0014737;positive regulation of muscle atrophy;122;9;GO:0048771
GO:0014736;negative regulation of muscle atrophy;39;7;GO:0048405
GO:0014735;regulation of muscle atrophy;161;5;GO:0045944
GO:0014734;skeletal muscle hypertrophy;162;26;GO:0048193
GO:0014733;regulation of skeletal muscle adaptation;564;44;GO:0048193
GO:0014732;skeletal muscle atrophy;104;55;GO:0048193
GO:0014731;spectrin-associated cytoskeleton;467;283;GO:0005576
GO:0000109;nucleotide-excision repair complex;1969;134;GO:0000724
GO:0000107;imidazoleglycerol-phosphate synthase activity;166165;510;GO:0004067
GO:0000105;histidine biosynthetic process;1517021;1560;GO:0006555
GO:0000104;succinate dehydrogenase activity;121168;587;GO:0005746
GO:0002770;T cell inhibitory signaling pathway;0;2;GO:0002821
GO:0000103;sulfate assimilation;158768;1300;GO:0006796
GO:0002771;inhibitory killer cell immunoglobulin-like receptor signaling pathway;0;3;GO:0002449
GO:0000102;L-methionine secondary active transmembrane transporter activity;10;5;GO:0005215
GO:0002772;inhibitory C-type lectin receptor signaling pathway;0;2;GO:0002449
GO:0000101;sulfur amino acid transport;54928;47;GO:0006865
GO:0002773;B cell inhibitory signaling pathway;0;2;GO:0002821
GO:0000111;nucleotide-excision repair factor 2 complex;157;10;GO:0005737
GO:0002763;positive regulation of myeloid leukocyte differentiation;3303;294;GO:0045580
GO:0000110;nucleotide-excision repair factor 1 complex;414;70;GO:0005737
GO:0002764;immune response-regulating signaling pathway;67870;889;GO:0002764
GO:0002765;immune response-inhibiting signal transduction;224;156;GO:0002821
GO:0002766;innate immune response-inhibiting signal transduction;0;2;GO:0002768
GO:0002767;immune response-inhibiting cell surface receptor signaling pathway;160;309;GO:0002821
GO:0002768;immune response-regulating cell surface receptor signaling pathway;28738;1120;GO:0002764
GO:0002769;natural killer cell inhibitory signaling pathway;70;10;GO:0002821
GO:0014748;negative regulation of tonic skeletal muscle contraction;0;2;GO:0048407
GO:0014747;positive regulation of tonic skeletal muscle contraction;0;2;GO:0048407
GO:0014746;regulation of tonic skeletal muscle contraction;0;1;GO:0048407
GO:0014745;negative regulation of muscle adaptation;298;22;GO:0048405
GO:0014744;positive regulation of muscle adaptation;323;5;GO:0048193
GO:0014743;regulation of muscle hypertrophy;2448;53;GO:0048193
GO:0014742;positive regulation of muscle hypertrophy;1176;178;GO:0048193
GO:0051709;regulation of killing of cells of another organism;6306;6;GO:0046505
GO:0051707;response to other organism;2161022;4320;GO:0051707
GO:0002730;regulation of dendritic cell cytokine production;615;114;GO:0045640
GO:0002731;negative regulation of dendritic cell cytokine production;26;94;GO:0045640
GO:0002732;positive regulation of dendritic cell cytokine production;430;49;GO:0046649
GO:0002733;regulation of myeloid dendritic cell cytokine production;249;6;GO:0050729
GO:0002734;negative regulation of myeloid dendritic cell cytokine production;0;2;GO:0050729
GO:0002735;positive regulation of myeloid dendritic cell cytokine production;249;73;GO:0050729
GO:0014719;skeletal muscle satellite cell activation;379;304;GO:0048771
GO:0002736;regulation of plasmacytoid dendritic cell cytokine production;22;3;GO:0032940
GO:0014718;positive regulation of satellite cell activation involved in skeletal muscle regeneration;118;85;GO:0048771
GO:0002737;negative regulation of plasmacytoid dendritic cell cytokine production;22;6;GO:0050727
GO:0014717;regulation of satellite cell activation involved in skeletal muscle regeneration;126;9;GO:0048771
GO:0002738;positive regulation of plasmacytoid dendritic cell cytokine production;0;1;GO:0032724
GO:0014716;skeletal muscle satellite stem cell asymmetric division involved in skeletal muscle regeneration;0;2;GO:0048771
GO:0014715;myoblast fate commitment in trunk;0;1;GO:0048704
GO:0014714;myoblast fate commitment in head;0;1;GO:0048704
GO:0051703;biological process involved in intraspecies interaction between organisms;15344;12;GO:0044419
GO:0014713;negative regulation of branchiomeric skeletal muscle development;0;3;GO:0048704
GO:0014712;positive regulation of branchiomeric skeletal muscle development;0;4;GO:0048704
GO:0051701;biological process involved in interaction with host;6051412;65;GO:0097194
GO:0014711;regulation of branchiomeric skeletal muscle development;0;4;GO:0048704
GO:0051702;biological process involved in interaction with symbiont;7496;120;GO:0044419
GO:0014710;negative regulation of somitomeric trunk muscle development;0;2;GO:0048704
GO:0051700;fructosyl-amino acid oxidase activity;6;2;GO:0004553
GO:0014730;skeletal muscle regeneration at neuromuscular junction;0;3;GO:0048771
GO:0051718;DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates;91;0;GO:0003729
GO:0051719;DNA (cytosine-5-)-methyltransferase activity, acting on CpN substrates;2;0;GO:0003729
GO:0002750;antigen processing and presentation following macropinocytosis;0;2;GO:0002474
GO:0002751;antigen processing and presentation following receptor mediated endocytosis;0;4;GO:0002474
GO:0002745;antigen processing and presentation initiated by receptor mediated uptake of antigen;0;5;GO:0002474
GO:0002746;antigen processing and presentation following pinocytosis;0;5;GO:0002474
GO:0002747;antigen processing and presentation following phagocytosis;60;7;GO:0002479
GO:0014729;regulation of the velocity of shortening of skeletal muscle modulating contraction;0;2;GO:0048407
GO:0002748;antigen processing and presentation initiated by pattern recognition receptor mediated uptake of antigen;0;2;GO:0002449
GO:0014728;regulation of the force of skeletal muscle contraction;184;22;GO:0048407
GO:0014727;positive regulation of extraocular skeletal muscle development;0;3;GO:0048704
GO:0051716;cellular response to stimulus;28846815;4050;GO:0050896
GO:0014726;negative regulation of extraocular skeletal muscle development;0;1;GO:0048704
GO:0051717;inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity;1988;10;GO:0004721
GO:0014725;regulation of extraocular skeletal muscle development;0;2;GO:0048704
GO:0014724;regulation of twitch skeletal muscle contraction;269;10;GO:0006936
GO:0051715;cytolysis in another organism;3058;9;GO:0006929
GO:0014723;regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril;4;4;GO:0048407
GO:0051712;positive regulation of killing of cells of another organism;465;29;GO:0046330
GO:0014722;regulation of skeletal muscle contraction by calcium ion signaling;207;40;GO:0048407
GO:0014721;twitch skeletal muscle contraction;359;7;GO:0006936
GO:0014720;tonic skeletal muscle contraction;0;4;GO:0006936
GO:0051711;negative regulation of killing of cells of another organism;2;1;GO:0045087
GO:0000139;Golgi membrane;401862;9950;GO:0005794
GO:0000138;Golgi trans cisterna;916;736;GO:0005783
GO:0000137;Golgi cis cisterna;1059;342;GO:0005829
GO:0000136;mannan polymerase complex;228;8;GO:0009536
GO:0000144;cellular bud neck septin ring;476;26;GO:0005929
GO:0002796;positive regulation of antimicrobial peptide secretion;0;2;GO:0046649
GO:0002797;regulation of antibacterial peptide secretion;0;2;GO:0046649
GO:0000142;cellular bud neck contractile ring;78;47;GO:0007088
GO:0002798;negative regulation of antibacterial peptide secretion;0;2;GO:0046649
GO:0002799;positive regulation of antibacterial peptide secretion;0;2;GO:0046655
GO:0000140;acylglycerone-phosphate reductase activity;58;8;GO:0008610
GO:0000149;SNARE binding;21423;1960;GO:0008047
GO:0000148;1,3-beta-D-glucan synthase complex;8090;155;GO:0005976
GO:0000147;actin cortical patch assembly;257;41;GO:0048471
GO:0000146;microfilament motor activity;8704;822;GO:0003774
GO:0000145;exocyst;55084;2300;GO:0008021
GO:0000155;phosphorelay sensor kinase activity;1545514;1880;GO:0004721
GO:0000154;rRNA modification;1652577;2360;GO:0006470
GO:0000153;cytoplasmic ubiquitin ligase complex;2477;137;GO:0005840
GO:0000152;nuclear ubiquitin ligase complex;37742;287;GO:0005829
GO:0000151;ubiquitin ligase complex;116489;4350;GO:0005829
GO:0000150;DNA strand exchange activity;135521;111;GO:0003676
GO:0000118;histone deacetylase complex;36945;1260;GO:0016570
GO:0000117;regulation of transcription involved in G2/M transition of mitotic cell cycle;121;162;GO:0000082
GO:0002780;antibacterial peptide biosynthetic process;616;4;GO:0046274
GO:0002781;antifungal peptide production;150;8;GO:0046274
GO:0002782;antifungal peptide secretion;0;2;GO:0009953
GO:0000113;nucleotide-excision repair factor 4 complex;41;9;GO:0005737
GO:0002783;antifungal peptide biosynthetic process;44;7;GO:0046274
GO:0000112;nucleotide-excision repair factor 3 complex;382;24;GO:0005737
GO:0002784;regulation of antimicrobial peptide production;1395;90;GO:0046649
GO:0000122;negative regulation of transcription by RNA polymerase II;97895;4830;GO:0006357
GO:0002774;Fc receptor mediated inhibitory signaling pathway;75;58;GO:0002764
GO:0000121;glycerol-1-phosphatase activity;95;7;GO:0004721
GO:0002775;antimicrobial peptide production;1541;33;GO:0046274
GO:0000120;RNA polymerase I transcription regulator complex;7232;8;GO:0000976
GO:0002776;antimicrobial peptide secretion;9;2;GO:0002757
GO:0002777;antimicrobial peptide biosynthetic process;731;2;GO:0046274
GO:0002778;antibacterial peptide production;907;10;GO:0046274
GO:0002779;antibacterial peptide secretion;2;2;GO:0002737
GO:0000128;flocculation;412;45;GO:0043161
GO:0002790;peptide secretion;17131;538;GO:0006955
GO:0000127;transcription factor TFIIIC complex;11905;134;GO:0000975
GO:0002791;regulation of peptide secretion;11126;556;GO:0032989
GO:0000126;transcription factor TFIIIB complex;733;37;GO:0000976
GO:0002792;negative regulation of peptide secretion;2339;349;GO:0048193
GO:0002793;positive regulation of peptide secretion;5277;444;GO:0048193
GO:0000124;SAGA complex;29538;778;GO:0000981
GO:0002794;regulation of antimicrobial peptide secretion;0;2;GO:0046649
GO:0000123;histone acetyltransferase complex;114851;1330;GO:0016569
GO:0002795;negative regulation of antimicrobial peptide secretion;0;2;GO:0046649
GO:0000133;polarisome;35;81;GO:0005815
GO:0002785;negative regulation of antimicrobial peptide production;172;5;GO:0046649
GO:0000132;establishment of mitotic spindle orientation;5311;1300;GO:0007018
GO:0002786;regulation of antibacterial peptide production;768;79;GO:0046274
GO:0000131;incipient cellular bud site;730;27;GO:0009987
GO:0002787;negative regulation of antibacterial peptide production;89;6;GO:0046274
GO:0002788;regulation of antifungal peptide production;150;4;GO:0046274
GO:0002789;negative regulation of antifungal peptide production;15;3;GO:0046274
GO:1905820;positive regulation of chromosome separation;1995;8;GO:0051321
GO:0002480;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;1;191;GO:0002474
GO:1905824;positive regulation of mitotic sister chromatid arm separation;44;1;GO:0048285
GO:0002481;antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent;89;37;GO:0019882
GO:1905823;negative regulation of mitotic sister chromatid arm separation;0;1;GO:0007067
GO:0002482;antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-independent;0;4;GO:0002474
GO:1905822;regulation of mitotic sister chromatid arm separation;44;2;GO:0007067
GO:0002483;antigen processing and presentation of endogenous peptide antigen;2553;2260;GO:0002474
GO:1905821;positive regulation of chromosome condensation;354;5;GO:0048285
GO:0002484;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway;435;48;GO:0002474
GO:1905828;regulation of prostaglandin catabolic process;66;1;GO:0043408
GO:0002485;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent;57;141;GO:0002474
GO:1905827;positive regulation of selenocysteine metabolic process;0;0;GO:0046395
GO:0002486;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent;378;104;GO:0002474
GO:1905826;negative regulation of selenocysteine metabolic process;0;0;GO:0046395
GO:0002487;antigen processing and presentation of endogenous peptide antigen via MHC class I via endolysosomal pathway;0;4;GO:0002474
GO:1905825;regulation of selenocysteine metabolic process;0;1;GO:0045934
GO:0002477;antigen processing and presentation of exogenous peptide antigen via MHC class Ib;210;60;GO:0002474
GO:0051400;BH domain binding;420;376;GO:0042802
GO:0002478;antigen processing and presentation of exogenous peptide antigen;1746;573;GO:0019882
GO:0051401;CH domain binding;45;3;GO:0042802
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6;1130;GO:0019882
GO:1905819;negative regulation of chromosome separation;18954;353;GO:0051321
GO:1905818;regulation of chromosome separation;20926;45;GO:0051301
GO:0051408;glyceraldehyde 3-phosphate:inorganic phosphate antiporter activity;0;2;GO:0009064
GO:0051409;response to nitrosative stress;5691;681;GO:0006979
GO:0051407;glycerone phosphate:inorganic phosphate antiporter activity;0;2;GO:0008023
GO:0051402;neuron apoptotic process;18430;1880;GO:0042981
GO:0051403;stress-activated MAPK cascade;29908;1320;GO:0007242
GO:1905831;negative regulation of spindle assembly;0;0;GO:0048285
GO:1905830;positive regulation of prostaglandin catabolic process;0;1;GO:0010467
GO:0002490;antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-independent;0;2;GO:0002474
GO:0002491;antigen processing and presentation of endogenous peptide antigen via MHC class II;63;8;GO:0002474
GO:1905835;cellular response to pyrimidine ribonucleotide;82;2;GO:0009739
GO:0002492;peptide antigen assembly with MHC class Ib protein complex;0;2;GO:0002474
GO:1905834;response to pyrimidine ribonucleotide;82;3;GO:0009739
GO:0002493;lipid antigen assembly with MHC class Ib protein complex;0;3;GO:0002474
GO:1905833;negative regulation of microtubule nucleation;9;2;GO:0048285
GO:0002494;lipid antigen transport;0;3;GO:0006869
GO:1905832;positive regulation of spindle assembly;277;6;GO:0048285
GO:0002495;antigen processing and presentation of peptide antigen via MHC class II;46586;478;GO:0002474
GO:1905839;negative regulation of telomeric D-loop disassembly;152;3;GO:0048285
GO:0002496;proteolysis associated with antigen processing and presentation;0;7;GO:0002576
GO:1905838;regulation of telomeric D-loop disassembly;152;0;GO:0048285
GO:0002497;proteasomal proteolysis associated with antigen processing and presentation;0;4;GO:0004867
GO:1905837;cellular response to triterpenoid;1;0;GO:0045727
GO:0002498;proteolysis within endoplasmic reticulum associated with antigen processing and presentation;0;3;GO:0002576
GO:1905836;response to triterpenoid;1;1;GO:0009611
GO:0002488;antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway;92;10;GO:0002474
GO:0002489;antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent;92;22;GO:0002474
GO:0051412;response to corticosterone;186;666;GO:0006950
GO:0051410;detoxification of nitrogen compound;309;138;GO:0006569
GO:1905829;negative regulation of prostaglandin catabolic process;0;2;GO:0010467
GO:0051417;microtubule nucleation by spindle pole body;22;4;GO:0000922
GO:0051418;microtubule nucleation by microtubule organizing center;2340;106;GO:0000904
GO:0051415;microtubule nucleation by interphase microtubule organizing center;110;150;GO:0000922
GO:0051413;response to cortisone;6;6;GO:0002455
GO:0051414;response to cortisol;314;284;GO:0006979
GO:1905842;cellular response to oxidopamine;7;0;GO:0006979
GO:1905841;response to oxidopamine;7;0;GO:0006979
GO:1905840;positive regulation of telomeric D-loop disassembly;0;0;GO:0048285
GO:1905846;regulation of cellular response to oxidopamine;7;1;GO:0050727
GO:1905845;positive regulation of cellular response to gamma radiation;8;1;GO:0045727
GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;27637;747;GO:0002449
GO:1905844;negative regulation of cellular response to gamma radiation;0;1;GO:0045727
GO:0002461;tolerance induction dependent upon immune response;214;9;GO:0002821
GO:1905843;regulation of cellular response to gamma radiation;8;1;GO:0045727
GO:0002462;tolerance induction to nonself antigen;5;5;GO:0002449
GO:0002463;central tolerance induction to nonself antigen;0;3;GO:0002449
GO:1905849;negative regulation of forward locomotion;0;1;GO:0048519
GO:0002464;peripheral tolerance induction to nonself antigen;0;3;GO:0002429
GO:1905848;positive regulation of cellular response to oxidopamine;0;0;GO:0046655
GO:0002465;peripheral tolerance induction;173;7;GO:0002821
GO:1905847;negative regulation of cellular response to oxidopamine;7;0;GO:0046686
GO:0002455;humoral immune response mediated by circulating immunoglobulin;9440;899;GO:0002520
GO:0002456;T cell mediated immunity;5634;750;GO:0002687
GO:0002457;T cell antigen processing and presentation;197;339;GO:0002474
GO:0002458;peripheral T cell tolerance induction;106;10;GO:0002821
GO:0002459;adaptive immune response based on somatic recombination of immune receptors built from leucine-rich repeat domains;0;3;GO:0002449
GO:0051428;peptide hormone receptor binding;1874;227;GO:0004872
GO:0051429;corticotropin-releasing hormone receptor binding;896;10;GO:0004930
GO:0051427;hormone receptor binding;4110;804;GO:0005515
GO:0051424;corticotropin-releasing hormone binding;1786;10;GO:0004930
GO:0051425;PTB domain binding;163;75;GO:0005515
GO:1905853;regulation of heparan sulfate binding;0;2;GO:0048407
GO:1905852;positive regulation of backward locomotion;31;2;GO:0048608
GO:1905851;negative regulation of backward locomotion;0;1;GO:0048608
GO:1905850;positive regulation of forward locomotion;17;1;GO:0040011
GO:1905857;positive regulation of pentose-phosphate shunt;72;6;GO:0046395
GO:0002470;plasmacytoid dendritic cell antigen processing and presentation;43;9;GO:0002449
GO:1905856;negative regulation of pentose-phosphate shunt;120;9;GO:0006096
GO:0002471;monocyte antigen processing and presentation;0;3;GO:0002446
GO:1905855;positive regulation of heparan sulfate binding;0;5;GO:0048193
GO:0002472;macrophage antigen processing and presentation;57;5;GO:0008615
GO:1905854;negative regulation of heparan sulfate binding;0;0;GO:0048193
GO:0002473;non-professional antigen presenting cell antigen processing and presentation;0;3;GO:0002449
GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;4172;2250;GO:0002474
GO:0002475;antigen processing and presentation via MHC class Ib;1054;1260;GO:0019882
GO:1905859;negative regulation of heparan sulfate proteoglycan binding;0;1;GO:0048407
GO:0002476;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;594;313;GO:0002474
GO:1905858;regulation of heparan sulfate proteoglycan binding;1;3;GO:0048407
GO:0002466;peripheral tolerance induction to self antigen;0;3;GO:0002429
GO:0051433;BH2 domain binding;3;3;GO:0005515
GO:0002467;germinal center formation;1283;1630;GO:0048311
GO:0051434;BH3 domain binding;335;524;GO:0005524
GO:0002468;dendritic cell antigen processing and presentation;536;147;GO:0002474
GO:0051431;corticotropin-releasing hormone receptor 2 binding;734;10;GO:0004930
GO:0002469;myeloid dendritic cell antigen processing and presentation;66;9;GO:0002449
GO:0051432;BH1 domain binding;3;2;GO:0005515
GO:0051430;corticotropin-releasing hormone receptor 1 binding;66;24;GO:0004930
GO:0051438;regulation of ubiquitin-protein transferase activity;927;555;GO:0004842
GO:0051435;BH4 domain binding;4;0;GO:0043169
GO:1905802;regulation of cellular response to manganese ion;46;3;GO:0045727
GO:1905801;positive regulation of intraciliary retrograde transport;9;1;GO:0048193
GO:1905800;negative regulation of intraciliary retrograde transport;0;2;GO:0048193
GO:1905806;regulation of synapse pruning;314;3;GO:0048608
GO:1905805;excitatory synapse pruning;39;10;GO:0048666
GO:1905804;positive regulation of cellular response to manganese ion;8;1;GO:0045727
GO:1905803;negative regulation of cellular response to manganese ion;38;1;GO:0045727
GO:0002499;proteolysis within endosome associated with antigen processing and presentation;0;4;GO:0006955
GO:1905813;negative regulation of motor neuron axon guidance;0;0;GO:0048704
GO:1905812;regulation of motor neuron axon guidance;97;3;GO:0048704
GO:1905811;negative regulation of excitatory synapse pruning;0;0;GO:0048167
GO:1905810;regulation of excitatory synapse pruning;0;0;GO:0048608
GO:1905817;positive regulation of dorsal/ventral axon guidance;0;0;GO:0048608
GO:1905816;negative regulation of dorsal/ventral axon guidance;0;0;GO:0048608
GO:0080117;secondary growth;104;9;GO:0048608
GO:0080118;brassinosteroid sulfotransferase activity;5;3;GO:0004723
GO:0080119;ER body organization;77;6;GO:0007049
GO:0102150;3-oxo-myristoyl-CoA hydrolase activity;0;0;GO:0004733
GO:0102156;2,5-DHBA UDP-glucosyltransferase activity;0;0;GO:0006022
GO:0031179;peptide modification;15813;29;GO:0006464
GO:0102155;S-sulfolactate dehydrogenase activity;212;2;GO:0004067
GO:0031176;endo-1,4-beta-xylanase activity;34148;22;GO:0004553
GO:0102158;very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity;0;0;GO:0006081
GO:0031177;phosphopantetheine binding;169706;1190;GO:0043169
GO:0102157;(R)-sulfopropanediol 2-dehydrogenase activity;0;0;GO:0004497
GO:0102152;Delta12-linoleate epoxygenase activity;0;0;GO:0004497
GO:0102151;3-oxo-myristate decarboxylase activity;25;1;GO:0006066
GO:0102154;8C-naringenin dibenzoylmethane tautomer glucosyltransferase activity;0;0;GO:0006073
GO:0031170;ferricrocin metabolic process;4;1;GO:0006733
GO:0031171;ferricrocin biosynthetic process;4;4;GO:0006073
GO:0031174;lifelong otolith mineralization;4;3;GO:0048608
GO:0031175;neuron projection development;143131;4530;GO:0043005
GO:0080120;CAAX-box protein maturation;247439;18;GO:0006464
GO:0102159;baicalein 7-O-glucuronosyltransferase activity;2;2;GO:0004497
GO:0031172;ornithine N5-monooxygenase activity;27;2;GO:0004497
GO:0080121;AMP transport;375;38;GO:0006810
GO:0031173;otolith mineralization completed early in development;7;1;GO:0048405
GO:0080122;AMP transmembrane transporter activity;189;24;GO:0008565
GO:0080123;jasmonate-amino synthetase activity;4;4;GO:0004497
GO:0080124;pheophytinase activity;638;8;GO:0004497
GO:0080126;ovary septum development;3;6;GO:0008544
GO:0080127;fruit septum development;3;2;GO:0009913
GO:0080128;anther septum development;0;2;GO:0048707
GO:0080129;proteasome core complex assembly;192;39;GO:0000502
GO:0102161;copal-8-ol diphosphate synthase activity;23;2;GO:0006030
GO:0102160;cyanidin-3-O-glucoside 2-O-glucuronosyltransferase activity;2;2;GO:0004725
GO:0031167;rRNA methylation;1417487;3220;GO:0006470
GO:0102167;[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity;266;0;GO:0004553
GO:0031168;ferrichrome metabolic process;42;2;GO:0006073
GO:0102166;[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity;266;0;GO:0004553
GO:0102169;pyocyanin hydroxylase activity;13;2;GO:0046395
GO:0102168;5-methyl-phenazine-1-carboxylate N-methyltransferase activity;2;1;GO:0004497
GO:0102163;3-hydroxyacyl-CoA-acyl carrier protein transferase activity;0;0;GO:0006081
GO:0102162;all-trans-8'-apo-beta-carotenal 15,15'-oxygenase activity;16;0;GO:0004497
GO:0031169;ferrichrome biosynthetic process;42;2;GO:0006033
GO:0102165;(Z)-3-hexen-1-ol acetyltransferase activity;2;0;GO:0004089
GO:0102164;2-heptyl-3-hydroxy-4(1H)-quinolone synthase activity;46;0;GO:0004497
GO:0055130;D-alanine catabolic process;1158;8;GO:0009065
GO:0055131;C3HC4-type RING finger domain binding;171;80;GO:0043161
GO:0043145;sno(s)RNA 3'-end cleavage;0;0;GO:0009063
GO:0043144;sno(s)RNA processing;1984;10;GO:0006364
GO:0043149;stress fiber assembly;5569;1930;GO:0007049
GO:0102170;5-epi-aristolochene-1,3-dihydroxylase activity;5;2;GO:0004497
GO:0043150;DNA synthesis involved in double-strand break repair via homologous recombination;76;6;GO:0006281
GO:0102172;4alpha-hydroxymethyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(241)-en-3beta-ol-4alpha-methyl oxidase activity;0;0;GO:0004497
GO:0102171;DMNT synthase activity;2;1;GO:0004497
GO:0043152;induction of bacterial agglutination;149;292;GO:0048285
GO:0070760;positive regulation of interleukin-35-mediated signaling pathway;0;1;GO:0046649
GO:0043151;DNA synthesis involved in double-strand break repair via single-strand annealing;0;4;GO:0006281
GO:0070761;pre-snoRNP complex;467;133;GO:0005840
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;200;1420;GO:0046330
GO:0043153;entrainment of circadian clock by photoperiod;1582;693;GO:0007623
GO:0055123;digestive system development;13589;440;GO:0048513
GO:0070764;gamma-secretase-Delta1 complex;0;1;GO:0004867
GO:0102178;4alpha-formyl-ergosta-7,24(241)-dien-3beta-ol-methyl oxidase activity;0;0;GO:0004497
GO:0070765;gamma-secretase complex;2590;265;GO:0004867
GO:0102177;24-methylenelophenol methyl oxidase activity;0;2;GO:0004497
GO:0070762;nuclear pore transmembrane ring;128;10;GO:0005576
GO:0070763;Delta1 complex;0;0;GO:0005576
GO:0102179;24-ethylidenelophenol 4alpha-methyl oxidase activity;0;1;GO:0004497
GO:0055127;vibrational conductance of sound to the inner ear;0;3;GO:0007623
GO:0070768;synaptotagmin-synaptobrevin 2-SNAP-25-syntaxin-1a-syntaxin-1b-Unc13 complex;0;1;GO:0008026
GO:0102174;4alpha-formyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(241)-en-3beta-ol-4alpha-methyl oxidase activity;0;0;GO:0004497
GO:0070769;alphaIIb-beta3 integrin-CIB complex;0;0;GO:0005976
GO:0102173;24-methylenecycloartanol 4alpha-methyl oxidase activity;0;1;GO:0004497
GO:0055129;L-proline biosynthetic process;123333;494;GO:0006565
GO:0070766;endobrevin-synaptobrevin 2-alpha-SNAP-NSF-syntaxin-4 complex;0;1;GO:0008023
GO:0070767;BRCA1-Rad51 complex;0;2;GO:0005576
GO:0102175;3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity;8;2;GO:0004089
GO:0070759;negative regulation of interleukin-35-mediated signaling pathway;0;1;GO:0046649
GO:0080100;L-glutamine:2-oxoglutarate aminotransferase activity;572;1;GO:0004073
GO:0080101;phosphatidyl-N-dimethylethanolamine N-methyltransferase activity;5314;137;GO:0004721
GO:0043155;negative regulation of photosynthesis, light reaction;76;8;GO:0015979
GO:0080102;3-methylthiopropyl glucosinolate S-oxygenase activity;4;4;GO:0004734
GO:0043158;heterocyst development;2251;5;GO:0048407
GO:0080103;4-methylthiopropyl glucosinolate S-oxygenase activity;11;4;GO:0004734
GO:0043157;response to cation stress;177;8;GO:0006950
GO:0080104;5-methylthiopropyl glucosinolate S-oxygenase activity;4;4;GO:0004734
GO:0080105;6-methylthiopropyl glucosinolate S-oxygenase activity;3;3;GO:0004734
GO:0043159;acrosomal matrix;140;96;GO:0005576
GO:0080106;7-methylthiopropyl glucosinolate S-oxygenase activity;4;3;GO:0004734
GO:0080107;8-methylthiopropyl glucosinolate S-oxygenase activity;16;5;GO:0004734
GO:0080108;S-alkylthiohydroximate lyase activity;4;2;GO:0004730
GO:0080109;indole-3-acetonitrile nitrile hydratase activity;9154;6;GO:0006073
GO:0102181;4alpha-formyl-stigmasta-7,24(241)-dien-3beta-ol-methyl oxidase activity;0;0;GO:0004497
GO:0102180;4alpha-hydroxymethyl-stigmasta-7,24(241)-dien-3beta-ol-methyl oxidase activity;0;0;GO:0004497
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;198971;5820;GO:0006986
GO:0043160;acrosomal lumen;22;6;GO:0005766
GO:0102182;4alpha-carboxy-stigmasta-7,24(241)-dien-3beta-ol dehydrogenase/C4-decarboxylase activity;0;0;GO:0004497
GO:0043163;cell envelope organization;134223;58;GO:0070062
GO:0043162;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;20252;381;GO:0006626
GO:0043165;Gram-negative-bacterium-type cell outer membrane assembly;134215;506;GO:0043169
GO:0043164;Gram-negative-bacterium-type cell wall biogenesis;37;10;GO:0022617
GO:0070753;interleukin-35 production;0;2;GO:0046649
GO:0102189;4alpha-hydroxymethyl-5alpha-cholesta-7,24-dien-3beta-ol-4alpha-methyl oxidase activity;0;1;GO:0004041
GO:0070754;regulation of interleukin-35 production;0;1;GO:0046330
GO:0102188;4alpha-methyl-5alpha-cholesta-7,24-dien-3beta-ol-4alpha-methyl oxidase activity;0;0;GO:0004497
GO:0070757;interleukin-35-mediated signaling pathway;1;222;GO:0007249
GO:0102185;4alpha-hydroxymethyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-cholest-24-en-3beta-ol-4alpha-methyl oxidase activity;0;0;GO:0004601
GO:0070758;regulation of interleukin-35-mediated signaling pathway;0;1;GO:0046649
GO:0102184;cycloartenol 4alpha-methyl oxidase activity;0;0;GO:0004497
GO:0070755;negative regulation of interleukin-35 production;0;1;GO:0046330
GO:0070756;positive regulation of interleukin-35 production;0;1;GO:0046330
GO:0102186;4alpha-formyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-cholest-24-en-3beta-ol-4alpha-methyl oxidase activity;0;1;GO:0004497
GO:0043167;ion binding;87158159;7490;GO:0043169
GO:0043169;cation binding;38664311;6850;GO:0043169
GO:0043168;anion binding;48959661;2680;GO:0043167
GO:0043170;macromolecule metabolic process;121152345;6490;GO:0005975
GO:0102191;4alpha-carboxy-5alpha-cholesta-7,24-dien-3beta-ol dehydrogenase/C4-decarboxylase activity;4;2;GO:0004041
GO:0102194;protein-fructosamine 3-kinase activity;105;3;GO:0004721
GO:0043171;peptide catabolic process;25887;1080;GO:0006519
GO:0102193;protein-ribulosamine 3-kinase activity;4258;5;GO:0004721
GO:0043174;nucleoside salvage;219553;336;GO:0009063
GO:0070782;phosphatidylserine exposure on apoptotic cell surface;473;173;GO:0008610
GO:0043173;nucleotide salvage;233229;96;GO:0006793
GO:0070783;growth of unicellular organism as a thread of attached cells;1285;6;GO:0044699
GO:0043176;amine binding;3520;379;GO:0043167
GO:0070780;dihydrosphingosine-1-phosphate phosphatase activity;9;7;GO:0004721
GO:0102190;4alpha-formyl-5alpha-cholesta-7,24-dien-3beta-ol-4alpha-methyl oxidase activity;0;0;GO:0004497
GO:0043175;RNA polymerase core enzyme binding;37439;239;GO:0003735
GO:0070781;response to biotin;69;10;GO:0046394
GO:0070786;positive regulation of growth of unicellular organism as a thread of attached cells;289;1;GO:0048608
GO:0070787;conidiophore development;33;2;GO:0048305
GO:0102199;nitric oxide reductase activity (NAD(P)H-dependent) activity;9;1;GO:0004784
GO:0070784;regulation of growth of unicellular organism as a thread of attached cells;542;2;GO:0048608
GO:0070785;negative regulation of growth of unicellular organism as a thread of attached cells;44;4;GO:0048589
GO:0102196;cortisol dehydrogenase activity;57;2;GO:0004721
GO:0102195;UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--D-lysine ligase activity;52;0;GO:0005524
GO:0070788;conidiophore stalk development;1;0;GO:0048305
GO:0102198;L-idonate 5-dehydrogenase activity (NAD-dependent);4;3;GO:0004497
GO:0070789;metula development;1;1;GO:0048608
GO:0102197;vinylacetate caboxylester hydrolase activity;0;0;GO:0046395
GO:0043178;alcohol binding;60386;188;GO:0005576
GO:0043177;organic acid binding;619339;598;GO:0043169
GO:0043179;rhythmic excitation;72;10;GO:0007623
GO:0043181;vacuolar sequestering;62;182;GO:0005737
GO:0043180;rhythmic inhibition;0;1;GO:0048608
GO:0043183;vascular endothelial growth factor receptor 1 binding;139;111;GO:0048010
GO:0043182;vacuolar sequestering of sodium ion;5;3;GO:0006836
GO:0043185;vascular endothelial growth factor receptor 3 binding;217;67;GO:0048010
GO:0070771;alphaIIb-beta3 integrin-CD47-Src complex;0;1;GO:0002576
GO:0043184;vascular endothelial growth factor receptor 2 binding;512;148;GO:0048010
GO:0070772;PAS complex;5003;121;GO:0005829
GO:0043186;P granule;4992;516;GO:0032544
GO:0070770;alphaIIb-beta3 integrin-CD47-FAK complex;0;0;GO:0002576
GO:0070775;H3 histone acetyltransferase complex;1980;226;GO:0016569
GO:0070776;MOZ/MORF histone acetyltransferase complex;1604;124;GO:0016569
GO:0070773;protein-N-terminal glutamine amidohydrolase activity;7571;10;GO:0004721
GO:0070774;phytoceramidase activity;164;8;GO:0004733
GO:0070779;D-aspartate import across plasma membrane;318;5;GO:0006836
GO:0070777;D-aspartate transport;434;380;GO:0006836
GO:0070778;L-aspartate transmembrane transport;1235;8;GO:0006836
GO:0008900;P-type potassium:proton transporter activity;855;30;GO:0005215
GO:0008911;lactaldehyde dehydrogenase activity;1409;5;GO:0004073
GO:0008910;kanamycin kinase activity;2169;9;GO:0005524
GO:0008904;hygromycin-B 7''-O-phosphotransferase activity;19;0;GO:0004721
GO:0008903;hydroxypyruvate isomerase activity;4632;94;GO:0006099
GO:0008902;hydroxymethylpyrimidine kinase activity;14737;9;GO:0004721
GO:0008901;ferredoxin hydrogenase activity;43082;93;GO:0008033
GO:0008908;isochorismatase activity;10362;8;GO:0004723
GO:0008907;integrase activity;94171;21;GO:0003677
GO:0008906;inosine kinase activity;5492;5;GO:0004721
GO:0008909;isochorismate synthase activity;56994;112;GO:0006099
GO:0021915;neural tube development;14442;1560;GO:0007420
GO:0021916;inductive cell-cell signaling between paraxial mesoderm and motor neuron precursors;0;3;GO:0048704
GO:0021917;somatic motor neuron fate commitment;0;5;GO:0048704
GO:0021911;retinoic acid metabolic process in spinal cord anterior-posterior patterning;0;3;GO:0048608
GO:0021914;negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning;138;40;GO:0048704
GO:0008940;nitrate reductase activity;56582;623;GO:0003954
GO:0021910;smoothened signaling pathway involved in ventral spinal cord patterning;388;4;GO:0007218
GO:0008942;nitrite reductase [NAD(P)H] activity;52933;66;GO:0006779
GO:0008941;nitric oxide dioxygenase activity;21735;37;GO:0004725
GO:0008937;ferredoxin-NAD(P) reductase activity;80690;3;GO:0003824
GO:0008936;nicotinamidase activity;5394;9;GO:0004721
GO:0008935;1,4-dihydroxy-2-naphthoyl-CoA synthase activity;52937;107;GO:0006081
GO:0008934;inositol monophosphate 1-phosphatase activity;71570;183;GO:0004721
GO:0008939;nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity;76390;68;GO:0004061
GO:0008938;nicotinate N-methyltransferase activity;57;3;GO:0004725
GO:0021904;dorsal/ventral neural tube patterning;1538;290;GO:0009952
GO:0021905;forebrain-midbrain boundary formation;55;10;GO:0007417
GO:0021906;hindbrain-spinal cord boundary formation;43;3;GO:0009952
GO:0021907;fibroblast growth factor receptor signaling pathway involved in spinal cord anterior/posterior pattern formation;0;3;GO:0048704
GO:0021900;ventricular zone cell fate commitment;0;1;GO:0048667
GO:0021901;early neuron fate commitment in forebrain;0;1;GO:0048704
GO:0021902;commitment of neuronal cell to specific neuron type in forebrain;312;224;GO:0048666
GO:0021903;rostrocaudal neural tube patterning;1643;218;GO:0007423
GO:0008951;palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity;1495;0;GO:0008610
GO:0008955;peptidoglycan glycosyltransferase activity;226286;361;GO:0006021
GO:0008953;penicillin amidase activity;1240;5;GO:0003954
GO:0008948;oxaloacetate decarboxylase activity;57157;162;GO:0006099
GO:0008946;oligonucleotidase activity;124;2;GO:0004518
GO:0008949;oxalyl-CoA decarboxylase activity;2934;9;GO:0006066
GO:0021908;retinoic acid receptor signaling pathway involved in spinal cord anterior/posterior pattern formation;0;1;GO:0030501
GO:0008922;long-chain fatty acid [acyl-carrier-protein] ligase activity;5279;5;GO:0004364
GO:0008921;lipopolysaccharide-1,6-galactosyltransferase activity;5;4;GO:0004553
GO:0008920;lipopolysaccharide heptosyltransferase activity;8254;7;GO:0004553
GO:0008915;lipid-A-disaccharide synthase activity;71712;730;GO:0003824
GO:0008914;leucyl-tRNA--protein transferase activity;99126;0;GO:0006413
GO:0008913;lauroyltransferase activity;154;2;GO:0004497
GO:0008912;lactaldehyde reductase activity;2544;6;GO:0004067
GO:0008919;lipopolysaccharide glucosyltransferase I activity;1437;2;GO:0004553
GO:0008918;lipopolysaccharide 3-alpha-galactosyltransferase activity;4756;6;GO:0004553
GO:0008917;lipopolysaccharide N-acetylglucosaminyltransferase activity;1005;3;GO:0004553
GO:0008933;lytic transglycosylase activity;167156;54;GO:0004553
GO:0008932;lytic endotransglycosylase activity;67703;9;GO:0004553
GO:0008930;methylthioadenosine nucleosidase activity;24269;9;GO:0004553
GO:0008926;mannitol-1-phosphate 5-dehydrogenase activity;19872;10;GO:0006067
GO:0008925;maltose O-acetyltransferase activity;2106;5;GO:0006066
GO:0008924;malate dehydrogenase (quinone) activity;45873;137;GO:0003824
GO:0008923;lysine decarboxylase activity;1692;5;GO:0004467
GO:0008929;methylglyoxal synthase activity;50808;72;GO:0004067
GO:0008928;mannose-1-phosphate guanylyltransferase (GDP) activity;586;6;GO:0006022
GO:0008927;mannonate dehydratase activity;50065;209;GO:0006067
GO:0021959;cuneatus tract morphogenesis;0;1;GO:0048704
GO:0045926;negative regulation of growth;18403;2180;GO:0048589
GO:0018306;iron incorporation into iron-sulfur cluster via bis-L-cysteinyl-L-N3'-histidino-L-serinyl tetrairon tetrasulfide;0;2;GO:0009516
GO:0045927;positive regulation of growth;19702;1450;GO:0048589
GO:0045924;regulation of female receptivity;519;607;GO:0030518
GO:0045925;positive regulation of female receptivity;81;162;GO:0048608
GO:0008980;propionate kinase activity;4372;7;GO:0004721
GO:0021955;central nervous system neuron axonogenesis;2659;826;GO:0048666
GO:0021956;central nervous system interneuron axonogenesis;49;2;GO:0048666
GO:0021957;corticospinal tract morphogenesis;393;37;GO:0048704
GO:0045928;negative regulation of juvenile hormone metabolic process;20;2;GO:0010468
GO:0021958;gracilis tract morphogenesis;0;1;GO:0048704
GO:0045929;positive regulation of juvenile hormone metabolic process;1;2;GO:0048608
GO:0008984;protein-glutamate methylesterase activity;112819;62;GO:0004725
GO:0021951;chemoattraction involved in precerebellar neuron migration;0;1;GO:0048608
GO:0008983;protein-glutamate O-methyltransferase activity;30504;10;GO:0004725
GO:0021952;central nervous system projection neuron axonogenesis;2120;1890;GO:0048666
GO:0008982;protein-N(PI)-phosphohistidine-sugar phosphotransferase activity;233476;0;GO:0005524
GO:0021953;central nervous system neuron differentiation;16071;1030;GO:0048699
GO:0021954;central nervous system neuron development;5204;949;GO:0007420
GO:0006325;chromatin organization;1596138;11300;GO:0043234
GO:0008988;rRNA (adenine-N6-)-methyltransferase activity;50065;0;GO:0003735
GO:0045922;negative regulation of fatty acid metabolic process;6873;221;GO:0045735
GO:0008987;quinolinate synthetase A activity;73911;237;GO:0009065
GO:0045923;positive regulation of fatty acid metabolic process;2107;427;GO:0045944
GO:0008986;pyruvate, water dikinase activity;61879;40;GO:0006099
GO:0045920;negative regulation of exocytosis;1365;244;GO:0048193
GO:0021950;chemorepulsion involved in precerebellar neuron migration;0;3;GO:0048704
GO:0045921;positive regulation of exocytosis;3730;756;GO:0048193
GO:0033937;3-deoxy-2-octulosonidase activity;0;1;GO:0004553
GO:0033936;polymannuronate hydrolase activity;0;2;GO:0004553
GO:0006316;movement of group I intron;2;2;GO:0005940
GO:0008979;prophage integrase activity;5;2;GO:0015979
GO:0033935;oligoxyloglucan beta-glycosidase activity;1;3;GO:0004553
GO:0033934;glucan 1,4-alpha-maltotriohydrolase activity;29;8;GO:0004553
GO:0033939;xylan alpha-1,2-glucuronosidase activity;1834;2;GO:0004553
GO:0033938;1,6-alpha-L-fucosidase activity;2;3;GO:0004553
GO:0033933;branched-dextran exo-1,2-alpha-glucosidase activity;0;2;GO:0004553
GO:0018313;peptide cross-linking via L-alanyl-5-imidazolinone glycine;0;3;GO:0048193
GO:0033932;1,3-alpha-L-fucosidase activity;2;5;GO:0004553
GO:0018316;peptide cross-linking via L-cystine;1;7;GO:0048193
GO:0033931;endogalactosaminidase activity;60;1;GO:0004553
GO:0018315;molybdenum incorporation into molybdenum-molybdopterin complex;2;26;GO:0009065
GO:0033930;keratan-sulfate endo-1,4-beta-galactosidase activity;27;2;GO:0004553
GO:0021948;inward migration of deep nuclear neurons;0;1;GO:0048704
GO:0045937;positive regulation of phosphate metabolic process;34395;1360;GO:0045735
GO:0021949;brainstem precerebellar neuron precursor migration;0;2;GO:0048704
GO:0045938;positive regulation of circadian sleep/wake cycle, sleep;376;23;GO:0048405
GO:0045935;positive regulation of nucleobase-containing compound metabolic process;891364;1910;GO:0045944
GO:0045936;negative regulation of phosphate metabolic process;69219;945;GO:0045735
GO:0021944;neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration;54;5;GO:0048666
GO:0008990;rRNA (guanine-N2-)-methyltransferase activity;96438;0;GO:0003729
GO:0021945;positive regulation of cerebellar granule cell migration by calcium;0;3;GO:0048704
GO:0021946;deep nuclear neuron cell migration;0;1;GO:0048608
GO:0045939;negative regulation of steroid metabolic process;1675;47;GO:0045935
GO:0021947;outward migration of deep nuclear neurons;0;2;GO:0048704
GO:0008995;ribonuclease E activity;13512;54;GO:0003723
GO:0021940;positive regulation of cerebellar granule cell precursor proliferation;526;29;GO:0048608
GO:0008994;rhamnulose-1-phosphate aldolase activity;8780;6;GO:0006032
GO:0021941;negative regulation of cerebellar granule cell precursor proliferation;37;8;GO:0048608
GO:0045930;negative regulation of mitotic cell cycle;44501;2030;GO:0010942
GO:0008993;rhamnulokinase activity;14965;10;GO:0006061
GO:0021942;radial glia guided migration of Purkinje cell;134;139;GO:0048704
GO:0021943;formation of radial glial scaffolds;137;44;GO:0048666
GO:0008999;peptide-alanine-alpha-N-acetyltransferase activity;18325;245;GO:0006021
GO:0045933;positive regulation of muscle contraction;2162;563;GO:0048407
GO:0006337;nucleosome disassembly;2080;1490;GO:0000786
GO:0008998;ribonucleoside-triphosphate reductase activity;38161;77;GO:0003954
GO:0045934;negative regulation of nucleobase-containing compound metabolic process;1204300;1320;GO:0045941
GO:0006334;nucleosome assembly;47922;7950;GO:0000786
GO:0008997;ribonuclease R activity;2;126;GO:0004518
GO:0045931;positive regulation of mitotic cell cycle;8074;1880;GO:0045786
GO:0006335;DNA replication-dependent chromatin assembly;4363;735;GO:0006364
GO:0008996;ribonuclease G activity;2;0;GO:0004518
GO:0045932;negative regulation of muscle contraction;938;43;GO:0048407
GO:0033926;glycopeptide alpha-N-acetylgalactosaminidase activity;10174;27;GO:0004553
GO:0033925;mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity;9390;14;GO:0004553
GO:0033924;dextran 1,6-alpha-isomaltotriosidase activity;2;2;GO:0004553
GO:0008989;rRNA (guanine-N1-)-methyltransferase activity;1990;0;GO:0003729
GO:0033923;glucan 1,6-alpha-isomaltosidase activity;25;2;GO:0005929
GO:0033929;blood-group-substance endo-1,4-beta-galactosidase activity;6;2;GO:0004553
GO:0033928;mannan 1,4-mannobiosidase activity;1;2;GO:0005929
GO:0033927;glucan 1,4-alpha-maltohexaosidase activity;192;2;GO:0004553
GO:0018301;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl-L-cysteine persulfido-bis-L-glutamato-L-histidino tetrairon;0;7;GO:0005737
GO:0018303;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl-L-N3'-histidino tetrairon tetrasulfide;0;2;GO:0009086
GO:0033922;peptidoglycan beta-N-acetylmuramidase activity;16017;5;GO:0004553
GO:0018302;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl-L-N1'-histidino tetrairon tetrasulfide;0;2;GO:0009086
GO:0033921;capsular-polysaccharide endo-1,3-alpha-galactosidase activity;0;2;GO:0004553
GO:0018305;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl-L-serinyl tetrairon tetrasulfide;0;5;GO:0009086
GO:0033920;6-phospho-beta-galactosidase activity;4333;6;GO:0006032
GO:0018304;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl-L-aspartato tetrairon tetrasulfide;0;6;GO:0009086
GO:0021937;cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation;350;67;GO:0048608
GO:0045948;positive regulation of translational initiation;9908;456;GO:0006414
GO:0021938;smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation;230;28;GO:0048608
GO:0045949;positive regulation of phosphorus utilization;0;2;GO:0045735
GO:0070905;serine binding;586;230;GO:0019901
GO:0021939;extracellular matrix-granule cell signaling involved in regulation of granule cell precursor proliferation;0;2;GO:0048608
GO:0070902;mitochondrial tRNA pseudouridine synthesis;60;7;GO:0006519
GO:0045947;negative regulation of translational initiation;24473;1390;GO:0006414
GO:0070903;mitochondrial tRNA thio-modification;83;1;GO:0008033
GO:0021933;radial glia guided migration of cerebellar granule cell;50;8;GO:0048666
GO:0070908;tyrosine:tyramine antiporter activity;0;4;GO:0005215
GO:0021934;hindbrain tangential cell migration;139;14;GO:0048704
GO:0070909;glutamate:gamma-aminobutyric acid antiporter activity;0;1;GO:0005215
GO:0021935;cerebellar granule cell precursor tangential migration;48;2;GO:0048704
GO:0070906;aspartate:alanine antiporter activity;0;5;GO:0005215
GO:0021936;regulation of cerebellar granule cell precursor proliferation;597;4;GO:0048608
GO:0070907;histidine:histamine antiporter activity;0;3;GO:0005215
GO:0008962;phosphatidylglycerophosphatase activity;43651;146;GO:0004721
GO:0045940;positive regulation of steroid metabolic process;1434;231;GO:0045935
GO:0008961;phosphatidylglycerol-prolipoprotein diacylglyceryl transferase activity;162263;445;GO:0008631
GO:0021930;cerebellar granule cell precursor proliferation;1005;42;GO:0048699
GO:0008960;phosphatidylglycerol-membrane-oligosaccharide glycerophosphotransferase activity;3861;5;GO:0005576
GO:0021931;rostral hindbrain neuronal precursor cell proliferation;0;2;GO:0048699
GO:0021932;hindbrain radial glia guided cell migration;375;8;GO:0048699
GO:0006303;double-strand break repair via nonhomologous end joining;60997;3980;GO:0006281
GO:0008966;phosphoglucosamine mutase activity;126630;483;GO:0006032
GO:0045944;positive regulation of transcription by RNA polymerase II;258738;5970;GO:0045944
GO:0006304;DNA modification;1131764;1990;GO:0006259
GO:0008965;phosphoenolpyruvate-protein phosphotransferase activity;77879;9;GO:0004723
GO:0045945;positive regulation of transcription by RNA polymerase III;896;122;GO:0045944
GO:0006301;postreplication repair;21724;2380;GO:0006281
GO:0008964;phosphoenolpyruvate carboxylase activity;100862;694;GO:0006099
GO:0045942;negative regulation of phosphorus utilization;0;2;GO:0045735
GO:0006302;double-strand break repair;292209;4600;GO:0006281
GO:0008963;phospho-N-acetylmuramoyl-pentapeptide-transferase activity;119021;1010;GO:0004553
GO:0045943;positive regulation of transcription by RNA polymerase I;2050;160;GO:0045944
GO:0008959;phosphate acetyltransferase activity;33368;47;GO:0004073
GO:0033915;mannan 1,2-(1,3)-alpha-mannosidase activity;0;0;GO:0004553
GO:0033914;xylan 1,3-beta-xylosidase activity;24;1;GO:0004553
GO:0008957;phenylacetaldehyde dehydrogenase activity;1031;5;GO:0004067
GO:0033913;glucan endo-1,2-beta-glucosidase activity;3;3;GO:0004553
GO:0033912;2,6-beta-fructan 6-levanbiohydrolase activity;88;2;GO:0004553
GO:0033919;glucan 1,3-alpha-glucosidase activity;233;9;GO:0004553
GO:0033918;kappa-carrageenase activity;265;5;GO:0004553
GO:0033917;exo-poly-alpha-galacturonosidase activity;446;3;GO:0004553
GO:0033916;beta-agarase activity;701;1;GO:0005929
GO:0033911;mycodextranase activity;3;1;GO:0004553
GO:0070900;mitochondrial tRNA modification;693;31;GO:0006519
GO:0033910;glucan 1,4-alpha-maltotetraohydrolase activity;18;3;GO:0004553
GO:0070901;mitochondrial tRNA methylation;292;18;GO:0006519
GO:0021926;Golgi cell precursor proliferation;0;2;GO:0048608
GO:0045959;negative regulation of complement activation, classical pathway;193;213;GO:0006958
GO:0021927;deep nuclear neuron precursor proliferation;0;2;GO:0048699
GO:0021928;basket cell precursor proliferation;0;2;GO:0048608
GO:0045957;negative regulation of complement activation, alternative pathway;81;9;GO:0006958
GO:0021929;stellate cell precursor proliferation;0;1;GO:0048608
GO:0045958;positive regulation of complement activation, alternative pathway;2;8;GO:0006958
GO:0021922;Wnt signaling pathway involved in regulation of cell proliferation in dorsal spinal cord;0;3;GO:0048704
GO:0021923;cell proliferation in hindbrain ventricular zone;34;1;GO:0042127
GO:0021924;cell proliferation in external granule layer;1045;12;GO:0042127
GO:0021925;cerebellar Purkinje cell precursor proliferation;0;2;GO:0048608
GO:0006310;DNA recombination;3756897;8950;GO:0006310
GO:0008973;phosphopentomutase activity;53234;103;GO:0004721
GO:0045951;positive regulation of mitotic recombination;198;8;GO:0048285
GO:0006311;meiotic gene conversion;112;35;GO:0007040
GO:0008972;phosphomethylpyrimidine kinase activity;57512;377;GO:0004721
GO:0045952;regulation of juvenile hormone catabolic process;0;2;GO:0010468
GO:0008970;phospholipase A1 activity;19501;44;GO:0004601
GO:0021921;regulation of cell proliferation in dorsal spinal cord;1;1;GO:0042127
GO:0033909;fucoidanase activity;0;1;GO:0004553
GO:0045950;negative regulation of mitotic recombination;339;290;GO:0048285
GO:0006314;intron homing;366;5;GO:0003700
GO:0008977;prephenate dehydrogenase (NAD+) activity;98882;0;GO:0006066
GO:0045955;negative regulation of calcium ion-dependent exocytosis;215;312;GO:0048608
GO:0006315;homing of group II introns;100;5;GO:0003700
GO:0008976;polyphosphate kinase activity;182112;211;GO:0005524
GO:0045956;positive regulation of calcium ion-dependent exocytosis;504;2320;GO:0048608
GO:0006312;mitotic recombination;3246;2540;GO:0000786
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;622;181;GO:0045087
GO:0006313;DNA transposition;531200;223;GO:0006259
GO:0008974;phosphoribulokinase activity;19859;63;GO:0004721
GO:0045954;positive regulation of natural killer cell mediated cytotoxicity;2658;875;GO:0046649
GO:0006307;DNA dealkylation involved in DNA repair;47210;758;GO:0006281
GO:0033904;dextranase activity;96;2;GO:0004553
GO:0006308;DNA catabolic process;186904;1880;GO:0006281
GO:0006305;DNA alkylation;703769;647;GO:0006974
GO:0008968;D-sedoheptulose 7-phosphate isomerase activity;36123;239;GO:0006099
GO:0033902;rRNA endonuclease activity;3;3;GO:0003729
GO:0006306;DNA methylation;703769;4030;GO:0003676
GO:0008967;phosphoglycolate phosphatase activity;53425;526;GO:0006067
GO:0033901;ribonuclease V activity;0;2;GO:0004518
GO:0033908;beta-L-rhamnosidase activity;0;2;GO:0004553
GO:0033907;beta-D-fucosidase activity;730;8;GO:0004553
GO:0006309;apoptotic DNA fragmentation;2537;493;GO:0008219
GO:0033906;hyaluronoglucuronidase activity;169;110;GO:0004553
GO:0033905;xylan endo-1,3-beta-xylosidase activity;73;4;GO:0004553
GO:0033900;ribonuclease F activity;0;2;GO:0004518
GO:0006361;transcription initiation at RNA polymerase I promoter;15557;17;GO:0006364
GO:0021999;neural plate anterior/posterior regionalization;431;18;GO:0009952
GO:0033980;phosphonopyruvate decarboxylase activity;2925;4;GO:0006099
GO:0006362;transcription elongation by RNA polymerase I;923;23;GO:0006364
GO:0006360;transcription by RNA polymerase I;48222;302;GO:0006364
GO:0021995;neuropore closure;5;8;GO:0048666
GO:0006366;transcription by RNA polymerase II;1920094;1930;GO:0006351
GO:0021996;lamina terminalis formation;0;2;GO:0048704
GO:0006363;termination of RNA polymerase I transcription;850;833;GO:0006364
GO:0021997;neural plate axis specification;102;156;GO:0009952
GO:0006364;rRNA processing;3403520;12500;GO:0006364
GO:0021998;neural plate mediolateral regionalization;53;9;GO:0009952
GO:0006369;termination of RNA polymerase II transcription;6610;1460;GO:0000981
GO:0021991;neural plate thickening;0;1;GO:0048704
GO:0021992;cell proliferation involved in neural plate elongation;0;3;GO:0048608
GO:0006367;transcription initiation at RNA polymerase II promoter;69243;201;GO:0006366
GO:0021993;initiation of neural tube closure;45;43;GO:0007530
GO:0006368;transcription elongation by RNA polymerase II;121350;173;GO:0006364
GO:0021994;progression of neural tube closure;0;4;GO:0007530
GO:0031318;detection of folic acid;1;2;GO:0007565
GO:0031319;detection of cAMP;0;4;GO:0007623
GO:0031316;extrinsic component of nuclear outer membrane;0;1;GO:0005635
GO:0033979;box H/ACA RNA metabolic process;240;3;GO:0006418
GO:0031317;tripartite ATP-independent periplasmic transporter complex;17367;104;GO:0015986
GO:0033978;phosphonopyruvate hydrolase activity;91;4;GO:0004553
GO:0018352;protein-pyridoxal-5-phosphate linkage;36;22;GO:0006468
GO:0033973;dCTP deaminase (dUMP-forming) activity;17821;5;GO:0003906
GO:0018353;protein-phycocyanobilin linkage via S-phycocyanobilin-L-cysteine;0;3;GO:0046395
GO:0033972;proclavaminate amidinohydrolase activity;143;4;GO:0004721
GO:0018356;protein-phycobiliviolin linkage via S-phycobiliviolin-L-cysteine;0;3;GO:0005576
GO:0033971;hydroxyisourate hydrolase activity;41285;9;GO:0004553
GO:0018355;protein-phosphoribosyl dephospho-coenzyme A linkage via O-(phosphoribosyl dephospho-coenzyme A)-L-serine;0;0;GO:0006457
GO:0033970;N-malonylurea hydrolase activity;0;4;GO:0004730
GO:0018358;protein-phytochromobilin linkage via S-phytochromobilin-L-cysteine;0;3;GO:0005576
GO:0031314;extrinsic component of mitochondrial inner membrane;12892;190;GO:0005743
GO:0033977;2-haloacid dehalogenase (configuration-retaining) activity;1;3;GO:0004721
GO:0018357;protein-phycourobilin linkage via phycourobilin-bis-L-cysteine;0;3;GO:0046395
GO:0031315;extrinsic component of mitochondrial outer membrane;45;19;GO:0005743
GO:0033976;2-haloacid dehalogenase (configuration-inverting) activity;0;1;GO:0004721
GO:0031312;extrinsic component of organelle membrane;14817;217;GO:0005737
GO:0033975;(R)-2-haloacid dehalogenase activity;17;0;GO:0004497
GO:0018359;protein-heme P460 linkage via heme P460-bis-L-cysteine-L-tyrosine;0;3;GO:0005525
GO:0031313;extrinsic component of endosome membrane;183;113;GO:0005768
GO:0033974;nucleoside phosphoacylhydrolase activity;1;3;GO:0004721
GO:0018339;peptidyl-L-beta-methylthioaspartic acid biosynthetic process from peptidyl-aspartic acid;27;713;GO:0009065
GO:0021988;olfactory lobe development;2054;41;GO:0007613
GO:0021989;olfactory cortex development;42;5;GO:0048666
GO:0006370;7-methylguanosine mRNA capping;251079;1280;GO:0006412
GO:0006376;mRNA splice site recognition;45064;355;GO:0000398
GO:0021984;adenohypophysis development;1338;199;GO:0007548
GO:0021985;neurohypophysis development;160;9;GO:0007565
GO:0021986;habenula development;581;53;GO:0048704
GO:0021987;cerebral cortex development;6483;2920;GO:0007420
GO:0021980;subpallium cell migration;0;2;GO:0048608
GO:0021981;subpallium radially oriented migration;0;2;GO:0048608
GO:0006378;mRNA polyadenylation;29843;2180;GO:0000786
GO:0021982;pineal gland development;128;5;GO:0007530
GO:0021983;pituitary gland development;3003;800;GO:0007520
GO:0033969;gamma-glutamyl-gamma-aminobutyrate hydrolase activity;901;6;GO:0004553
GO:0033968;glutaryl-7-aminocephalosporanic-acid acylase activity;88;3;GO:0004467
GO:0021990;neural plate formation;6;3;GO:0007423
GO:0033967;box C/D RNA metabolic process;510;0;GO:0010467
GO:0018341;peptidyl-lysine modification to peptidyl-N6-pyruvic acid 2-iminyl-L-lysine;0;2;GO:0006468
GO:0018340;peptidyl-O-(sn-1-glycerophosphoryl)-L-serine biosynthetic process from peptidyl-serine;0;0;GO:0009061
GO:0018343;protein farnesylation;32;56;GO:0006457
GO:0033962;P-body assembly;4459;262;GO:0048193
GO:0018342;protein prenylation;182;682;GO:0006639
GO:0033961;cis-stilbene-oxide hydrolase activity;4735;93;GO:0004553
GO:0018345;protein palmitoylation;371;830;GO:0006464
GO:0033960;N-methyl nucleosidase activity;0;2;GO:0004553
GO:0018344;protein geranylgeranylation;133;330;GO:0006464
GO:0033966;N-substituted formamide deformylase activity;2;3;GO:0009081
GO:0033965;aculeacin-A deacylase activity;0;4;GO:0004867
GO:0033964;glycosphingolipid deacylase activity;2;2;GO:0004553
GO:0033963;cholesterol-5,6-oxide hydrolase activity;6;2;GO:0004746
GO:0045904;negative regulation of translational termination;0;4;GO:0006414
GO:0045905;positive regulation of translational termination;14228;513;GO:0006414
GO:0045902;negative regulation of translational fidelity;0;5;GO:0006414
GO:0045903;positive regulation of translational fidelity;205;88;GO:0006414
GO:0021977;tectospinal tract morphogenesis;0;2;GO:0048704
GO:0021978;telencephalon regionalization;668;102;GO:0007420
GO:0021979;hypothalamus cell differentiation;635;37;GO:0048608
GO:0045906;negative regulation of vasoconstriction;286;374;GO:0050731
GO:0045907;positive regulation of vasoconstriction;1791;2450;GO:0050731
GO:0021973;corticospinal neuron axon decussation;0;3;GO:0048704
GO:0021974;trigeminothalamic tract morphogenesis;0;1;GO:0048704
GO:0021975;pons reticulospinal tract morphogenesis;0;2;GO:0048704
GO:0021976;medulla reticulospinal tract morphogenesis;0;2;GO:0048704
GO:0045900;negative regulation of translational elongation;52558;286;GO:0006414
GO:0021970;corticospinal neuron axon guidance through the basilar pons;0;1;GO:0048704
GO:0045901;positive regulation of translational elongation;14916;262;GO:0045944
GO:0021971;corticospinal neuron axon guidance through the medullary pyramid;0;2;GO:0048704
GO:0006346;DNA methylation-dependent heterochromatin formation;7099;25;GO:0016569
GO:0021972;corticospinal neuron axon guidance through spinal cord;52;7;GO:0048704
GO:0033959;deoxyribodipyrimidine endonucleosidase activity;20;2;GO:0004518
GO:0033958;DNA-deoxyinosine glycosylase activity;10588;5;GO:0004518
GO:0006338;chromatin remodeling;1309241;7010;GO:0043062
GO:0033957;lambda-carrageenase activity;22;4;GO:0004553
GO:0033956;beta-apiosyl-beta-glucosidase activity;7;4;GO:0004553
GO:0033951;oligosaccharide reducing-end xylanase activity;103;1;GO:0004553
GO:0033950;xyloglucan-specific exo-beta-1,4-glucanase activity;8;2;GO:0004553
GO:0018336;peptidyl-tyrosine hydroxylation;0;3;GO:0004714
GO:0018335;protein succinylation;27;2;GO:0006464
GO:0033954;alpha-neoagaro-oligosaccharide hydrolase activity;3;2;GO:0004553
GO:0033953;alpha-agarase activity;122;2;GO:0005576
GO:0033952;iota-carrageenase activity;32;2;GO:0004553
GO:0045915;positive regulation of catecholamine metabolic process;184;9;GO:0045944
GO:0018317;protein C-linked glycosylation via tryptophan;3;59;GO:0006486
GO:0045916;negative regulation of complement activation;662;523;GO:0006958
GO:0045913;positive regulation of carbohydrate metabolic process;5738;136;GO:0046394
GO:0045914;negative regulation of catecholamine metabolic process;32;6;GO:0045935
GO:0021966;corticospinal neuron axon guidance;94;23;GO:0048704
GO:0045919;positive regulation of cytolysis;0;78;GO:0045087
GO:0006351;DNA-templated transcription;28812283;5380;GO:0006351
GO:0021967;corticospinal neuron axon guidance through the cerebral cortex;0;3;GO:0048666
GO:0021968;corticospinal neuron axon guidance through the internal capsule;0;3;GO:0048704
GO:0045917;positive regulation of complement activation;178;73;GO:0006958
GO:0021969;corticospinal neuron axon guidance through the cerebral peduncle;0;4;GO:0048704
GO:0045918;negative regulation of cytolysis;2;86;GO:0045087
GO:0006354;DNA-templated transcription elongation;409538;782;GO:0006364
GO:0021962;vestibulospinal tract morphogenesis;0;1;GO:0048704
GO:0006355;regulation of DNA-templated transcription;23193868;11100;GO:0006355
GO:0021963;spinothalamic tract morphogenesis;1;3;GO:0048704
GO:0006352;DNA-templated transcription initiation;2961137;3260;GO:0006351
GO:0021964;rubrospinal tract morphogenesis;0;2;GO:0048704
GO:0006353;DNA-templated transcription termination;798213;2640;GO:0006366
GO:0021965;spinal cord ventral commissure morphogenesis;131;47;GO:0048704
GO:0045911;positive regulation of DNA recombination;3952;124;GO:0045727
GO:0006359;regulation of transcription by RNA polymerase III;7432;142;GO:0006351
GO:0045912;negative regulation of carbohydrate metabolic process;7597;71;GO:0045735
GO:0006356;regulation of transcription by RNA polymerase I;3041;249;GO:0006351
GO:0021960;anterior commissure morphogenesis;408;35;GO:0048704
GO:0006357;regulation of transcription by RNA polymerase II;1681500;7790;GO:0006355
GO:0021961;posterior commissure morphogenesis;1;1;GO:0048704
GO:0045910;negative regulation of DNA recombination;24634;1620;GO:0045944
GO:0033948;fructan beta-(2,1)-fructosidase activity;10;0;GO:0005986
GO:0033947;mannosylglycoprotein endo-beta-mannosidase activity;34;5;GO:0006029
GO:0033946;xyloglucan-specific endo-beta-1,4-glucanase activity;85;7;GO:0004553
GO:0033945;oligoxyloglucan reducing-end-specific cellobiohydrolase activity;6;4;GO:0004553
GO:0033949;fructan beta-(2,6)-fructosidase activity;3;0;GO:0005986
GO:0018321;protein glucuronylation;0;2;GO:0006469
GO:0033940;glucuronoarabinoxylan endo-1,4-beta-xylanase activity;169;2;GO:0004553
GO:0033944;beta-galactofuranosidase activity;0;2;GO:0004553
GO:0033943;galactan 1,3-beta-galactosidase activity;9;3;GO:0004553
GO:0033942;4-alpha-D-(1->4)-alpha-D-glucanotrehalose trehalohydrolase activity;9083;0;GO:0004553
GO:0033941;mannan exo-1,2-1,6-alpha-mannosidase activity;0;1;GO:0004553
GO:0070849;response to epidermal growth factor;1948;470;GO:0048608
GO:0006281;DNA repair;5995636;19700;GO:0006281
GO:0043229;intracellular organelle;68680432;5980;GO:0043226
GO:0070847;core mediator complex;2297;160;GO:0005829
GO:0070848;response to growth factor;105641;1700;GO:0048608
GO:0006284;base-excision repair;437044;3940;GO:0006284
GO:0031240;external side of cell outer membrane;9;132;GO:0009986
GO:0006285;base-excision repair, AP site formation;23968;879;GO:0004553
GO:0031241;periplasmic side of cell outer membrane;4638;7;GO:0016021
GO:0006282;regulation of DNA repair;91431;1820;GO:0006281
GO:0006283;transcription-coupled nucleotide-excision repair;44258;2000;GO:0006281
GO:0006288;base-excision repair, DNA ligation;132;55;GO:0004553
GO:0006289;nucleotide-excision repair;403706;4980;GO:0006281
GO:0043221;SMC family protein binding;3;1;GO:0005515
GO:0045886;negative regulation of synaptic assembly at neuromuscular junction;561;4;GO:0048666
GO:0043224;nuclear SCF ubiquitin ligase complex;194;91;GO:0005634
GO:0045883;positive regulation of sulfur utilization;2;2;GO:0046395
GO:0006287;base-excision repair, gap-filling;575;472;GO:0043154
GO:0043223;cytoplasmic SCF ubiquitin ligase complex;6;1;GO:0005829
GO:0043226;organelle;70524527;10500;GO:0005739
GO:0043225;ATPase-coupled inorganic anion transmembrane transporter activity;105287;51;GO:0008544
GO:0043228;non-membrane-bounded organelle;35877019;3000;GO:0005739
GO:0045887;positive regulation of synaptic assembly at neuromuscular junction;540;6;GO:0048666
GO:0043227;membrane-bounded organelle;35993536;4860;GO:0043226
GO:0018271;biotin-protein ligase activity;99714;39;GO:0004812
GO:0018270;GPI anchor biosynthetic process via N-alanyl-glycosylphosphatidylinositolethanolamine;0;3;GO:0006631
GO:0045892;negative regulation of DNA-templated transcription;1018160;5370;GO:0006355
GO:0018272;protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine;8;10;GO:0005524
GO:0045893;positive regulation of DNA-templated transcription;774793;4730;GO:0006355
GO:0018275;N-terminal peptidyl-cysteine acetylation;0;3;GO:0006464
GO:0043231;intracellular membrane-bounded organelle;35521413;12600;GO:0043231
GO:0018274;peptide cross-linking via L-lysinoalanine;0;6;GO:0009065
GO:0043230;extracellular organelle;9186;896;GO:0005783
GO:0018277;protein deamination;10;28;GO:0006457
GO:0033896;ribonuclease IX activity;0;3;GO:0004518
GO:0070841;inclusion body assembly;997;155;GO:0043161
GO:0031234;extrinsic component of cytoplasmic side of plasma membrane;20369;1520;GO:0005576
GO:0033895;ribonuclease [poly-(U)-specific] activity;0;0;GO:0004518
GO:0070842;aggresome assembly;288;82;GO:0007088
GO:0018279;protein N-linked glycosylation via asparagine;829;1870;GO:0006486
GO:0033894;ribonuclease P4 activity;0;3;GO:0003723
GO:0018278;N-terminal peptidyl-threonine deamination;0;4;GO:0006486
GO:0031232;extrinsic component of external side of plasma membrane;20;225;GO:0016021
GO:0033893;ribonuclease IV activity;0;3;GO:0004518
GO:0070840;dynein complex binding;10048;683;GO:0005515
GO:0070845;polyubiquitinated misfolded protein transport;46;28;GO:0006986
GO:0033899;ribonuclease U2 activity;1;1;GO:0003723
GO:0070846;Hsp90 deacetylation;0;87;GO:0016570
GO:0033898;Bacillus subtilis ribonuclease activity;7;2;GO:0004553
GO:0070843;misfolded protein transport;163;23;GO:0006986
GO:0031236;extrinsic component of periplasmic side of plasma membrane;0;1;GO:0016021
GO:0033897;ribonuclease T2 activity;22962;222;GO:0004518
GO:0070844;polyubiquitinated protein transport;46;9;GO:0007049
GO:0070836;caveola assembly;4742;291;GO:0005576
GO:0006290;pyrimidine dimer repair;1271;361;GO:0007049
GO:0070837;dehydroascorbic acid transport;896;244;GO:0006826
GO:0033892;deoxyribonuclease (pyrimidine dimer) activity;46;2;GO:0004518
GO:0033891;CC-preferring endodeoxyribonuclease activity;0;2;GO:0004518
GO:0006293;nucleotide-excision repair, preincision complex stabilization;0;133;GO:0007031
GO:0033890;ribonuclease D activity;30918;6;GO:0004518
GO:0006294;nucleotide-excision repair, preincision complex assembly;198;127;GO:0000724
GO:0043233;organelle lumen;1805281;5020;GO:0005737
GO:0043232;intracellular non-membrane-bounded organelle;34500926;5270;GO:0043226
GO:0006297;nucleotide-excision repair, DNA gap filling;682;2400;GO:0006281
GO:0043235;receptor complex;65274;3870;GO:0004872
GO:0045894;negative regulation of mating-type specific transcription, DNA-templated;4;3;GO:0010468
GO:0006298;mismatch repair;256038;4810;GO:0005943
GO:0045895;positive regulation of mating-type specific transcription, DNA-templated;1585;6;GO:0048285
GO:0043237;laminin-1 binding;290;69;GO:0005576
GO:0043236;laminin binding;3321;1180;GO:0005576
GO:0045898;regulation of RNA polymerase II transcription preinitiation complex assembly;1044;4;GO:0000976
GO:0045899;positive regulation of RNA polymerase II transcription preinitiation complex assembly;747;135;GO:0045944
GO:0018260;protein guanylylation;5;3;GO:0006464
GO:0018262;isopeptide cross-linking;19;62;GO:0006461
GO:0043240;Fanconi anaemia nuclear complex;11740;419;GO:0005524
GO:0018261;peptidyl-lysine guanylylation;0;3;GO:0016567
GO:0043242;negative regulation of protein-containing complex disassembly;344324;69;GO:0048193
GO:0018266;GPI anchor biosynthetic process via N-aspartyl-glycosylphosphatidylinositolethanolamine;0;4;GO:0006631
GO:0031222;arabinan catabolic process;8135;30;GO:0006073
GO:0033885;10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity;20;0;GO:0004721
GO:0070830;bicellular tight junction assembly;3502;764;GO:0005929
GO:0018265;GPI anchor biosynthetic process via N-asparaginyl-glycosylphosphatidylinositolethanolamine;0;4;GO:0006631
GO:0031223;auditory behavior;486;1930;GO:0007631
GO:0070831;basement membrane assembly;725;65;GO:0030062
GO:0018268;GPI anchor biosynthetic process via N-glycyl-glycosylphosphatidylinositolethanolamine;0;5;GO:0006631
GO:0031220;maltodextrin phosphorylase activity;2;3;GO:0006029
GO:0033883;pyridoxal phosphatase activity;1320;134;GO:0004721
GO:0018267;GPI anchor biosynthetic process via N-cysteinyl-glycosylphosphatidylinositolethanolamine;0;4;GO:0006631
GO:0031221;arabinan metabolic process;10431;9;GO:0006073
GO:0033882;choloyl-CoA hydrolase activity;131;8;GO:0004733
GO:0033889;N-sulfoglucosamine-3-sulfatase activity;111;3;GO:0004553
GO:0070834;phosphatidylcholine biosynthesis from phosphoryl-ethanolamine via N-dimethylethanolamine phosphate and CDP-N-dimethylethanolamine;0;2;GO:0006631
GO:0018269;GPI anchor biosynthetic process via N-seryl-glycosylphosphatidylinositolethanolamine;0;4;GO:0006631
GO:0033888;chondro-6-sulfatase activity;0;3;GO:0004553
GO:0070835;chromium ion transmembrane transporter activity;1;2;GO:0005215
GO:0033887;chondro-4-sulfatase activity;0;3;GO:0004553
GO:0070832;phosphatidylcholine biosynthesis from phosphoryl-ethanolamine via N-dimethylethanolamine phosphate and CDP-choline;4;2;GO:0006631
GO:0033886;cellulose-polysulfatase activity;0;1;GO:0004553
GO:0070833;phosphatidylcholine biosynthesis from phosphoryl-ethanolamine via CDP-N-methylethanolamine;0;2;GO:0006631
GO:0033881;bile-acid-CoA transferase activity;58;2;GO:0004497
GO:0033880;phenylacetyl-CoA hydrolase activity;1;2;GO:0046395
GO:0006260;DNA replication;3663556;15900;GO:0006260
GO:0006261;DNA-templated DNA replication;1129177;1020;GO:0006260
GO:0006266;DNA ligation;6977;1420;GO:0006364
GO:0021896;forebrain astrocyte differentiation;106;7;GO:0048667
GO:0043244;regulation of protein-containing complex disassembly;435583;89;GO:0048193
GO:0006267;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;1342;337;GO:0007049
GO:0021897;forebrain astrocyte development;106;27;GO:0048667
GO:0043243;positive regulation of protein-containing complex disassembly;19017;68;GO:0048193
GO:0006264;mitochondrial DNA replication;3411;995;GO:0006260
GO:0021898;commitment of multipotent stem cells to neuronal lineage in forebrain;76;9;GO:0048704
GO:0043246;megasome;0;1;GO:0048706
GO:0006265;DNA topological change;539773;4030;GO:0006325
GO:0021899;fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment;38;3;GO:0048608
GO:0043245;extraorganismal space;37;10;GO:0005615
GO:0021892;cerebral cortex GABAergic interneuron differentiation;574;162;GO:0048666
GO:0043248;proteasome assembly;29741;3900;GO:0000502
GO:0021893;cerebral cortex GABAergic interneuron fate commitment;111;44;GO:0048666
GO:0043247;telomere maintenance in response to DNA damage;2316;196;GO:0007050
GO:0006268;DNA unwinding involved in DNA replication;78952;3140;GO:0003674
GO:0021894;cerebral cortex GABAergic interneuron development;252;97;GO:0048666
GO:0006269;DNA replication, synthesis of RNA primer;505561;1980;GO:0006260
GO:0021895;cerebral cortex neuron differentiation;1303;501;GO:0048699
GO:0043249;erythrocyte maturation;1914;982;GO:0007599
GO:0031219;levanase activity;169;4;GO:0004553
GO:0031217;glucan 1,4-beta-glucosidase activity;54;5;GO:0004553
GO:0031218;arabinogalactan endo-1,4-beta-galactosidase activity;5742;1;GO:0004553
GO:0033879;acetylajmaline esterase activity;8;2;GO:0004497
GO:0018251;peptidyl-tyrosine dehydrogenation;0;3;GO:0006468
GO:0043251;sodium-dependent organic anion transport;6;3;GO:0015075
GO:0018250;peptidyl-dehydroalanine biosynthetic process from peptidyl-tyrosine or peptidyl-serine;0;4;GO:0009065
GO:0043250;sodium-dependent organic anion transmembrane transporter activity;6;3;GO:0015075
GO:0070860;RNA polymerase I core factor complex;3369;10;GO:0000976
GO:0018253;peptide cross-linking via 5-imidazolinone glycine;0;4;GO:0046395
GO:0043253;chloroplast ribosome;43;3;GO:0005840
GO:0043252;sodium-independent organic anion transport;406;430;GO:0015717
GO:0031211;endoplasmic reticulum palmitoyltransferase complex;1007;31;GO:0005783
GO:0033874;scymnol sulfotransferase activity;0;3;GO:0004730
GO:0070863;positive regulation of protein exit from endoplasmic reticulum;1137;84;GO:0010467
GO:0018254;peptidyl-tyrosine adenylylation;0;3;GO:0006468
GO:0033873;petromyzonol sulfotransferase activity;0;2;GO:0004730
GO:0070864;sperm individualization complex;127;6;GO:0008021
GO:0018257;peptidyl-lysine formylation;0;4;GO:0006468
GO:0033872;[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity;11;0;GO:0004553
GO:0070861;regulation of protein exit from endoplasmic reticulum;1763;64;GO:0006464
GO:0018256;protein formylation;0;3;GO:0006493
GO:0031210;phosphatidylcholine binding;1881;522;GO:0048193
GO:0033871;[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity;3;0;GO:0004553
GO:0070862;negative regulation of protein exit from endoplasmic reticulum;561;64;GO:0010467
GO:0018259;RNA-protein covalent cross-linking via peptidyl-serine;1;4;GO:0009063
GO:0031215;shell calcification;14;3;GO:0009579
GO:0033878;hormone-sensitive lipase activity;794;41;GO:0004784
GO:0070867;mating projection tip membrane;26;4;GO:0048305
GO:0018258;protein O-linked glycosylation via hydroxyproline;9;1;GO:0006493
GO:0031216;neopullulanase activity;1236;2;GO:0004553
GO:0033877;succinyl-CoA:(R)-benzylsuccinate CoA-transferase activity;635;0;GO:0006081
GO:0031213;RSF complex;4486;35;GO:0048471
GO:0033876;glycochenodeoxycholate sulfotransferase activity;0;3;GO:0004721
GO:0070865;investment cone;59;8;GO:0048608
GO:0031214;biomineral tissue development;14711;1360;GO:0048608
GO:0033875;ribonucleoside bisphosphate metabolic process;1232444;172;GO:0006790
GO:0070866;sterol-dependent protein binding;0;0;GO:0042803
GO:0006270;DNA replication initiation;192632;7320;GO:0006260
GO:0070858;negative regulation of bile acid biosynthetic process;192;39;GO:0010467
GO:0070859;positive regulation of bile acid biosynthetic process;180;172;GO:0045934
GO:0006273;lagging strand elongation;28034;348;GO:0007067
GO:0021889;olfactory bulb interneuron differentiation;487;56;GO:0048608
GO:0033870;thiol sulfotransferase activity;0;3;GO:0004734
GO:0006274;DNA replication termination;8474;55;GO:0006260
GO:0006271;DNA strand elongation involved in DNA replication;38107;2930;GO:0006260
GO:0006272;leading strand elongation;861;423;GO:0007049
GO:0006277;DNA amplification;191;153;GO:0007050
GO:0021885;forebrain cell migration;3587;195;GO:0048699
GO:0043255;regulation of carbohydrate biosynthetic process;12127;334;GO:0009405
GO:0006278;RNA-templated DNA biosynthetic process;1605921;31;GO:0006139
GO:0021886;hypothalamus gonadotrophin-releasing hormone neuron differentiation;431;21;GO:0048608
GO:0043254;regulation of protein-containing complex assembly;115648;444;GO:0048193
GO:0006275;regulation of DNA replication;157190;3150;GO:0006261
GO:0021887;hypothalamus gonadotrophin-releasing hormone neuron fate commitment;0;3;GO:0048608
GO:0043257;laminin-8 complex;59;93;GO:0048407
GO:0006276;plasmid maintenance;11064;75;GO:0048304
GO:0021888;hypothalamus gonadotrophin-releasing hormone neuron development;431;107;GO:0048608
GO:0043256;laminin complex;917;142;GO:0030198
GO:0021881;Wnt-activated signaling pathway involved in forebrain neuron fate commitment;0;4;GO:0007631
GO:0043259;laminin-10 complex;146;211;GO:0005576
GO:0043258;laminin-9 complex;0;1;GO:0048407
GO:0006279;premeiotic DNA replication;857;10;GO:0006260
GO:0021884;forebrain neuron development;1271;376;GO:0048699
GO:0031208;POZ domain binding;280;73;GO:0005515
GO:0031209;SCAR complex;2492;337;GO:0005576
GO:0021890;olfactory bulb interneuron fate commitment;0;2;GO:0048608
GO:0033869;nucleoside bisphosphate catabolic process;7524;6;GO:0009062
GO:0043260;laminin-11 complex;3;34;GO:0048407
GO:0021891;olfactory bulb interneuron development;241;34;GO:0048608
GO:0031207;Sec62/Sec63 complex;1617;77;GO:0005765
GO:0018240;protein S-linked glycosylation via cysteine;2;2;GO:0006486
GO:0043262;ADP phosphatase activity;271;2;GO:0004723
GO:0043261;laminin-12 complex;0;1;GO:0030199
GO:0018242;protein O-linked glycosylation via serine;74;166;GO:0006493
GO:0043264;extracellular non-membrane-bounded organelle;12;3;GO:0005615
GO:0018241;protein O-linked glycosylation via hydroxylysine;0;1;GO:0006493
GO:0043263;cellulosome;3;7;GO:0005576
GO:0018244;protein N-linked glycosylation via tryptophan;0;3;GO:0006486
GO:0033863;ribose 1,5-bisphosphate phosphokinase activity;17266;9;GO:0006096
GO:0070852;cell body fiber;100;221;GO:0043005
GO:0018243;protein O-linked glycosylation via threonine;142;85;GO:0006486
GO:0031201;SNARE complex;7992;1510;GO:0008023
GO:0033862;UMP kinase activity;107652;650;GO:0004721
GO:0070853;myosin VI binding;181;3;GO:0005524
GO:0018246;protein-coenzyme A linkage;0;4;GO:0008544
GO:0033861;negative regulation of NAD(P)H oxidase activity;2;49;GO:0046323
GO:0070850;TACC/TOG complex;10;1;GO:0005819
GO:0018245;protein O-linked glycosylation via tyrosine;0;1;GO:0006486
GO:0033860;regulation of NAD(P)H oxidase activity;14;10;GO:0004722
GO:0070851;growth factor receptor binding;21374;1150;GO:0048407
GO:0031204;post-translational protein targeting to membrane, translocation;2735;322;GO:0006464
GO:0033867;Fas-activated serine/threonine kinase activity;3;26;GO:0004713
GO:0070856;myosin VI light chain binding;60;1;GO:0005524
GO:0018247;protein-phosphoribosyl dephospho-coenzyme A linkage;0;4;GO:0006457
GO:0031205;endoplasmic reticulum Sec complex;1621;128;GO:0005783
GO:0033866;nucleoside bisphosphate biosynthetic process;971748;248;GO:0006730
GO:0070857;regulation of bile acid biosynthetic process;594;620;GO:0010467
GO:0033865;nucleoside bisphosphate metabolic process;1232766;482;GO:0006796
GO:0070854;myosin VI heavy chain binding;11;1;GO:0005524
GO:0018249;protein dehydration;1;3;GO:0006457
GO:0031203;post-translational protein targeting to membrane, docking;0;0;GO:0006612
GO:0033864;positive regulation of NAD(P)H oxidase activity;11;95;GO:0046332
GO:0070855;myosin VI head/neck binding;10;1;GO:0005524
GO:0031280;negative regulation of cyclase activity;24;90;GO:0010468
GO:0045849;negative regulation of nurse cell apoptotic process;33;1;GO:0010941
GO:0070805;regulation of phialide development;1;1;GO:0048405
GO:0031281;positive regulation of cyclase activity;168;569;GO:0010468
GO:0070806;negative regulation of phialide development;0;0;GO:0048405
GO:0045847;negative regulation of nitrogen utilization;0;2;GO:0046394
GO:0070803;negative regulation of metula development;0;1;GO:0048608
GO:0045848;positive regulation of nitrogen utilization;73;3;GO:0046394
GO:0070804;positive regulation of metula development;0;2;GO:0048608
GO:0031284;positive regulation of guanylate cyclase activity;32;497;GO:0048010
GO:0070809;negative regulation of Hulle cell development;1;1;GO:0050727
GO:0031285;regulation of sorocarp stalk cell differentiation;44;3;GO:0048468
GO:0031282;regulation of guanylate cyclase activity;36;956;GO:0005096
GO:0070807;positive regulation of phialide development;1;2;GO:0048707
GO:0031283;negative regulation of guanylate cyclase activity;3;14;GO:0008026
GO:0070808;regulation of Hulle cell development;1;1;GO:0050727
GO:0045841;negative regulation of mitotic metaphase/anaphase transition;18536;1300;GO:0048285
GO:0045842;positive regulation of mitotic metaphase/anaphase transition;1400;1140;GO:0048285
GO:0045840;positive regulation of mitotic nuclear division;2841;617;GO:0048285
GO:0045843;negative regulation of striated muscle tissue development;413;104;GO:0048731
GO:0045844;positive regulation of striated muscle tissue development;172;152;GO:0048731
GO:0031278;alpha-1,2-galactosyltransferase activity;17;4;GO:0004553
GO:0070801;positive regulation of conidiophore stalk development;0;1;GO:0048305
GO:0070802;regulation of metula development;0;1;GO:0048731
GO:0031279;regulation of cyclase activity;207;461;GO:0004872
GO:0070800;negative regulation of conidiophore stalk development;0;1;GO:0048285
GO:0031270;pseudopodium retraction;38;4;GO:0008092
GO:0045859;regulation of protein kinase activity;2148;3090;GO:0016310
GO:0031273;negative regulation of pseudopodium assembly;1;4;GO:0048193
GO:0031274;positive regulation of pseudopodium assembly;484;1010;GO:0048193
GO:0031271;lateral pseudopodium assembly;9;3;GO:0048193
GO:0031272;regulation of pseudopodium assembly;501;221;GO:0048193
GO:0045852;pH elevation;50;165;GO:0043161
GO:0045853;negative regulation of bicoid mRNA localization;0;1;GO:0048608
GO:0045850;positive regulation of nurse cell apoptotic process;54;4;GO:0048608
GO:0045851;pH reduction;296;357;GO:0043161
GO:0045856;positive regulation of pole plasm oskar mRNA localization;41;5;GO:0048704
GO:0045854;positive regulation of bicoid mRNA localization;0;2;GO:0048608
GO:0045855;negative regulation of pole plasm oskar mRNA localization;16;3;GO:0048706
GO:0045860;positive regulation of protein kinase activity;1276;2840;GO:0043406
GO:0031266;TRAIL death-inducing signaling complex;0;2;GO:0008631
GO:0031267;small GTPase binding;145793;2100;GO:0005524
GO:0031264;death-inducing signaling complex;539;279;GO:0006915
GO:0031265;CD95 death-inducing signaling complex;252;299;GO:0008631
GO:0031268;pseudopodium organization;737;123;GO:0009987
GO:0031269;pseudopodium assembly;614;25;GO:0005913
GO:0043208;glycosphingolipid binding;597;297;GO:0042379
GO:0043207;response to external biotic stimulus;2161170;2690;GO:0009607
GO:0070828;heterochromatin organization;28139;1600;GO:0034660
GO:0045869;negative regulation of single stranded viral RNA replication via double stranded DNA intermediate;413;152;GO:0010431
GO:0070825;chrorion micropyle;13;1;GO:0005576
GO:0043209;myelin sheath;8895;2690;GO:0043005
GO:0070826;paraferritin complex;47;71;GO:0005829
GO:0031262;Ndc80 complex;13858;476;GO:0005819
GO:0031260;pseudopodium membrane;19;5;GO:0009986
GO:0031261;DNA replication preinitiation complex;23801;64;GO:0005840
GO:0043200;response to amino acid;12376;1180;GO:0009064
GO:0045863;negative regulation of pteridine metabolic process;0;4;GO:0046395
GO:0045864;positive regulation of pteridine metabolic process;0;3;GO:0046395
GO:0043202;lysosomal lumen;2670;1910;GO:0005764
GO:0045861;negative regulation of proteolysis;6594;1820;GO:0010467
GO:0043201;response to leucine;697;32;GO:0009719
GO:0045862;positive regulation of proteolysis;59430;1620;GO:0048608
GO:0043204;perikaryon;19213;2680;GO:0005829
GO:0043203;axon hillock;263;321;GO:0043005
GO:0018291;molybdenum incorporation into iron-sulfur cluster;1;5;GO:0009065
GO:0018290;iron and molybdenum incorporation into iron-molybdenum-sulfur cluster via L-cysteinyl homocitryl molybdenum-heptairon-nonasulfide;0;7;GO:0009516
GO:0018293;protein-FAD linkage;52;146;GO:0005524
GO:0018292;molybdenum incorporation via L-cysteinyl molybdopterin;0;3;GO:0009065
GO:0018295;protein-FAD linkage via 3'-(8alpha-FAD)-L-histidine;0;0;GO:0005525
GO:0045870;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;116;161;GO:0010401
GO:0018294;protein-FAD linkage via S-(8alpha-FAD)-L-cysteine;0;0;GO:0005525
GO:0018297;protein-FAD linkage via 1'-(8alpha-FAD)-L-histidine;0;0;GO:0005525
GO:0018296;protein-FAD linkage via O4'-(8alpha-FAD)-L-tyrosine;0;0;GO:0005524
GO:0018299;iron incorporation into the Rieske iron-sulfur cluster via bis-L-cysteinyl bis-L-histidino diiron disulfide;0;7;GO:0009517
GO:0031255;lateral part of motile cell;4;1;GO:0048193
GO:0031256;leading edge membrane;18908;462;GO:0009986
GO:0070820;tertiary granule;504;583;GO:0005829
GO:0031253;cell projection membrane;44401;1180;GO:0042995
GO:0031254;cell trailing edge;670;68;GO:0002041
GO:0031259;uropod membrane;47;2;GO:0005576
GO:1905119;response to haloperidol;0;2;GO:0043161
GO:1905118;positive regulation of ribonucleoside-diphosphate reductase activity;0;0;GO:0003723
GO:1905117;regulation of ribonucleoside-diphosphate reductase activity;0;1;GO:0003735
GO:0090308;regulation of DNA methylation-dependent heterochromatin formation;980;2;GO:0016569
GO:0090309;positive regulation of DNA methylation-dependent heterochromatin formation;646;8;GO:0045944
GO:0090306;meiotic spindle assembly;854;8;GO:0007018
GO:0090307;mitotic spindle assembly;6859;1720;GO:0000910
GO:1905123;regulation of glucosylceramidase activity;5;10;GO:0006066
GO:1905120;cellular response to haloperidol;0;3;GO:0042592
GO:1905127;negative regulation of axo-dendritic protein transport;0;1;GO:0048193
GO:1905126;regulation of axo-dendritic protein transport;19;0;GO:0048193
GO:1905125;positive regulation of glucosylceramidase activity;2;0;GO:0010467
GO:1905124;negative regulation of glucosylceramidase activity;1;1;GO:0010467
GO:1905129;endocannabinoid signaling pathway involved in trans-synaptic signaling;0;0;GO:0048608
GO:1905128;positive regulation of axo-dendritic protein transport;10;0;GO:0048193
GO:1905134;positive regulation of meiotic chromosome separation;77;3;GO:0048285
GO:1905133;negative regulation of meiotic chromosome separation;415;3;GO:0048285
GO:1905132;regulation of meiotic chromosome separation;495;2;GO:0007059
GO:1905131;carcinine transmembrane transporter activity;12;2;GO:0005215
GO:1905138;positive regulation of viral DNA genome packaging via site-specific sequence recognition;0;0;GO:0048304
GO:1905137;regulation of viral DNA genome packaging via site-specific sequence recognition;0;1;GO:0048304
GO:1905136;dethiobiotin import across plasma membrane;4;1;GO:0005525
GO:1905135;biotin import across plasma membrane;127;2;GO:0005524
GO:1905139;apical ectodermal ridge formation;0;0;GO:0008544
GO:1905130;carcinine import across plasma membrane;12;3;GO:0006810
GO:0090399;replicative senescence;750;813;GO:0051127
GO:0090397;stigma papilla;5;0;GO:0048608
GO:0090398;cellular senescence;4936;1190;GO:0007049
GO:0090395;plant cell papilla;28;1;GO:0009986
GO:0090396;leaf papilla;0;0;GO:0009908
GO:0090393;sepal giant cell development;3;0;GO:0048608
GO:0090394;negative regulation of excitatory postsynaptic potential;317;177;GO:0048167
GO:0090391;granum assembly;572;2;GO:0022627
GO:0090392;sepal giant cell differentiation;75;3;GO:0048608
GO:0090390;phagosome acidification involved in apoptotic cell clearance;8;2;GO:0006979
GO:1905189;regulation of metaphase/anaphase transition of meiosis II;7;0;GO:0000976
GO:1905188;positive regulation of metaphase/anaphase transition of meiosis I;35;1;GO:0048285
GO:0090379;secondary cell wall biogenesis involved in seed trichome differentiation;32;3;GO:0009813
GO:1905187;negative regulation of metaphase/anaphase transition of meiosis I;0;0;GO:0048285
GO:1905186;regulation of metaphase/anaphase transition of meiosis I;35;2;GO:0000976
GO:0090377;seed trichome initiation;36;4;GO:0009908
GO:0090378;seed trichome elongation;159;189;GO:0009913
GO:0090375;negative regulation of transcription from RNA polymerase II promoter in response to iron ion starvation;2;0;GO:0045944
GO:0090376;seed trichome differentiation;256;9;GO:0009913
GO:0090373;negative regulation of glycerol transport;0;1;GO:0010425
GO:0090374;oligopeptide export from mitochondrion;80;3;GO:0006986
GO:0090371;regulation of glycerol transport;4;1;GO:0006869
GO:0090372;positive regulation of glycerol transport;4;4;GO:0010401
GO:0090370;negative regulation of cholesterol efflux;240;124;GO:0010467
GO:1905181;regulation of urease activity;3;0;GO:0010401
GO:1905180;positive regulation of cardiac muscle tissue regeneration;4;3;GO:0048407
GO:1905184;positive regulation of protein serine/threonine phosphatase activity;4;3;GO:0010468
GO:1905183;negative regulation of protein serine/threonine phosphatase activity;8;5;GO:0010468
GO:1905182;positive regulation of urease activity;3;1;GO:0010401
GO:1905199;manchette disassembly;45;2;GO:0008037
GO:1905198;manchette assembly;306;3;GO:0005576
GO:1905197;endocannabinoid signaling pathway involved in retrograde trans-synaptic signaling;0;0;GO:0048608
GO:0090388;phagosome-lysosome docking involved in apoptotic cell clearance;0;0;GO:0006979
GO:0090389;phagosome-lysosome fusion involved in apoptotic cell clearance;84;5;GO:0006979
GO:0090386;phagosome maturation involved in apoptotic cell clearance;202;4;GO:0006979
GO:0090387;phagolysosome assembly involved in apoptotic cell clearance;149;8;GO:0006979
GO:0090384;phagosome-lysosome docking;51;5;GO:0005764
GO:0090385;phagosome-lysosome fusion;737;153;GO:0006909
GO:0090382;phagosome maturation;3189;1030;GO:0006979
GO:0090383;phagosome acidification;366;229;GO:0008037
GO:0090380;seed trichome maturation;0;3;GO:0009913
GO:0090381;regulation of heart induction;156;5;GO:0048704
GO:1905192;regulation of chloroplast fission;0;0;GO:0048285
GO:1905191;positive regulation of metaphase/anaphase transition of meiosis II;4;1;GO:0048285
GO:1905190;negative regulation of metaphase/anaphase transition of meiosis II;0;0;GO:0048285
GO:1905194;positive regulation of chloroplast fission;0;0;GO:0048285
GO:1905193;negative regulation of chloroplast fission;0;0;GO:0048285
GO:0090359;negative regulation of abscisic acid biosynthetic process;16;3;GO:0010468
GO:0090357;regulation of tryptophan metabolic process;69;4;GO:0006559
GO:0090358;positive regulation of tryptophan metabolic process;6;4;GO:0046356
GO:0090355;positive regulation of auxin metabolic process;27;4;GO:0045735
GO:0090356;negative regulation of auxin metabolic process;63;1;GO:0045735
GO:0090353;polygalacturonase inhibitor activity;15;9;GO:0004553
GO:0090354;regulation of auxin metabolic process;138;2;GO:0045735
GO:0090351;seedling development;3383;258;GO:0048316
GO:0090352;regulation of nitrate assimilation;45;3;GO:0046394
GO:0090350;negative regulation of cellular organofluorine metabolic process;26;5;GO:0046395
GO:0090368;regulation of ornithine metabolic process;8;4;GO:0045944
GO:0090369;ornithine carbamoyltransferase inhibitor activity;5;4;GO:0004867
GO:0090366;positive regulation of mRNA modification;2;2;GO:0010467
GO:0090367;negative regulation of mRNA modification;10;2;GO:0010467
GO:0090364;regulation of proteasome assembly;55;8;GO:0016567
GO:0090365;regulation of mRNA modification;53;6;GO:0010467
GO:0090362;positive regulation of platelet-derived growth factor production;10;41;GO:0048010
GO:0090363;regulation of proteasome core complex assembly;32;2;GO:0043161
GO:0090360;platelet-derived growth factor production;60;38;GO:0048608
GO:0090361;regulation of platelet-derived growth factor production;60;40;GO:0048010
GO:0016524;latrotoxin receptor activity;20;9;GO:0004872
GO:0016525;negative regulation of angiogenesis;11018;2650;GO:0045766
GO:0016528;sarcoplasm;44774;793;GO:0005789
GO:0016529;sarcoplasmic reticulum;38657;1800;GO:0005789
GO:0004540;RNA nuclease activity;1791904;168;GO:0004518
GO:0004535;poly(A)-specific ribonuclease activity;29936;0;GO:0004518
GO:0004534;5'-3' RNA exonuclease activity;59220;5;GO:0003905
GO:0004536;DNA nuclease activity;963756;9;GO:0004518
GO:0016530;metallochaperone activity;62168;402;GO:0008021
GO:0016531;copper chaperone activity;4994;402;GO:0008037
GO:0016532;superoxide dismutase copper chaperone activity;218;526;GO:0008032
GO:0016533;protein kinase 5 complex;3335;8;GO:0005524
GO:0016513;core-binding factor complex;91;10;GO:0000976
GO:0016514;SWI/SNF complex;13561;1480;GO:0005829
GO:0016515;interleukin-13 receptor activity;3;1;GO:0005125
GO:0016516;interleukin-4 receptor complex;0;1;GO:0005125
GO:0016517;interleukin-12 receptor activity;44;6;GO:0005125
GO:0016519;gastric inhibitory peptide receptor activity;871;9;GO:0004930
GO:0004551;dinucleotide phosphatase activity;49313;10;GO:0004721
GO:0004550;nucleoside diphosphate kinase activity;131341;1520;GO:0004721
GO:0004553;hydrolase activity, hydrolyzing O-glycosyl compounds;3962162;6620;GO:0004553
GO:0004552;octanol dehydrogenase activity;25;5;GO:0004497
GO:0004555;alpha,alpha-trehalase activity;39022;232;GO:0004568
GO:0004549;tRNA-specific ribonuclease activity;236822;437;GO:0004518
GO:0016520;growth hormone-releasing hormone receptor activity;204;153;GO:0004930
GO:0016521;pituitary adenylate cyclase activating polypeptide activity;98;4;GO:0004930
GO:0016502;nucleotide receptor activity;16932;57;GO:0004872
GO:0016503;pheromone receptor activity;13852;417;GO:0004930
GO:0016504;peptidase activator activity;11156;760;GO:0004866
GO:0016505;peptidase activator activity involved in apoptotic process;862;117;GO:0004866
GO:0016507;mitochondrial fatty acid beta-oxidation multienzyme complex;1901;29;GO:0005739
GO:0016509;long-chain-3-hydroxyacyl-CoA dehydrogenase activity;189;160;GO:0006066
GO:0004520;DNA endonuclease activity;511661;283;GO:0004518
GO:0004522;ribonuclease A activity;209;99;GO:0004518
GO:0004521;RNA endonuclease activity;1177602;491;GO:0004518
GO:0004512;inositol-3-phosphate synthase activity;41738;475;GO:0004721
GO:0004515;nicotinate-nucleotide adenylyltransferase activity;105095;213;GO:0003964
GO:0004514;nicotinate-nucleotide diphosphorylase (carboxylating) activity;78992;669;GO:0003824
GO:0004517;nitric-oxide synthase activity;11719;351;GO:0004793
GO:0004516;nicotinate phosphoribosyltransferase activity;160224;800;GO:0004061
GO:0004519;endonuclease activity;4145049;3930;GO:0004518
GO:0004518;nuclease activity;8515560;5630;GO:0004518
GO:0004531;deoxyribonuclease II activity;6891;148;GO:0004518
GO:0004530;deoxyribonuclease I activity;2011;231;GO:0004518
GO:0004533;exoribonuclease H activity;24226;3;GO:0004518
GO:0004532;RNA exonuclease activity;327148;122;GO:0003968
GO:0004523;RNA-DNA hybrid ribonuclease activity;477124;2670;GO:0004518
GO:0004526;ribonuclease P activity;214906;877;GO:0003723
GO:0004525;ribonuclease III activity;157053;1340;GO:0004518
GO:0004528;phosphodiesterase I activity;5651;251;GO:0004721
GO:0004527;exonuclease activity;1870444;2610;GO:0004518
GO:0004529;DNA exonuclease activity;403914;1;GO:0004518
GO:0016500;protein-hormone receptor activity;15956;306;GO:0004872
GO:0016501;prostacyclin receptor activity;57;9;GO:0004930
GO:0004582;dolichyl-phosphate beta-D-mannosyltransferase activity;37140;112;GO:0003924
GO:0004581;dolichyl-phosphate beta-glucosyltransferase activity;2796;9;GO:0006029
GO:0004583;dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity;6;116;GO:0006029
GO:0004586;ornithine decarboxylase activity;8979;105;GO:0004061
GO:0004585;ornithine carbamoyltransferase activity;180682;1150;GO:0004041
GO:0004588;orotate phosphoribosyltransferase activity;162384;1210;GO:0004061
GO:0004587;ornithine aminotransferase activity;31790;2;GO:0004073
GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;5540;587;GO:0006029
GO:0004578;chitobiosyldiphosphodolichol beta-mannosyltransferase activity;1200;9;GO:0006029
GO:0016570;histone modification;37772;3980;GO:0016570
GO:0016571;histone methylation;2011;1500;GO:0016569
GO:0016573;histone acetylation;5004;3560;GO:0016570
GO:0016574;histone ubiquitination;102;1120;GO:0043687
GO:0016575;histone deacetylation;426;1870;GO:0016570
GO:0016577;histone demethylation;25;1060;GO:0016570
GO:0016578;histone deubiquitination;13;842;GO:0042335
GO:0016557;peroxisome membrane biogenesis;78;116;GO:0005764
GO:0016558;protein import into peroxisome matrix;34849;726;GO:0005764
GO:0016559;peroxisome fission;12155;884;GO:0007049
GO:0004591;oxoglutarate dehydrogenase (succinyl-transferring) activity;78844;738;GO:0004097
GO:0004590;orotidine-5'-phosphate decarboxylase activity;163170;6;GO:0006066
GO:0004593;pantothenase activity;0;4;GO:0004073
GO:0004592;pantoate-beta-alanine ligase activity;125800;248;GO:0006081
GO:0004595;pantetheine-phosphate adenylyltransferase activity;148298;813;GO:0006033
GO:0004594;pantothenate kinase activity;169978;817;GO:0003909
GO:0004596;peptide alpha-N-acetyltransferase activity;32015;307;GO:0009065
GO:0004598;peptidylamidoglycolate lyase activity;2090;96;GO:0006029
GO:0004589;dihydroorotate dehydrogenase (NADH) activity;5107;4;GO:0004061
GO:0016560;protein import into peroxisome matrix, docking;12958;351;GO:0005740
GO:0016561;protein import into peroxisome matrix, translocation;178;52;GO:0006626
GO:0016562;protein import into peroxisome matrix, receptor recycling;4213;10;GO:0006626
GO:0016567;protein ubiquitination;521595;12300;GO:0006464
GO:0016546;male courtship behavior, proboscis-mediated licking;6;5;GO:0009909
GO:0004560;alpha-L-fucosidase activity;50998;461;GO:0004553
GO:0004561;alpha-N-acetylglucosaminidase activity;232;15;GO:0004553
GO:0004564;beta-fructofuranosidase activity;22415;474;GO:0004553
GO:0004563;beta-N-acetylhexosaminidase activity;151802;519;GO:0004553
GO:0004566;beta-glucuronidase activity;2926;48;GO:0004553
GO:0004565;beta-galactosidase activity;122461;951;GO:0004553
GO:0004557;alpha-galactosidase activity;85218;139;GO:0004553
GO:0004556;alpha-amylase activity;60163;1110;GO:0004553
GO:0004559;alpha-mannosidase activity;87573;703;GO:0004553
GO:0004558;alpha-1,4-glucosidase activity;14242;188;GO:0004553
GO:0016553;base conversion or substitution editing;85757;165;GO:0003677
GO:0016554;cytidine to uridine editing;4042;464;GO:0006518
GO:0016555;uridine to cytidine editing;0;2;GO:0006518
GO:0016556;mRNA modification;137206;574;GO:0043687
GO:0016538;cyclin-dependent protein serine/threonine kinase regulator activity;60653;1310;GO:0005524
GO:0016539;intein-mediated protein splicing;32338;89;GO:0008544
GO:0004571;mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;32002;755;GO:0006029
GO:0004573;Glc3Man9GlcNAc2 oligosaccharide glucosidase activity;21207;5;GO:0005986
GO:0004572;mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity;34;136;GO:0004553
GO:0004575;sucrose alpha-glucosidase activity;3499;316;GO:0005986
GO:0004574;oligo-1,6-glucosidase activity;1965;87;GO:0004553
GO:0004577;N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity;3634;70;GO:0006029
GO:0004576;oligosaccharyl transferase activity;18584;414;GO:0006486
GO:0004568;chitinase activity;47145;2000;GO:0004568
GO:0004567;beta-mannosidase activity;22934;23;GO:0004553
GO:0004569;glycoprotein endo-alpha-1,2-mannosidase activity;84;13;GO:0004553
GO:0016540;protein autoprocessing;13724;787;GO:0006414
GO:0016543;male courtship behavior, orientation prior to leg tapping and wing vibration;7;117;GO:0007586
GO:0016544;male courtship behavior, tapping to detect pheromone;21;9;GO:0007528
GO:0016545;male courtship behavior, veined wing vibration;118;8;GO:0007530
GO:0102802;thebaine 6-O-demethylase activity;30;2;GO:0046395
GO:0102801;anthocyanin 5-O-glucoside-4'''-O-malonyltransferase activity;2;2;GO:0005975
GO:0102804;oripavine 6-O-demethylase activity;27;1;GO:0046395
GO:0102803;thebane O-demethylase activity;79;1;GO:0046395
GO:0102800;caffeoyl-CoA:pelargonidin-3,5-diglucoside-6''-O-acyltransferase activity;0;0;GO:0006073
GO:0102809;delphinidin 3-O-glucoside 2''-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102806;4-coumaroyl-CoA:cyanidin-3,5-diglucoside-6''-O-acyltransferase activity;0;0;GO:0006073
GO:0102805;codeine O-demethylase activity;81;3;GO:0004497
GO:0102808;pelargonidin 3-O-glucoside 2''-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102807;cyanidin 3-O-glucoside 2''-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102813;UDP-D-glucose:cyanidin 3-(p-coumaroyl)-glucoside 5-O-glucosyltransferase activity;0;0;GO:0006029
GO:0102812;4-coumaroyl-CoA:cyanidin-3-O-beta-D-glucoside-6''-O-acyltransferase activity;0;0;GO:0006073
GO:0090500;endocardial cushion to mesenchymal transition;196;21;GO:0048704
GO:0102815;caffeoyl-CoA:delphinidin-3,5-diglucoside 5-O-glucoside-6-O-hydroxycinnamoyltransferase activity;11;1;GO:0006073
GO:0102814;caffeoyl-CoA:delphinidin-3,5,3'-triglucoside 5-O-glucoside-6-O-hydroxycinnamoyltransferase activity;0;0;GO:0006073
GO:0102811;geraniol 10-hydroxylase activity;72;3;GO:0004497
GO:0102810;glutarate-semialdehyde dehydrogenase (NADP+) activity;1534;0;GO:0004067
GO:0102817;caffeoyl-CoA:3-O-glucosyl-5-O-(caffeoylglucoside-3'-O-glucoside) 3'-O-hydroxycinnamoyltransferase activity;0;0;GO:0006073
GO:0102816;UDP-D-glucose:delphinidin 3-O-glucosyl-5-O-caffeoylglucoside -O-beta-D-glucosyltransferase activity;13;2;GO:0006073
GO:0102819;bixin aldehyde dehydrogenase activity;0;0;GO:0004067
GO:0102818;lycopene cleavage oxygenase activity;0;0;GO:0004746
GO:0090508;phenylethylamine biosynthetic process involved in synaptic transmission;0;0;GO:0048167
GO:0090506;axillary shoot meristem initiation;77;5;GO:0048316
GO:0090507;phenylethylamine metabolic process involved in synaptic transmission;0;0;GO:0048167
GO:0090504;epiboly;3484;152;GO:0002064
GO:0090505;epiboly involved in wound healing;2105;117;GO:0048407
GO:0102824;UDP-L-rhamnose:quercetin 3-O-rhamnosyltransferase activity;1;1;GO:0006022
GO:0102823;kaempferol-3-rhamnoside-glucosyltransferase activity;0;0;GO:0005982
GO:0102826;kaempferol-3-glucoside-glucosyltransferase activity;0;0;GO:0006073
GO:0102825;quercetin 3-O-rhamnoside-glucosyltransferase activity;0;0;GO:0006073
GO:0102820;norbixin methyltransferase activity;0;0;GO:0004725
GO:0102822;quercetin 3'-O-methyltransferase activity;17;3;GO:0004497
GO:0102821;bixin methyltransferase activity;0;0;GO:0004725
GO:0102828;stachyose galactinol:verbascose galactosyltransferase activity;0;0;GO:0006073
GO:0102827;galactosylononitol-raffinose galactosyltransferase activity;0;0;GO:0006021
GO:0102829;ajugose synthase activity;0;0;GO:0006021
GO:0016590;ACF complex;176;7;GO:0005840
GO:0016591;RNA polymerase II, holoenzyme;113171;523;GO:0000981
GO:0016592;mediator complex;93967;2420;GO:0005829
GO:0016593;Cdc73/Paf1 complex;12896;638;GO:0000786
GO:0016594;glycine binding;4684;500;GO:0043169
GO:0016595;glutamate binding;269;279;GO:0043169
GO:0016596;thienylcyclohexylpiperidine binding;2;3;GO:0043169
GO:0016597;amino acid binding;142890;3710;GO:0043169
GO:0016598;protein arginylation;8;278;GO:0006464
GO:0016579;protein deubiquitination;1704;4830;GO:0016567
GO:0102835;1-18:2-2-16:0-monogalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102834;1-18:1-2-16:0-monogalactosyldiacylglycerol acyl-lipid omega-6 desaturase activity;7;2;GO:0008610
GO:0102837;1-18:2-2-16:1-monogalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102836;1-18:1-2-16:1-monogalactosyldiacylglyceroldesaturase activity;7;2;GO:0008610
GO:0102831;stachyose synthase activity;0;0;GO:0006073
GO:0102830;verbascose synthase activity;0;0;GO:0006021
GO:0102833;sequoyitol galactinol:D-galactosylononitol galactosyltransferase activity;0;0;GO:0006073
GO:0102832;verbascose galactinol:ajugose galactosyltransferase activity;0;0;GO:0006029
GO:0102839;1-18:2-2-16:2-monogalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102838;1-18:1-2-16:2-monogalactosyldiacylglycerol desaturase activity;7;2;GO:0008610
GO:0016580;Sin3 complex;521;482;GO:0005634
GO:0016581;NuRD complex;3414;1150;GO:0048471
GO:0102840;1-18:2-2-16:3-monogalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0016586;RSC-type complex;10449;21;GO:0022627
GO:0016587;Isw1 complex;52;4;GO:0048285
GO:0016589;NURF complex;4538;213;GO:0000976
GO:0102846;1-18:3-2-16:1-monogalactosyldiacylglycerol desaturase activity;0;0;GO:0008610
GO:0102845;1-18:3-2-16:0-monogalactosyldiacylglycerol desaturase activity;0;0;GO:0008610
GO:0102848;1-18:2-2-18:2-digalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102847;1-18:3-2-16:2-monogalactosyldiacylglycerol desaturase activity;0;0;GO:0008610
GO:0102842;1-18:1-2-16:2-monogalactosyldiacylglycerol desaturase activity (SN2-16:3 forming);17;2;GO:0008610
GO:0102841;1-18:1-2-16:2-monogalactosyldiacylglycerol synthase activity;7;2;GO:0008610
GO:0102844;1-18:2-2-16:1-monogalactosyldiacylglycerol desaturase activity (SN2-16:2 forming);7;2;GO:0008610
GO:0102843;1-18:2-2-16:0-monogalactosyldiacylglycerol desaturase activity (SN2-16:1 forming);2;2;GO:0008610
GO:0102849;1-18:2-2-18:3-digalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102851;1-18:2-2-16:0-phosphatidylglycerol desaturase activity;1;1;GO:0008610
GO:0102850;1-18:1-2-16:0-phosphatidylglycerol omega-6 desaturase activity;11;3;GO:0008610
GO:0102856;1-18:2-2-18:2-sn-glycerol-3-phosphocholine desaturase activity;15;1;GO:0008610
GO:0102859;1-18:1-2-18:2-phosphatidylcholine desaturase activity (SN2-18:3 forming);18;2;GO:0008610
GO:0102858;1-18:2-2-18:3-phosphatidylcholine desaturase activity;0;0;GO:0008610
GO:0102853;1-18:1-2-18:1-sn-glycerol-3-phosphocholine desaturase activity;0;0;GO:0008610
GO:0102852;1-18:3-2-16:0-phosphatidylglycerol desaturase activity;0;0;GO:0008610
GO:0102854;1-18:2-2-18:1-phosphatidylcholine desaturase activity;0;0;GO:0008610
GO:0102862;1-18:2-2-18:2-sn-glycerol-3-phosphocholine desaturase activity (SN2-18:3 forming);15;1;GO:0006631
GO:0102868;24-epi-campsterol desaturase activity;0;0;GO:0004746
GO:0102867;molybdenum cofactor sulfurtransferase activity;2754;4;GO:0004723
GO:0102869;6-hydroxyflavone-glucosyltransferase activity;0;0;GO:0006031
GO:0102864;1-18:3-2-18:2-phosphatidylcholine desaturase activity;0;0;GO:0008610
GO:0102863;1-18:3-2-18:1-phosphatidylcholine desaturase activity;0;0;GO:0008610
GO:0102866;di-homo-gamma-linolenate delta5 desaturase activity;5;1;GO:0008610
GO:0102865;delta6-acyl-lipid desaturase activity;2;2;GO:0008610
GO:0102870;7-hydroxyflavone-glucosyltransferase activity;0;0;GO:0006081
GO:0102873;1-18:1-2-16:0-digalactosyldiacylglycerol desaturase activity;7;2;GO:0008610
GO:0102872;1-16:0-2-18:2-phosphatidylcholine desaturase activity;15;1;GO:0008610
GO:0102879;(+)-thujopsene synthase activity;4;2;GO:0004497
GO:0102878;(+)-alpha-barbatene synthase activity;4;2;GO:0004497
GO:0102875;1-18:2-2-18:2-monogalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102874;1-16:0-2-18:2-digalactosyldiacylglycerol desaturase activity;14;1;GO:0008610
GO:0102877;alpha-copaene synthase activity;22;2;GO:0004497
GO:0102876;psoralen synthase activity;19;2;GO:0004073
GO:0102882;beta-acoradiene synthase activity;0;0;GO:0004497
GO:0102881;(+)-beta-barbatene synthase activity;3;0;GO:0004497
GO:0102884;alpha-zingiberene synthase activity;10;2;GO:0004497
GO:0102883;(+)-beta-chamigrene synthase activity;2;2;GO:0004497
GO:0102880;isobazzanene synthase activity;0;0;GO:0006033
GO:1905024;regulation of membrane repolarization during ventricular cardiac muscle cell action potential;60;7;GO:0048407
GO:0090459;intracellular aspartate homeostasis;0;5;GO:0006836
GO:0102889;beta-elemene synthase activity;4;1;GO:0004497
GO:1905023;positive regulation of threonine-tRNA ligase activity;0;1;GO:0006414
GO:0090454;glutamate transmembrane import into vacuole;54;2;GO:0006836
GO:0102886;alpha-chamigrene synthase activity;0;0;GO:0004497
GO:1905028;negative regulation of membrane depolarization during AV node cell action potential;0;2;GO:0048407
GO:0090455;ornithine transmembrane import into vacuole;0;1;GO:0006836
GO:0102885;alpha-cuprenene synthase activity;0;2;GO:0004497
GO:1905027;regulation of membrane depolarization during AV node cell action potential;2;2;GO:0048407
GO:0090452;lithium ion transmembrane transport;9;1;GO:0006812
GO:0102888;delta-cuprenene synthase activity;0;0;GO:0004497
GO:1905026;positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential;8;5;GO:0048407
GO:0090453;aspartate transmembrane import into vacuole;0;0;GO:0006836
GO:0102887;beta-sesquiphellandrene synthase activity;4;2;GO:0004497
GO:1905025;negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential;50;4;GO:0048407
GO:0090451;cotyledon boundary formation;10;2;GO:0009952
GO:1905029;positive regulation of membrane depolarization during AV node cell action potential;0;2;GO:0048407
GO:0102893;betanidin 6-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102892;betanidin 5-O-glucosyltransferase activity;0;0;GO:0006073
GO:0102895;colneleate synthase activity;9;3;GO:0004061
GO:0102894;UDPG:cyclo-DOPA 5-O-glucosyltransferase activity;0;0;GO:0006022
GO:1905020;positive regulation of methionine-tRNA ligase activity;0;2;GO:0010401
GO:0102891;2'4'6'34-pentahydroxychalcone 4'-O-glucosyltransferase activity;4;0;GO:0006073
GO:0102890;naringenin chalcone 4'-O-glucosyltransferase activity;4;0;GO:0006073
GO:1905035;negative regulation of antifungal innate immune response;124;5;GO:0046649
GO:1905034;regulation of antifungal innate immune response;288;7;GO:0050832
GO:1905033;positive regulation of membrane repolarization during cardiac muscle cell action potential;10;8;GO:0048407
GO:1905032;negative regulation of membrane repolarization during cardiac muscle cell action potential;54;3;GO:0048407
GO:0090465;intracellular arginine homeostasis;63;1;GO:0006874
GO:0102897;abietadienal hydroxylase activity;0;1;GO:0004497
GO:1905039;carboxylic acid transmembrane transport;1104463;376;GO:0008544
GO:0102896;colnelenate synthase activity;0;1;GO:0004497
GO:1905038;regulation of membrane lipid metabolic process;3658;10;GO:0045735
GO:0090463;intracellular lysine homeostasis;60;1;GO:0006457
GO:0102899;dehydroabietadienol hydroxylase activity;0;0;GO:0046395
GO:1905037;autophagosome organization;30695;120;GO:0007049
GO:0090464;intracellular histidine homeostasis;60;1;GO:0006730
GO:0102898;levopimaradienol hydroxylase activity;0;1;GO:0046395
GO:1905036;positive regulation of antifungal innate immune response;156;5;GO:0046655
GO:0090461;intracellular glutamate homeostasis;244;6;GO:0006874
GO:0090462;intracellular ornithine homeostasis;0;1;GO:0006865
GO:0090460;intracellular threonine homeostasis;0;1;GO:0006457
GO:1905031;regulation of membrane repolarization during cardiac muscle cell action potential;96;8;GO:0048407
GO:1905030;voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential;78;3;GO:0048169
GO:0090436;leaf pavement cell development;110;2;GO:0048316
GO:1905046;positive regulation of Schwann cell proliferation involved in axon regeneration;4;3;GO:0048608
GO:0090437;socket cell differentiation;2;0;GO:0048667
GO:1905045;negative regulation of Schwann cell proliferation involved in axon regeneration;5;5;GO:0048405
GO:0090434;oleoyl-CoA ligase activity;175;6;GO:0004364
GO:1905044;regulation of Schwann cell proliferation involved in axon regeneration;9;5;GO:0048608
GO:0090435;protein localization to nuclear envelope;805;128;GO:0005634
GO:1905043;positive regulation of epithelium regeneration;2;3;GO:0050731
GO:0090432;myristoyl-CoA ligase activity;9;4;GO:0004721
GO:0090433;palmitoyl-CoA ligase activity;88;6;GO:0004734
GO:1905049;negative regulation of metallopeptidase activity;28;31;GO:0048169
GO:0090430;caffeoyl-CoA: alcohol caffeoyl transferase activity;38;1;GO:0006096
GO:1905048;regulation of metallopeptidase activity;66;9;GO:0010467
GO:0090431;alkyl caffeate ester biosynthetic process;4;0;GO:0046148
GO:1905047;mitotic spindle pole body organization;167;0;GO:0000922
GO:1905042;negative regulation of epithelium regeneration;58;3;GO:0010717
GO:1905041;regulation of epithelium regeneration;64;2;GO:0050727
GO:0090438;camelliol C synthase activity;4;0;GO:0004497
GO:1905040;otic placode development;101;26;GO:0007530
GO:0090439;tetraketide alpha-pyrone synthase activity;15;3;GO:0004497
GO:0090447;glycerol-3-phosphate 2-O-acyltransferase activity;507;9;GO:0004089
GO:1905057;voltage-gated calcium channel activity involved in regulation of postsynaptic cytosolic calcium levels;0;0;GO:0008092
GO:0090448;glucosinolate:proton symporter activity;7;1;GO:0008544
GO:1905056;P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration;61;1;GO:0008026
GO:0090445;positive regulation of nematode larval development, heterochronic;0;0;GO:0048608
GO:1905055;calcium:monoatomic cation antiporter activity involved in regulation of presynaptic cytosolic calcium ion concentration;0;0;GO:0008047
GO:0090446;negative regulation of nematode larval development, heterochronic;0;0;GO:0048608
GO:1905054;calcium-induced calcium release activity involved in regulation of presynaptic cytosolic calcium ion concentration;0;0;GO:0008092
GO:0090443;FAR/SIN/STRIPAK complex;387;3;GO:0005576
GO:0090444;regulation of nematode larval development, heterochronic;23;0;GO:0048608
GO:0090441;trehalose biosynthesis in response to heat stress;0;1;GO:0006066
GO:1905059;P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration;56;2;GO:0008092
GO:0090442;trehalose catabolism in response to heat stress;0;0;GO:0006066
GO:1905058;calcium-induced calcium release activity involved in regulation of postsynaptic cytosolic calcium ion concentration;0;0;GO:0008092
GO:0090440;abscisic acid transmembrane transporter activity;9;1;GO:0008544
GO:1905053;positive regulation of base-excision repair;122;25;GO:0045727
GO:1905052;negative regulation of base-excision repair;0;1;GO:0045727
GO:0090449;phloem glucosinolate loading;7;1;GO:0009909
GO:1905051;regulation of base-excision repair;178;49;GO:0045727
GO:1905050;positive regulation of metallopeptidase activity;29;18;GO:0048193
GO:0090414;molybdate ion export from vacuole;43;4;GO:0006836
GO:0090415;7-hydroxymethyl chlorophyll a reductase activity;91;1;GO:0009536
GO:0090410;malonate catabolic process;91;5;GO:0006066
GO:0090411;brassinosteroid binding;0;0;GO:0005509
GO:0090419;negative regulation of transcription involved in G2/M transition of mitotic cell cycle;5;4;GO:0048285
GO:0090416;nicotinate transmembrane transporter activity;68;4;GO:0005215
GO:0090417;N-methylnicotinate transmembrane transporter activity;21;2;GO:0005215
GO:0090425;acinar cell differentiation;261;10;GO:0007517
GO:0090426;actin filament bundle convergence;39;0;GO:0048471
GO:0090423;phytochelatin-metal complex formation;4;1;GO:0008021
GO:0090424;phytochelatin-metal-sulfur complex formation;0;0;GO:0008033
GO:0090421;embryonic meristem initiation;347;6;GO:0009953
GO:0090422;thiamine pyrophosphate transmembrane transporter activity;253;8;GO:0008565
GO:0090429;detection of endogenous biotic stimulus;0;0;GO:0009615
GO:0090427;activation of meiosis;247;35;GO:0007126
GO:0090428;perianth development;4;1;GO:0009908
GO:1905002;positive regulation of membrane repolarization during atrial cardiac muscle cell action potential;0;1;GO:0048407
GO:1905001;negative regulation of membrane repolarization during atrial cardiac muscle cell action potential;2;3;GO:0048407
GO:1905000;regulation of membrane repolarization during atrial cardiac muscle cell action potential;4;203;GO:0048407
GO:1905006;negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;4;4;GO:0048704
GO:1905005;regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;163;9;GO:0048704
GO:1905004;picolinic acid biosynthetic process;1;1;GO:0009065
GO:1905003;picolinic acid metabolic process;1;1;GO:0006073
GO:1905009;negative regulation of L-lysine import across plasma membrane;0;1;GO:0046395
GO:1905008;regulation of L-lysine import across plasma membrane;2;0;GO:0006874
GO:1905007;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;153;366;GO:0048704
GO:0090403;oxidative stress-induced premature senescence;193;297;GO:0046686
GO:1905013;negative regulation of 'de novo' NAD biosynthetic process from tryptophan;0;2;GO:0046394
GO:0090404;pollen tube tip;171;8;GO:0009579
GO:1905012;regulation of 'de novo' NAD biosynthetic process from tryptophan;2;2;GO:0046394
GO:1905011;transmembrane phosphate ion transport from cytosol to vacuole;68;1;GO:0006826
GO:0090402;oncogene-induced cell senescence;267;158;GO:0048193
GO:1905010;positive regulation of L-lysine import across plasma membrane;2;4;GO:0046395
GO:1905017;positive regulation of isoleucine-tRNA ligase activity;0;1;GO:0010401
GO:0090400;stress-induced premature senescence;398;129;GO:0046686
GO:1905014;positive regulation of 'de novo' NAD biosynthetic process from tryptophan;0;1;GO:0046394
GO:0090409;malonyl-CoA synthetase activity;97;5;GO:0006081
GO:0090407;organophosphate biosynthetic process;16770760;1400;GO:0006725
GO:0090408;phloem nitrate loading;4;3;GO:0009909
GO:0090405;unicellular trichome branch;0;1;GO:0048305
GO:0090406;pollen tube;879;753;GO:0009555
GO:1905068;positive regulation of canonical Wnt signaling pathway involved in heart development;49;26;GO:0048704
GO:1905067;negative regulation of canonical Wnt signaling pathway involved in heart development;80;3;GO:0048704
GO:1905066;regulation of canonical Wnt signaling pathway involved in heart development;210;5;GO:0048704
GO:1905065;positive regulation of vascular associated smooth muscle cell differentiation;291;166;GO:0048010
GO:0090498;extrinsic component of Golgi membrane;5;28;GO:0005764
GO:0090499;pimelyl-[acyl-carrier protein] methyl ester esterase activity;1;0;GO:0004734
GO:0090496;mesenchyme migration involved in limb bud formation;0;0;GO:0048608
GO:0090497;mesenchymal cell migration;6041;4;GO:0030509
GO:1905069;allantois development;144;5;GO:0007565
GO:0090494;dopamine uptake;1826;37;GO:0006836
GO:0090495;low-density lipoprotein particle disassembly;0;0;GO:0048193
GO:0090492;N,N-Dihydroxy-L-tryptophan decarboxylase activity;0;0;GO:0009065
GO:0090493;catecholamine uptake;2551;114;GO:0006836
GO:0090490;L-tryptophan,NADPH:oxygen oxidoreductase (N-hydroxylating);0;0;GO:0006749
GO:0090491;N-hydroxy-L-tryptophan,NADPH:oxygen oxidoreductase (N-hydroxylating);0;0;GO:0006749
GO:0004500;dopamine beta-monooxygenase activity;7626;189;GO:0004497
GO:1905060;calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration;15;0;GO:0008047
GO:1905064;negative regulation of vascular associated smooth muscle cell differentiation;337;5;GO:0048608
GO:1905063;regulation of vascular associated smooth muscle cell differentiation;629;6;GO:0048608
GO:1905062;positive regulation of cardioblast proliferation;50;2;GO:0048608
GO:1905061;negative regulation of cardioblast proliferation;2;0;GO:0048608
GO:1905079;regulation of cerebellar neuron development;0;0;GO:0048699
GO:0004511;tyrosine 3-monooxygenase activity;2310;134;GO:0004497
GO:0004510;tryptophan 5-monooxygenase activity;3476;103;GO:0004497
GO:0004502;kynurenine 3-monooxygenase activity;16700;21;GO:0004721
GO:0004501;ecdysone 20-monooxygenase activity;22;6;GO:0004497
GO:0004504;peptidylglycine monooxygenase activity;1809;234;GO:0004497
GO:0004503;tyrosinase activity;2573;26;GO:0004073
GO:0004506;squalene monooxygenase activity;13976;713;GO:0004497
GO:0004505;phenylalanine 4-monooxygenase activity;17295;313;GO:0004497
GO:0004508;steroid 17-alpha-monooxygenase activity;799;18;GO:0004497
GO:0004507;steroid 11-beta-monooxygenase activity;306;37;GO:0004497
GO:1905071;tight junction disassembly;120;1;GO:0030199
GO:0004509;steroid 21-monooxygenase activity;69;10;GO:0004497
GO:1905070;anterior visceral endoderm cell migration;56;2;GO:0048704
GO:1905075;positive regulation of tight junction disassembly;120;10;GO:0048308
GO:1905074;negative regulation of tight junction disassembly;0;0;GO:0010467
GO:1905073;regulation of tight junction disassembly;120;1;GO:0048308
GO:1905072;cardiac jelly development;282;22;GO:0007530
GO:1905089;regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;95;0;GO:0048193
GO:1905088;positive regulation of synaptonemal complex assembly;51;2;GO:0048608
GO:1905087;positive regulation of bioluminescence;4;0;GO:0048608
GO:0090474;arg-arg specific dibasic protein processing;12;0;GO:0006414
GO:0090475;lys-lys specific dibasic protein processing;0;0;GO:0006414
GO:0090472;dibasic protein processing;85;51;GO:0016567
GO:0090473;lys-arg specific dibasic protein processing;0;0;GO:0006412
GO:0090470;shoot organ boundary specification;9;0;GO:0048316
GO:0090471;9,15,9'-tri-cis-zeta-carotene isomerase activity;38;1;GO:0003824
GO:1905082;regulation of mitochondrial translational elongation;0;1;GO:0006412
GO:1905081;positive regulation of cerebellar neuron development;0;1;GO:0048667
GO:1905080;negative regulation of cerebellar neuron development;0;1;GO:0048667
GO:1905086;negative regulation of bioluminescence;0;0;GO:0010468
GO:1905085;regulation of bioluminescence;4;0;GO:0048146
GO:1905084;positive regulation of mitochondrial translational elongation;0;1;GO:0045944
GO:1905083;negative regulation of mitochondrial translational elongation;0;1;GO:0045944
GO:0090489;L-tryptophan,NADPH:oxygen oxidoreductase (N-hydroxylating, decarboxylating);0;0;GO:0006749
GO:1905099;positive regulation of guanyl-nucleotide exchange factor activity;23;2;GO:0048193
GO:1905098;negative regulation of guanyl-nucleotide exchange factor activity;21;35;GO:0048193
GO:0090487;secondary metabolite catabolic process;6;53;GO:0046274
GO:0090488;polo box domain specific binding;3;2;GO:0005524
GO:0090486;small RNA 2'-O-methyltransferase activity;153;0;GO:0003729
GO:0090483;phosphatidylglycerol-phosphatidylethanolamine phosphatidyltransferase activity;886;0;GO:0008631
GO:0090481;pyrimidine nucleotide-sugar transmembrane transport;35679;35;GO:0008529
GO:0090482;vitamin transmembrane transporter activity;145450;248;GO:0005215
GO:0090480;purine nucleotide-sugar transmembrane transport;1247;2;GO:0008529
GO:1905093;cellular response to diosgenin;0;1;GO:0006954
GO:1905092;response to diosgenin;0;1;GO:0009725
GO:1905091;positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;39;1;GO:0048193
GO:1905090;negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;56;1;GO:0048193
GO:1905097;regulation of guanyl-nucleotide exchange factor activity;45;20;GO:0005085
GO:1905096;positive regulation of apolipoprotein A-I-mediated signaling pathway;0;0;GO:0030518
GO:1905095;negative regulation of apolipoprotein A-I-mediated signaling pathway;1;0;GO:0010468
GO:1905094;regulation of apolipoprotein A-I-mediated signaling pathway;1;0;GO:0030518
GO:0018824;(hydroxyamino)benzene mutase activity;2;2;GO:0006067
GO:0018823;cyclohexa-1,5-dienecarbonyl-CoA hydratase activity;76;4;GO:0006081
GO:0018826;methionine gamma-lyase activity;9473;9;GO:0004497
GO:0018825;triethanolamine lyase activity;0;0;GO:0004497
GO:0018828;halohydrin hydrogen-halide-lyase A activity;0;0;GO:0004497
GO:0018827;1-chloro-2,2-bis(4-chlorophenyl)ethane dehydrochlorinase activity;0;3;GO:0004497
GO:0018829;1,1-dichloro-2,2-bis(4-chlorophenyl)ethane dehydrochlorinase activity;0;2;GO:0004497
GO:0006842;tricarboxylic acid transport;14934;176;GO:0006836
GO:0006843;mitochondrial citrate transmembrane transport;217;6;GO:0006836
GO:0006835;dicarboxylic acid transport;115532;1360;GO:0006865
GO:0006836;neurotransmitter transport;59968;4380;GO:0006836
GO:0006833;water transport;24833;1680;GO:0006810
GO:0006839;mitochondrial transport;63727;3340;GO:0006890
GO:0006837;serotonin transport;6151;133;GO:0006836
GO:0018831;5-chloro-1,2,4-trihydroxybenzene dechlorinase activity;0;3;GO:0004497
GO:0018830;gamma-hexachlorocyclohexane dehydrochlorinase activity;0;3;GO:0004497
GO:0018833;DDT-dehydrochlorinase activity;27;57;GO:0004497
GO:0018832;halohydrin hydrogen-halide-lyase B activity;0;0;GO:0004479
GO:0018813;trans-o-hydroxybenzylidenepyruvate hydratase-aldolase activity;24;4;GO:0006067
GO:0018812;3-hydroxyacyl-CoA dehydratase activity;566;53;GO:0006081
GO:0018815;3-methyl-5-hydroxy-6-(3-carboxy-3-oxopropenyl)-1H-2-pyridon hydratase-aldolase activity;0;0;GO:0003824
GO:0018814;phenylacetaldoxime dehydratase activity;52;5;GO:0004067
GO:0018817;2-oxo-hept-3-ene-1,7-dioate hydratase activity;4308;10;GO:0004497
GO:0018816;2-hydroxyisobutyrate dehydratase activity;0;2;GO:0006099
GO:0018819;lactoyl-CoA dehydratase activity;9;3;GO:0006067
GO:0018818;acetylene hydratase activity;3201;6;GO:0004497
GO:0006850;mitochondrial pyruvate transmembrane transport;10232;60;GO:0009060
GO:0006853;carnitine shuttle;4;1060;GO:0006631
GO:0006851;mitochondrial calcium ion transmembrane transport;12448;423;GO:0006836
GO:0006846;acetate transport;5425;10;GO:0006810
GO:0006847;plasma membrane acetate transport;23;6;GO:0006830
GO:0006844;acyl carnitine transport;365;122;GO:0006836
GO:0006848;pyruvate transport;11018;74;GO:0015986
GO:0006849;plasma membrane pyruvate transport;15;6;GO:0006865
GO:0018820;cyanamide hydratase activity;99;7;GO:0004730
GO:0018822;nitrile hydratase activity;31835;126;GO:0004792
GO:0018802;2,4-dihydroxyhept-2-ene-1,7-dioate aldolase activity;3102;5;GO:0006032
GO:0043802;hydrogenobyrinic acid a,c-diamide synthase (glutamine-hydrolysing) activity;15484;5;GO:0006067
GO:0018801;glutaconyl-CoA decarboxylase activity;2426;4;GO:0006099
GO:0043801;hexulose-6-phosphate synthase activity;5001;22;GO:0006067
GO:0043804;imidazolone hydrolase activity;0;2;GO:0046395
GO:0018803;4-(2-carboxyphenyl)-2-oxobut-3-enoate aldolase activity;6;0;GO:0004089
GO:0043803;hydroxyneurosporene-O-methyltransferase activity;182;4;GO:0004067
GO:0043806;keto acid formate lyase activity;0;2;GO:0009065
GO:0018805;benzylsuccinate synthase activity;273;2;GO:0006033
GO:0043805;indolepyruvate ferredoxin oxidoreductase activity;30509;7;GO:0004091
GO:0018808;trans-4-(1'-hydroxynaphth-2'-yl)-2-oxobut-3-enoate hydratase-aldolase activity;0;0;GO:0006081
GO:0043808;lyso-ornithine lipid acyltransferase activity;0;1;GO:0008610
GO:0018807;6-hydroxycyclohex-1-ene-1-carboxyl-CoA hydratase activity;198;4;GO:0006067
GO:0043807;3-methyl-2-oxobutanoate dehydrogenase (ferredoxin) activity;1596;4;GO:0004091
GO:0018809;E-phenylitaconyl-CoA hydratase activity;0;3;GO:0006081
GO:0006820;monoatomic anion transport;1145381;347;GO:0006826
GO:0006821;chloride transport;605075;2650;GO:00068-25
GO:0043800;hexulose-6-phosphate isomerase activity;508;2;GO:0006064
GO:0006813;potassium ion transport;1678503;6930;GO:0006811
GO:0006814;sodium ion transport;1219662;6670;GO:0006811
GO:0006811;monoatomic ion transport;27452381;1740;GO:0006811
GO:0006812;monoatomic cation transport;22033401;1030;GO:0006811
GO:0006817;phosphate ion transport;501159;1390;GO:0006826
GO:0006816;calcium ion transport;730969;6060;GO:0006811
GO:0018811;cyclohex-1-ene-1-carboxyl-CoA hydratase activity;0;2;GO:0006081
GO:0018810;trans-4-[2-(3-hydroxy)-thionaphthenyl]-2-oxo-3-butenoate hydratase activity;0;0;GO:0004444
GO:0043813;phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity;6821;235;GO:0004721
GO:0043812;phosphatidylinositol-4-phosphate phosphatase activity;449;189;GO:0004721
GO:0043815;phosphoribosylglycinamide formyltransferase 2 activity;18560;4;GO:0006066
GO:0043814;phospholactate guanylyltransferase activity;10720;6;GO:0004733
GO:0043817;phosphosulfolactate synthase activity;417;4;GO:0003824
GO:0043816;phosphoserine-tRNA(Cys) ligase activity;674;5;GO:0006414
GO:0043819;precorrin-6A synthase (deacetylating) activity;9106;5;GO:0006032
GO:0043818;precorrin-3B synthase activity;1343;3;GO:0006032
GO:0043811;phosphate:acyl-[acyl carrier protein] acyltransferase activity;75415;0;GO:0008610
GO:0043810;ornithine-acyl [acyl carrier protein] N-acyltransferase activity;5;3;GO:0004081
GO:0006824;cobalt ion transport;117086;583;GO:0006826
GO:0006825;copper ion transport;124053;1600;GO:0006811
GO:0006828;manganese ion transport;85352;355;GO:0006826
GO:0006829;zinc ion transport;138408;1830;GO:0006836
GO:0006826;iron ion transport;890809;2910;GO:0006826
GO:0018800;5-oxopent-3-ene-1,2,5-tricarboxylate decarboxylase activity;4612;9;GO:0006081
GO:0016205;selenocysteine methyltransferase activity;6;5;GO:0003729
GO:0018868;2-aminobenzenesulfonate metabolic process;0;3;GO:0006749
GO:0016206;catechol O-methyltransferase activity;2211;122;GO:0004497
GO:0018867;alpha-pinene metabolic process;27;4;GO:0006721
GO:0016207;4-coumarate-CoA ligase activity;6248;99;GO:0004497
GO:0016208;AMP binding;39603;945;GO:0043531
GO:0016209;antioxidant activity;1906780;8880;GO:0016209
GO:0006882;intracellular zinc ion homeostasis;11148;54;GO:0006836
GO:0006883;intracellular sodium ion homeostasis;1349;53;GO:0006836
GO:0006880;intracellular sequestering of iron ion;968;475;GO:0006826
GO:0006881;extracellular sequestering of iron ion;5;3;GO:0005576
GO:0006886;intracellular protein transport;1746311;14900;GO:0015031
GO:0004222;metalloendopeptidase activity;955885;8130;GO:0008236
GO:0006887;exocytosis;177079;6300;GO:0006929
GO:0006884;cell volume homeostasis;6175;847;GO:0042592
GO:0006885;regulation of pH;59300;1640;GO:0010467
GO:0006879;intracellular iron ion homeostasis;264455;363;GO:0006879
GO:0031835;substance P receptor binding;31;4;GO:0005509
GO:0031836;neuromedin K receptor binding;4;2;GO:0005125
GO:0006877;intracellular cobalt ion homeostasis;9;1;GO:0006826
GO:0031833;type 7 serotonin receptor binding;0;1;GO:0005509
GO:0006878;intracellular copper ion homeostasis;12001;186;GO:0006865
GO:0031834;neurokinin receptor binding;48;1;GO:0005509
GO:0031839;type 1 neuromedin U receptor binding;53;2;GO:0004867
GO:0031837;substance K receptor binding;13;2;GO:0005509
GO:0031838;haptoglobin-hemoglobin complex;227;501;GO:0043161
GO:0018871;1-aminocyclopropane-1-carboxylate metabolic process;2555;9;GO:0006536
GO:0018870;anaerobic 2-aminobenzoate metabolic process;0;1;GO:0009065
GO:0016210;naringenin-chalcone synthase activity;1782;189;GO:0004497
GO:0018873;atrazine metabolic process;1129;4;GO:0006749
GO:0016211;ammonia ligase activity;219029;564;GO:0004497
GO:0018872;arsonoacetate metabolic process;121;9;GO:0006081
GO:0016212;kynurenine-oxoglutarate transaminase activity;1311;256;GO:0009065
GO:0018875;anaerobic benzoate metabolic process;3;1;GO:0006066
GO:0031831;type 5B serotonin receptor binding;0;0;GO:0005506
GO:0016213;linoleoyl-CoA desaturase activity;448;114;GO:0008610
GO:0018874;benzoate metabolic process;5470;59;GO:0006066
GO:0031832;type 6 serotonin receptor binding;0;1;GO:0005509
GO:0018877;beta-1,2,3,4,5,6-hexachlorocyclohexane metabolic process;0;2;GO:0046148
GO:0016215;acyl-CoA desaturase activity;11611;70;GO:0006631
GO:0018876;benzonitrile metabolic process;0;3;GO:0006096
GO:0031830;type 5A serotonin receptor binding;0;1;GO:0005509
GO:0018857;2,4-dichlorobenzoate-CoA ligase activity;0;2;GO:0006081
GO:0018856;benzoyl acetate-CoA ligase activity;0;2;GO:0006081
GO:0018859;4-hydroxybenzoate-CoA ligase activity;164;4;GO:0006099
GO:0018858;benzoate-CoA ligase activity;748;8;GO:0006081
GO:0006890;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;56355;1250;GO:0006986
GO:0006893;Golgi to plasma membrane transport;21461;906;GO:0006897
GO:0006891;intra-Golgi vesicle-mediated transport;24314;2190;GO:0006869
GO:0006892;post-Golgi vesicle-mediated transport;35912;1020;GO:0006890
GO:0006897;endocytosis;1141856;7930;GO:0006897
GO:0006898;receptor-mediated endocytosis;626046;4190;GO:0006897
GO:0006895;Golgi to endosome transport;8983;1520;GO:0006897
GO:0006896;Golgi to vacuole transport;4855;416;GO:0006897
GO:0031824;type 1E serotonin receptor binding;0;0;GO:0005509
GO:0031825;type 1F serotonin receptor binding;0;1;GO:0004984
GO:0006888;endoplasmic reticulum to Golgi vesicle-mediated transport;130681;1170;GO:0006986
GO:0031822;type 1B serotonin receptor binding;0;1;GO:0005509
GO:0031823;type 1D serotonin receptor binding;0;1;GO:0004867
GO:0031828;type 2C serotonin receptor binding;0;1;GO:0004930
GO:0031829;type 4 serotonin receptor binding;0;1;GO:0005509
GO:0031826;type 2A serotonin receptor binding;3;124;GO:0005509
GO:0031827;type 2B serotonin receptor binding;0;1;GO:0005509
GO:0018860;anthranilate-CoA ligase activity;144;4;GO:0006081
GO:0018862;phenylphosphate carboxylase activity;0;3;GO:0004497
GO:0016200;synaptic target attraction;15;55;GO:0048608
GO:0018861;4-chlorobenzoate-CoA ligase activity;179;3;GO:0006081
GO:0016201;synaptic target inhibition;149;37;GO:0048608
GO:0018864;acetylene metabolic process;0;3;GO:0006073
GO:0031820;P2Y11 nucleotide receptor binding;0;1;GO:0004930
GO:0016202;regulation of striated muscle tissue development;953;830;GO:0048731
GO:0018863;phenanthrene-9,10-epoxide hydrolase (9S,10S-forming) activity;0;2;GO:0008021
GO:0031821;G protein-coupled serotonin receptor binding;59;78;GO:0004930
GO:0016203;muscle attachment;917;91;GO:0007517
GO:0018866;adamantanone metabolic process;0;4;GO:0006073
GO:0016204;determination of muscle attachment site;77;21;GO:0048407
GO:0018865;acrylonitrile metabolic process;0;4;GO:0006073
GO:0018846;styrene-oxide isomerase activity;18;4;GO:0004497
GO:0018845;2-hydroxychromene-2-carboxylate isomerase activity;40838;5;GO:0004497
GO:0018848;pinocarveol isomerase activity;0;2;GO:0006099
GO:0018847;alpha-pinene lyase activity;0;2;GO:0046274
GO:0018849;muconate cycloisomerase activity;4317;7;GO:0003907
GO:0090199;regulation of release of cytochrome c from mitochondria;2336;101;GO:0048304
GO:0006860;extracellular amino acid transport;0;3;GO:0006865
GO:0031819;P2Y10 nucleotide receptor binding;0;1;GO:0004930
GO:0006864;pyrimidine nucleotide transport;1898;121;GO:0006865
GO:0090193;positive regulation of glomerulus development;174;8;GO:0048193
GO:0006865;amino acid transport;1588180;5780;GO:0006865
GO:0090194;negative regulation of glomerulus development;67;10;GO:0050731
GO:0006862;nucleotide transport;102045;144;GO:0006810
GO:0090191;negative regulation of branching involved in ureteric bud morphogenesis;138;82;GO:0048608
GO:0006863;purine nucleobase transport;61539;74;GO:0006873
GO:0090192;regulation of glomerulus development;242;8;GO:0050731
GO:0006857;oligopeptide transport;164304;1810;GO:0006865
GO:0031813;P2Y2 nucleotide receptor binding;0;1;GO:0005509
GO:0006858;extracellular transport;3226;70;GO:0006810
GO:0031814;P2Y4 nucleotide receptor binding;0;1;GO:0005509
GO:0006855;xenobiotic transmembrane transport;1839;641;GO:0006865
GO:0031811;G protein-coupled nucleotide receptor binding;4;44;GO:0005506
GO:0006856;eye pigment precursor transport;30;22;GO:0006836
GO:0031812;P2Y1 nucleotide receptor binding;4;10;GO:0005509
GO:0031817;P2Y8 nucleotide receptor binding;0;1;GO:0005509
GO:0031818;P2Y9 nucleotide receptor binding;0;0;GO:0005509
GO:0031815;P2Y5 nucleotide receptor binding;0;1;GO:0005509
GO:0031816;P2Y6 nucleotide receptor binding;0;1;GO:0005509
GO:0018851;alpha-pinene-oxide decyclase activity;1;3;GO:0004497
GO:0018850;chloromuconate cycloisomerase activity;4737;7;GO:0006099
GO:0018852;dichloromuconate cycloisomerase activity;0;3;GO:0006096
GO:0031810;H4 histamine receptor binding;0;1;GO:0005509
GO:0018855;2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity;0;4;GO:0006081
GO:0018854;3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity;0;2;GO:0006081
GO:0018835;carbon phosphorus lyase activity;10130;10;GO:0004553
GO:0018834;dichloromethane dehalogenase activity;112;5;GO:0004497
GO:0018837;2-hydroxy-2H-benzo[h]chromene-2-carboxylate isomerase activity;0;2;GO:0006073
GO:0018836;alkylmercury lyase activity;3691;9;GO:0004730
GO:0018839;cis-4-[2-(3-hydroxy)-thionaphthenyl]-2-oxo-3-butenoate isomerase activity;0;0;GO:0004497
GO:0018838;mandelate racemase activity;445;4;GO:0006081
GO:0031808;H2 histamine receptor binding;0;2;GO:0005509
GO:0031809;H3 histamine receptor binding;0;1;GO:0005509
GO:0006873;intracellular monoatomic ion homeostasis;436148;20;GO:0006874
GO:0006874;intracellular calcium ion homeostasis;86600;1160;GO:0006874
GO:0006868;glutamine transport;1736;139;GO:0006836
GO:0031802;type 5 metabotropic glutamate receptor binding;169;29;GO:0005509
GO:0006869;lipid transport;641424;8500;GO:0006869
GO:0031803;type 6 metabotropic glutamate receptor binding;0;0;GO:0005509
GO:0031800;type 3 metabotropic glutamate receptor binding;63;6;GO:0005509
GO:0006867;asparagine transport;622;119;GO:0006865
GO:0031801;type 4 metabotropic glutamate receptor binding;0;0;GO:0005509
GO:0031806;G protein-coupled histamine receptor binding;0;0;GO:0005509
GO:0031807;H1 histamine receptor binding;0;2;GO:0005509
GO:0031804;type 7 metabotropic glutamate receptor binding;0;0;GO:0005509
GO:0031805;type 8 metabotropic glutamate receptor binding;2;1;GO:0005509
GO:0018844;2-hydroxytetrahydrofuran isomerase activity;0;4;GO:0006091
GO:0043867;7-cyano-7-deazaguanine tRNA-ribosyltransferase activity;0;5;GO:0003906
GO:0043860;cyanophycin synthetase activity;10930;1;GO:0005524
GO:0043862;arginine:agmatine antiporter activity;1;3;GO:0009065
GO:0043861;agmatine:putrescine antiporter activity;0;1;GO:0009081
GO:0043864;indoleacetamide hydrolase activity;20791;54;GO:0004721
GO:0043863;4-hydroxy-2-ketopimelate aldolase activity;205;3;GO:0004073
GO:0043866;adenylyl-sulfate reductase (thioredoxin) activity;9116;4;GO:0004723
GO:0043865;methionine transmembrane transporter activity;21549;4;GO:0008565
GO:0031879;type 2 somatostatin receptor binding;0;1;GO:0005509
GO:0031877;somatostatin receptor binding;8;9;GO:0005509
GO:0031878;type 1 somatostatin receptor binding;1;1;GO:0005509
GO:0016250;N-sulfoglucosamine sulfohydrolase activity;267;26;GO:0004553
GO:0016251;RNA polymerase II general transcription initiation factor activity;8636;154;GO:0003700
GO:0031871;proteinase activated receptor binding;72;154;GO:0048407
GO:0031872;type 1 proteinase activated receptor binding;0;1;GO:0004930
GO:0016254;preassembly of GPI anchor in ER membrane;8;948;GO:0008544
GO:0016255;attachment of GPI anchor to protein;16696;344;GO:0043169
GO:0031870;thromboxane A2 receptor binding;85;10;GO:0005126
GO:0016256;N-glycan processing to lysosome;136;25;GO:0008029
GO:0031875;type 4 proteinase activated receptor binding;0;1;GO:0004930
GO:0016257;N-glycan processing to secreted and cell-surface N-glycans;0;4;GO:0008610
GO:0031876;secretin receptor binding;0;1;GO:0004872
GO:0016258;N-glycan diversification;0;3;GO:0008610
GO:0031873;type 2 proteinase activated receptor binding;0;0;GO:0004930
GO:0016259;selenocysteine metabolic process;50625;45;GO:0006457
GO:0031874;type 3 proteinase activated receptor binding;0;0;GO:0004930
GO:0043879;glycolate transmembrane transporter activity;1372;6;GO:0008544
GO:0016239;positive regulation of macroautophagy;5673;1020;GO:0045926
GO:0043878;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;17977;0;GO:0004073
GO:0043871;delta1-piperideine-6-carboxylate dehydrogenase activity;0;2;GO:0004497
GO:0043870;N-acetyl-gamma-aminoadipyl-phosphate reductase activity;830;2;GO:0004067
GO:0043873;pyruvate-flavodoxin oxidoreductase activity;265;3;GO:0004091
GO:0043872;lysine:cadaverine antiporter activity;1;6;GO:0009081
GO:0043875;2-ketobutyrate formate-lyase activity;2;2;GO:0006099
GO:0043874;acireductone synthase activity;14262;24;GO:0004497
GO:0043877;galactosamine-6-phosphate isomerase activity;1;0;GO:0006032
GO:0043876;D-threonine aldolase activity;636;4;GO:0006066
GO:0031868;prostaglandin F2-alpha receptor binding;0;1;GO:0005126
GO:0031869;prostacyclin receptor binding;0;1;GO:0005126
GO:0031866;EP3 subtype prostaglandin E2 receptor binding;0;1;GO:0005125
GO:0031867;EP4 subtype prostaglandin E2 receptor binding;49;7;GO:0005125
GO:0043880;crotonyl-CoA reductase activity;5395;3;GO:0006066
GO:0016240;autophagosome membrane docking;375;8;GO:0005764
GO:0016241;regulation of macroautophagy;9205;1410;GO:0048471
GO:0031860;telomeric 3' overhang formation;226;41;GO:0007030
GO:0016242;negative regulation of macroautophagy;2369;731;GO:0048471
GO:0031861;prolactin-releasing peptide receptor binding;19;2;GO:0005509
GO:0016243;regulation of autophagosome size;216;9;GO:0048471
GO:0031864;EP1 subtype prostaglandin E2 receptor binding;0;1;GO:0005125
GO:0031865;EP2 subtype prostaglandin E2 receptor binding;0;1;GO:0005125
GO:0016247;channel regulator activity;30320;577;GO:0048407
GO:0031862;prostanoid receptor binding;134;8;GO:0005126
GO:0016248;channel inhibitor activity;8249;66;GO:0048608
GO:0031863;prostaglandin D2 receptor binding;0;1;GO:0005125
GO:0102703;camphene synthase activity;6;3;GO:0004497
GO:0018889;2-chloro-N-isopropylacetanilide metabolic process;0;4;GO:0006569
GO:0043889;(S)-3-O-geranylgeranylglyceryl phosphate synthase activity;0;0;GO:0004721
GO:0102702;2-carene synthase activity;0;0;GO:0004497
GO:0016229;steroid dehydrogenase activity;72016;374;GO:0004730
GO:0102705;serine decarboxylase activity;4;1;GO:0004067
GO:0102704;GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity;6324;3;GO:0006022
GO:0102701;tricyclene synthase activity;22;3;GO:0004497
GO:0102700;alpha-thujene synthase activity;2;0;GO:0004497
GO:0043882;malate:sodium symporter activity;0;1;GO:0008544
GO:0043881;mesaconyl-CoA hydratase activity;0;2;GO:0006067
GO:0043884;CO-methylating acetyl-CoA synthase activity;2524;6;GO:0004497
GO:0043883;malolactic enzyme activity;1241;4;GO:0003954
GO:0043886;structural constituent of carboxysome shell;18816;5;GO:0043169
GO:0102707;S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity;20;1;GO:0004061
GO:0043885;carbon-monoxide dehydrogenase (ferredoxin) activity;8746;4;GO:0004746
GO:0102706;butein:oxygen oxidoreductase activity;4;2;GO:0004497
GO:0043888;(S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity;0;0;GO:0004721
GO:0102709;S-adenosyl-L-methionine:N,N-dimethyl-beta-alanine N-methyltransferase activity;0;0;GO:0004497
GO:0043887;melibiose:sodium symporter activity;1;1;GO:0008565
GO:0102708;S-adenosyl-L-methionine:N-methyl-beta-alanine N-methyltransferase activity;0;0;GO:0004497
GO:0031857;type 1 parathyroid hormone receptor binding;66;3;GO:0004930
GO:0031858;pituitary adenylate cyclase-activating polypeptide receptor binding;4;1;GO:0005125
GO:0031855;oxytocin receptor binding;15;5;GO:0004930
GO:0004239;initiator methionyl aminopeptidase activity;64237;6;GO:0004867
GO:0031856;parathyroid hormone receptor binding;83;3;GO:0004930
GO:0018891;cyclohexanol metabolic process;0;5;GO:0006066
GO:0031859;platelet activating factor receptor binding;3;10;GO:0005126
GO:0043891;glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity;40092;0;GO:0004073
GO:0018890;cyanamide metabolic process;4;5;GO:0006066
GO:0043890;N-acetylgalactosamine-6-sulfatase activity;1403;8;GO:0006029
GO:0016230;sphingomyelin phosphodiesterase activator activity;64;8;GO:0004867
GO:0018893;dibenzofuran metabolic process;7;5;GO:0006066
GO:0016231;beta-N-acetylglucosaminidase activity;7747;19;GO:0004553
GO:0018892;cyclohexylsulfamate metabolic process;0;6;GO:0006066
GO:0031850;delta-type opioid receptor binding;2;0;GO:0005509
GO:0016232;HNK-1 sulfotransferase activity;3;3;GO:0004723
GO:0018895;dibenzothiophene metabolic process;15;5;GO:0006749
GO:0016233;telomere capping;7623;485;GO:0007049
GO:0018894;dibenzo-p-dioxin metabolic process;72;289;GO:0046365
GO:0016234;inclusion body;4698;668;GO:0005737
GO:0018897;dibenzothiophene desulfurization;0;3;GO:0009081
GO:0031853;nociceptin receptor binding;0;1;GO:0005126
GO:0016235;aggresome;2114;899;GO:0006986
GO:0018896;dibenzothiophene catabolic process;15;4;GO:0046395
GO:0031854;orexigenic neuropeptide QRFP receptor binding;575;4;GO:0004930
GO:0016236;macroautophagy;62052;4020;GO:0006914
GO:0018899;1,2-dichloroethane metabolic process;2;1;GO:0006749
GO:0031851;kappa-type opioid receptor binding;6;2;GO:0031640
GO:0016237;lysosomal microautophagy;2679;115;GO:0006914
GO:0018898;2,4-dichlorobenzoate metabolic process;0;4;GO:0006749
GO:0031852;mu-type opioid receptor binding;67;323;GO:0005126
GO:0016216;isopenicillin-N synthase activity;64;6;GO:0004449
GO:0018879;biphenyl metabolic process;24;317;GO:0019438
GO:0102714;gibberellin A12,oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0016217;N-ethylammeline chlorohydrolase activity;0;1;GO:0004497
GO:0018878;aerobic beta-1,2,3,4,5,6-hexachlorocyclohexane metabolic process;0;1;GO:0046395
GO:0102713;gibberellin A25 hydroxylase activity;0;0;GO:0004497
GO:0016218;polyketide synthase activity;49;1;GO:0004415
GO:0102716;gibberellin A28,oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0102715;gibberellin A17,oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0102710;D-inositol-3-phosphate glycosyltransferase activity;9184;2;GO:0006030
GO:0102712;gibberellin A13,oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0102711;gibberellin A25,oxoglutarate:oxygen oxidoreductase activity;0;0;GO:0004091
GO:0004252;serine-type endopeptidase activity;1813687;11200;GO:0004252
GO:0043893;acetate:monoatomic cation symporter activity;22;2;GO:0005215
GO:0043892;methylglyoxal reductase (NADPH-dependent) activity;279;7;GO:0004067
GO:0043895;cyclomaltodextrin glucanotransferase activity;191;1;GO:0004553
GO:0043894;acetyl-CoA synthetase acetyltransferase activity;3;4;GO:0006081
GO:0043897;glucan 1,4-alpha-maltohydrolase activity;59;1;GO:0004553
GO:0102718;TRIBOA-glucoside methyltransferase activity;2;2;GO:0004725
GO:0043896;glucan 1,6-alpha-glucosidase activity;437;3;GO:0004553
GO:0102717;DIBOA-glucoside oxygenase activity;3;2;GO:0006073
GO:0043899;phosphoserine:homoserine phosphotransferase activity;1;1;GO:0004721
GO:0043898;2,3-dihydroxybiphenyl 1,2-dioxygenase activity;0;0;GO:0004497
GO:0102719;S-adenosyl-L-methionine:eugenol-O-methyltransferase activity;53;1;GO:0004725
GO:0031846;neurotensin receptor binding;0;1;GO:0005509
GO:0031847;type 1 neurotensin receptor binding;0;1;GO:0005509
GO:0031844;type 4 neuropeptide Y receptor binding;31;2;GO:0005509
GO:0031845;type 5 neuropeptide Y receptor binding;0;1;GO:0005509
GO:0018880;4-chlorobiphenyl metabolic process;5;2;GO:0006749
GO:0031848;protection from non-homologous end joining at telomere;1457;133;GO:0007050
GO:0031849;olfactory receptor binding;231;72;GO:0004930
GO:0018882;(+)-camphor metabolic process;13;2;GO:0006032
GO:0018881;bromoxynil metabolic process;0;2;GO:0046274
GO:0018884;carbazole metabolic process;9;1;GO:0006032
GO:0016222;procollagen-proline 4-dioxygenase complex;81;42;GO:0005581
GO:0018883;caprolactam metabolic process;0;3;GO:0006066
GO:0016223;beta-alanine-pyruvate transaminase activity;2784;7;GO:0004089
GO:0018886;anaerobic carbon tetrachloride metabolic process;0;2;GO:0009062
GO:0031842;type 1 neuropeptide Y receptor binding;0;1;GO:0005509
GO:0018885;carbon tetrachloride metabolic process;2;5;GO:0006725
GO:0031843;type 2 neuropeptide Y receptor binding;112;1;GO:0005509
GO:0018888;3-chloroacrylic acid metabolic process;0;3;GO:0006081
GO:0031840;type 2 neuromedin U receptor binding;52;2;GO:0004867
GO:0016226;iron-sulfur cluster assembly;433119;3320;GO:0005737
GO:0018887;4-carboxy-4'-sulfoazobenzene metabolic process;0;1;GO:0006725
GO:0031841;neuropeptide Y receptor binding;281;9;GO:0005509
GO:0043824;succinylglutamate-semialdehyde dehydrogenase activity;15275;3;GO:0004073
GO:0102725;24-methyldesmosterol reductase activity;0;1;GO:0004497
GO:0043823;spheroidene monooxygenase activity;58;4;GO:0004497
GO:0102724;UDP-glucose:curcumin monoglucoside glucosyltransferase activity;0;0;GO:0006029
GO:0043826;sulfur oxygenase reductase activity;0;4;GO:0004091
GO:0102727;3beta-hydroxysteroid dehydrogenase activity;0;0;GO:0004089
GO:0043825;succinylornithine transaminase activity;2042;5;GO:0004073
GO:0102726;DIMBOA glucoside beta-D-glucosidase activity;927;2;GO:0004553
GO:0043828;tRNA 2-selenouridine synthase activity;16028;25;GO:0006418
GO:0102721;ubiquinol:oxygen oxidoreductase activity;2706;4;GO:0003954
GO:0043827;tRNA (adenine-57, 58-N(1)-) methyltransferase activity;0;0;GO:0003735
GO:0102720;acetyl-coenzyme A:acetyl alcohol acetyltransferase activity;9;3;GO:0006081
GO:0102723;UDP-glucose:curcumin glucosyltransferase activity;0;0;GO:0006029
GO:0043829;tRNA-specific adenosine-37 deaminase activity;43;5;GO:0006418
GO:0043820;propionyl-CoA dehydrogenase activity;0;3;GO:0009061
GO:0102729;6-oxocampestanol hydroxylase activity;0;0;GO:0004497
GO:0035766;cell chemotaxis to fibroblast growth factor;477;7;GO:0048608
GO:0072757;cellular response to camptothecin;207;294;GO:0006974
GO:0033184;positive regulation of histone ubiquitination;47;19;GO:0016567
GO:0072709;cellular response to sorbitol;79;180;GO:0009432
GO:0033183;negative regulation of histone ubiquitination;0;30;GO:0043687
GO:0072708;response to sorbitol;193;8;GO:0009432
GO:0033182;regulation of histone ubiquitination;80;232;GO:0043687
GO:0072707;cellular response to sodium dodecyl sulfate;40;4;GO:0050829
GO:0033181;plasma membrane proton-transporting V-type ATPase complex;188;33;GO:0005576
GO:0072706;response to sodium dodecyl sulfate;40;1;GO:0006979
GO:0033188;sphingomyelin synthase activity;596;316;GO:0004722
GO:0033186;CAF-1 complex;577;173;GO:0000786
GO:0033185;dolichol-phosphate-mannose synthase complex;411;86;GO:0005524
GO:0047745;chlorogenate hydrolase activity;15;3;GO:0004553
GO:0060723;regulation of cell proliferation involved in embryonic placenta development;30;6;GO:0048608
GO:0047744;chloridazon-catechol dioxygenase activity;0;3;GO:0004497
GO:0047743;chlordecone reductase activity;32;4;GO:0004067
GO:0060725;regulation of coreceptor activity;0;3;GO:0030518
GO:1901820;alpha-zeacarotene catabolic process;0;0;GO:0009062
GO:0047742;chenodeoxycholoyltaurine hydrolase activity;4;4;GO:0004721
GO:0033180;proton-transporting V-type ATPase, V1 domain;25446;971;GO:0005525
GO:0047749;cholestanetriol 26-monooxygenase activity;172;6;GO:0004497
GO:1901822;delta-carotene metabolic process;0;0;GO:0006726
GO:0047748;cholestanetetraol 26-dehydrogenase activity;5;1;GO:0004497
GO:0060720;spongiotrophoblast cell proliferation;62;10;GO:0048608
GO:1901821;alpha-zeacarotene biosynthetic process;0;0;GO:0009081
GO:0047747;cholate-CoA ligase activity;110;7;GO:0004497
GO:0060721;regulation of spongiotrophoblast cell proliferation;30;10;GO:0048608
GO:1901824;delta-carotene biosynthetic process;0;0;GO:0006767
GO:0047746;chlorophyllase activity;2809;154;GO:0004497
GO:0060722;cell proliferation involved in embryonic placenta development;63;10;GO:0048608
GO:1901823;delta-carotene catabolic process;0;0;GO:0009813
GO:1901815;astaxanthin biosynthetic process;0;0;GO:0009813
GO:1901814;astaxanthin catabolic process;0;0;GO:0009812
GO:1901817;beta-zeacarotene catabolic process;0;0;GO:0046395
GO:1901816;beta-zeacarotene metabolic process;1;0;GO:0006745
GO:1901819;alpha-zeacarotene metabolic process;0;0;GO:0006745
GO:0047751;3-oxo-5alpha-steroid 4-dehydrogenase (NADP+);2922;10;GO:0004721
GO:1901818;beta-zeacarotene biosynthetic process;1;0;GO:0046395
GO:0047750;cholestenol delta-isomerase activity;4059;132;GO:0004067
GO:0060729;intestinal epithelial structure maintenance;696;309;GO:0032598
GO:0072701;cellular response to bismuth;0;0;GO:0071346
GO:0072700;response to bismuth;0;0;GO:0046686
GO:0033179;proton-transporting V-type ATPase, V0 domain;59705;744;GO:0005525
GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;583678;826;GO:0005524
GO:0072705;cellular response to mercaptoethanol;3;0;GO:0006950
GO:0072704;response to mercaptoethanol;3;0;GO:0006950
GO:0072703;cellular response to methyl methanesulfonate;58;4;GO:0045727
GO:0072702;response to methyl methanesulfonate;83;3;GO:0010033
GO:0033173;calcineurin-NFAT signaling cascade;2939;163;GO:0009986
GO:0033172;gas vesicle shell;6309;5;GO:0048646
GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;693026;441;GO:0005524
GO:0033176;proton-transporting V-type ATPase complex;93670;265;GO:0005764
GO:0033175;chloroplast proton-transporting ATP synthase complex, coupling factor CF(o);0;2;GO:0005746
GO:0033174;chloroplast proton-transporting ATP synthase complex, catalytic core CF(1);0;2;GO:0005746
GO:0047756;chondroitin 4-sulfotransferase activity;1153;27;GO:0004719
GO:0060712;spongiotrophoblast layer development;594;93;GO:0048608
GO:0047755;isocitrate epimerase activity;0;3;GO:0004067
GO:0060713;labyrinthine layer morphogenesis;900;139;GO:0048608
GO:0047754;choline sulfotransferase activity;0;3;GO:0004733
GO:0060714;labyrinthine layer formation;0;1;GO:0048608
GO:1901831;all-trans-neoxanthin metabolic process;0;1;GO:0009579
GO:0047753;choline-sulfatase activity;4028;3;GO:0005576
GO:0060715;syncytiotrophoblast cell differentiation involved in labyrinthine layer development;48;10;GO:0048608
GO:1901830;zeaxanthin bis(beta-D-glucoside) biosynthetic process;0;0;GO:0009865
GO:1901833;all-trans-neoxanthin biosynthetic process;0;0;GO:0009813
GO:0047759;butanal dehydrogenase activity;0;2;GO:0004474
GO:1901832;all-trans-neoxanthin catabolic process;0;0;GO:0009868
GO:0047758;ATP:2-methylpropanoate phosphotransferase activity;0;2;GO:0006089
GO:0060710;chorio-allantoic fusion;216;66;GO:0007565
GO:1901835;positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA;65;6;GO:0010467
GO:0047757;chondroitin-glucuronate 5-epimerase activity;122;60;GO:0004553
GO:0060711;labyrinthine layer development;2195;494;GO:0048608
GO:1901834;regulation of deadenylation-independent decapping of nuclear-transcribed mRNA;65;2;GO:0010467
GO:1901826;zeaxanthin catabolic process;5;1;GO:0009835
GO:1901825;zeaxanthin metabolic process;90;2;GO:0009865
GO:1901828;zeaxanthin bis(beta-D-glucoside) metabolic process;0;0;GO:0006073
GO:1901827;zeaxanthin biosynthetic process;85;5;GO:0009865
GO:0047763;caffeate O-methyltransferase activity;147;10;GO:0004725
GO:0060716;labyrinthine layer blood vessel development;860;635;GO:0001944
GO:0047762;caffeate 3,4-dioxygenase activity;0;3;GO:0004497
GO:0060717;chorion development;406;7;GO:0007565
GO:1901829;zeaxanthin bis(beta-D-glucoside) catabolic process;0;0;GO:0046274
GO:0047761;butyrate kinase activity;21130;9;GO:0004721
GO:0060718;chorionic trophoblast cell differentiation;319;233;GO:0048608
GO:0047760;butyrate-CoA ligase activity;343;41;GO:0006081
GO:0060719;chorionic trophoblast cell development;34;0;GO:0001944
GO:0033169;histone H3-K9 demethylation;9;1250;GO:0045944
GO:0033167;ARC complex;1067;3;GO:0005813
GO:0033162;melanosome membrane;9958;416;GO:0005576
GO:0033161;mitogen-activated protein kinase kinase kinase kinase binding;0;1;GO:0043406
GO:0072729;cellular response to Gentian violet;0;2;GO:0046686
GO:0060740;prostate gland epithelium morphogenesis;1882;677;GO:0048608
GO:0072728;response to Gentian violet;0;1;GO:0048608
GO:0033166;hyaline layer;2;6;GO:0048407
GO:0033165;interphotoreceptor matrix;2247;169;GO:0048407
GO:0033164;glycolipid 1,6-alpha-mannosyltransferase activity;54;4;GO:0006022
GO:0033163;microneme membrane;10;3;GO:0048305
GO:0045104;intermediate filament cytoskeleton organization;22947;1140;GO:0032989
GO:0060745;mammary gland branching involved in pregnancy;270;301;GO:0048608
GO:1901840;negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding;10;2;GO:0045944
GO:0045105;intermediate filament polymerization or depolymerization;53;8;GO:0048471
GO:0047766;carbamoyl-serine ammonia-lyase activity;0;3;GO:0004067
GO:0060746;parental behavior;395;23;GO:0007626
GO:0047765;caldesmon-phosphatase activity;0;2;GO:0004730
GO:0060747;oral incubation;0;1;GO:0007586
GO:1901842;negative regulation of high voltage-gated calcium channel activity;5;62;GO:0048608
GO:0045103;intermediate filament-based process;23131;694;GO:0030430
GO:0060748;tertiary branching involved in mammary gland duct morphogenesis;99;76;GO:0048608
GO:1901841;regulation of high voltage-gated calcium channel activity;28;307;GO:0048010
GO:0045108;regulation of intermediate filament polymerization or depolymerization;26;5;GO:0032989
GO:0060741;prostate gland stromal morphogenesis;89;39;GO:0048608
GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction;243;41;GO:0098609
GO:0045109;intermediate filament organization;2577;1110;GO:0043005
GO:0060742;epithelial cell differentiation involved in prostate gland development;488;679;GO:0030216
GO:1901843;positive regulation of high voltage-gated calcium channel activity;14;28;GO:0048010
GO:0045106;intermediate filament depolymerization;24;3;GO:0048193
GO:0047769;arogenate dehydratase activity;5377;80;GO:0006067
GO:0060743;epithelial cell maturation involved in prostate gland development;156;104;GO:0048608
GO:1901846;positive regulation of cell communication by electrical coupling involved in cardiac conduction;3;7;GO:0050890
GO:0045107;intermediate filament polymerization;22;3;GO:0043207
GO:0047768;carboxy-cis,cis-muconate cyclase activity;48;3;GO:0006032
GO:0060744;mammary gland branching involved in thelarche;221;64;GO:0048608
GO:1901845;negative regulation of cell communication by electrical coupling involved in cardiac conduction;26;2;GO:0048407
GO:0047770;carboxylate reductase activity;382;6;GO:0004067
GO:1901837;negative regulation of transcription of nucleolar large rRNA by RNA polymerase I;279;5;GO:0045944
GO:1901836;regulation of transcription of nucleolar large rRNA by RNA polymerase I;928;6;GO:0006351
GO:1901839;regulation of RNA polymerase I regulatory region sequence-specific DNA binding;10;0;GO:0045944
GO:1901838;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;554;74;GO:0045944
GO:0045111;intermediate filament cytoskeleton;139485;1620;GO:0030430
GO:0047774;cis-2-enoyl-CoA reductase (NADPH) activity;0;1;GO:0004089
GO:0060749;mammary gland alveolus development;862;1010;GO:0007517
GO:0045112;integrin biosynthetic process;415;26;GO:0008544
GO:0047773;carnitinamidase activity;0;4;GO:0004867
GO:0047772;carboxymethyloxysuccinate lyase activity;0;3;GO:0006081
GO:0045110;intermediate filament bundle assembly;504;185;GO:0048471
GO:0047771;carboxymethylhydantoinase activity;1;3;GO:0004553
GO:0072723;cellular response to amitrole;0;1;GO:0071346
GO:0072722;response to amitrole;4;0;GO:0046686
GO:0033157;regulation of intracellular protein transport;13568;1180;GO:0051603
GO:0072721;cellular response to dithiothreitol;44;0;GO:0006979
GO:0033156;oligogalacturonide transport;8;1;GO:0006869
GO:0072720;response to dithiothreitol;112;23;GO:0006979
GO:0072725;cellular response to 4-nitroquinoline N-oxide;0;2;GO:0006979
GO:0072724;response to 4-nitroquinoline N-oxide;1;2;GO:0006979
GO:0033151;V(D)J recombination;92044;949;GO:0002776
GO:0033150;cytoskeletal calyx;10;32;GO:0005925
GO:0072719;cellular response to cisplatin;156;27;GO:0048583
GO:0072718;response to cisplatin;301;40;GO:0097194
GO:0072717;cellular response to actinomycin D;132;40;GO:0006950
GO:0033154;ABC-type oligogalacturonide transporter activity;4;1;GO:0005576
GO:0033153;T cell receptor V(D)J recombination;235;125;GO:0002776
GO:0033152;immunoglobulin V(D)J recombination;457;101;GO:0002440
GO:0045115;regulation of beta 2 integrin biosynthetic process;0;2;GO:0048010
GO:0047778;[citrate-(pro-3S)-lyase] thiolesterase activity;0;0;GO:0004733
GO:0060734;regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation;6;9;GO:0006986
GO:1901851;7,8-didemethyl-8-hydroxy-5-deazariboflavin catabolic process;0;0;GO:0009065
GO:0045116;protein neddylation;24452;2610;GO:0006486
GO:0047777;(S)-citramalyl-CoA lyase activity;196;0;GO:0006081
GO:0060735;regulation of eIF2 alpha phosphorylation by dsRNA;25;128;GO:0010401
GO:1901850;7,8-didemethyl-8-hydroxy-5-deazariboflavin metabolic process;0;0;GO:0006749
GO:0045113;regulation of integrin biosynthetic process;371;39;GO:0048010
GO:0047776;citramalate lyase activity;1;3;GO:0006081
GO:0060736;prostate gland growth;457;886;GO:0048608
GO:1901853;5,6,7,8-tetrahydrosarcinapterin metabolic process;0;0;GO:0006765
GO:0045114;beta 2 integrin biosynthetic process;0;2;GO:0006916
GO:0047775;citramalate CoA-transferase activity;12;3;GO:0006081
GO:0060737;prostate gland morphogenetic growth;213;4;GO:0048608
GO:1901852;7,8-didemethyl-8-hydroxy-5-deazariboflavin biosynthetic process;0;0;GO:0009065
GO:0045119;azole:proton antiporter activity;62;1;GO:0005215
GO:0060730;regulation of intestinal epithelial structure maintenance;103;19;GO:0048407
GO:1901855;5,6,7,8-tetrahydrosarcinapterin biosynthetic process;0;0;GO:0046395
GO:0060731;positive regulation of intestinal epithelial structure maintenance;48;4;GO:0048407
GO:1901854;5,6,7,8-tetrahydrosarcinapterin catabolic process;0;0;GO:0046395
GO:0045117;azole transmembrane transport;19555;3;GO:0008565
GO:0060732;positive regulation of inositol phosphate biosynthetic process;444;248;GO:0046394
GO:1901857;positive regulation of cellular respiration;736;66;GO:0015986
GO:0047779;citrate-CoA ligase activity;1;2;GO:0006099
GO:1901856;negative regulation of cellular respiration;421;26;GO:0045747
GO:0047781;citrullinase activity;1;4;GO:0004721
GO:1901848;nicotinate catabolic process;12;0;GO:0009065
GO:0047780;citrate dehydratase activity;51017;69;GO:0004067
GO:1901847;nicotinate metabolic process;67;3;GO:0006749
GO:1901849;nicotinate biosynthetic process;0;1;GO:0009063
GO:0045122;aflatoxin biosynthetic process;1515;8;GO:0009813
GO:0047785;cortisol sulfotransferase activity;0;3;GO:0004730
GO:0060738;epithelial-mesenchymal signaling involved in prostate gland development;165;89;GO:0048608
GO:0045123;cellular extravasation;3848;1790;GO:0048661
GO:0047784;cortisol O-acetyltransferase activity;0;3;GO:0004721
GO:0060739;mesenchymal-epithelial cell signaling involved in prostate gland development;48;6;GO:0048608
GO:0045120;pronucleus;1233;765;GO:0005634
GO:0047783;corticosterone 18-monooxygenase activity;49;31;GO:0004497
GO:0045121;membrane raft;48351;6940;GO:0071944
GO:0047782;coniferin beta-glucosidase activity;19;6;GO:0004553
GO:0033148;positive regulation of intracellular estrogen receptor signaling pathway;570;127;GO:0030518
GO:0072712;response to thiabendazole;1;0;GO:0046686
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;658;998;GO:0030518
GO:0072711;cellular response to hydroxyurea;491;102;GO:0006974
GO:0033146;regulation of intracellular estrogen receptor signaling pathway;1748;272;GO:0030518
GO:0072710;response to hydroxyurea;579;9;GO:0006974
GO:0033145;positive regulation of intracellular steroid hormone receptor signaling pathway;651;9;GO:0030518
GO:0072716;response to actinomycin D;186;8;GO:0009628
GO:0072715;cellular response to selenite ion;5;1;GO:0046395
GO:0072714;response to selenite ion;7;3;GO:0046395
GO:0033149;FFAT motif binding;270;203;GO:0048471
GO:0072713;cellular response to thiabendazole;0;1;GO:0050832
GO:0070290;N-acylphosphatidylethanolamine-specific phospholipase D activity;26322;263;GO:0008033
GO:0070291;N-acylethanolamine metabolic process;683;34;GO:0006661
GO:0070284;4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate synthase activity;2;1;GO:0006061
GO:0070281;pyridoxamine binding;1;1;GO:0097367
GO:0070282;pyridoxine binding;1;0;GO:0097367
GO:0070287;ferritin receptor activity;805;7;GO:0004872
GO:0070288;ferritin complex;53;9;GO:0005829
GO:0070285;pigment cell development;178;5;GO:0048608
GO:0070286;axonemal dynein complex assembly;16171;2300;GO:0005525
GO:0070289;extracellular ferritin complex;0;2;GO:0005576
GO:0070280;pyridoxal binding;11;4;GO:0005524
GO:0070273;phosphatidylinositol-4-phosphate binding;12954;745;GO:0005524
GO:0070276;halogen metabolic process;1;4;GO:0006730
GO:0070277;iodide oxidation;0;0;GO:0046395
GO:0070274;RES complex;117;6;GO:0005737
GO:0070275;aerobic ammonia oxidation to nitrite via pyruvic oxime;0;1;GO:0009065
GO:0070278;extracellular matrix constituent secretion;767;42;GO:0005578
GO:0070279;vitamin B6 binding;1827642;427;GO:0097367
GO:0070294;renal sodium ion absorption;688;131;GO:0006836
GO:0070295;renal water absorption;263;150;GO:0006811
GO:0070292;N-acylphosphatidylethanolamine metabolic process;559;159;GO:0006631
GO:0070293;renal absorption;1802;261;GO:0007599
GO:0070298;negative regulation of phosphorelay signal transduction system;3870;7;GO:0009414
GO:0070299;positive regulation of phosphorelay signal transduction system;2;2;GO:0007218
GO:0070296;sarcoplasmic reticulum calcium ion transport;2039;1200;GO:0006836
GO:0070297;regulation of phosphorelay signal transduction system;4238;5;GO:0007218
GO:1901781;p-cumate metabolic process;0;1;GO:0006725
GO:1901780;pentalenolactone biosynthetic process;6;0;GO:0006032
GO:1901783;p-cumate biosynthetic process;0;1;GO:0046395
GO:1901782;p-cumate catabolic process;0;0;GO:0009065
GO:1901785;p-cresol catabolic process;1;1;GO:0009065
GO:1901784;p-cresol metabolic process;1;0;GO:0006096
GO:0045289;luciferin monooxygenase activity;145;3;GO:0004497
GO:1901787;benzoyl-CoA metabolic process;53;4;GO:0006066
GO:1901786;p-cresol biosynthetic process;0;0;GO:0006096
GO:1901789;benzoyl-CoA biosynthetic process;0;1;GO:0006022
GO:1901788;benzoyl-CoA catabolic process;4;1;GO:0009062
GO:0045294;alpha-catenin binding;830;457;GO:0005576
GO:0045295;gamma-catenin binding;622;325;GO:0005576
GO:0070240;negative regulation of activated T cell autonomous cell death;0;6;GO:0010942
GO:0045292;mRNA cis splicing, via spliceosome;60790;1560;GO:0000398
GO:0045293;mRNA editing complex;2771;117;GO:0000786
GO:0045298;tubulin complex;114;584;GO:0005839
GO:0070243;regulation of thymocyte apoptotic process;811;31;GO:0042981
GO:0045299;otolith mineralization;139;6;GO:0048608
GO:0070244;negative regulation of thymocyte apoptotic process;442;148;GO:0043066
GO:0045296;cadherin binding;14529;5060;GO:0048471
GO:0070241;positive regulation of activated T cell autonomous cell death;6;3;GO:0010942
GO:0070242;thymocyte apoptotic process;1323;78;GO:0042981
GO:0070247;regulation of natural killer cell apoptotic process;42;1;GO:0043066
GO:0070248;negative regulation of natural killer cell apoptotic process;0;2;GO:0043066
GO:0070245;positive regulation of thymocyte apoptotic process;221;294;GO:0043066
GO:0070246;natural killer cell apoptotic process;42;3;GO:0042981
GO:0045290;D-arabinose 1-dehydrogenase [NAD(P)+] activity;824;0;GO:0009065
GO:0045291;mRNA trans splicing, SL addition;139363;8;GO:0006415
GO:0070249;positive regulation of natural killer cell apoptotic process;0;0;GO:0043066
GO:1901790;3-(2,3-dihydroxyphenyl)propanoate metabolic process;0;0;GO:0009062
GO:1901792;3-(2,3-dihydroxyphenyl)propanoate biosynthetic process;0;0;GO:0046148
GO:1901791;3-(2,3-dihydroxyphenyl)propanoate catabolic process;0;0;GO:0046395
GO:1901794;3-(3-hydroxyphenyl)propanoate catabolic process;0;0;GO:0046395
GO:1901793;3-(3-hydroxyphenyl)propanoate metabolic process;0;0;GO:0009062
GO:1901796;regulation of signal transduction by p53 class mediator;6007;1310;GO:0030528
GO:1901795;3-(3-hydroxyphenyl)propanoate biosynthetic process;0;0;GO:0006073
GO:1901798;positive regulation of signal transduction by p53 class mediator;2543;58;GO:0030528
GO:1901797;negative regulation of signal transduction by p53 class mediator;2280;58;GO:0030528
GO:1901799;negative regulation of proteasomal protein catabolic process;2625;152;GO:0043161
GO:0070232;regulation of T cell apoptotic process;2137;100;GO:0042981
GO:0070233;negative regulation of T cell apoptotic process;1257;277;GO:0043066
GO:0070230;positive regulation of lymphocyte apoptotic process;851;30;GO:0042981
GO:0070231;T cell apoptotic process;3527;593;GO:0006915
GO:0070236;negative regulation of activation-induced cell death of T cells;166;75;GO:0043066
GO:0070237;positive regulation of activation-induced cell death of T cells;2;3;GO:0046330
GO:0070234;positive regulation of T cell apoptotic process;557;549;GO:0043066
GO:0070235;regulation of activation-induced cell death of T cells;219;98;GO:0046330
GO:0070238;activated T cell autonomous cell death;6;2;GO:0008219
GO:0070239;regulation of activated T cell autonomous cell death;6;5;GO:0010942
GO:0070262;peptidyl-serine dephosphorylation;246;377;GO:0006468
GO:0070260;5'-tyrosyl-DNA phosphodiesterase activity;175;4;GO:0004518
GO:0070266;necroptotic process;3783;852;GO:0043066
GO:0070263;external side of fungal-type cell wall;5;1;GO:0005618
GO:0070264;transcription factor TFIIIE complex;0;1;GO:0003700
GO:0070269;pyroptosis;1339;987;GO:0004637
GO:0070268;cornification;161;915;GO:0005578
GO:0070250;mating projection membrane;12;6;GO:0048608
GO:0070251;pristanate-CoA ligase activity;74;7;GO:0006081
GO:0070254;mucus secretion;1593;34;GO:0007517
GO:0070255;regulation of mucus secretion;918;18;GO:0002541
GO:0070252;actin-mediated cell contraction;6427;1060;GO:0048507
GO:0070253;somatostatin secretion;90;9;GO:0007596
GO:0070258;inner membrane pellicle complex;24;4;GO:0043169
GO:0070259;tyrosyl-DNA phosphodiesterase activity;442;8;GO:0008021
GO:0070256;negative regulation of mucus secretion;105;19;GO:0050729
GO:0070257;positive regulation of mucus secretion;781;77;GO:0050729
GO:0008302;female germline ring canal formation, actin assembly;5;10;GO:0008544
GO:0008301;DNA binding, bending;3384;652;GO:0003677
GO:0008300;isoprenoid catabolic process;7150;19;GO:0009062
GO:0008306;associative learning;4253;1500;GO:0007612
GO:0008305;integrin complex;32739;1770;GO:0005911
GO:0008303;caspase complex;20719;105;GO:0008312
GO:0035918;negative regulation of voltage-gated calcium channel activity in another organism;0;0;GO:0048704
GO:0035919;negative regulation of low voltage-gated calcium channel activity in another organism;0;0;GO:0048704
GO:0035914;skeletal muscle cell differentiation;4251;1370;GO:0045595
GO:0035915;pore formation in membrane of another organism;9;1;GO:0009986
GO:0035916;modulation of calcium channel activity in another organism;2;0;GO:0008092
GO:0035917;negative regulation of calcium channel activity in another organism;0;0;GO:0008092
GO:0035910;ascending aorta morphogenesis;145;151;GO:0048608
GO:0035911;descending aorta morphogenesis;0;3;GO:0048608
GO:0035912;dorsal aorta morphogenesis;566;194;GO:0048608
GO:0035913;ventral aorta morphogenesis;0;2;GO:0048608
GO:0008312;7S RNA binding;81655;1410;GO:0003723
GO:0008311;double-stranded DNA 3'-5' DNA exonuclease activity;88738;4;GO:0004518
GO:0008310;single-stranded DNA 3'-5' DNA exonuclease activity;20819;3;GO:0004518
GO:0008316;structural constituent of vitelline membrane;22;6;GO:0048407
GO:0008315;G2/MI transition of meiotic cell cycle;265;6;GO:0007067
GO:0035907;dorsal aorta development;841;10;GO:0002041
GO:0008309;double-stranded DNA exodeoxyribonuclease activity;91281;22;GO:0004518
GO:0035908;ventral aorta development;2;1;GO:0002044
GO:0008308;voltage-gated monoatomic anion channel activity;103830;29;GO:0005216
GO:0035909;aorta morphogenesis;1746;356;GO:0048589
GO:0008307;structural constituent of muscle;2136;1920;GO:0005544
GO:0035903;cellular response to immobilization stress;4;3;GO:0006950
GO:0035904;aorta development;3483;606;GO:0001944
GO:0035905;ascending aorta development;199;134;GO:0048589
GO:0035906;descending aorta development;56;4;GO:0048589
GO:0035900;response to isolation stress;27;39;GO:0009628
GO:0035901;cellular response to isolation stress;0;4;GO:0006950
GO:0035902;response to immobilization stress;209;470;GO:0006950
GO:0047829;D-nopaline dehydrogenase activity;17;4;GO:0006099
GO:0047828;D-lyxose ketol-isomerase activity;95;4;GO:0006067
GO:0047827;D-lysopine dehydrogenase activity;6;2;GO:0004449
GO:0047822;hypotaurine dehydrogenase activity;4806;5;GO:0004067
GO:0060800;regulation of cell differentiation involved in embryonic placenta development;224;48;GO:0030182
GO:0047821;D-glutamate oxidase activity;7;3;GO:0004725
GO:0047820;D-glutamate cyclase activity;36;19;GO:0004725
GO:0060802;epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification;50;5;GO:0009952
GO:0047826;D-lysine 5,6-aminomutase activity;108;3;GO:0003906
GO:0008228;opsonization;502;510;GO:0002376
GO:0047825;D-lactate-2-sulfatase activity;0;4;GO:0004733
GO:0008227;G protein-coupled amine receptor activity;47686;590;GO:0004930
GO:0047824;D-iditol 2-dehydrogenase activity;8;3;GO:0004497
GO:0008226;tyramine receptor activity;29;6;GO:0004930
GO:0047823;D-glutamyltransferase activity;2;3;GO:0004721
GO:0060808;positive regulation of mesodermal to mesenchymal transition involved in gastrulation;0;3;GO:0048704
GO:0060809;mesodermal to mesenchymal transition involved in gastrulation;119;7;GO:0048704
GO:0008219;cell death;416774;11500;GO:0008219
GO:0035837;ergot alkaloid biosynthetic process;99;4;GO:0046356
GO:0035838;growing cell tip;690;68;GO:0048316
GO:0035839;non-growing cell tip;107;4;GO:0048285
GO:0060806;negative regulation of cell differentiation involved in embryonic placenta development;56;2;GO:0048706
GO:0035833;berbamunine biosynthetic process;1;1;GO:0046395
GO:0035834;indole alkaloid metabolic process;737;2;GO:0006725
GO:0035835;indole alkaloid biosynthetic process;728;3;GO:0046394
GO:0035836;ergot alkaloid metabolic process;99;1;GO:0006032
GO:0035830;palmatine metabolic process;0;1;GO:0006749
GO:0035831;palmatine biosynthetic process;0;1;GO:0046395
GO:0035832;berbamunine metabolic process;1;3;GO:0006066
GO:0047839;dATP(dGTP)-DNA purinetransferase activity;0;0;GO:0003676
GO:0047838;D-xylose 1-dehydrogenase (NAD) activity;54;2;GO:0008800
GO:0008232;activator ecdysone receptor complex;29;5;GO:0005524
GO:0008231;repressor ecdysone receptor complex;23;4;GO:0048608
GO:0008230;ecdysone receptor holocomplex;97;9;GO:0005524
GO:0008236;serine-type peptidase activity;3567690;6040;GO:0004222
GO:0047833;D-sorbitol dehydrogenase (acceptor) activity;512;4;GO:0006066
GO:0008235;metalloexopeptidase activity;621032;1340;GO:0004721
GO:0047832;D-pinitol dehydrogenase activity;0;3;GO:0004067
GO:0008234;cysteine-type peptidase activity;991632;4650;GO:0004867
GO:0047831;D-ornithine 4,5-aminomutase activity;118;3;GO:0004467
GO:0008233;peptidase activity;15939776;12000;GO:0008233
GO:0047830;D-octopine dehydrogenase activity;42;3;GO:0004067
GO:0047837;D-xylose 1-dehydrogenase (NADP+) activity;274;0;GO:0003954
GO:0008239;dipeptidyl-peptidase activity;87024;1020;GO:0004867
GO:0047836;D-tryptophan N-malonyltransferase activity;0;3;GO:0006073
GO:0008238;exopeptidase activity;2685259;1310;GO:0004601
GO:0047835;D-tryptophan N-acetyltransferase activity;0;3;GO:0009065
GO:0008237;metallopeptidase activity;3104828;5100;GO:0008236
GO:0047834;D-threo-aldose 1-dehydrogenase activity;952;81;GO:0004089
GO:0047840;dCTP diphosphatase activity;3660;17;GO:0004553
GO:0035822;gene conversion;300;9;GO:0003677
GO:0035823;short tract gene conversion;0;1;GO:0043161
GO:0035824;long tract gene conversion;0;1;GO:0048285
GO:0035825;homologous recombination;27101;656;GO:0006310
GO:0035820;negative regulation of renal sodium excretion by angiotensin;0;1;GO:0048193
GO:0035821;modulation of process of another organism;2606112;179;GO:0048518
GO:0047849;dextransucrase activity;874;3;GO:0005929
GO:0008203;cholesterol metabolic process;57556;3510;GO:0008203
GO:0047844;deoxycytidine deaminase activity;14274;137;GO:0004518
GO:0008202;steroid metabolic process;297682;7440;GO:0008202
GO:0047843;dehydrogluconate dehydrogenase activity;78;3;GO:0004067
GO:0060823;canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation;137;7;GO:0007219
GO:0008201;heparin binding;45433;7440;GO:0048407
GO:0047842;dehydro-L-gulonate decarboxylase activity;0;4;GO:0006073
GO:0060824;retinoic acid receptor signaling pathway involved in neural plate anterior/posterior pattern formation;0;0;GO:0007631
GO:0008200;ion channel inhibitor activity;8189;304;GO:0048407
GO:0047841;dehydrogluconokinase activity;51;4;GO:0004730
GO:0060825;fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation;118;8;GO:0007218
GO:0008207;C21-steroid hormone metabolic process;2899;642;GO:0046649
GO:0047848;dephospho-[reductase kinase] kinase activity;0;0;GO:0004721
GO:0008206;bile acid metabolic process;4581;1470;GO:0007566
GO:0047847;deoxyuridine phosphorylase activity;1905;4;GO:0004518
GO:0008205;ecdysone metabolic process;139;7;GO:0019217
GO:0047846;deoxynucleotide 3'-phosphatase activity;309;0;GO:0004518
GO:0008204;ergosterol metabolic process;2880;155;GO:0006749
GO:0047845;deoxylimonate A-ring-lactonase activity;0;3;GO:0004746
GO:0035819;positive regulation of renal sodium excretion by pressure natriuresis;0;1;GO:0048193
GO:0035815;positive regulation of renal sodium excretion;120;208;GO:0050727
GO:0047851;dicarboxylate-CoA ligase activity;46;2;GO:0006099
GO:0047850;diaminopimelate dehydrogenase activity;13626;10;GO:0006066
GO:0060827;regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation;136;7;GO:0048704
GO:0035817;renal sodium ion absorption involved in negative regulation of renal sodium excretion;0;1;GO:0048193
GO:0060828;regulation of canonical Wnt signaling pathway;25007;1020;GO:0048216
GO:0035818;positive regulation of urine volume by pressure natriuresis;0;1;GO:0048193
GO:0060829;negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation;60;8;GO:0048704
GO:0035811;negative regulation of urine volume;144;198;GO:0050727
GO:0035812;renal sodium excretion;355;34;GO:0050921
GO:0035813;regulation of renal sodium excretion;189;48;GO:0050921
GO:0035814;negative regulation of renal sodium excretion;15;112;GO:0010468
GO:0035810;positive regulation of urine volume;300;194;GO:0050727
GO:0008210;estrogen metabolic process;3326;699;GO:0046649
GO:0008214;protein dealkylation;42;908;GO:0046395
GO:0047855;dihydrobunolol dehydrogenase activity;0;3;GO:0004073
GO:0060811;intracellular mRNA localization involved in anterior/posterior axis specification;1220;6;GO:0003700
GO:0008213;protein alkylation;2443;717;GO:0043161
GO:0047854;diguanidinobutanase activity;0;4;GO:0004553
GO:0060812;orthodenticle mRNA localization;0;1;GO:0003700
GO:0008212;mineralocorticoid metabolic process;610;33;GO:0046323
GO:0047853;difructose-anhydride synthase activity;0;3;GO:0006032
GO:0060813;anterior mRNA localization involved in anterior/posterior axis specification;13;1;GO:0003700
GO:0008211;glucocorticoid metabolic process;1304;438;GO:0009060
GO:0047852;diferric-transferrin reductase activity;0;3;GO:0003735
GO:0060814;posterior mRNA localization involved in anterior/posterior axis specification;24;0;GO:0003700
GO:0008218;bioluminescence;19934;232;GO:0048608
GO:0008217;regulation of blood pressure;16631;3120;GO:0048010
GO:0047858;dihydroxyfumarate decarboxylase activity;0;2;GO:0006066
GO:0008216;spermidine metabolic process;156635;339;GO:0009065
GO:0047857;dihydrouracil oxidase activity;0;3;GO:0004721
GO:0008215;spermine metabolic process;7981;35;GO:0006730
GO:0047856;dihydrocoumarin hydrolase activity;3;4;GO:0016829
GO:0060810;intracellular mRNA localization involved in pattern specification process;1274;7;GO:0048608
GO:0035808;meiotic recombination initiation complex;4;2;GO:0000786
GO:0035809;regulation of urine volume;617;245;GO:0050789
GO:0008209;androgen metabolic process;2360;772;GO:0007596
GO:0008208;C21-steroid hormone catabolic process;8;4;GO:0019217
GO:0035804;structural constituent of egg coat;3130;88;GO:0008544
GO:0047862;diisopropyl-fluorophosphatase activity;13;2;GO:0004730
GO:0060815;regulation of translation involved in anterior/posterior axis specification;0;4;GO:0006414
GO:0035805;egg coat;10340;10;GO:0005618
GO:0045200;establishment of neuroblast polarity;95;249;GO:0048666
GO:0047861;diiodotyrosine transaminase activity;0;2;GO:0004497
GO:0060816;random inactivation of X chromosome;157;5;GO:0007049
GO:0035806;perturbation of blood coagulation in another organism;186;1;GO:0007596
GO:0047860;diiodophenylpyruvate reductase activity;1;5;GO:0004067
GO:0035807;induction of blood coagulation in another organism;171;0;GO:0007596
GO:0060818;inactivation of paternal X chromosome by genomic imprinting;0;2;GO:0002034
GO:0035800;deubiquitinase activator activity;226;112;GO:0004842
GO:0035801;adrenal cortex development;105;6;GO:0007517
GO:0035802;adrenal cortex formation;57;16;GO:0007517
GO:0035803;egg coat formation;3275;103;GO:0008544
GO:0008261;allatostatin receptor activity;87;9;GO:0004930
GO:0035880;embryonic nail plate morphogenesis;235;228;GO:0048608
GO:0008260;succinyl-CoA:3-oxo-acid CoA-transferase activity;8446;7;GO:0006081
GO:0035881;amacrine cell differentiation;882;47;GO:0048666
GO:0035882;defecation rhythm;37;3;GO:0007599
GO:0035883;enteroendocrine cell differentiation;4137;36;GO:0007586
GO:0008265;Mo-molybdopterin cofactor sulfurase activity;6305;35;GO:0004723
GO:0033221;ATPase-coupled urea transmembrane transporter activity;0;5;GO:0005215
GO:0008263;pyrimidine-specific mismatch base pair DNA N-glycosylase activity;3216;10;GO:0004518
GO:0008269;JAK pathway signal transduction adaptor activity;53;58;GO:0030528
GO:0008267;poly-glutamine tract binding;0;24;GO:0005515
GO:0008266;poly(U) RNA binding;2103;1090;GO:0003723
GO:0033219;urea binding;1;16;GO:0043169
GO:0033214;siderophore-dependent iron import into cell;146158;4;GO:0006826
GO:0035877;death effector domain binding;237;251;GO:0005515
GO:0035878;nail development;560;47;GO:0008544
GO:0033212;iron import into cell;154586;385;GO:0006826
GO:0035879;plasma membrane lactate transport;102;180;GO:0006814
GO:0033211;adiponectin-activated signaling pathway;569;76;GO:0030599
GO:0033218;amide binding;627268;901;GO:0042302
GO:0035873;lactate transmembrane transport;77372;90;GO:0006814
GO:0033217;regulation of transcription from RNA polymerase II promoter in response to iron ion starvation;337;3;GO:0045944
GO:0035874;cellular response to copper ion starvation;75;8;GO:0009739
GO:0035875;maintenance of meiotic sister chromatid cohesion, centromeric;130;1;GO:0007070
GO:0033215;reductive iron assimilation;118;9;GO:0006879
GO:0035876;maintenance of meiotic sister chromatid cohesion, arms;0;1;GO:0007070
GO:0008272;sulfate transport;300810;2610;GO:0006826
GO:0008271;secondary active sulfate transmembrane transporter activity;19911;670;GO:0008544
GO:0035870;dITP diphosphatase activity;59051;26;GO:0004723
GO:0008270;zinc ion binding;4814413;29800;GO:0008270
GO:0035871;protein K11-linked deubiquitination;39;1060;GO:0006464
GO:0035872;nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;1796;263;GO:0007186
GO:0008276;protein methyltransferase activity;621241;988;GO:0008168
GO:0033210;leptin-mediated signaling pathway;950;144;GO:0007179
GO:0008275;gamma-tubulin small complex;190;204;GO:0005819
GO:0008273;calcium, potassium:sodium antiporter activity;1394;73;GO:0006811
GO:0008278;cohesin complex;18133;329;GO:0007030
GO:0008277;regulation of G protein-coupled receptor signaling pathway;23134;1230;GO:0007186
GO:0033209;tumor necrosis factor-mediated signaling pathway;13725;2010;GO:0006954
GO:0033208;UDP-N-acetylgalactosamine:N-acetylneuraminyl-alpha-2,3-galactosyl-beta-R 1,4-N-acetylgalactosaminyltransferase activity;0;1;GO:0005576
GO:0033203;DNA helicase A complex;1;3;GO:0005839
GO:0035866;alphav-beta3 integrin-PKCalpha complex;101;5;GO:0005976
GO:0033202;DNA helicase complex;42168;205;GO:0005839
GO:0035867;alphav-beta3 integrin-IGF-1-IGF1R complex;223;46;GO:0005975
GO:0033201;alpha-1,4-glucan synthase activity;33774;6;GO:0005976
GO:0035868;alphav-beta3 integrin-HMGB1 complex;126;9;GO:0030199
GO:0033200;inositol heptakisphosphate 5-kinase activity;0;1;GO:0004721
GO:0035869;ciliary transition zone;8255;524;GO:0005576
GO:0033207;beta-1,4-N-acetylgalactosaminyltransferase activity;81;1;GO:0004553
GO:0035862;dITP metabolic process;20;1;GO:0006796
GO:0033206;meiotic cytokinesis;1280;21;GO:0007067
GO:0035863;dITP catabolic process;20;8;GO:0006559
GO:0035864;response to potassium ion;453;145;GO:0043169
GO:0033204;ribonuclease P RNA binding;6818;199;GO:0003723
GO:0035865;cellular response to potassium ion;363;110;GO:0050832
GO:0047808;D(-)-tartrate dehydratase activity;2485;4;GO:0006066
GO:0047807;cytokinin 7-beta-glucosyltransferase activity;17;6;GO:0006029
GO:0035860;glial cell-derived neurotrophic factor receptor signaling pathway;1418;362;GO:0048169
GO:0047806;cytochrome-c3 hydrogenase activity;426;3;GO:0008856
GO:0035861;site of double-strand break;6207;1360;GO:0000723
GO:0047805;cytidylate cyclase activity;7;6;GO:0004723
GO:0008242;omega peptidase activity;163638;471;GO:0004867
GO:0008241;peptidyl-dipeptidase activity;9970;378;GO:0004722
GO:0008240;tripeptidyl-peptidase activity;4875;61;GO:0004867
GO:0047809;D-2-hydroxy-acid dehydrogenase activity;866;3;GO:0004089
GO:0008247;1-alkyl-2-acetylglycerophosphocholine esterase complex;66;7;GO:0005576
GO:0047800;cysteamine dioxygenase activity;73;34;GO:0004497
GO:0047804;cysteine-S-conjugate beta-lyase activity;1132;16;GO:0004449
GO:0047803;cysteine lyase activity;0;2;GO:0004730
GO:0047802;cysteine-conjugate transaminase activity;0;2;GO:0004449
GO:0047801;L-cysteine transaminase activity;75;7;GO:0004497
GO:0035859;Seh1-associated complex;3279;225;GO:0043161
GO:0035855;megakaryocyte development;1036;831;GO:0030198
GO:0035857;eosinophil fate specification;0;2;GO:0045595
GO:0035858;eosinophil fate determination;0;2;GO:0045595
GO:0035851;Krueppel-associated box domain binding;100;7;GO:0048471
GO:0035852;horizontal cell localization;1;5;GO:0007631
GO:0035853;chromosome passenger complex localization to spindle midzone;54;5;GO:0007062
GO:0035854;eosinophil fate commitment;116;476;GO:0045595
GO:0008250;oligosaccharyltransferase complex;26399;913;GO:0005869
GO:0047819;D-glutamate(D-aspartate) oxidase activity;0;2;GO:0004725
GO:0047818;D-fuconate dehydratase activity;3;3;GO:0006067
GO:0047817;D-arginase activity;37;4;GO:0004746
GO:0035850;epithelial cell differentiation involved in kidney development;3273;550;GO:0030216
GO:0047816;D-arabinose 1-dehydrogenase (NAD+) activity;10;0;GO:0003954
GO:0008254;3'-nucleotidase activity;12269;2;GO:0008529
GO:0008253;5'-nucleotidase activity;155699;305;GO:0004723
GO:0008252;nucleotidase activity;289988;549;GO:0008529
GO:0008251;tRNA-specific adenosine deaminase activity;134509;646;GO:0006418
GO:0008258;head involution;421;35;GO:0048608
GO:0047811;D-alanine gamma-glutamyltransferase activity;0;3;GO:0004721
GO:0008257;protein histidine tele-kinase activity;0;3;GO:0004721
GO:0047810;D-alanine:2-oxoglutarate aminotransferase activity;4378;10;GO:0004073
GO:0008256;protein histidine pros-kinase activity;23;2;GO:0004721
GO:0008255;ecdysis-triggering hormone activity;340;8;GO:0004974
GO:0047815;D-arabinonolactonase activity;2;2;GO:0004462
GO:0047814;D-arabinokinase activity;0;4;GO:0004721
GO:0047813;D-arabinitol 4-dehydrogenase activity;95;3;GO:0006066
GO:0047812;D-amino-acid N-acetyltransferase activity;6;5;GO:0004867
GO:0035848;oviduct morphogenesis;13;9;GO:0048598
GO:0035849;nephric duct elongation;57;6;GO:0048704
GO:0035844;cloaca development;375;8;GO:0007565
GO:0035845;photoreceptor cell outer segment organization;1256;244;GO:0048661
GO:0035846;oviduct epithelium development;408;7;GO:0030216
GO:0035847;uterine epithelium development;67;8;GO:0030216
GO:0035840;old growing cell tip;102;8;GO:0048471
GO:0035841;new growing cell tip;135;136;GO:0048471
GO:0035842;old cell tip after activation of bipolar cell growth;4;0;GO:0048608
GO:0035843;endonuclear canal;0;0;GO:0005576
GO:0060880;cell morphogenesis involved in semicircular canal fusion;0;1;GO:0048704
GO:0033260;nuclear DNA replication;30383;549;GO:0006260
GO:0060882;basement membrane disassembly involved in semicircular canal fusion;0;0;GO:0048771
GO:0070209;ASTRA complex;340;16;GO:0005576
GO:0033265;choline binding;8112;72;GO:0043169
GO:0033263;CORVET complex;3617;128;GO:0005815
GO:0033262;regulation of nuclear cell cycle DNA replication;674;1310;GO:0000086
GO:0045247;cytosolic electron transfer flavoprotein complex;0;1;GO:0005747
GO:0060888;limb epidermis stratification;0;2;GO:0008544
GO:1901741;positive regulation of myoblast fusion;718;559;GO:0048771
GO:0045248;cytosolic oxoglutarate dehydrogenase complex;1;8;GO:0005739
GO:0060889;limb basal epidermal cell differentiation;0;4;GO:0008544
GO:1901740;negative regulation of myoblast fusion;107;39;GO:0048706
GO:1901743;2-deoxystreptamine catabolic process;0;0;GO:0009065
GO:0045246;cytosolic tricarboxylic acid cycle enzyme complex;0;5;GO:0005746
GO:1901742;2-deoxystreptamine metabolic process;1;1;GO:0009065
GO:0060884;clearance of cells from fusion plate;0;3;GO:0048193
GO:1901745;prephenate(2-) metabolic process;46;0;GO:0006073
GO:0060885;clearance of cells from fusion plate by apoptotic process;0;0;GO:0010941
GO:1901744;2-deoxystreptamine biosynthetic process;0;0;GO:0006030
GO:0045249;cytosol pyruvate dehydrogenase (lipoamide) phosphatase complex;0;2;GO:0005737
GO:0060886;clearance of cells from fusion plate by epithelial to mesenchymal transition;0;2;GO:0010467
GO:1901747;prephenate(2-) biosynthetic process;46;0;GO:0006022
GO:0060887;limb epidermis development;118;6;GO:0009952
GO:1901746;prephenate(2-) catabolic process;0;0;GO:0009065
GO:0045250;cytosolic pyruvate dehydrogenase complex;3;338;GO:0005737
GO:1901738;regulation of vitamin A metabolic process;13;4;GO:0046148
GO:0045251;electron transfer flavoprotein complex;103;17;GO:0005747
GO:1901737;(R)-mevalonic acid biosynthetic process;2;0;GO:0009813
GO:1901739;regulation of myoblast fusion;1059;47;GO:0048471
GO:0045254;pyruvate dehydrogenase complex;46470;814;GO:0005737
GO:0070200;establishment of protein localization to telomere;952;48;GO:0007049
GO:0045252;oxoglutarate dehydrogenase complex;27886;827;GO:0005739
GO:0045253;pyruvate dehydrogenase (lipoamide) phosphatase complex;2;5;GO:0005743
GO:0033258;plastid DNA metabolic process;7;3;GO:0006259
GO:0070203;regulation of establishment of protein localization to telomere;572;44;GO:0048285
GO:0033257;Bcl3/NF-kappaB2 complex;110;55;GO:0043066
GO:0070204;2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic-acid synthase activity;48377;103;GO:0006096
GO:0033256;I-kappaB/NF-kappaB complex;115;128;GO:0005634
GO:0070201;regulation of establishment of protein localization;39417;930;GO:0050789
GO:0033255;SAS acetyltransferase complex;924;4;GO:0006464
GO:0070202;regulation of establishment of protein localization to chromosome;639;64;GO:0048285
GO:0070207;protein homotrimerization;850;1040;GO:0008021
GO:0070208;protein heterotrimerization;223;1880;GO:0046982
GO:0070205;2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase activity;19365;83;GO:0006022
GO:0033259;plastid DNA replication;7;6;GO:0006260
GO:0070206;protein trimerization;10970;915;GO:0008083
GO:0033250;penicillinase activity;2;4;GO:0020037
GO:0060870;cell wall disassembly involved in floral organ abscission;0;1;GO:0048471
GO:0060872;semicircular canal development;1036;81;GO:0007517
GO:0033254;vacuolar transporter chaperone complex;152;122;GO:0005737
GO:0033253;regulation of penicillinase activity;0;3;GO:0010468
GO:0033252;regulation of beta-lactamase activity;1;3;GO:0010467
GO:1901750;leukotriene D4 biosynthetic process;116;297;GO:0006022
GO:0033251;cephalosporinase activity;1;3;GO:0046274
GO:0045258;plasma membrane succinate dehydrogenase complex (ubiquinone);0;1;GO:0005739
GO:0060877;regionalization involved in semicircular canal formation;0;1;GO:0048704
GO:1901752;leukotriene A4 catabolic process;0;0;GO:0006559
GO:0045259;proton-transporting ATP synthase complex;1189606;736;GO:0005746
GO:0060878;pouch outgrowth involved in semicircular canal formation;0;1;GO:0048704
GO:1901751;leukotriene A4 metabolic process;148;2;GO:0006631
GO:0060879;semicircular canal fusion;62;8;GO:0005543
GO:1901754;vitamin D3 catabolic process;2;0;GO:0007568
GO:0045257;succinate dehydrogenase complex (ubiquinone);2262;67;GO:0005747
GO:1901753;leukotriene A4 biosynthetic process;96;3;GO:0006022
GO:0060873;anterior semicircular canal development;50;3;GO:0008544
GO:1901756;butirosin metabolic process;0;4;GO:0006032
GO:0060874;posterior semicircular canal development;0;2;GO:0008544
GO:1901755;vitamin D3 biosynthetic process;0;0;GO:0009065
GO:0060875;lateral semicircular canal development;92;3;GO:0008544
GO:1901758;butirosin biosynthetic process;0;1;GO:1901363
GO:0060876;semicircular canal formation;180;3;GO:0007517
GO:1901757;butirosin catabolic process;0;0;GO:0009062
GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);544935;1380;GO:0005746
GO:1901749;leukotriene D4 catabolic process;116;4;GO:0006559
GO:0045262;plasma membrane proton-transporting ATP synthase complex, catalytic core F(1);0;9;GO:0005746
GO:1901748;leukotriene D4 metabolic process;232;52;GO:0006631
GO:0045260;plasma membrane proton-transporting ATP synthase complex;7;8;GO:0005761
GO:0045265;proton-transporting ATP synthase, stator stalk;442;6;GO:0005761
GO:0045266;plasma membrane proton-transporting ATP synthase, stator stalk;0;3;GO:0009536
GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);551472;1550;GO:0005746
GO:0045264;plasma membrane proton-transporting ATP synthase complex, coupling factor F(o);0;50;GO:0005746
GO:0033247;regulation of penicillin catabolic process;1;2;GO:0046274
GO:0033246;positive regulation of penicillin metabolic process;12;1;GO:0046274
GO:0033245;negative regulation of penicillin metabolic process;4;2;GO:0046274
GO:0033244;regulation of penicillin metabolic process;17;3;GO:0046274
GO:0033249;positive regulation of penicillin catabolic process;0;1;GO:0046274
GO:0033248;negative regulation of penicillin catabolic process;1;2;GO:0046274
GO:0008283;cell population proliferation;1119296;2160;GO:0042127
GO:0008282;inward rectifying potassium channel;235;22;GO:0022836
GO:0008281;sulfonylurea receptor activity;3322;33;GO:0004930
GO:0008287;protein serine/threonine phosphatase complex;62517;677;GO:0005524
GO:0033243;positive regulation of amine catabolic process;12;0;GO:0045944
GO:0008286;insulin receptor signaling pathway;12038;2840;GO:0007179
GO:0033242;negative regulation of amine catabolic process;55;0;GO:0045944
GO:0008285;negative regulation of cell population proliferation;62190;2070;GO:0042127
GO:0033241;regulation of amine catabolic process;74;1;GO:0045944
GO:1901761;oxytetracycline metabolic process;0;0;GO:0006796
GO:0008284;positive regulation of cell population proliferation;93701;2230;GO:0042127
GO:0033240;positive regulation of amine metabolic process;488;1;GO:0045944
GO:1901760;beta-L-Ara4N-lipid A biosynthetic process;0;2;GO:0009405
GO:0045269;proton-transporting ATP synthase, central stalk;144;1;GO:0005761
GO:1901763;oxytetracycline biosynthetic process;0;0;GO:0009181
GO:1901762;oxytetracycline catabolic process;0;0;GO:0009065
GO:0008289;lipid binding;829615;8510;GO:0097159
GO:0045267;proton-transporting ATP synthase, catalytic core;206;5;GO:0005761
GO:1901765;phosphinothricin catabolic process;0;1;GO:0009065
GO:0008288;boss receptor activity;20;4;GO:0004872
GO:0045268;plasma membrane proton-transporting ATP synthase, catalytic core;0;4;GO:0005761
GO:1901764;phosphinothricin metabolic process;2;1;GO:0006796
GO:1901767;carbapenem metabolic process;1;0;GO:0009064
GO:1901766;phosphinothricin biosynthetic process;2;0;GO:0009065
GO:1901769;carbapenem biosynthetic process;0;0;GO:0009405
GO:1901768;carbapenem catabolic process;1;0;GO:0009065
GO:0045272;plasma membrane respiratory chain complex I;175;35;GO:0005746
GO:0045273;respiratory chain complex II;30753;83;GO:0005746
GO:1901759;beta-L-Ara4N-lipid A metabolic process;0;3;GO:0006631
GO:0045270;plasma membrane proton-transporting ATP synthase, central stalk;0;0;GO:0009536
GO:0045271;respiratory chain complex I;44561;739;GO:0005746
GO:0045276;plasma membrane respiratory chain complex III;0;1;GO:0005746
GO:0070221;sulfide oxidation, using sulfide:quinone oxidoreductase;448;25;GO:0004746
GO:0045277;respiratory chain complex IV;125195;354;GO:0005746
GO:0070222;sulfide oxidation, using sulfide dehydrogenase;0;0;GO:0009065
GO:0045274;plasma membrane respiratory chain complex II;3480;5;GO:0005746
GO:0045275;respiratory chain complex III;143943;598;GO:0005746
GO:0070220;aerobic sulfur oxidation;0;1;GO:0009065
GO:0035899;suppression of blood coagulation in another organism;15;1;GO:0007596
GO:0070225;sulfide dehydrogenase activity;456;2;GO:0004746
GO:0033235;positive regulation of protein sumoylation;1579;327;GO:0016567
GO:0070226;sulfur:ferric ion oxidoreductase activity;0;1;GO:0004091
GO:0033234;negative regulation of protein sumoylation;1059;247;GO:0016567
GO:0070223;sulfide oxidation, using sulfur dioxygenase;0;1;GO:0009579
GO:0033233;regulation of protein sumoylation;2705;38;GO:0016567
GO:0070224;sulfide:quinone oxidoreductase activity;236;8;GO:0004091
GO:0035895;modulation of mast cell degranulation in another organism;2;0;GO:0002548
GO:0070229;negative regulation of lymphocyte apoptotic process;2110;263;GO:0043066
GO:0033239;negative regulation of amine metabolic process;259;5;GO:0045944
GO:0035896;positive regulation of mast cell degranulation in another organism;1;1;GO:0048704
GO:0033238;regulation of amine metabolic process;16203;5;GO:0045944
GO:0070227;lymphocyte apoptotic process;5856;175;GO:0042981
GO:0035898;parathyroid hormone secretion;132;45;GO:0007596
GO:0070228;regulation of lymphocyte apoptotic process;3448;154;GO:0042981
GO:0008294;calcium- and calmodulin-responsive adenylate cyclase activity;532;96;GO:0005524
GO:0035891;exit from host cell;493988;9;GO:0048193
GO:0060891;limb granular cell differentiation;0;4;GO:0048667
GO:0008293;torso signaling pathway;354;307;GO:0007186
GO:0035892;perturbation of platelet aggregation in another organism;10;0;GO:0048407
GO:0060892;limb basal epidermal cell fate specification;0;1;GO:0048608
GO:0008292;acetylcholine biosynthetic process;280;78;GO:0006725
GO:0035893;suppression of platelet aggregation in another organism;7;0;GO:0007596
GO:0060893;limb granular cell fate specification;0;1;GO:0048699
GO:0008291;acetylcholine metabolic process;975;194;GO:0006725
GO:0035894;induction of platelet aggregation in another organism;3;0;GO:0002675
GO:0060894;limb spinous cell fate specification;0;0;GO:0048699
GO:0008298;intracellular mRNA localization;2330;643;GO:0006413
GO:0033232;ABC-type D-methionine transporter activity;21461;97;GO:0005215
GO:1901770;daunorubicin catabolic process;0;1;GO:0009065
GO:0008297;single-stranded DNA exodeoxyribonuclease activity;24343;250;GO:0004518
GO:0033231;carbohydrate export;1;8;GO:0009986
GO:0008296;3'-5'-DNA exonuclease activity;113708;3;GO:0004518
GO:0033230;ABC-type cysteine transporter activity;1;19;GO:0005215
GO:1901772;lincomycin metabolic process;0;3;GO:0009064
GO:0008295;spermidine biosynthetic process;156208;1320;GO:0009065
GO:0060890;limb spinous cell differentiation;0;4;GO:0048667
GO:1901771;daunorubicin biosynthetic process;20;0;GO:0009065
GO:1901774;lincomycin biosynthetic process;0;3;GO:0009266
GO:1901773;lincomycin catabolic process;0;0;GO:0009065
GO:0045278;plasma membrane respiratory chain complex IV;14368;1;GO:0005746
GO:1901776;mitomycin C catabolic process;0;0;GO:0046274
GO:0008299;isoprenoid biosynthetic process;1500739;4830;GO:0008299
GO:1901775;mitomycin C metabolic process;0;0;GO:0006790
GO:0060895;retinoic acid receptor signaling pathway involved in spinal cord dorsal/ventral patterning;0;1;GO:0030518
GO:1901778;pentalenolactone metabolic process;6;1;GO:0006073
GO:0060896;neural plate pattern specification;729;10;GO:0009952
GO:1901777;mitomycin C biosynthetic process;0;0;GO:0009055
GO:0060897;neural plate regionalization;528;7;GO:0009952
GO:0060898;eye field cell fate commitment involved in camera-type eye formation;44;0;GO:0007530
GO:1901779;pentalenolactone catabolic process;0;0;GO:0046395
GO:0045283;fumarate reductase complex;5582;71;GO:0005739
GO:0045284;plasma membrane fumarate reductase complex;3471;6;GO:0005739
GO:0045281;succinate dehydrogenase complex;25724;167;GO:0005739
GO:0045282;plasma membrane succinate dehydrogenase complex;9;9;GO:0005739
GO:0070210;Rpd3L-Expanded complex;263;40;GO:0048285
GO:0070211;Snt2C complex;27;6;GO:0048285
GO:0033225;ATPase-coupled 2-aminoethylphosphonate transporter activity;0;5;GO:0008029
GO:0035888;isoguanine deaminase activity;8;0;GO:0006066
GO:0070214;CSK-GAP-A.p62 complex;0;1;GO:0016128
GO:0035889;otolith tethering;86;1;GO:0005515
GO:0033223;2-aminoethylphosphonate transport;1590;6;GO:0006874
GO:0070212;protein poly-ADP-ribosylation;43;50;GO:0006468
GO:0033222;xylose binding;5;6;GO:0005576
GO:0070213;protein auto-ADP-ribosylation;39;88;GO:0006469
GO:0008290;F-actin capping protein complex;19489;1000;GO:0005524
GO:0033229;cysteine transmembrane transporter activity;265;17;GO:0005215
GO:0035884;arabinan biosynthetic process;7;3;GO:0006073
GO:0033228;cysteine export across plasma membrane;25;13;GO:0006835
GO:0035885;exochitinase activity;5;4;GO:0004553
GO:0033227;dsRNA transport;713;373;GO:0015031
GO:0035886;vascular associated smooth muscle cell differentiation;1720;73;GO:0048608
GO:0033226;2-aminoethylphosphonate binding;0;5;GO:0043169
GO:0035887;aortic smooth muscle cell differentiation;77;16;GO:0048608
GO:0070217;transcription factor TFIIIB complex assembly;0;2;GO:0003700
GO:0045209;MAPK phosphatase export from nucleus, leptomycin B sensitive;0;10;GO:0005576
GO:0047866;dimethylglycine oxidase activity;55;2;GO:0004067
GO:0060844;arterial endothelial cell fate commitment;203;172;GO:0030198
GO:0045204;MAPK export from nucleus;198;34;GO:0006793
GO:0047865;dimethylglycine dehydrogenase activity;280;113;GO:0009065
GO:0060845;venous endothelial cell fate commitment;38;1;GO:0048514
GO:0045201;maintenance of neuroblast polarity;57;6;GO:0048666
GO:0047864;dimethylaniline-N-oxide aldolase activity;0;2;GO:0006029
GO:0060846;blood vessel endothelial cell fate commitment;339;0;GO:0001944
GO:0045202;synapse;1006456;10900;GO:0007268
GO:0047863;dimethylallylcistransferase activity;6;2;GO:0004497
GO:0060847;endothelial cell fate specification;158;6;GO:0030182
GO:0060840;artery development;7054;1050;GO:0001944
GO:1901701;cellular response to oxygen-containing compound;722855;1350;GO:0072593
GO:0045208;MAPK phosphatase export from nucleus;0;9;GO:0006468
GO:0047869;dimethylpropiothetin dethiomethylase activity;2331;6;GO:0046395
GO:0060841;venous blood vessel development;1070;182;GO:0001944
GO:1901700;response to oxygen-containing compound;839383;3300;GO:0046395
GO:0047868;dimethylmaleate hydratase activity;530;4;GO:0004415
GO:0060842;arterial endothelial cell differentiation;358;10;GO:0001525
GO:1901703;protein localization involved in auxin polar transport;231;3;GO:0009734
GO:0047867;dimethylmalate dehydrogenase activity;0;2;GO:0004073
GO:0060843;venous endothelial cell differentiation;86;5;GO:0001944
GO:1901702;salt transmembrane transporter activity;1984732;82;GO:0005215
GO:0045210;FasL biosynthetic process;37;28;GO:0006915
GO:0047873;dolichyl-phosphatase activity;1;3;GO:0005525
GO:0060848;endothelial cell fate determination;0;2;GO:0030154
GO:0045211;postsynaptic membrane;302036;4250;GO:0048666
GO:0047872;dolichol O-acyltransferase activity;0;3;GO:0004866
GO:0047871;disulfoglucosamine-6-sulfatase activity;0;4;GO:0005576
GO:0047870;discadenine synthase activity;0;3;GO:0006030
GO:0033299;secretion of lysosomal enzymes;402;43;GO:0005764
GO:0033294;ectoine binding;3838;3;GO:0005576
GO:0033293;monocarboxylic acid binding;349502;463;GO:0097159
GO:0033292;T-tubule organization;484;41;GO:0005789
GO:0033291;eukaryotic 80S initiation complex;24;3;GO:0005840
GO:0033298;contractile vacuole organization;51;8;GO:0005730
GO:0033296;rhamnose binding;19;7;GO:0005576
GO:0033295;hydroxyectoine binding;0;3;GO:0043169
GO:0045214;sarcomere organization;3523;2220;GO:0006936
GO:0047877;ephedrine dehydrogenase activity;0;3;GO:0004067
GO:0060833;Wnt signaling pathway involved in animal/vegetal axis specification;0;2;GO:0043548
GO:0047876;endoglycosylceramidase activity;58;4;GO:0008544
GO:0060834;oral/aboral axis specification;0;2;GO:0009952
GO:0047875;ecdysone oxidase activity;12;3;GO:0004097
GO:1901710;regulation of homoserine biosynthetic process;11;0;GO:0046394
GO:0047874;dolichyldiphosphatase activity;4388;19;GO:0005524
GO:0060836;lymphatic endothelial cell differentiation;608;38;GO:0001944
GO:0033290;eukaryotic 48S preinitiation complex;36627;883;GO:0005840
GO:0045218;zonula adherens maintenance;142;192;GO:0007050
GO:1901712;positive regulation of homoserine biosynthetic process;0;0;GO:0046394
GO:0045219;regulation of FasL production;4;0;GO:0046649
GO:0060830;ciliary receptor clustering involved in smoothened signaling pathway;157;181;GO:0048608
GO:1901711;negative regulation of homoserine biosynthetic process;0;0;GO:0046395
GO:0045216;cell-cell junction organization;15872;2440;GO:0030054
GO:0047879;erythronolide synthase activity;1195;5;GO:0004497
GO:0060831;smoothened signaling pathway involved in dorsal/ventral neural tube patterning;861;22;GO:0007218
GO:1901714;positive regulation of urea catabolic process;8;0;GO:0046278
GO:0045217;cell-cell junction maintenance;1065;1010;GO:0030054
GO:0047878;erythritol kinase activity;98;3;GO:0005524
GO:0060832;oocyte animal/vegetal axis specification;10;2;GO:0009952
GO:1901713;negative regulation of urea catabolic process;0;0;GO:0046278
GO:0047880;erythrulose reductase activity;10;6;GO:0006067
GO:1901705;L-isoleucine biosynthetic process;0;0;GO:0009061
GO:1901704;L-glutamine biosynthetic process;12;0;GO:0006565
GO:1901707;leptomycin B binding;53;3;GO:0043405
GO:1901706;mesenchymal cell differentiation involved in bone development;99;4;GO:0045595
GO:0045221;negative regulation of FasL production;4;0;GO:0046330
GO:0047884;FAD diphosphatase activity;104;7;GO:0004746
GO:0060837;blood vessel endothelial cell differentiation;985;9;GO:0001944
GO:1901709;(+)-larreatricin metabolic process;1;1;GO:0046394
GO:0045222;CD4 biosynthetic process;69;2;GO:0002504
GO:0047883;ethanolamine oxidase activity;3;3;GO:0004722
GO:0060838;lymphatic endothelial cell fate commitment;159;5;GO:0030198
GO:1901708;(+)-3'-hydroxylarreatricin biosynthetic process;1;0;GO:0046274
GO:0047882;estradiol 6-beta-monooxygenase activity;0;4;GO:0004497
GO:0060839;endothelial cell fate commitment;616;5;GO:0030154
GO:0045220;positive regulation of FasL production;0;0;GO:0046649
GO:0047881;estradiol 17-alpha-dehydrogenase activity;0;1;GO:0004497
GO:0033289;intraconoid microtubule;0;5;GO:0005576
GO:0033288;ATPase-coupled hydroxyectoine transmembrane transporter activity;0;6;GO:0008544
GO:0104004;cellular response to environmental stimulus;82436;189;GO:0009628
GO:0033283;ATPase-coupled organic acid transmembrane transporter activity;130151;4;GO:0008544
GO:0033282;protein C inhibitor-acrosin complex;0;3;GO:0005576
GO:0033281;TAT protein transport complex;98233;9;GO:0005840
GO:0060860;regulation of floral organ abscission;75;2;GO:0048704
GO:0033280;response to vitamin D;1326;897;GO:0009719
GO:0060861;positive regulation of floral organ abscission;0;1;GO:0048704
GO:0033286;ATPase-coupled ectoine transmembrane transporter activity;0;7;GO:0005525
GO:0033285;ATPase-coupled monocarboxylic acid transmembrane transporter activity;194;2;GO:0008544
GO:0033284;ATPase-coupled carboxylic acid transmembrane transporter activity;130150;3;GO:0008544
GO:0045225;negative regulation of CD4 production;69;1;GO:0048018
GO:0047888;fatty acid peroxidase activity;7;9;GO:0004601
GO:0060866;leaf abscission;71;36;GO:0009813
GO:0045226;extracellular polysaccharide biosynthetic process;88293;462;GO:0009405
GO:0047887;farnesyl diphosphate kinase activity;0;3;GO:0004721
GO:0060867;fruit abscission;1;3;GO:0009813
GO:0045223;regulation of CD4 production;69;0;GO:0050729
GO:0047886;farnesol dehydrogenase activity;47;9;GO:0004091
GO:0045224;positive regulation of CD4 production;0;0;GO:0050729
GO:0047885;farnesol 2-isomerase activity;0;3;GO:0004497
GO:0045229;external encapsulating structure organization;1420384;2000;GO:0048608
GO:0060862;negative regulation of floral organ abscission;49;7;GO:0010468
GO:1901723;negative regulation of cell proliferation involved in kidney development;277;10;GO:0042127
GO:0060863;regulation of floral organ abscission by signal transduction;0;1;GO:0009913
GO:1901722;regulation of cell proliferation involved in kidney development;455;6;GO:0042127
GO:0045227;capsule polysaccharide biosynthetic process;9590;14;GO:0009405
GO:1901725;regulation of histone deacetylase activity;1;97;GO:0016568
GO:0045228;slime layer polysaccharide biosynthetic process;17;3;GO:0005976
GO:0047889;ferredoxin-nitrate reductase activity;65;2;GO:0008033
GO:1901724;positive regulation of cell proliferation involved in kidney development;172;28;GO:0042127
GO:0047891;flavone 7-O-beta-glucosyltransferase activity;4;4;GO:0004553
GO:1901716;negative regulation of gamma-aminobutyric acid catabolic process;0;0;GO:0048167
GO:0047890;flavanone 4-reductase activity;35;6;GO:0004497
GO:1901715;regulation of gamma-aminobutyric acid catabolic process;8;1;GO:0046356
GO:1901717;positive regulation of gamma-aminobutyric acid catabolic process;8;0;GO:0048167
GO:0045232;S-layer organization;34;4;GO:0043161
GO:0047895;formaldehyde dismutase activity;347;4;GO:0004553
GO:0047894;flavonol 3-sulfotransferase activity;58;155;GO:0004725
GO:0045230;capsule organization;9594;4;GO:0043234
GO:0047893;flavonol 3-O-glucosyltransferase activity;107;7;GO:0006073
GO:0045231;slime layer organization;17;4;GO:0032559
GO:0047892;flavone apiosyltransferase activity;0;2;GO:0004497
GO:0033278;cell proliferation in midbrain;598;223;GO:0042127
GO:0033272;myo-inositol hexakisphosphate transport;0;3;GO:0006826
GO:0033271;myo-inositol phosphate transport;0;4;GO:0006826
GO:0033270;paranode region of axon;1182;397;GO:0043005
GO:0033276;transcription factor TFTC complex;697;443;GO:0005667
GO:0033275;actin-myosin filament sliding;485;1230;GO:0006936
GO:0033274;response to vitamin B2;44;56;GO:0009719
GO:0033273;response to vitamin;3720;623;GO:0009719
GO:0045236;CXCR chemokine receptor binding;660;823;GO:0005125
GO:0047899;formate dehydrogenase (NADP+) activity;9;0;GO:0009065
GO:0060855;venous endothelial cell migration involved in lymph vessel development;81;3;GO:0048608
GO:1901730;monensin A biosynthetic process;0;0;GO:0046271
GO:0045237;CXCR1 chemokine receptor binding;40;1;GO:0005509
GO:0047898;formate dehydrogenase (cytochrome) activity;89;3;GO:0003954
GO:0060856;establishment of blood-brain barrier;1033;196;GO:0048582
GO:0045234;protein palmitoleylation;7;10;GO:0006464
GO:0047897;formate-dihydrofolate ligase activity;0;3;GO:0004497
GO:0060857;establishment of glial blood-brain barrier;307;25;GO:0048666
GO:1901732;quercetin metabolic process;57;1;GO:0009813
GO:0047896;formaldehyde transketolase activity;30;4;GO:0006099
GO:0060858;vesicle-mediated transport involved in floral organ abscission;14;2;GO:0009986
GO:1903571;negative regulation of protein kinase D signaling;0;2;GO:0043406
GO:0060034;notochord cell differentiation;410;4;GO:0048667
GO:1903572;positive regulation of protein kinase D signaling;56;19;GO:0043406
GO:0060035;notochord cell development;287;8;GO:0007517
GO:0060036;notochord cell vacuolation;165;3;GO:0048706
GO:1903570;regulation of protein kinase D signaling;56;5;GO:0043406
GO:1903575;cornified envelope assembly;926;126;GO:0005576
GO:0060030;dorsal convergence;369;7;GO:0007631
GO:1903576;response to L-arginine;212;4;GO:0006665
GO:0060031;mediolateral intercalation;244;6;GO:0006935
GO:1903573;negative regulation of response to endoplasmic reticulum stress;2582;200;GO:0034976
GO:0060032;notochord regression;96;89;GO:0048704
GO:1903574;negative regulation of cellular response to amino acid starvation;7;2;GO:0045735
GO:1903579;negative regulation of ATP metabolic process;293;340;GO:0045735
GO:1903577;cellular response to L-arginine;110;5;GO:0006979
GO:1903578;regulation of ATP metabolic process;1133;64;GO:0010467
GO:0060037;pharyngeal system development;2029;498;GO:0048731
GO:0098670;entry receptor-mediated virion attachment to host cell;3568;6;GO:0048193
GO:0060038;cardiac muscle cell proliferation;3197;1230;GO:0042127
GO:0098671;adhesion receptor-mediated virion attachment to host cell;2021;2;GO:0006915
GO:0060039;pericardium development;1233;499;GO:0002504
GO:0047088;dihydrosanguinarine 10-monooxygenase activity;0;2;GO:0004497
GO:0072011;glomerular endothelium development;209;132;GO:0001944
GO:0047087;protopine 6-monooxygenase activity;9;3;GO:0004497
GO:0072010;glomerular epithelium development;1876;139;GO:0030216
GO:0098664;G protein-coupled serotonin receptor signaling pathway;26245;212;GO:0007186
GO:0047086;ketosteroid monooxygenase activity;166;61;GO:0004497
GO:0098661;inorganic anion transmembrane transport;1107140;75;GO:0006811
GO:0047085;hydroxyphenylacetonitrile 2-monooxygenase activity;0;2;GO:0004497
GO:0098662;inorganic cation transmembrane transport;17288832;2020;GO:0006811
GO:0072015;podocyte development;870;8;GO:0030900
GO:0072014;proximal tubule development;557;19;GO:0042127
GO:0072013;glomus development;10;2;GO:0048608
GO:0098665;serotonin receptor complex;456;0;GO:0004872
GO:0047089;dihydrochelirubine 12-monooxygenase activity;0;2;GO:0004497
GO:0072012;glomerulus vasculature development;1191;56;GO:0048771
GO:0098666;G protein-coupled serotonin receptor complex;289;140;GO:0004872
GO:0047080;deoxyuridine 2'-dioxygenase activity;0;0;GO:0004721
GO:0072019;proximal convoluted tubule development;149;7;GO:0042127
GO:0072017;distal tubule development;815;106;GO:0042127
GO:0098669;superinfection exclusion;810;6;GO:0048285
GO:0072016;glomerular parietal epithelial cell development;59;3;GO:0048608
GO:0047084;methyltetrahydroprotoberberine 14-monooxygenase activity;4;3;GO:0004497
GO:0047083;5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase activity;8;0;GO:0004497
GO:0047082;3,9-dihydroxypterocarpan 6a-monooxygenase activity;17;2;GO:0004497
GO:0047081;3-hydroxy-2-methylpyridinecarboxylate dioxygenase activity;1;2;GO:0004497
GO:0060066;oviduct development;582;323;GO:0048598
GO:1903582;negative regulation of basophil degranulation;0;1;GO:0042592
GO:0060067;cervix development;113;10;GO:0007565
GO:1903583;positive regulation of basophil degranulation;0;1;GO:0042592
GO:0060068;vagina development;453;496;GO:0048598
GO:1903580;positive regulation of ATP metabolic process;473;230;GO:0045935
GO:0060069;Wnt signaling pathway, regulating spindle positioning;45;4;GO:0007507
GO:1903581;regulation of basophil degranulation;0;2;GO:0042592
GO:0060062;Spemann organizer formation at the dorsal lip of the blastopore;10;1;GO:0009952
GO:1903586;positive regulation of histone deubiquitination;0;1;GO:0016567
GO:0060063;Spemann organizer formation at the embryonic shield;110;2;GO:0008544
GO:1903587;regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;920;7;GO:0050727
GO:0060064;Spemann organizer formation at the anterior end of the primitive streak;49;5;GO:0009952
GO:1903584;regulation of histone deubiquitination;0;1;GO:0043687
GO:0060065;uterus development;1180;603;GO:0048589
GO:1903585;negative regulation of histone deubiquitination;0;0;GO:0042787
GO:1903588;negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;453;95;GO:0050727
GO:1903589;positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;466;107;GO:0050727
GO:0072051;juxtaglomerular apparatus development;87;8;GO:0048608
GO:0072050;S-shaped body morphogenesis;480;92;GO:0048608
GO:0047099;CDP-4-dehydro-6-deoxyglucose reductase activity;126;1;GO:0006066
GO:0072044;collecting duct development;602;119;GO:0048608
GO:0098630;aggregation of unicellular organisms;16010;4;GO:0044699
GO:0047098;Latia-luciferin monooxygenase (demethylating) activity;0;3;GO:0004497
GO:0072043;regulation of pre-tubular aggregate formation by cell-cell signaling;0;3;GO:0048608
GO:0098631;cell adhesion mediator activity;7501;92;GO:0005576
GO:0047097;phylloquinone monooxygenase (2,3-epoxidizing) activity;1;2;GO:0004497
GO:0072042;regulation of mesenchymal stem cell proliferation involved in nephron morphogenesis;0;0;GO:0048608
GO:0047096;androst-4-ene-3,17-dione monooxygenase activity;0;4;GO:0004497
GO:0072041;positive regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis;0;1;GO:0010942
GO:0072048;renal system pattern specification;662;7;GO:0042127
GO:0098634;cell-matrix adhesion mediator activity;1029;7;GO:0005576
GO:0072047;proximal/distal pattern formation involved in nephron development;439;7;GO:0048316
GO:0098635;protein complex involved in cell-cell adhesion;127;4;GO:0022610
GO:0072046;establishment of planar polarity involved in nephron morphogenesis;93;5;GO:0048704
GO:0098632;cell-cell adhesion mediator activity;4539;189;GO:0005576
GO:0072045;convergent extension involved in nephron morphogenesis;69;2;GO:0048706
GO:0098633;collagen fibril binding;85;5;GO:0005578
GO:0047091;L-lysine 6-monooxygenase (NADPH) activity;6029;3;GO:0004497
GO:0098638;laminin binding involved in cell-matrix adhesion;0;2;GO:0048407
GO:0047090;benzoyl-CoA 3-monooxygenase activity;2;2;GO:0004497
GO:0060070;canonical Wnt signaling pathway;38311;3190;GO:0016055
GO:0098639;collagen binding involved in cell-matrix adhesion;301;197;GO:0048407
GO:0060071;Wnt signaling pathway, planar cell polarity pathway;2914;1220;GO:0007179
GO:0098636;protein complex involved in cell adhesion;33758;148;GO:0022610
GO:0060072;large conductance calcium-activated potassium channel activity;123;286;GO:0005216
GO:0072049;comma-shaped body morphogenesis;279;9;GO:0048608
GO:0098637;protein complex involved in cell-matrix adhesion;507;6;GO:0022610
GO:0047095;2-hydroxycyclohexanone 2-monooxygenase activity;0;4;GO:0004497
GO:0047094;3-hydroxyphenylacetate 6-hydroxylase activity;2;2;GO:0004073
GO:0047093;4-hydroxyquinoline 3-monooxygenase activity;0;3;GO:0004497
GO:0047092;27-hydroxycholesterol 7-alpha-monooxygenase activity;6;3;GO:0004497
GO:0060055;angiogenesis involved in wound healing;1153;748;GO:0001525
GO:1903593;regulation of histamine secretion by mast cell;249;26;GO:0048608
GO:0060056;mammary gland involution;377;256;GO:0007517
GO:1903594;negative regulation of histamine secretion by mast cell;0;2;GO:0048608
GO:0060057;apoptotic process involved in mammary gland involution;93;10;GO:0042981
GO:1903591;negative regulation of lysozyme activity;5;1;GO:0048305
GO:0060058;positive regulation of apoptotic process involved in mammary gland involution;96;45;GO:0043066
GO:1903592;positive regulation of lysozyme activity;2;1;GO:0046356
GO:0060051;negative regulation of protein glycosylation;45;9;GO:0006486
GO:1903597;negative regulation of gap junction assembly;102;30;GO:0048285
GO:0060052;neurofilament cytoskeleton organization;493;960;GO:0048666
GO:1903598;positive regulation of gap junction assembly;342;235;GO:0048608
GO:0060053;neurofilament cytoskeleton;97;55;GO:0030425
GO:1903595;positive regulation of histamine secretion by mast cell;241;183;GO:0048608
GO:0060054;positive regulation of epithelial cell proliferation involved in wound healing;452;216;GO:0042127
GO:1903596;regulation of gap junction assembly;494;9;GO:0048608
GO:1903599;positive regulation of autophagy of mitochondrion;659;42;GO:0048471
GO:0060059;embryonic retina morphogenesis in camera-type eye;1087;526;GO:0048704
GO:0072040;negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis;125;4;GO:0010942
GO:0072033;renal vesicle formation;233;260;GO:0030198
GO:0098641;cadherin binding involved in cell-cell adhesion;84;1040;GO:0048608
GO:0072032;proximal convoluted tubule segment 2 development;40;0;GO:0048608
GO:0098642;network-forming collagen trimer;580;22;GO:0005578
GO:0072031;proximal convoluted tubule segment 1 development;0;0;GO:0048608
GO:0072030;short nephron development;0;1;GO:0048608
GO:0098640;integrin binding involved in cell-matrix adhesion;728;32;GO:0048010
GO:0072037;mesenchymal stem cell differentiation involved in nephron morphogenesis;0;0;GO:0048704
GO:0098645;collagen network;580;29;GO:0005578
GO:0072036;mesenchymal to epithelial transition involved in renal vesicle formation;51;1;GO:0048704
GO:0098646;collagen sheet;49;0;GO:0005578
GO:0072035;pre-tubular aggregate formation;0;1;GO:0048608
GO:0098643;banded collagen fibril;830;213;GO:0048407
GO:0072034;renal vesicle induction;146;84;GO:0048608
GO:0098644;complex of collagen trimers;1411;562;GO:0048407
GO:0060060;post-embryonic retina morphogenesis in camera-type eye;89;7;GO:0048608
GO:0072039;regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis;125;2;GO:0010942
GO:0098647;collagen beaded filament;4;106;GO:0005578
GO:0060061;Spemann organizer formation;491;120;GO:0009952
GO:0072038;mesenchymal stem cell maintenance involved in nephron morphogenesis;231;18;GO:0048608
GO:0098648;collagen anchoring fibril;1;0;GO:0005578
GO:1903590;regulation of lysozyme activity;7;0;GO:0010401
GO:0001621;G protein-coupled ADP receptor activity;272;9;GO:0004930
GO:0001626;nociceptin receptor activity;890;6;GO:0004930
GO:0001640;adenylate cyclase inhibiting G protein-coupled glutamate receptor activity;506;93;GO:0004930
GO:0001631;cysteinyl leukotriene receptor activity;33;8;GO:0004930
GO:0001632;leukotriene B4 receptor activity;102;7;GO:0004930
GO:0001634;pituitary adenylate cyclase-activating polypeptide receptor activity;2;4;GO:0004930
GO:0001635;calcitonin gene-related peptide receptor activity;256;24;GO:0004930
GO:0001637;G protein-coupled chemoattractant receptor activity;21230;123;GO:0004930
GO:0001639;PLC activating G protein-coupled glutamate receptor activity;6;3;GO:0004930
GO:0098597;observational learning;235;67;GO:0007612
GO:0098598;learned vocalization behavior or vocal learning;309;18;GO:0007631
GO:0098595;perivitelline space;100;7;GO:0005615
GO:0098596;imitative learning;204;99;GO:0007611
GO:0001601;peptide YY receptor activity;205;259;GO:0004930
GO:0001602;pancreatic polypeptide receptor activity;176;48;GO:0004930
GO:0098599;palmitoyl hydrolase activity;7503;48;GO:0010401
GO:0001604;urotensin II receptor activity;1605;8;GO:0004930
GO:0001605;adrenomedullin receptor activity;187;10;GO:0004930
GO:0001607;neuromedin U receptor activity;2577;9;GO:0004867
GO:0001608;G protein-coupled nucleotide receptor activity;0;156;GO:0004930
GO:0001609;G protein-coupled adenosine receptor activity;9343;336;GO:0004930
GO:0001614;purinergic nucleotide receptor activity;16650;212;GO:0004930
GO:0001616;growth hormone secretagogue receptor activity;98;100;GO:0004930
GO:0001618;virus receptor activity;1436;1610;GO:0048193
GO:0001671;ATPase activator activity;27458;928;GO:0005524
GO:0001673;male germ cell nucleus;2806;1080;GO:0009952
GO:0001664;G protein-coupled receptor binding;63856;2860;GO:0005506
GO:0001665;alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity;321;80;GO:0004553
GO:0001666;response to hypoxia;17886;12700;GO:0001666
GO:0001667;ameboidal-type cell migration;37041;1520;GO:0048608
GO:0001669;acrosomal vesicle;10230;2230;GO:0008037
GO:0011000;replication fork arrest at mating type locus;7;3;GO:0007050
GO:0050609;phosphonate dehydrogenase activity;85;3;GO:0009065
GO:0050607;mycothiol-dependent formaldehyde dehydrogenase activity;1961;7;GO:0009065
GO:0050608;vanillin dehydrogenase activity;188;3;GO:0004497
GO:0001680;tRNA 3'-terminal CCA addition;33923;1;GO:0009063
GO:0001681;sialate O-acetylesterase activity;20985;8;GO:0004553
GO:0001682;tRNA 5'-leader removal;73593;35;GO:0006418
GO:0001674;female germ cell nucleus;894;69;GO:0005634
GO:0001675;acrosome assembly;1236;1170;GO:0008037
GO:0001676;long-chain fatty acid metabolic process;81217;3110;GO:0006631
GO:0001677;formation of translation initiation ternary complex;23;12;GO:0006413
GO:0001678;intracellular glucose homeostasis;26965;44;GO:0007596
GO:0050605;superoxide reductase activity;3102;7;GO:0004622
GO:0050606;4-carboxy-2-hydroxymuconate semialdehyde hemiacetal dehydrogenase activity;492;2;GO:0004067
GO:0050603;thiophene-2-carbonyl-CoA monooxygenase activity;0;5;GO:0004497
GO:0050604;taxadiene 5-alpha-hydroxylase activity;2;6;GO:0004497
GO:0050600;acyl-CoA 11-(E)-desaturase activity;0;0;GO:0006631
GO:0050618;phycoerythrobilin:ferredoxin oxidoreductase activity;1182;5;GO:0004746
GO:0050619;phytochromobilin:ferredoxin oxidoreductase activity;55;4;GO:0004705
GO:0001650;fibrillar center;9695;1580;GO:0005829
GO:0001651;dense fibrillar component;61;99;GO:0032989
GO:0001641;group II metabotropic glutamate receptor activity;182;138;GO:0004930
GO:0001642;group III metabotropic glutamate receptor activity;97;17;GO:0004930
GO:0001646;cAMP receptor activity;10;3;GO:0004930
GO:0001647;G protein-coupled cytokinin receptor activity;0;4;GO:0004974
GO:0001648;proteinase-activated receptor activity;4011;4;GO:0004872
GO:0001649;osteoblast differentiation;13523;5000;GO:0045595
GO:0050616;secologanin synthase activity;17;6;GO:0006033
GO:0050617;15,16-dihydrobiliverdin:ferredoxin oxidoreductase activity;537;5;GO:0004091
GO:0050614;delta24-sterol reductase activity;4556;9;GO:0004639
GO:0050615;1,2-dihydrovomilenine reductase activity;0;3;GO:0004076
GO:0050612;arsenate reductase (donor) activity;5;3;GO:0004067
GO:0050613;delta14-sterol reductase activity;1055;90;GO:0004639
GO:0050610;methylarsonate reductase activity;2645;24;GO:0004497
GO:0050611;arsenate reductase (azurin) activity;665;3;GO:0004067
GO:0050629;tetrachloroethene reductive dehalogenase activity;8;3;GO:0004497
GO:0001660;fever generation;1938;141;GO:0009611
GO:0001661;conditioned taste aversion;100;335;GO:0007610
GO:0001662;behavioral fear response;1667;1370;GO:0007610
GO:0001652;granular component;321;246;GO:0048608
GO:2000308;negative regulation of tumor necrosis factor (ligand) superfamily member 11 production;8;5;GO:0046330
GO:0001653;peptide receptor activity;109803;1150;GO:0004930
GO:0050620;phycocyanobilin:ferredoxin oxidoreductase activity;2627;5;GO:0004784
GO:2000307;regulation of tumor necrosis factor (ligand) superfamily member 11 production;118;3;GO:0046330
GO:0001654;eye development;52017;2360;GO:0008544
GO:2000306;positive regulation of photomorphogenesis;65;28;GO:0048367
GO:0001655;urogenital system development;5641;1730;GO:0048513
GO:2000305;semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance;45;4;GO:0048608
GO:0001656;metanephros development;7930;1100;GO:0048513
GO:0001657;ureteric bud development;6583;1430;GO:0030900
GO:0001658;branching involved in ureteric bud morphogenesis;3450;1290;GO:0048608
GO:0001659;temperature homeostasis;9333;772;GO:0006936
GO:2000309;positive regulation of tumor necrosis factor (ligand) superfamily member 11 production;110;98;GO:0046330
GO:0050627;mycothione reductase activity;709;2;GO:0004067
GO:2000300;regulation of synaptic vesicle exocytosis;2013;3700;GO:0048608
GO:0050628;2-oxopropyl-CoM reductase (carboxylating) activity;6;4;GO:0006096
GO:0050625;2-hydroxy-1,4-benzoquinone reductase activity;55;5;GO:0004067
GO:0050626;trimethylamine-N-oxide reductase (cytochrome c) activity;7043;113;GO:0004091
GO:0050623;berberine reductase activity;0;2;GO:0004067
GO:2000304;positive regulation of ceramide biosynthetic process;267;408;GO:0010468
GO:0050624;vomilenine reductase activity;2;2;GO:0004091
GO:2000303;regulation of ceramide biosynthetic process;3309;34;GO:0010468
GO:0050621;tryptophan alpha,beta-oxidase activity;0;3;GO:0004073
GO:2000302;positive regulation of synaptic vesicle exocytosis;162;25;GO:0048167
GO:0050622;glycine dehydrogenase (cyanide-forming) activity;1387;3;GO:0004067
GO:2000301;negative regulation of synaptic vesicle exocytosis;254;198;GO:0048608
GO:0035000;oligosaccharyltransferase III complex;13;2;GO:0005765
GO:0035001;dorsal trunk growth, open tracheal system;165;96;GO:0048704
GO:0035002;liquid clearance, open tracheal system;177;16;GO:0048308
GO:0035003;subapical complex;259;104;GO:0048309
GO:0023019;signal transduction involved in regulation of gene expression;933;647;GO:0007165
GO:0023022;termination of T cell signal transduction;0;3;GO:0002821
GO:2000319;regulation of T-helper 17 cell differentiation;802;8;GO:0045580
GO:0023021;termination of signal transduction;164;44;GO:0007165
GO:2000318;positive regulation of T-helper 17 type immune response;516;235;GO:0046649
GO:0023024;MHC class I protein complex binding;220;43;GO:0042612
GO:2000317;negative regulation of T-helper 17 type immune response;675;27;GO:0046649
GO:0023023;MHC protein complex binding;1015;169;GO:0042612
GO:2000316;regulation of T-helper 17 type immune response;1209;148;GO:0046649
GO:2000311;regulation of AMPA receptor activity;109;171;GO:0048167
GO:2000310;regulation of NMDA receptor activity;85;145;GO:0048167
GO:2000315;positive regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation;0;0;GO:0048704
GO:2000314;negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation;7;8;GO:0048405
GO:2000313;regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation;62;8;GO:0048608
GO:2000312;regulation of kainate selective glutamate receptor activity;1;37;GO:0048169
GO:0023003;nuclear migration to the embryo sac center;0;2;GO:0006928
GO:2000329;negative regulation of T-helper 17 cell lineage commitment;113;15;GO:0045595
GO:2000328;regulation of T-helper 17 cell lineage commitment;185;9;GO:0045595
GO:2000322;regulation of glucocorticoid receptor signaling pathway;336;9;GO:0030528
GO:2000321;positive regulation of T-helper 17 cell differentiation;204;202;GO:0032724
GO:2000320;negative regulation of T-helper 17 cell differentiation;590;74;GO:0045595
GO:2000324;positive regulation of glucocorticoid receptor signaling pathway;61;217;GO:0045944
GO:2000323;negative regulation of glucocorticoid receptor signaling pathway;275;371;GO:0045944
GO:2000340;positive regulation of chemokine (C-X-C motif) ligand 1 production;242;18;GO:0050729
GO:0001691;pseudophosphatase activity;141;8;GO:0010468
GO:0001692;histamine metabolic process;374;50;GO:0006569
GO:0001694;histamine biosynthetic process;203;31;GO:0006569
GO:0001695;histamine catabolic process;64;6;GO:0006559
GO:0023002;nuclear migration to embryo sac poles;0;2;GO:0007049
GO:2000339;negative regulation of chemokine (C-X-C motif) ligand 1 production;1;2;GO:0050727
GO:2000338;regulation of chemokine (C-X-C motif) ligand 1 production;292;7;GO:0050921
GO:2000333;negative regulation of blood microparticle formation;0;0;GO:0048193
GO:2000332;regulation of blood microparticle formation;113;10;GO:0048193
GO:2000331;regulation of terminal button organization;451;19;GO:0048608
GO:2000330;positive regulation of T-helper 17 cell lineage commitment;72;19;GO:0032724
GO:2000337;positive regulation of endothelial microparticle formation;0;0;GO:0050727
GO:2000336;negative regulation of endothelial microparticle formation;0;0;GO:0050727
GO:2000335;regulation of endothelial microparticle formation;0;0;GO:0050727
GO:2000334;positive regulation of blood microparticle formation;113;48;GO:0048193
GO:2000351;regulation of endothelial cell apoptotic process;2499;104;GO:0043066
GO:2000350;positive regulation of CD40 signaling pathway;50;7;GO:0046649
GO:0001696;gastric acid secretion;1462;144;GO:0007596
GO:0001697;histamine-induced gastric acid secretion;3;3;GO:0002768
GO:0001698;gastrin-induced gastric acid secretion;62;9;GO:0007596
GO:0001699;acetylcholine-induced gastric acid secretion;0;3;GO:0002768
GO:2000349;negative regulation of CD40 signaling pathway;113;9;GO:0046649
GO:2000344;positive regulation of acrosome reaction;3475;105;GO:0048608
GO:2000343;positive regulation of chemokine (C-X-C motif) ligand 2 production;393;157;GO:0050729
GO:2000342;negative regulation of chemokine (C-X-C motif) ligand 2 production;143;115;GO:0050727
GO:2000341;regulation of chemokine (C-X-C motif) ligand 2 production;756;35;GO:0050921
GO:2000348;regulation of CD40 signaling pathway;296;69;GO:0046649
GO:2000347;positive regulation of hepatocyte proliferation;351;299;GO:0048010
GO:2000346;negative regulation of hepatocyte proliferation;83;160;GO:0048010
GO:2000345;regulation of hepatocyte proliferation;550;72;GO:0048010
GO:0072590;N-acetyl-L-aspartate-L-glutamate ligase activity;131;10;GO:0004867
GO:0072583;clathrin-dependent endocytosis;469527;496;GO:0006897
GO:0072582;17-beta-hydroxysteroid dehydrogenase (NADP+) activity;148;0;GO:0004089
GO:0072581;protein-N6-(L-lysyl)-L-lysine modification to protein-N6-(beta-lysyl)-L-lysine;0;0;GO:0046395
GO:0072580;bacterial-type EF-P lysine modification;0;1;GO:0008544
GO:0072587;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity;12;3;GO:0003677
GO:0072586;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity;17329;0;GO:0003677
GO:0072585;xanthosine nucleotidase activity;42;3;GO:0004721
GO:0072584;caveolin-mediated endocytosis;9211;51;GO:0006897
GO:0072589;box H/ACA scaRNP complex;4;67;GO:0008033
GO:0072588;box H/ACA RNP complex;1033;132;GO:0005840
GO:0060594;mammary gland specification;240;6;GO:0007518
GO:0060595;fibroblast growth factor receptor signaling pathway involved in mammary gland specification;141;116;GO:0048608
GO:0060596;mammary placode formation;125;8;GO:0007517
GO:0060590;ATPase regulator activity;111950;341;GO:0003924
GO:0060591;chondroblast differentiation;281;39;GO:0045595
GO:0060592;mammary gland formation;412;17;GO:0030216
GO:0060593;Wnt signaling pathway involved in mammary gland specification;0;1;GO:0007219
GO:0060598;dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis;47;7;GO:0048608
GO:0060599;lateral sprouting involved in mammary gland duct morphogenesis;73;19;GO:0048608
GO:0072572;poly-ADP-D-ribose binding;3510;10;GO:0043161
GO:0072571;mono-ADP-D-ribose binding;78;2;GO:0046907
GO:0072570;ADP-D-ribose binding;163;2;GO:0043161
GO:0072576;liver morphogenesis;1111;17;GO:0048608
GO:0072575;epithelial cell proliferation involved in liver morphogenesis;939;17;GO:0042127
GO:0072574;hepatocyte proliferation;939;40;GO:0042127
GO:0072573;tolerance induction to lipopolysaccharide;120;35;GO:0002526
GO:0072579;glycine receptor clustering;85;8;GO:0048704
GO:0072578;neurotransmitter-gated ion channel clustering;1074;10;GO:0048666
GO:0072577;endothelial cell apoptotic process;2878;215;GO:0006915
GO:0072594;establishment of protein localization to organelle;456053;2690;GO:0005737
GO:0072593;reactive oxygen species metabolic process;664394;4400;GO:0006979
GO:0072592;oxygen metabolic process;273;38;GO:0055114
GO:0072591;citrate-L-glutamate ligase activity;44;10;GO:0006099
GO:0072598;protein localization to chloroplast;3266;74;GO:0009536
GO:0072597;maintenance of protein location in chloroplast;0;0;GO:0006464
GO:0072596;establishment of protein localization to chloroplast;2997;6;GO:0009536
GO:0072595;maintenance of protein localization in organelle;11408;67;GO:0005737
GO:0072599;establishment of protein localization to endoplasmic reticulum;254353;2150;GO:0006464
GO:0060561;apoptotic process involved in morphogenesis;1678;1330;GO:0042127
GO:0060562;epithelial tube morphogenesis;33393;857;GO:0030900
GO:0060563;neuroepithelial cell differentiation;2155;604;GO:0030182
GO:1901660;calcium ion export;121;29;GO:0006836
GO:1901662;quinone catabolic process;160;21;GO:0006749
GO:0060560;developmental growth involved in morphogenesis;24461;1210;GO:0048731
GO:1901661;quinone metabolic process;1196933;463;GO:0006749
GO:0060569;positive regulation of peptide hormone processing;0;2;GO:0048608
GO:1901664;regulation of NAD+ ADP-ribosyltransferase activity;48;1;GO:0004867
GO:1901663;quinone biosynthetic process;1193248;970;GO:0006749
GO:0047589;5-aminovalerate transaminase activity;518;3;GO:0004073
GO:1901666;positive regulation of NAD+ ADP-ribosyltransferase activity;48;9;GO:0046356
GO:0047588;5-aminopentanamidase activity;61;4;GO:0004553
GO:1901665;negative regulation of NAD+ ADP-ribosyltransferase activity;0;0;GO:0010401
GO:1901668;regulation of superoxide dismutase activity;23;8;GO:0008629
GO:0060566;positive regulation of termination of DNA-templated transcription;2138;2;GO:0045944
GO:1901667;negative regulation of skeletal muscle satellite cell activation involved in skeletal muscle regeneration;0;0;GO:0048771
GO:0060567;negative regulation of termination of DNA-templated transcription;281855;4;GO:0045944
GO:0060568;regulation of peptide hormone processing;7;1;GO:0048608
GO:0047594;6-beta-hydroxyhyoscyamine epoxidase activity;9;3;GO:0004497
GO:0047593;6-acetylglucose deacetylase activity;0;2;GO:0006066
GO:0047592;5-pyridoxate dioxygenase activity;0;4;GO:0004497
GO:0047591;5-hydroxypentanoate CoA-transferase activity;0;3;GO:0006081
GO:0047598;7-dehydrocholesterol reductase activity;167;23;GO:0004637
GO:0047597;6-oxocineole dehydrogenase activity;0;3;GO:0004091
GO:0072542;protein phosphatase activator activity;2545;262;GO:0004723
GO:0047596;6-methylsalicylate decarboxylase activity;11;3;GO:0006073
GO:0072541;peroxynitrite reductase activity;2;6;GO:0008037
GO:0047595;6-hydroxynicotinate reductase activity;97;2;GO:0004067
GO:0072540;T-helper 17 cell lineage commitment;1471;157;GO:0046649
GO:0072547;tricoumaroylspermidine meta-hydroxylase activity;6;1;GO:0004073
GO:0072546;EMC complex;16865;210;GO:0005829
GO:0072545;tyrosine binding;1361;10;GO:0042802
GO:0072544;L-DOPA binding;1209;8;GO:0043169
GO:0047590;5-dehydro-2-deoxygluconokinase activity;8134;18;GO:0006099
GO:0072549;monocoumaroyl dicaffeoyl spermidine meta-hydroxylase activity;6;1;GO:0006073
GO:0072548;dicoumaroyl monocaffeoyl spermidine meta-hydroxylase activity;6;1;GO:0006073
GO:0060550;positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity;2;10;GO:0005524
GO:0060551;regulation of fructose 1,6-bisphosphate metabolic process;64;2;GO:0006096
GO:0060552;positive regulation of fructose 1,6-bisphosphate metabolic process;64;10;GO:0046395
GO:1901671;positive regulation of superoxide dismutase activity;16;50;GO:0046395
GO:1901670;negative regulation of superoxide dismutase activity;4;7;GO:0046395
GO:1901673;regulation of mitotic spindle assembly;1836;332;GO:0048285
GO:1901672;positive regulation of systemic acquired resistance;131;5;GO:0046274
GO:0060558;regulation of calcidiol 1-monooxygenase activity;10;72;GO:0010468
GO:0060559;positive regulation of calcidiol 1-monooxygenase activity;5;218;GO:0046395
GO:0047599;8-oxocoformycin reductase activity;3;3;GO:0006067
GO:1901679;nucleotide transmembrane transport;68013;6;GO:0008529
GO:1901678;iron coordination entity transport;503686;186;GO:0006826
GO:0060556;regulation of vitamin D biosynthetic process;242;6;GO:0045944
GO:0060557;positive regulation of vitamin D biosynthetic process;125;86;GO:0045944
GO:0072532;tri-(feruloyl or hydroxyferuloyl) spermidine meta-hydroxylase activity;17;0;GO:0006022
GO:0072531;pyrimidine-containing compound transmembrane transport;37777;318;GO:0008565
GO:0072530;purine-containing compound transmembrane transport;110544;21;GO:0008565
GO:0072536;interleukin-23 receptor complex;110;26;GO:0005125
GO:0072535;tumor necrosis factor (ligand) superfamily member 11 production;118;3;GO:0046330
GO:0072534;perineuronal net;370;38;GO:0048666
GO:0072533;tri-(coumaroyl or caffeoyl) spermidine meta-hydroxylase activity;18;0;GO:0004073
GO:0072539;T-helper 17 cell differentiation;2340;70;GO:0046649
GO:0072538;T-helper 17 type immune response;2953;60;GO:0046649
GO:0072537;fibroblast activation;377;164;GO:0032989
GO:0060583;regulation of actin cortical patch localization;0;1;GO:0048285
GO:0060584;regulation of prostaglandin-endoperoxide synthase activity;5;9;GO:0030530
GO:0060585;positive regulation of prostaglandin-endoperoxide synthase activity;5;37;GO:0010467
GO:1901680;sulfur-containing amino acid secondary active transmembrane transporter activity;195;0;GO:0008544
GO:0060586;multicellular organismal-level iron ion homeostasis;1555;114;GO:0006879
GO:1901682;sulfur compound transmembrane transporter activity;220696;165;GO:0005215
GO:0060580;ventral spinal cord interneuron fate determination;52;2;GO:0048704
GO:1901681;sulfur compound binding;1084673;1600;GO:0019901
GO:0060581;cell fate commitment involved in pattern specification;1246;132;GO:0032502
GO:1901684;arsenate ion transmembrane transport;6701;8;GO:0006826
GO:0060582;cell fate determination involved in pattern specification;323;2;GO:0030154
GO:1901683;arsenate ion transmembrane transporter activity;6678;2;GO:0005215
GO:1901686;glutathione derivative catabolic process;0;0;GO:0009062
GO:1901685;glutathione derivative metabolic process;83;563;GO:0006749
GO:1901687;glutathione derivative biosynthetic process;82;687;GO:0006749
GO:0060587;regulation of lipoprotein lipid oxidation;114;8;GO:0045595
GO:0060588;negative regulation of lipoprotein lipid oxidation;108;8;GO:0045579
GO:0060589;nucleoside-triphosphatase regulator activity;846669;947;GO:0005524
GO:0072560;type B pancreatic cell maturation;144;19;GO:0048193
GO:0072565;endothelial microparticle formation;0;0;GO:0002576
GO:0072564;blood microparticle formation;113;9;GO:0002576
GO:0072563;endothelial microparticle;64;124;GO:0002576
GO:0072562;blood microparticle;268;3100;GO:0002576
GO:0072567;chemokine (C-X-C motif) ligand 2 production;756;9;GO:0050921
GO:0072566;chemokine (C-X-C motif) ligand 1 production;292;4;GO:0050921
GO:0060572;morphogenesis of an epithelial bud;809;49;GO:0030216
GO:0060573;cell fate specification involved in pattern specification;676;83;GO:0032502
GO:0060574;intestinal epithelial cell maturation;212;46;GO:0007596
GO:1901691;proton binding;27;2;GO:0043167
GO:0060575;intestinal epithelial cell differentiation;1693;111;GO:0030216
GO:1901693;negative regulation of compound eye retinal cell apoptotic process;11;3;GO:0010941
GO:1901692;regulation of compound eye retinal cell apoptotic process;37;2;GO:0010941
GO:0060570;negative regulation of peptide hormone processing;7;9;GO:0048193
GO:1901695;tyramine biosynthetic process;8;0;GO:0006560
GO:0060571;morphogenesis of an epithelial fold;1413;265;GO:0030216
GO:1901694;positive regulation of compound eye retinal cell apoptotic process;26;5;GO:0010941
GO:1901697;olivetolic acid biosynthetic process;1;0;GO:0009061
GO:1901696;cannabinoid biosynthetic process;56;4;GO:0009809
GO:1901699;cellular response to nitrogen compound;121866;732;GO:0045735
GO:1901698;response to nitrogen compound;198037;1040;GO:0046395
GO:0060576;intestinal epithelial cell development;991;962;GO:0030900
GO:0060577;pulmonary vein morphogenesis;76;40;GO:0048706
GO:0060578;superior vena cava morphogenesis;12;57;GO:0048608
GO:0060579;ventral spinal cord interneuron fate commitment;715;23;GO:0048704
GO:0072550;triferuloylspermidine meta-hydroxylase activity;5;0;GO:0006032
GO:0072554;blood vessel lumenization;336;21;GO:0009986
GO:0072553;terminal button organization;708;81;GO:0048706
GO:0072552;monoferuloyl di-(hydroxyferuloyl) spermidine meta-hydroxylase activity;4;0;GO:0006073
GO:0072551;diferuloyl mono-(hydroxyferuloyl) spermidine meta-hydroxylase activity;4;0;GO:0006073
GO:0072558;NLRP1 inflammasome complex;171;55;GO:0009986
GO:0072557;IPAF inflammasome complex;77;66;GO:0005840
GO:0072555;17-beta-ketosteroid reductase activity;58;1;GO:0004497
GO:0072559;NLRP3 inflammasome complex;291;99;GO:0004637
GO:0035520;monoubiquitinated protein deubiquitination;41;1190;GO:0006464
GO:0035518;histone H2A monoubiquitination;0;1070;GO:0042379
GO:0035519;protein K29-linked ubiquitination;25;149;GO:0006464
GO:0035514;DNA demethylase activity;5894;10;GO:0004553
GO:0035515;oxidative RNA demethylase activity;3719;54;GO:0046395
GO:0035516;oxidative DNA demethylase activity;3700;9;GO:0004725
GO:0035517;PR-DUB complex;200;37;GO:0005615
GO:0035510;DNA dealkylation;74018;91;GO:0009628
GO:0035513;oxidative RNA demethylation;3168;87;GO:0045944
GO:0035507;regulation of myosin-light-chain-phosphatase activity;28;249;GO:0010467
GO:0035508;positive regulation of myosin-light-chain-phosphatase activity;1;7;GO:0048608
GO:0035509;negative regulation of myosin-light-chain-phosphatase activity;20;27;GO:0010468
GO:0035503;ureter part of ureteric bud development;0;1;GO:0048608
GO:0035504;regulation of myosin light chain kinase activity;2;5;GO:0048608
GO:0035505;positive regulation of myosin light chain kinase activity;2;22;GO:0048608
GO:0035506;negative regulation of myosin light chain kinase activity;0;3;GO:0048608
GO:0035500;MH2 domain binding;100;51;GO:0043169
GO:0035501;MH1 domain binding;37;35;GO:0005515
GO:0035502;metanephric part of ureteric bud development;188;30;GO:0048608
GO:0035561;regulation of chromatin binding;74;360;GO:0016570
GO:0035562;negative regulation of chromatin binding;34;290;GO:0016570
GO:0035563;positive regulation of chromatin binding;14;178;GO:0016569
GO:0035564;regulation of kidney size;220;29;GO:0048193
GO:0060520;activation of prostate induction by androgen receptor signaling pathway;36;7;GO:0030516
GO:0035560;pheophorbidase activity;13;2;GO:0004497
GO:0047547;2-methylcitrate dehydratase activity;13052;81;GO:0006081
GO:0060525;prostate glandular acinus development;506;9;GO:0048608
GO:1901620;regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;561;8;GO:0048704
GO:0047546;2-hydroxypyridine 5-monooxygenase activity;0;3;GO:0004497
GO:0060526;prostate glandular acinus morphogenesis;288;5;GO:0048608
GO:0047545;2-hydroxyglutarate dehydrogenase activity;2385;10;GO:0004067
GO:0060527;prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis;288;138;GO:0048608
GO:1901622;positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;49;1;GO:0048704
GO:0047544;2-hydroxybiphenyl 3-monooxygenase activity;2;4;GO:0004497
GO:0060528;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;142;158;GO:0048608
GO:1901621;negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;298;40;GO:0048704
GO:0060521;mesenchymal-epithelial cell signaling involved in prostate induction;0;0;GO:0048608
GO:1901624;negative regulation of lymphocyte chemotaxis;133;9;GO:0050900
GO:0060522;inductive mesenchymal to epithelial cell signaling;0;1;GO:0048010
GO:1901623;regulation of lymphocyte chemotaxis;1160;99;GO:0050900
GO:0047549;2-nitrophenol 2-monooxygenase activity;1;3;GO:0004497
GO:0060523;prostate epithelial cord elongation;114;53;GO:0048608
GO:1901626;regulation of postsynaptic membrane organization;35;6;GO:0048608
GO:0047548;2-methyleneglutarate mutase activity;23;2;GO:0006099
GO:0060524;dichotomous subdivision of prostate epithelial cord terminal unit;0;1;GO:0048471
GO:1901625;cellular response to ergosterol;4;3;GO:0009611
GO:0047550;2-oxoadipate reductase activity;0;3;GO:0004067
GO:1901617;organic hydroxy compound biosynthetic process;1529761;869;GO:0046394
GO:1901616;organic hydroxy compound catabolic process;201257;70;GO:0046274
GO:1901618;organic hydroxy compound transmembrane transporter activity;67956;53;GO:0015075
GO:0047554;2-pyrone-4,6-dicarboxylate lactonase activity;265;3;GO:0046274
GO:0060529;squamous basal epithelial stem cell differentiation involved in prostate gland acinus development;76;9;GO:0042127
GO:0047553;2-oxoglutarate synthase activity;5639;3;GO:0006099
GO:0047552;2-oxoaldehyde dehydrogenase (NADP+) activity;0;0;GO:0004073
GO:0047551;2-oxoaldehyde dehydrogenase (NAD+) activity;0;0;GO:0004073
GO:0035554;termination of Roundabout signal transduction;0;4;GO:0007626
GO:0035556;intracellular signal transduction;6652136;11200;GO:0007165
GO:0035550;urease complex;17694;27;GO:0005737
GO:0035552;oxidative single-stranded DNA demethylation;15580;249;GO:0006974
GO:0035553;oxidative single-stranded RNA demethylation;2782;92;GO:0045944
GO:0047558;3-cyanoalanine hydratase activity;21;12;GO:0006067
GO:0060514;prostate induction;0;3;GO:0048608
GO:1901631;positive regulation of presynaptic membrane organization;56;10;GO:0048608
GO:0047557;3-aci-nitropropanoate oxidase activity;0;2;GO:0004601
GO:0060515;prostate field specification;0;0;GO:0048608
GO:1901630;negative regulation of presynaptic membrane organization;0;7;GO:0048608
GO:0047556;3,4-dihydroxyphthalate decarboxylase activity;14;3;GO:0006073
GO:0060516;primary prostatic bud elongation;99;10;GO:0048608
GO:1901633;negative regulation of synaptic vesicle membrane organization;13;0;GO:0048666
GO:0047555;3',5'-cyclic-GMP phosphodiesterase activity;4881;81;GO:0008061
GO:0060517;epithelial cell proliferation involved in prostatic bud elongation;59;7;GO:0042127
GO:1901632;regulation of synaptic vesicle membrane organization;773;1;GO:0048666
GO:0060510;type II pneumocyte differentiation;322;64;GO:0048316
GO:1901634;positive regulation of synaptic vesicle membrane organization;404;1;GO:0048608
GO:0060512;prostate gland morphogenesis;2168;221;GO:0048608
GO:0047559;3-dehydro-L-gulonate 2-dehydrogenase activity;3089;5;GO:0004497
GO:0060513;prostatic bud formation;581;12;GO:0048608
GO:0047561;3-hydroxyanthranilate oxidase activity;0;3;GO:0004091
GO:1901628;positive regulation of postsynaptic membrane organization;26;5;GO:0048608
GO:0047560;3-dehydrosphinganine reductase activity;4688;109;GO:0004067
GO:1901629;regulation of presynaptic membrane organization;58;4;GO:0048608
GO:0047565;3-hydroxypropionate dehydrogenase (NAD+) activity;4;0;GO:0004067
GO:0060518;cell migration involved in prostatic bud elongation;0;2;GO:0048608
GO:0047564;3-hydroxycyclohexanone dehydrogenase activity;0;3;GO:0004091
GO:0060519;cell adhesion involved in prostatic bud elongation;0;3;GO:0005911
GO:0047563;3-hydroxybenzoate 2-monooxygenase activity;0;3;GO:0004497
GO:0047562;3-hydroxyaspartate aldolase activity;0;3;GO:0006032
GO:0035543;positive regulation of SNARE complex assembly;121;9;GO:0048193
GO:0035544;negative regulation of SNARE complex assembly;115;8;GO:0048193
GO:0035545;determination of left/right asymmetry in nervous system;294;6;GO:0007610
GO:0035540;positive regulation of SNARE complex disassembly;0;5;GO:0048193
GO:0060540;diaphragm morphogenesis;1;2;GO:0048704
GO:0035541;negative regulation of SNARE complex disassembly;0;3;GO:0048193
GO:0060541;respiratory system development;24441;1290;GO:0009952
GO:0035542;regulation of SNARE complex assembly;618;83;GO:0008023
GO:0060542;regulation of strand invasion;61;3;GO:0048285
GO:1901640;XTP binding;0;3;GO:0005524
GO:0047569;3-oxoadipate CoA-transferase activity;8757;6;GO:0006081
GO:1901642;nucleoside transmembrane transport;145431;355;GO:0008529
GO:0047568;3-oxo-5-beta-steroid 4-dehydrogenase activity;66;3;GO:0004497
GO:1901641;ITP binding;0;3;GO:0005515
GO:0047567;3-methyleneoxindole reductase activity;0;3;GO:0004067
GO:0060549;regulation of fructose 1,6-bisphosphate 1-phosphatase activity;2;2;GO:0005524
GO:0047566;3-ketovalidoxylamine C-N-lyase activity;0;3;GO:0004497
GO:0060543;negative regulation of strand invasion;9;4;GO:0010468
GO:1901646;negative regulation of synoviocyte proliferation;1;2;GO:0010628
GO:0060544;regulation of necroptotic process;1480;377;GO:0046330
GO:1901645;regulation of synoviocyte proliferation;141;4;GO:0050727
GO:0060545;positive regulation of necroptotic process;323;41;GO:0046330
GO:0060546;negative regulation of necroptotic process;810;513;GO:1903047
GO:1901647;positive regulation of synoviocyte proliferation;140;66;GO:0045944
GO:0047572;3-phosphoglycerate phosphatase activity;0;2;GO:0006066
GO:0047571;3-oxosteroid 1-dehydrogenase activity;1290;5;GO:0004497
GO:0047570;3-oxoadipate enol-lactonase activity;13558;8;GO:0006081
GO:0047576;4-chlorobenzoate dehalogenase activity;1;2;GO:0004497
GO:0072521;purine-containing compound metabolic process;9998792;1630;GO:0006725
GO:0047575;4-carboxymuconolactone decarboxylase activity;3744;9;GO:0006073
GO:0072520;seminiferous tubule development;764;921;GO:0007283
GO:0047574;4-acetamidobutyryl-CoA deacetylase activity;1;4;GO:0004089
GO:0047573;4-acetamidobutyrate deacetylase activity;0;5;GO:0004089
GO:0072525;pyridine-containing compound biosynthetic process;1982276;108;GO:0046394
GO:0072524;pyridine-containing compound metabolic process;2669480;523;GO:0006725
GO:0035538;carbohydrate response element binding;3;5;GO:0003700
GO:0072523;purine-containing compound catabolic process;126113;1430;GO:0006559
GO:0035539;8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity;3692;45;GO:0008033
GO:0072522;purine-containing compound biosynthetic process;8169748;849;GO:0009205
GO:0035532;negative regulation of chemokine (C-C motif) ligand 6 production;0;4;GO:0050727
GO:0072529;pyrimidine-containing compound catabolic process;185947;172;GO:0006559
GO:0035533;positive regulation of chemokine (C-C motif) ligand 6 production;0;3;GO:0050729
GO:0072528;pyrimidine-containing compound biosynthetic process;3421936;750;GO:0009405
GO:0072527;pyrimidine-containing compound metabolic process;3826282;992;GO:0006725
GO:0072526;pyridine-containing compound catabolic process;2533;5;GO:0046395
GO:0035530;chemokine (C-C motif) ligand 6 production;0;3;GO:0050921
GO:0060530;smooth muscle cell differentiation involved in prostate glandular acinus development;0;1;GO:0048608
GO:0035531;regulation of chemokine (C-C motif) ligand 6 production;0;1;GO:0050921
GO:0060531;neuroendocrine cell differentiation involved in prostate gland acinus development;0;1;GO:0048608
GO:0060536;cartilage morphogenesis;1045;237;GO:0048608
GO:1901653;cellular response to peptide;35102;1030;GO:0042221
GO:0047579;4-hydroxymandelate oxidase activity;0;2;GO:0004497
GO:0060537;muscle tissue development;33278;1510;GO:0007517
GO:1901652;response to peptide;40826;919;GO:0009615
GO:0047578;4-hydroxyglutamate transaminase activity;3;4;GO:0004041
GO:0060538;skeletal muscle organ development;14736;725;GO:0001501
GO:1901655;cellular response to ketone;5097;110;GO:0045735
GO:0047577;4-hydroxybutyrate dehydrogenase activity;111;5;GO:0004089
GO:0060539;diaphragm development;268;376;GO:0048589
GO:1901654;response to ketone;10464;785;GO:0046395
GO:0060532;bronchus cartilage development;109;62;GO:0002041
GO:1901657;glycosyl compound metabolic process;1238928;1310;GO:0005975
GO:0060533;bronchus cartilage morphogenesis;0;1;GO:0048608
GO:1901656;glycoside transport;49158;10;GO:0008565
GO:0060534;trachea cartilage development;328;198;GO:0002041
GO:1901659;glycosyl compound biosynthetic process;803071;260;GO:0005976
GO:0060535;trachea cartilage morphogenesis;111;303;GO:0048608
GO:1901658;glycosyl compound catabolic process;155882;1060;GO:0005975
GO:0047583;4-methyloxaloacetate esterase activity;0;4;GO:0004553
GO:0047582;4-methyleneglutaminase activity;0;3;GO:0004467
GO:0047581;4-methyleneglutamate-ammonia ligase activity;0;3;GO:0004466
GO:0047580;4-hydroxyproline epimerase activity;2096;2;GO:0004073
GO:0035529;NADH pyrophosphatase activity;21371;290;GO:0003954
GO:0047587;5-alpha-hydroxysteroid dehydratase activity;0;4;GO:0004067
GO:0047586;5'-acylphosphoadenosine hydrolase activity;0;1;GO:0004721
GO:0047585;4-pyridoxolactonase activity;58;4;GO:0004467
GO:0047584;4-oxalmesaconate hydratase activity;412;4;GO:0006081
GO:0035525;NF-kappaB p50/p65 complex;60;10;GO:0043123
GO:0072514;trehalose transport in response to water deprivation;0;0;GO:0009414
GO:0035526;retrograde transport, plasma membrane to Golgi;101;42;GO:0006836
GO:0072513;positive regulation of secondary heart field cardioblast proliferation;201;139;GO:0048608
GO:0035527;3-hydroxypropionate dehydrogenase (NADP+) activity;2658;0;GO:0004067
GO:0035521;monoubiquitinated histone deubiquitination;10;41;GO:0042335
GO:0072518;Rho-dependent protein serine/threonine kinase activity;156;9;GO:0004721
GO:0035522;monoubiquitinated histone H2A deubiquitination;10;447;GO:0043687
GO:0072517;host cell viral assembly compartment;71;10;GO:0043207
GO:0035523;protein K29-linked deubiquitination;19;15;GO:0006464
GO:0035524;proline transmembrane transport;1321;69;GO:0006810
GO:0072515;trehalose transport in response to desiccation;0;0;GO:0006865
GO:0047509;(R)-dehydropantoate dehydrogenase activity;0;0;GO:0006066
GO:0047508;(R)-2-methylmalate dehydratase activity;852;0;GO:0006099
GO:0047503;(-)-borneol dehydrogenase activity;0;5;GO:0004067
GO:0047502;(+)-sabinol dehydrogenase activity;0;3;GO:0004073
GO:0047501;(+)-neomenthol dehydrogenase activity;26;6;GO:0004067
GO:0047500;(+)-borneol dehydrogenase activity;4;3;GO:0004091
GO:0047507;(deoxy)nucleoside-phosphate kinase activity;109;2;GO:0004721
GO:0047506;(deoxy)adenylate kinase activity;0;2;GO:0004721
GO:0047505;(-)-menthol monooxygenase activity;0;3;GO:0004497
GO:0047504;(-)-menthol dehydrogenase activity;7;7;GO:0004067
GO:0047510;(S)-2-methylmalate dehydratase activity;0;0;GO:0006099
GO:0035598;N6-threonylcarbomyladenosine methylthiotransferase activity;12213;9;GO:0004497
GO:0035599;aspartic acid methylthiotransferase activity;27;0;GO:0004041
GO:0035594;ganglioside binding;522;4;GO:0005509
GO:0035595;N-acetylglucosaminylinositol deacetylase activity;8950;3;GO:0004553
GO:0035596;methylthiotransferase activity;163006;14;GO:0004497
GO:0035597;N6-isopentenyladenosine methylthiotransferase activity;151;3;GO:0003676
GO:0047519;quinate dehydrogenase (quinone) activity;488;3;GO:0004073
GO:0035590;purinergic nucleotide receptor signaling pathway;47725;649;GO:0007186
GO:0035591;signaling adaptor activity;18223;571;GO:0004872
GO:0035592;establishment of protein localization to extracellular region;715820;122;GO:0048471
GO:0035593;positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region;12;3;GO:0048407
GO:0047514;1,3-beta-D-glucan phosphorylase activity;3;2;GO:0004553
GO:0047513;1,2-alpha-L-fucosidase activity;18;4;GO:0004553
GO:0047512;(S,S)-butanediol dehydrogenase activity;236;0;GO:0004067
GO:0047511;(S)-methylmalonyl-CoA hydrolase activity;0;0;GO:0006081
GO:0047518;1-methyladenosine nucleosidase activity;0;3;GO:0004553
GO:0047517;1,4-beta-D-xylan synthase activity;118;6;GO:0004553
GO:0047516;1,3-propanediol dehydrogenase activity;950;3;GO:0004067
GO:0047515;1,3-beta-oligoglucan phosphorylase activity;2;3;GO:0004553
GO:0047521;3alpha,7alpha,12beta-trihydroxy-5beta-cholanate dehydrogenase activity;0;2;GO:0004073
GO:0047520;11-cis-retinyl-palmitate hydrolase activity;0;3;GO:0005576
GO:0035588;G protein-coupled purinergic receptor signaling pathway;14531;108;GO:0007186
GO:0035589;G protein-coupled purinergic nucleotide receptor signaling pathway;12173;653;GO:0007186
GO:0035583;sequestering of TGFbeta in extracellular matrix;223;62;GO:0048407
GO:0035584;calcium-mediated signaling using intracellular calcium source;1041;564;GO:0008083
GO:0035585;calcium-mediated signaling using extracellular calcium source;10;10;GO:0009719
GO:0035580;specific granule lumen;62;670;GO:0005829
GO:0035581;sequestering of extracellular ligand from receptor;678;8;GO:0004872
GO:0035582;sequestering of BMP in extracellular matrix;236;30;GO:0048407
GO:0047525;2'-hydroxydaidzein reductase activity;0;0;GO:0004067
GO:0060503;bud dilation involved in lung branching;62;21;GO:0048608
GO:0047524;16-hydroxysteroid epimerase activity;0;3;GO:0004497
GO:0060504;positive regulation of epithelial cell proliferation involved in lung bud dilation;0;2;GO:0048608
GO:0060505;epithelial cell proliferation involved in lung bud dilation;0;1;GO:0042127
GO:1901600;strigolactone metabolic process;257;1;GO:0009733
GO:0047522;15-oxoprostaglandin 13-oxidase activity;4527;122;GO:0004497
GO:0060506;smoothened signaling pathway involved in lung development;51;4;GO:0009952
GO:0047529;2,3-dimethylmalate lyase activity;354;4;GO:0006081
GO:1901602;dethiobiotin binding;0;0;GO:0043169
GO:0047528;2,3-dihydroxyindole 2,3-dioxygenase activity;0;3;GO:0004497
GO:1901601;strigolactone biosynthetic process;256;22;GO:1901363
GO:0047527;2,3-dihydroxybenzoate-serine ligase activity;876;5;GO:0006081
GO:0060501;positive regulation of epithelial cell proliferation involved in lung morphogenesis;233;185;GO:0048608
GO:1901604;dethiobiotin transmembrane transporter activity;13;1;GO:0005525
GO:0047526;2'-hydroxyisoflavone reductase activity;103;0;GO:0004497
GO:0060502;epithelial cell proliferation involved in lung morphogenesis;546;10;GO:0042127
GO:0047532;2,5-dioxopiperazine hydrolase activity;0;3;GO:0004553
GO:0060507;epidermal growth factor receptor signaling pathway involved in lung development;0;3;GO:0007179
GO:0060508;lung basal cell differentiation;0;1;GO:0030216
GO:0047530;2,4-diaminopentanoate dehydrogenase activity;100;2;GO:0009065
GO:0060509;type I pneumocyte differentiation;367;51;GO:0048308
GO:0035576;retinoic acid receptor signaling pathway involved in pronephric field specification;0;1;GO:0030501
GO:0035577;azurophil granule membrane;178;384;GO:0005766
GO:0035578;azurophil granule lumen;126;935;GO:0005766
GO:0035579;specific granule membrane;132;907;GO:0005829
GO:0035572;N-terminal peptidyl-serine dimethylation;9;8;GO:0046395
GO:0035573;N-terminal peptidyl-serine trimethylation;9;15;GO:0006477
GO:0035575;histone H4K20 demethylase activity;226;4;GO:0016569
GO:0035570;N-terminal peptidyl-serine methylation;18;7;GO:0006468
GO:0035571;N-terminal peptidyl-serine monomethylation;0;2;GO:0006464
GO:0047536;2-aminoadipate transaminase activity;1855;20;GO:0004073
GO:0047535;2-alkyn-1-ol dehydrogenase activity;0;3;GO:0004067
GO:0047534;2-acetolactate mutase activity;0;2;GO:0006099
GO:1901611;phosphatidylglycerol binding;1900;28;GO:0048193
GO:0047533;2,5-dioxovalerate dehydrogenase (NADP+) activity;901;0;GO:0009065
GO:1901610;positive regulation of vesicle transport along microtubule;201;5;GO:0048193
GO:1901613;negative regulation of terminal button organization;0;1;GO:0048706
GO:0047539;2-deoxyglucosidase activity;0;3;GO:0004553
GO:1901612;cardiolipin binding;1714;190;GO:0048407
GO:0047538;2-carboxy-D-arabinitol-1-phosphatase activity;12;4;GO:0006066
GO:1901615;organic hydroxy compound metabolic process;2267391;2700;GO:0046394
GO:0047537;2-aminohexanoate transaminase activity;0;2;GO:0009065
GO:1901614;positive regulation of terminal button organization;0;1;GO:0048608
GO:1901606;alpha-amino acid catabolic process;1169266;1470;GO:0009062
GO:1901605;alpha-amino acid metabolic process;12540006;1730;GO:0006520
GO:1901608;regulation of vesicle transport along microtubule;215;3;GO:0048193
GO:1901607;alpha-amino acid biosynthetic process;8810050;1300;GO:0009061
GO:0047543;2-hexadecenal reductase activity;1;3;GO:0004091
GO:0047542;2-furoyl-CoA dehydrogenase activity;70;3;GO:0006066
GO:1901609;negative regulation of vesicle transport along microtubule;8;2;GO:0048193
GO:0047541;2-furoate-CoA ligase activity;22;2;GO:0006099
GO:0047540;2-enoate reductase activity;149;3;GO:0004076
GO:0035565;regulation of pronephros size;58;61;GO:0048706
GO:0035566;regulation of metanephros size;64;158;GO:0048608
GO:0035567;non-canonical Wnt signaling pathway;5345;959;GO:0030198
GO:0035568;N-terminal peptidyl-proline methylation;12;6;GO:0043405
GO:1901583;tetrapeptide import across plasma membrane;30;0;GO:0005576
GO:0106329;L-phenylalaine oxidase activity;30;1;GO:0004497
GO:1901585;regulation of acid-sensing ion channel activity;1;2;GO:0006874
GO:0106328;acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity;4;2;GO:0006029
GO:1901584;tetrapeptide transmembrane transporter activity;15;0;GO:0008565
GO:1901587;positive regulation of acid-sensing ion channel activity;0;1;GO:0048169
GO:1901586;negative regulation of acid-sensing ion channel activity;0;1;GO:0048169
GO:1901589;axon microtubule bundle;0;3;GO:0048471
GO:1901588;dendritic microtubule;103;6;GO:0097183
GO:0070041;rRNA (uridine-C5-)-methyltransferase activity;10701;0;GO:0003729
GO:0106330;sialate 9-O-acetylesterase activity;1932;3;GO:0004553
GO:0070042;rRNA (uridine-N3-)-methyltransferase activity;5306;0;GO:0003729
GO:0045095;keratin filament;21458;2030;GO:0008544
GO:0070040;rRNA (adenine-C2-)-methyltransferase activity;69464;0;GO:0003735
GO:0070045;synaptobrevin 2-SNAP-25-syntaxin-2 complex;0;1;GO:0008021
GO:0070046;synaptobrevin 2-SNAP-25-syntaxin-3 complex;0;1;GO:0008021
GO:0045098;type III intermediate filament;97;185;GO:0030475
GO:0070043;rRNA (guanine-N7-)-methyltransferase activity;46358;0;GO:0003729
GO:0070044;synaptobrevin 2-SNAP-25-syntaxin-1a complex;213;40;GO:0008021
GO:0070049;endobrevin-SNAP-25-syntaxin-2 complex;0;1;GO:0008023
GO:0070047;synaptobrevin 2-SNAP-25-syntaxin-4 complex;0;0;GO:0008021
GO:0106336;yolk syncytial layer development;21;1;GO:0048704
GO:0070048;endobrevin-SNAP-25-syntaxin-1a complex;0;1;GO:0008023
GO:0106335;tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity;813;0;GO:0003729
GO:0045092;interleukin-18 receptor complex;103;5;GO:0005125
GO:0106334;3'-deoxyribose phosphate lyase activity;4;2;GO:0006032
GO:0106333;subcortical maternal complex;159;2;GO:0048608
GO:0106332;ds/ssDNA junction-specific dsDNA endonuclease activity;4;0;GO:0003690
GO:0045091;regulation of single stranded viral RNA replication via double stranded DNA intermediate;586;927;GO:0010401
GO:0106331;sialate 4-O-acetylesterase activity;1933;3;GO:0004553
GO:0033096;amyloplast envelope;3;3;GO:0009579
GO:0033095;aleurone grain;204;29;GO:0009566
GO:0033094;putrescine--2-oxoglutarate transaminase activity;4810;0;GO:0004449
GO:1901592;negative regulation of double-strand break repair via break-induced replication;0;2;GO:0048285
GO:0033093;Weibel-Palade body;383;330;GO:0005836
GO:1901591;regulation of double-strand break repair via break-induced replication;0;1;GO:0048285
GO:1901594;response to capsazepine;68;91;GO:0004930
GO:0033099;attachment organelle;13;7;GO:0005737
GO:1901593;response to GW 7647;0;1;GO:0046686
GO:0033098;amyloplast inner membrane;1;4;GO:0009986
GO:1901596;response to reversine;0;0;GO:0046686
GO:0033097;amyloplast membrane;3;7;GO:0009579
GO:0106339;tRNA (cytidine 32-2'-O)-methyltransferase activity;3623;0;GO:0003729
GO:1901595;response to hesperadin;0;1;GO:0009611
GO:1901598;(-)-pinoresinol metabolic process;12;2;GO:0046274
GO:1901597;response to carbendazim;0;0;GO:0046686
GO:1901599;(-)-pinoresinol biosynthetic process;9;1;GO:0046405
GO:0033092;positive regulation of immature T cell proliferation in thymus;237;55;GO:0045727
GO:0033091;positive regulation of immature T cell proliferation;237;107;GO:0045727
GO:0033090;positive regulation of extrathymic T cell differentiation;0;2;GO:0045595
GO:0070030;alphav-beta1 integrin-osteopontin complex;0;1;GO:0048407
GO:0106341;omega-hydroxyceramide transacylase activity;46;3;GO:0004721
GO:0070031;alphav-beta5 integrin-osteopontin complex;0;2;GO:0048193
GO:0106340;tRNA (guanosine 34-2'-O)-methyltransferase activity;0;0;GO:0003729
GO:0072690;single-celled organism vegetative growth phase;0;1;GO:0030529
GO:0070034;telomerase RNA binding;1574;345;GO:0003723
GO:0072697;protein localization to cell cortex;1043;314;GO:0005576
GO:0072696;positive regulation of DNA recombination at telomere;0;1;GO:0045727
GO:0070032;synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex;107;35;GO:0008023
GO:0072695;regulation of DNA recombination at telomere;196;9;GO:0006281
GO:0070033;synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex;13;10;GO:0008023
GO:0070038;rRNA (pseudouridine-N3-)-methyltransferase activity;28710;0;GO:0003729
GO:0106349;snRNA methylation;69;1;GO:0045944
GO:0070039;rRNA (guanosine-2'-O-)-methyltransferase activity;8188;0;GO:0003729
GO:0106348;U2 snRNA adenosine m6 methytransferase activity;11;0;GO:0003729
GO:0072699;protein localization to cortical microtubule cytoskeleton;75;2;GO:0005737
GO:0106347;U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity;2;0;GO:0003723
GO:0070037;rRNA (pseudouridine) methyltransferase activity;35028;9;GO:0003729
GO:0072698;protein localization to microtubule cytoskeleton;8593;26;GO:0007050
GO:0106346;snRNA methyltransferase activity;626;0;GO:0003729
GO:0106345;glyoxylate reductase activity;13660;1;GO:0004067
GO:0106344;4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate synthase activity from histidine and PLP;11;4;GO:0006061
GO:0106343;glutarate dioxygenase activity;1254;3;GO:0004497
GO:0106342;omega-hydroxyceramide biosynthetic process;44;2;GO:0006631
GO:0033085;negative regulation of T cell differentiation in thymus;592;507;GO:0045595
GO:0033084;regulation of immature T cell proliferation in thymus;562;19;GO:0045727
GO:0033083;regulation of immature T cell proliferation;564;9;GO:0045727
GO:0033082;regulation of extrathymic T cell differentiation;64;8;GO:0045595
GO:0033089;positive regulation of T cell differentiation in thymus;454;536;GO:0045944
GO:0033088;negative regulation of immature T cell proliferation in thymus;278;89;GO:0045727
GO:0033087;negative regulation of immature T cell proliferation;280;8;GO:0045727
GO:0033086;negative regulation of extrathymic T cell differentiation;0;2;GO:0045595
GO:0033081;regulation of T cell differentiation in thymus;1436;162;GO:0045595
GO:0070070;proton-transporting V-type ATPase complex assembly;12329;111;GO:0005764
GO:0033080;immature T cell proliferation in thymus;799;24;GO:0042127
GO:0070071;proton-transporting two-sector ATPase complex assembly;22545;8;GO:0005737
GO:0070063;RNA polymerase binding;114555;986;GO:0003729
GO:0070064;proline-rich region binding;892;800;GO:0042803
GO:0070061;fructose binding;259;191;GO:0005576
GO:0106350;octaprenyl pyrophosphate synthase activity;2963;2;GO:0006030
GO:0070062;extracellular exosome;7808;21300;GO:0070062
GO:0070067;syntaxin-6-syntaxin-16-Vti1a complex;0;1;GO:0008037
GO:0070068;VAMP4-syntaxin-6-syntaxin-16-Vti1a complex;0;0;GO:0008023
GO:0070065;cellubrevin-VAMP4-syntaxin-16 complex;0;1;GO:0008023
GO:0070066;cellubrevin-VAMP4-endobrevin-syntaxin-6 complex;0;1;GO:0008023
GO:0106359;2-hydroxyacyl-CoA lyase activity;72;2;GO:0004444
GO:0070069;cytochrome complex;385543;715;GO:0005739
GO:0106358;glycerol-1-phosphate dehydrogenase [NADP+] activity;1163;0;GO:0006066
GO:0033079;immature T cell proliferation;801;6;GO:0042127
GO:0106357;glycerol-1-phosphate dehydrogenase [NAD+] activity;1163;0;GO:0004067
GO:0106356;4-hydroxybenzoate 3-monooxygenase [NADPH] activity;5;1;GO:0004067
GO:0106355;4-hydroxybenzoate 3-monooxygenase [NADH] activity;2;1;GO:0004067
GO:0106354;tRNA surveillance;2163;3;GO:0006364
GO:0033074;pinene catabolic process;0;2;GO:0046274
GO:0033073;pinene metabolic process;27;2;GO:0006073
GO:0033072;vancomycin biosynthetic process;7334;3;GO:0009266
GO:0033071;vancomycin metabolic process;7334;2;GO:0009063
GO:0033078;extrathymic T cell differentiation;124;7;GO:0002273
GO:0033077;T cell differentiation in thymus;42152;1840;GO:0002521
GO:0033076;isoquinoline alkaloid metabolic process;804;27;GO:0006725
GO:0033075;isoquinoline alkaloid biosynthetic process;770;3;GO:0046148
GO:0033070;ansamycin biosynthetic process;0;1;GO:0046395
GO:0070060;'de novo' actin filament nucleation;48;2;GO:0008544
GO:0070052;collagen V binding;135;56;GO:0005581
GO:0106363;protein-cysteine methyltransferase activity;121;5;GO:0003729
GO:0070053;thrombospondin receptor activity;1404;160;GO:0004872
GO:0106362;protein-arginine N-acetylglucosaminyltransferase activity;29;2;GO:0006029
GO:0070050;neuron cellular homeostasis;3554;273;GO:0048666
GO:0106361;protein-arginine rhamnosyltransferase activity;4334;5;GO:0006061
GO:0070051;fibrinogen binding;220;220;GO:0005576
GO:0070056;prospore membrane leading edge;22;6;GO:0009987
GO:0070057;prospore membrane spindle pole body attachment site;13;1;GO:0005576
GO:0070054;mRNA splicing, via endonucleolytic cleavage and ligation;104;15;GO:0000398
GO:0033069;ansamycin metabolic process;0;4;GO:0006032
GO:0070058;tRNA gene clustering;95;36;GO:0006364
GO:0106369;(deoxy)nucleoside phosphate kinase activity, GTP as phosphate donor;0;1;GO:0004721
GO:0033068;macrolide biosynthetic process;28487;5;GO:0009405
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;3802;1550;GO:0006986
GO:0106368;(deoxy)nucleoside phosphate kinase activity, dTTP as phosphate donor;0;2;GO:0004721
GO:0106367;(deoxy)nucleoside phosphate kinase activity, dGTP as phosphate donor;0;1;GO:0004721
GO:0106366;guanosine kinase activity;3247;2;GO:0004721
GO:0106365;beta-carotene isomerase activity;32;2;GO:0004091
GO:0106364;4-hydroxy-3-all-trans-hexaprenylbenzoate oxygenase activity;1413;1;GO:0004497
GO:0060682;primary ureteric bud growth;55;2;GO:0048608
GO:0060683;regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling;4;2;GO:0048608
GO:0060684;epithelial-mesenchymal cell signaling;361;167;GO:0007179
GO:0060685;regulation of prostatic bud formation;326;93;GO:0048608
GO:0060680;lateral sprouting involved in ureteric bud morphogenesis;0;2;GO:0048608
GO:1901541;ent-pimara-8(14),15-diene biosynthetic process;0;0;GO:0046148
GO:0060681;branch elongation involved in ureteric bud branching;238;9;GO:0048608
GO:1901540;ent-pimara-8(14),15-diene catabolic process;0;0;GO:0046274
GO:0045049;protein insertion into ER membrane by N-terminal cleaved signal sequence;0;1;GO:0006464
GO:1901543;negative regulation of ent-pimara-8(14),15-diene biosynthetic process;0;1;GO:0010468
GO:1901542;regulation of ent-pimara-8(14),15-diene biosynthetic process;0;0;GO:0010468
GO:0045047;protein targeting to ER;254123;3100;GO:0006612
GO:1901545;response to raffinose;58;6;GO:0009813
GO:0045048;protein insertion into ER membrane;15895;123;GO:0009986
GO:1901544;positive regulation of ent-pimara-8(14),15-diene biosynthetic process;0;1;GO:0010468
GO:0060686;negative regulation of prostatic bud formation;213;210;GO:0010468
GO:1901547;negative regulation of synaptic vesicle lumen acidification;0;0;GO:0048608
GO:0060687;regulation of branching involved in prostate gland morphogenesis;254;373;GO:0048608
GO:1901546;regulation of synaptic vesicle lumen acidification;3;0;GO:0007613
GO:0060688;regulation of morphogenesis of a branching structure;3785;238;GO:0048468
GO:0060689;cell differentiation involved in salivary gland development;123;47;GO:0060537
GO:1901548;positive regulation of synaptic vesicle lumen acidification;0;0;GO:0048608
GO:0072660;maintenance of protein location in plasma membrane;110;49;GO:0007049
GO:0045053;protein retention in Golgi apparatus;1620;204;GO:0005767
GO:0106373;3-deoxyglucosone dehydrogenase activity;70;1;GO:0006066
GO:1901539;ent-pimara-8(14),15-diene metabolic process;0;1;GO:0006629
GO:0045050;protein insertion into ER membrane by stop-transfer membrane-anchor sequence;753;45;GO:0006631
GO:0106372;primary fluorescent dioxobilin-type chlorophyll catabolite methylesterase activity;5;1;GO:0009579
GO:0045051;protein insertion into ER membrane by internal uncleaved signal-anchor sequence;0;2;GO:0006464
GO:0106371;fluorescent chlorophyll catabolite monooxygenase (deformylase) activity;7;1;GO:0009579
GO:0045056;transcytosis;994;612;GO:0006867
GO:0070001;aspartic-type peptidase activity;1193781;498;GO:0004723
GO:0072664;maintenance of protein location in peroxisome;0;1;GO:0006626
GO:0106370;protein-L-histidine N-pros-methyltransferase activity;1938;3;GO:0004723
GO:0045057;cisternal progression;0;2;GO:0006936
GO:0070002;glutamic-type peptidase activity;3173;8;GO:0004222
GO:0072663;establishment of protein localization to peroxisome;40209;50;GO:0006626
GO:0045054;constitutive secretory pathway;315;39;GO:0005783
GO:0072662;protein localization to peroxisome;40270;68;GO:0009536
GO:0045055;regulated exocytosis;29708;1170;GO:0006916
GO:0070005;cysteine-type aminopeptidase activity;12916;4;GO:0004721
GO:0070006;metalloaminopeptidase activity;265243;1010;GO:0008236
GO:0072667;maintenance of protein location in vacuole;0;0;GO:0005737
GO:0070003;threonine-type peptidase activity;208434;509;GO:0010467
GO:0072666;establishment of protein localization to vacuole;39449;481;GO:0048471
GO:0070004;cysteine-type exopeptidase activity;29062;9;GO:0006486
GO:0072665;protein localization to vacuole;40931;338;GO:0005764
GO:0106379;8-oxo-(d)RTP hydrolase activity;0;0;GO:0008033
GO:0070009;serine-type aminopeptidase activity;20835;8;GO:0004073
GO:0106378;2-hydroxy-dATP hydrolase activity;107;3;GO:0004518
GO:0106377;2-hydroxy-ATP hydrolase activity;106;5;GO:0008061
GO:0070007;glutamic-type endopeptidase activity;3127;6;GO:0004722
GO:0106376;2-hydroxyphytanoyl-CoA lyase activity;3;1;GO:0006081
GO:1901731;positive regulation of platelet aggregation;380;31;GO:0050817
GO:0060851;vascular endothelial growth factor receptor signaling pathway involved in lymphatic endothelial cell fate commitment;0;2;GO:0048010
GO:1901734;quercetin biosynthetic process;0;0;GO:0009813
GO:1901733;quercetin catabolic process;57;3;GO:0009813
GO:0045238;CXCR2 chemokine receptor binding;0;2;GO:0005125
GO:0060853;Notch signaling pathway involved in arterial endothelial cell fate commitment;112;9;GO:0007219
GO:1901736;(R)-mevalonic acid catabolic process;0;0;GO:0006631
GO:0045239;tricarboxylic acid cycle enzyme complex;68188;166;GO:0005746
GO:0060854;branching involved in lymph vessel morphogenesis;61;2;GO:0048608
GO:1901735;(R)-mevalonic acid metabolic process;2;0;GO:0006631
GO:1901727;positive regulation of histone deacetylase activity;0;48;GO:0016568
GO:0045240;dihydrolipoyl dehydrogenase complex;28536;8;GO:0005739
GO:1901726;negative regulation of histone deacetylase activity;1;3;GO:0016568
GO:1901729;monensin A catabolic process;0;3;GO:0046395
GO:1901728;monensin A metabolic process;0;0;GO:0006066
GO:0045243;cytosolic isocitrate dehydrogenase complex (NAD+);0;4;GO:0005737
GO:0045244;succinate-CoA ligase complex (GDP-forming);174;7;GO:0005740
GO:0045241;cytosolic alpha-ketoglutarate dehydrogenase complex;0;2;GO:0005739
GO:0045242;isocitrate dehydrogenase complex (NAD+);228;3;GO:0005746
GO:0033269;internode region of axon;209;102;GO:0043005
GO:0033268;node of Ranvier;534;573;GO:0008026
GO:0033266;ABC-type choline transporter activity;2;1;GO:0005215
GO:0102093;acrylate:acyl-coA CoA transferase activity;0;1;GO:0006081
GO:0102094;S-adenosylmethionine:2-demethylmenaquinol methyltransferase activity;29124;2;GO:0004725
GO:0102091;phosphatidylinositol-5-phosphate phosphatase activity;0;0;GO:0004721
GO:0102090;adrenaline O-methyltransferase activity;0;0;GO:0004722
GO:0102097;(22S)-22-hydroxy-5alpha-campestan-3-one C-23 hydroxylase activity;23;0;GO:0004497
GO:0102096;decaprenyl-N-acetyl-alpha-D-glucosaminyl-pyrophosphate:dTDP-alpha-L-rhamnose rhamnosyltransferase activity;1039;2;GO:0006029
GO:0102099;FAD-dependent urate hydroxylase activity;536;2;GO:0004067
GO:0102098;D-galacturonate reductase activity;62;3;GO:0006073
GO:0080192;primary thickening;0;0;GO:0048608
GO:0080193;diffuse secondary thickening;0;1;GO:0048608
GO:0080170;hydrogen peroxide transmembrane transport;191;34;GO:0006879
GO:0080171;lytic vacuole organization;8517;85;GO:0005737
GO:0080172;petal epidermis patterning;19;4;GO:0048316
GO:0080173;male-female gamete recognition during double fertilization forming a zygote and endosperm;10;1;GO:0009566
GO:0080175;phragmoplast microtubule organization;659;5;GO:0048471
GO:0080176;xyloglucan 1,6-alpha-xylosidase activity;5;2;GO:0004553
GO:0080177;plastoglobule organization;81;3;GO:0009913
GO:0080178;5-carbamoylmethyl uridine residue modification;108;2;GO:0046395
GO:0080179;1-methylguanosine metabolic process;43;1;GO:0006749
GO:0008823;cupric reductase activity;177;159;GO:0004073
GO:0008821;crossover junction DNA endonuclease activity;82367;26;GO:0003690
GO:0008820;cobinamide phosphate guanylyltransferase activity;35708;6;GO:0006067
GO:0008816;citryl-CoA lyase activity;5696;10;GO:0006081
GO:0008815;citrate (pro-3S)-lyase activity;14126;1;GO:0006081
GO:0008814;citrate CoA-transferase activity;15647;121;GO:0004073
GO:0008813;chorismate lyase activity;23639;95;GO:0006032
GO:0008819;cobinamide kinase activity;2;2;GO:0004721
GO:0008818;cobalamin 5'-phosphate synthase activity;60827;1;GO:0006032
GO:0008817;corrinoid adenosyltransferase activity;146438;138;GO:0004073
GO:0080180;2-methylguanosine metabolic process;42;0;GO:0006749
GO:0080181;lateral root branching;9;6;GO:0048706
GO:0080182;histone H3-K4 trimethylation;10;1110;GO:0045944
GO:0080183;response to photooxidative stress;1112;9;GO:0006979
GO:0080184;response to phenylpropanoid;69;39;GO:0046340
GO:0080185;effector-mediated activation of plant hypersensitive response by symbiont;9;0;GO:0046686
GO:0080186;developmental vegetative growth;356;9;GO:0048731
GO:0080187;floral organ senescence;50;8;GO:0048608
GO:0080188;gene silencing by RNA-directed DNA methylation;5647;5;GO:0045727
GO:0008830;dTDP-4-dehydrorhamnose 3,5-epimerase activity;115625;116;GO:0006032
GO:0080189;primary growth;0;4;GO:0048608
GO:0008834;di-trans,poly-cis-decaprenylcistransferase activity;19028;403;GO:0004073
GO:0008833;deoxyribonuclease IV (phage-T4-induced) activity;31916;56;GO:0004518
GO:0008832;dGTPase activity;8397;290;GO:0003924
GO:0008831;dTDP-4-dehydrorhamnose reductase activity;59346;484;GO:0006032
GO:0008826;cysteine sulfinate desulfinase activity;2;2;GO:0004723
GO:0008825;cyclopropane-fatty-acyl-phospholipid synthase activity;5907;39;GO:0008631
GO:0008824;cyanate hydratase activity;24838;212;GO:0004067
GO:0008829;dCTP deaminase activity;65369;201;GO:0004518
GO:0008828;dATP diphosphatase activity;4020;20;GO:0004721
GO:0080190;lateral growth;117;10;GO:0048608
GO:0080191;secondary thickening;13;1;GO:0048608
GO:0080150;S-adenosyl-L-methionine:benzoic acid carboxyl methyl transferase activity;6;2;GO:0004725
GO:0080151;positive regulation of salicylic acid mediated signaling pathway;59;10;GO:0046274
GO:0080152;regulation of reductive pentose-phosphate cycle;141;3;GO:0006096
GO:0080153;negative regulation of reductive pentose-phosphate cycle;141;42;GO:0006096
GO:0080154;regulation of fertilization;1963;58;GO:0048608
GO:0080155;regulation of double fertilization forming a zygote and endosperm;1260;8;GO:0048704
GO:0080156;mitochondrial mRNA modification;929;154;GO:0006418
GO:0080157;regulation of plant-type cell wall organization or biogenesis;16;2;GO:0010467
GO:0080159;zygote elongation;6;1;GO:0009955
GO:0008801;beta-phosphoglucomutase activity;8774;34;GO:0006030
GO:0008800;beta-lactamase activity;162330;334;GO:0016787
GO:0080160;selenate transport;0;3;GO:0006830
GO:0080161;auxin transmembrane transporter activity;694;9;GO:0005215
GO:0080162;endoplasmic reticulum to cytosol auxin transport;3964;1;GO:0009813
GO:0080163;regulation of protein serine/threonine phosphatase activity;5;222;GO:0004721
GO:0080164;regulation of nitric oxide metabolic process;2037;31;GO:0046332
GO:0080165;callose deposition in phloem sieve plate;18;7;GO:0009953
GO:0080166;stomium development;6;3;GO:0048704
GO:0080167;response to karrikin;97;973;GO:0009743
GO:0080168;abscisic acid transport;53;26;GO:0006820
GO:0080169;cellular response to boron-containing substance deprivation;5;3;GO:0097190
GO:0008812;choline dehydrogenase activity;28730;167;GO:0004746
GO:0008811;chloramphenicol O-acetyltransferase activity;9498;16;GO:0004067
GO:0008810;cellulase activity;53450;760;GO:0004553
GO:0008805;carbon-monoxide oxygenase activity;578;7;GO:0004497
GO:0008804;carbamate kinase activity;22758;215;GO:0004721
GO:0008803;bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity;31900;0;GO:0004553
GO:0008802;betaine-aldehyde dehydrogenase activity;27747;551;GO:0004067
GO:0008809;carnitine racemase activity;1;2;GO:0004722
GO:0008808;cardiolipin synthase activity;38996;629;GO:0004784
GO:0008807;carboxyvinyl-carboxyphosphonate phosphorylmutase activity;551;4;GO:0005524
GO:0008806;carboxymethylenebutenolidase activity;2645;4;GO:0004553
GO:0021838;motogenic signaling involved in interneuron migration from the subpallium to the cortex;0;3;GO:0048608
GO:0045805;positive regulation of eclosion;17;5;GO:0048608
GO:0021839;interneuron-substratum interaction involved in interneuron migration from the subpallium to the cortex;0;4;GO:0048608
GO:0045806;negative regulation of endocytosis;2944;824;GO:0048193
GO:0045804;negative regulation of eclosion;11;4;GO:0048608
GO:0021834;chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration;9;9;GO:0048608
GO:0045809;positive regulation of establishment of competence for transformation;1;3;GO:0045765
GO:0021835;chemoattraction involved in embryonic olfactory bulb interneuron precursor migration;0;1;GO:0048608
GO:0021836;chemorepulsion involved in postnatal olfactory bulb interneuron migration;95;86;GO:0048608
GO:0045807;positive regulation of endocytosis;9475;1310;GO:0048193
GO:0021837;motogenic signaling involved in postnatal olfactory bulb interneuron migration;2;6;GO:0048608
GO:0045808;negative regulation of establishment of competence for transformation;1348;4;GO:0045730
GO:0008863;formate dehydrogenase (NAD+) activity;65632;0;GO:0009065
GO:0021830;interneuron migration from the subpallium to the cortex;286;27;GO:0048666
GO:0006201;GMP catabolic process to IMP;0;2;GO:0009065
GO:0021831;embryonic olfactory bulb interneuron precursor migration;38;149;GO:0048704
GO:0008861;formate C-acetyltransferase activity;35916;94;GO:0004497
GO:0021832;cell-cell adhesion involved in cerebral cortex tangential migration using cell-cell interactions;0;3;GO:0048608
GO:0008860;ferredoxin-NAD+ reductase activity;2130;5;GO:0003824
GO:0021833;cell-matrix adhesion involved in tangential migration using cell-cell interactions;0;3;GO:0022610
GO:0006204;IMP catabolic process;357;8;GO:0006559
GO:0008867;galactarate dehydratase activity;10690;9;GO:0006067
GO:0045801;positive regulation of chitin-based cuticle tanning;0;3;GO:0046405
GO:0008866;fructuronate reductase activity;1675;2;GO:0006067
GO:0006202;GMP catabolic process to guanine;3;3;GO:0006559
GO:0008865;fructokinase activity;5336;476;GO:0006094
GO:0006203;dGTP catabolic process;2199;127;GO:0006559
GO:0008864;formyltetrahydrofolate deformylase activity;90858;8;GO:0003735
GO:0045800;negative regulation of chitin-based cuticle tanning;0;2;GO:0046274
GO:0033816;diaminobutyrate acetyltransferase activity;11580;6;GO:0004073
GO:0008859;exoribonuclease II activity;62260;201;GO:0004553
GO:0033815;biphenyl synthase activity;15;4;GO:0004497
GO:0033814;propanoyl-CoA C-acyltransferase activity;1286;10;GO:0006081
GO:0033813;deacetylcephalosporin-C acetyltransferase activity;6;3;GO:0004723
GO:0033819;lipoyl(octanoyl) transferase activity;84359;197;GO:0008610
GO:0033818;beta-ketoacyl-acyl-carrier-protein synthase III activity;102800;58;GO:0006099
GO:0033812;3-oxoadipyl-CoA thiolase activity;12246;4;GO:0006066
GO:0033811;flavonol-3-O-triglucoside O-coumaroyltransferase activity;0;3;GO:0006073
GO:0033810;anthocyanin 5-O-glucoside 6'''-O-malonyltransferase activity;8;4;GO:0005975
GO:0021827;postnatal olfactory bulb interneuron migration;97;8;GO:0048608
GO:0021828;gonadotrophin-releasing hormone neuronal migration to the hypothalamus;328;121;GO:0048608
GO:0021829;oligodendrocyte cell migration from the subpallium to the cortex;0;1;GO:0048704
GO:0045814;negative regulation of gene expression, epigenetic;33478;2110;GO:0045944
GO:0045815;transcription initiation-coupled chromatin remodeling;2243;46;GO:0006364
GO:0008870;galactoside O-acetyltransferase activity;912;4;GO:0004553
GO:0021823;cerebral cortex tangential migration using cell-cell interactions;97;30;GO:0048666
GO:0021824;cerebral cortex tangential migration using cell-axon interactions;0;4;GO:0048666
GO:0021825;substrate-dependent cerebral cortex tangential migration;97;5;GO:0048704
GO:0045818;negative regulation of glycogen catabolic process;56;196;GO:0045944
GO:0021826;substrate-independent telencephalic tangential migration;324;9;GO:0048704
GO:0045819;positive regulation of glycogen catabolic process;131;120;GO:0045944
GO:0006211;5-methylcytosine catabolic process;6635;40;GO:0046395
GO:0008874;gluconate 5-dehydrogenase activity;4587;4;GO:0004067
GO:0006212;uracil catabolic process;11396;154;GO:0006559
GO:0008873;gluconate 2-dehydrogenase activity;529;5;GO:0004067
GO:0021820;extracellular matrix organization in marginal zone involved in cerebral cortex radial glia guided migration;0;3;GO:0048667
GO:0008872;glucarate dehydratase activity;8983;9;GO:0006067
GO:0021821;negative regulation of cell-glial cell adhesion involved in cerebral cortex lamination;0;2;GO:0048666
GO:0006210;thymine catabolic process;356;61;GO:0006559
GO:0008871;aminoglycoside 2''-nucleotidyltransferase activity;11;0;GO:0003929
GO:0021822;negative regulation of cell motility involved in cerebral cortex radial glia guided migration;49;4;GO:0048608
GO:0008878;glucose-1-phosphate adenylyltransferase activity;93431;438;GO:0006096
GO:0045812;negative regulation of Wnt signaling pathway, calcium modulating pathway;1;1;GO:0045944
GO:0006216;cytidine catabolic process;115026;693;GO:0006555
GO:0008877;glucose-1-phosphatase activity;1583;2;GO:0005975
GO:0045813;positive regulation of Wnt signaling pathway, calcium modulating pathway;39;4;GO:0048010
GO:0006213;pyrimidine nucleoside metabolic process;149350;631;GO:0006793
GO:0008876;quinoprotein glucose dehydrogenase activity;2386;5;GO:0006021
GO:0006214;thymidine catabolic process;58;23;GO:0006559
GO:0008875;gluconate dehydrogenase activity;6960;5;GO:0004067
GO:0006208;pyrimidine nucleobase catabolic process;12427;2350;GO:0006559
GO:0006209;cytosine catabolic process;8;3;GO:0006552
GO:0006206;pyrimidine nucleobase metabolic process;318980;795;GO:0006793
GO:0008869;galactonate dehydratase activity;11343;5;GO:0006067
GO:0033803;kaempferol 4'-O-methyltransferase activity;1;0;GO:0004497
GO:0006207;'de novo' pyrimidine nucleobase biosynthetic process;222776;1810;GO:0009061
GO:0008868;galactitol-1-phosphate 5-dehydrogenase activity;678;4;GO:0006067
GO:0033802;isoliquiritigenin 2'-O-methyltransferase activity;7;0;GO:0004497
GO:0033809;anthocyanin 6''-O-malonyltransferase activity;7;0;GO:0006073
GO:0033808;6'-deoxychalcone synthase activity;19;0;GO:0004497
GO:0033807;icosanoyl-CoA synthase activity;1;3;GO:0004497
GO:0033806;fluorothreonine transaldolase activity;52;3;GO:0006067
GO:0033801;vitexin 2''-O-rhamnoside 7-O-methyltransferase activity;0;0;GO:0004497
GO:0033800;isoflavone 7-O-methyltransferase activity;22;4;GO:0004714
GO:0021816;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration;58;34;GO:0048667
GO:0045827;negative regulation of isoprenoid metabolic process;231;3;GO:0046274
GO:0021817;nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration;151;221;GO:0048706
GO:0045828;positive regulation of isoprenoid metabolic process;309;5;GO:0046394
GO:0021819;layer formation in cerebral cortex;720;2590;GO:0048667
GO:0021812;neuronal-glial interaction involved in cerebral cortex radial glia guided migration;87;89;GO:0048699
GO:0021813;cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration;31;5;GO:0048699
GO:0021814;cell motility involved in cerebral cortex radial glia guided migration;314;17;GO:0048699
GO:0045829;negative regulation of isotype switching;265;32;GO:0048193
GO:0021815;modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration;209;6;GO:0048608
GO:0008841;dihydrofolate synthase activity;16769;100;GO:0004497
GO:0008840;4-hydroxy-tetrahydrodipicolinate synthase activity;223848;536;GO:0006099
GO:0045820;negative regulation of glycolytic process;997;194;GO:0045727
GO:0021810;neurotransmitter signaling initiating cell movement, involved in cerebral cortex radial glia guided migration;0;2;GO:0048704
GO:0021811;growth factor signaling initiating cell movement involved in cerebral cortex radial glia guided migration;0;2;GO:0048704
GO:0045823;positive regulation of heart contraction;2731;353;GO:0048407
GO:0045824;negative regulation of innate immune response;154381;1630;GO:0045087
GO:0008843;endochitinase activity;107;26;GO:0004553
GO:0045821;positive regulation of glycolytic process;778;1090;GO:0045727
GO:0008842;diphosphate-purine nucleoside kinase activity;0;1;GO:0004721
GO:0045822;negative regulation of heart contraction;936;242;GO:0048407
GO:0008838;diaminopropionate ammonia-lyase activity;6854;10;GO:0004466
GO:0008837;diaminopimelate epimerase activity;141918;267;GO:0006067
GO:0008836;diaminopimelate decarboxylase activity;141969;751;GO:0006066
GO:0008835;diaminohydroxyphosphoribosylaminopyrimidine deaminase activity;88639;576;GO:0006066
GO:0008839;4-hydroxy-tetrahydrodipicolinate reductase;87591;1070;GO:0009065
GO:0021805;cell movement involved in somal translocation;0;3;GO:0048471
GO:0045838;positive regulation of membrane potential;571;1230;GO:0048407
GO:0021806;initiation of movement involved in cerebral cortex radial glia guided migration;5;4;GO:0048704
GO:0045839;negative regulation of mitotic nuclear division;19022;710;GO:0048285
GO:0021807;motogenic signaling initiating cell movement in cerebral cortex;0;3;GO:0048608
GO:0045836;positive regulation of meiotic nuclear division;1032;301;GO:0048285
GO:0021808;cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration;5;2;GO:0048608
GO:0045837;negative regulation of membrane potential;384;143;GO:0048407
GO:0021801;cerebral cortex radial glia-guided migration;1413;116;GO:0048667
GO:0021802;somal translocation;0;3;GO:0002376
GO:0021803;extension of leading cell process to pial surface;0;0;GO:0048666
GO:0021804;negative regulation of cell adhesion in ventricular zone;0;4;GO:0048608
GO:0045830;positive regulation of isotype switching;1651;501;GO:0048193
GO:0008851;ethanolamine ammonia-lyase activity;42878;23;GO:0004497
GO:0045831;negative regulation of light-activated channel activity;0;3;GO:0048405
GO:0021800;cerebral cortex tangential migration;225;117;GO:0048666
GO:0045834;positive regulation of lipid metabolic process;8835;728;GO:0045944
GO:0008855;exodeoxyribonuclease VII activity;212110;497;GO:0004518
GO:0045835;negative regulation of meiotic nuclear division;2719;232;GO:0048285
GO:0008854;exodeoxyribonuclease V activity;56711;258;GO:0004518
GO:0045832;positive regulation of light-activated channel activity;0;3;GO:0048405
GO:0045833;negative regulation of lipid metabolic process;11375;484;GO:0045944
GO:0008849;enterochelin esterase activity;4410;121;GO:0004746
GO:0008847;Enterobacter ribonuclease activity;283;2;GO:0004553
GO:0021809;neurotrophic factor signaling initiating cell movement, involved in cerebral cortex radial glia guided migration;0;2;GO:0048704
GO:0006240;dCDP biosynthetic process;22;4;GO:0006749
GO:0021878;forebrain astrocyte fate commitment;0;2;GO:0048667
GO:0006241;CTP biosynthetic process;250519;1560;GO:0006061
GO:0021879;forebrain neuron differentiation;2597;638;GO:0048699
GO:0006244;pyrimidine nucleotide catabolic process;51204;9;GO:0006559
GO:0021874;Wnt signaling pathway involved in forebrain neuroblast division;55;5;GO:0007631
GO:0006245;TDP catabolic process;0;2;GO:0006032
GO:0021875;fibroblast growth factor receptor signaling pathway involved in forebrain neuroblast division;0;2;GO:0048010
GO:0006242;dCTP biosynthetic process;0;2;GO:0006559
GO:0021876;Notch signaling pathway involved in forebrain neuroblast division;0;2;GO:0007219
GO:0021877;forebrain neuron fate commitment;444;96;GO:0048699
GO:0006248;CMP catabolic process;210;10;GO:0006555
GO:0021870;Cajal-Retzius cell differentiation;112;8;GO:0048667
GO:0006249;dCMP catabolic process;280;33;GO:0006555
GO:0021871;forebrain regionalization;1636;68;GO:0007420
GO:0006246;dTDP catabolic process;0;1;GO:0006032
GO:0021872;forebrain generation of neurons;3363;414;GO:0048666
GO:0021873;forebrain neuroblast division;235;18;GO:0048666
GO:0033859;furaldehyde metabolic process;52;8;GO:0006066
GO:0006239;dCMP salvage;0;1;GO:0006796
GO:0033858;N-acetylgalactosamine kinase activity;47;21;GO:0004721
GO:0021880;Notch signaling pathway involved in forebrain neuron fate commitment;0;3;GO:0007219
GO:0033857;diphosphoinositol-pentakisphosphate kinase activity;13662;72;GO:0004721
GO:0018231;peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine;87;327;GO:0006631
GO:0018230;peptidyl-L-cysteine S-palmitoylation;87;192;GO:0006477
GO:0018233;peptide cross-linking via 2'-(S-L-cysteinyl)-L-histidine;0;0;GO:0048193
GO:0033852;thyroid-hormone transaminase activity;0;3;GO:0004867
GO:0018232;peptide cross-linking via S-(L-isoglutamyl)-L-cysteine;0;0;GO:0008544
GO:0033851;lavandulyl diphosphate synthase activity;3;3;GO:0004497
GO:0018235;peptidyl-lysine carboxylation;0;4;GO:0006468
GO:0033850;Z-farnesyl diphosphate synthase activity;197;2;GO:0004497
GO:0018234;peptide cross-linking via 3'-(S-L-cysteinyl)-L-tyrosine;0;0;GO:0048193
GO:0018237;urease activator activity;1;0;GO:0005576
GO:0033856;pyridoxine 5'-phosphate synthase activity;60743;3;GO:0004497
GO:0033855;nicotianamine aminotransferase activity;10;3;GO:0006067
GO:0033854;glutamate-prephenate aminotransferase activity;457;4;GO:0004073
GO:0018238;peptidyl-lysine carboxyethylation;0;4;GO:0046148
GO:0033853;aspartate-prephenate aminotransferase activity;55;4;GO:0004073
GO:0018219;peptidyl-cysteine S-acetylation;0;3;GO:0006464
GO:0018218;peptidyl-cysteine phosphorylation;0;5;GO:0006468
GO:0006251;dCDP catabolic process;0;2;GO:0006541
GO:0021869;forebrain ventricular zone progenitor cell division;201;48;GO:0048706
GO:0021863;forebrain neuroblast differentiation;0;2;GO:0048699
GO:0006256;UDP catabolic process;132;9;GO:0006519
GO:0006253;dCTP catabolic process;1258;6;GO:0006559
GO:0006254;CTP catabolic process;64;3;GO:0006559
GO:0006259;DNA metabolic process;22500642;10200;GO:0006259
GO:0021860;pyramidal neuron development;403;163;GO:0048699
GO:0006257;dUDP catabolic process;0;1;GO:0006569
GO:0021861;forebrain radial glial cell differentiation;477;159;GO:0048699
GO:0006258;UDP-glucose catabolic process;3;26;GO:0006032
GO:0021862;early neuron differentiation in forebrain;1;1;GO:0048699
GO:0033849;chrysanthemyl diphosphate synthase activity;8;3;GO:0004497
GO:0033848;N2-(2-carboxyethyl)arginine synthase activity;8;0;GO:0009065
GO:0033847;O-phosphoserine sulfhydrylase activity;71;2;GO:0004721
GO:0033846;adenosyl-fluoride synthase activity;44;2;GO:0004497
GO:0018220;peptidyl-threonine palmitoylation;0;2;GO:0006464
GO:0033841;6G-fructosyltransferase activity;8;2;GO:0006073
GO:0018221;peptidyl-serine palmitoylation;0;3;GO:0006464
GO:0033840;NDP-glucose-starch glucosyltransferase activity;61;6;GO:0006066
GO:0018226;peptidyl-S-farnesyl-L-cysteine biosynthetic process from peptidyl-cysteine;0;3;GO:0009061
GO:0033845;hydroxymethylfurfural reductase (NADPH) activity;1;4;GO:0004067
GO:0033844;galactose-6-sulfurylase activity;2;2;GO:0006032
GO:0018228;peptidyl-S-geranylgeranyl-L-cysteine biosynthetic process from peptidyl-cysteine;0;3;GO:0009065
GO:0033843;xyloglucan 6-xylosyltransferase activity;189;6;GO:0004553
GO:0018227;peptidyl-S-12-hydroxyfarnesyl-L-cysteine biosynthetic process from peptidyl-cysteine;0;3;GO:0009065
GO:0033842;N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity;1525;9;GO:0006029
GO:0018208;peptidyl-proline modification;213;617;GO:0006457
GO:0018207;peptidyl-phenylalanine modification;0;5;GO:0006464
GO:0018209;peptidyl-serine modification;6965;601;GO:0006464
GO:0008881;glutamate racemase activity;122700;253;GO:0006066
GO:0021856;hypothalamic tangential migration using cell-axon interactions;328;5;GO:0048666
GO:0008880;glucuronate isomerase activity;53832;35;GO:0006066
GO:0021858;GABAergic neuron differentiation in basal ganglia;54;4;GO:0048666
GO:0021859;pyramidal neuron differentiation;512;63;GO:0048699
GO:0006222;UMP biosynthetic process;452454;643;GO:0009061
GO:0008885;glutathionylspermidine synthase activity;551;3;GO:0004725
GO:0021852;pyramidal neuron migration to cerebral cortex;89;0;GO:0048666
GO:0006223;uracil salvage;27502;103;GO:0006552
GO:0008884;glutathionylspermidine amidase activity;332;4;GO:0008033
GO:0021853;cerebral cortex GABAergic interneuron migration;207;71;GO:0048666
GO:0006220;pyrimidine nucleotide metabolic process;2362426;589;GO:0006793
GO:0008883;glutamyl-tRNA reductase activity;109008;609;GO:0006401
GO:0021854;hypothalamus development;1409;668;GO:0007399
GO:0006221;pyrimidine nucleotide biosynthetic process;2224080;1590;GO:0006793
GO:0008882;[glutamate-ammonia-ligase] adenylyltransferase activity;63530;54;GO:0003824
GO:0021855;hypothalamus cell migration;401;8;GO:0048608
GO:0006226;dUMP biosynthetic process;101586;267;GO:0006796
GO:0008889;glycerophosphodiester phosphodiesterase activity;12727;487;GO:0004553
GO:0006227;dUDP biosynthetic process;234;139;GO:0009405
GO:0008888;glycerol dehydrogenase [NAD+] activity;2620;0;GO:0004073
GO:0008887;glycerate kinase activity;71822;199;GO:0004721
GO:0021850;subpallium glioblast cell division;0;1;GO:0048666
GO:0006225;UDP biosynthetic process;611;10;GO:0009405
GO:0008886;glyceraldehyde-3-phosphate dehydrogenase (NADP+) (non-phosphorylating) activity;817;0;GO:0004073
GO:0021851;neuroblast division in dorsal lateral ganglionic eminence;0;1;GO:0048704
GO:0006219;deoxyuridine catabolic process;0;2;GO:0006559
GO:0033838;flavonol-3-O-glucoside glucosyltransferase activity;6;3;GO:0006073
GO:0033837;anthocyanin 3'-O-beta-glucosyltransferase activity;2;0;GO:0005975
GO:0006217;deoxycytidine catabolic process;58;5;GO:0006518
GO:0033836;flavonol 7-O-beta-glucosyltransferase activity;37;3;GO:0006073
GO:0006218;uridine catabolic process;275;171;GO:0006559
GO:0008879;glucose-1-phosphate thymidylyltransferase activity;126118;6;GO:0006096
GO:0033835;flavanone 7-O-glucoside 2''-O-beta-L-rhamnosyltransferase activity;2;0;GO:0006073
GO:0033839;flavonol-3-O-glycoside glucosyltransferase activity;0;3;GO:0006073
GO:0018211;peptidyl-tryptophan modification;3;36;GO:0006464
GO:0033830;Skp1-protein-hydroxyproline N-acetylglucosaminyltransferase activity;32;3;GO:0006066
GO:0018210;peptidyl-threonine modification;11391;327;GO:0006468
GO:0018213;peptidyl-valine modification;0;3;GO:0006469
GO:0018212;peptidyl-tyrosine modification;10988;1180;GO:0006468
GO:0018215;protein phosphopantetheinylation;3;9;GO:0006464
GO:0033834;kaempferol 3-O-galactosyltransferase activity;2;4;GO:0004553
GO:0018214;protein carboxylation;55;1080;GO:0006464
GO:0033833;hydroxymethylfurfural reductase (NADH) activity;52;7;GO:0004067
GO:0018217;peptidyl-aspartic acid phosphorylation;1;5;GO:0006468
GO:0033832;alpha,alpha-trehalose phosphorylase (configuration-retaining) activity;6;2;GO:0006032
GO:0018216;peptidyl-arginine methylation;159;813;GO:0016567
GO:0033831;kojibiose phosphorylase activity;538;3;GO:0006032
GO:0021849;neuroblast division in subventricular zone;161;35;GO:0048666
GO:0008892;guanine deaminase activity;42499;263;GO:0004553
GO:0021845;neurotransmitter-mediated guidance of interneurons involved in substrate-independent cerebral cortex tangential migration;0;4;GO:0048666
GO:0006230;TMP biosynthetic process;2071;8;GO:0009181
GO:0021846;cell proliferation in forebrain;1454;910;GO:0042127
GO:0008890;glycine C-acetyltransferase activity;48402;110;GO:0004073
GO:0021847;ventricular zone neuroblast division;92;50;GO:0048666
GO:0021848;neuroblast division in subpallium;0;1;GO:0048666
GO:0006233;dTDP biosynthetic process;49668;29;GO:0006030
GO:0021841;chemoattraction involved in interneuron migration from the subpallium to the cortex;0;2;GO:0048608
GO:0006234;TTP biosynthetic process;2;2;GO:0009063
GO:0021842;chemorepulsion involved in interneuron migration from the subpallium to the cortex;33;54;GO:0048608
GO:0006231;dTMP biosynthetic process;99884;466;GO:0009181
GO:0008894;guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity;9167;3;GO:0005524
GO:0021843;substrate-independent telencephalic tangential interneuron migration;324;7;GO:0048704
GO:0006232;TDP biosynthetic process;0;3;GO:0006030
GO:0008893;guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity;8042;3;GO:0004723
GO:0021844;interneuron sorting involved in substrate-independent cerebral cortex tangential migration;0;4;GO:0048608
GO:0006237;deoxycytidine salvage;0;1;GO:0009063
GO:0006238;CMP salvage;0;172;GO:0006796
GO:0008899;homoserine O-succinyltransferase activity;38295;91;GO:0006067
GO:0006235;dTTP biosynthetic process;80952;162;GO:0006749
GO:0008898;S-adenosylmethionine-homocysteine S-methyltransferase activity;191;26;GO:0004725
GO:0006236;cytidine salvage;0;3;GO:0006519
GO:0008897;holo-[acyl-carrier-protein] synthase activity;153410;1;GO:0004497
GO:0021840;directional guidance of interneurons involved in migration from the subpallium to the cortex;33;10;GO:0048608
GO:0033827;high-mannose-oligosaccharide beta-1,4-N-acetylglucosaminyltransferase activity;0;3;GO:0006029
GO:0033826;xyloglucan 4-glucosyltransferase activity;0;2;GO:0004553
GO:0006228;UTP biosynthetic process;85596;1850;GO:0006561
GO:0033825;oligosaccharide 4-alpha-D-glucosyltransferase activity;88;2;GO:0004553
GO:0006229;dUTP biosynthetic process;38222;9;GO:0006559
GO:0033824;alternansucrase activity;3;1;GO:0005929
GO:0033829;O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;4585;54;GO:0006029
GO:0033828;glucosylglycerol-phosphate synthase activity;284;5;GO:0006081
GO:0018200;peptidyl-glutamic acid modification;295;481;GO:0006464
GO:0018202;peptidyl-histidine modification;2421006;1080;GO:0016567
GO:0018201;peptidyl-glycine modification;21;7;GO:0006469
GO:0018204;peptidyl-leucine modification;0;5;GO:0006464
GO:0033823;procollagen glucosyltransferase activity;145;30;GO:0004553
GO:0018203;peptidyl-isoleucine modification;0;4;GO:0006464
GO:0033822;glucosyl-DNA beta-glucosyltransferase activity;0;1;GO:0006073
GO:0018206;peptidyl-methionine modification;52;116;GO:0006464
GO:0033821;DNA beta-glucosyltransferase activity;35;3;GO:0004553
GO:0018205;peptidyl-lysine modification;91188;1120;GO:0006464
GO:0033820;DNA alpha-glucosyltransferase activity;3;2;GO:0004553
GO:0070728;leucine binding;353;69;GO:0005515
GO:0043108;pilus retraction;1;4;GO:0043403
GO:0070729;cyclic nucleotide transport;650;4;GO:0006826
GO:0070726;cell wall assembly;5524;59;GO:0042545
GO:0070727;cellular macromolecule localization;6407841;2440;GO:0051604
GO:0006163;purine nucleotide metabolic process;9430062;2960;GO:0006796
GO:0033782;24-hydroxycholesterol 7alpha-hydroxylase activity;20;4;GO:0004073
GO:0006164;purine nucleotide biosynthetic process;7804034;4100;GO:0006796
GO:0031120;snRNA pseudouridine synthesis;497;164;GO:0006461
GO:0033781;cholesterol 24-hydroxylase activity;2085;8;GO:0004637
GO:0006161;deoxyguanosine catabolic process;175;6;GO:0006559
GO:0033780;taurochenodeoxycholate 6alpha-hydroxylase activity;3;8;GO:0004073
GO:0006167;AMP biosynthetic process;200943;981;GO:0009181
GO:0021797;forebrain anterior/posterior pattern specification;211;359;GO:0007423
GO:0043101;purine-containing compound salvage;428441;688;GO:0009063
GO:0045764;positive regulation of amino acid metabolic process;236;6;GO:0045735
GO:0006168;adenine salvage;65709;789;GO:0009065
GO:0021798;forebrain dorsal/ventral pattern formation;414;198;GO:0007420
GO:0043100;pyrimidine nucleobase salvage;27531;4;GO:0009063
GO:0045765;regulation of angiogenesis;24891;3700;GO:0050727
GO:0021799;cerebral cortex radially oriented cell migration;1877;1420;GO:0048699
GO:0043103;hypoxanthine salvage;9658;198;GO:0009067
GO:0045762;positive regulation of adenylate cyclase activity;133;381;GO:0010468
GO:0006166;purine ribonucleoside salvage;178349;1360;GO:0009060
GO:0043102;amino acid salvage;163056;394;GO:0009063
GO:0045763;negative regulation of cellular amino acid metabolic process;223;27;GO:0045735
GO:0021793;chemorepulsion of branchiomotor axon;43;54;GO:0048706
GO:0043105;negative regulation of GTP cyclohydrolase I activity;0;171;GO:0010467
GO:0021794;thalamus development;709;422;GO:0007399
GO:0043104;positive regulation of GTP cyclohydrolase I activity;24;7;GO:0010468
GO:0045769;negative regulation of asymmetric cell division;37;7;GO:0048608
GO:0006169;adenosine salvage;3;7;GO:0009063
GO:0021795;cerebral cortex cell migration;2561;573;GO:0048699
GO:0043107;type IV pilus-dependent motility;14154;36;GO:0043403
GO:0045766;positive regulation of angiogenesis;9588;4250;GO:0045766
GO:0021796;cerebral cortex regionalization;315;265;GO:0007420
GO:0018150;peptide cross-linking via 3-(3'-L-histidyl)-L-tyrosine;0;0;GO:0048193
GO:0031118;rRNA pseudouridine synthesis;121910;154;GO:0006418
GO:0031119;tRNA pseudouridine synthesis;109798;379;GO:0006519
GO:0018152;peptide cross-linking via 3'-(1'-L-histidyl)-L-tyrosine;0;0;GO:0048193
GO:0045771;negative regulation of autophagosome size;21;4;GO:0048471
GO:0018151;peptide cross-linking via L-histidyl-L-tyrosine;0;7;GO:0048193
GO:0045772;positive regulation of autophagosome size;4;2;GO:0048471
GO:0018154;peptide cross-linking via (2R,6R)-lanthionine;0;0;GO:0048285
GO:0043110;rDNA spacer replication fork barrier binding;15;5;GO:0003676
GO:0018153;isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine;10;0;GO:0008529
GO:0045770;positive regulation of asymmetric cell division;5;5;GO:0048608
GO:0018156;peptide cross-linking via (2S,3S,6R)-3-methyl-lanthionine;0;0;GO:0008037
GO:0031112;positive regulation of microtubule polymerization or depolymerization;2957;67;GO:0048285
GO:0033775;deoxysarpagine hydroxylase activity;0;3;GO:0046395
GO:0070720;Grb2-SHP-2 complex;0;1;GO:0005515
GO:0018155;peptide cross-linking via sn-(2S,6R)-lanthionine;0;0;GO:0008021
GO:0031113;regulation of microtubule polymerization;3617;536;GO:0048608
GO:0033774;basal labyrinth;0;4;GO:0005829
GO:0070721;ISGF3 complex;154;7;GO:0005665
GO:0018158;protein oxidation;131;264;GO:0006979
GO:0031110;regulation of microtubule polymerization or depolymerization;12931;838;GO:0048608
GO:0033773;isoflavone 2'-hydroxylase activity;4;0;GO:0004497
GO:0018157;peptide cross-linking via an oxazole or thiazole;0;3;GO:0046395
GO:0031111;negative regulation of microtubule polymerization or depolymerization;2042;193;GO:0048285
GO:0033772;flavonoid 3',5'-hydroxylase activity;35;1;GO:0004497
GO:0031116;positive regulation of microtubule polymerization;1636;1120;GO:0048608
GO:0033779;5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity;4;2;GO:0004073
GO:0070724;BMP receptor complex;276;18;GO:0048407
GO:0018159;peptidyl-methionine oxidation;0;3;GO:0006457
GO:0031117;positive regulation of microtubule depolymerization;1321;356;GO:0048285
GO:0033778;7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity;7;3;GO:0004073
GO:0070725;Yb body;108;10;GO:0005576
GO:0031114;regulation of microtubule depolymerization;2841;159;GO:0048285
GO:0033777;lithocholate 6beta-hydroxylase activity;2;5;GO:0004073
GO:0070722;Tle3-Aes complex;0;3;GO:0048285
GO:0031115;negative regulation of microtubule polymerization;629;1150;GO:0048285
GO:0033776;phenylacetone monooxygenase activity;380;3;GO:0004497
GO:0070723;response to cholesterol;1139;425;GO:0032991
GO:0006170;dAMP biosynthetic process;1242;3;GO:0009181
GO:0070717;poly-purine tract binding;13752;50;GO:0005515
GO:0006171;cAMP biosynthetic process;49249;800;GO:0006096
GO:0070718;alphaPDGFR-SHP-2 complex;0;1;GO:0048193
GO:0070715;sodium-dependent organic cation transport;49;4;GO:0015075
GO:0070716;mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication;218;6;GO:0006281
GO:0033771;flavanone 2-hydroxylase activity;9;1;GO:0004497
GO:0006175;dATP biosynthetic process;46;10;GO:0006796
GO:0033770;2-hydroxyisoflavanone synthase activity;12;2;GO:0004497
GO:0006172;ADP biosynthetic process;7022;173;GO:0006066
GO:0070719;alphaPDGFR-PLC-gamma-1-PI3K-SHP-2 complex;0;1;GO:0005515
GO:0006173;dADP biosynthetic process;1;6;GO:0006061
GO:0055100;adiponectin binding;280;28;GO:0048193
GO:0006178;guanine salvage;215;10;GO:0006541
GO:0021786;branchiomotor neuron axon guidance in neural tube;0;2;GO:0048704
GO:0043112;receptor metabolic process;43520;752;GO:0004872
GO:0045775;positive regulation of beta 2 integrin biosynthetic process;0;3;GO:0048010
GO:0006179;guanosine salvage;2;2;GO:0009063
GO:0021787;chemorepulsion of branchiomotor neuron axon in neural tube;0;2;GO:0048704
GO:0043111;replication fork arrest;376;167;GO:0007050
GO:0045776;negative regulation of blood pressure;1480;743;GO:0050727
GO:0006176;dATP biosynthetic process from ADP;0;1;GO:0006796
GO:0021788;chemoattraction of branchiomotor neuron axon in neural tube;0;2;GO:0048704
GO:0043114;regulation of vascular permeability;2911;320;GO:0048010
GO:0045773;positive regulation of axon extension;1445;1200;GO:0048666
GO:0006177;GMP biosynthetic process;561482;1160;GO:0009181
GO:0021789;branchiomotor neuron axon guidance in branchial arch mesenchyme;0;3;GO:0048704
GO:0043113;receptor clustering;65089;751;GO:0048608
GO:0045774;negative regulation of beta 2 integrin biosynthetic process;0;2;GO:0048010
GO:0021782;glial cell development;7391;781;GO:0048667
GO:0043116;negative regulation of vascular permeability;861;330;GO:0050727
GO:0045779;negative regulation of bone resorption;646;556;GO:0048193
GO:0021783;preganglionic parasympathetic fiber development;1107;10;GO:0048608
GO:0043115;precorrin-2 dehydrogenase activity;61116;42;GO:0006073
GO:0021784;postganglionic parasympathetic fiber development;98;30;GO:0048608
GO:0045777;positive regulation of blood pressure;1061;434;GO:0050727
GO:0021785;branchiomotor neuron axon guidance;294;51;GO:0048666
GO:0043117;positive regulation of vascular permeability;727;666;GO:0050727
GO:0045778;positive regulation of ossification;2951;836;GO:0048609
GO:0031109;microtubule polymerization or depolymerization;58074;1800;GO:0007049
GO:0021790;chemorepulsion of branchiomotor neuron axon in branchial arch mesenchyme;0;2;GO:0048704
GO:0021791;chemoattraction of branchiomotor neuron axon in branchial arch mesenchyme;0;1;GO:0048608
GO:0031107;septin ring disassembly;110;6;GO:0048193
GO:0021792;chemoattraction of branchiomotor axon;0;3;GO:0048608
GO:0031108;holo-[acyl-carrier-protein] biosynthetic process;3;0;GO:0006081
GO:0033769;glyceollin synthase activity;0;3;GO:0004497
GO:0018141;peptide cross-linking via L-lysine thiazolecarboxylic acid;0;6;GO:0009065
GO:0045782;positive regulation of cell budding;0;3;GO:0048193
GO:0018140;peptide cross-linking via L-cysteine thiazolecarboxylic acid;0;6;GO:0009065
GO:0018143;nucleic acid-protein covalent cross-linking;11;4;GO:0097367
GO:0043121;neurotrophin binding;649;51;GO:0048608
GO:0045780;positive regulation of bone resorption;854;568;GO:0048193
GO:0018142;protein-DNA covalent cross-linking;10;19;GO:0048285
GO:0043120;tumor necrosis factor binding;383;284;GO:0005125
GO:0045781;negative regulation of cell budding;0;2;GO:0010467
GO:0018145;protein-DNA covalent cross-linking via peptidyl-serine;0;4;GO:0048285
GO:0031101;fin regeneration;1500;216;GO:0048407
GO:0033764;steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;28866;409;GO:0004721
GO:0018144;RNA-protein covalent cross-linking;1;7;GO:0006461
GO:0031102;neuron projection regeneration;2674;874;GO:0048666
GO:0033763;proline 3-hydroxylase activity;12;2;GO:0004073
GO:0070710;RNA uridine deletion;0;1;GO:0003676
GO:0018147;molybdenum incorporation via L-selenocysteinyl molybdenum bis(molybdopterin guanine dinucleotide);0;3;GO:0006873
GO:0033762;response to glucagon;3675;682;GO:0007596
GO:0018146;keratan sulfate biosynthetic process;284;241;GO:0006030
GO:0031100;animal organ regeneration;1105;550;GO:0042127
GO:0033761;mugineic-acid 3-dioxygenase activity;5;2;GO:0004497
GO:0018149;peptide cross-linking;104;2910;GO:0008021
GO:0031105;septin complex;4399;329;GO:0048193
GO:0033768;SUMO-targeted ubiquitin ligase complex;38;9;GO:0008031
GO:0070713;RNA guanosine-cytidine insertion;0;0;GO:0006461
GO:0018148;RNA-protein covalent cross-linking via peptidyl-tyrosine;0;2;GO:0048193
GO:0031106;septin ring organization;4324;143;GO:0005819
GO:0033767;4-hydroxyacetophenone monooxygenase activity;868;5;GO:0004497
GO:0070714;RNA guanosine-uridine insertion;0;1;GO:0006470
GO:0031103;axon regeneration;2356;574;GO:0048704
GO:0033766;2-hydroxyquinoline 8-monooxygenase activity;1;2;GO:0004497
GO:0070711;RNA adenosine-uridine insertion;0;1;GO:0006470
GO:0031104;dendrite regeneration;51;135;GO:0048608
GO:0033765;steroid dehydrogenase activity, acting on the CH-CH group of donors;41874;52;GO:0004730
GO:0070712;RNA cytidine-uridine insertion;0;2;GO:0006470
GO:0070748;interleukin-35 receptor binding;0;1;GO:0005125
GO:0006141;regulation of purine nucleobase metabolic process;3985;4;GO:0045944
GO:0021779;oligodendrocyte cell fate commitment;791;44;GO:0030182
GO:0033760;2'-deoxymugineic-acid 2'-dioxygenase activity;6;0;GO:0004497
GO:0006142;regulation of pyrimidine nucleobase metabolic process;4;2;GO:0045941
GO:0055110;involution involved in gastrulation with mouth forming second;0;2;GO:0048704
GO:0006140;regulation of nucleotide metabolic process;2550;922;GO:0009117
GO:0055111;ingression involved in gastrulation with mouth forming second;49;3;GO:0048704
GO:0006145;purine nucleobase catabolic process;71134;56;GO:0006559
GO:0021775;smoothened signaling pathway involved in ventral spinal cord interneuron specification;150;73;GO:0048704
GO:0043123;positive regulation of canonical NF-kappaB signal transduction;19070;7;GO:0043123
GO:0045786;negative regulation of cell cycle;93479;4120;GO:0010941
GO:0006146;adenine catabolic process;31303;43;GO:0006569
GO:0021776;smoothened signaling pathway involved in spinal cord motor neuron cell fate specification;149;36;GO:0048704
GO:0043122;regulation of canonical NF-kappaB signal transduction;24137;31;GO:0043123
GO:0045787;positive regulation of cell cycle;31778;2470;GO:0045786
GO:0043125;ErbB-3 class receptor binding;275;189;GO:0048407
GO:0006144;purine nucleobase metabolic process;341729;746;GO:0006796
GO:0021778;oligodendrocyte cell fate specification;749;81;GO:0048667
GO:0043124;negative regulation of canonical NF-kappaB signal transduction;2771;19;GO:0010468
GO:0045785;positive regulation of cell adhesion;91138;3550;GO:0022610
GO:0006149;deoxyinosine catabolic process;219;7;GO:0009065
GO:0021771;lateral geniculate nucleus development;3;4;GO:0048704
GO:0021772;olfactory bulb development;1921;737;GO:0007613
GO:0006147;guanine catabolic process;35226;40;GO:0006559
GO:0021773;striatal medium spiny neuron differentiation;147;33;GO:0048667
GO:0043129;surfactant homeostasis;924;1720;GO:0006929
GO:0006148;inosine catabolic process;302;111;GO:0006559
GO:0021774;retinoic acid receptor signaling pathway involved in ventral spinal cord interneuron specification;0;1;GO:0048704
GO:0055109;invagination involved in gastrulation with mouth forming second;35;3;GO:0048405
GO:0021780;glial cell fate specification;915;59;GO:0030182
GO:0033759;flavone synthase activity;27;7;GO:0004497
GO:0021781;glial cell fate commitment;1313;47;GO:0030182
GO:0033758;clavaminate synthase activity;43;3;GO:0004497
GO:0018130;heterocycle biosynthetic process;61204387;1810;GO:1901363
GO:0043130;ubiquitin binding;81397;1770;GO:0005515
GO:0045793;positive regulation of cell size;1045;933;GO:0045935
GO:0045794;negative regulation of cell volume;306;22;GO:0048193
GO:0018132;peptide cross-linking via L-cysteine oxazolecarboxylic acid;0;5;GO:0009065
GO:0043132;NAD transport;1006;22;GO:0006869
GO:0018131;oxazole or thiazole biosynthetic process;8969;23;GO:0006721
GO:0043131;erythrocyte enucleation;12;4;GO:0007079
GO:0045792;negative regulation of cell size;705;1450;GO:0010468
GO:0018134;peptide cross-linking via glycine oxazolecarboxylic acid;0;3;GO:0046395
GO:0070742;C2H2 zinc finger domain binding;692;252;GO:0030528
GO:0018133;peptide cross-linking via L-cysteine oxazolinecarboxylic acid;0;6;GO:0009065
GO:0033752;acetylacetone-cleaving enzyme activity;15;3;GO:0006029
GO:0055102;lipase inhibitor activity;5647;235;GO:0010401
GO:0070743;interleukin-23 complex;249;11;GO:0002419
GO:0018136;peptidyl-thiazoline dehydrogenase activity;0;2;GO:0009065
GO:0055103;ligase regulator activity;75;23;GO:0004842
GO:0070740;tubulin-glutamic acid ligase activity;965;50;GO:0006030
GO:0033750;ribosome localization;20047;72;GO:0005840
GO:0055104;ligase inhibitor activity;0;28;GO:0004866
GO:0070741;response to interleukin-6;2010;211;GO:0050727
GO:0018138;peptide cross-linking via L-serine thiazolecarboxylic acid;0;6;GO:0005576
GO:0033757;glucoside 3-dehydrogenase activity;6;3;GO:0006066
GO:0055105;ubiquitin-protein transferase inhibitor activity;524;78;GO:0004842
GO:0070746;interleukin-35 binding;0;1;GO:0005125
GO:0018137;peptide cross-linking via glycine thiazolecarboxylic acid;0;6;GO:0048193
GO:0033756;Oplophorus-luciferin 2-monooxygenase activity;3;2;GO:0004497
GO:0055106;ubiquitin-protein transferase regulator activity;13821;35;GO:0004842
GO:0070747;interleukin-35 receptor activity;0;1;GO:0005125
GO:0033755;sulfur oxygenase/reductase activity;7;3;GO:0004746
GO:0055107;Golgi to secretory granule transport;89;6;GO:0006986
GO:0070744;interleukin-27 complex;0;2;GO:0002768
GO:0018139;peptide cross-linking via L-phenylalanine thiazolecarboxylic acid;0;6;GO:0005576
GO:0033754;indoleamine 2,3-dioxygenase activity;261;145;GO:0004722
GO:0055108;Golgi to transport vesicle transport;4;7;GO:0006897
GO:0070745;interleukin-35 complex;0;2;GO:0004872
GO:0070739;protein-glutamic acid ligase activity;1633;50;GO:0004364
GO:0018119;peptidyl-cysteine S-nitrosylation;370;258;GO:0006464
GO:0070737;protein-glycine ligase activity, elongating;42;10;GO:0004497
GO:0070738;tubulin-glycine ligase activity;41;4;GO:0004061
GO:0006152;purine nucleoside catabolic process;5418;712;GO:0009065
GO:0021768;nucleus accumbens development;60;4;GO:0048608
GO:0021769;orbitofrontal cortex development;47;32;GO:0048666
GO:0055120;striated muscle dense body;395;9;GO:0048471
GO:0055121;response to high fluence blue light stimulus by blue high-fluence system;62;1;GO:0009416
GO:0055122;response to very low light intensity stimulus;39;3;GO:0009416
GO:0021764;amygdala development;229;257;GO:0007430
GO:0043134;regulation of hindgut contraction;21;8;GO:0048704
GO:0045797;positive regulation of intestinal cholesterol absorption;70;1;GO:0010467
GO:0006157;deoxyadenosine catabolic process;239;148;GO:0009065
GO:0021765;cingulate gyrus development;0;1;GO:0048666
GO:0043133;hindgut contraction;21;4;GO:0048704
GO:0006154;adenosine catabolic process;2478;46;GO:0006555
GO:0021766;hippocampus development;3525;2530;GO:0048608
GO:0043136;glycerol-3-phosphatase activity;199;4;GO:0004721
GO:0045795;positive regulation of cell volume;7;3;GO:0010467
GO:0021767;mammillary body development;246;19;GO:0048608
GO:0043135;5-phosphoribosyl 1-pyrophosphate pyrophosphatase activity;7;5;GO:0003964
GO:0045796;negative regulation of intestinal cholesterol absorption;114;234;GO:0010467
GO:0043138;3'-5' DNA helicase activity;42070;328;GO:0003677
GO:0021761;limbic system development;5597;417;GO:0007420
GO:0043137;DNA replication, removal of RNA primer;6824;284;GO:0006260
GO:0021762;substantia nigra development;94;1660;GO:0048608
GO:0021763;subthalamic nucleus development;12;59;GO:0048704
GO:0043139;5'-3' DNA helicase activity;21307;10;GO:0003677
GO:0033749;histone H4R3 demethylase activity;185;0;GO:0016570
GO:0033748;hydrogenase (acceptor) activity;6176;10;GO:0046395
GO:0021770;parahippocampal gyrus development;0;3;GO:0048666
GO:0018121;NAD(P)-asparagine ADP-ribosyltransferase activity;0;0;GO:0004867
GO:0043143;regulation of translation by machinery localization;42;10;GO:0010467
GO:0055112;delamination involved in gastrulation with mouth forming second;0;2;GO:0048405
GO:0070731;cGMP transport;63;7;GO:0006873
GO:0033741;adenylyl-sulfate reductase (glutathione) activity;27;7;GO:0004746
GO:0055113;epiboly involved in gastrulation with mouth forming second;930;10;GO:0009952
GO:0070732;spindle envelope;63;8;GO:0005819
GO:0018125;peptidyl-cysteine methylation;1;41;GO:0016567
GO:0033740;hydroxylamine oxidoreductase activity;9;4;GO:0004497
GO:0018124;peptide cross-linking via 5'-(N6-L-lysine)-L-topaquinone;0;0;GO:0046395
GO:0055115;entry into diapause;299;2;GO:0007548
GO:0070730;cAMP transport;109;3;GO:0006836
GO:0018127;NAD(P)-serine ADP-ribosyltransferase activity;0;0;GO:0004842
GO:0033746;histone H3R2 demethylase activity;129;1;GO:0016570
GO:0055116;entry into reproductive diapause;59;1;GO:0007548
GO:0070735;protein-glycine ligase activity;313;102;GO:0004497
GO:0018126;protein hydroxylation;119;568;GO:0046148
GO:0033745;L-methionine-(R)-S-oxide reductase activity;3592;0;GO:0006067
GO:0055117;regulation of cardiac muscle contraction;5094;765;GO:0002028
GO:0070736;protein-glycine ligase activity, initiating;137;10;GO:0004497
GO:0018129;peptidyl-oxazoline dehydrogenase activity;0;1;GO:0009081
GO:0033744;L-methionine:thioredoxin-disulfide S-oxidoreductase activity;37582;216;GO:0004746
GO:0055118;negative regulation of cardiac muscle contraction;180;81;GO:0048407
GO:0070733;AMPylase activity;39011;1;GO:0004553
GO:0033743;peptide-methionine (R)-S-oxide reductase activity;156335;0;GO:0006081
GO:0055119;relaxation of cardiac muscle;538;517;GO:0002044
GO:0070734;histone H3-K27 methylation;109;191;GO:0016569
GO:0045728;respiratory burst after phagocytosis;191;8;GO:0042592
GO:0031160;spore wall;1264;28;GO:0048305
GO:0045729;respiratory burst at fertilization;0;6;GO:0009743
GO:0045726;positive regulation of integrin biosynthetic process;227;157;GO:0048010
GO:0045727;positive regulation of translation;92286;3160;GO:0010467
GO:0031163;metallo-sulfur cluster assembly;433120;919;GO:0005737
GO:0031164;contractile vacuolar membrane;95;3;GO:0005730
GO:0031161;phosphatidylinositol catabolic process;77;35;GO:0006631
GO:0031162;sulfur incorporation into metallo-sulfur cluster;0;4;GO:0009065
GO:0045720;negative regulation of integrin biosynthetic process;128;10;GO:0048010
GO:0045721;negative regulation of gluconeogenesis;5558;633;GO:0045735
GO:0045724;positive regulation of cilium assembly;1573;269;GO:0048193
GO:0045725;positive regulation of glycogen biosynthetic process;705;985;GO:0045944
GO:0018190;protein octanoylation;13;7;GO:0016567
GO:0045722;positive regulation of gluconeogenesis;952;255;GO:0045944
GO:0045723;positive regulation of fatty acid biosynthetic process;1211;705;GO:0045944
GO:0018191;peptidyl-serine octanoylation;12;8;GO:0006486
GO:0018194;peptidyl-alanine modification;1;7;GO:0006464
GO:0018193;peptidyl-amino acid modification;2542968;1540;GO:0006464
GO:0018195;peptidyl-arginine modification;248;98;GO:0042555
GO:0018198;peptidyl-cysteine modification;521;258;GO:0006464
GO:0018197;peptidyl-aspartic acid modification;58;9;GO:0006464
GO:0031156;regulation of sorocarp development;113;5;GO:0048731
GO:0018199;peptidyl-glutamine modification;56;147;GO:0006464
GO:0031157;regulation of aggregate size involved in sorocarp development;99;4;GO:0048608
GO:0031154;culmination involved in sorocarp development;439;7;GO:0048707
GO:0031155;regulation of reproductive fruiting body development;13;3;GO:0048608
GO:0031158;negative regulation of aggregate size involved in sorocarp development;13;5;GO:0010468
GO:0031159;positive regulation of aggregate size involved in sorocarp development;7;2;GO:0048608
GO:0045739;positive regulation of DNA repair;12055;1080;GO:0006281
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;46;899;GO:0045944
GO:0045738;negative regulation of DNA repair;3463;591;GO:0030968
GO:0031152;aggregation involved in sorocarp development;423;9;GO:0048608
GO:0031153;slug development involved in sorocarp development;28;4;GO:0048608
GO:0031150;sorocarp stalk development;135;4;GO:0048468
GO:0031151;histone H3K79 methyltransferase activity;12000;9;GO:0016568
GO:0045732;positive regulation of protein catabolic process;56956;1790;GO:0019538
GO:0045730;respiratory burst;3188;2500;GO:0046395
GO:0045735;nutrient reservoir activity;21885;2390;GO:0045735
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;65;822;GO:0048285
GO:0045733;acetate catabolic process;23;8;GO:0006066
GO:0045734;regulation of acetate catabolic process;1;2;GO:0045735
GO:0018180;protein desulfurization;0;4;GO:0004705
GO:0018182;protein-heme linkage via 3'-L-histidine;0;1;GO:0046395
GO:0018185;poly-N-methyl-propylamination;0;3;GO:0046395
GO:0018184;protein polyamination;0;3;GO:0006461
GO:0018187;molybdenum incorporation via L-cysteinyl molybdopterin guanine dinucleotide;0;5;GO:0009065
GO:0018186;peroxidase-heme linkage;0;4;GO:0004601
GO:0018189;pyrroloquinoline quinone biosynthetic process;96839;19;GO:0009065
GO:0031145;anaphase-promoting complex-dependent catabolic process;16495;1070;GO:0007049
GO:0018188;peptidyl-proline di-hydroxylation;5;4;GO:0006457
GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;21399;1750;GO:0006511
GO:0102100;mycothiol-arsenate ligase activity;414;2;GO:0004872
GO:0031143;pseudopodium;631;1290;GO:0009986
GO:0102103;demethoxycurcumin synthase;2;2;GO:0042738
GO:0031144;proteasome localization;2965;11;GO:0005737
GO:0102102;homocarnosine synthase activity;76;3;GO:0006030
GO:0031149;sorocarp stalk cell differentiation;99;6;GO:0048468
GO:0031147;1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one metabolic process;7;0;GO:0006725
GO:0031148;DIF-1 biosynthetic process;6;3;GO:0009791
GO:0006181;dGMP biosynthetic process;1;2;GO:0009181
GO:0070706;RNA nucleotide deletion;3;3;GO:0003676
GO:0102109;tricaffeoyl spermidine O-methyltransferase activity;0;0;GO:0004725
GO:0006182;cGMP biosynthetic process;55957;1180;GO:0006096
GO:0070707;RNA dinucleotide insertion;0;1;GO:0003676
GO:0045748;positive regulation of R8 cell spacing in compound eye;0;2;GO:0048608
GO:0070704;sterol desaturase activity;302;3;GO:0004637
GO:0006180;deoxyguanosine salvage;3;3;GO:0006796
GO:0070705;RNA nucleotide insertion;3;3;GO:0003676
GO:0006185;dGDP biosynthetic process;14;3;GO:0006749
GO:0031141;induction of conjugation upon carbon starvation;3;1;GO:0046395
GO:0102105;demethoxycurcumin synthase activity from feruloylacetyl-CoA;2;2;GO:0006073
GO:0031142;induction of conjugation upon nitrogen starvation;5;2;GO:0046395
GO:0102104;demethoxycurcumin synthase activity;0;0;GO:0004497
GO:0006183;GTP biosynthetic process;85793;1490;GO:0006064
GO:0070708;RNA cytidine insertion;0;1;GO:0006470
GO:0031140;induction of conjugation upon nutrient starvation;8;1;GO:0048285
GO:0070709;RNA guanosine insertion;0;1;GO:0004576
GO:0102106;curcumin synthase activity;9;2;GO:0004497
GO:0006189;'de novo' IMP biosynthetic process;1116148;1860;GO:0046394
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;1341;646;GO:0030518
GO:0045743;positive regulation of fibroblast growth factor receptor signaling pathway;509;175;GO:0048010
GO:0006187;dGTP biosynthetic process from dGDP;1;2;GO:0009063
GO:0045740;positive regulation of DNA replication;2828;1290;GO:0045727
GO:0006188;IMP biosynthetic process;1192809;2030;GO:0009061
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity;11;239;GO:0048407
GO:0045746;negative regulation of Notch signaling pathway;4003;935;GO:0045730
GO:0045747;positive regulation of Notch signaling pathway;2900;1910;GO:0045730
GO:0045744;negative regulation of G protein-coupled receptor signaling pathway;2493;415;GO:0007186
GO:0045745;positive regulation of G protein-coupled receptor signaling pathway;1367;501;GO:0007186
GO:0018172;peptidyl-L-3',4',5'-trihydroxyphenylalanine biosynthetic process from peptidyl-tyrosine;0;1;GO:0009065
GO:0018171;peptidyl-cysteine oxidation;14;61;GO:0006483
GO:0018174;protein-heme P460 linkage;0;4;GO:0005539
GO:0018173;peptidyl-1-thioglycine biosynthetic process from peptidyl-glycine;0;5;GO:0009065
GO:0018175;protein nucleotidylation;3756;6;GO:0006464
GO:0018178;peptidyl-threonine adenylylation;1;4;GO:0006468
GO:0031134;sister chromatid biorientation;414;49;GO:0000786
GO:0033797;selenate reductase activity;134;6;GO:0008800
GO:0018177;protein uridylylation;1;5;GO:0006470
GO:0033796;sulfur reductase activity;144;4;GO:0004746
GO:0102111;gibberellin A20,2-oxoglutarate:oxygen oxidoreductase activity;24;0;GO:0004091
GO:0031132;serine 3-dehydrogenase activity;1054;6;GO:0004067
GO:0033795;betaine reductase activity;1791;3;GO:0004067
GO:0031133;regulation of axon diameter;207;56;GO:0048666
GO:0033794;sarcosine reductase activity;1677;2;GO:0004067
GO:0031138;negative regulation of conjugation with cellular fusion;331;8;GO:0048285
GO:0070702;inner mucus layer;5;6;GO:0005576
GO:0031139;positive regulation of conjugation with cellular fusion;2369;8;GO:0048285
GO:0070703;outer mucus layer;6;6;GO:0005576
GO:0033799;myricetin 3'-O-methyltransferase activity;16;1;GO:0004497
GO:0070700;BMP receptor binding;637;372;GO:0005178
GO:0031137;regulation of conjugation with cellular fusion;2765;4;GO:0048285
GO:0033798;thyroxine 5-deiodinase activity;190;7;GO:0004730
GO:0070701;mucus layer;63;256;GO:0030216
GO:0006193;ITP catabolic process;47;4;GO:0006541
GO:0102119;gibberellin A20 carboxyl methyltransferase activity;0;0;GO:0004714
GO:0006190;inosine salvage;1299;9;GO:0006559
GO:0045759;negative regulation of action potential;119;22;GO:0048608
GO:0006191;deoxyinosine salvage;0;3;GO:0009063
GO:0006196;AMP catabolic process;1932;93;GO:0006555
GO:0033793;aureusidin synthase activity;1;2;GO:0004497
GO:0031131;reception of an inductive signal;0;4;GO:0009954
GO:0033792;3alpha-hydroxy bile acid-CoA-ester 3-dehydrogenase activity;77;3;GO:0004497
GO:0102115;peptidoglycan asparagine synthase activity;0;0;GO:0006030
GO:0033791;3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity;94;6;GO:0004073
GO:0102118;gibberellin A4 carboxyl methyltransferase activity;2;3;GO:0004714
GO:0006195;purine nucleotide catabolic process;31919;1190;GO:0006559
GO:0033790;hydroxymethylfurfural reductase activity;0;1;GO:0004067
GO:0102117;gibberellin A9 carboxyl methyltransferase activity;2;2;GO:0004714
GO:0045753;negative regulation of acetate catabolic process;0;3;GO:0046394
GO:0045754;positive regulation of acetate catabolic process;0;3;GO:0046394
GO:0006198;cAMP catabolic process;15751;962;GO:0006555
GO:0045751;negative regulation of Toll signaling pathway;132;27;GO:0050829
GO:0045752;positive regulation of Toll signaling pathway;211;67;GO:0050829
GO:0045755;negative regulation of initiation of acetate catabolic process by acetate;0;1;GO:0046394
GO:0045756;positive regulation of initiation of acetate catabolic process by acetate;0;2;GO:0046394
GO:0018161;dipyrrin biosynthetic process;0;2;GO:0046395
GO:0031129;inductive cell-cell signaling;40;7;GO:0007267
GO:0018160;peptidyl-pyrromethane cofactor linkage;0;51;GO:0005525
GO:0018163;protein-DNA covalent cross-linking via the 5'-end to peptidyl-tyrosine;0;1;GO:0048193
GO:0045760;positive regulation of action potential;227;620;GO:0048407
GO:0018162;peptide cross-linking via S-(2-aminovinyl)-3-methyl-D-cysteine;0;0;GO:0009065
GO:0045761;regulation of adenylate cyclase activity;166;255;GO:0004872
GO:0018165;peptidyl-tyrosine uridylylation;0;3;GO:0006468
GO:0018164;protein-DNA covalent cross-linking via peptidyl-threonine;0;3;GO:0048285
GO:0018167;protein-phycoerythrobilin linkage via phycoerythrobilin-bis-L-cysteine;0;5;GO:0005576
GO:0031123;RNA 3'-end processing;290633;275;GO:0006364
GO:0033786;heptose-1-phosphate adenylyltransferase activity;15507;4;GO:0003824
GO:0102123;gibberellin A4 16alpha,17 epoxidase activity;0;0;GO:0004714
GO:0031124;mRNA 3'-end processing;63347;548;GO:0006364
GO:0033785;heptose 7-phosphate kinase activity;23066;5;GO:0004721
GO:0102122;gibberellin A34 carboxyl methyltransferase activity;0;1;GO:0004714
GO:0018169;ribosomal S6-glutamic acid ligase activity;554;19;GO:0003735
GO:0031121;equatorial microtubule organization;3;2;GO:0007088
GO:0033784;senecionine N-oxygenase activity;5;3;GO:0004497
GO:0102125;gibberellin A9 16alpha,17 epoxidase activity;0;0;GO:0004714
GO:0018168;protein-phycoerythrobilin linkage via S-phycoerythrobilin-L-cysteine;0;7;GO:0005576
GO:0031122;cytoplasmic microtubule organization;16756;1360;GO:0007010
GO:0033783;25-hydroxycholesterol 7alpha-hydroxylase activity;6;4;GO:0004073
GO:0102124;gibberellin A12 16alpha,17 epoxidase activity;0;0;GO:0004714
GO:0031127;alpha-(1,2)-fucosyltransferase activity;10880;0;GO:0004553
GO:0031128;developmental induction;2067;181;GO:0048731
GO:0033789;phenylacetyl-CoA dehydrogenase activity;4;3;GO:0004091
GO:0031125;rRNA 3'-end processing;8213;3;GO:0006364
GO:0033788;leucoanthocyanidin reductase activity;46;3;GO:0004497
GO:0102121;ceramidase activity;15093;9;GO:0004041
GO:0031126;sno(s)RNA 3'-end processing;1676;0;GO:0009063
GO:0033787;cyanocobalamin reductase (cyanide-eliminating) activity;685;8;GO:0009065
GO:0080130;L-phenylalanine:2-oxoglutarate aminotransferase activity;1299;109;GO:0004073
GO:0102127;8-oxoguanine deaminase activity;2818;2;GO:0006066
GO:0080131;hydroxyjasmonate sulfotransferase activity;2;1;GO:0004734
GO:0102126;coniferyl aldehyde 5-hydroxylase activity;0;0;GO:0006073
GO:0080132;fatty acid alpha-hydroxylase activity;7282;10;GO:0004076
GO:0080133;midchain alkane hydroxylase activity;3;1;GO:0046395
GO:0102128;chalcone synthase activity;1636;4;GO:0004497
GO:0043189;H4/H2A histone acetyltransferase complex;35710;143;GO:0016569
GO:0080134;regulation of response to stress;815692;1950;GO:0006950
GO:0043188;cell septum edging;30;0;GO:0009986
GO:0080135;regulation of cellular response to stress;137911;1590;GO:0006950
GO:0080136;priming of cellular response to stress;40;9;GO:0006974
GO:0080139;borate efflux transmembrane transporter activity;29;3;GO:0005215
GO:0043194;axon initial segment;629;633;GO:0043005
GO:0043196;varicosity;136;471;GO:0008092
GO:0043195;terminal bouton;2241;1440;GO:0008092
GO:0043198;dendritic shaft;958;979;GO:0030425
GO:0043197;dendritic spine;14734;3250;GO:0097403
GO:0102134;(22S)-22-hydroxy-campesterol C-23 hydroxylase activity;0;0;GO:0004497
GO:0102133;limonene hydroxylase activity;0;0;GO:0046395
GO:0102136;3-epi-6-deoxocathasterone C-23 hydroxylase activity;23;2;GO:0004497
GO:0102135;(22S)-22-hydroxy-campest-4-en-3-one C-23 hydroxylase activity;0;0;GO:0004497
GO:0102130;malonyl-CoA methyltransferase activity;14630;5;GO:0004041
GO:0043190;ATP-binding cassette (ABC) transporter complex;1174283;2370;GO:0005548
GO:0080140;regulation of jasmonic acid metabolic process;103;3;GO:0046274
GO:0080141;regulation of jasmonic acid biosynthetic process;102;10;GO:0009697
GO:0102138;7-oxatyphasterol synthase activity;0;0;GO:0004497
GO:0080142;regulation of salicylic acid biosynthetic process;535;66;GO:0046274
GO:0102137;7-oxateasterone synthase activity;0;0;GO:0004497
GO:0080143;regulation of amino acid export;3931;6;GO:0009065
GO:0080144;intracellular amino acid homeostasis;587;5;GO:0006865
GO:0102139;2-hydroxy-6-oxo-6-(2'-aminophenyl)-hexa-2,4dienoate hydrolase activity;165;0;GO:0004497
GO:0080145;intracellular cysteine homeostasis;3;1;GO:0006865
GO:0043199;sulfate binding;177;109;GO:0043167
GO:0080146;L-cysteine desulfhydrase activity;4443;10;GO:0004705
GO:0080147;root hair cell development;1944;35;GO:0048316
GO:0080148;negative regulation of response to water deprivation;81;8;GO:0010033
GO:0080149;sucrose induced translational repression;7;2;GO:0006414
GO:0070790;phialide development;5;2;GO:0048305
GO:0070793;regulation of conidiophore development;7;1;GO:0048285
GO:0070794;negative regulation of conidiophore development;3;1;GO:0046395
GO:0070791;cleistothecium development;33;3;GO:0048305
GO:0070792;Hulle cell development;2;2;GO:0048667
GO:0070797;negative regulation of cleistothecium development;2;1;GO:0048285
GO:0102145;(3R)-(E)-nerolidol synthase activity;5;0;GO:0004497
GO:0070798;positive regulation of cleistothecium development;6;3;GO:0048285
GO:0102144;carboxyspermidine dehydrogenase II activity;2;1;GO:0006067
GO:0070795;positive regulation of conidiophore development;3;2;GO:0046395
GO:0102147;3'-O-methyltricetin O methyl transferase activity;0;0;GO:0003676
GO:0070796;regulation of cleistothecium development;9;1;GO:0048285
GO:0102146;tricetin O-methytransferase activity;1;1;GO:0004725
GO:0102141;[chondroitin sulfate]-D-glucuronyl 2-O-sulfotransferase activity;0;0;GO:0004719
GO:0102140;heparan sulfate N-deacetylase activity;236;0;GO:0004553
GO:0070799;regulation of conidiophore stalk development;0;1;GO:0048285
GO:0102143;carboxynorspermidine dehydrogenase I activity;2;1;GO:0009065
GO:0102142;[dermatan sulfate]-L-iduronyl 2-Osulfotransferase activity;0;0;GO:0004730
GO:0102149;farnesylcysteine lyase activity;13;2;GO:0004721
GO:0102148;N-acetyl-beta-D-galactosaminidase activity;44326;9;GO:0004553
GO:0080110;sporopollenin biosynthetic process;149;76;GO:0009908
GO:0080111;DNA demethylation;26808;745;GO:0006974
GO:0080112;seed growth;291;150;GO:0009813
GO:0080113;regulation of seed growth;228;57;GO:0048316
GO:0080114;positive regulation of glycine hydroxymethyltransferase activity;1;2;GO:0046395
GO:0080115;myosin XI tail binding;4870;0;GO:0005525
GO:0080116;glucuronoxylan glucuronosyltransferase activity;62;4;GO:0004553
GO:0106255;hydroperoxy icosatetraenoate isomerase activity;7;2;GO:0004091
GO:0050996;positive regulation of lipid catabolic process;2763;1210;GO:0045944
GO:0072306;positive regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis;0;0;GO:0010942
GO:0098938;actin cytoskeleton of dendritic spine;1;1;GO:0030430
GO:0106254;lipid sensor activity;68;0;GO:0008083
GO:0060310;regulation of elastin catabolic process;38;3;GO:0048608
GO:0060311;negative regulation of elastin catabolic process;35;10;GO:0048608
GO:1901431;regulation of response to cycloalkane;0;1;GO:0010468
GO:1901430;positive regulation of syringal lignin biosynthetic process;14;3;GO:0046365
GO:0060316;positive regulation of ryanodine-sensitive calcium-release channel activity;15;905;GO:0048407
GO:1901433;positive regulation of response to cycloalkane;0;0;GO:0010468
GO:0047359;1-alkenyl-2-acylglycerol choline phosphotransferase activity;12;2;GO:0008631
GO:0060317;cardiac epithelial to mesenchymal transition;1871;432;GO:0048704
GO:1901432;negative regulation of response to cycloalkane;0;0;GO:0010468
GO:0047358;UDP-glucose-glycoprotein glucose phosphotransferase activity;3;3;GO:0006096
GO:0060318;definitive erythrocyte differentiation;274;10;GO:0008544
GO:1901435;negative regulation of toluene catabolic process;0;0;GO:0046365
GO:0047357;UDP-galactose-UDP-N-acetylglucosamine galactose phosphotransferase activity;0;3;GO:0008800
GO:0060319;primitive erythrocyte differentiation;703;90;GO:0002504
GO:1901434;regulation of toluene catabolic process;0;0;GO:0046365
GO:0060312;regulation of blood vessel remodeling;193;45;GO:0010717
GO:1901437;regulation of toluene metabolic process;0;0;GO:0010468
GO:0060313;negative regulation of blood vessel remodeling;77;33;GO:0010717
GO:1901436;positive regulation of toluene catabolic process;0;0;GO:0046356
GO:0060314;regulation of ryanodine-sensitive calcium-release channel activity;90;1070;GO:0008092
GO:1901439;positive regulation of toluene metabolic process;0;0;GO:0046356
GO:0060315;negative regulation of ryanodine-sensitive calcium-release channel activity;27;496;GO:0048407
GO:1901438;negative regulation of toluene metabolic process;0;1;GO:0046356
GO:0047363;triglucosylalkylacylglycerol sulfotransferase activity;0;3;GO:0004730
GO:0106264;protein serine kinase activity (using GTP as donor);75;4;GO:0004713
GO:0047362;thiosulfate-dithiol sulfurtransferase activity;13;3;GO:0004723
GO:0106263;1-acylglycerophosphoserine O-acyltransferase activity;300;1;GO:0008631
GO:1901429;negative regulation of syringal lignin biosynthetic process;0;0;GO:0046274
GO:0047361;phosphomannan mannosephosphotransferase activity;0;1;GO:0006032
GO:0106262;1-acylglycerophosphoethanolamine O-acyltransferase activity;283;1;GO:0008610
GO:0047360;undecaprenyl-phosphate galactose phosphotransferase activity;1929;3;GO:0008800
GO:0106261;tRNA uridine(34) acetyltransferase activity;1645;3;GO:0006021
GO:0047367;quercetin-3,3'-bissulfate 7-sulfotransferase activity;0;0;GO:0004725
GO:0098942;retrograde trans-synaptic signaling by trans-synaptic protein complex;77;7;GO:0048608
GO:0106260;DNA-DNA tethering activity;162;4;GO:0005524
GO:0047366;quercetin-3-sulfate 4'-sulfotransferase activity;2;0;GO:0004725
GO:0098943;neurotransmitter receptor transport, postsynaptic endosome to lysosome;260;15;GO:0006836
GO:0047365;quercetin-3-sulfate 3'-sulfotransferase activity;0;0;GO:0004725
GO:0098940;anterograde trans-synaptic signaling by nitric oxide;0;0;GO:0007218
GO:0047364;desulfoglucosinolate sulfotransferase activity;87;7;GO:0004733
GO:0098941;anterograde trans-synaptic signaling by trans-synaptic protein complex;0;0;GO:0048167
GO:0098944;postsynaptic recycling endosome membrane;39;2;GO:0006986
GO:0106268;3,5-dichloro-THPH methyl transferase activity;6;1;GO:0004497
GO:0106267;3,5 dichloro-THPH synthase activity;0;1;GO:0004497
GO:0106266;3-chloro THPH synthase activity;0;2;GO:0004497
GO:0106265;THPH synthase activity;1;2;GO:0004061
GO:0060341;regulation of cellular localization;198514;1290;GO:0051649
GO:0060342;photoreceptor inner segment membrane;102;50;GO:0005576
GO:0060343;trabecula formation;1036;194;GO:0048608
GO:0098919;structural constituent of postsynaptic density;259;9;GO:0048471
GO:0060344;liver trabecula formation;0;3;GO:0048514
GO:1901440;poly(hydroxyalkanoate) metabolic process;32568;0;GO:0006081
GO:1901442;regulation of response to furfural;0;2;GO:0010468
GO:0060340;positive regulation of type I interferon-mediated signaling pathway;1408;1070;GO:0060337
GO:1901441;poly(hydroxyalkanoate) biosynthetic process;32567;0;GO:0009405
GO:0060349;bone morphogenesis;6947;1300;GO:0001503
GO:1901444;positive regulation of response to furfural;0;1;GO:0010468
GO:1901443;negative regulation of response to furfural;0;0;GO:0010468
GO:0047369;succinate-hydroxymethylglutarate CoA-transferase activity;75;4;GO:0004089
GO:1901446;negative regulation of response to propan-1-ol;0;0;GO:0010468
GO:0047368;UDP-N-acetylgalactosamine-4-sulfate sulfotransferase activity;0;3;GO:0004364
GO:1901445;regulation of response to propan-1-ol;0;0;GO:0010468
GO:0060345;spleen trabecula formation;12;8;GO:0048771
GO:1901448;regulation of response to butan-1-ol;0;0;GO:0010468
GO:0060346;bone trabecula formation;461;1200;GO:0048608
GO:1901447;positive regulation of response to propan-1-ol;0;0;GO:0010468
GO:0060347;heart trabecula formation;563;623;GO:0048514
GO:0060348;bone development;16627;2100;GO:0007518
GO:1901449;negative regulation of response to butan-1-ol;0;0;GO:0010468
GO:0047374;methylumbelliferyl-acetate deacetylase activity;11;47;GO:0004723
GO:0047373;acetoxybutynylbithiophene deacetylase activity;0;3;GO:0004730
GO:0106274;NAD+-protein-arginine ADP-ribosyltransferase activity;26845;0;GO:0004812
GO:0047372;acylglycerol lipase activity;5071;756;GO:0008610
GO:0106273;cytosol to ERGIC protein transport;64;2;GO:0006986
GO:0047371;butyrate-acetoacetate CoA-transferase activity;575;5;GO:0004067
GO:0106272;protein localization to ERGIC;64;2;GO:0005764
GO:0047378;acetylalkylglycerol acetylhydrolase activity;5;3;GO:0008033
GO:0106271;D-arabinose 1-dehydrogenase (NADP+) activity;8;0;GO:0003954
GO:0047377;5-(3,4-diacetoxybut-1-ynyl)-2,2'-bithiophene deacetylase activity;0;0;GO:0004721
GO:0072322;protein transport across periplasmic space;0;2;GO:0006810
GO:0098910;regulation of atrial cardiac muscle cell action potential;162;83;GO:0048407
GO:0047376;all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity;31;3;GO:0005576
GO:0047375;N-acetylgalactosaminoglycan deacetylase activity;6;2;GO:0004553
GO:0072320;volume-sensitive chloride channel activity;217;76;GO:0005216
GO:0072327;vulval cell fate specification;51;0;GO:0009952
GO:0098913;membrane depolarization during ventricular cardiac muscle cell action potential;0;1;GO:0048407
GO:0072326;vulval cell fate determination;4;3;GO:0009952
GO:0098914;membrane repolarization during atrial cardiac muscle cell action potential;201;133;GO:0048407
GO:0072325;vulval cell fate commitment;59;0;GO:0009952
GO:0098911;regulation of ventricular cardiac muscle cell action potential;602;200;GO:0048407
GO:0072324;ascus epiplasm;26;3;GO:0005576
GO:0098912;membrane depolarization during atrial cardiac muscle cell action potential;148;193;GO:0048407
GO:0047370;succinate-citramalate CoA-transferase activity;4;1;GO:0006081
GO:0098917;retrograde trans-synaptic signaling;521;8;GO:0048167
GO:0106279;negative regulation of UDP-N-acetylglucosamine biosynthetic process;7;2;GO:0046394
GO:0098918;structural constituent of synapse;1202;22;GO:0030062
GO:0106278;regulation of UDP-N-acetylglucosamine biosynthetic process;7;1;GO:0006032
GO:0072329;monocarboxylic acid catabolic process;431603;1550;GO:0009062
GO:0098915;membrane repolarization during ventricular cardiac muscle cell action potential;938;276;GO:0048407
GO:0106277;biliverdin reductase (NADP+) activity;181;0;GO:0004067
GO:0072328;alkene binding;0;3;GO:0042169
GO:0098916;anterograde trans-synaptic signaling;219346;656;GO:0048167
GO:0106276;biliberdin reductase NAD+ activity;305;2;GO:0004067
GO:0060330;regulation of response to type II interferon;777;2;GO:0032496
GO:0060331;negative regulation of response to type II interferon;299;3;GO:0010468
GO:0060332;positive regulation of response to type II interferon;382;4;GO:0032724
GO:0060333;type II interferon-mediated signaling pathway;1901;228;GO:0060337
GO:1901451;regulation of response to benzene;0;1;GO:0010468
GO:1901450;positive regulation of response to butan-1-ol;0;0;GO:0010468
GO:1901453;positive regulation of response to benzene;0;0;GO:0010468
GO:1901452;negative regulation of response to benzene;0;0;GO:0010468
GO:0060338;regulation of type I interferon-mediated signaling pathway;152265;1020;GO:0060337
GO:1901455;negative regulation of response to toluene;0;0;GO:0048518
GO:0060339;negative regulation of type I interferon-mediated signaling pathway;150778;128;GO:0032727
GO:1901454;regulation of response to toluene;0;1;GO:0010468
GO:1901457;regulation of response to acetate;0;1;GO:0045735
GO:0047379;ADP-dependent short-chain-acyl-CoA hydrolase activity;16;3;GO:0004721
GO:1901456;positive regulation of response to toluene;0;0;GO:0050727
GO:0060334;regulation of type II interferon-mediated signaling pathway;674;2;GO:0060337
GO:1901459;positive regulation of response to acetate;0;0;GO:0046394
GO:0060335;positive regulation of type II interferon-mediated signaling pathway;333;6;GO:0032727
GO:1901458;negative regulation of response to acetate;0;0;GO:0046394
GO:0060336;negative regulation of type II interferon-mediated signaling pathway;299;6;GO:0032727
GO:0060337;type I interferon-mediated signaling pathway;153702;1990;GO:0060337
GO:0047385;[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity;0;0;GO:0004723
GO:0106286;(E)-caffeate-CoA ligase activity;17;0;GO:0006099
GO:0047384;[hydroxymethylglutaryl-CoA reductase (NADPH)]-phosphatase activity;0;0;GO:0004714
GO:0047383;guanidinodeoxy-scyllo-inositol-4-phosphatase activity;0;3;GO:0004721
GO:0047382;methylphosphothioglycerate phosphatase activity;0;4;GO:0010401
GO:0106283;ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity;61;0;GO:0004073
GO:0047389;glycerophosphocholine phosphodiesterase activity;160;41;GO:0004722
GO:0072312;metanephric glomerular epithelial cell differentiation;182;6;GO:0048193
GO:0098920;retrograde trans-synaptic signaling by lipid;320;0;GO:0048608
GO:0106282;isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity;61;0;GO:0004089
GO:0047388;[glutamine synthetase]-adenylyl-L-tyrosine phosphorylase;22635;0;GO:0006066
GO:0072311;glomerular epithelial cell differentiation;1641;84;GO:0048010
GO:0098921;retrograde trans-synaptic signaling by endocannabinoid;320;4;GO:0007218
GO:0106281;chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity;62;0;GO:0009065
GO:0047387;serine-ethanolaminephosphate phosphodiesterase activity;1;3;GO:0008021
GO:0072310;glomerular epithelial cell development;929;390;GO:0042127
GO:0106280;positive regulation of UDP-N-acetylglucosamine biosynthetic process;0;1;GO:0046394
GO:0047386;fructose-2,6-bisphosphate 6-phosphatase activity;11;3;GO:0006066
GO:0072316;alpha-glucan catabolic process involved in ascospore release from ascus;4;1;GO:0046395
GO:0098924;retrograde trans-synaptic signaling by nitric oxide;73;6;GO:0008066
GO:0072315;metanephric glomerular epithelial cell fate commitment;0;2;GO:0048193
GO:0098925;retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission;54;2;GO:0008066
GO:0072314;glomerular epithelial cell fate commitment;107;4;GO:0048193
GO:0098922;extrinsic component of dense core granule membrane;70;0;GO:0048471
GO:0072313;metanephric glomerular epithelial cell development;180;6;GO:0048193
GO:0098923;retrograde trans-synaptic signaling by soluble gas;73;8;GO:0048608
GO:0047381;dodecanoyl-[acyl-carrier-protein] hydrolase activity;92;0;GO:0004721
GO:0098928;presynaptic signal transduction;76;6;GO:0007268
GO:0047380;ADP-dependent medium-chain-acyl-CoA hydrolase activity;1;1;GO:0006081
GO:0072319;vesicle uncoating;819;7;GO:0008026
GO:0106289;negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA;55;2;GO:0010467
GO:0072318;clathrin coat disassembly;761;141;GO:0006986
GO:0098926;postsynaptic signal transduction;24008;15;GO:0007268
GO:0106288;regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA;114;2;GO:0010467
GO:0098927;vesicle-mediated transport between endosomal compartments;9237;31;GO:0008023
GO:0106297;E-series resolvin biosynthetic process;0;0;GO:0046323
GO:0106296;D-series resolvin biosynthetic process;0;0;GO:0046323
GO:0106295;resolvin biosynthetic process;0;0;GO:0046503
GO:0106294;NADPH oxidase H202-forming activity;614;2;GO:0004784
GO:0106293;NADH oxidase H202-forming activity;20;1;GO:0004746
GO:0106292;superoxide-generating NADPH oxidase activity;2052;1;GO:0004784
GO:0106291;superoxide-generating NADH oxidase activity;0;1;GO:0004784
GO:0106290;trans-cinnamate-CoA ligase activity;3933;2;GO:0006099
GO:0106299;resolution phase response;0;1;GO:0045735
GO:0106298;13-series resolvin biosynthetic process;0;0;GO:0046323
GO:0072392;phenol catabolic process;0;0;GO:0006073
GO:0072391;phenol biosynthetic process;0;1;GO:0006073
GO:0072390;phenol metabolic process;0;1;GO:0006082
GO:0072385;minus-end-directed organelle transport along microtubule;156;18;GO:0006810
GO:0072384;organelle transport along microtubule;4586;875;GO:0006810
GO:0072383;plus-end-directed vesicle transport along microtubule;148;47;GO:0006903
GO:0072382;minus-end-directed vesicle transport along microtubule;19;8;GO:0006903
GO:0072389;flavin adenine dinucleotide catabolic process;56;25;GO:0009062
GO:0072388;flavin adenine dinucleotide biosynthetic process;83852;4;GO:0006749
GO:0072387;flavin adenine dinucleotide metabolic process;84043;63;GO:0006749
GO:0072386;plus-end-directed organelle transport along microtubule;152;43;GO:0048471
GO:0060396;growth hormone receptor signaling pathway;964;912;GO:0007179
GO:0060397;growth hormone receptor signaling pathway via JAK-STAT;405;116;GO:0007179
GO:0060398;regulation of growth hormone receptor signaling pathway;199;9;GO:0030518
GO:0060399;positive regulation of growth hormone receptor signaling pathway;70;97;GO:0030516
GO:0060392;negative regulation of SMAD protein signal transduction;686;182;GO:0030516
GO:0060395;SMAD protein signal transduction;5293;1490;GO:0007179
GO:0072381;positive regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation;0;2;GO:0048704
GO:0072380;TRC complex;230;100;GO:0005737
GO:0072374;carotene epsilon hydroxylase activity;100;2;GO:0004747
GO:0072373;alpha-carotene epsilon hydroxylase activity;0;0;GO:0004497
GO:0072371;histone H2AS121 kinase activity;9;1;GO:0043406
GO:0072378;blood coagulation, fibrin clot formation;883;464;GO:0007596
GO:0072377;blood coagulation, common pathway;26;63;GO:0007596
GO:0072376;protein activation cascade;1382;1320;GO:0043434
GO:0072375;medium-term memory;162;113;GO:0007611
GO:0072379;ER membrane insertion complex;950;38;GO:0005737
GO:0098994;disruption of host cell envelope during viral entry;707;2;GO:0016021
GO:0098991;kainate selective glutamate receptor signaling pathway;0;0;GO:0048169
GO:0098992;neuronal dense core vesicle;924;128;GO:0005768
GO:0098997;fusion of virus membrane with host outer membrane;1;3;GO:0016021
GO:0098998;extrinsic component of postsynaptic early endosome membrane;32;1;GO:0005768
GO:0098995;disruption by virus of host envelope lipopolysaccharide during virus entry;3;3;GO:0046649
GO:0098996;disruption of host cell glycocalyx during viral entry;56;2;GO:0008544
GO:0098999;extrinsic component of postsynaptic endosome membrane;35;1;GO:0005768
GO:0072396;response to cell cycle checkpoint signaling;1242;8;GO:0007049
GO:0072393;microtubule anchoring at microtubule organizing center;3838;21;GO:0005815
GO:0072399;response to cytokinesis checkpoint signaling;0;0;GO:0007067
GO:0072398;signal transduction involved in cytokinesis checkpoint;0;0;GO:0007067
GO:0001940;male pronucleus;396;109;GO:0008544
GO:0001941;postsynaptic membrane organization;2455;2200;GO:0048666
GO:0001942;hair follicle development;4969;1770;GO:0008544
GO:0001944;vasculature development;97455;7260;GO:0001944
GO:0001945;lymph vessel development;4141;775;GO:0001944
GO:0001946;lymphangiogenesis;1980;1170;GO:0030530
GO:0001947;heart looping;5156;1270;GO:0002040
GO:0001949;sebaceous gland cell differentiation;96;9;GO:0007517
GO:0001951;intestinal D-glucose absorption;163;37;GO:0005929
GO:0001952;regulation of cell-matrix adhesion;6018;1020;GO:0007155
GO:0001953;negative regulation of cell-matrix adhesion;1707;993;GO:0022610
GO:0001954;positive regulation of cell-matrix adhesion;2716;729;GO:0022610
GO:0001955;blood vessel maturation;432;658;GO:0001944
GO:0001956;positive regulation of neurotransmitter secretion;717;1340;GO:0048167
GO:0001957;intramembranous ossification;372;878;GO:0007518
GO:0001958;endochondral ossification;1678;1210;GO:0002040
GO:0001959;regulation of cytokine-mediated signaling pathway;158273;938;GO:0007186
GO:0001920;negative regulation of receptor recycling;294;168;GO:0048193
GO:0001921;positive regulation of receptor recycling;690;975;GO:0048193
GO:0001922;B-1 B cell homeostasis;208;421;GO:0002429
GO:0001923;B-1 B cell differentiation;195;62;GO:0042113
GO:0001924;regulation of B-1 B cell differentiation;0;5;GO:0045595
GO:0001925;negative regulation of B-1 B cell differentiation;0;2;GO:0045595
GO:0001926;positive regulation of B-1 B cell differentiation;0;5;GO:0045595
GO:0001927;exocyst assembly;26;162;GO:0007030
GO:0001928;regulation of exocyst assembly;8;104;GO:0048193
GO:0001929;negative regulation of exocyst assembly;0;3;GO:0048193
GO:0050908;detection of light stimulus involved in visual perception;1339;1330;GO:0009583
GO:0050909;sensory perception of taste;36880;1360;GO:0007600
GO:0050906;detection of stimulus involved in sensory perception;392894;764;GO:0007600
GO:0050907;detection of chemical stimulus involved in sensory perception;384952;1070;GO:0009410
GO:0050904;diapedesis;279;79;GO:0006935
GO:0050905;neuromuscular process;10640;1550;GO:0048666
GO:0001930;positive regulation of exocyst assembly;0;3;GO:0048193
GO:0001931;uropod;542;585;GO:0009986
GO:0001932;regulation of protein phosphorylation;58405;3670;GO:0006468
GO:0001933;negative regulation of protein phosphorylation;19140;1910;GO:0016310
GO:0001934;positive regulation of protein phosphorylation;27577;5620;GO:0016310
GO:0001935;endothelial cell proliferation;11581;1440;GO:0042127
GO:0050902;leukocyte adhesive activation;7;106;GO:0002576
GO:0001936;regulation of endothelial cell proliferation;7696;885;GO:0050727
GO:0050903;leukocyte activation-dependent arrest;0;1;GO:0002684
GO:0001937;negative regulation of endothelial cell proliferation;2739;1340;GO:0050727
GO:0050900;leukocyte migration;31401;7800;GO:0002696
GO:0001938;positive regulation of endothelial cell proliferation;4567;2890;GO:0050727
GO:0050901;leukocyte tethering or rolling;1752;507;GO:0002526
GO:0001939;female pronucleus;480;228;GO:0002376
GO:0001990;regulation of systemic arterial blood pressure by hormone;3126;174;GO:0002026
GO:0001991;regulation of systemic arterial blood pressure by circulatory renin-angiotensin;758;199;GO:0048193
GO:0001992;regulation of systemic arterial blood pressure by vasopressin;214;139;GO:0002026
GO:0001982;baroreceptor response to decreased systemic arterial blood pressure;23;7;GO:0007623
GO:0001983;baroreceptor response to increased systemic arterial blood pressure;76;42;GO:0002881
GO:0001984;artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure;25;3;GO:0007596
GO:0001985;negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure;49;9;GO:0048608
GO:0001986;negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure;2;2;GO:0048407
GO:0001987;vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure;2;4;GO:0002873
GO:0001988;positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure;21;5;GO:0048608
GO:0001989;positive regulation of the force of heart contraction involved in baroreceptor response to decreased systemic arterial blood pressure;0;4;GO:0048407
GO:0001993;regulation of systemic arterial blood pressure by norepinephrine-epinephrine;594;34;GO:0048608
GO:0001994;norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure;93;99;GO:0008525
GO:0001995;norepinephrine-epinephrine catabolic process in blood stream;0;3;GO:0046649
GO:0001996;positive regulation of heart rate by epinephrine-norepinephrine;157;90;GO:0048608
GO:0001997;positive regulation of the force of heart contraction by epinephrine-norepinephrine;96;45;GO:0048010
GO:0001998;angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure;48;22;GO:0002026
GO:0001999;renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure;291;8;GO:0048193
GO:0001970;positive regulation of activation of membrane attack complex;39;42;GO:0046330
GO:0001960;negative regulation of cytokine-mediated signaling pathway;153543;476;GO:0050727
GO:0001961;positive regulation of cytokine-mediated signaling pathway;3585;563;GO:0050727
GO:0001962;alpha-1,3-galactosyltransferase activity;53;7;GO:0004553
GO:0001963;synaptic transmission, dopaminergic;11552;1510;GO:0007268
GO:0001964;startle response;1546;1690;GO:0007631
GO:0001965;G-protein alpha-subunit binding;6259;751;GO:0005516
GO:0001966;thigmotaxis;565;32;GO:0007626
GO:0001967;suckling behavior;467;469;GO:0007586
GO:0001968;fibronectin binding;1268;1790;GO:0005539
GO:0001969;regulation of activation of membrane attack complex;60;9;GO:0002376
GO:0001980;regulation of systemic arterial blood pressure by ischemic conditions;43;21;GO:0050727
GO:0001981;baroreceptor detection of arterial stretch;0;7;GO:0007623
GO:0001971;negative regulation of activation of membrane attack complex;21;23;GO:0046330
GO:0001972;retinoic acid binding;674;1110;GO:0097367
GO:0001973;G protein-coupled adenosine receptor signaling pathway;14531;337;GO:0007186
GO:0001974;blood vessel remodeling;2025;1280;GO:0043062
GO:0001975;response to amphetamine;971;1120;GO:0042330
GO:0001976;nervous system process involved in regulation of systemic arterial blood pressure;510;10;GO:0007623
GO:0001977;renal system process involved in regulation of blood volume;417;10;GO:0050727
GO:0001978;regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback;99;10;GO:0002074
GO:0001979;regulation of systemic arterial blood pressure by chemoreceptor signaling;41;6;GO:0002074
GO:0035320;imaginal disc-derived wing hair site selection;25;4;GO:0007600
GO:0035321;maintenance of imaginal disc-derived wing hair orientation;45;8;GO:0048608
GO:0035322;mesenchymal cell migration involved in limb bud formation;0;2;GO:0030509
GO:0050959;echolocation;0;2;GO:0009579
GO:0047305;(R)-3-amino-2-methylpropionate-pyruvate transaminase activity;32;0;GO:0004467
GO:0047304;2-aminoethylphosphonate-pyruvate transaminase activity;21578;10;GO:0009065
GO:0047303;glycine-oxaloacetate transaminase activity;3;2;GO:0009065
GO:0047302;UDP-2-acetamido-4-amino-2,4,6-trideoxyglucose transaminase activity;166;3;GO:0009065
GO:0047309;dihydroxyphenylalanine transaminase activity;3;3;GO:0004475
GO:0047308;alanine-oxomalonate transaminase activity;0;3;GO:0006066
GO:0047307;diaminobutyrate-pyruvate transaminase activity;5922;2;GO:0004089
GO:0047306;D-methionine-pyruvate transaminase activity;0;4;GO:0004449
GO:0050950;positive regulation of late stripe melanocyte differentiation;0;2;GO:0048405
GO:0047312;L-phenylalanine:pyruvate aminotransferase activity;4;4;GO:0004073
GO:0047311;1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol transaminase activity;0;3;GO:0004061
GO:0047310;glutamine-scyllo-inositol transaminase activity;569;3;GO:0006066
GO:0035316;non-sensory hair organization;639;14;GO:0048608
GO:0050957;equilibrioception;1247;348;GO:0007600
GO:0035317;imaginal disc-derived wing hair organization;613;55;GO:0048706
GO:0050958;magnetoreception;25;5;GO:0007623
GO:0035318;imaginal disc-derived wing hair outgrowth;12;4;GO:0048608
GO:0050955;thermoception;448;65;GO:0007623
GO:0035319;imaginal disc-derived wing hair elongation;0;3;GO:0048608
GO:0050956;electroception;0;1;GO:0007601
GO:0035312;5'-3' DNA exonuclease activity;12954;4;GO:0004518
GO:0050953;sensory perception of light stimulus;68118;1500;GO:0007600
GO:0035313;wound healing, spreading of epidermal cells;946;1520;GO:0048407
GO:0050954;sensory perception of mechanical stimulus;22622;685;GO:0007600
GO:0035314;scab formation;19;11;GO:0048285
GO:0050951;sensory perception of temperature stimulus;1178;226;GO:0007600
GO:0035315;hair cell differentiation;5905;337;GO:0008544
GO:0050952;sensory perception of electrical stimulus;0;0;GO:0007600
GO:0035310;notum cell fate specification;67;9;GO:0009952
GO:0098908;regulation of neuronal action potential;340;93;GO:0048167
GO:0035311;wing cell fate specification;82;12;GO:0009952
GO:0098909;regulation of cardiac muscle cell action potential involved in regulation of contraction;246;222;GO:0048407
GO:0047316;glutamine-phenylpyruvate transaminase activity;24;6;GO:0004073
GO:0047315;kynurenine-glyoxylate transaminase activity;873;7;GO:0009065
GO:0047313;aromatic-amino-acid-glyoxylate transaminase activity;0;2;GO:0004467
GO:0047319;aspartate-phenylpyruvate transaminase activity;0;3;GO:0004089
GO:0047317;N6-acetyl-beta-lysine transaminase activity;0;3;GO:0004465
GO:0050960;detection of temperature stimulus involved in thermoception;294;61;GO:0009416
GO:0050961;detection of temperature stimulus involved in sensory perception;913;339;GO:0009414
GO:0035309;wing and notum subfield formation;211;10;GO:0048608
GO:0047323;[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity;14;0;GO:0005524
GO:0047322;[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity;1570;0;GO:0004721
GO:0047321;diphosphate-protein phosphotransferase activity;0;1;GO:0004721
GO:0047320;D-4-hydroxyphenylglycine transaminase activity;0;3;GO:0004467
GO:0035305;negative regulation of dephosphorylation;1069;65;GO:0010468
GO:0050968;detection of chemical stimulus involved in sensory perception of pain;166;57;GO:0007600
GO:0098902;regulation of membrane depolarization during action potential;267;4;GO:0048407
GO:0035306;positive regulation of dephosphorylation;3324;31;GO:0010468
GO:0050969;detection of chemical stimulus involved in magnetoreception;0;2;GO:0007623
GO:0098903;regulation of membrane repolarization during action potential;161;50;GO:0048407
GO:0035307;positive regulation of protein dephosphorylation;3142;667;GO:0010468
GO:0050966;detection of mechanical stimulus involved in sensory perception of pain;517;228;GO:0007600
GO:0098900;regulation of action potential;2667;573;GO:0048407
GO:0035308;negative regulation of protein dephosphorylation;870;193;GO:0010468
GO:0050967;detection of electrical stimulus involved in sensory perception of pain;0;2;GO:0007600
GO:0098901;regulation of cardiac muscle cell action potential;1716;43;GO:0048407
GO:0035301;Hedgehog signaling complex;91;8;GO:0009952
GO:0050964;detection of electrical stimulus involved in electroception;0;1;GO:0007601
GO:0098906;regulation of Purkinje myocyte action potential;61;6;GO:0048407
GO:0035302;ecdysteroid 25-hydroxylase activity;12;3;GO:0004722
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;566;599;GO:0007600
GO:0098907;regulation of SA node cell action potential;154;131;GO:0048608
GO:0035303;regulation of dephosphorylation;7414;800;GO:0010468
GO:0050962;detection of light stimulus involved in sensory perception;1378;1080;GO:0009583
GO:0098904;regulation of AV node cell action potential;126;98;GO:0048407
GO:0035304;regulation of protein dephosphorylation;4116;439;GO:0010468
GO:0050963;detection of electrical stimulus involved in sensory perception;0;1;GO:0007600
GO:0098905;regulation of bundle of His cell action potential;117;40;GO:0048407
GO:0060300;regulation of cytokine activity;16;25;GO:0050727
GO:0047327;glycerol-3-phosphate-glucose phosphotransferase activity;0;3;GO:0005975
GO:0060305;regulation of cell diameter;65;10;GO:0048193
GO:1901400;positive regulation of transforming growth factor beta3 activation;0;0;GO:0048010
GO:0047326;inositol tetrakisphosphate 5-kinase activity;763;5;GO:0004721
GO:0060306;regulation of membrane repolarization;1852;648;GO:0048407
GO:0047325;inositol tetrakisphosphate 1-kinase activity;7981;40;GO:0004721
GO:0060307;regulation of ventricular cardiac muscle cell membrane repolarization;1025;793;GO:0048407
GO:1901402;negative regulation of tetrapyrrole metabolic process;9;2;GO:0046395
GO:0047324;phosphoenolpyruvate-glycerone phosphotransferase activity;15256;240;GO:0004723
GO:0060308;GTP cyclohydrolase I regulator activity;11;6;GO:0005524
GO:1901401;regulation of tetrapyrrole metabolic process;768;3;GO:0046395
GO:0060301;positive regulation of cytokine activity;1;146;GO:0050727
GO:1901404;regulation of tetrapyrrole catabolic process;97;2;GO:0046395
GO:0060302;negative regulation of cytokine activity;10;15;GO:0050727
GO:1901403;positive regulation of tetrapyrrole metabolic process;345;1;GO:0046395
GO:0047329;phosphoramidate-hexose phosphotransferase activity;0;3;GO:0005524
GO:1901406;positive regulation of tetrapyrrole catabolic process;8;1;GO:0046395
GO:0047328;acyl-phosphate-hexose phosphotransferase activity;0;3;GO:0005524
GO:0060304;regulation of phosphatidylinositol dephosphorylation;267;345;GO:0010468
GO:1901405;negative regulation of tetrapyrrole catabolic process;4;1;GO:0046395
GO:0047330;polyphosphate-glucose phosphotransferase activity;788;4;GO:0005524
GO:0050971;detection of mechanical stimulus involved in magnetoreception;0;0;GO:0009579
GO:0050972;detection of mechanical stimulus involved in echolocation;0;1;GO:0009579
GO:0050970;detection of electrical stimulus involved in magnetoreception;0;0;GO:0007623
GO:0047334;diphosphate-fructose-6-phosphate 1-phosphotransferase activity;55575;30;GO:0005975
GO:0060309;elastin catabolic process;145;7;GO:0006512
GO:0047333;dihydrostreptomycin-6-phosphate 3'-alpha-kinase activity;0;0;GO:0004721
GO:0047332;diphosphate-serine phosphotransferase activity;0;3;GO:0004721
GO:0047331;diphosphate-glycerol phosphotransferase activity;0;3;GO:0004721
GO:0050979;magnetoreception by sensory perception of mechanical stimulus;0;1;GO:0007611
GO:0050977;magnetoreception by sensory perception of chemical stimulus;0;2;GO:0007600
GO:0050978;magnetoreception by sensory perception of electrical stimulus;0;1;GO:0007623
GO:0050975;sensory perception of touch;716;32;GO:0007600
GO:0050976;detection of mechanical stimulus involved in sensory perception of touch;443;24;GO:0007600
GO:0050973;detection of mechanical stimulus involved in equilibrioception;18;8;GO:0007600
GO:0050974;detection of mechanical stimulus involved in sensory perception;2400;1030;GO:0007600
GO:0047338;UTP:xylose-1-phosphate uridylyltransferase activity;61;2;GO:0006073
GO:1901411;negative regulation of tetrapyrrole biosynthetic process from glutamate;0;0;GO:0046395
GO:0047337;dolichyl-diphosphate-polyphosphate phosphotransferase activity;0;3;GO:0003906
GO:1901410;regulation of tetrapyrrole biosynthetic process from glutamate;0;0;GO:0046395
GO:0047336;5-methyldeoxycytidine-5'-phosphate kinase activity;0;0;GO:0004721
GO:1901413;regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA;0;2;GO:0046395
GO:0047335;3-phosphoglyceroyl-phosphate-polyphosphate phosphotransferase activity;0;3;GO:0005524
GO:1901412;positive regulation of tetrapyrrole biosynthetic process from glutamate;0;0;GO:0046395
GO:1901415;positive regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA;0;1;GO:0046395
GO:1901414;negative regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA;0;0;GO:0046395
GO:1901417;negative regulation of response to ethanol;0;1;GO:0010033
GO:0047339;nucleoside-triphosphate-hexose-1-phosphate nucleotidyltransferase activity;1;2;GO:0004067
GO:1901416;regulation of response to ethanol;24;2;GO:0010468
GO:0047341;fucose-1-phosphate guanylyltransferase activity;153;6;GO:0006022
GO:0050982;detection of mechanical stimulus;3267;441;GO:0007626
GO:0050980;detection of light stimulus involved in magnetoreception;12;5;GO:0009579
GO:0050981;detection of electrical stimulus;0;2;GO:0007600
GO:0047345;ribose-5-phosphate adenylyltransferase activity;1;3;GO:0004067
GO:0047344;glucose-1-phosphate guanylyltransferase activity;0;2;GO:0006096
GO:0047343;glucose-1-phosphate cytidylyltransferase activity;14814;10;GO:0006096
GO:0047342;galactose-1-phosphate thymidylyltransferase activity;0;3;GO:0006030
GO:0050988;N-terminal peptidyl-methionine carboxylation;0;1;GO:0006464
GO:0050989;N-terminal protein amino acid carboxylation;0;3;GO:0006468
GO:0050986;isopeptide cross-linking via N-(L-isoglutamyl)-glycine;0;0;GO:0008544
GO:0050984;peptidyl-serine sulfation;0;1;GO:0004719
GO:0050985;peptidyl-threonine sulfation;0;1;GO:0004719
GO:0035363;histone locus body;366;108;GO:0032559
GO:0035364;thymine transport;126;3;GO:0006865
GO:0035365;regulation of thymine transport;0;1;GO:0006559
GO:0050919;negative chemotaxis;3406;1180;GO:0007626
GO:0035366;negative regulation of thymine transport;0;2;GO:0006559
GO:0050917;sensory perception of umami taste;425;119;GO:0007600
GO:0035360;positive regulation of peroxisome proliferator activated receptor signaling pathway;413;40;GO:0030528
GO:0050918;positive chemotaxis;5940;1200;GO:0042330
GO:0035361;Cul8-RING ubiquitin ligase complex;73;7;GO:0005819
GO:0050915;sensory perception of sour taste;372;44;GO:0007600
GO:0035362;protein-DNA ISRE complex assembly;0;2;GO:0048285
GO:0050916;sensory perception of sweet taste;4840;276;GO:0007600
GO:0050913;sensory perception of bitter taste;2752;113;GO:0007600
GO:0050914;sensory perception of salty taste;72;15;GO:0007600
GO:0050911;detection of chemical stimulus involved in sensory perception of smell;372770;1690;GO:0009410
GO:0050912;detection of chemical stimulus involved in sensory perception of taste;11612;240;GO:0009410
GO:0035356;intracellular triglyceride homeostasis;396;5;GO:0006629
GO:0035357;peroxisome proliferator activated receptor signaling pathway;965;188;GO:0030528
GO:0050910;detection of mechanical stimulus involved in sensory perception of sound;946;1510;GO:0009414
GO:0035358;regulation of peroxisome proliferator activated receptor signaling pathway;612;490;GO:0030528
GO:0035359;negative regulation of peroxisome proliferator activated receptor signaling pathway;130;60;GO:0030518
GO:0035352;NAD transmembrane transport;784;4;GO:0006869
GO:0035353;nicotinamide mononucleotide transmembrane transport;2;2;GO:0006826
GO:0035354;Toll-like receptor 1-Toll-like receptor 2 protein complex;101;44;GO:0005737
GO:0035355;Toll-like receptor 2-Toll-like receptor 6 protein complex;108;5;GO:0005737
GO:0050928;negative regulation of positive chemotaxis;70;8;GO:0050921
GO:0050929;induction of negative chemotaxis;53;9;GO:0050921
GO:0035350;FAD transmembrane transport;788;10;GO:0008565
GO:0050926;regulation of positive chemotaxis;1179;385;GO:0042330
GO:0035351;heme transmembrane transport;17064;10;GO:0015075
GO:0050927;positive regulation of positive chemotaxis;1094;554;GO:0050921
GO:0035349;coenzyme A transmembrane transport;815;22;GO:0006869
GO:0050924;positive regulation of negative chemotaxis;53;6;GO:0050921
GO:0106305;mannogen catabolic process;0;1;GO:0006032
GO:0050925;negative regulation of negative chemotaxis;53;81;GO:0050921
GO:0106304;mannogen biosynthetic process;0;0;GO:1901363
GO:0050922;negative regulation of chemotaxis;2523;347;GO:0050921
GO:0106303;mannogen metabolic process;0;0;GO:0006073
GO:0050923;regulation of negative chemotaxis;149;31;GO:0050921
GO:0106302;arachidonic acid 8,9-epoxygenase activity;0;2;GO:0004097
GO:0035345;regulation of hypoxanthine transport;0;2;GO:0046395
GO:0050920;regulation of chemotaxis;23549;1180;GO:0042330
GO:0106301;arachidonic acid 5,6-epoxygenase activity;1;2;GO:0004097
GO:0035346;positive regulation of hypoxanthine transport;0;2;GO:0010401
GO:0050921;positive regulation of chemotaxis;9627;2150;GO:0042330
GO:0106300;protein-DNA covalent cross-linking repair;441;9;GO:0048285
GO:0035347;negative regulation of hypoxanthine transport;0;2;GO:0010401
GO:0035348;acetyl-CoA transmembrane transport;67;4;GO:0046394
GO:0035341;regulation of inosine transport;0;2;GO:0010401
GO:0035342;positive regulation of inosine transport;0;2;GO:0010401
GO:0035343;negative regulation of inosine transport;0;2;GO:0010401
GO:0035344;hypoxanthine transport;267;10;GO:0006873
GO:0050939;regulation of early stripe melanocyte differentiation;0;1;GO:0048608
GO:0106309;progesterone 21-hydroxylase activity;15;1;GO:0004722
GO:0050937;regulation of iridophore differentiation;1;1;GO:0048608
GO:0035340;inosine transport;267;3;GO:0006865
GO:0050938;regulation of xanthophore differentiation;39;2;GO:0048608
GO:0035338;long-chain fatty-acyl-CoA biosynthetic process;2724;689;GO:0006631
GO:0050935;iridophore differentiation;317;8;GO:0048608
GO:0106316;nitrite reductase NADH activity;15;1;GO:0009065
GO:0035339;SPOTS complex;447;69;GO:0005829
GO:0050936;xanthophore differentiation;227;4;GO:0008544
GO:0050933;early stripe melanocyte differentiation;0;3;GO:0048608
GO:0106314;nitrite reductase NADPH activity;6;1;GO:0003954
GO:0050934;late stripe melanocyte differentiation;71;2;GO:0048608
GO:0106313;methylenetetrahydrofolate reductase NADPH activity;323;2;GO:0006749
GO:0035334;Notch receptor processing, ligand-independent;0;2;GO:0007548
GO:0050931;pigment cell differentiation;3933;176;GO:0048608
GO:0106312;methylenetetrahydrofolate reductase NADH activity;14733;2;GO:0006749
GO:0035335;peptidyl-tyrosine dephosphorylation;190;1780;GO:0006468
GO:0050932;regulation of pigment cell differentiation;487;8;GO:0045595
GO:0035336;long-chain fatty-acyl-CoA metabolic process;3671;607;GO:0006631
GO:0106310;protein serine kinase activity;75061;1080;GO:0004713
GO:0035337;fatty-acyl-CoA metabolic process;4620;337;GO:0006631
GO:0050930;induction of positive chemotaxis;715;631;GO:0042330
GO:0035330;regulation of hippo signaling;2500;1240;GO:0048407
GO:0035331;negative regulation of hippo signaling;1305;287;GO:0010941
GO:0035332;positive regulation of hippo signaling;809;23;GO:0042127
GO:0035333;Notch receptor processing, ligand-dependent;44;106;GO:0004867
GO:0106319;(R)-limonene 1,2-monooxygenase NADH activity;1375;0;GO:0004497
GO:0050948;positive regulation of early stripe melanocyte differentiation;0;3;GO:0048405
GO:0106318;methane monooxygenase NADPH activity;320;2;GO:0004497
GO:0050949;negative regulation of late stripe melanocyte differentiation;0;0;GO:0048405
GO:0106317;methane monooxygenase NADH activity;320;2;GO:0004497
GO:0047301;valine-3-methyl-2-oxovalerate transaminase activity;0;2;GO:0004474
GO:0047300;pyridoxamine-pyruvate transaminase activity;21;4;GO:0004073
GO:0050946;positive regulation of xanthophore differentiation;0;2;GO:0048608
GO:0106327;acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity;4;2;GO:0006029
GO:0050947;negative regulation of early stripe melanocyte differentiation;0;1;GO:0048405
GO:0106326;acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;26;2;GO:0006029
GO:0035329;hippo signaling;11908;1840;GO:0007219
GO:0050944;negative regulation of xanthophore differentiation;0;1;GO:0048608
GO:0106325;acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;26;2;GO:0006022
GO:0050945;positive regulation of iridophore differentiation;1;2;GO:0048608
GO:0106324;(S)-limonene 1,2-monooxygenase NADH activity;1;0;GO:0004497
GO:0035323;male germline ring canal;129;7;GO:0008544
GO:0050942;positive regulation of pigment cell differentiation;345;16;GO:0048608
GO:0106323;(S)-limonene 1,2-monooxygenase NADPH activity;1;0;GO:0004091
GO:0035324;female germline ring canal;189;7;GO:0005576
GO:0050943;negative regulation of iridophore differentiation;0;0;GO:0048706
GO:0106322;S-(hydroxymethyl)glutathione dehydrogenase NAD activity;23946;0;GO:0009065
GO:0035325;Toll-like receptor binding;2623;156;GO:0005125
GO:0050940;regulation of late stripe melanocyte differentiation;0;0;GO:0048608
GO:0106321;S-(hydroxymethyl)glutathione dehydrogenase NADP activity;23946;0;GO:0009065
GO:0050941;negative regulation of pigment cell differentiation;7;6;GO:0045595
GO:0106320;(R)-limonene 1,2-monooxygenase NADPH activity;1375;0;GO:0004497
GO:0060484;lung-associated mesenchyme development;341;996;GO:0030509
GO:0060485;mesenchyme development;29503;1320;GO:0001501
GO:0060486;club cell differentiation;204;3;GO:0045595
GO:0060487;lung epithelial cell differentiation;1693;253;GO:0030216
GO:0060480;lung goblet cell differentiation;166;70;GO:0030216
GO:1901341;positive regulation of store-operated calcium channel activity;33;10;GO:0048407
GO:0060481;lobar bronchus epithelium development;267;97;GO:0030216
GO:1901340;negative regulation of store-operated calcium channel activity;4;7;GO:0048407
GO:0060482;lobar bronchus development;271;6;GO:0048513
GO:1901343;negative regulation of vasculature development;11181;284;GO:0050731
GO:0060483;lobar bronchus mesenchyme development;0;1;GO:0030900
GO:1901342;regulation of vasculature development;25325;965;GO:0001944
GO:1901345;response to L-thialysine;0;0;GO:0009065
GO:1901344;response to leptomycin B;56;0;GO:0048285
GO:1901347;negative regulation of secondary cell wall biogenesis;19;4;GO:0046274
GO:1901346;negative regulation of vasculature development involved in avascular cornea development in camera-type eye;64;3;GO:0048405
GO:0060488;orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis;46;9;GO:0048704
GO:1901349;glucosinolate transport;14;3;GO:0006879
GO:0060489;planar dichotomous subdivision of terminal units involved in lung branching morphogenesis;46;9;GO:0048704
GO:1901348;positive regulation of secondary cell wall biogenesis;24;5;GO:0046364
GO:0072461;response to meiotic recombination checkpoint signaling;0;1;GO:0007067
GO:0072464;response to meiotic spindle assembly checkpoint signaling;0;0;GO:0007067
GO:0060490;lateral sprouting involved in lung morphogenesis;46;25;GO:0048704
GO:0060473;cortical granule;321;39;GO:0008021
GO:0060474;positive regulation of flagellated sperm motility involved in capacitation;160;7;GO:0048407
GO:0060476;protein localization involved in acrosome reaction;0;4;GO:0006929
GO:1901352;negative regulation of phosphatidylglycerol biosynthetic process;21;4;GO:0046395
GO:0060470;positive regulation of cytosolic calcium ion concentration involved in egg activation;154;2;GO:0048608
GO:1901351;regulation of phosphatidylglycerol biosynthetic process;21;1;GO:0008610
GO:0060471;cortical granule exocytosis;76;6;GO:0008021
GO:1901354;response to L-canavanine;45;0;GO:0009628
GO:0060472;positive regulation of cortical granule exocytosis by positive regulation of cytosolic calcium ion concentration;37;1;GO:0048608
GO:1901353;positive regulation of phosphatidylglycerol biosynthetic process;0;1;GO:0046394
GO:1901356;beta-D-galactofuranose metabolic process;1;1;GO:0006032
GO:1901355;response to rapamycin;235;30;GO:0009628
GO:1901358;beta-D-galactofuranose biosynthetic process;1;0;GO:0006022
GO:1901357;beta-D-galactofuranose catabolic process;0;0;GO:0006032
GO:0060478;acrosomal vesicle exocytosis;511;100;GO:0006974
GO:1901359;tungstate binding;718;3;GO:0043169
GO:0060479;lung cell differentiation;1744;141;GO:0030216
GO:0072452;response to G2 transition size control checkpoint signaling;0;0;GO:0045727
GO:0106107;regulation of (R)-mevalonic acid biosynthetic process;2;0;GO:0046394
GO:0106106;cold-induced thermogenesis;5954;56;GO:0006916
GO:0106105;Ala-tRNA(Thr) hydrolase activity;106;0;GO:0008544
GO:0106104;regulation of glutamate receptor clustering;228;0;GO:0048169
GO:0106103;COPII vesicles tethering complex;5;3;GO:0008023
GO:0106101;ER-dependent peroxisome localization;61;1;GO:0009570
GO:0106100;beta-pinacene synthase activity;1;1;GO:0004497
GO:1901361;organic cyclic compound catabolic process;2170948;1990;GO:0046274
GO:1901360;organic cyclic compound metabolic process;106203800;2500;GO:0019438
GO:1901363;heterocyclic compound binding;73858810;3830;GO:0097159
GO:1901362;organic cyclic compound biosynthetic process;62766994;1650;GO:0009405
GO:0106109;positive regulation of (R)-mevalonic acid biosynthetic process;0;0;GO:0045944
GO:1901365;funalenone catabolic process;0;0;GO:0046274
GO:0106108;negative regulation of (R)-mevalonic acid biosynthetic process;2;0;GO:0010468
GO:1901364;funalenone metabolic process;1;1;GO:0006081
GO:1901367;response to L-cysteine;4;0;GO:0006979
GO:1901366;funalenone biosynthetic process;1;0;GO:0046274
GO:1901369;cyclic 2,3-bisphospho-D-glycerate biosynthetic process;510;3;GO:0006099
GO:0072491;toluene-containing compound catabolic process;83;1;GO:0046365
GO:0072490;toluene-containing compound metabolic process;86;0;GO:0046365
GO:0106110;vomitoxin biosynthetic process;0;0;GO:0046395
GO:0072482;response to mitotic cell cycle spindle orientation checkpoint signaling;0;0;GO:0048285
GO:0072488;ammonium transmembrane transport;218447;881;GO:0008544
GO:0072487;MSL complex;3225;58;GO:0005819
GO:0072485;response to spindle assembly checkpoint signaling;249;0;GO:0007067
GO:0106118;regulation of sterol biosynthetic process;1159;9;GO:0010468
GO:0106117;acidocalcisome organization;1;4;GO:0005840
GO:0106116;positive regulation of mitotic cohesin dsDNA (leading strand) loading;0;0;GO:0048285
GO:0072489;methylammonium transmembrane transport;283;3;GO:0008544
GO:0106115;negative regulation of mitotic cohesin dsDNA (leading strand) loading;0;0;GO:0048285
GO:0035499;carnosine biosynthetic process;1045;8;GO:0009065
GO:0106114;regulation of mitotic cohesin dsDNA (leading strand) loading;0;0;GO:0048285
GO:0106113;positive regulation of mitotic cohesin ssDNA (lagging strand) loading;0;0;GO:0048285
GO:0106112;negative regulation of mitotic cohesin ssDNA (lagging strand) loading;0;0;GO:0048285
GO:0106111;regulation of mitotic cohesin ssDNA (lagging strand) loading;0;0;GO:0048285
GO:0035495;regulation of SNARE complex disassembly;0;3;GO:0008023
GO:0060495;cell-cell signaling involved in lung development;107;2;GO:0007267
GO:1901370;response to glutathione;0;1;GO:0006979
GO:0035496;lipopolysaccharide-1,5-galactosyltransferase activity;2;3;GO:0004553
GO:0060496;mesenchymal-epithelial cell signaling involved in lung development;56;2;GO:0048704
GO:0035497;cAMP response element binding;694;290;GO:0003700
GO:0060497;mesenchymal-endodermal cell signaling;0;2;GO:0007275
GO:0035498;carnosine metabolic process;1151;7;GO:0006066
GO:0060498;retinoic acid receptor signaling pathway involved in lung bud formation;0;0;GO:0030518
GO:1901371;regulation of leaf morphogenesis;360;5;GO:0048468
GO:0035491;positive regulation of leukotriene production involved in inflammatory response;54;19;GO:0050729
GO:0060491;regulation of cell projection assembly;37792;299;GO:0048608
GO:1901374;acetate ester transport;775;5;GO:0006865
GO:0035492;negative regulation of leukotriene production involved in inflammatory response;0;4;GO:0050729
GO:0060492;lung induction;179;190;GO:0030900
GO:1901373;lipid hydroperoxide transport;119;6;GO:0006869
GO:0035493;SNARE complex assembly;1421;66;GO:0008023
GO:0060493;mesenchymal-endodermal cell signaling involved in lung induction;0;2;GO:0048704
GO:1901376;organic heteropentacyclic compound metabolic process;1717;15;GO:0019438
GO:0035494;SNARE complex disassembly;6502;47;GO:0008023
GO:0060494;inductive mesenchymal-endodermal cell signaling;0;1;GO:0048704
GO:0106119;negative regulation of sterol biosynthetic process;245;4;GO:0010468
GO:1901375;acetate ester transmembrane transporter activity;276;25;GO:0008544
GO:1901378;organic heteropentacyclic compound biosynthetic process;1634;1;GO:0046394
GO:1901377;organic heteropentacyclic compound catabolic process;15;54;GO:0046274
GO:0035490;regulation of leukotriene production involved in inflammatory response;54;4;GO:0050729
GO:1901379;regulation of potassium ion transmembrane transport;5327;620;GO:0015031
GO:0060499;fibroblast growth factor receptor signaling pathway involved in lung induction;0;1;GO:0048010
GO:0106121;positive regulation of cobalamin metabolic process;48;2;GO:0046395
GO:0106120;positive regulation of sterol biosynthetic process;422;2;GO:0045944
GO:0072470;response to cell size control checkpoint signaling;0;0;GO:0045727
GO:0072476;response to mitotic spindle checkpoint signaling;249;0;GO:0007067
GO:0106129;positive regulation of store-operated calcium entry;2;1;GO:0048407
GO:0106128;negative regulation of store-operated calcium entry;2;1;GO:0048407
GO:0072479;response to mitotic cell cycle spindle assembly checkpoint signaling;249;1;GO:0007067
GO:0106126;reservosome membrane;0;0;GO:0005768
GO:0035488;cytosine/thymine mispair binding;1;2;GO:0003676
GO:0106125;reservosome matrix;0;0;GO:0048471
GO:0035489;guanine/guanine mispair binding;0;2;GO:0003676
GO:0106124;reservosome lumen;0;0;GO:0005840
GO:0106123;reservosome;0;4;GO:0005764
GO:0106122;negative regulation of cobalamin metabolic process;0;0;GO:0046395
GO:0060440;trachea formation;318;337;GO:0048513
GO:0060441;epithelial tube branching involved in lung morphogenesis;2165;579;GO:0048706
GO:0060442;branching involved in prostate gland morphogenesis;918;223;GO:0048608
GO:0060443;mammary gland morphogenesis;2984;208;GO:0030900
GO:1903960;negative regulation of anion transmembrane transport;10;10;GO:0045730
GO:1903961;positive regulation of anion transmembrane transport;5;140;GO:0050877
GO:0060448;dichotomous subdivision of terminal units involved in lung branching;143;138;GO:0048704
GO:1901301;regulation of cargo loading into COPII-coated vesicle;117;9;GO:0008023
GO:1903964;monounsaturated fatty acid metabolic process;73;9;GO:0006631
GO:0047469;4-carboxymethyl-4-methylbutenolide mutase activity;0;2;GO:0004067
GO:0060449;bud elongation involved in lung branching;328;48;GO:0048608
GO:1901300;positive regulation of hydrogen peroxide-mediated programmed cell death;60;108;GO:0010941
GO:1903965;monounsaturated fatty acid catabolic process;24;2;GO:0006631
GO:0047468;phosphoglucomutase (glucose-cofactor) activity;1;2;GO:0006031
GO:1901303;negative regulation of cargo loading into COPII-coated vesicle;54;5;GO:0008023
GO:1903962;arachidonate transmembrane transporter activity;0;1;GO:0005515
GO:0047467;4-hydroxyphenylacetaldehyde-oxime isomerase activity;0;0;GO:0006021
GO:1903963;arachidonate transport;23180;44;GO:0006869
GO:0060444;branching involved in mammary gland duct morphogenesis;1502;640;GO:0048608
GO:1901305;negative regulation of spermidine biosynthetic process;0;0;GO:0010468
GO:1903968;cellular response to micafungin;0;0;GO:0071346
GO:0060445;branching involved in salivary gland morphogenesis;1173;1040;GO:0048608
GO:1901304;regulation of spermidine biosynthetic process;54;0;GO:0010401
GO:1903969;regulation of response to macrophage colony-stimulating factor;300;5;GO:0050727
GO:0060446;branching involved in open tracheal system development;866;9;GO:0048704
GO:1901307;positive regulation of spermidine biosynthetic process;54;1;GO:0046356
GO:1903966;monounsaturated fatty acid biosynthetic process;49;62;GO:0006633
GO:0060447;bud outgrowth involved in lung branching;118;75;GO:0048608
GO:1903967;response to micafungin;0;1;GO:0046284
GO:0047473;D-alanine [D-alanyl carrier protein] ligase activity;4558;32;GO:0004867
GO:0047472;3-carboxy-cis,cis-muconate cycloisomerase activity;3123;8;GO:0006032
GO:0047471;maltose alpha-D-glucosyltransferase activity;9434;10;GO:0006029
GO:0106130;purine phosphoribosyltransferase activity;275914;1;GO:0004061
GO:1903959;regulation of monoatomic anion transmembrane transport;24;2;GO:0045730
GO:0047470;(1,4)-alpha-D-glucan 1-alpha-D-glucosylmutase activity;1457;0;GO:0004553
GO:0047476;3-alpha,7-alpha-dihydroxy-5-beta-cholestanate-CoA ligase activity;0;3;GO:0006081
GO:0047475;phenylacetate-CoA ligase activity;35924;9;GO:0006081
GO:0047474;long-chain fatty acid luciferin component ligase activity;5864;6;GO:0004866
GO:0072426;response to G2 DNA damage checkpoint signaling;23;0;GO:0007050
GO:0106139;symbiont cell surface;89;7;GO:0005615
GO:0106138;Sec61 translocon complex binding;52;1;GO:0005581
GO:0072423;response to DNA damage checkpoint signaling;978;152;GO:0007050
GO:0106137;IkappaB kinase complex binding;71;3;GO:0043408
GO:0106136;lectin-induced modified bacterial internalization;1;1;GO:0002576
GO:0072429;response to intra-S DNA damage checkpoint signaling;252;6;GO:0007050
GO:0106135;negative regulation of cardiac muscle cell contraction;49;2;GO:0048407
GO:0106134;positive regulation of cardiac muscle cell contraction;9;2;GO:0048407
GO:0060430;lung saccule development;509;36;GO:0008544
GO:0060431;primary lung bud formation;64;104;GO:0048704
GO:0060432;lung pattern specification process;56;2;GO:0048513
GO:1903971;positive regulation of response to macrophage colony-stimulating factor;111;10;GO:0050727
GO:1903972;regulation of cellular response to macrophage colony-stimulating factor stimulus;300;6;GO:0050727
GO:1903970;negative regulation of response to macrophage colony-stimulating factor;0;10;GO:0050727
GO:0060437;lung growth;302;26;GO:0048513
GO:1903975;regulation of glial cell migration;792;47;GO:0048699
GO:0060438;trachea development;1492;196;GO:0008544
GO:1903976;negative regulation of glial cell migration;247;32;GO:0048771
GO:0047479;trypanothione synthase activity;48;3;GO:0004784
GO:0060439;trachea morphogenesis;819;245;GO:0048513
GO:1901314;regulation of histone H2A K63-linked ubiquitination;0;26;GO:0016567
GO:1903973;negative regulation of cellular response to macrophage colony-stimulating factor stimulus;0;30;GO:0050727
GO:0047478;aspartate-ammonia ligase (ADP-forming) activity;0;3;GO:0006099
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;111;250;GO:0050727
GO:0060433;bronchus development;592;21;GO:0048513
GO:1901316;positive regulation of histone H2A K63-linked ubiquitination;0;0;GO:0045944
GO:1903979;negative regulation of microglial cell activation;324;46;GO:0050729
GO:0060434;bronchus morphogenesis;98;172;GO:0048513
GO:1901315;negative regulation of histone H2A K63-linked ubiquitination;0;153;GO:0016567
GO:0060435;bronchiole development;330;30;GO:0048513
GO:1901318;negative regulation of flagellated sperm motility;182;6;GO:0048193
GO:1903977;positive regulation of glial cell migration;385;59;GO:0048771
GO:0060436;bronchiole morphogenesis;57;4;GO:0048608
GO:1901317;regulation of flagellated sperm motility;1025;9;GO:0048407
GO:1903978;regulation of microglial cell activation;780;264;GO:0050729
GO:0047484;regulation of response to osmotic stress;1804;480;GO:0006970
GO:0106143;tRNA (m7G46) methyltransferase complex;154;1;GO:0005737
GO:0047483;imidazoleacetate-phosphoribosyldiphosphate ligase activity;0;4;GO:0003824
GO:0106142;rRNA (adenine-N1-)-methyltransferase activity;21;0;GO:0003735
GO:0047482;UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-L-lysine ligase activity;3338;4;GO:0005524
GO:0106141;flavin prenyltransferase activity;29691;87;GO:0004067
GO:0047481;D-alanine-alanyl-poly(glycerolphosphate) ligase activity;0;2;GO:0005524
GO:0106140;P-TEFb complex binding;242;3;GO:0045944
GO:0047488;heparin lyase activity;76;1;GO:0004465
GO:0047487;oligogalacturonide lyase activity;1998;5;GO:0004553
GO:0072410;response to meiotic cell cycle checkpoint signaling;1;0;GO:0007067
GO:0072414;response to mitotic cell cycle checkpoint signaling;286;0;GO:0007067
GO:0106149;indole-3-carbonyl nitrile 4-hydroxylase activity;3;2;GO:0004497
GO:0106148;4-hydroxyindole-3- carbonyl nitrile biosynthesis;0;0;GO:0046148
GO:0047480;UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase activity;111093;10;GO:0005524
GO:0106147;fraxetin biosynthesis;4;1;GO:0046395
GO:0106146;sideretin biosynthesis;2;0;GO:0009065
GO:0072417;response to spindle checkpoint signaling;250;1;GO:0007067
GO:0106145;scopoletin 8-hydroxylase activity;6;3;GO:0004497
GO:0106144;fraxetin 5-hydroxylase activity;4;3;GO:0004497
GO:0060462;lung lobe development;321;7;GO:0009952
GO:0060463;lung lobe morphogenesis;320;332;GO:0048704
GO:0060464;lung lobe formation;2;4;GO:0048704
GO:0060465;pharynx development;432;39;GO:0009952
GO:1903982;negative regulation of microvillus length;0;0;GO:0048193
GO:1903983;positive regulation of microvillus length;0;1;GO:0048193
GO:0060460;left lung morphogenesis;65;150;GO:0048513
GO:1901321;positive regulation of heart induction;153;1;GO:0048704
GO:1903980;positive regulation of microglial cell activation;361;58;GO:0050729
GO:0060461;right lung morphogenesis;49;5;GO:0048704
GO:1901320;negative regulation of heart induction;3;0;GO:0048704
GO:1903981;enterobactin binding;119;4;GO:0008152
GO:1901323;response to erythromycin;1;1;GO:0046686
GO:1901322;response to chloramphenicol;4;0;GO:0046686
GO:1901325;response to antimycin A;2;0;GO:0006979
GO:1903984;positive regulation of TRAIL-activated apoptotic signaling pathway;155;43;GO:0046330
GO:0047489;pectate disaccharide-lyase activity;162;3;GO:0004553
GO:1901324;response to trichodermin;0;1;GO:0046686
GO:1903985;regulation of intestinal D-glucose absorption;0;1;GO:0007586
GO:0060466;activation of meiosis involved in egg activation;111;9;GO:0007018
GO:1901327;response to tacrolimus;10;5;GO:0042493
GO:0060467;negative regulation of fertilization;264;9;GO:0048608
GO:1901326;response to tetracycline;0;0;GO:0046686
GO:0060468;prevention of polyspermy;259;13;GO:0007565
GO:1901329;regulation of odontoblast differentiation;117;6;GO:0045944
GO:1903988;iron ion export across plasma membrane;21;1;GO:0006826
GO:1901328;response to cytochalasin B;50;1;GO:0046330
GO:0047495;membrane-oligosaccharide glycerophosphotransferase activity;3;2;GO:0005576
GO:0106154;perithecium formation;0;0;GO:0048305
GO:0047494;serine-phosphoethanolamine synthase activity;0;3;GO:0004723
GO:0106153;phosphorylated histone binding;57;1;GO:0016569
GO:1901319;positive regulation of trehalose catabolic process;20;2;GO:0046274
GO:0047493;ceramide cholinephosphotransferase activity;405;191;GO:0004725
GO:0047492;xanthan lyase activity;333;3;GO:0004553
GO:0106151;CNBH domain intrinsic ligand binding;11;0;GO:0005515
GO:0047499;calcium-independent phospholipase A2 activity;3572;66;GO:0004601
GO:0072444;response to mitotic DNA replication checkpoint signaling;0;0;GO:0007050
GO:0106150;zearalenone biosynthetic process;8;0;GO:0046271
GO:0047498;calcium-dependent phospholipase A2 activity;1162;229;GO:0004601
GO:0047497;mitochondrion transport along microtubule;1207;1230;GO:0048285
GO:0047496;vesicle transport along microtubule;2170;1430;GO:0008029
GO:0072441;response to meiotic DNA replication checkpoint signaling;1;1;GO:0007050
GO:0047491;poly(alpha-L-guluronate) lyase activity;20;1;GO:0004553
GO:0106158;glycero-3-phosphocholine acyltransferase activity;13;4;GO:0008610
GO:0047490;pectin lyase activity;176;9;GO:0004553
GO:0106157;peptidyl-arginine 3-dioxygenase activity;66;2;GO:0004723
GO:0106156;peptidyl-lysine 4-dioxygenase activity;6;3;GO:0004723
GO:0072449;response to G1 cell size control checkpoint signaling;0;0;GO:0045727
GO:0106155;peptidyl-lysine 3-dioxygenase activity;54;4;GO:0004723
GO:0060451;negative regulation of hindgut contraction;0;1;GO:0048704
GO:0060452;positive regulation of cardiac muscle contraction;245;107;GO:0048407
GO:0060453;regulation of gastric acid secretion;159;47;GO:0007596
GO:0060454;positive regulation of gastric acid secretion;0;18;GO:0045944
GO:1901330;negative regulation of odontoblast differentiation;0;0;GO:0045944
GO:1901332;negative regulation of lateral root development;45;8;GO:0048771
GO:0060450;positive regulation of hindgut contraction;8;4;GO:0048704
GO:1901331;positive regulation of odontoblast differentiation;103;5;GO:0045944
GO:0060459;left lung development;105;8;GO:0048513
GO:1901334;lactone metabolic process;48997;1;GO:0006066
GO:1903997;positive regulation of non-membrane spanning protein tyrosine kinase activity;1;53;GO:0046330
GO:1901333;positive regulation of lateral root development;106;3;GO:0048771
GO:1903998;regulation of eating behavior;586;8;GO:0050789
GO:1901336;lactone biosynthetic process;40954;5;GO:0006032
GO:1903995;regulation of non-membrane spanning protein tyrosine kinase activity;4;3;GO:0046330
GO:1901335;lactone catabolic process;4916;0;GO:0006032
GO:1903996;negative regulation of non-membrane spanning protein tyrosine kinase activity;3;1;GO:0046330
GO:0060455;negative regulation of gastric acid secretion;52;194;GO:0045944
GO:1901338;catecholamine binding;2056;47;GO:0005509
GO:0060456;positive regulation of digestive system process;431;10;GO:0050721
GO:1901337;thioester transport;14531;0;GO:0006865
GO:0060457;negative regulation of digestive system process;666;9;GO:0050727
GO:1903999;negative regulation of eating behavior;141;8;GO:0050789
GO:0060458;right lung development;89;8;GO:0048513
GO:1901339;regulation of store-operated calcium channel activity;37;8;GO:0008092
GO:0106165;negative regulation of exonucleolytic catabolism of deadenylated mRNA;0;0;GO:0010467
GO:0106164;positive regulation of exonucleolytic catabolism of deadenylated mRNA;0;1;GO:0010467
GO:0106163;regulation of exonucleolytic catabolism of deadenylated mRNA;0;0;GO:0010467
GO:0106162;mRNA N-acetyltransferase activity;62;1;GO:0006464
GO:0072432;response to G1 DNA damage checkpoint signaling;1;1;GO:0007049
GO:0072435;response to mitotic G2 DNA damage checkpoint signaling;23;2;GO:0007050
GO:0106167;extracellular ATP signaling;98;1;GO:0008521
GO:0072438;response to DNA replication checkpoint signaling;1;0;GO:0007050
GO:0106166;spindle pole body-nuclear membrane anchor activity;19;3;GO:0005576
GO:0106176;clathrin-coated endocytic vesicle lumen;0;1;GO:0005768
GO:0106175;phagolysosome vesicle membrane;0;1;GO:0005764
GO:0106174;phagolysosome vesicle lumen;0;3;GO:0005764
GO:0106173;COPII-coated vesicle lumen;0;1;GO:0005768
GO:0106172;COPI-coated vesicle lumen;0;2;GO:0005829
GO:0106177;cyclic-GMP-AMP hydrolase activity;56;5;GO:0004553
GO:0106186;cytoplasmic side of plasma membrane, cell tip;1;2;GO:0009986
GO:1901381;positive regulation of potassium ion transmembrane transport;3544;1100;GO:0045735
GO:1901380;negative regulation of potassium ion transmembrane transport;694;1010;GO:0045735
GO:1901383;negative regulation of chorionic trophoblast cell proliferation;110;7;GO:0048608
GO:1901382;regulation of chorionic trophoblast cell proliferation;210;9;GO:0048608
GO:1901385;regulation of voltage-gated calcium channel activity;127;1180;GO:0048407
GO:1901384;positive regulation of chorionic trophoblast cell proliferation;1;2;GO:0048608
GO:1901387;positive regulation of voltage-gated calcium channel activity;49;139;GO:0048407
GO:1901386;negative regulation of voltage-gated calcium channel activity;60;473;GO:0048407
GO:1901389;negative regulation of transforming growth factor beta activation;44;17;GO:0030518
GO:1901388;regulation of transforming growth factor beta activation;555;49;GO:0030516
GO:1901392;regulation of transforming growth factor beta1 activation;56;0;GO:0030516
GO:1901394;positive regulation of transforming growth factor beta1 activation;56;3;GO:0030516
GO:1901393;negative regulation of transforming growth factor beta1 activation;0;0;GO:0030518
GO:1901396;negative regulation of transforming growth factor beta2 activation;0;0;GO:0030518
GO:1901395;regulation of transforming growth factor beta2 activation;1;1;GO:0030516
GO:1901398;regulation of transforming growth factor beta3 activation;52;1;GO:0030516
GO:1901397;positive regulation of transforming growth factor beta2 activation;1;0;GO:0030516
GO:1901399;negative regulation of transforming growth factor beta3 activation;0;1;GO:0048010
GO:0072495;host cell Cajal body;0;0;GO:0005819
GO:0072494;host multivesicular body;1938;2;GO:0005768
GO:0072493;host cell endosome lumen;1;1;GO:0005768
GO:0072492;host cell mitochondrial intermembrane space;0;1;GO:0005743
GO:0072499;photoreceptor cell axon guidance;319;226;GO:0048608
GO:0072498;embryonic skeletal joint development;1144;82;GO:0002040
GO:0072497;mesenchymal stem cell differentiation;672;92;GO:0030182
GO:0072496;Pup transferase activity;0;1;GO:0004497
GO:1901390;positive regulation of transforming growth factor beta activation;112;5;GO:0030516
GO:0035440;tuberculosinol biosynthetic process;2;2;GO:0046395
GO:0035441;cell migration involved in vasculogenesis;63;34;GO:0048008
GO:0035442;dipeptide transmembrane transport;31270;9;GO:0008544
GO:0035443;tripeptide transmembrane transport;18;5;GO:0008565
GO:0047426;ricinine nitrilase activity;0;2;GO:0004730
GO:0060404;axonemal microtubule depolymerization;49;6;GO:0008030
GO:1903920;positive regulation of actin filament severing;2;1;GO:0048193
GO:0047425;1-pyrroline-4-hydroxy-2-carboxylate deaminase activity;97;4;GO:0006066
GO:0060405;regulation of penile erection;100;111;GO:0030520
GO:1903921;regulation of protein processing in phagocytic vesicle;117;7;GO:0006955
GO:0047424;methylenediurea deaminase activity;0;4;GO:0004466
GO:0060406;positive regulation of penile erection;46;36;GO:0050729
GO:0047423;N-methylhydantoinase (ATP-hydrolyzing) activity;1518;3;GO:0004721
GO:0060407;negative regulation of penile erection;48;8;GO:0050729
GO:0060400;negative regulation of growth hormone receptor signaling pathway;127;6;GO:0030518
GO:1903924;estradiol binding;148;2;GO:0005515
GO:0047429;nucleoside triphosphate diphosphatase activity;636496;745;GO:0008528
GO:1903925;response to bisphenol A;142;6;GO:0046686
GO:0047428;arylacetonitrilase activity;19;3;GO:0004067
GO:0060402;calcium ion transport into cytosol;817;518;GO:0006836
GO:1903922;negative regulation of protein processing in phagocytic vesicle;0;2;GO:0006915
GO:0047427;cyanoalanine nitrilase activity;562;13;GO:0006067
GO:1903923;positive regulation of protein processing in phagocytic vesicle;117;253;GO:0048193
GO:1903917;positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation;39;4;GO:0010401
GO:1903918;regulation of actin filament severing;121;8;GO:0048193
GO:1903915;positive regulation of fusion of virus membrane with host plasma membrane;0;4;GO:0048193
GO:1903916;regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation;39;1;GO:0006986
GO:0047433;branched-chain-2-oxoacid decarboxylase activity;84;7;GO:0006066
GO:0060408;regulation of acetylcholine metabolic process;53;4;GO:0032787
GO:0047432;2,2-dialkylglycine decarboxylase (pyruvate) activity;329;2;GO:0006099
GO:0060409;positive regulation of acetylcholine metabolic process;2;3;GO:0048608
GO:0047431;3-hydroxy-2-methylpyridine-4,5-dicarboxylate 4-decarboxylase activity;7;3;GO:0006073
GO:1903919;negative regulation of actin filament severing;119;17;GO:0048193
GO:0047430;oligosaccharide-diphosphodolichol diphosphatase activity;0;5;GO:0005576
GO:0035437;maintenance of protein localization in endoplasmic reticulum;9669;1270;GO:0006464
GO:0035438;cyclic-di-GMP binding;96650;369;GO:0042773
GO:0035439;halimadienyl-diphosphate synthase activity;9;3;GO:0004497
GO:0035433;acetate transmembrane transport;5356;3;GO:0006810
GO:0035434;copper ion transmembrane transport;54237;414;GO:0006811
GO:0035435;phosphate ion transmembrane transport;162961;1000;GO:0006814
GO:0035436;triose phosphate transmembrane transport;455;173;GO:0006869
GO:0035430;regulation of gluconate transmembrane transport;3;3;GO:0006826
GO:0035431;negative regulation of gluconate transmembrane transport;0;3;GO:0045765
GO:0035432;positive regulation of gluconate transmembrane transport;3;3;GO:0045765
GO:0047437;4-oxalocrotonate decarboxylase activity;576;6;GO:0006073
GO:1903931;positive regulation of pyrimidine-containing compound salvage;7;0;GO:0009063
GO:0047436;arylmalonate decarboxylase activity;268;3;GO:0006081
GO:1903932;regulation of DNA primase activity;3;1;GO:0005524
GO:1903625;negative regulation of DNA catabolic process;178;4;GO:0042770
GO:1903626;positive regulation of DNA catabolic process;110;7;GO:0045944
GO:0050531;mannosyl-3-phosphoglycerate phosphatase activity;5521;6;GO:0006032
GO:0050532;2-phosphosulfolactate phosphatase activity;25534;8;GO:0004723
GO:1903618;regulation of transdifferentiation;10;1;GO:0045595
GO:0050530;glucosylglycerol 3-phosphatase activity;399;4;GO:0006081
GO:1903619;negative regulation of transdifferentiation;0;1;GO:0048704
GO:0050539;maleimide hydrolase activity;52;3;GO:0004553
GO:0050537;mandelamide amidase activity;274;4;GO:0046271
GO:0050538;N-carbamoyl-L-amino-acid hydrolase activity;2267;4;GO:0004721
GO:0050535;beta-primeverosidase activity;7;4;GO:0004553
GO:0050536;(S)-N-acetyl-1-phenylethylamine hydrolase activity;0;0;GO:0004497
GO:0050533;5-phytase activity;0;3;GO:0004553
GO:0050534;3-deoxyoctulosonase activity;0;2;GO:0006032
GO:1903630;regulation of aminoacyl-tRNA ligase activity;0;5;GO:0006412
GO:1903634;negative regulation of leucine-tRNA ligase activity;0;0;GO:0006412
GO:1903638;positive regulation of protein insertion into mitochondrial outer membrane;34;1;GO:0048285
GO:1903639;regulation of gastrin-induced gastric acid secretion;16;1;GO:0048608
GO:1903636;regulation of protein insertion into mitochondrial outer membrane;35;3;GO:0006626
GO:1903637;negative regulation of protein insertion into mitochondrial outer membrane;1;1;GO:0006941
GO:0050542;icosanoid binding;285;250;GO:0042632
GO:0050543;icosatetraenoic acid binding;209;37;GO:0042379
GO:0050540;2-aminomuconate deaminase activity;410;3;GO:0006032
GO:1903629;positive regulation of dUTP diphosphatase activity;0;2;GO:0010401
GO:0050541;beta,beta-carotene-9',10'-dioxygenase activity;0;0;GO:0004497
GO:0050548;trans-feruloyl-CoA hydratase activity;509;4;GO:0006081
GO:0050549;cyclohexyl-isocyanide hydratase activity;691;4;GO:0006067
GO:0050546;4-hydroxyphenylpyruvate decarboxylase activity;3;3;GO:0006099
GO:0050547;vanillin synthase activity;68;3;GO:0004497
GO:0050544;arachidonic acid binding;207;469;GO:0005506
GO:0050545;sulfopyruvate decarboxylase activity;1263;3;GO:0006099
GO:1901062;guaiacyl lignin catabolic process;0;1;GO:0046274
GO:1901061;guaiacyl lignin metabolic process;0;0;GO:0006073
GO:1901064;syringal lignin metabolic process;14;0;GO:0006073
GO:1901063;guaiacyl lignin biosynthetic process;0;2;GO:0009809
GO:1901066;syringal lignin biosynthetic process;14;2;GO:0009699
GO:1901065;syringal lignin catabolic process;0;1;GO:0046274
GO:1901068;guanosine-containing compound metabolic process;178;359;GO:0006790
GO:1901067;ferulate catabolic process;1;0;GO:0009813
GO:1901069;guanosine-containing compound catabolic process;54;80;GO:0009062
GO:0098582;innate vocalization behavior;10;100;GO:0050890
GO:0098583;learned vocalization behavior;100;5;GO:0007611
GO:0098581;detection of external biotic stimulus;1652;987;GO:0009593
GO:0098575;lumenal side of lysosomal membrane;2;10;GO:0005764
GO:0098576;lumenal side of membrane;14876;57;GO:0009986
GO:0098574;cytoplasmic side of lysosomal membrane;303;82;GO:0005764
GO:0098579;active sex chromosome;0;0;GO:0048608
GO:0098577;inactive sex chromosome;116;6;GO:0048608
GO:0098578;condensed chromatin of inactivated sex chromosome;0;0;GO:0048608
GO:1901060;p-hydroxyphenyl lignin biosynthetic process;0;2;GO:0046395
GO:1901073;glucosamine-containing compound biosynthetic process;13430;9;GO:0006030
GO:1901072;glucosamine-containing compound catabolic process;42414;197;GO:0006073
GO:1901075;negative regulation of engulfment of apoptotic cell;25;1;GO:0048661
GO:1901074;regulation of engulfment of apoptotic cell;203;119;GO:0048471
GO:1901077;regulation of relaxation of muscle;541;505;GO:0048407
GO:1901076;positive regulation of engulfment of apoptotic cell;131;20;GO:0048661
GO:1901079;positive regulation of relaxation of muscle;70;5;GO:0048407
GO:1901078;negative regulation of relaxation of muscle;312;28;GO:0048407
GO:0098590;plasma membrane region;851550;737;GO:0005886
GO:0098593;goblet cell theca;0;0;GO:0005576
GO:0098594;mucin granule;121;2;GO:0005576
GO:0098591;external side of apical plasma membrane;82;8;GO:0009986
GO:0098592;cytoplasmic side of apical plasma membrane;244;45;GO:0009986
GO:0098586;cellular response to virus;6119;1170;GO:0043207
GO:0098584;host cell synaptic vesicle;0;0;GO:0008092
GO:0098585;host cell synaptic vesicle membrane;0;1;GO:0008092
GO:0098588;bounding membrane of organelle;2608657;675;GO:0005789
GO:1901071;glucosamine-containing compound metabolic process;132215;244;GO:0006073
GO:1901070;guanosine-containing compound biosynthetic process;2;364;GO:0009061
GO:1901083;pyrrolizidine alkaloid metabolic process;0;1;GO:0006749
GO:1901086;benzylpenicillin metabolic process;2;1;GO:0009060
GO:1901085;pyrrolizidine alkaloid biosynthetic process;0;0;GO:0046148
GO:1901088;benzylpenicillin biosynthetic process;0;0;GO:0009405
GO:1901087;benzylpenicillin catabolic process;0;0;GO:0009065
GO:1901089;acetate ester metabolic process involved in fermentation;6;2;GO:0046394
GO:0098560;cytoplasmic side of late endosome membrane;171;9;GO:0005768
GO:0098561;methyl accepting chemotaxis protein complex;12;8;GO:0005975
GO:0098553;lumenal side of endoplasmic reticulum membrane;14544;280;GO:0005789
GO:0098554;cytoplasmic side of endoplasmic reticulum membrane;1036;84;GO:0005789
GO:0098551;lumenal side of late endosome membrane;0;1;GO:0005768
GO:0098552;side of membrane;194317;967;GO:0016021
GO:0098557;cytoplasmic side of smooth endoplasmic reticulum membrane;0;0;GO:0005789
GO:0098558;lumenal side of smooth endoplasmic reticulum membrane;0;1;GO:0005789
GO:0098555;lumenal side of rough endoplasmic reticulum membrane;0;1;GO:0005789
GO:0098556;cytoplasmic side of rough endoplasmic reticulum membrane;127;9;GO:0005789
GO:0098559;cytoplasmic side of early endosome membrane;207;218;GO:0005768
GO:1901080;regulation of relaxation of smooth muscle;131;1;GO:0050729
GO:1901082;positive regulation of relaxation of smooth muscle;19;1;GO:0048010
GO:1901081;negative regulation of relaxation of smooth muscle;112;0;GO:0048010
GO:1901095;positive regulation of protein homotetramerization;0;3;GO:0048193
GO:1901094;negative regulation of protein homotetramerization;0;34;GO:0048193
GO:1901097;negative regulation of autophagosome maturation;347;27;GO:0048471
GO:1901096;regulation of autophagosome maturation;1165;41;GO:0048471
GO:1901099;negative regulation of signal transduction in absence of ligand;1287;43;GO:0030528
GO:1901098;positive regulation of autophagosome maturation;408;45;GO:0048471
GO:0098571;lumenal side of plastid thylakoid membrane;0;1;GO:0009941
GO:0098572;stromal side of plastid thylakoid membrane;111;3;GO:0009986
GO:0098570;stromal side of plastid inner membrane;0;1;GO:0009579
GO:0098564;trans-Golgi network transport vesicle lumen;0;2;GO:0005829
GO:0098565;lumenal side of endosome membrane;0;0;GO:0005768
GO:0098562;cytoplasmic side of membrane;80531;143;GO:0005737
GO:0098568;external side of mycolate outer membrane;0;0;GO:0009579
GO:0098569;internal side of mycolate outer membrane;0;1;GO:0008629
GO:0098566;transport vesicle lumen;0;1;GO:0005768
GO:0098567;periplasmic side of plasma membrane;39;65;GO:0009986
GO:1901091;negative regulation of protein tetramerization;0;38;GO:0048193
GO:1901090;regulation of protein tetramerization;0;8;GO:0048193
GO:1901093;regulation of protein homotetramerization;0;16;GO:0048285
GO:1901092;positive regulation of protein tetramerization;0;2;GO:0048193
GO:1903681;regulation of epithelial cell-cell adhesion involved in epithelium migration;3;2;GO:0022610
GO:1903682;negative regulation of epithelial cell-cell adhesion involved in epithelium migration;0;2;GO:0048193
GO:1901020;negative regulation of calcium ion transmembrane transporter activity;128;220;GO:0006836
GO:1903680;acinar cell of sebaceous gland differentiation;0;1;GO:0008544
GO:1901022;4-hydroxyphenylacetate metabolic process;7198;1;GO:0006081
GO:1901021;positive regulation of calcium ion transmembrane transporter activity;133;495;GO:0006811
GO:1901024;4-hydroxyphenylacetate biosynthetic process;0;0;GO:0006096
GO:1903683;positive regulation of epithelial cell-cell adhesion involved in epithelium migration;3;2;GO:0048608
GO:1901023;4-hydroxyphenylacetate catabolic process;7198;10;GO:0046395
GO:1903684;regulation of border follicle cell migration;528;1;GO:0048285
GO:1901026;ripoptosome assembly involved in necroptotic process;94;14;GO:1903047
GO:1903689;regulation of wound healing, spreading of epidermal cells;329;77;GO:0048407
GO:1901025;ripoptosome assembly involved in extrinsic apoptotic signaling pathway;0;1;GO:0008631
GO:1901028;regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;1446;157;GO:0043066
GO:1903687;negative regulation of border follicle cell migration;10;0;GO:0048285
GO:1901027;dextrin catabolic process;45;3;GO:0006032
GO:1903688;positive regulation of border follicle cell migration;512;2;GO:0048285
GO:1901029;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;969;63;GO:0048193
GO:0050597;taxane 10-beta-hydroxylase activity;3;5;GO:0006096
GO:0098531;ligand-activated transcription factor activity;40259;196;GO:0003700
GO:0050598;taxane 13-alpha-hydroxylase activity;4;6;GO:0004073
GO:0098532;histone H3-K27 trimethylation;46;271;GO:0045944
GO:0050595;7-deoxyloganin 7-hydroxylase activity;2;2;GO:0004497
GO:0050596;vinorine hydroxylase activity;0;3;GO:0046395
GO:0098530;positive regulation of strand invasion;52;6;GO:0048285
GO:0050593;N-methylcoclaurine 3'-monooxygenase activity;10;0;GO:0004497
GO:0098535;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation;193;8;GO:0048608
GO:0050594;tabersonine 16-hydroxylase activity;9;3;GO:0004497
GO:0098536;deuterosome;334;38;GO:0005730
GO:0050591;quinine 3-monooxygenase activity;2;67;GO:0004497
GO:0098533;ATPase dependent transmembrane transport complex;1182267;41;GO:0048471
GO:0050592;4-hydroxyphenylacetaldehyde oxime monooxygenase activity;14;7;GO:0004497
GO:0098534;centriole assembly;10040;705;GO:0005819
GO:0098539;cytoplasmic side of transport vesicle membrane;61;0;GO:0005737
GO:0098538;lumenal side of transport vesicle membrane;0;0;GO:0005737
GO:0050599;deacetoxycephalosporin-C synthase activity;25;3;GO:0004497
GO:1903692;methionine import across plasma membrane;30;3;GO:0006865
GO:1901031;regulation of response to reactive oxygen species;5003;108;GO:0046686
GO:1903690;negative regulation of wound healing, spreading of epidermal cells;107;247;GO:0048407
GO:1901030;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;366;131;GO:0010941
GO:1903691;positive regulation of wound healing, spreading of epidermal cells;222;52;GO:0048407
GO:1901033;positive regulation of response to reactive oxygen species;2;4;GO:0046686
GO:1903696;protein localization to horsetail-astral microtubule array;0;0;GO:0005737
GO:1901032;negative regulation of response to reactive oxygen species;17;21;GO:0042744
GO:1903697;negative regulation of microvillus assembly;48;29;GO:0048193
GO:1901035;negative regulation of L-glutamine import across plasma membrane;0;2;GO:0046395
GO:1901034;regulation of L-glutamine import across plasma membrane;8;0;GO:0006874
GO:1901036;positive regulation of L-glutamine import across plasma membrane;8;2;GO:0046395
GO:1901039;regulation of peptide antigen transport;0;0;GO:0006955
GO:1903698;positive regulation of microvillus assembly;0;0;GO:0048193
GO:1901038;cyanidin 3-O-glucoside metabolic process;8;2;GO:0005975
GO:1903699;tarsal gland development;53;1;GO:0008544
GO:0098550;lumenal side of early endosome membrane;0;1;GO:0009986
GO:0098542;defense response to other organism;1023347;1850;GO:0050832
GO:0098543;detection of other organism;851;9;GO:0009579
GO:0098540;lumenal side of trans-Golgi network transport vesicle membrane;0;0;GO:0005764
GO:0098541;cytoplasmic side of trans-Golgi network transport vesicle membrane;61;0;GO:0005764
GO:0098547;lumenal side of Golgi membrane;2;2;GO:0005764
GO:0098544;maintenance of protein complex location;0;0;GO:0048471
GO:0098545;maintenance of protein complex location in cytoplasm;0;1;GO:0048471
GO:0098548;cytoplasmic side of Golgi membrane;134;3;GO:0005764
GO:0098549;somatic ring canal;75;7;GO:0048706
GO:1901040;negative regulation of peptide antigen transport;0;0;GO:0048193
GO:1901041;positive regulation of peptide antigen transport;0;0;GO:0048193
GO:1901046;positive regulation of egg-laying behavior;155;2;GO:0048608
GO:1901045;negative regulation of egg-laying behavior;22;1;GO:0048608
GO:0098510;sensory perception of high humidity;0;0;GO:0007600
GO:0098513;detection of humidity;0;0;GO:0009410
GO:0098514;detection of high humidity stimulus involved in sensory perception;0;0;GO:0009414
GO:0098511;sensory perception of low humidity;0;0;GO:0007600
GO:0098512;detection of humidity stimulus involved in sensory perception;0;0;GO:0009414
GO:0098517;detection of low humidity;0;0;GO:0009415
GO:0098515;detection of low humidity stimulus involved in sensory perception;0;0;GO:0009414
GO:0098516;detection of high humidity;0;0;GO:0009415
GO:1901051;atropine biosynthetic process;0;0;GO:0009065
GO:1901053;sarcosine catabolic process;2673;49;GO:0006559
GO:1901052;sarcosine metabolic process;2722;7;GO:0006066
GO:1901055;trimethylenediamine metabolic process;0;3;GO:0006559
GO:1901054;sarcosine biosynthetic process;12;1;GO:0009061
GO:1901057;trimethylenediamine biosynthetic process;0;0;GO:0006559
GO:1901056;trimethylenediamine catabolic process;0;0;GO:0006559
GO:1901059;p-hydroxyphenyl lignin catabolic process;0;1;GO:0046395
GO:1901058;p-hydroxyphenyl lignin metabolic process;0;0;GO:0046148
GO:0098520;excitatory neuromuscular junction;0;5;GO:0008092
GO:0098521;inhibitory neuromuscular junction;0;5;GO:0008092
GO:0098524;neuromuscular junction of somatic muscle myotube;0;1;GO:0008092
GO:0098525;excitatory neuromuscular junction of somatic myotube;0;1;GO:0008092
GO:0098522;neuromuscular junction of skeletal muscle fiber;0;6;GO:0008092
GO:0098523;neuromuscular junction of myotube;0;4;GO:0008092
GO:0098528;skeletal muscle fiber differentiation;337;10;GO:0048675
GO:0098529;neuromuscular junction development, skeletal muscle fiber;124;3;GO:0007517
GO:0098526;inhibitory neuromuscular junction of somatic myotube;0;1;GO:0008092
GO:0098527;neuromuscular junction of somatic muscle;23;4;GO:0008092
GO:0001501;skeletal system development;65113;8640;GO:0001501
GO:0001502;cartilage condensation;928;890;GO:0048609
GO:0001503;ossification;38168;5030;GO:0007538
GO:0001504;neurotransmitter uptake;5326;1140;GO:0006836
GO:0001507;acetylcholine catabolic process in synaptic cleft;350;30;GO:0006836
GO:0001508;action potential;13723;1780;GO:0007631
GO:0001510;RNA methylation;3516770;2050;GO:0032555
GO:0001512;dihydronicotinamide riboside quinone reductase activity;86;110;GO:0004067
GO:0001514;selenocysteine incorporation;42036;345;GO:0006417
GO:0001515;opioid peptide activity;799;73;GO:0004930
GO:0001516;prostaglandin biosynthetic process;9591;1320;GO:0009791
GO:0001517;N-acetylglucosamine 6-O-sulfotransferase activity;373;84;GO:0004723
GO:0001518;voltage-gated sodium channel complex;32199;1390;GO:0005244
GO:0001519;peptide amidation;66;47;GO:0006464
GO:0001550;ovarian cumulus expansion;156;61;GO:0048608
GO:0001551;ovarian follicle endowment;0;3;GO:0007518
GO:0001552;ovarian follicle atresia;69;18;GO:0048608
GO:0001542;ovulation from ovarian follicle;339;435;GO:0008544
GO:0001543;ovarian follicle rupture;50;39;GO:0048507
GO:0001544;initiation of primordial ovarian follicle growth;105;136;GO:0048608
GO:0001545;primary ovarian follicle growth;65;53;GO:0048608
GO:0001546;preantral ovarian follicle growth;94;39;GO:0048608
GO:0001547;antral ovarian follicle growth;576;39;GO:0048608
GO:0001548;follicular fluid formation in ovarian follicle antrum;0;3;GO:0048608
GO:0001549;cumulus cell differentiation;99;8;GO:0030199
GO:0001560;regulation of cell growth by extracellular stimulus;155;51;GO:0048608
GO:0001561;fatty acid alpha-oxidation;4759;251;GO:0006635
GO:0001562;response to protozoan;1166;1040;GO:0050832
GO:0001563;detection of protozoan;0;2;GO:0050877
GO:0001553;luteinization;609;295;GO:0007548
GO:2000407;regulation of T cell extravasation;234;4;GO:0002696
GO:0001554;luteolysis;128;94;GO:0009583
GO:2000406;positive regulation of T cell migration;1882;1060;GO:0050900
GO:0001555;oocyte growth;243;90;GO:0048608
GO:2000405;negative regulation of T cell migration;240;324;GO:0050900
GO:0001556;oocyte maturation;2260;775;GO:0007530
GO:2000404;regulation of T cell migration;2848;2920;GO:0050900
GO:0001558;regulation of cell growth;30162;4920;GO:0042127
GO:2000409;positive regulation of T cell extravasation;146;8;GO:0050900
GO:2000408;negative regulation of T cell extravasation;37;3;GO:0048011
GO:2000403;positive regulation of lymphocyte migration;2838;349;GO:0050900
GO:2000402;negative regulation of lymphocyte migration;626;46;GO:0050900
GO:2000401;regulation of lymphocyte migration;4806;235;GO:0050900
GO:2000400;positive regulation of thymocyte aggregation;0;10;GO:0048364
GO:0001530;lipopolysaccharide binding;13929;1280;GO:0042592
GO:0001520;outer dense fiber;307;106;GO:0015629
GO:2000418;positive regulation of eosinophil migration;143;34;GO:0050900
GO:2000417;negative regulation of eosinophil migration;105;23;GO:0050900
GO:0001522;pseudouridine synthesis;904771;3830;GO:0006519
GO:2000416;regulation of eosinophil migration;248;6;GO:0050900
GO:0001523;retinoid metabolic process;15166;1500;GO:0006765
GO:2000415;positive regulation of fibronectin-dependent thymocyte migration;44;9;GO:0048608
GO:0001525;angiogenesis;60107;15000;GO:0001525
GO:0001527;microfibril;4448;544;GO:0005578
GO:2000419;regulation of eosinophil extravasation;81;4;GO:0050729
GO:2000410;regulation of thymocyte migration;166;8;GO:0050900
GO:2000414;negative regulation of fibronectin-dependent thymocyte migration;0;0;GO:0048308
GO:2000413;regulation of fibronectin-dependent thymocyte migration;44;1;GO:0048608
GO:2000412;positive regulation of thymocyte migration;108;14;GO:0050900
GO:2000411;negative regulation of thymocyte migration;0;0;GO:0048703
GO:0050508;glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;1536;44;GO:0006029
GO:0050509;N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity;1457;63;GO:0004553
GO:0001540;amyloid-beta binding;15155;737;GO:0005576
GO:0001541;ovarian follicle development;5087;2070;GO:0008544
GO:0001531;interleukin-21 receptor binding;0;3;GO:0005125
GO:2000429;negative regulation of neutrophil aggregation;1;1;GO:0050729
GO:0001532;interleukin-21 receptor activity;1;7;GO:0004872
GO:2000428;regulation of neutrophil aggregation;1;1;GO:0050921
GO:0001533;cornified envelope;2410;1390;GO:0005576
GO:2000427;positive regulation of apoptotic cell clearance;263;176;GO:0043066
GO:0001534;radial spoke;3330;38;GO:0005576
GO:2000426;negative regulation of apoptotic cell clearance;46;76;GO:0043066
GO:0001535;radial spoke head;302;4;GO:0005576
GO:0001536;radial spoke stalk;17;5;GO:0009986
GO:0001537;N-acetylgalactosamine 4-O-sulfotransferase activity;350;52;GO:0004734
GO:0001539;cilium or flagellum-dependent cell motility;527817;2090;GO:0006928
GO:0050506;vomilenine glucosyltransferase activity;3;3;GO:0006073
GO:2000421;positive regulation of eosinophil extravasation;0;1;GO:0050729
GO:0050507;indoxyl-UDPG glucosyltransferase activity;0;3;GO:0006073
GO:2000420;negative regulation of eosinophil extravasation;81;8;GO:0050729
GO:0050504;mannosyl-3-phosphoglycerate synthase activity;627;7;GO:0006021
GO:0050505;hydroquinone glucosyltransferase activity;89;2;GO:0006073
GO:0050502;cis-zeatin O-beta-D-glucosyltransferase activity;26;94;GO:0004553
GO:2000425;regulation of apoptotic cell clearance;465;412;GO:0043066
GO:0050503;trehalose 6-phosphate phosphorylase activity;88;3;GO:0006032
GO:2000424;positive regulation of eosinophil chemotaxis;65;10;GO:0050900
GO:0050500;1,3-beta-galactosyl-N-acetylhexosamine phosphorylase activity;572;5;GO:0006022
GO:2000423;negative regulation of eosinophil chemotaxis;0;0;GO:0050900
GO:0050501;hyaluronan synthase activity;2852;95;GO:0005578
GO:2000422;regulation of eosinophil chemotaxis;65;1;GO:0050900
GO:0001591;dopamine neurotransmitter receptor activity, coupled via Gi/Go;456;70;GO:0004872
GO:0001594;trace-amine receptor activity;3482;85;GO:0004930
GO:0001595;angiotensin receptor activity;3283;10;GO:0004930
GO:0001596;angiotensin type I receptor activity;907;138;GO:0004930
GO:0001586;Gi/o-coupled serotonin receptor activity;2;3;GO:0004930
GO:0001587;Gq/11-coupled serotonin receptor activity;186;26;GO:0004930
GO:2000439;positive regulation of monocyte extravasation;95;49;GO:0050729
GO:0001588;dopamine neurotransmitter receptor activity, coupled via Gs;199;59;GO:0004867
GO:2000438;negative regulation of monocyte extravasation;50;6;GO:0050729
GO:2000437;regulation of monocyte extravasation;145;6;GO:0002696
GO:2000432;negative regulation of cytokinesis, actomyosin contractile ring assembly;32;0;GO:0048285
GO:2000431;regulation of cytokinesis, actomyosin contractile ring assembly;3004;2;GO:0048285
GO:2000430;positive regulation of neutrophil aggregation;0;1;GO:0050729
GO:2000436;positive regulation of protein neddylation;324;8;GO:0045944
GO:2000435;negative regulation of protein neddylation;178;35;GO:0046330
GO:2000434;regulation of protein neddylation;862;30;GO:0045944
GO:2000433;positive regulation of cytokinesis, actomyosin contractile ring assembly;127;2;GO:0048285
GO:2000450;negative regulation of CD8-positive, alpha-beta T cell extravasation;0;0;GO:0048247
GO:2000449;regulation of CD8-positive, alpha-beta T cell extravasation;156;4;GO:0002687
GO:2000448;positive regulation of macrophage migration inhibitory factor signaling pathway;114;7;GO:0050921
GO:2000443;regulation of toll-like receptor 21 signaling pathway;0;0;GO:1901362
GO:2000442;positive regulation of toll-like receptor 15 signaling pathway;0;0;GO:0046649
GO:2000441;negative regulation of toll-like receptor 15 signaling pathway;0;0;GO:0046649
GO:2000440;regulation of toll-like receptor 15 signaling pathway;0;0;GO:1903047
GO:2000447;negative regulation of macrophage migration inhibitory factor signaling pathway;0;0;GO:0050727
GO:2000446;regulation of macrophage migration inhibitory factor signaling pathway;166;6;GO:0050729
GO:2000445;positive regulation of toll-like receptor 21 signaling pathway;0;0;GO:0046649
GO:2000444;negative regulation of toll-like receptor 21 signaling pathway;0;0;GO:1901362
GO:0001570;vasculogenesis;5583;2700;GO:0001525
GO:0001571;non-tyrosine kinase fibroblast growth factor receptor activity;1;2;GO:0008083
GO:0001572;lactosylceramide biosynthetic process;119;7;GO:0006631
GO:0001573;ganglioside metabolic process;3766;410;GO:0006030
GO:0001574;ganglioside biosynthetic process;977;935;GO:0006030
GO:0001565;phorbol ester receptor activity;36;9;GO:0004930
GO:0001566;non-kinase phorbol ester receptor activity;2;10;GO:0004872
GO:0001567;cholesterol 25-hydroxylase activity;107;10;GO:0004076
GO:2000459;negative regulation of astrocyte chemotaxis;0;1;GO:0048169
GO:0001568;blood vessel development;86809;6080;GO:0001944
GO:0001569;branching involved in blood vessel morphogenesis;2082;497;GO:0001944
GO:2000454;positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation;67;9;GO:0048011
GO:2000453;negative regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation;0;0;GO:0048247
GO:2000452;regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation;118;18;GO:0002687
GO:2000451;positive regulation of CD8-positive, alpha-beta T cell extravasation;105;8;GO:0048011
GO:2000458;regulation of astrocyte chemotaxis;107;78;GO:0050921
GO:2000457;positive regulation of T-helper 17 cell extravasation;0;0;GO:0046649
GO:2000456;negative regulation of T-helper 17 cell extravasation;0;0;GO:0046649
GO:2000455;regulation of T-helper 17 cell extravasation;0;0;GO:0050900
GO:2000472;negative regulation of hematopoietic stem cell migration;37;1;GO:0045766
GO:2000471;regulation of hematopoietic stem cell migration;198;8;GO:0045765
GO:2000470;positive regulation of peroxidase activity;4;83;GO:0046329
GO:0001580;detection of chemical stimulus involved in sensory perception of bitter taste;2316;647;GO:0009593
GO:0001581;detection of chemical stimulus involved in sensory perception of sour taste;122;68;GO:0009410
GO:0001582;detection of chemical stimulus involved in sensory perception of sweet taste;4124;19;GO:0009410
GO:0001583;detection of chemical stimulus involved in sensory perception of salty taste;11;2;GO:0009410
GO:0001575;globoside metabolic process;111;197;GO:0006021
GO:0001576;globoside biosynthetic process;109;5;GO:0006021
GO:0001578;microtubule bundle formation;27688;1500;GO:0048471
GO:0001579;medium-chain fatty acid transport;179;53;GO:0006869
GO:2000465;regulation of glycogen (starch) synthase activity;25;22;GO:0005976
GO:2000464;positive regulation of astrocyte chemotaxis;44;8;GO:0045765
GO:2000463;positive regulation of excitatory postsynaptic potential;769;409;GO:0048167
GO:2000469;negative regulation of peroxidase activity;3;4;GO:0046209
GO:2000468;regulation of peroxidase activity;8;5;GO:0046329
GO:2000467;positive regulation of glycogen (starch) synthase activity;15;32;GO:0010467
GO:2000466;negative regulation of glycogen (starch) synthase activity;9;7;GO:0010467
GO:0035044;sperm aster formation;41;9;GO:0048608
GO:0035045;sperm plasma membrane disassembly;28;5;GO:0009986
GO:0060001;minus-end directed microfilament motor activity;2;8;GO:0003774
GO:0035046;pronuclear migration;126;210;GO:0006929
GO:0060002;plus-end directed microfilament motor activity;142;107;GO:0003774
GO:0035047;centrosomal and pronuclear rotation;13;4;GO:0007049
GO:0060003;copper ion export;163;25;GO:0006810
GO:0035040;sperm nuclear envelope removal;0;2;GO:0008325
GO:1903520;negative regulation of mammary gland involution;0;0;GO:0048608
GO:2000241;regulation of reproductive process;42328;665;GO:0048608
GO:0035041;sperm DNA decondensation;103;1;GO:0007049
GO:1903521;positive regulation of mammary gland involution;3;8;GO:0048608
GO:2000240;positive regulation of tRNA export from nucleus;0;1;GO:0010467
GO:0035043;male pronuclear envelope synthesis;0;2;GO:0005737
GO:0060008;Sertoli cell differentiation;841;75;GO:0007267
GO:1903524;positive regulation of blood circulation;2747;62;GO:0010717
GO:0047029;(R)-4-hydroxyphenyllactate dehydrogenase (NADPH) activity;3;0;GO:0004073
GO:0060009;Sertoli cell development;469;321;GO:0007267
GO:1903525;regulation of membrane tubulation;289;8;GO:0048193
GO:0047028;6-pyruvoyltetrahydropterin 2'-reductase activity;4;0;GO:0004073
GO:1903522;regulation of blood circulation;32797;584;GO:0010717
GO:0047027;benzyl-2-methyl-hydroxybutyrate dehydrogenase activity;0;4;GO:0004067
GO:1903523;negative regulation of blood circulation;988;26;GO:0010721
GO:0023059;positive adaptation of signaling pathway;0;2;GO:0043406
GO:0060004;reflex;1082;1200;GO:0007631
GO:1903528;regulation of dCDP biosynthetic process;0;1;GO:0045944
GO:0023058;adaptation of signaling pathway;1386;339;GO:0009968
GO:0060005;vestibular reflex;319;47;GO:0007623
GO:1903529;negative regulation of dCDP biosynthetic process;0;1;GO:0045944
GO:0060006;angular vestibuloocular reflex;0;1;GO:0008030
GO:1903526;negative regulation of membrane tubulation;107;18;GO:0048193
GO:0060007;linear vestibuloocular reflex;28;3;GO:0007623
GO:1903527;positive regulation of membrane tubulation;171;62;GO:0048193
GO:0047033;15-hydroxyprostaglandin-I dehydrogenase (NADP+) activity;0;0;GO:0004497
GO:0050674;urothelial cell proliferation;178;4;GO:0042127
GO:0047032;3-alpha-hydroxyglycyrrhetinate dehydrogenase activity;0;3;GO:0004073
GO:0050675;regulation of urothelial cell proliferation;88;0;GO:0042127
GO:0047031;diethyl 2-methyl-3-oxosuccinate reductase activity;0;2;GO:0004091
GO:0050672;negative regulation of lymphocyte proliferation;5185;303;GO:0042110
GO:1903519;regulation of mammary gland involution;3;6;GO:0048608
GO:0047030;4-hydroxycyclohexanecarboxylate dehydrogenase activity;0;2;GO:0004067
GO:0050673;epithelial cell proliferation;33677;1790;GO:0042127
GO:2000239;negative regulation of tRNA export from nucleus;0;1;GO:0006511
GO:0047037;salutaridine reductase (NADPH) activity;14;2;GO:0004067
GO:0050670;regulation of lymphocyte proliferation;17003;853;GO:0050729
GO:0023061;signal release;49454;1330;GO:0009986
GO:0047036;codeinone reductase (NADPH) activity;25;3;GO:0004067
GO:0050671;positive regulation of lymphocyte proliferation;8644;864;GO:0050729
GO:0098613;methaneselenol methyltransferase activity;0;1;GO:0004497
GO:0047035;testosterone dehydrogenase (NAD+) activity;368;0;GO:0004073
GO:0098610;adhesion between unicellular organisms;412;1;GO:0022610
GO:0047034;15-hydroxyicosatetraenoate dehydrogenase activity;4;3;GO:0004073
GO:0098616;selenate adenylyltransferase (ATP) activity;2;2;GO:0004730
GO:2000234;positive regulation of rRNA processing;683;65;GO:0045944
GO:0098617;adenylylselenate kinase activity;0;1;GO:0004721
GO:2000233;negative regulation of rRNA processing;108;8;GO:0045944
GO:0098614;hydrogen selenide methyltransferase activity;0;2;GO:0004730
GO:2000232;regulation of rRNA processing;1288;57;GO:0006364
GO:0098615;dimethyl selenide methyltransferase activity;1;2;GO:0004730
GO:2000231;positive regulation of pancreatic stellate cell proliferation;3;2;GO:0048010
GO:0035037;sperm entry;34;7;GO:0005737
GO:0050678;regulation of epithelial cell proliferation;21315;1880;GO:0042127
GO:2000238;regulation of tRNA export from nucleus;55;5;GO:0006613
GO:0035038;female pronucleus assembly;76;142;GO:0007049
GO:0050679;positive regulation of epithelial cell proliferation;10820;2100;GO:0042127
GO:2000237;positive regulation of tRNA processing;13;2;GO:0006519
GO:0035039;male pronucleus assembly;117;10;GO:0007049
GO:0050676;negative regulation of urothelial cell proliferation;0;2;GO:0042127
GO:0098618;selenomethionine-tRNA ligase activity;0;2;GO:0003735
GO:2000236;negative regulation of tRNA processing;0;3;GO:0006519
GO:0050677;positive regulation of urothelial cell proliferation;88;5;GO:0042127
GO:0098619;selenocysteine-tRNA ligase activity;60;4;GO:0003735
GO:2000235;regulation of tRNA processing;121;5;GO:0006518
GO:0035033;histone deacetylase regulator activity;161;41;GO:0016570
GO:0035034;histone acetyltransferase regulator activity;98;10;GO:0016567
GO:0035035;histone acetyltransferase binding;1200;971;GO:0016569
GO:0035036;sperm-egg recognition;6980;1640;GO:0007600
GO:1903531;negative regulation of secretion by cell;10787;90;GO:0050727
GO:2000252;negative regulation of feeding behavior;402;120;GO:0050789
GO:1903532;positive regulation of secretion by cell;14536;444;GO:0050727
GO:0035032;phosphatidylinositol 3-kinase complex, class III;6916;170;GO:0005520
GO:1903530;regulation of secretion by cell;39481;335;GO:0050727
GO:1903535;negative regulation of lactose biosynthetic process;0;0;GO:0046395
GO:1903536;positive regulation of lactose biosynthetic process;0;1;GO:0046394
GO:0047039;tetrahydroxynaphthalene reductase activity;33;4;GO:0004073
GO:1903533;regulation of protein targeting;5173;47;GO:0006613
GO:0047038;D-arabinitol 2-dehydrogenase activity;22;3;GO:0006066
GO:1903534;regulation of lactose biosynthetic process;0;0;GO:0010467
GO:1903539;protein localization to postsynaptic membrane;2454;135;GO:0048471
GO:1903537;meiotic cell cycle process involved in oocyte maturation;404;31;GO:0000086
GO:1903538;regulation of meiotic cell cycle process involved in oocyte maturation;175;10;GO:0048285
GO:0047044;androstan-3-alpha,17-beta-diol dehydrogenase activity;1174;17;GO:0004497
GO:0050685;positive regulation of mRNA processing;1719;317;GO:0010467
GO:0047043;3-alpha-hydroxycholanate dehydrogenase activity;7;3;GO:0004497
GO:0050686;negative regulation of mRNA processing;121407;793;GO:0000398
GO:0098620;seryl-selenocysteinyl-tRNA kinase activity;0;1;GO:0006413
GO:0023057;negative regulation of signaling;346966;1190;GO:0030528
GO:0047042;androsterone dehydrogenase (B-specific) activity;395;6;GO:0004067
GO:0050683;AF-1 domain binding;59;5;GO:0005515
GO:0023056;positive regulation of signaling;189747;1150;GO:0030528
GO:0047041;(S)-carnitine 3-dehydrogenase activity;0;0;GO:0004067
GO:0050684;regulation of mRNA processing;148081;1050;GO:0006397
GO:0023051;regulation of signaling;805219;2840;GO:0007165
GO:0047048;3-hydroxybenzyl-alcohol dehydrogenase activity;0;3;GO:0004089
GO:0050681;nuclear androgen receptor binding;1453;7;GO:0005515
GO:0098623;selenite reductase activity;0;2;GO:0009065
GO:0047047;oxaloglycolate reductase (decarboxylating) activity;0;2;GO:0006067
GO:0050682;AF-2 domain binding;109;8;GO:0005515
GO:0098624;3'-phosphoadenylylselenate reductase activity;1;1;GO:0009065
GO:0047046;homoisocitrate dehydrogenase activity;398;7;GO:0004067
GO:0098621;O-phosphoseryl-tRNA(Sec) selenium transferase activity;4185;4;GO:0006414
GO:0023052;signaling;15797323;11100;GO:0007165
GO:0047045;testosterone 17-beta-dehydrogenase (NADP+) activity;204;0;GO:0004721
GO:0050680;negative regulation of epithelial cell proliferation;7716;1690;GO:0042127
GO:0098622;selenodiglutathione-disulfide reductase (NADP) activity;0;2;GO:0008033
GO:0098627;protein arginine phosphatase activity;65;4;GO:0004723
GO:2000245;negative regulation of FtsZ-dependent cytokinesis;3;0;GO:0048285
GO:0098628;peptidyl-N-phospho-arginine dephosphorylation;13;2;GO:0043405
GO:2000244;regulation of FtsZ-dependent cytokinesis;4;1;GO:0048285
GO:0098625;methylselenol reductase activity;0;5;GO:0004067
GO:2000243;positive regulation of reproductive process;11961;362;GO:0048589
GO:0098626;methylseleninic acid reductase activity;0;5;GO:0046395
GO:2000242;negative regulation of reproductive process;8489;759;GO:0010468
GO:0035026;leading edge cell differentiation;77;101;GO:0030154
GO:0047040;pteridine reductase activity;589;4;GO:0004067
GO:0050689;negative regulation of defense response to virus by host;162;83;GO:0050832
GO:0035027;leading edge cell fate commitment;0;1;GO:0030182
GO:2000248;negative regulation of establishment or maintenance of neuroblast polarity;0;0;GO:0048666
GO:0035028;leading edge cell fate determination;0;3;GO:0030182
GO:0050687;negative regulation of defense response to virus;4209;313;GO:0050832
GO:0098629;trans-Golgi network membrane organization;138;2;GO:0005829
GO:2000247;positive regulation of establishment or maintenance of bipolar cell polarity regulating cell shape;71;2;GO:0048608
GO:0035029;dorsal closure, leading edge cell fate commitment;0;2;GO:0009913
GO:0050688;regulation of defense response to virus;9914;1110;GO:0050832
GO:2000246;positive regulation of FtsZ-dependent cytokinesis;1;0;GO:0048285
GO:0035022;positive regulation of Rac protein signal transduction;348;165;GO:0043403
GO:0060022;hard palate development;327;39;GO:0009952
GO:0035023;regulation of Rho protein signal transduction;11122;2350;GO:0007165
GO:0060023;soft palate development;134;272;GO:0007530
GO:0035024;negative regulation of Rho protein signal transduction;1496;1020;GO:0030516
GO:0060024;rhythmic synaptic transmission;95;48;GO:0007613
GO:0035025;positive regulation of Rho protein signal transduction;3543;929;GO:0030516
GO:0060025;regulation of synaptic activity;196;80;GO:0048167
GO:1903542;negative regulation of exosomal secretion;204;91;GO:0048193
GO:2000263;regulation of blood coagulation, extrinsic pathway;0;1;GO:0007596
GO:1903543;positive regulation of exosomal secretion;713;280;GO:0050921
GO:2000262;positive regulation of blood coagulation, common pathway;0;0;GO:0050817
GO:0035020;regulation of Rac protein signal transduction;1059;636;GO:0007165
GO:0060020;Bergmann glial cell differentiation;540;250;GO:0048666
GO:1903540;establishment of protein localization to postsynaptic membrane;943;18;GO:0048608
GO:2000261;negative regulation of blood coagulation, common pathway;1;5;GO:0007596
GO:0035021;negative regulation of Rac protein signal transduction;164;102;GO:0043403
GO:0060021;roof of mouth development;4703;340;GO:0009952
GO:1903541;regulation of exosomal secretion;922;24;GO:0048193
GO:2000260;regulation of blood coagulation, common pathway;1;0;GO:0007596
GO:1903546;protein localization to photoreceptor outer segment;383;79;GO:0008037
GO:1903547;regulation of growth hormone activity;0;5;GO:0048608
GO:1903544;response to butyrate;12;1;GO:0046394
GO:0047049;(R)-2-hydroxy-fatty acid dehydrogenase activity;0;0;GO:0004497
GO:1903545;cellular response to butyrate;6;0;GO:0045765
GO:0060026;convergent extension;5311;682;GO:0048608
GO:0060027;convergent extension involved in gastrulation;2537;78;GO:0009952
GO:0060028;convergent extension involved in axis elongation;1058;160;GO:0048704
GO:1903548;negative regulation of growth hormone activity;0;0;GO:0048608
GO:0060029;convergent extension involved in organogenesis;792;88;GO:0048608
GO:1903549;positive regulation of growth hormone activity;0;1;GO:0048608
GO:0047055;salutaridine synthase activity;3;3;GO:0004497
GO:0050696;trichloroethylene catabolic process;0;1;GO:0009065
GO:0072000;extracellular polysaccharide catabolic process involved in ascospore release from ascus;11;2;GO:0046395
GO:0047054;berbamunine synthase activity;2;4;GO:0004497
GO:0050697;1,1,2-trichloroethene reductive dehalogenase activity;0;2;GO:0004497
GO:0047053;(S)-cheilanthifoline synthase activity;6;0;GO:0004497
GO:0050694;galactose 3-O-sulfotransferase activity;5628;66;GO:0004734
GO:0047052;(S)-stylopine synthase activity;9;0;GO:0004497
GO:0050695;benzoylformate decarboxylase activity;1223;4;GO:0006099
GO:0047059;polyvinyl alcohol dehydrogenase (cytochrome) activity;92;2;GO:0004073
GO:0050692;DNA binding domain binding;123;8;GO:0003677
GO:0072004;kidney field specification;33;6;GO:0008544
GO:0047058;vitamin-K-epoxide reductase (warfarin-insensitive) activity;49;5;GO:0008037
GO:0050693;LBD domain binding;311;59;GO:0005515
GO:0072003;kidney rudiment formation;128;117;GO:0008544
GO:0047057;vitamin-K-epoxide reductase (warfarin-sensitive) activity;3617;202;GO:0008037
GO:0072002;Malpighian tubule development;1177;9;GO:0009952
GO:0023041;neuronal signal transduction;2870;128;GO:0007268
GO:0047056;(S)-canadine synthase activity;10;0;GO:0004497
GO:0050691;regulation of defense response to virus by host;2495;653;GO:0050832
GO:0072001;renal system development;42227;1360;GO:0042127
GO:0035019;somatic stem cell population maintenance;3232;769;GO:0045727
GO:0072008;glomerular mesangial cell differentiation;245;9;GO:0048407
GO:2000256;positive regulation of male germ cell proliferation;61;5;GO:0048608
GO:0072007;mesangial cell differentiation;299;15300;GO:0042592
GO:2000255;negative regulation of male germ cell proliferation;146;40;GO:0048608
GO:0072006;nephron development;16656;1170;GO:0048667
GO:2000254;regulation of male germ cell proliferation;214;6;GO:0048608
GO:0072005;maintenance of kidney identity;5;1;GO:0048667
GO:2000253;positive regulation of feeding behavior;389;115;GO:0050789
GO:0035015;elongation of arista core;20;10;GO:0048608
GO:0047051;D-lactate dehydrogenase (cytochrome c-553) activity;26;3;GO:0003954
GO:0035016;elongation of arista lateral;0;2;GO:0048285
GO:0047050;(S)-2-hydroxy-fatty acid dehydrogenase activity;0;0;GO:0004497
GO:2000259;positive regulation of protein activation cascade;0;17;GO:0043565
GO:0035017;cuticle pattern formation;380;218;GO:0009913
GO:0050698;proteoglycan sulfotransferase activity;49;7;GO:0004719
GO:2000258;negative regulation of protein activation cascade;45;515;GO:0043565
GO:0035018;adult chitin-based cuticle pattern formation;24;5;GO:0048608
GO:0050699;WW domain binding;1320;852;GO:0042803
GO:0072009;nephron epithelium development;10843;246;GO:0030216
GO:2000257;regulation of protein activation cascade;102;1760;GO:0043565
GO:0035011;melanotic encapsulation of foreign target;304;131;GO:0002376
GO:0060011;Sertoli cell proliferation;259;122;GO:0042127
GO:2000270;negative regulation of fibroblast apoptotic process;410;401;GO:0043066
GO:0060012;synaptic transmission, glycinergic;381;39;GO:0007268
GO:0035013;myosuppressin receptor activity;60;2;GO:0004872
GO:0060013;righting reflex;400;718;GO:0007626
GO:0035014;phosphatidylinositol 3-kinase regulator activity;210;135;GO:0005524
GO:0060014;granulosa cell differentiation;16;7;GO:0048608
GO:1903553;positive regulation of extracellular exosome assembly;191;34;GO:0048193
GO:2000274;regulation of epithelial cell migration, open tracheal system;120;10;GO:0030574
GO:1903554;G protein-coupled receptor signaling pathway involved in defense response to Gram-negative bacterium;12;1;GO:0009620
GO:2000273;positive regulation of signaling receptor activity;68;138;GO:0048010
GO:1903551;regulation of extracellular exosome assembly;326;30;GO:0048193
GO:2000272;negative regulation of signaling receptor activity;101;205;GO:0030518
GO:0035010;encapsulation of foreign target;439;17;GO:0048407
GO:0060010;Sertoli cell fate commitment;53;53;GO:0048608
GO:1903552;negative regulation of extracellular exosome assembly;0;0;GO:0048193
GO:2000271;positive regulation of fibroblast apoptotic process;449;188;GO:0010941
GO:0060019;radial glial cell differentiation;866;196;GO:0048667
GO:1903557;positive regulation of tumor necrosis factor superfamily cytokine production;4665;261;GO:0050727
GO:0023029;MHC class Ib protein binding;197;122;GO:0048308
GO:1903558;3-cyano-L-alanine metabolic process;0;0;GO:0006559
GO:1903555;regulation of tumor necrosis factor superfamily cytokine production;8862;152;GO:0032724
GO:1903556;negative regulation of tumor necrosis factor superfamily cytokine production;3069;45;GO:0050727
GO:0023026;MHC class II protein complex binding;702;688;GO:0042612
GO:0060015;granulosa cell fate commitment;0;1;GO:0048608
GO:0023025;MHC class Ib protein complex binding;93;31;GO:0042612
GO:0060016;granulosa cell development;0;3;GO:0048608
GO:0023028;MHC class I protein binding, via lateral surface;0;2;GO:0048308
GO:0060017;parathyroid gland development;335;101;GO:0007517
GO:1903559;3-cyano-L-alanine catabolic process;0;0;GO:0009065
GO:0023027;MHC class I protein binding, via antigen binding groove;2;1;GO:0044429
GO:0060018;astrocyte fate commitment;201;147;GO:0048667
GO:0047066;phospholipid-hydroperoxide glutathione peroxidase activity;240;55;GO:0004601
GO:0047065;sulochrin oxidase [(-)-bisdechlorogeodin-forming] activity;0;2;GO:0004730
GO:0023035;CD40 signaling pathway;785;40;GO:0002449
GO:0047064;sulochrin oxidase [(+)-bisdechlorogeodin-forming] activity;0;2;GO:0004730
GO:0098601;selenomethionine adenosyltransferase activity;0;4;GO:0004497
GO:0047069;7,8-dihydroxykynurenate 8,8a-dioxygenase activity;0;3;GO:0004497
GO:0023031;MHC class Ib protein binding, via lateral surface;0;1;GO:0048308
GO:0047068;N5,N10-methenyltetrahydromethanopterin hydrogenase activity;394;6;GO:0009065
GO:0023030;MHC class Ib protein binding, via antigen binding groove;88;37;GO:0019882
GO:0047067;hydrogen:quinone oxidoreductase activity;463;2;GO:0004091
GO:0098600;selenomethionine gamma-lyase activity;0;1;GO:0004730
GO:0035008;positive regulation of melanization defense response;83;9;GO:0046148
GO:0098605;selenocystathionine beta-synthase activity;0;1;GO:0004784
GO:2000267;negative regulation of blood coagulation, intrinsic pathway;0;8;GO:0007596
GO:0035009;negative regulation of melanization defense response;74;13;GO:0046148
GO:0098606;selenocystathionine gamma-lyase activity;5;2;GO:0004734
GO:2000266;regulation of blood coagulation, intrinsic pathway;0;8;GO:0007596
GO:0098603;selenol Se-methyltransferase activity;3;1;GO:0004784
GO:2000265;positive regulation of blood coagulation, extrinsic pathway;0;0;GO:0007596
GO:0098604;adenosylselenohomocysteinase activity;1;1;GO:0004734
GO:2000264;negative regulation of blood coagulation, extrinsic pathway;0;3;GO:0007596
GO:0047062;trans-acenaphthene-1,2-diol dehydrogenase activity;0;3;GO:0004073
GO:0098609;cell-cell adhesion;324437;5240;GO:0007155
GO:0035005;1-phosphatidylinositol-4-phosphate 3-kinase activity;2302;303;GO:0004721
GO:0047061;glucose-fructose oxidoreductase activity;1796;5;GO:0006096
GO:0035006;melanization defense response;3143;30;GO:0009611
GO:0047060;(R)-pantolactone dehydrogenase (flavin) activity;1;0;GO:0004073
GO:0098607;methylselenocysteine deselenhydrase activity;0;1;GO:0003902
GO:2000269;regulation of fibroblast apoptotic process;1012;105;GO:0010941
GO:0035007;regulation of melanization defense response;170;19;GO:0046148
GO:0098608;methylselenol demethylase activity;0;2;GO:0046395
GO:2000268;positive regulation of blood coagulation, intrinsic pathway;0;1;GO:0007596
GO:0035088;establishment or maintenance of apical/basal cell polarity;3495;748;GO:0030154
GO:0035089;establishment of apical/basal cell polarity;1382;1020;GO:0031589
GO:2000280;regulation of root development;1267;285;GO:0048731
GO:2000284;positive regulation of amino acid biosynthetic process;75;2;GO:0046394
GO:2000283;negative regulation of amino acid biosynthetic process;54;1;GO:0046394
GO:2000282;regulation of cellular amino acid biosynthetic process;201;4;GO:0009060
GO:0035080;heat shock-mediated polytene chromosome puffing;48;140;GO:0007096
GO:0035081;induction of programmed cell death by hormones;143;3;GO:0010941
GO:0035082;axoneme assembly;25783;1920;GO:0005576
GO:0050630;(iso)eugenol O-methyltransferase activity;58;3;GO:0004714
GO:0050631;corydaline synthase activity;0;3;GO:0004073
GO:0050638;taxadien-5-alpha-ol O-acetyltransferase activity;39;3;GO:0004497
GO:2000278;regulation of DNA biosynthetic process;5067;383;GO:0006261
GO:0050639;10-hydroxytaxane O-acetyltransferase activity;0;3;GO:0006073
GO:2000277;positive regulation of oxidative phosphorylation uncoupler activity;7;10;GO:0046395
GO:0050636;vinorine synthase activity;57;6;GO:0004497
GO:2000276;negative regulation of oxidative phosphorylation uncoupler activity;4;21;GO:0046395
GO:0050637;lovastatin nonaketide synthase activity;69;3;GO:0004497
GO:2000275;regulation of oxidative phosphorylation uncoupler activity;11;9;GO:0008856
GO:0050634;phloroisovalerophenone synthase activity;8;3;GO:0004497
GO:0050635;acridone synthase activity;7;3;GO:0004497
GO:0050632;propionyl-CoA C2-trimethyltridecanoyltransferase activity;1287;126;GO:0006081
GO:0050633;acetyl-CoA C-myristoyltransferase activity;1004;6;GO:0004089
GO:2000279;negative regulation of DNA biosynthetic process;1949;194;GO:0045727
GO:0035077;ecdysone-mediated polytene chromosome puffing;8;2;GO:0005576
GO:2000292;regulation of defecation;122;5;GO:0050789
GO:0035078;induction of programmed cell death by ecdysone;143;4;GO:0010941
GO:2000291;regulation of myoblast proliferation;1020;272;GO:0045944
GO:0035079;polytene chromosome puffing;57;7;GO:0048706
GO:2000290;regulation of myotome development;96;0;GO:0048704
GO:0035073;pupariation;154;77;GO:0007548
GO:2000296;negative regulation of hydrogen peroxide catabolic process;10;110;GO:0046395
GO:0035074;pupation;91;9;GO:0048608
GO:2000295;regulation of hydrogen peroxide catabolic process;72;10;GO:0046395
GO:0035075;response to ecdysone;1467;124;GO:0030529
GO:2000294;positive regulation of defecation;52;3;GO:0050789
GO:0035076;ecdysone receptor-mediated signaling pathway;1027;108;GO:0007218
GO:2000293;negative regulation of defecation;14;8;GO:0050789
GO:0035070;salivary gland histolysis;407;29;GO:0048405
GO:0035071;salivary gland cell autophagic cell death;296;82;GO:0043066
GO:0035072;ecdysone-mediated induction of salivary gland cell autophagic cell death;143;20;GO:0048608
GO:0047000;2-dehydro-3-deoxy-D-gluconate 6-dehydrogenase activity;0;3;GO:0006066
GO:0050641;6-methylsalicylic acid synthase activity;49;3;GO:0004497
GO:0050642;2-alpha-hydroxytaxane 2-O-benzoyltransferase activity;3;5;GO:0006022
GO:0050640;isopenicillin-N N-acyltransferase activity;42;3;GO:0004721
GO:0047004;UDP-N-acetylglucosamine 6-dehydrogenase activity;1089;5;GO:0006032
GO:0047003;dTDP-6-deoxy-L-talose 4-dehydrogenase activity;1;2;GO:0006073
GO:0047002;L-arabinitol 2-dehydrogenase activity;6;2;GO:0006066
GO:0047001;2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase activity;2945;2;GO:0004497
GO:0050649;testosterone 6-beta-hydroxylase activity;136;30;GO:0004497
GO:2000289;regulation of photoreceptor cell axon guidance;77;4;GO:0048608
GO:2000288;positive regulation of myoblast proliferation;636;213;GO:0048771
GO:0050647;5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding;26;4;GO:0046906
GO:2000287;positive regulation of myotome development;50;1;GO:0048704
GO:0050648;5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding;26;0;GO:0097159
GO:2000286;receptor internalization involved in canonical Wnt signaling pathway;152;74;GO:0009986
GO:0050645;limonoid glucosyltransferase activity;11;2;GO:0006081
GO:0050646;5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding;26;4;GO:0046906
GO:0050643;10-deacetylbaccatin III 10-O-acetyltransferase activity;10;3;GO:0004714
GO:0050644;cis-p-coumarate glucosyltransferase activity;0;3;GO:0006073
GO:0035066;positive regulation of histone acetylation;588;580;GO:0045944
GO:0035067;negative regulation of histone acetylation;252;518;GO:0045944
GO:0035069;larval midgut histolysis;495;22;GO:0048405
GO:0035062;omega speckle;114;9;GO:0005576
GO:0035063;nuclear speck organization;185;36;GO:0005829
GO:0035064;methylated histone binding;9219;1070;GO:0016569
GO:0035065;regulation of histone acetylation;4898;293;GO:0016569
GO:0047008;pregnan-21-ol dehydrogenase (NADP+) activity;0;0;GO:0004073
GO:1903502;translation repressor complex;4;0;GO:0048316
GO:0047007;pregnan-21-ol dehydrogenase (NAD+) activity;0;0;GO:0046274
GO:1903503;ATPase inhibitor complex;146;0;GO:0006073
GO:0035060;brahma complex;5810;115;GO:0050789
GO:0047006;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;151;125;GO:0006066
GO:1903500;negative regulation of mitotic actomyosin contractile ring assembly;32;2;GO:0048316
GO:0035061;interchromatin granule;163;61;GO:0050890
GO:0047005;16-alpha-hydroxysteroid dehydrogenase activity;0;2;GO:0042175
GO:1903501;positive regulation of mitotic actomyosin contractile ring assembly;113;5;GO:0048731
GO:1903504;regulation of mitotic spindle checkpoint;2772;856;GO:0007264
GO:0047009;3-alpha-hydroxy-5-beta-androstane-17-one 3-alpha-dehydrogenase activity;0;3;GO:0009909
GO:0047011;2-dehydropantolactone reductase (A-specific) activity;6;2;GO:0006869
GO:0050652;dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;1;4;GO:0006935
GO:0047010;hydroxycyclohexanecarboxylate dehydrogenase activity;10;3;GO:0008023
GO:0050653;chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;62;134;GO:0009628
GO:0050650;chondroitin sulfate proteoglycan biosynthetic process;6214;182;GO:0008544
GO:0050651;dermatan sulfate proteoglycan biosynthetic process;262;190;GO:0048731
GO:0047015;3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity;207;90;GO:0048731
GO:0047014;glycerol-3-phosphate 1-dehydrogenase [NADP+] activity;0;0;GO:0006474
GO:0047013;cholate 12-alpha dehydrogenase activity;2;2;GO:0006073
GO:0047012;sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity;92;9;GO:0006099
GO:2000299;negative regulation of Rho-dependent protein serine/threonine kinase activity;4;2;GO:0006629
GO:0050658;RNA transport;197359;1540;GO:0004089
GO:2000298;regulation of Rho-dependent protein serine/threonine kinase activity;8;8;GO:0006631
GO:0050659;N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity;174;191;GO:0006869
GO:2000297;negative regulation of synapse maturation;163;92;GO:0009952
GO:0035059;RCAF complex;23;2;GO:0009081
GO:0050656;3'-phosphoadenosine 5'-phosphosulfate binding;173;8;GO:0004553
GO:0050657;nucleic acid transport;199013;1750;GO:0046148
GO:0050654;chondroitin sulfate proteoglycan metabolic process;6663;205;GO:0006635
GO:0050655;dermatan sulfate proteoglycan metabolic process;543;122;GO:0004733
GO:0035051;cardiocyte differentiation;11356;644;GO:0004734
GO:0035052;dorsal vessel aortic cell fate commitment;1;2;GO:0004733
GO:1903510;mucopolysaccharide metabolic process;21239;64;GO:0004734
GO:0035053;dorsal vessel heart proper cell fate commitment;31;7;GO:0004364
GO:0035054;embryonic heart tube anterior/posterior pattern specification;137;45;GO:0006021
GO:0047019;indole-3-acetaldehyde reductase (NADPH) activity;14;4;GO:0006081
GO:1903513;endoplasmic reticulum to cytosol transport;2352;75;GO:0004553
GO:0047018;indole-3-acetaldehyde reductase (NADH) activity;12;3;GO:0004332
GO:1903514;release of sequestered calcium ion into cytosol by endoplasmic reticulum;1724;9;GO:0003954
GO:0047017;prostaglandin-F synthase activity;150;10;GO:0004073
GO:1903511;orotic acid metabolic process;0;1;GO:0004449
GO:0035050;embryonic heart tube development;9469;1050;GO:0004553
GO:0047016;cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity;64;4;GO:0004734
GO:1903512;phytanic acid metabolic process;110;1;GO:0004733
GO:1903517;negative regulation of single strand break repair;1;8;GO:0046148
GO:1903518;positive regulation of single strand break repair;180;8;GO:0046274
GO:1903515;calcium ion transport from cytosol to endoplasmic reticulum;169;155;GO:0046395
GO:1903516;regulation of single strand break repair;183;5;GO:0046649
GO:0047022;7-beta-hydroxysteroid dehydrogenase (NADP+) activity;26;0;GO:0009813
GO:0047021;15-hydroxyprostaglandin dehydrogenase (NADP+) activity;42;0;GO:0046274
GO:0050664;oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor;11888;82;GO:0046274
GO:0047020;15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity;46;0;GO:0046274
GO:0050661;NADP binding;1038255;4860;GO:0045735
GO:1903509;liposaccharide metabolic process;1115748;461;GO:0006032
GO:0047026;androsterone dehydrogenase (A-specific) activity;4;3;GO:0006064
GO:0047025;3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity;1;0;GO:0006073
GO:0050660;flavin adenine dinucleotide binding;2880781;8650;GO:0006073
GO:0047024;5alpha-androstane-3beta,17beta-diol dehydrogenase activity;219;5;GO:0006073
GO:0047023;androsterone dehydrogenase activity;798;61;GO:0006073
GO:0050669;negative regulation of homocysteine metabolic process;0;1;GO:0006096
GO:0050667;homocysteine metabolic process;153642;1270;GO:0006096
GO:0035049;juvenile hormone acid methyltransferase activity;14;8;GO:0003854
GO:0050668;positive regulation of homocysteine metabolic process;2;10;GO:0048704
GO:0050665;hydrogen peroxide biosynthetic process;725;1220;GO:0048704
GO:0050666;regulation of homocysteine metabolic process;5;6;GO:0048704
GO:0060088;auditory receptor cell stereocilium organization;1072;592;GO:0048704
GO:0060089;molecular transducer activity;3207315;3020;GO:0048704
GO:0060084;synaptic transmission involved in micturition;137;34;GO:0048704
GO:0060085;smooth muscle relaxation of the bladder outlet;4;1;GO:0048666
GO:0060086;circadian temperature homeostasis;224;48;GO:0006096
GO:0060087;relaxation of vascular associated smooth muscle;257;5;GO:0006099
GO:0072073;kidney epithelium development;15129;376;GO:0048666
GO:0072072;kidney stroma development;0;1;GO:0003824
GO:0072071;kidney interstitial fibroblast differentiation;105;5;GO:0048704
GO:0072070;loop of Henle development;559;43;GO:0048608
GO:0072066;prebend segment development;0;2;GO:0006749
GO:0098696;regulation of neurotransmitter receptor localization to postsynaptic specialization membrane;490;9;GO:0004553
GO:0072065;long descending thin limb bend development;0;1;GO:0004726
GO:0098697;ryanodine-sensitive calcium-release channel activity involved in regulation of postsynaptic cytosolic calcium levels;0;0;GO:0009065
GO:0072064;long descending thin limb development;0;1;GO:0006064
GO:0098694;regulation of synaptic vesicle budding from presynaptic endocytic zone membrane;6;2;GO:0004721
GO:0072063;short descending thin limb development;0;1;GO:0004553
GO:0098695;inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels;48;3;GO:0008544
GO:0072069;DCT cell differentiation;55;8;GO:0048666
GO:0072068;late distal convoluted tubule development;69;1;GO:0048667
GO:0098698;postsynaptic specialization assembly;1358;73;GO:0048666
GO:0072067;early distal convoluted tubule development;0;1;GO:0048666
GO:0098699;structural constituent of presynaptic actin cytoskeleton;5;2;GO:0007423
GO:0060091;kinocilium;556;106;GO:0048608
GO:0060092;regulation of synaptic transmission, glycinergic;96;2;GO:0008544
GO:0060093;negative regulation of synaptic transmission, glycinergic;0;2;GO:0004784
GO:0060094;positive regulation of synaptic transmission, glycinergic;53;2;GO:0004067
GO:0060090;molecular adaptor activity;4717238;1060;GO:0007548
GO:0060077;inhibitory synapse;519;545;GO:0006749
GO:0060078;regulation of postsynaptic membrane potential;117429;2480;GO:0048666
GO:0060079;excitatory postsynaptic potential;84918;1480;GO:0004725
GO:0060073;micturition;412;55;GO:0006081
GO:0060074;synapse maturation;1573;240;GO:0003906
GO:0060075;regulation of resting membrane potential;274;102;GO:0004867
GO:0060076;excitatory synapse;2186;1300;GO:0004067
GO:0072062;proximal convoluted tubule segment 1 cell differentiation;0;0;GO:0004734
GO:0072061;inner medullary collecting duct development;32;19;GO:0048704
GO:0072060;outer medullary collecting duct development;4;4;GO:0048704
GO:0072055;renal cortex development;55;2;GO:0048704
GO:0072054;renal outer medulla development;57;152;GO:0048704
GO:0072053;renal inner medulla development;60;141;GO:0048704
GO:0072052;juxtaglomerulus cell differentiation;0;0;GO:0048704
GO:0072059;cortical collecting duct development;55;1;GO:0004746
GO:0072058;outer stripe development;0;2;GO:0048608
GO:0072057;inner stripe development;0;2;GO:0004497
GO:0072056;pyramid development;0;1;GO:0048608
GO:0060080;inhibitory postsynaptic potential;523;151;GO:0009065
GO:0060081;membrane hyperpolarization;494;1620;GO:0048608
GO:0060082;eye blink reflex;8;7;GO:0004867
GO:0060083;smooth muscle contraction involved in micturition;118;39;GO:0004722
GO:0072091;regulation of stem cell proliferation;5505;464;GO:0004553
GO:0072090;mesenchymal stem cell proliferation involved in nephron morphogenesis;0;1;GO:0006096
GO:0072095;regulation of branch elongation involved in ureteric bud branching;158;185;GO:0004867
GO:0098681;synaptic ribbon;0;2;GO:0045735
GO:0072094;metanephric renal vesicle induction;0;0;GO:0045944
GO:0098682;arciform density;0;2;GO:0004067
GO:0072093;metanephric renal vesicle formation;145;6;GO:0048704
GO:0072092;ureteric bud invasion;94;237;GO:0004073
GO:0098680;template-free RNA nucleotidyltransferase;44;3;GO:0004073
GO:0072088;nephron epithelium morphogenesis;6266;734;GO:0003824
GO:0098674;extrinsic component of neuronal dense core vesicle membrane;70;1;GO:0048704
GO:0072087;renal vesicle development;903;263;GO:0006099
GO:0072086;specification of loop of Henle identity;175;240;GO:0048704
GO:0098672;inhibition of host CRISPR-cas system by virus;8;2;GO:0004721
GO:0072085;specification of connecting tubule identity;0;1;GO:0006021
GO:0098673;inhibition of host DNA replication by virus;358;5;GO:0004497
GO:0098678;viral tropism switching;10;2;GO:0004518
GO:0098676;modulation of host virulence by virus;210;4;GO:0016567
GO:0072089;stem cell proliferation;9735;800;GO:0016310
GO:0098677;virion maturation;0;2;GO:0006066
GO:0035099;hemocyte migration;2868;35;GO:0048666
GO:0060099;regulation of phagocytosis, engulfment;790;106;GO:0005746
GO:0035095;behavioral response to nicotine;462;2310;GO:0004734
GO:0060095;zinc potentiation of synaptic transmission, glycinergic;0;0;GO:0048666
GO:0035096;larval midgut cell programmed cell death;341;5;GO:0006021
GO:0060096;serotonin secretion, neurotransmission;2;3;GO:0048608
GO:0035097;histone methyltransferase complex;32996;1070;GO:0005746
GO:0060097;cytoskeletal rearrangement involved in phagocytosis, engulfment;51;6;GO:0006032
GO:0035098;ESC/E(Z) complex;1665;671;GO:0048704
GO:0060098;membrane reorganization involved in phagocytosis, engulfment;1;3;GO:0006749
GO:0035091;phosphatidylinositol binding;221691;3500;GO:0008032
GO:0072080;nephron tubule development;8130;209;GO:0048704
GO:0035092;sperm DNA condensation;1312;9;GO:0005746
GO:0035094;response to nicotine;1660;1630;GO:0006066
GO:0072084;specification of distal tubule identity;2;1;GO:0045595
GO:0098692;noradrenergic synapse;0;0;GO:0005746
GO:0098693;regulation of synaptic vesicle cycle;695;98;GO:0004721
GO:0072082;specification of proximal tubule identity;3;1;GO:0048608
GO:0098690;glycinergic synapse;396;6;GO:0006081
GO:0035090;maintenance of apical/basal cell polarity;658;36;GO:0006067
GO:0072081;specification of nephron tubule identity;294;4;GO:0048704
GO:0098691;dopaminergic synapse;666;74;GO:0006066
GO:0072077;renal vesicle morphogenesis;847;30;GO:0048608
GO:0098685;Schaffer collateral - CA1 synapse;4387;381;GO:0004721
GO:0072076;nephrogenic mesenchyme development;137;6;GO:0048704
GO:0098686;hippocampal mossy fiber to CA3 synapse;1752;28;GO:0006021
GO:0072075;metanephric mesenchyme development;722;994;GO:0003824
GO:0098683;cochlear hair cell ribbon synapse;94;5;GO:0009065
GO:0072074;kidney mesenchyme development;950;6;GO:0015986
GO:0098684;photoreceptor ribbon synapse;517;51;GO:0004497
GO:0098689;latency-replication decision;13;7;GO:0006073
GO:0072079;nephron tubule formation;1273;253;GO:0006066
GO:0098687;chromosomal region;339608;1690;GO:0004721
GO:0072078;nephron tubule morphogenesis;5513;455;GO:0006749
GO:0098688;parallel fiber to Purkinje cell synapse;821;175;GO:0006030
GO:0060044;negative regulation of cardiac muscle cell proliferation;431;523;GO:0004721
GO:1903560;3-cyano-L-alanine biosynthetic process;0;0;GO:0006464
GO:0060045;positive regulation of cardiac muscle cell proliferation;1003;898;GO:0009063
GO:1903561;extracellular vesicle;8626;1850;GO:0006033
GO:0060046;regulation of acrosome reaction;3582;382;GO:0006066
GO:0060047;heart contraction;28687;2030;GO:0006464
GO:0060040;retinal bipolar neuron differentiation;506;71;GO:0004497
GO:1903564;regulation of protein localization to cilium;720;9;GO:0004073
GO:0060041;retina development in camera-type eye;18872;1880;GO:0048608
GO:1903565;negative regulation of protein localization to cilium;254;28;GO:0006066
GO:0060042;retina morphogenesis in camera-type eye;7573;413;GO:0048704
GO:1903562;microtubule bundle formation involved in mitotic spindle midzone assembly;74;4;GO:0004073
GO:0060043;regulation of cardiac muscle cell proliferation;1785;215;GO:0048704
GO:1903563;microtubule bundle formation involved in horsetail-astral microtubule organization;4;3;GO:0006032
GO:1903568;negative regulation of protein localization to ciliary membrane;59;9;GO:0048704
GO:1903569;positive regulation of protein localization to ciliary membrane;79;1;GO:0004067
GO:1903566;positive regulation of protein localization to cilium;406;148;GO:0048706
GO:1903567;regulation of protein localization to ciliary membrane;138;195;GO:0004553
GO:0060048;cardiac muscle contraction;10708;2860;GO:0048704
GO:0060049;regulation of protein glycosylation;422;136;GO:0006749
GO:0098660;inorganic ion transmembrane transport;18380300;784;GO:0048704
GO:0047077;Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity;116;21;GO:0004746
GO:0072022;descending thin limb development;40;1;GO:0048704
GO:0098652;collagen type VII anchoring fibril;1;1;GO:0006793
GO:0072021;ascending thin limb development;169;6;GO:0048704
GO:0098653;centromere clustering;121;3;GO:0043169
GO:0047075;2,5-dihydroxypyridine 5,6-dioxygenase activity;248;4;GO:0048699
GO:0072020;proximal straight tubule development;43;1;GO:0009536
GO:0098650;peptidyl-proline 4-dioxygenase binding;0;2;GO:0004041
GO:0047074;4-hydroxycatechol 1,2-dioxygenase activity;358;3;GO:0004091
GO:0098651;basement membrane collagen trimer;537;35;GO:0004497
GO:0098656;monoatomic anion transmembrane transport;975647;391;GO:0004073
GO:0072025;distal convoluted tubule development;256;6;GO:0006486
GO:0098657;import into cell;1827994;842;GO:0009065
GO:0047079;deoxyuridine 1'-dioxygenase activity;0;1;GO:0006468
GO:0072024;macula densa development;28;0;GO:0008061
GO:0098654;CENP-A recruiting complex;18;2;GO:0009065
GO:0047078;3-hydroxy-4-oxoquinoline 2,4-dioxygenase activity;8;3;GO:0006468
GO:0072023;thick ascending limb development;77;30;GO:0004041
GO:0098655;monoatomic cation transmembrane transport;18738945;149;GO:0043403
GO:0072029;long nephron development;0;1;GO:0004073
GO:0072028;nephron morphogenesis;7564;226;GO:0048704
GO:0098658;inorganic anion import across plasma membrane;638;3;GO:0006029
GO:0060050;positive regulation of protein glycosylation;207;95;GO:0048704
GO:0072027;connecting tubule development;56;1;GO:0048285
GO:0098659;inorganic cation import across plasma membrane;9499;330;GO:0048706
GO:0047073;2,4'-dihydroxyacetophenone dioxygenase activity;30;0;GO:0048706
GO:0047072;2,3-dihydroxybenzoate 2,3-dioxygenase activity;1;3;GO:0006096
GO:0047071;3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase activity;145;0;GO:0005524
GO:0047070;3-carboxyethylcatechol 2,3-dioxygenase activity;5259;8;GO:0048704
GO:0060033;anatomical structure regression;1700;252;GO:0006096
GO:1901129;gentamycin catabolic process;0;0;GO:0006030
GO:0060269;centripetally migrating follicle cell migration;41;2;GO:0009952
GO:1901128;gentamycin metabolic process;4;1;GO:0006022
GO:0047297;asparagine-oxo-acid transaminase activity;8;2;GO:0006029
GO:0072242;metanephric DCT cell fate commitment;0;1;GO:0006096
GO:0047296;homospermidine synthase activity;402;3;GO:0004553
GO:0072241;metanephric DCT cell development;0;1;GO:0006096
GO:0047295;geranylgeranylglycerol-phosphate geranylgeranyltransferase activity;3473;6;GO:0008800
GO:0072240;metanephric DCT cell differentiation;55;7;GO:0006066
GO:0047294;phosphoglycerol geranylgeranyltransferase activity;14874;6;GO:0005524
GO:2000019;negative regulation of male gonad development;51;8;GO:0006094
GO:0072246;metanephric glomerular parietal epithelial cell development;0;1;GO:0005524
GO:0098832;peri-centrosomal recycling endosome;0;2;GO:0048704
GO:0072245;metanephric glomerular parietal epithelial cell differentiation;0;1;GO:0006066
GO:0098833;presynaptic endocytic zone;390;223;GO:0004725
GO:0047299;tryptophan-phenylpyruvate transaminase activity;1;2;GO:0004553
GO:0072244;metanephric glomerular epithelium development;184;9;GO:0004725
GO:0098830;presynaptic endosome;217;10;GO:0004553
GO:0047298;(S)-3-amino-2-methylpropionate transaminase activity;1295;0;GO:0006032
GO:0072243;metanephric nephron epithelium development;1605;132;GO:0046274
GO:0098831;presynaptic active zone cytoplasmic component;916;166;GO:0006790
GO:0098836;cytoskeleton of dendritic spine;1;1;GO:0050729
GO:2000014;regulation of endosperm development;194;19700;GO:0046274
GO:0072249;metanephric podocyte development;180;4;GO:0050727
GO:0098837;postsynaptic recycling endosome;336;29;GO:0009061
GO:2000013;regulation of arginine biosynthetic process via ornithine;1;2;GO:0009813
GO:0072248;metanephric podocyte differentiation;182;1;GO:0003723
GO:0098834;presynaptic endocytic zone cytoplasmic component;1;0;GO:0048519
GO:2000012;regulation of auxin polar transport;1190;10400;GO:0003723
GO:0060270;main body follicle cell migration;0;1;GO:0006468
GO:0072247;metanephric glomerular parietal epithelial cell fate commitment;0;2;GO:0004091
GO:0098835;presynaptic endocytic zone membrane;278;9;GO:0009611
GO:2000011;regulation of adaxial/abaxial pattern formation;219;3;GO:0009611
GO:0047293;4-hydroxybenzoate nonaprenyltransferase activity;15378;9;GO:0009611
GO:2000018;regulation of male gonad development;457;7;GO:0004872
GO:0047292;trihydroxypterocarpan dimethylallyltransferase activity;1;2;GO:0005576
GO:2000017;positive regulation of determination of dorsal identity;112;126;GO:0048407
GO:0035259;nuclear glucocorticoid receptor binding;486;8;GO:0048407
GO:0047291;lactosylceramide alpha-2,3-sialyltransferase activity;164;9;GO:0002526
GO:0098838;folate transmembrane transport;882;171;GO:0002526
GO:2000016;negative regulation of determination of dorsal identity;211;14;GO:0002757
GO:0047290;alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity;6;4;GO:0005126
GO:0098839;postsynaptic density membrane;6171;599;GO:0046148
GO:2000015;regulation of determination of dorsal identity;323;6;GO:0004896
GO:0035253;ciliary rootlet;665;541;GO:0005126
GO:0060253;negative regulation of glial cell proliferation;603;309;GO:0005126
GO:1903791;uracil transmembrane transport;665;1;GO:0005125
GO:0035254;glutamate receptor binding;6011;403;GO:0005520
GO:0060254;regulation of N-terminal protein palmitoylation;74;5;GO:0048407
GO:1903792;negative regulation of monoatomic anion transport;64;2;GO:0005126
GO:0035255;ionotropic glutamate receptor binding;792;594;GO:0004872
GO:0060255;regulation of macromolecule metabolic process;28768965;3760;GO:0004872
GO:1901130;gentamycin biosynthetic process;0;0;GO:0046148
GO:0035256;G protein-coupled glutamate receptor binding;4872;54;GO:0004872
GO:0060256;regulation of flocculation;21;5;GO:0046323
GO:1903790;guanine nucleotide transmembrane transport;1073;4;GO:0006725
GO:1901132;kanamycin catabolic process;0;1;GO:0046649
GO:1903795;regulation of inorganic anion transmembrane transport;114;1;GO:0050729
GO:2000032;regulation of secondary shoot formation;552;28;GO:0048608
GO:0035250;UDP-galactosyltransferase activity;11602;175;GO:0002273
GO:0060250;germ-line stem-cell niche homeostasis;260;257;GO:0032724
GO:1901131;kanamycin metabolic process;7;1;GO:0048167
GO:1903796;negative regulation of inorganic anion transmembrane transport;39;1;GO:0009986
GO:2000031;regulation of salicylic acid mediated signaling pathway;5140;65;GO:0048010
GO:0035251;UDP-glucosyltransferase activity;161793;998;GO:0005518
GO:0060251;regulation of glial cell proliferation;1466;56;GO:0007596
GO:1903793;positive regulation of monoatomic anion transport;7;5;GO:0005576
GO:2000030;regulation of response to red or far red light;2168;8;GO:0010467
GO:0035252;UDP-xylosyltransferase activity;11858;49;GO:0042802
GO:0060252;positive regulation of glial cell proliferation;811;403;GO:0050729
GO:1901133;kanamycin biosynthetic process;7;1;GO:0050729
GO:1903794;cortisol binding;2;0;GO:0005578
GO:1901136;carbohydrate derivative catabolic process;702871;1460;GO:0005126
GO:1903799;negative regulation of miRNA processing;513;160;GO:0048407
GO:1901135;carbohydrate derivative metabolic process;16346315;3000;GO:0005178
GO:1903797;positive regulation of inorganic anion transmembrane transport;8;3;GO:0048010
GO:1901137;carbohydrate derivative biosynthetic process;12258847;2250;GO:0005126
GO:1903798;regulation of miRNA processing;1339;5;GO:0048405
GO:0060257;negative regulation of flocculation;14;3;GO:0048608
GO:0060258;negative regulation of filamentous growth;179;7;GO:0048408
GO:0060259;regulation of feeding behavior;1643;563;GO:0048405
GO:0072231;metanephric proximal convoluted tubule segment 1 development;0;0;GO:0046330
GO:0072230;metanephric proximal straight tubule development;40;3;GO:0050729
GO:0098840;protein transport along microtubule;450;32;GO:0050729
GO:0072235;metanephric distal tubule development;356;10;GO:0003723
GO:0098843;postsynaptic endocytic zone;138;62;GO:0003723
GO:0072234;metanephric nephron tubule development;1393;313;GO:0046649
GO:0098844;postsynaptic endocytic zone membrane;16;64;GO:0005747
GO:0072233;metanephric thick ascending limb development;77;333;GO:0050729
GO:0098841;protein localization to cell division site after cytokinesis;63;1;GO:0005518
GO:0072232;metanephric proximal convoluted tubule segment 2 development;40;2;GO:0004866
GO:0098842;postsynaptic early endosome;87;9;GO:0046649
GO:0072239;metanephric glomerulus vasculature development;307;4;GO:0004721
GO:0098847;sequence-specific single stranded DNA binding;8051;61;GO:0004073
GO:2000025;regulation of leaf formation;44;6;GO:0050727
GO:0072238;metanephric long nephron development;0;1;GO:0004866
GO:0098848;alpha-D-ribose 1-methylphosphonate 5-phosphate C-P-lyase activity;10129;5;GO:0050729
GO:2000024;regulation of leaf development;681;56;GO:0050729
GO:0072237;metanephric proximal tubule development;135;6;GO:0050729
GO:0098845;postsynaptic endosome;500;204;GO:0008610
GO:2000023;regulation of lateral root development;283;9;GO:0005794
GO:0072236;metanephric loop of Henle development;241;8;GO:0004974
GO:0098846;podocyte foot;65;6;GO:0005125
GO:2000022;regulation of jasmonic acid mediated signaling pathway;8080;730;GO:0004872
GO:0035246;peptidyl-arginine N-methylation;53;583;GO:0005125
GO:2000029;regulation of proanthocyanidin biosynthetic process;17;2;GO:0005125
GO:0035247;peptidyl-arginine omega-N-methylation;45;650;GO:0005125
GO:2000028;regulation of photoperiodism, flowering;5280;123;GO:0005125
GO:0035248;alpha-1,4-N-acetylgalactosaminyltransferase activity;146;22;GO:0005125
GO:0098849;cellular detoxification of cadmium ion;361;5;GO:0005125
GO:2000027;regulation of animal organ morphogenesis;8974;722;GO:0005125
GO:0035249;synaptic transmission, glutamatergic;3845;3190;GO:0046649
GO:2000026;regulation of multicellular organismal development;138233;2720;GO:0005515
GO:0060200;clathrin-sculpted acetylcholine transport vesicle;9;8;GO:0046649
GO:0060201;clathrin-sculpted acetylcholine transport vesicle membrane;9;50;GO:0050729
GO:2000043;regulation of cardiac cell fate specification;101;7;GO:0050729
GO:2000042;negative regulation of double-strand break repair via homologous recombination;2497;174;GO:0004842
GO:2000041;negative regulation of planar cell polarity pathway involved in axis elongation;111;24;GO:0004867
GO:2000040;regulation of planar cell polarity pathway involved in axis elongation;112;6;GO:0004842
GO:0047228;1,2-diacylglycerol 3-glucosyltransferase activity;971;3;GO:0006629
GO:0060206;estrous cycle phase;0;9;GO:0004842
GO:1903722;regulation of centriole elongation;419;26;GO:0050729
GO:0047227;indolylacetyl-myo-inositol galactosyltransferase activity;0;3;GO:0005581
GO:0060207;diestrus;0;2;GO:0048193
GO:1903723;negative regulation of centriole elongation;120;2;GO:0050729
GO:0060208;proestrus;0;2;GO:0008033
GO:1903720;negative regulation of I-kappaB phosphorylation;5;4;GO:0005515
GO:0047225;acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;103;9;GO:0048195
GO:0060209;estrus;0;4;GO:0004518
GO:1903721;positive regulation of I-kappaB phosphorylation;279;57;GO:0004842
GO:0060202;clathrin-sculpted acetylcholine transport vesicle lumen;0;1;GO:0046649
GO:1903726;negative regulation of phospholipid metabolic process;471;8;GO:0007049
GO:0060203;clathrin-sculpted glutamate transport vesicle membrane;22;23;GO:0004842
GO:1903727;positive regulation of phospholipid metabolic process;694;211;GO:0050729
GO:0060204;clathrin-sculpted glutamate transport vesicle lumen;0;2;GO:0046649
GO:1903724;positive regulation of centriole elongation;299;6;GO:0008030
GO:0047229;13-hydroxydocosanoate 13-beta-glucosyltransferase activity;0;2;GO:0008037
GO:0060205;cytoplasmic vesicle lumen;6302;1640;GO:0050729
GO:1903725;regulation of phospholipid metabolic process;2217;207;GO:0004518
GO:0047231;pyridoxine 5'-O-beta-D-glucosyltransferase activity;0;0;GO:0004974
GO:0050872;white fat cell differentiation;762;483;GO:0048608
GO:1903719;regulation of I-kappaB phosphorylation;284;10;GO:0005739
GO:0047230;flavonol-3-O-glucoside L-rhamnosyltransferase activity;6;5;GO:0032501
GO:0050873;brown fat cell differentiation;2537;1460;GO:0005125
GO:0050870;positive regulation of T cell activation;75625;3050;GO:0005125
GO:0050871;positive regulation of B cell activation;5469;945;GO:0005125
GO:0047235;sucrose 6F-alpha-galactotransferase activity;0;3;GO:0005125
GO:0098810;neurotransmitter reuptake;4415;110;GO:0005125
GO:0047234;raffinose-raffinose alpha-galactotransferase activity;34;3;GO:0005125
GO:0047233;N-acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase activity;0;3;GO:0005125
GO:0047232;galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,6-N-acetylglucosaminyltransferase activity;0;1;GO:0005125
GO:0098814;spontaneous synaptic transmission;624;48;GO:0004872
GO:2000036;regulation of stem cell population maintenance;6567;148;GO:0005125
GO:0098815;modulation of excitatory postsynaptic potential;1394;253;GO:0046330
GO:2000035;regulation of stem cell division;575;71;GO:0032724
GO:0050878;regulation of body fluid levels;73198;2860;GO:0050729
GO:2000034;regulation of seed maturation;216;20;GO:0002768
GO:0050879;multicellular organismal movement;3139;346;GO:0050729
GO:0098813;nuclear chromosome segregation;109947;740;GO:0004872
GO:2000033;regulation of seed dormancy process;173;23;GO:0004725
GO:0098818;hyperpolarization of postsynaptic membrane;0;2;GO:0005840
GO:0050877;nervous system process;825680;3240;GO:0004723
GO:0098819;depolarization of postsynaptic membrane;0;2;GO:0002768
GO:2000039;regulation of trichome morphogenesis;62;5;GO:0050729
GO:0098816;mini excitatory postsynaptic potential;65;3;GO:0008544
GO:2000038;regulation of stomatal complex development;529;24;GO:0009065
GO:0098817;evoked excitatory postsynaptic potential;2;2;GO:0005840
GO:2000037;regulation of stomatal complex patterning;16;6;GO:0004842
GO:2000050;regulation of non-canonical Wnt signaling pathway;1469;1450;GO:0050727
GO:2000054;negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification;185;10;GO:0004842
GO:1903730;regulation of phosphatidate phosphatase activity;33;3;GO:0050729
GO:2000053;regulation of Wnt signaling pathway involved in dorsal/ventral axis specification;271;8;GO:0003690
GO:2000052;positive regulation of non-canonical Wnt signaling pathway;843;68;GO:0004846
GO:2000051;negative regulation of non-canonical Wnt signaling pathway;258;128;GO:0050729
GO:0047239;hydroxymandelonitrile glucosyltransferase activity;0;2;GO:0005524
GO:0047238;glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity;956;32;GO:0004842
GO:0047237;glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity;126;35;GO:0050729
GO:0047236;methyl-ONN-azoxymethanol beta-D-glucosyltransferase activity;0;3;GO:0005125
GO:0047242;hydroxyanthraquinone glucosyltransferase activity;0;2;GO:0050729
GO:0050883;musculoskeletal movement, spinal reflex action;46;146;GO:0050727
GO:0047241;lipopolysaccharide N-acetylmannosaminouronosyltransferase activity;3323;5;GO:0042995
GO:0050884;neuromuscular process controlling posture;972;1110;GO:0032727
GO:0047240;lactosylceramide beta-1,3-galactosyltransferase activity;0;4;GO:0032989
GO:0050881;musculoskeletal movement;2957;379;GO:0050729
GO:1903728;luteal cell differentiation;0;0;GO:0005125
GO:0050882;voluntary musculoskeletal movement;321;52;GO:0006099
GO:1903729;regulation of plasma membrane organization;61202;8;GO:0004872
GO:0047246;luteolin-7-O-glucuronide 7-O-glucuronosyltransferase activity;0;2;GO:0005576
GO:0098821;BMP receptor activity;426;253;GO:0005125
GO:0047245;N-acetylglucosaminyldiphosphoundecaprenol glucosyltransferase activity;0;2;GO:0009065
GO:0098822;peptidyl-cysteine modification to L-cysteine persulfide;0;1;GO:0043408
GO:0047244;N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase activity;12685;5;GO:0005125
GO:0047243;flavanone 7-O-beta-glucosyltransferase activity;4;2;GO:0005737
GO:0098820;trans-synaptic protein complex;31;1;GO:0005125
GO:0098825;peptidyl-histidine guanylation;0;2;GO:0005737
GO:2000047;regulation of cell-cell adhesion mediated by cadherin;923;10;GO:0005125
GO:0098826;endoplasmic reticulum tubular network membrane;3369;69;GO:0005737
GO:0050889;determination of stimulus intensity;0;1;GO:0005125
GO:0098823;peptidyl-cysteine modification to S-amindino-L-cysteine;0;1;GO:0005125
GO:2000045;regulation of G1/S transition of mitotic cell cycle;7397;602;GO:0009086
GO:0098824;peptidyl-cysteine sulfation;0;1;GO:0003779
GO:2000044;negative regulation of cardiac cell fate specification;48;1;GO:0004553
GO:0050887;determination of sensory modality;0;2;GO:0004465
GO:0098829;intestinal folate absorption;1;4;GO:0005746
GO:0050888;determination of stimulus location;0;0;GO:0005737
GO:0050885;neuromuscular process controlling balance;3617;3100;GO:0005524
GO:0098827;endoplasmic reticulum subcompartment;1013323;282;GO:0004553
GO:2000049;positive regulation of cell-cell adhesion mediated by cadherin;411;147;GO:0005125
GO:0050886;endocrine process;6084;752;GO:0004497
GO:0098828;modulation of inhibitory postsynaptic potential;93;34;GO:0004518
GO:2000048;negative regulation of cell-cell adhesion mediated by cadherin;432;329;GO:0004872
GO:0060220;camera-type eye photoreceptor cell fate commitment;172;5;GO:0005524
GO:2000061;regulation of ureter smooth muscle cell differentiation;84;0;GO:0048193
GO:0060221;retinal rod cell differentiation;1045;185;GO:0004730
GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process;8597;389;GO:0022610
GO:0060222;regulation of retinal cone cell fate commitment;5;2;GO:0048193
GO:0060223;retinal rod cell fate commitment;6;1;GO:0048608
GO:1903740;positive regulation of phosphatidate phosphatase activity;8;3;GO:0003723
GO:2000065;negative regulation of cortisol biosynthetic process;226;59;GO:0005578
GO:1903741;negative regulation of phosphatidate phosphatase activity;24;3;GO:0048169
GO:2000064;regulation of cortisol biosynthetic process;382;10;GO:0006836
GO:2000063;positive regulation of ureter smooth muscle cell differentiation;42;3;GO:0032940
GO:2000062;negative regulation of ureter smooth muscle cell differentiation;42;3;GO:0032727
GO:0060228;phosphatidylcholine-sterol O-acyltransferase activator activity;296;383;GO:0009987
GO:1903744;positive regulation of anterograde synaptic vesicle transport;46;4;GO:0010467
GO:0047249;sarsapogenin 3-beta-glucosyltransferase activity;0;2;GO:0043169
GO:0060229;lipase activator activity;808;26;GO:0050921
GO:1903745;negative regulation of nematode pharyngeal pumping;28;0;GO:0050921
GO:0047248;nuatigenin 3-beta-glucosyltransferase activity;2;2;GO:0022610
GO:1903742;regulation of anterograde synaptic vesicle transport;60;1;GO:0005085
GO:0047247;luteolin-7-O-diglucuronide 4'-O-glucuronosyltransferase activity;0;0;GO:0032724
GO:1903743;negative regulation of anterograde synaptic vesicle transport;8;1;GO:0005125
GO:0060224;regulation of retinal rod cell fate commitment;0;2;GO:0004067
GO:1903748;negative regulation of establishment of protein localization to mitochondrion;266;32;GO:0007049
GO:0060225;positive regulation of retinal rod cell fate commitment;0;2;GO:0009065
GO:1903749;positive regulation of establishment of protein localization to mitochondrion;408;48;GO:0004497
GO:0060226;negative regulation of retinal cone cell fate commitment;5;1;GO:0005634
GO:1903746;positive regulation of nematode pharyngeal pumping;34;0;GO:0004061
GO:0060227;Notch signaling pathway involved in camera-type eye photoreceptor fate commitment;0;2;GO:0006457
GO:1903747;regulation of establishment of protein localization to mitochondrion;947;49;GO:0004497
GO:0047253;alpha-1,6-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity;16;2;GO:0004723
GO:0050894;determination of affect;38;72;GO:0005576
GO:0047252;beta-mannosylphosphodecaprenol-mannooligosaccharide 6-mannosyltransferase activity;0;3;GO:0004721
GO:0047251;thiohydroximate beta-D-glucosyltransferase activity;13;5;GO:0004073
GO:0050892;intestinal absorption;2010;1110;GO:0003723
GO:0047250;4-hydroxybenzoate 4-O-beta-D-glucosyltransferase activity;2;2;GO:0005524
GO:0050893;sensory processing;104;27;GO:0007596
GO:0047257;diglucosyl diacylglycerol synthase activity;32;4;GO:0005667
GO:0050890;cognition;19299;3260;GO:0016021
GO:0072202;cell differentiation involved in metanephros development;1331;140;GO:0043405
GO:0047256;lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity;18;67;GO:0005215
GO:0050891;multicellular organismal-level water homeostasis;1810;10;GO:0045944
GO:0072201;negative regulation of mesenchymal cell proliferation;461;88;GO:0007049
GO:0047255;galactogen 6-beta-galactosyltransferase activity;0;2;GO:0050729
GO:0072200;negative regulation of mesenchymal cell proliferation involved in ureter development;68;19;GO:0008511
GO:0047254;2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-D-glucosyltransferase activity;6;0;GO:0030154
GO:0072206;metanephric juxtaglomerular apparatus development;28;4;GO:0050727
GO:2000058;regulation of ubiquitin-dependent protein catabolic process;15195;324;GO:0006067
GO:0072205;metanephric collecting duct development;361;27;GO:0050729
GO:2000057;negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis;57;4;GO:0005515
GO:0072204;cell-cell signaling involved in metanephros development;104;20;GO:0050729
GO:2000056;regulation of Wnt signaling pathway involved in digestive tract morphogenesis;58;0;GO:0005576
GO:0072203;cell proliferation involved in metanephros development;288;319;GO:0005840
GO:2000055;positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification;49;3;GO:0050729
GO:0050898;nitrile metabolic process;106;9;GO:0005840
GO:0050899;nitrile catabolic process;2;1;GO:0046330
GO:0072209;metanephric mesangial cell differentiation;60;7;GO:0005544
GO:0050896;response to stimulus;35577860;18800;GO:0050729
GO:0072208;metanephric smooth muscle tissue development;109;8;GO:0005575
GO:0050897;cobalt ion binding;55677;992;GO:0050729
GO:0072207;metanephric epithelium development;2001;284;GO:0046649
GO:2000059;negative regulation of ubiquitin-dependent protein catabolic process;2772;213;GO:0046649
GO:0035297;regulation of Malpighian tubule diameter;46;42;GO:0005576
GO:0035298;regulation of Malpighian tubule size;57;7;GO:0005576
GO:0060210;metestrus;0;4;GO:0004872
GO:2000071;regulation of defense response by callose deposition;60;5;GO:0048193
GO:0035299;inositol pentakisphosphate 2-kinase activity;12675;44;GO:0005576
GO:0060211;regulation of nuclear-transcribed mRNA poly(A) tail shortening;1161;222;GO:0004872
GO:0098809;nitrite reductase activity;93159;22;GO:0048285
GO:2000070;regulation of response to water deprivation;709;58;GO:0016567
GO:0060212;negative regulation of nuclear-transcribed mRNA poly(A) tail shortening;80;5;GO:0016567
GO:0035293;chitin-based larval cuticle pattern formation;184;10;GO:0009986
GO:1903751;negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;352;31;GO:0000922
GO:2000076;positive regulation of cytokinesis, site selection;5;0;GO:0006873
GO:0035294;determination of wing disc primordium;25;7;GO:0046649
GO:1903752;positive regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;0;0;GO:0004722
GO:2000075;negative regulation of cytokinesis, site selection;0;0;GO:0009065
GO:0035295;tube development;155267;2710;GO:0004553
GO:2000074;regulation of type B pancreatic cell development;272;159;GO:0009065
GO:0035296;regulation of tube diameter;39607;187;GO:0048608
GO:1903750;regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;352;5;GO:0004930
GO:2000073;regulation of cytokinesis, site selection;29;1;GO:0050729
GO:0060217;hemangioblast cell differentiation;275;9;GO:0004930
GO:1903755;positive regulation of SUMO transferase activity;1;6;GO:0046330
GO:0035290;trunk segmentation;415;200;GO:0005520
GO:0060218;hematopoietic stem cell differentiation;2947;658;GO:0006874
GO:0035291;specification of segmental identity, intercalary segment;1;5;GO:0050729
GO:0047259;glucomannan 4-beta-mannosyltransferase activity;127;6;GO:0006810
GO:0060219;camera-type eye photoreceptor cell differentiation;2676;67;GO:0046649
GO:1903753;negative regulation of p38MAPK cascade;561;83;GO:0050729
GO:0035292;specification of segmental identity, trunk;96;5;GO:0006874
GO:0047258;sphingosine beta-galactosyltransferase activity;0;3;GO:0048608
GO:1903754;cortical microtubule plus-end;43;4;GO:0050729
GO:0060213;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;985;600;GO:0032724
GO:0060214;endocardium formation;220;185;GO:0050729
GO:0060215;primitive hemopoiesis;1755;83;GO:0006811
GO:0060216;definitive hemopoiesis;2140;1810;GO:0007586
GO:0047264;heteroglycan alpha-mannosyltransferase activity;1;3;GO:0004872
GO:0047263;N-acylsphingosine galactosyltransferase activity;15;4;GO:0006790
GO:0047262;polygalacturonate 4-alpha-galacturonosyltransferase activity;7478;26;GO:0006022
GO:0047261;steroid N-acetylglucosaminyltransferase activity;0;3;GO:0007610
GO:0047268;galactinol-raffinose galactosyltransferase activity;49;8;GO:0006631
GO:0047267;undecaprenyl-phosphate mannosyltransferase activity;1420;3;GO:0006796
GO:0098800;inner mitochondrial membrane protein complex;187748;457;GO:0050727
GO:0047266;poly(ribitol-phosphate) beta-glucosyltransferase activity;6;3;GO:0050729
GO:0047265;poly(glycerol-phosphate) alpha-glucosyltransferase activity;999;4;GO:0006073
GO:0098803;respiratory chain complex;344461;861;GO:0008544
GO:2000069;regulation of post-embryonic root development;324;5;GO:0009952
GO:0098804;non-motile cilium membrane;0;2;GO:0006081
GO:2000068;regulation of defense response to insect;141;8;GO:0043403
GO:0098801;regulation of renal system process;1102;18;GO:0005215
GO:2000067;regulation of root morphogenesis;1826;8;GO:0006073
GO:0098802;plasma membrane signaling receptor complex;49297;149;GO:0016567
GO:2000066;positive regulation of cortisol biosynthetic process;48;2;GO:0046148
GO:0047260;alpha,alpha-trehalose-phosphate synthase (GDP-forming) activity;147;4;GO:0050729
GO:0098807;chloroplast thylakoid membrane protein complex;363;40;GO:0006541
GO:0098808;mRNA cap binding;2764;68;GO:0050727
GO:1901183;positive regulation of camalexin biosynthetic process;45;5;GO:0006073
GO:2000083;negative regulation of L-ascorbic acid biosynthetic process;1;0;GO:0050729
GO:1901182;regulation of camalexin biosynthetic process;45;1;GO:0006067
GO:2000082;regulation of L-ascorbic acid biosynthetic process;32;4;GO:0050729
GO:1901185;negative regulation of ERBB signaling pathway;1303;160;GO:0050729
GO:2000081;positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation;52;4;GO:0006810
GO:1901184;regulation of ERBB signaling pathway;5666;82;GO:0046330
GO:2000080;negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation;52;7;GO:0032724
GO:1901187;regulation of ephrin receptor signaling pathway;57;23;GO:0006958
GO:2000087;regulation of mesonephric glomerulus development;0;0;GO:0002456
GO:1901186;positive regulation of ERBB signaling pathway;1438;36;GO:0000922
GO:2000086;positive regulation of mesenchymal to epithelial transition involved in mesonephros morphogenesis;0;0;GO:0007596
GO:1901189;positive regulation of ephrin receptor signaling pathway;52;10;GO:0006958
GO:2000085;negative regulation of mesenchymal to epithelial transition involved in mesonephros morphogenesis;0;0;GO:0007596
GO:1901188;negative regulation of ephrin receptor signaling pathway;1;1;GO:0007548
GO:2000084;regulation of mesenchymal to epithelial transition involved in mesonephros morphogenesis;0;2;GO:0009579
GO:2000079;regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation;104;0;GO:0006954
GO:2000078;positive regulation of type B pancreatic cell development;101;149;GO:0006959
GO:2000077;negative regulation of type B pancreatic cell development;45;5;GO:0006958
GO:1901181;negative regulation of cellular response to caffeine;5;0;GO:0006958
GO:1901180;spheroidene biosynthetic process;4;1;GO:0006956
GO:1901194;negative regulation of formation of translation preinitiation complex;28;3;GO:0002757
GO:2000094;negative regulation of mesonephric nephron tubule epithelial cell differentiation;1;1;GO:0006958
GO:1901193;regulation of formation of translation preinitiation complex;103;1;GO:0005576
GO:2000093;regulation of mesonephric nephron tubule epithelial cell differentiation;1;1;GO:0005576
GO:1901196;positive regulation of calcium-mediated signaling involved in cellular response to salt stress;0;1;GO:0045944
GO:2000092;positive regulation of mesonephric glomerular mesangial cell proliferation;0;0;GO:0003854
GO:1901195;positive regulation of formation of translation preinitiation complex;75;5;GO:0005746
GO:2000091;negative regulation of mesonephric glomerular mesangial cell proliferation;0;0;GO:0005737
GO:1901198;positive regulation of calcium ion transport into cytosol involved in cellular response to calcium ion;0;3;GO:0005739
GO:2000098;negative regulation of smooth muscle cell-matrix adhesion;120;100;GO:0004867
GO:1901197;positive regulation of calcium-mediated signaling involved in cellular response to calcium ion;0;1;GO:0004721
GO:2000097;regulation of smooth muscle cell-matrix adhesion;243;136;GO:0006958
GO:2000096;positive regulation of Wnt signaling pathway, planar cell polarity pathway;402;331;GO:0006958
GO:1901199;positive regulation of calcium ion transport into cytosol involved in cellular response to salt stress;0;1;GO:0006958
GO:2000095;regulation of Wnt signaling pathway, planar cell polarity pathway;662;306;GO:0006958
GO:2000090;regulation of mesonephric glomerular mesangial cell proliferation;0;0;GO:0006956
GO:0072297;specification of metanephric proximal tubule identity;0;1;GO:0006958
GO:0072296;specification of metanephric loop of Henle identity;0;0;GO:0005929
GO:0072295;specification of metanephric distal tubule identity;0;1;GO:0005576
GO:0072294;specification of metanephric connecting tubule identity;0;0;GO:0002768
GO:0072299;negative regulation of metanephric glomerulus development;0;8;GO:0004553
GO:0072298;regulation of metanephric glomerulus development;63;3;GO:0004725
GO:2000089;positive regulation of mesonephric glomerulus development;0;0;GO:0022610
GO:2000088;negative regulation of mesonephric glomerulus development;0;0;GO:0005126
GO:1901190;regulation of formation of translation initiation ternary complex;8;0;GO:0006631
GO:1901192;positive regulation of formation of translation initiation ternary complex;0;0;GO:0005911
GO:1901191;negative regulation of formation of translation initiation ternary complex;0;0;GO:0005911
GO:2000099;regulation of establishment or maintenance of bipolar cell polarity;258;4;GO:0005576
GO:0060287;epithelial cilium movement involved in determination of left/right asymmetry;784;2140;GO:0008026
GO:0060288;formation of a compartment boundary;56;8;GO:0005578
GO:1901141;regulation of lignin biosynthetic process;133;218;GO:0004723
GO:0060289;compartment boundary maintenance;57;4;GO:0009065
GO:1901140;p-coumaryl alcohol transport;5;3;GO:0009065
GO:0060282;positive regulation of oocyte development;111;134;GO:0010717
GO:1901143;insulin catabolic process;134;27;GO:0005085
GO:0060283;negative regulation of oocyte development;52;10;GO:0005840
GO:1901142;insulin metabolic process;730;45;GO:0048193
GO:0060284;regulation of cell development;57449;1520;GO:0005525
GO:1901145;mesenchymal cell apoptotic process involved in nephron morphogenesis;179;4;GO:0005524
GO:0060285;cilium-dependent cell motility;31743;307;GO:0008061
GO:1901147;mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis;27;5;GO:0005524
GO:1901146;mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis;45;5;GO:0006936
GO:1901149;salicylic acid binding;31;2;GO:0005524
GO:1901148;gene expression involved in extracellular matrix organization;59;6;GO:0007050
GO:0072271;metanephric short descending thin limb development;0;1;GO:0005085
GO:0072270;metanephric short nephron development;0;0;GO:0007050
GO:0072264;metanephric glomerular endothelium development;2;1;GO:0048407
GO:0098894;extrinsic component of presynaptic endocytic zone membrane;195;2;GO:0022610
GO:0072263;metanephric intraglomerular mesangial cell proliferation;0;1;GO:0005986
GO:0098895;postsynaptic endosome membrane;78;1;GO:0005982
GO:0072262;metanephric glomerular mesangial cell proliferation involved in metanephros development;25;6;GO:0048193
GO:0098892;extrinsic component of postsynaptic specialization membrane;138;4;GO:0006979
GO:0072261;metanephric extraglomerular mesangial cell proliferation involved in metanephros development;0;2;GO:0048285
GO:0098893;extrinsic component of postsynaptic endocytic zone;0;0;GO:0048169
GO:0072268;pattern specification involved in metanephros development;188;25;GO:0004730
GO:0098898;dense core granule lumen;79;1;GO:0003700
GO:0072267;metanephric capsule specification;25;1;GO:0004073
GO:0098899;spine apparatus lumen;0;0;GO:0004553
GO:0072266;metanephric capsule formation;25;1;GO:0003676
GO:0098896;postsynaptic early endosome membrane;32;2;GO:0006099
GO:0072265;metanephric capsule morphogenesis;25;1;GO:0006974
GO:0098897;spine apparatus membrane;6;2;GO:0048608
GO:0060290;transdifferentiation;206;278;GO:0005215
GO:0060291;long-term synaptic potentiation;4525;2150;GO:0005737
GO:0001905;activation of membrane attack complex;66;103;GO:0009579
GO:0060292;long-term synaptic depression;1210;1650;GO:0005743
GO:0072269;metanephric long descending thin limb development;0;1;GO:0048193
GO:0001906;cell killing;109910;1300;GO:0005764
GO:0001907;killing by symbiont of host cells;15785;21;GO:0005576
GO:0001909;leukocyte mediated cytotoxicity;8416;607;GO:0007088
GO:0060275;maintenance of stationary phase in response to starvation;0;3;GO:0042127
GO:1901150;vistamycin metabolic process;0;3;GO:0008544
GO:0060276;maintenance of stationary phase in response to toxin;0;1;GO:0007067
GO:1901152;vistamycin biosynthetic process;0;2;GO:0003723
GO:0060278;regulation of ovulation;223;120;GO:0005730
GO:1901151;vistamycin catabolic process;0;0;GO:0006928
GO:0060271;cilium assembly;109198;4100;GO:0006936
GO:1901154;paromomycin catabolic process;0;0;GO:0004073
GO:0060272;embryonic skeletal joint morphogenesis;754;414;GO:0006936
GO:1901153;paromomycin metabolic process;0;1;GO:0004497
GO:0060273;crying behavior;0;1;GO:0004896
GO:1901156;neomycin metabolic process;6;1;GO:0005125
GO:0060274;maintenance of stationary phase;3;22;GO:0007067
GO:1901155;paromomycin biosynthetic process;0;0;GO:0048666
GO:1901158;neomycin biosynthetic process;6;0;GO:0006029
GO:1901157;neomycin catabolic process;0;0;GO:0003779
GO:1901159;xylulose 5-phosphate biosynthetic process;34835;7;GO:0006986
GO:0060279;positive regulation of ovulation;157;155;GO:0045595
GO:0072260;metanephric interstitial fibroblast fate commitment;0;0;GO:0007548
GO:0072253;metanephric juxtaglomerulus cell fate commitment;0;1;GO:0048608
GO:0072252;metanephric juxtaglomerulus cell development;0;1;GO:0007548
GO:0072251;metanephric juxtaglomerulus cell differentiation;0;2;GO:0007548
GO:0072250;metanephric podocyte cell fate commitment;0;1;GO:0005215
GO:0072257;metanephric nephron tubule epithelial cell differentiation;243;5;GO:0009579
GO:0001910;regulation of leukocyte mediated cytotoxicity;5634;647;GO:0048608
GO:0072256;metanephric glomerular mesangial cell fate commitment;0;0;GO:0007548
GO:0001911;negative regulation of leukocyte mediated cytotoxicity;937;1590;GO:0008565
GO:0072255;metanephric glomerular mesangial cell development;7;25;GO:0005125
GO:0001912;positive regulation of leukocyte mediated cytotoxicity;4309;537;GO:0005215
GO:0072254;metanephric glomerular mesangial cell differentiation;60;9;GO:0003924
GO:0001913;T cell mediated cytotoxicity;2391;1650;GO:0003723
GO:0001914;regulation of T cell mediated cytotoxicity;1709;881;GO:0008026
GO:0001915;negative regulation of T cell mediated cytotoxicity;301;1180;GO:0004870
GO:0060280;negative regulation of ovulation;58;1;GO:0005829
GO:0072259;metanephric interstitial fibroblast development;54;2;GO:0008037
GO:0001916;positive regulation of T cell mediated cytotoxicity;1308;1270;GO:0009086
GO:0060281;regulation of oocyte development;170;7;GO:0046872
GO:0072258;metanephric interstitial fibroblast differentiation;54;0;GO:0004872
GO:0001917;photoreceptor inner segment;5370;834;GO:0048305
GO:0001918;farnesylated protein binding;45;3;GO:0046271
GO:0001919;regulation of receptor recycling;3337;496;GO:0008856
GO:1901161;primary amino compound catabolic process;31935;2;GO:0005576
GO:1901160;primary amino compound metabolic process;48322;7;GO:0050727
GO:1901163;regulation of trophoblast cell migration;779;36;GO:0048193
GO:1901162;primary amino compound biosynthetic process;6069;18;GO:0048706
GO:1901165;positive regulation of trophoblast cell migration;342;164;GO:0010467
GO:1901164;negative regulation of trophoblast cell migration;326;149;GO:0005929
GO:1901167;3-chlorocatechol metabolic process;3;0;GO:0032727
GO:1901166;neural crest cell migration involved in autonomic nervous system development;360;146;GO:0051015
GO:1901169;3-chlorocatechol biosynthetic process;0;0;GO:0006418
GO:1901168;3-chlorocatechol catabolic process;3;0;GO:0046330
GO:0072293;specification of metanephric nephron tubule identity;0;1;GO:0006457
GO:0072292;epithelial cell migration involved in metanephric proximal tubule morphogenesis;0;1;GO:0003779
GO:0098880;maintenance of postsynaptic specialization structure;762;5;GO:0050727
GO:0072291;epithelial cell migration involved in metanephric distal tubule morphogenesis;0;0;GO:0000976
GO:0072290;epithelial cell migration involved in metanephric nephron tubule morphogenesis;0;1;GO:2001271
GO:0072286;metanephric connecting tubule development;56;2;GO:0009986
GO:0098872;G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration;53;1;GO:0002376
GO:0072285;mesenchymal to epithelial transition involved in metanephric renal vesicle formation;51;2;GO:0006865
GO:0098873;neuronal action potential back-propagation;0;0;GO:0004497
GO:0072284;metanephric S-shaped body morphogenesis;300;57;GO:0004866
GO:0098870;action potential propagation;494;51;GO:0008629
GO:0072283;metanephric renal vesicle morphogenesis;691;33;GO:0008083
GO:0098871;postsynaptic actin cytoskeleton;436;8;GO:0006986
GO:0098876;vesicle-mediated transport to the plasma membrane;36708;71;GO:0048169
GO:0072289;metanephric nephron tubule formation;136;35;GO:0048608
GO:0098877;neurotransmitter receptor transport to plasma membrane;1065;17;GO:0043161
GO:0072288;metanephric proximal tubule morphogenesis;0;1;GO:0006066
GO:0098874;spike train;48;3;GO:0004872
GO:0072287;metanephric distal tubule morphogenesis;37;24;GO:0007186
GO:0098875;epididymosome;4;0;GO:0030097
GO:0098878;neurotransmitter receptor complex;5011;63;GO:0042113
GO:0098879;structural constituent of postsynaptic specialization;332;1;GO:0003676
GO:0060297;regulation of sarcomere organization;668;448;GO:0043154
GO:1901172;phytoene metabolic process;0;2;GO:0005576
GO:0060298;positive regulation of sarcomere organization;348;33;GO:0016567
GO:0060299;negative regulation of sarcomere organization;63;7;GO:0009579
GO:1901174;phytoene biosynthetic process;0;1;GO:0009579
GO:1901173;phytoene catabolic process;0;0;GO:0009579
GO:0060293;germ plasm;5097;195;GO:0007596
GO:1901176;lycopene catabolic process;5;0;GO:0009579
GO:0060294;cilium movement involved in cell motility;30433;215;GO:0004812
GO:1901175;lycopene metabolic process;73;0;GO:0003924
GO:0060295;regulation of cilium movement involved in cell motility;1592;7;GO:0003690
GO:1901178;spheroidene metabolic process;4;0;GO:0003774
GO:0060296;regulation of cilium beat frequency involved in ciliary motility;567;97;GO:0046274
GO:1901177;lycopene biosynthetic process;68;0;GO:0046274
GO:1901179;spheroidene catabolic process;0;0;GO:0009536
GO:0072282;metanephric nephron tubule morphogenesis;316;7;GO:0048285
GO:0098890;extrinsic component of postsynaptic membrane;278;5;GO:0048667
GO:0072281;mesenchymal stem cell differentiation involved in metanephric nephron morphogenesis;0;1;GO:0006099
GO:0098891;extrinsic component of presynaptic active zone membrane;18;4;GO:0048285
GO:0072280;establishment of planar polarity involved in metanephric nephron morphogenesis;0;1;GO:0009579
GO:0072275;metanephric glomerulus morphogenesis;125;6;GO:0005812
GO:0098883;synapse pruning;725;287;GO:0009579
GO:0072274;metanephric glomerular basement membrane development;55;5;GO:0009579
GO:0098884;postsynaptic neurotransmitter receptor internalization;961;42;GO:0009579
GO:0072273;metanephric nephron morphogenesis;1493;20;GO:0016477
GO:0098881;exocytic insertion of neurotransmitter receptor to plasma membrane;0;9;GO:0048308
GO:0072272;proximal/distal pattern formation involved in metanephric nephron development;87;7;GO:0046330
GO:0098882;structural constituent of presynaptic active zone;323;7;GO:0009579
GO:0072279;convergent extension involved in metanephric nephron morphogenesis;0;0;GO:0048285
GO:0098887;neurotransmitter receptor transport, endosome to postsynaptic membrane;559;38;GO:0009579
GO:0072278;metanephric comma-shaped body morphogenesis;119;10;GO:0000910
GO:0098888;extrinsic component of presynaptic membrane;288;6;GO:0019827
GO:0072277;metanephric glomerular capillary formation;124;32;GO:0007062
GO:0098885;modification of postsynaptic actin cytoskeleton;427;9;GO:0044436
GO:0072276;metanephric glomerulus vasculature morphogenesis;124;4;GO:0004091
GO:0098886;modification of dendritic spine;126;5;GO:0044436
GO:1901170;naphthalene catabolic process;10984;4;GO:0008544
GO:0001820;serotonin secretion;542;78;GO:0003824
GO:0001821;histamine secretion;466;407;GO:0006836
GO:0001822;kidney development;38866;5200;GO:0005576
GO:0001823;mesonephros development;8338;1010;GO:0016569
GO:0001824;blastocyst development;5774;1230;GO:0006897
GO:0001825;blastocyst formation;2334;354;GO:0005085
GO:0001826;inner cell mass cell differentiation;434;98;GO:0030425
GO:0001827;inner cell mass cell fate commitment;145;26;GO:0030518
GO:0001828;inner cell mass cellular morphogenesis;137;34;GO:0030518
GO:0001829;trophectodermal cell differentiation;975;1160;GO:0097403
GO:0001830;trophectodermal cell fate commitment;53;19;GO:0005524
GO:0001831;trophectodermal cellular morphogenesis;98;96;GO:0043005
GO:0001832;blastocyst growth;1110;605;GO:0007268
GO:0001833;inner cell mass cell proliferation;606;809;GO:0048407
GO:0001834;trophectodermal cell proliferation;205;202;GO:0008092
GO:0001835;blastocyst hatching;1101;185;GO:0030528
GO:0001836;release of cytochrome c from mitochondria;3662;2340;GO:0048667
GO:0001837;epithelial to mesenchymal transition;10672;2300;GO:0005215
GO:0001838;embryonic epithelial tube formation;9386;482;GO:0042127
GO:0001839;neural plate morphogenesis;527;91;GO:0006081
GO:0001800;negative regulation of type IIb hypersensitivity;0;2;GO:0007623
GO:0001801;positive regulation of type IIb hypersensitivity;0;3;GO:0003700
GO:0001802;type III hypersensitivity;21;60;GO:0005524
GO:0001803;regulation of type III hypersensitivity;21;123;GO:0005576
GO:0001804;negative regulation of type III hypersensitivity;0;3;GO:0005634
GO:0001805;positive regulation of type III hypersensitivity;21;100;GO:0006364
GO:0001806;type IV hypersensitivity;206;23;GO:0048667
GO:0001807;regulation of type IV hypersensitivity;148;85;GO:0097458
GO:0001808;negative regulation of type IV hypersensitivity;50;135;GO:0048667
GO:0001809;positive regulation of type IV hypersensitivity;51;10;GO:0048666
GO:0001810;regulation of type I hypersensitivity;29;54;GO:0043005
GO:0001811;negative regulation of type I hypersensitivity;3;8;GO:0048608
GO:0001812;positive regulation of type I hypersensitivity;26;71;GO:0048666
GO:0001813;regulation of antibody-dependent cellular cytotoxicity;101;4;GO:0010468
GO:0001814;negative regulation of antibody-dependent cellular cytotoxicity;1;7;GO:0046274
GO:0001815;positive regulation of antibody-dependent cellular cytotoxicity;99;257;GO:0043005
GO:0001816;cytokine production;93249;4510;GO:0097403
GO:0001817;regulation of cytokine production;91878;3050;GO:0048666
GO:0001818;negative regulation of cytokine production;24474;1750;GO:0043005
GO:0001819;positive regulation of cytokine production;57774;4010;GO:0048704
GO:0001870;positive regulation of complement activation, lectin pathway;0;6;GO:0004930
GO:0001861;complement component C4b receptor activity;4;6;GO:0006810
GO:0001862;collectin binding;0;2;GO:0048608
GO:0001863;collectin receptor activity;0;2;GO:0048608
GO:0001864;pentraxin binding;1;3;GO:0048608
GO:0001865;NK T cell differentiation;579;65;GO:0009536
GO:0001866;NK T cell proliferation;498;98;GO:0048608
GO:0001867;complement activation, lectin pathway;5999;647;GO:0006486
GO:0001868;regulation of complement activation, lectin pathway;5431;40;GO:0006086
GO:0001869;negative regulation of complement activation, lectin pathway;94;52;GO:0008029
GO:0001880;Mullerian duct regression;219;50;GO:0003774
GO:0001881;receptor recycling;11075;605;GO:0003673
GO:0001882;nucleoside binding;147230;2940;GO:0003774
GO:0001872;(1->3)-beta-D-glucan binding;1081;0;GO:0008092
GO:0001873;polysaccharide immune receptor activity;11;1;GO:0006457
GO:0001874;(1->3)-beta-D-glucan immune receptor activity;5;0;GO:0006486
GO:0001875;lipopolysaccharide immune receptor activity;371;30;GO:0048608
GO:0001876;lipoarabinomannan binding;0;2;GO:0006091
GO:0001877;lipoarabinomannan immune receptor activity;0;1;GO:0009061
GO:0001878;response to yeast;779;337;GO:0003700
GO:0001879;detection of yeast;45;241;GO:0003700
GO:0001840;neural plate development;778;52;GO:0004725
GO:0001841;neural tube formation;7843;2370;GO:0004497
GO:0001842;neural fold formation;344;121;GO:0004067
GO:0001843;neural tube closure;6557;2560;GO:0007062
GO:0001844;protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;154;253;GO:0004067
GO:0001845;phagolysosome assembly;1072;51;GO:0004076
GO:0001846;opsonin binding;783;375;GO:0048608
GO:0001847;opsonin receptor activity;155;37;GO:0044464
GO:0001848;complement binding;1152;375;GO:0005739
GO:0001849;complement component C1q complex binding;456;90;GO:0006457
GO:0001860;complement component C3d receptor activity;0;2;GO:0002821
GO:0001850;complement component C3a binding;42;57;GO:0006955
GO:0001851;complement component C3b binding;204;71;GO:0046649
GO:0001852;complement component iC3b binding;0;3;GO:0042127
GO:0001853;complement component C3dg binding;0;4;GO:0016569
GO:0001854;complement component C3d binding;0;3;GO:0016569
GO:0001855;complement component C4b binding;53;30;GO:0016570
GO:0001856;complement component C5a binding;4;10;GO:0016569
GO:0001857;complement component C1q receptor activity;0;1;GO:0016569
GO:0001858;complement component iC3b receptor activity;0;1;GO:0005819
GO:0001859;complement component C3dg receptor activity;0;2;GO:0003735
GO:0035200;leg disc anterior/posterior pattern formation;0;2;GO:0006826
GO:0035201;leg disc anterior/posterior lineage restriction;0;2;GO:0009065
GO:0050838;peptidyl-5-hydroxy-L-lysine trimethylation;0;2;GO:0009987
GO:0050839;cell adhesion molecule binding;37082;3160;GO:0005576
GO:0050836;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl L-arginyl diiron disulfide;0;5;GO:0006486
GO:0050837;peptide cross-linking via L-cysteinyl-L-selenocysteine;0;5;GO:0005743
GO:0050834;molybdenum incorporation via L-cysteinyl copper sulfido molybdopterin cytosine dinucleotide;0;1;GO:0005576
GO:0050835;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl S-adenosylmethion-N,O-diyl tetrairon tetrasulfide;0;5;GO:0005819
GO:0050832;defense response to fungus;37019;5840;GO:0048193
GO:0050833;pyruvate transmembrane transporter activity;509;46;GO:0006464
GO:0050830;defense response to Gram-positive bacterium;7298;2890;GO:0009536
GO:0050831;male-specific defense response to bacterium;11;3;GO:0006974
GO:0050849;negative regulation of calcium-mediated signaling;1230;253;GO:0007165
GO:0050840;extracellular matrix binding;5930;1830;GO:0000786
GO:0047202;sinapoylglucose-choline O-sinapoyltransferase activity;9;3;GO:0003700
GO:0047201;beta-glucogallin O-galloyltransferase activity;0;3;GO:0007031
GO:0047200;tetrahydrodipicolinate N-acetyltransferase activity;9256;146;GO:0005737
GO:0050847;progesterone receptor signaling pathway;480;571;GO:0048285
GO:0050848;regulation of calcium-mediated signaling;4250;382;GO:0005764
GO:0050845;teichuronic acid biosynthetic process;7;4;GO:0006929
GO:0050846;teichuronic acid metabolic process;7;2;GO:0005819
GO:0050843;S-adenosylmethionine catabolic process;13;5;GO:0005737
GO:0050844;peptidyl-selenocysteine modification;0;3;GO:0003777
GO:0050841;peptidyl-N6,N6,N6-trimethyl-lysine hydroxylation to peptidyl-N6,N6,N6-trimethyl-5-hydroxy-L-lysine;0;1;GO:0004867
GO:0050842;copper incorporation via L-cysteinyl copper sulfido molybdopterin cytosine dinucleotide;0;2;GO:0006631
GO:0047206;UDP-N-acetylmuramoylpentapeptide-lysine N6-alanyltransferase activity;80;2;GO:0005524
GO:1903700;caecum development;0;0;GO:0004872
GO:0047205;quinate O-hydroxycinnamoyltransferase activity;23;4;GO:0003674
GO:1903701;substantia propria of cornea development;57;3;GO:0005524
GO:0047204;chlorogenate-glucarate O-hydroxycinnamoyltransferase activity;7;3;GO:0006865
GO:0047203;13-hydroxylupinine O-tigloyltransferase activity;6;4;GO:0005215
GO:0001890;placenta development;8372;2160;GO:0008047
GO:1903704;negative regulation of siRNA processing;0;1;GO:0048193
GO:0001891;phagocytic cup;1538;1160;GO:0006955
GO:0047209;coniferyl-alcohol glucosyltransferase activity;68;7;GO:0005515
GO:1903705;positive regulation of siRNA processing;12;2;GO:0043005
GO:0001892;embryonic placenta development;4873;1210;GO:0048193
GO:0047208;o-dihydroxycoumarin 7-O-glucosyltransferase activity;0;3;GO:0048193
GO:1903702;esophagus development;0;0;GO:0004867
GO:0001893;maternal placenta development;1343;900;GO:0006631
GO:0047207;1,2-beta-fructan 1F-fructosyltransferase activity;14;1;GO:0005913
GO:1903703;enterocyte differentiation;104;4;GO:0007517
GO:0001883;purine nucleoside binding;992;1980;GO:0048193
GO:0050850;positive regulation of calcium-mediated signaling;1886;697;GO:0005524
GO:0001884;pyrimidine nucleoside binding;4;86;GO:0097367
GO:0050851;antigen receptor-mediated signaling pathway;14384;1310;GO:0097159
GO:0001885;endothelial cell development;3410;327;GO:0003735
GO:0001886;endothelial cell morphogenesis;440;868;GO:0097367
GO:0001887;selenium compound metabolic process;169;196;GO:0019825
GO:0047213;anthocyanidin 3-O-glucosyltransferase activity;1675;8;GO:0009536
GO:0001888;glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;168;56;GO:0019827
GO:0047212;2-coumarate O-beta-glucosyltransferase activity;0;4;GO:0009416
GO:0001889;liver development;10696;3360;GO:0008565
GO:0047211;alpha-1,4-glucan-protein synthase (ADP-forming) activity;0;3;GO:0004867
GO:0050858;negative regulation of antigen receptor-mediated signaling pathway;1369;742;GO:0005200
GO:0050859;negative regulation of B cell receptor signaling pathway;339;96;GO:0005201
GO:0050856;regulation of T cell receptor signaling pathway;2154;879;GO:0048407
GO:0050857;positive regulation of antigen receptor-mediated signaling pathway;1902;2090;GO:0002504
GO:0050854;regulation of antigen receptor-mediated signaling pathway;4129;963;GO:0005576
GO:0050855;regulation of B cell receptor signaling pathway;1928;2300;GO:0002474
GO:0050852;T cell receptor signaling pathway;7438;4950;GO:0005766
GO:0050853;B cell receptor signaling pathway;6754;3980;GO:0005783
GO:0047217;sucrose-1,6-alpha-glucan 3(6)-alpha-glucosyltransferase activity;0;0;GO:0009536
GO:1903711;spermidine transmembrane transport;7615;4;GO:0005742
GO:0047216;inositol 3-alpha-galactosyltransferase activity;837;9;GO:0009536
GO:1903712;cysteine transmembrane transport;486;4;GO:0009536
GO:0047215;indole-3-acetate beta-glucosyltransferase activity;54;5;GO:0006486
GO:0047214;cyanidin-3-rhamnosylglucoside 5-O-glucosyltransferase activity;2;3;GO:0006486
GO:1903710;spermine transmembrane transport;154;3;GO:0009065
GO:1903715;regulation of aerobic respiration;1998;139;GO:0006066
GO:1903716;guanine transmembrane transport;575;2;GO:0004601
GO:0047219;monoterpenol beta-glucosyltransferase activity;0;2;GO:0043169
GO:1903713;asparagine transmembrane transport;65;2;GO:0030198
GO:0047218;hydroxycinnamate 4-beta-glucosyltransferase activity;10;3;GO:0005525
GO:1903714;isoleucine transmembrane transport;67;0;GO:0005576
GO:0001894;tissue homeostasis;16623;1110;GO:0005509
GO:0047220;galactosylxylosylprotein 3-beta-galactosyltransferase activity;125;8;GO:0006099
GO:0050861;positive regulation of B cell receptor signaling pathway;970;85;GO:0006030
GO:1903708;positive regulation of hemopoiesis;10413;340;GO:0046394
GO:0001895;retina homeostasis;5864;1340;GO:0042127
GO:0050862;positive regulation of T cell receptor signaling pathway;885;244;GO:0007049
GO:1903709;uterine gland development;50;1;GO:0000070
GO:0001896;autolysis;256;12;GO:0005216
GO:1903706;regulation of hemopoiesis;27955;1100;GO:0005216
GO:0001897;cytolysis by symbiont of host cells;12934;64;GO:0010467
GO:0050860;negative regulation of T cell receptor signaling pathway;1030;579;GO:0046649
GO:1903707;negative regulation of hemopoiesis;5944;121;GO:0022836
GO:0047224;acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity;10;2;GO:0046649
GO:0047223;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity;99;27;GO:0008061
GO:0047222;mannotetraose 2-alpha-N-acetylglucosaminyltransferase activity;0;3;GO:0048193
GO:0047221;sn-glycerol-3-phosphate 2-alpha-galactosyltransferase activity;0;2;GO:0048193
GO:0050869;negative regulation of B cell activation;1600;692;GO:0048169
GO:0050867;positive regulation of cell activation;86231;1700;GO:0045735
GO:0050868;negative regulation of T cell activation;9109;841;GO:0005244
GO:0050865;regulation of cell activation;113334;1780;GO:0045727
GO:0050866;negative regulation of cell activation;16393;809;GO:0008026
GO:0050863;regulation of T cell activation;90671;2880;GO:0045727
GO:0050864;regulation of B cell activation;9049;1050;GO:0019882
GO:0035242;protein-arginine omega-N asymmetric methyltransferase activity;1577;389;GO:0019882
GO:0035243;protein-arginine omega-N symmetric methyltransferase activity;8943;35;GO:0005515
GO:0035244;protein-arginine C-methyltransferase activity;3;2;GO:0002474
GO:0035240;dopamine binding;1488;679;GO:0019882
GO:0035241;protein-arginine omega-N monomethyltransferase activity;1472;224;GO:0030528
GO:0035239;tube morphogenesis;112627;2570;GO:0004622
GO:0035235;ionotropic glutamate receptor signaling pathway;85237;3890;GO:0002474
GO:0035236;proctolin receptor activity;13;1;GO:0006749
GO:0035237;corazonin receptor activity;33;3;GO:0004867
GO:0035238;vitamin A biosynthetic process;16;16;GO:0004721
GO:0035231;cytoneme assembly;37;5;GO:0048169
GO:0035232;germ cell attraction;16;5;GO:0006879
GO:0035233;germ cell repulsion;58;4;GO:0046686
GO:0050809;diazepam binding;7;3;GO:0007548
GO:0035234;ectopic germ cell programmed cell death;951;516;GO:0044464
GO:0050807;regulation of synapse organization;20917;1040;GO:0022836
GO:0050808;synapse organization;48945;4120;GO:0022836
GO:0050805;negative regulation of synaptic transmission;2022;932;GO:0005829
GO:0035230;cytoneme;147;3;GO:0008021
GO:0050806;positive regulation of synaptic transmission;7777;2120;GO:0005829
GO:0035228;negative regulation of glutamate-cysteine ligase activity;0;3;GO:0008092
GO:0050803;regulation of synapse structure or activity;21598;945;GO:0007049
GO:0035229;positive regulation of glutamate-cysteine ligase activity;7;6;GO:0005509
GO:0050804;modulation of chemical synaptic transmission;40914;2170;GO:0005829
GO:0050801;monoatomic ion homeostasis;516974;82;GO:0005244
GO:0050802;circadian sleep/wake cycle, sleep;3757;50;GO:0005929
GO:0035224;genital disc anterior/posterior pattern formation;92;23;GO:0022836
GO:0035225;determination of genital disc primordium;128;10;GO:0000786
GO:0035226;glutamate-cysteine ligase catalytic subunit binding;2508;10;GO:0043588
GO:0035227;regulation of glutamate-cysteine ligase activity;7;3;GO:0051704
GO:0035220;wing disc development;6963;265;GO:0045595
GO:0035221;genital disc pattern formation;92;2;GO:0048608
GO:0035222;wing disc pattern formation;985;149;GO:0048169
GO:0035223;leg disc pattern formation;195;13;GO:0042995
GO:0050818;regulation of coagulation;9345;1040;GO:0008092
GO:0050819;negative regulation of coagulation;7348;1140;GO:0009405
GO:0050816;phosphothreonine residue binding;122;9;GO:0048169
GO:0050817;coagulation;54313;2260;GO:0005524
GO:0035217;labial disc development;51;129;GO:0006073
GO:0050814;epothilone biosynthetic process;2;4;GO:0050729
GO:0035218;leg disc development;1348;86;GO:0005576
GO:0050815;phosphoserine residue binding;822;9;GO:0045595
GO:0035219;prothoracic disc development;0;2;GO:0006541
GO:0050812;regulation of acyl-CoA biosynthetic process;343;473;GO:0045582
GO:0050813;epothilone metabolic process;2;1;GO:0009061
GO:0035213;clypeo-labral disc development;70;2;GO:0045595
GO:0050810;regulation of steroid biosynthetic process;4498;411;GO:0006552
GO:0035214;eye-antennal disc development;918;106;GO:0005911
GO:0050811;GABA receptor binding;1042;759;GO:0006548
GO:0035215;genital disc development;831;39;GO:0030163
GO:0035216;haltere disc development;148;2;GO:0006559
GO:0035210;prepupal development;178;7;GO:0016021
GO:0035211;spermathecum morphogenesis;31;9;GO:0007548
GO:0035212;cell competition in a multicellular organism;258;20;GO:0008544
GO:0050829;defense response to Gram-negative bacterium;10047;1800;GO:0005576
GO:2000109;regulation of macrophage apoptotic process;202;10;GO:0016021
GO:2000108;positive regulation of leukocyte apoptotic process;1258;50;GO:0005515
GO:2000107;negative regulation of leukocyte apoptotic process;2840;192;GO:0016020
GO:0035206;regulation of hemocyte proliferation;360;180;GO:0005215
GO:0050825;ice binding;1816;39;GO:0005886
GO:2000102;negative regulation of mammary stem cell proliferation;0;2;GO:0005576
GO:0035207;negative regulation of hemocyte proliferation;74;7;GO:0005886
GO:0050826;response to freezing;263;961;GO:0046649
GO:2000101;regulation of mammary stem cell proliferation;42;1;GO:0046649
GO:0035208;positive regulation of hemocyte proliferation;52;8;GO:0045595
GO:0050823;peptide antigen stabilization;6;14;GO:0045595
GO:2000100;regulation of establishment or maintenance of bipolar cell polarity regulating cell shape;258;4;GO:0045595
GO:0035209;pupal development;193;15;GO:0046649
GO:0035202;tracheal pit formation in open tracheal system;103;9;GO:0046649
GO:0050821;protein stabilization;37927;3950;GO:0006555
GO:2000106;regulation of leukocyte apoptotic process;4638;112;GO:0042605
GO:0035203;regulation of lamellocyte differentiation;80;7;GO:0043407
GO:0050822;peptide stabilization;6;5;GO:0044421
GO:2000105;positive regulation of DNA-templated DNA replication;1027;4;GO:0050727
GO:0035204;negative regulation of lamellocyte differentiation;66;8;GO:0044421
GO:2000104;negative regulation of DNA-templated DNA replication;13561;4;GO:0046649
GO:0035205;positive regulation of lamellocyte differentiation;13;3;GO:0016021
GO:0050820;positive regulation of coagulation;2094;1050;GO:0005737
GO:2000103;positive regulation of mammary stem cell proliferation;42;2;GO:0050727
GO:1903641;positive regulation of gastrin-induced gastric acid secretion;0;1;GO:0046395
GO:2000362;negative regulation of prostaglandin-E synthase activity;0;1;GO:0048193
GO:1903642;regulation of recombination hotspot binding;0;1;GO:0009062
GO:2000361;regulation of prostaglandin-E synthase activity;5;1;GO:0030528
GO:2000360;negative regulation of binding of sperm to zona pellucida;120;83;GO:0009062
GO:1903640;negative regulation of gastrin-induced gastric acid secretion;16;3;GO:0046274
GO:1903645;negative regulation of chaperone-mediated protein folding;132;2;GO:0008092
GO:1903646;positive regulation of chaperone-mediated protein folding;10;4;GO:0006810
GO:1903643;positive regulation of recombination hotspot binding;0;3;GO:0005886
GO:1903644;regulation of chaperone-mediated protein folding;199;152;GO:0005216
GO:1903649;regulation of cytoplasmic transport;5991;30;GO:0006067
GO:1903647;negative regulation of chlorophyll catabolic process;4;0;GO:0048285
GO:1903648;positive regulation of chlorophyll catabolic process;8;0;GO:0005216
GO:0050553;taxadiene synthase activity;8;6;GO:0046271
GO:0050554;abietadiene synthase activity;12;4;GO:0006810
GO:0050551;myrcene synthase activity;55;7;GO:0046148
GO:0050552;(4S)-limonene synthase activity;21;0;GO:0010467
GO:0050550;pinene synthase activity;26;6;GO:0005216
GO:2000355;negative regulation of ovarian follicle development;71;4;GO:0009065
GO:2000354;regulation of ovarian follicle development;293;10;GO:0010467
GO:0050559;copalyl diphosphate synthase activity;49;3;GO:0046274
GO:2000353;positive regulation of endothelial cell apoptotic process;834;763;GO:0030528
GO:2000352;negative regulation of endothelial cell apoptotic process;1561;683;GO:0005216
GO:0050557;deacetylipecoside synthase activity;0;2;GO:0046395
GO:2000359;regulation of binding of sperm to zona pellucida;136;10;GO:0048193
GO:0050558;maltose epimerase activity;630;2;GO:0005216
GO:2000358;positive regulation of kidney smooth muscle cell differentiation;42;3;GO:0050727
GO:0050555;2-hydroxypropyl-CoM lyase activity;299;4;GO:0022836
GO:2000357;negative regulation of kidney smooth muscle cell differentiation;42;3;GO:0045087
GO:0050556;deacetylisoipecoside synthase activity;0;3;GO:0008092
GO:2000356;regulation of kidney smooth muscle cell differentiation;84;0;GO:0048608
GO:1903652;modulation by virus of host cytoplasmic transport;1;1;GO:0005126
GO:2000373;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;27;34;GO:0045727
GO:1903653;modulation by symbiont of host cell motility;0;0;GO:0045727
GO:2000372;negative regulation of DNA topoisomerase (ATP-hydrolyzing) activity;1;5;GO:0046649
GO:1903650;negative regulation of cytoplasmic transport;199;4;GO:0046148
GO:2000371;regulation of DNA topoisomerase (ATP-hydrolyzing) activity;28;9;GO:0045727
GO:1903651;positive regulation of cytoplasmic transport;667;235;GO:0005975
GO:2000370;positive regulation of clathrin-dependent endocytosis;300;28;GO:0009986
GO:1903656;regulation of type IV pilus biogenesis;1;0;GO:0030528
GO:1903657;negative regulation of type IV pilus biogenesis;0;0;GO:0009813
GO:1903658;positive regulation of type IV pilus biogenesis;1;2;GO:0048608
GO:1903659;regulation of complement-dependent cytotoxicity;233;46;GO:0006793
GO:0050564;N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase activity;81;0;GO:0008026
GO:0050565;aerobactin synthase activity;4;1;GO:0045735
GO:0050562;lysine-tRNA(Pyl) ligase activity;0;0;GO:0045765
GO:0050563;trans-feruloyl-CoA synthase activity;183;4;GO:0005261
GO:0050560;aspartate-tRNA(Asn) ligase activity;42393;3;GO:0005215
GO:0050561;glutamate-tRNA(Gln) ligase activity;137;6;GO:0005215
GO:0098506;polynucleotide 3' dephosphorylation;0;3;GO:0005543
GO:0098507;polynucleotide 5' dephosphorylation;24;18;GO:0005215
GO:0098505;G-rich strand telomeric DNA binding;606;95;GO:0004872
GO:2000363;positive regulation of prostaglandin-E synthase activity;5;8;GO:0006952
GO:0050568;protein-glutamine glutaminase activity;104532;136;GO:0004872
GO:0050569;glycolaldehyde dehydrogenase activity;144;5;GO:0030168
GO:2000369;regulation of clathrin-dependent endocytosis;899;333;GO:0010401
GO:0050566;asparaginyl-tRNA synthase (glutamine-hydrolyzing) activity;46405;7;GO:0010467
GO:0098508;endothelial to hematopoietic transition;361;21;GO:0045595
GO:2000368;positive regulation of acrosomal vesicle exocytosis;71;4;GO:0046394
GO:0050567;glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;268746;721;GO:0002521
GO:0098509;sensory perception of humidity;0;0;GO:0046274
GO:2000367;regulation of acrosomal vesicle exocytosis;121;1;GO:0002548
GO:2000380;regulation of mesoderm development;350;9;GO:0048285
GO:1903660;negative regulation of complement-dependent cytotoxicity;112;73;GO:0002274
GO:1901000;regulation of response to salt stress;1042;40;GO:0048285
GO:1903663;L-altrarate catabolic process;1;1;GO:0004872
GO:2000384;negative regulation of ectoderm development;20;5;GO:0009405
GO:1903664;regulation of asexual reproduction;206;1;GO:0002576
GO:2000383;regulation of ectoderm development;20;5;GO:0048471
GO:1901002;positive regulation of response to salt stress;518;48;GO:0005215
GO:1903661;positive regulation of complement-dependent cytotoxicity;32;1;GO:0006979
GO:2000382;positive regulation of mesoderm development;117;125;GO:0006919
GO:1901001;negative regulation of response to salt stress;181;32;GO:0046649
GO:1903662;L-altrarate metabolic process;1;1;GO:0051649
GO:2000381;negative regulation of mesoderm development;178;23;GO:0003677
GO:1901004;ubiquinone-6 metabolic process;262;0;GO:0050921
GO:1903667;regulation of chemorepellent activity;0;2;GO:0005215
GO:1901003;negative regulation of fermentation;150;4;GO:0046503
GO:1903668;negative regulation of chemorepellent activity;0;1;GO:0005215
GO:1901006;ubiquinone-6 biosynthetic process;262;5;GO:0005215
GO:1903665;negative regulation of asexual reproduction;91;3;GO:0045595
GO:1901005;ubiquinone-6 catabolic process;0;0;GO:0030216
GO:1903666;positive regulation of asexual reproduction;53;2;GO:0045595
GO:1901007;(S)-scoulerine metabolic process;0;0;GO:0048608
GO:1903669;positive regulation of chemorepellent activity;0;3;GO:0002576
GO:1901009;(S)-scoulerine biosynthetic process;0;0;GO:0051649
GO:0050575;2-(S)-hydroxypropyl-CoM dehydrogenase activity;185;0;GO:0043406
GO:0050573;dTDP-4-dehydro-6-deoxyglucose reductase activity;72;4;GO:0043407
GO:0050574;2-(R)-hydroxypropyl-CoM dehydrogenase activity;492;0;GO:0046395
GO:0050571;1,5-anhydro-D-fructose reductase activity;17;8;GO:0009725
GO:0050572;L-idonate 5-dehydrogenase activity;619;5;GO:0008544
GO:0050570;4-hydroxythreonine-4-phosphate dehydrogenase activity;55869;258;GO:0048608
GO:2000377;regulation of reactive oxygen species metabolic process;7538;1980;GO:0005576
GO:2000376;positive regulation of oxygen metabolic process;67;8;GO:0045944
GO:2000375;negative regulation of oxygen metabolic process;0;0;GO:0005578
GO:2000374;regulation of oxygen metabolic process;124;6;GO:0005840
GO:0050579;vellosimine dehydrogenase activity;0;3;GO:0002449
GO:0050577;GDP-L-fucose synthase activity;42944;256;GO:0006865
GO:2000379;positive regulation of reactive oxygen species metabolic process;2805;1300;GO:0006066
GO:0050578;(R)-2-hydroxyacid dehydrogenase activity;468;0;GO:0006072
GO:2000378;negative regulation of reactive oxygen species metabolic process;1644;1190;GO:0008092
GO:1903670;regulation of sprouting angiogenesis;2223;252;GO:0043169
GO:2000391;positive regulation of neutrophil extravasation;255;26;GO:0043169
GO:1903671;negative regulation of sprouting angiogenesis;658;211;GO:0043604
GO:2000390;negative regulation of neutrophil extravasation;0;0;GO:0003729
GO:1903674;regulation of cap-dependent translational initiation;52;9;GO:0050729
GO:2000395;regulation of ubiquitin-dependent endocytosis;109;6;GO:0050729
GO:1901010;(S)-reticuline metabolic process;2;0;GO:0050727
GO:1903675;negative regulation of cap-dependent translational initiation;0;0;GO:0006073
GO:2000394;positive regulation of lamellipodium morphogenesis;342;61;GO:0009089
GO:1903672;positive regulation of sprouting angiogenesis;1082;604;GO:0006072
GO:2000393;negative regulation of lamellipodium morphogenesis;100;95;GO:0006066
GO:1901012;(S)-reticuline biosynthetic process;2;0;GO:0005576
GO:1903673;mitotic cleavage furrow formation;72;6;GO:0002576
GO:2000392;regulation of lamellipodium morphogenesis;612;27;GO:0043169
GO:1901015;3alpha(S)-strictosidine biosynthetic process;0;0;GO:0048285
GO:1903678;negative regulation of cap-independent translational initiation;0;1;GO:0005819
GO:0050590;desacetoxyvindoline 4-hydroxylase activity;168;7;GO:1901169
GO:1903679;positive regulation of cap-independent translational initiation;171;29;GO:0005634
GO:1901017;negative regulation of potassium ion transmembrane transporter activity;92;657;GO:0005634
GO:1903676;positive regulation of cap-dependent translational initiation;52;73;GO:0005576
GO:1901016;regulation of potassium ion transmembrane transporter activity;315;224;GO:0007049
GO:1903677;regulation of cap-independent translational initiation;171;8;GO:0000786
GO:1901019;regulation of calcium ion transmembrane transporter activity;340;371;GO:0044419
GO:1901018;positive regulation of potassium ion transmembrane transporter activity;171;1230;GO:0048706
GO:0050586;3-hydroxy-2-methylquinolin-4-one 2,4-dioxygenase activity;20;3;GO:0004930
GO:0050587;chlorite O2-lyase activity;274;3;GO:0003929
GO:0050584;linoleate 11-lipoxygenase activity;1001;3;GO:0007218
GO:0050585;4-hydroxymandelate synthase activity;44;3;GO:0005215
GO:0050582;xylitol oxidase activity;260;3;GO:0005576
GO:0050583;hydrogen dehydrogenase (NADP+) activity;2305;0;GO:0005215
GO:0050580;2,5-didehydrogluconate reductase activity;2816;3;GO:0004721
GO:0050581;D-mannitol oxidase activity;4;4;GO:0007518
GO:2000388;positive regulation of antral ovarian follicle growth;54;6;GO:0048523
GO:2000387;regulation of antral ovarian follicle growth;54;2;GO:0007623
GO:2000386;positive regulation of ovarian follicle development;62;9;GO:0009913
GO:2000385;positive regulation of ectoderm development;0;1;GO:0000786
GO:0050588;apo-beta-carotenoid-14',13'-dioxygenase activity;0;0;GO:0007030
GO:0050589;leucocyanidin oxygenase activity;33;8;GO:0048285
GO:2000389;regulation of neutrophil extravasation;300;8;GO:0048285
GO:0050519;holo-citrate lyase synthase activity;4525;140;GO:0048387
GO:1903601;thermospermine metabolic process;99;2;GO:0007067
GO:1903602;thermospermine catabolic process;99;0;GO:0003677
GO:1903600;glutaminase complex;113;3;GO:0005576
GO:1903605;cytochrome biosynthetic process;63;1;GO:0005840
GO:1903606;cytochrome c metabolic process;72;1;GO:0005886
GO:1903603;thermospermine biosynthetic process;0;0;GO:0009953
GO:1903604;cytochrome metabolic process;72;2;GO:0009953
GO:0050510;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;394;42;GO:0012501
GO:2000399;negative regulation of thymocyte aggregation;1;5;GO:0007631
GO:0050518;2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity;120678;325;GO:2001242
GO:2000398;regulation of thymocyte aggregation;1;6;GO:0048193
GO:0050515;4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activity;130167;0;GO:0046395
GO:2000397;positive regulation of ubiquitin-dependent endocytosis;109;10;GO:0007049
GO:2000396;negative regulation of ubiquitin-dependent endocytosis;0;1;GO:0007517
GO:0050513;glycoprotein 2-beta-D-xylosyltransferase activity;82;4;GO:0002541
GO:0050514;homospermidine synthase (spermidine-specific) activity;51;3;GO:0048608
GO:0050511;undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase activity;124318;513;GO:0007600
GO:0050512;lactosylceramide 4-alpha-galactosyltransferase activity;76;89;GO:0006935
GO:1903612;positive regulation of calcium-dependent ATPase activity;2;1;GO:0007600
GO:1903613;regulation of protein tyrosine phosphatase activity;6;33;GO:0004930
GO:1903610;regulation of calcium-dependent ATPase activity;4;1;GO:0009555
GO:1903611;negative regulation of calcium-dependent ATPase activity;2;1;GO:0007046
GO:1903617;positive regulation of mitotic cytokinesis, division site positioning;5;4;GO:0004896
GO:1903614;negative regulation of protein tyrosine phosphatase activity;2;1;GO:0002449
GO:1903615;positive regulation of protein tyrosine phosphatase activity;4;27;GO:0046649
GO:0050520;phosphatidylcholine synthase activity;9577;4;GO:0046330
GO:1903609;negative regulation of inward rectifier potassium channel activity;9;10;GO:0048608
GO:0050521;alpha-glucan, water dikinase activity;225;6;GO:0048608
GO:1903607;cytochrome c biosynthetic process;63;2;GO:0009101
GO:1903608;protein localization to cytoplasmic stress granule;406;56;GO:0009065
GO:0050528;acyloxyacyl hydrolase activity;5003;21;GO:0004872
GO:0050529;polyneuridine-aldehyde esterase activity;51;4;GO:0048608
GO:0050526;poly(3-hydroxybutyrate) depolymerase activity;348;3;GO:0048608
GO:0050527;poly(3-hydroxyoctanoate) depolymerase activity;22;2;GO:0006779
GO:0050524;coenzyme-B sulfoethylthiotransferase activity;32591;10;GO:0006749
GO:0050525;cutinase activity;21618;174;GO:0006749
GO:0050522;oxidoreductase activity, acting on phosphorus or arsenic in donors, with other known acceptors;0;1;GO:0005840
GO:1903620;positive regulation of transdifferentiation;10;2;GO:0005524
GO:1903623;negative regulation of RNA polymerase III activity;0;0;GO:0007596
GO:1903624;regulation of DNA catabolic process;436;3;GO:0005524
GO:1903621;protein localization to photoreceptor connecting cilium;70;0;GO:0043588
GO:1903622;regulation of RNA polymerase III activity;0;1;GO:0005819
GO:0008458;carnitine O-octanoyltransferase activity;176;15;GO:0048608
GO:0045436;lycopene beta cyclase activity;9998;15;GO:0000226
GO:1901934;bicyclogermacrene biosynthetic process;1;0;GO:0048608
GO:0008457;beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity;98;118;GO:0005524
GO:0045437;uridine nucleosidase activity;10896;41;GO:0006734
GO:1901933;bicyclogermacrene catabolic process;0;0;GO:0002040
GO:1901925;negative regulation of protein import into nucleus during spindle assembly checkpoint;14;3;GO:0048608
GO:1901924;positive regulation of sclerotium development;0;0;GO:0008092
GO:1901927;cadinene catabolic process;0;0;GO:0048513
GO:1901926;cadinene metabolic process;4;1;GO:0005737
GO:1901929;alpha-copaene metabolic process;2;0;GO:0048513
GO:0045442;deacetoxycephalosporin-C hydroxylase activity;35;3;GO:0042692
GO:1901928;cadinene biosynthetic process;4;2;GO:0048598
GO:0033463;GGA codon-amino acid adaptor activity;3;4;GO:0005815
GO:0033462;GGC codon-amino acid adaptor activity;2;2;GO:0007517
GO:0033461;GGU codon-amino acid adaptor activity;0;2;GO:0009065
GO:0033460;GAG codon-amino acid adaptor activity;3;4;GO:0005543
GO:0033456;GCG codon-amino acid adaptor activity;1;2;GO:0006749
GO:0033455;GCA codon-amino acid adaptor activity;3;3;GO:0009065
GO:0033454;GCC codon-amino acid adaptor activity;0;2;GO:0002376
GO:0033453;GCU codon-amino acid adaptor activity;2;2;GO:0008565
GO:0033459;GAA codon-amino acid adaptor activity;2;2;GO:0000976
GO:0033458;GAC codon-amino acid adaptor activity;4;2;GO:0016570
GO:0033457;GAU codon-amino acid adaptor activity;0;2;GO:0005829
GO:0033452;GUG codon-amino acid adaptor activity;2;3;GO:0005819
GO:0033451;GUA codon-amino acid adaptor activity;2;1;GO:0030424
GO:0033450;GUC codon-amino acid adaptor activity;0;2;GO:0048608
GO:0033445;AGU codon-amino acid adaptor activity;0;1;GO:0005737
GO:0033444;AAG codon-amino acid adaptor activity;2;2;GO:0048608
GO:0033443;AAA codon-amino acid adaptor activity;3;3;GO:0008579
GO:0033442;AAC codon-amino acid adaptor activity;2;2;GO:0048608
GO:0033449;GUU codon-amino acid adaptor activity;2;2;GO:0043005
GO:0033448;AGG codon-amino acid adaptor activity;1;2;GO:0048608
GO:0033447;AGA codon-amino acid adaptor activity;3;1;GO:0005886
GO:0033446;AGC codon-amino acid adaptor activity;3;0;GO:0006559
GO:0008481;sphinganine kinase activity;216;49;GO:0048608
GO:0008480;sarcosine dehydrogenase activity;196;19;GO:0005515
GO:0033441;AAU codon-amino acid adaptor activity;0;2;GO:0009065
GO:0008484;sulfuric ester hydrolase activity;315274;1460;GO:0048608
GO:0033440;ACG codon-amino acid adaptor activity;1;2;GO:0045941
GO:0008483;transaminase activity;2590144;3560;GO:0048608
GO:0008482;sulfite oxidase activity;1023;203;GO:0005524
GO:0008489;UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;293;8;GO:0045944
GO:0008488;gamma-glutamyl carboxylase activity;8594;14;GO:0007596
GO:0008486;diphosphoinositol-polyphosphate diphosphatase activity;608;68;GO:0005576
GO:0033439;ACA codon-amino acid adaptor activity;3;2;GO:0045941
GO:0033434;AUC codon-amino acid adaptor activity;1;1;GO:0007596
GO:0033433;AUU codon-amino acid adaptor activity;1;2;GO:0045941
GO:0033432;CGG codon-amino acid adaptor activity;0;1;GO:0043588
GO:0033431;CGA codon-amino acid adaptor activity;5;2;GO:0007517
GO:0033438;ACC codon-amino acid adaptor activity;0;2;GO:0030165
GO:0033437;ACU codon-amino acid adaptor activity;2;1;GO:0048285
GO:0033436;AUG codon-amino acid adaptor activity;5;2;GO:0006073
GO:0033435;AUA codon-amino acid adaptor activity;1;0;GO:0006073
GO:0008490;arsenite secondary active transmembrane transporter activity;3;48;GO:0006066
GO:0008496;mannan endo-1,6-alpha-mannosidase activity;13799;16;GO:0006073
GO:0033430;CGC codon-amino acid adaptor activity;0;1;GO:0009117
GO:0008495;protoheme IX farnesyltransferase activity;117122;306;GO:0045944
GO:0008494;translation activator activity;465;373;GO:0005737
GO:0008493;tetracycline transmembrane transporter activity;1;5;GO:0005743
GO:0008499;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;430;156;GO:0005737
GO:0033429;CGU codon-amino acid adaptor activity;1;2;GO:0003743
GO:0033428;CAG codon-amino acid adaptor activity;4;2;GO:0050832
GO:0033423;CCA codon-amino acid adaptor activity;2;1;GO:0005840
GO:0033422;CCC codon-amino acid adaptor activity;0;2;GO:0005829
GO:0033421;CCU codon-amino acid adaptor activity;1;2;GO:0003723
GO:0033420;CUG codon-amino acid adaptor activity;1;2;GO:0003723
GO:0033427;CAA codon-amino acid adaptor activity;3;1;GO:0000976
GO:0033426;CAC codon-amino acid adaptor activity;2;1;GO:0008380
GO:0033425;CAU codon-amino acid adaptor activity;0;1;GO:0010468
GO:0033424;CCG codon-amino acid adaptor activity;3;1;GO:0006096
GO:1901981;phosphatidylinositol phosphate binding;64678;195;GO:0006096
GO:1901980;positive regulation of inward rectifier potassium channel activity;3;8;GO:0006096
GO:0045489;pectin biosynthetic process;6690;37;GO:0006032
GO:1901983;regulation of protein acetylation;5858;152;GO:0006032
GO:1901982;maltose binding;108;119;GO:0006032
GO:0045487;gibberellin catabolic process;408;159;GO:0005525
GO:1901985;positive regulation of protein acetylation;1196;93;GO:0006073
GO:0045488;pectin metabolic process;90507;194;GO:0048704
GO:1901984;negative regulation of protein acetylation;604;259;GO:0005737
GO:1901987;regulation of cell cycle phase transition;91240;999;GO:0006073
GO:1901986;response to ketamine;4;2;GO:0048704
GO:1901989;positive regulation of cell cycle phase transition;12536;88;GO:0006066
GO:1901988;negative regulation of cell cycle phase transition;70282;1060;GO:0048704
GO:0045492;xylan biosynthetic process;4309;1170;GO:0005524
GO:0045493;xylan catabolic process;81222;465;GO:0006073
GO:1901979;regulation of inward rectifier potassium channel activity;18;38;GO:0005737
GO:0045490;pectin catabolic process;82435;641;GO:0005925
GO:0045491;xylan metabolic process;90172;110;GO:0005524
GO:0045496;male analia development;17;6;GO:0005525
GO:0070441;G-protein beta/gamma-Btk complex;0;1;GO:0005215
GO:0045497;female analia development;17;5;GO:0005525
GO:0070442;integrin alphaIIb-beta3 complex;20;5;GO:0015075
GO:0045494;photoreceptor cell maintenance;4676;2230;GO:0005215
GO:0045495;pole plasm;5272;184;GO:0005215
GO:0070440;Mad-Max-mSin3B complex;0;1;GO:0048608
GO:0070445;regulation of oligodendrocyte progenitor proliferation;259;92;GO:0048608
GO:0033499;galactose catabolic process via UDP-galactose;21300;223;GO:0048608
GO:0070446;negative regulation of oligodendrocyte progenitor proliferation;7;6;GO:0048704
GO:0033498;galactose catabolic process via D-galactonate;3;2;GO:0048169
GO:0070443;Mad-Max complex;108;1;GO:0048667
GO:0033497;sinapate biosynthetic process;0;5;GO:0048405
GO:0070444;oligodendrocyte progenitor proliferation;362;21;GO:0050921
GO:0070449;elongin complex;5328;59;GO:0048608
GO:0070447;positive regulation of oligodendrocyte progenitor proliferation;62;43;GO:0071013
GO:0070448;laricitrin 5'-O-methyltransferase activity;9;1;GO:0048608
GO:0033492;esculetin metabolic process;0;2;GO:0005789
GO:0033491;coniferin metabolic process;11;7;GO:0005783
GO:0033490;cholesterol biosynthetic process via lathosterol;33;131;GO:0005840
GO:0033496;sinapate metabolic process;0;7;GO:0030216
GO:1901990;regulation of mitotic cell cycle phase transition;50510;2750;GO:0005215
GO:0033495;ferulate biosynthetic process;0;2;GO:0048316
GO:0033494;ferulate metabolic process;756;7;GO:0005543
GO:1901992;positive regulation of mitotic cell cycle phase transition;6027;384;GO:0048316
GO:0033493;esculetin biosynthetic process;0;2;GO:0005543
GO:1901991;negative regulation of mitotic cell cycle phase transition;36630;867;GO:0005911
GO:1901994;negative regulation of meiotic cell cycle phase transition;543;30;GO:0005215
GO:1901993;regulation of meiotic cell cycle phase transition;747;10;GO:0015629
GO:0045498;sex comb development;69;15;GO:0005525
GO:1901996;regulation of indoleacetic acid biosynthetic process via tryptophan;53;0;GO:0008565
GO:0045499;chemorepellent activity;973;517;GO:0005215
GO:1901995;positive regulation of meiotic cell cycle phase transition;197;1;GO:0005215
GO:1901998;toxin transport;27483;1310;GO:0048608
GO:1901997;negative regulation of indoleacetic acid biosynthetic process via tryptophan;53;0;GO:0048704
GO:1901999;homogentisate metabolic process;185;2;GO:0048704
GO:0070430;positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway;160;10;GO:0048608
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway;1095;278;GO:0048608
GO:0033489;cholesterol biosynthetic process via desmosterol;66;120;GO:0048608
GO:0070434;positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;214;37;GO:0048608
GO:0033488;cholesterol biosynthetic process via 24,25-dihydrolanosterol;2;9;GO:0048704
GO:0070435;Shc-EGFR complex;5;71;GO:0048010
GO:0033487;pelargonidin 3-O-glucoside biosynthetic process;0;1;GO:0030216
GO:0070432;regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;476;6;GO:0048704
GO:0033486;delphinidin 3-O-glucoside biosynthetic process;2;3;GO:0045595
GO:0070433;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;261;64;GO:0032989
GO:0070439;Mad-Max-mSin3A complex;0;1;GO:0060537
GO:0070436;Grb2-EGFR complex;68;154;GO:0030216
GO:0070437;Grb2-Shc complex;0;1;GO:0045944
GO:0033481;galacturonate biosynthetic process;18;4;GO:0002576
GO:0033480;UDP-D-galacturonate biosynthetic process;0;4;GO:0007517
GO:0033485;cyanidin 3-O-glucoside biosynthetic process;5;2;GO:0045595
GO:0033484;intracellular nitric oxide homeostasis;94;2;GO:0045595
GO:0033482;D-galacturonate biosynthetic process;0;2;GO:0008528
GO:0070460;thyroid-stimulating hormone secretion;109;19;GO:0008565
GO:0070463;tubulin-dependent ATPase activity;75;5;GO:0008565
GO:0070464;alphav-beta3 integrin-collagen alpha3(VI) complex;0;1;GO:0008528
GO:0070461;SAGA-type complex;52985;363;GO:0008565
GO:0070462;plus-end specific microtubule depolymerization;80;7;GO:0005509
GO:0033478;UDP-rhamnose metabolic process;158;5;GO:0008047
GO:0070467;RC-1 DNA recombination complex;0;1;GO:0007517
GO:0033477;S-methylmethionine metabolic process;191;5;GO:0004872
GO:0070468;dentin extracellular matrix secretion;0;1;GO:0043588
GO:0033476;indoleacetic acid ester conjugate biosynthetic process;0;2;GO:0005244
GO:0070465;alpha1-beta1 integrin-alpha3(VI) complex;0;2;GO:0048608
GO:0033475;indoleacetic acid amide conjugate biosynthetic process;0;3;GO:0004896
GO:0070466;alpha2-beta1 integrin-alpha3(VI) complex;0;1;GO:0048706
GO:0070469;respirasome;2807999;744;GO:0030168
GO:0033479;UDP-D-galacturonate metabolic process;0;4;GO:0048706
GO:0033470;gibberellin 12 biosynthetic process;0;3;GO:0004872
GO:0033474;indoleacetic acid conjugate biosynthetic process;0;2;GO:0008544
GO:0033473;indoleacetic acid conjugate metabolic process;4;5;GO:0005125
GO:0033472;GDP-L-galactose biosynthetic process;0;3;GO:0048608
GO:0033471;GDP-L-galactose metabolic process;0;4;GO:0048193
GO:0070452;positive regulation of ergosterol biosynthetic process;5;5;GO:0048608
GO:0070453;regulation of heme biosynthetic process;283;6;GO:0048193
GO:0070450;interleukin4-interleukin-4 receptor complex;0;2;GO:0048608
GO:0070451;cell hair;47;8;GO:0000981
GO:0033467;CMP-keto-3-deoxy-D-manno-octulosonic acid metabolic process;38222;3;GO:0043547
GO:0070456;galactose-1-phosphate phosphatase activity;40;3;GO:0008026
GO:0033466;trans-zeatin biosynthetic process;10;5;GO:0007186
GO:0070457;D-galactose-1-phosphate phosphatase activity;0;1;GO:0043588
GO:0033465;cis-zeatin biosynthetic process;0;2;GO:0006032
GO:0070454;negative regulation of heme biosynthetic process;0;1;GO:0000976
GO:0033464;GGG codon-amino acid adaptor activity;0;3;GO:0000786
GO:0070455;positive regulation of heme biosynthetic process;183;2;GO:0005529
GO:0033469;gibberellin 12 metabolic process;0;3;GO:0008565
GO:0070458;cellular detoxification of nitrogen compound;189;42;GO:0008565
GO:0033468;CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process;38222;6;GO:0048193
GO:0070459;prolactin secretion;204;33;GO:0008529
GO:0070409;carbamoyl phosphate biosynthetic process;58;23;GO:0048193
GO:0070407;oxidation-dependent protein catabolic process;2951;46;GO:0005215
GO:0070408;carbamoyl phosphate metabolic process;4068;10;GO:0048608
GO:0045445;myoblast differentiation;5063;1310;GO:0005515
GO:0045446;endothelial cell differentiation;6937;862;GO:0016567
GO:0045443;juvenile hormone secretion;0;2;GO:0005525
GO:1901941;(+)-epi-alpha-bisabolol metabolic process;1;1;GO:0005515
GO:0045444;fat cell differentiation;13319;2940;GO:0042803
GO:1901940;(-)-exo-alpha-bergamotene biosynthetic process;1;1;GO:0055085
GO:1901943;(+)-epi-alpha-bisabolol biosynthetic process;1;1;GO:0005215
GO:1901942;(+)-epi-alpha-bisabolol catabolic process;0;0;GO:0003779
GO:1901945;miltiradiene catabolic process;0;0;GO:0005529
GO:0045448;mitotic cell cycle, embryonic;962;22;GO:0005737
GO:1901944;miltiradiene metabolic process;24;1;GO:0048706
GO:1901936;beta-caryophyllene catabolic process;0;0;GO:0048608
GO:1901935;beta-caryophyllene metabolic process;4;1;GO:0006942
GO:1901938;(-)-exo-alpha-bergamotene metabolic process;1;0;GO:0048608
GO:1901937;beta-caryophyllene biosynthetic process;4;1;GO:0048608
GO:0045453;bone resorption;3079;1640;GO:0048608
GO:1901939;(-)-exo-alpha-bergamotene catabolic process;0;0;GO:0048608
GO:0045450;bicoid mRNA localization;468;69;GO:0048706
GO:0045451;pole plasm oskar mRNA localization;590;320;GO:0008544
GO:0070401;NADP+ binding;75336;213;GO:0048010
GO:0070402;NADPH binding;50177;833;GO:0008544
GO:0070400;teichoic acid D-alanylation;7938;1;GO:0005125
GO:0070405;ammonium ion binding;1;45;GO:0048608
GO:0070406;glutamine binding;689;5;GO:0007565
GO:0070403;NAD+ binding;287559;1450;GO:0048608
GO:0070404;NADH binding;195;55;GO:0048706
GO:0045456;ecdysteroid biosynthetic process;237;22;GO:0050921
GO:1901950;dense core granule transport;252;4;GO:0048010
GO:0045457;ecdysteroid secretion;14;3;GO:0048608
GO:0045454;cell redox homeostasis;64488;6010;GO:0048608
GO:1901952;negative regulation of anterograde dense core granule transport;0;0;GO:0048010
GO:0045455;ecdysteroid metabolic process;311;39;GO:0003700
GO:1901951;regulation of anterograde dense core granule transport;16;0;GO:0008528
GO:1901954;regulation of retrograde dense core granule transport;5;0;GO:0005026
GO:1901953;positive regulation of anterograde dense core granule transport;16;4;GO:0005215
GO:0045458;recombination within rDNA repeats;1;3;GO:0008529
GO:1901956;positive regulation of retrograde dense core granule transport;5;2;GO:0005576
GO:0045459;iron incorporation into iron-sulfur cluster via tetrakis-L-cysteinyl triiron tetrasulfide;0;5;GO:0008092
GO:1901955;negative regulation of retrograde dense core granule transport;0;0;GO:0005509
GO:1901947;5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate metabolic process;2;2;GO:0048169
GO:0045460;sterigmatocystin metabolic process;108;8;GO:0048706
GO:1901946;miltiradiene biosynthetic process;24;1;GO:0005216
GO:1901949;5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate biosynthetic process;1;0;GO:0048706
GO:1901948;5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate catabolic process;1;0;GO:0008092
GO:0045463;R8 cell development;104;5;GO:0048608
GO:0045464;R8 cell fate specification;197;9;GO:0008026
GO:0045461;sterigmatocystin biosynthetic process;103;29;GO:0048514
GO:0045462;trichothecene 3-O-acetyltransferase activity;2;3;GO:0048608
GO:0070429;negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway;55;9;GO:0008092
GO:0045467;R7 cell development;126;147;GO:0048608
GO:1901961;isobutanol biosynthetic process;0;1;GO:0022836
GO:0045468;regulation of R8 cell spacing in compound eye;0;5;GO:0008565
GO:1901960;isobutanol metabolic process;0;0;GO:0043066
GO:0045465;R8 cell differentiation;490;10;GO:0008544
GO:1901963;regulation of cell proliferation involved in outflow tract morphogenesis;55;3;GO:0002044
GO:0045466;R7 cell differentiation;1026;51;GO:0006869
GO:1901962;S-adenosyl-L-methionine transmembrane transport;953;6;GO:0048193
GO:1901965;endoplasmic reticulum to chloroplast transport;901;0;GO:0048193
GO:1901964;positive regulation of cell proliferation involved in outflow tract morphogenesis;1;9;GO:0005543
GO:0045469;negative regulation of R8 cell spacing in compound eye;0;2;GO:0005543
GO:1901967;negative regulation of cellular response to iron ion starvation;0;0;GO:0005525
GO:1901966;regulation of cellular response to iron ion starvation;0;0;GO:0015986
GO:0045470;R8 cell-mediated photoreceptor organization;26;6;GO:0006099
GO:1901958;negative regulation of cutin biosynthetic process;0;1;GO:0005216
GO:0045471;response to ethanol;3050;3090;GO:0008092
GO:1901957;regulation of cutin biosynthetic process;18;4;GO:0005829
GO:1901959;positive regulation of cutin biosynthetic process;12;6;GO:0042113
GO:0045475;locomotor rhythm;1645;1060;GO:0007062
GO:0070420;Ku-DNA ligase complex;0;1;GO:0007062
GO:0045472;response to ether;557;103;GO:0000976
GO:0070423;nucleotide-binding oligomerization domain containing signaling pathway;1743;680;GO:0005840
GO:0070424;regulation of nucleotide-binding oligomerization domain containing signaling pathway;757;91;GO:0005737
GO:0070421;DNA ligase III-XRCC1 complex;32;5;GO:0007067
GO:0070422;G-protein beta/gamma-Raf-1 complex;0;1;GO:0005215
GO:0070427;nucleotide-binding oligomerization domain containing 1 signaling pathway;580;241;GO:0005215
GO:0070428;regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway;218;10;GO:0048704
GO:0070425;negative regulation of nucleotide-binding oligomerization domain containing signaling pathway;320;7;GO:0022836
GO:0070426;positive regulation of nucleotide-binding oligomerization domain containing signaling pathway;374;101;GO:0048608
GO:0070418;DNA-dependent protein kinase complex;253;7;GO:0007596
GO:0070419;nonhomologous end joining complex;1177;196;GO:0005215
GO:1901970;positive regulation of mitotic sister chromatid separation;1570;695;GO:0030900
GO:0045478;fusome organization;165;158;GO:0007596
GO:0045479;vesicle targeting to fusome;0;2;GO:0043066
GO:0045476;nurse cell apoptotic process;232;10;GO:0043066
GO:1901974;glycerate transmembrane transporter activity;56;1;GO:0043066
GO:0045477;regulation of nurse cell apoptotic process;110;6;GO:0043066
GO:1901973;proline binding;2;2;GO:0002044
GO:1901976;regulation of cell cycle checkpoint;3912;59;GO:0042127
GO:1901975;glycerate transmembrane transport;112;4;GO:0046649
GO:1901978;positive regulation of cell cycle checkpoint;802;15;GO:0045727
GO:1901977;negative regulation of cell cycle checkpoint;601;9;GO:0005840
GO:0045481;6-endo-hydroxycineole dehydrogenase activity;0;3;GO:0042803
GO:1901969;positive regulation of polynucleotide 3'-phosphatase activity;1;1;GO:0048193
GO:0045482;trichodiene synthase activity;439;5;GO:0042803
GO:1901968;regulation of polynucleotide 3'-phosphatase activity;1;0;GO:0042803
GO:0045480;galactose oxidase activity;158;5;GO:0046649
GO:0045485;omega-6 fatty acid desaturase activity;107;24;GO:0005525
GO:0045486;naringenin 3-dioxygenase activity;271;82;GO:0046649
GO:0045483;aristolochene synthase activity;11;4;GO:0048407
GO:0045484;L-lysine 6-transaminase activity;4702;4;GO:0005216
GO:0070412;R-SMAD binding;3707;718;GO:0005216
GO:0070413;trehalose metabolism in response to stress;655;85;GO:0048471
GO:0070410;co-SMAD binding;575;411;GO:0002064
GO:0070411;I-SMAD binding;1000;368;GO:0048608
GO:0070416;trehalose metabolism in response to water deprivation;0;2;GO:0007517
GO:0070417;cellular response to cold;9856;473;GO:0048704
GO:0070414;trehalose metabolism in response to heat stress;13;6;GO:0048704
GO:0070415;trehalose metabolism in response to cold stress;4;1;GO:0048704
GO:0070170;regulation of tooth mineralization;567;20;GO:0048706
GO:0070162;adiponectin secretion;174;29;GO:0048706
GO:0070163;regulation of adiponectin secretion;174;209;GO:0048316
GO:0070160;tight junction;124303;447;GO:0005125
GO:0070161;anchoring junction;465323;2030;GO:0030216
GO:0070166;enamel mineralization;983;87;GO:0007517
GO:0070167;regulation of biomineral tissue development;6040;51;GO:0005934
GO:0070164;negative regulation of adiponectin secretion;108;81;GO:0005929
GO:0070165;positive regulation of adiponectin secretion;66;5;GO:0000786
GO:0070168;negative regulation of biomineral tissue development;1332;346;GO:0009813
GO:0070169;positive regulation of biomineral tissue development;2766;52;GO:0046274
GO:0070151;mitochondrial histidyl-tRNA aminoacylation;0;1;GO:0006033
GO:0070152;mitochondrial isoleucyl-tRNA aminoacylation;0;3;GO:0046395
GO:0070150;mitochondrial glycyl-tRNA aminoacylation;126;6;GO:0046395
GO:0070155;mitochondrial methionyl-tRNA aminoacylation;1;1;GO:0006066
GO:0070156;mitochondrial phenylalanyl-tRNA aminoacylation;62;3;GO:0006559
GO:0070153;mitochondrial leucyl-tRNA aminoacylation;1;1;GO:0006559
GO:0070154;mitochondrial lysyl-tRNA aminoacylation;34;0;GO:0006559
GO:0070159;mitochondrial threonyl-tRNA aminoacylation;51;6;GO:0006073
GO:0070157;mitochondrial prolyl-tRNA aminoacylation;0;1;GO:0006096
GO:0070158;mitochondrial seryl-tRNA aminoacylation;177;2;GO:0006096
GO:0070192;chromosome organization involved in meiotic cell cycle;17648;186;GO:0010467
GO:0070184;mitochondrial tyrosyl-tRNA aminoacylation;69;3;GO:0006810
GO:0070185;mitochondrial valyl-tRNA aminoacylation;1;0;GO:0006735
GO:0070182;DNA polymerase binding;1407;509;GO:0046395
GO:0070183;mitochondrial tryptophanyl-tRNA aminoacylation;56;2;GO:0046395
GO:0070189;kynurenine metabolic process;105287;1950;GO:0006021
GO:0070186;growth hormone activity;32;2;GO:0009405
GO:0070187;shelterin complex;2761;21;GO:0046395
GO:0033195;response to alkyl hydroperoxide;2;3;GO:0005215
GO:0033194;response to hydroperoxide;748;301;GO:0005215
GO:0033193;Lsd1/2 complex;19;6;GO:0005215
GO:0033192;calmodulin-dependent protein phosphatase activity;11083;94;GO:0005215
GO:0033198;response to ATP;8575;572;GO:0005215
GO:0033197;response to vitamin E;60;432;GO:0005215
GO:0033196;tryparedoxin peroxidase activity;2;2;GO:0008544
GO:0033191;macrophomate synthase activity;0;2;GO:0006836
GO:0070180;large ribosomal subunit rRNA binding;93756;525;GO:0005215
GO:0033190;solanapyrone synthase activity;0;2;GO:0015075
GO:0070181;small ribosomal subunit rRNA binding;38219;349;GO:0006810
GO:0070173;regulation of enamel mineralization;394;34;GO:0008544
GO:0070174;negative regulation of enamel mineralization;0;2;GO:0009400
GO:0070171;negative regulation of tooth mineralization;111;128;GO:0005215
GO:0070172;positive regulation of tooth mineralization;413;98;GO:0005026
GO:0070177;contractile vacuole discharge;27;2;GO:0005543
GO:0070178;D-serine metabolic process;513;22;GO:0005215
GO:0070175;positive regulation of enamel mineralization;351;22;GO:0008544
GO:0070176;DRM complex;1837;34;GO:0006865
GO:0070179;D-serine biosynthetic process;199;1;GO:0015986
GO:0033189;response to vitamin A;198;652;GO:0008565
GO:0141010;retrotransposon silencing by RNA-directed DNA methylation;0;0;GO:0006810
GO:0045168;cell-cell signaling involved in cell fate commitment;1839;257;GO:0008544
GO:0045169;fusome;429;45;GO:0046686
GO:0045173;O-sialoglycoprotein catabolic process;0;1;GO:0009615
GO:0045174;glutathione dehydrogenase (ascorbate) activity;8891;230;GO:0007623
GO:0045171;intercellular bridge;7310;853;GO:0048608
GO:0045172;germline ring canal;407;42;GO:0010942
GO:0045177;apical part of cell;201724;3790;GO:0045737
GO:0141009;piRNA-mediated retrotransposon silencing by mRNA destabilization;3;0;GO:0009611
GO:0045178;basal part of cell;38226;603;GO:0009617
GO:0070123;transforming growth factor beta receptor activity, type III;71;6;GO:0046686
GO:0141008;retrotransposon silencing by mRNA destabilization;172;1;GO:0046686
GO:0045175;basal protein localization;107;27;GO:0046686
GO:0070120;ciliary neurotrophic factor-mediated signaling pathway;1791;296;GO:0002821
GO:0045176;apical protein localization;977;1120;GO:0002821
GO:0070121;Kupffer's vesicle development;1581;137;GO:0002449
GO:0070126;mitochondrial translational termination;289;856;GO:0050832
GO:0141005;retrotransposon silencing by heterochromatin formation;820;2;GO:0045087
GO:0070127;tRNA aminoacylation for mitochondrial protein translation;3218;38;GO:0046686
GO:0070124;mitochondrial translational initiation;194;226;GO:0032496
GO:0141007;siRNA-mediated retrotransposon silencing by heterochromatin formation;348;4;GO:0009617
GO:0070125;mitochondrial translational elongation;4022;1020;GO:0009617
GO:0141006;piRNA-mediated retrotransposon silencing by heterochromatin formation;188;1;GO:0004872
GO:0045170;spectrosome;67;17;GO:0005819
GO:0141000;histone H4K91 ubiquitin ligase activity;0;1;GO:0005815
GO:0141003;histone H2AX kinase activity;1751;0;GO:0005819
GO:0070129;regulation of mitochondrial translation;1718;1300;GO:0005819
GO:0141002;histone H4K16 propionyltransferase activity;0;0;GO:0005576
GO:0060792;sweat gland development;51;5;GO:0005815
GO:0060793;sweat gland placode formation;0;2;GO:0000776
GO:0060794;leaflet morphogenesis;0;2;GO:0007030
GO:0060795;cell fate commitment involved in formation of primary germ layer;2963;215;GO:0005829
GO:0060790;tooth placode formation;0;2;GO:0005840
GO:0060791;sebaceous gland placode formation;0;1;GO:0005829
GO:0045179;apical cortex;1019;487;GO:0005840
GO:0045184;establishment of protein localization;6186903;3940;GO:0005840
GO:0045185;maintenance of protein location;17919;797;GO:0005737
GO:0045182;translation regulator activity;2367270;2610;GO:0006631
GO:0045183;translation factor activity, non-nucleic acid binding;57;5;GO:0000502
GO:0045188;regulation of circadian sleep/wake cycle, non-REM sleep;142;8;GO:0005840
GO:0070111;organellar chromatophore;116;6;GO:0005764
GO:0070112;organellar chromatophore membrane;26;3;GO:0005764
GO:0045186;zonula adherens assembly;162;166;GO:0005811
GO:0045187;regulation of circadian sleep/wake cycle, sleep;3627;227;GO:0005813
GO:0070110;ciliary neurotrophic factor receptor complex;163;32;GO:0000226
GO:0070115;organellar chromatophore intermembrane space;0;3;GO:0005813
GO:0070116;organellar chromatophore thylakoid;26;5;GO:0000976
GO:0070113;organellar chromatophore inner membrane;0;1;GO:0007088
GO:0070114;organellar chromatophore outer membrane;0;2;GO:0005934
GO:0045180;basal cortex;435;339;GO:0042302
GO:0070119;ciliary neurotrophic factor binding;46;46;GO:0048407
GO:0045181;glutamate synthase activity, NAD(P)H as acceptor;31192;6;GO:0005578
GO:0070117;organellar chromatophore thylakoid lumen;0;5;GO:0005507
GO:0070118;organellar chromatophore thylakoid membrane;26;2;GO:0008270
GO:0141030;symbiont-mediated perturbation of host actin cytoskeleton via filamentous actin depolymerization;0;0;GO:0005509
GO:0141032;symbiont-mediated perturbation of host actin cytoskeleton via actin filament reorganization;0;0;GO:0005515
GO:0141031;symbiont-mediated perturbation of host actin cytoskeleton via actin crosslinking;0;0;GO:0008289
GO:0045196;establishment or maintenance of neuroblast polarity;299;44;GO:0005524
GO:0070141;response to UV-A;863;250;GO:0005525
GO:0045199;maintenance of epithelial cell apical/basal polarity;615;214;GO:0006873
GO:0070144;mitochondrial arginyl-tRNA aminoacylation;2;2;GO:0005524
GO:0070145;mitochondrial asparaginyl-tRNA aminoacylation;122;2;GO:0005515
GO:0045197;establishment or maintenance of epithelial cell apical/basal polarity;2985;819;GO:0005518
GO:0070142;synaptic vesicle budding;265;33;GO:0042802
GO:0045198;establishment of epithelial cell apical/basal polarity;1112;282;GO:0097367
GO:0070143;mitochondrial alanyl-tRNA aminoacylation;2431;5;GO:0005524
GO:0070148;mitochondrial glutaminyl-tRNA aminoacylation;0;1;GO:0005525
GO:0141027;symbiont-mediated perturbation of host actin cytoskeleton;0;0;GO:0097367
GO:0070149;mitochondrial glutamyl-tRNA aminoacylation;1;2;GO:0097367
GO:0141026;adhesion of symbiont to host cell surface via host membrane cholesterol;0;0;GO:0048193
GO:0070146;mitochondrial aspartyl-tRNA aminoacylation;35;3;GO:0005549
GO:0141029;disruption by symbiont of host focal adhesion;0;0;GO:0006865
GO:0070147;mitochondrial cysteinyl-tRNA aminoacylation;0;2;GO:0005543
GO:0141028;symbiont-mediated perturbation of host microtubule cytoskeleton;0;0;GO:0008544
GO:0045191;regulation of isotype switching;2175;206;GO:0005515
GO:0141023;disruption by symbiont of host cell-cell adhesion;0;0;GO:0005515
GO:0141025;adhesion of symbiont to host cell surface via host glycoprotein;0;0;GO:0007179
GO:0045190;isotype switching;3327;974;GO:0048609
GO:0141024;adhesion of symbiont to host cell surface via host membrane carbohydrate;0;0;GO:0048609
GO:0070130;negative regulation of mitochondrial translation;78;9;GO:0008152
GO:0070133;negative regulation of mitochondrial translational initiation;0;1;GO:0005524
GO:0070134;positive regulation of mitochondrial translational initiation;5;4;GO:0005524
GO:0070131;positive regulation of mitochondrial translation;1049;203;GO:0046955
GO:0070132;regulation of mitochondrial translational initiation;5;1;GO:0005515
GO:0070137;ubiquitin-like protein-specific endopeptidase activity;252;9;GO:0005578
GO:0141016;G/T mismatch-specific thymine-DNA glycosylase activity;7;1;GO:0097159
GO:0070135;beta-1,2-oligomannoside metabolic process;8;1;GO:0005509
GO:0141018;adhesion of symbiont to host via host extracellular matrix;0;1;GO:0005525
GO:0070136;beta-1,2-oligomannoside biosynthetic process;5;2;GO:0048407
GO:0141017;effector-mediated induction of cell cycle reactivation in host;1;0;GO:0019825
GO:0141011;siRNA-mediated retrotransposon silencing by mRNA destabilization;0;0;GO:0042592
GO:0070139;SUMO-specific endopeptidase activity;252;102;GO:0005539
GO:0141014;ribosome hibernation;109;3;GO:0019438
GO:0141013;purine nucleotide import into lysosome;55;2;GO:0009416
GO:0141052;histone H3 demethylase activity;31096;2;GO:0009416
GO:0141051;histone H4K deacetylase activity;325;0;GO:0005578
GO:0141054;histone H2B ubiquitin ligase activity;123;1;GO:0005581
GO:0141053;histone H2A ubiquitin ligase activity;343;0;GO:0005578
GO:0141050;histone H3K deacetylase activity;1612;0;GO:0005581
GO:0141049;protein-glutathione oxidoreductase (glutathione) activity;4;1;GO:0005581
GO:0141048;membrane tag activity;0;0;GO:0005578
GO:0141044;epigenetic programming in the endosperm;0;0;GO:0005581
GO:0141047;molecular tag activity;11320;1;GO:0048010
GO:0141046;Atg8-family conjugating enzyme activity;0;0;GO:0005578
GO:0141041;disruption of extracellular matrix of another organism;1;0;GO:0043406
GO:0141040;very-long-chain 3-oxoacyl-CoA reductase activity;1902;3;GO:0005578
GO:0141043;evasion of host innate immune recognition;0;1;GO:0005581
GO:0141042;symbiont-mediated cAMP intoxication of host cell;1;0;GO:0004872
GO:0141038;phosphatidylinositol 3-kinase activator activity;0;0;GO:0004872
GO:0141039;phosphatidylinositol 3-kinase inhibitor activity;0;1;GO:0048608
GO:0141034;symbiont-mediated perturbation of host actin cytoskeleton via inhibition of actin polymerization;0;0;GO:0004872
GO:0141033;symbiont-mediated perturbation of host actin cytoskeleton via actin polymerization;0;0;GO:0048304
GO:0141035;CTP-dependent diacylglycerol kinase activity;25;3;GO:0007565
GO:0141074;symbiont-mediated suppression of host cGAS-STING signal transduction;0;0;GO:0007049
GO:0141073;disruption by symbiont of host opsonization;0;0;GO:0004872
GO:0141076;symbiont-mediated suppression of host TRAF-mediated signal transduction;4712;0;GO:0005515
GO:0141075;symbiont-mediated suppression of host JAK-STAT cascade;29839;0;GO:0010467
GO:0141070;symbiont-mediated suppression of host MAPK signal transduction pathway;0;0;GO:0015979
GO:0141072;symbiont-mediated suppression of host tumor necrosis factor-mediated signaling pathway;0;0;GO:0009416
GO:0141071;symbiont-mediated activation of host MAPK signal transduction pathway;0;0;GO:0006796
GO:0141067;intracellular nitrogen homeostasis;94776;0;GO:0006096
GO:0141066;symbiont-mediated disruption of host extracellular matrix;0;0;GO:0046686
GO:0141069;receptor ligand inhibitor activity;0;2;GO:0006486
GO:0141068;autosome genomic imprinting;24;1;GO:0006032
GO:0141063;epigenetic programming in the central cell;0;2;GO:0009277
GO:0141062;disruption of tissue in another organism;0;0;GO:0009653
GO:0141065;maternal mRNA clearance;0;2;GO:0007548
GO:0141064;zygotic genome activation;0;2;GO:0008544
GO:0141061;disruption of cell in another organism;101408;1;GO:0007626
GO:0141060;disruption of anatomical structure in another organism;254661;2;GO:0007548
GO:0141059;symbiont-mediated disruption of host antimicrobial peptide activity;0;0;GO:0000786
GO:0141056;histone H4 ubiquitin ligase activity;0;0;GO:0007610
GO:0141055;histone H3 ubiquitin ligase activity;56;0;GO:0005525
GO:0141058;histone H4 demethylase activity;411;0;GO:0006749
GO:0141057;histone H3 arginine deiminase activity;253;0;GO:0006749
GO:0141095;retrotransposon silencing by DNA methylation-dependent heterochromatin formation;0;0;GO:0009579
GO:0141092;positive regulation of nodal signaling pathway;0;1;GO:0048666
GO:0141091;transforming growth factor beta receptor superfamily signaling pathway;45067;3;GO:0030428
GO:0141094;DNA loop anchor binding;0;0;GO:0005576
GO:0141093;5-amino-6-(D-ribitylamino)uracil--L-tyrosine 4-hydroxyphenyl transferase activity;0;0;GO:0006879
GO:0141090;protein serine pyrophosphorylase activity;0;0;GO:0005575
GO:0141089;glucose sensor activity;0;0;GO:0005840
GO:0141088;symbiont-mediated activation of host autophagy;0;1;GO:0005524
GO:0141085;regulation of inflammasome-mediated signaling pathway;1843;0;GO:0005576
GO:0141084;inflammasome-mediated signaling pathway;2242;2;GO:0005524
GO:0141087;positive regulation of inflammasome-mediated signaling pathway;1215;1;GO:0003682
GO:0141086;negative regulation of inflammasome-mediated signaling pathway;579;0;GO:0004872
GO:0141081;symbiont-mediated suppression of host inflammasome-mediated signal transduction;0;0;GO:0046395
GO:0141080;symbiont-mediated activation of host interferon signaling pathway;0;0;GO:0004730
GO:0141083;symbiont-mediated suppression of host reactive oxygen species generation;0;0;GO:0030522
GO:0141082;symbiont-mediated detoxification of host-generated reactive oxygen species;0;0;GO:0007186
GO:0070195;growth hormone receptor complex;82;27;GO:0005578
GO:0070196;eukaryotic translation initiation factor 3 complex assembly;6;1;GO:0005578
GO:0070193;synaptonemal complex organization;7212;623;GO:0004497
GO:0070194;synaptonemal complex disassembly;162;27;GO:0005581
GO:0070199;establishment of protein localization to chromosome;1608;107;GO:0005515
GO:0070197;meiotic attachment of telomere to nuclear envelope;2323;382;GO:0005581
GO:0070198;protein localization to chromosome, telomeric region;1717;129;GO:0005581
GO:0141078;symbiont-mediated suppression of host RIG-I signaling pathway;0;0;GO:0005840
GO:0141077;suppression of host interferon-mediated signaling pathway;149577;1;GO:0005581
GO:0141079;symbiont-mediated activation of host inflammasome-mediated signal transduction;0;0;GO:0008340
GO:0047709;bis(2-ethylhexyl)phthalate esterase activity;0;2;GO:0005581
GO:0047708;biotinidase activity;29;91;GO:0005746
GO:0047707;biotin-CoA ligase activity;4;3;GO:0005578
GO:0047706;biochanin-A reductase activity;0;3;GO:0005520
GO:0008104;protein localization;6405224;6700;GO:0005581
GO:0047701;beta-L-arabinosidase activity;35;5;GO:0048608
GO:0008103;oocyte microtubule cytoskeleton polarization;199;49;GO:0048704
GO:0047700;beta-glucoside kinase activity;849;4;GO:0002344
GO:0008108;UDP-glucose:hexose-1-phosphate uridylyltransferase activity;82143;186;GO:0048704
GO:0047705;bilirubin oxidase activity;173;4;GO:0048666
GO:0008107;galactoside 2-alpha-L-fucosyltransferase activity;10738;460;GO:0003729
GO:0047704;bile-salt sulfotransferase activity;54;6;GO:0009908
GO:0008106;alcohol dehydrogenase (NADP+) activity;8337;0;GO:0048704
GO:0047703;beta-nitroacrylate reductase activity;0;3;GO:0003729
GO:0047702;beta-lysine 5,6-aminomutase activity;189;2;GO:0002504
GO:0035716;chemokine (C-C motif) ligand 12 binding;36;2;GO:0048704
GO:0035717;chemokine (C-C motif) ligand 7 binding;98;7;GO:0030518
GO:0035718;macrophage migration inhibitory factor binding;1196;6;GO:0030518
GO:0035719;tRNA import into nucleus;55;6;GO:0007049
GO:0035712;T-helper 2 cell activation;60;8;GO:0006796
GO:0035713;response to nitrogen dioxide;10;3;GO:0004812
GO:0035714;cellular response to nitrogen dioxide;4;2;GO:0048285
GO:0035715;chemokine (C-C motif) ligand 2 binding;36;2;GO:0048608
GO:0035710;CD4-positive, alpha-beta T cell activation;8511;335;GO:0006099
GO:0035711;T-helper 1 cell activation;83;60;GO:0048468
GO:0047719;indole 2,3-dioxygenase activity;1;2;GO:0048468
GO:0047718;indanol dehydrogenase activity;40;162;GO:0003824
GO:0047717;imidazoleacetate 4-monooxygenase activity;0;2;GO:0009952
GO:0008111;alpha-methylacyl-CoA racemase activity;784;9;GO:0009952
GO:0008110;L-histidine:2-oxoglutarate aminotransferase activity;3;4;GO:0043005
GO:0008115;sarcosine oxidase activity;39975;58;GO:0045944
GO:0047712;Cypridina-luciferin 2-monooxygenase activity;5;5;GO:0003676
GO:0008114;phosphogluconate 2-dehydrogenase activity;91;3;GO:0004175
GO:0047711;blasticidin-S deaminase activity;92;3;GO:0043406
GO:0008113;peptide-methionine (S)-S-oxide reductase activity;215237;0;GO:0004721
GO:0047710;bis(5'-adenosyl)-triphosphatase activity;5030;0;GO:0032963
GO:0008112;nicotinamide N-methyltransferase activity;137;34;GO:0007566
GO:0008119;thiopurine S-methyltransferase activity;14234;37;GO:0005819
GO:0047716;imidazole N-acetyltransferase activity;4;4;GO:0032559
GO:0008118;N-acetyllactosaminide alpha-2,3-sialyltransferase activity;103;8;GO:0032559
GO:0047715;hypotaurocyamine kinase activity;0;3;GO:0048731
GO:0008117;sphinganine-1-phosphate aldolase activity;401;15;GO:0004553
GO:0047714;galactolipase activity;99;19;GO:0003729
GO:0008116;prostaglandin-I synthase activity;837;110;GO:0003729
GO:0047713;galactitol 2-dehydrogenase activity;32;2;GO:0003729
GO:0035709;memory T cell activation;116;41;GO:0003729
GO:0008109;N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity;74;52;GO:0003723
GO:0035705;T-helper 17 cell chemotaxis;38;30;GO:0003729
GO:0035706;T-helper 1 cell chemotaxis;0;2;GO:0003723
GO:0035707;T-helper 2 cell chemotaxis;0;2;GO:0003729
GO:0035708;interleukin-4-dependent isotype switching to IgE isotypes;5;1;GO:0006418
GO:0035701;hematopoietic stem cell migration;753;140;GO:0003729
GO:0035702;monocyte homeostasis;106;9;GO:0048608
GO:0035703;monocyte migration into blood stream;0;3;GO:0005524
GO:0035704;helper T cell chemotaxis;0;6;GO:0043531
GO:0035700;astrocyte chemotaxis;117;7;GO:0005524
GO:0047729;carnitine decarboxylase activity;0;2;GO:0043531
GO:0047728;carnitine 3-dehydrogenase activity;9255;5;GO:0003729
GO:0047723;inosinate nucleosidase activity;5;3;GO:0003723
GO:0060701;negative regulation of ribonuclease activity;20;8;GO:0008565
GO:0047722;indolelactate dehydrogenase (NADH) activity;3;2;GO:0002224
GO:0060702;negative regulation of endoribonuclease activity;17;40;GO:0042803
GO:0047721;indoleacetate-lysine synthetase activity;12;3;GO:0005576
GO:0060703;deoxyribonuclease inhibitor activity;718;5;GO:0046274
GO:0047720;indoleacetaldoxime dehydratase activity;16;5;GO:0009579
GO:0060704;acinar cell differentiation involved in salivary gland development;0;2;GO:0006631
GO:0047727;isobutyryl-CoA mutase activity;19607;5;GO:0007050
GO:1901800;positive regulation of proteasomal protein catabolic process;51448;606;GO:0003677
GO:0047726;iron-cytochrome-c reductase activity;2;7;GO:0006364
GO:0047725;inulosucrase activity;18;4;GO:0006096
GO:1901802;1,5-anhydro-D-fructose catabolic process;0;1;GO:0019825
GO:0047724;inosine nucleosidase activity;103;8;GO:0005576
GO:0060700;regulation of ribonuclease activity;67;84;GO:0002537
GO:1901801;1,5-anhydro-D-fructose metabolic process;0;2;GO:0006461
GO:0060709;glycogen cell differentiation involved in embryonic placenta development;48;7;GO:0004721
GO:0047730;carnosine synthase activity;1061;9;GO:0007050
GO:0060705;neuron differentiation involved in salivary gland development;0;3;GO:0000976
GO:0060706;cell differentiation involved in embryonic placenta development;1472;583;GO:0048305
GO:0060707;trophoblast giant cell differentiation;617;230;GO:0005911
GO:0060708;spongiotrophoblast differentiation;181;114;GO:0005929
GO:0047739;cephalosporin-C deacetylase activity;666;4;GO:0006559
GO:0047734;CDP-glycerol diphosphatase activity;875;7;GO:0006749
GO:0047733;CDP-glucose 4,6-dehydratase activity;2425;10;GO:0006749
GO:0047732;CDP-abequose epimerase activity;346;4;GO:0006749
GO:0047731;catechol oxidase (dimerizing) activity;0;3;GO:0009060
GO:0047738;cellobiose phosphorylase activity;131;4;GO:0009063
GO:1901811;beta-carotene catabolic process;5;1;GO:0009693
GO:1901810;beta-carotene metabolic process;64;1;GO:0006559
GO:0047736;cellobiose epimerase activity;7183;5;GO:0048699
GO:1901813;astaxanthin metabolic process;0;0;GO:0008544
GO:0047735;cellobiose dehydrogenase (acceptor) activity;57;3;GO:0048608
GO:1901812;beta-carotene biosynthetic process;2;0;GO:0007568
GO:1901804;beta-glucoside metabolic process;104;39;GO:0048870
GO:1901803;1,5-anhydro-D-fructose biosynthetic process;0;0;GO:0042330
GO:1901806;beta-glucoside biosynthetic process;13;3;GO:0048608
GO:1901805;beta-glucoside catabolic process;72;9;GO:0006928
GO:0047741;cetraxate benzylesterase activity;0;3;GO:0004067
GO:1901808;capsanthin catabolic process;0;0;GO:0005576
GO:0047740;cephalosporin-C transaminase activity;0;3;GO:0009952
GO:1901807;capsanthin metabolic process;0;0;GO:0048598
GO:1901809;capsanthin biosynthetic process;0;0;GO:0009952
GO:0008140;cAMP response element binding protein binding;2966;259;GO:0048513
GO:0035760;cytoplasmic polyadenylation-dependent rRNA catabolic process;0;2;GO:0008544
GO:0035761;dorsal motor nucleus of vagus nerve maturation;0;2;GO:0032502
GO:0035762;dorsal motor nucleus of vagus nerve morphogenesis;0;2;GO:0048608
GO:0033100;NuA3 histone acetyltransferase complex;85;5;GO:0048608
GO:0008143;poly(A) binding;13205;781;GO:0048405
GO:0008142;oxysterol binding;3704;274;GO:0030900
GO:0008147;structural constituent of bone;69;91;GO:0048731
GO:0008146;sulfotransferase activity;162370;1660;GO:0048731
GO:0008145;phenylalkylamine binding;1;4;GO:0048731
GO:0035756;transepithelial migration of symbiont in host;2;1;GO:0048609
GO:0035757;chemokine (C-C motif) ligand 19 binding;81;4;GO:0048609
GO:0035758;chemokine (C-C motif) ligand 21 binding;81;3;GO:0048608
GO:0035759;mesangial cell-matrix adhesion;72;24;GO:0008544
GO:0035752;lysosomal lumen pH elevation;292;36;GO:0046649
GO:0035753;maintenance of DNA trinucleotide repeats;154;10;GO:0002504
GO:0035754;B cell chemotaxis;344;96;GO:0046395
GO:0035755;cardiolipin hydrolase activity;72;7;GO:0005576
GO:0008150;biological_process;361945692;21900;GO:0005811
GO:0035750;protein localization to myelin sheath abaxonal region;60;6;GO:0048305
GO:0035751;regulation of lysosomal lumen pH;1422;54;GO:0005737
GO:0008154;actin polymerization or depolymerization;126319;918;GO:0005634
GO:0008153;para-aminobenzoic acid biosynthetic process;117;10;GO:0005576
GO:0008152;metabolic process;245991529;44600;GO:0005739
GO:0008158;hedgehog receptor activity;2822;423;GO:0008544
GO:0008157;protein phosphatase 1 binding;3301;528;GO:0005634
GO:0008156;negative regulation of DNA replication;19155;801;GO:0005634
GO:0035749;myelin sheath adaxonal region;196;174;GO:0005730
GO:0035745;T-helper 2 cell cytokine production;555;187;GO:0005576
GO:0035746;granzyme A production;3;5;GO:0030199
GO:0035747;natural killer cell chemotaxis;235;269;GO:0030199
GO:0035748;myelin sheath abaxonal region;225;236;GO:0005576
GO:0035741;activated CD4-positive, alpha-beta T cell proliferation;2;1;GO:0005576
GO:0035742;activated CD8-positive, alpha-beta T cell proliferation;0;1;GO:0005604
GO:0035743;CD4-positive, alpha-beta T cell cytokine production;930;41;GO:0030199
GO:0035744;T-helper 1 cell cytokine production;375;24;GO:0030199
GO:0035740;CD8-positive, alpha-beta T cell proliferation;343;13;GO:0030199
GO:0008121;ubiquinol-cytochrome-c reductase activity;175906;1150;GO:0030199
GO:0008120;ceramide glucosyltransferase activity;3033;9;GO:0004067
GO:0008126;acetylesterase activity;21348;53;GO:0044421
GO:0008124;4-alpha-hydroxytetrahydrobiopterin dehydratase activity;94611;586;GO:0042605
GO:0008123;cholesterol 7-alpha-monooxygenase activity;1778;10;GO:0004872
GO:0008127;quercetin 2,3-dioxygenase activity;2606;7;GO:0004872
GO:0035738;envenomation resulting in modulation of process in another organism;3586;6;GO:0044464
GO:0035739;CD4-positive, alpha-beta T cell proliferation;1384;43;GO:0005576
GO:0035735;intraciliary transport involved in cilium assembly;4253;314;GO:0048285
GO:0035736;cell proliferation involved in compound eye morphogenesis;158;6;GO:0048304
GO:0035730;S-nitrosoglutathione binding;31;6;GO:0048407
GO:0035731;dinitrosyl-iron complex binding;28210;10;GO:0005615
GO:0035732;nitric oxide storage;1;5;GO:0022610
GO:0035733;hepatic stellate cell activation;168;144;GO:0005576
GO:0008131;primary amine oxidase activity;144155;690;GO:0048305
GO:0008137;NADH dehydrogenase (ubiquinone) activity;1479289;4320;GO:0009505
GO:0008135;translation factor activity, RNA binding;2341438;1410;GO:0007517
GO:0008134;transcription factor binding;97646;11700;GO:0003700
GO:0008139;nuclear localization sequence binding;5731;745;GO:0006936
GO:0008138;protein tyrosine/serine/threonine phosphatase activity;99163;1920;GO:0003700
GO:0035727;lysophosphatidic acid binding;394;318;GO:0007517
GO:0035728;response to hepatocyte growth factor;707;216;GO:0003700
GO:0035729;cellular response to hepatocyte growth factor stimulus;694;636;GO:0007599
GO:0035723;interleukin-15-mediated signaling pathway;2347;71;GO:0003700
GO:0035724;CD24 biosynthetic process;49;1;GO:0042254
GO:0035725;sodium ion transmembrane transport;607725;3080;GO:0000786
GO:0035726;common myeloid progenitor cell proliferation;279;145;GO:0048598
GO:0035720;intraciliary anterograde transport;285;33;GO:0048608
GO:0035721;intraciliary retrograde transport;6333;150;GO:0000976
GO:0035722;interleukin-12-mediated signaling pathway;466;457;GO:0003723
GO:0008184;glycogen phosphorylase activity;49291;390;GO:0032502
GO:0033140;negative regulation of peptidyl-serine phosphorylation of STAT protein;190;10;GO:0032991
GO:0060760;positive regulation of response to cytokine stimulus;4056;321;GO:0003723
GO:0060761;negative regulation of response to cytokine stimulus;153794;186;GO:0007517
GO:0060762;regulation of branching involved in mammary gland duct morphogenesis;201;59;GO:0003723
GO:0008188;neuropeptide receptor activity;39915;639;GO:0009987
GO:0033144;negative regulation of intracellular steroid hormone receptor signaling pathway;1894;266;GO:0000976
GO:0008187;poly-pyrimidine tract binding;2492;168;GO:0005524
GO:0033143;regulation of intracellular steroid hormone receptor signaling pathway;3634;285;GO:0006936
GO:0008186;ATP-dependent activity, acting on RNA;615212;427;GO:0003723
GO:0033142;nuclear progesterone receptor binding;66;3;GO:0003723
GO:1901860;positive regulation of mitochondrial DNA metabolic process;204;23;GO:0003723
GO:0033141;positive regulation of peptidyl-serine phosphorylation of STAT protein;404;323;GO:0003723
GO:0047789;creatininase activity;2843;5;GO:0003723
GO:0060767;epithelial cell proliferation involved in prostate gland development;1027;28;GO:0003723
GO:1901862;negative regulation of muscle tissue development;668;10;GO:0032963
GO:0045127;N-acetylglucosamine kinase activity;10311;205;GO:0046330
GO:0047788;2-coumarate reductase activity;1;3;GO:0006865
GO:0060768;regulation of epithelial cell proliferation involved in prostate gland development;544;80;GO:0032963
GO:1901861;regulation of muscle tissue development;2411;76;GO:0002034
GO:0045124;regulation of bone resorption;1810;901;GO:0010467
GO:0047787;delta4-3-oxosteroid 5beta-reductase activity;875;10;GO:0010467
GO:0060769;positive regulation of epithelial cell proliferation involved in prostate gland development;127;50;GO:0010467
GO:1901864;capsorubin metabolic process;0;0;GO:0009987
GO:0045125;bioactive lipid receptor activity;6712;81;GO:0005929
GO:1901863;positive regulation of muscle tissue development;1166;470;GO:0008565
GO:0060763;mammary duct terminal end bud growth;145;187;GO:0005215
GO:1901866;capsorubin biosynthetic process;0;0;GO:0005524
GO:0060764;cell-cell signaling involved in mammary gland development;86;5;GO:0005215
GO:1901865;capsorubin catabolic process;0;0;GO:0004497
GO:0045128;negative regulation of reciprocal meiotic recombination;103;25;GO:0006836
GO:0060765;regulation of androgen receptor signaling pathway;1281;267;GO:0016802
GO:1901868;ecgonine methyl ester catabolic process;1;1;GO:0005215
GO:0045129;NAD-independent histone deacetylase activity;58;2;GO:0042302
GO:0060766;negative regulation of androgen receptor signaling pathway;779;674;GO:0005215
GO:1901867;ecgonine methyl ester metabolic process;2;1;GO:0007530
GO:0047792;cyanohydrin beta-glucosyltransferase activity;43;3;GO:0005215
GO:1901859;negative regulation of mitochondrial DNA metabolic process;112;5;GO:0006631
GO:0045130;keratan sulfotransferase activity;111;10;GO:0006631
GO:0047791;cucurbitacin delta23-reductase activity;0;2;GO:0005215
GO:1901858;regulation of mitochondrial DNA metabolic process;480;6;GO:0006661
GO:0047790;creatinine deaminase activity;17;4;GO:0048285
GO:0045133;2,3-dihydroxybenzoate 3,4-dioxygenase activity;24;3;GO:0071013
GO:0047796;cyclohexane-1,3-dione hydrolase activity;0;3;GO:0007067
GO:0072741;protein localization to cell division site;290;5;GO:0006661
GO:0045134;UDP phosphatase activity;538;3;GO:0006559
GO:0047795;cyclohexane-1,2-diol dehydrogenase activity;0;3;GO:0055085
GO:0072740;cellular response to anisomycin;118;8;GO:0046395
GO:0045131;pre-mRNA branch point binding;27320;193;GO:0046394
GO:0047794;cyclohexadienyl dehydrogenase activity;897;3;GO:0048285
GO:0045132;meiotic chromosome segregation;22752;3060;GO:0046394
GO:0047793;cycloeucalenol cycloisomerase activity;805;4;GO:0046394
GO:0033137;negative regulation of peptidyl-serine phosphorylation;1449;517;GO:0005125
GO:0072745;cellular response to antimycin A;2;1;GO:0006032
GO:0072744;cellular response to trichodermin;0;2;GO:0005125
GO:0033135;regulation of peptidyl-serine phosphorylation;6313;519;GO:0046274
GO:0072743;cellular response to erythromycin;1;1;GO:0009306
GO:0033134;ubiquitin activating enzyme binding;85;3;GO:0006836
GO:0072742;SAGA complex localization to transcription regulatory region;16;0;GO:0005215
GO:0008180;COP9 signalosome;22926;1710;GO:0002096
GO:0035796;ATP-binding cassette (ABC) transporter complex, transmembrane substrate-binding subunit-containing;10;2;GO:0007596
GO:0072749;cellular response to cytochalasin B;50;10;GO:0006836
GO:0035797;tellurite methyltransferase activity;0;0;GO:0043403
GO:0072748;cellular response to tacrolimus;0;2;GO:0046148
GO:0033139;regulation of peptidyl-serine phosphorylation of STAT protein;598;134;GO:0006836
GO:0035798;2-alkenal reductase (NADP+) activity;100;0;GO:0045727
GO:0072747;cellular response to chloramphenicol;4;1;GO:0005215
GO:0033138;positive regulation of peptidyl-serine phosphorylation;4592;2010;GO:0042127
GO:0035799;ureter maturation;147;56;GO:0006836
GO:0072746;cellular response to tetracycline;0;0;GO:0045727
GO:0008195;phosphatidate phosphatase activity;17607;1260;GO:0005125
GO:0035792;host cell postsynaptic membrane;566;5;GO:0046394
GO:0008194;UDP-glycosyltransferase activity;764718;1460;GO:0010467
GO:0035793;positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway;109;170;GO:0042379
GO:0008193;tRNA guanylyltransferase activity;11575;230;GO:0005125
GO:0035794;positive regulation of mitochondrial membrane permeability;2353;247;GO:0005125
GO:0060750;epithelial cell proliferation involved in mammary gland duct elongation;183;47;GO:0004721
GO:0008192;RNA guanylyltransferase activity;29227;21;GO:0007049
GO:0035795;negative regulation of mitochondrial membrane permeability;1125;32;GO:0042127
GO:0060751;branch elongation involved in mammary gland duct branching;280;244;GO:0006418
GO:0072739;response to anisomycin;172;2;GO:0005615
GO:0008199;ferric iron binding;139495;1810;GO:0005576
GO:0033133;positive regulation of glucokinase activity;4;328;GO:0016310
GO:0008198;ferrous iron binding;58886;1050;GO:0004553
GO:0033132;negative regulation of glucokinase activity;11;46;GO:0005578
GO:0033131;regulation of glucokinase activity;15;489;GO:0005125
GO:0035790;platelet-derived growth factor receptor-alpha signaling pathway;1830;15;GO:0008529
GO:1901871;ecgonone methyl ester catabolic process;1;2;GO:0048405
GO:0008196;vitellogenin receptor activity;1;2;GO:0005215
GO:0033130;acetylcholine receptor binding;1824;488;GO:0048405
GO:0035791;platelet-derived growth factor receptor-beta signaling pathway;1265;45;GO:0015075
GO:1901870;ecgonone methyl ester metabolic process;2;1;GO:0048405
GO:0045137;development of primary sexual characteristics;19590;911;GO:0008528
GO:0060756;foraging behavior;57;6;GO:0048405
GO:1901873;regulation of post-translational protein modification;24191;99;GO:0015979
GO:0045138;nematode male tail tip morphogenesis;553;6;GO:0005509
GO:0047799;cyclopentanone monooxygenase activity;16;3;GO:0008565
GO:0060757;adult foraging behavior;0;2;GO:0016310
GO:1901872;ecgonone methyl ester biosynthetic process;1;2;GO:0005065
GO:0045135;poly(beta-D-mannuronate) lyase activity;3355;5;GO:0016310
GO:0047798;cyclomaltodextrinase activity;505;3;GO:0008528
GO:0060758;foraging behavior by probing substrate;0;6;GO:0008610
GO:1901875;positive regulation of post-translational protein modification;11307;3;GO:0008529
GO:0045136;development of secondary sexual characteristics;474;42;GO:0005840
GO:0047797;cyclohexanone dehydrogenase activity;0;3;GO:0030514
GO:0060759;regulation of response to cytokine stimulus;159050;514;GO:0097159
GO:1901874;negative regulation of post-translational protein modification;5485;8;GO:0010401
GO:0060752;intestinal phytosterol absorption;0;6;GO:0005869
GO:1901877;negative regulation of calcium ion binding;7;9;GO:0010468
GO:0060753;regulation of mast cell chemotaxis;377;40;GO:0005125
GO:1901876;regulation of calcium ion binding;10;4;GO:0005125
GO:0060754;positive regulation of mast cell chemotaxis;262;96;GO:0005125
GO:1901879;regulation of protein depolymerization;64089;417;GO:0005125
GO:0060755;negative regulation of mast cell chemotaxis;56;2;GO:0016569
GO:1901878;positive regulation of calcium ion binding;0;0;GO:0048285
GO:0045140;inositol phosphoceramide synthase activity;1414;5;GO:0005125
GO:0045141;meiotic telomere clustering;2745;121;GO:0042379
GO:1901869;ecgonine methyl ester biosynthetic process;1;1;GO:0046395
GO:0045144;meiotic sister chromatid segregation;1131;32;GO:0005215
GO:0072730;response to papulacandin B;0;2;GO:0030528
GO:0045145;single-stranded DNA 5'-3' DNA exonuclease activity;2799;1;GO:0008047
GO:0045142;triplex DNA binding;124;14;GO:0004553
GO:0045143;homologous chromosome segregation;15003;361;GO:0005576
GO:0035789;metanephric mesenchymal cell migration;238;3;GO:0004722
GO:0072734;cellular response to staurosporine;153;394;GO:0004073
GO:0072733;response to staurosporine;153;103;GO:0008544
GO:0072732;cellular response to calcium ion starvation;3;3;GO:0048407
GO:0033123;positive regulation of purine nucleotide catabolic process;0;61;GO:0004073
GO:0072731;cellular response to papulacandin B;0;1;GO:0005524
GO:0008191;metalloendopeptidase inhibitor activity;13889;886;GO:0004872
GO:0035785;intracellular nickel ion homeostasis;0;1;GO:0004633
GO:0072738;cellular response to diamide;102;10;GO:0006974
GO:0008190;eukaryotic initiation factor 4E binding;4568;490;GO:0032991
GO:0072737;response to diamide;102;6;GO:0048193
GO:0035787;cell migration involved in kidney development;256;6;GO:0005515
GO:0072736;cellular response to tert-butyl hydroperoxide;0;0;GO:0043234
GO:0035788;cell migration involved in metanephros development;252;5;GO:0005515
GO:0072735;response to tert-butyl hydroperoxide;0;0;GO:0043169
GO:0035781;CD86 biosynthetic process;105;5;GO:0030334
GO:0060781;mesenchymal cell proliferation involved in prostate gland development;40;1;GO:0004872
GO:0035782;mature natural killer cell chemotaxis;25;4;GO:0004872
GO:0060782;regulation of mesenchymal cell proliferation involved in prostate gland development;40;6;GO:0030509
GO:0008160;protein tyrosine phosphatase activator activity;243;26;GO:0032989
GO:0035783;CD4-positive, alpha-beta T cell costimulation;91;6;GO:0016477
GO:0060783;mesenchymal smoothened signaling pathway involved in prostate gland development;40;7;GO:0043065
GO:0060784;regulation of cell proliferation involved in tissue homeostasis;133;8;GO:0042127
GO:0033122;negative regulation of purine nucleotide catabolic process;0;7;GO:0008565
GO:1901880;negative regulation of protein depolymerization;61939;527;GO:0005215
GO:0033121;regulation of purine nucleotide catabolic process;1;378;GO:0005215
GO:0033120;positive regulation of RNA splicing;2280;947;GO:0046274
GO:1901882;4-hydroxycoumarin metabolic process;2;0;GO:0009952
GO:0035780;CD80 biosynthetic process;75;1;GO:0009064
GO:0060780;intercalary leaflet morphogenesis;0;1;GO:0048193
GO:1901881;positive regulation of protein depolymerization;2048;238;GO:0009065
GO:0045148;tripeptide aminopeptidase activity;34747;211;GO:0048608
GO:0060789;hair follicle placode formation;209;646;GO:0005524
GO:1901884;4-hydroxycoumarin biosynthetic process;2;0;GO:0008076
GO:0008169;C-methyltransferase activity;233513;17;GO:0006836
GO:0045149;acetoin metabolic process;42146;8;GO:0046332
GO:1901883;4-hydroxycoumarin catabolic process;0;0;GO:0005743
GO:0008168;methyltransferase activity;12351654;7660;GO:0048608
GO:0045146;initiation of acetate catabolic process by acetate;0;1;GO:0048285
GO:1901886;2-hydroxybenzoyl-CoA catabolic process;2;0;GO:0048407
GO:0045147;regulation of initiation of acetate catabolic process by acetate;0;2;GO:0048193
GO:1901885;2-hydroxybenzoyl-CoA metabolic process;2;1;GO:0007517
GO:0060785;regulation of apoptosis involved in tissue homeostasis;113;8;GO:0048193
GO:1901888;regulation of cell junction assembly;17966;302;GO:0030900
GO:0060786;regulation of cell differentiation involved in tissue homeostasis;20;3;GO:0048193
GO:1901887;2-hydroxybenzoyl-CoA biosynthetic process;0;0;GO:0008565
GO:0060787;positive regulation of posterior neural plate formation by fibroblast growth factor receptor signaling pathway;0;2;GO:0005215
GO:0060788;ectodermal placode formation;1452;291;GO:0008565
GO:1901889;negative regulation of cell junction assembly;1853;175;GO:0005215
GO:0045151;acetoin biosynthetic process;16942;91;GO:0007596
GO:0045152;antisigma factor binding;2045;10;GO:0005743
GO:0045150;acetoin catabolic process;18308;40;GO:0005789
GO:0070100;negative regulation of chemokine-mediated signaling pathway;289;57;GO:0008544
GO:0072763;cellular response to hesperadin;0;2;GO:0004842
GO:0045156;electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity;111223;78;GO:0006928
GO:0070101;positive regulation of chemokine-mediated signaling pathway;175;86;GO:0016021
GO:0072762;cellular response to carbendazim;0;1;GO:0048608
GO:0072761;cellular response to capsazepine;0;1;GO:0048608
GO:0072760;cellular response to GW 7647;0;3;GO:0006032
GO:0033115;cyanelle thylakoid membrane;108;3;GO:0045935
GO:0035778;pronephric nephron tubule epithelial cell differentiation;157;5;GO:0005576
GO:0070104;negative regulation of interleukin-6-mediated signaling pathway;60;58;GO:0008565
GO:0033114;cyanelle thylakoid lumen;1;2;GO:0006032
GO:0035779;angioblast cell differentiation;75;5;GO:0048471
GO:0070105;positive regulation of interleukin-6-mediated signaling pathway;186;83;GO:0048471
GO:0072766;centromere clustering at the mitotic interphase nuclear envelope;12;6;GO:0008544
GO:0033113;cyanelle membrane;5;2;GO:0009277
GO:0070102;interleukin-6-mediated signaling pathway;1329;642;GO:0008544
GO:0072765;centromere localization;121;0;GO:0004497
GO:0033112;cyanelle envelope;5;1;GO:0004930
GO:0070103;regulation of interleukin-6-mediated signaling pathway;246;7;GO:0006022
GO:0072764;cellular response to reversine;0;0;GO:0006364
GO:0033119;negative regulation of RNA splicing;1616;1400;GO:0006414
GO:0035774;positive regulation of insulin secretion involved in cellular response to glucose stimulus;1392;592;GO:0005840
GO:0070108;negative regulation of interleukin-27-mediated signaling pathway;0;2;GO:0006873
GO:0033118;esterosome membrane;2;4;GO:0006974
GO:0035775;pronephric glomerulus morphogenesis;243;4;GO:0004930
GO:0070109;positive regulation of interleukin-27-mediated signaling pathway;0;2;GO:0043066
GO:0033117;esterosome;2;4;GO:0007050
GO:0035776;pronephric proximal tubule development;119;7;GO:0004067
GO:0070106;interleukin-27-mediated signaling pathway;430;214;GO:0008021
GO:0033116;endoplasmic reticulum-Golgi intermediate compartment membrane;17523;1100;GO:0004497
GO:0035777;pronephric distal tubule development;125;3;GO:0004067
GO:0070107;regulation of interleukin-27-mediated signaling pathway;0;2;GO:0004497
GO:0008173;RNA methyltransferase activity;1837749;1820;GO:0008219
GO:0035770;ribonucleoprotein granule;73141;682;GO:0007062
GO:0060770;negative regulation of epithelial cell proliferation involved in prostate gland development;330;342;GO:0006457
GO:0008172;S-methyltransferase activity;391661;516;GO:0002221
GO:0035771;interleukin-4-mediated signaling pathway;547;31;GO:0045087
GO:0060771;phyllotactic patterning;103;2;GO:0002237
GO:0008171;O-methyltransferase activity;456749;2380;GO:0002821
GO:0035772;interleukin-13-mediated signaling pathway;10;4;GO:0002213
GO:0060772;leaf phyllotactic patterning;41;0;GO:0005740
GO:0008170;N-methyltransferase activity;944113;1140;GO:0006412
GO:0035773;insulin secretion involved in cellular response to glucose stimulus;3018;222;GO:0006414
GO:0060773;flower phyllotactic patterning;26;2;GO:0055085
GO:0008177;succinate dehydrogenase (ubiquinone) activity;34187;553;GO:0007586
GO:0033111;attachment organelle membrane;10;7;GO:0055085
GO:1901891;regulation of cell septum assembly;33419;4;GO:0055085
GO:0008176;tRNA (guanine-N7-)-methyltransferase activity;137455;0;GO:0015986
GO:0033110;Cvt vesicle membrane;8;6;GO:0042746
GO:1901890;positive regulation of cell junction assembly;5859;586;GO:0008610
GO:0008175;tRNA methyltransferase activity;573792;574;GO:0006629
GO:1901893;positive regulation of cell septum assembly;266;0;GO:0005215
GO:0008174;mRNA methyltransferase activity;94039;186;GO:0005215
GO:1901892;negative regulation of cell septum assembly;3424;2;GO:0008565
GO:0045159;myosin II binding;530;55;GO:0005215
GO:0060778;primary leaflet morphogenesis;0;1;GO:0008021
GO:1901895;negative regulation of ATPase-coupled calcium transmembrane transporter activity;21;5;GO:0005215
GO:0060779;secondary leaflet morphogenesis;0;1;GO:0005021
GO:1901894;regulation of ATPase-coupled calcium transmembrane transporter activity;51;8;GO:0005215
GO:0008179;adenylate cyclase binding;923;363;GO:0006281
GO:0045157;electron transporter, transferring electrons within the noncyclic electron transport pathway of photosynthesis activity;10;4;GO:0007049
GO:1901897;regulation of relaxation of cardiac muscle;134;268;GO:0005515
GO:0045158;electron transporter, transferring electrons within cytochrome b6/f complex of photosystem II activity;68850;23;GO:0005215
GO:1901896;positive regulation of ATPase-coupled calcium transmembrane transporter activity;22;4;GO:0006796
GO:0060774;auxin mediated signaling pathway involved in phyllotactic patterning;16;5;GO:0003954
GO:1901899;positive regulation of relaxation of cardiac muscle;51;10;GO:0004870
GO:0060775;planar cell polarity pathway involved in gastrula mediolateral intercalation;129;12;GO:0005525
GO:1901898;negative regulation of relaxation of cardiac muscle;51;50;GO:0005215
GO:0060776;simple leaf morphogenesis;97;9;GO:0005096
GO:0060777;compound leaf morphogenesis;0;1;GO:0004867
GO:0045162;clustering of voltage-gated sodium channels;1922;161;GO:0004812
GO:0045163;clustering of voltage-gated potassium channels;127;66;GO:0006029
GO:0045160;myosin I complex;85;167;GO:0004842
GO:0045161;neuronal ion channel clustering;2117;1760;GO:0004721
GO:0072752;cellular response to rapamycin;123;49;GO:0006029
GO:0045167;asymmetric protein localization involved in cell fate determination;319;36;GO:0004721
GO:0072751;cellular response to L-thialysine;0;1;GO:0008610
GO:0072750;cellular response to leptomycin B;56;2;GO:0005215
GO:0045165;cell fate commitment;40811;5230;GO:0004553
GO:0033104;type VI protein secretion system complex;3957;38;GO:0005215
GO:0035767;endothelial cell chemotaxis;1826;1150;GO:0006914
GO:0072756;cellular response to paraquat;14;2;GO:0005524
GO:0033103;protein secretion by the type VI secretion system;938;29;GO:0009507
GO:0035768;endothelial cell chemotaxis to fibroblast growth factor;475;9;GO:0005976
GO:0033102;acidocalcisome membrane;4;4;GO:0030246
GO:0035769;B cell chemotaxis across high endothelial venule;11;5;GO:0005976
GO:0072754;cellular response to purvalanol A;0;0;GO:0005576
GO:0033101;cellular bud membrane;30;7;GO:0035095
GO:0072753;cellular response to glutathione;0;0;GO:0005544
GO:0033108;mitochondrial respiratory chain complex assembly;52718;2120;GO:0004067
GO:0035763;dorsal motor nucleus of vagus nerve structural organization;0;1;GO:0005515
GO:0033107;Cvt vesicle;8;2;GO:0043167
GO:0035764;dorsal motor nucleus of vagus nerve formation;0;1;GO:0048407
GO:0072759;cellular response to topoisomerase inhibitor;0;1;GO:0004867
GO:0033106;cis-Golgi network membrane;430;168;GO:0004867
GO:0035765;motor neuron precursor migration involved in dorsal motor nucleus of vagus nerve formation;0;2;GO:0004721
GO:0072758;response to topoisomerase inhibitor;0;0;GO:0007517
GO:0033105;chlorosome envelope;247;2;GO:0004867
GO:0070008;serine-type exopeptidase activity;374064;448;GO:0007548
GO:0072669;tRNA-splicing ligase complex;4037;134;GO:0004867
GO:0106375;deoxynucleoside triphosphate hydrolase activity;7;1;GO:0004842
GO:0060671;epithelial cell differentiation involved in embryonic placenta development;139;51;GO:0004872
GO:0060672;epithelial cell morphogenesis involved in placental branching;139;38;GO:0004867
GO:0060673;cell-cell signaling involved in placenta development;0;5;GO:0003824
GO:0060674;placenta blood vessel development;1311;325;GO:0005524
GO:1901550;regulation of endothelial cell development;907;126;GO:0005215
GO:1901552;positive regulation of endothelial cell development;324;10;GO:0004725
GO:0060670;branching involved in labyrinthine layer morphogenesis;579;473;GO:0004867
GO:1901551;negative regulation of endothelial cell development;100;1;GO:0004867
GO:0060679;trifid subdivision of terminal units involved in ureteric bud branching;0;3;GO:0008529
GO:1901554;response to paracetamol;0;1;GO:0045735
GO:1901553;malonic acid transmembrane transport;4370;0;GO:0048608
GO:0045058;T cell selection;3972;2050;GO:0030528
GO:1901556;response to candesartan;0;1;GO:0048608
GO:0045059;positive thymic T cell selection;694;1660;GO:0030528
GO:0060675;ureteric bud morphogenesis;4351;358;GO:0048608
GO:1901558;response to metformin;2;9;GO:0007548
GO:0060676;ureteric bud formation;583;29;GO:0006631
GO:1901557;response to fenofibrate;41;5;GO:0010467
GO:0060677;ureteric bud elongation;432;12;GO:0009065
GO:0060678;dichotomous subdivision of terminal units involved in ureteric bud branching;25;4;GO:0009813
GO:1901559;response to ribavirin;0;0;GO:0000724
GO:0045063;T-helper 1 cell differentiation;1005;117;GO:0006569
GO:0106385;dIMP salvage;1;1;GO:0006614
GO:0045064;T-helper 2 cell differentiation;1047;104;GO:0046395
GO:0106384;dGMP salvage;1;0;GO:0048193
GO:0045061;thymic T cell selection;1482;1260;GO:0046395
GO:0106383;dAMP salvage;159;2;GO:0008544
GO:0045062;extrathymic T cell selection;60;136;GO:0006073
GO:0045067;positive extrathymic T cell selection;0;2;GO:0005509
GO:0072653;interferon-omega production;0;2;GO:0006559
GO:0106381;purine deoxyribonucleotide salvage;161;0;GO:0009065
GO:0045068;negative extrathymic T cell selection;0;2;GO:0006721
GO:0106380;purine ribonucleotide salvage;164913;0;GO:0004067
GO:0045065;cytotoxic T cell differentiation;97;34;GO:0006066
GO:0072651;interferon-tau production;3;2;GO:0007067
GO:0045066;regulatory T cell differentiation;2162;86;GO:0046274
GO:0072657;protein localization to membrane;679413;2100;GO:0043169
GO:0072656;maintenance of protein location in mitochondrion;273;38;GO:0003729
GO:0072655;establishment of protein localization to mitochondrion;52778;1010;GO:0003729
GO:0106389;ecdysteroid 22-kinase activity;52;3;GO:0003723
GO:0045060;negative thymic T cell selection;559;1870;GO:0003729
GO:0106388;18S rRNA aminocarboxypropyltransferase activity;5817;4;GO:0005215
GO:0072659;protein localization to plasma membrane;23389;2220;GO:0003729
GO:0106387;'de novo' GMP biosynthetic process;0;2;GO:0003729
GO:0072658;maintenance of protein location in membrane;110;206;GO:0003729
GO:0106386;(3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity;69;0;GO:0005215
GO:1901560;response to purvalanol A;0;0;GO:0005215
GO:1901563;response to camptothecin;235;8;GO:0042592
GO:1901562;response to paraquat;165;10;GO:0042221
GO:1901565;organonitrogen compound catabolic process;3547445;2090;GO:0005215
GO:1901564;organonitrogen compound metabolic process;90459562;3830;GO:0004601
GO:0045069;regulation of viral genome replication;3946;773;GO:0005215
GO:1901567;fatty acid derivative binding;27624;120;GO:0008033
GO:1901566;organonitrogen compound biosynthetic process;65606780;2970;GO:0005215
GO:1901569;fatty acid derivative catabolic process;11505;21;GO:0005576
GO:1901568;fatty acid derivative metabolic process;57882;500;GO:0004812
GO:0072682;eosinophil extravasation;81;3;GO:0004721
GO:0106396;regulation of R7 cell fate commitment;0;0;GO:0004601
GO:0072681;fibronectin-dependent thymocyte migration;44;2;GO:0004872
GO:0106395;positive regulation of palmitic acid catabolic process;0;2;GO:0030548
GO:0072680;extracellular matrix-dependent thymocyte migration;44;1;GO:0007586
GO:0106394;negative regulation of palmitic acid catabolic process;0;1;GO:0030548
GO:0106393;regulation of palmitic acid catabolic process;0;0;GO:0006897
GO:0070023;interleukin-12-interleukin-12 receptor complex;0;0;GO:0048407
GO:0072686;mitotic spindle;22986;2390;GO:0004872
GO:0106392;bI3 intron splicing complex;0;1;GO:0004872
GO:0070024;CD19-Vav-PIK3R1 complex;0;1;GO:0030548
GO:0072685;Mre11 complex assembly;0;0;GO:0030528
GO:0106391;bI4 intron splicing complex;0;2;GO:0004872
GO:0070021;transforming growth factor beta ligand-receptor complex;128;7;GO:0004842
GO:0072683;T cell extravasation;499;126;GO:0004497
GO:0070027;carbon monoxide sensor activity;7;0;GO:0007186
GO:0072689;MCM complex assembly;4;0;GO:0004721
GO:0070025;carbon monoxide binding;140;84;GO:0004842
GO:0072688;SHREC complex localization;0;0;GO:0004721
GO:0070026;nitric oxide binding;230;79;GO:0005819
GO:0072687;meiotic spindle;1194;214;GO:0004842
GO:0045070;positive regulation of viral genome replication;1473;852;GO:0004842
GO:0045071;negative regulation of viral genome replication;2307;2160;GO:0005622
GO:0106399;acyl-coenzyme A diphosphatase activity;3009;6;GO:0004842
GO:0070029;alphav-beta3 integrin-osteopontin complex;0;1;GO:0005618
GO:0106398;negative regulation of R7 cell fate commitment;0;1;GO:0008610
GO:0106397;positive regulation of R7 cell fate commitment;0;1;GO:0000942
GO:0060693;regulation of branching involved in salivary gland morphogenesis;413;837;GO:0008544
GO:0060694;regulation of cholesterol transporter activity;2;26;GO:0007538
GO:0060695;negative regulation of cholesterol transporter activity;1;6;GO:0042302
GO:1901570;fatty acid derivative biosynthetic process;37349;167;GO:0003700
GO:0060696;regulation of phospholipid catabolic process;272;10;GO:0006720
GO:0060690;epithelial cell differentiation involved in salivary gland development;7;5;GO:0006021
GO:1901571;fatty acid derivative transport;2;142;GO:0009699
GO:0060691;epithelial cell maturation involved in salivary gland development;3;7;GO:0048305
GO:0060692;mesenchymal cell differentiation involved in salivary gland development;0;2;GO:0006281
GO:1901576;organic substance biosynthetic process;134075409;3200;GO:0042127
GO:1901575;organic substance catabolic process;10051362;1660;GO:0048608
GO:1901578;negative regulation of alkane biosynthetic process;0;1;GO:0048608
GO:1901577;regulation of alkane biosynthetic process;0;1;GO:0009952
GO:0060697;positive regulation of phospholipid catabolic process;106;133;GO:0045944
GO:0060698;endoribonuclease inhibitor activity;4614;33;GO:0005215
GO:1901579;positive regulation of alkane biosynthetic process;0;0;GO:0006091
GO:0060699;regulation of endoribonuclease activity;35;29;GO:0003729
GO:0072671;mitochondria-associated ubiquitin-dependent protein catabolic process;177;16;GO:0048608
GO:0072670;mitochondrial tRNA threonylcarbamoyladenosine modification;29;2;GO:0004812
GO:0045089;positive regulation of innate immune response;56924;1590;GO:0048608
GO:0070012;oligopeptidase activity;161;10;GO:0006357
GO:0072675;osteoclast fusion;324;448;GO:0009952
GO:0070013;intracellular organelle lumen;1805255;2820;GO:0045944
GO:0072674;multinuclear osteoclast differentiation;500;257;GO:0005515
GO:0045087;innate immune response;328231;19000;GO:0048608
GO:0072673;lamellipodium morphogenesis;1019;252;GO:0003729
GO:0045088;regulation of innate immune response;218555;2500;GO:0042127
GO:0072672;neutrophil extravasation;432;198;GO:0003729
GO:0070016;armadillo repeat domain binding;530;329;GO:0005515
GO:0072679;thymocyte migration;281;19;GO:0003723
GO:0070017;alphav-beta3 integrin-thrombospondin complex;0;0;GO:0048609
GO:0072678;T cell migration;4053;1600;GO:0048609
GO:0070014;sucrase-isomaltase complex;0;2;GO:0055085
GO:0072677;eosinophil migration;827;209;GO:0048167
GO:0072676;lymphocyte migration;7893;847;GO:0046395
GO:0070092;regulation of glucagon secretion;267;185;GO:0046395
GO:0070093;negative regulation of glucagon secretion;78;225;GO:0009813
GO:0070090;metaphase plate;33;4;GO:0046395
GO:0070091;glucagon secretion;272;68;GO:0046395
GO:0070085;glycosylation;198515;1660;GO:0046395
GO:0070086;ubiquitin-dependent endocytosis;565;180;GO:0046395
GO:0070083;clathrin-sculpted monoamine transport vesicle membrane;28;283;GO:0009405
GO:0070089;chloride-activated potassium channel activity;62;3;GO:0003729
GO:0070087;chromo shadow domain binding;320;490;GO:0010468
GO:0070088;polyhydroxyalkanoate granule;3;0;GO:0003676
GO:0070081;clathrin-sculpted monoamine transport vesicle;28;8;GO:0007267
GO:0070082;clathrin-sculpted monoamine transport vesicle lumen;0;1;GO:0007186
GO:0070080;titin Z domain binding;123;8;GO:0004812
GO:0070074;mononeme;0;4;GO:0006749
GO:0070075;tear secretion;144;5;GO:0016570
GO:0070072;vacuolar proton-transporting V-type ATPase complex assembly;12208;494;GO:0004842
GO:0070073;clustering of voltage-gated calcium channels;59;4;GO:0004842
GO:0070078;histone H3-R2 demethylation;0;6;GO:0004842
GO:0070079;histone H4-R3 demethylation;0;6;GO:0004067
GO:0070076;histone lysine demethylation;25;689;GO:0007049
GO:0070096;mitochondrial outer membrane translocase complex assembly;2383;8;GO:0010467
GO:0070097;delta-catenin binding;298;99;GO:0007165
GO:0070094;positive regulation of glucagon secretion;61;7;GO:0007186
GO:0070095;fructose-6-phosphate binding;233;55;GO:1903047
GO:0070098;chemokine-mediated signaling pathway;46407;2360;GO:0007600
GO:0070099;regulation of chemokine-mediated signaling pathway;464;63;GO:0003682
GO:0047609;acetylputrescine deacetylase activity;17;4;GO:0010467
GO:0047608;acetylindoxyl oxidase activity;0;3;GO:0005215
GO:0047602;acetoacetate decarboxylase activity;3530;6;GO:0005215
GO:0047601;acetate kinase (diphosphate) activity;0;4;GO:0045944
GO:0047600;abequosyltransferase activity;53;4;GO:0060337
GO:0047606;hydroxynitrilase activity;11;2;GO:0007067
GO:0047605;acetolactate decarboxylase activity;18924;34;GO:0006909
GO:0047604;acetoin racemase activity;0;3;GO:1901169
GO:0047603;acetoacetyl-CoA hydrolase activity;6;3;GO:1901169
GO:0047619;acylcarnitine hydrolase activity;7;3;GO:0046649
GO:0047618;acylagmatine amidase activity;0;3;GO:0006021
GO:0047613;aconitate decarboxylase activity;100;6;GO:0046394
GO:0047612;acid-CoA ligase (GDP-forming) activity;0;3;GO:0006836
GO:0047611;acetylspermidine deacetylase activity;156;5;GO:0007600
GO:0047610;acetylsalicylate deacetylase activity;1;4;GO:0004497
GO:0047617;acyl-CoA hydrolase activity;85732;676;GO:0048608
GO:0047616;acyl-CoA dehydrogenase (NADP+) activity;11;0;GO:0048167
GO:0047615;actinomycin lactonase activity;0;2;GO:0031982
GO:0047614;aconitate delta-isomerase activity;83;3;GO:0048666
GO:0047620;acylglycerol kinase activity;157;8;GO:0004890
GO:0035640;exploration behavior;1400;2190;GO:0005768
GO:0035641;locomotory exploration behavior;732;2380;GO:0048608
GO:0008023;transcription elongation factor complex;41950;1020;GO:0048608
GO:0008021;synaptic vesicle;34551;3640;GO:0005576
GO:0008020;G protein-coupled photoreceptor activity;1647;498;GO:0008023
GO:0008024;cyclin/CDK positive transcription elongation factor complex;2306;56;GO:0048608
GO:0008029;pentraxin receptor activity;3;1;GO:0007186
GO:0008028;monocarboxylic acid transmembrane transporter activity;111961;792;GO:0005215
GO:0035639;purine ribonucleoside triphosphate binding;41464400;2380;GO:0005576
GO:0035635;entry of bacterium into host cell;360;330;GO:0048608
GO:0035631;CD40 receptor complex;521;284;GO:0048608
GO:0035632;mitochondrial prohibitin complex;257;10;GO:0007423
GO:0035633;maintenance of blood-brain barrier;716;202;GO:0007186
GO:0035634;response to stilbenoid;298;612;GO:0007186
GO:0008030;neuronal pentraxin receptor activity;0;1;GO:0048608
GO:0035630;bone mineralization involved in bone maturation;577;55;GO:0048608
GO:0008033;tRNA processing;5727993;6030;GO:0097403
GO:0008031;eclosion hormone activity;2;4;GO:0048608
GO:0008038;neuron recognition;5328;3210;GO:0043169
GO:0008037;cell recognition;44315;2340;GO:0008023
GO:0008036;diuretic hormone receptor activity;551;8;GO:0048193
GO:0008035;high-density lipoprotein particle binding;400;376;GO:0043005
GO:0008039;synaptic target recognition;707;400;GO:0048193
GO:0035628;cystic duct development;0;1;GO:0048193
GO:0035629;N-terminal protein amino acid N-linked glycosylation;0;4;GO:0007416
GO:0035624;receptor transactivation;6;28;GO:0008092
GO:0035626;juvenile hormone mediated signaling pathway;56;60;GO:0048167
GO:0035627;ceramide transport;2363;263;GO:0048608
GO:0035621;ER to Golgi ceramide transport;367;239;GO:0048608
GO:0035622;intrahepatic bile duct development;437;60;GO:0045202
GO:0035623;renal glucose absorption;120;21;GO:0008021
GO:0008009;chemokine activity;25456;5630;GO:0048608
GO:0035617;stress granule disassembly;312;295;GO:0006811
GO:0035618;root hair;89;4;GO:0048666
GO:0035619;root hair tip;34;6;GO:0048167
GO:0035613;RNA stem-loop binding;984;208;GO:0005215
GO:0035614;snRNA stem-loop binding;14;43;GO:0048608
GO:0035615;clathrin adaptor activity;13944;653;GO:0006986
GO:0035616;histone H2B conserved C-terminal lysine deubiquitination;2;37;GO:0043161
GO:0035610;protein side chain deglutamylation;42;39;GO:0007268
GO:0035611;protein branching point deglutamylation;9;3;GO:0050877
GO:0035612;AP-2 adaptor complex binding;475;165;GO:0008565
GO:0008012;structural constituent of adult chitin-based cuticle;1;2;GO:0016567
GO:0008011;structural constituent of pupal chitin-based cuticle;13;9;GO:0010467
GO:0008010;structural constituent of chitin-based larval cuticle;665;88;GO:0007530
GO:0008016;regulation of heart contraction;21648;3070;GO:0016567
GO:0008015;blood circulation;90294;2670;GO:0048193
GO:0008013;beta-catenin binding;14190;2680;GO:0005215
GO:0008017;microtubule binding;271547;12200;GO:0010467
GO:0035606;peptidyl-cysteine S-trans-nitrosylation;26;53;GO:0046394
GO:0035607;fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development;20;10;GO:0010401
GO:0035608;protein deglutamylation;96;133;GO:0046356
GO:0035609;C-terminal protein deglutamylation;30;35;GO:0046395
GO:0035602;fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell;18;5;GO:0046394
GO:0035603;fibroblast growth factor receptor signaling pathway involved in hemopoiesis;18;20;GO:0050729
GO:0035604;fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow;18;10;GO:0050729
GO:0035605;peptidyl-cysteine S-nitrosylase activity;324;44;GO:0010468
GO:0035600;tRNA methylthiolation;21066;19;GO:0006954
GO:0035601;protein deacylation;42179;154;GO:0050729
GO:0008063;Toll signaling pathway;5268;917;GO:0008565
GO:0035682;toll-like receptor 21 signaling pathway;0;4;GO:0005215
GO:0008062;eclosion rhythm;84;117;GO:0006790
GO:0035683;memory T cell extravasation;100;8;GO:0006511
GO:0008061;chitin binding;134987;2310;GO:0006511
GO:0035684;helper T cell extravasation;99;10;GO:0009060
GO:0060640;positive regulation of dentin-containing tooth bud formation by mesenchymal-epithelial signaling;1;0;GO:0009072
GO:0035685;helper T cell diapedesis;93;7;GO:0005215
GO:0060641;mammary gland duct regression in males;0;3;GO:0006081
GO:0072629;interleukin-28B production;0;1;GO:0005044
GO:0033023;mast cell homeostasis;221;29;GO:0006836
GO:0008066;glutamate receptor activity;44426;1300;GO:0006541
GO:0033022;cyclopentanol catabolic process;3;2;GO:0009062
GO:0008065;establishment of blood-nerve barrier;91;42;GO:0004473
GO:0033021;cyclopentanol biosynthetic process;0;2;GO:0048608
GO:0035680;posterior lateral line neuromast hair cell morphogenesis;0;1;GO:0009060
GO:0008064;regulation of actin polymerization or depolymerization;99094;1100;GO:0097458
GO:0033020;cyclopentanol metabolic process;3;3;GO:0007067
GO:0035681;toll-like receptor 15 signaling pathway;0;3;GO:0009987
GO:0045005;DNA-templated DNA replication maintenance of fidelity;16097;6;GO:0004721
GO:0047668;amygdalin beta-glucosidase activity;23;6;GO:0048285
GO:0060646;internal mammary gland bud epithelial cell differentiation;0;1;GO:0006364
GO:0045006;DNA deamination;534;2710;GO:0007586
GO:0047667;AMP-thymidine kinase activity;0;3;GO:0043005
GO:0060647;mesenchymal cell condensation involved in mammary fat development;0;1;GO:0006559
GO:0008069;dorsal/ventral axis specification, ovarian follicular epithelium;148;8;GO:0006749
GO:0045003;double-strand break repair via synthesis-dependent strand annealing;3051;85;GO:0006575
GO:0047666;ammonia kinase activity;0;4;GO:0006575
GO:0060648;mammary gland bud morphogenesis;124;7;GO:0005096
GO:1901501;response to xylene;0;0;GO:0008083
GO:0008068;extracellularly glutamate-gated chloride channel activity;18;8;GO:0006511
GO:0045004;DNA replication proofreading;422;63;GO:0006767
GO:0047665;aminolevulinate transaminase activity;0;3;GO:0005488
GO:0060649;mammary gland bud elongation;2;4;GO:0006559
GO:1901500;response to p-xylene;0;0;GO:0006022
GO:0045009;chitosome;10073;58;GO:0006567
GO:0060642;white fat cell differentiation involved in mammary gland fat development;0;1;GO:0006541
GO:1901503;ether biosynthetic process;4360;43;GO:0004867
GO:0060643;epithelial cell differentiation involved in mammary gland bud morphogenesis;0;0;GO:0006790
GO:1901502;ether catabolic process;135;3;GO:0006541
GO:0045007;depurination;6;48;GO:0006559
GO:0060644;mammary gland epithelial cell differentiation;641;359;GO:0006790
GO:1901505;carbohydrate derivative transmembrane transporter activity;240793;86;GO:0006067
GO:0045008;depyrimidination;19;36;GO:0004497
GO:0047669;amylosucrase activity;3156;4;GO:0009814
GO:0060645;peripheral mammary gland bud epithelial cell differentiation;0;1;GO:0004497
GO:1901504;triazole transport;0;0;GO:0009065
GO:0047671;anthranilate adenylyltransferase activity;1;2;GO:0006073
GO:0047670;anhydrotetracycline monooxygenase activity;128;3;GO:0006553
GO:0047675;arabinonate dehydratase activity;12;3;GO:0006749
GO:0045013;carbon catabolite repression of transcription;980;134;GO:0006749
GO:0047674;apiose 1-reductase activity;1;3;GO:0005215
GO:0045010;actin nucleation;47925;1100;GO:0009061
GO:0047673;anthranilate N-malonyltransferase activity;0;3;GO:0009065
GO:0047672;anthranilate N-benzoyltransferase activity;40;3;GO:0005576
GO:0033016;rhoptry membrane;5;3;GO:1901363
GO:0035679;anterior lateral line neuromast hair cell morphogenesis;0;1;GO:0005525
GO:0033015;tetrapyrrole catabolic process;21879;38;GO:0046274
GO:0033014;tetrapyrrole biosynthetic process;2981449;2640;GO:0004497
GO:0033013;tetrapyrrole metabolic process;3017593;890;GO:0004866
GO:0035675;neuromast hair cell development;705;6;GO:0006955
GO:0033019;5-hydroxyvalerate dehydrogenase activity;0;1;GO:0005529
GO:0035676;anterior lateral line neuromast hair cell development;75;3;GO:0005529
GO:0072627;interleukin-28A production;0;1;GO:0006725
GO:0033018;sarcoplasmic reticulum lumen;2959;470;GO:0005543
GO:0035677;posterior lateral line neuromast hair cell development;347;6;GO:0009065
GO:0033017;sarcoplasmic reticulum membrane;15125;821;GO:0005576
GO:0035678;neuromast hair cell morphogenesis;43;1;GO:0046148
GO:0008074;guanylate cyclase complex, soluble;366;279;GO:0005576
GO:0035671;enone reductase activity;3852;9;GO:0009065
GO:0008073;ornithine decarboxylase inhibitor activity;3568;159;GO:0009065
GO:0035672;oligopeptide transmembrane transport;111548;64;GO:0042446
GO:0035673;oligopeptide transmembrane transporter activity;58333;107;GO:0009755
GO:0008071;maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded;13;2;GO:0006520
GO:0035674;tricarboxylic acid transmembrane transport;7705;147;GO:0005529
GO:0008078;mesodermal cell migration;917;148;GO:0008528
GO:0033012;porosome;0;3;GO:0006569
GO:0033011;perinuclear theca;103;25;GO:0000786
GO:0008076;voltage-gated potassium channel complex;40376;2730;GO:0006958
GO:0033010;paranodal junction;1896;51;GO:0006958
GO:0035670;plant-type ovary development;732;9;GO:0005515
GO:0045016;mitochondrial magnesium ion transmembrane transport;254;6;GO:0042641
GO:0047679;arginine racemase activity;215;3;GO:0097367
GO:0060635;positive regulation of (1->3)-beta-D-glucan biosynthetic process;12;0;GO:0030430
GO:1901510;(-)-microperfuranone metabolic process;1;0;GO:0048308
GO:0045017;glycerolipid biosynthetic process;488492;1340;GO:0006956
GO:0047678;arginine 2-monooxygenase activity;0;3;GO:0031224
GO:0060636;negative regulation of (1->3)-beta-D-glucan biosynthetic process;0;0;GO:0031532
GO:0045014;carbon catabolite repression of transcription by glucose;199;1;GO:0006518
GO:0047677;arachidonate 8(R)-lipoxygenase activity;58;0;GO:0005768
GO:0060637;positive regulation of lactation by mesenchymal-epithelial cell signaling;0;2;GO:0005783
GO:1901512;(-)-microperfuranone biosynthetic process;1;0;GO:0005743
GO:0008079;translation termination factor activity;328426;102;GO:0004725
GO:0045015;HDEL sequence binding;6;5;GO:0046274
GO:0047676;arachidonate-CoA ligase activity;283;49;GO:0006560
GO:0060638;mesenchymal-epithelial cell signaling;489;593;GO:0006569
GO:1901511;(-)-microperfuranone catabolic process;0;0;GO:0006790
GO:0060631;regulation of meiosis I;319;10;GO:0048305
GO:1901514;ATPase-coupled lipo-chitin oligosaccharide transmembrane transporter activity;0;0;GO:0000976
GO:0060632;regulation of microtubule-based movement;4864;1110;GO:0007631
GO:1901513;lipo-chitin oligosaccharide transmembrane transporter activity;0;0;GO:0005737
GO:0045018;retrograde transport, vacuole to Golgi;0;2;GO:0006486
GO:0060633;negative regulation of transcription initiation by RNA polymerase II;368;3;GO:0007599
GO:1901516;aspyridone A metabolic process;0;0;GO:0048304
GO:0045019;negative regulation of nitric oxide biosynthetic process;445;729;GO:0006066
GO:0060634;regulation of 4,6-pyruvylated galactose residue biosynthetic process;0;2;GO:0006066
GO:1901515;poly-beta-1,6-N-acetyl-D-glucosamine transmembrane transporter activity;2032;8;GO:0006094
GO:0047682;aryl-alcohol oxidase activity;13;4;GO:0006066
GO:1901507;negative regulation of acylglycerol transport;1;1;GO:0006767
GO:0047681;aryl-alcohol dehydrogenase (NADP+) activity;409;0;GO:0009062
GO:1901506;regulation of acylglycerol transport;152;1;GO:0006559
GO:0047680;aryl-acylamidase activity;520;3;GO:0005125
GO:1901509;regulation of endothelial tube morphogenesis;270;28;GO:0004067
GO:1901508;positive regulation of acylglycerol transport;151;1;GO:0007596
GO:0045023;G0 to G1 transition;912;56;GO:0005829
GO:0047686;arylsulfate sulfotransferase activity;1383;5;GO:0005737
GO:0060639;positive regulation of salivary gland formation by mesenchymal-epithelial signaling;0;1;GO:0005737
GO:0047685;amine sulfotransferase activity;7;10;GO:0006066
GO:0047684;arylamine glucosyltransferase activity;0;1;GO:0006096
GO:0045022;early endosome to late endosome transport;9048;975;GO:0048706
GO:0047683;aryl-aldehyde dehydrogenase (NADP+) activity;6;0;GO:0005125
GO:0033005;positive regulation of mast cell activation;824;969;GO:0005739
GO:0035668;TRAM-dependent toll-like receptor signaling pathway;149;103;GO:0048608
GO:0033004;negative regulation of mast cell activation;514;798;GO:0002576
GO:0035669;TRAM-dependent toll-like receptor 4 signaling pathway;149;39;GO:0002504
GO:0033003;regulation of mast cell activation;1761;1830;GO:0009734
GO:0033002;muscle cell proliferation;10914;859;GO:0008610
GO:0008070;maternal determination of dorsal/ventral axis, ovarian follicular epithelium, germ-line encoded;22;2;GO:0009734
GO:0033009;nucleomorph;31;4;GO:0048407
GO:0035664;TIRAP-dependent toll-like receptor signaling pathway;54;4;GO:0004722
GO:0033008;positive regulation of mast cell activation involved in immune response;616;485;GO:0003682
GO:0035665;TIRAP-dependent toll-like receptor 4 signaling pathway;54;6;GO:0008544
GO:0033007;negative regulation of mast cell activation involved in immune response;382;39;GO:0003712
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;1207;925;GO:0048193
GO:0033006;regulation of mast cell activation involved in immune response;1354;846;GO:0006030
GO:0035667;TRIF-dependent toll-like receptor 4 signaling pathway;0;3;GO:0004896
GO:0035660;MyD88-dependent toll-like receptor 4 signaling pathway;2;3;GO:0004930
GO:0060660;epidermis morphogenesis involved in nipple formation;0;1;GO:0048407
GO:0035661;MyD88-dependent toll-like receptor 2 signaling pathway;0;5;GO:0048193
GO:0060661;submandibular salivary gland formation;57;10;GO:0003735
GO:0035662;Toll-like receptor 4 binding;918;218;GO:0006096
GO:0060662;salivary gland cavitation;262;98;GO:0006544
GO:0035663;Toll-like receptor 2 binding;374;56;GO:0006520
GO:0060663;apoptotic process involved in salivary gland cavitation;0;0;GO:0006099
GO:0008045;motor neuron axon guidance;3125;1280;GO:0005125
GO:0033001;Fc-gamma receptor III complex;105;3;GO:0004721
GO:0033000;Fc-gamma receptor I complex;0;1;GO:0002429
GO:0008043;intracellular ferritin complex;53;47;GO:0005125
GO:0008049;male courtship behavior;932;374;GO:0004722
GO:0045027;DNA end binding;1182;201;GO:0004721
GO:0060668;regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling;53;3;GO:0004930
GO:1901521;aspyridone B biosynthetic process;0;1;GO:0048405
GO:0008048;calcium sensitive guanylate cyclase activator activity;254;57;GO:0009913
GO:0045028;G protein-coupled purinergic nucleotide receptor activity;6102;603;GO:0006030
GO:0047689;aspartate racemase activity;1813;9;GO:0007626
GO:0060669;embryonic placenta morphogenesis;1055;189;GO:0007600
GO:1901520;aspyridone B catabolic process;0;1;GO:0007623
GO:0008047;enzyme activator activity;444848;2840;GO:0006935
GO:0045025;mitochondrial degradosome;298;7;GO:0009729
GO:0047688;aspartate 4-decarboxylase activity;352;8;GO:0000786
GO:1901523;icosanoid catabolic process;522;4;GO:0009913
GO:0008046;axon guidance receptor activity;2337;437;GO:0009913
GO:0045026;plasma membrane fusion;4147;1210;GO:0006418
GO:0060664;epithelial cell proliferation involved in salivary gland morphogenesis;234;94;GO:0048305
GO:1901525;negative regulation of mitophagy;248;54;GO:0016570
GO:0060665;regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling;220;450;GO:0048193
GO:1901524;regulation of mitophagy;718;10;GO:0048193
GO:0045029;G protein-coupled UDP receptor activity;129;1;GO:0008029
GO:0060666;dichotomous subdivision of terminal units involved in salivary gland branching;153;225;GO:0006032
GO:1901527;abscisic acid-activated signaling pathway involved in stomatal movement;135;4;GO:0022627
GO:0060667;branch elongation involved in salivary gland morphogenesis;78;19;GO:0048704
GO:1901526;positive regulation of mitophagy;372;27;GO:0006099
GO:0045030;G protein-coupled UTP receptor activity;153;0;GO:0006032
GO:0047693;ATP diphosphatase activity;1967;8;GO:0009813
GO:1901518;aspyridone A biosynthetic process;0;0;GO:0006749
GO:0045031;G protein-coupled ATP receptor activity;183;5;GO:0009835
GO:0047692;ATP deaminase activity;0;3;GO:0005576
GO:1901517;aspyridone A catabolic process;0;0;GO:0008030
GO:0047691;aspulvinone dimethylallyltransferase activity;0;4;GO:0005524
GO:1901519;aspyridone B metabolic process;0;2;GO:0005576
GO:0047697;beta-alanopine dehydrogenase activity;0;3;GO:0005576
GO:0045035;sensory organ precursor cell division;153;16;GO:0004061
GO:0047696;beta-adrenergic receptor kinase activity;1268;107;GO:0004061
GO:0047695;benzoin aldolase activity;19;3;GO:0006022
GO:0045033;peroxisome inheritance;1013;10;GO:0043531
GO:0047694;barbiturase activity;1193;5;GO:0006022
GO:0035657;eRF1 methyltransferase complex;188;6;GO:0005524
GO:0035658;Mon1-Ccz1 complex;7121;25;GO:0009063
GO:0072645;interferon-delta production;0;2;GO:0006032
GO:0035659;Wnt signaling pathway involved in wound healing, spreading of epidermal cells;0;7;GO:0006032
GO:0035653;clathrin-coated vesicle cargo loading, AP-1-mediated;5;3;GO:0006032
GO:0035654;clathrin-coated vesicle cargo loading, AP-3-mediated;22;1;GO:0006022
GO:0072649;interferon-kappa production;0;2;GO:0006749
GO:0035655;interleukin-18-mediated signaling pathway;795;131;GO:0006559
GO:0072647;interferon-epsilon production;0;2;GO:0006767
GO:0008052;sensory organ boundary specification;378;65;GO:0005576
GO:0035650;AP-1 adaptor complex binding;1417;287;GO:0009986
GO:0060650;epithelial cell proliferation involved in mammary gland bud elongation;0;1;GO:1903047
GO:0008050;female courtship behavior;116;41;GO:0004812
GO:0035651;AP-3 adaptor complex binding;162;163;GO:0006749
GO:0060651;regulation of epithelial cell proliferation involved in mammary gland bud elongation;0;1;GO:0046395
GO:0035652;clathrin-coated vesicle cargo loading;114;4;GO:0009065
GO:0060652;mammary gland cord morphogenesis;0;2;GO:0006631
GO:0008056;ocellus development;35;9;GO:0006749
GO:0008055;ocellus pigment biosynthetic process;403;6;GO:0046356
GO:1901530;response to hypochlorite;17;2;GO:0048608
GO:0008053;mitochondrial fusion;11845;1790;GO:0010468
GO:0045038;protein import into chloroplast thylakoid membrane;110;86;GO:0048608
GO:0060657;regulation of mammary gland cord elongation by mammary fat precursor cell-epithelial cell signaling;0;3;GO:0009062
GO:1901532;regulation of hematopoietic progenitor cell differentiation;2856;202;GO:0006779
GO:0045039;protein insertion into mitochondrial inner membrane;9762;255;GO:0009062
GO:0060658;nipple morphogenesis;50;4;GO:0009065
GO:1901531;hypochlorite binding;0;0;GO:0009062
GO:0008058;ocellus pigment granule organization;0;2;GO:0006767
GO:0045036;protein targeting to chloroplast;2997;189;GO:0007568
GO:0047699;beta-diketone hydrolase activity;15;2;GO:0048285
GO:0060659;nipple sheath formation;2;3;GO:0003700
GO:1901534;positive regulation of hematopoietic progenitor cell differentiation;546;5;GO:0046686
GO:0008057;eye pigment granule organization;272;39;GO:0006468
GO:0045037;protein import into chloroplast stroma;720;42;GO:0046395
GO:0047698;beta-alanyl-CoA ammonia-lyase activity;12;2;GO:0009065
GO:1901533;negative regulation of hematopoietic progenitor cell differentiation;922;22;GO:0046274
GO:0060653;epithelial cell differentiation involved in mammary gland cord morphogenesis;0;1;GO:0006767
GO:1901536;negative regulation of DNA demethylation;110;208;GO:0046405
GO:0060654;mammary gland cord elongation;0;2;GO:0006779
GO:1901535;regulation of DNA demethylation;1579;7;GO:0006865
GO:0060655;branching involved in mammary gland cord morphogenesis;0;1;GO:0042330
GO:0060656;regulation of branching involved in mammary cord morphogenesis by fat precursor cell-epithelial cell signaling;0;2;GO:0006626
GO:1901537;positive regulation of DNA demethylation;1394;145;GO:0000786
GO:0045041;protein import into mitochondrial intermembrane space;3751;254;GO:0042592
GO:1901529;positive regulation of anion channel activity;5;24;GO:0004812
GO:1901528;hydrogen peroxide mediated signaling pathway involved in stomatal movement;5;2;GO:0006914
GO:0045040;protein insertion into mitochondrial outer membrane;6170;209;GO:0016569
GO:0072631;interleukin-29 production;0;1;GO:0048193
GO:0045046;protein import into peroxisome membrane;1487;198;GO:0022626
GO:0035646;endosome to melanosome transport;519;317;GO:0004867
GO:0072635;interleukin-31 production;0;1;GO:0004867
GO:0035647;3-oxo-delta(4,5)-steroid 5-beta-reductase activity;0;0;GO:0003682
GO:0035648;circadian mating behavior;0;2;GO:0005976
GO:0072633;interleukin-30 production;0;1;GO:0004553
GO:0106402;Lewis x epitope biosynthetic process;0;1;GO:0016021
GO:0035649;Nrd1 complex;22;7;GO:0003682
GO:0035642;histone H3R17 methyltransferase activity;127;1;GO:0046395
GO:0072639;interleukin-33 production;71;4;GO:0004553
GO:0106400;double-strand break repair via transcription-associated homologous recombination;0;1;GO:0045944
GO:0035643;L-DOPA receptor activity;70;4;GO:0006351
GO:0035644;phosphoanandamide dephosphorylation;56;4;GO:0016071
GO:0072637;interleukin-32 production;1;1;GO:0006351
GO:0035645;enteric smooth muscle cell differentiation;54;3;GO:0008037
GO:0033063;Rad51B-Rad51C-Rad51D-XRCC2 complex;4312;54;GO:0008544
GO:0033061;DNA recombinase mediator complex;5696;9;GO:0006351
GO:0033060;ocellus pigmentation;403;2;GO:0045944
GO:0047629;ADP deaminase activity;0;3;GO:0003700
GO:0106409;cyclic-di-AMP phosphodiesterase activity;3925;2;GO:0003777
GO:0033067;macrolide metabolic process;28488;4;GO:0046649
GO:0106408;diadenylate cyclase activity;36635;3;GO:0004866
GO:0033066;Rad51B-Rad51C complex;0;1;GO:0005525
GO:0106407;Glc2Man9GlcNAc2 oligosaccharide glucosidase activity;46;1;GO:0003700
GO:0033065;Rad51C-XRCC3 complex;271;5;GO:0004842
GO:0033064;XRCC2-RAD51D complex;0;1;GO:0004812
GO:0106405;isoprenoid diphosphate phosphatase activity;45;1;GO:0004721
GO:0047624;adenosine-tetraphosphatase activity;32;6;GO:0004812
GO:0060602;branch elongation of an epithelium;1307;39;GO:0016570
GO:0047623;adenosine-phosphate deaminase activity;18577;9;GO:0004842
GO:0060603;mammary gland duct morphogenesis;2036;291;GO:0004842
GO:0047622;adenosine nucleosidase activity;46;6;GO:0004812
GO:0060604;mammary gland duct cavitation;0;1;GO:0006066
GO:0047621;acylpyruvate hydrolase activity;228;6;GO:0006281
GO:0060605;tube lumen cavitation;264;9;GO:0003723
GO:0047628;ADP-thymidine kinase activity;0;4;GO:0016569
GO:0047627;adenylylsulfatase activity;2546;5;GO:0016569
GO:0060600;dichotomous subdivision of an epithelial terminal unit;368;512;GO:0004721
GO:0047625;adenosylmethionine cyclotransferase activity;1;3;GO:0048452
GO:0060601;lateral sprouting from an epithelium;721;774;GO:0046330
GO:0047631;ADP-ribose diphosphatase activity;14418;78;GO:0048193
GO:0060606;tube closure;6667;358;GO:0005215
GO:0047630;ADP-phosphoglycerate phosphatase activity;0;3;GO:0004721
GO:0060607;cell-cell adhesion involved in sealing an epithelial fold;0;1;GO:0048305
GO:0060608;cell-cell adhesion involved in neural tube closure;0;4;GO:0004721
GO:0060609;apoptotic process involved in tube lumen cavitation;0;0;GO:0004721
GO:0106415;muramoyltetrapeptide carboxypeptidase activity;2708;3;GO:0004725
GO:0033059;cellular pigmentation;5891;279;GO:0005524
GO:0106414;mRNA dihydrouridine synthase activity;50;0;GO:0004721
GO:0033058;directional locomotion;381;301;GO:0046330
GO:0106413;RNA dihydrouridine synthase activity;176447;0;GO:0046330
GO:0106411;XMP 5'-nucleosidase activity;36846;1;GO:0046330
GO:0106410;box C/D RNA 5'-end processing;6;1;GO:0046649
GO:0033052;cyanoamino acid metabolic process;0;2;GO:0048169
GO:0033051;aminophosphonate metabolic process;1;2;GO:0004721
GO:0033050;clavulanic acid biosynthetic process;8;2;GO:0048608
GO:0033056;D-ornithine metabolic process;0;4;GO:0003700
GO:0106419;NAD-dependent protein lipoamidase activity;142;1;GO:0006468
GO:0033055;D-arginine metabolic process;0;6;GO:0004930
GO:0106418;UDP-N-acetylmuramate-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate ligase activity;12560;2;GO:0008026
GO:0033054;D-glutamate metabolic process;0;5;GO:0046271
GO:0106417;dopaminechrome tautomerase activity;15;1;GO:1901363
GO:0033053;D-glutamine metabolic process;0;5;GO:0046395
GO:0047635;alanine-oxo-acid transaminase activity;5108;4;GO:0048471
GO:0047634;agmatine N4-coumaroyltransferase activity;21;3;GO:0005911
GO:0047633;agmatine kinase activity;0;3;GO:0030155
GO:0047632;agmatine deiminase activity;18681;24;GO:0070942
GO:0047639;alcohol oxidase activity;225;2;GO:0015671
GO:0047638;albendazole monooxygenase activity;38;5;GO:0048471
GO:0047637;phosphatidylglycerol alanyltransferase activity;4;2;GO:0050729
GO:0047636;alanopine dehydrogenase activity;4;2;GO:0048010
GO:0047642;aldose beta-D-fructosyltransferase activity;0;1;GO:0048193
GO:0047641;aldose-6-phosphate reductase (NADPH) activity;335;5;GO:0030198
GO:0047640;aldose 1-dehydrogenase activity;2;4;GO:0048010
GO:0033049;clavulanic acid metabolic process;8;4;GO:0009986
GO:0106426;regulation of kainate selective glutamate receptor signaling pathway;0;0;GO:0030198
GO:0033048;negative regulation of mitotic sister chromatid segregation;18539;1190;GO:0006457
GO:0106425;3,4-dihydroxyphenylacetaldehyde synthase activity;29;3;GO:0005576
GO:0033047;regulation of mitotic sister chromatid segregation;19454;750;GO:0005576
GO:0033046;negative regulation of sister chromatid segregation;18557;940;GO:0009570
GO:0106423;tubulin-tyrosine carboxypeptidase;68;3;GO:0004553
GO:0106422;carotenoid isomerooxygenase activity;19;3;GO:0005829
GO:0106421;L-glutamate:proton antiporter activity;0;0;GO:0005737
GO:0106420;NAD-dependent protein biotinidase activity;142;1;GO:0045087
GO:0033041;sweet taste receptor activity;2092;10;GO:0005789
GO:0008084;imaginal disc growth factor receptor binding;54;2;GO:0016570
GO:0033040;sour taste receptor activity;61;9;GO:0003700
GO:0008083;growth factor activity;164024;7310;GO:0003700
GO:0008089;anterograde axonal transport;3361;359;GO:0006325
GO:0033045;regulation of sister chromatid segregation;24720;1070;GO:0007186
GO:0008088;axo-dendritic transport;5930;260;GO:0005524
GO:0033044;regulation of chromosome organization;39105;2060;GO:0003700
GO:0106429;11-cis-retinol dehydrogenase;8;2;GO:0006457
GO:0008087;light-activated voltage-gated calcium channel complex;0;2;GO:0006469
GO:0033043;regulation of organelle organization;273158;2320;GO:0006096
GO:0106428;positive regulation of kainate selective glutamate receptor signaling pathway;0;1;GO:0009968
GO:0008086;light-activated voltage-gated calcium channel activity;0;5;GO:0002449
GO:0033042;umami taste receptor activity;0;1;GO:0006469
GO:0106427;negative regulation of kainate selective glutamate receptor signaling pathway;0;0;GO:0006457
GO:0047646;alkanal monooxygenase (FMN-linked) activity;2742;5;GO:0004722
GO:0060624;regulation of ascospore wall (1->3)-beta-D-glucan biosynthetic process;8;0;GO:0004725
GO:0047645;alkan-1-ol dehydrogenase (acceptor) activity;4;3;GO:0006631
GO:0060625;regulation of protein deneddylation;27;2;GO:0004364
GO:0047644;alizarin 2-beta-glucosyltransferase activity;0;2;GO:0009086
GO:0047643;alginate synthase activity;115;4;GO:0009065
GO:0060627;regulation of vesicle-mediated transport;45167;1630;GO:0009061
GO:0060620;regulation of cholesterol import;163;10;GO:0004812
GO:0047649;alkylglycerol kinase activity;0;3;GO:0016567
GO:0060621;negative regulation of cholesterol import;87;46;GO:0009062
GO:0047648;alkylamidase activity;0;3;GO:0004723
GO:0060622;regulation of ascospore wall beta-glucan biosynthetic process;12;2;GO:0009813
GO:0047647;alkylacetylglycerophosphatase activity;0;2;GO:0004723
GO:0060623;regulation of chromosome condensation;551;48;GO:0005524
GO:0047653;allantoin racemase activity;248;3;GO:0048608
GO:0060628;regulation of ER to Golgi vesicle-mediated transport;844;524;GO:0008544
GO:0047652;allantoate deiminase activity;1667;113;GO:0005665
GO:0060629;regulation of homologous chromosome segregation;182;9;GO:0048407
GO:0047651;alkylhalidase activity;6;5;GO:0048407
GO:0047650;alkylglycerone kinase activity;0;2;GO:0048405
GO:0033038;bitter taste receptor activity;918;311;GO:0048193
GO:0106437;protein-glutamic acid ligase activity, initiating;0;0;GO:0048608
GO:0033037;polysaccharide localization;120655;48;GO:0032727
GO:0106436;glutathione-dependent sulfide quinone oxidoreductase activity;65;4;GO:0008076
GO:0033036;macromolecule localization;7411325;2270;GO:0048608
GO:0106435;carboxylesterase activity;8289;112;GO:0046649
GO:0106434;retinal isomerization;0;0;GO:0006073
GO:0008081;phosphoric diester hydrolase activity;713796;3730;GO:0032727
GO:0035697;CD8-positive, alpha-beta T cell extravasation;158;6;GO:0032724
GO:0106433;O6-methyl-dGTP hydrolase activity;56;2;GO:0009813
GO:0008080;N-acetyltransferase activity;611685;4280;GO:0009813
GO:0035698;CD8-positive, alpha-beta cytotoxic T cell extravasation;118;6;GO:0005737
GO:0106432;queuosine nucleosidase activity;4;0;GO:0005737
GO:0035699;T-helper 17 cell extravasation;0;2;GO:0004872
GO:0106431;N6-methyl-(d)ATP hydrolase activity;112;0;GO:0006073
GO:0033039;ionotropic salty taste receptor activity;11;0;GO:0002729
GO:0106430;dihydroorotate dehydrogenase (quinone) activity;43650;3;GO:0050921
GO:0008096;juvenile hormone epoxide hydrolase activity;52;2;GO:0048608
GO:0033030;negative regulation of neutrophil apoptotic process;52;10;GO:0006631
GO:0035693;NOS2-CD74 complex;51;6;GO:0004974
GO:0035694;mitochondrial protein catabolic process;2472;123;GO:0032727
GO:0008094;ATP-dependent activity, acting on DNA;2113863;905;GO:0004872
GO:0035695;mitophagy by induced vacuole formation;90;6;GO:0048010
GO:0008093;cytoskeletal anchor activity;6791;31;GO:0019748
GO:0035696;monocyte extravasation;274;90;GO:0045944
GO:0033034;positive regulation of myeloid cell apoptotic process;390;136;GO:0006725
GO:0033033;negative regulation of myeloid cell apoptotic process;732;722;GO:0045944
GO:0008098;5S rRNA primary transcript binding;12;2;GO:0006936
GO:0033032;regulation of myeloid cell apoptotic process;1226;145;GO:0045944
GO:0035691;macrophage migration inhibitory factor signaling pathway;217;16;GO:0003677
GO:0106439;L-lysine:L-arginine antiporter activity;62;1;GO:0005543
GO:0008097;5S rRNA binding;50224;1330;GO:0048608
GO:0033031;positive regulation of neutrophil apoptotic process;196;72;GO:0048608
GO:0035692;macrophage migration inhibitory factor receptor complex;177;68;GO:0005576
GO:0106438;protein-glutamic acid ligase activity, elongating;0;0;GO:0002237
GO:0047657;alpha-1,3-glucan synthase activity;1300;5;GO:0006874
GO:0060613;fat pad development;334;322;GO:0005506
GO:0047656;alpha,alpha-trehalose phosphorylase activity;421;4;GO:0006626
GO:0060614;negative regulation of mammary gland development in males by androgen receptor signaling pathway;0;4;GO:0004872
GO:0047655;allyl-alcohol dehydrogenase activity;182;4;GO:0005125
GO:0060615;mammary gland bud formation;70;19;GO:0005525
GO:0047654;alliin lyase activity;64;4;GO:0050727
GO:0060616;mammary gland cord formation;0;2;GO:0003700
GO:0060610;mesenchymal cell differentiation involved in mammary gland development;0;3;GO:0050727
GO:0047659;alpha-santonin 1,2-reductase activity;0;2;GO:0050729
GO:0060611;mammary gland fat development;42;30;GO:0005523
GO:0047658;alpha-amino-acid esterase activity;71;5;GO:0050729
GO:0060612;adipose tissue development;2434;1260;GO:0046330
GO:0047660;amidinoaspartase activity;0;4;GO:0050727
GO:0047664;aminoimidazolase activity;0;4;GO:0050729
GO:0060617;positive regulation of mammary placode formation by mesenchymal-epithelial signaling;0;2;GO:0006066
GO:0045002;double-strand break repair via single-strand annealing;2623;185;GO:0009536
GO:0047663;aminoglycoside 6'-N-acetyltransferase activity;2835;0;GO:0006082
GO:0060618;nipple development;52;5;GO:0006865
GO:0047662;aminobenzoate decarboxylase activity;3;3;GO:0048405
GO:0060619;cell migration involved in mammary placode formation;0;4;GO:0050727
GO:0047661;amino-acid racemase activity;513139;45;GO:0006073
GO:0033027;positive regulation of mast cell apoptotic process;31;2;GO:0006021
GO:0033026;negative regulation of mast cell apoptotic process;53;20;GO:0050727
GO:0033025;regulation of mast cell apoptotic process;87;17;GO:0008092
GO:0033024;mast cell apoptotic process;171;237;GO:0006468
GO:0008092;cytoskeletal protein binding;1061198;6390;GO:0004930
GO:0035686;sperm fibrous sheath;355;129;GO:0048169
GO:0008091;spectrin;5513;870;GO:0048169
GO:0035687;T-helper 1 cell extravasation;2;3;GO:0005737
GO:0008090;retrograde axonal transport;744;138;GO:0005581
GO:0033029;regulation of neutrophil apoptotic process;296;55;GO:0008092
GO:0035688;T-helper 1 cell diapedesis;2;4;GO:0000910
GO:0033028;myeloid cell apoptotic process;1875;39;GO:0008092
GO:0035689;chemokine (C-C motif) ligand 5 signaling pathway;0;2;GO:0002218
GO:0060363;cranial suture morphogenesis;424;504;GO:0046330
GO:0060364;frontal suture morphogenesis;68;15;GO:0050727
GO:0060365;coronal suture morphogenesis;17;8;GO:0046649
GO:1901460;regulation of response to formic acid;0;3;GO:0045087
GO:0060366;lambdoid suture morphogenesis;50;3;GO:0048608
GO:1901462;positive regulation of response to formic acid;0;0;GO:0046649
GO:0060360;negative regulation of leucine import in response to ammonium ion;0;1;GO:0050727
GO:1901461;negative regulation of response to formic acid;0;1;GO:0050729
GO:0060361;flight;98;311;GO:0009064
GO:1901464;negative regulation of tetrapyrrole biosynthetic process;5;0;GO:0004497
GO:0060362;flight involved in flight behavior;0;1;GO:0004091
GO:1901463;regulation of tetrapyrrole biosynthetic process;480;2;GO:0004073
GO:1901466;regulation of ferulate catabolic process;0;0;GO:0004089
GO:1901465;positive regulation of tetrapyrrole biosynthetic process;289;0;GO:0006032
GO:1901468;positive regulation of ferulate catabolic process;0;1;GO:0006096
GO:1901467;negative regulation of ferulate catabolic process;0;0;GO:0048704
GO:0060367;sagittal suture morphogenesis;50;3;GO:0048704
GO:0060368;regulation of Fc receptor mediated stimulatory signaling pathway;320;36;GO:0005524
GO:1901469;regulation of syringal lignin catabolic process;0;0;GO:0048704
GO:0060369;positive regulation of Fc receptor mediated stimulatory signaling pathway;188;47;GO:0003954
GO:0047396;glycosylphosphatidylinositol diacylglycerol-lyase activity;23;9;GO:0048704
GO:0072341;modified amino acid binding;199461;568;GO:0048704
GO:0098971;anterograde dendritic transport of neurotransmitter receptor complex;248;113;GO:0048704
GO:0047395;glycerophosphoinositol glycerophosphodiesterase activity;78;5;GO:0006091
GO:0072340;lactam catabolic process;47719;4;GO:0004497
GO:0098972;anterograde dendritic transport of mitochondrion;50;4;GO:0048704
GO:0047394;glycerophosphoinositol inositolphosphodiesterase activity;4;4;GO:0000228
GO:0047393;glycerol-1,2-cyclic-phosphate 2-phosphodiesterase activity;0;3;GO:0004089
GO:0098970;postsynaptic neurotransmitter receptor diffusion trapping;300;20;GO:0043005
GO:0072345;NAADP-sensitive calcium-release channel activity;269;48;GO:0010467
GO:0098975;postsynapse of neuromuscular junction;276;5;GO:0004734
GO:0047399;glucose-1-phospho-D-mannosylglycoprotein phosphodiesterase activity;0;3;GO:0048704
GO:0072344;rescue of stalled ribosome;31709;231;GO:0032787
GO:0098976;excitatory chemical synaptic transmission;255;267;GO:0004721
GO:0047398;dolichylphosphate-mannose phosphodiesterase activity;0;3;GO:0048704
GO:0072343;pancreatic stellate cell proliferation;7;4;GO:0046395
GO:0098973;structural constituent of postsynaptic actin cytoskeleton;160;97;GO:0008610
GO:0047397;dolichylphosphate-glucose phosphodiesterase activity;0;3;GO:0006066
GO:0072342;response to anion stress;0;1;GO:0006091
GO:0098974;postsynaptic actin cytoskeleton organization;758;302;GO:0004041
GO:0072349;modified amino acid transmembrane transporter activity;24275;121;GO:0006066
GO:0098979;polyadic synapse;0;1;GO:0004721
GO:0106217;tRNA C3-cytosine methylation;105;2;GO:0005975
GO:0072348;sulfur compound transport;499145;457;GO:0006066
GO:0106216;positive regulation of vesicle fusion with Golgi apparatus;0;0;GO:0006066
GO:0072347;response to anesthetic;174;236;GO:0004089
GO:0098977;inhibitory chemical synaptic transmission;155;8;GO:0006096
GO:0106215;negative regulation of vesicle fusion with Golgi apparatus;0;0;GO:0004089
GO:0072346;cADPR-sensitive calcium-release channel activity;0;0;GO:0006066
GO:0098978;glutamatergic synapse;21615;2290;GO:0004067
GO:0106214;regulation of vesicle fusion with Golgi apparatus;9;1;GO:0004067
GO:0047392;CMP-N-acylneuraminate phosphodiesterase activity;0;2;GO:0004073
GO:0106213;kinetochore disassembly involved in meiotic chromosome organization;0;0;GO:0006022
GO:0047391;alkylglycerophosphoethanolamine phosphodiesterase activity;118;10;GO:0006869
GO:0106212;centromere detachment from spindle pole body involved in meiotic chromosome organization;0;0;GO:0005976
GO:0047390;glycerophosphocholine cholinephosphodiesterase activity;902;7;GO:0005976
GO:0106211;inositol-5-diphosphate-1,3,4,6-tetrakisphosphate diphosphatase activity;13;3;GO:0045595
GO:0106210;culmorin biosynthetic process;0;1;GO:0005976
GO:0035396;positive regulation of chemokine (C-X-C motif) ligand 9 production;0;4;GO:0010467
GO:0060352;cell adhesion molecule production;501;21;GO:0006030
GO:0035397;helper T cell enhancement of adaptive immune response;19;13;GO:0009627
GO:0060353;regulation of cell adhesion molecule production;367;117;GO:0006073
GO:0035398;helper T cell enhancement of T cell mediated immune response;0;3;GO:0046274
GO:0060354;negative regulation of cell adhesion molecule production;251;66;GO:0005975
GO:1901471;positive regulation of syringal lignin catabolic process;0;0;GO:0005976
GO:0035399;helper T cell enhancement of B cell mediated immune response;0;2;GO:0006073
GO:0060355;positive regulation of cell adhesion molecule production;63;42;GO:0006032
GO:1901470;negative regulation of syringal lignin catabolic process;0;0;GO:0048704
GO:0035393;chemokine (C-X-C motif) ligand 9 production;35;3;GO:0045595
GO:1901472;regulation of Golgi calcium ion export;0;0;GO:0006032
GO:0035394;regulation of chemokine (C-X-C motif) ligand 9 production;35;2;GO:0048704
GO:0060350;endochondral bone morphogenesis;4279;651;GO:0045595
GO:0106219;zinc ion sensor activity;64;4;GO:0006032
GO:1901475;pyruvate transmembrane transport;10928;54;GO:0007565
GO:0035395;negative regulation of chemokine (C-X-C motif) ligand 9 production;35;7;GO:0050729
GO:0060351;cartilage development involved in endochondral bone morphogenesis;2198;1220;GO:0006032
GO:0106218;galactosaminogalactan biosynthetic process;0;1;GO:0048704
GO:1901474;azole transmembrane transporter activity;9635;222;GO:0050729
GO:1901478;aminotriazole transmembrane transporter activity;0;0;GO:0048704
GO:0060357;regulation of leucine import;121;1;GO:0045595
GO:0098990;AMPA selective glutamate receptor signaling pathway;11;1;GO:0048704
GO:0060358;negative regulation of leucine import;121;1;GO:0050877
GO:0060359;response to ammonium ion;385;351;GO:0006032
GO:0072330;monocarboxylic acid biosynthetic process;3052109;1510;GO:0048704
GO:0098982;GABA-ergic synapse;3599;478;GO:0050729
GO:0106220;pyocyanine biosynthetic process;2;0;GO:0006032
GO:0098983;symmetric, GABA-ergic, inhibitory synapse;4;10;GO:0007517
GO:0098980;presynaptic density;0;1;GO:0050877
GO:0098981;cholinergic synapse;550;9;GO:0048667
GO:0072334;UDP-galactose transmembrane transport;1565;177;GO:0048667
GO:0098986;T-bar;0;2;GO:0007517
GO:0098987;regulation of modification of synapse structure, modulating synaptic transmission;0;0;GO:0044429
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;4796;1240;GO:0004867
GO:0098984;neuron to neuron synapse;29053;357;GO:0045595
GO:0072331;signal transduction by p53 class mediator;12683;665;GO:0004812
GO:0098985;asymmetric, glutamatergic, excitatory synapse;504;10;GO:0045595
GO:0072338;lactam metabolic process;47891;7;GO:0006464
GO:0106228;peptide glutaryltransferase activity;57;2;GO:0009579
GO:0072337;modified amino acid transport;77313;207;GO:0044436
GO:0106227;peptidyl-lysine glutarylation;3;2;GO:0005976
GO:0072336;negative regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation;0;3;GO:0009579
GO:0098988;G protein-coupled glutamate receptor activity;512;10;GO:0009536
GO:0106226;peptide 2-hydroxyisobutyryltransferase activity;1124;3;GO:0046274
GO:0072335;regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation;0;0;GO:0005524
GO:0098989;NMDA selective glutamate receptor signaling pathway;8;6;GO:0046274
GO:0106225;peptidyl-lysine 2-hydroxyisobutyrylation;0;1;GO:0007030
GO:0106223;germacrene A hydroxylase activity;22;2;GO:0044464
GO:0106222;lncRNA binding;707;13;GO:0007070
GO:0072339;lactam biosynthetic process;72;1;GO:0006032
GO:0035385;Roundabout signaling pathway;2150;648;GO:0006032
GO:0060385;axonogenesis involved in innervation;516;83;GO:0048704
GO:1901480;oleate transmembrane transporter activity;130;7;GO:0005739
GO:0035386;regulation of Roundabout signaling pathway;14;8;GO:0006022
GO:0060386;synapse assembly involved in innervation;81;3;GO:0006032
GO:0035387;negative regulation of Roundabout signaling pathway;0;6;GO:0006032
GO:0060387;fertilization envelope;0;1;GO:0006032
GO:1901482;L-lysine import into vacuole involved in cellular response to nitrogen starvation;58;0;GO:0048704
GO:0035388;positive regulation of Roundabout signaling pathway;0;3;GO:0045595
GO:0060388;vitelline envelope;79;8;GO:0046274
GO:1901481;L-glutamate import involved in cellular response to nitrogen starvation;54;0;GO:0048704
GO:0035381;ATP-gated ion channel activity;11955;133;GO:0045595
GO:0060381;positive regulation of single-stranded telomeric DNA binding;1;10;GO:0006022
GO:0035382;sterol transmembrane transport;12;5;GO:0048704
GO:0060382;regulation of DNA strand elongation;959;25;GO:0045595
GO:0035383;thioester metabolic process;423484;398;GO:0006032
GO:0060383;positive regulation of DNA strand elongation;57;2;GO:0048704
GO:0035384;thioester biosynthetic process;263215;612;GO:0045595
GO:0060384;innervation;2376;1580;GO:0048704
GO:0106229;histone glutaryltransferase activity;54;3;GO:0045595
GO:0035380;very long-chain-3-hydroxyacyl-CoA dehydrogenase activity;0;2;GO:0048704
GO:0106231;protein-propionyllysine depropionylase activity;104;3;GO:0045595
GO:0106230;protein depropionylation;7;2;GO:0006096
GO:0072360;vascular cord development;0;2;GO:0048704
GO:0098953;receptor diffusion trapping;303;10;GO:0045595
GO:0098954;presynaptic endosome membrane;5;2;GO:0048704
GO:0098957;anterograde axonal transport of mitochondrion;154;4;GO:0045595
GO:0106239;9,13-epoxylabda-14-ene synthase activity;6;2;GO:0007417
GO:0098958;retrograde axonal transport of mitochondrion;111;6;GO:0048704
GO:0106238;peregrinol diphosphate synthase activity;6;2;GO:0005737
GO:0060390;regulation of SMAD protein signal transduction;2467;8;GO:0016567
GO:0106237;arachidonate 12(R)-lipoxygenase activity;3;0;GO:0045595
GO:0060391;positive regulation of SMAD protein signal transduction;1477;731;GO:0045595
GO:0106236;rhamnolipid biosynthesis;1;1;GO:0016567
GO:0035378;carbon dioxide transmembrane transport;604;39;GO:0016567
GO:0106235;ceramide-1-phosphate phosphatase activity;205;3;GO:0045595
GO:0035379;carbon dioxide transmembrane transporter activity;305;39;GO:0044464
GO:0106234;outer membrane protein complex;2;2;GO:0016567
GO:0098959;retrograde dendritic transport of mitochondrion;0;0;GO:0016567
GO:0106233;glycosome organization;1;0;GO:0004725
GO:0106232;hydroxyisourate hydrolase complex;0;1;GO:0006469
GO:0035374;chondroitin sulfate binding;309;632;GO:0005737
GO:0060374;mast cell differentiation;255;33;GO:0016567
GO:1901491;negative regulation of lymphangiogenesis;136;27;GO:0044424
GO:0035375;zymogen binding;75;18;GO:0005789
GO:0060375;regulation of mast cell differentiation;138;3;GO:0006464
GO:1901490;regulation of lymphangiogenesis;351;5;GO:0016021
GO:0035376;sterol import;58;62;GO:0005975
GO:0060376;positive regulation of mast cell differentiation;54;5;GO:0006483
GO:1901493;response to decalin;0;0;GO:0009952
GO:0035377;transepithelial water transport;217;31;GO:0004842
GO:0060377;negative regulation of mast cell differentiation;31;4;GO:0006796
GO:1901492;positive regulation of lymphangiogenesis;148;26;GO:0006099
GO:0035370;UBC13-UEV1A complex;86;30;GO:0048704
GO:0060370;susceptibility to T cell mediated cytotoxicity;65;40;GO:0006633
GO:1901495;negative regulation of cysteine metabolic process;0;0;GO:0004091
GO:0035371;microtubule plus-end;1825;790;GO:0048704
GO:0060371;regulation of atrial cardiac muscle cell membrane depolarization;534;1400;GO:0004497
GO:1901494;regulation of cysteine metabolic process;63;3;GO:0005518
GO:0035372;protein localization to microtubule;1159;842;GO:0004497
GO:0060372;regulation of atrial cardiac muscle cell membrane repolarization;237;283;GO:0048704
GO:1901497;response to diphenyl ether;0;0;GO:0048699
GO:0035373;chondroitin sulfate proteoglycan binding;52;30;GO:0006030
GO:0060373;regulation of ventricular cardiac muscle cell membrane depolarization;243;49;GO:0006099
GO:1901496;positive regulation of cysteine metabolic process;0;0;GO:0048704
GO:1901499;response to hexane;0;0;GO:0048193
GO:1901498;response to tetralin;0;0;GO:0048667
GO:0060378;regulation of brood size;194;8;GO:0006030
GO:0060379;cardiac muscle cell myoblast differentiation;695;49;GO:0006096
GO:0072352;tricarboxylic acid catabolic process;0;1;GO:0048704
GO:0098960;postsynaptic neurotransmitter receptor activity;50491;71;GO:0045595
GO:0106242;kolavenyl diphosphate synthase activity;5;2;GO:0006030
GO:0072351;tricarboxylic acid biosynthetic process;100452;7;GO:0004497
GO:0098961;dendritic transport of ribonucleoprotein complex;156;8;GO:0048704
GO:0072350;tricarboxylic acid metabolic process;133863;966;GO:0048699
GO:0106240;labd-13Z-ene-9,15,16-triol synthase activity;2;1;GO:0006073
GO:0072356;chromosome passenger complex localization to kinetochore;51;184;GO:0048704
GO:0098964;anterograde dendritic transport of messenger ribonucleoprotein complex;58;9;GO:0045944
GO:0098965;extracellular matrix of synaptic cleft;51;2;GO:0006041
GO:0072354;histone H3T3 kinase activity;257;2;GO:0048704
GO:0098962;regulation of postsynaptic neurotransmitter receptor activity;17;244;GO:0043005
GO:0098963;dendritic transport of messenger ribonucleoprotein complex;156;9;GO:0006073
GO:0098968;neurotransmitter receptor transport postsynaptic membrane to endosome;62;8;GO:0004497
GO:0072359;circulatory system development;188830;1820;GO:0048704
GO:0098969;neurotransmitter receptor transport to postsynaptic membrane;936;22;GO:0005524
GO:0106249;Nicalin-NOMO complex;0;0;GO:0045944
GO:0098966;perisynaptic extracellular matrix;496;4;GO:0006073
GO:0106248;positive regulation of poly(A)-specific ribonuclease activity;0;0;GO:0004497
GO:0060380;regulation of single-stranded telomeric DNA binding;1;9;GO:0048704
GO:0072357;PTW/PP1 phosphatase complex;516;189;GO:0045944
GO:0098967;exocytic insertion of neurotransmitter receptor to postsynaptic membrane;278;75;GO:0045944
GO:0106247;negative regulation of poly(A)-specific ribonuclease activity;0;0;GO:0006457
GO:0035367;positive regulation of thymine transport;0;2;GO:0046365
GO:0106246;regulation of poly(A)-specific ribonuclease activity;0;0;GO:0048704
GO:0035368;selenocysteine insertion sequence binding;2985;47;GO:0045595
GO:0106245;L-serine-phosphatidylethanolamine phosphatidyltransferase activity;12861;7;GO:0006469
GO:0035369;pre-B cell receptor complex;0;1;GO:0045580
GO:0106244;eupatolide synthase activity;3;2;GO:0045595
GO:0106243;syn-isopimara-7,15-diene synthase activity;2;1;GO:0007600
GO:0060320;rejection of self pollen;6944;53;GO:0045595
GO:0060321;acceptance of pollen;245;8;GO:0008544
GO:0060322;head development;87153;2390;GO:0007156
GO:1901420;negative regulation of response to alcohol;3731;6;GO:0048193
GO:0047349;D-ribitol-5-phosphate cytidylyltransferase activity;4083;7;GO:0006477
GO:0060327;cytoplasmic actin-based contraction involved in cell motility;179;6;GO:0007155
GO:1901422;response to butan-1-ol;2;1;GO:0005764
GO:0047348;glycerol-3-phosphate cytidylyltransferase activity;3696;19;GO:0016567
GO:0060328;cytoplasmic actin-based contraction involved in forward cell motility;3;2;GO:0048010
GO:1901421;positive regulation of response to alcohol;13;7;GO:0016567
GO:0047347;aldose-1-phosphate nucleotidyltransferase activity;11;2;GO:0048193
GO:0060329;cytoplasmic actin-based contraction involved in rearward cell motility;0;1;GO:0006953
GO:1901424;response to toluene;1;1;GO:0043405
GO:0047346;aldose-1-phosphate adenylyltransferase activity;0;2;GO:0010033
GO:1901423;response to benzene;6;0;GO:0006066
GO:0060323;head morphogenesis;2177;422;GO:0046395
GO:1901426;response to furfural;4;3;GO:0007156
GO:0060324;face development;2781;753;GO:0046395
GO:1901425;response to formic acid;1;1;GO:0022610
GO:0060325;face morphogenesis;1719;1050;GO:0046395
GO:1901428;regulation of syringal lignin biosynthetic process;14;0;GO:0006022
GO:0060326;cell chemotaxis;69305;3730;GO:0005515
GO:1901427;response to propan-1-ol;0;0;GO:0005515
GO:0047352;adenylylsulfate-ammonia adenylyltransferase activity;56;4;GO:0046395
GO:0050993;dimethylallyl diphosphate metabolic process;120463;9;GO:0046395
GO:0106253;positive regulation of DNA strand resection involved in replication fork processing;0;0;GO:0006030
GO:1901419;regulation of response to alcohol;4954;8;GO:0006021
GO:0047351;GTP guanylyltransferase activity;0;2;GO:0008544
GO:0050994;regulation of lipid catabolic process;5760;460;GO:0006032
GO:1901418;positive regulation of response to ethanol;12;2;GO:0006081
GO:0047350;glucuronate-1-phosphate uridylyltransferase activity;61;4;GO:0048704
GO:0106251;N4-acetylcytidine amidohydrolase activity;84;1;GO:0006081
GO:0050992;dimethylallyl diphosphate biosynthetic process;120461;288;GO:0048666
GO:0106250;DNA-binding transcription repressor activity, RNA polymerase III-specific;1;2;GO:0006032
GO:0047356;CDP-ribitol ribitolphosphotransferase activity;48;3;GO:0004089
GO:0072301;regulation of metanephric glomerular mesangial cell proliferation;19;6;GO:0007517
GO:0098931;virion attachment to host cell flagellum;0;1;GO:0006030
GO:0047355;CDP-glycerol glycerophosphotransferase activity;23562;43;GO:0007517
GO:0050990;N-terminal protein amino acid carbamoylation;0;4;GO:0048193
GO:0072300;positive regulation of metanephric glomerulus development;63;35;GO:0045595
GO:0098932;disruption by virus of host cell wall peptidoglycan during virus entry;1747;5;GO:0006032
GO:0047354;sphingosine cholinephosphotransferase activity;0;3;GO:0006032
GO:0047353;N-methylphosphoethanolamine cytidylyltransferase activity;0;4;GO:0048704
GO:0098930;axonal transport;4864;48;GO:0006986
GO:0072305;negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis;27;10;GO:0045595
GO:0098935;dendritic transport;580;206;GO:0005976
GO:0072304;regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis;27;6;GO:0006099
GO:0050999;regulation of nitric-oxide synthase activity;102;818;GO:0008092
GO:0072303;positive regulation of glomerular metanephric mesangial cell proliferation;6;4;GO:0005524
GO:0098933;symbiont-mediated disruption of host cell envelope;763;0;GO:0006030
GO:0106259;cell-to-cell migration in host;1;0;GO:0004497
GO:0072302;negative regulation of metanephric glomerular mesangial cell proliferation;13;30;GO:0008544
GO:0098934;retrograde dendritic transport;0;0;GO:0005524
GO:0106258;L-serine-phosphatidylcholine phosphatidyltransferase activity;84;2;GO:0006032
GO:0050997;quaternary ammonium group binding;425296;274;GO:0008544
GO:0072309;mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis;30;6;GO:0006032
GO:0098939;dendritic transport of mitochondrion;61;5;GO:0048704
GO:0050998;nitric-oxide synthase binding;546;742;GO:0045595
GO:0072308;negative regulation of metanephric nephron tubule epithelial cell differentiation;17;164;GO:0006073
GO:0106256;hydroperoxy icosatetraenoate dehydratase activity;1009;6;GO:0048704
GO:0050995;negative regulation of lipid catabolic process;1423;644;GO:0045595
GO:0072307;regulation of metanephric nephron tubule epithelial cell differentiation;243;314;GO:0022610
GO:0098937;anterograde dendritic transport;427;18;GO:0007156
GO:0032877;positive regulation of DNA endoreduplication;295;74;GO:0045595
GO:0030215;semaphorin receptor binding;32141;458;GO:0007155
GO:0032874;positive regulation of stress-activated MAPK cascade;12421;1270;GO:0048010
GO:0030214;hyaluronan catabolic process;1144;1100;GO:0005739
GO:0032875;regulation of DNA endoreduplication;3483;1020;GO:0048608
GO:0044814;glycolytic fermentation via PFL pathway;0;1;GO:0048608
GO:0044813;glycolytic fermentation via PFOR pathway;0;1;GO:0006469
GO:0044816;Nsk1-Dlc1 complex;6;1;GO:0005840
GO:0044818;mitotic G2/M transition checkpoint;10816;987;GO:0045595
GO:0044817;hydrogen generation via biophotolysis;0;1;GO:0003735
GO:0005251;delayed rectifier potassium channel activity;1601;674;GO:0060429
GO:0005250;A-type (transient outward) potassium channel activity;314;226;GO:0006469
GO:0044819;mitotic G1/S transition checkpoint signaling;1344;5;GO:0006470
GO:0005253;monoatomic anion channel activity;242656;13;GO:0005976
GO:0005252;open rectifier potassium channel activity;644;5;GO:0006469
GO:0005254;chloride channel activity;185812;1850;GO:0048285
GO:0044812;fermentative hydrogen production;0;1;GO:0016568
GO:0030206;chondroitin sulfate biosynthetic process;5304;648;GO:0006464
GO:0032869;cellular response to insulin stimulus;17996;2530;GO:0009065
GO:0005249;voltage-gated potassium channel activity;112355;2670;GO:0006469
GO:0030205;dermatan sulfate metabolic process;387;461;GO:0048010
GO:0030208;dermatan sulfate biosynthetic process;144;555;GO:0006836
GO:0032867;L-arabinose:NADP reductase activity;3;3;GO:0006469
GO:0030207;chondroitin sulfate catabolic process;174;256;GO:0048010
GO:0032868;response to insulin;20518;2720;GO:0006469
GO:0030209;dermatan sulfate catabolic process;196;65;GO:0048010
GO:0030200;heparan sulfate proteoglycan catabolic process;496;53;GO:0016570
GO:0030202;heparin metabolic process;6652;190;GO:0006469
GO:0032865;ERMES complex;9998;31;GO:0002576
GO:0030201;heparan sulfate proteoglycan metabolic process;1620;253;GO:0010467
GO:0032866;D-xylose:NADP reductase activity;674;3;GO:0006082
GO:0030204;chondroitin sulfate metabolic process;5752;589;GO:0050877
GO:0030203;glycosaminoglycan metabolic process;2708971;1510;GO:0006066
GO:0044824;retroviral 3' processing activity;1;0;GO:0048704
GO:0044827;modulation by host of viral genome replication;1198;246;GO:0006029
GO:0044826;viral genome integration into host DNA;357987;9;GO:0046332
GO:0005260;intracellularly ATP-gated chloride channel activity;1248;3;GO:0006066
GO:0044829;positive regulation by host of viral genome replication;482;62;GO:0046317
GO:0044828;negative regulation by host of viral genome replication;387;59;GO:0006099
GO:0005262;calcium channel activity;175757;2560;GO:0008544
GO:0005261;monoatomic cation channel activity;1659330;375;GO:0008021
GO:0044821;meiotic telomere tethering at nuclear periphery;2329;164;GO:0006082
GO:0005267;potassium channel activity;276918;2510;GO:0007067
GO:0044820;mitotic telomere tethering at nuclear periphery;40;4;GO:0050877
GO:0044823;retroviral integrase activity;2;0;GO:0006094
GO:0019894;kinesin binding;13905;1260;GO:0008544
GO:0019896;axonal transport of mitochondrion;789;447;GO:0045595
GO:0019898;extrinsic component of membrane;99157;2290;GO:0006096
GO:0019897;extrinsic component of plasma membrane;48918;761;GO:0050731
GO:0019899;enzyme binding;517995;11700;GO:0045595
GO:0030150;protein import into mitochondrial matrix;24479;835;GO:0050731
GO:0030152;bacteriocin biosynthetic process;79;6;GO:0050727
GO:0030151;molybdenum ion binding;134485;1220;GO:0004867
GO:0005198;structural molecule activity;12272625;16700;GO:0006486
GO:0042132;fructose 1,6-bisphosphate 1-phosphatase activity;154592;986;GO:0006066
GO:0044795;trans-Golgi network to recycling endosome transport;7;3;GO:0006464
GO:0044794;positive regulation by host of viral process;1104;198;GO:0006936
GO:0042134;rRNA primary transcript binding;8454;57;GO:0048285
GO:0005199;structural constituent of cell wall;8826;846;GO:0005524
GO:0044796;DNA polymerase processivity factor complex;341;2;GO:0030198
GO:0044799;NarGHI complex;9;4;GO:0007030
GO:0042137;sequestering of neurotransmitter;3;406;GO:0005524
GO:0042138;meiotic DNA double-strand break formation;7126;279;GO:0004497
GO:0042139;early meiotic recombination nodule assembly;16;2;GO:0005730
GO:0017183;protein histidyl modification to diphthamide;585;2;GO:0005524
GO:0042140;late meiotic recombination nodule assembly;18;2;GO:0030155
GO:0017185;peptidyl-lysine hydroxylation;39;143;GO:0004518
GO:0017186;peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase;40;79;GO:0045944
GO:0017187;peptidyl-glutamic acid carboxylation;31;1260;GO:0046317
GO:0030143;COPI-coated inter-Golgi transport vesicle;0;2;GO:0006094
GO:0017188;aspartate N-acetyltransferase activity;83;6;GO:0045595
GO:0030142;COPI-coated Golgi to ER transport vesicle;20;2;GO:0006091
GO:0017189;N-terminal peptidyl-alanine acetylation;0;4;GO:0045595
GO:0030145;manganese ion binding;452852;4180;GO:0046332
GO:0030144;alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity;8136;171;GO:0006099
GO:0030149;sphingolipid catabolic process;25032;469;GO:0048285
GO:0030148;sphingolipid biosynthetic process;47218;1730;GO:0004497
GO:0030141;secretory granule;33457;3740;GO:0006091
GO:0030140;trans-Golgi network transport vesicle;28478;686;GO:0003779
GO:0042144;vacuole fusion, non-autophagic;1572;149;GO:0048704
GO:0042147;retrograde transport, endosome to Golgi;47127;1810;GO:0006096
GO:0042148;strand invasion;805;88;GO:0048285
GO:0042149;cellular response to glucose starvation;3901;1680;GO:0008328
GO:0030139;endocytic vesicle;48700;2840;GO:0045595
GO:0017171;serine hydrolase activity;3568116;2000;GO:0045595
GO:0017172;cysteine dioxygenase activity;9043;84;GO:0006099
GO:0042150;plasmid recombination;4;10;GO:0048405
GO:0042151;nematocyst;5185;109;GO:0048405
GO:0017174;glycine N-methyltransferase activity;4582;18;GO:0045595
GO:0042152;RNA-mediated DNA recombination;0;2;GO:0048405
GO:0017176;phosphatidylinositol N-acetylglucosaminyltransferase activity;7393;205;GO:0006483
GO:0030132;clathrin coat of coated pit;26431;1100;GO:0006464
GO:0032795;heterotrimeric G-protein binding;129;50;GO:0009065
GO:0017177;glucosidase II complex;390;63;GO:0004723
GO:0030131;clathrin adaptor complex;65051;1230;GO:0005576
GO:0032796;uropod organization;103;92;GO:0006021
GO:0017178;diphthine-ammonia ligase activity;5211;10;GO:0000976
GO:0030134;COPII-coated ER to Golgi transport vesicle;70083;244;GO:0042127
GO:0032793;positive regulation of CREB transcription factor activity;59;931;GO:0009065
GO:0030133;transport vesicle;144297;1830;GO:0007049
GO:0032794;GTPase activating protein binding;807;586;GO:0048608
GO:0030136;clathrin-coated vesicle;90454;1840;GO:0006928
GO:0032799;low-density lipoprotein receptor particle metabolic process;441;378;GO:0048608
GO:0030135;coated vesicle;227196;1210;GO:0009065
GO:0032797;SMN complex;3964;185;GO:0000226
GO:0030137;COPI-coated vesicle;66446;651;GO:0048608
GO:0032798;Swi5-Sfr1 complex;1105;118;GO:0007165
GO:0005170;neurotrophin TRKC receptor binding;1;2;GO:0006096
GO:0005172;vascular endothelial growth factor receptor binding;2405;317;GO:0048285
GO:0032791;lead ion binding;115;7;GO:0009536
GO:0005171;hepatocyte growth factor receptor binding;135;8;GO:0045944
GO:0032792;negative regulation of CREB transcription factor activity;18;72;GO:0005746
GO:0005174;CD40 receptor binding;423;46;GO:0045944
GO:0030130;clathrin coat of trans-Golgi network vesicle;25426;607;GO:0006096
GO:0005173;stem cell factor receptor binding;1457;86;GO:0050729
GO:0032790;ribosome disassembly;4227;182;GO:0006096
GO:0005176;ErbB-2 class receptor binding;73;97;GO:0046649
GO:0005175;CD27 receptor binding;128;2;GO:0050729
GO:0005178;integrin binding;12760;5110;GO:0006073
GO:0042157;lipoprotein metabolic process;199393;2890;GO:0008033
GO:0042158;lipoprotein biosynthetic process;187121;1510;GO:0006022
GO:0005179;hormone activity;111101;5240;GO:0000904
GO:0042159;lipoprotein catabolic process;378;299;GO:0006032
GO:0030129;clathrin coat of synaptic vesicle;0;2;GO:0006073
GO:0030128;clathrin coat of endocytic vesicle;12448;104;GO:0006066
GO:0042160;lipoprotein modification;132;4;GO:0030529
GO:0017161;inositol-1,3,4-trisphosphate 4-phosphatase activity;10;127;GO:0045595
GO:0042161;lipoprotein oxidation;132;4;GO:0006874
GO:0017162;aryl hydrocarbon receptor binding;459;163;GO:0048666
GO:0042162;telomeric DNA binding;28931;875;GO:0045640
GO:0042163;interleukin-12 beta subunit binding;65;10;GO:0006066
GO:0042164;interleukin-12 alpha subunit binding;139;9;GO:0006066
GO:0030121;AP-1 adaptor complex;11633;221;GO:0045595
GO:0032784;regulation of DNA-templated transcription elongation;209495;1230;GO:0048666
GO:0017166;vinculin binding;835;1120;GO:0045640
GO:0030120;vesicle coat;103099;527;GO:0048666
GO:0032785;negative regulation of DNA-templated transcription, elongation;1476;143;GO:0045660
GO:0030123;AP-3 adaptor complex;15245;453;GO:0048666
GO:0032782;bile acid secretion;326;51;GO:0045595
GO:0017168;5-oxoprolinase (ATP-hydrolyzing) activity;41748;37;GO:0048666
GO:0030122;AP-2 adaptor complex;12446;580;GO:0045640
GO:0032783;super elongation complex;3112;5;GO:0005743
GO:0017169;CDP-alcohol phosphatidyltransferase activity;113513;21;GO:0006479
GO:0030125;clathrin vesicle coat;38818;440;GO:0005525
GO:0032788;saturated monocarboxylic acid metabolic process;37;8;GO:0005525
GO:0030124;AP-4 adaptor complex;2312;9;GO:0009986
GO:0032789;unsaturated monocarboxylic acid metabolic process;37;8;GO:0006486
GO:0030127;COPII vesicle coat;25142;1310;GO:0005524
GO:0032786;positive regulation of DNA-templated transcription, elongation;29452;358;GO:0043406
GO:0030126;COPI vesicle coat;39032;1120;GO:0006479
GO:0032787;monocarboxylic acid metabolic process;7773102;4710;GO:0031012
GO:0005183;gonadotropin hormone-releasing hormone activity;670;9;GO:0043406
GO:0032780;negative regulation of ATP-dependent activity;101;29;GO:0007596
GO:0032781;positive regulation of ATP-dependent activity;263;80;GO:0007596
GO:0005185;neurohypophyseal hormone activity;2054;82;GO:0003676
GO:0005184;neuropeptide hormone activity;13746;1600;GO:0003676
GO:0005186;pheromone activity;2187;37;GO:0001837
GO:0042166;acetylcholine binding;492;608;GO:0003676
GO:0042167;heme catabolic process;1768;444;GO:0006066
GO:0042168;heme metabolic process;889956;912;GO:0006066
GO:0042169;SH2 domain binding;1858;952;GO:0045595
GO:0030118;clathrin coat;100449;1210;GO:0006725
GO:0030117;membrane coat;253127;1670;GO:0045595
GO:0042170;plastid membrane;1162237;495;GO:0006073
GO:0030119;AP-type membrane coat adaptor complex;85374;245;GO:0046356
GO:0042171;lysophosphatidic acid acyltransferase activity;70720;44;GO:0006073
GO:0017150;tRNA dihydrouridine synthase activity;176397;1060;GO:0005524
GO:0017151;DEAD/H-box RNA helicase binding;483;298;GO:0046324
GO:0042173;regulation of sporulation resulting in formation of a cellular spore;13842;7;GO:0010468
GO:0042174;negative regulation of sporulation resulting in formation of a cellular spore;5518;6;GO:0006073
GO:0017153;sodium:dicarboxylate symporter activity;2401;195;GO:0006073
GO:0042175;nuclear outer membrane-endoplasmic reticulum membrane network;1015138;445;GO:0048704
GO:0017154;semaphorin receptor activity;22913;598;GO:0048704
GO:0030110;HLA-C specific inhibitory MHC class I receptor activity;4;2;GO:0048666
GO:0032773;positive regulation of tyrosinase activity;4;2;GO:0048704
GO:0032774;RNA biosynthetic process;32441059;2460;GO:0006073
GO:0017156;calcium-ion regulated exocytosis;11496;340;GO:0030529
GO:0030112;glycocalyx;9625;7;GO:0050729
GO:0032771;regulation of tyrosinase activity;4;2;GO:0006073
GO:0017157;regulation of exocytosis;9827;1470;GO:0048704
GO:0030111;regulation of Wnt signaling pathway;54979;1860;GO:0048667
GO:0032772;negative regulation of tyrosinase activity;0;2;GO:0046503
GO:0017158;regulation of calcium ion-dependent exocytosis;1842;974;GO:0048666
GO:0030114;slime layer;1;2;GO:0045595
GO:0032777;Piccolo NuA4 histone acetyltransferase complex;8145;683;GO:0048667
GO:0017159;pantetheine hydrolase activity;201;72;GO:0046148
GO:0032778;P-type cobalt transporter activity;2;13;GO:0048666
GO:0030116;glial cell-derived neurotrophic factor receptor binding;2695;6;GO:0046503
GO:0032775;DNA methylation on adenine;316686;104;GO:0048608
GO:0030115;S-layer;6259;131;GO:0048666
GO:0032776;DNA methylation on cytosine;206629;259;GO:0048666
GO:0044759;negative regulation by symbiont of host synaptic transmission;0;2;GO:0048667
GO:0044758;modulation by symbiont of host synaptic transmission;0;1;GO:0009536
GO:0030194;positive regulation of blood coagulation;1992;1120;GO:0050729
GO:0030193;regulation of blood coagulation;7243;2020;GO:0008092
GO:0030196;cyanide hydratase activity;1445;5;GO:0005930
GO:0030195;negative regulation of blood coagulation;5348;1560;GO:0042330
GO:0044751;cellular response to human chorionic gonadotropin stimulus;121;4;GO:0009611
GO:0044750;high-affinity nickel cation transmembrane transporter activity;3;0;GO:0048706
GO:0044753;amphisome;1394;37;GO:0008047
GO:0044752;response to human chorionic gonadotropin;149;18;GO:0005515
GO:0044754;autolysosome;721;211;GO:0005576
GO:0044760;modulation by symbiont of host cholinergic synaptic transmission;0;1;GO:0005840
GO:0030187;melatonin biosynthetic process;422;326;GO:0005829
GO:0030186;melatonin metabolic process;570;83;GO:0005548
GO:0044769;ATPase activity, coupled to transmembrane movement of ions, rotational mechanism;259043;73;GO:0005553
GO:0030183;B cell differentiation;44983;2100;GO:0010467
GO:0030182;neuron differentiation;232589;6090;GO:0008565
GO:0030185;nitric oxide transport;224;253;GO:0006414
GO:0030184;nitric oxide transmembrane transporter activity;58;5;GO:0005215
GO:0044762;negative regulation by symbiont of host neurotransmitter secretion;1;1;GO:0005576
GO:0042100;B cell proliferation;5807;1740;GO:0005215
GO:0044761;negative regulation by symbiont of host cholinergic synaptic transmission;0;1;GO:0004497
GO:0042101;T cell receptor complex;2361;1590;GO:0005840
GO:0042102;positive regulation of T cell proliferation;5566;2000;GO:0005215
GO:0042103;positive regulation of T cell homeostatic proliferation;2;7;GO:0004725
GO:0042104;positive regulation of activated T cell proliferation;1076;668;GO:0010941
GO:0042105;alpha-beta T cell receptor complex;1662;231;GO:0004497
GO:0042106;gamma-delta T cell receptor complex;6;6;GO:0010941
GO:0044771;meiotic cell cycle phase transition;1015;99;GO:0046395
GO:0044770;cell cycle phase transition;120408;1620;GO:0004497
GO:0030175;filopodium;21960;1790;GO:0010941
GO:0030178;negative regulation of Wnt signaling pathway;38034;1470;GO:0004497
GO:0030177;positive regulation of Wnt signaling pathway;12032;1170;GO:0004497
GO:0042118;endothelial cell activation;543;220;GO:0005975
GO:0042119;neutrophil activation;1824;2940;GO:0006066
GO:0030170;pyridoxal phosphate binding;1827624;5910;GO:0006414
GO:0030172;troponin C binding;213;301;GO:0005634
GO:0030171;voltage-gated proton channel activity;2748;108;GO:0007596
GO:0030174;regulation of DNA-templated DNA replication initiation;28350;10;GO:0006099
GO:0042110;T cell activation;149201;5950;GO:0006464
GO:0044773;mitotic DNA damage checkpoint signaling;11227;59;GO:0005576
GO:0044772;mitotic cell cycle phase transition;78756;3040;GO:0005840
GO:0044775;DNA polymerase III, beta sliding clamp processivity factor complex;0;1;GO:0048304
GO:0042113;B cell activation;58666;2520;GO:0005929
GO:0044774;mitotic DNA integrity checkpoint signaling;13959;131;GO:0000278
GO:0044777;single-stranded DNA-binding protein complex;2;1;GO:0007586
GO:0044776;DNA polymerase III, core complex;6;4;GO:0007062
GO:0042116;macrophage activation;6897;2400;GO:0008021
GO:0044779;meiotic spindle checkpoint signaling;326;3;GO:0016569
GO:0042117;monocyte activation;360;124;GO:0008047
GO:0044778;meiotic DNA integrity checkpoint signaling;134;3;GO:0009062
GO:0044780;bacterial-type flagellum assembly;219217;385;GO:0004705
GO:0044782;cilium organization;132237;2050;GO:0048608
GO:0042120;alginic acid metabolic process;66499;5;GO:0005515
GO:0044781;bacterial-type flagellum organization;491374;171;GO:0006874
GO:0030165;PDZ domain binding;4542;1840;GO:0006461
GO:0030164;protein denaturation;4;8;GO:0006836
GO:0030167;proteoglycan catabolic process;548;88;GO:0006811
GO:0030166;proteoglycan biosynthetic process;32872;572;GO:0046394
GO:0030169;low-density lipoprotein particle binding;1012;664;GO:0008544
GO:0030168;platelet activation;12001;4460;GO:0046148
GO:0042129;regulation of T cell proliferation;12556;1060;GO:0004076
GO:0030160;synaptic receptor adaptor activity;165;5;GO:0048316
GO:0030163;protein catabolic process;1026234;6360;GO:0005840
GO:0030162;regulation of proteolysis;76617;2070;GO:0005634
GO:0042121;alginic acid biosynthetic process;64639;54;GO:0009065
GO:0044784;metaphase/anaphase transition of cell cycle;23670;58;GO:0005634
GO:0042122;alginic acid catabolic process;1854;7;GO:0097367
GO:0042123;glucanosyltransferase activity;2368;4;GO:0009410
GO:0044786;cell cycle DNA replication;35529;283;GO:0009617
GO:0042124;1,3-beta-glucanosyltransferase activity;169;9;GO:1901363
GO:0044785;metaphase/anaphase transition of meiotic cell cycle;633;2;GO:0010033
GO:0042125;protein galactosylation;12;5;GO:0005634
GO:0044788;modulation by host of viral process;2553;156;GO:0007596
GO:0042126;nitrate metabolic process;178906;359;GO:0005615
GO:0044787;bacterial-type DNA replication;5;4;GO:0050789
GO:0042127;regulation of cell population proliferation;218768;1780;GO:0046649
GO:0042128;nitrate assimilation;159043;1310;GO:0050789
GO:0017190;N-terminal peptidyl-aspartic acid acetylation;21;5;GO:0071346
GO:0017192;N-terminal peptidyl-glutamine acetylation;6;3;GO:0050729
GO:0017193;N-terminal peptidyl-glycine acetylation;0;3;GO:0007264
GO:0017194;N-terminal peptidyl-isoleucine acetylation;0;3;GO:0071346
GO:0017195;N-terminal peptidyl-lysine N2-acetylation;0;3;GO:0048666
GO:0044790;suppression of viral release by host;934;39;GO:0008036
GO:0017196;N-terminal peptidyl-methionine acetylation;28;191;GO:0048608
GO:0042130;negative regulation of T cell proliferation;4148;1040;GO:0048608
GO:0044793;negative regulation by host of viral process;643;22;GO:0003729
GO:0017197;N-terminal peptidyl-proline acetylation;0;3;GO:0048608
GO:0042131;thiamine phosphate phosphatase activity;139;9;GO:0004073
GO:0017198;N-terminal peptidyl-serine acetylation;0;186;GO:0004725
GO:0030154;cell differentiation;987528;30400;GO:0019901
GO:0017199;N-terminal peptidyl-threonine acetylation;0;3;GO:0005509
GO:0030153;bacteriocin immunity;13584;103;GO:0045944
GO:0030156;benzodiazepine receptor binding;74;10;GO:0006879
GO:0030155;regulation of cell adhesion;126468;4000;GO:0045944
GO:0030158;protein xylosyltransferase activity;9439;35;GO:0006873
GO:0030157;pancreatic juice secretion;495;203;GO:0045944
GO:0030159;signaling receptor complex adaptor activity;1821;52;GO:0006873
GO:0140517;protein-RNA adaptor activity;10884;2;GO:0045944
GO:0140513;nuclear protein-containing complex;1790419;215;GO:0045944
GO:0140515;mitotic nuclear bridge organization;8;1;GO:0008021
GO:0140516;mitotic nuclear pore complex disassembly;5;1;GO:0016569
GO:0140510;mitotic nuclear bridge;34;0;GO:0006836
GO:0140511;mitotic nuclear bridge stalk;1;0;GO:0006879
GO:0140512;mitotic nuclear bridge midzone;31;1;GO:0007067
GO:0140506;endoplasmic reticulum-autophagosome adaptor activity;149;6;GO:0006464
GO:0140507;granzyme-mediated programmed cell death signaling pathway;375;29;GO:0009067
GO:0140509;epithelium-like organization;8;1;GO:0006464
GO:0140502;effector-mediated suppression of host salicylic acid-mediated innate immune signaling;3;0;GO:0006836
GO:0140504;microlipophagy;91;1;GO:0009063
GO:0140505;regulation of microlipophagy;0;1;GO:0009065
GO:0140500;regulation of reticulophagy;5;1;GO:0009060
GO:0140501;positive regulation of reticulophagy;5;3;GO:0009063
GO:0140539;regulation of melanotic encapsulation of foreign target;30;0;GO:0009063
GO:0140535;intracellular protein-containing complex;2800095;43;GO:0006826
GO:0140536;nuclear receptor corepressor activity;17;2;GO:0007030
GO:0140537;transcription regulator activator activity;816;8;GO:0045944
GO:0140538;negative regulation of conjugation with zygote;8;4;GO:0009060
GO:0140531;regulation of osmosensory signaling MAPK cascade;0;2;GO:0042592
GO:0140532;negative regulation of osmosensory signaling MAPK cascade;0;1;GO:0008565
GO:0140533;suppression of host RNAi-mediated antiviral immune response;8;0;GO:0016071
GO:0140534;endoplasmic reticulum protein-containing complex;125140;85;GO:0006790
GO:0140530;MCM complex loading;10;2;GO:0007061
GO:0140528;bilobe structure assembly;2;1;GO:0005840
GO:0140529;CMG complex assembly;58;1;GO:0006629
GO:0140525;antipodal site;0;0;GO:0000723
GO:0140526;double membrane vesicle viral factory assembly;0;0;GO:0006631
GO:0140527;reciprocal homologous recombination;24180;2;GO:0048771
GO:0030198;extracellular matrix organization;51178;23600;GO:0006022
GO:0030197;extracellular matrix constituent, lubricant activity;5;73;GO:0006749
GO:0140522;fusogenic activity;3;3;GO:0008610
GO:0030199;collagen fibril organization;3901;4850;GO:0009416
GO:0140523;GTPase-dependent fusogenic activity;0;2;GO:0048608
GO:0042176;regulation of protein catabolic process;86992;1940;GO:0004725
GO:0042177;negative regulation of protein catabolic process;5634;1190;GO:0006874
GO:0042178;xenobiotic catabolic process;85183;873;GO:0005829
GO:0042179;nicotine biosynthetic process;349;5;GO:0045730
GO:0042180;cellular ketone metabolic process;1446848;2070;GO:0003729
GO:0042181;ketone biosynthetic process;1246722;164;GO:0009065
GO:0042182;ketone catabolic process;59620;202;GO:0006559
GO:0042183;formate catabolic process;3031;17;GO:0008021
GO:0042184;xylene catabolic process;6;3;GO:0045944
GO:0042185;m-xylene catabolic process;0;2;GO:0009061
GO:0042186;o-xylene catabolic process;0;2;GO:0009065
GO:0140550;phosphatidylinositol-4,5-bisphosphate sensor activity;1;0;GO:0004553
GO:0140552;TEAD-YAP complex;228;6;GO:0006412
GO:0042187;p-xylene catabolic process;0;2;GO:0005819
GO:0042188;1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane catabolic process;0;0;GO:0005524
GO:0042189;vanillin biosynthetic process;2;3;GO:0048285
GO:0042190;vanillin catabolic process;0;4;GO:0008015
GO:0042191;methylmercury metabolic process;0;2;GO:0010468
GO:0042192;methylmercury biosynthetic process;0;1;GO:0008201
GO:0042193;methylmercury catabolic process;0;2;GO:0008021
GO:0042194;quinate biosynthetic process;0;2;GO:0043169
GO:0140546;defense response to symbiont;248731;107;GO:0005829
GO:0042195;aerobic gallate catabolic process;0;2;GO:0005509
GO:0140547;acquisition of seed longevity;100;3;GO:0016570
GO:0042196;chlorinated hydrocarbon metabolic process;9;5;GO:0006281
GO:0140548;envenomation resulting in blood agglutination in another organism;1;0;GO:0008544
GO:0042197;halogenated hydrocarbon metabolic process;19;9;GO:0048608
GO:0140549;spore inner membrane;0;1;GO:0042592
GO:0140542;regulation of piRNA transcription;36;1;GO:0043547
GO:0140543;positive regulation of piRNA transcription;36;1;GO:0003735
GO:0140544;septin collar organization;0;0;GO:0048666
GO:0140545;ATP-dependent protein disaggregase activity;92;7;GO:0003735
GO:0140540;negative regulation melanotic encapsulation of foreign target;30;3;GO:0048608
GO:0140541;piRNA transcription;76;1;GO:0048666
GO:0140580;mitochondrion autophagosome adaptor activity;1106;1;GO:0005996
GO:0140581;P-type monovalent copper transporter activity;6518;8;GO:0048666
GO:0042198;nylon metabolic process;10;4;GO:0046330
GO:0042199;cyanuric acid metabolic process;0;2;GO:0004866
GO:0140575;transmembrane monodehydroascorbate reductase activity;4995;4;GO:0048608
GO:0140576;ascorbate homeostasis;192;5;GO:0002821
GO:0140571;transmembrane ascorbate ferrireductase activity;853;7;GO:0048608
GO:0140572;vacuole fission;67;3;GO:0048704
GO:0140573;histone H3-containing nucleosome;1;1;GO:0050729
GO:0140570;extraction of mislocalized protein from mitochondrial outer membrane;175;2;GO:0048704
GO:0140568;extraction of mislocalized protein from membrane;300;1;GO:0002684
GO:0140569;extraction of mislocalized protein from ER membrane;125;2;GO:0048704
GO:0140566;histone reader activity;644;8;GO:0006767
GO:0140567;membrane protein dislocase activity;201;7;GO:0005929
GO:0140560;xylosyl alpha-1,3-xylosyltransferase activity;98;2;GO:0048704
GO:0140561;EGF-domain serine glucosyltransferase activity;26;3;GO:0050729
GO:0140562;EGF-domain serine xylosyltransferase activity;25;2;GO:0048608
GO:0140563;UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity;16;4;GO:0048731
GO:0030709;border follicle cell delamination;100;10;GO:0004073
GO:0030708;germarium-derived female germ-line cyst encapsulation;103;66;GO:0007517
GO:0005750;mitochondrial respiratory chain complex III;20836;1040;GO:0030528
GO:0005751;mitochondrial respiratory chain complex IV;29461;1170;GO:0007517
GO:0005754;mitochondrial proton-transporting ATP synthase, catalytic core;206;43;GO:0006767
GO:0005753;mitochondrial proton-transporting ATP synthase complex;55601;978;GO:0006936
GO:0005745;m-AAA complex;464;90;GO:0006767
GO:0030701;NAD+-dinitrogen-reductase ADP-D-ribosyltransferase activity;851;0;GO:0048513
GO:0005744;TIM23 mitochondrial import inner membrane translocase complex;19009;431;GO:0043687
GO:0030700;glycine reductase complex;2228;5;GO:0042692
GO:0005747;mitochondrial respiratory chain complex I;21517;2980;GO:0008544
GO:0030703;eggshell formation;1697;47;GO:0048731
GO:0005746;mitochondrial respirasome;78841;275;GO:0005576
GO:0005749;mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone);2111;157;GO:0048608
GO:0030705;cytoskeleton-dependent intracellular transport;43466;1660;GO:0016567
GO:0030704;vitelline membrane formation;221;34;GO:0009065
GO:0030707;follicle cell of egg chamber development;5129;5;GO:0006767
GO:0030706;germarium-derived oocyte differentiation;471;9;GO:0048407
GO:0042701;progesterone secretion;224;9;GO:0048608
GO:0042702;uterine wall growth;0;5;GO:0048407
GO:0042703;menstruation;0;847;GO:0048407
GO:0042704;uterine wall breakdown;2;10;GO:0016569
GO:0042705;ocellus photoreceptor cell differentiation;25;3;GO:0048704
GO:0042706;eye photoreceptor cell fate commitment;1296;150;GO:0005925
GO:0042707;ocellus photoreceptor cell fate commitment;0;1;GO:0048608
GO:0005761;mitochondrial ribosome;38555;1920;GO:0048608
GO:0005760;gamma DNA polymerase complex;3671;35;GO:0048471
GO:0003100;regulation of systemic arterial blood pressure by endothelin;369;199;GO:0048608
GO:0005763;mitochondrial small ribosomal subunit;11300;1030;GO:0006418
GO:0003101;regulation of systemic arterial blood pressure by circulatory epinephrine-norepinephrine;0;2;GO:0009065
GO:0005762;mitochondrial large ribosomal subunit;17481;2040;GO:0009061
GO:0005765;lysosomal membrane;97726;4840;GO:0009061
GO:0005764;lysosome;250147;8570;GO:0009061
GO:0042700;luteinizing hormone signaling pathway;2079;20;GO:0006412
GO:0005756;mitochondrial proton-transporting ATP synthase, central stalk;144;4;GO:0048513
GO:0005758;mitochondrial intermembrane space;54311;2310;GO:0048513
GO:0005757;mitochondrial permeability transition pore complex;413;46;GO:0006817
GO:0005759;mitochondrial matrix;182806;10100;GO:0048513
GO:0042709;succinate-CoA ligase complex;609;13;GO:0005976
GO:0042712;paternal behavior;0;3;GO:0002041
GO:0042713;sperm ejaculation;83;361;GO:0000922
GO:0042714;dosage compensation complex assembly;13;3;GO:0048407
GO:0042716;plasma membrane-derived chromatophore;97481;3;GO:0006073
GO:0042717;plasma membrane-derived chromatophore membrane;77344;2;GO:0048608
GO:0042718;yolk granule;17;4;GO:0009065
GO:0042719;mitochondrial intermembrane space protein transporter complex;726;162;GO:0048405
GO:0005730;nucleolus;667178;23500;GO:0006826
GO:0005732;sno(s)RNA-containing ribonucleoprotein complex;39690;178;GO:0046395
GO:0042710;biofilm formation;15999;217;GO:0009952
GO:0005731;nucleolus organizer region;97;20;GO:0010468
GO:0042711;maternal behavior;346;639;GO:0006030
GO:0005723;alpha-heterochromatin;11;2;GO:0003677
GO:0005722;beta-heterochromatin;12;4;GO:0007530
GO:0005725;intercalary heterochromatin;12;7;GO:0048608
GO:0005727;extrachromosomal circular DNA;1619;45;GO:0006936
GO:0005726;perichromatin fibrils;252;156;GO:0042493
GO:0005729;2-micrometer circle DNA;40;3;GO:0042113
GO:0005728;extrachromosomal rDNA circle;0;0;GO:0007623
GO:0042723;thiamine-containing compound metabolic process;982042;51;GO:0042127
GO:0042724;thiamine-containing compound biosynthetic process;916472;169;GO:0007517
GO:0042725;thiamine-containing compound catabolic process;2;4;GO:0007548
GO:0042726;flavin-containing compound metabolic process;819117;54;GO:0048704
GO:0042727;flavin-containing compound biosynthetic process;816000;10;GO:0048608
GO:0042728;flavin-containing compound catabolic process;56;5;GO:0050729
GO:0042729;DASH complex;10618;23;GO:0048407
GO:0005741;mitochondrial outer membrane;211447;5510;GO:0050729
GO:0005740;mitochondrial envelope;5877387;3600;GO:0048608
GO:0042720;mitochondrial inner membrane peptidase complex;4423;52;GO:0048407
GO:0005743;mitochondrial inner membrane;5395607;12400;GO:0050729
GO:0042721;TIM22 mitochondrial import inner membrane insertion complex;10106;48;GO:0050729
GO:0005742;mitochondrial outer membrane translocase complex;16095;565;GO:0008092
GO:0042722;alpha-beta T cell activation by superantigen;0;2;GO:0006955
GO:0005736;RNA polymerase I complex;4935;864;GO:0005634
GO:0005737;cytoplasm;62950576;110000;GO:0050729
GO:0005739;mitochondrion;10297088;53100;GO:0050729
GO:0015115;silicate transmembrane transporter activity;18;2;GO:0005829
GO:0015114;phosphate ion transmembrane transporter activity;37211;386;GO:0043230
GO:0015113;nitrite transmembrane transporter activity;7791;6;GO:0005829
GO:0015112;nitrate transmembrane transporter activity;50637;194;GO:0043169
GO:0015111;iodide transmembrane transporter activity;546;141;GO:0030168
GO:0015110;cyanate transmembrane transporter activity;0;1;GO:0004067
GO:0005790;smooth endoplasmic reticulum;989;815;GO:0043005
GO:0005791;rough endoplasmic reticulum;25096;1920;GO:0006081
GO:0003131;mesodermal-endodermal cell signaling;38;37;GO:0007242
GO:0005794;Golgi apparatus;1407018;23900;GO:0009065
GO:0003132;mesodermal-endodermal cell signaling involved in heart induction;0;1;GO:0030198
GO:0005793;endoplasmic reticulum-Golgi intermediate compartment;33710;1490;GO:0009579
GO:0003133;endodermal-mesodermal cell signaling;60;14;GO:0005576
GO:0005796;Golgi lumen;2711;2080;GO:0048706
GO:0003134;endodermal-mesodermal cell signaling involved in heart induction;0;7;GO:0040011
GO:0005795;Golgi stack;63359;1480;GO:0040011
GO:0003135;fibroblast growth factor receptor signaling pathway involved in heart induction;0;1;GO:0040011
GO:0005798;Golgi-associated vesicle;99108;1180;GO:0048608
GO:0003136;negative regulation of heart induction by canonical Wnt signaling pathway;3;5;GO:0016020
GO:0005797;Golgi medial cisterna;1321;333;GO:0000922
GO:0005789;endoplasmic reticulum membrane;1004559;21100;GO:0043062
GO:0030745;dimethylhistidine N-methyltransferase activity;6774;8;GO:0000922
GO:0003127;detection of nodal flow;74;95;GO:0050921
GO:0005788;endoplasmic reticulum lumen;51905;7660;GO:0048471
GO:0030744;luteolin O-methyltransferase activity;48;6;GO:0006364
GO:0003128;heart field specification;764;10;GO:0042981
GO:0030747;indolepyruvate C-methyltransferase activity;2;3;GO:0042981
GO:0003129;heart induction;392;21;GO:0009536
GO:0030746;isoflavone 4'-O-methyltransferase activity;15;0;GO:0043161
GO:0030749;loganate O-methyltransferase activity;57;3;GO:0016021
GO:0030748;amine N-methyltransferase activity;59;6;GO:0048704
GO:0015109;chromate transmembrane transporter activity;43736;10;GO:0030168
GO:0015108;chloride transmembrane transporter activity;256081;804;GO:0007041
GO:0030741;inositol 1-methyltransferase activity;0;3;GO:0048285
GO:0015107;chlorate transmembrane transporter activity;0;1;GO:0005829
GO:0030740;inositol 3-methyltransferase activity;0;3;GO:0007041
GO:0015106;bicarbonate transmembrane transporter activity;3974;754;GO:0004872
GO:0030743;23S rRNA (adenosine(1067)-2'-O)-methyltransferase activity;77;0;GO:0005576
GO:0015105;arsenite transmembrane transporter activity;23860;149;GO:0048608
GO:0030742;GTP-dependent protein binding;973;711;GO:0048608
GO:0015126;canalicular bile acid transmembrane transporter activity;133;8;GO:0048704
GO:0015125;bile acid transmembrane transporter activity;810;188;GO:0048608
GO:0015124;allantoate transmembrane transporter activity;33;5;GO:0005524
GO:0015123;acetate transmembrane transporter activity;2682;6;GO:0006629
GO:0015121;phosphoenolpyruvate:phosphate antiporter activity;98;2;GO:0005524
GO:0015120;phosphoglycerate transmembrane transporter activity;1748;7;GO:0006457
GO:0003140;determination of left/right asymmetry in lateral mesoderm;461;237;GO:0006468
GO:0003142;cardiogenic plate morphogenesis;41;8;GO:0016567
GO:0003143;embryonic heart tube morphogenesis;6742;320;GO:0016567
GO:0003144;embryonic heart tube formation;79;7;GO:0045944
GO:0003145;embryonic heart tube formation via epithelial folding;0;2;GO:0046394
GO:0003146;heart jogging;583;7;GO:0009065
GO:0003147;neural crest cell migration involved in heart formation;74;137;GO:0009065
GO:0003137;Notch signaling pathway involved in heart induction;94;5;GO:0019901
GO:0030734;polysaccharide O-methyltransferase activity;0;3;GO:0019901
GO:0003138;primary heart field specification;108;486;GO:0019901
GO:0030733;fatty acid O-methyltransferase activity;3;3;GO:0019901
GO:0003139;secondary heart field specification;537;382;GO:0008037
GO:0030736;phenol O-methyltransferase activity;0;4;GO:0005634
GO:0030735;carnosine N-methyltransferase activity;1160;7;GO:0005524
GO:0030738;tyramine N-methyltransferase activity;0;4;GO:0046394
GO:0030737;iodophenol O-methyltransferase activity;0;3;GO:0005524
GO:0030739;O-demethylpuromycin O-methyltransferase activity;91;3;GO:0046394
GO:0015119;hexose phosphate transmembrane transporter activity;2826;9;GO:0046394
GO:0030730;sequestering of triglyceride;1197;384;GO:0046394
GO:0015117;thiosulfate transmembrane transporter activity;243;34;GO:0046395
GO:0030732;methionine S-methyltransferase activity;963;6;GO:0048193
GO:0015116;sulfate transmembrane transporter activity;88823;1240;GO:0048193
GO:0030731;guanidinoacetate N-methyltransferase activity;1097;10;GO:0030425
GO:0005770;late endosome;88743;3970;GO:0005739
GO:0003110;positive regulation of the force of heart contraction by neuronal norepinephrine;0;2;GO:0048608
GO:0005771;multivesicular body;11264;1230;GO:0048608
GO:0003111;positive regulation of heart rate by circulating epinephrine;0;2;GO:0048608
GO:0005774;vacuolar membrane;225171;3120;GO:0048608
GO:0003112;positive regulation of heart rate by neuronal epinephrine;0;1;GO:0030054
GO:0005773;vacuole;460360;8520;GO:0048608
GO:0003113;positive regulation of heart rate by neuronal norepinephrine;0;2;GO:0030062
GO:0005776;autophagosome;27146;2800;GO:0050729
GO:0003114;positive regulation of heart rate by circulating norepinephrine;0;2;GO:0019901
GO:0005775;vacuolar lumen;4045;412;GO:0046653
GO:0003104;positive regulation of glomerular filtration;32;75;GO:0050729
GO:0005767;secondary lysosome;969;38;GO:0050729
GO:0030723;ovarian fusome organization;102;24;GO:0046330
GO:0003105;negative regulation of glomerular filtration;46;156;GO:0048608
GO:0005766;primary lysosome;780;153;GO:0050729
GO:0003106;negative regulation of glomerular filtration by angiotensin;2;7;GO:0048407
GO:0005769;early endosome;109032;4960;GO:0042165
GO:0030725;germline ring canal formation;147;5;GO:0005125
GO:0005768;endosome;680077;16300;GO:0042165
GO:0030724;testicular fusome organization;1;6;GO:0008565
GO:0003108;negative regulation of the force of heart contraction by chemical signal;56;6;GO:0005215
GO:0030727;germarium-derived female germ-line cyst formation;283;10;GO:0005215
GO:0003109;positive regulation of the force of heart contraction by circulating norepinephrine;0;2;GO:0007179
GO:0030726;male germline ring canal formation;31;7;GO:0005215
GO:0030729;acetoacetate-CoA ligase activity;21608;21;GO:0030516
GO:0030728;ovulation;973;964;GO:0005215
GO:0030721;spectrosome organization;40;8;GO:0048407
GO:0030720;oocyte localization involved in germarium-derived egg chamber formation;172;57;GO:0006073
GO:0015104;antimonite transmembrane transporter activity;50;1;GO:0005215
GO:0015103;inorganic anion transmembrane transporter activity;735504;862;GO:0046395
GO:0015101;organic cation transmembrane transporter activity;44166;216;GO:0005215
GO:0015100;vanadium ion transmembrane transporter activity;4;27;GO:0046395
GO:0005780;extrinsic component of intraperoxisomal membrane;927;1;GO:0030516
GO:0030719;P granule organization;406;118;GO:0030516
GO:0003120;regulation of vasoconstriction by circulating epinephrine;0;2;GO:0008509
GO:0005783;endoplasmic reticulum;2088468;31000;GO:0035023
GO:0003121;epinephrine-mediated vasodilation;0;1;GO:0030528
GO:0005782;peroxisomal matrix;9510;1780;GO:0035020
GO:0003122;norepinephrine-mediated vasodilation;0;1;GO:0046395
GO:0005785;signal recognition particle receptor complex;3893;292;GO:0009536
GO:0005784;Sec61 translocon complex;5364;100;GO:0005125
GO:0005787;signal peptidase complex;19788;824;GO:0004842
GO:0005786;signal recognition particle, endoplasmic reticulum targeting;70552;1520;GO:0016525
GO:0003115;regulation of vasoconstriction by epinephrine;0;3;GO:0008544
GO:0005778;peroxisomal membrane;75590;2740;GO:0008565
GO:0030712;negative regulation of border follicle cell delamination;0;2;GO:0010468
GO:0003116;regulation of vasoconstriction by norepinephrine;45;2;GO:0008529
GO:0005777;peroxisome;279774;6650;GO:0048010
GO:0030711;positive regulation of border follicle cell delamination;0;3;GO:0010468
GO:0003117;regulation of vasoconstriction by circulating norepinephrine;45;6;GO:0010468
GO:0030714;anterior/posterior axis specification, follicular epithelium;3;4;GO:0046395
GO:0003118;regulation of vasoconstriction by neuronal norepinephrine;0;1;GO:0005554
GO:0030713;follicle cell of egg chamber stalk formation;277;4;GO:0016525
GO:0003119;regulation of vasoconstriction by neuronal epinephrine;0;2;GO:0048010
GO:0030716;oocyte fate determination;551;16;GO:0048010
GO:0030715;oocyte growth in germarium-derived egg chamber;21;2;GO:0019953
GO:0030718;germ-line stem cell population maintenance;1663;65;GO:0048010
GO:0030717;oocyte karyosome formation;344;5;GO:0005125
GO:0030710;regulation of border follicle cell delamination;0;5;GO:0000003
GO:0015159;polysaccharide transmembrane transporter activity;52984;127;GO:0007186
GO:0042778;tRNA end turnover;0;2;GO:0007186
GO:0015158;raffinose transmembrane transporter activity;1;0;GO:0009065
GO:0015157;oligosaccharide transmembrane transporter activity;10550;25;GO:0030518
GO:0015156;melibiose transmembrane transporter activity;3;1;GO:0030518
GO:0015155;lactose transmembrane transporter activity;848;5;GO:0046330
GO:0003170;heart valve development;6726;298;GO:0048608
GO:0015154;disaccharide transmembrane transporter activity;10543;32;GO:0046330
GO:0003171;atrioventricular valve development;2477;180;GO:0048608
GO:0015153;rhamnose transmembrane transporter activity;5074;10;GO:0046330
GO:0030790;chlorophenol O-methyltransferase activity;2;3;GO:0048608
GO:0003172;sinoatrial valve development;55;24;GO:0048608
GO:0015152;glucose-6-phosphate transmembrane transporter activity;2824;9;GO:0046330
GO:0003173;ventriculo bulbo valve development;113;2;GO:0048010
GO:0015151;alpha-glucoside transmembrane transporter activity;115;15;GO:0006874
GO:0042770;signal transduction in response to DNA damage;39549;770;GO:0048608
GO:0003174;mitral valve development;664;146;GO:0046330
GO:0015150;fucose transmembrane transporter activity;13051;6;GO:0042632
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;2652;1350;GO:0006468
GO:0003175;tricuspid valve development;352;13;GO:0008021
GO:0042772;DNA damage response, signal transduction resulting in transcription;932;221;GO:0009065
GO:0003176;aortic valve development;1664;37;GO:0008021
GO:0042773;ATP synthesis coupled electron transport;611190;4430;GO:0005215
GO:0003177;pulmonary valve development;931;110;GO:0005215
GO:0042774;plasma membrane ATP synthesis coupled electron transport;28;6;GO:0006021
GO:0003178;coronary sinus valve development;47;2;GO:0007623
GO:0042775;mitochondrial ATP synthesis coupled electron transport;154468;1310;GO:0007186
GO:0003179;heart valve morphogenesis;4803;466;GO:0008565
GO:0042776;proton motive force-driven mitochondrial ATP synthesis;1619;288;GO:0005215
GO:0042777;proton motive force-driven plasma membrane ATP synthesis;68132;9;GO:0005215
GO:0030789;precorrin-3B C17-methyltransferase activity;4609;5;GO:0008528
GO:0030788;precorrin-2 C20-methyltransferase activity;21660;5;GO:0008544
GO:0042780;tRNA 3'-end processing;126650;8;GO:0005215
GO:0030781;6-O-methylnorlaudanosoline 5'-O-methyltransferase activity;0;0;GO:0005215
GO:0030780;12-hydroxydihydrochelirubine 12-O-methyltransferase activity;0;3;GO:0005215
GO:0030783;[cytochrome c]-methionine S-methyltransferase activity;0;0;GO:0004553
GO:0030782;(S)-tetrahydroprotoberberine N-methyltransferase activity;9;0;GO:0045944
GO:0030785;[ribulose-bisphosphate carboxylase]-lysine N-methyltransferase activity;533;1;GO:0048193
GO:0030784;3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase activity;12;0;GO:0042127
GO:0030787;inositol 4-methyltransferase activity;2;3;GO:0032963
GO:0015149;hexose transmembrane transporter activity;67267;254;GO:0048407
GO:0030786;(RS)-norcoclaurine 6-O-methyltransferase activity;12;0;GO:0006032
GO:0042789;mRNA transcription by RNA polymerase II;2216;178;GO:0048523
GO:0015169;glycerol-3-phosphate transmembrane transporter activity;7165;7;GO:0046330
GO:0015168;glycerol transmembrane transporter activity;720;232;GO:0010467
GO:0015167;arabitol transmembrane transporter activity;0;1;GO:0006869
GO:0003180;aortic valve morphogenesis;1359;266;GO:0032963
GO:0015166;polyol transmembrane transporter activity;14273;38;GO:0007586
GO:0003181;atrioventricular valve morphogenesis;1876;1690;GO:0003723
GO:0015165;pyrimidine nucleotide-sugar transmembrane transporter activity;17679;52;GO:0006869
GO:0003182;coronary sinus valve morphogenesis;47;3;GO:0008544
GO:0015164;glucuronoside transmembrane transporter activity;41;2;GO:0008544
GO:0003183;mitral valve morphogenesis;603;97;GO:0008544
GO:0003184;pulmonary valve morphogenesis;735;526;GO:0008565
GO:0042781;3'-tRNA processing endoribonuclease activity;41222;2;GO:0006836
GO:0003185;sinoatrial valve morphogenesis;7;24;GO:0006810
GO:0015161;lipid III floppase activity;2;1;GO:0006869
GO:0003186;tricuspid valve morphogenesis;295;80;GO:0004067
GO:0015160;beta-glucan transmembrane transporter activity;2461;0;GO:0004073
GO:0042783;evasion of host immune response;2832;9;GO:0004867
GO:0003187;ventriculo bulbo valve morphogenesis;38;3;GO:0004553
GO:0042784;evasion of host immune response via modulation of host complement system;9;1;GO:0004067
GO:0003188;heart valve formation;887;227;GO:0004067
GO:0042785;evasion of host immune response via modulation of host cytokine network;25;3;GO:0004067
GO:0003189;aortic valve formation;51;6;GO:0008610
GO:0042786;evasion of host immune response via modulation of host antigen processing and presentation;1;1;GO:0006096
GO:0042788;polysomal ribosome;1916;938;GO:0006073
GO:0030778;columbamine O-methyltransferase activity;2;2;GO:0006067
GO:0052104;induction by symbiont of host systemic acquired resistance;0;1;GO:0004553
GO:0030777;(S)-scoulerine 9-O-methyltransferase activity;21;0;GO:0004721
GO:0052102;positive regulation by symbiont of defense-related host calcium-dependent protein kinase pathway;0;1;GO:0004553
GO:0030779;10-hydroxydihydrosanguinarine 10-O-methyltransferase activity;0;3;GO:0004497
GO:0052103;induction of host induced systemic resistance;0;0;GO:0008037
GO:0042790;nucleolar large rRNA transcription by RNA polymerase I;3943;18;GO:0008610
GO:0042791;5S class rRNA transcription by RNA polymerase III;129;101;GO:0004076
GO:0030770;demethylmacrocin O-methyltransferase activity;31;3;GO:0004497
GO:0030772;tryptophan 2-C-methyltransferase activity;26;4;GO:0006067
GO:0030771;N-benzoyl-4-hydroxyanthranilate 4-O-methyltransferase activity;0;3;GO:0004721
GO:0030774;anthranilate N-methyltransferase activity;7;2;GO:0006081
GO:0030773;6-hydroxymellein O-methyltransferase activity;0;3;GO:0004867
GO:0030776;(RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline N-methyltransferase activity;1;0;GO:0004730
GO:0030775;glucuronoxylan 4-O-methyltransferase activity;113;4;GO:0009405
GO:0015137;citrate transmembrane transporter activity;7335;371;GO:0006067
GO:0015136;sialic acid transmembrane transporter activity;2142;25;GO:0004721
GO:0015135;glucuronate transmembrane transporter activity;58;1;GO:0007186
GO:0015134;hexuronate transmembrane transporter activity;8;0;GO:0006810
GO:0015133;uronic acid transmembrane transporter activity;8;1;GO:0007411
GO:0015132;prostaglandin transmembrane transporter activity;581;105;GO:0004497
GO:0015131;oxaloacetate transmembrane transporter activity;367;33;GO:0004497
GO:0003150;muscular septum morphogenesis;124;43;GO:0006879
GO:0015130;mevalonate transmembrane transporter activity;1;10;GO:0006873
GO:0003151;outflow tract morphogenesis;4505;1390;GO:0043603
GO:0003152;morphogenesis of an epithelial fold involved in embryonic heart tube formation;0;3;GO:0007067
GO:0042793;plastid transcription;1234;9;GO:0004497
GO:0003153;closure of embryonic heart tube;0;2;GO:0004497
GO:0042794;plastid rRNA transcription;103;1;GO:0006021
GO:0042795;snRNA transcription by RNA polymerase II;1168;401;GO:0002237
GO:0042796;snRNA transcription by RNA polymerase III;642;10;GO:0004553
GO:0003156;regulation of animal organ formation;1564;32;GO:0004067
GO:0042797;tRNA transcription by RNA polymerase III;1202;135;GO:0004721
GO:0003157;endocardium development;1260;35;GO:0004067
GO:0003158;endothelium development;8334;815;GO:0004073
GO:0042799;histone H4K20 methyltransferase activity;10086;8;GO:0004497
GO:0003148;outflow tract septum morphogenesis;1100;1030;GO:0004067
GO:0030767;3-hydroxyanthranilate 4-C-methyltransferase activity;0;3;GO:0004073
GO:0003149;membranous septum morphogenesis;298;80;GO:0004073
GO:0030766;11-O-demethyl-17-O-deacetylvindoline O-methyltransferase activity;3;2;GO:0004497
GO:0030769;macrocin O-methyltransferase activity;75;3;GO:0006081
GO:0030768;16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase activity;2;3;GO:0006865
GO:0052111;symbiont-mediated disruption of host anatomical structure;152102;0;GO:0006067
GO:0052112;symbiont-mediated occlusion of host xylem;0;0;GO:0004497
GO:0030761;8-hydroxyquercitin 8-O-methyltransferase activity;4;4;GO:0006865
GO:0030760;pyridine N-methyltransferase activity;1;8;GO:0004497
GO:0030763;isobutyraldoxime O-methyltransferase activity;0;2;GO:0004497
GO:0015129;lactate transmembrane transporter activity;38708;157;GO:0006836
GO:0030762;tetrahydrocolumbamine 2-O-methyltransferase activity;4;3;GO:0004497
GO:0015128;gluconate transmembrane transporter activity;39407;213;GO:0009065
GO:0015127;bilirubin transmembrane transporter activity;84;51;GO:0006865
GO:0015148;D-xylose transmembrane transporter activity;3625;8;GO:0004067
GO:0015147;L-arabinose transmembrane transporter activity;2300;4;GO:0004497
GO:0015146;pentose transmembrane transporter activity;6102;8;GO:0009719
GO:0015145;monosaccharide transmembrane transporter activity;92131;119;GO:0048193
GO:0015144;carbohydrate transmembrane transporter activity;460148;747;GO:0050829
GO:0015143;urate transmembrane transporter activity;607;240;GO:0046365
GO:0003160;endocardium morphogenesis;419;366;GO:0048285
GO:0015142;tricarboxylic acid transmembrane transporter activity;7438;86;GO:0048285
GO:0003161;cardiac conduction system development;1713;129;GO:0048193
GO:0015141;succinate transmembrane transporter activity;807;93;GO:0005509
GO:0003162;atrioventricular node development;408;48;GO:0045765
GO:0015140;malate transmembrane transporter activity;4861;141;GO:0045765
GO:0003163;sinoatrial node development;597;25;GO:0005576
GO:0052130;negative aerotaxis;0;0;GO:0004497
GO:0003164;His-Purkinje system development;408;143;GO:0004091
GO:0003165;Purkinje myocyte development;130;41;GO:0004553
GO:0003166;bundle of His development;230;158;GO:0004061
GO:0003167;atrioventricular bundle cell differentiation;146;19;GO:0009065
GO:0003168;Purkinje myocyte differentiation;26;6;GO:0005576
GO:0003169;coronary vein morphogenesis;51;65;GO:0004497
GO:0003159;morphogenesis of an endothelium;996;343;GO:0004784
GO:0030756;isoorientin 3'-O-methyltransferase activity;0;0;GO:0004497
GO:0030755;quercetin 3-O-methyltransferase activity;62;9;GO:0046148
GO:0030758;3,7-dimethylquercitin 4'-O-methyltransferase activity;0;0;GO:0004073
GO:0030757;3-methylquercitin 7-O-methyltransferase activity;1;4;GO:0009536
GO:0030759;methylquercetagetin 6-O-methyltransferase activity;0;3;GO:0006826
GO:0030750;putrescine N-methyltransferase activity;78;4;GO:0003906
GO:0030752;5-hydroxyfuranocoumarin 5-O-methyltransferase activity;7;2;GO:0004067
GO:0030751;licodione 2'-O-methyltransferase activity;4;0;GO:0004091
GO:0015139;alpha-ketoglutarate transmembrane transporter activity;395;14;GO:0006826
GO:0030754;apigenin 4'-O-methyltransferase activity;0;0;GO:0004076
GO:0052128;positive energy taxis;76;2;GO:0006029
GO:0015138;fumarate transmembrane transporter activity;191;4;GO:0006029
GO:0030753;8-hydroxyfuranocoumarin 8-O-methyltransferase activity;0;3;GO:0004497
GO:0052129;negative energy taxis;41;1;GO:0004497
GO:0042734;presynaptic membrane;10824;1850;GO:0004067
GO:0042735;endosperm protein body;39;1;GO:0004497
GO:0042736;NADH kinase activity;67;59;GO:0004721
GO:0015199;amino-acid betaine transmembrane transporter activity;242;10;GO:0004721
GO:0015196;L-tryptophan transmembrane transporter activity;245;8;GO:0004721
GO:0015195;L-threonine transmembrane transporter activity;948;5;GO:0004518
GO:0015194;L-serine transmembrane transporter activity;305;138;GO:0004721
GO:0015193;L-proline transmembrane transporter activity;584;108;GO:0004721
GO:0015192;L-phenylalanine transmembrane transporter activity;301;4;GO:0004721
GO:0015191;L-methionine transmembrane transporter activity;87;5;GO:0004721
GO:0042730;fibrinolysis;4091;2550;GO:0004553
GO:0015190;L-leucine transmembrane transporter activity;529;18;GO:0004518
GO:0042731;PH domain binding;369;408;GO:0004553
GO:0042732;D-xylose metabolic process;103708;779;GO:0004721
GO:0042733;embryonic digit morphogenesis;3293;1560;GO:0004721
GO:0042745;circadian sleep/wake cycle;4540;657;GO:0006749
GO:0042746;circadian sleep/wake cycle, wakefulness;90;8;GO:0004721
GO:0042747;circadian sleep/wake cycle, REM sleep;64;30;GO:0004721
GO:0042748;circadian sleep/wake cycle, non-REM sleep;194;327;GO:0009061
GO:0042749;regulation of circadian sleep/wake cycle;3850;217;GO:0004721
GO:0042740;exogenous antibiotic catabolic process;0;4;GO:0004721
GO:0042741;endogenous antibiotic catabolic process;0;3;GO:0004721
GO:0042742;defense response to bacterium;101478;8340;GO:0004721
GO:0042743;hydrogen peroxide metabolic process;141915;1250;GO:0005524
GO:0042744;hydrogen peroxide catabolic process;140293;3340;GO:0004721
GO:0042756;drinking behavior;300;651;GO:0004721
GO:0042757;giant axon;0;1;GO:0004067
GO:0015179;L-amino acid transmembrane transporter activity;37785;872;GO:0004723
GO:0042758;long-chain fatty acid catabolic process;1268;50;GO:0005524
GO:0003190;atrioventricular valve formation;454;50;GO:0005524
GO:0042759;long-chain fatty acid biosynthetic process;7228;2040;GO:0004721
GO:0003191;coronary sinus valve formation;0;2;GO:0004723
GO:0003192;mitral valve formation;128;285;GO:0005524
GO:0003193;pulmonary valve formation;118;10;GO:0010468
GO:0015175;neutral L-amino acid transmembrane transporter activity;13319;198;GO:0045730
GO:0003194;sinoatrial valve formation;0;1;GO:0048193
GO:0015174;basic amino acid transmembrane transporter activity;16282;219;GO:0048167
GO:0003195;tricuspid valve formation;84;10;GO:0048405
GO:0015173;aromatic amino acid transmembrane transporter activity;14732;214;GO:0006073
GO:0003196;ventriculo bulbo valve formation;0;2;GO:0048608
GO:0015172;acidic amino acid transmembrane transporter activity;3183;93;GO:0004067
GO:0003197;endocardial cushion development;3131;1150;GO:0048608
GO:0015171;amino acid transmembrane transporter activity;476837;3780;GO:0004073
GO:0042750;hibernation;13;6;GO:0048167
GO:0003198;epithelial to mesenchymal transition involved in endocardial cushion formation;698;374;GO:0048169
GO:0015170;propanediol transmembrane transporter activity;0;0;GO:0004721
GO:0042751;estivation;0;3;GO:0004721
GO:0003199;endocardial cushion to mesenchymal transition involved in heart valve formation;135;102;GO:0004041
GO:0042752;regulation of circadian rhythm;18392;1980;GO:0006096
GO:0042753;positive regulation of circadian rhythm;2794;820;GO:0004723
GO:0042754;negative regulation of circadian rhythm;1758;282;GO:0004465
GO:0042755;eating behavior;1670;651;GO:0006073
GO:0042767;ecdysteroid 22-hydroxylase activity;20;4;GO:0004553
GO:0042768;ecdysteroid 2-hydroxylase activity;10;2;GO:0009813
GO:0015189;L-lysine transmembrane transporter activity;8151;123;GO:0009813
GO:0015188;L-isoleucine transmembrane transporter activity;275;8;GO:0006073
GO:0015187;glycine transmembrane transporter activity;4981;415;GO:0048608
GO:0015186;L-glutamine transmembrane transporter activity;823;56;GO:0048608
GO:0015185;gamma-aminobutyric acid transmembrane transporter activity;6699;50;GO:0048193
GO:0015184;L-cystine transmembrane transporter activity;427;61;GO:0048608
GO:0015183;L-aspartate transmembrane transporter activity;491;161;GO:0004073
GO:0042760;very long-chain fatty acid catabolic process;802;387;GO:0008030
GO:0015182;L-asparagine transmembrane transporter activity;344;57;GO:0016817
GO:0042761;very long-chain fatty acid biosynthetic process;8328;540;GO:0004867
GO:0042762;regulation of sulfur metabolic process;1598;630;GO:0004497
GO:0015180;L-alanine transmembrane transporter activity;662;63;GO:0005576
GO:0042763;intracellular immature spore;6205;3;GO:0009734
GO:0042764;ascospore-type prospore;799;5;GO:0048661
GO:0042765;GPI-anchor transamidase complex;20505;397;GO:0007062
GO:0030792;methylarsonite methyltransferase activity;121;6;GO:0004067
GO:0030791;arsenite methyltransferase activity;1546;9;GO:0048706
GO:0030794;(S)-coclaurine-N-methyltransferase activity;18;0;GO:0004067
GO:0030793;3'-demethylstaurosporine O-methyltransferase activity;0;0;GO:0044421
GO:0030796;cycloartenol 24-C-methyltransferase activity;0;3;GO:0009065
GO:0030795;methyl jasmonate methylesterase activity;107;2;GO:0003712
GO:0030798;trans-aconitate 2-methyltransferase activity;22399;143;GO:0006081
GO:0030797;24-methylenesterol C-methyltransferase activity;9;7;GO:0006869
GO:0052064;induction by symbiont of defense-related host reactive oxygen species production;2;0;GO:0004067
GO:0052062;induction by symbiont of host phytoalexin production;1;1;GO:0006066
GO:0052055;modulation by symbiont of host molecular function;10;78;GO:0004553
GO:0052074;positive regulation by symbiont of host salicylic acid-mediated defense response;0;1;GO:0042592
GO:0052075;induction by symbiont of host jasmonic acid-mediated defense response;0;0;GO:0048167
GO:0052067;disruption of host phagocytosis;4;0;GO:0048608
GO:0015099;nickel cation transmembrane transporter activity;39911;35;GO:0010401
GO:0015098;molybdate ion transmembrane transporter activity;73429;64;GO:0007586
GO:0015097;mercury ion transmembrane transporter activity;16502;15;GO:0048010
GO:0052085;suppression of host T-cell mediated immune response;12;1;GO:0048193
GO:0015095;magnesium ion transmembrane transporter activity;136890;1320;GO:0005524
GO:0052086;suppression of host B-cell mediated immune response;0;0;GO:0006464
GO:0015094;lead ion transmembrane transporter activity;70;117;GO:0006364
GO:0052083;suppression by symbiont of host cell-mediated immune response;20;0;GO:0048407
GO:0015093;ferrous iron transmembrane transporter activity;34878;730;GO:0005634
GO:0052084;modulation by symbiont of host ethylene-mediated defense response;0;2;GO:0043161
GO:0015092;high-affinity ferric iron transmembrane transporter activity;12;0;GO:0071363
GO:0052081;perturbation of defense-related host salicylic acid-mediated signal transduction pathway;3;0;GO:0000976
GO:0015091;ferric iron transmembrane transporter activity;34847;7;GO:0006281
GO:0015090;low-affinity ferric iron ion transmembrane transporter activity;0;0;GO:0004721
GO:0052080;perturbation of host MAPK signal transduction pathway;0;0;GO:0007067
GO:0052078;symbiont-mediated suppression of host pathogen-associated molecular pattern receptor signaling pathway;1;1;GO:0004497
GO:0052096;formation of syncytium involving giant cell for nutrient acquisition;5;0;GO:0006021
GO:0052094;formation of haustorium for nutrient acquisition;0;0;GO:0006826
GO:0052092;positive regulation of nutrient release by host;0;0;GO:0005840
GO:0052093;formation of specialized structure for nutrient acquisition;5;5;GO:0004553
GO:0052091;modulation of nutrient release by host;0;1;GO:0004730
GO:0052089;modulation by symbiont of host salicylic acid-mediated defense response;3;2;GO:0004497
GO:0052088;symbiont defense to host-produced jasmonic acid;0;1;GO:0006073
GO:0040038;polar body extrusion after meiotic divisions;302;186;GO:0048608
GO:0040037;negative regulation of fibroblast growth factor receptor signaling pathway;2067;800;GO:0007530
GO:0040036;regulation of fibroblast growth factor receptor signaling pathway;3133;357;GO:0008152
GO:0040034;regulation of development, heterochronic;1636;864;GO:0009719
GO:0040033;sRNA-mediated post-transcriptional gene silencing;2392;3;GO:0009065
GO:0040032;post-embryonic body morphogenesis;117;136;GO:0005576
GO:0040031;snRNA modification;847;26;GO:0043407
GO:0042693;muscle cell fate commitment;1022;391;GO:0006790
GO:0042694;muscle cell fate specification;219;198;GO:0048407
GO:0042695;thelarche;221;178;GO:0048731
GO:0042696;menarche;0;3;GO:0048704
GO:0042697;menopause;0;19;GO:0048704
GO:0042698;ovulation cycle;4615;950;GO:0048608
GO:0042699;follicle-stimulating hormone signaling pathway;2036;107;GO:0048193
GO:0040039;inductive cell migration;93;30;GO:0048193
GO:0040040;thermosensory behavior;397;49;GO:0048193
GO:0052019;modulation by symbiont of host hormone or growth regulator levels;0;2;GO:0048193
GO:0052031;modulation by symbiont of host defense response;1172900;2520;GO:0048608
GO:0052027;perturbation of host signal transduction pathway;178023;0;GO:0048704
GO:0052028;symbiont-mediated activation of host signal transduction pathway;1;0;GO:0048731
GO:0052025;symbiont-mediated perturbation of host cell endomembrane system;2;1;GO:0048704
GO:0052026;modulation by symbiont of host transcription;376373;10;GO:0048285
GO:0052023;modulation by symbiont of salicylic acid levels in host;0;1;GO:0048704
GO:0052024;positive regulation by symbiont of hormone or growth regulator levels in host;0;0;GO:0007050
GO:0052021;modulation by symbiont of ethylene levels in host;0;1;GO:0048704
GO:0052022;modulation by symbiont of jasmonic acid levels in host;0;0;GO:0048193
GO:0052029;symbiont-mediated suppression of host signal transduction pathway;163296;0;GO:0004601
GO:0052041;symbiont-mediated suppression of host programmed cell death;18;0;GO:0004730
GO:0052042;symbiont-mediated activation of host programmed cell death;13;2;GO:0004721
GO:0052040;symbiont-mediated perturbation of host programmed cell death;9649;0;GO:0004091
GO:0052038;modulation by symbiont of host intracellular transport;6876;1;GO:0004073
GO:0052039;symbiont-mediated perturbation of host cytoskeleton;3;0;GO:0004091
GO:0052036;suppression by symbiont of host inflammatory response;6;1;GO:0006030
GO:0052034;effector-mediated suppression of host pattern-triggered immunity;12;3;GO:0004091
GO:0052032;perturbation by symbiont of host inflammatory response;9;0;GO:0004073
GO:0052053;negative regulation by symbiont of host catalytic activity;6;3;GO:0004091
GO:0047435;5-guanidino-2-oxopentanoate decarboxylase activity;832;4;GO:0006067
GO:0047434;indolepyruvate decarboxylase activity;1088;4;GO:0004497
GO:1903930;regulation of pyrimidine-containing compound salvage;7;1;GO:0004721
GO:1903935;response to sodium arsenite;274;137;GO:0004073
GO:1903936;cellular response to sodium arsenite;255;79;GO:0004601
GO:0047439;3-deoxy-D-manno-octulosonate aldolase activity;0;3;GO:0004073
GO:1903933;negative regulation of DNA primase activity;0;0;GO:0004721
GO:0047438;2-dehydro-3-deoxy-L-pentonate aldolase activity;0;3;GO:0004497
GO:1903934;positive regulation of DNA primase activity;3;4;GO:0006066
GO:0047440;2-dehydro-3-deoxy-D-pentonate aldolase activity;27;4;GO:0048608
GO:1903928;cellular response to cyanide;1;1;GO:0007050
GO:1903929;primary palate development;116;3;GO:0003906
GO:1903926;cellular response to bisphenol A;141;74;GO:0005576
GO:1903927;response to cyanide;1;1;GO:0006954
GO:0047444;N-acylneuraminate-9-phosphate synthase activity;231;8;GO:0002526
GO:0047443;4-hydroxy-4-methyl-2-oxoglutarate aldolase activity;17889;8;GO:0048316
GO:0047442;17-alpha-hydroxyprogesterone aldolase activity;175;7;GO:0048285
GO:0047441;5-dehydro-2-deoxyphosphogluconate aldolase activity;173;3;GO:0048407
GO:0035426;extracellular matrix-cell signaling;253;160;GO:0043403
GO:0035429;gluconate transmembrane transport;78867;86;GO:0005524
GO:0035425;autocrine signaling;99;280;GO:0005524
GO:0060420;regulation of heart growth;2395;213;GO:0010468
GO:0060421;positive regulation of heart growth;1306;75;GO:0010467
GO:0047448;5-dehydro-4-deoxyglucarate dehydratase activity;21255;9;GO:0004091
GO:0060426;lung vasculature development;494;348;GO:0006096
GO:1903942;positive regulation of respiratory gaseous exchange;167;1;GO:0004497
GO:0047447;erythro-3-hydroxyaspartate ammonia-lyase activity;0;3;GO:0004553
GO:0060427;lung connective tissue development;111;5;GO:0004497
GO:1903943;regulation of hepatocyte apoptotic process;318;35;GO:0006099
GO:0047446;(1-hydroxycyclohexan-1-yl)acetyl-CoA lyase activity;0;2;GO:0004067
GO:0060428;lung epithelium development;2882;515;GO:0004497
GO:1903940;negative regulation of TORC2 signaling;159;1;GO:0004553
GO:0047445;3-hydroxy-3-isohexenylglutaryl-CoA lyase activity;119;4;GO:0004730
GO:0060429;epithelium development;173265;3350;GO:0005741
GO:1903941;negative regulation of respiratory gaseous exchange;5;1;GO:0010468
GO:0060422;peptidyl-dipeptidase inhibitor activity;58;23;GO:0016021
GO:1903946;negative regulation of ventricular cardiac muscle cell action potential;44;6;GO:0005768
GO:0060423;foregut regionalization;0;6;GO:0009536
GO:1903947;positive regulation of ventricular cardiac muscle cell action potential;0;5;GO:0005576
GO:0060424;lung field specification;0;6;GO:0046395
GO:1903944;negative regulation of hepatocyte apoptotic process;257;43;GO:0005576
GO:0047449;2-dehydro-3-deoxy-L-arabinonate dehydratase activity;237;3;GO:0046395
GO:0060425;lung morphogenesis;4204;593;GO:0016021
GO:1903945;positive regulation of hepatocyte apoptotic process;61;2;GO:0046395
GO:0047451;(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity;52;0;GO:0016021
GO:1903939;regulation of TORC2 signaling;439;7;GO:0048285
GO:0047450;(3R)-hydroxybutanoyl-[acyl-carrier-protein] hydratase activity;54;0;GO:0006826
GO:1903937;response to acrylamide;8;5;GO:0048193
GO:1903938;cellular response to acrylamide;0;0;GO:0006094
GO:0047455;16-alpha-hydroxyprogesterone dehydratase activity;0;4;GO:0048193
GO:0047454;phaseollidin hydratase activity;0;3;GO:0004872
GO:0047453;ATP-dependent NAD(P)H-hydrate dehydratase activity;8380;9;GO:0048305
GO:0047452;protoaphin-aglucone dehydratase (cyclizing) activity;0;3;GO:0006826
GO:0072402;response to DNA integrity checkpoint signaling;992;7;GO:0006032
GO:0035418;protein localization to synapse;3971;2950;GO:0004713
GO:0035410;dihydrotestosterone 17-beta-dehydrogenase activity;229;9;GO:0004723
GO:0060410;negative regulation of acetylcholine metabolic process;0;2;GO:0006032
GO:1903950;negative regulation of AV node cell action potential;0;2;GO:0004041
GO:0047459;3-aminobutyryl-CoA ammonia-lyase activity;159;3;GO:0005576
GO:0060415;muscle tissue morphogenesis;4608;1050;GO:0004073
GO:1903953;negative regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization;0;0;GO:0006066
GO:0047458;beta-pyrazolylalanine synthase activity;9;6;GO:0004067
GO:0060416;response to growth hormone;1308;1240;GO:0009072
GO:1903954;positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization;2;1;GO:0042127
GO:0047457;exo-(1,4)-alpha-D-glucan lyase activity;8;0;GO:0046395
GO:0060417;yolk;36;26;GO:0006826
GO:1903951;positive regulation of AV node cell action potential;0;1;GO:0048704
GO:0047456;2-methylisocitrate dehydratase activity;32177;51;GO:0048407
GO:0060418;yolk plasma;2;0;GO:0048193
GO:1903952;regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization;2;3;GO:0048704
GO:0060411;cardiac septum morphogenesis;4774;412;GO:0048193
GO:0060412;ventricular septum morphogenesis;2059;692;GO:0048704
GO:1903958;nitric-oxide synthase complex;133;5;GO:0048010
GO:0060413;atrial septum morphogenesis;888;559;GO:0046274
GO:1903955;positive regulation of protein targeting to mitochondrion;345;552;GO:0048193
GO:0060414;aorta smooth muscle tissue morphogenesis;153;106;GO:0048193
GO:0047462;phenylalanine racemase (ATP-hydrolyzing) activity;558;5;GO:0048193
GO:0047461;(+)-delta-cadinene synthase activity;1102;5;GO:0004730
GO:0047460;L-2-amino-4-chloropent-4-enoate dehydrochlorinase activity;0;4;GO:0006874
GO:1903948;negative regulation of atrial cardiac muscle cell action potential;0;2;GO:0004497
GO:1903949;positive regulation of atrial cardiac muscle cell action potential;4;9;GO:0048193
GO:0047466;2-chloro-4-carboxymethylenebut-2-en-1,4-olide isomerase activity;0;4;GO:0048608
GO:0060419;heart growth;4135;203;GO:0005576
GO:0047465;N-acylglucosamine-6-phosphate 2-epimerase activity;20027;6;GO:0005576
GO:0047464;heparosan-N-sulfate-glucuronate 5-epimerase activity;4035;5;GO:0004497
GO:0047463;2-aminohexano-6-lactam racemase activity;8;3;GO:0003729
GO:0035401;histone H3Y41 kinase activity;61;7;GO:0004073
GO:0035402;histone H3T11 kinase activity;205;3;GO:0004073
GO:0035403;histone H3T6 kinase activity;118;4;GO:0004721
GO:0035484;adenine/adenine mispair binding;0;2;GO:0003824
GO:0035485;adenine/guanine mispair binding;113;4;GO:0004497
GO:0035486;cytosine/cytosine mispair binding;1;2;GO:0004553
GO:0035487;thymine/thymine mispair binding;2;2;GO:0004073
GO:0035480;regulation of Notch signaling pathway involved in heart induction;94;2;GO:0005576
GO:0035481;positive regulation of Notch signaling pathway involved in heart induction;94;7;GO:0005576
GO:0035482;gastric motility;164;7;GO:0005829
GO:0035483;gastric emptying;121;27;GO:0005829
GO:0035477;regulation of angioblast cell migration involved in selective angioblast sprouting;20;5;GO:0005840
GO:0035478;chylomicron binding;45;6;GO:0005576
GO:0035479;angioblast cell migration from lateral mesoderm to midline;228;4;GO:0005515
GO:0035473;lipase binding;810;332;GO:0005515
GO:0035474;selective angioblast sprouting;86;3;GO:0007070
GO:0035475;angioblast cell migration involved in selective angioblast sprouting;85;2;GO:0048193
GO:0035476;angioblast cell migration;402;7;GO:0005576
GO:0035470;positive regulation of vascular wound healing;140;27;GO:0048193
GO:0035471;luteinizing hormone signaling pathway involved in ovarian follicle development;2;4;GO:0005524
GO:0035472;choriogonadotropin hormone receptor activity;53;3;GO:0048193
GO:0047400;phosphonoacetate hydrolase activity;2870;6;GO:0005524
GO:0035469;determination of pancreatic left/right asymmetry;568;229;GO:0005524
GO:0035462;determination of left/right asymmetry in diencephalon;144;4;GO:0048405
GO:0047409;alkenylglycerophosphoethanolamine hydrolase activity;64;4;GO:0048608
GO:0035460;L-ascorbate 6-phosphate lactonase activity;1229;6;GO:0048608
GO:0035461;vitamin transmembrane transport;174480;526;GO:0048285
GO:0047404;glucuronosyl-disulfoglucosamine glucuronidase activity;0;3;GO:0048405
GO:0047403;lacto-N-biosidase activity;1;3;GO:0005764
GO:0047402;protein-glucosylgalactosylhydroxylysine glucosidase activity;84;6;GO:0048608
GO:0047401;trithionate hydrolase activity;0;3;GO:0005524
GO:0047408;alkenylglycerophosphocholine hydrolase activity;178;6;GO:0005578
GO:1903902;positive regulation of viral life cycle;1187;129;GO:0005581
GO:0047407;ADP-ribosyl-[dinitrogen reductase] hydrolase activity;957;0;GO:0048407
GO:1903903;regulation of establishment of T cell polarity;60766;21;GO:0004497
GO:0047406;beta-aspartyl-N-acetylglucosaminidase activity;0;2;GO:0048193
GO:1903900;regulation of viral life cycle;6715;298;GO:0048167
GO:0047405;pyrimidine-5'-nucleotide nucleosidase activity;13;0;GO:0048167
GO:1903901;negative regulation of viral life cycle;1196;261;GO:0048193
GO:0047411;2-(acetamidomethylene)succinate hydrolase activity;166;0;GO:0004497
GO:0047410;N-formylmethionylaminoacyl-tRNA deformylase activity;0;1;GO:0005765
GO:0035459;vesicle cargo loading;2031;85;GO:0004497
GO:0035455;response to interferon-alpha;873;1150;GO:0006457
GO:0035456;response to interferon-beta;2271;2060;GO:0004497
GO:0035457;cellular response to interferon-alpha;547;847;GO:0048193
GO:0035458;cellular response to interferon-beta;1878;1640;GO:0004497
GO:0035451;extrinsic component of stromal side of plastid thylakoid membrane;40;0;GO:0048193
GO:0035452;extrinsic component of plastid membrane;74;0;GO:0005737
GO:0035453;extrinsic component of plastid inner membrane;0;0;GO:0005581
GO:0035454;extrinsic component of stromal side of plastid inner membrane;0;0;GO:0048285
GO:0035450;extrinsic component of lumenal side of plastid thylakoid membrane;0;0;GO:0004730
GO:0047415;D-benzoylarginine-4-nitroanilide amidase activity;0;3;GO:0005581
GO:0047414;2-(hydroxymethyl)-3-(acetamidomethylene)succinate hydrolase activity;0;0;GO:0048285
GO:1903910;negative regulation of receptor clustering;53;0;GO:0005578
GO:0047413;N(alpha)-benzyloxycarbonylleucine hydrolase activity;0;0;GO:0007070
GO:0047412;N-(long-chain-acyl)ethanolamine deacylase activity;246;0;GO:0005581
GO:0047419;N-acetylgalactosamine-6-phosphate deacetylase activity;12950;3;GO:0048285
GO:1903913;regulation of fusion of virus membrane with host plasma membrane;49;1;GO:0004721
GO:0047418;phthalyl amidase activity;35;3;GO:0005581
GO:1903914;negative regulation of fusion of virus membrane with host plasma membrane;49;5;GO:0007070
GO:0047417;N-carbamoyl-D-amino acid hydrolase activity;1188;3;GO:0004721
GO:1903911;positive regulation of receptor clustering;60778;57;GO:0005578
GO:0047416;arylalkyl acylamidase activity;2;2;GO:0048285
GO:1903912;negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation;460;43;GO:0004497
GO:1903906;regulation of plasma membrane raft polarization;60519;69;GO:0005578
GO:1903907;negative regulation of plasma membrane raft polarization;0;0;GO:0048285
GO:1903904;negative regulation of establishment of T cell polarity;9;2;GO:0006081
GO:1903905;positive regulation of establishment of T cell polarity;60705;10;GO:0005581
GO:0047422;N-acyl-D-aspartate deacylase activity;154;4;GO:0007067
GO:0047421;N-acyl-D-glutamate deacylase activity;395;2;GO:0006032
GO:0047420;N-acyl-D-amino-acid deacylase activity;1199;5;GO:0043161
GO:1903908;positive regulation of plasma membrane raft polarization;60467;6;GO:0004553
GO:1903909;regulation of receptor clustering;61181;8;GO:0005737
GO:0035448;extrinsic component of thylakoid membrane;40;1;GO:0005819
GO:0035449;extrinsic component of plastid thylakoid membrane;40;0;GO:0048285
GO:0035444;nickel cation transmembrane transport;62463;22;GO:0048471
GO:0035445;borate transmembrane transport;270;4;GO:0048285
GO:0035446;cysteine-glucosaminylinositol ligase activity;15173;6;GO:0048193
GO:0035447;mycothiol synthase activity;4100;7;GO:0048193
GO:0070393;teichoic acid catabolic process;0;3;GO:1901363
GO:0070394;lipoteichoic acid metabolic process;23034;6;GO:0009628
GO:0070391;response to lipoteichoic acid;491;31;GO:0004073
GO:0070392;detection of lipoteichoic acid;39;8;GO:0002526
GO:0070397;wall teichoic acid metabolic process;0;1;GO:0050832
GO:0070398;wall teichoic acid biosynthetic process;0;0;GO:0050832
GO:0070395;lipoteichoic acid biosynthetic process;23034;27;GO:0046395
GO:0070396;lipoteichoic acid catabolic process;0;1;GO:0046395
GO:0070399;wall teichoic acid catabolic process;0;0;GO:0048666
GO:0070360;actin polymerization-dependent cell migration in host;6;0;GO:0007042
GO:0070365;hepatocyte differentiation;752;278;GO:0045944
GO:0070368;positive regulation of hepatocyte differentiation;38;9;GO:0005576
GO:0070369;beta-catenin-TCF7L2 complex;179;93;GO:0009611
GO:0070366;regulation of hepatocyte differentiation;94;6;GO:0048407
GO:0070367;negative regulation of hepatocyte differentiation;56;4;GO:0005578
GO:0070350;regulation of white fat cell proliferation;113;5;GO:0043405
GO:0070353;GATA1-TAL1-TCF3-Lmo2 complex;0;1;GO:0048407
GO:0070354;GATA2-TAL1-TCF3-Lmo2 complex;0;1;GO:0009536
GO:0070351;negative regulation of white fat cell proliferation;3;3;GO:0045944
GO:0070352;positive regulation of white fat cell proliferation;61;8;GO:0006468
GO:0070357;alphav-beta3 integrin-CD47 complex;0;1;GO:0007067
GO:0070358;actin polymerization-dependent cell motility;156;263;GO:0048608
GO:0070355;synaptotagmin-synaptobrevin 2-SNAP-25-syntaxin-1a-syntaxin-1b-Rab3a-complexin II complex;0;1;GO:0048193
GO:0070356;synaptotagmin-synaptobrevin 2-SNAP-25-syntaxin-1a-syntaxin-1b-Rab3a complex;0;0;GO:0048608
GO:0070390;transcription export complex 2;2680;13;GO:0048608
GO:0070382;exocytic vesicle;35700;864;GO:0048608
GO:0070383;DNA cytosine deamination;339;162;GO:0005576
GO:0070380;high mobility group box 1 receptor activity;0;2;GO:0048407
GO:0070381;endosome to plasma membrane transport vesicle;125;54;GO:0004073
GO:0070386;procollagen-proline 4-dioxygenase complex, alpha(I) type;0;1;GO:0005576
GO:0070387;procollagen-proline 4-dioxygenase complex, alpha(II) type;0;1;GO:0004073
GO:0070384;Harderian gland development;220;164;GO:0048285
GO:0070385;egasyn-beta-glucuronidase complex;0;2;GO:0004073
GO:0070388;procollagen-proline 4-dioxygenase complex, alpha(III) type;0;0;GO:0004722
GO:0070371;ERK1 and ERK2 cascade;16812;1800;GO:0048608
GO:0070372;regulation of ERK1 and ERK2 cascade;14380;1900;GO:0006486
GO:0070370;cellular heat acclimation;418;360;GO:0005764
GO:0070375;ERK5 cascade;227;140;GO:0006493
GO:0070376;regulation of ERK5 cascade;161;9;GO:0004073
GO:0070373;negative regulation of ERK1 and ERK2 cascade;3287;1200;GO:0048704
GO:0070374;positive regulation of ERK1 and ERK2 cascade;9670;5720;GO:0048666
GO:0070379;high mobility group box 1 binding;14;7;GO:0048608
GO:0070377;negative regulation of ERK5 cascade;1;10;GO:0048608
GO:0070378;positive regulation of ERK5 cascade;112;5;GO:0005539
GO:0008422;beta-glucosidase activity;81697;938;GO:0048666
GO:0008421;long-chain fatty-acyl-glutamate deacylase activity;0;3;GO:0005975
GO:0008420;RNA polymerase II CTD heptapeptide repeat phosphatase activity;21843;153;GO:0005576
GO:0008427;calcium-dependent protein kinase inhibitor activity;134;91;GO:0005576
GO:0008426;protein kinase C inhibitor activity;51;88;GO:0000786
GO:0008425;2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;51891;150;GO:0045766
GO:0008424;glycoprotein 6-alpha-L-fucosyltransferase activity;2061;41;GO:0000786
GO:0008419;RNA lariat debranching enzyme activity;2720;6;GO:0045595
GO:0008418;protein-N-terminal asparagine amidohydrolase activity;8126;112;GO:0048285
GO:0008417;fucosyltransferase activity;46628;671;GO:0005829
GO:0008430;selenium binding;10110;1130;GO:0048405
GO:0008432;JUN kinase binding;438;315;GO:0048704
GO:0008431;vitamin E binding;93;55;GO:0045595
GO:0008437;thyrotropin-releasing hormone activity;805;33;GO:0007030
GO:0008429;phosphatidylethanolamine binding;516;1180;GO:0045766
GO:0008428;ribonuclease inhibitor activity;16703;114;GO:0045944
GO:0008401;retinoic acid 4-hydroxylase activity;352;59;GO:0045944
GO:0008405;arachidonic acid 11,12-epoxygenase activity;66;8;GO:0045944
GO:0008404;arachidonic acid 14,15-epoxygenase activity;74;120;GO:0048608
GO:0008403;25-hydroxycholecalciferol-24-hydroxylase activity;135;9;GO:0048608
GO:0008412;4-hydroxybenzoate octaprenyltransferase activity;38447;275;GO:0048608
GO:0008411;4-hydroxybutyrate CoA-transferase activity;0;1;GO:0048608
GO:0008410;CoA-transferase activity;193813;651;GO:0048666
GO:0008414;CDP-alcohol phosphotransferase activity;0;3;GO:0048193
GO:0008413;8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity;16372;88;GO:0009628
GO:0008409;5'-3' exonuclease activity;122896;235;GO:0043408
GO:0008408;3'-5' exonuclease activity;617569;1320;GO:0005740
GO:0008407;chaeta morphogenesis;508;31;GO:0006066
GO:0008406;gonad development;19167;1650;GO:0005576
GO:0047948;glutarate-CoA ligase activity;7;3;GO:0045944
GO:0008340;determination of adult lifespan;5594;3100;GO:0004842
GO:0008346;larval walking behavior;1;2;GO:0009064
GO:0047943;glutamate-methylamine ligase activity;111;3;GO:0048305
GO:0060921;sinoatrial node cell differentiation;446;12;GO:0009579
GO:0008345;larval locomotory behavior;624;46;GO:0048608
GO:0047942;glutamate-ethylamine ligase activity;2;3;GO:0006950
GO:0060922;atrioventricular node cell differentiation;330;8;GO:0048608
GO:0008344;adult locomotory behavior;5232;2110;GO:0048608
GO:0047941;glucuronolactone reductase activity;296;3;GO:0045595
GO:0060923;cardiac muscle cell fate commitment;473;303;GO:0048704
GO:0008343;adult feeding behavior;2189;400;GO:0048704
GO:0047940;glucuronokinase activity;64;4;GO:0048704
GO:0060924;atrial cardiac muscle cell fate commitment;0;0;GO:0045595
GO:0047947;glutamine N-phenylacetyltransferase activity;0;4;GO:0006836
GO:0008349;MAP kinase kinase kinase kinase activity;5920;213;GO:0006066
GO:0047946;glutamine N-acyltransferase activity;25;7;GO:0006022
GO:0008348;negative regulation of antimicrobial humoral response;185;16;GO:0008610
GO:0047945;L-glutamine:pyruvate aminotransferase activity;4;3;GO:0006066
GO:0008347;glial cell migration;3337;1160;GO:0006030
GO:0060920;cardiac pacemaker cell differentiation;888;6;GO:0005976
GO:0060929;atrioventricular node cell fate commitment;77;7;GO:0004089
GO:0047950;glutathione oxidase activity;0;2;GO:0016567
GO:0060925;ventricular cardiac muscle cell fate commitment;0;1;GO:0004734
GO:0060926;cardiac pacemaker cell development;544;5;GO:0010401
GO:0060927;cardiac pacemaker cell fate commitment;133;3;GO:0008610
GO:0060928;atrioventricular node cell development;189;38;GO:0006836
GO:0047959;glycine dehydrogenase (cytochrome) activity;0;3;GO:0045944
GO:0008353;RNA polymerase II CTD heptapeptide repeat kinase activity;11837;44;GO:0004061
GO:0008352;katanin complex;3215;42;GO:0006865
GO:0047954;glycerol-2-phosphatase activity;1;4;GO:0016567
GO:0060910;negative regulation of DNA replication initiation involved in plasmid copy number maintenance;404;2;GO:0006099
GO:0008356;asymmetric cell division;7522;671;GO:0006865
GO:0047953;glycerol 2-dehydrogenase (NADP+) activity;17;0;GO:0046394
GO:0060911;cardiac cell fate commitment;1065;10;GO:0006865
GO:0008355;olfactory learning;608;350;GO:0046394
GO:0047952;glycerol-3-phosphate dehydrogenase [NAD(P)+] activity;191246;0;GO:0006865
GO:0060912;cardiac cell fate specification;253;9;GO:0046395
GO:0008354;germ cell migration;1267;778;GO:0006865
GO:0047951;glutathione thiolesterase activity;2;4;GO:0046395
GO:0060913;cardiac cell fate determination;219;51;GO:0006865
GO:0047958;glycine:2-oxoglutarate aminotransferase activity;138;4;GO:0006836
GO:0047957;4'-methoxyisoflavone 2'-hydroxylase activity;3;0;GO:0006865
GO:0008359;regulation of bicoid mRNA localization;13;7;GO:0048706
GO:0047956;glycerol dehydrogenase [NADP+] activity;20;0;GO:0006810
GO:0008358;maternal determination of anterior/posterior axis, embryo;2082;56;GO:0006836
GO:0047955;glycerol dehydrogenase (acceptor) activity;88;4;GO:0006873
GO:0060918;auxin transport;10557;278;GO:0006081
GO:0060919;auxin import into cell;180;1;GO:0006099
GO:0047961;glycine N-acyltransferase activity;2878;50;GO:0004073
GO:0060914;heart formation;2220;155;GO:0006099
GO:0047960;glycine dehydrogenase activity;2;2;GO:0004089
GO:0060915;mesenchymal cell differentiation involved in lung development;77;20;GO:0004091
GO:0060916;mesenchymal cell proliferation involved in lung development;338;143;GO:0006099
GO:0060917;regulation of (1->6)-beta-D-glucan biosynthetic process;7;0;GO:0006099
GO:0035943;estrone secretion;0;2;GO:0010467
GO:0035944;perforin production;0;4;GO:0004089
GO:0035945;mitochondrial ncRNA surveillance;64;2;GO:0048193
GO:0035946;mitochondrial mRNA surveillance;64;2;GO:0004089
GO:0035941;androstenedione secretion;3;2;GO:0048608
GO:0035942;dehydroepiandrosterone secretion;0;2;GO:0006869
GO:0045309;protein phosphorylated amino acid binding;15006;505;GO:0006826
GO:0008320;protein transmembrane transporter activity;377215;824;GO:0006865
GO:0008324;monoatomic cation transmembrane transporter activity;9694549;833;GO:0048608
GO:0045302;choloylglycine hydrolase activity;943;4;GO:0006869
GO:0047965;glycoprotein O-fatty-acyltransferase activity;2;2;GO:0006412
GO:0060943;neural crest-derived cardiac fibroblast cell development;0;1;GO:0006811
GO:0045303;diaminobutyrate-2-oxoglutarate transaminase activity;10510;5;GO:0010467
GO:0047964;glyoxylate reductase (NAD+) activity;1343;0;GO:0008544
GO:0060944;neural crest-derived cardiac fibroblast cell fate commitment;0;1;GO:0006865
GO:0045300;acyl-[acyl-carrier-protein] desaturase activity;11284;1;GO:0016567
GO:0047963;glycine N-choloyltransferase activity;64;7;GO:0016567
GO:0060945;cardiac neuron differentiation;37;7;GO:0046274
GO:0045301;tRNA-(2-methylthio-N-6-(cis-hydroxy)isopentenyl adenosine)-hydroxylase activity;9645;0;GO:0048285
GO:0047962;glycine N-benzoyltransferase activity;74;8;GO:0044421
GO:0060946;cardiac blood vessel endothelial cell differentiation;0;2;GO:0003824
GO:0008328;ionotropic glutamate receptor complex;4844;487;GO:0006865
GO:0047969;glyoxylate oxidase activity;68;5;GO:0006281
GO:0008327;methyl-CpG binding;1521;780;GO:0006032
GO:0047968;glyoxylate dehydrogenase (acylating) activity;2;3;GO:0005215
GO:0060940;epithelial to mesenchymal transition involved in cardiac fibroblast development;13;8;GO:0006865
GO:0045304;regulation of establishment of competence for transformation;1349;1;GO:0006029
GO:0047967;glycyrrhizinate beta-glucuronidase activity;0;2;GO:0006849
GO:0060941;epicardium-derived cardiac fibroblast cell fate commitment;0;1;GO:0045944
GO:0047966;glycosulfatase activity;0;3;GO:0006022
GO:0060942;neural crest-derived cardiac fibroblast cell differentiation;0;2;GO:0006865
GO:0008318;protein prenyltransferase activity;51013;138;GO:0004553
GO:0035936;testosterone secretion;104;8;GO:0006865
GO:0047972;guanidinopropionase activity;168;4;GO:0015837
GO:0060947;cardiac vascular smooth muscle cell differentiation;317;382;GO:0016567
GO:0035937;estrogen secretion;1;8;GO:0006865
GO:0047971;guanidinobutyrase activity;743;3;GO:0048608
GO:0060948;cardiac vascular smooth muscle cell development;104;267;GO:0006865
GO:0035938;estradiol secretion;233;8;GO:0048608
GO:0047970;guanidinoacetase activity;0;4;GO:0010942
GO:0060949;cardiac vascular smooth muscle cell fate commitment;0;0;GO:0010942
GO:0035939;microsatellite binding;37;36;GO:0048704
GO:0035932;aldosterone secretion;192;78;GO:0048704
GO:0035933;glucocorticoid secretion;602;4;GO:0004553
GO:0035934;corticosterone secretion;205;6;GO:0009065
GO:0035935;androgen secretion;118;2;GO:0008021
GO:0035930;corticosteroid hormone secretion;794;7;GO:0006029
GO:0035931;mineralocorticoid secretion;192;3;GO:0006029
GO:0008331;high voltage-gated calcium channel activity;782;553;GO:0004867
GO:0008330;protein tyrosine/threonine phosphatase activity;548;148;GO:0004497
GO:0008335;female germline ring canal stabilization;68;21;GO:0004497
GO:0045313;rhabdomere membrane biogenesis;81;11;GO:0048706
GO:0047976;hamamelose kinase activity;0;3;GO:0004553
GO:0060932;His-Purkinje system cell differentiation;220;7;GO:0006865
GO:0008334;histone mRNA metabolic process;3265;1280;GO:0004553
GO:0045314;regulation of compound eye photoreceptor development;134;10;GO:0006869
GO:0047975;guanosine phosphorylase activity;11659;6;GO:0004479
GO:0060933;His-Purkinje system cell development;0;0;GO:0006865
GO:0008333;endosome to lysosome transport;3497;985;GO:0004714
GO:0045311;invasive growth in response to pheromone;0;1;GO:0006836
GO:0047974;guanosine deaminase activity;126;6;GO:0009065
GO:0060934;His-Purkinje system cell fate commitment;0;1;GO:0048471
GO:0008332;low voltage-gated calcium channel activity;326;128;GO:0006469
GO:0045312;nor-spermidine biosynthetic process;8785;4;GO:0006749
GO:0047973;guanidinoacetate kinase activity;2;3;GO:0048471
GO:0060935;cardiac fibroblast cell differentiation;24;5;GO:0006874
GO:0045317;equator specification;55;9;GO:0006730
GO:0047979;hexose oxidase activity;45;2;GO:0048706
GO:0045315;positive regulation of compound eye photoreceptor development;10;9;GO:0006836
GO:0047978;hexadecanol dehydrogenase activity;0;3;GO:0009065
GO:0060930;sinoatrial node cell fate commitment;56;1;GO:0048706
GO:0008336;gamma-butyrobetaine dioxygenase activity;1373;102;GO:0006836
GO:0045316;negative regulation of compound eye photoreceptor development;50;8;GO:0046148
GO:0047977;hepoxilin-epoxide hydrolase activity;6;6;GO:0045727
GO:0060931;sinoatrial node cell development;355;145;GO:0006836
GO:0035929;steroid hormone secretion;1398;8;GO:0006749
GO:0035925;mRNA 3'-UTR AU-rich region binding;4946;93;GO:0048608
GO:0045320;chloroplast proton-transporting ATP synthase complex;0;2;GO:0006836
GO:0047983;homoglutathione synthase activity;1;2;GO:0048608
GO:0060936;cardiac fibroblast cell development;24;4;GO:0046395
GO:0045321;leukocyte activation;231144;3340;GO:0048608
GO:0047982;homocysteine desulfhydrase activity;142;5;GO:0006836
GO:0060937;cardiac fibroblast cell fate commitment;0;0;GO:0006836
GO:0035927;RNA import into mitochondrion;360;19;GO:0006869
GO:0047981;histidine N-acetyltransferase activity;12;2;GO:0006869
GO:0060938;epicardium-derived cardiac fibroblast cell differentiation;16;5;GO:0003700
GO:0035928;rRNA import into mitochondrion;189;34;GO:0003700
GO:0047980;hippurate hydrolase activity;1996;4;GO:0030528
GO:0060939;epicardium-derived cardiac fibroblast cell development;16;5;GO:0004497
GO:0035921;desmosome disassembly;59;5;GO:0003729
GO:0035922;foramen ovale closure;66;10;GO:0003964
GO:0035923;flurbiprofen binding;0;0;GO:0048010
GO:0035924;cellular response to vascular endothelial growth factor stimulus;17913;1080;GO:0045766
GO:0035920;negative regulation of high voltage-gated calcium channel activity in another organism;0;0;GO:0006413
GO:0047907;furylfuramide isomerase activity;0;3;GO:0045766
GO:0008381;mechanosensitive monoatomic ion channel activity;153288;410;GO:0006873
GO:0047906;fucosterol-epoxide lyase activity;0;2;GO:0045766
GO:0008380;RNA splicing;1039972;9640;GO:0006810
GO:0047905;fructose-6-phosphate phosphoketolase activity;401;3;GO:0048704
GO:0047904;fructose 5-dehydrogenase activity;211;2;GO:0006865
GO:0008386;cholesterol monooxygenase (side-chain-cleaving) activity;1447;97;GO:0048608
GO:0033342;negative regulation of collagen binding;3;10;GO:0006865
GO:0008385;IkappaB kinase complex;378;371;GO:0048608
GO:0033341;regulation of collagen binding;3;56;GO:0006865
GO:0008384;IkappaB kinase activity;3602;107;GO:0048608
GO:0033340;pelvic fin development;124;3;GO:0006826
GO:0047909;galactolipid O-acyltransferase activity;0;2;GO:0006865
GO:0047908;fusarinine-C ornithinesterase activity;0;3;GO:0006869
GO:0008389;coumarin 7-hydroxylase activity;10;10;GO:0006826
GO:0008388;testosterone 15-alpha-hydroxylase activity;0;1;GO:0006873
GO:0008387;steroid 7-alpha-hydroxylase activity;63;3;GO:0006869
GO:0047903;fructose 5-dehydrogenase (NADP+) activity;2;0;GO:0003676
GO:0047902;formylaspartate deformylase activity;1;3;GO:0003899
GO:0047901;formyl-CoA hydrolase activity;0;3;GO:0006836
GO:0047900;formate kinase activity;1;2;GO:0006865
GO:0033335;anal fin development;43;2;GO:0006874
GO:0035998;7,8-dihydroneopterin 3'-triphosphate biosynthetic process;54582;4;GO:0006869
GO:0033334;fin morphogenesis;1347;6;GO:0006873
GO:0035999;tetrahydrofolate interconversion;235082;680;GO:0015717
GO:0033333;fin development;2900;50;GO:0004497
GO:0033332;ent-kaurene biosynthetic process;4;2;GO:0006749
GO:0033339;pectoral fin development;1457;6;GO:0006096
GO:0035994;response to muscle stretch;1037;361;GO:0006094
GO:0033338;medial fin development;547;3;GO:0006066
GO:0035995;detection of muscle stretch;258;131;GO:0006081
GO:0033337;dorsal fin development;43;2;GO:0004497
GO:0035996;rhabdomere microvillus;98;4;GO:0006099
GO:0033336;caudal fin development;284;3;GO:0004089
GO:0035997;rhabdomere microvillus membrane;60;3;GO:0004497
GO:0035990;tendon cell differentiation;147;40;GO:0006865
GO:0047918;GDP-mannose 3,5-epimerase activity;1083;10;GO:0006826
GO:0008392;arachidonic acid epoxygenase activity;545;383;GO:0006826
GO:0035991;nitric oxide sensor activity;0;1;GO:0006869
GO:0047917;GDP-glucosidase activity;74;3;GO:0006836
GO:0008391;arachidonic acid monooxygenase activity;686;183;GO:0006865
GO:0035992;tendon formation;228;80;GO:0007612
GO:0047916;GDP-6-deoxy-D-talose 4-dehydrogenase activity;59;1;GO:0006836
GO:0008390;testosterone 16-alpha-hydroxylase activity;42;6;GO:0006836
GO:0035993;deltoid tuberosity development;157;22;GO:0006865
GO:0047915;ganglioside galactosyltransferase activity;13;8;GO:0008528
GO:0008397;sterol 12-alpha-hydroxylase activity;47;3;GO:0003700
GO:0033331;ent-kaurene metabolic process;798;3;GO:0003700
GO:0008396;oxysterol 7-alpha-hydroxylase activity;171;8;GO:0003729
GO:0033330;kaempferol O-glucoside biosynthetic process;0;2;GO:0008610
GO:0008395;steroid hydroxylase activity;6377;974;GO:0004722
GO:0047919;GDP-mannose 6-dehydrogenase activity;3498;4;GO:0006099
GO:0047910;galactose 1-dehydrogenase (NADP+) activity;35;0;GO:0004401
GO:0008399;naphthalene hydroxylase activity;0;0;GO:0003700
GO:0008398;sterol 14-demethylase activity;426;31;GO:0004497
GO:0047914;gamma-glutamylhistamine synthase activity;0;2;GO:0030528
GO:0047913;gallate 1-beta-glucosyltransferase activity;8;4;GO:0004867
GO:0047912;galacturonokinase activity;57;6;GO:0004553
GO:0047911;galacturan 1,4-alpha-galacturonidase activity;325;7;GO:0003964
GO:0033329;kaempferol O-glucoside metabolic process;5;4;GO:0006099
GO:0033324;choline biosynthetic process via N-monomethylethanolamine;0;1;GO:0003964
GO:0035987;endodermal cell differentiation;3233;2710;GO:0006873
GO:0033323;choline biosynthetic process via CDP-choline;0;2;GO:0006873
GO:0035988;chondrocyte proliferation;1699;1950;GO:0006869
GO:0033322;homomethionine biosynthetic process;0;2;GO:0006865
GO:0035989;tendon development;440;73;GO:0006865
GO:0033321;homomethionine metabolic process;9;3;GO:0006865
GO:0033328;peroxisome membrane targeting sequence binding;213;6;GO:0006873
GO:0035983;response to trichostatin A;75;10;GO:0006414
GO:0033327;Leydig cell differentiation;541;375;GO:0048704
GO:0035984;cellular response to trichostatin A;73;194;GO:0006986
GO:0033326;cerebrospinal fluid secretion;145;34;GO:0048706
GO:0035985;senescence-associated heterochromatin focus;106;238;GO:0006986
GO:0033325;choline biosynthetic process via phosphoryl-ethanolamine;0;1;GO:0006836
GO:0008360;regulation of cell shape;1282838;6460;GO:0006986
GO:0047929;gluconate dehydratase activity;279;4;GO:0006986
GO:0047928;gibberellin beta-D-glucosyltransferase activity;0;4;GO:0046395
GO:0035981;tongue muscle cell differentiation;56;9;GO:0010401
GO:0047927;gibberellin-44 dioxygenase activity;51;4;GO:0046394
GO:0047926;geranyl-diphosphate cyclase activity;4;3;GO:0010401
GO:0008364;pupal chitin-based cuticle development;1;4;GO:0030900
GO:0033320;UDP-D-xylose biosynthetic process;20484;64;GO:0048703
GO:0008363;larval chitin-based cuticle development;339;24;GO:0010467
GO:0008362;chitin-based embryonic cuticle biosynthetic process;275;28;GO:0048704
GO:0008361;regulation of cell size;15007;2670;GO:0046394
GO:0047921;aminoglycoside 2'-N-acetyltransferase activity;37;0;GO:0005576
GO:0047920;geissoschizine dehydrogenase activity;4;3;GO:0005026
GO:0060900;embryonic camera-type eye formation;2901;43;GO:0006986
GO:0008366;axon ensheathment;9713;1590;GO:0006468
GO:0060901;regulation of hair cycle by canonical Wnt signaling pathway;47;13;GO:0006986
GO:0008365;adult chitin-based cuticle development;82;7;GO:0048608
GO:0047925;geranoyl-CoA carboxylase activity;113;5;GO:0005576
GO:0047924;geraniol dehydrogenase activity;19;7;GO:0048608
GO:0047923;gentisate decarboxylase activity;0;3;GO:0048608
GO:0047922;gentisate 1,2-dioxygenase activity;3155;7;GO:0007275
GO:0060907;positive regulation of macrophage cytokine production;1107;714;GO:0006826
GO:0060908;plasmid copy number maintenance;490;3;GO:0005215
GO:0033319;UDP-D-xylose metabolic process;20487;5;GO:0006826
GO:0060909;regulation of DNA replication initiation involved in plasmid copy number maintenance;404;1;GO:0007517
GO:0060903;positive regulation of meiosis I;184;27;GO:0007420
GO:0060904;regulation of protein folding in endoplasmic reticulum;1;8;GO:0007517
GO:0060905;regulation of induction of conjugation upon nitrogen starvation;0;1;GO:0009908
GO:0060906;negative regulation of regulatory ncRNA-mediated heterochromatin formation;4;0;GO:0008030
GO:0033313;meiotic cell cycle checkpoint signaling;959;2;GO:0008030
GO:0035976;transcription factor AP-1 complex;341;106;GO:0008026
GO:0033312;chlorophyll a biosynthetic process via geranylgeranyl-chlorophyll a;0;2;GO:0007188
GO:0035977;protein deglycosylation involved in glycoprotein catabolic process;19;156;GO:0005524
GO:0033311;chlorophyll a biosynthetic process via phytyl diphosphate;0;2;GO:0009739
GO:0033310;chlorophyll a catabolic process;7;2;GO:0007517
GO:0035979;histone H2AXS139 kinase activity;0;0;GO:0048608
GO:0033316;meiotic spindle assembly checkpoint signaling;253;3;GO:0048706
GO:0035973;aggrephagy;751;70;GO:0006073
GO:0033315;meiotic G2/MI DNA replication checkpoint signaling;13;2;GO:0009908
GO:0035974;meiotic spindle pole body;248;8;GO:0008021
GO:0033314;mitotic DNA replication checkpoint signaling;2682;145;GO:0048608
GO:0035975;carbamoyl phosphate catabolic process;4010;4;GO:0048407
GO:0047939;L-glucuronate reductase activity;318;5;GO:0048704
GO:0035970;peptidyl-threonine dephosphorylation;64;568;GO:0048608
GO:0047938;glucose-6-phosphate 1-epimerase activity;28364;9;GO:0048704
GO:0035971;peptidyl-histidine dephosphorylation;3;8;GO:0007507
GO:0047937;glucose-1-phosphate phosphodismutase activity;32;3;GO:0005976
GO:0008375;acetylglucosaminyltransferase activity;290766;1160;GO:0004872
GO:0008374;O-acyltransferase activity;590653;1880;GO:0048608
GO:0008373;sialyltransferase activity;29095;657;GO:0048193
GO:0008379;thioredoxin peroxidase activity;49248;1020;GO:0007530
GO:0047932;glucosamine N-acetyltransferase activity;2;3;GO:0008630
GO:0008378;galactosyltransferase activity;19406;1190;GO:0002684
GO:0047931;glucosamine kinase activity;946;4;GO:0097190
GO:0008377;light-induced release of internally sequestered calcium ion;42;5;GO:0045087
GO:0047930;glucosaminate ammonia-lyase activity;42;3;GO:0097190
GO:0008376;acetylgalactosaminyltransferase activity;24517;391;GO:0000786
GO:0047936;glucose 1-dehydrogenase [NAD(P)] activity;20171;0;GO:0048704
GO:0047935;glucose 1-dehydrogenase (NADP+) activity;623;0;GO:0001944
GO:0047934;glucose 1-dehydrogenase (NAD+) activity;514;0;GO:0016569
GO:0047933;glucose-1,6-bisphosphate synthase activity;123;4;GO:0048699
GO:0033309;SBF transcription complex;83;10;GO:0050729
GO:0033308;hydroxyectoine transport;0;7;GO:0050729
GO:0033307;phytol salvage;0;1;GO:0050729
GO:0033302;quercetin O-glucoside metabolic process;6;5;GO:0097190
GO:0035965;cardiolipin acyl-chain remodeling;315;116;GO:0050729
GO:0033301;cell cycle comprising mitosis without cytokinesis;425;10;GO:0048704
GO:0035966;response to topologically incorrect protein;42502;861;GO:0007517
GO:0033300;dehydroascorbic acid transmembrane transporter activity;403;147;GO:0007517
GO:0035967;cellular response to topologically incorrect protein;29845;869;GO:0046330
GO:0033306;phytol metabolic process;144;9;GO:0001501
GO:0033305;chlorophyll a biosynthetic process;0;4;GO:0048731
GO:0035962;response to interleukin-13;166;10;GO:0008092
GO:0033304;chlorophyll a metabolic process;7;1;GO:0009536
GO:0035963;cellular response to interleukin-13;107;23;GO:0048608
GO:0033303;quercetin O-glucoside biosynthetic process;1;2;GO:0009536
GO:0035964;COPI-coated vesicle budding;340;69;GO:0005578
GO:0033382;maintenance of granzyme B location in T cell secretory granule;37;4;GO:0048471
GO:0033381;establishment of granzyme B localization to T cell secretory granule;0;1;GO:0009719
GO:0033380;granzyme B localization to T cell secretory granule;37;2;GO:0048316
GO:0033386;geranylgeranyl diphosphate biosynthetic process;118;44;GO:0048207
GO:0033385;geranylgeranyl diphosphate metabolic process;172;17;GO:0048316
GO:0033384;geranyl diphosphate biosynthetic process;89;53;GO:0048207
GO:0033383;geranyl diphosphate metabolic process;154;159;GO:0048169
GO:0070320;inward rectifier potassium channel inhibitor activity;58;10;GO:0048167
GO:0033379;maintenance of protease location in T cell secretory granule;37;3;GO:0043161
GO:0070324;thyroid hormone binding;1470;435;GO:0048309
GO:0033378;establishment of protease localization to T cell secretory granule;0;1;GO:0004867
GO:0070325;lipoprotein particle receptor binding;4905;87;GO:0009536
GO:0033377;maintenance of protein location in T cell secretory granule;37;2;GO:0004601
GO:0033376;establishment of protein localization to T cell secretory granule;0;3;GO:0006929
GO:0070328;triglyceride homeostasis;2659;1710;GO:0005737
GO:0070329;tRNA seleno-modification;4;1;GO:0006903
GO:0070326;very-low-density lipoprotein particle receptor binding;220;10;GO:0030168
GO:0070327;thyroid hormone transport;1171;257;GO:0005829
GO:0033371;T cell secretory granule organization;74;3;GO:0006418
GO:0060990;lipid tube assembly involved in organelle fission;12;2;GO:0010467
GO:0033370;maintenance of protein location in mast cell secretory granule;37;3;GO:0007596
GO:0060992;response to fungicide;50;223;GO:0097458
GO:0070319;Golgi to plasma membrane transport vesicle;116;7;GO:0030518
GO:0060993;kidney morphogenesis;9341;947;GO:0004872
GO:0033375;protease localization to T cell secretory granule;37;2;GO:0042254
GO:0033374;protein localization to T cell secretory granule;37;2;GO:0046395
GO:0033373;maintenance of protease location in mast cell secretory granule;37;3;GO:0000976
GO:0033372;establishment of protease localization to mast cell secretory granule;0;1;GO:0007067
GO:0060998;regulation of dendritic spine development;1817;938;GO:0005576
GO:0060999;positive regulation of dendritic spine development;1278;1190;GO:0010401
GO:0060995;cell-cell signaling involved in kidney development;104;10;GO:0004721
GO:0060996;dendritic spine development;4035;402;GO:0048407
GO:0060997;dendritic spine morphogenesis;2138;2790;GO:0045727
GO:0070310;ATR-ATRIP complex;170;4;GO:0005576
GO:0033368;protease localization to mast cell secretory granule;37;2;GO:0048407
GO:0070313;RGS6-DNMT1-DMAP1 complex;0;1;GO:009748
GO:0033367;protein localization to mast cell secretory granule;37;2;GO:0006958
GO:0070314;G1 to G0 transition;1077;260;GO:0004465
GO:0033366;protein localization to secretory granule;173;7;GO:0004497
GO:0070311;nucleosomal methylation activator complex;0;2;GO:0009065
GO:0033365;protein localization to organelle;540003;2410;GO:0004896
GO:0070312;RAD52-ERCC4-ERCC1 complex;0;2;GO:0004721
GO:0070317;negative regulation of G0 to G1 transition;201;604;GO:0005740
GO:0070318;positive regulation of G0 to G1 transition;387;99;GO:0008030
GO:0070315;G1 to G0 transition involved in cell differentiation;282;58;GO:0007049
GO:0033369;establishment of protein localization to mast cell secretory granule;0;3;GO:0050829
GO:0070316;regulation of G0 to G1 transition;750;289;GO:0048193
GO:0033360;lysine biosynthetic process via diaminopimelate and L-2-acetamido-6-oxoheptanedioate;0;2;GO:0097190
GO:0033364;mast cell secretory granule organization;80;10;GO:0005764
GO:0033363;secretory granule organization;2374;284;GO:0045727
GO:0033362;lysine biosynthetic process via diaminopimelate, diaminopimelate-aminotransferase pathway;3881;4;GO:0000976
GO:0033361;lysine biosynthetic process via diaminopimelate, dehydrogenase pathway;0;2;GO:0048608
GO:0070342;brown fat cell proliferation;56;7;GO:0006067
GO:0070343;white fat cell proliferation;172;8;GO:0005576
GO:0070340;detection of bacterial lipopeptide;182;8;GO:0005178
GO:0070341;fat cell proliferation;644;8;GO:0048608
GO:0033357;L-arabinose biosynthetic process;0;2;GO:0005576
GO:0070346;positive regulation of fat cell proliferation;186;10;GO:0045944
GO:0033356;UDP-L-arabinose metabolic process;1550;6;GO:0048471
GO:0070347;regulation of brown fat cell proliferation;3;5;GO:0048608
GO:0033355;ascorbate glutathione cycle;1350;7;GO:0048706
GO:0070344;regulation of fat cell proliferation;428;73;GO:0048608
GO:0033354;chlorophyll cycle;91;5;GO:0005576
GO:0070345;negative regulation of fat cell proliferation;193;150;GO:0048316
GO:0033359;lysine biosynthetic process via diaminopimelate and N-succinyl-2-amino-6-ketopimelate;2;2;GO:0005576
GO:0070348;negative regulation of brown fat cell proliferation;1;2;GO:0042981
GO:0033358;UDP-L-arabinose biosynthetic process;10;5;GO:0009908
GO:0070349;positive regulation of brown fat cell proliferation;2;2;GO:0045944
GO:0033353;S-adenosylmethionine cycle;51579;155;GO:0007589
GO:0033352;UDP-D-apiose biosynthetic process;0;2;GO:0048285
GO:0033351;UDP-D-apiose metabolic process;0;3;GO:0045944
GO:0033350;apiose biosynthetic process;0;2;GO:0004041
GO:0070331;CD20-Lck-Fyn complex;0;1;GO:0042981
GO:0070332;CD20-Lck-Lyn-Fyn complex;0;1;GO:0045944
GO:0070330;aromatase activity;16466;1170;GO:0043066
GO:0033346;asparagine catabolic process via 2-oxosuccinamate;0;3;GO:0097159
GO:0070335;aspartate binding;3;5;GO:0006355
GO:0033345;asparagine catabolic process via L-aspartate;114;7;GO:0008023
GO:0070336;flap-structured DNA binding;395;123;GO:0045944
GO:0033344;cholesterol efflux;4227;2070;GO:0006816
GO:0070333;alpha6-beta4 integrin-Shc-Grb2 complex;0;0;GO:0048437
GO:0033343;positive regulation of collagen binding;0;7;GO:0045944
GO:0070334;alpha6-beta4 integrin-laminin 5 complex;0;1;GO:0005737
GO:0070339;response to bacterial lipopeptide;676;8;GO:0009908
GO:0033349;apiose metabolic process;0;2;GO:0009086
GO:0033348;tetrose biosynthetic process;0;2;GO:0009952
GO:0070337;3'-flap-structured DNA binding;65;5;GO:0009536
GO:0033347;tetrose metabolic process;1;4;GO:0005576
GO:0070338;5'-flap-structured DNA binding;4;1;GO:0048608
GO:0060960;cardiac neuron fate commitment;0;2;GO:0048468
GO:0045324;late endosome to vacuole transport;24948;552;GO:0009908
GO:0060965;negative regulation of miRNA-mediated gene silencing;656;18;GO:0009908
GO:0045325;peptidyl-tryptophan hydroxylation;0;3;GO:0004712
GO:0047986;hydrogen-sulfide S-acetyltransferase activity;0;2;GO:0004721
GO:0060966;regulation of gene silencing by regulatory ncRNA;8371;2;GO:0009416
GO:0045322;unmethylated CpG binding;814;204;GO:0009416
GO:0047985;hydrogen dehydrogenase activity;1027;5;GO:0042981
GO:0060967;negative regulation of gene silencing by regulatory ncRNA;4665;6;GO:0009628
GO:0045323;interleukin-1 receptor complex;1;43;GO:0043473
GO:0045328;cytochrome P450 4A1-heme linkage;0;4;GO:0048437
GO:0060961;phospholipase D inhibitor activity;2;38;GO:0006950
GO:0045329;carnitine biosynthetic process;9987;95;GO:0048193
GO:0060962;regulation of ribosomal protein gene transcription by RNA polymerase II;2179;2;GO:0048468
GO:0045326;protein-DNA covalent cross-linking via the 3'-end to peptidyl-tyrosine;0;1;GO:0045944
GO:0047989;hydroxybutyrate-dimer hydrolase activity;3291;6;GO:0005576
GO:0060963;positive regulation of ribosomal protein gene transcription by RNA polymerase II;57;5;GO:0016567
GO:0045327;protein-DNA covalent cross-linking via peptidyl-tyrosine;0;3;GO:0048316
GO:0047988;hydroxyacid-oxoacid transhydrogenase activity;3113;10;GO:0045944
GO:0060964;regulation of miRNA-mediated gene silencing;2951;8;GO:0005576
GO:0047990;hydroxyglutamate decarboxylase activity;0;2;GO:0042981
GO:0047994;hydroxymethylglutaryl-CoA hydrolase activity;9;4;GO:0048437
GO:0045332;phospholipid translocation;27123;1060;GO:0045944
GO:0047993;hydroxymalonate dehydrogenase activity;0;2;GO:0005929
GO:0047992;hydroxylysine kinase activity;82;6;GO:0010468
GO:0045330;aspartyl esterase activity;52111;182;GO:0016567
GO:0047991;hydroxylamine oxidase activity;166;6;GO:0045944
GO:0045335;phagocytic vesicle;31102;1630;GO:0016567
GO:0047998;hyoscyamine (6S)-dioxygenase activity;23;0;GO:0043687
GO:0060954;neural crest-derived cardiac glial cell development;0;1;GO:0042787
GO:0045336;clathrin-coated phagocytic vesicle;0;2;GO:0048437
GO:0047997;hydroxypyruvate decarboxylase activity;0;3;GO:0048316
GO:0060955;neural crest-derived cardiac glial cell fate commitment;0;1;GO:0048468
GO:0045333;cellular respiration;6435927;4270;GO:0010033
GO:0047996;hydroxyphytanate oxidase activity;0;3;GO:0042127
GO:0060956;endocardial cell differentiation;523;47;GO:0048316
GO:0045334;clathrin-coated endocytic vesicle;13511;481;GO:0048316
GO:0047995;hydroxyphenylpyruvate reductase activity;189;4;GO:0048468
GO:0060957;endocardial cell fate commitment;58;2;GO:0048316
GO:0045339;farnesyl diphosphate catabolic process;66;17;GO:0001503
GO:0060950;cardiac glial cell differentiation;0;3;GO:0004867
GO:0060951;neural crest-derived cardiac glial cell differentiation;0;1;GO:0004067
GO:0045337;farnesyl diphosphate biosynthetic process;11934;99;GO:0004812
GO:0060952;cardiac glial cell development;0;1;GO:0006073
GO:0045338;farnesyl diphosphate metabolic process;12167;39;GO:0004497
GO:0047999;hyponitrite reductase activity;2;3;GO:0004497
GO:0060953;cardiac glial cell fate commitment;0;2;GO:0009065
GO:0045342;MHC class II biosynthetic process;787;74;GO:0009065
GO:0060958;endocardial cell development;26;1;GO:0004713
GO:0045343;regulation of MHC class I biosynthetic process;232;166;GO:0004061
GO:0060959;cardiac neuron development;33;1;GO:0046356
GO:0045340;mercury ion binding;12775;86;GO:0016569
GO:0045341;MHC class I biosynthetic process;232;6;GO:0046274
GO:0060980;cell migration involved in coronary vasculogenesis;3;8;GO:0048193
GO:0060981;cell migration involved in coronary angiogenesis;5;3;GO:0048193
GO:0070308;lens fiber cell fate commitment;0;2;GO:0048193
GO:0060982;coronary artery morphogenesis;322;74;GO:0046274
GO:0070309;lens fiber cell morphogenesis;468;230;GO:0045944
GO:0045346;regulation of MHC class II biosynthetic process;682;27;GO:0046405
GO:0060987;lipid tube;54;3;GO:0000122
GO:0045347;negative regulation of MHC class II biosynthetic process;234;125;GO:0046405
GO:0060988;lipid tube assembly;187;100;GO:0016567
GO:0045344;negative regulation of MHC class I biosynthetic process;41;2;GO:0046356
GO:0060989;lipid tube assembly involved in organelle fusion;12;3;GO:0016525
GO:0045345;positive regulation of MHC class I biosynthetic process;190;38;GO:0046274
GO:0060983;epicardium-derived cardiac vascular smooth muscle cell differentiation;2;5;GO:0046356
GO:0060984;epicardium-derived cardiac vascular smooth muscle cell development;0;0;GO:0048666
GO:0045348;positive regulation of MHC class II biosynthetic process;448;147;GO:0003906
GO:0060985;epicardium-derived cardiac vascular smooth muscle cell fate commitment;0;1;GO:0046274
GO:0060986;endocrine hormone secretion;2957;130;GO:0045944
GO:0045353;interleukin-1 type II receptor antagonist activity;50;5;GO:0006029
GO:0045352;interleukin-1 type I receptor antagonist activity;50;5;GO:0006081
GO:0070302;regulation of stress-activated protein kinase signaling cascade;20060;475;GO:0006066
GO:0070303;negative regulation of stress-activated protein kinase signaling cascade;2667;52;GO:0004061
GO:0033399;cis-zeatin metabolic process;0;3;GO:0006029
GO:0070300;phosphatidic acid binding;3085;418;GO:0006032
GO:0033398;zeatin biosynthetic process;10;3;GO:0004497
GO:0070301;cellular response to hydrogen peroxide;2568;1960;GO:0009719
GO:0070306;lens fiber cell differentiation;1955;528;GO:0009719
GO:0070307;lens fiber cell development;809;439;GO:0045727
GO:0070304;positive regulation of stress-activated protein kinase signaling cascade;12546;140;GO:0045727
GO:0070305;response to cGMP;361;10;GO:0006066
GO:0033393;homogalacturonan catabolic process;0;2;GO:0004553
GO:0033391;chromatoid body;583;338;GO:0048285
GO:0060970;embryonic heart tube dorsal/ventral pattern formation;0;2;GO:0009065
GO:0033390;putrescine biosynthetic process from arginine via N-carbamoylputrescine;785;4;GO:0048285
GO:0060971;embryonic heart tube left/right pattern formation;281;28;GO:0004553
GO:0033397;zeatin metabolic process;10;3;GO:0006067
GO:0033396;beta-alanine biosynthetic process via 3-ureidopropionate;153;1;GO:0004730
GO:0033395;beta-alanine biosynthetic process via 3-hydroxypropionate;0;2;GO:0004073
GO:0033394;beta-alanine biosynthetic process via 1,3 diaminopropane;0;2;GO:0004073
GO:0060976;coronary vasculature development;2402;563;GO:0006066
GO:0060977;coronary vasculature morphogenesis;723;499;GO:0004553
GO:0060978;angiogenesis involved in coronary vascular morphogenesis;86;75;GO:0003964
GO:0060979;vasculogenesis involved in coronary vascular morphogenesis;128;38;GO:0004721
GO:0060972;left/right pattern formation;19658;810;GO:0006826
GO:0060973;cell migration involved in heart development;1513;590;GO:0002576
GO:0060974;cell migration involved in heart formation;436;10;GO:0005524
GO:0060975;cardioblast migration to the midline involved in heart field formation;254;6;GO:0048608
GO:0033389;putrescine biosynthetic process from arginine, using agmatinase;148;4;GO:0030528
GO:0033388;putrescine biosynthetic process from arginine;3606;8;GO:0004721
GO:0033387;putrescine biosynthetic process from ornithine;822;51;GO:0004721
GO:0070481;nuclear-transcribed mRNA catabolic process, non-stop decay;8201;60;GO:0005829
GO:0070482;response to oxygen levels;19978;2850;GO:0004721
GO:0070480;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-independent decay;9;1;GO:0004721
GO:0070485;dehydro-D-arabinono-1,4-lactone biosynthetic process;75;5;GO:0042127
GO:0070486;leukocyte aggregation;711;1770;GO:0005525
GO:0070483;detection of hypoxia;2780;58;GO:0008021
GO:0070484;dehydro-D-arabinono-1,4-lactone metabolic process;75;2;GO:0043161
GO:0070489;T cell aggregation;48;75;GO:0005737
GO:0070487;monocyte aggregation;324;23;GO:0006836
GO:0070488;neutrophil aggregation;119;136;GO:0005766
GO:0070470;plasma membrane respirasome;18033;2;GO:0005766
GO:0070471;uterine smooth muscle contraction;320;7;GO:0043161
GO:0070474;positive regulation of uterine smooth muscle contraction;94;167;GO:0043161
GO:0070475;rRNA base methylation;257153;486;GO:0006066
GO:0070472;regulation of uterine smooth muscle contraction;318;3;GO:0048704
GO:0070473;negative regulation of uterine smooth muscle contraction;7;6;GO:0048193
GO:0070478;nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay;1418;9;GO:0048193
GO:0070479;nuclear-transcribed mRNA catabolic process, 5'-3' exonucleolytic nonsense-mediated decay;9;1;GO:0043405
GO:0070476;rRNA (guanine-N7)-methylation;97234;0;GO:0005764
GO:0070477;endospore core;0;2;GO:0006986
GO:0070492;oligosaccharide binding;1090;177;GO:0002504
GO:0070493;thrombin-activated receptor signaling pathway;8085;269;GO:0002449
GO:0070490;protein pupylation;17058;7;GO:0006906
GO:0070496;positive regulation of thrombin-activated receptor signaling pathway;0;0;GO:0005764
GO:0070497;6-carboxy-5,6,7,8-tetrahydropterin synthase activity;39254;9;GO:0005764
GO:0070494;regulation of thrombin-activated receptor signaling pathway;141;0;GO:0005764
GO:0070495;negative regulation of thrombin-activated receptor signaling pathway;141;9;GO:0005743
GO:0070498;interleukin-1-mediated signaling pathway;3859;838;GO:0016569
GO:0070499;exosporium assembly;1;3;GO:0016569
GO:0008504;monoamine transmembrane transporter activity;3337;328;GO:0050832
GO:0008503;benzodiazepine receptor activity;251;312;GO:0048704
GO:0008502;melatonin receptor activity;2978;71;GO:0010713
GO:0008511;sodium:potassium:chloride symporter activity;267;49;GO:0006950
GO:0008510;sodium:bicarbonate symporter activity;619;179;GO:0009065
GO:0008515;sucrose transmembrane transporter activity;2146;88;GO:0048704
GO:0008514;organic anion transmembrane transporter activity;774601;1400;GO:0048704
GO:0008513;secondary active organic cation transmembrane transporter activity;5;10;GO:0005764
GO:0008512;sulfate:proton symporter activity;10;1;GO:0005764
GO:0008508;bile acid:sodium symporter activity;127;325;GO:0005764
GO:0008507;sodium:iodide symporter activity;249;6;GO:0007040
GO:0008506;sucrose:proton symporter activity;587;66;GO:0030529
GO:0008509;monoatomic anion transmembrane transporter activity;431425;212;GO:0003824
GO:0021519;spinal cord association neuron specification;1;2;GO:0005829
GO:0008540;proteasome regulatory particle, base subcomplex;21438;504;GO:0004497
GO:0021515;cell differentiation in spinal cord;7036;282;GO:0006869
GO:0021516;dorsal spinal cord development;1342;146;GO:0005840
GO:0021517;ventral spinal cord development;5955;325;GO:0006099
GO:0021518;spinal cord commissural neuron specification;0;2;GO:0006869
GO:0008544;epidermis development;27436;4970;GO:0006986
GO:0021511;spinal cord patterning;1506;21;GO:0005576
GO:0008543;fibroblast growth factor receptor signaling pathway;22826;2470;GO:0006612
GO:0021512;spinal cord anterior/posterior patterning;50;5;GO:0003924
GO:0008542;visual learning;1953;1770;GO:0005764
GO:0021513;spinal cord dorsal/ventral patterning;1405;65;GO:0004930
GO:0008541;proteasome regulatory particle, lid subcomplex;8757;502;GO:0005215
GO:0021514;ventral spinal cord interneuron differentiation;1059;210;GO:0008565
GO:0008545;JUN kinase kinase activity;134;31;GO:0006811
GO:0021510;spinal cord development;10178;1750;GO:0006810
GO:0021508;floor plate formation;356;16;GO:0010721
GO:0021509;roof plate formation;87;6;GO:0010468
GO:0008551;P-type cadmium transporter activity;43;3;GO:0045765
GO:0021504;neural fold hinge point formation;0;3;GO:0006021
GO:0021505;neural fold folding;0;3;GO:0046395
GO:0021506;anterior neuropore closure;5;6;GO:0006721
GO:0021507;posterior neuropore closure;0;4;GO:0009065
GO:0008554;P-type sodium transporter activity;900;10;GO:0009813
GO:0021501;prechordal plate formation;169;7;GO:0046274
GO:0008553;P-type proton-exporting transporter activity;24436;139;GO:0048608
GO:0021502;neural fold elevation formation;126;10;GO:0045766
GO:0021503;neural fold bending;69;8;GO:0048471
GO:0008559;ABC-type xenobiotic transporter activity;4393;254;GO:0048608
GO:0008558;ABC-type guanine transporter activity;11;5;GO:0006464
GO:0008556;P-type potassium transmembrane transporter activity;111008;320;GO:0048193
GO:0008521;acetyl-CoA transmembrane transporter activity;7198;8;GO:0004721
GO:0008520;L-ascorbate:sodium symporter activity;249;35;GO:0006629
GO:0008526;phosphatidylinositol transfer activity;3779;67;GO:0004734
GO:0008525;phosphatidylcholine transporter activity;1424;44;GO:0004721
GO:0008523;sodium-dependent multivitamin transmembrane transporter activity;77;10;GO:0006869
GO:0008519;ammonium transmembrane transporter activity;81265;934;GO:0004721
GO:0008518;folate:monoatomic anion antiporter activity;387;4;GO:0010468
GO:0008517;folic acid transmembrane transporter activity;868;189;GO:0004061
GO:0008516;hexose uniporter activity;10;3;GO:0006869
GO:0008532;N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;233;151;GO:0010468
GO:0008531;riboflavin kinase activity;156626;55;GO:0006869
GO:0008537;proteasome activator complex;4249;136;GO:0045944
GO:0008535;respiratory chain complex IV assembly;21977;2920;GO:0004497
GO:0008534;oxidized purine nucleobase lesion DNA N-glycosylase activity;92563;677;GO:0004721
GO:0008528;G protein-coupled peptide receptor activity;105430;1330;GO:0006869
GO:0008527;taste receptor activity;5223;1120;GO:0004497
GO:0008463;formylmethionine deformylase activity;44;7;GO:0008544
GO:0008460;dTDP-glucose 4,6-dehydratase activity;97829;587;GO:0006865
GO:0008467;[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity;633;0;GO:0048608
GO:0008466;glycogenin glucosyltransferase activity;199;44;GO:0006869
GO:0008465;glycerate dehydrogenase activity;3708;20;GO:0006836
GO:0008469;histone arginine N-methyltransferase activity;270;311;GO:0006635
GO:1901901;regulation of protein localization to cell division site involved in cytokinesis;40;2;GO:0046395
GO:1901900;regulation of protein localization to cell division site;69;5;GO:0006836
GO:0033419;CUA codon-amino acid adaptor activity;2;1;GO:0006836
GO:0033418;CUC codon-amino acid adaptor activity;0;0;GO:0005509
GO:0033417;CUU codon-amino acid adaptor activity;1;1;GO:0000086
GO:0033412;UAG codon-amino acid adaptor activity;0;0;GO:0045944
GO:0033411;UAA codon-amino acid adaptor activity;0;1;GO:0048193
GO:0033410;UAC codon-amino acid adaptor activity;3;2;GO:0048193
GO:0033416;UGG codon-amino acid adaptor activity;2;1;GO:0045944
GO:0033415;UGA codon-amino acid adaptor activity;2;0;GO:0045944
GO:0033414;UGC codon-amino acid adaptor activity;5;2;GO:0004730
GO:0033413;UGU codon-amino acid adaptor activity;0;0;GO:0004518
GO:0008470;isovaleryl-CoA dehydrogenase activity;3287;27;GO:0010401
GO:0008474;palmitoyl-(protein) hydrolase activity;3744;1;GO:0048169
GO:0008473;ornithine cyclodeaminase activity;4028;9;GO:0004518
GO:0008478;pyridoxal kinase activity;40002;427;GO:0048193
GO:0008477;purine nucleosidase activity;25960;9;GO:0048193
GO:0008476;protein-tyrosine sulfotransferase activity;23611;89;GO:0003729
GO:0008475;procollagen-lysine 5-dioxygenase activity;5455;70;GO:0048193
GO:1901910;adenosine 5'-(hexahydrogen pentaphosphate) metabolic process;142;0;GO:0004518
GO:0008479;tRNA-guanosine(34) queuine transglycosylase activity;122144;9;GO:0010468
GO:1901911;adenosine 5'-(hexahydrogen pentaphosphate) catabolic process;142;4;GO:0046395
GO:0033409;UAU codon-amino acid adaptor activity;0;2;GO:0045934
GO:1901903;tyrocidine catabolic process;0;0;GO:0045730
GO:0033408;UCG codon-amino acid adaptor activity;1;0;GO:0004518
GO:1901902;tyrocidine metabolic process;0;0;GO:0004518
GO:0033407;UCA codon-amino acid adaptor activity;3;2;GO:0045944
GO:1901905;response to tamsulosin;0;1;GO:0004518
GO:0033406;UCC codon-amino acid adaptor activity;0;1;GO:0010433
GO:1901904;tyrocidine biosynthetic process;0;0;GO:0003677
GO:1901907;diadenosine pentaphosphate catabolic process;142;117;GO:0045730
GO:1901906;diadenosine pentaphosphate metabolic process;142;34;GO:0003677
GO:1901909;diadenosine hexaphosphate catabolic process;196;42;GO:0045730
GO:1901908;diadenosine hexaphosphate metabolic process;196;32;GO:0045944
GO:0033401;UUU codon-amino acid adaptor activity;0;1;GO:0003676
GO:0033400;trans-zeatin metabolic process;10;1;GO:0006281
GO:0033405;UCU codon-amino acid adaptor activity;3;2;GO:0003676
GO:0033404;UUG codon-amino acid adaptor activity;2;2;GO:0045944
GO:0033403;UUA codon-amino acid adaptor activity;5;0;GO:0003676
GO:0033402;UUC codon-amino acid adaptor activity;2;2;GO:0045944
GO:0045429;positive regulation of nitric oxide biosynthetic process;1383;2020;GO:0004867
GO:0008441;3'(2'),5'-bisphosphate nucleotidase activity;55678;5;GO:0006749
GO:0008440;inositol-1,4,5-trisphosphate 3-kinase activity;607;178;GO:0006749
GO:0008445;D-aspartate oxidase activity;469;16;GO:0004518
GO:0008444;CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity;82663;1290;GO:0004067
GO:0008443;phosphofructokinase activity;324818;276;GO:0045944
GO:0008442;3-hydroxyisobutyrate dehydrogenase activity;32088;228;GO:0003964
GO:0008449;N-acetylglucosamine-6-sulfatase activity;5424;77;GO:0003964
GO:0008448;N-acetylglucosamine-6-phosphate deacetylase activity;45962;231;GO:0010467
GO:0045428;regulation of nitric oxide biosynthetic process;1909;462;GO:0010467
GO:1901920;peptidyl-tyrosine dephosphorylation involved in activation of protein kinase activity;0;2;GO:0003964
GO:0008447;L-ascorbate oxidase activity;964;68;GO:0045730
GO:1901923;negative regulation of sclerotium development;0;1;GO:0006749
GO:0008446;GDP-mannose 4,6-dehydratase activity;124927;121;GO:0030514
GO:1901922;regulation of sclerotium development;0;0;GO:0009061
GO:1901914;negative regulation of capsule organization;0;0;GO:0010467
GO:1901913;regulation of capsule organization;3;0;GO:0006096
GO:1901915;positive regulation of capsule organization;0;1;GO:0010467
GO:0045430;chalcone isomerase activity;2310;42;GO:0032787
GO:1901918;negative regulation of exoribonuclease activity;1;1;GO:0010467
GO:0045431;flavonol synthase activity;97;10;GO:0006091
GO:1901917;regulation of exoribonuclease activity;1;0;GO:0010467
GO:1901919;positive regulation of exoribonuclease activity;0;4;GO:0009062
GO:0008452;RNA ligase activity;65205;386;GO:0006099
GO:0008456;alpha-N-acetylgalactosaminidase activity;337;21;GO:0006066
GO:0045434;negative regulation of female receptivity, post-mating;86;21;GO:0009062
GO:0008455;alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity;3990;125;GO:0045730
GO:0045435;lycopene epsilon cyclase activity;1;8;GO:0006793
GO:0008454;alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity;253;149;GO:0046395
GO:1901930;alpha-copaene catabolic process;0;0;GO:0009065
GO:0008453;alanine-glyoxylate transaminase activity;3852;170;GO:0003906
GO:0045433;male courtship behavior, veined wing generated song production;111;42;GO:0003906
GO:0045438;delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase activity;0;0;GO:0003735
GO:1901932;bicyclogermacrene metabolic process;1;0;GO:0003735
GO:0008459;chondroitin 6-sulfotransferase activity;219;16;GO:0005581
GO:0045439;isopenicillin-N epimerase activity;483;4;GO:0006096
GO:1901931;alpha-copaene biosynthetic process;2;0;GO:0004091
GO:0005680;anaphase-promoting complex;33094;2000;GO:0006029
GO:0005682;U5 snRNP;21695;1180;GO:0006029
GO:0003020;detection of reduced oxygen by chemoreceptor signaling;0;2;GO:0005929
GO:0005681;spliceosomal complex;226552;3940;GO:0006032
GO:0003021;detection of increased carbon dioxide by chemoreceptor signaling;0;2;GO:0048608
GO:0005684;U2-type spliceosomal complex;21115;669;GO:0006032
GO:0003022;detection of pH by chemoreceptor signaling;0;3;GO:0045766
GO:0005683;U7 snRNP;383;180;GO:0006096
GO:0003023;baroreceptor detection of increased arterial stretch;0;2;GO:0045727
GO:0005686;U2 snRNP;29756;1220;GO:0005215
GO:0003024;baroreceptor detection of decreased arterial stretch;0;1;GO:0006073
GO:0005685;U1 snRNP;45913;864;GO:0006096
GO:0003025;regulation of systemic arterial blood pressure by baroreceptor feedback;198;186;GO:0048193
GO:0005688;U6 snRNP;128184;289;GO:0009065
GO:0003026;regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback;41;6;GO:0003735
GO:0005687;U4 snRNP;18243;468;GO:0048193
GO:0003016;respiratory system process;1791;374;GO:0009065
GO:0030613;oxidoreductase activity, acting on phosphorus or arsenic in donors;63998;7;GO:0004091
GO:0003017;lymph circulation;93;12;GO:0048608
GO:0030612;arsenate reductase (thioredoxin) activity;3787;7;GO:0006519
GO:0003018;vascular process in circulatory system;43327;710;GO:0006096
GO:0003019;central nervous system control of baroreceptor feedback;0;3;GO:0048608
GO:0030614;oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor;63242;45;GO:0006793
GO:0030619;U1 snRNA binding;5946;32;GO:0004730
GO:0030611;arsenate reductase activity;64403;38;GO:0006793
GO:0005652;nuclear lamina;3271;398;GO:0004091
GO:0005655;nucleolar ribonuclease P complex;8287;415;GO:0006793
GO:0005654;nucleoplasm;655771;48400;GO:0030513
GO:0030604;1-deoxy-D-xylulose-5-phosphate reductoisomerase activity;131109;455;GO:0006796
GO:0030603;oxaloacetase activity;8;5;GO:0048193
GO:0030600;feruloyl esterase activity;16353;8;GO:0004073
GO:0005662;DNA replication factor A complex;2115;634;GO:0005524
GO:0005664;nuclear origin of replication recognition complex;10901;472;GO:0006022
GO:0003002;regionalization;68021;4500;GO:0004867
GO:0005663;DNA replication factor C complex;7338;691;GO:0004553
GO:0003003;follicular fluid formation in ovarian follicle antrum involved in fused antrum stage;0;1;GO:0004067
GO:0005666;RNA polymerase III complex;27738;1610;GO:0004067
GO:0003004;follicular fluid formation in ovarian follicle antrum involved in distinct antral spaces stage;0;2;GO:0006029
GO:0005665;RNA polymerase II, core complex;16780;1050;GO:0004553
GO:0005657;replication fork;282944;1560;GO:0048193
GO:0005656;nuclear pre-replicative complex;12613;180;GO:0006029
GO:0005658;alpha DNA polymerase:primase complex;4296;675;GO:0004553
GO:0015038;glutathione disulfide oxidoreductase activity;53352;161;GO:0048193
GO:0039005;specification of pronephric tubule identity;9;2;GO:0004553
GO:0042657;MHC class II protein binding, via lateral surface;0;2;GO:0050729
GO:0039004;specification of pronephric proximal tubule identity;1;4;GO:0006029
GO:0042658;MHC class II protein binding, via antigen binding groove;57;7;GO:0006032
GO:0015036;disulfide oxidoreductase activity;394602;1600;GO:0004553
GO:0039007;pronephric nephron morphogenesis;27;6;GO:0004553
GO:0042659;regulation of cell fate specification;2121;396;GO:0003735
GO:0015035;protein-disulfide reductase activity;202813;1370;GO:0003954
GO:0039006;pronephric nephron tubule formation;0;2;GO:0004553
GO:0003050;regulation of systemic arterial blood pressure by atrial natriuretic peptide;157;39;GO:0003735
GO:0039003;pronephric field specification;32;60;GO:0048545
GO:0003051;angiotensin-mediated drinking behavior;70;81;GO:0006029
GO:0015031;protein transport;5909601;20200;GO:0003735
GO:0003052;circadian regulation of systemic arterial blood pressure;0;9;GO:0010468
GO:0015030;Cajal body;12092;1480;GO:0004553
GO:0003053;circadian regulation of heart rate;18;5;GO:0003735
GO:0042650;prothylakoid membrane;0;1;GO:0048193
GO:0003054;circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus;0;3;GO:0003735
GO:0042651;thylakoid membrane;1371863;1200;GO:0003735
GO:0003055;circadian regulation of heart rate by the suprachiasmatic nucleus;0;2;GO:0045766
GO:0042652;mitochondrial respiratory chain complex I, peripheral segment;1;4;GO:0005553
GO:0003056;regulation of vascular associated smooth muscle contraction;401;10;GO:0050890
GO:0042653;mitochondrial respiratory chain complex I, membrane segment;0;3;GO:0003906
GO:0003057;regulation of the force of heart contraction by chemical signal;234;236;GO:0046364
GO:0042654;ecdysis-triggering hormone receptor activity;11;6;GO:0009061
GO:0003058;hormonal regulation of the force of heart contraction;1;2;GO:0043066
GO:0003059;positive regulation of the force of heart contraction by epinephrine;2;3;GO:0003964
GO:0042656;JUN kinase kinase kinase kinase activity;6;1;GO:0004067
GO:0003049;regulation of systemic arterial blood pressure by capillary fluid shift;0;4;GO:0004073
GO:0030668;merozoite dense granule membrane;0;1;GO:0004721
GO:0030667;secretory granule membrane;5966;1910;GO:0004723
GO:0030669;clathrin-coated endocytic vesicle membrane;12847;1060;GO:0004725
GO:0030660;Golgi-associated vesicle membrane;92307;700;GO:0003954
GO:0030662;coated vesicle membrane;179743;939;GO:0004746
GO:0030661;chitosome membrane;0;3;GO:0043066
GO:0030663;COPI-coated vesicle membrane;65872;765;GO:0043066
GO:0030666;endocytic vesicle membrane;33871;1630;GO:0006749
GO:0030665;clathrin-coated vesicle membrane;51973;737;GO:0009063
GO:0015049;methane monooxygenase activity;1028;8;GO:0004067
GO:0040005;chitin-based cuticle attachment to epithelium;61;7;GO:0009062
GO:0042668;auditory receptor cell fate determination;105;115;GO:0004784
GO:0015048;phthalate dioxygenase reductase activity;0;1;GO:0006022
GO:0040004;collagen and cuticulin-based cuticle attachment to epithelium;0;3;GO:0006022
GO:0042669;regulation of inner ear auditory receptor cell fate specification;4;1;GO:0006732
GO:0015047;NADPH-cytochrome-c2 reductase activity;0;3;GO:0006457
GO:0040003;chitin-based cuticle development;1469;440;GO:0005840
GO:0015046;rubredoxin-NADP+ reductase activity;4;2;GO:0004497
GO:0040002;collagen and cuticulin-based cuticle development;251;24;GO:0005840
GO:0015045;rubredoxin-NAD(P)+ reductase activity;560;0;GO:0006022
GO:0040001;establishment of mitotic spindle localization;6946;633;GO:0004091
GO:0003060;negative regulation of the force of heart contraction by acetylcholine;0;2;GO:0050729
GO:0015044;rubredoxin-NAD+ reductase activity;556;3;GO:0008528
GO:0003061;positive regulation of the force of heart contraction by norepinephrine;2;4;GO:0006096
GO:0015043;leghemoglobin reductase activity;4;2;GO:0050729
GO:0003062;regulation of heart rate by chemical signal;118;34;GO:0006865
GO:0015042;trypanothione-disulfide reductase (NADP) activity;98;2;GO:0003824
GO:0003063;negative regulation of heart rate by acetylcholine;4;5;GO:0009579
GO:0042660;positive regulation of cell fate specification;175;9;GO:0019613
GO:0003064;regulation of heart rate by hormone;2;119;GO:009700
GO:0042661;regulation of mesodermal cell fate specification;628;137;GO:0030528
GO:0003065;positive regulation of heart rate by epinephrine;3;32;GO:0003676
GO:0042662;negative regulation of mesodermal cell fate specification;205;38;GO:0004518
GO:0003066;positive regulation of heart rate by norepinephrine;0;3;GO:0009416
GO:0042663;regulation of endodermal cell fate specification;417;36;GO:0043066
GO:0003067;circadian regulation of systemic arterial blood pressure by hormone;0;2;GO:0043161
GO:0040009;regulation of growth rate;562;357;GO:0010941
GO:0042664;negative regulation of endodermal cell fate specification;225;9;GO:0003723
GO:0003068;regulation of systemic arterial blood pressure by acetylcholine;15;9;GO:0003700
GO:0040008;regulation of growth;67584;4310;GO:0005524
GO:0042665;regulation of ectodermal cell fate specification;150;3;GO:0010468
GO:0003069;acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure;11;2;GO:0015986
GO:0040007;growth;117137;11100;GO:0048608
GO:0042666;negative regulation of ectodermal cell fate specification;57;6;GO:0009060
GO:0042667;auditory receptor cell fate specification;88;5;GO:0007062
GO:0030656;regulation of vitamin metabolic process;753;408;GO:0048608
GO:0030659;cytoplasmic vesicle membrane;618677;2540;GO:0005746
GO:0030658;transport vesicle membrane;113702;961;GO:0005524
GO:0042670;retinal cone cell differentiation;1145;42;GO:0048608
GO:0030651;peptide antibiotic biosynthetic process;7415;2;GO:0015986
GO:0030650;peptide antibiotic metabolic process;7420;4;GO:0043066
GO:0030653;beta-lactam antibiotic metabolic process;46788;6;GO:0048608
GO:0030652;peptide antibiotic catabolic process;5;4;GO:0048405
GO:0030655;beta-lactam antibiotic catabolic process;46725;197;GO:0010468
GO:0015039;NADPH-adrenodoxin reductase activity;4238;10;GO:0003700
GO:0030654;beta-lactam antibiotic biosynthetic process;49;1;GO:0006412
GO:0015016;[heparan sulfate]-glucosamine N-sulfotransferase activity;8328;0;GO:0048471
GO:0040016;embryonic cleavage;494;571;GO:0048193
GO:0042679;compound eye cone cell fate specification;40;3;GO:0006836
GO:0015015;heparan sulfate proteoglycan biosynthetic process, enzymatic modification;319;117;GO:0048193
GO:0040015;negative regulation of multicellular organism growth;752;581;GO:0003779
GO:0015014;heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;527;228;GO:0016569
GO:0040014;regulation of multicellular organism growth;6419;1210;GO:0050817
GO:0015013;heparan sulfate proteoglycan biosynthetic process, linkage to polypeptide;0;3;GO:0010468
GO:0040013;negative regulation of locomotion;20675;683;GO:0046274
GO:0015012;heparan sulfate proteoglycan biosynthetic process;14961;740;GO:0010468
GO:0040012;regulation of locomotion;100681;2800;GO:0009065
GO:0015011;nickel-tetrapyrrole coenzyme metabolic process;0;2;GO:0006790
GO:0040011;locomotion;1069543;7840;GO:0006559
GO:0005691;U6atac snRNP;5124;4;GO:0009065
GO:0015010;tetrahydrocorphin metabolic process;0;7;GO:0048285
GO:0040010;positive regulation of growth rate;247;401;GO:0004497
GO:0005690;U4atac snRNP;1078;6;GO:0048285
GO:0003030;detection of hydrogen ion;0;4;GO:0004721
GO:0005693;U12 snRNP;1067;3;GO:0004073
GO:0042671;retinal cone cell fate determination;77;2;GO:0004723
GO:0003031;detection of carbon dioxide;49;8;GO:0004067
GO:0005692;U11 snRNP;1176;5;GO:0004474
GO:0042672;retinal cone cell fate specification;0;3;GO:0004497
GO:0003032;detection of oxygen;2808;170;GO:0004553
GO:0042673;regulation of retinal cone cell fate specification;0;7;GO:0004497
GO:0003033;detection of hypoxic conditions in blood by aortic body chemoreceptor signaling;0;1;GO:0005576
GO:0005694;chromosome;2782232;12700;GO:0004497
GO:0003034;detection of increased carbon dioxide by aortic body chemoreceptor signaling;0;2;GO:0005576
GO:0005697;telomerase holoenzyme complex;2751;505;GO:0004497
GO:0042675;compound eye cone cell differentiation;185;9;GO:0048193
GO:0003035;detection of increased carbon dioxide by carotid body chemoreceptor signaling;0;2;GO:0005576
GO:0040019;positive regulation of embryonic development;1075;403;GO:0004842
GO:0042676;compound eye cone cell fate commitment;58;8;GO:0010467
GO:0003036;detection of pH by aortic body chemoreceptor signaling;0;1;GO:0048316
GO:0040018;positive regulation of multicellular organism growth;2361;1090;GO:0006790
GO:0003037;detection of pH by carotid body chemoreceptor signaling;0;1;GO:0005743
GO:0040017;positive regulation of locomotion;40076;2420;GO:0048704
GO:0003027;regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling;41;3;GO:0009628
GO:0003028;regulation of systemic arterial blood pressure by aortic body chemoreceptor signaling;0;3;GO:0005743
GO:0005689;U12-type spliceosomal complex;5958;746;GO:0048010
GO:0030645;glucose catabolic process to butyrate;0;3;GO:0009081
GO:0003029;detection of hypoxic conditions in blood by carotid body chemoreceptor signaling;41;7;GO:0009065
GO:0030648;aminoglycoside antibiotic biosynthetic process;66;4;GO:0005576
GO:0030647;aminoglycoside antibiotic metabolic process;406;950;GO:0048704
GO:0030649;aminoglycoside antibiotic catabolic process;12;3;GO:0006073
GO:0042680;compound eye cone cell fate determination;0;4;GO:0048285
GO:0030640;polyketide catabolic process;2;3;GO:0006064
GO:0015009;corrin metabolic process;10922;7;GO:0006064
GO:0030642;intracellular sulfate ion homeostasis;0;0;GO:0048316
GO:0030641;regulation of cellular pH;11804;557;GO:0006091
GO:0030644;intracellular chloride ion homeostasis;371;9;GO:0004049
GO:0030643;intracellular phosphate ion homeostasis;45385;10;GO:0004049
GO:0040027;negative regulation of vulval development;517;8;GO:0009986
GO:0015026;coreceptor activity;7200;1570;GO:0004721
GO:0040026;positive regulation of vulval development;230;5;GO:0005515
GO:0040025;vulval development;1337;12;GO:0004073
GO:0015024;glucuronate-2-sulfatase activity;103;2;GO:0048608
GO:0040024;dauer larval development;960;284;GO:0000786
GO:0040022;feminization of hermaphroditic germ-line;53;4;GO:0048193
GO:0015021;heparin-sulfate lyase activity;163;2;GO:0043005
GO:0040021;hermaphrodite germ-line sex determination;145;3;GO:0048608
GO:0003040;excitation of vasomotor center by aortic body chemoreceptor signaling;0;3;GO:0048608
GO:0015020;glucuronosyltransferase activity;40551;1190;GO:0015979
GO:0040020;regulation of meiotic nuclear division;4341;493;GO:0045766
GO:0003041;excitation of vasomotor center by carotid body chemoreceptor signaling;0;3;GO:0006096
GO:0042682;regulation of compound eye cone cell fate specification;40;8;GO:0006091
GO:0003042;vasoconstriction of artery involved in carotid body chemoreceptor response to lowering of systemic arterial blood pressure;0;2;GO:0006091
GO:0042683;negative regulation of compound eye cone cell fate specification;9;9;GO:0009065
GO:0003043;vasoconstriction of artery involved in aortic body chemoreceptor response to lowering of systemic arterial blood pressure;0;1;GO:0010468
GO:0042684;cardioblast cell fate commitment;145;8;GO:0043403
GO:0003044;regulation of systemic arterial blood pressure mediated by a chemical signal;3786;735;GO:0046686
GO:0042685;cardioblast cell fate specification;93;10;GO:0046686
GO:0003045;regulation of systemic arterial blood pressure by physical factors;0;3;GO:0046686
GO:0042686;regulation of cardioblast cell fate specification;63;7;GO:0046686
GO:0003046;regulation of systemic arterial blood pressure by stress relaxation;0;1;GO:0043407
GO:0003047;regulation of systemic arterial blood pressure by epinephrine;0;1;GO:0051015
GO:0040029;epigenetic regulation of gene expression;42366;702;GO:0048010
GO:0042688;crystal cell differentiation;306;9;GO:0051015
GO:0003048;regulation of systemic arterial blood pressure by norepinephrine;0;2;GO:0043407
GO:0040028;regulation of vulval development;931;7;GO:0005518
GO:0042689;regulation of crystal cell differentiation;156;6;GO:0048167
GO:0003038;detection of reduced oxygen by aortic body chemoreceptor signaling;0;2;GO:0002864
GO:0052005;suppression by symbiont of host ethylene-mediated defense response;0;0;GO:0006081
GO:0003039;detection of reduced oxygen by carotid body chemoreceptor signaling;0;2;GO:0048193
GO:0030634;carbon fixation by acetyl-CoA pathway;0;5;GO:0006099
GO:0052003;symbiont-mediated suppression of defense-related host salicylic acid-mediated signal transduction pathway;3;0;GO:0048193
GO:0030639;polyketide biosynthetic process;31684;32;GO:0008083
GO:0052001;adhesion to host cell via type IV pili;9;0;GO:0043603
GO:0030638;polyketide metabolic process;66367;1200;GO:0045765
GO:0042690;negative regulation of crystal cell differentiation;74;4;GO:0010467
GO:0042691;positive regulation of crystal cell differentiation;82;7;GO:0007186
GO:0042692;muscle cell differentiation;33247;3030;GO:0004474
GO:0030631;pyrrolysine incorporation;12;3;GO:0048169
GO:0052009;symbiont-mediated disruption of host cell wall;1750;2;GO:0005576
GO:0015019;heparan-alpha-glucosaminide N-acetyltransferase activity;107;6;GO:0048165
GO:0015018;galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity;16568;238;GO:0032989
GO:0030632;D-alanine biosynthetic process;39341;9;GO:0050727
GO:0052008;symbiont-mediated disruption of host cellular anatomical entity;152102;0;GO:0050727
GO:0042613;MHC class II protein complex;79129;2170;GO:0050727
GO:0042614;CD70 receptor binding;0;1;GO:0045727
GO:0003090;positive regulation of the force of heart contraction by neuronal epinephrine-norepinephrine;0;2;GO:0032989
GO:0042615;CD154 receptor binding;23;2;GO:0048608
GO:0003091;renal water homeostasis;923;415;GO:0048666
GO:0015079;potassium ion transmembrane transporter activity;539710;1770;GO:0009611
GO:0003092;renal water retention;1;3;GO:0046686
GO:0015078;proton transmembrane transporter activity;7167091;1330;GO:0030599
GO:0042617;paclitaxel biosynthetic process;995;8;GO:0048167
GO:0003093;regulation of glomerular filtration;381;111;GO:0006099
GO:0042618;poly-hydroxybutyrate metabolic process;32568;2;GO:0006099
GO:0003094;glomerular filtration;1478;1830;GO:0010033
GO:0042619;poly-hydroxybutyrate biosynthetic process;32567;20;GO:0006099
GO:0003095;pressure natriuresis;22;85;GO:0046394
GO:0015075;monoatomic ion transmembrane transporter activity;11124096;187;GO:0004497
GO:0003096;renal sodium ion transport;906;44;GO:0032989
GO:0015074;DNA integration;1298247;4970;GO:0004067
GO:0003097;renal water transport;520;109;GO:0004073
GO:0003098;tubuloglomerular feedback;0;3;GO:0006865
GO:0003099;positive regulation of the force of heart contraction by chemical signal;97;8;GO:0009081
GO:0042610;CD8 receptor binding;160;288;GO:0006874
GO:0042611;MHC protein complex;81811;1090;GO:0004725
GO:0042612;MHC class I protein complex;2505;1100;GO:0045765
GO:0042625;ATPase-coupled ion transmembrane transporter activity;259050;797;GO:0009719
GO:0042626;ATPase-coupled transmembrane transporter activity;2493940;1930;GO:0009737
GO:0042627;chylomicron;3408;667;GO:0071346
GO:0015089;high-affinity copper ion transmembrane transporter activity;5;1;GO:0006955
GO:0042628;mating plug formation;70;11;GO:0043066
GO:0042629;mast cell granule;109;495;GO:0043066
GO:0015087;cobalt ion transmembrane transporter activity;50633;310;GO:0043066
GO:0015086;cadmium ion transmembrane transporter activity;1860;78;GO:0071456
GO:0015085;calcium ion transmembrane transporter activity;292017;557;GO:0046347
GO:0015083;aluminum ion transmembrane transporter activity;22;0;GO:0006955
GO:0015081;sodium ion transmembrane transporter activity;365434;798;GO:0006749
GO:0042620;poly(3-hydroxyalkanoate) metabolic process;13;5;GO:0004601
GO:0015080;silver ion transmembrane transporter activity;118;1;GO:0009065
GO:0042621;poly(3-hydroxyalkanoate) biosynthetic process;13;4;GO:0009065
GO:0042622;photoreceptor outer segment membrane;723;449;GO:0006099
GO:0030692;Noc4p-Nop14p complex;267;9;GO:0004497
GO:0030695;GTPase regulator activity;846669;2420;GO:0048608
GO:0030694;bacterial-type flagellum basal body, rod;126433;72;GO:0004073
GO:0030697;S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity;22231;22;GO:0048608
GO:0030696;tRNA (m5U54) methyltransferase activity;34893;2;GO:0006067
GO:0030699;glycine reductase activity;5010;7;GO:0048608
GO:0030698;5,10-methylenetetrahydrofolate-dependent tRNA (m5U54) methyltransferase activity;12543;2;GO:0004449
GO:0042635;positive regulation of hair cycle;91;30;GO:0006950
GO:0042636;negative regulation of hair cycle;53;10;GO:0006979
GO:0042637;catagen;294;9;GO:0009432
GO:0015057;thrombin-activated receptor activity;3867;48;GO:0006541
GO:0042638;exogen;0;8;GO:0046274
GO:0003070;regulation of systemic arterial blood pressure by neurotransmitter;15;9;GO:0010467
GO:0015056;corticotrophin-releasing factor receptor activity;126;23;GO:0042605
GO:0039023;pronephric duct morphogenesis;203;9;GO:0071346
GO:0042639;telogen;0;3;GO:0043066
GO:0003071;renal system process involved in regulation of systemic arterial blood pressure;1028;295;GO:0045727
GO:0015055;secretin receptor activity;75;2;GO:0006779
GO:0039022;pronephric duct development;418;7;GO:0006779
GO:0003072;renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure;248;10;GO:0008033
GO:0015054;gastrin receptor activity;1472;9;GO:0004067
GO:0030691;Noc2p-Noc3p complex;213;9;GO:0004734
GO:0003073;regulation of systemic arterial blood pressure;5759;873;GO:0004497
GO:0030690;Noc1p-Noc2p complex;179;53;GO:0006067
GO:0015052;beta3-adrenergic receptor activity;85;6;GO:0004497
GO:0003075;renal vasodilation of the peripheral vascular system involved in regulation of systemic arterial blood pressure;0;3;GO:0004497
GO:0015050;methane monooxygenase complex;5;1;GO:0006021
GO:0039021;pronephric glomerulus development;551;4;GO:0004721
GO:0039020;pronephric nephron tubule development;526;14;GO:0004721
GO:0042630;behavioral response to water deprivation;0;5;GO:0004721
GO:0042631;cellular response to water deprivation;451;783;GO:0004721
GO:0042632;cholesterol homeostasis;8021;2990;GO:0004721
GO:0042633;hair cycle;6276;1070;GO:0005576
GO:0042634;regulation of hair cycle;1599;637;GO:0006067
GO:0030689;Noc complex;659;105;GO:0004553
GO:0030682;mitigation of host defenses by symbiont;539862;9;GO:0006073
GO:0030681;multimeric ribonuclease P complex;11717;105;GO:0006081
GO:0030684;preribosome;86950;858;GO:0004721
GO:0030686;90S preribosome;16796;813;GO:0004723
GO:0030685;nucleolar preribosome;9;10;GO:0046395
GO:0039019;pronephric nephron development;1160;60;GO:0046395
GO:0030688;preribosome, small subunit precursor;9131;313;GO:0004067
GO:0030687;preribosome, large subunit precursor;11889;745;GO:0006073
GO:0039016;cell-cell signaling involved in pronephros development;0;1;GO:0004721
GO:0042646;plastid nucleoid;2018;32;GO:0004466
GO:0039015;cell proliferation involved in pronephros development;1;3;GO:0048193
GO:0042647;proplastid nucleoid;0;1;GO:0008026
GO:0015069;scyllo-inosamine-4-phosphate amidinotransferase activity;126;2;GO:0006810
GO:0039018;nephrostome development;1;2;GO:0005576
GO:0042648;chloroplast chromosome;0;3;GO:0042981
GO:0015068;glycine amidinotransferase activity;2049;137;GO:0048193
GO:0039017;pattern specification involved in pronephros development;139;8;GO:0048193
GO:0042649;prothylakoid;0;1;GO:0006099
GO:0003081;regulation of systemic arterial blood pressure by renin-angiotensin;2371;653;GO:0004553
GO:0015067;amidinotransferase activity;6105;24;GO:0004784
GO:0039012;pronephric sinus development;0;1;GO:0006734
GO:0015066;alpha-amylase inhibitor activity;1466;231;GO:0006790
GO:0039011;pronephric proximal tubule morphogenesis;2;3;GO:0004721
GO:0003083;negative regulation of renal output by angiotensin;2;5;GO:0004721
GO:0030680;dimeric ribonuclease P complex;73802;2;GO:0046394
GO:0039014;cell differentiation involved in pronephros development;157;3;GO:0048010
GO:0003084;positive regulation of systemic arterial blood pressure;260;698;GO:0048704
GO:0039013;pronephric distal tubule morphogenesis;4;2;GO:0048608
GO:0003085;negative regulation of systemic arterial blood pressure;779;538;GO:0048608
GO:0003086;regulation of systemic arterial blood pressure by local renal renin-angiotensin;0;3;GO:0045765
GO:0003087;positive regulation of the force of heart contraction by neuronal epinephrine;0;2;GO:0048608
GO:0039010;specification of pronephric distal tubule identity;2;2;GO:0045765
GO:0042640;anagen;203;187;GO:0048608
GO:0003088;positive regulation of the force of heart contraction by circulating epinephrine;0;2;GO:0045765
GO:0042641;actomyosin;4038;903;GO:0045766
GO:0003089;positive regulation of the force of heart contraction by circulating epinephrine-norepinephrine;0;2;GO:0048010
GO:0042642;actomyosin, myosin complex part;3;5;GO:0010033
GO:0042644;chloroplast nucleoid;1788;284;GO:0045765
GO:0042645;mitochondrial nucleoid;18262;1410;GO:0045765
GO:0030679;cyanelle ribonuclease P complex;0;2;GO:0048608
GO:0030678;mitochondrial ribonuclease P complex;239;177;GO:0045944
GO:0030671;clathrin-coated phagocytic vesicle membrane;0;3;GO:0043066
GO:0030670;phagocytic vesicle membrane;20809;1300;GO:0043066
GO:0030673;axolemma;319;1140;GO:0010033
GO:0030672;synaptic vesicle membrane;16187;1900;GO:0043066
GO:0039009;rectal diverticulum development;0;1;GO:0046649
GO:0030674;protein-macromolecule adaptor activity;123841;544;GO:0006836
GO:0039008;pronephric nephron tubule morphogenesis;27;10;GO:0046649
GO:0030677;ribonuclease P complex;115349;91;GO:0046330
GO:0140917;zinc ion import into mitochondrion;52;1;GO:0006066
GO:0140918;centrosomal core;3;1;GO:0046274
GO:0140919;thermomorphogenesis;93;3;GO:0046394
GO:0140913;viral release via disruption of host peptidoglycan cell wall;0;0;GO:0046274
GO:0140914;zinc ion import into secretory vesicle;6;0;GO:0005524
GO:0140915;zinc ion import into zymogen granule;4;0;GO:0005524
GO:0140916;zinc ion import into lysosome;54;0;GO:0006749
GO:0140910;iRhom2/ADAM17 sheddase complex;0;0;GO:0048285
GO:0140911;pore-forming activity;23134;235;GO:0046356
GO:0140912;membrane destabilizing activity;141;5;GO:0006749
GO:0140906;halogenase activity;31627;0;GO:0048285
GO:0140907;flavin-dependent halogenase activity;28218;1;GO:0046395
GO:0140908;histone H3K122 acetyltransferase activity;64;3;GO:0007601
GO:0140909;kinetoplast DNA replication;0;2;GO:0046395
GO:0140902;L-glutamine:sodium symporter activity;124;2;GO:0006032
GO:0140903;histone H3R26 methyltransferase activity;21;0;GO:0030522
GO:0140904;cytoophidium organization;0;2;GO:0048193
GO:0140905;haloperoxidase activity;3409;0;GO:0010467
GO:0140900;chloride:bicarbonate antiporter activity;882;10;GO:0048285
GO:0140901;L-asparagine:sodium symporter activity;66;3;GO:0006032
GO:0140939;histone H4 methyltransferase activity;11458;4;GO:0043066
GO:0140935;histone H2B conserved C-terminal lysine deubiquitinase activity;1;0;GO:0050727
GO:0140936;histone H2B deubiquitinase activity;105;0;GO:0050730
GO:0140937;histone H4K12 deacetylase activity;47;0;GO:0007067
GO:0140938;histone H3 methyltransferase activity;77096;9;GO:0043066
GO:0140931;neutral L-amino acid:sodium:chloride symporter activity;54;2;GO:0050877
GO:0140932;5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase activity;1335;0;GO:0009410
GO:0140933;5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity;3575;0;GO:0006029
GO:0140934;histone deubiquitinase activity;367;0;GO:0007600
GO:0140930;fructose:sodium symporter activity;57;1;GO:0048661
GO:0140928;inhibition of non-skeletal tissue mineralization;247;7;GO:0006865
GO:0140929;mannose:sodium symporter activity;57;1;GO:0004497
GO:0140924;L-kynurenine transmembrane transport;132;1;GO:0004867
GO:0140925;L-phenylalanine import across plasma membrane;0;0;GO:0006066
GO:0140926;L-kynurenine transmembrane transporter activity;66;4;GO:0006030
GO:0140927;cyclic-di-GMP transmembrane transporter activity;1;2;GO:0009065
GO:0140920;regulation of thermomorphogenesis;93;1;GO:0004722
GO:0140921;negative regulation of thermomorphogenesis;0;1;GO:0009813
GO:0140922;positive regulation of thermomorphogenesis;93;1;GO:0004497
GO:0140923;magnetosome assembly;8;0;GO:0009593
GO:0030594;neurotransmitter receptor activity;99677;1210;GO:0009593
GO:0030593;neutrophil chemotaxis;4363;3760;GO:0010401
GO:0030596;alpha-L-rhamnosidase activity;11895;4;GO:0010467
GO:0030595;leukocyte chemotaxis;16114;2570;GO:0010401
GO:0030598;rRNA N-glycosylase activity;5663;124;GO:0006559
GO:0030597;RNA glycosylase activity;5700;5;GO:0016567
GO:0030599;pectinesterase activity;67417;1830;GO:0006869
GO:0042572;retinol metabolic process;10767;2030;GO:0009593
GO:0042573;retinoic acid metabolic process;2019;749;GO:0045944
GO:0042574;retinal metabolic process;1096;699;GO:0008544
GO:0042575;DNA polymerase complex;200340;309;GO:0006879
GO:0042577;lipid phosphatase activity;18951;376;GO:0048193
GO:0042578;phosphoric ester hydrolase activity;3887388;1890;GO:0004091
GO:0042579;microbody;279780;1270;GO:0010467
GO:0140958;target-directed miRNA degradation;70;4;GO:0043161
GO:0140953;histone H3K27 monomethyltransferase activity;7;2;GO:0004497
GO:0042580;mannosome;0;1;GO:0045944
GO:0140954;histone H3K36 dimethyltransferase activity;100;4;GO:0004842
GO:0042581;specific granule;887;758;GO:0048169
GO:0140955;histone H3K36 trimethyltransferase activity;1259;3;GO:0048169
GO:0042582;azurophil granule;780;494;GO:0016740
GO:0140956;histone H3K79 trimethyltransferase activity;5075;3;GO:0004601
GO:0140950;histone H2A deubiquitinase activity;262;2;GO:0008021
GO:0140951;histone H3K27 trimethyltransferase activity;3596;3;GO:0004073
GO:0140952;histone H3K27 dimethyltransferase activity;5;2;GO:0006631
GO:0042583;chromaffin granule;2373;72;GO:0004497
GO:0042584;chromaffin granule membrane;899;227;GO:0004721
GO:0042585;germinal vesicle;277;62;GO:0004721
GO:0042586;peptide deformylase activity;305123;838;GO:0045727
GO:0042587;glycogen granule;125;130;GO:0010467
GO:0042588;zymogen granule;766;267;GO:0045727
GO:0042589;zymogen granule membrane;278;350;GO:0009211
GO:0140946;histone H3K4 dimethyltransferase activity;70;2;GO:0045766
GO:0140947;histone H3K9me2 methyltransferase activity;34;3;GO:0009266
GO:0140948;histone H3K9 monomethyltransferase activity;20;3;GO:0045727
GO:0140949;histone H3K9 trimethyltransferase activity;1452;3;GO:0006021
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;161;1580;GO:0045727
GO:0140942;histone H3K9 dimethyltransferase activity;4;2;GO:0009266
GO:0140943;histone H4K20 trimethyltransferase activity;706;2;GO:0045727
GO:0042592;homeostatic process;868499;6710;GO:0048407
GO:0140944;histone H4K20 monomethyltransferase activity;2063;3;GO:0048193
GO:0042593;glucose homeostasis;34733;2980;GO:0006869
GO:0140945;histone H3K4 monomethyltransferase activity;1787;6;GO:0006021
GO:0140940;histone H2A methyltransferase activity;308;2;GO:0003735
GO:0140941;histone H4K20me methyltransferase activity;1232;3;GO:0009063
GO:0042594;response to starvation;111134;2730;GO:0045766
GO:0042595;behavioral response to starvation;171;86;GO:0048608
GO:0042596;fear response;1936;823;GO:0004734
GO:0042597;periplasmic space;1920736;2020;GO:0006066
GO:0042599;lamellar body;771;248;GO:0004784
GO:0140979;intracellular nucleotide homeostasis;1;0;GO:0004497
GO:0140975;disruption of cellular anatomical structure in another organism;162347;2;GO:0006631
GO:0140976;defense response against perturbation of plasma membrane integrity;0;2;GO:0004073
GO:0140977;cellular detoxification of acetone;3;1;GO:0006631
GO:0140978;mitochondrial large ribosomal subunit binding;117;1;GO:0008610
GO:0140971;regulation of AIM2 inflammasome complex assembly;82;0;GO:0048193
GO:0140972;negative regulation of AIM2 inflammasome complex assembly;63;1;GO:0048407
GO:0140973;positive regulation of AIM2 inflammasome complex assembly;19;2;GO:0030529
GO:0140974;cellular detoxification of sulfide;0;1;GO:0010468
GO:0140970;AIM2 inflammasome complex assembly;187;0;GO:0030528
GO:0140968;polyspecific organic cation:proton antiporter activity;161;2;GO:0008565
GO:0140969;determination of lung left/right asymmetry;0;1;GO:0006865
GO:0140964;intracellular auxin homeostasis;111;0;GO:0048285
GO:0140965;secondary piRNA processing;66;1;GO:0006879
GO:0140966;piRNA-mediated heterochromatin formation;189;0;GO:0048285
GO:0140967;manganese import into cell;0;0;GO:0006865
GO:0140961;cellular detoxification of metal ion;365;2;GO:0048169
GO:0140962;multicellular organismal-level chemical homeostasis;4334;5;GO:0048169
GO:0140997;histone H4 kinase activity;0;0;GO:0048608
GO:0140998;histone H2B kinase activity;152;0;GO:0006412
GO:0140999;histone H3K4 trimethyltransferase activity;4810;6;GO:0048608
GO:0140993;histone modifying activity;380564;8;GO:0006414
GO:0140994;RNA polymerase II CTD heptapeptide repeat modifying activity;33680;0;GO:0007062
GO:0140995;histone H2A kinase activity;147;1;GO:0048706
GO:0140996;histone H3 kinase activity;1194;0;GO:0048608
GO:0140990;primary piRNA processing;61;2;GO:0005840
GO:0140991;piRNA-mediated gene silencing by mRNA destabilization;3;1;GO:0005515
GO:0140986;G protein-coupled chemorepellent receptor signaling pathway;66;2;GO:0005730
GO:0140987;ATP:inorganic phosphate antiporter activity;155;5;GO:0048285
GO:0140988;ADP:inorganic phosphate antiporter activity;108;3;GO:0043161
GO:0140989;7-deoxyloganate 7-hydroxylase activity;2;3;GO:0005576
GO:0140982;detoxification of aluminum ion;25;0;GO:0005576
GO:0140983;calcium:manganese antiporter activity;56;3;GO:0005766
GO:0140984;histone H4K12 methyltransferase activity;48;1;GO:0006950
GO:0140985;G protein-coupled chemorepellent receptor activity;4;1;GO:0005737
GO:0140980;intracellular nucleoside homeostasis;0;0;GO:0004730
GO:0140981;medium-chain fatty acid omega-hydroxylase activity;10;3;GO:0048666
GO:0005600;collagen type XIII trimer;2;5;GO:0006836
GO:0039522;suppression by virus of host mRNA export from nucleus;6872;6;GO:0007088
GO:0015554;tartrate transmembrane transporter activity;0;0;GO:0006073
GO:0039521;suppression by virus of host autophagy;153848;69;GO:0006869
GO:0015553;xanthosine transmembrane transporter activity;1;3;GO:0009060
GO:0039524;suppression by virus of host mRNA processing;115515;4;GO:0006836
GO:0015552;propionate transmembrane transporter activity;56;3;GO:0007049
GO:0039523;suppression by virus of host mRNA transcription via inhibition of RNA polymerase II activity;375937;7;GO:0008544
GO:0015551;3-hydroxyphenyl propanoate transmembrane transporter activity;0;2;GO:0009060
GO:0015550;galacturonate transmembrane transporter activity;0;2;GO:0006836
GO:0039520;induction by virus of host autophagy;23285;17;GO:0006890
GO:0039519;modulation by virus of host autophagy;177136;8;GO:0008047
GO:0015548;organomercurial transmembrane transporter activity;0;0;GO:0005746
GO:0039514;disruption by virus of host JAK-STAT cascade;29839;0;GO:0006890
GO:0015546;sulfathiazole transmembrane transporter activity;1;1;GO:0006836
GO:0015545;bicyclomycin transmembrane transporter activity;0;2;GO:0008023
GO:0039516;modulation by virus of host catalytic activity;0;5;GO:0008023
GO:0015565;threonine efflux transmembrane transporter activity;873;4;GO:0006836
GO:0039513;suppression by virus of host catalytic activity;0;5;GO:0009060
GO:0015562;efflux transmembrane transporter activity;279728;871;GO:0006836
GO:0015561;rhamnose:proton symporter activity;0;1;GO:0006836
GO:0039507;suppression by virus of host molecular function;0;6;GO:0006836
GO:0039504;suppression by virus of host adaptive immune response;134346;8;GO:0008544
GO:0015558;secondary active p-aminobenzoyl-glutamate transmembrane transporter activity;9225;6;GO:0000786
GO:0039503;suppression by virus of host innate immune response;536248;10;GO:0005840
GO:0039506;modulation by virus of host molecular function;2;7;GO:0072335
GO:0015556;C4-dicarboxylate transmembrane transporter activity;20227;324;GO:0070062
GO:0039505;suppression by virus of host antigen processing and presentation of peptide antigen via MHC class II;44390;4;GO:0006464
GO:0015533;shikimate:proton symporter activity;0;0;GO:0005833
GO:0015532;alpha-ketoglutarate:proton symporter activity;0;0;GO:0008092
GO:0015531;citrate:proton symporter activity;1;1;GO:0005737
GO:0039502;suppression by virus of host type I interferon-mediated signaling pathway;149574;130;GO:0008565
GO:0015530;shikimate transmembrane transporter activity;1;2;GO:0006414
GO:0039501;suppression by virus of host type I interferon production;25;5;GO:0005525
GO:0052519;positive regulation of nutrient release by symbiont;0;0;GO:0006836
GO:0015529;raffinose:proton symporter activity;1;1;GO:0007062
GO:0015528;lactose:proton symporter activity;14;3;GO:0006836
GO:0015527;glycerol-phosphate:inorganic phosphate antiporter activity;1;0;GO:0004930
GO:0015526;hexose-phosphate:inorganic phosphate antiporter activity;2789;32;GO:0006465
GO:0015544;phenyl propionate uniporter activity;0;0;GO:0005789
GO:0015541;secondary active cyanate transmembrane transporter activity;0;0;GO:0006468
GO:0015540;3-hydroxyphenyl propionate:proton symporter activity;0;0;GO:0045944
GO:0015539;hexuronate:monoatomic cation symporter activity;0;0;GO:0008544
GO:0015538;sialic acid:proton symporter activity;918;10;GO:0006469
GO:0015537;xanthosine:proton symporter activity;0;0;GO:0003735
GO:0015535;fucose:proton symporter activity;6523;9;GO:0004067
GO:0015599;ATPase-coupled L-glutamine transmembrane transporter activity;3;4;GO:0005576
GO:0039562;disruption by virus of host JAK-STAT cascade via inhibition of STAT activity;21227;0;GO:0004073
GO:0015594;ABC-type putrescine transporter activity;14077;5;GO:0005840
GO:0015593;allose transmembrane transporter activity;1;0;GO:0043161
GO:0039564;disruption by virus of host JAK-STAT cascade via inhibition of STAT2 activity;14001;5;GO:0005576
GO:0015592;methylgalactoside transmembrane transporter activity;4;1;GO:0045944
GO:0039563;disruption by virus of host JAK-STAT cascade via inhibition of STAT1 activity;7225;2;GO:0004930
GO:0015591;D-ribose transmembrane transporter activity;144;8;GO:0050900
GO:0039560;disruption by virus of host JAK-STAT cascade via inhibition of host IRF9 activity;5;1;GO:0005737
GO:0039554;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of host MDA-5 activity;3300;3;GO:0050900
GO:0039557;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF7 activity;6626;6;GO:0004518
GO:0039556;MDA-5 binding;0;1;GO:0050900
GO:0039552;RIG-I binding;196;28;GO:0010717
GO:0039548;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF3 activity;12065;7;GO:0050900
GO:0015577;galactitol transmembrane transporter activity;6770;4;GO:0050900
GO:0015576;sorbitol transmembrane transporter activity;6;10;GO:0042110
GO:0015575;mannitol transmembrane transporter activity;6358;8;GO:0032727
GO:0015574;trehalose transmembrane transporter activity;4621;87;GO:0042110
GO:0039545;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of MAVS activity;35617;7;GO:0042110
GO:0015573;beta-glucoside transmembrane transporter activity;39;23;GO:0050821
GO:0039540;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of host RIG-I activity;58976;2;GO:0046649
GO:0015572;N-acetylglucosamine transmembrane transporter activity;6250;28;GO:0050900
GO:0015571;N-acetylgalactosamine transmembrane transporter activity;0;2;GO:0048608
GO:0039537;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway;119614;1;GO:0048193
GO:0039536;negative regulation of RIG-I signaling pathway;1621;130;GO:0048308
GO:0015568;L-idonate transmembrane transporter activity;3;1;GO:0050900
GO:0015567;alkane transmembrane transporter activity;0;2;GO:0042110
GO:0039533;regulation of MDA-5 signaling pathway;407;229;GO:0048193
GO:0039532;negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway;3201;34;GO:0050900
GO:0039535;regulation of RIG-I signaling pathway;2137;264;GO:0050900
GO:0039534;negative regulation of MDA-5 signaling pathway;233;39;GO:0048308
GO:0039531;regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway;7084;9;GO:0048011
GO:0039530;MDA-5 signaling pathway;526;60;GO:0042110
GO:0039529;RIG-I signaling pathway;2449;152;GO:0042110
GO:0039526;perturbation by virus of host apoptosis;5813;2;GO:0002227
GO:0039525;modulation by virus of host chromatin organization;18774;5;GO:0005026
GO:0015578;mannose transmembrane transporter activity;86;42;GO:0008528
GO:0039527;disruption by virus of host TRAF-mediated signal transduction;4712;3;GO:0008544
GO:1904331;regulation of error-prone translesion synthesis;30;0;GO:0008565
GO:1904330;positive regulation of myofibroblast contraction;12;2;GO:0005740
GO:1904335;regulation of ductus arteriosus closure;2;1;GO:0048285
GO:1904334;heme import across plasma membrane;10;3;GO:0007165
GO:1904333;positive regulation of error-prone translesion synthesis;26;2;GO:0005524
GO:1904332;negative regulation of error-prone translesion synthesis;4;1;GO:0048608
GO:0052580;(+)-pulegone reductase, (-)-menthone as substrate, activity;3;1;GO:0048304
GO:1904339;negative regulation of dopaminergic neuron differentiation;97;29;GO:0050900
GO:0052581;(-)-isopiperitenone reductase activity;3;2;GO:0050900
GO:1904338;regulation of dopaminergic neuron differentiation;332;56;GO:0048193
GO:1904337;positive regulation of ductus arteriosus closure;0;0;GO:0048193
GO:1904336;negative regulation of ductus arteriosus closure;2;2;GO:0010468
GO:1990250;transcription-coupled nucleotide-excision repair, DNA damage recognition complex;0;0;GO:0010468
GO:1990251;nuclear exosome focus;151;7;GO:0048304
GO:1990252;Syp1 complex;4;0;GO:0030900
GO:1990253;cellular response to leucine starvation;749;300;GO:0048304
GO:0052577;germacrene-D synthase activity;67;3;GO:0048002
GO:1990243;atf1-pcr1 complex;9;4;GO:0048002
GO:0052578;alpha-farnesene synthase activity;11;1;GO:0048002
GO:1990244;histone H2AT120 kinase activity;75;1;GO:0048704
GO:0052575;carbohydrate localization;81;2;GO:0048010
GO:0052576;carbohydrate storage;81;7;GO:0048010
GO:1990246;uniplex complex;3016;354;GO:0048010
GO:0052573;UDP-D-galactose metabolic process;79;3;GO:0048193
GO:1990247;N6-methyladenosine-containing RNA reader activity;10473;4;GO:0048193
GO:0052574;UDP-galactose biosynthetic process;17;0;GO:0048704
GO:1990249;nucleotide-excision repair, DNA damage recognition complex;0;0;GO:0048608
GO:0052572;response to host immune response;674353;1700;GO:0050729
GO:0052579;(+)-pulegone reductase, (+)-isomenthone as substrate, activity;3;0;GO:0048608
GO:1904342;negative regulation of colon smooth muscle contraction;0;0;GO:0050727
GO:1904341;regulation of colon smooth muscle contraction;11;0;GO:0050727
GO:1904340;positive regulation of dopaminergic neuron differentiation;80;4;GO:0050729
GO:0039595;induction by virus of catabolism of host mRNA;20470;8;GO:0050729
GO:1904346;positive regulation of gastric mucosal blood circulation;11;5;GO:0050900
GO:0039594;endoribonuclease activity involved in viral induction of host mRNA catabolic process;0;1;GO:0050729
GO:1904345;negative regulation of gastric mucosal blood circulation;0;0;GO:0050729
GO:1904344;regulation of gastric mucosal blood circulation;11;7;GO:0050729
GO:1904343;positive regulation of colon smooth muscle contraction;11;6;GO:0050729
GO:0052591;sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity;27296;65;GO:0046649
GO:0052592;oxidoreductase activity, acting on CH or CH2 groups, with an iron-sulfur protein as acceptor;79653;5;GO:0050729
GO:1904349;positive regulation of small intestine smooth muscle contraction;25;7;GO:0045727
GO:0039593;peturbation by virus of host exit from mitosis;249;1;GO:0045727
GO:1904348;negative regulation of small intestine smooth muscle contraction;4;3;GO:0046649
GO:0039592;perturbation by virus of G2/M transition of host mitotic cell cycle;36164;6;GO:0048011
GO:0052590;sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity;54594;35;GO:0046649
GO:1904347;regulation of small intestine smooth muscle contraction;29;5;GO:0045727
GO:1990261;pre-mRNA catabolic process;91;184;GO:0048011
GO:1990262;anti-Mullerian hormone signaling pathway;145;8;GO:0045727
GO:1990263;spore wall assembly MAPK cascade;0;2;GO:0005829
GO:1990264;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity;12;8;GO:0005576
GO:0052588;diacetyl reductase ((S)-acetoin forming) activity;3608;0;GO:0008021
GO:1990254;keratin filament binding;274;66;GO:0008021
GO:0052589;malate dehydrogenase (menaquinone) activity;11637;3;GO:0008021
GO:1990255;subsynaptic reticulum organization;59;1;GO:0007067
GO:0052586;oxidoreductase activity, acting on other nitrogenous compounds as donors, with a quinone or similar compound as acceptor;0;1;GO:0006260
GO:1990256;signal clustering;10;1;GO:0005524
GO:0052587;diacetyl reductase ((R)-acetoin forming) activity;204;0;GO:0046649
GO:1990257;piccolo-bassoon transport vesicle;4;6;GO:0005524
GO:1990258;histone glutamine methylation;0;81;GO:0045944
GO:0052585;oxidoreductase activity, acting on the CH-NH2 group of donors, with a quinone or similar compound as acceptor;0;2;GO:0048706
GO:1990259;histone H2AQ104 methyltransferase activity;246;2;GO:0048608
GO:0052582;(+)-menthofuran synthase activity;6;3;GO:0048608
GO:0039588;suppression by virus of host antigen processing and presentation;89142;3;GO:0048706
GO:1904353;regulation of telomere capping;1361;18;GO:0005840
GO:0039587;suppression by virus of host tetherin activity;28219;9;GO:0005819
GO:1904352;positive regulation of protein catabolic process in the vacuole;215;76;GO:0003724
GO:1904351;negative regulation of protein catabolic process in the vacuole;133;7;GO:0006026
GO:1904350;regulation of protein catabolic process in the vacuole;521;6;GO:0030518
GO:1904357;negative regulation of telomere maintenance via telomere lengthening;1657;130;GO:0006281
GO:1904356;regulation of telomere maintenance via telomere lengthening;3859;39;GO:0048010
GO:1904355;positive regulation of telomere capping;921;113;GO:0048608
GO:0039585;PKR-mediated signaling;0;1;GO:0003690
GO:1904354;negative regulation of telomere capping;439;250;GO:0009060
GO:0039580;suppression by virus of host PKR signaling;68051;3;GO:0030518
GO:1904359;regulation of spore germination;12;1;GO:0030518
GO:1990270;platelet-derived growth factor receptor-ligand complex;0;1;GO:0048010
GO:1904358;positive regulation of telomere maintenance via telomere lengthening;1826;73;GO:0030518
GO:1990272;anti-Mullerian hormone receptor activity;50;2;GO:0006826
GO:1990273;snRNA capping;2;0;GO:0008544
GO:1990274;mitotic actomyosin contractile ring disassembly;76;3;GO:0006826
GO:1990275;preribosome binding;615;7;GO:0006869
GO:0052599;methylputrescine oxidase activity;7;4;GO:0008565
GO:1990265;platelet-derived growth factor complex;100;2;GO:0006826
GO:1990266;neutrophil migration;5791;1400;GO:0006826
GO:0052597;diamine oxidase activity;543;8;GO:0005576
GO:1990267;response to transition metal nanoparticle;12;341;GO:0003677
GO:0052598;histamine oxidase activity;12;5;GO:0003700
GO:1990268;response to gold nanoparticle;10;97;GO:0004721
GO:0052595;aliphatic amine oxidase activity;20348;95;GO:0009065
GO:1990269;RNA polymerase II C-terminal domain phosphoserine binding;504;240;GO:0004497
GO:0052596;phenethylamine:oxygen oxidoreductase (deaminating) activity;4838;130;GO:0006032
GO:0052593;tryptamine:oxygen oxidoreductase (deaminating) activity;4677;23;GO:0048193
GO:0052594;aminoacetone:oxygen oxidoreductase(deaminating) activity;4674;86;GO:0005764
GO:1904364;positive regulation of calcitonin secretion;2;1;GO:0048193
GO:0039576;disruption by virus of host JAK-STAT cascade via inhibition of JAK1 activity;583;1;GO:0010467
GO:1904363;negative regulation of calcitonin secretion;0;0;GO:0048193
GO:0039579;suppression by virus of host ISG15-protein conjugation;14227;2;GO:0004553
GO:1904362;regulation of calcitonin secretion;2;1;GO:0006559
GO:1904361;positive regulation of spore germination;0;0;GO:0050921
GO:0039573;suppression by virus of host complement activation;591;5;GO:0010467
GO:1904368;regulation of sclerenchyma cell differentiation;4;1;GO:0050921
GO:1904367;positive regulation of chemokinesis;2;1;GO:0010467
GO:1904366;negative regulation of chemokinesis;0;0;GO:0005525
GO:0039574;disruption by virus of host JAK-STAT cascade via inhibition of host TYK2 activity;8023;2;GO:0006464
GO:1904365;regulation of chemokinesis;2;1;GO:0010467
GO:1990280;RNA localization to chromatin;70;10;GO:0006029
GO:1990281;efflux pump complex;216;10;GO:0006464
GO:1904369;positive regulation of sclerenchyma cell differentiation;4;2;GO:0010467
GO:1990276;RNA 5'-methyltransferase activity;56;0;GO:0006790
GO:1990277;parasexual reproduction with cellular fusion;10;1;GO:0006559
GO:1904360;negative regulation of spore germination;3;0;GO:0000786
GO:1990294;peptidyl-threonine trans-autophosphorylation;0;2;GO:0006793
GO:1990295;post-anaphase microtubule array;21;3;GO:0004725
GO:1990297;renal amino acid absorption;53;1;GO:0006796
GO:1904302;negative regulation of maternal process involved in parturition;0;1;GO:0006836
GO:1904301;regulation of maternal process involved in parturition;4;7;GO:0006583
GO:1904300;positive regulation of transcytosis;16;48;GO:0000976
GO:1904306;positive regulation of gastro-intestinal system smooth muscle contraction;130;5;GO:0004930
GO:1904305;negative regulation of gastro-intestinal system smooth muscle contraction;4;3;GO:0006351
GO:1904304;regulation of gastro-intestinal system smooth muscle contraction;134;4;GO:0006555
GO:1904303;positive regulation of maternal process involved in parturition;4;7;GO:0000398
GO:1904309;response to cordycepin;1;0;GO:0004872
GO:1904308;cellular response to desipramine;1;1;GO:0045944
GO:1904307;response to desipramine;3;1;GO:0006796
GO:0052544;defense response by callose deposition in cell wall;118;169;GO:0000976
GO:1990298;bub1-bub3 complex;181;10;GO:0005576
GO:0052545;callose localization;394;33;GO:0045944
GO:1990299;Bub1-Bub3 complex localization to kinetochore;8;0;GO:0006749
GO:0052542;defense response by callose deposition;259;198;GO:0000398
GO:0052543;callose deposition in cell wall;218;55;GO:0005515
GO:0052541;plant-type cell wall cellulose metabolic process;540;9;GO:0000976
GO:0052548;regulation of endopeptidase activity;1237;1200;GO:0007267
GO:0052546;cell wall pectin metabolic process;573;9;GO:0008033
GO:0052547;regulation of peptidase activity;1365;1380;GO:0007186
GO:1904313;response to methamphetamine hydrochloride;6;5;GO:0045595
GO:1904312;cellular response to gold(3+);1;0;GO:0008033
GO:1904311;response to gold(3+);1;1;GO:0005525
GO:1904310;cellular response to cordycepin;1;1;GO:0045595
GO:1904317;cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine;3;6;GO:0004067
GO:1904316;response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine;6;9;GO:0008033
GO:1904315;transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential;29259;113;GO:0004872
GO:1904314;cellular response to methamphetamine hydrochloride;1;0;GO:0045595
GO:1904319;negative regulation of smooth muscle contraction involved in micturition;0;0;GO:0006796
GO:1904318;regulation of smooth muscle contraction involved in micturition;6;0;GO:0006796
GO:0052553;perturbation of host immune response;671400;2;GO:0046649
GO:0052559;induction by symbiont of host immune response;31;2;GO:0008380
GO:1904320;positive regulation of smooth muscle contraction involved in micturition;6;1;GO:0005576
GO:1904324;negative regulation of inhibitory G protein-coupled receptor phosphorylation;0;2;GO:0048706
GO:1904323;regulation of inhibitory G protein-coupled receptor phosphorylation;64;2;GO:0007030
GO:1904322;cellular response to forskolin;711;144;GO:0006914
GO:1904321;response to forskolin;713;332;GO:0003700
GO:1904328;regulation of myofibroblast contraction;35;9;GO:0004553
GO:1904327;protein localization to cytosolic proteasome complex;43;79;GO:0048731
GO:1904326;negative regulation of circadian sleep/wake cycle, wakefulness;2;2;GO:0003964
GO:1904325;positive regulation of inhibitory G protein-coupled receptor phosphorylation;64;6;GO:0004497
GO:1904329;negative regulation of myofibroblast contraction;0;1;GO:0003929
GO:0052562;suppression by symbiont of host immune response;670697;0;GO:0043066
GO:1904298;regulation of transcytosis;16;8;GO:0005764
GO:1904297;positive regulation of osmolarity-sensing cation channel activity;0;1;GO:0006099
GO:1904296;negative regulation of osmolarity-sensing cation channel activity;0;1;GO:0043066
GO:1904295;regulation of osmolarity-sensing cation channel activity;0;0;GO:0005524
GO:1904299;negative regulation of transcytosis;0;1;GO:0006099
GO:1904290;negative regulation of mitotic DNA damage checkpoint;77;3;GO:0048704
GO:1904294;positive regulation of ERAD pathway;4150;127;GO:0048706
GO:1904293;negative regulation of ERAD pathway;365;48;GO:0043066
GO:1904292;regulation of ERAD pathway;4690;84;GO:0048193
GO:1904291;positive regulation of mitotic DNA damage checkpoint;63;1;GO:0048706
GO:1904254;regulation of iron ion transmembrane transporter activity;1;0;GO:0005576
GO:1904253;positive regulation of bile acid metabolic process;180;17;GO:0009628
GO:1904252;negative regulation of bile acid metabolic process;192;8;GO:0006096
GO:1904251;regulation of bile acid metabolic process;705;32;GO:0048010
GO:1904258;nuclear dicing body assembly;0;0;GO:0005929
GO:1904257;zinc ion import into Golgi lumen;351;2;GO:0006513
GO:1904256;positive regulation of iron ion transmembrane transporter activity;0;1;GO:0008021
GO:1904255;negative regulation of iron ion transmembrane transporter activity;1;1;GO:0006559
GO:1904259;regulation of basement membrane assembly involved in embryonic body morphogenesis;185;9;GO:0006796
GO:1990200;SsuD-SsuE complex;0;1;GO:0005576
GO:1990201;alkanesulfonate monooxygenase complex;2;0;GO:0006559
GO:1990202;FMN reductase complex;2;0;GO:0005554
GO:1990203;MdtBC Complex;0;0;GO:0006559
GO:1990204;oxidoreductase complex;593393;1180;GO:0008033
GO:1990205;taurine dioxygenase complex;2;0;GO:0008021
GO:1990206;jasmonyl-Ile conjugate hydrolase activity;36;1;GO:0000976
GO:1990207;EmrE multidrug transporter complex;1;0;GO:0044421
GO:1904250;positive regulation of age-related resistance;4;1;GO:0006096
GO:1904263;positive regulation of TORC1 signaling;3750;596;GO:0005096
GO:1904262;negative regulation of TORC1 signaling;7578;647;GO:0002449
GO:1904269;cell leading edge cell cortex;17;1;GO:0006559
GO:1904268;positive regulation of Schwann cell chemotaxis;7;1;GO:0008033
GO:1904267;negative regulation of Schwann cell chemotaxis;0;0;GO:0050840
GO:1904266;regulation of Schwann cell chemotaxis;7;1;GO:0000976
GO:1990220;GroEL-GroES complex;55;3;GO:0005576
GO:1990210;positive regulation by symbiont of indole acetic acid levels in host;0;0;GO:0050727
GO:1990211;positive regulation by symbiont of jasmonic acid levels in host;0;0;GO:0000976
GO:1990212;positive regulation by symbiont of ethylene levels in host;0;1;GO:0004721
GO:1990213;negative regulation by symbiont of salicylic acid levels in host;0;0;GO:0006979
GO:1990215;negative regulation by symbiont of host intracellular transport;0;0;GO:0008033
GO:1990216;positive regulation by symbiont of host transcription;8;0;GO:0006906
GO:1990217;suppression by symbiont of host phytoalexin production;0;0;GO:0008033
GO:1990218;positive regulation by symbiont of abscisic acid levels in host;0;1;GO:0009063
GO:1904261;positive regulation of basement membrane assembly involved in embryonic body morphogenesis;185;286;GO:0009693
GO:1904260;negative regulation of basement membrane assembly involved in embryonic body morphogenesis;0;0;GO:0006796
GO:1904276;regulation of wax biosynthetic process;179;2;GO:0010467
GO:1904275;tricellular tight junction disassembly;0;0;GO:0008380
GO:1904274;tricellular tight junction assembly;140;143;GO:0001525
GO:1904273;L-alanine import across plasma membrane;304;6;GO:0006561
GO:1904279;regulation of transcription by RNA polymerase V;5;2;GO:0005576
GO:1904278;positive regulation of wax biosynthetic process;176;4;GO:0050727
GO:1904277;negative regulation of wax biosynthetic process;3;1;GO:0006540
GO:1990230;iron-sulfur cluster transfer complex;12;4;GO:0048608
GO:1990231;STING complex;107;2;GO:0097194
GO:1990221;L-cysteine desulfurase complex;201;2;GO:0048608
GO:1990222;ProVWX complex;3;1;GO:0046274
GO:1990223;positive regulation by symbiont of cytokinin levels in host;0;1;GO:0009061
GO:1990224;NMN phosphatase activity;0;2;GO:0009953
GO:1990225;rhoptry neck;12;3;GO:0046274
GO:1990226;histone methyltransferase binding;1051;218;GO:0045944
GO:1990227;paranodal junction maintenance;114;3;GO:0045727
GO:1990228;sulfurtransferase complex;34;1;GO:0006559
GO:1990229;iron-sulfur cluster assembly complex;414;80;GO:0048316
GO:1904272;L-tryptophan import across plasma membrane;0;0;GO:0012501
GO:1904271;L-proline import across plasma membrane;189;2;GO:0050832
GO:1904270;pyroptosome complex assembly;67;2;GO:0048285
GO:1904287;positive regulation of protein-pyridoxal-5-phosphate linkage;24;1;GO:0048316
GO:1904286;negative regulation of protein-pyridoxal-5-phosphate linkage;0;1;GO:0003676
GO:1904285;regulation of protein-pyridoxal-5-phosphate linkage;24;1;GO:0045944
GO:1904284;positive regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I;0;1;GO:0048316
GO:1904289;regulation of mitotic DNA damage checkpoint;140;3;GO:0003700
GO:1904288;BAT3 complex binding;224;224;GO:0045944
GO:1990232;phosphomannomutase complex;0;0;GO:0006536
GO:1990233;intramolecular phosphotransferase complex;0;0;GO:0048608
GO:1990234;transferase complex;1596065;1320;GO:0043066
GO:1990235;diamine N-acetyltransferase complex;1;0;GO:0048608
GO:1990236;proteasome core complex import into nucleus;4;0;GO:0006576
GO:1990238;double-stranded DNA endonuclease activity;126;3;GO:0048316
GO:1990239;steroid hormone binding;460;55;GO:0048608
GO:1904283;negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I;47;4;GO:0048608
GO:1904282;regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I;47;2;GO:0048609
GO:1904281;positive regulation of transcription by RNA polymerase V;5;1;GO:0048608
GO:1904280;negative regulation of transcription by RNA polymerase V;0;0;GO:0048316
GO:0015506;nucleoside:proton symporter activity;827;3;GO:0048609
GO:0015505;uracil:monoatomic cation symporter activity;110;1;GO:0048193
GO:0015504;cytosine:proton symporter activity;0;0;GO:0009065
GO:0015503;glutathione-regulated potassium exporter activity;6297;170;GO:0008380
GO:0015501;glutamate:sodium symporter activity;19359;570;GO:0006749
GO:0015520;tetracycline:proton antiporter activity;0;1;GO:0007049
GO:0015519;D-xylose:proton symporter activity;2;1;GO:0009065
GO:0015518;arabinose:proton symporter activity;1;2;GO:0006548
GO:0015517;galactose:proton symporter activity;6;2;GO:0008380
GO:0015516;tartrate:succinate antiporter activity;0;2;GO:0022627
GO:0015515;citrate:succinate antiporter activity;0;1;GO:0004497
GO:0015514;nitrite efflux transmembrane transporter activity;1;5;GO:0010468
GO:0015513;high-affinity secondary active nitrite transmembrane transporter activity;89;0;GO:0010467
GO:0015676;vanadium ion transport;8;18;GO:0004073
GO:0039643;host cell viral nucleoid;1;1;GO:0006749
GO:0015675;nickel cation transport;77353;112;GO:0006836
GO:0039642;virion nucleoid;1;0;GO:0006749
GO:0039645;perturbation by virus of host G1/S transition checkpoint;9172;6;GO:0046274
GO:0015673;silver ion transport;2;2;GO:0006414
GO:0039644;suppression by virus of host NF-kappaB cascade;9108;7;GO:0045944
GO:0015671;oxygen transport;171357;2170;GO:0005215
GO:0015670;carbon dioxide transport;956;285;GO:0006811
GO:0039641;viral inner membrane;52;2;GO:0005576
GO:0039640;viral release via suppression of host peptidoglycan biosynthetic process;4;0;GO:0050890
GO:0003690;double-stranded DNA binding;675571;5560;GO:0010467
GO:0003691;double-stranded telomeric DNA binding;6062;309;GO:0005215
GO:0003692;left-handed Z-DNA binding;11;10;GO:0005515
GO:0042905;9-cis-retinoic acid metabolic process;184;236;GO:0006415
GO:0003381;epithelial cell morphogenesis involved in gastrulation;210;3;GO:0005215
GO:0015361;low-affinity sodium:dicarboxylate symporter activity;7;6;GO:0010468
GO:0042906;xanthine transport;157;5;GO:0006520
GO:0003382;epithelial cell morphogenesis;2725;505;GO:0048316
GO:0015360;acetate:proton symporter activity;22;1;GO:0006725
GO:0003383;apical constriction;512;405;GO:0005737
GO:0003384;apical constriction involved in gastrulation;173;4;GO:0009060
GO:0003385;cell-cell signaling involved in amphid sensory organ development;0;6;GO:0048316
GO:0003386;amphid sensory organ development;66;4;GO:0006569
GO:0003387;neuron differentiation involved in amphid sensory organ development;46;5;GO:0030900
GO:0003388;neuron development involved in amphid sensory organ development;40;4;GO:0048699
GO:0003389;retrograde extension;23;4;GO:0009062
GO:0003379;establishment of cell polarity involved in gastrulation cell migration;41;2;GO:0006559
GO:0030976;thiamine pyrophosphate binding;425279;1980;GO:0048699
GO:0030975;thiamine binding;28400;34;GO:0009061
GO:0030978;alpha-glucan metabolic process;17203;4;GO:0006559
GO:0030977;taurine binding;66;24;GO:0048699
GO:0030979;alpha-glucan biosynthetic process;15247;12;GO:0048316
GO:0042907;xanthine transmembrane transporter activity;79;4;GO:0004553
GO:0042908;xenobiotic transport;528998;901;GO:0048285
GO:0030970;retrograde protein transport, ER to cytosol;2352;915;GO:0048316
GO:0030971;receptor tyrosine kinase binding;7600;1010;GO:0005525
GO:0030974;thiamine pyrophosphate transmembrane transport;581;26;GO:0043066
GO:0030973;molybdate ion binding;7334;37;GO:0048316
GO:0042910;xenobiotic transmembrane transporter activity;245851;1180;GO:0008565
GO:0015334;high-affinity oligopeptide transmembrane transporter activity;7;1;GO:0048193
GO:0015333;peptide:proton symporter activity;3233;238;GO:0043407
GO:0042912;colicin transmembrane transporter activity;8;2;GO:0048707
GO:0042913;group A colicin transmembrane transporter activity;0;1;GO:0008023
GO:0042914;colicin transport;4;1;GO:0043066
GO:0015330;high-affinity glutamine transmembrane transporter activity;0;1;GO:0009908
GO:0042915;group A colicin transport;0;1;GO:0005515
GO:0003350;pulmonary myocardium development;88;23;GO:0048513
GO:0003351;epithelial cilium movement involved in extracellular fluid movement;3039;63;GO:0005737
GO:0003352;regulation of cilium movement;4287;1400;GO:0048193
GO:0003353;positive regulation of cilium movement;648;10;GO:0048316
GO:0003354;negative regulation of cilium movement;182;4;GO:0005576
GO:0003355;cilium movement involved in otolith formation;12;2;GO:0048608
GO:0003356;regulation of cilium beat frequency;1011;57;GO:0048316
GO:0003346;epicardium-derived cell migration to the myocardium;0;2;GO:0004553
GO:0030965;plasma membrane electron transport, NADH to quinone;0;6;GO:0048169
GO:0003347;epicardial cell to mesenchymal cell transition;42;6;GO:0048169
GO:0030964;NADH dehydrogenase complex;49060;785;GO:0048309
GO:0003348;cardiac endothelial cell differentiation;525;10;GO:0048608
GO:0003349;epicardium-derived cardiac endothelial cell differentiation;2;9;GO:0030528
GO:0030968;endoplasmic reticulum unfolded protein response;22288;3490;GO:0006520
GO:0042918;alkanesulfonate transport;6464;5;GO:0000398
GO:0042919;benzoate transport;25016;57;GO:0006541
GO:0015328;cystine secondary active transmembrane transporter activity;72;5;GO:0009986
GO:0030961;peptidyl-arginine hydroxylation;5;6;GO:0009065
GO:0015327;cystine:glutamate antiporter activity;72;7;GO:0006518
GO:0030960;peptide cross-linking via 3'-(O4'-L-tyrosinyl)-L-tyrosine;0;0;GO:0009986
GO:0030963;peptidyl-lysine dihydroxylation to 4,5-dihydroxy-L-lysine;0;3;GO:0005783
GO:0015325;acetyl-CoA:CoA antiporter activity;0;0;GO:0006364
GO:0030962;peptidyl-arginine dihydroxylation to peptidyl-3,4-dihydroxy-L-arginine;0;2;GO:0006541
GO:0015346;ferric triacetylfusarinine C:proton symporter activity;0;0;GO:0009986
GO:0042921;glucocorticoid receptor signaling pathway;3340;958;GO:0000398
GO:0015345;ferric enterobactin:proton symporter activity;0;1;GO:0004721
GO:0042922;neuromedin U receptor binding;841;2;GO:0008340
GO:0015344;siderophore uptake transmembrane transporter activity;223;29;GO:0043407
GO:0042923;neuropeptide binding;1060;598;GO:0004730
GO:0015343;siderophore-iron transmembrane transporter activity;73524;7;GO:0006556
GO:0042924;neuromedin U binding;111;3;GO:0008380
GO:0042925;benzoate transmembrane transporter activity;12508;164;GO:0043066
GO:0015341;zinc efflux active transmembrane transporter activity;20;2;GO:0009065
GO:0042926;3-hydroxyphenylpropionic acid transmembrane transporter activity;0;3;GO:0006364
GO:0042928;ferrichrome import into cell;17;1;GO:0006865
GO:0003360;brainstem development;226;103;GO:0046330
GO:0003361;noradrenergic neuron differentiation involved in brainstem development;0;2;GO:0006066
GO:0003362;noradrenergic neuron fate commitment involved in brainstem development;0;1;GO:0006364
GO:0003363;lamellipodium assembly involved in ameboidal cell migration;6;8;GO:0043407
GO:0003364;lamellipodium assembly involved in mesendodermal cell migration;0;3;GO:0006796
GO:0003365;establishment of cell polarity involved in ameboidal cell migration;142;252;GO:0048285
GO:0003366;cell-matrix adhesion involved in ameboidal cell migration;115;28;GO:0048468
GO:0003367;cell-cell adhesion involved in ameboidal cell migration;1;3;GO:0006790
GO:0042920;3-hydroxyphenylpropionic acid transmembrane transport;0;2;GO:0006865
GO:0003357;noradrenergic neuron differentiation;594;235;GO:0042981
GO:0030954;astral microtubule nucleation;83;10;GO:0009065
GO:0003358;noradrenergic neuron development;250;25;GO:0043066
GO:0030953;astral microtubule organization;622;178;GO:0006518
GO:0003359;noradrenergic neuron fate commitment;46;5;GO:0042981
GO:0030956;glutamyl-tRNA(Gln) amidotransferase complex;47529;753;GO:0004842
GO:0030955;potassium ion binding;96500;1310;GO:0046395
GO:0030958;RITS complex;12;2;GO:0004842
GO:0030957;Tat protein binding;430;759;GO:0071013
GO:0030959;peptide cross-linking via 3'-(3'-L-tyrosinyl)-L-tyrosine;0;0;GO:0003735
GO:0042929;ferrichrome transmembrane transporter activity;7;0;GO:0071013
GO:0030950;establishment or maintenance of actin cytoskeleton polarity;534;276;GO:0004867
GO:0030952;establishment or maintenance of cytoskeleton polarity;7805;51;GO:0010942
GO:0030951;establishment or maintenance of microtubule cytoskeleton polarity;7173;236;GO:0045786
GO:0015399;primary active transmembrane transporter activity;9351766;1240;GO:0005524
GO:0015398;high-affinity secondary active ammonium transmembrane transporter activity;62;4;GO:0010468
GO:0015395;nucleoside transmembrane transporter activity, down a concentration gradient;0;0;GO:0048704
GO:0015394;uridine:proton symporter activity;0;1;GO:0004842
GO:0015391;nucleobase:monoatomic cation symporter activity;344;1;GO:0006732
GO:0015390;purine-specific nucleoside:sodium symporter activity;69;5;GO:0010468
GO:1990010;compound eye retinal cell apoptotic process;37;1;GO:0048771
GO:1990011;laminated body;0;1;GO:0010831
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;18;67;GO:0045944
GO:1990002;methylglyoxal reductase (NADPH-dependent, acetol producing);28;1;GO:0048704
GO:1990003;IDP phosphatase activity;177;5;GO:0010468
GO:1990005;granular vesicle;64;1;GO:0004842
GO:1990006;amorphous vesicle;0;1;GO:0009061
GO:1990007;membrane stack;0;3;GO:0004364
GO:1990008;neurosecretory vesicle;2;2;GO:0006790
GO:1990009;retinal cell apoptotic process;253;110;GO:0008037
GO:1904100;positive regulation of protein O-linked glycosylation;53;9;GO:0006732
GO:1904104;negative regulation of convergent extension involved in gastrulation;0;1;GO:0004842
GO:1904103;regulation of convergent extension involved in gastrulation;170;1;GO:0006790
GO:1904102;cellular response to acadesine;0;1;GO:0048704
GO:1904101;response to acadesine;10;0;GO:0048704
GO:1904108;protein localization to ciliary inversin compartment;113;2;GO:0048704
GO:1904107;protein localization to microvillus membrane;8;0;GO:0000077
GO:1904106;protein localization to microvillus;135;100;GO:0048704
GO:1904105;positive regulation of convergent extension involved in gastrulation;93;2;GO:0048704
GO:1990020;recurrent axon collateral;0;1;GO:0006022
GO:1990021;Schaffer axon collateral;0;0;GO:0048704
GO:1904109;positive regulation of cholesterol import;21;5;GO:0048704
GO:1990012;complex laminated body;0;1;GO:0048407
GO:1990013;presynaptic grid;0;1;GO:0048704
GO:0052344;positive regulation by symbiont of host phytoalexin production;0;1;GO:0004553
GO:1990014;orthogonal array;0;1;GO:0005216
GO:1990015;ensheathing process;6;4;GO:0046394
GO:1990016;neck portion of tanycyte;0;1;GO:0005515
GO:1990017;somatic portion of tanycyte;0;2;GO:0009065
GO:1990018;tail portion of tanycyte;0;1;GO:0046395
GO:1990019;protein storage vacuole organization;179;1;GO:0005216
GO:0015379;potassium:chloride symporter activity;35406;672;GO:0043066
GO:0015378;sodium:chloride symporter activity;6361;261;GO:0010941
GO:0015377;chloride:monoatomic cation symporter activity;66718;31;GO:0048446
GO:0015375;glycine:sodium symporter activity;148;94;GO:0045944
GO:1904115;axon cytoplasm;7828;593;GO:0048446
GO:0003390;dendrite development by retrograde extension;23;4;GO:0046394
GO:0015374;neutral, basic amino acid:sodium:chloride symporter activity;27;0;GO:0048608
GO:1904114;positive regulation of muscle filament sliding;0;0;GO:0007067
GO:0003391;amphid sensory organ dendrite retrograde extension;23;3;GO:0048608
GO:0015373;monoatomic anion:sodium symporter activity;6667;2;GO:0050921
GO:1904113;negative regulation of muscle filament sliding;5;2;GO:0048608
GO:0003392;cell adhesion involved in retrograde extension;0;4;GO:0048247
GO:0003393;neuron migration involved in retrograde extension;0;3;GO:0045595
GO:0015371;galactose:sodium symporter activity;60;0;GO:0048704
GO:1904119;negative regulation of otic vesicle morphogenesis;0;1;GO:0045595
GO:0003394;cell adhesion involved in dendrite retrograde extension;0;2;GO:0006790
GO:0015370;solute:sodium symporter activity;150356;286;GO:0048608
GO:1904118;regulation of otic vesicle morphogenesis;35;1;GO:0009523
GO:0003395;neuron migration involved in dendrite retrograde extension;0;2;GO:0016569
GO:1904117;cellular response to vasopressin;36;10;GO:0010467
GO:0003396;cell adhesion involved in amphid sensory organ dendrite retrograde extension;0;1;GO:0004067
GO:1904116;response to vasopressin;37;6;GO:0048608
GO:0003397;neuron migration involved in amphid sensory organ dendrite retrograde extension;0;1;GO:0034976
GO:1990030;pericellular basket;10;3;GO:0048771
GO:0003398;glial cell differentiation involved in amphid sensory organ development;6;4;GO:0003676
GO:1990031;pinceau fiber;5;22;GO:0048706
GO:0003399;cytoneme morphogenesis;37;3;GO:0042393
GO:1990032;parallel fiber;56;10;GO:0048608
GO:1990033;dendritic branch point;15;3;GO:0048704
GO:1990023;mitotic spindle midzone;1453;363;GO:0008610
GO:1990024;C bouton;0;2;GO:0048704
GO:1990025;F bouton;0;2;GO:0034976
GO:1990026;hippocampal mossy fiber expansion;98;3;GO:0048704
GO:1990027;S bouton;12;2;GO:0048706
GO:1990028;intermediate voltage-gated calcium channel activity;0;2;GO:0048193
GO:1990029;vasomotion;5;7;GO:0010468
GO:0015369;calcium:proton antiporter activity;35103;27;GO:0005819
GO:1904122;positive regulation of fatty acid beta-oxidation by octopamine signaling pathway;4;1;GO:0048193
GO:0015389;pyrimidine- and adenosine-specific:sodium symporter activity;233;2;GO:0008029
GO:1904121;phosphatidylethanolamine transfer activity;269;4;GO:0048704
GO:1904120;positive regulation of otic vesicle morphogenesis;35;3;GO:0006633
GO:0015387;potassium:proton symporter activity;2;2;GO:0048167
GO:0015386;potassium:proton antiporter activity;9194;319;GO:0030522
GO:1904126;convergent extension involved in notochord morphogenesis;0;0;GO:0006022
GO:0015385;sodium:proton antiporter activity;66882;906;GO:0006096
GO:1904125;convergent extension involved in rhombomere morphogenesis;0;0;GO:0048704
GO:1904124;microglial cell migration;380;22;GO:0006066
GO:0015383;sulfate:bicarbonate antiporter activity;14;5;GO:0048704
GO:1904123;positive regulation of fatty acid beta-oxidation by serotonin receptor signaling pathway;13;1;GO:0048704
GO:0015382;sodium:sulfate symporter activity;177;9;GO:0004721
GO:0015381;high-affinity sulfate transmembrane transporter activity;0;4;GO:0048704
GO:0052372;modulation by symbiont of entry into host;2363;122;GO:0006511
GO:1904129;positive regulation of convergent extension involved in somitogenesis;0;0;GO:0048704
GO:1904128;negative regulation of convergent extension involved in somitogenesis;0;0;GO:0009986
GO:1904127;regulation of convergent extension involved in somitogenesis;0;0;GO:0006096
GO:1990040;sub-surface cisterna;0;1;GO:0048608
GO:1990042;glycerol dehydrogenase [NAD(P)+] activity;2643;0;GO:0006555
GO:1990043;5' deoxyribonuclease (pyrimidine dimer) activity;14;1;GO:0048608
GO:1990044;protein localization to lipid droplet;352;2;GO:0005576
GO:0030998;linear element;32;3;GO:0006091
GO:1990034;calcium ion export across plasma membrane;427;8;GO:0048704
GO:0030997;regulation of centriole-centriole cohesion;190;273;GO:0005576
GO:1990036;calcium ion import into sarcoplasmic reticulum;299;9;GO:0005576
GO:0030999;linear element assembly;28;5;GO:0022836
GO:1990037;Lewy body core;172;94;GO:0005576
GO:1990038;Lewy body corona;57;5;GO:0022836
GO:1990039;hypolemmal cisterna;0;1;GO:0048285
GO:0030990;intraciliary transport particle;10567;76;GO:0048285
GO:0030992;intraciliary transport particle B;7239;365;GO:0048704
GO:0030991;intraciliary transport particle A;3267;61;GO:0005576
GO:0030994;primary cell septum disassembly;6;4;GO:0006873
GO:0030993;axonemal heterotrimeric kinesin-II complex;11;1;GO:0005737
GO:0030995;cell septum edging catabolic process;5;1;GO:0022836
GO:0042976;activation of Janus kinase activity;34;230;GO:0032496
GO:0042978;ornithine decarboxylase activator activity;832;26;GO:0008021
GO:0042979;ornithine decarboxylase regulator activity;4400;8;GO:0046330
GO:0042970;homoserine transmembrane transporter activity;11;2;GO:0048285
GO:1990050;phosphatidic acid transfer activity;555;54;GO:0007088
GO:1990051;activation of protein kinase C activity;35;55;GO:0048285
GO:0042972;licheninase activity;1237;10;GO:0000724
GO:1990052;ER to chloroplast lipid transport;873;0;GO:0007070
GO:0042973;glucan endo-1,3-beta-D-glucosidase activity;11755;53;GO:0042802
GO:1990053;DNA-5-methylcytosine glycosylase activity;0;0;GO:0043406
GO:0042974;nuclear retinoic acid receptor binding;2025;9;GO:0005524
GO:1990054;response to temozolomide;0;1;GO:0005829
GO:0042975;peroxisome proliferator activated receptor binding;407;537;GO:0007611
GO:1990055;phenylacetaldehyde synthase activity;14;3;GO:0045944
GO:1990045;sclerotium development;0;0;GO:0010468
GO:1990046;stress-induced mitochondrial fusion;125;19;GO:0046330
GO:1990047;spindle matrix;106;9;GO:0005737
GO:1990048;anterograde neuronal dense core vesicle transport;41;5;GO:0043405
GO:1990049;retrograde neuronal dense core vesicle transport;32;6;GO:0045944
GO:0042987;amyloid precursor protein catabolic process;5703;1570;GO:0010468
GO:0042988;X11-like protein binding;7026;5;GO:0046330
GO:0042989;sequestering of actin monomers;706;957;GO:0006096
GO:1990060;maltose transport complex;36;6;GO:0045944
GO:0042981;regulation of apoptotic process;194029;10100;GO:0006066
GO:1990061;bacterial degradosome;5;2;GO:0045944
GO:0042982;amyloid precursor protein metabolic process;6949;898;GO:0006032
GO:1990062;RPAP3/R2TP/prefoldin-like complex;606;9;GO:0006073
GO:0042983;amyloid precursor protein biosynthetic process;588;134;GO:0007165
GO:1990063;Bam protein complex;52;4;GO:0006897
GO:0042984;regulation of amyloid precursor protein biosynthetic process;536;35;GO:0006066
GO:1990064;ground tissue pattern formation;1;0;GO:0048699
GO:0042985;negative regulation of amyloid precursor protein biosynthetic process;261;218;GO:0045944
GO:1990065;Dxr protein complex;1;1;GO:0005743
GO:0042986;positive regulation of amyloid precursor protein biosynthetic process;181;69;GO:0048285
GO:1990066;energy quenching;398;6;GO:0005515
GO:1990058;fruit replum development;30;1;GO:0010941
GO:1990059;fruit valve development;40;1;GO:0007067
GO:0042998;positive regulation of Golgi to plasma membrane protein transport;1427;146;GO:0006099
GO:1990070;TRAPPI protein complex;175;103;GO:0030528
GO:1990071;TRAPPII protein complex;5758;26;GO:0007067
GO:1990072;TRAPPIII protein complex;521;182;GO:0006096
GO:1990073;perforation plate;0;1;GO:0042981
GO:0042994;cytoplasmic sequestering of transcription factor;73;263;GO:0046686
GO:1990074;polyuridylation-dependent mRNA catabolic process;1555;174;GO:0007070
GO:0042995;cell projection;2402327;8560;GO:0006099
GO:1990075;periciliary membrane compartment;354;46;GO:0043066
GO:0042996;regulation of Golgi to plasma membrane protein transport;1589;86;GO:0050727
GO:1990076;cell wall polysaccharide catabolic process involved in abscission;0;0;GO:0006022
GO:0042997;negative regulation of Golgi to plasma membrane protein transport;159;211;GO:0006749
GO:1990077;primosome complex;237038;22;GO:0045944
GO:1990067;intrachromosomal DNA recombination;67;1;GO:0006541
GO:0052314;phytoalexin metabolic process;181;78;GO:0006796
GO:1990068;seed dehydration;0;2;GO:0006511
GO:1990069;stomatal opening;281;8;GO:0006559
GO:0052319;regulation of phytoalexin biosynthetic process;48;1;GO:0006790
GO:0052317;camalexin metabolic process;124;63;GO:0006559
GO:0052318;regulation of phytoalexin metabolic process;48;1;GO:0046330
GO:0052315;phytoalexin biosynthetic process;176;20;GO:0050921
GO:0052316;phytoalexin catabolic process;1;1;GO:0007409
GO:1990080;2-phenylethylamine receptor activity;50;2;GO:0046330
GO:1990081;trimethylamine receptor activity;98;3;GO:0046330
GO:1990082;DnaA-L2 complex;2;0;GO:0007067
GO:1990083;DnaA-Hda complex;0;0;GO:0004842
GO:1990084;DnaA-Dps complex;2;1;GO:0048608
GO:1990085;Hda-beta clamp complex;2;3;GO:0007059
GO:1990086;lens fiber cell apoptotic process;154;58;GO:0004867
GO:1990088;[methyl-Co(III) methanol-specific corrinoid protein]:coenzyme M methyltransferase;49;0;GO:0050890
GO:0052324;plant-type cell wall cellulose biosynthetic process;522;5;GO:0048608
GO:1990078;replication inhibiting complex;9;3;GO:0004723
GO:0052325;cell wall pectin biosynthetic process;247;166;GO:0004842
GO:1990079;cartilage homeostasis;275;7;GO:0048704
GO:0052322;positive regulation of phytoalexin biosynthetic process;48;1;GO:0009536
GO:0052323;negative regulation of phytoalexin biosynthetic process;0;2;GO:0004871
GO:0052320;positive regulation of phytoalexin metabolic process;48;2;GO:0048193
GO:0052321;negative regulation of phytoalexin metabolic process;0;1;GO:0048407
GO:1904056;positive regulation of cholangiocyte proliferation;16;5;GO:0050727
GO:1904055;negative regulation of cholangiocyte proliferation;64;3;GO:0007059
GO:1904054;regulation of cholangiocyte proliferation;129;1;GO:0046686
GO:1904053;positive regulation of protein targeting to vacuole involved in autophagy;0;1;GO:0046394
GO:1904059;regulation of locomotor rhythm;351;32;GO:0007067
GO:1904058;positive regulation of sensory perception of pain;122;47;GO:0048407
GO:1904057;negative regulation of sensory perception of pain;12;8;GO:0071346
GO:1904052;negative regulation of protein targeting to vacuole involved in autophagy;0;0;GO:0048608
GO:1904051;regulation of protein targeting to vacuole involved in autophagy;0;1;GO:0007059
GO:1904050;positive regulation of spontaneous neurotransmitter secretion;44;1;GO:0004842
GO:1904067;ascr#2 binding;5;1;GO:0048407
GO:1904066;G protein-coupled receptor signaling pathway involved in dauer larval development;16;0;GO:0046686
GO:1904065;G protein-coupled acetylcholine receptor signaling pathway involved in positive regulation of acetylcholine secretion, neurotransmission;0;1;GO:0048193
GO:1904064;positive regulation of cation transmembrane transport;6034;43;GO:0007611
GO:1904069;ascaroside metabolic process;50;2;GO:0048706
GO:1904068;G protein-coupled receptor signaling pathway involved in social behavior;16;0;GO:0050727
GO:1904063;negative regulation of cation transmembrane transport;1856;166;GO:0048608
GO:1904062;regulation of monoatomic cation transmembrane transport;12560;10;GO:0046686
GO:1904061;positive regulation of locomotor rhythm;30;2;GO:0006790
GO:1904060;negative regulation of locomotor rhythm;11;3;GO:0010401
GO:1904078;positive regulation of estrogen biosynthetic process;0;1;GO:0050727
GO:1904077;negative regulation of estrogen biosynthetic process;1;0;GO:0006561
GO:1904076;regulation of estrogen biosynthetic process;2;0;GO:0010401
GO:1904075;positive regulation of trophectodermal cell proliferation;55;10;GO:0046686
GO:1904070;ascaroside biosynthetic process;50;6;GO:0009536
GO:1904074;negative regulation of trophectodermal cell proliferation;0;2;GO:0004842
GO:1904073;regulation of trophectodermal cell proliferation;55;5;GO:0048407
GO:1904072;presynaptic active zone disassembly;0;0;GO:0005576
GO:1904071;presynaptic active zone assembly;112;7;GO:0004842
GO:1904088;positive regulation of epiboly involved in gastrulation with mouth forming second;62;0;GO:0010401
GO:1904087;negative regulation of epiboly involved in gastrulation with mouth forming second;1;1;GO:0007067
GO:1904086;regulation of epiboly involved in gastrulation with mouth forming second;136;0;GO:0004842
GO:1904082;pyrimidine nucleobase transmembrane transport;783;0;GO:0050727
GO:1904011;cellular response to Aroclor 1254;0;0;GO:0005740
GO:1904010;response to Aroclor 1254;3;1;GO:0048407
GO:1904016;response to Thyroglobulin triiodothyronine;125;23;GO:0006519
GO:1904015;cellular response to serotonin;65;7;GO:0006561
GO:1904014;response to serotonin;101;3;GO:0006561
GO:1904019;epithelial cell apoptotic process;7316;90;GO:0006519
GO:1904018;positive regulation of vasculature development;9590;674;GO:0006066
GO:1904017;cellular response to Thyroglobulin triiodothyronine;112;27;GO:0006096
GO:1904023;regulation of glucose catabolic process to lactate via pyruvate;158;4;GO:0006066
GO:1904022;positive regulation of G protein-coupled receptor internalization;93;6;GO:0006096
GO:1904021;negative regulation of G protein-coupled receptor internalization;86;4;GO:0006511
GO:1904020;regulation of G protein-coupled receptor internalization;179;9;GO:0006559
GO:1904027;negative regulation of collagen fibril organization;103;8;GO:0046394
GO:1904026;regulation of collagen fibril organization;323;8;GO:0046394
GO:1904025;positive regulation of glucose catabolic process to lactate via pyruvate;54;7;GO:0006631
GO:1904024;negative regulation of glucose catabolic process to lactate via pyruvate;104;173;GO:0009062
GO:1904029;regulation of cyclin-dependent protein kinase activity;218;399;GO:0006096
GO:1904028;positive regulation of collagen fibril organization;162;3;GO:0006569
GO:1904034;positive regulation of t-SNARE clustering;4;1;GO:0006569
GO:1904033;negative regulation of t-SNARE clustering;0;0;GO:0006979
GO:1904032;regulation of t-SNARE clustering;4;0;GO:0009060
GO:1904031;positive regulation of cyclin-dependent protein kinase activity;52;36;GO:0009062
GO:1904038;regulation of iron export across plasma membrane;3;0;GO:0006081
GO:1904037;positive regulation of epithelial cell apoptotic process;1514;378;GO:0048193
GO:1904036;negative regulation of epithelial cell apoptotic process;2829;50;GO:0005911
GO:1904035;regulation of epithelial cell apoptotic process;4765;242;GO:0005976
GO:1904039;negative regulation of iron export across plasma membrane;3;1;GO:0005925
GO:1904030;negative regulation of cyclin-dependent protein kinase activity;69;93;GO:0005916
GO:1904045;cellular response to aldosterone;211;7;GO:0048193
GO:1904044;response to aldosterone;358;35;GO:0048193
GO:1904043;positive regulation of cystathionine beta-synthase activity;0;0;GO:0006629
GO:1904042;negative regulation of cystathionine beta-synthase activity;1;0;GO:0005976
GO:1904049;negative regulation of spontaneous neurotransmitter secretion;58;10;GO:0005925
GO:1904048;regulation of spontaneous neurotransmitter secretion;102;5;GO:0005929
GO:1904047;S-adenosyl-L-methionine binding;76377;1370;GO:0005911
GO:1904046;negative regulation of vascular endothelial growth factor production;132;51;GO:0005911
GO:1990000;amyloid fibril formation;1618;435;GO:0002576
GO:1904041;regulation of cystathionine beta-synthase activity;1;0;GO:0005911
GO:1904040;positive regulation of iron export across plasma membrane;0;0;GO:0005975
GO:0005901;caveola;19397;2710;GO:0005929
GO:0005900;oncostatin-M receptor complex;106;113;GO:0005929
GO:0005903;brush border;5048;1580;GO:0005976
GO:0005902;microvillus;13671;1730;GO:0006569
GO:0005905;clathrin-coated pit;76413;1420;GO:0009065
GO:0005912;adherens junction;23735;3230;GO:0010828
GO:0005911;cell-cell junction;295581;6540;GO:0010828
GO:0005914;spot adherens junction;102;48;GO:0010468
GO:0005916;fascia adherens;428;1210;GO:0046405
GO:0005915;zonula adherens;578;391;GO:0010468
GO:0005918;septate junction;528;80;GO:0005929
GO:0005917;nephrocyte diaphragm;46;9;GO:0046395
GO:0005919;pleated septate junction;50;10;GO:0005929
GO:1904099;negative regulation of protein O-linked glycosylation;0;0;GO:0045944
GO:1904098;regulation of protein O-linked glycosylation;53;8;GO:0070062
GO:1904097;acid phosphatase complex;1;1;GO:0005911
GO:0030907;MBF transcription complex;88;8;GO:0005576
GO:0030906;retromer, cargo-selective complex;5355;38;GO:0005911
GO:0030909;non-intein-mediated protein splicing;0;1;GO:0008092
GO:0030908;protein splicing;33848;28;GO:0006461
GO:0005950;anthranilate synthase complex;74;8;GO:0005576
GO:0005952;cAMP-dependent protein kinase complex;6863;667;GO:0005911
GO:0005951;carbamoyl-phosphate synthase complex;272;311;GO:0005576
GO:0005943;phosphatidylinositol 3-kinase complex, class IA;403;112;GO:0030199
GO:0005942;phosphatidylinositol 3-kinase complex;13141;915;GO:0005576
GO:0005945;6-phosphofructokinase complex;279;991;GO:0005929
GO:0030901;midbrain development;3909;1210;GO:0005576
GO:0005944;phosphatidylinositol 3-kinase complex, class IB;2644;134;GO:0005911
GO:0030900;forebrain development;36851;3910;GO:0030199
GO:0005947;mitochondrial alpha-ketoglutarate dehydrogenase complex;3067;238;GO:0048169
GO:0030903;notochord development;3108;1380;GO:0005929
GO:0005946;alpha,alpha-trehalose-phosphate synthase complex (UDP-forming);243;45;GO:0045944
GO:0030902;hindbrain development;14022;2570;GO:0007049
GO:0030905;retromer, tubulation complex;145;78;GO:0010468
GO:0005948;acetolactate synthase complex;363;99;GO:0000910
GO:0030904;retromer complex;12579;1650;GO:0046356
GO:1904092;regulation of autophagic cell death;221;4;GO:0000786
GO:1904091;non-ribosomal peptide synthetase activity;79183;1;GO:0046148
GO:1904090;peptidase inhibitor complex;977;8;GO:0000786
GO:1904096;protein tyrosine phosphatase complex;0;0;GO:0048193
GO:1904095;negative regulation of endosperm development;4;1;GO:0007067
GO:1904094;positive regulation of autophagic cell death;54;8;GO:0046356
GO:1904093;negative regulation of autophagic cell death;167;7;GO:0006096
GO:0005960;glycine cleavage complex;52566;581;GO:0022617
GO:0003300;cardiac muscle hypertrophy;3408;1150;GO:0006073
GO:0005963;magnesium-dependent protein serine/threonine phosphatase complex;0;4;GO:0022610
GO:0003301;physiological cardiac muscle hypertrophy;445;78;GO:0006066
GO:0005962;mitochondrial isocitrate dehydrogenase complex (NAD+);228;14;GO:0004518
GO:0005954;calcium- and calmodulin-dependent protein kinase complex;148;298;GO:0050921
GO:0005953;CAAX-protein geranylgeranyltransferase complex;1873;32;GO:0004518
GO:0005956;protein kinase CK2 complex;15277;747;GO:0010467
GO:0005955;calcineurin complex;705;515;GO:0007049
GO:0005958;DNA-dependent protein kinase-DNA ligase 4 complex;336;144;GO:0046274
GO:0005930;axoneme;36974;1820;GO:0005576
GO:0005921;gap junction;111762;1460;GO:0010467
GO:0005920;smooth septate junction;69;22;GO:0007165
GO:0005923;bicellular tight junction;121401;2110;GO:0010467
GO:0005922;connexin complex;18923;244;GO:0048193
GO:0005925;focal adhesion;47491;11900;GO:0010467
GO:0005927;muscle tendon junction;422;122;GO:0007049
GO:0005929;cilium;362754;4930;GO:0010467
GO:0005940;septin ring;4898;86;GO:0003729
GO:0005931;axonemal nexin link;0;1;GO:0022613
GO:0005934;cellular bud tip;876;34;GO:0022613
GO:0005933;cellular bud;6694;167;GO:0048146
GO:0005935;cellular bud neck;4267;140;GO:0010467
GO:0005938;cell cortex;139150;5280;GO:0048608
GO:0005937;mating projection;4178;173;GO:0045734
GO:0015434;ABC-type cadmium transporter activity;18;3;GO:0048608
GO:0015433;ABC-type peptide antigen transporter activity;121;10;GO:0048608
GO:0015432;ABC-type bile acid transporter activity;191;8;GO:0046274
GO:0160090;internal mRNA (guanine-N7-)-methyltransferase activity;0;0;GO:0046274
GO:0015431;ABC-type glutathione S-conjugate transporter activity;1021;29;GO:0048285
GO:0160091;spliceosome-depend formation of circular RNA;0;0;GO:0046405
GO:0015430;ABC-type glycerol-3-phosphate transporter activity;3892;5;GO:0005911
GO:0160092;hemozoin formation complex;0;0;GO:0002576
GO:0160093;chordate pharynx development;105;0;GO:0005929
GO:0160094;nematode pharynx development;0;0;GO:0005515
GO:0160095;insect pharynx development;0;0;GO:0005929
GO:0160086;protein localization to polar microtubule;0;0;GO:0005840
GO:0160087;spermatid cytoplasm removal during spermiation of flagellated sperm;0;1;GO:0005515
GO:0160089;internal N(7)-methylguanine-containing RNA reader activity;0;0;GO:0005576
GO:0015426;ATPase-coupled polar amino acid-transporter activity;14;5;GO:0005576
GO:0015425;ATPase-coupled nonpolar-amino acid transporter activity;0;2;GO:0045944
GO:0015424;ABC-type amino acid transporter activity;129954;31;GO:0005515
GO:0015445;P-type silver transporter activity;2;3;GO:0003735
GO:0015444;P-type magnesium transporter activity;22620;79;GO:0005515
GO:0015441;ABC-type beta-glucan transporter activity;2461;5;GO:0005911
GO:0015440;ABC-type peptide transporter activity;4087;20;GO:0005515
GO:0160096;nematode pharyngeal muscle development;0;1;GO:0005515
GO:0160097;reverse gyrase activity;0;0;GO:0008565
GO:0015439;ABC-type heme transporter activity;8489;256;GO:0005515
GO:0015438;ABC-type teichoic acid transporter activity;888;2;GO:0005578
GO:0015437;lipopolysaccharide floppase activity;5;3;GO:0005515
GO:0015436;ABC-type capsular-polysaccharide transporter activity;2;2;GO:0005829
GO:0015412;ABC-type molybdate transporter activity;6078;10;GO:0005576
GO:0015411;ABC-type taurine transporter transporter activity;1;10;GO:0045734
GO:0015410;ABC-type manganese transporter activity;12;6;GO:0045734
GO:0160070;intracellular borate homeostasis;0;0;GO:0045944
GO:0160071;prevention of polyspermy during double fertilization;0;1;GO:0045944
GO:0160072;ubiquitin ligase complex scaffold activity;323;4;GO:0006281
GO:0160073;Casparian strip assembly;6;0;GO:0005929
GO:0003430;growth plate cartilage chondrocyte growth;175;190;GO:0006281
GO:0003431;growth plate cartilage chondrocyte development;207;55;GO:0048193
GO:0003432;cell growth involved in growth plate cartilage chondrocyte morphogenesis;0;1;GO:0005515
GO:0003433;chondrocyte development involved in endochondral bone morphogenesis;352;38;GO:0048010
GO:0003423;growth plate cartilage chondrocyte division;0;2;GO:0005829
GO:0003424;establishment of cell polarity involved in growth plate cartilage chondrocyte division;0;3;GO:0005911
GO:0003425;establishment of mitotic spindle orientation involved in growth plate cartilage chondrocyte division;0;2;GO:0005829
GO:0003426;cytoskeleton polarization involved in growth plate cartilage chondrocyte division;0;2;GO:0007600
GO:0003427;regulation of cytoskeleton polarization involved in growth plate cartilage chondrocyte division;0;4;GO:0005515
GO:0003428;chondrocyte intercalation involved in growth plate cartilage morphogenesis;63;3;GO:0005911
GO:0003429;growth plate cartilage chondrocyte morphogenesis;43;9;GO:0016569
GO:0160063;multi-pass transmembrane protein insertion into ER membrane;340;10;GO:0005929
GO:0015408;ABC-type ferric iron transporter activity;34372;5;GO:0005515
GO:0160064;multi-pass translocon complex;336;8;GO:0007600
GO:0015407;ABC-type monosaccharide transporter activity;6058;4;GO:0019901
GO:0160065;SIN/MEN signaling complex;0;0;GO:0030199
GO:0160066;interphase SIN signaling complex;0;0;GO:0030528
GO:0160067;new spindle pole body SIN signaling complex;0;0;GO:0004867
GO:0160068;negative regulation of pollen tube guidance;0;0;GO:0004073
GO:0160069;surfactant secretion;0;1;GO:0004721
GO:0015423;ABC-type maltose transporter activity;1267;6;GO:0003677
GO:0015422;ABC-type oligosaccharide transporter activity;1271;2;GO:0003729
GO:0015421;ABC-type oligopeptide transporter activity;187;10;GO:0003700
GO:0015420;ABC-type vitamin B12 transporter activity;47409;20;GO:0048285
GO:0160080;ABC-type indole transporter activity;0;0;GO:0004721
GO:0160081;iodide channel activity;0;1;GO:0048316
GO:0160082;hypoxia-inducible factor-proline dioxygenase activity;0;2;GO:0005976
GO:0160083;exhausted T cell differentiation;0;0;GO:0004518
GO:0003435;smoothened signaling pathway involved in growth plate cartilage chondrocyte development;0;4;GO:0004867
GO:0003436;regulation of cell adhesion involved in growth plate cartilage morphogenesis;0;3;GO:0004067
GO:0003437;regulation of cell communication involved in growth plate cartilage morphogenesis;0;2;GO:0004073
GO:0160074;non-canonical inflammasome complex;29;1;GO:0004553
GO:0015419;ABC-type sulfate transporter activity;59306;163;GO:0008030
GO:0160075;non-canonical inflammasome complex assembly;125;2;GO:0048731
GO:0015418;ABC-type quaternary ammonium compound transporting activity;26;5;GO:0006396
GO:0160076;negative regulation of non-canonical inflammasome complex assembly;2;0;GO:0031589
GO:0015417;ABC-type polyamine transporter activity;72783;28;GO:0004721
GO:0160077;lipid droplet fusion;262;6;GO:0048704
GO:0015416;ABC-type phosphonate transporter activity;44272;40;GO:0048731
GO:0160078;negative regulation of lipid droplet fusion;4;0;GO:0006096
GO:0015415;ATPase-coupled phosphate ion transmembrane transporter activity;31979;650;GO:0005509
GO:0160079;metabotropic glycine receptor activity;51;1;GO:0003677
GO:0015414;ABC-type nitrate transporter activity;8;8;GO:0048699
GO:0052403;negative regulation by host of symbiont catalytic activity;196;2;GO:0048731
GO:0015413;ABC-type nickel transporter activity;2568;9;GO:0006096
GO:0015478;oligosaccharide transporting porin activity;2;4;GO:0004518
GO:0015476;hemaglutinin autotransporter activity;0;2;GO:0007420
GO:0015475;adhesin autotransporter activity;1;2;GO:0048193
GO:0015474;autotransporter activity;3;165;GO:0005743
GO:0015473;fimbrial usher porin activity;33130;205;GO:0048704
GO:0015471;nucleoside-specific channel forming porin activity;1;4;GO:0006094
GO:0015489;putrescine transmembrane transporter activity;17993;9;GO:0048704
GO:0015488;glucuronide:cation symporter activity;0;0;GO:0048589
GO:0015487;melibiose:monoatomic cation symporter activity;3;0;GO:0006096
GO:0015486;glycoside-pentoside-hexuronide:cation symporter activity;1;5;GO:0007430
GO:0015485;cholesterol binding;8334;1180;GO:0048731
GO:0015483;long-chain fatty acid transporting porin activity;21;3;GO:0006096
GO:0015481;maltose transporting porin activity;1558;8;GO:0004890
GO:0015454;light-driven active monoatomic ion transmembrane transporter activity;0;0;GO:0009952
GO:0015453;oxidoreduction-driven active transmembrane transporter activity;6764899;161;GO:0006096
GO:0015452;methyl transfer-driven active transmembrane transporter activity;0;2;GO:0048666
GO:0015451;decarboxylation-driven active transmembrane transporter activity;16755;5;GO:0046686
GO:0015450;protein-transporting ATPase activity;165182;1300;GO:0030428
GO:0015446;ATPase-coupled arsenite transmembrane transporter activity;6673;31;GO:0048608
GO:0015467;G-protein activated inward rectifier potassium channel activity;3586;384;GO:0048731
GO:0015464;acetylcholine receptor activity;15454;753;GO:0048731
GO:0015462;ABC-type protein transporter activity;354;3;GO:0006096
GO:0015459;potassium channel regulator activity;4217;1300;GO:0048731
GO:0052460;modulation of nutrient release by symbiont;0;0;GO:0071456
GO:0015499;formate transmembrane transporter activity;2653;146;GO:0048731
GO:0015498;pantothenate:sodium symporter activity;50;4;GO:0009765
GO:0015496;putrescine:ornithine antiporter activity;1870;47;GO:0048731
GO:0015495;gamma-aminobutyric acid:proton symporter activity;10;12;GO:0009913
GO:0015494;aromatic amino acid:proton symporter activity;0;0;GO:0009765
GO:0015493;lysine:proton symporter activity;0;1;GO:0043169
GO:0015492;phenylalanine:proton symporter activity;0;0;GO:0004497
GO:0052482;defense response by cell wall thickening;118;25;GO:0048468
GO:0052472;modulation by host of symbiont transcription;121;21;GO:0048316
GO:1904000;positive regulation of eating behavior;66;139;GO:0004089
GO:1904005;regulation of phospholipase D activity;0;0;GO:0009908
GO:1904004;positive regulation of sebum secreting cell proliferation;0;2;GO:0004721
GO:1904003;negative regulation of sebum secreting cell proliferation;47;4;GO:0010033
GO:1904002;regulation of sebum secreting cell proliferation;95;2;GO:0006067
GO:1904007;positive regulation of phospholipase D activity;0;0;GO:0010033
GO:1904006;negative regulation of phospholipase D activity;0;0;GO:0007062
GO:0052489;negative regulation by host of symbiont programmed cell death;2;0;GO:0004721
GO:0052422;modulation by host of symbiont catalytic activity;245;6;GO:0005975
GO:0052381;tRNA dimethylallyltransferase activity;118099;522;GO:0004553
GO:0052373;suppression of symbiont entry into host;39;3;GO:0009952
GO:0052391;induction by symbiont of defense-related host calcium ion flux;4;3;GO:0004721
GO:0052390;induction by symbiont of host innate immune response;9;1;GO:0048608
GO:0052386;cell wall thickening;248;150;GO:0048513
GO:0003410;anterior rotation of the optic cup;0;3;GO:0004723
GO:0003411;cell motility involved in camera-type eye morphogenesis;0;2;GO:0048608
GO:0003401;axis elongation;3448;225;GO:0007568
GO:0003402;planar cell polarity pathway involved in axis elongation;389;42;GO:0048513
GO:0003403;optic vesicle formation;34;4;GO:0004721
GO:0003404;optic vesicle morphogenesis;165;19;GO:0007568
GO:0003405;optic vesicle elongation;38;2;GO:0048731
GO:0003406;retinal pigment epithelium development;749;298;GO:0006464
GO:0003407;neural retina development;7905;662;GO:0048704
GO:0003408;optic cup formation involved in camera-type eye development;13;139;GO:0048193
GO:0003409;optic cup structural organization;9;9;GO:0009952
GO:0015401;urea:sodium symporter activity;0;1;GO:0048771
GO:0015400;low-affinity secondary active ammonium transmembrane transporter activity;0;1;GO:0009952
GO:0003420;regulation of growth plate cartilage chondrocyte proliferation;9;123;GO:0006096
GO:0003421;growth plate cartilage axis specification;61;8;GO:0048771
GO:0003422;growth plate cartilage morphogenesis;167;7;GO:0009952
GO:0003412;establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis;60;6;GO:0048704
GO:0003413;chondrocyte differentiation involved in endochondral bone morphogenesis;785;79;GO:0009987
GO:0003414;chondrocyte morphogenesis involved in endochondral bone morphogenesis;43;4;GO:0048704
GO:0003415;chondrocyte hypertrophy;390;69;GO:0048316
GO:0003416;endochondral bone growth;1709;272;GO:0009081
GO:0003417;growth plate cartilage development;1330;249;GO:0009908
GO:0003418;growth plate cartilage chondrocyte differentiation;423;32;GO:0005524
GO:0003419;growth plate cartilage chondrocyte proliferation;173;198;GO:0009909
GO:0198738;cell-cell signaling by wnt;261138;504;GO:0004073
GO:0003400;regulation of COPII vesicle coating;1896;74;GO:0009909
GO:1904731;positive regulation of intestinal lipid absorption;109;1;GO:0009579
GO:1904730;negative regulation of intestinal lipid absorption;228;5;GO:0009986
GO:1904735;regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase;89;1;GO:0010033
GO:1904734;positive regulation of electron transfer activity;22;1;GO:0006749
GO:1904733;negative regulation of electron transfer activity;5;3;GO:0009813
GO:1904732;regulation of electron transfer activity;34;1;GO:0009913
GO:1904738;vascular associated smooth muscle cell migration;946;10;GO:0009865
GO:1904737;positive regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase;0;1;GO:0004842
GO:1904736;negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase;89;1;GO:0004842
GO:0050310;sulfite dehydrogenase activity;877;3;GO:0004073
GO:0050312;sulfoacetaldehyde lyase activity;0;2;GO:0003929
GO:0050311;sulfite reductase (ferredoxin) activity;10999;77;GO:0005986
GO:1904729;regulation of intestinal lipid absorption;613;23;GO:0006066
GO:0050318;tannase activity;41;3;GO:0006066
GO:0050317;tagatose kinase activity;8;4;GO:0048707
GO:0050319;tartrate decarboxylase activity;2650;3;GO:0048608
GO:0050314;sym-norspermidine synthase activity;14;3;GO:0004073
GO:2000594;positive regulation of metanephric DCT cell differentiation;27;112;GO:0048471
GO:0050313;sulfur dioxygenase activity;32082;7;GO:0048608
GO:2000595;regulation of optic nerve formation;6;4;GO:0004721
GO:0050316;T2-induced deoxynucleotide kinase activity;1;4;GO:0048471
GO:2000596;negative regulation of optic nerve formation;0;0;GO:0007049
GO:0050315;synephrine dehydratase activity;0;4;GO:0045944
GO:2000597;positive regulation of optic nerve formation;6;5;GO:0006032
GO:1904742;regulation of telomeric DNA binding;6;86;GO:0048471
GO:1904746;negative regulation of apoptotic process involved in development;377;3;GO:0048608
GO:1904745;Atg1/ULK1 kinase complex assembly;16;2;GO:0048608
GO:1904744;positive regulation of telomeric DNA binding;3;10;GO:0003723
GO:1904743;negative regulation of telomeric DNA binding;3;5;GO:0048193
GO:1904749;regulation of protein localization to nucleolus;433;47;GO:0006096
GO:1904748;regulation of apoptotic process involved in development;808;15;GO:0048608
GO:1904747;positive regulation of apoptotic process involved in development;402;230;GO:0003735
GO:0050321;tau-protein kinase activity;2633;819;GO:0004553
GO:0050320;tartrate epimerase activity;0;3;GO:0048193
GO:0050323;taurine dehydrogenase activity;0;2;GO:0006094
GO:0050322;taurine-2-oxoglutarate transaminase activity;0;3;GO:0042127
GO:0050329;tetrahydroxypteridine cycloisomerase activity;0;3;GO:0010468
GO:0050328;tetrahydroberberine oxidase activity;67;3;GO:0048193
GO:0050325;tauropine dehydrogenase activity;2;3;GO:0048010
GO:0050324;taurocyamine kinase activity;4;3;GO:0045944
GO:0050326;taxifolin 8-monooxygenase activity;1;2;GO:0048608
GO:1904753;negative regulation of vascular associated smooth muscle cell migration;350;193;GO:0048771
GO:1904752;regulation of vascular associated smooth muscle cell migration;806;30;GO:0048608
GO:1904751;positive regulation of protein localization to nucleolus;224;122;GO:0048285
GO:1904750;negative regulation of protein localization to nucleolus;102;6;GO:0048699
GO:1904757;positive regulation of gut granule assembly;8;0;GO:0048285
GO:1904756;negative regulation of gut granule assembly;0;0;GO:0030182
GO:1904755;regulation of gut granule assembly;8;0;GO:0048608
GO:1904754;positive regulation of vascular associated smooth muscle cell migration;456;62;GO:0030182
GO:1904759;protein localization to equatorial microtubule organizing center;0;0;GO:0048285
GO:1904758;protein localization to new growing cell tip;0;0;GO:0048010
GO:0050332;thiamine pyridinylase activity;91;2;GO:0003735
GO:0050331;thiamine-diphosphate kinase activity;0;5;GO:0009734
GO:0050334;thiaminase activity;26550;31;GO:0006096
GO:0050333;thiamine triphosphate phosphatase activity;1599;5;GO:0006096
GO:0050330;theanine hydrolase activity;0;3;GO:0003729
GO:0050339;TTPase activity;0;5;GO:0004091
GO:0050336;thioethanolamine S-acetyltransferase activity;0;3;GO:0045727
GO:0050335;thiocyanate isomerase activity;0;3;GO:0048608
GO:0050338;thiosulfate dehydrogenase activity;116;3;GO:0006096
GO:0050337;thiosulfate-thiol sulfurtransferase activity;313;4;GO:0048193
GO:1904760;regulation of myofibroblast differentiation;290;52;GO:0004073
GO:1902101;positive regulation of metaphase/anaphase transition of cell cycle;1476;1090;GO:0045727
GO:1904764;chaperone-mediated autophagy translocation complex disassembly;29;9;GO:0048608
GO:1902102;regulation of metaphase/anaphase transition of meiotic cell cycle;494;1;GO:0048704
GO:1904763;chaperone-mediated autophagy translocation complex assembly;0;2;GO:0048193
GO:1904762;positive regulation of myofibroblast differentiation;7;5;GO:0006081
GO:1902100;negative regulation of metaphase/anaphase transition of cell cycle;18951;857;GO:0048285
GO:1904761;negative regulation of myofibroblast differentiation;225;115;GO:0048667
GO:1902105;regulation of leukocyte differentiation;20794;573;GO:0004497
GO:1904768;all-trans-retinol binding;112;1;GO:0006099
GO:1902106;negative regulation of leukocyte differentiation;5769;97;GO:0048405
GO:1904767;octanoic acid binding;0;1;GO:0048699
GO:1902103;negative regulation of metaphase/anaphase transition of meiotic cell cycle;415;1;GO:0016569
GO:1902104;positive regulation of metaphase/anaphase transition of meiotic cell cycle;76;1;GO:0042981
GO:1902109;negative regulation of mitochondrial membrane permeability involved in apoptotic process;105;40;GO:0006096
GO:1902107;positive regulation of leukocyte differentiation;10371;194;GO:0048661
GO:1902108;regulation of mitochondrial membrane permeability involved in apoptotic process;2523;594;GO:0006096
GO:1904769;isopentadecanoic acid binding;0;0;GO:0048661
GO:0050343;trans-2-enoyl-CoA reductase (NAD+) activity;11985;0;GO:0030518
GO:0050342;tocopherol O-methyltransferase activity;139;8;GO:0006096
GO:0050345;trans-epoxysuccinate hydrolase activity;0;3;GO:0048193
GO:0050344;trans-cinnamate 2-monooxygenase activity;0;3;GO:0004721
GO:0050341;thymine dioxygenase activity;119;4;GO:0048608
GO:0050340;thymidylate 5'-phosphatase activity;63;1;GO:0006066
GO:0050346;trans-L-3-hydroxyproline dehydratase activity;737;5;GO:0048407
GO:0050349;triacetate-lactonase activity;0;3;GO:0048608
GO:0050348;trehalose O-mycolyltransferase activity;2301;4;GO:0048405
GO:0052933;alcohol dehydrogenase (cytochrome c(L)) activity;889;0;GO:0048704
GO:0052934;alcohol dehydrogenase (cytochrome c) activity;489;2;GO:0048608
GO:1904702;regulation of protein localization to adherens junction;63;5;GO:0048608
GO:1904701;Wnt-Frizzled-LRP5/6 complex assembly;64;2;GO:0045727
GO:1904700;granulosa cell apoptotic process;82;1;GO:0003700
GO:1904706;negative regulation of vascular associated smooth muscle cell proliferation;1040;223;GO:0005768
GO:1904705;regulation of vascular associated smooth muscle cell proliferation;2498;10;GO:0045727
GO:1904704;positive regulation of protein localization to adherens junction;0;0;GO:0043005
GO:1904703;negative regulation of protein localization to adherens junction;7;0;GO:0010401
GO:1904713;beta-catenin destruction complex binding;108;9;GO:0048704
GO:1904712;positive regulation of Wnt-Frizzled-LRP5/6 complex assembly;0;1;GO:0010401
GO:1904711;regulation of Wnt-Frizzled-LRP5/6 complex assembly;64;1;GO:0048704
GO:1904710;positive regulation of granulosa cell apoptotic process;4;0;GO:0005765
GO:1904717;regulation of AMPA glutamate receptor clustering;217;6;GO:0043005
GO:1904716;positive regulation of chaperone-mediated autophagy;59;2;GO:0005768
GO:1904715;negative regulation of chaperone-mediated autophagy;109;22;GO:0009516
GO:1904714;regulation of chaperone-mediated autophagy;247;86;GO:0048608
GO:1904709;negative regulation of granulosa cell apoptotic process;2;0;GO:0048667
GO:1904708;regulation of granulosa cell apoptotic process;82;3;GO:0009952
GO:1904707;positive regulation of vascular associated smooth muscle cell proliferation;1410;873;GO:0048731
GO:1904724;tertiary granule lumen;55;704;GO:0009065
GO:1904723;negative regulation of Wnt-Frizzled-LRP5/6 complex assembly;64;3;GO:0009065
GO:1904728;positive regulation of replicative senescence;1;2;GO:0048704
GO:1904727;negative regulation of replicative senescence;0;1;GO:0006030
GO:1904726;regulation of replicative senescence;1;2;GO:0009061
GO:0050301;streptomycin-6-phosphatase activity;13;3;GO:0048316
GO:1904719;positive regulation of AMPA glutamate receptor clustering;26;80;GO:0009060
GO:0050300;aminoglycoside 6-kinase activity;282;3;GO:0009908
GO:1904718;negative regulation of AMPA glutamate receptor clustering;0;0;GO:0009061
GO:0050307;sucrose-phosphate phosphatase activity;3309;9;GO:0048706
GO:0050306;sucrose 1F-fructosyltransferase activity;33;4;GO:0006749
GO:0050309;sugar-terminal-phosphatase activity;4526;37;GO:0006096
GO:0050308;sugar-phosphatase activity;174826;202;GO:0009065
GO:0050303;lysine 6-dehydrogenase activity;249;3;GO:0048704
GO:0050302;indole-3-acetaldehyde oxidase activity;35;7;GO:0006730
GO:0050305;strombine dehydrogenase activity;5;3;GO:0048704
GO:0050304;nitrous-oxide reductase activity;9000;9;GO:0006730
GO:1902152;positive regulation of response to DNA integrity checkpoint signaling;0;0;GO:0009065
GO:1902153;regulation of response to DNA damage checkpoint signaling;55;2;GO:0006022
GO:1902151;regulation of response to DNA integrity checkpoint signaling;55;0;GO:0004867
GO:1902156;positive regulation of response to G1 DNA damage checkpoint signaling;0;0;GO:0004867
GO:1902157;regulation of response to G2 DNA damage checkpoint signaling;0;0;GO:0009062
GO:1902154;positive regulation of response to DNA damage checkpoint signaling;0;0;GO:0009952
GO:1902155;regulation of response to G1 DNA damage checkpoint signaling;0;0;GO:0009061
GO:1902158;positive regulation of response to G2 DNA damage checkpoint signaling;0;0;GO:0048608
GO:1902159;regulation of cyclic nucleotide-gated ion channel activity;6;4;GO:0048608
GO:0050398;wax-ester hydrolase activity;0;3;GO:0048608
GO:0050397;Watasenia-luciferin 2-monooxygenase activity;0;3;GO:0004089
GO:0050399;xanthommatin reductase activity;0;3;GO:0006541
GO:0050394;viomycin kinase activity;8;3;GO:0048316
GO:0050393;vinylacetyl-CoA delta-isomerase activity;194;3;GO:0004730
GO:0050396;vomifoliol 4'-dehydrogenase activity;0;0;GO:0006541
GO:0050395;vitexin beta-glucosyltransferase activity;0;3;GO:0048316
GO:1902163;negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;4;1;GO:0009065
GO:1902164;positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;221;182;GO:0048316
GO:1902161;positive regulation of cyclic nucleotide-gated ion channel activity;2;8;GO:0032502
GO:1902162;regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;282;9;GO:0006544
GO:1902167;positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;86;8;GO:0009908
GO:1902168;response to catechin;14;4;GO:0048608
GO:1902165;regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;820;7;GO:0048316
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;646;283;GO:0004866
GO:1902169;cellular response to catechin;0;0;GO:0006541
GO:1902160;negative regulation of cyclic nucleotide-gated ion channel activity;4;2;GO:0048608
GO:1902174;positive regulation of keratinocyte apoptotic process;216;21;GO:0003906
GO:1902175;regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;2338;103;GO:0006565
GO:1902172;regulation of keratinocyte apoptotic process;376;19;GO:0048316
GO:1902173;negative regulation of keratinocyte apoptotic process;43;6;GO:0004067
GO:1902178;fibroblast growth factor receptor apoptotic signaling pathway;54;8;GO:0006541
GO:1902179;verruculogen metabolic process;18;0;GO:0009953
GO:1902176;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;1683;376;GO:0046686
GO:1902177;positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;443;37;GO:0008544
GO:1902170;cellular response to reactive nitrogen species;567;114;GO:0032502
GO:1902171;regulation of tocopherol cyclase activity;2;0;GO:0048608
GO:1902185;positive regulation of shoot apical meristem development;1;1;GO:0048699
GO:1902183;regulation of shoot apical meristem development;216;8;GO:0007430
GO:1902184;negative regulation of shoot apical meristem development;54;1;GO:0007417
GO:1902189;2-methylbutanoyl-CoA(4-) metabolic process;1;0;GO:0006066
GO:1902181;verruculogen biosynthetic process;18;0;GO:0008610
GO:1902182;shoot apical meristem development;270;2;GO:0006094
GO:1904770;intramembranous bone morphogenesis;0;0;GO:0006629
GO:1902112;cellular response to diethyl maleate;0;0;GO:0009060
GO:1904775;positive regulation of ubiquinone biosynthetic process;1;0;GO:0048316
GO:1904774;negative regulation of ubiquinone biosynthetic process;0;0;GO:0009062
GO:1902110;positive regulation of mitochondrial membrane permeability involved in apoptotic process;2171;452;GO:0048608
GO:1902111;response to diethyl maleate;0;1;GO:0009064
GO:1904772;response to tetrachloromethane;71;78;GO:0048608
GO:1902116;negative regulation of organelle assembly;10037;326;GO:0004091
GO:1904779;regulation of protein localization to centrosome;589;67;GO:0006879
GO:1902117;positive regulation of organelle assembly;7591;47;GO:0006066
GO:1904778;positive regulation of protein localization to cell cortex;341;70;GO:0006826
GO:1902114;D-valine metabolic process;18;1;GO:0006066
GO:1904777;negative regulation of protein localization to cell cortex;45;1;GO:0009628
GO:1902115;regulation of organelle assembly;45144;287;GO:0009062
GO:1904776;regulation of protein localization to cell cortex;513;230;GO:0009739
GO:1902118;calcidiol binding;52;2;GO:0007565
GO:1902119;regulation of meiotic spindle elongation;6;0;GO:0043170
GO:0050354;triokinase activity;2078;8;GO:0004067
GO:0050353;trimethyllysine dioxygenase activity;3634;132;GO:0006511
GO:0050356;tropine dehydrogenase activity;101;9;GO:0004746
GO:0050355;inorganic triphosphate phosphatase activity;9605;3;GO:0004746
GO:0050350;trihydroxystilbene synthase activity;377;9;GO:0006826
GO:0050352;trimethylamine-oxide aldolase activity;1;4;GO:0004723
GO:0050351;trimetaphosphatase activity;0;4;GO:0004734
GO:0050358;tropinone reductase activity;22;7;GO:0048666
GO:0050357;tropinesterase activity;731;8;GO:0048731
GO:0050359;tropomyosin kinase activity;1;7;GO:0048699
GO:1904782;negative regulation of NMDA glutamate receptor activity;5;8;GO:0007565
GO:1902120;negative regulation of meiotic spindle elongation;6;0;GO:0009059
GO:1904781;positive regulation of protein localization to centrosome;387;140;GO:0003700
GO:1904780;negative regulation of protein localization to centrosome;130;3;GO:0004723
GO:1902123;(-)-pinoresinol catabolic process;3;1;GO:0003700
GO:1904786;negative regulation of asymmetric protein localization involved in cell fate determination;0;2;GO:0004730
GO:1902124;(+)-pinoresinol metabolic process;8;3;GO:0004734
GO:1904785;regulation of asymmetric protein localization involved in cell fate determination;42;4;GO:0004723
GO:1902121;lithocholic acid binding;58;4;GO:0004497
GO:1904784;NLRP1 inflammasome complex assembly;48;7;GO:0003729
GO:1902122;chenodeoxycholic acid binding;62;38;GO:0008544
GO:1904783;positive regulation of NMDA glutamate receptor activity;10;10;GO:0004553
GO:1902127;(-)-lariciresinol metabolic process;7;2;GO:0006066
GO:1902128;(-)-lariciresinol catabolic process;3;1;GO:0008565
GO:0050370;tyrosine N-monooxygenase activity;0;2;GO:0006099
GO:1902125;(+)-pinoresinol catabolic process;8;1;GO:0045944
GO:1902126;(+)-pinoresinol biosynthetic process;0;0;GO:0045944
GO:1904787;positive regulation of asymmetric protein localization involved in cell fate determination;9;1;GO:0045944
GO:1902129;(-)-lariciresinol biosynthetic process;4;2;GO:0048193
GO:0003693;P-element binding;15;4;GO:0045727
GO:0003696;satellite DNA binding;91;214;GO:0045727
GO:0001025;RNA polymerase III general transcription initiation factor binding;320;1;GO:0045727
GO:0003697;single-stranded DNA binding;480451;5610;GO:0004721
GO:0052610;beta-cryptoxanthin hydroxylase activity;2;1;GO:0004721
GO:0003688;DNA replication origin binding;102547;2190;GO:0003700
GO:0052611;beta-carotene 3-hydroxylase activity;2;1;GO:0008610
GO:0003689;DNA clamp loader activity;17135;1010;GO:0003700
GO:0052618;coenzyme F420-0:L-glutamate ligase activity;7376;4;GO:0004497
GO:0039639;suppression by virus of host cell lysis in response to superinfection;0;3;GO:0003700
GO:0052619;coenzyme F420-1:gamma-L-glutamate ligase activity;5042;4;GO:0003700
GO:0052616;ent-kaur-16-en-19-ol oxidase activity;12;2;GO:0003700
GO:0052617;ent-kaur-16-en-19-al oxidase activity;12;2;GO:0004553
GO:0015669;gas transport;172313;725;GO:0006096
GO:0039636;suppression by virus of host cell wall biogenesis;5;3;GO:0006073
GO:0052614;uracil oxygenase activity;1175;1;GO:0006869
GO:0015668;type III site-specific deoxyribonuclease activity;6396;4;GO:0004721
GO:0039635;suppression by virus of host peptidoglycan biosynthetic process;3;2;GO:0006869
GO:0052615;ent-kaurene oxidase activity;730;2;GO:0004721
GO:0015667;site-specific DNA-methyltransferase (cytosine-N4-specific) activity;45986;4;GO:0006865
GO:0039638;lipopolysaccharide-mediated virion attachment to host cell;3;2;GO:0008565
GO:0052612;adonirubin 3-hydroxylase activity;0;1;GO:0006830
GO:0015666;restriction endodeoxyribonuclease activity;77096;145;GO:0005985
GO:0039637;catabolism by virus of host DNA;406;1;GO:0006865
GO:0052613;canthaxanthin 3-hydroxylase activity;0;0;GO:0005922
GO:0015687;ferric-hydroxamate import into cell;19;1;GO:0006869
GO:0015686;ferric triacetylfusarinine C import into cell;1;2;GO:0048193
GO:0015685;ferric-enterobactin import into cell;21;3;GO:1901563
GO:0039634;killing by virus of host cell during superinfection exclusion;0;2;GO:0045740
GO:0039630;RNA translocase activity;0;0;GO:0045740
GO:0015680;protein maturation by copper ion transfer;122;9;GO:0000086
GO:0001039;RNA polymerase III hybrid type promoter sequence-specific DNA binding;0;0;GO:0005840
GO:0001046;core promoter sequence-specific DNA binding;7166;1620;GO:0005737
GO:0052621;diguanylate cyclase activity;11840;6;GO:0004721
GO:0052622;ATP dimethylallyltransferase activity;12;1;GO:0043066
GO:0052620;thymine dehydrogenase activity;0;2;GO:0003779
GO:0001042;RNA polymerase I core binding;197;241;GO:0006096
GO:0039629;T=219 icosahedral capsid;0;1;GO:0003906
GO:0052629;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity;3542;92;GO:0006032
GO:0039628;T=169 icosahedral viral capsid;0;1;GO:0003700
GO:0052627;vanillate amino acid synthetase activity;1;1;GO:0008800
GO:0052628;4-hydroxybenzoate amino acid synthetase activity;2;1;GO:0048193
GO:0039625;viral inner capsid;6049;3;GO:0004091
GO:0052625;4-aminobenzoate amino acid synthetase activity;1;1;GO:0009065
GO:0015679;plasma membrane copper ion transport;147;5;GO:0006830
GO:0039624;viral outer capsid;32476;8;GO:0006865
GO:0052626;benzoate amino acid synthetase activity;1;1;GO:0004553
GO:0039627;T=147 icosahedral capsid;0;1;GO:0005929
GO:0052623;ADP dimethylallyltransferase activity;12;2;GO:0009065
GO:0015677;copper ion import;621;486;GO:0005985
GO:0039626;viral intermediate capsid;7067;5;GO:0008800
GO:0052624;2-phytyl-1,4-naphthoquinone methyltransferase activity;1455;33;GO:0006869
GO:0015654;tellurite transmembrane transporter activity;2;1;GO:0006029
GO:0039621;T=13 icosahedral viral capsid;24114;3;GO:0008565
GO:0015653;glycine betaine:proton symporter activity;1;0;GO:0008544
GO:0039620;T=7 icosahedral viral capsid;9679;4;GO:0006826
GO:0015652;quaternary ammonium group:proton symporter activity;1;2;GO:0043066
GO:0039623;T=25 icosahedral viral capsid;13840;7;GO:0043066
GO:0015651;quaternary ammonium group transmembrane transporter activity;8844;408;GO:0008529
GO:0039622;T=16 icosahedral viral capsid;1308;5;GO:0043066
GO:0015650;lactate:proton symporter activity;127;1;GO:0048608
GO:0001006;RNA polymerase III type 3 promoter sequence-specific DNA binding;709;16;GO:0045944
GO:0003673;obsolete Gene_Ontology;1086762287;3;GO:0045944
GO:0003674;molecular_function;521534069;28500;GO:0003712
GO:0001003;RNA polymerase III type 2 promoter sequence-specific DNA binding;282;102;GO:0045944
GO:0052633;isocitrate hydro-lyase (cis-aconitate-forming) activity;2;6;GO:0003779
GO:0052630;UDP-N-acetylgalactosamine diphosphorylase activity;29;7;GO:0048285
GO:0001010;RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity;66;7;GO:0048285
GO:0052631;sphingolipid delta-8 desaturase activity;36;1;GO:0004553
GO:0039618;T=pseudo3 icosahedral viral capsid;21084;1;GO:0004553
GO:0039617;T=3 icosahedral viral capsid;12846;4;GO:0004497
GO:0015649;2-keto-3-deoxygluconate:proton symporter activity;6723;10;GO:0008800
GO:0052638;indole-3-butyrate beta-glucosyltransferase activity;4;6;GO:0004553
GO:0015648;lipid-linked peptidoglycan transporter activity;51882;9;GO:0004733
GO:0039619;T=4 icosahedral viral capsid;18699;5;GO:0006029
GO:0052639;salicylic acid glucosyltransferase (ester-forming) activity;11;4;GO:0004733
GO:0015647;peptidoglycan transmembrane transporter activity;52007;5;GO:0009065
GO:0052636;arabinosyltransferase activity;3731;10;GO:0004553
GO:0052637;delta 3-trans-hexadecenoic acid phosphatidylglycerol desaturase activity;4;0;GO:0004497
GO:0015645;fatty acid ligase activity;46890;132;GO:0004497
GO:0039616;T=2 icosahedral viral capsid;5611;3;GO:0008565
GO:0052634;C-19 gibberellin 2-beta-dioxygenase activity;384;43;GO:1901169
GO:0039615;T=1 icosahedral viral capsid;37368;4;GO:0004730
GO:0052635;C-20 gibberellin 2-beta-dioxygenase activity;114;6;GO:0006029
GO:0015665;alcohol transmembrane transporter activity;9433;7;GO:0008565
GO:0015663;nicotinamide mononucleotide transmembrane transporter activity;1;456;GO:1901169
GO:0015662;P-type ion transporter activity;301492;112;GO:0004497
GO:0015661;L-lysine efflux transmembrane transporter activity;7077;8;GO:0004553
GO:0015660;formate efflux transmembrane transporter activity;0;2;GO:0006826
GO:0003680;minor groove of adenine-thymine-rich DNA binding;18640;131;GO:0004497
GO:0001019;plastid promoter transcription regulatory region sequence-specific DNA binding;0;1;GO:0006032
GO:0003681;bent DNA binding;1049;34;GO:0008544
GO:0001018;mitochondrial promoter sequence-specific DNA binding;192;7;GO:0004553
GO:0003682;chromatin binding;105764;15300;GO:0006029
GO:0001016;RNA polymerase III transcription regulatory region sequence-specific DNA binding;1369;3;GO:0006091
GO:0003684;damaged DNA binding;355470;5680;GO:0006470
GO:0001015;snoRNA transcription by RNA polymerase II;30;6;GO:0045944
GO:0001014;snoRNA transcription by RNA polymerase III;0;0;GO:0006541
GO:0003676;nucleic acid binding;61338108;31600;GO:0009061
GO:0052643;chlorophyllide metabolic process;0;0;GO:0004723
GO:0003677;DNA binding;31475374;58500;GO:0009061
GO:0052644;chlorophyllide a metabolic process;0;1;GO:0009065
GO:0003678;DNA helicase activity;840294;4620;GO:0004721
GO:0052641;benzoic acid glucosyltransferase activity;16;3;GO:0046395
GO:0052642;lysophosphatidic acid phosphatase activity;292;27;GO:0006730
GO:0052640;salicylic acid glucosyltransferase (glucoside-forming) activity;21;4;GO:0006559
GO:0039606;suppression by virus of host translation initiation;9624;2;GO:0006730
GO:0052649;coenzyme gamma-F420-2 metabolic process;3;1;GO:0004518
GO:0015658;branched-chain amino acid transmembrane transporter activity;172481;392;GO:0006366
GO:0052647;pentitol phosphate metabolic process;95039;0;GO:0006355
GO:0015657;branched-chain amino acid:sodium symporter activity;149;2;GO:0009065
GO:0039602;suppression by virus of host transcription initiation from RNA polymerase II promoter;6;2;GO:0000976
GO:0052648;ribitol phosphate metabolic process;95039;0;GO:0000976
GO:0052645;F420-0 metabolic process;9380;4;GO:0006366
GO:0015655;alanine:sodium symporter activity;275;8;GO:0006351
GO:0039604;suppression by virus of host translation;9635;6;GO:0006412
GO:0052646;alditol phosphate metabolic process;388108;90;GO:0008544
GO:0039687;viral DNA strand displacement replication;825;5;GO:0005737
GO:0039686;bidirectional double-stranded viral DNA replication;4790;4;GO:0005576
GO:0039689;negative stranded viral RNA replication;1625;43;GO:0004497
GO:0039688;viral double stranded DNA replication via reverse transcription;0;1;GO:0005576
GO:0039683;rolling circle double-stranded viral DNA replication;0;1;GO:0005576
GO:0039682;rolling circle viral DNA replication;17;1;GO:0004650
GO:0039685;rolling hairpin viral DNA replication;3;1;GO:0003729
GO:0039684;rolling circle single-stranded viral DNA replication;17;3;GO:0004518
GO:0039680;actin-dependent intracellular transport of virus towards nucleus;5;2;GO:0000786
GO:0001069;regulatory region RNA binding;109;234;GO:0000976
GO:0001079;nitrogen catabolite regulation of transcription from RNA polymerase II promoter;103;10;GO:0003700
GO:0001073;transcription antitermination factor activity, DNA binding;2332;5;GO:0006032
GO:0001072;transcription antitermination factor activity, RNA binding;22;52;GO:0004067
GO:0001070;RNA-binding transcription regulator activity;26222;7;GO:0004721
GO:0039679;viral occlusion body;817;5;GO:0004497
GO:0039675;exit of virus from host cell nucleus through nuclear pore;117670;5;GO:0004721
GO:0039678;viral genome ejection through host cell envelope;6799;6;GO:0004721
GO:0039677;exit of virus from host cell nucleus via nuclear envelope disassembly;0;1;GO:0004497
GO:0039672;suppression by virus of host natural killer cell activation;1;1;GO:0004721
GO:0039671;evasion by virus of host natural killer cell activity;9;3;GO:0004497
GO:0039674;exit of virus from host cell nucleus;118709;3;GO:0048285
GO:0039673;evasion by virus of host dendritic cell activity;4;3;GO:0004497
GO:0039670;viral capsid, turret;0;1;GO:0010467
GO:0001081;nitrogen catabolite repression of transcription from RNA polymerase II promoter;2;2;GO:0004497
GO:0001080;nitrogen catabolite activation of transcription from RNA polymerase II promoter;98;7;GO:0046395
GO:0039669;viral entry into host cell via pilus retraction and membrane fusion;0;3;GO:0004467
GO:0039668;viral entry into host cell via pilus basal pore;4;3;GO:0046395
GO:0015698;inorganic anion transport;2215009;2400;GO:0005840
GO:0039665;permeabilization of host organelle membrane involved in viral entry into host cell;12485;6;GO:0009061
GO:0015697;quaternary ammonium group transport;52246;521;GO:0009065
GO:0039664;lysis of host organelle involved in viral entry into host cell;1325;14;GO:0048193
GO:0039667;viral entry into host cell via pilus retraction;54;3;GO:0004497
GO:0015695;organic cation transport;192292;1190;GO:0048193
GO:0039666;virion attachment to host cell pilus;2454;6;GO:0006081
GO:0015694;mercury ion transport;30945;27;GO:0005746
GO:0039661;host organelle outer membrane;629;0;GO:0004553
GO:0015693;magnesium ion transport;395276;2170;GO:0019316
GO:0039660;structural constituent of virion;144767;10;GO:0007600
GO:0015692;lead ion transport;158;66;GO:0006081
GO:0039663;membrane fusion involved in viral entry into host cell;1165397;227;GO:0006099
GO:0015691;cadmium ion transport;3991;181;GO:0006631
GO:0039662;host cell outer membrane;1;1;GO:0004067
GO:0015690;aluminum cation transport;20;3;GO:0046395
GO:0001049;RNA polymerase V core binding;0;0;GO:0004721
GO:0001048;RNA polymerase IV core binding;0;0;GO:0006099
GO:0001057;RNA polymerase IV activity;0;1;GO:0004553
GO:0001056;RNA polymerase III activity;5498;638;GO:0006073
GO:0001055;RNA polymerase II activity;5065;352;GO:0004497
GO:0001054;RNA polymerase I activity;5476;411;GO:0004721
GO:0001052;plastid PEP RNA polymerase core enzyme binding;7;0;GO:0009086
GO:0001051;plastid single-subunit type RNA polymerase binding;0;0;GO:0004497
GO:0001050;single-subunit type RNA polymerase binding;0;0;GO:0009579
GO:0039658;TBK1-IKKE-DDX3 complex;0;0;GO:0006073
GO:0039657;suppression by virus of host gene expression;771321;19;GO:0046394
GO:0015689;molybdate ion transport;177368;758;GO:0006986
GO:0039654;fusion of virus membrane with host endosome membrane;519889;48;GO:0005576
GO:0039653;suppression by virus of host transcription;376350;7;GO:0005840
GO:0039656;modulation by virus of host gene expression;850253;7;GO:0010467
GO:0039652;induction by virus of host NF-kappaB cascade;14713;5;GO:0005840
GO:0052609;4-ketotorulene 3-hydroxylase activity;0;0;GO:0010467
GO:0001059;transcription by RNA polymerase IV;0;1;GO:0022610
GO:0001058;RNA polymerase V activity;0;1;GO:0002576
GO:0001068;transcription regulatory region RNA binding;6;1;GO:0004734
GO:0001067;transcription regulatory region nucleic acid binding;269857;815;GO:0002576
GO:0052600;propane-1,3-diamine oxidase activity;6;5;GO:0006570
GO:0001066;plastid single subunit type RNA polymerase activity;0;0;GO:0009725
GO:0001065;mitochondrial single subunit type RNA polymerase activity;6;0;GO:0046395
GO:0001064;single subunit type RNA polymerase activity;6;1;GO:0009725
GO:0001060;transcription by RNA polymerase V;5;1;GO:0008021
GO:0052607;7-hydroxy-chlorophyllide a oxygenase activity;0;1;GO:0004497
GO:0052608;echinenone 3-hydroxylase activity;0;0;GO:0004553
GO:0052605;gamma-tocopherol cyclase activity;1;1;GO:0015031
GO:0052606;chlorophyllide a oxygenase activity;0;1;GO:0008544
GO:0052603;1-chloro-4-nitrosobenzene nitroreductase activity;0;0;GO:0009065
GO:0039646;perturbation by virus of host G0/G1 transition checkpoint;1801;3;GO:0009065
GO:0052604;delta-tocopherol cyclase activity;1;1;GO:0010467
GO:0052601;(S)-limonene 1,2-monooxygenase activity;1376;0;GO:0000910
GO:0015699;antimonite transport;99;7;GO:0004730
GO:0039648;modulation by symbiont of host protein ubiquitination;21547;7;GO:0005737
GO:0052602;4-chloronitrobenzene nitroreductase activity;0;0;GO:0004723
GO:1904210;VCP-NPL4-UFD1 AAA ATPase complex assembly;24;1;GO:0004601
GO:0062025;regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;96;1;GO:0004721
GO:0062026;negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process;96;5;GO:0004073
GO:0062027;positive regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process;0;2;GO:0008037
GO:1904214;positive regulation of iodide transmembrane transport;0;0;GO:0034660
GO:0062021;mitotic cohesin dsDNA (leading strand) loading;0;0;GO:0005576
GO:1904213;negative regulation of iodide transmembrane transport;2;4;GO:0045944
GO:0062022;mitotic cohesin ssDNA (lagging strand) loading;0;0;GO:0048285
GO:1904212;regulation of iodide transmembrane transport;2;0;GO:0006366
GO:0062023;collagen-containing extracellular matrix;82338;4670;GO:0048285
GO:1904211;membrane protein proteolysis involved in retrograde protein transport, ER to cytosol;111;21;GO:0042632
GO:1904218;negative regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;0;0;GO:0016570
GO:1904217;regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;10;25;GO:0048285
GO:0050040;lactate 2-monooxygenase activity;464;3;GO:0030199
GO:1904216;positive regulation of protein import into chloroplast stroma;86;3;GO:0048285
GO:1904215;regulation of protein import into chloroplast stroma;91;0;GO:0010717
GO:0062028;regulation of stress granule assembly;488;3;GO:0048285
GO:0062029;positive regulation of stress granule assembly;242;6;GO:0050729
GO:1990130;GATOR1 complex;2217;12;GO:0048285
GO:1990131;Gtr1-Gtr2 GTPase complex;2702;255;GO:0010717
GO:1904219;positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;10;253;GO:0004722
GO:0050035;L-sorbose oxidase activity;0;3;GO:0004553
GO:0052698;ergothioneine metabolic process;45079;2;GO:0008610
GO:0050034;L-rhamnose 1-dehydrogenase activity;37;3;GO:0006081
GO:0052699;ergothioneine biosynthetic process;45079;7;GO:0004067
GO:0050037;L-xylose 1-dehydrogenase activity;1;3;GO:0006099
GO:0052696;flavonoid glucuronidation;39;353;GO:0004073
GO:1990124;messenger ribonucleoprotein complex;615;229;GO:0006073
GO:0050036;L-threonate 3-dehydrogenase activity;0;3;GO:0004073
GO:0052697;xenobiotic glucuronidation;54;205;GO:0009065
GO:1990125;DiaA complex;0;0;GO:0009579
GO:0050031;L-pipecolate oxidase activity;167;6;GO:0009579
GO:0052694;jasmonoyl-isoleucine-12-hydroxylase activity;7;2;GO:0009062
GO:0050030;L-pipecolate dehydrogenase activity;4;3;GO:0046395
GO:0052695;cellular glucuronidation;448;1810;GO:0048193
GO:1990127;intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator;181;1;GO:0015031
GO:0050033;L-rhamnono-1,4-lactonase activity;3;2;GO:0008092
GO:0052692;raffinose alpha-galactosidase activity;10671;28;GO:0007186
GO:0050032;L-rhamnonate dehydratase activity;6569;5;GO:0008092
GO:0052693;epoxyqueuosine reductase activity;68222;150;GO:0008021
GO:0062030;negative regulation of stress granule assembly;139;6;GO:0005215
GO:0050039;lactaldehyde reductase (NADPH) activity;1;4;GO:0005788
GO:0050038;L-xylulose reductase (NADP+) activity;245;0;GO:0007186
GO:0062013;positive regulation of small molecule metabolic process;7820;92;GO:0003729
GO:0086002;cardiac muscle cell action potential involved in contraction;4028;741;GO:0003700
GO:1904221;negative regulation of serine C-palmitoyltransferase activity;0;0;GO:0004553
GO:0062014;negative regulation of small molecule metabolic process;21246;53;GO:0007186
GO:0086003;cardiac muscle cell contraction;4901;50;GO:0048193
GO:1904220;regulation of serine C-palmitoyltransferase activity;17;7;GO:0004721
GO:0086001;cardiac muscle cell action potential;8467;806;GO:0003824
GO:0086006;voltage-gated sodium channel activity involved in cardiac muscle cell action potential;688;80;GO:0046395
GO:1904225;positive regulation of glucuronosyltransferase activity;0;1;GO:0004721
GO:0062010;primitive palate development;0;1;GO:0006096
GO:0086007;voltage-gated calcium channel activity involved in cardiac muscle cell action potential;328;86;GO:0004723
GO:1904224;negative regulation of glucuronosyltransferase activity;8;148;GO:0006099
GO:0062011;mitochondrial respiratory chain complex IV pre-assembly complex;0;2;GO:0005525
GO:0086004;regulation of cardiac muscle cell contraction;1431;796;GO:0008610
GO:1904223;regulation of glucuronosyltransferase activity;8;1;GO:0004721
GO:0062012;regulation of small molecule metabolic process;66301;524;GO:0004723
GO:0086005;ventricular cardiac muscle cell action potential;2233;795;GO:0044419
GO:1904222;positive regulation of serine C-palmitoyltransferase activity;12;169;GO:0046395
GO:1904229;regulation of succinate dehydrogenase activity;15;1;GO:0046395
GO:1904228;positive regulation of glycogen synthase activity, transferring glucose-1-phosphate;0;1;GO:0004867
GO:0050051;leukotriene-B4 20-monooxygenase activity;77;44;GO:0048608
GO:0086008;voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization;929;159;GO:0003700
GO:1904227;negative regulation of glycogen synthase activity, transferring glucose-1-phosphate;1;1;GO:0048285
GO:0050050;leucine N-acetyltransferase activity;0;4;GO:0048010
GO:0086009;membrane repolarization;5067;519;GO:0010942
GO:1904226;regulation of glycogen synthase activity, transferring glucose-1-phosphate;1;1;GO:0048010
GO:1990140;MPT synthase complex;2;0;GO:0048285
GO:1990143;CoA-synthesizing protein complex;42;5;GO:0048285
GO:0050046;delta7-sterol 5(6)-desaturase activity;71;0;GO:0048285
GO:1990133;molybdopterin cofactor (Moco) biosynthesis adenylyltransferase complex;2;1;GO:0048285
GO:0050045;laminaribiose phosphorylase activity;2;3;GO:0048285
GO:1990134;epithelial cell apoptotic process involved in palatal shelf morphogenesis;43;3;GO:0003729
GO:0050048;L-leucine:2-oxoglutarate aminotransferase activity;29226;4;GO:0048285
GO:1990135;flavonoid sulfotransferase activity;6;1;GO:0045727
GO:0050047;leucine 2,3-aminomutase activity;0;3;GO:0048285
GO:1990136;linoleate 9S-lipoxygenase activity;198;6;GO:0006096
GO:0050042;lactate-malate transhydrogenase activity;0;2;GO:0004723
GO:1990137;plant seed peroxidase activity;59;4;GO:0004553
GO:0050041;lactate aldolase activity;0;2;GO:0006021
GO:1990138;neuron projection extension;10717;1210;GO:0006032
GO:0050044;galactose-6-phosphate isomerase activity;5523;79;GO:0006073
GO:1990139;protein localization to nuclear periphery;24;2;GO:0006029
GO:0050043;lactate racemase activity;14443;9;GO:0004725
GO:0050049;leucine dehydrogenase activity;862;3;GO:0004553
GO:0086010;membrane depolarization during action potential;3076;3300;GO:0003824
GO:0062046;dehydropipecolic acid reductase;44;0;GO:0005576
GO:1904232;regulation of aconitate hydratase activity;4;1;GO:0004553
GO:0062047;pipecolic acid N-hydroxylase;4;0;GO:0005524
GO:1904231;positive regulation of succinate dehydrogenase activity;15;3;GO:0004553
GO:0062048;lymphotoxin complex;0;0;GO:0004553
GO:1904230;negative regulation of succinate dehydrogenase activity;0;1;GO:0006032
GO:0062049;protein phosphatase inhibitor complex;23;1;GO:0004721
GO:0062042;regulation of cardiac epithelial to mesenchymal transition;366;5;GO:0004721
GO:1904236;negative regulation of substrate-dependent cell migration, cell attachment to substrate;0;1;GO:0006032
GO:0062043;positive regulation of cardiac epithelial to mesenchymal transition;303;10;GO:0004723
GO:1904235;regulation of substrate-dependent cell migration, cell attachment to substrate;117;150;GO:0006032
GO:0062044;negative regulation of cardiac epithelial to mesenchymal transition;57;0;GO:0045727
GO:1904234;positive regulation of aconitate hydratase activity;3;4;GO:0016567
GO:0062045;L-lysine alpha-aminotransferase;40;0;GO:0016567
GO:1904233;negative regulation of aconitate hydratase activity;1;2;GO:0006464
GO:0050060;long-chain-alcohol dehydrogenase activity;233;3;GO:0048285
GO:1904239;regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly;24;0;GO:0004553
GO:0050062;long-chain-fatty-acyl-CoA reductase activity;2348;34;GO:0045737
GO:1904238;pericyte cell differentiation;555;10;GO:0006032
GO:0050061;long-chain-aldehyde dehydrogenase activity;142;5;GO:0005976
GO:1904237;positive regulation of substrate-dependent cell migration, cell attachment to substrate;117;44;GO:0004553
GO:1990150;VEGF-A complex;43;2;GO:0005976
GO:1990151;protein localization to cell tip;45;1;GO:0004721
GO:1990153;maintenance of protein localization to heterochromatin;0;0;GO:1901363
GO:1990154;enzyme IIA-maltose transporter complex;4;5;GO:0004721
GO:0050057;linamarin synthase activity;4;6;GO:0005976
GO:1990144;intrinsic apoptotic signaling pathway in response to hypoxia;386;228;GO:0006032
GO:0050056;linalool 8-monooxygenase activity;77;5;GO:0006091
GO:1990145;maintenance of translational fidelity;177;26;GO:0006021
GO:0001099;basal RNA polymerase II transcription machinery binding;20890;31;GO:0006032
GO:0050059;lombricine kinase activity;6;3;GO:0006032
GO:1990146;protein localization to rhabdomere;57;2;GO:0006032
GO:0001098;basal transcription machinery binding;20896;81;GO:0004553
GO:0050058;linoleate isomerase activity;11;3;GO:0004725
GO:1990147;talin binding;54;2;GO:0009081
GO:0001097;TFIIH-class transcription factor complex binding;324;8;GO:0004553
GO:0050053;levansucrase activity;2725;10;GO:0006081
GO:1990148;glutamate dehydrogenase complex;1;1;GO:0004553
GO:0001096;TFIIF-class transcription factor complex binding;176;4;GO:0048608
GO:0050052;leukotriene-E4 20-monooxygenase activity;0;2;GO:0006954
GO:0001095;TFIIE-class transcription factor complex binding;10;3;GO:0004930
GO:0050055;limonin-D-ring-lactonase activity;0;3;GO:0006954
GO:0001094;TFIID-class transcription factor complex binding;563;173;GO:0045944
GO:0050054;lignostilbene alpha beta-dioxygenase activity;15;4;GO:0006631
GO:0001093;TFIIB-class transcription factor binding;202;66;GO:0006865
GO:0001092;TFIIA-class transcription factor complex binding;79;3;GO:0005840
GO:0062050;GPI-mannose ethanolamine phosphate phosphodiesterase activity;11;2;GO:0050921
GO:0001091;RNA polymerase II general transcription initiation factor binding;7020;38;GO:0005576
GO:0062051;lipopolysaccharide transport system;0;2;GO:0050921
GO:0062052;starch granule initiation;99;2;GO:0016569
GO:0039698;polyadenylation of viral mRNA by polymerase stuttering;0;1;GO:0002684
GO:0062035;sensory perception of cold stimulus;52;0;GO:0042493
GO:1904243;negative regulation of pancreatic trypsinogen secretion;0;0;GO:0042493
GO:0039697;negative stranded viral RNA transcription;253839;1;GO:0006836
GO:0062036;sensory perception of hot stimulus;49;0;GO:0006865
GO:1904242;regulation of pancreatic trypsinogen secretion;2;0;GO:0009062
GO:0062037;D-loop DNA binding;267;9;GO:0005524
GO:1904241;positive regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly;0;0;GO:0005576
GO:0039699;viral mRNA cap methylation;0;3;GO:0004725
GO:0062038;positive regulation of pheromone response MAPK cascade;40;5;GO:0004553
GO:1904240;negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly;24;0;GO:0004730
GO:0039694;viral RNA genome replication;420624;366;GO:0004553
GO:0062031;filamentous growth MAPK cascade;0;1;GO:0004746
GO:1904247;positive regulation of polynucleotide adenylyltransferase activity;11;27;GO:0004553
GO:0039693;viral DNA genome replication;31691;26;GO:0004725
GO:0062032;cichorine biosynthetic process;7;0;GO:0004553
GO:1904246;negative regulation of polynucleotide adenylyltransferase activity;5;1;GO:0004723
GO:0039696;RNA-templated viral transcription;255211;8;GO:0004553
GO:0062033;positive regulation of mitotic sister chromatid segregation;532;7;GO:0004553
GO:1904245;regulation of polynucleotide adenylyltransferase activity;16;8;GO:0009065
GO:0039695;DNA-templated viral transcription;463;7;GO:0004553
GO:0062034;L-pipecolic acid biosynthetic process;92;1;GO:0004449
GO:1904244;positive regulation of pancreatic trypsinogen secretion;2;1;GO:0004553
GO:0039690;positive stranded viral RNA replication;527;4;GO:0009065
GO:0050071;phosphatidylglycerol lysyltransferase activity;13331;2;GO:0004601
GO:0050070;lysolecithin acylmutase activity;0;3;GO:0046395
GO:0039692;single stranded viral RNA replication via double stranded DNA intermediate;647;16;GO:0006073
GO:0050073;macrolide 2'-kinase activity;1;0;GO:0006631
GO:1904249;negative regulation of age-related resistance;0;2;GO:0006631
GO:1990160;DnaB-DnaC-Rep-PriC complex;4;2;GO:0005768
GO:0039691;double stranded viral RNA replication;0;2;GO:0006954
GO:1904248;regulation of age-related resistance;4;2;GO:0009615
GO:1990161;DnaB helicase complex;0;0;GO:0006631
GO:0062039;biofilm matrix;732;5;GO:0006631
GO:1990162;histone H3K4 deacetylase activity;40;0;GO:0048285
GO:1990165;single-strand break-containing DNA binding;102;4;GO:0005737
GO:0050068;lysine carbamoyltransferase activity;0;3;GO:0006836
GO:1990155;Dsc E3 ubiquitin ligase complex assembly;0;0;GO:0006631
GO:0050067;lysine 2-monooxygenase activity;47;3;GO:0006457
GO:1990156;DnaB-DnaG complex;2;2;GO:0006073
GO:1990157;DnaA-DnaB-DnaC complex;0;0;GO:0006974
GO:0050069;lysine dehydrogenase activity;0;2;GO:0006974
GO:1990158;DnaB-DnaC-DnaT-PriA-PriB complex;6;2;GO:0009941
GO:0050064;luteolin 7-O-glucuronosyltransferase activity;0;3;GO:0005840
GO:1990159;DnaB-DnaC-DnaT-PriA-PriC complex;5;3;GO:0004721
GO:0050066;lysine 2,3-aminomutase activity;4216;6;GO:0004518
GO:0050065;lysine-pyruvate 6-transaminase activity;0;3;GO:0004518
GO:0062040;fungal biofilm matrix;410;5;GO:0004721
GO:0062041;positive regulation of meiotic sister chromatid arm separation;0;0;GO:0004784
GO:1990170;stress response to cadmium ion;592;5;GO:0003954
GO:1990171;SCF complex disassembly in response to cadmium stress;4;5;GO:0004497
GO:1990172;G protein-coupled receptor catabolic process;70;7;GO:0009579
GO:1990173;protein localization to nucleoplasm;278;91;GO:0004721
GO:1990174;phosphodiesterase decapping endonuclease activity;257;5;GO:0004553
GO:1990175;EH domain binding;54;56;GO:0008021
GO:1990176;MalFGK2 complex;0;0;GO:0008021
GO:0052654;L-leucine transaminase activity;43669;193;GO:0008021
GO:1990166;protein localization to site of double-strand break;329;9;GO:0044427
GO:0052655;L-valine transaminase activity;72886;306;GO:0003735
GO:1990167;protein K27-linked deubiquitination;14;55;GO:0009952
GO:0052652;cyclic purine nucleotide metabolic process;121560;166;GO:0007565
GO:1990168;protein K33-linked deubiquitination;19;9;GO:0007420
GO:0052653;3',5'-cyclic diguanylic acid metabolic process;0;1;GO:0004812
GO:1990169;stress response to copper ion;455;152;GO:0005576
GO:0052650;NADP-retinol dehydrogenase activity;1760;126;GO:0042802
GO:0052651;monoacylglycerol catabolic process;396;164;GO:0005929
GO:0052658;inositol-1,4,5-trisphosphate 5-phosphatase activity;3070;42;GO:0004872
GO:0052659;inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity;2935;19;GO:0048308
GO:0052656;L-isoleucine transaminase activity;72886;299;GO:0004930
GO:0052657;guanine phosphoribosyltransferase activity;34121;8;GO:0005929
GO:1990180;mitochondrial tRNA 3'-end processing;274;4;GO:0007186
GO:1990181;acetyl-CoA biosynthetic process from pantothenate;5;2;GO:0048608
GO:1990182;exosomal secretion;1231;178;GO:0005576
GO:1990183;lymphatic vascular process in circulatory system;4;1;GO:0048507
GO:1990184;amino acid transport complex;121;5;GO:0005929
GO:1990185;regulation of lymphatic vascular permeability;0;0;GO:0005929
GO:1990186;regulation of lymphatic vessel size;4;2;GO:0048507
GO:0050002;D-proline reductase (dithiol) activity;1324;3;GO:0048407
GO:0052665;tRNA (uracil-2'-O-)-methyltransferase activity;5484;0;GO:0006091
GO:1990177;IHF-DNA complex;2;3;GO:0012501
GO:0050001;D-glutaminase activity;1;3;GO:0043066
GO:0052666;tRNA (cytosine-2'-O-)-methyltransferase activity;9712;0;GO:0048608
GO:1990178;HU-DNA complex;3;1;GO:0048608
GO:0050004;isoflavone 7-O-glucosyltransferase activity;16;4;GO:0045944
GO:1990179;protein localization to actomyosin contractile ring;17;0;GO:0045944
GO:0050003;deoxycytidylate C-methyltransferase activity;0;3;GO:0007186
GO:0052664;nitroalkane oxidase activity;37;1;GO:0045944
GO:0052661;S-lactaldehyde reductase activity;2;1;GO:0006067
GO:0052662;zeaxanthin epoxidase activity;890;5;GO:0048608
GO:0050000;chromosome localization;32759;232;GO:0004730
GO:0052660;R-lactaldehyde reductase activity;2;1;GO:0048608
GO:0050009;isopropanol dehydrogenase (NADP+) activity;156;0;GO:0048507
GO:0050006;isomaltulose synthase activity;13;3;GO:0005576
GO:0050005;isohexenylglutaconyl-CoA hydratase activity;34;5;GO:0048608
GO:0050008;isopiperitenone delta-isomerase activity;0;3;GO:0000724
GO:0052667;phosphomethylethanolamine N-methyltransferase activity;98;2;GO:0048608
GO:0050007;isonocardicin synthase activity;1;3;GO:0007186
GO:0052668;CTP:farnesol kinase activity;26;2;GO:0048608
GO:0062002;regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity;1;1;GO:0048010
GO:0062003;negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity;1;2;GO:0006661
GO:0062000;positive regulation of cardiac endothelial to mesenchymal transition;49;2;GO:0002080
GO:0062001;negative regulation of cardiac endothelial to mesenchymal transition;0;0;GO:0030516
GO:1990190;peptide-glutamate-alpha-N-acetyltransferase activity;143;2;GO:0048407
GO:1990191;cobalamin transport complex;3;1;GO:0008021
GO:0052680;epi-isozizaene synthase activity;16;2;GO:0002026
GO:1990192;collecting lymphatic vessel constriction;4;0;GO:0048608
GO:1990193;BtuCD complex;2;2;GO:0008021
GO:1990194;cytoplasmic U snRNP body assembly;12;2;GO:0008092
GO:1990195;macrolide transmembrane transporter complex;11831;92;GO:0008092
GO:1990196;MacAB-TolC complex;6;3;GO:0006936
GO:1990197;methionine-importing ABC transporter complex;3;1;GO:0008092
GO:0062009;secondary palate development;1100;12;GO:0008092
GO:1990198;ModE complex;1;1;GO:0006281
GO:0050013;2-dehydropantoate aldolase activity;0;3;GO:0042254
GO:0052676;3-methylbutanol:NAD oxidoreductase activity;1;2;GO:0010467
GO:1990188;euchromatin binding;82;9;GO:0048285
GO:0050012;juglone 3-hydroxylase activity;0;2;GO:0048285
GO:0052677;D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity;2;0;GO:0016021
GO:1990189;peptide-serine-alpha-N-acetyltransferase activity;346;2;GO:0016021
GO:0050015;kievitone hydratase activity;3;4;GO:0004067
GO:0052674;ent-pimara-9(11),15-diene synthase activity;6;2;GO:0048771
GO:0050014;ketotetrose-phosphate aldolase activity;45;3;GO:0006313
GO:0052675;3-methylbutanol:NADP oxidoreductase activity;1;1;GO:0005819
GO:0052672;CTP:geranylgeraniol kinase activity;3;1;GO:0010942
GO:0052673;prenol kinase activity;79;2;GO:0006313
GO:0050011;itaconyl-CoA hydratase activity;28;5;GO:0004721
GO:0052670;geraniol kinase activity;22;0;GO:0048608
GO:0050010;isovitexin beta-glucosyltransferase activity;0;4;GO:0008092
GO:0052671;geranylgeraniol kinase activity;29;0;GO:0048193
GO:0050017;L-3-cyanoalanine synthase activity;83;8;GO:0007067
GO:0050016;kynurenine 7,8-hydroxylase activity;1;3;GO:0048608
GO:0050019;L-arabinitol 4-dehydrogenase activity;37;3;GO:0048507
GO:0052678;levopimaradiene synthase activity;15;2;GO:0005578
GO:0050018;L-amino-acid dehydrogenase activity;0;3;GO:0048169
GO:0052679;terpentetriene synthase activity;3;2;GO:0030529
GO:1904203;positive regulation of iodide transport;0;0;GO:0005765
GO:1904202;negative regulation of iodide transport;2;0;GO:0048316
GO:1904201;regulation of iodide transport;2;0;GO:0007154
GO:1904200;iodide transmembrane transport;127;1;GO:0007154
GO:0052690;trichloro-p-hydroquinone reductive dehalogenase activity;1;3;GO:0008092
GO:0052691;UDP-arabinopyranose mutase activity;1118;4;GO:0008026
GO:1904206;positive regulation of skeletal muscle hypertrophy;63;5;GO:0007517
GO:1904205;negative regulation of skeletal muscle hypertrophy;40;0;GO:0048193
GO:1904204;regulation of skeletal muscle hypertrophy;103;7;GO:0005986
GO:2000907;negative regulation of glucomannan catabolic process;0;0;GO:0007218
GO:2000908;positive regulation of glucomannan catabolic process;0;0;GO:0045944
GO:2000909;regulation of sterol import;0;6;GO:0015986
GO:0050024;L-galactonolactone oxidase activity;5;4;GO:0050840
GO:0052687;(3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity;0;0;GO:0048608
GO:1990199;MsbA transporter complex;1;2;GO:0043169
GO:2000903;cellooligosaccharide catabolic process;0;1;GO:0008033
GO:0050023;L-fuconate dehydratase activity;10733;6;GO:0007042
GO:0052688;(3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity;0;0;GO:0003723
GO:2000904;regulation of starch metabolic process;542;7;GO:0048193
GO:0050026;L-glycol dehydrogenase activity;0;2;GO:0005667
GO:0052685;perillic acid-CoA ligase (ADP-forming) activity;0;2;GO:0048193
GO:2000905;negative regulation of starch metabolic process;6;4;GO:0008544
GO:0050025;L-glutamate oxidase activity;9;3;GO:0007610
GO:0052686;perillic acid-CoA ligase (AMP-forming) activity;0;0;GO:0005524
GO:2000906;positive regulation of starch metabolic process;0;2;GO:0045944
GO:0050020;L-arabinonate dehydratase activity;657;4;GO:0030518
GO:0052683;(Z)-gamma-bisabolene synthase activity;4;0;GO:0045202
GO:0052684;L-serine hydro-lyase (adding indole, L-tryptophan-forming) activity;99;3;GO:0045944
GO:2000900;cyclodextrin metabolic process;54;1;GO:0044421
GO:0050022;L-arabinose 1-dehydrogenase (NAD+) activity;133;0;GO:0004721
GO:0052681;alpha-bisabolene synthase activity;6;2;GO:0006936
GO:2000901;cyclodextrin catabolic process;0;0;GO:0050789
GO:0050021;L-arabinonolactonase activity;421;3;GO:0008021
GO:0052682;epi-cedrol synthase activity;4;3;GO:0008021
GO:2000902;cellooligosaccharide metabolic process;0;1;GO:0048608
GO:0050028;L-lysine-lactamase activity;0;3;GO:0048608
GO:0052689;carboxylic ester hydrolase activity;1497771;1840;GO:0009579
GO:0050029;L-lysine oxidase activity;5;3;GO:0048471
GO:1904177;regulation of adipose tissue development;558;8;GO:0048608
GO:1904176;carbon phosphorus lyase complex;11;1;GO:0048193
GO:1904179;positive regulation of adipose tissue development;353;89;GO:0048407
GO:1904178;negative regulation of adipose tissue development;170;6;GO:0005515
GO:2000918;regulation of glucuronoarabinoxylan catabolic process;0;0;GO:0048608
GO:2000919;negative regulation of glucuronoarabinoxylan catabolic process;0;0;GO:0008021
GO:2000914;positive regulation of galactoglucomannan catabolic process;0;0;GO:0006414
GO:2000915;regulation of glucuronoxylan catabolic process;0;0;GO:0048608
GO:2000916;negative regulation of glucuronoxylan catabolic process;0;0;GO:0016567
GO:2000917;positive regulation of glucuronoxylan catabolic process;0;0;GO:0005524
GO:2000910;negative regulation of sterol import;0;5;GO:0003735
GO:2000911;positive regulation of sterol import;0;2;GO:0008092
GO:2000912;regulation of galactoglucomannan catabolic process;0;0;GO:0043161
GO:2000913;negative regulation of galactoglucomannan catabolic process;0;0;GO:0000786
GO:1904172;positive regulation of bleb assembly;108;10;GO:0043169
GO:1904171;negative regulation of bleb assembly;4;6;GO:0008092
GO:1904170;regulation of bleb assembly;112;5;GO:0007067
GO:1904188;negative regulation of transformation of host cell by virus;7;7;GO:0009536
GO:1904187;regulation of transformation of host cell by virus;73;3;GO:0006836
GO:1904186;post-anaphase microtubule array organization;0;0;GO:0006032
GO:1904185;equatorial microtubule organizing center assembly;0;0;GO:0006032
GO:1904189;positive regulation of transformation of host cell by virus;64;3;GO:0006032
GO:2000929;positive regulation of cellodextrin catabolic process;0;0;GO:0006081
GO:2000925;negative regulation of cellodextrin metabolic process;0;1;GO:0009063
GO:2000926;positive regulation of cellodextrin metabolic process;3;0;GO:0016021
GO:2000927;regulation of cellodextrin catabolic process;0;0;GO:0009579
GO:2000928;negative regulation of cellodextrin catabolic process;0;0;GO:0005515
GO:2000921;regulation of arabinoxylan-containing compound catabolic process;0;0;GO:0044436
GO:2000922;negative regulation of arabinoxylan-containing compound catabolic process;0;0;GO:0005765
GO:2000923;positive regulation of arabinoxylan-containing compound catabolic process;0;0;GO:0006950
GO:2000924;regulation of cellodextrin metabolic process;3;0;GO:0006081
GO:1904180;negative regulation of membrane depolarization;244;9;GO:0045944
GO:2000920;positive regulation of glucuronoarabinoxylan catabolic process;0;0;GO:0048608
GO:1904184;positive regulation of pyruvate dehydrogenase activity;0;6;GO:0004067
GO:1904183;negative regulation of pyruvate dehydrogenase activity;0;3;GO:0008629
GO:1904182;regulation of pyruvate dehydrogenase activity;3;3;GO:0010468
GO:1904181;positive regulation of membrane depolarization;371;23;GO:0016032
GO:1904199;positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization;4;2;GO:0004672
GO:1904198;negative regulation of regulation of vascular associated smooth muscle cell membrane depolarization;0;0;GO:0048608
GO:1904197;positive regulation of granulosa cell proliferation;46;3;GO:0005515
GO:1904196;negative regulation of granulosa cell proliferation;2;1;GO:0004067
GO:2000936;regulation of cellotriose catabolic process;0;2;GO:0042803
GO:2000937;negative regulation of cellotriose catabolic process;0;1;GO:0030520
GO:2000938;positive regulation of cellotriose catabolic process;0;1;GO:0006099
GO:2000939;regulation of plant-type cell wall cellulose catabolic process;0;0;GO:0005524
GO:2000932;positive regulation of cellobiose metabolic process;0;0;GO:0030518
GO:2000933;regulation of cellotriose metabolic process;0;1;GO:0006099
GO:2000934;negative regulation of cellotriose metabolic process;0;1;GO:0005524
GO:2000935;positive regulation of cellotriose metabolic process;0;0;GO:0048608
GO:1904191;positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in meiotic nuclear division;0;0;GO:0004067
GO:2000930;regulation of cellobiose metabolic process;0;0;GO:0016021
GO:2000931;negative regulation of cellobiose metabolic process;0;0;GO:0005615
GO:1904195;regulation of granulosa cell proliferation;48;0;GO:0048608
GO:1904194;positive regulation of cholangiocyte apoptotic process;0;0;GO:0005576
GO:1904193;negative regulation of cholangiocyte apoptotic process;8;4;GO:0016569
GO:1904192;regulation of cholangiocyte apoptotic process;31;0;GO:0048193
GO:2000947;positive regulation of amylopectin catabolic process;0;0;GO:0045944
GO:2000948;regulation of xyloglucan metabolic process;0;2;GO:0030518
GO:2000949;negative regulation of xyloglucan metabolic process;0;1;GO:0009555
GO:2000943;negative regulation of amylopectin metabolic process;0;1;GO:0010468
GO:2000944;positive regulation of amylopectin metabolic process;0;1;GO:0007155
GO:2000945;regulation of amylopectin catabolic process;0;0;GO:0005515
GO:2000946;negative regulation of amylopectin catabolic process;0;0;GO:0048407
GO:2000940;negative regulation of plant-type cell wall cellulose catabolic process;0;0;GO:0005576
GO:2000941;positive regulation of plant-type cell wall cellulose catabolic process;0;0;GO:0048407
GO:2000942;regulation of amylopectin metabolic process;0;1;GO:0000976
GO:1904133;regulation of convergent extension involved in rhombomere morphogenesis;0;0;GO:0048507
GO:1904132;positive regulation of convergent extension involved in neural plate elongation;0;0;GO:0009060
GO:1904131;negative regulation of convergent extension involved in neural plate elongation;0;0;GO:0048407
GO:1904130;regulation of convergent extension involved in neural plate elongation;0;0;GO:0009813
GO:1904137;negative regulation of convergent extension involved in notochord morphogenesis;0;0;GO:0003700
GO:1904136;regulation of convergent extension involved in notochord morphogenesis;0;0;GO:0048407
GO:1904135;positive regulation of convergent extension involved in rhombomere morphogenesis;0;0;GO:0008565
GO:1904134;negative regulation of convergent extension involved in rhombomere morphogenesis;0;0;GO:0003677
GO:1904139;regulation of microglial cell migration;300;176;GO:0006936
GO:1904138;positive regulation of convergent extension involved in notochord morphogenesis;0;0;GO:0048407
GO:2000958;negative regulation of cyclodextrin catabolic process;0;0;GO:0005525
GO:2000959;positive regulation of cyclodextrin catabolic process;0;0;GO:0005216
GO:2000954;regulation of cyclodextrin metabolic process;0;1;GO:0015979
GO:2000955;negative regulation of cyclodextrin metabolic process;0;2;GO:0048407
GO:2000956;positive regulation of cyclodextrin metabolic process;0;1;GO:0048608
GO:2000957;regulation of cyclodextrin catabolic process;0;0;GO:0048407
GO:2000950;positive regulation of xyloglucan metabolic process;0;2;GO:0004089
GO:2000951;regulation of xyloglucan catabolic process;0;1;GO:0004721
GO:2000952;negative regulation of xyloglucan catabolic process;0;1;GO:0004497
GO:2000953;positive regulation of xyloglucan catabolic process;0;1;GO:0004871
GO:1904144;phosphatidylinositol phosphate phosphatase complex;2;0;GO:0004497
GO:1904143;positive regulation of carotenoid biosynthetic process;147;1;GO:0005743
GO:1904142;negative regulation of carotenoid biosynthetic process;0;2;GO:0044427
GO:1904141;positive regulation of microglial cell migration;203;234;GO:0006826
GO:1904148;cellular response to nonylphenol;1;0;GO:0044436
GO:1904147;response to nonylphenol;1;1;GO:0006631
GO:1904146;positive regulation of meiotic cell cycle process involved in oocyte maturation;27;0;GO:0005125
GO:1904145;negative regulation of meiotic cell cycle process involved in oocyte maturation;14;1;GO:0004497
GO:1904149;regulation of microglial cell mediated cytotoxicity;140;1;GO:0043169
GO:2000969;positive regulation of AMPA receptor activity;13;19;GO:0005525
GO:2000965;positive regulation of cellooligosaccharide catabolic process;0;0;GO:0006879
GO:2000966;regulation of cell wall polysaccharide catabolic process;3;0;GO:0004067
GO:2000967;negative regulation of cell wall polysaccharide catabolic process;0;1;GO:0043169
GO:2000968;positive regulation of cell wall polysaccharide catabolic process;3;0;GO:0005524
GO:2000961;negative regulation of cellooligosaccharide metabolic process;0;1;GO:0005764
GO:2000962;positive regulation of cellooligosaccharide metabolic process;0;1;GO:0042803
GO:2000963;regulation of cellooligosaccharide catabolic process;0;0;GO:0008033
GO:2000964;negative regulation of cellooligosaccharide catabolic process;0;0;GO:0010817
GO:1904140;negative regulation of microglial cell migration;47;3;GO:0004553
GO:2000960;regulation of cellooligosaccharide metabolic process;0;1;GO:0042303
GO:1904155;DN2 thymocyte differentiation;130;74;GO:0000786
GO:1904154;positive regulation of retrograde protein transport, ER to cytosol;274;9;GO:0048608
GO:1904153;negative regulation of retrograde protein transport, ER to cytosol;511;81;GO:0016021
GO:1904152;regulation of retrograde protein transport, ER to cytosol;788;110;GO:0005509
GO:1904159;megasporocyte differentiation;3;1;GO:0042165
GO:1904158;axonemal central apparatus assembly;383;101;GO:0005524
GO:1904157;DN4 thymocyte differentiation;59;10;GO:0004067
GO:1904156;DN3 thymocyte differentiation;15;6;GO:0042303
GO:1990110;callus formation;286;132;GO:0005743
GO:1990100;DnaB-DnaC complex;2;3;GO:0010468
GO:1990101;DnaA-oriC complex;2;1;GO:0004067
GO:1990102;DnaA-DiaA complex;2;1;GO:0016021
GO:1990103;DnaA-HU complex;3;2;GO:0005764
GO:1990104;DNA bending complex;6;9;GO:0030520
GO:2000977;regulation of forebrain neuron differentiation;212;8;GO:0006066
GO:2000978;negative regulation of forebrain neuron differentiation;103;60;GO:0008643
GO:1990107;thiazole synthase activity;17151;127;GO:0048608
GO:2000979;positive regulation of forebrain neuron differentiation;57;173;GO:0004067
GO:1990108;protein linear deubiquitination;37;7;GO:0044436
GO:2000972;positive regulation of detection of glucose;9;0;GO:0004872
GO:1990109;rejection of pollen from other species;3;1;GO:0010467
GO:2000973;regulation of pro-B cell differentiation;434;35;GO:0045944
GO:2000974;negative regulation of pro-B cell differentiation;117;34;GO:0048608
GO:2000975;positive regulation of pro-B cell differentiation;61;1;GO:0005515
GO:1904151;positive regulation of microglial cell mediated cytotoxicity;127;9;GO:0048407
GO:1904150;negative regulation of microglial cell mediated cytotoxicity;13;5;GO:0010467
GO:2000970;regulation of detection of glucose;9;3;GO:0005576
GO:2000971;negative regulation of detection of glucose;0;2;GO:0048608
GO:1990120;messenger ribonucleoprotein complex assembly;199;6;GO:0005576
GO:1990121;H-NS complex;1;1;GO:0030518
GO:1990111;spermatoproteasome complex;256;207;GO:0008021
GO:1990112;RQC complex;9650;27;GO:0048608
GO:1990113;RNA polymerase I assembly;111;1;GO:0048407
GO:1990114;RNA polymerase II core complex assembly;200;4;GO:0048407
GO:1990115;RNA polymerase III assembly;112;2;GO:0048407
GO:2000987;positive regulation of behavioral fear response;130;9;GO:0008629
GO:1990116;ribosome-associated ubiquitin-dependent protein catabolic process;10045;18;GO:0048407
GO:2000988;regulation of hemicellulose catabolic process;3;0;GO:0048407
GO:1990117;B cell receptor apoptotic signaling pathway;99;6;GO:0048010
GO:2000989;negative regulation of hemicellulose catabolic process;0;1;GO:0048407
GO:1990119;RNA helicase inhibitor activity;5;1;GO:0048010
GO:2000983;regulation of ATP citrate synthase activity;4;1;GO:0007186
GO:2000984;negative regulation of ATP citrate synthase activity;1;2;GO:0048010
GO:2000985;positive regulation of ATP citrate synthase activity;1;1;GO:0048608
GO:2000986;negative regulation of behavioral fear response;2;0;GO:0010468
GO:1904161;DNA synthesis involved in UV-damage excision repair;145;8;GO:0007631
GO:2000980;regulation of inner ear receptor cell differentiation;563;6;GO:0007186
GO:1904160;protein localization to chloroplast starch grain;0;0;GO:0044822
GO:2000981;negative regulation of inner ear receptor cell differentiation;279;9;GO:0044822
GO:2000982;positive regulation of inner ear receptor cell differentiation;126;3;GO:0048305
GO:2000998;negative regulation of cellulose catabolic process;0;2;GO:0005576
GO:2000999;positive regulation of cellulose catabolic process;3;1;GO:0048666
GO:2000994;regulation of mannan catabolic process;0;0;GO:0048193
GO:2000995;negative regulation of mannan catabolic process;0;0;GO:0004089
GO:2000996;positive regulation of mannan catabolic process;0;0;GO:0004497
GO:2000997;regulation of cellulose catabolic process;3;1;GO:0006470
GO:2000990;positive regulation of hemicellulose catabolic process;3;0;GO:0006030
GO:2000991;regulation of galactomannan catabolic process;0;0;GO:0043161
GO:2000992;negative regulation of galactomannan catabolic process;0;0;GO:0048193
GO:2000993;positive regulation of galactomannan catabolic process;0;1;GO:0004474
GO:0015631;tubulin binding;341759;3080;GO:0043161
GO:0015630;microtubule cytoskeleton;1136393;7430;GO:0048193
GO:0015629;actin cytoskeleton;384842;7000;GO:0004067
GO:0015628;protein secretion by the type II secretion system;157955;612;GO:0005576
GO:0015627;type II protein secretion system complex;161132;237;GO:0048193
GO:0015626;L-diaminopimelate transmembrane transporter activity;0;2;GO:0016829
GO:0015625;ABC-type ferric hydroxamate transporter activity;5;3;GO:0048193
GO:0015624;ABC-type ferric-enterobactin transporter activity;0;5;GO:0006914
GO:0015643;toxic substance binding;12076;618;GO:0010467
GO:0015640;peptidoglycan peptide transmembrane transporter activity;1;1;GO:0007586
GO:0001002;RNA polymerase III type 1 promoter sequence-specific DNA binding;279;181;GO:0010817
GO:0001001;mitochondrial single-subunit type RNA polymerase binding;0;1;GO:0005743
GO:0001000;bacterial-type RNA polymerase core enzyme binding;16624;4;GO:0010817
GO:0015638;microcin transmembrane transporter activity;2;1;GO:0000786
GO:0015636;short-chain fatty acid transmembrane transporter activity;212;3;GO:0010817
GO:0015633;ABC-type zinc transporter activity;5481;10;GO:0008021
GO:0015608;carbohydrate-importing ABC transporter activity;2;0;GO:0046356
GO:0015607;ABC-type fatty-acyl-CoA transporter activity;62;5;GO:0006986
GO:0015606;spermidine transmembrane transporter activity;3804;10;GO:0005576
GO:0015605;organophosphate ester transmembrane transporter activity;57218;51;GO:0043161
GO:0015603;iron chelate transmembrane transporter activity;147;1;GO:0010467
GO:0015621;ferric triacetylfusarinine C transmembrane transporter activity;0;1;GO:0005783
GO:0015620;ferric-enterobactin transmembrane transporter activity;10;2;GO:0007623
GO:0015616;DNA translocase activity;51759;259;GO:0045202
GO:0015615;D-allose-importing ATPase activity;1;1;GO:0007218
GO:0015614;ABC-type D-xylose transporter activity;3617;3;GO:0009555
GO:0015612;ABC-type L-arabinose transporter activity;2298;7;GO:0048407
GO:0015611;ABC-type D-ribose transporter activity;136;3;GO:0006631
GO:0015313;fluconazole:proton antiporter activity;0;0;GO:0007186
GO:0042932;chrysobactin transport;0;4;GO:0009536
GO:0015312;polyamine:proton antiporter activity;57;1;GO:0007186
GO:0042933;chrysobactin transmembrane transporter activity;0;0;GO:0005524
GO:0015311;monoamine:proton antiporter activity;282;4;GO:0007186
GO:0042934;achromobactin transmembrane transporter activity;0;2;GO:0006631
GO:0015310;benomyl:proton antiporter activity;0;0;GO:0006081
GO:0042935;achromobactin transport;4;6;GO:0016570
GO:0042937;tripeptide transmembrane transporter activity;5061;6;GO:0006099
GO:0042938;dipeptide transport;38004;355;GO:0048285
GO:1990090;cellular response to nerve growth factor stimulus;1293;747;GO:0005768
GO:0042939;tripeptide transport;10143;47;GO:0048285
GO:1990091;sodium-dependent self proteolysis;2;1;GO:0008030
GO:0005990;lactose catabolic process;12893;38;GO:0042803
GO:1990092;calcium-dependent self proteolysis;61;2;GO:0005768
GO:0005992;trehalose biosynthetic process;92453;2260;GO:0016021
GO:0003330;regulation of extracellular matrix constituent secretion;464;42;GO:0005737
GO:0005991;trehalose metabolic process;159811;787;GO:0016021
GO:0003331;positive regulation of extracellular matrix constituent secretion;184;56;GO:0009611
GO:0005994;melibiose metabolic process;3;4;GO:0010468
GO:0003332;negative regulation of extracellular matrix constituent secretion;185;10;GO:0043405
GO:0005993;trehalose catabolic process;12563;121;GO:0010468
GO:1990097;SeqA-DNA complex;1;0;GO:0010468
GO:0003333;amino acid transmembrane transport;760040;2070;GO:0010468
GO:0005996;monosaccharide metabolic process;2017797;2790;GO:0004872
GO:0042930;enterobactin transport;2590;157;GO:0010468
GO:1990098;core primosome complex;2;1;GO:0004872
GO:0003334;keratinocyte development;1587;1160;GO:0005576
GO:0005995;melibiose catabolic process;3;5;GO:0010468
GO:0042931;enterobactin transmembrane transporter activity;1294;122;GO:0046395
GO:1990099;pre-primosome complex;17;5;GO:0010468
GO:0003324;pancreatic D cell development;38;3;GO:0046395
GO:0005987;sucrose catabolic process;3741;36;GO:0010468
GO:0030943;mitochondrion targeting sequence binding;545;36;GO:0004930
GO:1990089;response to nerve growth factor;1304;97;GO:0048193
GO:0003325;pancreatic PP cell development;0;3;GO:0002449
GO:0005986;sucrose biosynthetic process;6294;728;GO:0008021
GO:0030942;endoplasmic reticulum signal peptide binding;10853;86;GO:0010468
GO:0003326;pancreatic A cell fate commitment;105;9;GO:0003729
GO:0005989;lactose biosynthetic process;666;272;GO:0003964
GO:0030945;protein tyrosine phosphatase activity, via thiol-phosphate intermediate;1;0;GO:0003964
GO:0003327;type B pancreatic cell fate commitment;53;2;GO:0003723
GO:0005988;lactose metabolic process;28079;36;GO:0003797
GO:0030944;DDEL sequence binding;0;2;GO:0045765
GO:0003328;pancreatic D cell fate commitment;0;2;GO:0003723
GO:0030947;regulation of vascular endothelial growth factor receptor signaling pathway;1360;402;GO:0006849
GO:0003329;pancreatic PP cell fate commitment;104;8;GO:0045765
GO:0030946;protein tyrosine phosphatase activity, metal-dependent;87;2;GO:0004518
GO:0030949;positive regulation of vascular endothelial growth factor receptor signaling pathway;461;423;GO:0006830
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway;536;263;GO:0045765
GO:0015309;cycloheximide:proton antiporter activity;0;1;GO:0003723
GO:0015306;sialate:monoatomic cation symporter activity;0;0;GO:0006879
GO:0015304;glucose uniporter activity;9;4;GO:0006865
GO:0030941;chloroplast targeting sequence binding;279;1;GO:0003735
GO:0015324;peptide-acetyl-CoA secondary active transmembrane transporter activity;0;1;GO:0006826
GO:0042943;D-amino acid transmembrane transporter activity;21543;10;GO:0006099
GO:0042944;D-alanine transmembrane transporter activity;1;0;GO:0006826
GO:0015322;secondary active oligopeptide transmembrane transporter activity;129;7;GO:0046394
GO:0042945;D-serine transmembrane transporter activity;3;4;GO:0006865
GO:0042946;glucoside transport;429;10;GO:0046394
GO:0042947;glucoside transmembrane transporter activity;214;7;GO:0006826
GO:0042948;salicin transport;60;3;GO:0006874
GO:0042949;arbutin transport;18;2;GO:0048608
GO:0003340;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;59;67;GO:0006830
GO:0003341;cilium movement;45553;2670;GO:0048608
GO:0003342;proepicardium development;233;98;GO:0048608
GO:0003343;septum transversum development;233;8;GO:0006873
GO:0042940;D-amino acid transport;41793;34;GO:0006029
GO:0003344;pericardium morphogenesis;514;96;GO:0003735
GO:0042941;D-alanine transport;130;8;GO:0006073
GO:0003345;proepicardium cell migration involved in pericardium morphogenesis;60;51;GO:0006091
GO:0042942;D-serine transport;86;11;GO:0006869
GO:0003335;corneocyte development;160;7;GO:0006865
GO:0005998;xylulose catabolic process;16012;8;GO:0006096
GO:0030932;amyloplast ADPG pyrophosphorylase complex;0;2;GO:0006032
GO:0003336;corneocyte desquamation;110;7;GO:0006865
GO:0005997;xylulose metabolic process;36469;106;GO:0006032
GO:0030931;heterotetrameric ADPG pyrophosphorylase complex;4;5;GO:0006865
GO:0003337;mesenchymal to epithelial transition involved in metanephros morphogenesis;540;706;GO:0006073
GO:0030934;anchoring collagen complex;6;10;GO:0006865
GO:0003338;metanephros morphogenesis;1895;377;GO:0006073
GO:0005999;xylulose biosynthetic process;1;8;GO:0006869
GO:0030933;chloroplast ADPG pyrophosphorylase complex;0;1;GO:0045765
GO:0003339;regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;238;19;GO:0006865
GO:0030936;transmembrane collagen trimer;2;7;GO:0045735
GO:0030935;sheet-forming collagen trimer;49;2;GO:0015717
GO:0030938;collagen type XVIII trimer;4;1;GO:0045766
GO:0030937;collagen type XVII trimer;0;2;GO:0006830
GO:0015319;sodium:inorganic phosphate symporter activity;76;140;GO:0045735
GO:0015318;inorganic molecular entity transmembrane transporter activity;9908713;622;GO:0003700
GO:0015317;phosphate:proton symporter activity;11;3;GO:0006073
GO:0015315;organophosphate:inorganic phosphate antiporter activity;2923;7;GO:0006073
GO:0030930;homotetrameric ADPG pyrophosphorylase complex;0;1;GO:0003700
GO:0015314;aminotriazole:proton antiporter activity;0;0;GO:0005976
GO:0042955;dextrin transport;0;2;GO:0006032
GO:0042956;maltodextrin transmembrane transport;3191;2;GO:0046395
GO:0042957;dextrin transmembrane transporter activity;0;1;GO:0006094
GO:0042958;maltodextrin transmembrane transporter activity;1559;5;GO:0006032
GO:0042959;alkanesulfonate transmembrane transporter activity;3321;4;GO:0006032
GO:0030929;ADPG pyrophosphorylase complex;4;2;GO:0006032
GO:0042950;salicin transmembrane transporter activity;30;3;GO:0004930
GO:0003310;pancreatic A cell differentiation;854;97;GO:0004930
GO:0005971;ribonucleoside-diphosphate reductase complex;8302;470;GO:0004930
GO:0042951;arbutin transmembrane transporter activity;9;2;GO:0004930
GO:0003311;pancreatic D cell differentiation;220;9;GO:0048316
GO:0042952;beta-ketoadipate pathway;19525;78;GO:0003729
GO:0003312;pancreatic PP cell differentiation;104;3;GO:0003712
GO:0042953;lipoprotein transport;31119;947;GO:0003712
GO:0005965;protein farnesyltransferase complex;6259;38;GO:0003700
GO:0030921;peptidyl-tyrosine dehydrogenation to form (Z)-2,3-didehydrotyrosine;0;0;GO:0005553
GO:0005964;phosphorylase kinase complex;2427;78;GO:0048407
GO:0030920;peptidyl-serine acetylation;2;9;GO:0006869
GO:0003304;myocardial epithelial involution involved in heart jogging;0;2;GO:0008544
GO:0005967;mitochondrial pyruvate dehydrogenase complex;889;144;GO:1902535
GO:0003305;cell migration involved in heart jogging;1;5;GO:0008528
GO:0030922;peptidyl-tyrosine dehydrogenation to form (E)-2,3-didehydrotyrosine;0;0;GO:0048608
GO:0003306;Wnt signaling pathway involved in heart development;1014;6;GO:0045944
GO:0005969;serine-pyruvate aminotransferase complex;43;10;GO:0003700
GO:0003307;regulation of Wnt signaling pathway involved in heart development;564;5;GO:0003774
GO:0005968;Rab-protein geranylgeranyltransferase complex;10423;256;GO:0000976
GO:0003308;negative regulation of Wnt signaling pathway involved in heart development;398;286;GO:0000976
GO:0003309;type B pancreatic cell differentiation;2232;225;GO:0000976
GO:0042966;biotin carboxyl carrier protein biosynthetic process;3;4;GO:0016032
GO:0042968;homoserine transport;22;3;GO:0008565
GO:0030917;midbrain-hindbrain boundary development;1308;51;GO:0016032
GO:0005981;regulation of glycogen catabolic process;463;95;GO:0006869
GO:0005980;glycogen catabolic process;40155;1530;GO:0016021
GO:0030919;peptidyl-serine O-acetylation;2;2;GO:0006836
GO:0042960;antimonite secondary active transmembrane transporter activity;3;2;GO:0016021
GO:0003320;heart rudiment involution;0;2;GO:0006836
GO:0005983;starch catabolic process;1334;333;GO:0016032
GO:0042961;ATPase-coupled antimonite transmembrane transporter activity;0;1;GO:0006836
GO:0003321;positive regulation of blood pressure by epinephrine-norepinephrine;346;10;GO:0006820
GO:0005982;starch metabolic process;27979;686;GO:0005634
GO:0042962;acridine:proton antiporter activity;0;2;GO:0006836
GO:0003322;pancreatic A cell development;185;29;GO:0005737
GO:0005985;sucrose metabolic process;24579;1420;GO:0006865
GO:0003323;type B pancreatic cell development;1414;663;GO:0005576
GO:0005984;disaccharide metabolic process;231231;681;GO:0005576
GO:0003313;heart rudiment development;302;3;GO:0043169
GO:0005976;polysaccharide metabolic process;2066013;2110;GO:0008528
GO:0030910;olfactory placode formation;159;223;GO:0044427
GO:0003314;heart rudiment morphogenesis;220;2;GO:0006865
GO:0005975;carbohydrate metabolic process;13595119;23300;GO:0048193
GO:0003315;heart rudiment formation;219;4;GO:0003700
GO:0005978;glycogen biosynthetic process;303653;2110;GO:0048193
GO:0030912;response to deep water;2;8;GO:0043234
GO:0003316;establishment of myocardial progenitor cell apical/basal polarity;0;3;GO:0043234
GO:0005977;glycogen metabolic process;468392;2490;GO:0032991
GO:0030911;TPR domain binding;250;141;GO:0000976
GO:0003317;cardioblast cell midline fusion;1;4;GO:0005516
GO:0003318;cell migration to the midline involved in heart development;476;4;GO:0003774
GO:0005979;regulation of glycogen biosynthetic process;1461;333;GO:0048285
GO:0030913;paranodal junction assembly;294;43;GO:0003779
GO:0003319;cardioblast migration to the midline involved in heart rudiment formation;146;4;GO:0043161
GO:0030916;otic vesicle formation;1112;1100;GO:0048247
GO:0030915;Smc5-Smc6 complex;23729;383;GO:0006415
GO:0015355;secondary active monocarboxylate transmembrane transporter activity;11053;150;GO:0006865
GO:0015351;bilirubin secondary active transmembrane transporter activity;0;0;GO:0048305
GO:0003370;cell-cell adhesion involved in mesendodermal cell migration;1;3;GO:0048304
GO:0015350;methotrexate transmembrane transporter activity;483;8;GO:0008528
GO:0003371;establishment or maintenance of cytoskeleton polarity involved in ameboidal cell migration;39;3;GO:0005740
GO:0003372;establishment or maintenance of cytoskeleton polarity involved in mesendodermal cell migration;0;2;GO:0005576
GO:0003376;sphingosine-1-phosphate receptor signaling pathway;8080;332;GO:0048193
GO:0003368;cell-matrix adhesion involved in mesendodermal cell migration;0;3;GO:0006869
GO:0030987;high molecular weight kininogen receptor binding;0;2;GO:0006412
GO:0003369;establishment of cell polarity involved in mesendodermal cell migration;1;1;GO:0006869
GO:0030986;low molecular weight kininogen binding;0;1;GO:0006260
GO:0030989;dynein-driven meiotic oscillatory nuclear movement;87;6;GO:0006869
GO:0030988;high molecular weight kininogen receptor complex;0;1;GO:0008544
GO:0030981;cortical microtubule cytoskeleton;1271;62;GO:0009986
GO:0030980;alpha-glucan catabolic process;1911;5;GO:0048010
GO:0030983;mismatched DNA binding;163568;2020;GO:0003735
GO:0015349;thyroid hormone transmembrane transporter activity;449;68;GO:0003735
GO:0030982;adventurous gliding motility;0;2;GO:0003735
GO:0030985;high molecular weight kininogen binding;5;1;GO:0015731
GO:0015347;sodium-independent organic anion transmembrane transporter activity;473;525;GO:0006890
GO:0030984;kininogen binding;77;194;GO:0006836
GO:0015368;calcium:monoatomic cation antiporter activity;46095;15;GO:0006869
GO:0015367;oxoglutarate:malate antiporter activity;61;9;GO:0006890
GO:0042900;arabinose transmembrane transporter activity;2324;2;GO:0006865
GO:0015366;malate:proton symporter activity;22;1;GO:0006865
GO:0042901;arabinan transmembrane transporter activity;0;0;GO:0006865
GO:0042902;peptidoglycan-protein cross-linking via L-threonyl-pentaglycyl-murein;0;3;GO:0006836
GO:0015364;dicarboxylate:inorganic phosphate antiporter activity;0;1;GO:0006836
GO:0042903;tubulin deacetylase activity;288;225;GO:0006869
GO:0042904;9-cis-retinoic acid biosynthetic process;182;87;GO:0097159
GO:0003380;establishment or maintenance of cytoskeleton polarity involved in gastrulation;39;2;GO:0048285
GO:0015362;high-affinity sodium:dicarboxylate symporter activity;56;7;GO:0004867
GO:0070823;HDA1 complex;760;7;GO:0006836
GO:0070824;SHREC complex;1724;4;GO:0006541
GO:0031257;cell trailing edge membrane;55;0;GO:0008565
GO:0070821;tertiary granule membrane;171;720;GO:0006541
GO:0031258;lamellipodium membrane;3007;957;GO:0003676
GO:0070822;Sin3-type complex;1321;216;GO:0008544
GO:0043219;lateral loop;178;305;GO:0048706
GO:0043218;compact myelin;1142;300;GO:0010468
GO:0070817;P-TEFb-cap methyltransferase complex localization;0;1;GO:0050727
GO:0070814;hydrogen sulfide biosynthetic process;64286;192;GO:0007548
GO:0070815;peptidyl-lysine 5-dioxygenase activity;5522;26;GO:0010468
GO:0031251;PAN complex;11350;75;GO:0050727
GO:0031252;cell leading edge;73417;1940;GO:0008565
GO:0070818;protoporphyrinogen oxidase activity;72675;5;GO:0042127
GO:0031250;anaerobic ribonucleoside-triphosphate reductase complex;27;2;GO:0045944
GO:0070819;menaquinone-dependent protoporphyrinogen oxidase activity;5609;3;GO:0046356
GO:0043211;ABC-type carbohydrate transporter activity;15417;5;GO:0005125
GO:0045874;positive regulation of sevenless signaling pathway;50;3;GO:0045944
GO:0043210;alkanesulfonate binding;67;1;GO:0010468
GO:0045875;negative regulation of sister chromatid cohesion;265;40;GO:0005544
GO:0043213;bacteriocin transport;29155;195;GO:0006364
GO:0043212;carbohydrate-exporting ABC transporter activity;0;0;GO:0005576
GO:0045873;negative regulation of sevenless signaling pathway;47;5;GO:0048704
GO:0043215;daunorubicin transport;24287;72;GO:0006213
GO:0043214;ABC-type bacteriocin transporter activity;2021;8;GO:0048608
GO:0045879;negative regulation of smoothened signaling pathway;2643;818;GO:0006260
GO:0043217;myelin maintenance;826;742;GO:0050727
GO:0045876;positive regulation of sister chromatid cohesion;494;299;GO:0005840
GO:0018280;protein S-linked glycosylation;2;2;GO:0048010
GO:0018282;metal incorporation into metallo-sulfur cluster;7;26;GO:0007179
GO:0018281;GSI anchor biosynthetic process via N-seryl-glycosylsphingolipidinositolethanolamine;0;3;GO:0006073
GO:0018284;iron incorporation into protein via tetrakis-L-cysteinyl iron;0;6;GO:0048010
GO:0045881;positive regulation of sporulation resulting in formation of a cellular spore;1559;6;GO:0048407
GO:0018283;iron incorporation into metallo-sulfur cluster;5;46;GO:0048010
GO:0045882;negative regulation of sulfur utilization;0;2;GO:0006096
GO:0043220;Schmidt-Lanterman incisure;1028;224;GO:0048608
GO:0018285;iron incorporation into iron-sulfur cluster via tetrakis-L-cysteinyl diiron disulfide;0;6;GO:0004518
GO:0045880;positive regulation of smoothened signaling pathway;2374;762;GO:0045944
GO:0018288;iron incorporation into iron-sulfur cluster via tetrakis-L-cysteinyl tetrairon tetrasulfide;0;6;GO:0004518
GO:0031244;extrinsic component of cell outer membrane;1;2;GO:0010467
GO:0102002;valine N-monooxygenase (oxime forming) activity;5;2;GO:0048608
GO:0018287;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl triiron tetrasulfide;0;6;GO:0006725
GO:0031245;extrinsic component of periplasmic side of cell outer membrane;0;0;GO:0006826
GO:0102001;isoleucine N-monooxygenase (oxime forming) activity;12;2;GO:0048169
GO:0031242;extrinsic component of external side of cell outer membrane;0;0;GO:0004497
GO:0102004;2-octaprenyl-6-hydroxyphenol methylase activity;0;1;GO:0004497
GO:0018289;molybdenum incorporation into metallo-sulfur cluster;1;2;GO:0007179
GO:0102003;Delta8-sphingolipid desaturase activity;24;1;GO:0004746
GO:0031248;protein acetyltransferase complex;128916;81;GO:0045944
GO:0031249;denatured protein binding;61;10;GO:0048608
GO:0070813;hydrogen sulfide metabolic process;64468;37;GO:0048167
GO:0070810;positive regulation of Hulle cell development;0;2;GO:0048608
GO:0031247;actin rod assembly;102;37;GO:0048167
GO:0070811;glycerol-2-phosphate transmembrane transport;0;0;GO:0009065
GO:0102009;proline dipeptidase activity;5506;6;GO:0048608
GO:0102006;4-methyl-2-oxopentanoate dehydrogenase activity;0;1;GO:0009081
GO:0102007;acyl-L-homoserine-lactone lactonohydrolase activity;1347;111;GO:0048608
GO:0102013;ATPase-coupled L-glutamate tranmembrane transporter activity;0;0;GO:0003676
GO:0102014;beta-D-galactose-importing ATPase activity;0;1;GO:0050729
GO:0102025;ABC-type thiosulfate transporter activity;7887;2;GO:0006260
GO:0102028;cystathionine gamma-synthase activity (acts on O-phosphohomoserine);9375;1;GO:0030168
GO:0102027;S-adenosylmethionine:2-demethylquinol-8 methyltransferase activity;29124;2;GO:0002688
GO:0102029;D-lactate dehydrogenase (quinone) activity;5521;4;GO:0048704
GO:0031299;taurine-pyruvate aminotransferase activity;11;3;GO:0005524
GO:0102035;isobutyryl-CoA:FAD oxidoreductase activity;15;2;GO:0048193
GO:0031297;replication fork processing;15028;2000;GO:0048167
GO:0102037;4-nitrotoluene monooxygenase activity;0;0;GO:0048608
GO:0031298;replication fork protection complex;1824;228;GO:0050900
GO:0102036;methyltetrahydrofolate:corrinoid/iron-sulfur protein methyltransferase activity;342;2;GO:0043066
GO:0102031;4-acetamido-4,6-dideoxy-D-galactose transferase activity;2138;2;GO:0050900
GO:0102030;dTDP-L-rhamnose synthetase activity;0;0;GO:0009410
GO:0102033;long-chain fatty acid omega-hydroxylase activity;163;9;GO:0030168
GO:0031291;Ran protein signal transduction;169;42;GO:0009986
GO:0031290;retinal ganglion cell axon guidance;1988;1660;GO:0050900
GO:0031295;T cell costimulation;2159;2800;GO:0048706
GO:0102039;NADH-dependent peroxiredoxin activity;16165;5;GO:0000278
GO:0031296;B cell costimulation;120;61;GO:0048706
GO:0102038;4-nitrobenzyl alcohol oxidase activity;0;0;GO:0007049
GO:0031293;membrane protein intracellular domain proteolysis;807;397;GO:0048704
GO:0031294;lymphocyte costimulation;2280;592;GO:0043066
GO:0102040;fumarate reductase (menaquinone);40564;44;GO:0004725
GO:0031288;sorocarp morphogenesis;208;295;GO:0048704
GO:0102046;3,4-dichlorobenzoate-4,5-oxygenase activity;0;0;GO:0043066
GO:0031289;actin phosphorylation;51;5;GO:0005509
GO:0102045;3-chlorobenzoate-3,4-oxygenase activity;0;0;GO:0007600
GO:0031286;negative regulation of sorocarp stalk cell differentiation;14;3;GO:0004073
GO:0102048;indole-3-acetyl-isoleucine synthetase activity;0;1;GO:0048704
GO:0031287;positive regulation of sorocarp stalk cell differentiation;9;3;GO:0004721
GO:0102047;indole-3-acetyl-glycine synthetase activity;0;1;GO:0031591
GO:0102042;dehydroquinate synthase activity;1634;2;GO:0048513
GO:0102041;7,8-dihydropterin-6-yl-methyl-4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase;127;0;GO:0005737
GO:0102044;3-chlorobenzoate-4,5-oxygenase activity;0;0;GO:0048285
GO:0102043;isopentenyl phosphate kinase activity;4063;3;GO:0005929
GO:0102049;indole-3-acetyl-methionine synthetase activity;0;1;GO:0007067
GO:0043266;regulation of potassium ion transport;6117;344;GO:0051301
GO:0043265;ectoplasm;5;3;GO:0007610
GO:0043268;positive regulation of potassium ion transport;3843;611;GO:0009719
GO:0043267;negative regulation of potassium ion transport;899;295;GO:0048193
GO:0043269;regulation of monoatomic ion transport;151146;66;GO:0048193
GO:0043271;negative regulation of monoatomic ion transport;3618;6;GO:0007050
GO:0102051;indole-3-acetyl-tryptophan synthetase activity;0;1;GO:0005730
GO:0043270;positive regulation of monoatomic ion transport;8887;5;GO:0004723
GO:0102050;indole-3-acetyl-tyrosine synthetase activity;0;1;GO:0048608
GO:0043273;CTPase activity;251;7;GO:0004721
GO:0070881;regulation of proline transport;117;2;GO:0048608
GO:0043272;ethylene biosynthesis involved in jasmonic acid and ethylene-dependent systemic resistance;0;1;GO:0048285
GO:0043274;phospholipase binding;889;769;GO:0009737
GO:0070880;fungal-type cell wall beta-glucan biosynthetic process;270;18;GO:0045595
GO:0070885;negative regulation of calcineurin-NFAT signaling cascade;945;183;GO:0005819
GO:0102057;jasmonoyl-valine synthetase activity;41;4;GO:0048608
GO:0070886;positive regulation of calcineurin-NFAT signaling cascade;937;346;GO:0005929
GO:0102056;11-hydroxyjasmonate sulfotransferase activity;1;2;GO:0046395
GO:0070883;pre-miRNA binding;9862;137;GO:0008544
GO:0102059;2-cis,6-cis-farnesyl pyrophosphate synthase activity;4;2;GO:0004723
GO:0070884;regulation of calcineurin-NFAT signaling cascade;2069;828;GO:0048608
GO:0102058;jasmonoyl-leucine synthetase activity;41;4;GO:0048608
GO:0070889;platelet alpha granule organization;141;46;GO:0009733
GO:0102053;(-)-jasmonoyl-isoleucine synthetase activity;31;2;GO:0071347
GO:0102052;indole-3-acetyl-proline synthetase activity;0;1;GO:0046356
GO:0070887;cellular response to chemical stimulus;4728107;3570;GO:0000786
GO:0102055;12-hydroxyjasmonate sulfotransferase activity;2;2;GO:0048608
GO:0070888;E-box binding;3273;988;GO:0048704
GO:0102054;maleylpyruvate hydrolase activity;1;2;GO:0006415
GO:0043277;apoptotic cell clearance;3432;1590;GO:0048513
GO:0043276;anoikis;1523;652;GO:0006936
GO:0043279;response to alkaloid;3564;449;GO:0010467
GO:0043278;response to morphine;618;483;GO:0048608
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;598;1260;GO:0004721
GO:0102060;endo-alpha-bergamotene synthase activity;4;2;GO:0008544
GO:0043282;chordate pharyngeal muscle development;105;1;GO:0006464
GO:0102062;alpha-santalene synthase activity;2;2;GO:0006826
GO:0043281;regulation of cysteine-type endopeptidase activity involved in apoptotic process;831;598;GO:0008528
GO:0102061;endo-beta-bergamotene synthase activity;2;2;GO:0043406
GO:0070871;cell wall organization involved in conjugation with cellular fusion;42;3;GO:0006631
GO:0043286;regulation of poly(3-hydroxyalkanoate) biosynthetic process;0;4;GO:0004073
GO:0070874;negative regulation of glycogen metabolic process;431;20;GO:0008021
GO:0102068;alpha-humulene 10-hydroxylase activity;4;2;GO:0010467
GO:0070875;positive regulation of glycogen metabolic process;837;36;GO:0008092
GO:0102067;geranylgeranyl diphosphate reductase activity;2101;3;GO:0006396
GO:0070873;regulation of glycogen metabolic process;2139;187;GO:0006414
GO:0102069;zerumbone synthase activity;3;3;GO:0004553
GO:0070878;primary miRNA binding;759;60;GO:0004721
GO:0102064;gamma-curcumene synthase activity;12;2;GO:0007088
GO:0070879;fungal-type cell wall beta-glucan metabolic process;293;3;GO:0048608
GO:0102063;beta-curcumene synthase activity;0;0;GO:0048608
GO:0070876;SOSS complex;2374;50;GO:0003723
GO:0102066;alpha-patchoulene synthase activityy;0;0;GO:0004553
GO:0070877;microprocessor complex;2177;35;GO:0007040
GO:0102065;patchoulene synthase activity;0;0;GO:0048285
GO:0043288;apocarotenoid metabolic process;2772;19;GO:0006979
GO:0043287;poly(3-hydroxyalkanoate) binding;0;1;GO:0050832
GO:0043289;apocarotenoid biosynthetic process;2577;5;GO:0050832
GO:0043291;RAVE complex;291;33;GO:0007049
GO:0102071;9,10-epoxy-18-hydroxystearate hydrolase activity;0;0;GO:0006468
GO:0043290;apocarotenoid catabolic process;67;2;GO:0042127
GO:0102070;18-hydroxyoleate peroxygenase activity;48;3;GO:0006468
GO:0043293;apoptosome;1174;203;GO:0048608
GO:0043292;contractile fiber;56407;2140;GO:0003673
GO:0043295;glutathione binding;4728;1090;GO:0005524
GO:0043294;mitochondrial glutamate synthase complex (NADH);0;1;GO:0006979
GO:0043297;apical junction assembly;5537;805;GO:0005764
GO:0043296;apical junction complex;124064;795;GO:0048666
GO:0102076;beta,beta-carotene-9',10'-cleaving oxygenase activity;69;0;GO:0048666
GO:0043299;leukocyte degranulation;3352;1880;GO:0042127
GO:0102082;demethylrebeccamycin--D-glucose O-methyltransferase activity;1148;0;GO:0042127
GO:0102081;homotaurine:2-oxoglutarate aminotransferase activity;0;0;GO:0046655
GO:0102084;L-dopa O-methyltransferase activity;1338;6;GO:0006626
GO:0102083;7,8-dihydromonapterin aldolase activity;0;0;GO:0005764
GO:0070892;lipoteichoic acid immune receptor activity;52;4;GO:0006626
GO:0102080;phenylacetyl-coenzyme A:glycine N-acyltransferase activity;2;2;GO:0005840
GO:0070891;lipoteichoic acid binding;336;53;GO:0006936
GO:0070897;transcription preinitiation complex assembly;38783;31;GO:0048608
GO:0102089;dehydroscoulerine synthase activity;0;0;GO:0009611
GO:0102086;N-vanillate-L-glutamate synthetase activity;0;1;GO:0006468
GO:0102085;N-(4-aminobenzoyl)-L-glutamate synthetase activity;0;0;GO:0048704
GO:0070898;RNA polymerase III preinitiation complex assembly;201;10;GO:0000976
GO:0102088;N-(4-hydroxybenzoyl)-L-glutamate synthetase activity;0;0;GO:0005576
GO:0070899;mitochondrial tRNA wobble uridine modification;140;6;GO:0005764
GO:0102087;N-benzoyl-L-glutamate synthetase activity;0;1;GO:0048608
GO:0070591;ascospore wall biogenesis;436;7;GO:0009611
GO:0070592;cell wall polysaccharide biosynthetic process;6542;49;GO:0006626
GO:0070590;spore wall biogenesis;475;7;GO:0048608
GO:0070595;(1->3)-alpha-glucan metabolic process;88;0;GO:0005829
GO:0070596;(1->3)-alpha-glucan biosynthetic process;88;1;GO:0048608
GO:0070593;dendrite self-avoidance;816;113;GO:0005829
GO:0070594;juvenile hormone response element binding;20;71;GO:0048699
GO:0070599;fungal-type cell wall (1->3)-alpha-glucan metabolic process;87;0;GO:0006836
GO:0070597;cell wall (1->3)-alpha-glucan metabolic process;87;1;GO:0006626
GO:0070598;cell wall (1->3)-alpha-glucan biosynthetic process;87;2;GO:0008023
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;4538;1030;GO:0006974
GO:0008623;CHRAC;288;31;GO:0045735
GO:0008622;epsilon DNA polymerase complex;11291;171;GO:0009416
GO:0008618;7-methylguanosine metabolic process;35;3;GO:0007409
GO:0008617;guanosine metabolic process;46;6;GO:0006986
GO:0008616;queuosine biosynthetic process;581476;902;GO:0008029
GO:0008615;pyridoxine biosynthetic process;226746;1460;GO:0005766
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;3423;473;GO:0005813
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7511;1570;GO:0006950
GO:0008635;activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c;35;86;GO:0048167
GO:0008628;hormone-mediated apoptotic signaling pathway;37;48;GO:0030198
GO:0008627;intrinsic apoptotic signaling pathway in response to osmotic stress;514;38;GO:0048285
GO:0008626;granzyme-mediated apoptotic signaling pathway;57;89;GO:0006974
GO:0008603;cAMP-dependent protein kinase regulator activity;10536;632;GO:0050729
GO:0008610;lipid biosynthetic process;6307651;6350;GO:0030518
GO:0008614;pyridoxine metabolic process;226858;134;GO:0010468
GO:0008613;diuretic hormone activity;353;8;GO:0042127
GO:0008612;peptidyl-lysine modification to peptidyl-hypusine;36;242;GO:0006915
GO:0008611;ether lipid biosynthetic process;4160;134;GO:0007409
GO:0008607;phosphorylase kinase regulator activity;182;72;GO:0005576
GO:0008609;alkylglycerone-phosphate synthase activity;14497;40;GO:0048704
GO:0008608;attachment of spindle microtubules to kinetochore;23460;1880;GO:0048608
GO:0008661;1-deoxy-D-xylulose-5-phosphate synthase activity;144237;590;GO:0006986
GO:0021636;trigeminal nerve morphogenesis;268;25;GO:0007219
GO:0008660;1-aminocyclopropane-1-carboxylate deaminase activity;11190;114;GO:0048608
GO:0021637;trigeminal nerve structural organization;173;39;GO:0048193
GO:0021638;trigeminal nerve formation;0;2;GO:0006869
GO:0021639;trochlear nerve morphogenesis;44;2;GO:0005746
GO:0006002;fructose 6-phosphate metabolic process;66768;832;GO:0048608
GO:0021632;optic nerve maturation;0;2;GO:0048608
GO:0006003;fructose 2,6-bisphosphate metabolic process;18190;643;GO:0006906
GO:0008664;2'-5'-RNA ligase activity;25642;1;GO:0048608
GO:0021633;optic nerve structural organization;64;9;GO:0002223
GO:0006000;fructose metabolic process;19635;1310;GO:0048193
GO:0008663;2',3'-cyclic-nucleotide 2'-phosphodiesterase activity;11938;4;GO:0005737
GO:0021634;optic nerve formation;160;5;GO:0009579
GO:0006001;fructose catabolic process;202;69;GO:0005976
GO:0008662;1-phosphofructokinase activity;39911;8;GO:0046364
GO:0021635;trigeminal nerve maturation;0;2;GO:0005581
GO:0006006;glucose metabolic process;986427;7070;GO:0005576
GO:0006007;glucose catabolic process;34665;2020;GO:0005819
GO:0008668;(2,3-dihydroxybenzoyl)adenylate synthase activity;5479;6;GO:0005829
GO:0006004;fucose metabolic process;81530;1010;GO:0007626
GO:0008667;2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase activity;9327;128;GO:0006950
GO:0021630;olfactory nerve maturation;84;6;GO:0022627
GO:0006005;L-fucose biosynthetic process;5;5;GO:0007610
GO:0008666;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity;70837;150;GO:0005976
GO:0021631;optic nerve morphogenesis;396;27;GO:0016569
GO:0033618;plasma membrane respiratory chain complex IV assembly;0;2;GO:0002599
GO:0033617;mitochondrial cytochrome c oxidase assembly;14187;464;GO:0006464
GO:0033616;plasma membrane proton-transporting ATP synthase complex assembly;0;2;GO:0003700
GO:0008659;(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity;37801;0;GO:0032555
GO:0033615;mitochondrial proton-transporting ATP synthase complex assembly;1816;104;GO:0004840
GO:0033619;membrane protein proteolysis;5194;535;GO:0005737
GO:0033610;oxalate biosynthetic process;0;2;GO:0046887
GO:0033614;chloroplast proton-transporting ATP synthase complex assembly;57;3;GO:0007623
GO:0033612;receptor serine/threonine kinase binding;2798;379;GO:0045944
GO:0033611;oxalate catabolic process;4563;9;GO:0006897
GO:0021629;olfactory nerve structural organization;21;7;GO:0008544
GO:0008672;2-dehydro-3-deoxyglucarate aldolase activity;4466;5;GO:0008544
GO:0021625;oculomotor nerve maturation;0;1;GO:0005819
GO:0008671;2-dehydro-3-deoxygalactonokinase activity;9449;7;GO:0045747
GO:0021626;central nervous system maturation;361;20;GO:0048316
GO:0008670;2,4-dienoyl-CoA reductase (NADPH) activity;12060;304;GO:0046395
GO:0021627;olfactory nerve morphogenesis;191;3;GO:0006749
GO:0021628;olfactory nerve formation;170;10;GO:0006810
GO:0006013;mannose metabolic process;36364;2600;GO:0005215
GO:0008676;3-deoxy-8-phosphooctulonate synthase activity;82348;151;GO:0046394
GO:0021621;hypoglossal nerve structural organization;0;2;GO:0003743
GO:0006014;D-ribose metabolic process;108643;285;GO:0009813
GO:0008675;2-dehydro-3-deoxy-phosphogluconate aldolase activity;23734;10;GO:0046394
GO:0021622;oculomotor nerve morphogenesis;85;6;GO:0045735
GO:0006011;UDP-glucose metabolic process;84806;396;GO:0010468
GO:0008674;2-dehydro-3-deoxy-6-phosphogalactonate aldolase activity;2562;5;GO:0048608
GO:0021623;oculomotor nerve formation;85;174;GO:0015031
GO:0006012;galactose metabolic process;284180;2740;GO:0048285
GO:0008673;2-dehydro-3-deoxygluconokinase activity;2940;8;GO:0045766
GO:0021624;oculomotor nerve structural organization;0;2;GO:0007067
GO:0006017;deoxyribose 1,5-bisphosphate biosynthetic process;0;2;GO:0007276
GO:0006018;2-deoxyribose 1-phosphate catabolic process;0;1;GO:0048405
GO:0008679;2-hydroxy-3-oxopropionate reductase activity;18254;99;GO:0006633
GO:0006015;5-phosphoribose 1-diphosphate biosynthetic process;62807;255;GO:0043169
GO:0008678;2-deoxy-D-gluconate 3-dehydrogenase activity;6835;7;GO:0006633
GO:0006016;2-deoxyribose 1-phosphate biosynthetic process;0;1;GO:0048316
GO:0008677;2-dehydropantoate 2-reductase activity;94672;388;GO:0048305
GO:0021620;hypoglossal nerve formation;0;2;GO:0005509
GO:0033607;SOD1-Bcl-2 complex;0;0;GO:0006979
GO:0033606;chemokine receptor transport within lipid bilayer;5;2;GO:0006950
GO:0033605;positive regulation of catecholamine secretion;268;254;GO:0042803
GO:0006009;glucose 1-phosphate phosphorylation;0;4;GO:0009986
GO:0033604;negative regulation of catecholamine secretion;317;27;GO:0005840
GO:0033609;oxalate metabolic process;8809;40;GO:0048285
GO:0033608;formyl-CoA transferase activity;11651;8;GO:0030430
GO:0033603;positive regulation of dopamine secretion;86;143;GO:0006032
GO:0033602;negative regulation of dopamine secretion;93;325;GO:0048704
GO:0033601;positive regulation of mammary gland epithelial cell proliferation;413;163;GO:0005576
GO:0033600;negative regulation of mammary gland epithelial cell proliferation;202;114;GO:0030163
GO:0021618;hypoglossal nerve morphogenesis;49;3;GO:0005667
GO:0021619;hypoglossal nerve maturation;0;1;GO:0048285
GO:0021614;glossopharyngeal nerve maturation;0;2;GO:0000724
GO:0021615;glossopharyngeal nerve morphogenesis;242;86;GO:0048608
GO:0021616;glossopharyngeal nerve formation;0;1;GO:0043005
GO:0021617;glossopharyngeal nerve structural organization;0;1;GO:0010468
GO:0008643;carbohydrate transport;1876827;6830;GO:0048608
GO:0021610;facial nerve morphogenesis;587;22;GO:0008544
GO:0021611;facial nerve formation;19;2;GO:0006749
GO:0008641;ubiquitin-like modifier activating enzyme activity;164861;977;GO:0006810
GO:0021612;facial nerve structural organization;390;477;GO:0004518
GO:0021613;facial nerve maturation;0;1;GO:0005515
GO:0008645;hexose transmembrane transport;137547;192;GO:0004867
GO:0008637;apoptotic mitochondrial changes;7684;1730;GO:0048608
GO:0021607;accessory nerve morphogenesis;0;2;GO:0048193
GO:0021608;accessory nerve formation;0;2;GO:0010942
GO:0021609;accessory nerve structural organization;0;1;GO:0009044
GO:0008650;rRNA (uridine-2'-O-)-methyltransferase activity;17644;0;GO:0010942
GO:0021603;cranial nerve formation;768;7;GO:0002521
GO:0021604;cranial nerve structural organization;718;18;GO:0005576
GO:0021605;cranial nerve maturation;142;2;GO:0048608
GO:0021606;accessory nerve maturation;0;2;GO:0005929
GO:0008654;phospholipid biosynthetic process;2098127;4340;GO:0005576
GO:0008653;lipopolysaccharide metabolic process;431768;488;GO:0005743
GO:0021600;abducens nerve structural organization;0;1;GO:0043066
GO:0008652;amino acid biosynthetic process;13407968;7620;GO:0006022
GO:0021601;abducens nerve maturation;0;2;GO:0042546
GO:0021602;cranial nerve morphogenesis;2430;834;GO:0043161
GO:0008658;penicillin binding;325030;850;GO:0097159
GO:0008657;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) inhibitor activity;17317;10;GO:0042593
GO:0008656;cysteine-type endopeptidase activator activity involved in apoptotic process;765;449;GO:0046983
GO:0008655;pyrimidine-containing compound salvage;125743;411;GO:0043169
GO:0008649;rRNA methyltransferase activity;832372;1340;GO:0009987
GO:0008584;male gonad development;7422;2780;GO:0016525
GO:0021559;trigeminal nerve development;609;250;GO:0010401
GO:0033540;fatty acid beta-oxidation using acyl-CoA oxidase;4621;1610;GO:0048706
GO:0008583;mystery cell differentiation;8;3;GO:0048193
GO:0008582;regulation of synaptic assembly at neuromuscular junction;1758;10;GO:0048608
GO:0021555;midbrain-hindbrain boundary morphogenesis;406;27;GO:0005575
GO:0045522;interleukin-26 receptor binding;0;1;GO:0048704
GO:0008587;imaginal disc-derived wing margin morphogenesis;613;132;GO:0005576
GO:0021556;central nervous system formation;320;7;GO:0009952
GO:0045523;interleukin-27 receptor binding;256;128;GO:0044421
GO:0008586;imaginal disc-derived wing vein morphogenesis;633;44;GO:0005819
GO:0021557;oculomotor nerve development;262;10;GO:0048706
GO:0045520;interleukin-24 receptor binding;0;1;GO:0007067
GO:0008585;female gonad development;7882;2260;GO:0048706
GO:0021558;trochlear nerve development;99;211;GO:0007067
GO:0045521;interleukin-25 receptor binding;0;1;GO:0048608
GO:0021551;central nervous system morphogenesis;730;30;GO:0007088
GO:0021552;midbrain-hindbrain boundary structural organization;1;2;GO:0048608
GO:0021553;olfactory nerve development;340;51;GO:0005575
GO:0008589;regulation of smoothened signaling pathway;6078;1430;GO:0005524
GO:0021554;optic nerve development;979;133;GO:0007067
GO:0021560;abducens nerve development;95;2;GO:0004497
GO:0033539;fatty acid beta-oxidation using acyl-CoA dehydrogenase;11772;584;GO:0004497
GO:0021561;facial nerve development;631;86;GO:0004867
GO:0033538;ajugose biosynthetic process using galactan:galactan galactosyltransferase;0;2;GO:0004497
GO:0033533;verbascose metabolic process;0;1;GO:0002576
GO:0033532;stachyose biosynthetic process;1;2;GO:0015075
GO:0033531;stachyose metabolic process;3;2;GO:0004067
GO:0033530;raffinose metabolic process;24;4;GO:0005829
GO:0033537;ajugose biosynthetic process using galactinol:raffinose galactosyltransferase;0;2;GO:0004067
GO:0033536;ajugose biosynthetic process;0;2;GO:0004067
GO:0033535;ajugose metabolic process;0;1;GO:0004497
GO:0033534;verbascose biosynthetic process;0;1;GO:0009952
GO:0008591;regulation of Wnt signaling pathway, calcium modulating pathway;83;3;GO:0009952
GO:0008595;anterior/posterior axis specification, embryo;3069;612;GO:0007631
GO:0021548;pons development;1056;23;GO:0007631
GO:0008594;photoreceptor cell morphogenesis;485;195;GO:0007067
GO:0021549;cerebellum development;6809;1250;GO:0048285
GO:0008593;regulation of Notch signaling pathway;8311;693;GO:0005576
GO:0008592;regulation of Toll signaling pathway;3813;124;GO:0005576
GO:0021544;subpallium development;1372;55;GO:0004721
GO:0021545;cranial nerve development;5455;510;GO:0048646
GO:0008597;calcium-dependent protein serine/threonine phosphatase regulator activity;4658;213;GO:0005524
GO:0021546;rhombomere development;1235;133;GO:0048193
GO:0021547;midbrain-hindbrain boundary initiation;48;5;GO:0048870
GO:0021540;corpus callosum morphogenesis;298;22;GO:0048285
GO:0021541;ammon gyrus development;58;4;GO:0005576
GO:0021542;dentate gyrus development;957;891;GO:0006415
GO:0021543;pallium development;10223;420;GO:0009948
GO:0033529;raffinose biosynthetic process;5;2;GO:0048704
GO:0033528;S-methylmethionine cycle;151;9;GO:0005576
GO:0021550;medulla oblongata development;316;8;GO:0005576
GO:0033527;tetrapyrrole biosynthetic process from glycine and succinyl-CoA;0;4;GO:0008037
GO:0045540;regulation of cholesterol biosynthetic process;1030;780;GO:0009566
GO:0045541;negative regulation of cholesterol biosynthetic process;240;263;GO:0010467
GO:0033522;histone H2A ubiquitination;7;606;GO:0030518
GO:0033521;phytyl diphosphate biosynthetic process;1;1;GO:0030518
GO:0033520;phytol biosynthetic process;12;2;GO:0030501
GO:0033526;tetrapyrrole biosynthetic process from glutamate;36;2;GO:0006955
GO:0033525;sinapate ester biosynthetic process;5;2;GO:0005840
GO:0033524;sinapate ester metabolic process;5;3;GO:0005743
GO:0033523;histone H2B ubiquitination;4;406;GO:0005576
GO:0070508;cholesterol import;675;346;GO:0009414
GO:0070509;calcium ion import;2485;974;GO:0009739
GO:0070506;high-density lipoprotein particle receptor activity;128;10;GO:0048017
GO:0070507;regulation of microtubule cytoskeleton organization;26323;1010;GO:0005829
GO:0021537;telencephalon development;17834;984;GO:0048193
GO:0021538;epithalamus development;738;51;GO:0048870
GO:0021539;subthalamus development;102;83;GO:0005576
GO:0008566;mitochondrial protein-transporting ATPase activity;4;9;GO:0009986
GO:0021533;cell differentiation in hindbrain;1450;741;GO:0045727
GO:0045544;gibberellin 20-oxidase activity;248;59;GO:0046686
GO:0021534;cell proliferation in hindbrain;1132;19;GO:0042981
GO:0045545;syndecan binding;301;242;GO:0048608
GO:0008564;protein-exporting ATPase activity;839;3;GO:0048706
GO:0021535;cell migration in hindbrain;813;2410;GO:0071456
GO:0045542;positive regulation of cholesterol biosynthetic process;415;149;GO:0048608
GO:0021536;diencephalon development;7059;357;GO:0046686
GO:0045543;gibberellin 2-beta-dioxygenase activity;732;8;GO:0048193
GO:0045548;phenylalanine ammonia-lyase activity;4274;298;GO:0000976
GO:0008569;minus-end-directed microtubule motor activity;49331;364;GO:0048193
GO:0021530;spinal cord oligodendrocyte cell fate specification;136;38;GO:0048407
GO:0045549;9-cis-epoxycarotenoid dioxygenase activity;160;116;GO:0048608
GO:0008568;microtubule severing ATPase activity;7880;399;GO:0003905
GO:0021531;spinal cord radial glial cell differentiation;40;3;GO:0048661
GO:0021532;neural tube patterning;3609;132;GO:0048608
GO:0045547;dehydrodolichyl diphosphate synthase activity;4872;155;GO:0048661
GO:0033519;phytyl diphosphate metabolic process;1;3;GO:0048608
GO:0033517;myo-inositol hexakisphosphate metabolic process;250;2;GO:0048608
GO:0033516;L-methionine biosynthetic process from homoserine via O-phospho-L-homoserine and cystathionine;0;2;GO:0006826
GO:0045551;cinnamyl-alcohol dehydrogenase activity;1031;129;GO:0007219
GO:0045552;dihydrokaempferol 4-reductase activity;623;91;GO:0006836
GO:0045550;geranylgeranyl reductase activity;3739;402;GO:0008544
GO:0033511;luteolin biosynthetic process;12;3;GO:0048405
GO:0033510;luteolin metabolic process;12;4;GO:0048608
GO:0070501;poly-gamma-glutamate biosynthetic process;0;5;GO:0048513
GO:0033515;L-lysine catabolic process using lysine 6-aminotransferase;0;2;GO:0048471
GO:0070504;selenium-containing prosthetic group biosynthetic process;0;1;GO:0045944
GO:0033514;L-lysine catabolic process to acetyl-CoA via L-pipecolate;98;4;GO:0005743
GO:0070505;pollen coat;27;24;GO:0004637
GO:0033513;L-lysine catabolic process to acetyl-CoA via 5-aminopentanamide;0;2;GO:0002541
GO:0070502;capsule poly-gamma-glutamate biosynthetic process;0;1;GO:0004867
GO:0033512;L-lysine catabolic process to acetyl-CoA via saccharopine;41740;343;GO:0002755
GO:0070503;selenium-containing prosthetic group metabolic process;0;2;GO:0009096
GO:0021526;medial motor column neuron differentiation;114;53;GO:0005730
GO:0021527;spinal cord association neuron differentiation;619;451;GO:0005764
GO:0021528;commissural neuron differentiation in spinal cord;397;7;GO:0048304
GO:0021529;spinal cord oligodendrocyte cell differentiation;489;40;GO:0008521
GO:0021522;spinal cord motor neuron differentiation;4373;1120;GO:0005576
GO:0021523;somatic motor neuron differentiation;334;24;GO:0005576
GO:0021524;visceral motor neuron differentiation;155;101;GO:0048608
GO:0008574;plus-end-directed microtubule motor activity;1366;121;GO:0002504
GO:0021525;lateral motor column neuron differentiation;0;4;GO:0010467
GO:0008579;JUN kinase phosphatase activity;71;10;GO:0048706
GO:0021520;spinal cord motor neuron cell fate specification;2545;237;GO:0010467
GO:0021521;ventral spinal cord interneuron specification;506;144;GO:0048706
GO:0033508;glutamate catabolic process to butyrate;0;3;GO:0010467
GO:0033507;glucosinolate biosynthetic process from phenylalanine;0;3;GO:0048468
GO:0033506;glucosinolate biosynthetic process from homomethionine;9;6;GO:0048305
GO:0033505;floor plate morphogenesis;406;7;GO:0005766
GO:0033509;glutamate catabolic process to propionate;0;3;GO:0048305
GO:0033500;carbohydrate homeostasis;34951;1100;GO:0048706
GO:0033504;floor plate development;705;90;GO:0048608
GO:0033503;HULC complex;558;630;GO:0009986
GO:0033584;tyrosine biosynthetic process from chorismate via L-arogenate;0;2;GO:0042981
GO:0033583;rhabdomere membrane;95;3;GO:0048405
GO:0021599;abducens nerve formation;54;6;GO:0005576
GO:0021595;rhombomere structural organization;107;3;GO:0048608
GO:0021597;central nervous system structural organization;0;2;GO:0004746
GO:0021598;abducens nerve morphogenesis;54;3;GO:0005819
GO:0033574;response to testosterone;704;902;GO:0048285
GO:0033573;high-affinity iron permease complex;18802;114;GO:0048608
GO:0033572;transferrin transport;2681;1080;GO:0009536
GO:0033571;lactoferrin transport;0;4;GO:0048608
GO:0021588;cerebellum formation;134;7;GO:0030216
GO:0021589;cerebellum structural organization;78;38;GO:0048285
GO:0021584;pons formation;0;3;GO:0048608
GO:0021585;pons structural organization;0;1;GO:0048285
GO:0021586;pons maturation;94;142;GO:0010467
GO:0021587;cerebellum morphogenesis;2775;110;GO:0048704
GO:0021591;ventricular system development;2542;961;GO:0048608
GO:0021592;fourth ventricle development;240;25;GO:0048706
GO:0021593;rhombomere morphogenesis;431;6;GO:0048193
GO:0021594;rhombomere formation;215;9;GO:0048193
GO:0021590;cerebellum maturation;151;168;GO:0009725
GO:0033566;gamma-tubulin complex localization;2580;99;GO:0048193
GO:0033565;ESCRT-0 complex;272;56;GO:0032989
GO:0033564;anterior/posterior axon guidance;536;166;GO:0030163
GO:0033563;dorsal/ventral axon guidance;300;205;GO:0046649
GO:0033569;lactoferrin transmembrane transporter activity;0;1;GO:0009725
GO:0033568;lactoferrin receptor activity;0;2;GO:0048193
GO:0033567;DNA replication, Okazaki fragment processing;27512;75;GO:0006986
GO:0045508;interleukin-26 receptor activity;0;1;GO:0005524
GO:0045509;interleukin-27 receptor activity;48;20;GO:0048193
GO:0045506;interleukin-24 receptor activity;0;1;GO:0048193
GO:0045507;interleukin-25 receptor activity;0;1;GO:0002776
GO:0033562;co-transcriptional gene silencing by RNA interference machinery;25;5;GO:0005576
GO:0033560;folate reductase activity;2;6;GO:0005576
GO:0021577;hindbrain structural organization;79;9;GO:0046274
GO:0045500;sevenless signaling pathway;340;92;GO:0048285
GO:0021578;hindbrain maturation;246;77;GO:0048193
GO:0045501;regulation of sevenless signaling pathway;97;2;GO:0048285
GO:0021579;medulla oblongata morphogenesis;0;2;GO:0050729
GO:0021573;rhombomere 7 development;0;1;GO:0005525
GO:0045504;dynein heavy chain binding;2598;205;GO:0002729
GO:0021574;rhombomere 8 development;0;2;GO:0008150
GO:0045505;dynein intermediate chain binding;51598;419;GO:0002729
GO:0021575;hindbrain morphogenesis;3113;135;GO:0030518
GO:0021576;hindbrain formation;136;2;GO:0048608
GO:0045503;dynein light chain binding;2311;217;GO:0048706
GO:0021580;medulla oblongata formation;0;1;GO:0010467
GO:0021581;medulla oblongata structural organization;0;1;GO:0048193
GO:0021582;medulla oblongata maturation;0;2;GO:0046649
GO:0021583;pons morphogenesis;0;2;GO:0010467
GO:0033555;multicellular organismal response to stress;4214;901;GO:0048608
GO:0033554;cellular response to stress;9657400;5650;GO:0030199
GO:0033553;rDNA heterochromatin;605;267;GO:0006519
GO:0033552;response to vitamin B3;42;17;GO:0048608
GO:0033559;unsaturated fatty acid metabolic process;36639;1220;GO:0010467
GO:0033558;protein lysine deacetylase activity;138949;194;GO:0048608
GO:0033557;Slx1-Slx4 complex;7570;193;GO:0048608
GO:0033556;dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity;0;1;GO:0048608
GO:0045519;interleukin-23 receptor binding;183;14;GO:0045944
GO:0045517;interleukin-20 receptor binding;60;3;GO:0048608
GO:0045518;interleukin-22 receptor binding;58;7;GO:0048608
GO:0033551;monopolin complex;1165;5;GO:0008092
GO:0033550;MAP kinase tyrosine phosphatase activity;453;6;GO:0048193
GO:0021566;hypoglossal nerve development;49;2;GO:0048608
GO:0045511;interleukin-25 binding;0;1;GO:0048010
GO:0021567;rhombomere 1 development;0;1;GO:0048704
GO:0045512;interleukin-26 binding;0;2;GO:0048010
GO:0021568;rhombomere 2 development;103;9;GO:0048704
GO:0021569;rhombomere 3 development;313;156;GO:0048010
GO:0045510;interleukin-24 binding;0;1;GO:0048010
GO:0021562;vestibulocochlear nerve development;442;20;GO:0048285
GO:0045515;interleukin-18 receptor binding;67;5;GO:0016568
GO:0021563;glossopharyngeal nerve development;341;99;GO:0016570
GO:0045516;interleukin-19 receptor binding;0;1;GO:0048193
GO:0021564;vagus nerve development;214;257;GO:0048608
GO:0045513;interleukin-27 binding;52;5;GO:0046395
GO:0021565;accessory nerve development;0;2;GO:0048706
GO:0045514;interleukin-16 receptor binding;0;1;GO:0006073
GO:0021570;rhombomere 4 development;166;68;GO:0048608
GO:0021571;rhombomere 5 development;293;272;GO:0009416
GO:0021572;rhombomere 6 development;129;6;GO:0006081
GO:0033549;MAP kinase phosphatase activity;11862;272;GO:0048706
GO:0033544;fatty acid beta-oxidation, unsaturated, even number, epimerase pathway;0;2;GO:0009416
GO:0033543;fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway;11;5;GO:0046395
GO:0033542;fatty acid beta-oxidation, unsaturated, even number;66;9;GO:0048704
GO:0033541;fatty acid beta-oxidation, unsaturated, odd number;0;2;GO:0097367
GO:0033548;myo-inositol hexakisphosphate biosynthetic process, lipid-independent;0;1;GO:0048706
GO:0033546;myo-inositol hexakisphosphate biosynthetic process, via inositol 1,3,4-trisphosphate;0;2;GO:0004872
GO:0033545;myo-inositol hexakisphosphate biosynthetic process, lipid-dependent;0;2;GO:0048608
GO:0070562;regulation of vitamin D receptor signaling pathway;523;53;GO:0009062
GO:0070563;negative regulation of vitamin D receptor signaling pathway;116;42;GO:0048608
GO:0070560;protein secretion by platelet;37;100;GO:0006073
GO:0070561;vitamin D receptor signaling pathway;626;126;GO:0006869
GO:0070566;adenylyltransferase activity;939626;220;GO:0048608
GO:0070567;cytidylyltransferase activity;447844;38;GO:0005576
GO:0070564;positive regulation of vitamin D receptor signaling pathway;255;8;GO:0048193
GO:0070565;telomere-telomerase complex;10;2;GO:0005524
GO:0070568;guanylyltransferase activity;169243;27;GO:0048704
GO:0070569;uridylyltransferase activity;414052;257;GO:0006950
GO:0070551;endoribonuclease activity, cleaving siRNA-paired mRNA;1042;6;GO:0003723
GO:0070552;BRISC complex;6647;96;GO:0048608
GO:0070550;rDNA chromatin condensation;137;7;GO:0048608
GO:0070555;response to interleukin-1;7197;1450;GO:0005576
GO:0070556;TAF4B-containing transcription factor TFIID complex;0;1;GO:0005539
GO:0070553;nicotinic acid receptor activity;17;5;GO:0000786
GO:0070554;synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex;2;7;GO:0010467
GO:0070559;lysosomal multienzyme complex;0;1;GO:0003954
GO:0070557;PCNA-p21 complex;127;413;GO:0016570
GO:0070558;alphaM-beta2 integrin-CD63 complex;0;0;GO:0004091
GO:0070580;base J metabolic process;108;2;GO:0004089
GO:0070581;rolling circle DNA replication;4;3;GO:0016569
GO:0070584;mitochondrion morphogenesis;1360;599;GO:0042127
GO:0070585;protein localization to mitochondrion;53556;1030;GO:0010467
GO:0070582;theta DNA replication;0;2;GO:0000786
GO:0070583;spore membrane bending pathway;38;5;GO:0000786
GO:0033599;regulation of mammary gland epithelial cell proliferation;846;888;GO:0048471
GO:0070588;calcium ion transmembrane transport;522178;3800;GO:0046274
GO:0033598;mammary gland epithelial cell proliferation;1570;515;GO:0009987
GO:0033597;mitotic checkpoint complex;315;30;GO:0046274
GO:0070586;cell-cell adhesion involved in gastrulation;624;12;GO:0046655
GO:0033596;TSC1-TSC2 complex;2795;190;GO:0046274
GO:0070587;regulation of cell-cell adhesion involved in gastrulation;532;15;GO:0010467
GO:0033591;response to L-ascorbic acid;100;186;GO:0046655
GO:0033590;response to cobalamin;31;47;GO:0045944
GO:0033595;response to genistein;33;8;GO:0046274
GO:0033594;response to hydroxyisoflavone;45;38;GO:0005923
GO:0033593;BRCA2-MAGE-D1 complex;50;9;GO:0046274
GO:0033592;RNA strand annealing activity;7866;84;GO:0030054
GO:0070570;regulation of neuron projection regeneration;1670;62;GO:0046323
GO:0070573;metallodipeptidase activity;56632;137;GO:0048704
GO:0070574;cadmium ion transmembrane transport;3932;405;GO:0046274
GO:0070571;negative regulation of neuron projection regeneration;717;58;GO:0048704
GO:0070572;positive regulation of neuron projection regeneration;504;10;GO:0046274
GO:0033588;elongator holoenzyme complex;19408;709;GO:0010468
GO:0070577;lysine-acetylated histone binding;8111;447;GO:0002541
GO:0070578;RISC-loading complex;1256;142;GO:0048608
GO:0033586;L-phenylalanine biosynthetic process from chorismate via L-arogenate;0;2;GO:0008630
GO:0070575;peptide mating pheromone maturation involved in regulation of pheromone-induced unidirectional conjugation;0;0;GO:0042981
GO:0033585;L-phenylalanine biosynthetic process from chorismate via phenylpyruvate;18;3;GO:0008630
GO:0070576;vitamin D 24-hydroxylase activity;298;38;GO:0008631
GO:0070579;methylcytosine dioxygenase activity;6991;77;GO:0007631
GO:0070528;protein kinase C signaling;2777;599;GO:0010941
GO:0070529;L-tryptophan aminotransferase activity;50;1;GO:0005615
GO:0045569;TRAIL binding;527;85;GO:0005524
GO:0045570;regulation of imaginal disc growth;568;97;GO:0008544
GO:0045574;sterigmatocystin catabolic process;1;4;GO:0007586
GO:0045571;negative regulation of imaginal disc growth;129;19;GO:0008219
GO:0045572;positive regulation of imaginal disc growth;288;7;GO:0004637
GO:0070522;ERCC4-ERCC1 complex;314;154;GO:0045944
GO:0070523;11-beta-hydroxysteroid dehydrogenase (NAD+) activity;113;0;GO:0006022
GO:0070520;alpha4-beta1 integrin-CD81 complex;0;0;GO:0006032
GO:0070521;alpha4-beta1 integrin-CD82 complex;0;0;GO:0006032
GO:0070527;platelet aggregation;2855;1770;GO:0006032
GO:0070524;11-beta-hydroxysteroid dehydrogenase (NADP+) activity;197;0;GO:0006032
GO:0070525;tRNA threonylcarbamoyladenosine metabolic process;234323;55;GO:0006032
GO:0070519;alpha4-beta1 integrin-CD63 complex;0;1;GO:0042127
GO:0070517;DNA replication factor C core complex;0;1;GO:0050729
GO:0070518;alpha4-beta1 integrin-CD53 complex;0;1;GO:0007050
GO:0045577;regulation of B cell differentiation;2297;1380;GO:0050832
GO:0045578;negative regulation of B cell differentiation;181;62;GO:0042127
GO:0045575;basophil activation;169;8;GO:0050832
GO:0045576;mast cell activation;2952;1220;GO:0006413
GO:0045579;positive regulation of B cell differentiation;1169;2440;GO:0050832
GO:0045580;regulation of T cell differentiation;9747;935;GO:0048407
GO:0045581;negative regulation of T cell differentiation;2494;192;GO:0010468
GO:0045584;negative regulation of cytotoxic T cell differentiation;10;9;GO:0048193
GO:0045585;positive regulation of cytotoxic T cell differentiation;69;19;GO:0005576
GO:0045582;positive regulation of T cell differentiation;5180;1110;GO:0048523
GO:0045583;regulation of cytotoxic T cell differentiation;79;7;GO:0048771
GO:0070512;positive regulation of histone H4-K20 methylation;3;35;GO:0045727
GO:0070515;alphaIIb-beta3 integrin-talin complex;0;2;GO:0048667
GO:0070516;CAK-ERCC2 complex;225;5;GO:0002684
GO:0070513;death domain binding;2182;344;GO:0002684
GO:0070514;SRF-myogenin-E12 complex;1;1;GO:0048704
GO:0045588;positive regulation of gamma-delta T cell differentiation;332;123;GO:0002684
GO:0045589;regulation of regulatory T cell differentiation;1619;1180;GO:0048193
GO:0045586;regulation of gamma-delta T cell differentiation;449;1370;GO:0030900
GO:0045587;negative regulation of gamma-delta T cell differentiation;0;1;GO:0048407
GO:0045591;positive regulation of regulatory T cell differentiation;1055;434;GO:0048407
GO:0045592;regulation of cumulus cell differentiation;0;2;GO:0005578
GO:0045590;negative regulation of regulatory T cell differentiation;249;148;GO:0005576
GO:0045595;regulation of cell differentiation;132048;3860;GO:0005576
GO:0070540;stearic acid binding;8;6;GO:0046686
GO:0045596;negative regulation of cell differentiation;43793;3200;GO:0005576
GO:0070541;response to platinum ion;16;32;GO:0008544
GO:0045593;negative regulation of cumulus cell differentiation;0;2;GO:0048308
GO:0045594;positive regulation of cumulus cell differentiation;0;1;GO:0006979
GO:0070544;histone H3-K36 demethylation;1;945;GO:0002821
GO:0070545;PeBoW complex;574;131;GO:0005743
GO:0070542;response to fatty acid;17899;1030;GO:0002821
GO:0070543;response to linoleic acid;72;148;GO:0006720
GO:0070548;L-glutamine aminotransferase activity;169076;3;GO:0002821
GO:0070549;siRNA-mediated gene silencing by inhibition of translation;0;0;GO:0005578
GO:0070546;L-phenylalanine aminotransferase activity;1303;157;GO:0048704
GO:0070547;L-tyrosine aminotransferase activity;4812;4;GO:0005576
GO:0070539;linoleic acid binding;73;2;GO:0048706
GO:0045599;negative regulation of fat cell differentiation;2725;1190;GO:0048704
GO:0045597;positive regulation of cell differentiation;59511;2950;GO:0002576
GO:0045598;regulation of fat cell differentiation;6764;726;GO:0002821
GO:0070530;K63-linked polyubiquitin modification-dependent protein binding;4707;70;GO:0008092
GO:0070533;BRCA1-C complex;309;10;GO:0048011
GO:0070534;protein K63-linked ubiquitination;851;849;GO:0006936
GO:0070531;BRCA1-A complex;8068;898;GO:0048011
GO:0070532;BRCA1-B complex;208;8;GO:0006936
GO:0070537;histone H2A K63-linked deubiquitination;0;37;GO:0002821
GO:0070538;oleic acid binding;160;33;GO:0006936
GO:0070535;histone H2A K63-linked ubiquitination;0;22;GO:0002526
GO:0070536;protein K63-linked deubiquitination;281;722;GO:0048511
GO:0080093;regulation of photorespiration;46;4;GO:0009611
GO:0080094;response to trehalose-6-phosphate;5;5;GO:0002537
GO:0080095;phosphatidylethanolamine-sterol O-acyltransferase activity;33;4;GO:0006936
GO:0080096;phosphatidate-sterol O-acyltransferase activity;33;5;GO:0048608
GO:0080097;L-tryptophan:pyruvate aminotransferase activity;28;4;GO:0048699
GO:0080098;L-tyrosine:pyruvate aminotransferase activity;4;2;GO:0004637
GO:0080099;L-methionine:2-oxoglutarate aminotransferase activity;5;1;GO:0043066
GO:0080071;indol-3-yl-methyl-desulfoglucosinolate sulfotransferase activity;3;1;GO:0005737
GO:0080072;spermidine:sinapoyl CoA N-acyltransferase activity;10;3;GO:0005615
GO:0080073;spermidine:coumaroyl CoA N-acyltransferase activity;11;4;GO:0005737
GO:0080074;spermidine:caffeoyl CoA N-acyltransferase activity;8;3;GO:0046274
GO:0080075;spermidine:feruloyl CoA N-acyltransferase activity;8;3;GO:0005840
GO:0080076;caffeoyl CoA:S-adenosyl-L-methionine O-methyltransferase activity;9;4;GO:0046274
GO:0080077;trihydroxyferuloyl spermidine:S-adenosyl-L-methionine O-methyltransferase activity;6;1;GO:0042981
GO:0080078;tricaffeoyl spermidine:S-adenosyl-L-methionine O-methyltransferase activity;6;2;GO:0046274
GO:0080079;cellobiose glucosidase activity;53;17;GO:0005737
GO:0080081;4-methylumbelliferyl-beta-D-glucopyranoside beta-glucosidase activity;4;3;GO:0046274
GO:0080082;esculin beta-glucosidase activity;4;3;GO:0046274
GO:0080083;beta-gentiobiose beta-glucosidase activity;49;8;GO:0005815
GO:0080084;5S rDNA binding;337;2;GO:0046274
GO:0080085;signal recognition particle, chloroplast targeting;0;7;GO:0046274
GO:0080086;stamen filament development;40;97;GO:0048316
GO:0080088;spermidine hydroxycinnamate conjugate biosynthetic process;19;2;GO:0046274
GO:0080089;sinapoyl spermidine:sinapoyl CoA N-acyltransferase activity;2;2;GO:0006073
GO:0080090;regulation of primary metabolic process;27323168;2990;GO:0050789
GO:0080091;regulation of raffinose metabolic process;10;1;GO:0006066
GO:0080092;regulation of pollen tube growth;238;135;GO:0048316
GO:0055093;response to hyperoxia;483;540;GO:0050890
GO:0055094;response to lipoprotein particle;1300;544;GO:0042175
GO:0080050;regulation of seed development;355;8;GO:0048731
GO:0055095;lipoprotein particle mediated signaling;167;9;GO:0007264
GO:0080051;cutin transport;52;12;GO:0009909
GO:0055096;low-density lipoprotein particle mediated signaling;167;250;GO:0006869
GO:0080052;response to histidine;65;5;GO:0006935
GO:0055097;high density lipoprotein particle mediated signaling;0;0;GO:0008023
GO:0080053;response to phenylalanine;44;7;GO:0009628
GO:0080054;low-affinity nitrate transmembrane transporter activity;27;3;GO:0008544
GO:0080056;petal vascular tissue pattern formation;4;2;GO:0048731
GO:0080057;sepal vascular tissue pattern formation;4;2;GO:0048731
GO:0080058;protein deglutathionylation;21;10;GO:0006474
GO:0080059;flavonol 3-O-arabinosyltransferase activity;8;1;GO:0006073
GO:0008701;4-hydroxy-2-oxovalerate aldolase activity;25917;51;GO:0006099
GO:0055090;acylglycerol homeostasis;2890;1140;GO:0006629
GO:0008700;4-hydroxy-2-oxoglutarate aldolase activity;5809;75;GO:0004089
GO:0055091;phospholipid homeostasis;1284;1030;GO:0006631
GO:0055092;sterol homeostasis;8319;1160;GO:0006869
GO:0080060;integument development;105;132;GO:0009952
GO:0080061;indole-3-acetonitrile nitrilase activity;774;7;GO:0009081
GO:0080062;cytokinin 9-beta-glucosyltransferase activity;8;4;GO:0004553
GO:0080064;4,4-dimethyl-9beta,19-cyclopropylsterol oxidation;2;0;GO:0046148
GO:0080065;4-alpha-methyl-delta7-sterol oxidation;78;0;GO:0006635
GO:0080066;3-methylthiopropyl-desulfoglucosinolate sulfotransferase activity;3;1;GO:0004733
GO:0080067;4-methylthiobutyl-desulfoglucosinolate sulfotransferase activity;3;1;GO:0004734
GO:0080068;5-methylthiopentyl-desulfoglucosinolate sulfotransferase activity;3;1;GO:0004733
GO:0080069;7-methylthioheptyl-desulfoglucosinolate sulfotransferase activity;3;1;GO:0004734
GO:0008713;ADP-heptose-lipopolysaccharide heptosyltransferase activity;66;3;GO:0004364
GO:0008712;ADP-glyceromanno-heptose 6-epimerase activity;31812;7;GO:0006021
GO:0008710;8-amino-7-oxononanoate synthase activity;30065;126;GO:0006081
GO:0008706;6-phospho-beta-glucosidase activity;7890;9;GO:0004553
GO:0008705;methionine synthase activity;105788;215;GO:0004332
GO:0008704;5-carboxymethyl-2-hydroxymuconate delta-isomerase activity;13420;10;GO:0003954
GO:0008703;5-amino-6-(5-phosphoribosylamino)uracil reductase activity;155101;0;GO:0004073
GO:0008709;cholate 7-alpha-dehydrogenase activity;961;8;GO:0004449
GO:0008707;4-phytase activity;471;4;GO:0004553
GO:0080070;8-methylthiooctyl-desulfoglucosinolate sulfotransferase activity;3;1;GO:0004734
GO:0080030;methyl indole-3-acetate esterase activity;687;9;GO:0004733
GO:0080031;methyl salicylate esterase activity;587;7;GO:0046148
GO:0080032;methyl jasmonate esterase activity;694;7;GO:0046274
GO:0080033;response to nitrite;20;3;GO:0046395
GO:0080034;host response to induction by symbiont of tumor, nodule or growth in host;8;4;GO:0046649
GO:0080035;2-hydroxy-but-3-enyl glucosinolate biosynthetic process;0;1;GO:0009813
GO:0080036;regulation of cytokinin-activated signaling pathway;1856;185;GO:0046274
GO:0080037;negative regulation of cytokinin-activated signaling pathway;1717;40;GO:0046274
GO:0080038;positive regulation of cytokinin-activated signaling pathway;124;1;GO:0046274
GO:0080040;positive regulation of cellular response to phosphate starvation;93;6;GO:0045735
GO:0080041;ADP-ribose pyrophosphohydrolase activity;83;9;GO:0006032
GO:0080042;ADP-glucose pyrophosphohydrolase activity;83;6;GO:0006064
GO:0080043;quercetin 3-O-glucosyltransferase activity;2087;93;GO:0006073
GO:0080044;quercetin 7-O-glucosyltransferase activity;2034;68;GO:0006073
GO:0080045;quercetin 3'-O-glucosyltransferase activity;7;0;GO:0006073
GO:0080046;quercetin 4'-O-glucosyltransferase activity;35;1;GO:0006073
GO:0080047;GDP-L-galactose phosphorylase activity;40;4;GO:0006096
GO:0080048;GDP-D-glucose phosphorylase activity;3946;19;GO:0006096
GO:0080049;L-gulono-1,4-lactone dehydrogenase activity;25;0;GO:0003854
GO:0021717;inferior olivary nucleus maturation;0;2;GO:0048704
GO:0021718;superior olivary nucleus development;92;22;GO:0048704
GO:0021719;superior olivary nucleus morphogenesis;0;2;GO:0048704
GO:0021713;inferior olivary nucleus development;0;1;GO:0048704
GO:0021714;inferior olivary nucleus morphogenesis;0;2;GO:0048704
GO:0021715;inferior olivary nucleus formation;0;3;GO:0048704
GO:0021716;inferior olivary nucleus structural organization;0;2;GO:0048666
GO:0008742;L-ribulose-phosphate 4-epimerase activity;13750;143;GO:0006096
GO:0008741;ribulokinase activity;20093;314;GO:0006099
GO:0021710;cerebellar stellate cell differentiation;0;2;GO:0048666
GO:0008740;L-rhamnose isomerase activity;16396;99;GO:0003824
GO:0021711;cerebellar unipolar brush cell differentiation;0;2;GO:0048704
GO:0021712;candelabrum cell differentiation;0;3;GO:0048608
GO:0008746;NAD(P)+ transhydrogenase activity;55751;3;GO:0006749
GO:0008745;N-acetylmuramoyl-L-alanine amidase activity;173117;1180;GO:0004553
GO:0008744;L-xylulokinase activity;333;2;GO:0004726
GO:0008743;L-threonine 3-dehydrogenase activity;30952;89;GO:0009065
GO:0008738;L-fuculose-phosphate aldolase activity;6919;8;GO:0006064
GO:0008737;L-fuculokinase activity;4472;10;GO:0004721
GO:0008736;L-fucose isomerase activity;19522;20;GO:0004553
GO:0021706;locus ceruleus maturation;0;1;GO:0008544
GO:0021707;cerebellar granule cell differentiation;473;1800;GO:0048666
GO:0021708;Lugaro cell differentiation;0;2;GO:0048667
GO:0021709;cerebellar basket cell differentiation;0;2;GO:0048666
GO:0021702;cerebellar Purkinje cell differentiation;779;1970;GO:0048666
GO:0021703;locus ceruleus development;273;57;GO:0007423
GO:0021704;locus ceruleus morphogenesis;0;2;GO:0048608
GO:0021705;locus ceruleus formation;0;2;GO:0008544
GO:0008753;NADPH dehydrogenase (quinone) activity;4766;20;GO:0004784
GO:0008752;FMN reductase (NAD(P)H) activity;6825;7;GO:0004067
GO:0021700;developmental maturation;31299;1500;GO:0007548
GO:0008750;NAD(P)+ transhydrogenase (AB-specific) activity;26285;0;GO:0006749
GO:0021701;cerebellar Golgi cell differentiation;0;1;GO:0048666
GO:0008757;S-adenosylmethionine-dependent methyltransferase activity;5497734;2850;GO:0004725
GO:0008756;o-succinylbenzoate-CoA ligase activity;16448;120;GO:0006081
GO:0008755;O antigen polymerase activity;4;3;GO:0003906
GO:0008754;O antigen ligase activity;1;7;GO:0004867
GO:0008748;N-ethylmaleimide reductase activity;2;3;GO:0004067
GO:0008747;N-acetylneuraminate lyase activity;5959;133;GO:0004734
GO:0045706;positive regulation of salivary gland boundary specification;0;2;GO:0048704
GO:0045707;regulation of adult salivary gland boundary specification;0;1;GO:0048704
GO:0045704;regulation of salivary gland boundary specification;32;2;GO:0048704
GO:0045705;negative regulation of salivary gland boundary specification;32;27;GO:0048704
GO:0045708;regulation of larval salivary gland boundary specification;0;2;GO:0048704
GO:0045709;negative regulation of adult salivary gland boundary specification;0;3;GO:0048704
GO:0008720;D-lactate dehydrogenase activity;3597;9;GO:0004746
GO:0045702;positive regulation of spermatid nuclear differentiation;0;2;GO:0048608
GO:0045703;ketoreductase activity;2628;25;GO:0004497
GO:0045700;regulation of spermatid nuclear differentiation;0;2;GO:0048608
GO:0008721;D-serine ammonia-lyase activity;12327;10;GO:0009065
GO:0045701;negative regulation of spermatid nuclear differentiation;0;2;GO:0048608
GO:0008716;D-alanine-D-alanine ligase activity;188714;313;GO:0004867
GO:0008715;CDP-diacylglycerol diphosphatase activity;9639;271;GO:0004722
GO:0008714;AMP nucleosidase activity;59679;7;GO:0004553
GO:0008719;dihydroneopterin triphosphate 2'-epimerase activity;563;0;GO:0006096
GO:0008718;D-amino-acid dehydrogenase activity;20766;10;GO:0004867
GO:0045717;negative regulation of fatty acid biosynthetic process;5882;1350;GO:0045735
GO:0045719;negative regulation of glycogen biosynthetic process;375;533;GO:0045944
GO:0008730;L(+)-tartrate dehydratase activity;1992;0;GO:0004067
GO:0045710;negative regulation of larval salivary gland boundary specification;0;2;GO:0048704
GO:0008735;L-carnitine CoA-transferase activity;418;1;GO:0004073
GO:0008734;L-aspartate oxidase activity;81353;103;GO:0004073
GO:0008733;L-arabinose isomerase activity;29843;475;GO:0003824
GO:0045711;positive regulation of adult salivary gland boundary specification;0;2;GO:0048704
GO:0008732;L-allo-threonine aldolase activity;3766;96;GO:0006099
GO:0045712;positive regulation of larval salivary gland boundary specification;0;1;GO:0048704
GO:0008728;GTP diphosphokinase activity;15595;97;GO:0004721
GO:0008727;GDP-mannose mannosyl hydrolase activity;3238;5;GO:0006021
GO:0008726;alkanesulfonate monooxygenase activity;22942;9;GO:0004497
GO:0008725;DNA-3-methyladenine glycosylase activity;46464;392;GO:0004518
GO:0018109;peptidyl-arginine phosphorylation;1;6;GO:0016567
GO:0018108;peptidyl-tyrosine phosphorylation;10957;5340;GO:0016310
GO:0008782;adenosylhomocysteine nucleosidase activity;37425;9;GO:0006066
GO:0021757;caudate nucleus development;61;10;GO:0048666
GO:0006120;mitochondrial electron transport, NADH to ubiquinone;102456;5470;GO:0005746
GO:0008781;N-acylneuraminate cytidylyltransferase activity;3652;53;GO:0004734
GO:0021758;putamen development;61;9;GO:0048666
GO:0008780;acyl-[acyl-carrier-protein]-UDP-N-acetylglucosamine O-acyltransferase activity;63308;0;GO:0006021
GO:0021759;globus pallidus development;132;139;GO:0048608
GO:0006123;mitochondrial electron transport, cytochrome c to oxygen;27200;1490;GO:0005746
GO:0008786;allose 6-phosphate isomerase activity;3;3;GO:0006032
GO:0021753;superior salivary nucleus development;0;2;GO:0048704
GO:0006124;ferredoxin metabolic process;498;6;GO:0006749
GO:0008785;alkyl hydroperoxide reductase activity;14600;6;GO:0008032
GO:0021754;facial nucleus development;235;6;GO:0048704
GO:0006121;mitochondrial electron transport, succinate to ubiquinone;3520;373;GO:0005746
GO:0008784;alanine racemase activity;220994;444;GO:0006066
GO:0021755;eurydendroid cell differentiation;32;2;GO:0045595
GO:0006122;mitochondrial electron transport, ubiquinol to cytochrome c;20586;1440;GO:0005746
GO:0008783;agmatinase activity;13502;149;GO:0004721
GO:0021756;striatum development;883;784;GO:0048608
GO:0006127;glycerophosphate shuttle;107;269;GO:0006081
GO:0008789;altronate dehydratase activity;1292;5;GO:0006067
GO:0021750;vestibular nucleus development;84;8;GO:0048704
GO:0008788;alpha,alpha-phosphotrehalase activity;8649;36;GO:0006066
GO:0021751;salivary nucleus development;0;2;GO:0048608
GO:0008787;allose kinase activity;617;4;GO:0004721
GO:0021752;inferior salivary nucleus development;0;2;GO:0048704
GO:0033739;preQ1 synthase activity;80319;10;GO:0006021
GO:0033738;methylenetetrahydrofolate reductase (ferredoxin) activity;0;3;GO:0003824
GO:0033737;1-pyrroline dehydrogenase activity;3169;6;GO:0009065
GO:0006119;oxidative phosphorylation;2498741;5360;GO:0015986
GO:0033736;L-lysine 6-oxidase activity;323;3;GO:0004497
GO:0018112;proline racemase activity;596;7;GO:0006073
GO:0033731;arogenate dehydrogenase [NAD(P)+] activity;1575;0;GO:0006066
GO:0018111;methionine racemase activity;5;2;GO:0004721
GO:0033730;arogenate dehydrogenase (NADP+) activity;1575;0;GO:0006749
GO:0018114;threonine racemase activity;152;4;GO:0006030
GO:0018113;lysine racemase activity;227;2;GO:0004721
GO:0018116;peptidyl-lysine adenylylation;0;4;GO:0006464
GO:0033735;aspartate dehydrogenase activity;17994;33;GO:0009063
GO:0018115;peptidyl-S-diphytanylglycerol diether-L-cysteine biosynthetic process from peptidyl-cysteine;0;2;GO:0006033
GO:0033734;(R)-benzylsuccinyl-CoA dehydrogenase activity;755;0;GO:0006066
GO:0018117;protein adenylylation;3750;18;GO:0006464
GO:0033732;pyrroloquinoline-quinone synthase activity;8416;2;GO:0004497
GO:0008793;aromatic-amino-acid:2-oxoglutarate aminotransferase activity;2714;9;GO:0004073
GO:0021746;solitary nucleus development;0;2;GO:0048608
GO:0008792;arginine decarboxylase activity;51685;752;GO:0006066
GO:0021747;cochlear nucleus development;157;18;GO:0048704
GO:0008791;arginine N-succinyltransferase activity;14973;69;GO:0004073
GO:0021748;dorsal cochlear nucleus development;0;2;GO:0048704
GO:0008790;arabinose isomerase activity;22;5;GO:0006032
GO:0021749;ventral cochlear nucleus development;0;1;GO:0048704
GO:0008797;aspartate ammonia-lyase activity;23446;140;GO:0004067
GO:0021742;abducens nucleus development;99;3;GO:0048706
GO:0008796;bis(5'-nucleosyl)-tetraphosphatase activity;36983;0;GO:0004553
GO:0021743;hypoglossal nucleus development;56;3;GO:0048704
GO:0008795;NAD+ synthase activity;93067;652;GO:0006749
GO:0021744;dorsal motor nucleus of vagus nerve development;78;3;GO:0048704
GO:0008794;arsenate reductase (glutaredoxin) activity;60597;68;GO:0004746
GO:0021745;nucleus ambiguus development;0;1;GO:0048704
GO:0006139;nucleobase-containing compound metabolic process;93429875;5100;GO:0006793
GO:0021740;principal sensory nucleus of trigeminal nerve development;128;118;GO:0048704
GO:0008798;beta-aspartyl-peptidase activity;6903;48;GO:0043169
GO:0021741;spinal trigeminal nucleus development;0;2;GO:0048699
GO:0033728;divinyl chlorophyllide a 8-vinyl-reductase activity;835;3;GO:0009536
GO:0033727;aldehyde dehydrogenase (FAD-independent) activity;315;5;GO:0004041
GO:0033726;aldehyde ferredoxin oxidoreductase activity;5621;3;GO:0004091
GO:0033729;anthocyanidin reductase activity;68;5;GO:0004497
GO:0033720;(S)-mandelate dehydrogenase activity;362;0;GO:0004073
GO:0018103;protein C-linked glycosylation;3;10;GO:0006486
GO:0018102;peptidyl-arginine hydroxylation to peptidyl-4-hydroxy-L-arginine;0;4;GO:0009065
GO:0018105;peptidyl-serine phosphorylation;6853;3670;GO:0006468
GO:0018104;peptidoglycan-protein cross-linking;74;6;GO:0008061
GO:0033723;fluoroacetaldehyde dehydrogenase activity;7;3;GO:0009065
GO:0018107;peptidyl-threonine phosphorylation;11246;1950;GO:0006468
GO:0033722;malonate-semialdehyde dehydrogenase activity;0;3;GO:0004041
GO:0018106;peptidyl-histidine phosphorylation;2420396;623;GO:0043403
GO:0033721;aldehyde dehydrogenase (NADP+) activity;994;0;GO:0004073
GO:0021739;mesencephalic trigeminal nucleus development;0;2;GO:0048704
GO:0008760;UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity;165929;381;GO:0006029
GO:0021735;dentate nucleus development;0;3;GO:0048704
GO:0021736;globose nucleus development;0;3;GO:0048285
GO:0021737;emboliform nucleus development;0;4;GO:0048706
GO:0021738;fastigial nucleus development;0;3;GO:0048706
GO:0006101;citrate metabolic process;8038;1720;GO:0006096
GO:0008764;UDP-N-acetylmuramoylalanine-D-glutamate ligase activity;153184;852;GO:0005524
GO:0021731;trigeminal motor nucleus development;61;1;GO:0048704
GO:0006102;isocitrate metabolic process;24998;1550;GO:0006096
GO:0008763;UDP-N-acetylmuramate-L-alanine ligase activity;141725;10;GO:0006030
GO:0021732;midbrain-hindbrain boundary maturation;62;2;GO:0009952
GO:0008762;UDP-N-acetylmuramate dehydrogenase activity;161856;1050;GO:0006022
GO:0008761;UDP-N-acetylglucosamine 2-epimerase activity;56358;319;GO:0006029
GO:0006105;succinate metabolic process;22651;651;GO:0006096
GO:0008768;UDP-sugar diphosphatase activity;1347;20;GO:0004553
GO:0006106;fumarate metabolic process;64259;508;GO:0006096
GO:0008767;UDP-galactopyranose mutase activity;18198;158;GO:0008800
GO:0006103;2-oxoglutarate metabolic process;21464;2070;GO:0006066
GO:0008766;UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity;56325;9;GO:0005524
GO:0006104;succinyl-CoA metabolic process;1936;507;GO:0006094
GO:0008765;UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase activity;85570;7;GO:0005524
GO:0021730;trigeminal sensory nucleus development;210;21;GO:0048704
GO:0033717;gluconate 2-dehydrogenase (acceptor) activity;1844;3;GO:0006066
GO:0033716;nucleoside oxidase (hydrogen peroxide-forming) activity;0;2;GO:0004725
GO:0008759;UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity;98719;0;GO:0004553
GO:0033715;nucleoside oxidase activity;0;4;GO:0004725
GO:0008758;UDP-2,3-diacylglucosamine hydrolase activity;15810;70;GO:0004553
GO:0019742;pentacyclic triterpenoid metabolic process;23;4;GO:0006032
GO:0019741;pentacyclic triterpenoid catabolic process;2;2;GO:0046274
GO:0019744;hopanoid metabolic process;0;2;GO:0006790
GO:0032700;negative regulation of interleukin-17 production;845;653;GO:0050729
GO:0019743;hopanoid catabolic process;0;1;GO:0046274
GO:0032701;negative regulation of interleukin-18 production;103;25;GO:0050727
GO:0019746;hopanoid biosynthetic process;0;5;GO:0009061
GO:0019745;pentacyclic triterpenoid biosynthetic process;13;118;GO:0009813
GO:0044748;3'-5'-exoribonuclease activity involved in mature miRNA 3'-end processing;19;0;GO:0003723
GO:0019725;cellular homeostasis;683305;4690;GO:0048519
GO:0044747;pre-miRNA 3'-end processing;38;2;GO:0003723
GO:0019728;peptidyl-allysine oxidation to 2-aminoadipic acid;0;3;GO:0006468
GO:0019727;mevaldate reductase (NAD+) activity;0;0;GO:0004091
GO:0044740;negative regulation of sensory perception of pain in another organism;0;0;GO:0009611
GO:0044742;envenomation resulting in modulation of sensory perception of pain in another organism;1;0;GO:0009611
GO:0044741;envenomation resulting in negative regulation of sensory perception of pain in another organism;0;0;GO:0009611
GO:0005102;signaling receptor binding;801512;3700;GO:0004872
GO:0044743;protein transmembrane import into intracellular organelle;63260;163;GO:0005576
GO:0005105;type 1 fibroblast growth factor receptor binding;257;288;GO:0048407
GO:0005104;fibroblast growth factor receptor binding;2102;655;GO:0048407
GO:0019731;antibacterial humoral response;3779;2380;GO:0002526
GO:0019730;antimicrobial humoral response;7314;1630;GO:0002526
GO:0019732;antifungal humoral response;577;279;GO:0002757
GO:0005150;interleukin-1, type I receptor binding;61;39;GO:0005126
GO:0032770;positive regulation of monooxygenase activity;60;349;GO:0046148
GO:0005152;interleukin-1 receptor antagonist activity;168;49;GO:0004896
GO:0005151;interleukin-1, type II receptor binding;51;20;GO:0005126
GO:0005154;epidermal growth factor receptor binding;2294;1160;GO:0005126
GO:0005153;interleukin-8 receptor binding;99;186;GO:0005125
GO:0005158;insulin receptor binding;4901;1240;GO:0005520
GO:0005157;macrophage colony-stimulating factor receptor binding;1008;69;GO:0048407
GO:0005159;insulin-like growth factor receptor binding;830;827;GO:0005126
GO:0030107;HLA-A specific inhibitory MHC class I receptor activity;6;19;GO:0004872
GO:0030109;HLA-B specific inhibitory MHC class I receptor activity;7;10;GO:0004872
GO:0032768;regulation of monooxygenase activity;132;160;GO:0046148
GO:0030108;HLA-A specific activating MHC class I receptor activity;63;7;GO:0004872
GO:0032769;negative regulation of monooxygenase activity;46;176;GO:0046323
GO:0017143;insecticide metabolic process;40;57;GO:0006725
GO:0032762;mast cell cytokine production;229;40;GO:0046649
GO:0032763;regulation of mast cell cytokine production;229;7;GO:0050729
GO:0017145;stem cell division;2276;475;GO:0048608
GO:0030101;natural killer cell activation;4079;1460;GO:0002273
GO:0032760;positive regulation of tumor necrosis factor production;4378;2300;GO:0032724
GO:0017146;NMDA selective glutamate receptor complex;3115;255;GO:0048167
GO:0030100;regulation of endocytosis;22868;2360;GO:0009986
GO:0032761;positive regulation of lymphotoxin A production;44;4;GO:0048010
GO:0017147;Wnt-protein binding;8880;1010;GO:0005518
GO:0030103;vasopressin secretion;65;6;GO:0007596
GO:0032766;NHE3/E3KARP/ACTN4 complex;0;1;GO:0005576
GO:0017148;negative regulation of translation;224775;3710;GO:0010467
GO:0032767;copper-dependent protein binding;96;52;GO:0042802
GO:0032764;negative regulation of mast cell cytokine production;99;67;GO:0050729
GO:0032765;positive regulation of mast cell cytokine production;130;44;GO:0050729
GO:0017129;triglyceride binding;180;47;GO:0005578
GO:0005161;platelet-derived growth factor receptor binding;655;1160;GO:0005126
GO:0005160;transforming growth factor beta receptor binding;6023;1410;GO:0048407
GO:0005163;nerve growth factor receptor binding;135;37;GO:0005178
GO:0005165;neurotrophin receptor binding;3666;94;GO:0048010
GO:0005164;tumor necrosis factor receptor binding;21850;2430;GO:0005126
GO:0005167;neurotrophin TRK receptor binding;342;8;GO:0048405
GO:0005166;neurotrophin p75 receptor binding;13;10;GO:0048608
GO:0005169;neurotrophin TRKB receptor binding;37;8;GO:0048408
GO:0005168;neurotrophin TRKA receptor binding;304;129;GO:0048405
GO:0032759;positive regulation of TRAIL production;133;43;GO:0046330
GO:0032757;positive regulation of interleukin-8 production;2973;1490;GO:0050729
GO:0032758;positive regulation of interleukin-9 production;0;2;GO:0050729
GO:0017130;poly(C) RNA binding;84;36;GO:0003723
GO:0017131;uridine-rich cytoplasmic polyadenylylation element binding;1;1;GO:0003723
GO:0032751;positive regulation of interleukin-27 production;0;2;GO:0046649
GO:0017133;mitochondrial electron transfer flavoprotein complex;3;94;GO:0005747
GO:0032752;positive regulation of interleukin-3 production;51;27;GO:0050729
GO:0017134;fibroblast growth factor binding;1376;818;GO:0005518
GO:0019797;procollagen-proline 3-dioxygenase activity;2106;165;GO:0004866
GO:0032750;positive regulation of interleukin-26 production;0;1;GO:0046649
GO:0017136;NAD-dependent histone deacetylase activity;3703;340;GO:0004721
GO:0019799;tubulin N-acetyltransferase activity;7914;38;GO:0004073
GO:0032755;positive regulation of interleukin-6 production;4892;2040;GO:0050727
GO:0019798;procollagen-proline dioxygenase activity;15541;125;GO:0004866
GO:0032756;positive regulation of interleukin-7 production;0;3;GO:0050729
GO:0032753;positive regulation of interleukin-4 production;1163;539;GO:0050729
GO:0032754;positive regulation of interleukin-5 production;518;122;GO:0050729
GO:0017118;lipoyltransferase activity;182;196;GO:0008610
GO:0017119;Golgi transport complex;24505;1460;GO:0005794
GO:0005130;granulocyte colony-stimulating factor receptor binding;75;8;GO:0004974
GO:0005132;type I interferon receptor binding;244;449;GO:0005125
GO:0005131;growth hormone receptor binding;1954;181;GO:0004872
GO:0005134;interleukin-2 receptor binding;584;178;GO:0005125
GO:0005133;type II interferon receptor binding;1094;9;GO:0005125
GO:0005136;interleukin-4 receptor binding;585;173;GO:0005125
GO:0005135;interleukin-3 receptor binding;170;9;GO:0005125
GO:0005138;interleukin-6 receptor binding;1379;234;GO:0005125
GO:0005137;interleukin-5 receptor binding;659;57;GO:0005125
GO:0005129;granulocyte macrophage colony-stimulating factor receptor binding;225;24;GO:0005125
GO:0032748;positive regulation of interleukin-24 production;0;1;GO:0046649
GO:0005128;erythropoietin receptor binding;774;29;GO:0005515
GO:0032749;positive regulation of interleukin-25 production;0;3;GO:0046649
GO:0032746;positive regulation of interleukin-22 production;0;1;GO:0050729
GO:0032747;positive regulation of interleukin-23 production;326;226;GO:0050729
GO:0019780;FAT10 activating enzyme activity;136;1;GO:0004842
GO:0019782;ISG15 activating enzyme activity;136;9;GO:0004867
GO:0019781;NEDD8 activating enzyme activity;18305;138;GO:0004842
GO:0017121;plasma membrane phospholipid scrambling;21037;31;GO:0006629
GO:0019784;deNEDDylase activity;5990;10;GO:0004842
GO:0032740;positive regulation of interleukin-17 production;1057;745;GO:0050729
GO:0017122;protein N-acetylglucosaminyltransferase complex;1744;4;GO:0005581
GO:0019783;ubiquitin-like protein peptidase activity;319669;5;GO:0048193
GO:0032741;positive regulation of interleukin-18 production;144;289;GO:0050729
GO:0019786;protein-phosphatidylethanolamide deconjugating activity;8263;5;GO:0008033
GO:0017124;SH3 domain binding;77244;2280;GO:0005515
GO:0019785;ISG15-specific peptidase activity;26;5;GO:0048195
GO:0017125;deoxycytidyl transferase activity;146;6;GO:0004518
GO:0019788;NEDD8 transferase activity;531;40;GO:0004842
GO:0032744;positive regulation of interleukin-20 production;0;2;GO:0046649
GO:0017126;nucleologenesis;188;10;GO:0007049
GO:0019787;ubiquitin-like protein transferase activity;693624;633;GO:0004842
GO:0032745;positive regulation of interleukin-21 production;9;7;GO:0050729
GO:0032742;positive regulation of interleukin-19 production;0;2;GO:0046649
GO:0017128;phospholipid scramblase activity;10076;200;GO:0008030
GO:0019789;SUMO transferase activity;8107;660;GO:0008037
GO:0032743;positive regulation of interleukin-2 production;1865;998;GO:0050729
GO:0017108;5'-flap endonuclease activity;37796;50;GO:0004518
GO:0019769;low-affinity IgE receptor activity;43;6;GO:0004974
GO:0044703;multi-organism reproductive process;7100;1450;GO:0048608
GO:0017109;glutamate-cysteine ligase complex;342;112;GO:0005739
GO:0044706;multi-multicellular organism process;13340;518;GO:0032501
GO:0005141;interleukin-10 receptor binding;12;3;GO:0005125
GO:0005140;interleukin-9 receptor binding;15;1;GO:0005125
GO:0005143;interleukin-12 receptor binding;819;45;GO:0005125
GO:0005142;interleukin-11 receptor binding;43;4;GO:0005125
GO:0005144;interleukin-13 receptor binding;3;6;GO:0005125
GO:0005147;oncostatin-M receptor binding;218;4;GO:0005125
GO:0005146;leukemia inhibitory factor receptor binding;696;41;GO:0005125
GO:0005149;interleukin-1 receptor binding;5394;751;GO:0005125
GO:0005148;prolactin receptor binding;167;45;GO:0004872
GO:0005139;interleukin-7 receptor binding;822;15;GO:0005125
GO:0032738;positive regulation of interleukin-15 production;54;6;GO:0046330
GO:0032735;positive regulation of interleukin-12 production;1877;1470;GO:0032724
GO:0032736;positive regulation of interleukin-13 production;628;108;GO:0050729
GO:0019771;high-affinity IgG receptor activity;35;2;GO:0002768
GO:0032739;positive regulation of interleukin-16 production;55;5;GO:0050729
GO:0019770;IgG receptor activity;81;97;GO:0004872
GO:0017110;nucleoside diphosphate phosphatase activity;15539;10;GO:0004725
GO:0019773;proteasome core complex, alpha-subunit complex;83184;1270;GO:0005840
GO:0017111;ribonucleoside triphosphate phosphatase activity;9546169;64;GO:0004723
GO:0019772;low-affinity IgG receptor activity;6;9;GO:0002768
GO:0032730;positive regulation of interleukin-1 alpha production;292;25;GO:0050729
GO:0019775;FAT10 transferase activity;0;2;GO:0008544
GO:0017113;dihydropyrimidine dehydrogenase (NADP+) activity;3895;1;GO:0009065
GO:0019774;proteasome core complex, beta-subunit complex;17804;248;GO:0005840
GO:0019777;Atg12 transferase activity;184;8;GO:0004842
GO:0032733;positive regulation of interleukin-10 production;1801;929;GO:0050727
GO:0019776;Atg8-family ligase activity;4339;5;GO:0004842
GO:0032734;positive regulation of interleukin-11 production;0;1;GO:0050729
GO:0017116;single-stranded DNA helicase activity;7915;476;GO:0003690
GO:0019779;Atg8 activating enzyme activity;145;9;GO:0004846
GO:0032731;positive regulation of interleukin-1 beta production;2653;799;GO:0050729
GO:0017117;single-stranded DNA-dependent ATP-dependent DNA helicase complex;69;3;GO:0005524
GO:0019778;Atg12 activating enzyme activity;177;9;GO:0004842
GO:0032732;positive regulation of interleukin-1 production;6777;234;GO:0050729
GO:0042019;interleukin-23 binding;102;10;GO:0005125
GO:0032692;negative regulation of interleukin-1 production;1553;102;GO:0050729
GO:0032693;negative regulation of interleukin-10 production;782;537;GO:0050727
GO:0030031;cell projection assembly;418879;1280;GO:0042995
GO:0032690;negative regulation of interleukin-1 alpha production;73;213;GO:0032727
GO:0030030;cell projection organization;901119;4020;GO:0032989
GO:0032691;negative regulation of interleukin-1 beta production;1268;456;GO:0050729
GO:0042011;interleukin-16 binding;46;3;GO:0005125
GO:0044674;methyl coenzyme M reductase complex;0;1;GO:0006099
GO:0042012;interleukin-16 receptor activity;46;4;GO:0004872
GO:0044673;7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase complex;0;1;GO:0005576
GO:0042013;interleukin-19 binding;0;1;GO:0005125
GO:0044676;formyl-methanofuran dehydrogenase (molybdenum enzyme) complex;0;0;GO:0009065
GO:0005078;MAP-kinase scaffold activity;7596;522;GO:0043408
GO:0042014;interleukin-19 receptor activity;0;1;GO:0005125
GO:0044675;formyl-methanofuran dehydrogenase (tungsten enzyme) complex;0;0;GO:0005737
GO:0042015;interleukin-20 binding;170;10;GO:0005125
GO:0044678;CoB-CoM heterodisulfide reductase complex;0;1;GO:0005737
GO:0042016;interleukin-20 receptor activity;0;1;GO:0005125
GO:0044677;methyl-tetrahydromethanopterin:coenzyme M methyltransferase complex;0;0;GO:0005737
GO:0042017;interleukin-22 binding;54;2;GO:0005125
GO:0042018;interleukin-22 receptor activity;132;4;GO:0005125
GO:0044679;methanophenazine reducing hydrogenase complex;0;0;GO:0009086
GO:0030029;actin filament-based process;373304;3890;GO:0003779
GO:0017060;3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity;77;81;GO:0004553
GO:0017061;S-methyl-5-thioadenosine phosphorylase activity;76839;485;GO:0004465
GO:0017062;respiratory chain complex III assembly;9399;64;GO:0005746
GO:0044681;sulfopyruvate decarboxylase complex;0;0;GO:0005737
GO:0044680;methylthiol:coenzyme M methyltransferase complex;0;0;GO:0005524
GO:0017064;fatty acid amide hydrolase activity;2666;81;GO:0004553
GO:0042020;interleukin-23 receptor activity;93;127;GO:0005125
GO:0044683;methylthiol:coenzyme M methyltransferase activity;24;2;GO:0004497
GO:0017065;single-strand selective uracil DNA N-glycosylase activity;2549;7;GO:0004518
GO:0042021;granulocyte macrophage colony-stimulating factor complex binding;0;0;GO:0004872
GO:0044682;archaeal-specific GTP cyclohydrolase activity;2;1;GO:0005524
GO:0032685;negative regulation of granulocyte macrophage colony-stimulating factor production;47;8;GO:0048193
GO:0017067;tyrosine-ester sulfotransferase activity;0;5;GO:0004730
GO:0030021;extracellular matrix structural constituent conferring compression resistance;486;269;GO:0022610
GO:0032686;negative regulation of hepatocyte growth factor production;62;6;GO:0048193
GO:0032683;negative regulation of connective tissue growth factor production;62;1;GO:0048608
GO:0017069;snRNA binding;162264;441;GO:0003723
GO:0030023;extracellular matrix constituent conferring elasticity;156;337;GO:0005578
GO:0032684;negative regulation of fractalkine production;0;3;GO:0048169
GO:0030026;intracellular manganese ion homeostasis;31107;8;GO:0006836
GO:0032689;negative regulation of type II interferon production;1577;83;GO:0032940
GO:0032687;negative regulation of interferon-alpha production;166;41;GO:0032727
GO:0030027;lamellipodium;39034;3960;GO:0009987
GO:0032688;negative regulation of interferon-beta production;611;490;GO:0010467
GO:0005080;protein kinase C binding;1950;1350;GO:0043169
GO:0032681;regulation of lymphotoxin A production;44;3;GO:0050921
GO:0032682;negative regulation of chemokine production;1208;280;GO:0050921
GO:0030020;extracellular matrix structural constituent conferring tensile strength;1082;1020;GO:0022610
GO:0005085;guanyl-nucleotide exchange factor activity;478113;4810;GO:0005085
GO:0032680;regulation of tumor necrosis factor production;8512;652;GO:0032724
GO:0042022;interleukin-12 receptor complex;46;10;GO:0005125
GO:0044685;tetrahydromethanopterin-dependent serine hydroxymethyltransferase activity;0;1;GO:0004067
GO:0042023;DNA endoreduplication;5125;328;GO:0007049
GO:0044684;dihydromethanopterin reductase activity;89;2;GO:0009065
GO:0044687;geranylfarnesyl diphosphate synthase activity;108;3;GO:0004497
GO:0042025;host cell nucleus;2424328;728;GO:0005634
GO:0044686;cysteate synthase activity;437;4;GO:0004061
GO:0042026;protein refolding;211732;2630;GO:0006457
GO:0044689;7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase activity;4830;4;GO:0004497
GO:0044688;7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity;0;0;GO:0004723
GO:0030018;Z disc;16348;3380;GO:0005576
GO:0017050;D-erythro-sphingosine kinase activity;4170;83;GO:0004721
GO:0017051;retinol dehydratase activity;0;2;GO:0004073
GO:0044692;exoribonuclease activator activity;9;4;GO:0003723
GO:0042030;ATPase inhibitor activity;22805;398;GO:0005524
GO:0044691;tooth eruption;252;159;GO:0007596
GO:0017053;transcription repressor complex;48543;328;GO:0005667
GO:0044694;pore-mediated entry of viral genome into host cell;20166;4;GO:0016021
GO:0017054;negative cofactor 2 complex;2790;7;GO:0043405
GO:0044693;trehalose:proton symporter activity;0;1;GO:0005215
GO:0017055;negative regulation of RNA polymerase II transcription preinitiation complex assembly;136;1;GO:0045944
GO:0030011;maintenance of cell polarity;1375;285;GO:0007049
GO:0032674;regulation of interleukin-5 production;828;177;GO:0050729
GO:0017056;structural constituent of nuclear pore;53119;1140;GO:0008511
GO:0030010;establishment of cell polarity;80132;2460;GO:0030154
GO:0032675;regulation of interleukin-6 production;7628;783;GO:0050727
GO:0017057;6-phosphogluconolactonase activity;89044;445;GO:0006067
GO:0032672;regulation of interleukin-3 production;93;9;GO:0050729
GO:0017058;FH1 domain binding;0;2;GO:0005515
GO:0032673;regulation of interleukin-4 production;1549;174;GO:0050729
GO:0017059;serine C-palmitoyltransferase complex;985;67;GO:0005576
GO:0030015;CCR4-NOT core complex;24678;186;GO:0005840
GO:0032678;regulation of interleukin-9 production;0;1;GO:0050729
GO:0030014;CCR4-NOT complex;54296;720;GO:0005840
GO:0032679;regulation of TRAIL production;135;6;GO:0046330
GO:0030017;sarcomere;48627;3000;GO:0005544
GO:0032676;regulation of interleukin-7 production;2;1;GO:0050729
GO:0030016;myofibril;54926;3000;GO:0005575
GO:0032677;regulation of interleukin-8 production;3884;206;GO:0050729
GO:0032670;regulation of interleukin-26 production;0;2;GO:0046649
GO:0032671;regulation of interleukin-27 production;1;2;GO:0046649
GO:0005053;peroxisome matrix targeting signal-2 binding;3446;5;GO:0005576
GO:0005052;peroxisome matrix targeting signal-1 binding;230;37;GO:0005576
GO:0005055;laminin receptor activity;1725;811;GO:0004872
GO:0044696;killing by virus of host cell by post-segregational killing;2;1;GO:0048193
GO:0044695;Dsc E3 ubiquitin ligase complex;2320;5;GO:0005576
GO:0005056;tiggrin receptor activity;0;1;GO:0004872
GO:0044697;HICS complex;18;2;GO:0048285
GO:0042037;peptidyl-histidine methylation, to form pros-methylhistidine;0;3;GO:0016567
GO:0042038;peptidyl-histidine methylation, to form tele-methylhistidine;2;2;GO:0016567
GO:0042039;vanadium incorporation into metallo-sulfur cluster;0;3;GO:0009986
GO:0030008;TRAPP complex;28439;580;GO:0000922
GO:0030007;intracellular potassium ion homeostasis;5023;40;GO:0006873
GO:0032669;regulation of interleukin-25 production;0;3;GO:0046649
GO:0017040;N-acylsphingosine amidohydrolase activity;31948;207;GO:0004722
GO:0042040;metal incorporation into metallo-molybdopterin complex;2;58;GO:0009065
GO:0017042;glycosylceramidase activity;35;8;GO:0004553
GO:0042042;tungsten incorporation into tungsten-molybdopterin complex;0;3;GO:0009065
GO:0042043;neurexin family protein binding;6011;458;GO:0048608
GO:0017044;melanocyte-stimulating hormone activity;0;2;GO:0004930
GO:0032663;regulation of interleukin-2 production;4160;499;GO:0050729
GO:0017045;corticotropin-releasing hormone activity;17;2;GO:0004930
GO:0032664;regulation of interleukin-20 production;0;1;GO:0046330
GO:0017046;peptide hormone binding;4357;1120;GO:0005520
GO:0030002;intracellular monoatomic anion homeostasis;373;4;GO:0006874
GO:0032661;regulation of interleukin-18 production;248;9;GO:0050729
GO:0030001;metal ion transport;6028852;6960;GO:0006810
GO:0032662;regulation of interleukin-19 production;0;2;GO:0046649
GO:0032667;regulation of interleukin-23 production;470;22;GO:0050729
GO:0030003;intracellular monoatomic cation homeostasis;433124;21;GO:0006874
GO:0032668;regulation of interleukin-24 production;0;2;GO:0048608
GO:0032665;regulation of interleukin-21 production;14;4;GO:0050729
GO:0032666;regulation of interleukin-22 production;0;1;GO:0032724
GO:0032660;regulation of interleukin-17 production;1902;108;GO:0050729
GO:0042044;fluid transport;25467;315;GO:0006811
GO:0042045;epithelial fluid transport;647;39;GO:0007586
GO:0005068;transmembrane receptor protein tyrosine kinase adaptor activity;668;349;GO:0004872
GO:0042046;W-molybdopterin cofactor metabolic process;0;3;GO:0006790
GO:0042047;W-molybdopterin cofactor biosynthetic process;0;3;GO:0006022
GO:0042048;olfactory behavior;1691;900;GO:0007610
GO:0042049;intracellular acyl-CoA homeostasis;1;0;GO:0006631
GO:0019690;pyrimidine deoxyribonucleoside interconversion;0;3;GO:0006796
GO:0032658;regulation of interleukin-15 production;56;3;GO:0050727
GO:0032659;regulation of interleukin-16 production;58;2;GO:0050729
GO:0019692;deoxyribose phosphate metabolic process;453640;27;GO:0006073
GO:0042051;compound eye photoreceptor development;1264;175;GO:0008544
GO:0042052;rhabdomere development;597;119;GO:0009952
GO:0019694;alkanesulfonate metabolic process;10192;5;GO:0006081
GO:0042053;regulation of dopamine metabolic process;649;650;GO:0043403
GO:0017032;amino acid:potassium symporter activity;0;1;GO:0005215
GO:0019693;ribose phosphate metabolic process;7636570;2210;GO:0006073
GO:0042054;histone methyltransferase activity;147202;917;GO:0016567
GO:0019696;toluene oxidation via toluene-cis-1,2-dihydrodiol;0;2;GO:0046148
GO:0032652;regulation of interleukin-1 production;8800;281;GO:0050729
GO:0019695;choline metabolic process;48837;63;GO:0006541
GO:0032653;regulation of interleukin-10 production;2652;311;GO:0050727
GO:0019698;D-galacturonate catabolic process;85;4;GO:0006073
GO:0032650;regulation of interleukin-1 alpha production;365;5;GO:0050729
GO:0019697;L-xylitol catabolic process to xylulose 5-phosphate;2;3;GO:0006067
GO:0032651;regulation of interleukin-1 beta production;4308;409;GO:0050729
GO:0032656;regulation of interleukin-13 production;927;121;GO:0050729
GO:0017038;protein import;78996;2690;GO:0006810
GO:0032654;regulation of interleukin-11 production;3;2;GO:0046330
GO:0032655;regulation of interleukin-12 production;2854;536;GO:0032724
GO:0044638;envenomation resulting in positive regulation of complement activation, classical pathway in another organism;0;0;GO:0006958
GO:0044637;envenomation resulting in negative regulation of complement activation, classical pathway in another organism;0;0;GO:0002456
GO:0030071;regulation of mitotic metaphase/anaphase transition;22409;3150;GO:0000922
GO:0030070;insulin processing;410;59;GO:0007596
GO:0044639;envenomation resulting in modulation of complement activation, lectin pathway in another organism;0;0;GO:0006958
GO:0030073;insulin secretion;13703;2200;GO:0007596
GO:0030072;peptide hormone secretion;16850;610;GO:0007548
GO:0030075;bacterial thylakoid;77574;7;GO:0009579
GO:0044630;modulation of complement activation, lectin pathway in another organism;0;1;GO:0006954
GO:0044632;negative regulation of complement activation, lectin pathway in another organism;0;0;GO:0006959
GO:0044631;positive regulation of complement activation, lectin pathway in another organism;0;1;GO:0006958
GO:0044634;negative regulation of complement activation, alternative pathway in another organism;0;0;GO:0006958
GO:0044633;modulation of complement activation, alternative pathway in another organism;0;0;GO:0006956
GO:0044636;envenomation resulting in modulation of complement activation, classical pathway in another organism;0;0;GO:0002757
GO:0044635;positive regulation of complement activation, alternative pathway in another organism;0;0;GO:0006958
GO:0101002;ficolin-1-rich granule;185;361;GO:0005576
GO:0101003;ficolin-1-rich granule membrane;61;676;GO:0005576
GO:0044648;histone H3-K4 dimethylation;8;77;GO:0045944
GO:0030060;L-malate dehydrogenase activity;108966;756;GO:0003854
GO:0030062;mitochondrial tricarboxylic acid cycle enzyme complex;3470;10;GO:0005746
GO:0101004;cytolytic granule membrane;165;5;GO:0005737
GO:0030061;mitochondrial crista;449;691;GO:0005739
GO:0101005;deubiquitinase activity;306296;31;GO:0004867
GO:0101006;protein histidine phosphatase activity;8451;6;GO:0004721
GO:0044641;envenomation resulting in positive regulation of complement activation, lectin pathway in another organism;0;0;GO:0006958
GO:0044640;envenomation resulting in negative regulation of complement activation, lectin pathway in another organism;0;0;GO:0006958
GO:0044643;envenomation resulting in positive regulation of complement activation, alternative pathway in another organism;0;0;GO:0006958
GO:0044642;envenomation resulting in modulation of complement activation, alternative pathway in another organism;0;0;GO:0006958
GO:0044645;modulation of complement activation in another organism;0;0;GO:0006956
GO:0044644;envenomation resulting in negative regulation of complement activation, alternative pathway in another organism;0;0;GO:0006958
GO:0044647;host-symbiont bicellular tight junction;2;2;GO:0005929
GO:0017090;meprin A complex;76;5;GO:0005576
GO:0044646;envenomation resulting in modulation of complement activation in another organism;0;0;GO:0002768
GO:0017095;heparan sulfate 6-O-sulfotransferase activity;268;35;GO:0004553
GO:0017096;acetylserotonin O-methyltransferase activity;193;8;GO:0004725
GO:0044650;adhesion of symbiont to host cell;1032073;1250;GO:0022610
GO:0017098;sulfonylurea receptor binding;14;293;GO:0005126
GO:0017099;very-long-chain-acyl-CoA dehydrogenase activity;170;160;GO:0006631
GO:0030055;cell-substrate junction;48693;2160;GO:0005911
GO:0030054;cell junction;1500357;11300;GO:0005911
GO:0030057;desmosome;6056;1030;GO:0005576
GO:0101013;mechanosensitive voltage-gated sodium channel activity;0;0;GO:0008026
GO:0030056;hemidesmosome;584;464;GO:0005578
GO:0101014;[isocitrate dehydrogenase (NADP+)] phosphatase activity;0;0;GO:0004723
GO:0030059;aralkylamine dehydrogenase (azurin) activity;120;2;GO:0009065
GO:0030058;amine dehydrogenase activity;3442;10;GO:0009065
GO:0101010;pulmonary blood vessel remodeling;12;2;GO:0010717
GO:0005091;guanyl-nucleotide exchange factor adaptor activity;78;8;GO:0005085
GO:0101019;nucleolar exosome (RNase complex);20;5;GO:0005840
GO:0044659;viral release from host cell by cytolysis;11632;111;GO:0048193
GO:0005093;Rab GDP-dissociation inhibitor activity;6206;148;GO:0005525
GO:0005092;GDP-dissociation inhibitor activity;25789;1250;GO:0005524
GO:0005095;GTPase inhibitor activity;336;628;GO:0008061
GO:0005094;Rho GDP-dissociation inhibitor activity;6572;680;GO:0005524
GO:0030050;vesicle transport along actin filament;1289;217;GO:0006936
GO:0101016;FMN-binding domain binding;1;0;GO:0005524
GO:0101017;regulation of mitotic DNA replication initiation from late origin;1;0;GO:0007050
GO:0005096;GTPase activator activity;328735;8410;GO:0005085
GO:0101018;negative regulation of mitotic DNA replication initiation from late origin;1;1;GO:0007050
GO:0044652;adhesion of symbiont to host endothelial cell;3;2;GO:0048407
GO:0044651;adhesion of symbiont to host epithelial cell;13;3;GO:0022610
GO:0044654;starch alpha-glucosidase activity;6;2;GO:0005986
GO:0044653;dextrin alpha-glucosidase activity;4;1;GO:0005982
GO:0044656;regulation of post-lysosomal vacuole size;15;2;GO:0048193
GO:0044655;phagosome reneutralization;22;1;GO:0006979
GO:0044658;symbiont-mediated pore formation in host plasma membrane;149564;1;GO:0048285
GO:0017080;sodium channel regulator activity;5960;803;GO:0048169
GO:0140616;iodotyrosine deiodinase activity;2132;4;GO:0004730
GO:0017081;chloride channel regulator activity;489;93;GO:0003700
GO:0140618;ferric-chelate reductase (NADH) activity;159;3;GO:0004073
GO:0017083;4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity;1791;115;GO:0004553
GO:0140619;DNA strand exchange activator activity;0;1;GO:0003676
GO:0017084;delta1-pyrroline-5-carboxylate synthetase activity;1;6;GO:0006099
GO:0140612;DNA damage sensor activity;288512;3;GO:0006974
GO:0017085;response to insecticide;326;369;GO:0048608
GO:0140613;P-type manganese transporter activity;905;7;GO:0005215
GO:0017086;3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex;2;2;GO:0005737
GO:0140614;1,8-dihydroxynaphthalene-melanin biosynthetic process;2;1;GO:0009579
GO:0017087;mitochondrial processing peptidase complex;111;42;GO:0005743
GO:0044660;viral release via pore formation in host cell membrane;927;2;GO:0048193
GO:0140615;ATP-dependent citrate lyase complex;9;3;GO:0005764
GO:0017089;glycolipid transfer activity;149;7;GO:0005576
GO:0030043;actin filament fragmentation;230;49;GO:0007088
GO:0101023;vascular endothelial cell proliferation;1262;4;GO:0042127
GO:0030046;parallel actin filament bundle assembly;572;115;GO:0008544
GO:0101024;mitotic nuclear membrane organization;413;9;GO:0007067
GO:0140610;RNA sequestering activity;63;4;GO:0003723
GO:0101025;nuclear membrane biogenesis;159;1;GO:0005730
GO:0030048;actin filament-based movement;14705;2360;GO:0006928
GO:0030047;actin modification;80;69;GO:0006936
GO:0101020;estrogen 16-alpha-hydroxylase activity;261;173;GO:0004073
GO:0030049;muscle filament sliding;364;3750;GO:0006936
GO:0101021;estrogen 2-hydroxylase activity;178;116;GO:0004497
GO:0042008;interleukin-18 receptor activity;181;7;GO:0004896
GO:0042009;interleukin-15 binding;0;0;GO:0005125
GO:0101026;mitotic nuclear membrane biogenesis;135;6;GO:0007067
GO:0101027;optical nerve axon regeneration;1;1;GO:0048666
GO:0030042;actin filament depolymerization;74061;2760;GO:0006029
GO:0030041;actin filament polymerization;109735;1690;GO:0003779
GO:0042000;translocation of peptides or proteins into host;16;8;GO:0006986
GO:0044663;establishment or maintenance of cell type involved in phenotypic switching;5;7;GO:0045595
GO:0042001;hermaphrodite somatic sex determination;74;2;GO:0007548
GO:0044665;MLL1/2 complex;5875;147;GO:0048608
GO:0042003;masculinization of hermaphrodite soma;0;1;GO:0007548
GO:0042004;feminization of hermaphrodite soma;3;2;GO:0007548
GO:0044667;(R)-carnitine:4-(trimethylammonio)butanoate antiporter activity;1283;0;GO:0005215
GO:0140609;phycocyanobilin biosynthetic process;0;0;GO:0009579
GO:0044666;MLL3/4 complex;1812;228;GO:0048608
GO:0042006;masculinization of hermaphroditic germ-line;28;3;GO:0007548
GO:0044669;sodium:galactoside symporter activity;0;1;GO:0008565
GO:0042007;interleukin-18 binding;445;90;GO:0005125
GO:0044668;sodium:malonate symporter activity;2127;3;GO:0005215
GO:0140605;proton motive force-driven motor activity;0;1;GO:0003924
GO:0017070;U6 snRNA binding;18831;385;GO:0003723
GO:0017071;intracellular cyclic nucleotide activated cation channel complex;226;134;GO:0008026
GO:0140608;cysteine-type endopeptidase activator activity;107;7;GO:0004870
GO:0140602;nucleolar peripheral inclusion body;414;5;GO:0005829
GO:0017075;syntaxin-1 binding;1661;1250;GO:0008037
GO:0044672;acetyl-CoA decarbonylase/synthase-carbon monoxide dehydrogenase complex;0;1;GO:0009086
GO:0017076;purine nucleotide binding;44758603;3540;GO:0046872
GO:0042010;interleukin-15 receptor activity;965;6;GO:0004872
GO:0044671;sorocarp spore cell differentiation;117;4;GO:0048305
GO:0140604;mycofactocin biosynthetic process;0;8;GO:0046271
GO:0017077;oxidative phosphorylation uncoupler activity;649;261;GO:0008856
GO:0030033;microvillus assembly;843;162;GO:0005576
GO:0032696;negative regulation of interleukin-13 production;231;125;GO:0050727
GO:0030032;lamellipodium assembly;3893;971;GO:0048193
GO:0030035;microspike assembly;173;425;GO:0048706
GO:0032694;negative regulation of interleukin-11 production;3;3;GO:0010467
GO:0030034;microvillar actin bundle assembly;28;5;GO:0005929
GO:0032695;negative regulation of interleukin-12 production;861;1600;GO:0032727
GO:0030036;actin cytoskeleton organization;351768;11000;GO:0051015
GO:0101030;tRNA-guanine transglycosylation;57695;15;GO:0006418
GO:0032698;negative regulation of interleukin-15 production;0;2;GO:0046330
GO:0101031;protein folding chaperone complex;22957;80;GO:0006457
GO:0030038;contractile actin filament bundle assembly;5646;272;GO:0003779
GO:0032699;negative regulation of interleukin-16 production;3;6;GO:0050727
GO:0140638;small ribosomal subunit processing complex;0;2;GO:0000976
GO:0140639;positive regulation of pyroptosis;132;5;GO:2001271
GO:0140634;CARD8 inflammasome complex;4;0;GO:0009986
GO:0140635;neutrophil dispersal;0;0;GO:0002376
GO:0140636;copper import into the mitochondrion;0;1;GO:0006865
GO:0140630;all-trans-phytoene synthase activity;0;0;GO:0004497
GO:0140631;aldehyde dehydrogenase (NAD+) inhibitor activity;0;0;GO:0004866
GO:0140632;canonical inflammasome complex assembly;2158;0;GO:0008629
GO:0140633;CARD8 inflammasome complex assembly;22;0;GO:0008083
GO:0140627;ubiquitin-dependent protein catabolic process via the C-end degron rule pathway;775;10;GO:0006986
GO:0140628;outward rectifier potassium channel inhibitor activity;1;0;GO:0048169
GO:0140629;small conductance calcium-activated potassium channel inhibitor activity;1;0;GO:0048608
GO:0140623;type I pilus assembly;0;0;GO:0043161
GO:0140624;EGAD pathway;0;1;GO:0006066
GO:0140625;opioid growth factor receptor activity;3292;4;GO:0004872
GO:0140626;opioid growth factor receptor signaling pathway;0;0;GO:0007186
GO:0030099;myeloid cell differentiation;39418;3470;GO:0030097
GO:0030098;lymphocyte differentiation;108095;2140;GO:0042113
GO:0140620;DNA strand exchange inhibitor activity;0;1;GO:0003676
GO:0140621;type I pilus;0;1;GO:0043154
GO:0140622;ER-to-endosome phospholipid transfer complex;1;2;GO:0005576
GO:0030091;protein repair;108178;1460;GO:0016567
GO:0030093;chloroplast photosystem I;95;68;GO:0009579
GO:0030095;chloroplast photosystem II;2;76;GO:0009579
GO:0030094;plasma membrane-derived photosystem I;6;4;GO:0009579
GO:0030097;hemopoiesis;176055;5080;GO:0007596
GO:0030096;plasma membrane-derived thylakoid photosystem II;32;101;GO:0009579
GO:0140656;endodeoxyribonuclease activator activity;7;1;GO:0004812
GO:0140657;ATP-dependent activity;15296952;175;GO:0003924
GO:0140658;ATP-dependent chromatin remodeler activity;185151;10;GO:0003690
GO:0140659;cytoskeletal motor regulator activity;58;3;GO:0003774
GO:0140652;pyripyropene A biosynthetic process;0;0;GO:0046274
GO:0140654;tryprostatin A biosynthetic process;0;0;GO:0046274
GO:0030089;phycobilisome;64544;34;GO:0009536
GO:0140655;mitochondrial proliferation;1;0;GO:0048285
GO:0140650;radial glia-guided pyramidal neuron migration;220;7;GO:0048667
GO:0140651;futile creatine cycle;96;6;GO:0006099
GO:0030080;B875 antenna complex;0;3;GO:0048285
GO:0030082;B800-850 antenna complex;0;1;GO:0009579
GO:0030081;B800-820 antenna complex;0;3;GO:0005812
GO:0030084;PSI associated light-harvesting complex I, LHCIb subcomplex;0;1;GO:0009579
GO:0030083;PSI associated light-harvesting complex I, LHCIa subcomplex;0;1;GO:0009579
GO:0030085;PSII associated light-harvesting complex II, peripheral complex, LHCIIb subcomplex;0;2;GO:0009579
GO:0140649;cell-to-cell migration by invasive hypha;1;0;GO:0016477
GO:0140645;neutrophic extracellular trap formation;0;0;GO:0048308
GO:0140646;negative regulation of pre-B cell receptor expression;3;1;GO:0046330
GO:0140647;P450-containing electron transport chain;30799;4;GO:0009579
GO:0140648;positive regulation of cell cycle switching, mitotic to meiotic cell cycle;2;0;GO:0048285
GO:0030077;plasma membrane light-harvesting complex;20137;145;GO:0009579
GO:0140641;mitotic spindle formation (spindle phase two);13;2;GO:0000910
GO:0030076;light-harvesting complex;115418;318;GO:0019827
GO:0140642;meiotic spindle formation (spindle phase two);13;1;GO:0007062
GO:0030079;light-harvesting complex, peripheral complex;0;2;GO:0044436
GO:0140643;hydroxymethylglutaryl-CoA reductase (NADH) activity;8998;2;GO:0004091
GO:0030078;light-harvesting complex, core complex;0;3;GO:0044436
GO:0140644;neutrophil extracellular trap;0;0;GO:0008544
GO:0140640;catalytic activity, acting on a nucleic acid;26056643;31;GO:0003824
GO:0150008;bulk synaptic vesicle endocytosis;56;2;GO:0006836
GO:0150006;urease activator complex;118;0;GO:0005576
GO:0140680;histone H3K36me/H3K36me2 demethylase activity;2505;4;GO:0016569
GO:0150007;clathrin-dependent synaptic vesicle endocytosis;121;6;GO:0006897
GO:0042056;chemoattractant activity;1665;985;GO:0005085
GO:0150001;primary dendrite;12;5;GO:0030425
GO:0042058;regulation of epidermal growth factor receptor signaling pathway;5387;542;GO:0030518
GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway;1193;1010;GO:0030518
GO:0150004;dendritic spine origin;0;0;GO:0097403
GO:0150005;enzyme activator complex;2536;0;GO:0005524
GO:0150002;distal dendrite;12;5;GO:0043005
GO:0150003;regulation of spontaneous synaptic transmission;253;19;GO:0007268
GO:0042060;wound healing;64084;7620;GO:0048407
GO:0042062;long-term strengthening of neuromuscular junction;2;10;GO:0008092
GO:0140678;molecular function inhibitor activity;599338;32;GO:0030528
GO:0042063;gliogenesis;26951;2010;GO:0048667
GO:0140679;ABC-type sodium transporter activity;34;2;GO:0005215
GO:0042065;glial cell growth;275;156;GO:0042127
GO:0140674;ATP-dependent histone chaperone activity;4578;3;GO:0006081
GO:0140676;oscillatory cAMP signaling;15;2;GO:0007623
GO:0140677;molecular function activator activity;873818;34;GO:0003700
GO:0140670;cohesin unloader activity;15;1;GO:0005524
GO:0140671;ADA complex;137;3;GO:0005576
GO:0140672;ATAC complex;1473;9;GO:0005634
GO:0140673;transcription elongation-coupled chromatin remodeling;62472;177;GO:0006364
GO:0150019;basal dendrite morphogenesis;122;1;GO:0048667
GO:0150017;basal proximal dendrite;2;3;GO:0097458
GO:0150018;basal dendrite development;142;4;GO:0048667
GO:0042066;perineurial glial growth;90;6;GO:0048666
GO:0150011;regulation of neuron projection arborization;419;8;GO:0043005
GO:0042067;establishment of ommatidial planar polarity;827;36;GO:0048608
GO:0150012;positive regulation of neuron projection arborization;198;8;GO:0048666
GO:0042068;regulation of pteridine metabolic process;22;2;GO:0010468
GO:0042069;regulation of catecholamine metabolic process;670;137;GO:0046274
GO:0150015;apical proximal dendrite;0;2;GO:0043005
GO:0150016;basal distal dendrite;0;2;GO:0097403
GO:0150013;negative regulation of neuron projection arborization;38;1;GO:0048666
GO:0150014;apical distal dendrite;3;4;GO:0043005
GO:0042070;maintenance of oocyte nucleus location involved in oocyte dorsal/ventral axis specification;0;4;GO:0048704
GO:0042071;leucokinin receptor activity;14;4;GO:0004930
GO:0042073;intraciliary transport;23215;1610;GO:0006810
GO:0140667;regulation of oxytocin production;44;1;GO:0048608
GO:0042074;cell migration involved in gastrulation;2940;639;GO:0048608
GO:0140668;positive regulation of oxytocin production;44;0;GO:0048608
GO:0042075;nickel incorporation into nickel-iron-sulfur cluster via pentakis-L-cysteinyl L-histidino nickel tetrairon pentasulfide;0;5;GO:0009536
GO:0140669;negative regulation of oxytocin production;0;0;GO:0048608
GO:0042076;protein phosphate-linked glycosylation;0;2;GO:0006486
GO:0140663;ATP-dependent FeS chaperone activity;56769;8;GO:0006086
GO:0140664;ATP-dependent DNA damage sensor activity;288307;19;GO:0008029
GO:0140665;ATP-dependent H3-H4 histone complex chaperone activity;9;4;GO:0003774
GO:0140666;annealing activity;8401;4;GO:0003673
GO:0140660;cytoskeletal motor activator activity;34;2;GO:0003774
GO:0140661;cytoskeletal motor inhibitor activity;5;3;GO:0008092
GO:0140662;ATP-dependent protein folding chaperone;408346;598;GO:0006457
GO:0042077;protein phosphate-linked glycosylation via serine;0;2;GO:0006486
GO:0042078;germ-line stem cell division;840;243;GO:0048608
GO:0042081;GSI anchor metabolic process;0;4;GO:0006091
GO:0042082;GSI anchor biosynthetic process;0;5;GO:0009061
GO:0042083;5,10-methylenetetrahydrofolate-dependent methyltransferase activity;186573;4;GO:0003700
GO:0042084;5-methyltetrahydrofolate-dependent methyltransferase activity;105788;2;GO:0003700
GO:0042085;5-methyltetrahydropteroyltri-L-glutamate-dependent methyltransferase activity;88959;6;GO:0004725
GO:0042086;5-methyl-5,6,7,8-tetrahydromethanopterin-dependent methyltransferase activity;10574;2;GO:0004497
GO:0140696;(S)-2-hydroxyglutarate dehydrogenase activity;1073;0;GO:0004067
GO:0140698;attachment of telomeric heterochromatin to nuclear envelope;8;4;GO:0007062
GO:0140699;cyclic GMP-AMP synthase activity;821;1;GO:0004067
GO:0140692;very long-chain fatty acid omega-hydroxylase activity;13;2;GO:0004076
GO:0140693;molecular condensate scaffold activity;1480;30;GO:0048608
GO:0140694;non-membrane-bounded organelle assembly;491713;153;GO:0044464
GO:0140690;dihydropyrimidine dehydrogenase (NAD+) complex;2;0;GO:0005739
GO:0140691;RNA folding chaperone;43;2;GO:0006457
GO:0042088;T-helper 1 type immune response;2392;1210;GO:0002821
GO:0042092;type 2 immune response;2395;400;GO:0006955
GO:0042093;T-helper cell differentiation;5023;834;GO:0046649
GO:0042098;T cell proliferation;16523;1840;GO:0042127
GO:0140685;FAD-dependent histone H3K9me/H3K9me2 demethylase activity;0;1;GO:0016569
GO:0140681;histone H3K36me2/H3K36me3 demethylase activity;17;2;GO:0016569
GO:0140682;FAD-dependent H3K4me/H3K4me3 demethylase activity;3581;2;GO:0016570
GO:0140683;histone H3K9me/H3K9me2 demethylase activity;126;4;GO:0016569
GO:0140684;histone H3K9me2/H3K9me3 demethylase activity;2981;3;GO:0016569
GO:0140480;mitotic spindle pole body insertion into the nuclear envelope;25;4;GO:0005819
GO:0140481;ABC-type iron-sulfur cluster transporter activity;65;0;GO:0003735
GO:0140482;iron sensor activity;3;1;GO:0006826
GO:0140479;ergothioneine biosynthesis from histidine via hercynylcysteine sulfoxide synthase;12;0;GO:0009065
GO:0140472;cell cortex of non-growing cell tip;39;2;GO:0009987
GO:0140473;telomere-nuclear envelope anchor activity;11;1;GO:0005576
GO:0019801;cyclization of asparagine involved in intein-mediated protein splicing;0;3;GO:0006486
GO:0140474;mitochondrion-endoplasmic reticulum membrane tether activity;4;0;GO:0005743
GO:0019800;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;3;613;GO:0005576
GO:0140475;spindle pole body anchor activity;29;3;GO:0005819
GO:0140471;positive regulation of transepithelial migration of symbiont in host;1;2;GO:0048193
GO:0140469;GCN2-mediated signaling;366;7;GO:0006464
GO:0140466;iron-sulfur cluster export from the mitochondrion;75;0;GO:0009536
GO:0140467;integrated stress response signaling;1729;324;GO:0006974
GO:0140468;HRI-mediated signaling;183;5;GO:0007165
GO:0140462;pericentric heterochromatin organization;5;4;GO:0000786
GO:0140463;chromatin-protein adaptor activity;821;15;GO:0003700
GO:0140464;subnuclear spatial organization of silent mating-type cassette heterochromatin;2;4;GO:0007031
GO:0140498;mannan polymerase I complex;0;0;GO:0005737
GO:0140499;negative regulation of mitotic spindle assembly checkpoint signaling;260;2;GO:0048285
GO:0140494;migrasome;107;1;GO:0005764
GO:0140495;migracytosis;167;0;GO:0006929
GO:0140496;gamma-tubulin complex binding;696;1;GO:0005819
GO:0140497;mannan polymerase II complex;28;3;GO:0005737
GO:0140490;microtubule nucleator activity;57;2;GO:0003777
GO:0140492;metal-dependent deubiquitinase activity;6339;5;GO:0004867
GO:0140493;very long-chain fatty acid beta-oxidation;76;3;GO:0006631
GO:0140487;metal ion sequestering activity;195;3;GO:0005524
GO:0140488;heme receptor activity;1;3;GO:0004872
GO:0140489;molecular template activity;65;3;GO:0003674
GO:0140483;kinetochore adaptor activity;93;4;GO:0005524
GO:0140484;5-aminolevulinic acid import across plasma membrane;51;2;GO:0006865
GO:0140485;5-aminolevulinic acid transmembrane transporter activity;51;4;GO:0005215
GO:0140486;zinc ion sequestering activity;56;2;GO:0008047
GO:0019836;hemolysis by symbiont of host erythrocytes;1279;309;GO:0048193
GO:0019835;cytolysis;5501;1910;GO:0006955
GO:0019838;growth factor binding;25980;5310;GO:0005515
GO:0032809;neuronal cell body membrane;893;696;GO:0043005
GO:0032803;regulation of low-density lipoprotein particle receptor catabolic process;348;128;GO:0048193
GO:0032804;negative regulation of low-density lipoprotein particle receptor catabolic process;133;26;GO:0048193
GO:0032801;receptor catabolic process;32363;551;GO:0004867
GO:0032802;low-density lipoprotein particle receptor catabolic process;405;52;GO:0006631
GO:0032807;DNA ligase IV complex;371;129;GO:0005913
GO:0032808;lacrimal gland development;380;126;GO:0007517
GO:0032805;positive regulation of low-density lipoprotein particle receptor catabolic process;121;195;GO:0048193
GO:0032806;carboxy-terminal domain protein kinase complex;23683;31;GO:0005524
GO:0019841;retinol binding;2267;456;GO:0097367
GO:0019840;isoprenoid binding;12466;151;GO:0097159
GO:0019843;rRNA binding;4053839;6650;GO:0003735
GO:0019842;vitamin binding;2973736;1070;GO:0097367
GO:0019825;oxygen binding;94247;4900;GO:0019825
GO:0019824;P6 peroxisome;0;4;GO:0009536
GO:0019827;stem cell population maintenance;16133;1340;GO:0019827
GO:0019826;oxygen sensor activity;304;173;GO:0009416
GO:0019829;ATPase-coupled monoatomic cation transmembrane transporter activity;681641;202;GO:0008565
GO:0019828;aspartic-type endopeptidase inhibitor activity;359;145;GO:0004867
GO:0005200;structural constituent of cytoskeleton;110112;6210;GO:0005200
GO:0005201;extracellular matrix structural constituent;29528;6630;GO:0005201
GO:0019834;phospholipase A2 inhibitor activity;1519;442;GO:0048407
GO:0019814;immunoglobulin complex;2879;611;GO:0002504
GO:0019813;type III site-specific deoxyribonuclease complex;0;1;GO:0005576
GO:0019815;B cell receptor complex;1686;181;GO:0002474
GO:0019817;vesicle fusion with peroxisome;0;2;GO:0005766
GO:0019819;P1 peroxisome;0;3;GO:0005783
GO:0019821;P3 peroxisome;0;3;GO:0009536
GO:0019820;P2 peroxisome;0;2;GO:0005742
GO:0019823;P5 peroxisome;0;2;GO:0009536
GO:0019822;P4 peroxisome;0;2;GO:0009536
GO:0019803;peptidyl-aspartic acid carboxylation;0;2;GO:0006486
GO:0019802;cyclization of glutamine involved in intein-mediated protein splicing;0;4;GO:0006486
GO:0019805;quinolinate biosynthetic process;178057;271;GO:0009065
GO:0019807;aspartoacylase activity;1520;46;GO:0006066
GO:0019806;bromide peroxidase activity;455;2;GO:0004601
GO:0019809;spermidine binding;43;9;GO:0043169
GO:0019808;polyamine binding;48135;54;GO:0030198
GO:0019810;putrescine binding;27;6;GO:0005525
GO:0019812;type I site-specific deoxyribonuclease complex;6;8;GO:0005576
GO:0019811;cocaine binding;5;127;GO:0005509
GO:0044836;D-xylose fermentation;2;2;GO:0006099
GO:0019879;peptidyl-thyronine biosynthetic process from peptidyl-tyrosine;0;4;GO:0006030
GO:0044835;hydrogen generation via nitrogenase;0;1;GO:0046394
GO:0044838;cell quiescence;0;9;GO:0042127
GO:0044837;actomyosin contractile ring organization;4856;332;GO:0007049
GO:0044839;cell cycle G2/M phase transition;25726;717;GO:0000070
GO:0005231;excitatory extracellular ligand-gated monoatomic ion channel activity;41323;54;GO:0005216
GO:0005230;extracellular ligand-gated monoatomic ion channel activity;181977;262;GO:0005216
GO:0044830;modulation by host of viral RNA genome replication;266;15;GO:0010467
GO:0044832;induction by virus of host cytokine production;0;0;GO:0046649
GO:0005234;extracellularly glutamate-gated ion channel activity;96;19;GO:0022836
GO:0044831;modulation by virus of host cytokine production;28;1;GO:0046649
GO:0005237;inhibitory extracellular ligand-gated monoatomic ion channel activity;3386;8;GO:0008061
GO:0044834;retroviral intasome;0;0;GO:0048193
GO:0044833;modulation by virus of host protein transport;1;1;GO:0048193
GO:0005228;intracellular sodium activated potassium channel activity;83;6;GO:0048169
GO:0032847;regulation of cellular pH reduction;244;7;GO:0045735
GO:0005227;calcium activated cation channel activity;41273;453;GO:0005244
GO:0032848;negative regulation of cellular pH reduction;62;170;GO:0045727
GO:0005229;intracellular calcium activated chloride channel activity;3107;266;GO:0008026
GO:0032849;positive regulation of cellular pH reduction;119;427;GO:0045727
GO:0019883;antigen processing and presentation of endogenous antigen;2708;2230;GO:0019882
GO:0019882;antigen processing and presentation;148011;4370;GO:0019882
GO:0032840;intramolecular proline-rich ligand binding;0;2;GO:0005515
GO:0019885;antigen processing and presentation of endogenous peptide antigen via MHC class I;1896;2720;GO:0002474
GO:0019884;antigen processing and presentation of exogenous antigen;2000;1050;GO:0019882
GO:0019887;protein kinase regulator activity;182392;2050;GO:0030528
GO:0032843;hydroperoxide reductase activity;4325;3;GO:0004622
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;1375;2030;GO:0002474
GO:0019889;pteridine metabolic process;104;10;GO:0006749
GO:0032841;calcitonin binding;66;11;GO:0004867
GO:0019888;protein phosphatase regulator activity;103140;1290;GO:0004721
GO:0019869;chloride channel inhibitor activity;343;337;GO:0048169
GO:0044847;iron acquisition from host;3;1;GO:0006879
GO:0044846;negative regulation by symbiont of indole acetic acid levels in host;0;1;GO:0046686
GO:0044849;estrous cycle;234;126;GO:0007548
GO:0044848;biological phase;497;145;GO:0044464
GO:0005242;inward rectifier potassium channel activity;26461;952;GO:0022836
GO:0005244;voltage-gated monoatomic ion channel activity;386761;271;GO:0022836
GO:0044841;gut granule membrane;40;1;GO:0005829
GO:0005243;gap junction channel activity;2421;365;GO:0008021
GO:0044840;gut granule;55;0;GO:0005829
GO:0005246;calcium channel regulator activity;7261;1160;GO:0008092
GO:0044843;cell cycle G1/S phase transition;17045;1440;GO:0007049
GO:0005245;voltage-gated calcium channel activity;48718;1750;GO:0005509
GO:0044842;gut granule lumen;0;0;GO:0005829
GO:0005248;voltage-gated sodium channel activity;17692;1380;GO:0005244
GO:0044845;chain elongation of O-linked mannose residue;2;2;GO:0005929
GO:0005247;voltage-gated chloride channel activity;90561;1710;GO:0022836
GO:0044844;meiotic interphase II;0;2;GO:0000786
GO:0032836;glomerular basement membrane development;827;1250;GO:0043588
GO:0032837;distributive segregation;90;7;GO:0051704
GO:0032834;positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response;70;9;GO:0045595
GO:0032835;glomerulus development;5384;875;GO:0048608
GO:0019870;potassium channel inhibitor activity;319;145;GO:0048169
GO:0032838;plasma membrane bounded cell projection cytoplasm;47771;150;GO:0042995
GO:0032839;dendrite cytoplasm;1485;1200;GO:0008092
GO:0019872;streptomycin biosynthetic process;33;6;GO:0009405
GO:0019871;sodium channel inhibitor activity;1763;142;GO:0048169
GO:0019874;6-aminohexanoate-cyclic-dimer hydrolase activity;665;5;GO:0005524
GO:0019876;nylon catabolic process;10;7;GO:0006073
GO:0032832;regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response;70;5;GO:0050729
GO:0019875;6-aminohexanoate-dimer hydrolase activity;1010;2;GO:0005576
GO:0032833;negative regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response;0;3;GO:0045595
GO:0019878;lysine biosynthetic process via aminoadipic acid;22219;37;GO:0006541
GO:0032830;negative regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;0;3;GO:0045582
GO:0019877;diaminopimelate biosynthetic process;342005;74;GO:0009061
GO:0032831;positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;312;259;GO:0045595
GO:0019858;cytosine metabolic process;88;58;GO:0006552
GO:0044858;plasma membrane raft polarization;60519;28;GO:0005911
GO:0019857;5-methylcytosine metabolic process;6637;8;GO:0006548
GO:0044857;plasma membrane raft organization;5069;41;GO:0030163
GO:0019859;thymine metabolic process;365;204;GO:0006559
GO:0044859;protein insertion into plasma membrane raft;0;1;GO:0016021
GO:0044850;menstrual cycle;0;1;GO:0007548
GO:0044851;hair cycle phase;497;7;GO:0008544
GO:0005213;structural constituent of egg chorion;1011;4;GO:0005576
GO:0044854;plasma membrane raft assembly;4852;113;GO:0016021
GO:0005212;structural constituent of eye lens;10592;1250;GO:0005515
GO:0044853;plasma membrane raft;20708;1080;GO:0016020
GO:0005215;transporter activity;23887256;21100;GO:0005215
GO:0044856;plasma membrane raft localization;60613;6;GO:0005886
GO:0005214;structural constituent of chitin-based cuticle;780;421;GO:0005576
GO:0044855;plasma membrane raft distribution;60613;61;GO:0005886
GO:0032825;positive regulation of natural killer cell differentiation;391;931;GO:0046649
GO:0032826;regulation of natural killer cell differentiation involved in immune response;123;142;GO:0046649
GO:0032823;regulation of natural killer cell differentiation;580;113;GO:0045595
GO:0032824;negative regulation of natural killer cell differentiation;115;8;GO:0045595
GO:0032829;regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;313;8;GO:0045595
GO:0032827;negative regulation of natural killer cell differentiation involved in immune response;115;81;GO:0046649
GO:0032828;positive regulation of natural killer cell differentiation involved in immune response;0;2;GO:0046649
GO:0019860;uracil metabolic process;38912;119;GO:0006555
GO:0019863;IgE binding;1502;145;GO:0042605
GO:0019862;IgA binding;202;33;GO:0043407
GO:0019865;immunoglobulin binding;2975;538;GO:0044421
GO:0032821;negative regulation of natural killer cell proliferation involved in immune response;0;4;GO:0050727
GO:0019864;IgG binding;280;537;GO:0044421
GO:0032822;positive regulation of natural killer cell proliferation involved in immune response;0;3;GO:0046649
GO:0019867;outer membrane;3891083;2290;GO:0016021
GO:0019866;organelle inner membrane;5493996;2800;GO:0005737
GO:0032820;regulation of natural killer cell proliferation involved in immune response;0;5;GO:0050727
GO:0042206;halogenated hydrocarbon catabolic process;4;3;GO:0046395
GO:0044869;negative regulation by host of viral exo-alpha-sialidase activity;106;8;GO:0048193
GO:0042207;styrene catabolic process;4;4;GO:0009062
GO:0044868;modulation by host of viral molecular function;107;4;GO:0030528
GO:0042208;propylene catabolic process;4;3;GO:0009062
GO:0042209;orcinol catabolic process;0;2;GO:0046274
GO:0005220;inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;12909;499;GO:0008092
GO:0044861;protein transport into plasma membrane raft;54;156;GO:0006810
GO:0044860;protein localization to plasma membrane raft;154;10;GO:0005886
GO:0005222;intracellular cAMP-activated cation channel activity;405;144;GO:0005216
GO:0042200;cyanuric acid catabolic process;0;2;GO:0006067
GO:0044863;modulation by virus of host cell division;2;1;GO:0048285
GO:0005221;intracellular cyclic nucleotide activated monoatomic cation channel activity;961;5;GO:0005216
GO:0042201;N-cyclopropylmelamine metabolic process;0;2;GO:0046271
GO:0044862;protein transport out of plasma membrane raft;0;2;GO:0006810
GO:0042202;N-cyclopropylmelamine catabolic process;0;2;GO:0046148
GO:0044865;negative regulation by virus of host cell division;1;1;GO:0010467
GO:0005223;intracellular cGMP-activated cation channel activity;483;203;GO:0005216
GO:0042203;toluene catabolic process;61;3;GO:0009065
GO:0044864;positive regulation by virus of host cell division;1;1;GO:0010467
GO:0042204;s-triazine compound catabolic process;1129;3;GO:0046274
GO:0044867;modulation by host of viral catalytic activity;106;3;GO:0030528
GO:0005225;volume-sensitive anion channel activity;713;251;GO:0005216
GO:0042205;chlorinated hydrocarbon catabolic process;0;4;GO:0046395
GO:0044866;modulation by host of viral exo-alpha-sialidase activity;106;3;GO:0048193
GO:0005217;intracellular ligand-gated monoatomic ion channel activity;22715;1;GO:0005216
GO:0032814;regulation of natural killer cell activation;2026;370;GO:0050727
GO:0005216;monoatomic ion channel activity;2931567;739;GO:0022836
GO:0032815;negative regulation of natural killer cell activation;376;40;GO:0045087
GO:0005219;ryanodine-sensitive calcium-release channel activity;6333;237;GO:0008092
GO:0032812;positive regulation of epinephrine secretion;84;10;GO:0048608
GO:0032813;tumor necrosis factor receptor superfamily binding;23591;411;GO:0005126
GO:0032818;negative regulation of natural killer cell proliferation;0;4;GO:0045727
GO:0032819;positive regulation of natural killer cell proliferation;493;66;GO:0045727
GO:0032816;positive regulation of natural killer cell activation;1346;320;GO:0046649
GO:0044870;modulation by host of viral glycoprotein metabolic process;106;4;GO:0046148
GO:0032817;regulation of natural killer cell proliferation;575;34;GO:0045727
GO:0019852;L-ascorbic acid metabolic process;19436;490;GO:0005975
GO:0019854;L-ascorbic acid catabolic process;4914;10;GO:0009986
GO:0032810;sterol response element binding;177;43;GO:0030528
GO:0019853;L-ascorbic acid biosynthetic process;11396;273;GO:0009813
GO:0032811;negative regulation of epinephrine secretion;52;147;GO:0048608
GO:0019856;pyrimidine nucleobase biosynthetic process;274359;314;GO:0006793
GO:0019855;calcium channel inhibitor activity;754;346;GO:0008026
GO:0032890;regulation of organic acid transport;6426;158;GO:0045735
GO:0032891;negative regulation of organic acid transport;716;8;GO:0045765
GO:0005272;sodium channel activity;95397;1540;GO:0005261
GO:0005275;amine transmembrane transporter activity;3254;394;GO:0005215
GO:0005274;allantoin:proton symporter activity;111;2;GO:0005215
GO:0005277;acetylcholine transmembrane transporter activity;276;50;GO:0005543
GO:0005278;acetylcholine:proton antiporter activity;61;2;GO:0005215
GO:0030228;lipoprotein particle receptor activity;1526;63;GO:0004872
GO:0032889;regulation of vacuole fusion, non-autophagic;177;85;GO:0006952
GO:0030229;very-low-density lipoprotein particle receptor activity;230;92;GO:0004872
GO:0030220;platelet formation;1043;643;GO:0030168
GO:0032883;regulation of chitin biosynthetic process;0;2;GO:0010401
GO:0032884;regulation of cell wall chitin biosynthetic process;0;2;GO:0010467
GO:0030222;eosinophil differentiation;367;27;GO:0045595
GO:0032881;regulation of polysaccharide metabolic process;5039;86;GO:0046394
GO:0030221;basophil differentiation;110;20;GO:0002521
GO:0032882;regulation of chitin metabolic process;0;1;GO:0046274
GO:0030224;monocyte differentiation;1678;619;GO:0002548
GO:0032887;regulation of spindle elongation;216;18;GO:0048285
GO:0030223;neutrophil differentiation;1331;138;GO:0002274
GO:0032888;regulation of mitotic spindle elongation;210;23;GO:0048285
GO:0030226;apolipoprotein receptor activity;108;28;GO:0004872
GO:0032885;regulation of polysaccharide biosynthetic process;3876;203;GO:0009405
GO:0030225;macrophage differentiation;3169;993;GO:0002576
GO:0032886;regulation of microtubule-based process;38906;1270;GO:0048471
GO:0005280;amino acid:proton symporter activity;2732;8;GO:0005215
GO:0044805;late nucleophagy;667;351;GO:0006979
GO:0044804;nucleophagy;3616;84;GO:0006919
GO:0044807;macrophage migration inhibitory factor production;0;3;GO:0046649
GO:0032880;regulation of protein localization;124886;2550;GO:0051649
GO:0044806;G-quadruplex DNA unwinding;528;409;GO:0003677
GO:0044809;chemokine (C-C motif) ligand 17 production;0;2;GO:0050921
GO:0005283;amino acid:sodium symporter activity;96770;200;GO:0005215
GO:0044808;oncostatin M production;0;2;GO:0046503
GO:0005287;high-affinity basic amino acid transmembrane transporter activity;152;6;GO:0005215
GO:0005289;high-affinity L-arginine transmembrane transporter activity;91;1;GO:0005215
GO:0030217;T cell differentiation;60537;3330;GO:0045595
GO:0030216;keratinocyte differentiation;8569;4160;GO:0030216
GO:0030219;megakaryocyte differentiation;2758;661;GO:0045595
GO:0032878;regulation of establishment or maintenance of cell polarity;62595;348;GO:0048608
GO:0030218;erythrocyte differentiation;12584;1800;GO:0002576
GO:0032879;regulation of localization;468100;2410;GO:0051649
GO:0032872;regulation of stress-activated MAPK cascade;19850;646;GO:0043406
GO:0032873;negative regulation of stress-activated MAPK cascade;2637;513;GO:0043407
GO:0030211;heparin catabolic process;58;5;GO:0046395
GO:0032870;cellular response to hormone stimulus;288748;2650;GO:0009725
GO:0030210;heparin biosynthetic process;6244;144;GO:0008544
GO:0032871;regulation of karyogamy;0;2;GO:0048608
GO:0030213;hyaluronan biosynthetic process;1820;218;GO:0005576
GO:0032876;negative regulation of DNA endoreduplication;211;243;GO:0045944
GO:0030212;hyaluronan metabolic process;8082;1060;GO:0005578
GO:0160005;PAT complex;2;4;GO:0005840
GO:0160006;Fc receptor-mediated immune complex endocytosis;67;6;GO:0002449
GO:0160007;glutathione import into mitochondrion;53;2;GO:0006865
GO:0160008;protein decrotonylase activity;841;4;GO:0006066
GO:0160009;histone decrotonylase activity;365;8;GO:0006072
GO:0160001;extrasynaptic signaling via GABA;0;1;GO:0008092
GO:0160002;ADP-D-ribose modification-dependent protein binding;315;4;GO:0043169
GO:0160003;mono-ADP-D-ribose modification-dependent protein binding;0;0;GO:0043169
GO:0160004;poly-ADP-D-ribose modification-dependent protein binding;154;2;GO:0043604
GO:0160016;CCACCA tRNA nucleotidyltransferase activity;75;0;GO:0003729
GO:0160017;regulation of platelet rolling;0;0;GO:0050729
GO:0160018;positive regulation of platelet rolling;0;1;GO:0050729
GO:0160019;negative regulation of platelet rolling;0;0;GO:0050727
GO:0160010;protein de-2-hydroxyisobutyrylase activity;132;6;GO:0006073
GO:0160011;NAD-dependent protein decrotonylase activity;54;1;GO:0009089
GO:0160012;NAD-dependent histone decrotonylase activity;51;0;GO:0006072
GO:0160013;NAD-dependent protein de-2-hydroxyisobutyrylase activity;625;2;GO:0006066
GO:0160014;exopher;0;1;GO:0005576
GO:0160015;platelet rolling;0;1;GO:0002576
GO:0160050;xanthine binding;0;2;GO:0043169
GO:0160051;Cyc8(Ssn6)-Tup1 general repressor complex;3;0;GO:0048285
GO:0005701;polytene chromosome chromocenter;131;309;GO:0005819
GO:0160049;negative regulation of cGAS/STING signaling pathway;13;4;GO:1901169
GO:0005700;polytene chromosome;2961;169;GO:0005634
GO:0005703;polytene chromosome puff;501;30;GO:0005634
GO:0005702;polytene chromosome weak point;0;1;GO:0005576
GO:0005705;polytene chromosome interband;519;132;GO:0007049
GO:0005704;polytene chromosome band;177;15;GO:0000786
GO:0052098;formation by host of specialized structure for nutrient acquisition from symbiont;0;2;GO:0044419
GO:0005706;polytene chromosome ectopic fiber;0;1;GO:0048706
GO:0160041;neuropeptide activity;13746;2;GO:0004930
GO:0160042;purine nucleotide uniporter activity;110;1;GO:0003929
GO:0160043;catecholamine secretion, neurotransmission;0;1;GO:0007218
GO:0160044;sulfate:chloride antiporter activity;88;3;GO:0005215
GO:0160045;TMEM240-body;63;1;GO:0005576
GO:0160046;oxalate:chloride antiporter activity;33;0;GO:0005215
GO:0160047;muramyl dipeptide kinase activity;53;1;GO:0004721
GO:0160048;craniofacial suture closure;0;0;GO:0007518
GO:0160060;sleep homeostasis;0;4;GO:0048523
GO:0160061;respiratory chemosensitivity;0;2;GO:0007623
GO:0160062;cutin-based cuticle development;695;0;GO:0009913
GO:0005721;pericentric heterochromatin;2529;599;GO:0000786
GO:0005712;chiasma;158;122;GO:0007030
GO:0005714;early recombination nodule;0;1;GO:0048285
GO:0005713;recombination nodule;93;5;GO:0048285
GO:0005715;late recombination nodule;37;8;GO:0048387
GO:0160052;mitotic nuclear envelope segregation;0;0;GO:0007067
GO:0160053;serine-based site-specific recombinase activity;0;0;GO:0003677
GO:0160054;microfibril assembly;55;2;GO:0005576
GO:0160055;glideosome;12;0;GO:0005840
GO:0160056;macropinosome membrane;0;1;GO:0005886
GO:0160057;plant endodermal cell fate specification;0;0;GO:0009953
GO:0160058;plant endodermal cell differentiation;0;0;GO:0009953
GO:0160059;programmed cell death in response to retinoic acid;0;1;GO:0012501
GO:0160027;egg deposition;0;1;GO:0007631
GO:0160028;negative regulation of pyroptosis;1;3;GO:2001242
GO:0160029;kidney cortex tubule cell dedifferentiation;0;0;GO:0048193
GO:0160020;positive regulation of ferroptosis;57;5;GO:0046395
GO:0160021;maternal-to-zygotic transition of gene expression;60;5;GO:0007049
GO:0160022;apocrine secretion;0;1;GO:0007517
GO:0160023;sneeze reflex;62;1;GO:0002541
GO:0160024;Leydig cell proliferation;43;0;GO:0048608
GO:0160025;sensory perception of itch;52;3;GO:0007600
GO:0160040;mitocytosis;167;0;GO:0006935
GO:0160038;somatic sensory system development;0;0;GO:0007600
GO:0160039;serotonin-gated chloride channel activity;11;1;GO:0004930
GO:0160030;pollen intine formation;0;0;GO:0009555
GO:0160031;endoplasmic reticulum membrane biogenesis;0;0;GO:0007046
GO:0160032;Toll receptor ligand protein activation cascade;282;6;GO:0004896
GO:0160033;regulation of Toll receptor ligand protein activation cascade;44;2;GO:0002449
GO:0160034;positive regulation of Toll receptor ligand protein activation cascade;0;1;GO:0046649
GO:0160035;negative regulation of Toll receptor ligand protein activation cascade;44;5;GO:0046330
GO:0160036;positive regulation of postsynaptic density assembly;0;0;GO:0048608
GO:0160037;negative regulation of postsynaptic density assembly;0;0;GO:0048608
GO:0042811;pheromone biosynthetic process;2838;72;GO:0009101
GO:0042812;pheromone catabolic process;0;3;GO:0009065
GO:0042813;Wnt receptor activity;3363;245;GO:0004872
GO:0042814;monopolar cell growth;1951;11;GO:0048608
GO:0042815;bipolar cell growth;48;4;GO:0048608
GO:0042816;vitamin B6 metabolic process;663093;42;GO:0006779
GO:0042817;pyridoxal metabolic process;31;10;GO:0006749
GO:0042818;pyridoxamine metabolic process;68;6;GO:0006749
GO:0005871;kinesin complex;36023;2330;GO:0005840
GO:0005870;actin capping protein of dynactin complex;0;0;GO:0005524
GO:0003210;cardiac atrium formation;119;6;GO:0007596
GO:0005873;plus-end kinesin complex;74;164;GO:0005524
GO:0003211;cardiac ventricle formation;468;324;GO:0043588
GO:0005872;minus-end kinesin complex;10;3;GO:0005819
GO:0003212;cardiac left atrium morphogenesis;0;3;GO:0048608
GO:0005875;microtubule associated complex;206860;4820;GO:0000226
GO:0003213;cardiac right atrium morphogenesis;148;8;GO:0048608
GO:0005874;microtubule;497035;10200;GO:0005524
GO:0042810;pheromone metabolic process;2854;39;GO:0006734
GO:0003203;endocardial cushion morphogenesis;2444;1070;GO:0002040
GO:0003204;cardiac skeleton development;0;3;GO:0048608
GO:0005865;striated muscle thin filament;14907;1200;GO:0008092
GO:0003205;cardiac chamber development;15053;575;GO:0048513
GO:0005868;cytoplasmic dynein complex;22825;785;GO:0005737
GO:0003206;cardiac chamber morphogenesis;11375;495;GO:0048513
GO:0003207;cardiac chamber formation;875;203;GO:0042692
GO:0003208;cardiac ventricle morphogenesis;4651;920;GO:0048598
GO:0005869;dynactin complex;12780;529;GO:0005815
GO:0003209;cardiac atrium morphogenesis;1908;114;GO:0007517
GO:0042819;vitamin B6 biosynthetic process;590873;135;GO:0009065
GO:0015203;polyamine transmembrane transporter activity;83744;75;GO:0005543
GO:0042822;pyridoxal phosphate metabolic process;326852;333;GO:0006749
GO:0042823;pyridoxal phosphate biosynthetic process;326639;843;GO:0009065
GO:0042824;MHC class I peptide loading complex;1241;353;GO:0002376
GO:0015200;methylammonium transmembrane transporter activity;145;10;GO:0008565
GO:0042825;TAP complex;652;120;GO:0000976
GO:0042826;histone deacetylase binding;6368;3070;GO:0016570
GO:0042827;platelet dense granule;227;90;GO:0005829
GO:0005880;nuclear microtubule;711;41;GO:0005819
GO:0005882;intermediate filament;135926;4060;GO:0030424
GO:0003220;left ventricular cardiac muscle tissue morphogenesis;200;166;GO:0048608
GO:0005881;cytoplasmic microtubule;11424;1570;GO:0005737
GO:0003221;right ventricular cardiac muscle tissue morphogenesis;176;366;GO:0048608
GO:0005884;actin filament;8314;2520;GO:0008579
GO:0003222;ventricular trabecula myocardium morphogenesis;747;452;GO:0048608
GO:0005883;neurofilament;1276;746;GO:0043005
GO:0003223;ventricular compact myocardium morphogenesis;398;263;GO:0048608
GO:0005886;plasma membrane;29981688;83200;GO:0005886
GO:0042820;vitamin B6 catabolic process;106;1;GO:0006559
GO:0003224;left ventricular compact myocardium morphogenesis;0;2;GO:0048608
GO:0005885;Arp2/3 protein complex;30868;1010;GO:0005515
GO:0042821;pyridoxal biosynthetic process;12;7;GO:0009065
GO:0003214;cardiac left ventricle morphogenesis;876;329;GO:0048608
GO:0030811;regulation of nucleotide catabolic process;2;144;GO:0045941
GO:0003215;cardiac right ventricle morphogenesis;888;1210;GO:0048608
GO:0005876;spindle microtubule;11387;1990;GO:0005524
GO:0030810;positive regulation of nucleotide biosynthetic process;452;10;GO:0045944
GO:0003216;cardiac left atrium formation;0;1;GO:0007596
GO:0005879;axonemal microtubule;5375;103;GO:0005576
GO:0030813;positive regulation of nucleotide catabolic process;1;6;GO:0045941
GO:0003217;cardiac right atrium formation;0;3;GO:0007596
GO:0030812;negative regulation of nucleotide catabolic process;0;8;GO:0045941
GO:0003218;cardiac left ventricle formation;129;36;GO:0043588
GO:0003219;cardiac right ventricle formation;201;31;GO:0007517
GO:0042834;peptidoglycan binding;98147;913;GO:0030165
GO:0042835;BRE binding;7;23;GO:0048285
GO:0042836;D-glucarate metabolic process;9974;4;GO:0006073
GO:0042837;D-glucarate biosynthetic process;0;3;GO:0006073
GO:0042838;D-glucarate catabolic process;9970;6;GO:0006066
GO:0042839;D-glucuronate metabolic process;109;2;GO:0006073
GO:0030808;regulation of nucleotide biosynthetic process;1546;140;GO:0009117
GO:0030809;negative regulation of nucleotide biosynthetic process;199;9;GO:0045944
GO:0005851;eukaryotic translation initiation factor 2B complex;1197;328;GO:0005737
GO:0005850;eukaryotic translation initiation factor 2 complex;799;576;GO:0005743
GO:0005853;eukaryotic translation elongation factor 1 complex;6899;1200;GO:0005737
GO:0005852;eukaryotic translation initiation factor 3 complex;91059;1500;GO:0003743
GO:0042832;defense response to protozoan;1063;2430;GO:0050832
GO:0005844;polysome;5114;2430;GO:0005840
GO:0005846;nuclear cap binding complex;8820;225;GO:0005829
GO:0005845;mRNA cap binding complex;2874;1020;GO:0003723
GO:0005848;mRNA cleavage stimulating factor complex;2246;7;GO:0003723
GO:0005847;mRNA cleavage and polyadenylation specificity factor complex;8004;935;GO:0000976
GO:0005849;mRNA cleavage factor complex;21945;330;GO:0008380
GO:0030805;regulation of cyclic nucleotide catabolic process;0;9;GO:0010468
GO:0042844;glycol metabolic process;9196;3;GO:0006096
GO:0042845;glycol biosynthetic process;42;3;GO:0006096
GO:0042846;glycol catabolic process;6579;3;GO:0006096
GO:0042847;sorbose biosynthetic process;0;2;GO:0006032
GO:0042848;sorbose catabolic process;4;1;GO:0006032
GO:0042849;L-sorbose biosynthetic process;0;2;GO:0006032
GO:0005862;muscle thin filament tropomyosin;12;233;GO:0005525
GO:0042840;D-glucuronate catabolic process;109;6;GO:0006073
GO:0003200;endocardial cushion to mesenchymal transition involved in heart chamber septation;0;1;GO:0048704
GO:0005861;troponin complex;14222;1280;GO:0005737
GO:0042841;D-glucuronate biosynthetic process;0;2;GO:0006073
GO:0003201;epithelial to mesenchymal transition involved in coronary vasculature morphogenesis;4;2;GO:0048704
GO:0042842;D-xylose biosynthetic process;0;2;GO:0006066
GO:0003202;endocardial cushion to mesenchymal transition involved in cardiac skeleton development;0;2;GO:0048704
GO:0005863;striated muscle myosin thick filament;159;57;GO:0005524
GO:0042843;D-xylose catabolic process;1261;10;GO:0006073
GO:0005854;nascent polypeptide-associated complex;6439;617;GO:0005737
GO:0005856;cytoskeleton;2725535;21500;GO:0005925
GO:0005859;muscle myosin complex;122;707;GO:0005524
GO:0005858;axonemal dynein complex;5787;573;GO:0005525
GO:0015234;thiamine transmembrane transporter activity;8928;84;GO:0005215
GO:0015233;pantothenate transmembrane transporter activity;3383;6;GO:0005525
GO:0015232;heme transmembrane transporter activity;88578;133;GO:0015075
GO:0015231;5-formyltetrahydrofolate transmembrane transporter activity;12;2;GO:0005215
GO:0015230;FAD transmembrane transporter activity;399;36;GO:0005215
GO:0003250;regulation of cell proliferation involved in heart valve morphogenesis;192;8;GO:0048608
GO:0003251;positive regulation of cell proliferation involved in heart valve morphogenesis;61;6;GO:0048608
GO:0003252;negative regulation of cell proliferation involved in heart valve morphogenesis;105;7;GO:0048608
GO:0003253;cardiac neural crest cell migration involved in outflow tract morphogenesis;442;171;GO:0048704
GO:0003254;regulation of membrane depolarization;2476;386;GO:0048169
GO:0003255;endocardial precursor cell differentiation;0;2;GO:0048667
GO:0003247;post-embryonic cardiac muscle cell growth involved in heart morphogenesis;3;4;GO:0048405
GO:0030866;cortical actin cytoskeleton organization;18367;1600;GO:0050921
GO:0003248;heart capillary growth;0;2;GO:0048608
GO:0030865;cortical cytoskeleton organization;22610;1130;GO:0071013
GO:0003249;cell proliferation involved in heart valve morphogenesis;192;8;GO:0048608
GO:0030868;smooth endoplasmic reticulum membrane;141;336;GO:0005789
GO:0030867;rough endoplasmic reticulum membrane;18922;319;GO:0005783
GO:0030869;RENT complex;60;4;GO:0005840
GO:0030860;regulation of polarized epithelial cell differentiation;98;134;GO:0030216
GO:0015229;L-ascorbic acid transmembrane transporter activity;6105;10;GO:0005215
GO:0030862;positive regulation of polarized epithelial cell differentiation;18;15;GO:0048316
GO:0015228;coenzyme A transmembrane transporter activity;414;29;GO:0005543
GO:0030861;negative regulation of polarized epithelial cell differentiation;0;3;GO:0048316
GO:0015227;acyl carnitine transmembrane transporter activity;134;30;GO:0005543
GO:0030864;cortical actin cytoskeleton;20682;1290;GO:0005911
GO:0015226;carnitine transmembrane transporter activity;1777;45;GO:0005215
GO:0030863;cortical cytoskeleton;23534;2020;GO:0015629
GO:0015247;aminophospholipid flippase activity;1170;9;GO:0005525
GO:0015245;fatty acid transmembrane transporter activity;930;203;GO:0008565
GO:0015244;fluconazole transmembrane transporter activity;20;3;GO:0005215
GO:0015243;cycloheximide transmembrane transporter activity;0;0;GO:0005215
GO:0003260;cardioblast migration;321;5;GO:0048608
GO:0003261;cardiac muscle progenitor cell migration to the midline involved in heart field formation;44;3;GO:0048704
GO:0003262;endocardial progenitor cell migration to the midline involved in heart field formation;29;2;GO:0048704
GO:0003263;cardioblast proliferation;561;7;GO:0048608
GO:0003264;regulation of cardioblast proliferation;561;8;GO:0048608
GO:0003265;regulation of primary heart field cardioblast proliferation;0;2;GO:0048608
GO:0003266;regulation of secondary heart field cardioblast proliferation;505;312;GO:0048608
GO:0003267;canonical Wnt signaling pathway involved in positive regulation of secondary heart field cardioblast proliferation;0;1;GO:0048704
GO:0003268;fibroblast growth factor receptor signaling pathway involved in regulation of secondary heart field cardioblast proliferation;0;1;GO:0048010
GO:0030855;epithelial cell differentiation;58945;5240;GO:0030216
GO:0003259;cardioblast anterior-lateral migration;34;5;GO:0048704
GO:0030854;positive regulation of granulocyte differentiation;535;1600;GO:0045595
GO:0030857;negative regulation of epithelial cell differentiation;2753;1240;GO:0032989
GO:0030856;regulation of epithelial cell differentiation;9001;1110;GO:0060537
GO:0030859;polarized epithelial cell differentiation;1432;627;GO:0030216
GO:0030858;positive regulation of epithelial cell differentiation;3210;482;GO:0045944
GO:0030851;granulocyte differentiation;3449;465;GO:0002576
GO:0030850;prostate gland development;4497;529;GO:0007517
GO:0030853;negative regulation of granulocyte differentiation;497;879;GO:0045595
GO:0030852;regulation of granulocyte differentiation;1305;335;GO:0045595
GO:0015214;pyrimidine nucleoside transmembrane transporter activity;2628;4;GO:0008528
GO:0015213;uridine transmembrane transporter activity;2254;10;GO:0008565
GO:0015212;cytidine transmembrane transporter activity;192;4;GO:0008565
GO:0015211;purine nucleoside transmembrane transporter activity;10599;10;GO:0008528
GO:0015210;uracil transmembrane transporter activity;331;6;GO:0008565
GO:0005891;voltage-gated calcium channel complex;41163;1430;GO:0005509
GO:0005890;sodium:potassium-exchanging ATPase complex;7826;493;GO:0008047
GO:0003230;cardiac atrium development;2408;127;GO:0007517
GO:0005893;interleukin-2 receptor complex;2;6;GO:0004872
GO:0003231;cardiac ventricle development;8772;1070;GO:0043588
GO:0005892;acetylcholine-gated channel complex;2607;1010;GO:0005244
GO:0003232;bulbus arteriosus development;73;3;GO:0048608
GO:0005895;interleukin-5 receptor complex;37;3;GO:0004896
GO:0003233;bulbus arteriosus morphogenesis;34;1;GO:0048706
GO:0005894;interleukin-3 receptor complex;0;0;GO:0030168
GO:0003234;bulbus arteriosus formation;34;1;GO:0048706
GO:0005897;interleukin-9 receptor complex;0;1;GO:0004872
GO:0003235;sinus venosus development;34;3;GO:0008544
GO:0005896;interleukin-6 receptor complex;198;149;GO:0005125
GO:0003225;left ventricular trabecular myocardium morphogenesis;0;1;GO:0048608
GO:0030844;positive regulation of intermediate filament depolymerization;21;6;GO:0048193
GO:0003226;right ventricular compact myocardium morphogenesis;56;3;GO:0048608
GO:0030843;negative regulation of intermediate filament depolymerization;0;2;GO:0048193
GO:0003227;right ventricular trabecular myocardium morphogenesis;0;2;GO:0048608
GO:0030846;termination of RNA polymerase II transcription, poly(A)-coupled;314;0;GO:0000981
GO:0003228;atrial cardiac muscle tissue development;1183;14;GO:0043547
GO:0005889;potassium:proton exchanging ATPase complex;9;2;GO:0008026
GO:0030845;phospholipase C-inhibiting G protein-coupled receptor signaling pathway;82;8;GO:0007186
GO:0003229;ventricular cardiac muscle tissue development;3334;297;GO:0043588
GO:0030848;threo-3-hydroxyaspartate ammonia-lyase activity;909;3;GO:0006032
GO:0030847;termination of RNA polymerase II transcription, exosome-dependent;165;7;GO:0000976
GO:0030849;autosome;196;63;GO:0000786
GO:0015209;cytosine transmembrane transporter activity;15370;5;GO:0005529
GO:0015208;guanine transmembrane transporter activity;293;9;GO:0008565
GO:0015207;adenine transmembrane transporter activity;216;50;GO:0008565
GO:0030840;negative regulation of intermediate filament polymerization;0;2;GO:0048193
GO:0015205;nucleobase transmembrane transporter activity;147255;290;GO:0008529
GO:0030842;regulation of intermediate filament depolymerization;24;1;GO:0048193
GO:0015204;urea transmembrane transporter activity;18396;460;GO:0005215
GO:0030841;positive regulation of intermediate filament polymerization;0;2;GO:0048608
GO:0015225;biotin transmembrane transporter activity;44502;10;GO:0005515
GO:0042800;histone H3K4 methyltransferase activity;18780;21;GO:0016567
GO:0015224;biopterin transmembrane transporter activity;5;0;GO:0005525
GO:0042802;identical protein binding;311891;25200;GO:0005515
GO:0042803;protein homodimerization activity;186757;20700;GO:0042803
GO:0015221;lipopolysaccharide transmembrane transporter activity;19656;7;GO:0055085
GO:0015220;choline transmembrane transporter activity;4175;456;GO:0005215
GO:0042805;actinin binding;10696;553;GO:0003779
GO:0042806;fucose binding;6936;265;GO:0005529
GO:0042807;central vacuole;59;9;GO:0005737
GO:0003240;conus arteriosus formation;0;1;GO:0048706
GO:0003241;growth involved in heart morphogenesis;153;154;GO:0048608
GO:0003242;cardiac chamber ballooning;8;4;GO:0006942
GO:0003243;circumferential growth involved in left ventricle morphogenesis;2;3;GO:0048608
GO:0003244;radial growth involved in right ventricle morphogenesis;0;2;GO:0048608
GO:0003245;cardiac muscle tissue growth involved in heart morphogenesis;61;46;GO:0048608
GO:0003246;embryonic cardiac muscle cell growth involved in heart morphogenesis;0;2;GO:0048608
GO:0003236;sinus venosus morphogenesis;34;5;GO:0048706
GO:0005899;insulin receptor complex;129;475;GO:0008544
GO:0030833;regulation of actin filament polymerization;97720;1640;GO:0048010
GO:0003237;sinus venosus formation;0;2;GO:0008544
GO:0005898;interleukin-13 receptor complex;1;3;GO:0005125
GO:0030832;regulation of actin filament length;99227;868;GO:0048608
GO:0003238;conus arteriosus development;0;2;GO:0007565
GO:0030835;negative regulation of actin filament depolymerization;60543;474;GO:0048608
GO:0003239;conus arteriosus morphogenesis;0;2;GO:0048706
GO:0030834;regulation of actin filament depolymerization;61205;541;GO:0050921
GO:0030837;negative regulation of actin filament polymerization;75998;753;GO:0048010
GO:0030836;positive regulation of actin filament depolymerization;704;375;GO:0048608
GO:0030839;regulation of intermediate filament polymerization;1;1;GO:0048608
GO:0030838;positive regulation of actin filament polymerization;3411;2020;GO:0048010
GO:0042809;nuclear vitamin D receptor binding;332;15;GO:0003700
GO:0015218;pyrimidine nucleotide transmembrane transporter activity;892;55;GO:0008528
GO:0015217;ADP transmembrane transporter activity;27770;107;GO:0005026
GO:0015216;purine nucleotide transmembrane transporter activity;41496;40;GO:0005215
GO:0015215;nucleotide transmembrane transporter activity;42933;58;GO:0008529
GO:0042899;arabinan transmembrane transport;0;1;GO:0005576
GO:0015279;store-operated calcium channel activity;632;243;GO:0008092
GO:0015278;calcium-release channel activity;20261;382;GO:0005509
GO:0015277;kainate selective glutamate receptor activity;417;401;GO:0048169
GO:0003290;atrial septum secundum morphogenesis;98;16;GO:0048706
GO:0015276;ligand-gated monoatomic ion channel activity;337948;44;GO:0005216
GO:0003291;atrial septum intermedium morphogenesis;0;3;GO:0048706
GO:0015275;stretch-activated, monoatomic cation-selective, calcium channel activity;141;5;GO:0008092
GO:0003292;cardiac septum cell differentiation;330;9;GO:0048608
GO:0015274;organellar voltage-gated chloride channel activity;0;1;GO:0008026
GO:0003293;heart valve cell differentiation;0;4;GO:0048514
GO:0003294;atrial ventricular junction remodeling;53;17;GO:0048608
GO:0015272;ATP-activated inward rectifier potassium channel activity;1535;78;GO:0008092
GO:0003295;cell proliferation involved in atrial ventricular junction remodeling;0;3;GO:0048608
GO:0015271;outward rectifier potassium channel activity;1515;455;GO:0022836
GO:0042892;chloramphenicol transmembrane transport;0;1;GO:0008565
GO:0003296;apoptotic process involved in atrial ventricular junction remodeling;0;1;GO:0043066
GO:0042893;polymyxin transport;0;2;GO:0008544
GO:0003297;heart wedging;0;3;GO:0002044
GO:0042894;fosmidomycin transport;0;4;GO:0006869
GO:0003298;physiological muscle hypertrophy;445;64;GO:0048193
GO:0003299;muscle hypertrophy in response to stress;1043;165;GO:0048193
GO:0042896;chloramphenicol transmembrane transporter activity;0;0;GO:0005543
GO:0042897;polymyxin transmembrane transporter activity;0;0;GO:0005543
GO:0042898;fosmidomycin transmembrane transporter activity;0;0;GO:0005525
GO:0015288;porin activity;219790;1270;GO:0015986
GO:0015284;fructose uniporter activity;1;2;GO:0006099
GO:0015280;ligand-gated sodium channel activity;6338;113;GO:0005216
GO:0030899;calcium-dependent ATPase activity;143;42;GO:0008092
GO:0030891;VCB complex;1658;261;GO:0005829
GO:0030890;positive regulation of B cell proliferation;2145;1990;GO:0042113
GO:0030893;meiotic cohesin complex;572;52;GO:0007062
GO:0030892;mitotic cohesin complex;337;46;GO:0007062
GO:0030895;apolipoprotein B mRNA editing enzyme complex;166;62;GO:0000976
GO:0030894;replisome;255919;272;GO:0005840
GO:0030897;HOPS complex;6348;702;GO:0005737
GO:0030896;checkpoint clamp complex;10058;309;GO:0007067
GO:0015255;propanediol channel activity;0;2;GO:0005215
GO:0015254;glycerol channel activity;471;610;GO:0005215
GO:0003270;Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation;47;5;GO:0048704
GO:0015252;proton channel activity;946003;107;GO:0022836
GO:0003271;smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation;51;6;GO:0048608
GO:0003272;endocardial cushion formation;1368;91;GO:0007596
GO:0015250;water channel activity;13948;1390;GO:0005215
GO:0003273;cell migration involved in endocardial cushion formation;152;65;GO:0030900
GO:0003274;endocardial cushion fusion;216;122;GO:0007596
GO:0003275;apoptotic process involved in outflow tract morphogenesis;139;7;GO:0043066
GO:0003276;apoptotic process involved in heart valve morphogenesis;0;1;GO:0043066
GO:0003277;apoptotic process involved in endocardial cushion morphogenesis;3;17;GO:0043066
GO:0003278;apoptotic process involved in heart morphogenesis;275;55;GO:0043066
GO:0003279;cardiac septum development;7810;733;GO:0002044
GO:0030888;regulation of B cell proliferation;3192;702;GO:0042127
GO:0030887;positive regulation of myeloid dendritic cell activation;27;10;GO:0046649
GO:0030889;negative regulation of B cell proliferation;797;1280;GO:0045727
GO:0030880;RNA polymerase complex;797630;532;GO:0005840
GO:0030882;lipid antigen binding;334;31;GO:0042803
GO:0030881;beta-2-microglobulin binding;369;124;GO:0048193
GO:0030884;exogenous lipid antigen binding;114;51;GO:0042803
GO:0030883;endogenous lipid antigen binding;82;181;GO:0042803
GO:0030886;negative regulation of myeloid dendritic cell activation;133;323;GO:0046649
GO:0015248;sterol transporter activity;5706;810;GO:0005525
GO:0030885;regulation of myeloid dendritic cell activation;169;9;GO:0046649
GO:0015269;calcium-activated potassium channel activity;18045;712;GO:0048407
GO:0015267;channel activity;3351298;4310;GO:0005216
GO:0015265;urea channel activity;174;37;GO:0005216
GO:0015264;methylammonium channel activity;58;7;GO:0048471
GO:0003281;ventricular septum development;3640;887;GO:0002064
GO:0003282;ventricular septum intermedium development;0;1;GO:0048608
GO:0003283;atrial septum development;1340;468;GO:0007517
GO:0003284;septum primum development;206;8;GO:0048704
GO:0003285;septum secundum development;160;19;GO:0048704
GO:0003286;atrial septum intermedium development;0;2;GO:0048704
GO:0003288;ventricular septum intermedium morphogenesis;0;3;GO:0048706
GO:0003289;atrial septum primum morphogenesis;204;33;GO:0048706
GO:0030877;beta-catenin destruction complex;772;639;GO:0048316
GO:0030876;interleukin-20 receptor complex;0;1;GO:0005125
GO:0030879;mammary gland development;9198;1650;GO:0030216
GO:0030878;thyroid gland development;1881;750;GO:0007517
GO:0030870;Mre11 complex;12880;547;GO:0005934
GO:0030875;rDNA protrusion;38;1;GO:0005929
GO:0030874;nucleolar chromatin;175;9;GO:0000786
GO:0042855;eugenol biosynthetic process;2;6;GO:0009813
GO:0042856;eugenol catabolic process;2;2;GO:0046274
GO:0042857;chrysobactin metabolic process;7;4;GO:0006033
GO:0042858;chrysobactin biosynthetic process;6;2;GO:0046395
GO:0042859;chrysobactin catabolic process;1;5;GO:0046395
GO:0042850;L-sorbose catabolic process;4;2;GO:0006066
GO:0042851;L-alanine metabolic process;44305;69;GO:0006559
GO:0042852;L-alanine biosynthetic process;2;4;GO:0006559
GO:0042853;L-alanine catabolic process;44240;531;GO:0006559
GO:0042854;eugenol metabolic process;5;5;GO:0006073
GO:0042866;pyruvate biosynthetic process;7849;376;GO:0006096
GO:0042867;pyruvate catabolic process;4224;17;GO:0006096
GO:0042868;antisense RNA metabolic process;362;7;GO:0010467
GO:0042869;aldarate transmembrane transport;0;1;GO:0006810
GO:0042860;achromobactin metabolic process;8;5;GO:0006735
GO:0042861;achromobactin biosynthetic process;8;2;GO:0046395
GO:0042862;achromobactin catabolic process;0;3;GO:0046395
GO:0042863;pyochelin metabolic process;3;2;GO:0006021
GO:0042864;pyochelin biosynthetic process;3;2;GO:0009405
GO:0042865;pyochelin catabolic process;0;1;GO:0046395
GO:0042878;D-glucarate transmembrane transporter activity;0;1;GO:0005215
GO:0042879;aldonate transmembrane transporter activity;41215;5;GO:0005215
GO:0015297;antiporter activity;897675;3570;GO:0005215
GO:0015296;monoatomic anion:monoatomic cation symporter activity;67083;6;GO:0005215
GO:0015295;solute:proton symporter activity;52966;267;GO:0005215
GO:0015294;solute:monoatomic cation symporter activity;264309;4;GO:0005215
GO:0015293;symporter activity;722087;4300;GO:0008544
GO:0042870;D-glucarate transmembrane transport;0;1;GO:0006836
GO:0015292;uniporter activity;5861;13;GO:0005215
GO:0015291;secondary active transmembrane transporter activity;1886193;1440;GO:0015075
GO:0042873;aldonate transmembrane transport;82432;2;GO:0006810
GO:0042874;D-glucuronate transmembrane transport;116;0;GO:0008544
GO:0042875;D-galactonate transmembrane transport;10;2;GO:0009400
GO:0042876;aldarate transmembrane transporter activity;0;2;GO:0005215
GO:0042888;molybdenum ion transmembrane transporter activity;1;2;GO:0005026
GO:0042880;D-glucuronate transmembrane transporter activity;58;1;GO:0005543
GO:0042881;D-galactonate transmembrane transporter activity;1;0;GO:0005215
GO:0042882;L-arabinose transmembrane transport;5892;8;GO:0008544
GO:0042883;cysteine transport;12451;176;GO:0006865
GO:0042884;microcin transport;44;2;GO:0015986
GO:0042885;microcin B17 transport;1;1;GO:0008565
GO:0042886;amide transport;723679;1130;GO:0006810
GO:0042887;amide transmembrane transporter activity;201176;23;GO:0008544
GO:0052201;response to symbiont defenses;0;1;GO:0046686
GO:0052200;response to host defenses;1179457;932;GO:0009615
GO:0052131;positive aerotaxis;3;1;GO:0007623
GO:0052151;symbiont-mediated activation of host apoptosis;4;1;GO:0048608
GO:0052150;symbiont-mediated perturbation of host apoptosis;5818;1;GO:0010942
GO:0052148;modulation by symbiont of host catalytic activity;6;4;GO:0045737
GO:0052162;modulation by symbiont of defense-related host calcium ion flux;6;2;GO:0009611
GO:0052163;symbiont defense to host-produced nitric oxide;6;1;GO:0009617
GO:0052160;perturbation of host systemic acquired resistance;0;0;GO:0046686
GO:0052159;perturbation of host induced systemic resistance;0;0;GO:0046686
GO:0052158;modulation by symbiont of host resistance gene-dependent defense response;9;0;GO:0046686
GO:0052155;perturbation of host cell-mediated immune response;23;0;GO:0002821
GO:0052156;perturbation of host T-cell mediated immune response;12;0;GO:0002821
GO:0052154;perturbation of host B-cell mediated immune response;0;0;GO:0002449
GO:0052173;response to defenses of other organism;1179457;1340;GO:0050832
GO:0052170;suppression of host innate immune response;536316;0;GO:0045087
GO:0052168;modulation by symbiont of defense-related host calcium-dependent protein kinase pathway;0;2;GO:0046686
GO:0052167;perturbation of host innate immune response;536349;1;GO:0032496
GO:0052164;symbiont defense to host-produced reactive oxygen species;11;1;GO:0009617
GO:0052165;symbiont defense to host-produced phytoalexin;0;1;GO:0009617
GO:0005831;steroid hormone aporeceptor complex;1;1;GO:0004872
GO:0005822;inner plaque of spindle pole body;158;5;GO:0005819
GO:0005821;intermediate layer of spindle pole body;1;2;GO:0005815
GO:0005824;outer plaque of spindle pole body;77;5;GO:0005819
GO:0005823;central plaque of spindle pole body;106;8;GO:0005819
GO:0005826;actomyosin contractile ring;1436;441;GO:0005576
GO:0005825;half bridge of spindle pole body;179;5;GO:0005815
GO:0005828;kinetochore microtubule;1935;395;GO:0000776
GO:0005827;polar microtubule;376;454;GO:0007030
GO:0005829;cytosol;1116296;73200;GO:0005829
GO:0005840;ribosome;24712011;16400;GO:0005840
GO:0005833;hemoglobin complex;12047;1460;GO:0005829
GO:0005832;chaperonin-containing T-complex;21069;814;GO:0005840
GO:0005835;fatty acid synthase complex;19150;180;GO:0005840
GO:0005834;heterotrimeric G-protein complex;15399;1500;GO:0005737
GO:0005836;fatty-acyl-CoA synthase complex;0;2;GO:0006631
GO:0005839;proteasome core complex;207958;3310;GO:0000502
GO:0005838;proteasome regulatory particle;37755;1380;GO:0005840
GO:0005802;trans-Golgi network;43568;4360;GO:0005764
GO:0005801;cis-Golgi network;13419;2200;GO:0005764
GO:0005811;lipid droplet;138826;1210;GO:0005811
GO:0005813;centrosome;70033;10100;GO:0005813
GO:0005815;microtubule organizing center;257388;5020;GO:0000226
GO:0005814;centriole;35965;2410;GO:0005813
GO:0005816;spindle pole body;12396;432;GO:0000976
GO:0005819;spindle;152023;6150;GO:0007088
GO:0005818;aster;1047;77;GO:0005934
GO:0005503;all-trans retinal binding;247;10;GO:0042302
GO:0005502;11-cis retinal binding;468;53;GO:0048407
GO:0005504;fatty acid binding;8928;1440;GO:0005578
GO:0005507;copper ion binding;437991;7370;GO:0005507
GO:0005506;iron ion binding;1902488;16100;GO:0008270
GO:0005509;calcium ion binding;1314988;30500;GO:0005509
GO:0005521;lamin binding;611;883;GO:0005515
GO:0005520;insulin-like growth factor binding;10358;2070;GO:0008289
GO:0005523;tropomyosin binding;8719;1760;GO:0005524
GO:0005522;profilin binding;406;595;GO:0005525
GO:0005513;detection of calcium ion;1351;2520;GO:0006873
GO:0005516;calmodulin binding;160376;9480;GO:0005524
GO:0005515;protein binding;6225519;145000;GO:0005515
GO:0005518;collagen binding;7739;3840;GO:0005518
GO:0005519;cytoskeletal regulatory protein binding;1496;32;GO:0042802
GO:0005501;retinoid binding;6283;384;GO:0097367
GO:0005500;juvenile hormone binding;5;4;GO:0005524
GO:0005550;pheromone binding;462;120;GO:0005525
GO:0005547;phosphatidylinositol-3,4,5-trisphosphate binding;5071;927;GO:0097367
GO:0005546;phosphatidylinositol-4,5-bisphosphate binding;16750;1150;GO:0097367
GO:0030502;negative regulation of bone mineralization;856;741;GO:0048193
GO:0005549;odorant binding;39890;1260;GO:0005549
GO:0030505;inorganic diphosphate transport;286;549;GO:0006865
GO:0005548;phospholipid transporter activity;40094;783;GO:0005543
GO:0030504;inorganic diphosphate transmembrane transporter activity;136;7;GO:0008544
GO:0030507;spectrin binding;6521;1340;GO:0005515
GO:0030506;ankyrin binding;1068;1030;GO:0005515
GO:0030509;BMP signaling pathway;15832;2460;GO:0007179
GO:0030501;positive regulation of bone mineralization;2129;1080;GO:0048609
GO:0030500;regulation of bone mineralization;4884;781;GO:0048609
GO:0005534;galactose binding;225;178;GO:0008152
GO:0005525;GTP binding;4610710;19600;GO:0005524
GO:0005524;ATP binding;36853627;61700;GO:0005524
GO:0005527;macrolide binding;353;248;GO:0046955
GO:0005528;FK506 binding;220;2190;GO:0005515
GO:0005540;hyaluronic acid binding;16097;1170;GO:0005578
GO:0005543;phospholipid binding;353040;4680;GO:0097159
GO:0005542;folic acid binding;25524;440;GO:0005509
GO:0005545;1-phosphatidylinositol binding;16770;1030;GO:0005525
GO:0005544;calcium-dependent phospholipid binding;69268;2940;GO:0048407
GO:0005536;glucose binding;38648;1020;GO:0019825
GO:0005537;mannose binding;4144;1110;GO:0042592
GO:0005539;glycosaminoglycan binding;161284;3440;GO:0005539
GO:0042537;benzene-containing compound metabolic process;277439;969;GO:0019438
GO:0042538;hyperosmotic salinity response;1325;1490;GO:0009416
GO:0042539;hypotonic salinity response;252;35;GO:0009416
GO:0005590;collagen type VII trimer;1;5;GO:0005578
GO:0005592;collagen type XI trimer;81;34;GO:0005581
GO:0005591;collagen type VIII trimer;1;3;GO:0005578
GO:0005594;collagen type IX trimer;180;44;GO:0005581
GO:0005593;FACIT collagen trimer;186;158;GO:0005581
GO:0005596;collagen type XIV trimer;1;6;GO:0005578
GO:0005595;collagen type XII trimer;4;227;GO:0005581
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;2723;1200;GO:0048010
GO:0005598;short-chain collagen trimer;49;1;GO:0005578
GO:0042532;negative regulation of tyrosine phosphorylation of STAT protein;605;189;GO:0043406
GO:0005597;collagen type XVI trimer;1;2;GO:0005578
GO:0005599;collagen type X trimer;48;2;GO:0005581
GO:0030547;signaling receptor inhibitor activity;3856;10;GO:0004872
GO:0030546;signaling receptor activator activity;400448;841;GO:0004872
GO:0030549;acetylcholine receptor activator activity;130;49;GO:0048608
GO:0030548;acetylcholine receptor regulator activity;3736;239;GO:0004872
GO:0030541;plasmid partitioning;170;253;GO:0048304
GO:0030540;female genitalia development;931;226;GO:0007565
GO:0030543;2-micrometer plasmid partitioning;57;5;GO:0007049
GO:0030545;signaling receptor regulator activity;406943;377;GO:0004872
GO:0030544;Hsp70 protein binding;26711;932;GO:0005515
GO:0042547;cell wall modification involved in multidimensional cell growth;73;24;GO:0010467
GO:0042548;regulation of photosynthesis, light reaction;18578;169;GO:0015979
GO:0042549;photosystem II stabilization;17952;114;GO:0009416
GO:0042540;hemoglobin catabolic process;6;6;GO:0006796
GO:0042541;hemoglobin biosynthetic process;1165;116;GO:0006096
GO:0042542;response to hydrogen peroxide;7558;4470;GO:0046686
GO:0042543;protein N-linked glycosylation via arginine;75;5;GO:0006486
GO:0042544;melibiose biosynthetic process;0;3;GO:0006032
GO:0042545;cell wall modification;53092;2000;GO:0009277
GO:0042546;cell wall biogenesis;2333759;2180;GO:0009653
GO:0030536;larval feeding behavior;232;39;GO:0007548
GO:0030538;embryonic genitalia morphogenesis;90;77;GO:0008544
GO:0030537;larval behavior;897;9;GO:0007626
GO:0030539;male genitalia development;1335;558;GO:0007548
GO:0030532;small nuclear ribonucleoprotein complex;438569;1100;GO:0000786
GO:0030534;adult behavior;11071;1920;GO:0007610
GO:0030533;triplet codon-amino acid adaptor activity;4568517;616;GO:0005525
GO:0042558;pteridine-containing compound metabolic process;1480938;587;GO:0006749
GO:0042559;pteridine-containing compound biosynthetic process;1076648;964;GO:0006749
GO:0042550;photosystem I stabilization;75;9;GO:0009579
GO:0042551;neuron maturation;4519;563;GO:0048666
GO:0042552;myelination;9380;3240;GO:0030428
GO:0005576;extracellular region;3173102;55000;GO:0005576
GO:0042554;superoxide anion generation;1797;2220;GO:0006879
GO:0005575;cellular_component;287263480;15100;GO:0005575
GO:0042555;MCM complex;54355;1420;GO:0005840
GO:0042556;eukaryotic elongation factor-2 kinase regulator activity;1;2;GO:0005524
GO:0005577;fibrinogen complex;3032;1160;GO:0005576
GO:0042557;eukaryotic elongation factor-2 kinase activator activity;1;1;GO:0005524
GO:0030527;structural constituent of chromatin;254019;577;GO:0003682
GO:0030526;granulocyte macrophage colony-stimulating factor receptor complex;175;102;GO:0004872
GO:0042560;pteridine-containing compound catabolic process;127;10;GO:0046395
GO:0030521;androgen receptor signaling pathway;2986;2380;GO:0004730
GO:0030520;intracellular estrogen receptor signaling pathway;3959;856;GO:0030522
GO:0030522;intracellular receptor signaling pathway;135119;1880;GO:0007186
GO:0005581;collagen trimer;50055;3970;GO:0005578
GO:0005583;fibrillar collagen trimer;830;498;GO:0005578
GO:0042561;alpha-amyrin synthase activity;1;2;GO:0004497
GO:0005582;collagen type XV trimer;1;3;GO:0005581
GO:0042562;hormone binding;18299;1330;GO:0005515
GO:0005585;collagen type II trimer;120;22;GO:0005581
GO:0005584;collagen type I trimer;258;200;GO:0005581
GO:0042564;NLS-dependent protein nuclear import complex;637;242;GO:0005840
GO:0005587;collagen type IV trimer;531;253;GO:0005581
GO:0042565;RNA nuclear export complex;166;94;GO:0008340
GO:0005586;collagen type III trimer;82;53;GO:0005581
GO:0042566;hydrogenosome;72;51;GO:0005746
GO:0005589;collagen type VI trimer;4;95;GO:0005578
GO:0042567;insulin-like growth factor ternary complex;219;72;GO:0005520
GO:0005588;collagen type V trimer;196;134;GO:0005581
GO:0042568;insulin-like growth factor binary complex;50;4;GO:0048608
GO:0030514;negative regulation of BMP signaling pathway;6165;1470;GO:0048704
GO:0005579;membrane attack complex;11955;616;GO:0002344
GO:0030513;positive regulation of BMP signaling pathway;2510;1400;GO:0048704
GO:0030516;regulation of axon extension;4258;1220;GO:0048666
GO:0030515;snoRNA binding;29602;929;GO:0003729
GO:0030518;intracellular steroid hormone receptor signaling pathway;12382;535;GO:0009908
GO:0030517;negative regulation of axon extension;1852;1150;GO:0048704
GO:0030519;snoRNP binding;124;7;GO:0003729
GO:0042571;immunoglobulin complex, circulating;739;588;GO:0002504
GO:0030510;regulation of BMP signaling pathway;9365;657;GO:0048704
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;6904;2350;GO:0030518
GO:0030511;positive regulation of transforming growth factor beta receptor signaling pathway;1618;730;GO:0030518
GO:0030590;first cell cycle pseudocleavage;31;2;GO:0007049
GO:0030592;DNA ADP-ribosylation;201;7;GO:0006796
GO:0030591;2'-deoxyguanosine DNA ADP-ribosyltransferase activity;2;0;GO:0004812
GO:0030583;myxococcal fruiting body development;0;2;GO:0048285
GO:0030582;reproductive fruiting body development;74;12;GO:0048608
GO:0030585;phosphoenolpyruvate carboxykinase (diphosphate) activity;22;3;GO:0006099
GO:0030584;sporocarp development;69;5;GO:0048468
GO:0030587;sorocarp development;1643;19;GO:0048468
GO:0030586;[methionine synthase] reductase activity;137;7;GO:0003824
GO:0030589;pseudocleavage involved in syncytial blastoderm formation;85;10;GO:0009952
GO:0030588;pseudocleavage;122;5;GO:0009952
GO:0030581;symbiont intracellular protein transport in host;567;6;GO:0043005
GO:0042509;regulation of tyrosine phosphorylation of STAT protein;3643;274;GO:0045944
GO:0030580;quinone cofactor methyltransferase activity;51893;3;GO:0003676
GO:0042500;aspartic endopeptidase activity, intramembrane cleaving;19498;124;GO:0004175
GO:0042501;serine phosphorylation of STAT protein;602;84;GO:0043406
GO:0030572;phosphatidyltransferase activity;40405;110;GO:0004721
GO:0030574;collagen catabolic process;4282;4230;GO:0032963
GO:0030573;bile acid catabolic process;45;347;GO:0007566
GO:0030576;Cajal body organization;1450;27;GO:0005819
GO:0030575;nuclear body organization;2029;129;GO:0032559
GO:0030578;PML body organization;288;138;GO:0032559
GO:0030577;Lands organization;0;2;GO:0048731
GO:0030570;pectate lyase activity;40860;535;GO:0004553
GO:0030561;RNA 2'-O-ribose methylation guide activity;108;2;GO:0003729
GO:0030560;tRNA pseudouridylation guide activity;0;1;GO:0003729
GO:0030563;snRNA 2'-O-ribose methylation guide activity;4;1;GO:0003729
GO:0030562;rRNA 2'-O-ribose methylation guide activity;103;2;GO:0003729
GO:0030565;snRNA pseudouridylation guide activity;7;3;GO:0003723
GO:0030564;tRNA 2'-O-ribose methylation guide activity;0;1;GO:0003729
GO:0030566;snRNA modification guide activity;11;2;GO:0003723
GO:0030558;RNA pseudouridylation guide activity;58;1;GO:0003729
GO:0030557;tRNA modification guide activity;0;2;GO:0006418
GO:0030559;rRNA pseudouridylation guide activity;51;8;GO:0003729
GO:0030550;acetylcholine receptor inhibitor activity;1596;57;GO:0048608
GO:0030552;cAMP binding;8232;1320;GO:0005524
GO:0030551;cyclic nucleotide binding;115147;591;GO:0043531
GO:0030554;adenyl nucleotide binding;39882431;4500;GO:0005524
GO:0030553;cGMP binding;9780;388;GO:0043531
GO:0030556;rRNA modification guide activity;154;4;GO:0003729
GO:0030555;RNA modification guide activity;166;6;GO:0003723
GO:0042495;detection of triacyl bacterial lipopeptide;92;155;GO:0008565
GO:0042496;detection of diacyl bacterial lipopeptide;90;17;GO:0002224
GO:0042497;triacyl lipopeptide binding;81;7;GO:0042803
GO:0042498;diacyl lipopeptide binding;9;6;GO:0005576
GO:0030495;bacteriochlorophyll catabolic process;0;2;GO:0046274
GO:0030494;bacteriochlorophyll biosynthetic process;26480;67;GO:0009579
GO:0030497;fatty acid elongation;16499;1310;GO:0006631
GO:0030496;midbody;29879;4040;GO:0007050
GO:0030491;heteroduplex formation;119;110;GO:0003677
GO:0030490;maturation of SSU-rRNA;66105;3610;GO:0006364
GO:0030493;bacteriochlorophyll metabolic process;26480;3;GO:0006096
GO:0030492;hemoglobin binding;1437;752;GO:0019825
GO:0030486;smooth muscle dense body;171;82;GO:0005576
GO:0030485;smooth muscle contractile fiber;318;399;GO:0002537
GO:0030488;tRNA methylation;1163489;1910;GO:0006461
GO:0030487;inositol-4,5-bisphosphate 5-phosphatase activity;6;6;GO:0004721
GO:0030473;nuclear migration along microtubule;563;229;GO:0007050
GO:0030474;spindle pole body duplication;304;31;GO:0000976
GO:0030476;ascospore wall assembly;345;214;GO:0048305
GO:0030479;actin cortical patch;7910;437;GO:0005911
GO:0030478;actin cap;242;267;GO:0005929
GO:0042459;octopine catabolic process to proline;0;2;GO:0006559
GO:0042451;purine nucleoside biosynthetic process;178781;581;GO:0006749
GO:0042452;deoxyguanosine biosynthetic process;0;2;GO:0006749
GO:0042453;deoxyguanosine metabolic process;175;2;GO:0006749
GO:0042454;ribonucleoside catabolic process;118479;561;GO:0009060
GO:0042455;ribonucleoside biosynthetic process;760309;216;GO:0009063
GO:0042457;ethylene catabolic process;0;2;GO:0009693
GO:0042458;nopaline catabolic process to proline;0;2;GO:0006559
GO:0042461;photoreceptor cell development;6719;1430;GO:0048699
GO:0042462;eye photoreceptor cell development;4391;1740;GO:0008544
GO:0042463;ocellus photoreceptor cell development;25;7;GO:0048608
GO:0042464;dosage compensation by hypoactivation of X chromosome;53;6;GO:0007568
GO:0042465;kinesis;6;3;GO:0048870
GO:0042466;chemokinesis;6;8;GO:0042330
GO:0042467;orthokinesis;0;1;GO:0048608
GO:0042468;klinokinesis;0;1;GO:0006928
GO:0042469;versicolorin reductase activity;3;4;GO:0004067
GO:0042470;melanosome;23873;3910;GO:0005576
GO:0042471;ear morphogenesis;10276;462;GO:0009952
GO:0042472;inner ear morphogenesis;8696;2130;GO:0048598
GO:0042473;outer ear morphogenesis;252;1580;GO:0009952
GO:0042474;middle ear morphogenesis;1002;647;GO:0048513
GO:0042475;odontogenesis of dentin-containing tooth;5009;1400;GO:0008544
GO:0042476;odontogenesis;7845;2260;GO:0032502
GO:0042478;regulation of eye photoreceptor cell development;644;8;GO:0048608
GO:0042479;positive regulation of eye photoreceptor cell development;11;4;GO:0048608
GO:0042480;negative regulation of eye photoreceptor cell development;72;2;GO:0048405
GO:0042481;regulation of odontogenesis;935;189;GO:0030900
GO:0042482;positive regulation of odontogenesis;286;232;GO:0048731
GO:0042483;negative regulation of odontogenesis;117;22;GO:0048731
GO:0042487;regulation of odontogenesis of dentin-containing tooth;537;637;GO:0048731
GO:0042488;positive regulation of odontogenesis of dentin-containing tooth;91;127;GO:0048609
GO:0042489;negative regulation of odontogenesis of dentin-containing tooth;115;7;GO:0048609
GO:0042490;mechanoreceptor differentiation;7460;326;GO:0048608
GO:0042491;inner ear auditory receptor cell differentiation;3514;38;GO:0008544
GO:0042492;gamma-delta T cell differentiation;821;108;GO:0046649
GO:0042494;detection of bacterial lipoprotein;228;9;GO:0002504
GO:0005631;chitosan layer of spore wall;1;4;GO:0046395
GO:0005630;dityrosine layer of spore wall;0;2;GO:0005576
GO:0005633;ascus lipid droplet;1;2;GO:0005811
GO:0005632;inner layer of spore wall;4;1;GO:0048305
GO:0005628;prospore membrane;686;136;GO:0005737
GO:0005640;nuclear outer membrane;7885;1220;GO:0005634
GO:0005642;annulate lamellae;282;154;GO:0005576
GO:0005641;nuclear envelope lumen;681;550;GO:0005739
GO:0005643;nuclear pore;237730;5230;GO:0008544
GO:0005635;nuclear envelope;366363;5980;GO:0005634
GO:0005634;nucleus;13539028;95900;GO:0005634
GO:0005637;nuclear inner membrane;18862;1410;GO:0005730
GO:0005638;lamin filament;275;302;GO:0005576
GO:0005611;laminin-6 complex;0;1;GO:0030199
GO:0005610;laminin-5 complex;118;105;GO:0030199
GO:0005602;complement component C1 complex;10;235;GO:0005576
GO:0005601;classical-complement-pathway C3/C5 convertase complex;39;7;GO:0005576
GO:0005604;basement membrane;55301;3940;GO:0005604
GO:0005606;laminin-1 complex;158;102;GO:0030199
GO:0005608;laminin-3 complex;161;90;GO:0030199
GO:0005607;laminin-2 complex;63;44;GO:0030199
GO:0005609;laminin-4 complex;0;0;GO:0030199
GO:0042602;riboflavin reductase (NADPH) activity;1476;86;GO:0004067
GO:0042603;capsule;9575;29;GO:0044421
GO:0042605;peptide antigen binding;1681;2780;GO:0042605
GO:0042608;T cell receptor binding;473;293;GO:0004872
GO:0042609;CD4 receptor binding;59323;154;GO:0004872
GO:0005622;intracellular anatomical structure;119951415;1460;GO:0044464
GO:0042600;egg chorion;2351;26;GO:0005576
GO:0005621;cellular bud scar;101;10;GO:0048285
GO:0042601;endospore-forming forespore;5398;6;GO:0048304
GO:0005612;laminin-7 complex;0;0;GO:0048407
GO:0005615;extracellular space;360493;35500;GO:0005615
GO:0005614;interstitial matrix;720;558;GO:0022610
GO:0005616;larval serum protein complex;22;48;GO:0005576
GO:0005619;ascospore wall;150;10;GO:0048305
GO:0005618;cell wall;80708;7210;GO:0009505
GO:0003010;voluntary skeletal muscle contraction;366;8;GO:0007517
GO:0005673;transcription factor TFIIE complex;5880;205;GO:0003700
GO:0003011;involuntary skeletal muscle contraction;135;140;GO:0006936
GO:0005672;transcription factor TFIIA complex;9609;774;GO:0003700
GO:0003012;muscle system process;50210;2990;GO:0007517
GO:0005675;transcription factor TFIIH holo complex;21137;129;GO:0003700
GO:0003013;circulatory system process;92645;1630;GO:0007599
GO:0005674;transcription factor TFIIF complex;4555;84;GO:0003700
GO:0003014;renal system process;8015;609;GO:0042254
GO:0005677;chromatin silencing complex;991;345;GO:0000786
GO:0003015;heart process;29922;1340;GO:0048598
GO:0003005;follicular fluid formation in ovarian follicle antrum involved in scattered antral spaces stage;0;2;GO:0048608
GO:0005668;RNA polymerase transcription factor SL1 complex;898;23;GO:0000976
GO:0030624;U6atac snRNA binding;1026;4;GO:0003723
GO:0003006;developmental process involved in reproduction;210183;3090;GO:0032502
GO:0005667;transcription regulator complex;272124;1290;GO:0032991
GO:0030623;U5 snRNA binding;4264;36;GO:0003723
GO:0003007;heart morphogenesis;33371;3760;GO:0007517
GO:0030626;U12 snRNA binding;143;132;GO:0003723
GO:0003008;system process;973616;2930;GO:0009987
GO:0005669;transcription factor TFIID complex;41594;2040;GO:0000976
GO:0030625;U11 snRNA binding;0;0;GO:0005524
GO:0003009;skeletal muscle contraction;2177;7440;GO:0006936
GO:0030628;pre-mRNA 3'-splice site binding;9212;28;GO:0003723
GO:0030627;pre-mRNA 5'-splice site binding;32955;5;GO:0003723
GO:0030629;U6 snRNA 3'-end binding;101;2;GO:0003723
GO:0030620;U2 snRNA binding;5345;79;GO:0003723
GO:0030622;U4atac snRNA binding;5234;9;GO:0003723
GO:0030621;U4 snRNA binding;117244;82;GO:0003723
GO:0032965;regulation of collagen biosynthetic process;1248;75;GO:0032963
GO:0032962;positive regulation of inositol trisphosphate biosynthetic process;184;56;GO:0046330
GO:0030302;deoxynucleotide transport;27;9;GO:0006865
GO:0032963;collagen metabolic process;10385;2760;GO:0032963
GO:0042305;specification of segmental identity, mandibular segment;4;2;GO:0002034
GO:0042306;regulation of protein import into nucleus;2975;577;GO:0010467
GO:0042307;positive regulation of protein import into nucleus;2148;1200;GO:0010467
GO:0042308;negative regulation of protein import into nucleus;620;632;GO:0010467
GO:0042309;homoiothermy;54;82;GO:0009987
GO:0005360;insulin-responsive glucose:proton symporter activity;1;0;GO:0005929
GO:0005363;maltose transmembrane transporter activity;2925;10;GO:0008565
GO:0005362;low-affinity glucose:sodium symporter activity;7;8;GO:0005215
GO:0005365;myo-inositol transmembrane transporter activity;405;159;GO:0005524
GO:0005364;maltose:proton symporter activity;38;2;GO:0005215
GO:0042300;beta-amyrin synthase activity;172;10;GO:0004497
GO:0005367;myo-inositol:sodium symporter activity;31;9;GO:0006836
GO:0042301;phosphate ion binding;70906;1390;GO:0016802
GO:0005366;myo-inositol:proton symporter activity;288;7;GO:0005215
GO:0042302;structural constituent of cuticle;61430;1380;GO:0042302
GO:0005369;taurine:sodium symporter activity;3129;125;GO:0005215
GO:0042303;molting cycle;9968;673;GO:0007530
GO:0005368;taurine transmembrane transporter activity;3320;291;GO:0005215
GO:0042304;regulation of fatty acid biosynthetic process;8081;680;GO:0006631
GO:0032957;inositol trisphosphate metabolic process;4936;305;GO:0006631
GO:0005359;low-affinity glucose:proton symporter activity;0;1;GO:0005215
GO:0032958;inositol phosphate biosynthetic process;14810;392;GO:0006661
GO:0032955;regulation of division septum assembly;17209;116;GO:0048285
GO:0032956;regulation of actin cytoskeleton organization;125025;2440;GO:0071013
GO:0019991;septate junction assembly;1277;146;GO:0007067
GO:0032959;inositol trisphosphate biosynthetic process;432;414;GO:0006661
GO:0019990;pteridine catabolic process;0;2;GO:0006559
GO:0019992;diacylglycerol binding;8909;673;GO:0055085
GO:0032950;regulation of beta-glucan metabolic process;1627;2;GO:0046395
GO:0032953;regulation of (1->3)-beta-D-glucan biosynthetic process;73;0;GO:0046394
GO:0032954;regulation of cytokinetic process;36826;140;GO:0048285
GO:0032951;regulation of beta-glucan biosynthetic process;1624;5;GO:0046394
GO:0032952;regulation of (1->3)-beta-D-glucan metabolic process;73;0;GO:0046394
GO:0019979;interleukin-4 binding;1;1;GO:0005125
GO:0042316;penicillin metabolic process;63;3;GO:0006032
GO:0019978;interleukin-3 binding;1;3;GO:0005125
GO:0042317;penicillin catabolic process;1;2;GO:0046274
GO:0042318;penicillin biosynthetic process;49;8;GO:0009306
GO:0005330;dopamine:sodium symporter activity;554;29;GO:0006836
GO:0005332;gamma-aminobutyric acid:sodium:chloride symporter activity;3655;135;GO:0005215
GO:0042310;vasoconstriction;23492;954;GO:0002096
GO:0042311;vasodilation;3478;1310;GO:0007596
GO:0005334;norepinephrine:sodium symporter activity;164;9;GO:0006836
GO:0042313;protein kinase C deactivation;67;8;GO:0043403
GO:0042314;bacteriochlorophyll binding;7050;8;GO:0046148
GO:0005335;serotonin:sodium:chloride symporter activity;1496;6;GO:0006836
GO:0032946;positive regulation of mononuclear cell proliferation;8870;1080;GO:0045727
GO:0005326;neurotransmitter transmembrane transporter activity;2215;50;GO:0005215
GO:0032944;regulation of mononuclear cell proliferation;17293;731;GO:0042127
GO:0005328;neurotransmitter:sodium symporter activity;840;1300;GO:0006836
GO:0032945;negative regulation of mononuclear cell proliferation;5243;118;GO:0045727
GO:0019980;interleukin-5 binding;0;3;GO:0005125
GO:0032948;regulation of alpha-glucan metabolic process;107;2;GO:0046394
GO:0032949;regulation of alpha-glucan biosynthetic process;62;2;GO:0010467
GO:0019982;interleukin-7 binding;0;2;GO:0042379
GO:0019981;interleukin-6 binding;124;119;GO:0005125
GO:0019983;interleukin-9 binding;22;7;GO:0005125
GO:0032942;inositol tetrakisphosphate 2-kinase activity;4;3;GO:0004721
GO:0019985;translesion synthesis;17119;2210;GO:0007049
GO:0032943;mononuclear cell proliferation;24727;1210;GO:0042127
GO:0019988;charged-tRNA amino acid modification;267346;264;GO:0006418
GO:0032940;secretion by cell;920476;3080;GO:0005615
GO:0032941;secretion by tissue;3681;22;GO:0005576
GO:0042327;positive regulation of phosphorylation;29288;2090;GO:0016310
GO:0042328;heparan sulfate N-acetylglucosaminyltransferase activity;7;99;GO:0004553
GO:0042329;structural constituent of collagen and cuticulin-based cuticle;39;5;GO:0005578
GO:0019969;interleukin-10 binding;6;4;GO:0005125
GO:0005340;nucleotide-sulfate transmembrane transporter activity;0;0;GO:0008529
GO:0042320;regulation of circadian sleep/wake cycle, REM sleep;62;7;GO:0048405
GO:0005343;organic acid:sodium symporter activity;103402;60;GO:0005215
GO:0042321;negative regulation of circadian sleep/wake cycle, sleep;111;38;GO:0048405
GO:0005342;organic acid transmembrane transporter activity;693958;1330;GO:0015075
GO:0042322;negative regulation of circadian sleep/wake cycle, REM sleep;48;82;GO:0048405
GO:0005345;purine nucleobase transmembrane transporter activity;9419;41;GO:0008528
GO:0042323;negative regulation of circadian sleep/wake cycle, non-REM sleep;6;184;GO:0048405
GO:0005344;oxygen carrier activity;70114;746;GO:0015979
GO:0042324;orexin receptor binding;40;0;GO:0005509
GO:0005347;ATP transmembrane transporter activity;30473;319;GO:0008565
GO:0042325;regulation of phosphorylation;66417;2470;GO:0016310
GO:0005346;purine ribonucleotide transmembrane transporter activity;40432;9;GO:0005065
GO:0042326;negative regulation of phosphorylation;20822;1650;GO:0016310
GO:0005338;nucleotide-sugar transmembrane transporter activity;18416;55;GO:0008528
GO:0032935;sterol sensor activity;67;2;GO:0008610
GO:0005337;nucleoside transmembrane transporter activity;85397;783;GO:0008529
GO:0032936;SREBP-SCAP complex;51;2;GO:0005840
GO:0032933;SREBP signaling pathway;8097;415;GO:0030514
GO:0032934;sterol binding;22613;570;GO:0097159
GO:0032939;positive regulation of translation in response to oxidative stress;0;3;GO:0010401
GO:0032937;SREBP-SCAP-Insig complex;205;114;GO:0005869
GO:0032938;negative regulation of translation in response to oxidative stress;2;8;GO:0010468
GO:0019970;interleukin-11 binding;71;10;GO:0005125
GO:0019973;interleukin-13 binding;0;1;GO:0005125
GO:0019972;interleukin-12 binding;205;3;GO:0005125
GO:0019975;interleukin-17 binding;52;4;GO:0005125
GO:0032931;histone H3K56 acetyltransferase activity;32;0;GO:0016569
GO:0032932;negative regulation of astral microtubule depolymerization;0;3;GO:0048285
GO:0019977;interleukin-21 binding;0;2;GO:0005125
GO:0019976;interleukin-2 binding;856;48;GO:0042379
GO:0032930;positive regulation of superoxide anion generation;583;782;GO:0046395
GO:0005391;P-type sodium:potassium-exchanging transporter activity;826;50;GO:0005215
GO:0030350;iron-responsive element binding;2701;91;GO:0030528
GO:0030348;syntaxin-3 binding;82;356;GO:0008047
GO:0030341;chondroitin AC lyase activity;130;1;GO:0004553
GO:0030340;hyaluronate lyase activity;325;3;GO:0005576
GO:0030343;vitamin D3 25-hydroxylase activity;214;79;GO:0004722
GO:0030342;1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity;91;15;GO:0004073
GO:0030345;structural constituent of tooth enamel;394;47;GO:0008544
GO:0030346;protein phosphatase 2B binding;342;126;GO:0048407
GO:0030338;CMP-N-acetylneuraminate monooxygenase activity;528;6;GO:0004073
GO:0030337;DNA polymerase processivity factor activity;14919;347;GO:0005524
GO:0032999;Fc-alpha receptor I complex;0;0;GO:0004872
GO:0030339;fatty-acyl-ethyl-ester synthase activity;4;5;GO:0004633
GO:0030330;DNA damage response, signal transduction by p53 class mediator;5447;1180;GO:0006974
GO:0032993;protein-DNA complex;1684642;2560;GO:0032991
GO:0032994;protein-lipid complex;15139;304;GO:0048193
GO:0030332;cyclin binding;11549;903;GO:0005515
GO:0032991;protein-containing complex;18805001;5540;GO:0043234
GO:0030331;nuclear estrogen receptor binding;1788;85;GO:0005515
GO:0032992;protein-carbohydrate complex;27;8;GO:0043169
GO:0030334;regulation of cell migration;69944;7080;GO:0030334
GO:0032997;Fc receptor complex;700;5;GO:0004872
GO:0032998;Fc-epsilon receptor I complex;595;90;GO:0004872
GO:0030336;negative regulation of cell migration;16445;4500;GO:0030509
GO:0032995;regulation of fungal-type cell wall biogenesis;139;7;GO:0032989
GO:0030335;positive regulation of cell migration;35647;8060;GO:0016477
GO:0032996;Bcl3-Bcl10 complex;49;8;GO:0043065
GO:0032990;cell part morphogenesis;112262;1760;GO:0042127
GO:0005372;water transmembrane transporter activity;14558;342;GO:0008565
GO:0005371;tricarboxylate secondary active transmembrane transporter activity;208;7;GO:0005215
GO:0005375;copper ion transmembrane transporter activity;34345;1100;GO:0005215
GO:0030327;prenylated protein catabolic process;243;43;GO:0046274
GO:0030326;embryonic limb morphogenesis;9283;1920;GO:0009952
GO:0030329;prenylcysteine metabolic process;4827;7;GO:0009064
GO:0032988;protein-RNA complex disassembly;5372;2;GO:0048193
GO:0030328;prenylcysteine catabolic process;4827;190;GO:0009065
GO:0032989;cellular component morphogenesis;125592;3430;GO:0048608
GO:0032982;myosin filament;3261;712;GO:0005524
GO:0032983;kainate selective glutamate receptor complex;238;39;GO:0008076
GO:0030321;transepithelial chloride transport;1076;446;GO:0006836
GO:0032980;keratinocyte activation;95;73;GO:0046332
GO:0032981;mitochondrial respiratory chain complex I assembly;22032;3540;GO:0005743
GO:0030323;respiratory tube development;16350;874;GO:0048608
GO:0032986;protein-DNA complex disassembly;2165;869;GO:0048285
GO:0030322;stabilization of membrane potential;926;282;GO:0048407
GO:0032987;protein-lipid complex disassembly;0;2;GO:0048193
GO:0030325;adrenal gland development;1500;891;GO:0007517
GO:0032984;protein-containing complex disassembly;1093981;291;GO:0048193
GO:0030324;lung development;15740;4460;GO:0030900
GO:0032985;protein-carbohydrate complex disassembly;0;2;GO:0048193
GO:0005381;iron ion transmembrane transporter activity;99039;1270;GO:0008565
GO:0005385;zinc ion transmembrane transporter activity;30428;1320;GO:0005215
GO:0005384;manganese ion transmembrane transporter activity;42320;849;GO:0008565
GO:0005388;P-type calcium transporter activity;68876;57;GO:0005215
GO:0030316;osteoclast differentiation;7615;1300;GO:0007596
GO:0032979;protein insertion into mitochondrial inner membrane from matrix;987;51;GO:0005743
GO:0030315;T-tubule;4386;1210;GO:0005789
GO:0030318;melanocyte differentiation;2216;1740;GO:0008544
GO:0032977;membrane insertase activity;62899;243;GO:0004842
GO:0030317;flagellated sperm motility;10808;575;GO:0006928
GO:0032978;protein insertion into membrane from inner side;1028;9;GO:0016021
GO:0032971;regulation of muscle filament sliding;118;241;GO:0048608
GO:0032972;regulation of muscle filament sliding speed;60;44;GO:0048608
GO:0030310;poly-N-acetyllactosamine catabolic process;0;4;GO:0006032
GO:0032970;regulation of actin filament-based process;126953;1370;GO:0045935
GO:0030312;external encapsulating structure;2467423;1820;GO:0005576
GO:0032975;amino acid transmembrane import into vacuole;464;1;GO:0008565
GO:0030311;poly-N-acetyllactosamine biosynthetic process;270;182;GO:0006032
GO:0032976;release of matrix enzymes from mitochondria;56;10;GO:0048471
GO:0030314;junctional membrane complex;5475;112;GO:0048471
GO:0032973;amino acid export across plasma membrane;5310;6;GO:0008544
GO:0030313;cell envelope;2566254;245;GO:0009277
GO:0032974;amino acid transmembrane export from vacuole;2049;6;GO:0008544
GO:0030270;formylmethanofuran-tetrahydromethanopterin N-formyltransferase activity;7902;5;GO:0004497
GO:0030273;melanin-concentrating hormone receptor activity;896;6;GO:0004930
GO:0030272;5-formyltetrahydrofolate cyclo-ligase activity;57671;475;GO:0006022
GO:0042254;ribosome biogenesis;4695693;12600;GO:0006364
GO:0042255;ribosome assembly;202113;2780;GO:0006414
GO:0042256;cytosolic ribosome assembly;54810;10;GO:0005840
GO:0042258;molybdenum incorporation via L-serinyl molybdopterin guanine dinucleotide;0;2;GO:0006873
GO:0042262;DNA protection;8197;61;GO:0006974
GO:0042263;neuropeptide F receptor activity;2;2;GO:0004930
GO:0030264;nuclear fragmentation involved in apoptotic nuclear change;5;27;GO:0043066
GO:0030263;apoptotic chromosome condensation;190;128;GO:0007050
GO:0030266;quinate 3-dehydrogenase (NAD+) activity;2007;0;GO:0004067
GO:0030265;phospholipase C-activating rhodopsin mediated signaling pathway;14;8;GO:0008021
GO:0030268;methylenetetrahydromethanopterin dehydrogenase activity;1556;8;GO:0004497
GO:0030267;glyoxylate reductase (NADP+) activity;12317;65;GO:0004067
GO:0030269;tetrahydromethanopterin S-methyltransferase activity;10574;26;GO:0004497
GO:0030262;apoptotic nuclear changes;3001;257;GO:0008219
GO:0030261;chromosome condensation;100933;3870;GO:0007062
GO:0042264;peptidyl-aspartic acid hydroxylation;1;317;GO:0006457
GO:0042267;natural killer cell mediated cytotoxicity;4502;1070;GO:0002221
GO:0042268;regulation of cytolysis;3;9;GO:0045087
GO:0042269;regulation of natural killer cell mediated cytotoxicity;3436;556;GO:0002237
GO:0042270;protection from natural killer cell mediated cytotoxicity;215;184;GO:0002821
GO:0042271;susceptibility to natural killer cell mediated cytotoxicity;149;88;GO:0002213
GO:0042272;nuclear RNA export factor complex;217;99;GO:0005740
GO:0042273;ribosomal large subunit biogenesis;186371;4160;GO:0006412
GO:0042274;ribosomal small subunit biogenesis;272533;5050;GO:0006414
GO:0030253;protein secretion by the type I secretion system;13460;55;GO:0055085
GO:0030252;growth hormone secretion;878;361;GO:0007586
GO:0030255;protein secretion by the type IV secretion system;17190;73;GO:0055085
GO:0030254;protein secretion by the type III secretion system;44316;61;GO:0055085
GO:0030257;type III protein secretion system complex;29602;122;GO:0015986
GO:0030256;type I protein secretion system complex;13441;0;GO:0042746
GO:0030259;lipid glycosylation;108050;802;GO:0008610
GO:0030258;lipid modification;310500;1360;GO:0006629
GO:0005291;high-affinity L-histidine transmembrane transporter activity;9;5;GO:0005215
GO:0005290;L-histidine transmembrane transporter activity;618;288;GO:0005215
GO:0005292;high-affinity lysine transmembrane transporter activity;52;9;GO:0008565
GO:0005295;neutral L-amino acid:sodium symporter activity;692;6;GO:0005215
GO:0030251;guanylate cyclase inhibitor activity;51;4;GO:0008021
GO:0005294;neutral L-amino acid secondary active transmembrane transporter activity;130;37;GO:0005215
GO:0030250;guanylate cyclase activator activity;1426;47;GO:0005021
GO:0005297;proline:proton symporter activity;167;3;GO:0005215
GO:0042275;error-free postreplication DNA repair;137;23;GO:0006281
GO:0042276;error-prone translesion synthesis;6323;931;GO:0007049
GO:0042277;peptide binding;71900;3060;GO:0005515
GO:0005298;proline:sodium symporter activity;29977;266;GO:0005215
GO:0042278;purine nucleoside metabolic process;194024;1300;GO:0006796
GO:0042279;nitrite reductase (cytochrome, ammonia-forming) activity;19222;148;GO:0003954
GO:0140818;mRNA 5'-phosphatase activity;6367;1;GO:0004870
GO:0140819;UDP-beta-L-arabinofuranose transporter activity;0;3;GO:0005525
GO:0140814;glycine betaine:sodium:chloride symporter activity;0;1;GO:0005215
GO:0030249;guanylate cyclase regulator activity;1588;106;GO:0005096
GO:0140815;NAD+-protein-histidine ADP-ribosyltransferase activity;271;0;GO:0004867
GO:0140816;NAD+-histone H2BS6 serine ADP-ribosyltransferase activity;56;0;GO:0004812
GO:0042281;dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity;2841;9;GO:0006029
GO:0140817;NAD+-histone H3S10 serine ADP-ribosyltransferase activity;56;0;GO:0004842
GO:0140810;histone H1R54 arginine deiminase activity;0;0;GO:0004721
GO:0042283;dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity;3942;6;GO:0006029
GO:0140811;histone H2AR3 arginine deiminase activity;0;0;GO:0004721
GO:0042284;sphingolipid delta-4 desaturase activity;10068;27;GO:0008610
GO:0140812;orotate:monoatomic anion antiporter activity;0;2;GO:0005215
GO:0042285;xylosyltransferase activity;12540;57;GO:0004553
GO:0140813;urate:monoatomic anion antiporter activity;0;1;GO:0005215
GO:0030242;autophagy of peroxisome;2073;193;GO:0006914
GO:0030241;skeletal muscle myosin thick filament assembly;191;347;GO:0005524
GO:0030244;cellulose biosynthetic process;48407;1600;GO:0009507
GO:0030243;cellulose metabolic process;157182;665;GO:0005976
GO:0030246;carbohydrate binding;1032199;14300;GO:0030246
GO:0030245;cellulose catabolic process;108753;681;GO:0005976
GO:0030248;cellulose binding;27199;407;GO:0005576
GO:0030247;polysaccharide binding;132559;2200;GO:0035095
GO:0030240;skeletal muscle thin filament assembly;482;661;GO:0005544
GO:0042286;glutamate-1-semialdehyde 2,1-aminomutase activity;111331;384;GO:0004067
GO:0042287;MHC protein binding;4123;397;GO:0005515
GO:0042288;MHC class I protein binding;1598;872;GO:0043167
GO:0042289;MHC class II protein binding;1716;291;GO:0048407
GO:0140807;NAD+-protein-glutamate ADP-ribosyltransferase activity;236;0;GO:0004867
GO:0140808;NAD+-protein-tyrosine ADP-ribosyltransferase activity;272;0;GO:0004867
GO:0140809;histone H4R3 arginine deiminase activity;0;0;GO:0004721
GO:0030239;myofibril assembly;7023;2820;GO:0007517
GO:0140803;NAD+- protein-cysteine ADP-ribosyltransferase activity;212;0;GO:0004867
GO:0030238;male sex determination;1350;694;GO:0007548
GO:0140804;NAD+- protein-lysine ADP-ribosyltransferase activity;123;0;GO:0004867
GO:0140805;NAD+-protein-serine ADP-ribosyltransferase activity;457;0;GO:0004842
GO:0042292;URM1 activating enzyme activity;223;2;GO:0004872
GO:0140806;NAD+- protein-aspartate ADP-ribosyltransferase activity;292;0;GO:0004867
GO:0042293;Hub1 activating enzyme activity;0;1;GO:0003824
GO:0042294;URM1 transferase activity;0;1;GO:0005524
GO:0140800;gamma-aminobutyric acid:proton antiporter activity;75;2;GO:0005215
GO:0140801;histone H2AXY142 kinase activity;1751;1;GO:0004725
GO:0042296;ISG15 transferase activity;277;47;GO:0004867
GO:0140802;NAD+-protein-C-terminal glycine ADP-ribosyltransferase activity;55;0;GO:0004867
GO:0030233;deoxynucleotide transmembrane transporter activity;8;6;GO:0008529
GO:0032892;positive regulation of organic acid transport;1458;143;GO:0045735
GO:0030232;insulin control element activator complex;1;3;GO:0048608
GO:0030235;nitric-oxide synthase regulator activity;283;884;GO:0030528
GO:0032898;neurotrophin production;133;5;GO:0048608
GO:0030234;enzyme regulator activity;1829573;6540;GO:0030528
GO:0032899;regulation of neurotrophin production;15;6;GO:0048608
GO:0030237;female sex determination;270;39;GO:0007548
GO:0032896;palmitoyl-CoA 9-desaturase activity;45;4;GO:0006631
GO:0032897;negative regulation of viral transcription;1094;310;GO:0010467
GO:0042217;1-aminocyclopropane-1-carboxylate catabolic process;0;4;GO:0009065
GO:0042218;1-aminocyclopropane-1-carboxylate biosynthetic process;808;8;GO:0009813
GO:0044879;mitotic morphogenesis checkpoint signaling;17;4;GO:0000724
GO:0042219;cellular modified amino acid catabolic process;66492;1820;GO:0006569
GO:0044872;lipoprotein localization;62467;53;GO:0006614
GO:0042210;octamethylcyclotetrasiloxane catabolic process to dimethylsilanediol;0;2;GO:0046395
GO:0044871;negative regulation by host of viral glycoprotein metabolic process;106;8;GO:0048193
GO:0042211;dimethylsilanediol catabolic process;0;2;GO:0046395
GO:0044874;lipoprotein localization to outer membrane;16419;7;GO:0008544
GO:0042212;cresol metabolic process;1;1;GO:0006073
GO:0044873;lipoprotein localization to membrane;31348;2;GO:0005509
GO:0042213;m-cresol catabolic process;0;2;GO:0006559
GO:0044876;hercynylselenocysteine synthase;4;2;GO:0009065
GO:0042214;terpene metabolic process;18355;191;GO:0006721
GO:0044875;gamma-glutamyl hercynylcysteine sulfoxide synthase activity;3756;2;GO:0004067
GO:0042215;anaerobic phenol-containing compound metabolic process;1;1;GO:0006066
GO:0044878;mitotic cytokinesis checkpoint signaling;285;8;GO:0007067
GO:0042216;phenanthrene catabolic process;4;3;GO:0046274
GO:0044877;protein-containing complex binding;276266;2480;GO:0043169
GO:0140836;RNA polymerase II CTD heptapeptide repeat S5 kinase activity;52;1;GO:0003729
GO:0140837;RNA polymerase II CTD heptapeptide repeat S7 kinase activity;0;0;GO:0003729
GO:0140838;RNA polymerase II CTD heptapeptide repeat peptidyl-prolyl isomerase activity;0;1;GO:0003723
GO:0140839;RNA polymerase II CTD heptapeptide repeat P3 isomerase activity;0;0;GO:0003729
GO:0140832;L-histidine, sodium:proton antiporter activity;62;3;GO:0005215
GO:0140833;RNA polymerase II CTD heptapeptide repeat Y1 kinase activity;0;0;GO:0003729
GO:0140834;RNA polymerase II CTD heptapeptide repeat S2 kinase activity;4;1;GO:0003729
GO:0140835;RNA polymerase II CTD heptapeptide repeat T4 kinase activity;0;0;GO:0003729
GO:0140830;L-glutamine, sodium:proton antiporter activity;89;4;GO:0005215
GO:0140831;L-asparagine, sodium:proton antiporter activity;64;3;GO:0005215
GO:0042220;response to cocaine;1503;1360;GO:0042592
GO:0042221;response to chemical;7231406;8550;GO:0042221
GO:0140829;bicarbonate:monoatomic anion antiporter activity;882;0;GO:0005215
GO:0140825;lactoperoxidase activity;37868;5;GO:0004601
GO:0140826;zinc:proton antiporter activity;136;5;GO:0005215
GO:0140827;zinc chaperone activity;133;2;GO:0008033
GO:0140828;metal cation:monoatomic cation antiporter activity;122924;1;GO:0005215
GO:0140821;UDP-beta-L-arabinofuranose import into Golgi lumen;0;0;GO:0005576
GO:0140822;NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity;3;0;GO:0004812
GO:0140823;histone H2BS36 kinase activity;115;2;GO:0004721
GO:0140824;thioredoxin-dependent peroxiredoxin activity;80393;5;GO:0004601
GO:0030297;transmembrane receptor protein tyrosine kinase activator activity;981;129;GO:0004872
GO:0030296;protein tyrosine kinase activator activity;4494;560;GO:0030548
GO:0030299;intestinal cholesterol absorption;799;1120;GO:0007586
GO:0030298;receptor signaling protein tyrosine kinase activator activity;2808;22;GO:0030548
GO:0140820;cytosol to Golgi apparatus transport;470;1;GO:0006897
GO:0030291;protein serine/threonine kinase inhibitor activity;82371;1010;GO:0048407
GO:0030290;sphingolipid activator protein activity;1;4;GO:0004872
GO:0030293;transmembrane receptor protein tyrosine kinase inhibitor activity;11;7;GO:0004872
GO:0030292;protein tyrosine kinase inhibitor activity;324;302;GO:0030548
GO:0030295;protein kinase activator activity;25880;1040;GO:0030528
GO:0030294;receptor signaling protein tyrosine kinase inhibitor activity;80;6;GO:0004872
GO:0140858;histone H2AK15 ubiquitin ligase activity;50;0;GO:0004842
GO:0140859;pterocarpan synthase activity;2;2;GO:0004497
GO:0140854;interleukin-19-mediated signaling pathway;0;0;GO:0007186
GO:0140855;histone H3S57 kinase activity;0;0;GO:0004721
GO:0140856;histone H2AK13 ubiquitin ligase activity;0;0;GO:0004842
GO:0140857;histone H3T45 kinase activity;58;2;GO:0004721
GO:0030286;dynein complex;135110;1530;GO:0005819
GO:0140850;histone H2B C-terminal K residue ubiquitin ligase activity;123;2;GO:0004842
GO:0140851;histone H3K14 ubiquitin ligase activity;6;0;GO:0004842
GO:0030288;outer membrane-bounded periplasmic space;347858;3080;GO:0005622
GO:0140852;histone ubiquitin ligase activity;793;4;GO:0004842
GO:0030287;cell wall-bounded periplasmic space;25;10;GO:0005618
GO:0140853;cholesterol-protein transferase activity;70;3;GO:0008610
GO:0030289;protein phosphatase 4 complex;7954;67;GO:0000942
GO:0030280;structural constituent of skin epidermis;818;140;GO:0008544
GO:0030282;bone mineralization;9515;1570;GO:0007538
GO:0030281;structural constituent of cutaneous appendage;1;2;GO:0042302
GO:0030284;nuclear estrogen receptor activity;3345;10;GO:0003700
GO:0030283;testosterone dehydrogenase [NAD(P)] activity;741;0;GO:0006720
GO:0042242;cobyrinic acid a,c-diamide synthase activity;43946;10;GO:0006021
GO:0042243;asexual spore wall assembly;7;2;GO:0009699
GO:0042244;spore wall assembly;378;20;GO:0048305
GO:0042245;RNA repair;20231;31;GO:0006281
GO:0042246;tissue regeneration;12531;1550;GO:0042127
GO:0042247;establishment of planar polarity of follicular epithelium;68;109;GO:0048608
GO:0042248;maintenance of polarity of follicular epithelium;19;4;GO:0048608
GO:0042249;establishment of planar polarity of embryonic epithelium;849;107;GO:0009952
GO:0140847;negative regulation of promoter clearance from RNA polymerase II promoter;0;0;GO:0045944
GO:0140848;amino acid:monoatomic cation antiporter activity;581;2;GO:0005215
GO:0140849;ATP-dependent H2AZ histone chaperone activity;4510;4;GO:0006091
GO:0140843;RNA polymerase II C-terminal domain S7 O-GlcNAc transferase activity;0;0;GO:0003729
GO:0042250;maintenance of polarity of embryonic epithelium;0;6;GO:0048608
GO:0140844;NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity;0;0;GO:0004812
GO:0042251;maintenance of polarity of larval imaginal disc epithelium;0;2;GO:0048608
GO:0140845;regulation of promoter clearance from RNA polymerase II promoter;0;1;GO:0006357
GO:0042252;establishment of planar polarity of larval imaginal disc epithelium;0;2;GO:0009952
GO:0140846;positive regulation of promoter clearance from RNA polymerase II promoter;0;1;GO:0045944
GO:0030275;LRR domain binding;758;174;GO:0005515
GO:0030274;LIM domain binding;3739;368;GO:0048608
GO:0140840;RNA polymerase II CTD heptapeptide repeat P6 isomerase activity;0;0;GO:0003729
GO:0030277;maintenance of gastrointestinal epithelium;1800;753;GO:0042127
GO:0140841;RNA polymerase II C-terminal domain O-GlcNAc transferase activity;0;0;GO:0003729
GO:0030276;clathrin binding;56587;1470;GO:0005515
GO:0140842;RNA polymerase II C-terminal domain S5 O-GlcNAc transferase activity;0;0;GO:0003723
GO:0030279;negative regulation of ossification;2050;676;GO:0048609
GO:0030278;regulation of ossification;7713;1340;GO:0048609
GO:0150200;regulation of transport across blood-brain barrier;51;4;GO:0055085
GO:0150201;positive regulation of transport across blood-brain barrier;49;2;GO:0048167
GO:0140876;andrastin A biosynthetic process;0;3;GO:0046395
GO:0140877;mevastatin biosynthetic process;2;0;GO:0046395
GO:0140878;griseofulvin biosynthetic process;7;0;GO:0009813
GO:0140879;conidiogenone biosynthetic process;4;0;GO:0046395
GO:0140872;viridicatumtoxin biosynthetic process;12;1;GO:0046395
GO:0140873;paxilline biosynthetic process;8;0;GO:0046395
GO:0140874;paraherquonin biosynthetic process;5;1;GO:0046395
GO:0140875;PR-toxin biosynthetic process;0;0;GO:0009405
GO:0140870;RNA polymerase inhibitor activity;1;1;GO:0003729
GO:0140871;repressor of RNA polymerase inhibitor activity;0;1;GO:0010468
GO:0140869;miRNA inhibitor activity via base-pairing;20;9;GO:0003676
GO:0140865;interleukin-22-mediated signaling pathway;264;3;GO:0007267
GO:0140866;interleukin-20-mediated signaling pathway;0;1;GO:0007186
GO:0140867;NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity;0;0;GO:0004812
GO:0140868;4,4'-diapophytoene desaturase (4,4'-diapolycopene-forming);374;0;GO:0006749
GO:0140861;DNA repair-dependent chromatin remodeling;1171;116;GO:0016570
GO:0140862;histone H2AK119 ubiquitin ligase activity;293;2;GO:0004842
GO:0140863;histone H2AK127 ubiquitin ligase activity;0;0;GO:0004842
GO:0140864;histone H2AK129 ubiquitin ligase activity;0;0;GO:0004842
GO:0140860;(3R)-2'-hydroxyisoflavanone reductase activity;0;0;GO:0004067
GO:0140898;CENP-A eviction from euchromatin;1;2;GO:0007049
GO:0140899;plastid gene expression;11;1;GO:0010467
GO:0140894;endolysosomal toll-like receptor signaling pathway;3181;1;GO:0007165
GO:0140895;cell surface toll-like receptor signaling pathway;3975;3;GO:0007186
GO:0140896;cGAS/STING signaling pathway;105;5;GO:1903047
GO:0140897;mechanoreceptor activity;4;1;GO:0007600
GO:0140890;H1 histone chaperone activity;0;0;GO:0003682
GO:0140891;tRNA-derived regulatory ncRNA processing;0;1;GO:0010467
GO:0140892;sodium,bicarbonate:chloride antiporter activity;165;4;GO:0005215
GO:0140893;neutral amino acid, sodium:proton antiporter activity;56;1;GO:0005215
GO:0140887;positive regulation of nucleosome disassembly;0;2;GO:0045944
GO:0140888;interferon-mediated signaling pathway;155781;4;GO:0060337
GO:0140889;DNA replication-dependent chromatin disassembly;170;3;GO:0007067
GO:0140883;induction by virus of host reticulophagy;1;1;GO:0006909
GO:0140884;suppression by virus of host type II interferon-mediated signaling pathway;0;2;GO:1901169
GO:0140885;suppression by virus of host type III interferon-mediated signaling pathway;0;0;GO:1901169
GO:0140886;suppression by virus of host interferon-mediated signaling pathway;3;2;GO:0046649
GO:0140880;terrein biosynthetic process;0;0;GO:0006021
GO:0140881;positive regulation terrein biosynthetic process;0;0;GO:0046394
GO:0140882;zinc export across plasma membrane;126;2;GO:0006836
GO:0042297;vocal learning;204;954;GO:0007600
GO:0042299;lupeol synthase activity;30;13;GO:0004497
GO:0150044;regulation of postsynaptic dense core vesicle exocytosis;21;1;GO:0048608
GO:0150045;regulation of synaptic signaling by nitric oxide;20;2;GO:0048167
GO:0150043;structural constituent of synapse-associated extracellular matrix;112;6;GO:0031982
GO:0150048;cerebellar granule cell to Purkinje cell synapse;105;2;GO:0048666
GO:0150047;G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential;91;2;GO:0004890
GO:0150051;postsynaptic Golgi apparatus;11;3;GO:0005768
GO:0150052;regulation of postsynapse assembly;119;5;GO:0048608
GO:0150050;postsynaptic septin cytoskeleton;5;1;GO:0048608
GO:0150056;amylin receptor complex 1;97;0;GO:0005576
GO:0150053;cerebellar climbing fiber to Purkinje cell synapse;323;4;GO:0008023
GO:0150054;regulation of postsynaptic neurotransmitter receptor diffusion trapping;20;3;GO:0048608
GO:0150059;amylin receptor 1 signaling pathway;0;0;GO:0007186
GO:0005402;carbohydrate:monoatomic cation symporter activity;45444;1;GO:0005215
GO:0150057;amylin receptor complex 2;99;0;GO:0005576
GO:0150058;amylin receptor complex 3;98;1;GO:0048608
GO:0150062;complement-mediated synapse pruning;135;59;GO:0048608
GO:0150063;visual system development;52160;149;GO:0007423
GO:0150060;amylin receptor 2 signaling pathway;0;0;GO:0007186
GO:0150061;amylin receptor 3 signaling pathway;0;0;GO:0007186
GO:0150022;apical dendrite development;0;1;GO:0048608
GO:0150023;apical dendrite arborization;0;0;GO:0048608
GO:0150020;basal dendrite arborization;73;3;GO:0097403
GO:0150021;apical dendrite morphogenesis;0;1;GO:0048608
GO:0150024;oxidised low-density lipoprotein particle clearance;60;4;GO:0043169
GO:0150025;oxidised low-density lipoprotein particle receptor activity;60;2;GO:0008023
GO:0150033;negative regulation of protein localization to lysosome;101;9;GO:0048193
GO:0150034;distal axon;19717;154;GO:0043005
GO:0150031;regulation of protein localization to lysosome;259;3;GO:0048193
GO:0150032;positive regulation of protein localization to lysosome;158;1;GO:0048193
GO:0150037;regulation of calcium-dependent activation of synaptic vesicle fusion;119;3;GO:0007416
GO:0150038;postsynaptic dense core vesicle exocytosis;25;2;GO:0008092
GO:0150035;regulation of trans-synaptic signaling by BDNF, modulating synaptic transmission;21;1;GO:0048167
GO:0150036;regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;23;1;GO:0048608
GO:0150088;multiple synapse bouton, contacting multiple dendrites;0;0;GO:0048608
GO:0150089;multiple spine synapse organization;10;1;GO:0045202
GO:0150086;multiple synapse bouton;0;1;GO:0008021
GO:0150087;multiple synapse bouton, contacting single dendrite;0;0;GO:0048608
GO:0005432;calcium:sodium antiporter activity;9720;493;GO:0006811
GO:0150091;multiple spine synapse organization, multiple dendrites;0;0;GO:0048666
GO:0150092;regulation of synaptic scaling;2;1;GO:0048167
GO:0005427;proton-dependent oligopeptide secondary active transmembrane transporter activity;129;24;GO:0005215
GO:0150090;multiple spine synapse organization, single dendrite;10;6;GO:0048608
GO:0150093;amyloid-beta clearance by transcytosis;414;19;GO:0006986
GO:0150094;amyloid-beta clearance by cellular catabolic process;471;41;GO:0043161
GO:0150099;neuron-glial cell signaling;67;6;GO:0007268
GO:0150098;glial cell-neuron signaling;178;4;GO:0050877
GO:0005436;sodium:phosphate symporter activity;34858;360;GO:0008565
GO:0150066;negative regulation of deacetylase activity;1;1;GO:0016567
GO:0150067;regulation of tubulin deacetylase activity;0;0;GO:0010467
GO:0150064;vertebrate eye-specific patterning;96;104;GO:0007530
GO:0150065;regulation of deacetylase activity;5;1;GO:0016567
GO:0150068;positive regulation of tubulin deacetylase activity;0;0;GO:0048193
GO:0005412;glucose:sodium symporter activity;772;81;GO:0005215
GO:0150069;negative regulation of tubulin deacetylase activity;0;0;GO:0010467
GO:0150070;regulation of arginase activity;2;1;GO:0046394
GO:0150073;regulation of protein-glutamine gamma-glutamyltransferase activity;2;1;GO:0010401
GO:0150074;positive regulation of protein-glutamine gamma-glutamyltransferase activity;2;2;GO:0046356
GO:0150071;negative regulation of arginase activity;0;1;GO:0046395
GO:0150072;positive regulation of arginase activity;2;3;GO:0046394
GO:0150077;regulation of neuroinflammatory response;3308;86;GO:0050729
GO:0150078;positive regulation of neuroinflammatory response;578;85;GO:0050729
GO:0150075;negative regulation of protein-glutamine gamma-glutamyltransferase activity;0;1;GO:0010468
GO:0150076;neuroinflammatory response;5672;216;GO:0006954
GO:0150079;negative regulation of neuroinflammatory response;793;35;GO:0050729
GO:0005415;nucleoside:sodium symporter activity;341;139;GO:0008565
GO:0005416;amino acid:monoatomic cation symporter activity;99513;5;GO:0005215
GO:0042415;norepinephrine metabolic process;1271;752;GO:0006790
GO:0042416;dopamine biosynthetic process;1622;597;GO:0006511
GO:0042417;dopamine metabolic process;3212;1370;GO:0006511
GO:0042418;epinephrine biosynthetic process;67;32;GO:0009060
GO:0042419;epinephrine catabolic process;0;4;GO:0009072
GO:0005471;ATP:ADP antiporter activity;26307;524;GO:0005215
GO:0042410;6-carboxyhexanoate-CoA ligase activity;2582;5;GO:0006081
GO:0005477;pyruvate secondary active transmembrane transporter activity;6;106;GO:0005044
GO:0005476;carnitine:acyl carnitine antiporter activity;13;6;GO:0006836
GO:0042412;taurine biosynthetic process;3195;34;GO:0006541
GO:0042413;carnitine catabolic process;3471;7;GO:0009062
GO:0042414;epinephrine metabolic process;72;103;GO:0004473
GO:0030426;growth cone;15207;3140;GO:0048608
GO:0005469;succinate:fumarate antiporter activity;89;7;GO:0009060
GO:0030425;dendrite;61978;8490;GO:0097458
GO:0030428;cell septum;12657;348;GO:0007067
GO:0030427;site of polarized growth;25670;729;GO:0009987
GO:0030429;kynureninase activity;54404;39;GO:0004721
GO:0030420;establishment of competence for transformation;41929;50;GO:0048285
GO:0030422;siRNA processing;4959;24;GO:0006364
GO:0030421;defecation;389;86;GO:0007586
GO:0030424;axon;75425;9750;GO:0043005
GO:0042426;choline catabolic process;1089;144;GO:0006559
GO:0042427;serotonin biosynthetic process;6048;36;GO:0006749
GO:0042428;serotonin metabolic process;6377;1670;GO:0006575
GO:0042429;serotonin catabolic process;3;7;GO:0006575
GO:0005484;SNAP receptor activity;41845;1850;GO:0005096
GO:0005483;soluble NSF attachment protein activity;379;89;GO:0008083
GO:0042420;dopamine catabolic process;364;565;GO:0006511
GO:0042421;norepinephrine biosynthetic process;1003;102;GO:0006767
GO:0005488;binding;197826249;38500;GO:0005488
GO:0042422;norepinephrine catabolic process;0;4;GO:0006559
GO:0042423;catecholamine biosynthetic process;7596;615;GO:0006022
GO:0042424;catecholamine catabolic process;544;72;GO:0006567
GO:0042425;choline biosynthetic process;6;8;GO:0006541
GO:0030414;peptidase inhibitor activity;345116;4730;GO:0004867
GO:0030417;nicotianamine metabolic process;3600;9;GO:0006790
GO:0030416;methylamine metabolic process;8485;7;GO:0006541
GO:0030419;nicotianamine catabolic process;0;2;GO:0006559
GO:0030418;nicotianamine biosynthetic process;3600;258;GO:0006790
GO:0030411;scytalone dehydratase activity;1136;9;GO:0006067
GO:0030410;nicotianamine synthase activity;3739;45;GO:0004497
GO:0030413;competence pheromone activity;3;2;GO:0009814
GO:0030412;formimidoyltetrahydrofolate cyclodeaminase activity;2643;8;GO:0004497
GO:0042437;indoleacetic acid catabolic process;0;2;GO:0009065
GO:0042438;melanin biosynthetic process;13108;957;GO:0006073
GO:0042439;ethanolamine-containing compound metabolic process;34260;119;GO:0006553
GO:0042430;indole-containing compound metabolic process;1633356;692;GO:0006749
GO:0042431;indole metabolic process;5;5;GO:0006749
GO:0005452;solute:inorganic anion antiporter activity;32395;137;GO:0005215
GO:0042432;indole biosynthetic process;0;4;GO:0009061
GO:0042433;indole catabolic process;0;2;GO:0009065
GO:0005457;GDP-fucose transmembrane transporter activity;443;28;GO:0005576
GO:0042435;indole-containing compound biosynthetic process;1213730;392;GO:1901363
GO:0005456;CMP-N-acetylneuraminate transmembrane transporter activity;62;7;GO:0005525
GO:0042436;indole-containing compound catabolic process;176915;1570;GO:0046274
GO:0030408;glycine formimidoyltransferase activity;0;3;GO:0004497
GO:0030409;glutamate formimidoyltransferase activity;5800;8;GO:0004866
GO:0042448;progesterone metabolic process;689;600;GO:0006955
GO:0005460;UDP-glucose transmembrane transporter activity;515;10;GO:0005529
GO:0005462;UDP-N-acetylglucosamine transmembrane transporter activity;219;31;GO:0005529
GO:0042440;pigment metabolic process;1132262;1060;GO:0006725
GO:0005461;UDP-glucuronic acid transmembrane transporter activity;74;7;GO:0005543
GO:0042441;eye pigment metabolic process;738;22;GO:0009065
GO:0005464;UDP-xylose transmembrane transporter activity;364;8;GO:0005576
GO:0042442;melatonin catabolic process;0;3;GO:0046148
GO:0005463;UDP-N-acetylgalactosamine transmembrane transporter activity;99;5;GO:0005576
GO:0042443;phenylethylamine metabolic process;6;4;GO:0009065
GO:0042444;phenylethylamine biosynthetic process;0;2;GO:0009065
GO:0042445;hormone metabolic process;191422;2420;GO:0042446
GO:0042446;hormone biosynthetic process;155775;886;GO:0009755
GO:0042447;hormone catabolic process;747;800;GO:0006520
GO:0005459;UDP-galactose transmembrane transporter activity;767;158;GO:0005529
GO:0005458;GDP-mannose transmembrane transporter activity;184;3;GO:0008528
GO:0042450;arginine biosynthetic process via ornithine;88965;839;GO:0006569
GO:0030466;silent mating-type cassette heterochromatin formation;914;97;GO:0000786
GO:0030451;regulation of complement activation, alternative pathway;120;30;GO:0006958
GO:0030450;regulation of complement activation, classical pathway;237;29;GO:0006958
GO:0005497;androgen binding;216;148;GO:0005515
GO:0005496;steroid binding;40961;2140;GO:0042641
GO:0005499;vitamin D binding;1887;106;GO:0097367
GO:0030448;hyphal growth;152;73;GO:0030430
GO:0030447;filamentous growth;4333;795;GO:0048308
GO:0030449;regulation of complement activation;7337;2000;GO:0006956
GO:0030446;hyphal cell wall;105;31;GO:0031224
GO:0030445;yeast-form cell wall;87;13;GO:0031532
GO:0042404;thyroid hormone catabolic process;15;22;GO:0006518
GO:0042405;nuclear inclusion body;1133;429;GO:0005768
GO:0042406;extrinsic component of endoplasmic reticulum membrane;127;99;GO:0005783
GO:0042407;cristae formation;6369;810;GO:0005743
GO:0042409;caffeoyl-CoA O-methyltransferase activity;822;49;GO:0004725
GO:0042400;ectoine catabolic process;11;6;GO:0046274
GO:0042401;biogenic amine biosynthetic process;1600013;339;GO:0006560
GO:0042402;cellular biogenic amine catabolic process;45055;1170;GO:0006569
GO:0042403;thyroid hormone metabolic process;3980;706;GO:0006790
GO:0030437;ascospore formation;2062;843;GO:0048305
GO:0030436;asexual sporulation;28431;419;GO:0000976
GO:0030431;sleep;11440;1610;GO:0007631
GO:0030430;host cell cytoplasm;2570377;353;GO:0005737
GO:0030433;ubiquitin-dependent ERAD pathway;37628;1720;GO:0006486
GO:0030432;peristalsis;501;490;GO:0007599
GO:0030435;sporulation resulting in formation of a cellular spore;119771;827;GO:0048304
GO:0030392;fructosamine catabolic process;61;5;GO:0006066
GO:0030391;fructosamine biosynthetic process;0;2;GO:0006066
GO:0030394;fructoseglycine metabolic process;0;4;GO:0006094
GO:0030393;fructoselysine metabolic process;2;4;GO:0006066
GO:0042374;phylloquinone metabolic process;10893;21;GO:0006767
GO:0042376;phylloquinone catabolic process;43;57;GO:0009062
GO:0042377;vitamin K catabolic process;71;83;GO:0006559
GO:0042379;chemokine receptor binding;28659;2420;GO:0005125
GO:0042380;hydroxymethylbutenyl pyrophosphate reductase activity;1;3;GO:0004067
GO:0042381;hemolymph coagulation;185;31;GO:0007596
GO:0042382;paraspeckles;811;548;GO:0005829
GO:0042383;sarcolemma;25331;3230;GO:0005737
GO:0030386;ferredoxin-thioredoxin reductase complex;0;4;GO:0005737
GO:0030389;fructosamine metabolic process;119;10;GO:0006066
GO:0030388;fructose 1,6-bisphosphate metabolic process;11265;469;GO:0006096
GO:0030381;chorion-containing eggshell pattern formation;103;32;GO:0048706
GO:0030380;interleukin-17E receptor binding;2;6;GO:0005125
GO:0030382;sperm mitochondrion organization;328;45;GO:0005739
GO:0042385;myosin III complex;1;2;GO:0048608
GO:0042386;hemocyte differentiation;796;17;GO:0002576
GO:0042387;plasmatocyte differentiation;122;6;GO:0002504
GO:0042388;gibberellic acid mediated signaling pathway, G-alpha-dependent;0;3;GO:0009734
GO:0042389;omega-3 fatty acid desaturase activity;316;9;GO:0008610
GO:0042390;gibberellic acid mediated signaling pathway, G-alpha-independent;0;3;GO:0009734
GO:0042391;regulation of membrane potential;153250;3450;GO:0048407
GO:0042392;sphingosine-1-phosphate phosphatase activity;821;36;GO:0004722
GO:0042393;histone binding;98941;3740;GO:0003682
GO:0042395;ecdysis, collagen and cuticulin-based cuticle;81;6;GO:0008544
GO:0030374;nuclear receptor coactivator activity;10513;375;GO:0003712
GO:0030373;high molecular weight B cell growth factor receptor activity;0;1;GO:0048193
GO:0030378;serine racemase activity;370;8;GO:0006030
GO:0030377;urokinase plasminogen activator receptor activity;3;8;GO:0004896
GO:0030379;neurotensin receptor activity, non-G protein-coupled;53;6;GO:0004930
GO:0030370;intercellular adhesion molecule-3 receptor binding;0;1;GO:0048407
GO:0030372;high molecular weight B cell growth factor receptor binding;0;2;GO:0048193
GO:0030371;translation repressor activity;8463;515;GO:0003735
GO:0042396;phosphagen biosynthetic process;24306;10;GO:0006096
GO:0042397;phosphagen catabolic process;0;6;GO:0006544
GO:0042398;cellular modified amino acid biosynthetic process;1656980;710;GO:0006520
GO:0042399;ectoine metabolic process;36074;4;GO:0006099
GO:0030367;interleukin-17 receptor binding;0;1;GO:0005125
GO:0030366;molybdopterin synthase activity;22386;37;GO:0004721
GO:0030369;ICAM-3 receptor activity;60;43;GO:0002429
GO:0030368;interleukin-17 receptor activity;6395;62;GO:0005125
GO:0030352;inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity;2;6;GO:0004722
GO:0030351;inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity;3;6;GO:0004721
GO:0030354;melanin-concentrating hormone activity;817;7;GO:0004930
GO:0030353;fibroblast growth factor receptor antagonist activity;0;3;GO:0048405
GO:0042338;cuticle development involved in collagen and cuticulin-based cuticle molting cycle;136;6;GO:0009913
GO:0042339;keratan sulfate metabolic process;366;339;GO:0006030
GO:0042330;taxis;984525;2730;GO:0007626
GO:0042331;phototaxis;248;33;GO:0007600
GO:0042332;gravitaxis;245;10;GO:0007623
GO:0042333;chemotaxis to oxidizable substrate;1;5;GO:0006935
GO:0042334;taxis to electron acceptor;0;2;GO:0009729
GO:0140719;constitutive heterochromatin formation;7555;3;GO:0000786
GO:0042335;cuticle development;2907;854;GO:0009913
GO:0042337;cuticle development involved in chitin-based cuticle molting cycle;340;2;GO:0009913
GO:0140715;serine-tRNA ligase complex;24;0;GO:0006418
GO:0140717;entry into host through the stromata;0;0;GO:0048305
GO:0140718;facultative heterochromatin formation;9558;3;GO:0016570
GO:0140711;positive regulation of Frizzled Nuclear Import pathway;0;0;GO:0048193
GO:0140712;negative regulation of Frizzled Nuclear Import pathway;0;0;GO:0048193
GO:0140713;histone chaperone activity;5395;95;GO:0008029
GO:0042340;keratan sulfate catabolic process;9;702;GO:0006032
GO:0140714;large ribosomal subunit pre-assembly complex;0;2;GO:0022627
GO:0140710;regulation of Frizzled Nuclear Import pathway;0;0;GO:0048704
GO:0042349;guiding stereospecific synthesis activity;10;5;GO:0006099
GO:0042341;cyanogenic glycoside metabolic process;8;9;GO:0006032
GO:0042342;cyanogenic glycoside catabolic process;0;3;GO:0009813
GO:0042343;indole glucosinolate metabolic process;70;52;GO:0006749
GO:0042344;indole glucosinolate catabolic process;15;8;GO:0009835
GO:0140708;CAT tailing;138;3;GO:0005576
GO:0140709;Frizzled Nuclear Import pathway;0;1;GO:0008030
GO:0140704;3',2'-cyclic GMP-AMP binding;13;1;GO:0005524
GO:0140706;protein-containing complex localization to centriolar satellite;108;4;GO:0005576
GO:0140707;chromatin-nuclear membrane anchor activity;5;1;GO:0005576
GO:0140700;3',2'-cyclic GMP-AMP synthase activity;21;2;GO:0004061
GO:0140701;3',3'-cyclic GMP-AMP synthase activity;605;0;GO:0004061
GO:0042350;GDP-L-fucose biosynthetic process;82675;10;GO:0006022
GO:0140702;cyclic GMP-AMP binding;462;0;GO:0043531
GO:0042351;'de novo' GDP-L-fucose biosynthetic process;35737;161;GO:0006022
GO:0140703;3',3'-cyclic GMP-AMP binding;0;1;GO:0005524
GO:0042352;GDP-L-fucose salvage;196;5;GO:0009063
GO:0042353;fucose biosynthetic process;35;7;GO:0006032
GO:0042354;L-fucose metabolic process;7328;1010;GO:0006032
GO:0042355;L-fucose catabolic process;5685;1130;GO:0006032
GO:0042356;GDP-4-dehydro-D-rhamnose reductase activity;9;5;GO:0006022
GO:0042357;thiamine diphosphate metabolic process;235046;164;GO:0006749
GO:0042358;thiamine diphosphate catabolic process;0;1;GO:0006559
GO:0042359;vitamin D metabolic process;1465;425;GO:0006767
GO:0140737;encapsulin nanocompartment;4469;71;GO:0005576
GO:0140738;NLRP6 inflammasome complex;185;3;GO:0009986
GO:0140739;NLRP6 inflammasome complex assembly;73;1;GO:1903047
GO:0140733;tRNA ligase activator activity;0;1;GO:0004812
GO:0042360;vitamin E metabolic process;583;26;GO:0006749
GO:0140734;ammonium excretion;0;1;GO:0046395
GO:0042361;menaquinone catabolic process;37;14;GO:0009065
GO:0140735;lovastatin biosynthetic process;12;0;GO:0006631
GO:0042362;fat-soluble vitamin biosynthetic process;12406;976;GO:0006749
GO:0140736;positive regulation of lovastatin biosynthetic process;0;0;GO:0046356
GO:0140730;amphiregulin production;0;0;GO:0048608
GO:0140731;regulation of amphiregulin production;0;0;GO:0010468
GO:0140732;positive regulation of amphiregulin production;0;0;GO:0048608
GO:0042363;fat-soluble vitamin catabolic process;547;9;GO:0009062
GO:0042364;water-soluble vitamin biosynthetic process;4197686;2280;GO:0006779
GO:0042365;water-soluble vitamin catabolic process;45077;4;GO:0009062
GO:0042366;cobalamin catabolic process;2;4;GO:0009065
GO:0042367;biotin catabolic process;0;2;GO:0009062
GO:0042368;vitamin D biosynthetic process;898;145;GO:0006767
GO:0042369;vitamin D catabolic process;235;30;GO:0007568
GO:0140727;siRNA-dependent pericentric heterochromatin formation;25;4;GO:0048285
GO:0140728;GC-box binding;0;0;GO:0003700
GO:0140729;self-resistance to endogenously produced metabolite;3;3;GO:0046686
GO:0042370;thiamine diphosphate dephosphorylation;0;1;GO:0006468
GO:0140722;mycophenolic acid biosynthetic process;21;0;GO:0046395
GO:0042371;vitamin K biosynthetic process;11022;9;GO:0009065
GO:0140723;patulin biosynthetic process;29;0;GO:0046274
GO:0042372;phylloquinone biosynthetic process;10850;45;GO:0006767
GO:0140724;positive regulation of patulin biosynthetic process;2;0;GO:0046405
GO:0042373;vitamin K metabolic process;13766;53;GO:0006779
GO:0140725;detoxification of free heme;0;2;GO:0006865
GO:0030395;lactose binding;128;10;GO:0042330
GO:0030398;peroxisomal membrane disassembly;0;3;GO:0006626
GO:0140720;subtelomeric heterochromatin;8;4;GO:0000786
GO:0030397;membrane disassembly;404;1380;GO:0042592
GO:0140721;nuclease inhibitor activity;17422;2;GO:0004812
GO:0030399;autophagosome membrane disassembly;0;2;GO:0006914
GO:0140759;histone H3K56 methyltransferase activity;101;2;GO:0016569
GO:0140755;reorganization of host cellular membranes to establish sites of replication;0;0;GO:0048193
GO:0140756;structural constituent of proteasome;0;2;GO:0022626
GO:0140757;cysteine-type deNEDDylase activity;12;2;GO:0004867
GO:0140758;metal-dependent deNEDDylase activity;13;2;GO:0004867
GO:0140751;histone octamer slider activity;191;4;GO:0003682
GO:0140752;branched 1,3-beta-D-glucan synthase activity;1;1;GO:0005976
GO:0140753;linear 1,3-beta-D-glucan synthase activity;0;1;GO:0004553
GO:0140754;reorganization of cellular membranes to establish viral sites of replication;57;2;GO:0016021
GO:0140750;nucleosome array spacer activity;24;1;GO:0003682
GO:0140748;positive regulation of regulation of ascospore wall (1->3)-beta-D-glucan biosynthetic process;8;0;GO:0046395
GO:0140749;phlorizin hydrolase activity;62;2;GO:0004553
GO:0140744;negative regulation of lncRNA transcription;142;4;GO:0045944
GO:0140745;siRNA transcription;65;3;GO:0006351
GO:0140746;siRNA catabolic process;0;0;GO:0016071
GO:0140747;regulation of ncRNA transcription;5495;0;GO:0006351
GO:0140740;ADP-riboxanase activity;184;2;GO:0008037
GO:0140741;tRNA U4 sulfurtransferase;21617;7;GO:0008544
GO:0140742;lncRNA transcription;142;1;GO:0006351
GO:0140743;regulation of lncRNA transcription;142;0;GO:0045944
GO:0140777;protein-containing complex stabilizing activity;4;2;GO:0003700
GO:0140778;microtubule stabilizing activity;3;1;GO:0003777
GO:0140779;XCL1 production;0;1;GO:0046649
GO:0140773;NAD-dependent protein demyristoylase activity;128;4;GO:0004866
GO:0140774;NAD-dependent protein depalmitoylase activity;126;3;GO:0005525
GO:0140775;actin filament debranching activity;4;2;GO:0003700
GO:0140776;protein-containing complex destabilizing activity;7985;1;GO:0004842
GO:0140770;CoA-dependent peptidyl-lysine N6-myristoyltransferase activity;0;2;GO:0004812
GO:0140771;ACP-dependent peptidyl-lysine N6-palmitoyltransferase activity;3;1;GO:0004721
GO:0140772;CoA-dependent peptidyl-lysine N6-palmitoyltransferase activity;1;1;GO:0004812
GO:0140766;siRNA-mediated post-transcriptional gene silencing;137;0;GO:0016570
GO:0140767;enzyme-substrate adaptor activity;4218;5;GO:0004842
GO:0140768;protein ADP-ribosyltransferase-substrate adaptor activity;237;5;GO:0004842
GO:0140769;ACP-dependent peptidyl-lysine N6-myristoyltransferase activity;3;2;GO:0004812
GO:0140762;glucose dehydrogenase (FAD, quinone) activity;17;2;GO:0006066
GO:0140763;programmed DNA elimination by elimination of internal DNA segments;0;0;GO:0006281
GO:0140764;small RNA binding translational repressor activity;0;1;GO:0003723
GO:0140765;NAD-dependent histone H3K56 deacetylase activity;77;0;GO:0016569
GO:0140760;histone H3K56me2/H3K56me3 demethylase activity;12;0;GO:0016569
GO:0140761;calmodulin-activated 3',5'-cyclic-AMP phosphodiesterase activity;0;1;GO:0004721
GO:0150129;positive regulation of interleukin-33 production;61;42;GO:0048452
GO:0150127;regulation of interleukin-33 production;71;1;GO:0046330
GO:0150128;negative regulation of interleukin-33 production;10;0;GO:0048193
GO:0140799;glycine:proton antiporter activity;64;2;GO:0005215
GO:0140795;histone H3R2 arginine deiminase activity;49;1;GO:0004721
GO:0140796;histone H3R8 arginine deiminase activity;49;1;GO:0048305
GO:0140797;histone H3R17 arginine deiminase activity;49;1;GO:0004721
GO:0140798;histone H3R26 arginine deiminase activity;106;2;GO:0004721
GO:0140791;histone H2AXS140 phosphatase activity;0;0;GO:0004725
GO:0140793;histone H2AXY142 phosphatase activity;179;4;GO:0005524
GO:0140794;histone arginine deiminase activity;324;2;GO:0004721
GO:0150138;negative regulation of interleukin-37 production;1;0;GO:0046330
GO:0150139;positive regulation of interleukin-37 production;0;0;GO:0046330
GO:0150136;regulation of interleukin-37 production;1;0;GO:0046330
GO:0150137;interleukin-37 production;1;0;GO:0046649
GO:0140788;L-glutamate uniporter activity;230;1;GO:0048169
GO:0140789;histone phosphatase activity;179;0;GO:0004721
GO:0150140;regulation of CD86 production;28;0;GO:0048608
GO:0140784;metal ion sensor activity;323;0;GO:0003700
GO:0140785;amino acid sensor activity;39;0;GO:0006468
GO:0140786;glutamine sensor activity;1;1;GO:0004930
GO:0140787;phosphate ion uniporter activity;81;2;GO:0008026
GO:0140781;ilicicolin H biosynthetic process;10;0;GO:0046271
GO:0140782;novofumigatonin biosynthetic process;13;1;GO:1901363
GO:0140783;(M)-viriditoxin biosynthetic process;6;0;GO:0046395
GO:0150107;positive regulation of protein localization to cell-cell junction;48;3;GO:0048471
GO:0150105;protein localization to cell-cell junction;1209;10;GO:0005911
GO:0150106;regulation of protein localization to cell-cell junction;175;3;GO:0030155
GO:0150103;reactive gliosis;319;10;GO:0070942
GO:0150104;transport across blood-brain barrier;935;45;GO:0015671
GO:0150101;regulation of microtubule anchoring at centrosome;58;4;GO:0048471
GO:0150102;negative regulation of monocyte activation;141;8;GO:0050729
GO:0150118;negative regulation of cell-substrate junction organization;738;5;GO:0048010
GO:0150119;negative regulation of protein localization to cell-cell junction;7;1;GO:0048193
GO:0150116;regulation of cell-substrate junction organization;3080;6;GO:0030198
GO:0150117;positive regulation of cell-substrate junction organization;1358;7;GO:0048010
GO:0150111;regulation of transepithelial transport;202;30;GO:0009986
GO:0150115;cell-substrate junction organization;5356;36;GO:0030198
GO:0140597;protein carrier chaperone;68495;6;GO:0006457
GO:0140598;lipoprotein carrier activity;0;0;GO:0005576
GO:0140599;mitotic nuclear bridge midzone membrane domain;24;4;GO:0005576
GO:0140593;host apoplast;5;1;GO:0009570
GO:0140594;xyloglucan-specific endo-beta-1,4-glucanase inhibitor activity;0;0;GO:0004553
GO:0140595;MIM complex;8;0;GO:0005829
GO:0140596;TOM complex;0;1;GO:0005737
GO:0140590;effector-mediated suppression of host defense response;24;0;GO:0045087
GO:0140591;nuclear envelope budding;121;2;GO:0005789
GO:0140592;histone H3R8 methyltransferase activity;4;1;GO:0016570
GO:0140586;promoter-terminator loop anchoring activity;4;0;GO:0003700
GO:0140587;chromatin loop anchoring activity;156;2;GO:0003700
GO:0140588;chromatin looping;257;10;GO:0006325
GO:0140582;adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway;67;3;GO:0007186
GO:0140584;chromatin extrusion motor activity;0;1;GO:0005524
GO:0140585;promoter-enhancer loop anchoring activity;133;4;GO:0003700
GO:0019715;peptidyl-aspartic acid hydroxylation to form L-erythro-beta-hydroxyaspartic acid;0;2;GO:0006457
GO:0019716;N-terminal peptidyl-alanine monomethylation;0;3;GO:0006469
GO:0019720;Mo-molybdopterin cofactor metabolic process;665509;50;GO:0006096
GO:0019722;calcium-mediated signaling;56543;2750;GO:0009968
GO:0019724;B cell mediated immunity;15475;2320;GO:0002449
GO:0019704;peptidyl-L-cysteine S-myristoylation;0;1;GO:0006469
GO:0019703;coenzyme A-peptidyl-cysteine covalent linking;0;2;GO:0006457
GO:0019706;protein-cysteine S-palmitoyltransferase activity;67148;530;GO:0004722
GO:0019705;protein-cysteine S-myristoyltransferase activity;83;4;GO:0004725
GO:0019708;peptidyl-glycine cholesteryl ester biosynthesis from peptidyl-glycine;0;5;GO:0006631
GO:0019707;protein-cysteine S-acyltransferase activity;67603;10;GO:0004364
GO:0019709;iron incorporation into iron-sulfur cluster via pentakis-L-cysteinyl L-histidino nickel tetrairon pentasulfide;0;6;GO:0009086
GO:0019711;peptidyl-beta-carboxyaspartic acid biosynthetic process from peptidyl-aspartic acid;0;2;GO:0009065
GO:0019700;organic phosphonate catabolic process;30128;30;GO:0009061
GO:0019702;protein arginine N5-methyltransferase activity;49;3;GO:0004812
GO:0019701;peptidyl-arginine N5-methylation;0;3;GO:0016567
GO:0019759;glycosinolate catabolic process;194;8;GO:0009062
GO:0044715;8-oxo-dGDP phosphatase activity;295;30;GO:0004723
GO:0019758;glycosinolate biosynthetic process;256;160;GO:0009813
GO:0044717;8-hydroxy-dADP phosphatase activity;58;6;GO:0004723
GO:0044716;8-oxo-GDP phosphatase activity;127;8;GO:0005524
GO:0044719;regulation of imaginal disc-derived wing size;202;8;GO:0048608
GO:0044718;siderophore transmembrane transport;145723;8;GO:0008544
GO:0005112;Notch binding;5538;754;GO:0005665
GO:0005111;type 2 fibroblast growth factor receptor binding;278;34;GO:0048407
GO:0005114;type II transforming growth factor beta receptor binding;788;281;GO:0048407
GO:0005113;patched binding;701;383;GO:0048405
GO:0005115;receptor tyrosine kinase-like orphan receptor binding;60;8;GO:0048193
GO:0032726;positive regulation of hepatocyte growth factor production;0;4;GO:0048608
GO:0032727;positive regulation of interferon-alpha production;1369;1740;GO:0032727
GO:0005109;frizzled binding;2171;1250;GO:0008076
GO:0032724;positive regulation of fractalkine production;36;10;GO:0048608
GO:0032725;positive regulation of granulocyte macrophage colony-stimulating factor production;602;574;GO:0046649
GO:0019760;glucosinolate metabolic process;643;171;GO:0006073
GO:0032728;positive regulation of interferon-beta production;2318;1600;GO:0032727
GO:0032729;positive regulation of type II interferon production;3749;189;GO:0032724
GO:0019762;glucosinolate catabolic process;194;49;GO:0009813
GO:0019761;glucosinolate biosynthetic process;256;436;GO:0009813
GO:0017101;aminoacyl-tRNA synthetase multienzyme complex;8632;577;GO:0005737
GO:0017102;methionyl glutamyl tRNA synthetase complex;390;67;GO:0005737
GO:0019763;immunoglobulin receptor activity;782;103;GO:0004872
GO:0017103;UTP:galactose-1-phosphate uridylyltransferase activity;214;21;GO:0006073
GO:0019766;IgA receptor activity;1;5;GO:0002729
GO:0032722;positive regulation of chemokine production;4049;1130;GO:0050921
GO:0032723;positive regulation of connective tissue growth factor production;6;5;GO:0048608
GO:0017105;acyl-CoA delta11-(Z)-desaturase activity;14;0;GO:0006631
GO:0019768;high-affinity IgE receptor activity;41;2;GO:0004974
GO:0032720;negative regulation of tumor necrosis factor production;3008;1550;GO:0032727
GO:0019767;IgE receptor activity;646;30;GO:0004872
GO:0032721;negative regulation of lymphotoxin A production;0;1;GO:0048010
GO:0019748;secondary metabolic process;339176;3400;GO:0019748
GO:0044726;epigenetic programing of female pronucleus;100;2;GO:0045944
GO:0019747;regulation of isoprenoid metabolic process;1402;149;GO:0006725
GO:0044725;epigenetic programming in the zygotic pronuclei;531;1;GO:0045944
GO:0019749;cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte;18;6;GO:0006936
GO:0044727;epigenetic programing of male pronucleus;170;4;GO:0045944
GO:0044729;hemi-methylated DNA-binding;258;50;GO:0003677
GO:0005121;Toll binding;179;62;GO:0005543
GO:0005123;death receptor binding;523;597;GO:0048608
GO:0044720;negative regulation of imaginal disc-derived wing size;24;8;GO:0048608
GO:0005122;torso binding;20;5;GO:0005576
GO:0005125;cytokine activity;112690;11400;GO:0002237
GO:0044722;renal phosphate excretion;113;3;GO:0006874
GO:0005124;scavenger receptor binding;98;108;GO:0005506
GO:0044721;protein import into peroxisome matrix, substrate release;136;1;GO:0006626
GO:0005127;ciliary neurotrophic factor receptor binding;1362;103;GO:0004872
GO:0005126;cytokine receptor binding;93134;3300;GO:0005125
GO:0005118;sevenless binding;398;16;GO:0005525
GO:0032715;negative regulation of interleukin-6 production;2316;1450;GO:0050727
GO:0005117;wishful thinking binding;0;0;GO:0003700
GO:0032716;negative regulation of interleukin-7 production;2;2;GO:0050727
GO:0032713;negative regulation of interleukin-4 production;368;242;GO:0050729
GO:0005119;smoothened binding;318;126;GO:0005523
GO:0032714;negative regulation of interleukin-5 production;255;332;GO:0050729
GO:0032719;negative regulation of TRAIL production;0;2;GO:0046330
GO:0032717;negative regulation of interleukin-8 production;689;309;GO:0050727
GO:0032718;negative regulation of interleukin-9 production;0;2;GO:0050729
GO:0019751;polyol metabolic process;385302;820;GO:0006066
GO:0019750;chloroplast localization;1449;10;GO:0009536
GO:0019752;carboxylic acid metabolic process;33595725;6560;GO:0006082
GO:0019755;one-carbon compound transport;44045;520;GO:0006865
GO:0032711;negative regulation of interleukin-27 production;1;3;GO:0048405
GO:0032712;negative regulation of interleukin-3 production;42;7;GO:0050727
GO:0019757;glycosinolate metabolic process;643;70;GO:0006073
GO:0019756;cyanogenic glycoside biosynthetic process;8;4;GO:0006021
GO:0032710;negative regulation of interleukin-26 production;0;3;GO:0050727
GO:0044737;modulation of acid-sensing ion channel in another organism;0;0;GO:0008092
GO:0019736;peptidyl-sarcosine incorporation;0;3;GO:0006468
GO:0044736;acid-sensing ion channel activity;159;29;GO:0004930
GO:0044739;positive regulation of acid-sensing ion channel in another organism;0;0;GO:0048169
GO:0044738;negative regulation of acid-sensing ion channel in another organism;0;0;GO:0048169
GO:0044731;Ost-alpha/Ost-beta complex;0;0;GO:0005737
GO:0044730;bone sialoprotein binding;2;5;GO:0005581
GO:0044733;envenomation resulting in modulation of acid-sensing ion channel activity in another organism;0;0;GO:0008092
GO:0044732;mitotic spindle pole body;1937;190;GO:0000910
GO:0044735;envenomation resulting in negative regulation of acid-sensing ion channel activity in another organism;0;0;GO:0008092
GO:0044734;envenomation resulting in positive regulation of acid-sensing ion channel activity in another organism;0;0;GO:0002218
GO:0032704;negative regulation of interleukin-20 production;0;1;GO:0046330
GO:0032705;negative regulation of interleukin-21 production;5;52;GO:0050727
GO:0032702;negative regulation of interleukin-19 production;0;2;GO:0046649
GO:0032703;negative regulation of interleukin-2 production;2200;500;GO:0045087
GO:0032708;negative regulation of interleukin-24 production;0;1;GO:0048608
GO:0032709;negative regulation of interleukin-25 production;0;1;GO:0046649
GO:0032706;negative regulation of interleukin-22 production;0;1;GO:0050727
GO:0032707;negative regulation of interleukin-23 production;92;130;GO:0050729
GO:0019740;nitrogen utilization;94776;338;GO:0009064
GO:0033714;secondary-alcohol oxidase activity;0;3;GO:0004497
GO:0033719;2-oxo-acid reductase activity;3;3;GO:0004091
GO:0033718;pyranose dehydrogenase (acceptor) activity;107;2;GO:0004073
GO:0033713;choline:oxygen 1-oxidoreductase activity;151;3;GO:0004089
GO:0033712;1,5-anhydro-D-fructose reductase (1,5-anhydro-D-mannitol-forming) activity;2379;3;GO:0006032
GO:0033711;4-phosphoerythronate dehydrogenase activity;17091;10;GO:0006096
GO:0021728;inferior reticular formation development;0;2;GO:0048704
GO:0021729;superior reticular formation development;0;2;GO:0048704
GO:0008771;[citrate (pro-3S)-lyase] ligase activity;9083;0;GO:0005524
GO:0021724;inferior raphe nucleus development;0;2;GO:0048704
GO:0008770;[acyl-carrier-protein] phosphodiesterase activity;10259;25;GO:0003954
GO:0021725;superior raphe nucleus development;0;2;GO:0048704
GO:0021726;lateral reticular nucleus development;0;2;GO:0048704
GO:0021727;intermediate reticular formation development;0;1;GO:0048704
GO:0006112;energy reserve metabolic process;469008;1290;GO:0006091
GO:0008775;acetate CoA-transferase activity;33703;182;GO:0004497
GO:0021720;superior olivary nucleus formation;0;1;GO:0048704
GO:0006113;fermentation;12633;756;GO:0000228
GO:0008774;acetaldehyde dehydrogenase (acetylating) activity;46822;27;GO:0004089
GO:0021721;superior olivary nucleus structural organization;0;1;GO:0043005
GO:0006110;regulation of glycolytic process;2603;444;GO:0010467
GO:0008773;[protein-PII] uridylyltransferase activity;87971;37;GO:0004734
GO:0021722;superior olivary nucleus maturation;92;27;GO:0048704
GO:0006111;regulation of gluconeogenesis;7353;635;GO:0032787
GO:0008772;[isocitrate dehydrogenase (NADP+)] kinase activity;20810;0;GO:0004721
GO:0021723;medullary reticular formation development;49;7;GO:0048704
GO:0006116;NADH oxidation;33595;252;GO:0046395
GO:0008779;acyl-[acyl-carrier-protein]-phospholipid O-acyltransferase activity;4986;0;GO:0008610
GO:0006117;acetaldehyde metabolic process;107;28;GO:0006066
GO:0006114;glycerol biosynthetic process;401;233;GO:0006091
GO:0008777;acetylornithine deacetylase activity;14996;20;GO:0004041
GO:0006115;ethanol biosynthetic process;4;3;GO:0006066
GO:0008776;acetate kinase activity;81802;9;GO:0004721
GO:0006109;regulation of carbohydrate metabolic process;78379;1060;GO:0005975
GO:0033705;GDP-4-dehydro-6-deoxy-D-mannose reductase activity;357;3;GO:0006066
GO:0006107;oxaloacetate metabolic process;18621;1090;GO:0006066
GO:0033704;3beta-hydroxy-5alpha-steroid dehydrogenase activity;0;3;GO:0004089
GO:0006108;malate metabolic process;58171;2010;GO:0006096
GO:0033703;3beta-hydroxy-5beta-steroid dehydrogenase activity;6;3;GO:0004089
GO:0033709;D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity;2;0;GO:0006066
GO:0033708;isocitrate-homoisocitrate dehydrogenase activity;10;2;GO:0004067
GO:0033707;3''-deamino-3''-oxonicotianamine reductase activity;35;0;GO:0004067
GO:0033702;(+)-trans-carveol dehydrogenase activity;177;3;GO:0004073
GO:0033701;dTDP-galactose 6-dehydrogenase activity;0;3;GO:0006022
GO:0033700;phospholipid efflux;899;1700;GO:0006869
GO:0070607;regulation of cell wall (1->3)-alpha-glucan metabolic process;62;1;GO:0005976
GO:0070608;regulation of cell wall (1->3)-alpha-glucan biosynthetic process;62;1;GO:0005976
GO:0045649;regulation of macrophage differentiation;1017;57;GO:0045595
GO:0070605;regulation of (1->3)-alpha-glucan metabolic process;62;0;GO:0005976
GO:0070606;regulation of (1->3)-alpha-glucan biosynthetic process;62;0;GO:0010467
GO:0006042;glucosamine biosynthetic process;5;3;GO:0006030
GO:0033661;effector-mediated defense to host-produced reactive oxygen species;1;1;GO:0009627
GO:0006043;glucosamine catabolic process;158;244;GO:0006073
GO:0033660;suppression by symbiont of host resistance gene-dependent defense response;0;0;GO:0046274
GO:0006040;amino sugar metabolic process;420030;1790;GO:0005975
GO:0070609;regulation of fungal-type cell wall (1->3)-alpha-glucan metabolic process;62;1;GO:0005976
GO:0006041;glucosamine metabolic process;176;300;GO:0006073
GO:0006046;N-acetylglucosamine catabolic process;196;56;GO:0006032
GO:0021676;rhombomere 8 structural organization;0;2;GO:0048704
GO:0045643;regulation of eosinophil differentiation;54;7;GO:0045595
GO:0006047;UDP-N-acetylglucosamine metabolic process;88878;753;GO:0006032
GO:0021677;rhombomere 8 formation;0;2;GO:0048704
GO:0045644;negative regulation of eosinophil differentiation;0;2;GO:0045595
GO:0006044;N-acetylglucosamine metabolic process;76450;730;GO:0006032
GO:0021678;third ventricle development;247;166;GO:0007565
GO:0045641;negative regulation of basophil differentiation;0;2;GO:0050729
GO:0006045;N-acetylglucosamine biosynthetic process;25;25;GO:0006032
GO:0021679;cerebellar molecular layer development;110;8;GO:0048704
GO:0045642;positive regulation of basophil differentiation;0;2;GO:0050729
GO:0021672;rhombomere 7 structural organization;0;2;GO:0048704
GO:0045647;negative regulation of erythrocyte differentiation;569;1960;GO:0045595
GO:0021673;rhombomere 7 formation;0;2;GO:0048704
GO:0045648;positive regulation of erythrocyte differentiation;1504;1040;GO:0050877
GO:0006048;UDP-N-acetylglucosamine biosynthetic process;81694;967;GO:0006032
GO:0021674;rhombomere 8 morphogenesis;0;1;GO:0048704
GO:0045645;positive regulation of eosinophil differentiation;54;10;GO:0050729
GO:0006049;UDP-N-acetylglucosamine catabolic process;25;8;GO:0006032
GO:0021675;nerve development;8708;645;GO:0007517
GO:0045646;regulation of erythrocyte differentiation;2889;1110;GO:0050877
GO:0021680;cerebellar Purkinje cell layer development;1771;1140;GO:0048667
GO:0021681;cerebellar granular layer development;717;25;GO:0048667
GO:0021682;nerve maturation;220;10;GO:0007517
GO:0033659;symbiont-mediated disruption of host mitochondrion;0;0;GO:0044429
GO:0018031;peptidyl-lysine N6-palmitoyltransferase activity;8;1;GO:0004867
GO:0045650;negative regulation of macrophage differentiation;286;338;GO:0045595
GO:0018030;peptidyl-lysine N6-myristoyltransferase activity;128;5;GO:0004812
GO:0045651;positive regulation of macrophage differentiation;683;971;GO:0045595
GO:0018032;protein amidation;0;10;GO:0006464
GO:0033654;host cell chloroplast thylakoid membrane;0;1;GO:0009579
GO:0033653;host cell chloroplast part;0;2;GO:0044436
GO:0070600;fungal-type cell wall (1->3)-alpha-glucan biosynthetic process;87;1;GO:0005976
GO:0033652;host cell chloroplast;2;2;GO:0009579
GO:0033651;host cell plastid;2;1;GO:0009536
GO:0033658;symbiont-mediated disruption of host chloroplast thylakoid;0;0;GO:0046274
GO:0070603;SWI/SNF superfamily-type complex;92081;281;GO:0005524
GO:0033656;symbiont-mediated disruption of host chloroplast;0;0;GO:0046274
GO:0070601;centromeric sister chromatid cohesion;1582;53;GO:0007030
GO:0033655;host cell cytoplasm part;1341169;205;GO:0044464
GO:0070602;regulation of centromeric sister chromatid cohesion;345;53;GO:0007070
GO:0006050;mannosamine metabolic process;16516;10;GO:0006032
GO:0006053;N-acetylmannosamine catabolic process;13;3;GO:0006032
GO:0021669;rhombomere 6 formation;0;1;GO:0048704
GO:0033650;host cell mitochondrion;178840;15;GO:0005739
GO:0006054;N-acetylneuraminate metabolic process;28492;375;GO:0006022
GO:0006051;N-acetylmannosamine metabolic process;16516;37;GO:0006032
GO:0006052;N-acetylmannosamine biosynthetic process;0;2;GO:0006032
GO:0006057;mannoprotein biosynthetic process;363;4;GO:0006032
GO:0021665;rhombomere 5 structural organization;54;4;GO:0048704
GO:0045654;positive regulation of megakaryocyte differentiation;597;375;GO:0045595
GO:0006058;mannoprotein catabolic process;4;4;GO:0046274
GO:0021666;rhombomere 5 formation;48;7;GO:0048704
GO:0045655;regulation of monocyte differentiation;894;283;GO:0045595
GO:0006055;CMP-N-acetylneuraminate biosynthetic process;2;2;GO:0006022
GO:0021667;rhombomere 6 morphogenesis;2;2;GO:0048704
GO:0045652;regulation of megakaryocyte differentiation;1153;895;GO:0045595
GO:0006056;mannoprotein metabolic process;367;3;GO:0006032
GO:0021668;rhombomere 6 structural organization;0;1;GO:0048704
GO:0045653;negative regulation of megakaryocyte differentiation;261;338;GO:0045595
GO:0021661;rhombomere 4 morphogenesis;46;5;GO:0048704
GO:0045658;regulation of neutrophil differentiation;400;10;GO:0045595
GO:0021662;rhombomere 4 structural organization;0;1;GO:0048704
GO:0045659;negative regulation of neutrophil differentiation;154;81;GO:0045595
GO:0006059;hexitol metabolic process;22458;30;GO:0006096
GO:0021663;rhombomere 4 formation;1;1;GO:0048704
GO:0045656;negative regulation of monocyte differentiation;394;283;GO:0045595
GO:0021664;rhombomere 5 morphogenesis;104;6;GO:0048704
GO:0045657;positive regulation of monocyte differentiation;439;302;GO:0045595
GO:0021670;lateral ventricle development;668;491;GO:0007417
GO:0021671;rhombomere 7 morphogenesis;0;2;GO:0048704
GO:0033648;host intracellular membrane-bounded organelle;3386310;89;GO:0005737
GO:0018020;peptidyl-glutamic acid methylation;0;4;GO:0016567
GO:0045661;regulation of myoblast differentiation;2955;435;GO:0045595
GO:0045662;negative regulation of myoblast differentiation;1269;735;GO:0045595
GO:0018022;peptidyl-lysine methylation;1776;1060;GO:0016567
GO:0018021;peptidyl-histidine methylation;25;8;GO:0016567
GO:0045660;positive regulation of neutrophil differentiation;71;7;GO:0045595
GO:0033643;host cell part;7701507;469;GO:0044464
GO:0018023;peptidyl-lysine trimethylation;52;1110;GO:0016567
GO:0018026;peptidyl-lysine monomethylation;51;329;GO:0016567
GO:0018025;calmodulin-lysine N-methyltransferase activity;3200;6;GO:0004725
GO:0018028;peptidyl-lysine myristoylation;0;3;GO:0006469
GO:0033647;host intracellular organelle;3405831;8;GO:0005737
GO:0018027;peptidyl-lysine dimethylation;698;790;GO:0016567
GO:0033646;host intracellular part;5017785;147;GO:0044424
GO:0033645;host cell endomembrane system;221473;6;GO:0005789
GO:0018029;peptidyl-lysine palmitoylation;0;3;GO:0006464
GO:0033644;host cell membrane;3079385;385;GO:0016021
GO:0070629;(1->4)-alpha-glucan metabolic process;0;1;GO:0005975
GO:0018009;N-terminal peptidyl-L-cysteine N-palmitoylation;17;9;GO:0006483
GO:0043009;chordate embryonic development;61324;1780;GO:0009952
GO:0070628;proteasome binding;22648;714;GO:0004842
GO:0006020;inositol metabolic process;76272;838;GO:0006796
GO:0008683;2-oxoglutarate decarboxylase activity;1016;4;GO:0006099
GO:0021658;rhombomere 3 morphogenesis;155;8;GO:0048704
GO:0006021;inositol biosynthetic process;32517;545;GO:0006633
GO:0008682;3-demethoxyubiquinol 3-hydroxylase activity;13461;4;GO:0004091
GO:0021659;rhombomere 3 structural organization;53;4;GO:0048704
GO:0008681;2-octaprenyl-6-methoxyphenol hydroxylase activity;8223;14;GO:0004497
GO:0006024;glycosaminoglycan biosynthetic process;2232824;1020;GO:0005518
GO:0008687;3,4-dihydroxyphenylacetate 2,3-dioxygenase activity;4401;77;GO:0004497
GO:0021654;rhombomere boundary formation;79;8;GO:0048704
GO:0045665;negative regulation of neuron differentiation;4047;1920;GO:0048699
GO:0006025;galactosaminoglycan biosynthetic process;0;3;GO:0006030
GO:0008686;3,4-dihydroxy-2-butanone-4-phosphate synthase activity;149729;399;GO:0006099
GO:0021655;rhombomere 2 morphogenesis;0;2;GO:0048704
GO:0043001;Golgi to plasma membrane protein transport;5026;768;GO:0048193
GO:0045666;positive regulation of neuron differentiation;7984;2540;GO:0048667
GO:0006022;aminoglycan metabolic process;2764832;1620;GO:0006030
GO:0008685;2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity;127680;252;GO:0006096
GO:0021656;rhombomere 2 structural organization;0;2;GO:0048704
GO:0045663;positive regulation of myoblast differentiation;1230;748;GO:0045595
GO:0006023;aminoglycan biosynthetic process;2246494;302;GO:0006030
GO:0008684;2-oxopent-4-enoate hydratase activity;2805;7;GO:0004497
GO:0021657;rhombomere 2 formation;0;2;GO:0048704
GO:0045664;regulation of neuron differentiation;15527;2340;GO:0048699
GO:0006028;galactosaminoglycan catabolic process;0;3;GO:0006073
GO:0021650;vestibulocochlear nerve formation;166;67;GO:0048704
GO:0045669;positive regulation of osteoblast differentiation;3350;2010;GO:0045944
GO:0006029;proteoglycan metabolic process;36089;724;GO:0006041
GO:0021651;rhombomere 1 morphogenesis;0;2;GO:0048704
GO:0043005;neuron projection;196150;8980;GO:0043005
GO:0006026;aminoglycan catabolic process;242335;863;GO:0006073
GO:0008689;3-demethylubiquinone-9 3-O-methyltransferase activity;14682;8;GO:0004497
GO:0021652;rhombomere 1 formation;0;2;GO:0048704
GO:0043008;ATP-dependent protein binding;282;152;GO:0005524
GO:0045667;regulation of osteoblast differentiation;7009;1090;GO:0045944
GO:0006027;glycosaminoglycan catabolic process;200275;967;GO:0006073
GO:0008688;3-(3-hydroxyphenyl)propionate hydroxylase activity;4184;0;GO:0004497
GO:0021653;rhombomere 1 structural organization;0;2;GO:0048704
GO:0043007;maintenance of rDNA;468;27;GO:0045944
GO:0045668;negative regulation of osteoblast differentiation;2441;1110;GO:0045944
GO:0006019;deoxyribose 5-phosphate phosphorylation;0;4;GO:0006457
GO:0033638;modulation by symbiont of host heat acclimation;1;0;GO:0046365
GO:0021660;rhombomere 3 formation;48;7;GO:0048704
GO:0045672;positive regulation of osteoclast differentiation;1500;1110;GO:0045595
GO:0018011;N-terminal peptidyl-alanine methylation;1;8;GO:0006469
GO:0043011;myeloid dendritic cell differentiation;1131;1470;GO:0045580
GO:0045670;regulation of osteoclast differentiation;3852;797;GO:0045595
GO:0043010;camera-type eye development;37688;2010;GO:0007600
GO:0045671;negative regulation of osteoclast differentiation;1490;1200;GO:0045595
GO:0018013;N-terminal peptidyl-glycine methylation;9;13;GO:0008544
GO:0033632;regulation of cell-cell adhesion mediated by integrin;539;221;GO:0007156
GO:0070621;EGFR-Shc-Grb2-Sos complex;0;1;GO:0048193
GO:0018012;N-terminal peptidyl-alanine trimethylation;1;7;GO:0006477
GO:0033631;cell-cell adhesion mediated by integrin;901;288;GO:0007155
GO:0070622;UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex;50;2;GO:0005764
GO:0018015;N-terminal peptidyl-phenylalanine methylation;0;3;GO:0016567
GO:0033630;positive regulation of cell adhesion mediated by integrin;1003;411;GO:0048010
GO:0018014;N-terminal peptidyl-methionine methylation;0;3;GO:0016567
GO:0070620;EGFR-Grb2-Sos complex;0;1;GO:0048193
GO:0070625;zymogen granule exocytosis;6;4;GO:0006953
GO:0018016;N-terminal peptidyl-proline dimethylation;12;14;GO:0043405
GO:0033635;modulation by symbiont of host response to abiotic stimulus;1;3;GO:0010033
GO:0070626;(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity;67093;0;GO:0006066
GO:0018019;N-terminal peptidyl-glutamine methylation;0;4;GO:0046395
GO:0033634;positive regulation of cell-cell adhesion mediated by integrin;204;585;GO:0007156
GO:0070623;regulation of thiamine biosynthetic process;23;1;GO:0046395
GO:0033633;negative regulation of cell-cell adhesion mediated by integrin;102;7;GO:0022610
GO:0070624;negative regulation of thiamine biosynthetic process;0;2;GO:0046395
GO:0008690;3-deoxy-manno-octulosonate cytidylyltransferase activity;79187;196;GO:0006022
GO:0070618;Grb2-Sos complex;4;5;GO:0005515
GO:0070619;Shc-Grb2-Sos complex;0;1;GO:0005515
GO:0070616;regulation of thiamine diphosphate biosynthetic process;0;2;GO:0046395
GO:0070617;negative regulation of thiamine diphosphate biosynthetic process;0;2;GO:0046395
GO:0006031;chitin biosynthetic process;13400;64;GO:0006030
GO:0008694;3-octaprenyl-4-hydroxybenzoate carboxy-lyase activity;17054;6;GO:0006021
GO:0021647;vestibulocochlear nerve maturation;58;4;GO:0008544
GO:0006032;chitin catabolic process;42060;2250;GO:0006032
GO:0008693;(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity;21401;0;GO:0006081
GO:0021648;vestibulocochlear nerve morphogenesis;236;3;GO:0048704
GO:0008692;3-hydroxybutyryl-CoA epimerase activity;22664;10;GO:0006081
GO:0021649;vestibulocochlear nerve structural organization;70;28;GO:0048666
GO:0006030;chitin metabolic process;55589;1840;GO:0006032
GO:0008691;3-hydroxybutyryl-CoA dehydrogenase activity;13668;5;GO:0004089
GO:0055001;muscle cell development;16887;1540;GO:0007517
GO:0006035;cuticle chitin biosynthetic process;116;7;GO:0006030
GO:0021643;vagus nerve maturation;0;2;GO:0007517
GO:0043013;negative regulation of fusion of sperm to egg plasma membrane;0;2;GO:0048193
GO:0045676;regulation of R7 cell differentiation;238;29;GO:0045595
GO:0006036;cuticle chitin catabolic process;0;5;GO:0006032
GO:0008697;4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase activity;29231;10;GO:0006032
GO:0021644;vagus nerve morphogenesis;77;88;GO:0048704
GO:0043012;regulation of fusion of sperm to egg plasma membrane;1;9;GO:0006986
GO:0045677;negative regulation of R7 cell differentiation;105;7;GO:0045595
GO:0006033;chitin localization;4;7;GO:0005976
GO:0008696;4-amino-4-deoxychorismate lyase activity;12267;71;GO:0006099
GO:0021645;vagus nerve structural organization;0;2;GO:0008092
GO:0043015;gamma-tubulin binding;25106;1030;GO:0005524
GO:0006034;cuticle chitin metabolic process;127;2;GO:0006030
GO:0008695;3-phenylpropionate dioxygenase activity;2486;5;GO:0004497
GO:0021646;vagus nerve formation;0;2;GO:0008544
GO:0043014;alpha-tubulin binding;10588;995;GO:0005524
GO:0006039;cell wall chitin catabolic process;16;5;GO:0006032
GO:0021640;trochlear nerve maturation;0;2;GO:0008544
GO:0006037;cell wall chitin metabolic process;571;17;GO:0006032
GO:0021641;trochlear nerve structural organization;0;2;GO:0048704
GO:0045678;positive regulation of R7 cell differentiation;25;10;GO:0045595
GO:0006038;cell wall chitin biosynthetic process;438;8;GO:0006073
GO:0021642;trochlear nerve formation;44;6;GO:0048704
GO:0045679;regulation of R8 cell differentiation;14;1;GO:0045595
GO:0033629;negative regulation of cell adhesion mediated by integrin;489;398;GO:0022610
GO:0033628;regulation of cell adhesion mediated by integrin;2360;520;GO:0007156
GO:0045680;negative regulation of R8 cell differentiation;14;3;GO:0045595
GO:0033627;cell adhesion mediated by integrin;4458;2220;GO:0007155
GO:0033626;positive regulation of integrin activation by cell surface receptor linked signal transduction;60;4;GO:0048010
GO:0043020;NADPH oxidase complex;2744;415;GO:0005739
GO:0045683;negative regulation of epidermis development;720;10;GO:0048608
GO:0045684;positive regulation of epidermis development;1437;296;GO:0048608
GO:0018000;N-terminal peptidyl-tyrosine acetylation;0;3;GO:0006469
GO:0043022;ribosome binding;386186;3790;GO:0005840
GO:0045681;positive regulation of R8 cell differentiation;0;2;GO:0045595
GO:0043021;ribonucleoprotein complex binding;406325;1370;GO:0003735
GO:0045682;regulation of epidermis development;3522;374;GO:0060429
GO:0018002;N-terminal peptidyl-glutamic acid acetylation;21;270;GO:0006469
GO:0033621;nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts;197;10;GO:0006470
GO:0070610;regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process;62;0;GO:0005976
GO:0018001;N-terminal peptidyl-valine acetylation;0;3;GO:0006469
GO:0033620;Mei2 nuclear dot complex;232;7;GO:0048285
GO:0070611;histone H3R2 methyltransferase activity;168;0;GO:0016568
GO:0018004;N-terminal protein formylation;0;5;GO:0006464
GO:0018003;peptidyl-lysine N6-acetylation;7;7;GO:0009065
GO:0018006;N-terminal protein amino acid glucuronylation;0;4;GO:0006469
GO:0033625;positive regulation of integrin activation;419;202;GO:0048010
GO:0070614;tungstate ion transport;4;2;GO:0006836
GO:0018005;N-terminal peptidyl-glycine N-formylation;0;3;GO:0006469
GO:0033624;negative regulation of integrin activation;188;121;GO:0048010
GO:0018008;N-terminal peptidyl-glycine N-myristoylation;12;29;GO:0006469
GO:0033623;regulation of integrin activation;767;790;GO:0048010
GO:0070612;histone H2AR3 methyltransferase activity;60;1;GO:0016570
GO:0018007;N-terminal peptidyl-glycine N-glucuronylation;0;1;GO:0006469
GO:0033622;integrin activation;1445;273;GO:0002576
GO:0070613;regulation of protein processing;3759;1130;GO:0010467
GO:0006082;organic acid metabolic process;34258307;7210;GO:0006082
GO:0045607;regulation of inner ear auditory receptor cell differentiation;427;2;GO:0050877
GO:0006083;acetate metabolic process;69188;200;GO:0006066
GO:0045608;negative regulation of inner ear auditory receptor cell differentiation;189;51;GO:0048704
GO:0006080;substituted mannan metabolic process;11937;14;GO:0006029
GO:0045605;negative regulation of epidermal cell differentiation;720;704;GO:0046332
GO:0006081;cellular aldehyde metabolic process;865190;1700;GO:0006066
GO:0045606;positive regulation of epidermal cell differentiation;1329;443;GO:0046317
GO:0006086;acetyl-CoA biosynthetic process from pyruvate;79665;1080;GO:0006099
GO:0031042;O-glycan processing, core 6;0;3;GO:0008544
GO:0031043;O-glycan processing, core 7;0;3;GO:0008021
GO:0006084;acetyl-CoA metabolic process;272818;2320;GO:0006082
GO:0031040;micronucleus;0;1;GO:0007067
GO:0045609;positive regulation of inner ear auditory receptor cell differentiation;82;3;GO:0050877
GO:0006085;acetyl-CoA biosynthetic process;161173;690;GO:0006094
GO:0031041;O-glycan processing, core 5;0;3;GO:0008544
GO:0045600;positive regulation of fat cell differentiation;3057;1200;GO:0045595
GO:0006089;lactate metabolic process;65532;1610;GO:0006096
GO:0045603;positive regulation of endothelial cell differentiation;557;633;GO:0050731
GO:0045604;regulation of epidermal cell differentiation;3194;646;GO:0045595
GO:0045601;regulation of endothelial cell differentiation;1811;355;GO:0050731
GO:0045602;negative regulation of endothelial cell differentiation;423;348;GO:0050727
GO:0018071;NAD(P)-cysteine ADP-ribosyltransferase activity;0;0;GO:0004867
GO:0018070;peptidyl-serine phosphopantetheinylation;0;4;GO:0006486
GO:0018072;peptidyl-L-glutamyl 5-glycerylphosphorylethanolamine biosynthetic process from peptidyl-glutamic acid;0;4;GO:0006066
GO:0018076;N-terminal peptidyl-lysine acetylation;48;410;GO:0006464
GO:0031035;myosin filament disassembly;112;3;GO:0006936
GO:0033698;Rpd3L complex;229;10;GO:0048285
GO:0031036;myosin II filament assembly;79;6;GO:0005524
GO:0031033;myosin filament organization;697;50;GO:0030198
GO:0033696;heterochromatin boundary formation;251;7;GO:0007030
GO:0031034;myosin filament assembly;441;199;GO:0005524
GO:0033695;oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor;1748;10;GO:0004497
GO:0031039;macronucleus;3;4;GO:0005730
GO:0031037;myosin II filament disassembly;112;7;GO:0005524
GO:0031038;myosin II filament organization;330;9;GO:0030155
GO:0033699;DNA 5'-adenosine monophosphate hydrolase activity;907;2;GO:0004518
GO:0033690;positive regulation of osteoblast proliferation;733;628;GO:0045944
GO:0045618;positive regulation of keratinocyte differentiation;839;639;GO:0046317
GO:0006094;gluconeogenesis;739627;7830;GO:0006094
GO:0045619;regulation of lymphocyte differentiation;13077;789;GO:0045595
GO:0006091;generation of precursor metabolites and energy;25882711;8580;GO:0006091
GO:0045616;regulation of keratinocyte differentiation;1861;1210;GO:0045595
GO:0045617;negative regulation of keratinocyte differentiation;381;61;GO:0046332
GO:0006097;glyoxylate cycle;139586;796;GO:0006099
GO:0031031;positive regulation of septation initiation signaling;139;5;GO:0048285
GO:0033694;oxidoreductase activity, acting on the CH-NH group of donors, iron-sulfur protein as acceptor;0;2;GO:0004497
GO:0006098;pentose-phosphate shunt;496316;4470;GO:0006091
GO:0031032;actomyosin structure organization;23377;3110;GO:0003779
GO:0033693;neurofilament bundle assembly;145;281;GO:0048704
GO:0006096;glycolytic process;2297927;7780;GO:0006096
GO:0031030;negative regulation of septation initiation signaling;203;8;GO:0048285
GO:0033691;sialic acid binding;725;306;GO:0008328
GO:0045610;regulation of hemocyte differentiation;369;235;GO:0045595
GO:0045611;negative regulation of hemocyte differentiation;235;52;GO:0045595
GO:0006099;tricarboxylic acid cycle;1310484;7040;GO:0006099
GO:0045614;negative regulation of plasmatocyte differentiation;34;3;GO:0048405
GO:0045615;positive regulation of plasmatocyte differentiation;13;3;GO:0048405
GO:0045612;positive regulation of hemocyte differentiation;120;2;GO:0045595
GO:0045613;regulation of plasmatocyte differentiation;47;3;GO:0048405
GO:0018060;N-terminal peptidyl-cysteine deamination;0;3;GO:0006483
GO:0018062;peptidyl-tryptophan succinylation;0;4;GO:0006464
GO:0018061;peptidyl-L-3-phenyllactic acid biosynthetic process from peptidyl-phenylalanine;0;3;GO:0009065
GO:0018064;protein-L-histidine N-tele-methyltransferase activity;3612;4;GO:0004723
GO:0018063;cytochrome c-heme linkage;9;22;GO:0005576
GO:0018068;peptidyl-L-2',4',5'-topaquinone biosynthetic process from peptidyl-tyrosine;0;1;GO:0006021
GO:0031024;interphase microtubule organizing center assembly;32;3;GO:0000976
GO:0033687;osteoblast proliferation;2039;87;GO:0042127
GO:0018067;peptidyl-L-3',4'-dihydroxyphenylalanine biosynthetic process from peptidyl-tyrosine;0;2;GO:0009065
GO:0031025;equatorial microtubule organizing center disassembly;3;4;GO:0007049
GO:0033686;positive regulation of luteinizing hormone secretion;116;151;GO:0048608
GO:0031022;nuclear migration along microfilament;142;54;GO:0006928
GO:0033685;negative regulation of luteinizing hormone secretion;27;21;GO:0048608
GO:0018069;peptide cross-linking via 4'-(L-tryptophan)-L-tryptophyl quinone;0;0;GO:0009065
GO:0031023;microtubule organizing center organization;30373;1050;GO:0000226
GO:0033684;regulation of luteinizing hormone secretion;144;6;GO:0048608
GO:0031028;septation initiation signaling;409;5;GO:0007165
GO:0006090;pyruvate metabolic process;2779994;2840;GO:0006096
GO:0031029;regulation of septation initiation signaling;342;2;GO:0048285
GO:0031026;glutamate synthase complex;2;2;GO:0009536
GO:0033689;negative regulation of osteoblast proliferation;644;739;GO:0045944
GO:0031027;glutamate synthase complex (NADH);0;0;GO:0005746
GO:0033688;regulation of osteoblast proliferation;1485;215;GO:0045944
GO:0006060;sorbitol metabolic process;462;7;GO:0006096
GO:0045629;negative regulation of T-helper 2 cell differentiation;319;698;GO:0050729
GO:0006061;sorbitol biosynthetic process;5;6;GO:0006096
GO:0045627;positive regulation of T-helper 1 cell differentiation;247;106;GO:0046649
GO:0045628;regulation of T-helper 2 cell differentiation;518;1110;GO:0050729
GO:0006064;glucuronate catabolic process;29621;108;GO:0006073
GO:0031020;plastid mRNA editing complex;0;2;GO:0008033
GO:0006065;UDP-glucuronate biosynthetic process;44506;526;GO:0006022
GO:0031021;interphase microtubule organizing center;335;146;GO:0000904
GO:0006062;sorbitol catabolic process;393;9;GO:0006032
GO:0006063;uronic acid metabolic process;30211;989;GO:0006073
GO:0006068;ethanol catabolic process;288;426;GO:0006066
GO:0021698;cerebellar cortex structural organization;182;7;GO:0030529
GO:0045621;positive regulation of lymphocyte differentiation;6937;728;GO:0045595
GO:0006069;ethanol oxidation;17794;2440;GO:0006874
GO:0021699;cerebellar cortex maturation;149;9;GO:0048666
GO:0045622;regulation of T-helper cell differentiation;1950;363;GO:0045640
GO:0006066;alcohol metabolic process;1370528;4390;GO:0006066
GO:0006067;ethanol metabolic process;18235;1470;GO:0006066
GO:0045620;negative regulation of lymphocyte differentiation;2881;67;GO:0045595
GO:0021694;cerebellar Purkinje cell layer formation;867;29;GO:0048666
GO:0045625;regulation of T-helper 1 cell differentiation;363;725;GO:0045640
GO:0021695;cerebellar cortex development;3362;655;GO:0048666
GO:0045626;negative regulation of T-helper 1 cell differentiation;61;182;GO:0045660
GO:0021696;cerebellar cortex morphogenesis;2160;92;GO:0048666
GO:0045623;negative regulation of T-helper cell differentiation;1028;566;GO:0045595
GO:0021697;cerebellar cortex formation;1540;155;GO:0048666
GO:0045624;positive regulation of T-helper cell differentiation;699;240;GO:0045640
GO:0031019;mitochondrial mRNA editing complex;116;5;GO:0005743
GO:0018057;peptidyl-lysine oxidation;25;246;GO:0006479
GO:0031013;troponin I binding;321;242;GO:0005525
GO:0031014;troponin T binding;166;116;GO:0005525
GO:0033675;pericanalicular vesicle;0;2;GO:0009986
GO:0018059;N-terminal peptidyl-serine deamination;0;3;GO:0006486
GO:0031011;Ino80 complex;24678;1230;GO:0005524
GO:0033674;positive regulation of kinase activity;1329;1770;GO:0043406
GO:0018058;N-terminal protein amino acid deamination, from amino carbon;0;4;GO:0006479
GO:0031012;extracellular matrix;176879;16100;GO:0031012
GO:0033673;negative regulation of kinase activity;677;960;GO:0043406
GO:0031017;exocrine pancreas development;1066;586;GO:0007596
GO:0031018;endocrine pancreas development;5346;1970;GO:0007596
GO:0033679;3'-5' DNA/RNA helicase activity;1116;4;GO:0003676
GO:0033678;5'-3' DNA/RNA helicase activity;96;1;GO:0003676
GO:0031016;pancreas development;11735;1260;GO:0001837
GO:0033677;DNA/RNA helicase activity;1412;31;GO:0003676
GO:0006071;glycerol metabolic process;201355;3170;GO:0006066
GO:0006072;glycerol-3-phosphate metabolic process;292910;972;GO:0006066
GO:0045638;negative regulation of myeloid cell differentiation;4737;1210;GO:0045595
GO:0006070;octanol metabolic process;1;1;GO:0006725
GO:0045639;positive regulation of myeloid cell differentiation;6367;855;GO:0045595
GO:0006075;(1->3)-beta-D-glucan biosynthetic process;8315;4;GO:0006073
GO:0033672;positive regulation of NAD+ kinase activity;0;5;GO:0046356
GO:0006076;(1->3)-beta-D-glucan catabolic process;3;0;GO:0006073
GO:0031010;ISWI-type complex;13319;34;GO:0005524
GO:0033671;negative regulation of NAD+ kinase activity;0;5;GO:0046324
GO:0033670;regulation of NAD+ kinase activity;0;3;GO:0010468
GO:0006074;(1->3)-beta-D-glucan metabolic process;8353;1;GO:0006073
GO:0006079;(1->6)-beta-D-glucan catabolic process;0;1;GO:0006073
GO:0021687;cerebellar molecular layer morphogenesis;107;2;GO:0048704
GO:0045632;negative regulation of mechanoreceptor differentiation;279;7;GO:0048704
GO:0021688;cerebellar molecular layer formation;44;7;GO:0048666
GO:0045633;positive regulation of mechanoreceptor differentiation;126;5;GO:0048704
GO:0006077;(1->6)-beta-D-glucan metabolic process;1373;0;GO:0006073
GO:0021689;cerebellar molecular layer structural organization;0;2;GO:0030529
GO:0045630;positive regulation of T-helper 2 cell differentiation;199;249;GO:0050729
GO:0006078;(1->6)-beta-D-glucan biosynthetic process;1366;0;GO:0006073
GO:0045631;regulation of mechanoreceptor differentiation;563;78;GO:0048704
GO:0021683;cerebellar granular layer morphogenesis;569;10;GO:0048667
GO:0045636;positive regulation of melanocyte differentiation;240;422;GO:0046503
GO:0021684;cerebellar granular layer formation;473;95;GO:0048666
GO:0045637;regulation of myeloid cell differentiation;13870;1020;GO:0045595
GO:0021685;cerebellar granular layer structural organization;48;5;GO:0048667
GO:0045634;regulation of melanocyte differentiation;336;111;GO:0046148
GO:0021686;cerebellar granular layer maturation;47;6;GO:0048666
GO:0045635;negative regulation of melanocyte differentiation;0;3;GO:0046503
GO:0021690;cerebellar molecular layer maturation;0;2;GO:0048608
GO:0021691;cerebellar Purkinje cell layer maturation;102;56;GO:0048666
GO:0021692;cerebellar Purkinje cell layer morphogenesis;1109;10;GO:0048666
GO:0021693;cerebellar Purkinje cell layer structural organization;129;9;GO:0048667
GO:0031009;plastid ADPG pyrophosphorylase complex;0;2;GO:0009536
GO:0045640;regulation of basophil differentiation;0;2;GO:0050729
GO:0031002;actin rod;3;0;GO:0008092
GO:0031003;actin tubule;0;1;GO:0005930
GO:0031000;response to caffeine;605;1610;GO:0042330
GO:0031001;response to brefeldin A;4;4;GO:0009611
GO:0033668;symbiont-mediated suppression of host apoptosis;7;2;GO:0048706
GO:0031004;potassium ion-transporting ATPase complex;27;9;GO:0008047
GO:0031005;filamin binding;2173;519;GO:0005515
GO:0031082;BLOC complex;8907;254;GO:0005576
GO:0031083;BLOC-1 complex;7645;409;GO:0005840
GO:0031080;nuclear pore outer ring;10647;315;GO:0005829
GO:0055051;ATP-binding cassette (ABC) transporter complex, integrated substrate binding;0;10;GO:0005548
GO:0055052;ATP-binding cassette (ABC) transporter complex, substrate-binding subunit-containing;3328;1300;GO:0005553
GO:0031086;nuclear-transcribed mRNA catabolic process, deadenylation-independent decay;6463;118;GO:0010467
GO:0055053;mannose:proton symporter activity;0;0;GO:0008565
GO:0031087;deadenylation-independent decapping of nuclear-transcribed mRNA;6383;99;GO:0006414
GO:0055054;fructose:proton symporter activity;1;1;GO:0005215
GO:0031084;BLOC-2 complex;1048;10;GO:0005576
GO:0055055;D-glucose:proton symporter activity;5;1;GO:0005215
GO:0080011;baruol synthase activity;5;5;GO:0004497
GO:0031085;BLOC-3 complex;207;149;GO:0005840
GO:0055056;D-glucose transmembrane transporter activity;695;155;GO:0005215
GO:0080012;trihydroxyferuloyl spermidine O-methyltransferase activity;7;1;GO:0004725
GO:0043068;positive regulation of programmed cell death;39373;3100;GO:0010941
GO:0080013;(E,E)-geranyllinalool synthase activity;18;0;GO:0004497
GO:0043067;regulation of programmed cell death;204233;4800;GO:0010941
GO:0080014;thalianol hydroxylase activity;2;4;GO:0046395
GO:0080015;sabinene synthase activity;10;6;GO:0004497
GO:0043069;negative regulation of programmed cell death;83887;3380;GO:0010941
GO:0080016;(-)-E-beta-caryophyllene synthase activity;27;8;GO:0004497
GO:0080017;alpha-humulene synthase activity;18;7;GO:0004497
GO:0080018;anthocyanin 5-O-glucosyltransferase activity;5;0;GO:0005975
GO:0080019;alcohol-forming very long-chain fatty acyl-CoA reductase activity;24689;5;GO:0006066
GO:0070680;asparaginyl-tRNAAsn biosynthesis via transamidation;0;1;GO:0006414
GO:0043073;germ cell nucleus;4085;232;GO:0005634
GO:0070684;seminal clot liquefaction;12;2;GO:0007596
GO:0043077;initiation of acetate catabolic process;0;2;GO:0006099
GO:0070681;glutaminyl-tRNAGln biosynthesis via transamidation;7094;52;GO:0006464
GO:0043076;megasporocyte nucleus;155;4;GO:0005576
GO:0070682;proteasome regulatory particle assembly;6044;42;GO:0005840
GO:0055046;microgametogenesis;591;37;GO:0048304
GO:0070687;macropinocytic cup cytoskeleton;28;1;GO:0005929
GO:0055047;generative cell mitosis;59;7;GO:0000278
GO:0031077;post-embryonic camera-type eye development;294;97;GO:0007586
GO:0055048;anastral spindle assembly;54;140;GO:0007062
GO:0070685;macropinocytic cup;135;15;GO:0008021
GO:0031078;histone H3K14 deacetylase activity;944;5;GO:0016569
GO:0070686;macropinocytic cup membrane;3;2;GO:0008047
GO:0070689;L-threonine catabolic process to propionate;4103;8;GO:0009062
GO:0031071;cysteine desulfurase activity;210215;632;GO:0004705
GO:0055060;asymmetric neuroblast division resulting in ganglion mother cell formation;2;4;GO:0048608
GO:0031072;heat shock protein binding;117924;4590;GO:0005515
GO:0055062;phosphate ion homeostasis;47831;414;GO:0006874
GO:0031070;intronic snoRNA processing;77;4;GO:0006461
GO:0055063;sulfate ion homeostasis;8;3;GO:0006836
GO:0055064;chloride ion homeostasis;966;245;GO:0006811
GO:0080020;regulation of coenzyme A biosynthetic process;26;4;GO:0046394
GO:0031076;embryonic camera-type eye development;4766;693;GO:0008544
GO:0080021;response to benzoic acid;21;6;GO:0046148
GO:0031073;cholesterol 26-hydroxylase activity;91;6;GO:0004076
GO:0080022;primary root development;405;161;GO:0048316
GO:0031074;nucleocytoplasmic transport complex;803;5;GO:0005840
GO:0043079;antipodal cell nucleus;0;0;GO:0005634
GO:0080024;indolebutyric acid metabolic process;53;6;GO:0009065
GO:0043078;polar nucleus;62;3;GO:0005634
GO:0080025;phosphatidylinositol-3,5-bisphosphate binding;4039;652;GO:0097367
GO:0080026;response to indolebutyric acid;51;7;GO:0009410
GO:0080027;response to herbivore;158;58;GO:0009617
GO:0080028;nitrile biosynthetic process;99;274;GO:1901363
GO:0080029;cellular response to boron-containing substance levels;37;2;GO:0010033
GO:0043082;megagametophyte egg cell nucleus;0;1;GO:0005634
GO:0043084;penile erection;192;236;GO:0007596
GO:0043083;synaptic cleft;1521;510;GO:0005615
GO:0043086;negative regulation of catalytic activity;1806;4310;GO:0050789
GO:0070672;response to interleukin-15;2393;1220;GO:0046649
GO:0043085;positive regulation of catalytic activity;5004;4410;GO:0050789
GO:0070673;response to interleukin-18;962;54;GO:0071346
GO:0070670;response to interleukin-4;1785;530;GO:0050729
GO:0043087;regulation of GTPase activity;1231;3250;GO:0007264
GO:0070671;response to interleukin-12;633;185;GO:0071346
GO:0055057;neuroblast division;1330;109;GO:0048666
GO:0070676;intralumenal vesicle formation;493;39;GO:0008036
GO:0031069;hair follicle morphogenesis;1316;1510;GO:0048608
GO:0055058;symmetric neuroblast division;0;1;GO:0048608
GO:0070677;rRNA (cytosine-2'-O-)-methyltransferase activity;40796;0;GO:0003729
GO:0055059;asymmetric neuroblast division;899;586;GO:0048608
GO:0070674;hypoxanthine dehydrogenase activity;109;2;GO:0004073
GO:0070675;hypoxanthine oxidase activity;53;2;GO:0004725
GO:0070678;preprotein binding;17;5;GO:0019901
GO:0070679;inositol 1,4,5 trisphosphate binding;13395;135;GO:0005509
GO:0031060;regulation of histone methylation;1844;731;GO:0045944
GO:0055071;manganese ion homeostasis;31334;9;GO:0006879
GO:0031061;negative regulation of histone methylation;138;1200;GO:0045944
GO:0055074;calcium ion homeostasis;90078;2380;GO:0006873
GO:0031064;negative regulation of histone deacetylation;9;139;GO:0045944
GO:0055075;potassium ion homeostasis;6284;1340;GO:0006873
GO:0031065;positive regulation of histone deacetylation;318;1660;GO:0045944
GO:0031062;positive regulation of histone methylation;1451;412;GO:0045944
GO:0055077;gap junction hemi-channel activity;334;25;GO:0008021
GO:0031063;regulation of histone deacetylation;388;374;GO:0016569
GO:0055078;sodium ion homeostasis;2694;605;GO:0006836
GO:0055070;copper ion homeostasis;17102;692;GO:0006879
GO:0043093;FtsZ-dependent cytokinesis;183103;459;GO:0007067
GO:0018095;protein polyglutamylation;58;1470;GO:0006464
GO:0043095;regulation of GTP cyclohydrolase I activity;34;24;GO:0009067
GO:0018094;protein polyglycylation;87;100;GO:0006464
GO:0043094;cellular metabolic compound salvage;952449;683;GO:0006836
GO:0043097;pyrimidine nucleoside salvage;7;350;GO:0009063
GO:0018096;peptide cross-linking via S-(2-aminovinyl)-D-cysteine;0;0;GO:0009065
GO:0043096;purine nucleobase salvage;75582;95;GO:0009060
GO:0043099;pyrimidine deoxyribonucleoside salvage;1;3;GO:0009063
GO:0043098;purine deoxyribonucleoside salvage;3;3;GO:0009063
GO:0055068;cobalt ion homeostasis;10;2;GO:0006826
GO:0031055;chromatin remodeling at centromere;4244;1980;GO:0007030
GO:0031056;regulation of histone modification;7258;557;GO:0045944
GO:0043090;amino acid import;42;1670;GO:0009060
GO:0055082;intracellular chemical homeostasis;605740;8;GO:0042592
GO:0055085;transmembrane transport;47841925;26500;GO:0008565
GO:0031053;primary miRNA processing;3298;507;GO:0016071
GO:0055086;nucleobase-containing small molecule metabolic process;17780524;2500;GO:0006790
GO:0031054;pre-miRNA processing;7323;1890;GO:0007061
GO:0055087;Ski complex;5186;90;GO:0005840
GO:0055088;lipid homeostasis;21104;1920;GO:0006629
GO:0031052;programmed DNA elimination by chromosome breakage;0;1;GO:0000723
GO:0055089;fatty acid homeostasis;618;670;GO:0006631
GO:0080001;mucilage extrusion from seed coat;120;39;GO:0048771
GO:0080002;UDP-glucose:4-aminobenzoate acylglucosyltransferase activity;17;2;GO:0006022
GO:0080003;thalianol metabolic process;6;6;GO:0006749
GO:0080004;thalian-diol desaturase activity;2;2;GO:0008610
GO:0080005;photosystem stoichiometry adjustment;191;7;GO:0009416
GO:0080006;internode patterning;46;22;GO:0048608
GO:0080007;S-nitrosoglutathione reductase activity;25;3;GO:0004725
GO:0055080;monoatomic cation homeostasis;512362;9;GO:0006874
GO:0080008;Cul4-RING E3 ubiquitin ligase complex;10081;804;GO:0005829
GO:0055081;monoatomic anion homeostasis;1029;4;GO:0045730
GO:0080009;mRNA methylation;134587;354;GO:0003729
GO:0018082;peptidyl-(Z)-dehydrobutyrine biosynthetic process from peptidyl-threonine;0;0;GO:0009065
GO:0070690;L-threonine catabolic process to acetyl-CoA;0;2;GO:0006559
GO:0018081;peptide cross-linking via lanthionine or 3-methyl-lanthionine;0;4;GO:0008021
GO:0070691;P-TEFb complex;211;4;GO:0045944
GO:0018084;peptidyl-lactic acid biosynthetic process from peptidyl-serine;0;3;GO:0009061
GO:0018083;peptidyl-L-3-oxoalanine biosynthetic process from peptidyl-cysteine or peptidyl-serine;1;6;GO:0009065
GO:0070694;deoxyribonucleoside 5'-monophosphate N-glycosidase activity;1142;2;GO:0004553
GO:0018085;peptidyl-L-amino acid racemization;0;4;GO:0006412
GO:0070695;FHF complex;311;226;GO:0005819
GO:0070692;CTDK-1 complex;1345;4;GO:0005524
GO:0070693;P-TEFb-cap methyltransferase complex;72;3;GO:0048285
GO:0070698;type I activin receptor binding;104;24;GO:0008015
GO:0031047;regulatory ncRNA-mediated gene silencing;211970;131;GO:0010468
GO:0070699;type II activin receptor binding;96;358;GO:0008201
GO:0031044;O-glycan processing, core 8;0;3;GO:0008021
GO:0070696;transmembrane receptor protein serine/threonine kinase binding;1119;30;GO:0043169
GO:0031045;dense core granule;1570;254;GO:0005829
GO:0070697;activin receptor binding;390;20;GO:0005509
GO:0031048;regulatory ncRNA-mediated heterochromatin formation;6537;10;GO:0016570
GO:0031049;programmed DNA elimination;1;9;GO:0006281
GO:0070649;formin-nucleated actin cable assembly;402;22;GO:0008544
GO:0055010;ventricular cardiac muscle tissue morphogenesis;2654;1210;GO:0048608
GO:0055011;atrial cardiac muscle cell differentiation;245;89;GO:0042592
GO:0055012;ventricular cardiac muscle cell differentiation;834;185;GO:0043547
GO:0043024;ribosomal small subunit binding;3188;1040;GO:0003735
GO:0045687;positive regulation of glial cell differentiation;1624;189;GO:0048666
GO:0043023;ribosomal large subunit binding;79294;545;GO:0003735
GO:0045688;regulation of antipodal cell differentiation;0;2;GO:0048608
GO:0045685;regulation of glial cell differentiation;3150;502;GO:0048666
GO:0043025;neuronal cell body;33086;7390;GO:0005996
GO:0045686;negative regulation of glial cell differentiation;1141;98;GO:0048666
GO:0043028;cysteine-type endopeptidase regulator activity involved in apoptotic process;2391;114;GO:0046330
GO:0043027;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;1576;710;GO:0004866
GO:0045689;negative regulation of antipodal cell differentiation;0;2;GO:0048608
GO:0043029;T cell homeostasis;2431;1470;GO:0002821
GO:0045690;positive regulation of antipodal cell differentiation;0;4;GO:0048608
GO:0045691;regulation of embryo sac central cell differentiation;6;4;GO:0048704
GO:0043031;negative regulation of macrophage activation;2497;157;GO:0050729
GO:0045694;regulation of embryo sac egg cell differentiation;22;5;GO:0048704
GO:0043030;regulation of macrophage activation;4014;448;GO:0002684
GO:0045695;negative regulation of embryo sac egg cell differentiation;0;2;GO:0048704
GO:0070640;vitamin D3 metabolic process;717;30;GO:0006767
GO:0043033;isoamylase complex;134;9;GO:0005929
GO:0045692;negative regulation of embryo sac central cell differentiation;0;2;GO:0048704
GO:0043032;positive regulation of macrophage activation;1060;1190;GO:0050729
GO:0045693;positive regulation of embryo sac central cell differentiation;0;3;GO:0048608
GO:0055002;striated muscle cell development;7404;2010;GO:0048731
GO:0070643;vitamin D 25-hydroxylase activity;295;10;GO:0004073
GO:0055003;cardiac myofibril assembly;976;1610;GO:0007517
GO:0070644;vitamin D response element binding;204;167;GO:0030528
GO:0055004;atrial cardiac myofibril assembly;32;0;GO:0007517
GO:0070641;vitamin D4 metabolic process;0;2;GO:0006767
GO:0055005;ventricular cardiac myofibril assembly;175;337;GO:0006936
GO:0070642;vitamin D5 metabolic process;0;1;GO:0006767
GO:0055006;cardiac cell development;4278;1110;GO:0048513
GO:0070647;protein modification by small protein conjugation or removal;619736;1670;GO:0043687
GO:0055007;cardiac muscle cell differentiation;7267;1150;GO:0042692
GO:0070648;formin-nucleated actin cable;60;1;GO:0008544
GO:0055008;cardiac muscle tissue morphogenesis;3944;1630;GO:0048731
GO:0070645;Ubisch body;3;2;GO:0005576
GO:0055009;atrial cardiac muscle tissue morphogenesis;346;59;GO:0048608
GO:0070646;protein modification by small protein removal;2073;1160;GO:0016567
GO:0070638;pyridine nucleoside catabolic process;48;5;GO:0009065
GO:0070639;vitamin D2 metabolic process;0;2;GO:0006767
GO:0055020;positive regulation of cardiac muscle fiber development;68;87;GO:0048407
GO:0055021;regulation of cardiac muscle tissue growth;2117;144;GO:0048608
GO:0055022;negative regulation of cardiac muscle tissue growth;581;158;GO:0048407
GO:0055023;positive regulation of cardiac muscle tissue growth;1182;9;GO:0048407
GO:0043035;chromatin insulator sequence binding;554;91;GO:0016569
GO:0045698;negative regulation of synergid differentiation;0;2;GO:0048704
GO:0043034;costamere;656;858;GO:0005925
GO:0045699;positive regulation of synergid differentiation;0;3;GO:0048608
GO:0045696;positive regulation of embryo sac egg cell differentiation;0;4;GO:0048608
GO:0043036;starch grain;387;8;GO:0048471
GO:0045697;regulation of synergid differentiation;8;7;GO:0048608
GO:0043039;tRNA aminoacylation;3776429;2580;GO:0006418
GO:0043038;amino acid activation;3776654;1420;GO:0009065
GO:0043040;tRNA aminoacylation for nonribosomal peptide biosynthetic process;0;2;GO:0009061
GO:0043042;amino acid adenylylation by nonribosomal peptide synthase;18;4;GO:0009061
GO:0043041;amino acid activation for nonribosomal peptide biosynthetic process;225;8;GO:0009061
GO:0043043;peptide biosynthetic process;27134545;3110;GO:0006412
GO:0055013;cardiac muscle cell development;3963;992;GO:0048513
GO:0055014;atrial cardiac muscle cell development;165;196;GO:0048513
GO:0070633;transepithelial transport;2386;442;GO:0006817
GO:0055015;ventricular cardiac muscle cell development;627;645;GO:0048513
GO:0070630;(1->4)-alpha-glucan biosynthetic process;0;1;GO:0005976
GO:0055016;hypochord development;46;4;GO:0002041
GO:0070631;spindle pole body localization;54;29;GO:0000922
GO:0055017;cardiac muscle tissue growth;3752;64;GO:0048407
GO:0070636;nicotinic acid riboside hydrolase activity;13;3;GO:0006073
GO:0055018;regulation of cardiac muscle fiber development;103;7;GO:0048608
GO:0070637;pyridine nucleoside metabolic process;129;6;GO:0009065
GO:0055019;negative regulation of cardiac muscle fiber development;0;1;GO:0048405
GO:0070634;transepithelial ammonium transport;231;84;GO:0006826
GO:0070635;nicotinamide riboside hydrolase activity;23;3;GO:0046395
GO:0055034;Bolwig's organ development;88;3;GO:0009952
GO:0043045;post-fertilization epigenetic regulation of gene expression;764;7;GO:0010468
GO:0043048;dolichyl monophosphate biosynthetic process;165;7;GO:0006030
GO:0043047;single-stranded telomeric DNA binding;7987;207;GO:0003677
GO:0043049;otic placode formation;554;190;GO:0007530
GO:0043051;regulation of nematode pharyngeal pumping;323;1;GO:0048608
GO:0043050;nematode pharyngeal pumping;438;0;GO:0006936
GO:0043053;dauer entry;226;5;GO:0042493
GO:0070661;leukocyte proliferation;27007;964;GO:0042113
GO:0043052;thermotaxis;429;33;GO:0007623
GO:0070662;mast cell proliferation;642;104;GO:0042127
GO:0043055;maintenance of dauer;20;2;GO:0007517
GO:0043054;dauer exit;39;2;GO:0007548
GO:0070660;inner ear receptor cell differentiation involved in inner ear sensory epithelium regeneration;3;2;GO:0048704
GO:0055024;regulation of cardiac muscle tissue development;239;286;GO:0048608
GO:0070665;positive regulation of leukocyte proliferation;9679;623;GO:0050729
GO:0055025;positive regulation of cardiac muscle tissue development;101;58;GO:0048407
GO:0070666;regulation of mast cell proliferation;441;24;GO:0050729
GO:0031099;regeneration;16998;1860;GO:0048608
GO:0055026;negative regulation of cardiac muscle tissue development;102;25;GO:0048407
GO:0070663;regulation of leukocyte proliferation;18524;1160;GO:0050729
GO:0070664;negative regulation of leukocyte proliferation;5542;223;GO:0050729
GO:0055028;cortical microtubule;1141;33;GO:0008092
GO:0070669;response to interleukin-2;1996;94;GO:0006955
GO:0055029;nuclear DNA-directed RNA polymerase complex;162003;417;GO:0005634
GO:0070667;negative regulation of mast cell proliferation;160;8;GO:0050729
GO:0070668;positive regulation of mast cell proliferation;226;174;GO:0050729
GO:0031093;platelet alpha granule lumen;69;2610;GO:0005829
GO:0031094;platelet dense tubular network;282;147;GO:0043230
GO:0031091;platelet alpha granule;1024;2050;GO:0005829
GO:0055040;periplasmic flagellum;4427;8;GO:0043169
GO:0031092;platelet alpha granule membrane;171;809;GO:0030168
GO:0055041;cyclopentanol dehydrogenase activity;945;3;GO:0004067
GO:0031097;medial cortex;804;8;GO:0043005
GO:0055042;5-valerolactone hydrolase activity;0;1;GO:0006081
GO:0031098;stress-activated protein kinase signaling cascade;31518;1200;GO:0007242
GO:0055043;5-oxovalerate dehydrogenase activity;0;1;GO:0009065
GO:0031095;platelet dense tubular network membrane;126;71;GO:0030198
GO:0055044;symplast;10201;171;GO:0009579
GO:0031096;platelet dense tubular network lumen;0;1;GO:0005576
GO:0055045;antipodal cell degeneration;0;1;GO:0048706
GO:0043057;backward locomotion;118;4;GO:0040011
GO:0043056;forward locomotion;91;25;GO:0040011
GO:0043059;regulation of forward locomotion;54;9;GO:0040011
GO:0043058;regulation of backward locomotion;99;6;GO:0048608
GO:0031090;organelle membrane;9516989;4020;GO:0016020
GO:0043060;meiotic metaphase I homologous chromosome alignment;387;1;GO:0000922
GO:0043062;extracellular structure organization;52529;4310;GO:0043062
GO:0043061;meiotic metaphase II chromosome alignment;8;0;GO:0000922
GO:0070650;actin filament bundle distribution;95;5;GO:0050921
GO:0043063;intercellular bridge organization;1338;9;GO:0048471
GO:0070651;nonfunctional rRNA decay;1240;48;GO:0006364
GO:0043066;negative regulation of apoptotic process;80826;14600;GO:0042981
GO:0043065;positive regulation of apoptotic process;36697;7980;GO:0042981
GO:0055035;plastid thylakoid membrane;1051237;182;GO:0009536
GO:0070654;sensory epithelium regeneration;331;6;GO:0043161
GO:0055036;virion membrane;1309405;807;GO:0016021
GO:0070655;mechanosensory epithelium regeneration;120;1;GO:0048704
GO:0031088;platelet dense granule membrane;159;163;GO:0030168
GO:0055037;recycling endosome;60309;1900;GO:0007041
GO:0070652;HAUS complex;10484;172;GO:0048285
GO:0031089;platelet dense granule lumen;14;115;GO:0005829
GO:0055038;recycling endosome membrane;31809;1070;GO:0007041
GO:0070653;high-density lipoprotein particle receptor binding;191;164;GO:0004872
GO:0055039;trichocyst;8;3;GO:0005576
GO:0070658;neuromast hair cell differentiation involved in neuromast regeneration;43;3;GO:0048608
GO:0070659;inner ear sensory epithelium regeneration;3;1;GO:0048608
GO:0070656;mechanoreceptor differentiation involved in mechanosensory epithelium regeneration;46;3;GO:0048704
GO:0070657;neuromast regeneration;117;2;GO:0048608
GO:0019912;cyclin-dependent protein kinase activating kinase activity;113;249;GO:0005524
GO:0019915;lipid storage;24430;2080;GO:0006629
GO:0019914;cyclin-dependent protein kinase activating kinase regulator activity;1;1;GO:0005524
GO:0019917;peptidyl-D-alanine racemization via peptidyl-L-serine;0;2;GO:0006457
GO:0019916;peptidyl-D-alanine racemization, direct;0;3;GO:0006468
GO:0019919;peptidyl-arginine methylation, to asymmetrical-dimethyl arginine;35;102;GO:0016567
GO:0019918;peptidyl-arginine methylation, to symmetrical-dimethyl arginine;9;37;GO:0016567
GO:0150172;regulation of phosphatidylcholine metabolic process;480;9;GO:0045944
GO:0150173;positive regulation of phosphatidylcholine metabolic process;88;1;GO:0046394
GO:0019920;peptidyl-1-thioglycine biosynthetic process, internal;0;3;GO:0009065
GO:0019921;peptidyl-1-thioglycine biosynthetic process, carboxy-terminal;0;3;GO:0009065
GO:0019902;phosphatase binding;24231;2020;GO:0019901
GO:0019901;protein kinase binding;82582;16600;GO:0019901
GO:0019904;protein domain specific binding;139381;7580;GO:0019901
GO:0019903;protein phosphatase binding;19029;2860;GO:0019901
GO:0019905;syntaxin binding;14658;2520;GO:0008037
GO:0019908;nuclear cyclin-dependent protein kinase holoenzyme complex;2858;40;GO:0005634
GO:0019907;cyclin-dependent protein kinase activating kinase holoenzyme complex;183;494;GO:0005524
GO:0150176;positive regulation of phosphatidylethanolamine metabolic process;0;0;GO:0046394
GO:0019909;[pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity;36;0;GO:0005524
GO:0150177;negative regulation of phosphatidylethanolamine metabolic process;0;0;GO:0046394
GO:0150174;negative regulation of phosphatidylcholine metabolic process;78;1;GO:0046394
GO:0150175;regulation of phosphatidylethanolamine metabolic process;56;3;GO:0046394
GO:0150178;regulation of phosphatidylserine metabolic process;56;3;GO:0046395
GO:0150179;positive regulation of phosphatidylserine metabolic process;0;1;GO:0048193
GO:0150180;negative regulation of phosphatidylserine metabolic process;0;1;GO:0048193
GO:0019911;structural constituent of myelin sheath;3056;442;GO:0030425
GO:0019910;mitochondrial pyruvate dehydrogenase (lipoamide) phosphatase complex;0;2;GO:0005739
GO:0150143;regulation of CD80 production;28;0;GO:0048608
GO:0150144;negative regulation of CD80 production;1;0;GO:0048608
GO:0150141;negative regulation of CD86 production;1;0;GO:0048608
GO:0150142;positive regulation of CD86 production;27;1;GO:0048608
GO:0150147;cell-cell junction disassembly;183;0;GO:0030054
GO:0150145;positive regulation of CD80 production;27;1;GO:0048608
GO:0150146;cell junction disassembly;1216;162;GO:0030062
GO:0150151;regulation of interleukin-17A production;8;0;GO:0050729
GO:0019900;kinase binding;108615;5180;GO:0019901
GO:0150155;interleukin-34 production;2;0;GO:0046653
GO:0150152;negative regulation of interleukin-17A production;1;2;GO:0050729
GO:0150153;positive regulation of interleukin-17A production;7;5;GO:0050729
GO:0150158;positive regulation of interleukin-34 production;0;0;GO:0046330
GO:0150159;negative regulation of interleukin-34 production;2;1;GO:0048608
GO:0150157;regulation of interleukin-34 production;2;0;GO:0050729
GO:0019957;C-C chemokine binding;1808;514;GO:0048407
GO:0019956;chemokine binding;5937;801;GO:0042165
GO:0019959;interleukin-8 binding;318;203;GO:0005125
GO:0019958;C-X-C chemokine binding;459;149;GO:0042165
GO:0005310;dicarboxylic acid transmembrane transporter activity;22328;423;GO:0008565
GO:0005314;high-affinity L-glutamate transmembrane transporter activity;365;10;GO:0005215
GO:0005313;L-glutamate transmembrane transporter activity;1958;481;GO:0005215
GO:0032924;activin receptor signaling pathway;4797;684;GO:0007179
GO:0005304;L-valine transmembrane transporter activity;148;6;GO:0005215
GO:0032925;regulation of activin receptor signaling pathway;2305;98;GO:0030516
GO:0005307;choline:sodium symporter activity;133;7;GO:0005215
GO:0032922;circadian regulation of gene expression;10045;1880;GO:0048407
GO:0032923;organic phosphonate biosynthetic process;2311;3;GO:0006073
GO:0005309;creatine:sodium symporter activity;307;10;GO:0005215
GO:0032928;regulation of superoxide anion generation;769;309;GO:0046395
GO:0005308;creatine transmembrane transporter activity;456;22;GO:0005215
GO:0032929;negative regulation of superoxide anion generation;129;53;GO:0046395
GO:0032926;negative regulation of activin receptor signaling pathway;1694;293;GO:0030516
GO:0032927;positive regulation of activin receptor signaling pathway;384;346;GO:0030516
GO:0019960;C-X3-C chemokine binding;328;210;GO:0008509
GO:0019962;type I interferon binding;121;8;GO:0035023
GO:0019961;interferon binding;223;10;GO:0030528
GO:0019964;type II interferon binding;102;1;GO:0035020
GO:0032920;putrescine acetylation;44;3;GO:0046395
GO:0032921;sarcosine oxidase complex;1;1;GO:0009536
GO:0019966;interleukin-1 binding;573;195;GO:0005125
GO:0019948;SUMO activating enzyme activity;8581;35;GO:0004842
GO:0032919;spermine acetylation;48;5;GO:0016525
GO:0005324;long-chain fatty acid transporter activity;2482;658;GO:0008544
GO:0005316;high-affinity inorganic phosphate:sodium symporter activity;6;5;GO:0008565
GO:0032913;negative regulation of transforming growth factor beta3 production;21;9;GO:0010468
GO:0005315;inorganic phosphate transmembrane transporter activity;198006;761;GO:0008529
GO:0032914;positive regulation of transforming growth factor beta1 production;273;77;GO:0048010
GO:0032911;negative regulation of transforming growth factor beta1 production;277;195;GO:0010468
GO:0032912;negative regulation of transforming growth factor beta2 production;94;9;GO:0010468
GO:0032917;polyamine acetylation;251;8;GO:0046395
GO:0005319;lipid transporter activity;179716;3100;GO:0005554
GO:0032918;spermidine acetylation;157;25;GO:0016525
GO:0032915;positive regulation of transforming growth factor beta2 production;164;32;GO:0048010
GO:0032916;positive regulation of transforming growth factor beta3 production;10;34;GO:0048010
GO:0019953;sexual reproduction;273923;4720;GO:0019953
GO:0032910;regulation of transforming growth factor beta3 production;83;8;GO:0048010
GO:0019955;cytokine binding;20143;2010;GO:0005125
GO:0019954;asexual reproduction;212534;164;GO:0000003
GO:0019935;cyclic-nucleotide-mediated signaling;4051;721;GO:0007186
GO:0019934;cGMP-mediated signaling;1586;699;GO:0007186
GO:0019939;peptidyl-S-palmitoleyl-L-cysteine biosynthetic process from peptidyl-cysteine;0;2;GO:0009065
GO:0032908;regulation of transforming growth factor beta1 production;550;8;GO:0030518
GO:0032909;regulation of transforming growth factor beta2 production;561;1360;GO:0030518
GO:0150189;regulation of interleukin-32 production;1;0;GO:0046330
GO:0032902;nerve growth factor production;122;17;GO:0048608
GO:0150190;negative regulation of interleukin-32 production;1;1;GO:0046330
GO:0032903;regulation of nerve growth factor production;4;7;GO:0048608
GO:0150191;positive regulation of interleukin-32 production;0;0;GO:0046330
GO:0032900;negative regulation of neurotrophin production;6;123;GO:0048608
GO:0032901;positive regulation of neurotrophin production;7;6;GO:0048608
GO:0032906;transforming growth factor beta2 production;561;5;GO:0046330
GO:0032907;transforming growth factor beta3 production;85;8;GO:0048010
GO:0150195;transport across blood-cerebrospinal fluid barrier;0;0;GO:0006874
GO:0032904;negative regulation of nerve growth factor production;2;113;GO:0048608
GO:0032905;transforming growth factor beta1 production;743;46;GO:0046330
GO:0019941;modification-dependent protein catabolic process;455453;2790;GO:0042632
GO:0019926;peptidyl-tryptophan oxidation to tryptophyl quinone;0;3;GO:0006468
GO:0019928;peptide cross-linking via 3-(S-L-cysteinyl)-L-aspartic acid;0;0;GO:0008021
GO:0019927;peptide cross-linking via 4'-(S-L-cysteinyl)-L-tryptophyl quinone;0;0;GO:0009065
GO:0019929;peptide cross-linking via 4-(S-L-cysteinyl)-L-glutamic acid;0;0;GO:0008021
GO:0005300;high-affinity tryptophan transmembrane transporter activity;4;3;GO:0005215
GO:0005302;L-tyrosine transmembrane transporter activity;280;38;GO:0005215
GO:0019930;cis-14-hydroxy-10,13-dioxo-7-heptadecenoic acid peptidyl-aspartate ester biosynthetic process from peptidyl-aspartic acid;0;2;GO:0006021
GO:0019933;cAMP-mediated signaling;2440;1650;GO:0007623
GO:0019932;second-messenger-mediated signaling;84033;2180;GO:0007186
GO:0005350;pyrimidine nucleobase transmembrane transporter activity;15943;9;GO:0008565
GO:0005352;alpha-glucoside:proton symporter activity;3;4;GO:0005215
GO:0005351;carbohydrate:proton symporter activity;44239;64;GO:0005215
GO:0005354;galactose transmembrane transporter activity;7867;37;GO:0008528
GO:0005353;fructose transmembrane transporter activity;22124;78;GO:0008544
GO:0005356;glucose:proton symporter activity;184;3;GO:0005215
GO:0005355;glucose transmembrane transporter activity;17045;1020;GO:0005215
GO:0005358;high-affinity glucose:proton symporter activity;12;0;GO:0005215
GO:0030305;heparanase activity;124;9;GO:0004553
GO:0032968;positive regulation of transcription elongation by RNA polymerase II;23862;87;GO:0045944
GO:0032969;endosomal scaffold complex;0;2;GO:0048193
GO:0030307;positive regulation of cell growth;7624;3610;GO:0042127
GO:0032966;negative regulation of collagen biosynthetic process;159;420;GO:0032963
GO:0032967;positive regulation of collagen biosynthetic process;1050;652;GO:0048407
GO:0030309;poly-N-acetyllactosamine metabolic process;272;127;GO:0006032
GO:0030308;negative regulation of cell growth;8442;3800;GO:0048523
GO:0032960;regulation of inositol trisphosphate biosynthetic process;307;9;GO:0046330
GO:0032961;negative regulation of inositol trisphosphate biosynthetic process;0;1;GO:0010467
GO:0030301;cholesterol transport;20675;1480;GO:0006869
GO:0032964;collagen biosynthetic process;1786;727;GO:0032963
GO:0030300;regulation of intestinal cholesterol absorption;417;300;GO:0007586
GO:0003756;protein disulfide isomerase activity;30958;1310;GO:0003723
GO:0015739;sialic acid transport;4271;153;GO:0006869
GO:0015738;glucuronate transmembrane transport;116;0;GO:0008544
GO:0015737;galacturonate transmembrane transport;0;0;GO:0008544
GO:0015736;hexuronate transmembrane transport;131;0;GO:0008544
GO:0015735;uronic acid transmembrane transport;131;1;GO:0008565
GO:0015734;taurine transport;6449;35;GO:0006836
GO:0015733;shikimate transmembrane transport;2;3;GO:0006810
GO:0015732;prostaglandin transport;1844;205;GO:0006869
GO:0052850;NADPH-dependent dihydrocurcumin reductase activity;0;0;GO:0004067
GO:0052851;ferric-chelate reductase (NADPH) activity;821;59;GO:0004073
GO:0052858;peptidyl-lysine acetyltransferase activity;121;2;GO:0004867
GO:0052859;glucan endo-1,4-beta-glucosidase activity;98;1;GO:0004553
GO:0052856;NADHX epimerase activity;89301;77;GO:0004067
GO:0052857;NADPHX epimerase activity;54870;27;GO:0004067
GO:0052855;ADP-dependent NAD(P)H-hydrate dehydratase activity;137380;108;GO:0004067
GO:0050200;plasmalogen synthase activity;23;2;GO:0008610
GO:0052863;1-deoxy-D-xylulose 5-phosphate metabolic process;37256;3;GO:0006096
GO:0052864;1-deoxy-D-xylulose 5-phosphate catabolic process;0;0;GO:0006073
GO:0050202;octopamine dehydratase activity;0;3;GO:0006067
GO:0052861;glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group;8256;18;GO:0004553
GO:0050201;fucokinase activity;290;8;GO:0004721
GO:0052862;glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group;2675;8;GO:0004553
GO:0052860;2'-deoxymugineic-acid 3-dioxygenase activity;5;0;GO:0004497
GO:0050208;polysialic-acid O-acetyltransferase activity;33;4;GO:0008037
GO:0050207;plasmanylethanolamine desaturase activity;118;5;GO:0008610
GO:0052869;arachidonic acid omega-hydroxylase activity;1263;9;GO:0004076
GO:0050209;polyvinyl-alcohol oxidase activity;0;3;GO:0004497
GO:0050204;oxalomalate lyase activity;0;3;GO:0006067
GO:0052867;phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity;0;3;GO:0004721
GO:0050203;oxalate-CoA ligase activity;64;7;GO:0006081
GO:0052868;protein-lysine lysyltransferase activity;1;0;GO:0004867
GO:0050206;oximinotransferase activity;0;3;GO:0004730
GO:0052865;1-deoxy-D-xylulose 5-phosphate biosynthetic process;37256;16;GO:0009405
GO:0050205;oxamate carbamoyltransferase activity;2;3;GO:0006067
GO:0052866;phosphatidylinositol phosphate phosphatase activity;61321;84;GO:0004721
GO:0062200;RAM/MOR signaling pathway;81;3;GO:0007186
GO:0015895;alkane transport;0;4;GO:0006810
GO:0062201;actin wave;24;3;GO:0007411
GO:0062202;Labd-13(16),14-diene-9-ol synthase activity;2;1;GO:0004497
GO:0062203;Viteagnusin D synthase activity;2;1;GO:0004497
GO:0015891;siderophore transport;242387;988;GO:0006879
GO:0015890;nicotinamide mononucleotide transport;2;282;GO:0006873
GO:0062208;positive regulation of pattern recognition receptor signaling pathway;5030;38;GO:0043603
GO:0062209;spatial regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination;1;0;GO:0007067
GO:0062204;(13S)-vitexifolin A synthase activity;3;0;GO:0004497
GO:0062205;miltiradiene synthase activity;13;2;GO:0004497
GO:0062206;manoyl oxide synthase activity;3;2;GO:0006021
GO:0062207;regulation of pattern recognition receptor signaling pathway;14065;34;GO:0002237
GO:0050211;procollagen galactosyltransferase activity;223;133;GO:0004553
GO:0052874;FMN reductase (NADH) activity;2100;3;GO:0004067
GO:0050210;prenyl-diphosphatase activity;9;3;GO:0004721
GO:0052875;riboflavin reductase (NAD(P)H) activity;859;2;GO:0004067
GO:0052872;tocotrienol omega-hydroxylase activity;17;3;GO:0004073
GO:0050212;progesterone 11-alpha-monooxygenase activity;0;3;GO:0004497
GO:0052873;FMN reductase (NADPH) activity;3398;9;GO:0004067
GO:0052870;tocopherol omega-hydroxylase activity;17;38;GO:0004073
GO:0052871;alpha-tocopherol omega-hydroxylase activity;17;45;GO:0004073
GO:0050219;prostaglandin-A1 delta-isomerase activity;0;4;GO:0004497
GO:0050218;propionate-CoA ligase activity;9640;10;GO:0006081
GO:0015889;cobalamin transport;105941;545;GO:0006865
GO:0050215;propanediol dehydratase activity;648;6;GO:0006067
GO:0052878;linoleate 8R-lipoxygenase activity;394;4;GO:0004497
GO:0015888;thiamine transport;36181;174;GO:0006865
GO:0050214;progesterone monooxygenase activity;1;2;GO:0004497
GO:0052879;9,12-octadecadienoate 8-hydroperoxide 8S-isomerase activity;5;2;GO:0004497
GO:0015887;pantothenate transmembrane transport;6827;15;GO:0006836
GO:0050217;propioin synthase activity;0;3;GO:0004497
GO:0052876;methylamine dehydrogenase (amicyanin) activity;899;4;GO:0009065
GO:0015886;heme transport;188582;1110;GO:0006865
GO:0050216;propanediol-phosphate dehydrogenase activity;12;2;GO:0004067
GO:0052877;oxidoreductase activity, acting on the CH-NH2 group of donors, with a copper protein as acceptor;1019;2;GO:0004497
GO:1904401;cellular response to Thyroid stimulating hormone;58;1;GO:0009719
GO:1904400;response to Thyroid stimulating hormone;62;0;GO:0048193
GO:1904405;cellular response to formaldehyde;0;1;GO:0050829
GO:1904404;response to formaldehyde;7;88;GO:0046365
GO:1904403;cellular response to nocodazole;1;2;GO:0048285
GO:1904402;response to nocodazole;1;0;GO:0048285
GO:1904409;regulation of secretory granule organization;13;1;GO:0048193
GO:1904408;melatonin binding;127;10;GO:0005509
GO:1904407;positive regulation of nitric oxide metabolic process;1432;314;GO:0045765
GO:1904406;negative regulation of nitric oxide metabolic process;445;36;GO:0045765
GO:0052885;all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity;142;4;GO:0005576
GO:0050221;prostaglandin-E2 9-reductase activity;55;14;GO:0004497
GO:0052886;9,9'-dicis-carotene:quinone oxidoreductase activity;1083;1;GO:0004091
GO:0050224;prunasin beta-glucosidase activity;22;4;GO:0004553
GO:0052883;tyrosine ammonia-lyase activity;49;3;GO:0004061
GO:0050223;protocatechuate decarboxylase activity;10;3;GO:0009065
GO:0052884;all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity;90;6;GO:0005576
GO:0052881;4-hydroxyphenylacetate 3-monooxygenase activity;1528;4;GO:0004497
GO:0052882;oxidoreductase activity, acting on phosphorus or arsenic in donors, with a copper protein as acceptor;665;1;GO:0004784
GO:0050220;prostaglandin-E synthase activity;4082;102;GO:0004497
GO:0052880;oxidoreductase activity, acting on diphenols and related substances as donors, with copper protein as acceptor;2325;1;GO:0046148
GO:0050226;psychosine sulfotransferase activity;0;3;GO:0004073
GO:0052889;9,9'-di-cis-zeta-carotene desaturation to 7,9,7',9'-tetra-cis-lycopene;67;1;GO:0009536
GO:0015899;aminotriazole transport;0;2;GO:0006826
GO:0050225;pseudouridine kinase activity;642;6;GO:0003906
GO:0050228;pterin deaminase activity;207;4;GO:0004067
GO:0052887;7,9,9'-tricis-neurosporene:quinone oxidoreductase activity;1016;1;GO:0004091
GO:0015897;organomercurial transport;0;2;GO:0006826
GO:0050227;pteridine oxidase activity;0;2;GO:0004076
GO:0052818;heteroglycan 3-alpha-mannosyltransferase activity;0;1;GO:0006029
GO:0052819;heteroglycan 2-alpha-mannosyltransferase activity;0;1;GO:0006029
GO:0052816;long-chain acyl-CoA hydrolase activity;58;2;GO:0004497
GO:0052817;very long chain acyl-CoA hydrolase activity;47;1;GO:0004497
GO:0052814;medium-chain-aldehyde dehydrogenase activity;56;5;GO:0004067
GO:0052815;medium-chain acyl-CoA hydrolase activity;116;3;GO:0004497
GO:0052810;1-phosphatidylinositol-5-kinase activity;141;9;GO:0004721
GO:0052811;1-phosphatidylinositol-3-phosphate 4-kinase activity;14;80;GO:0004721
GO:0052829;inositol-1,3,4-trisphosphate 1-phosphatase activity;60;8;GO:0004721
GO:0052820;DNA-1,N6-ethenoadenine N-glycosylase activity;4;0;GO:0004518
GO:0052827;inositol pentakisphosphate phosphatase activity;7;3;GO:0004721
GO:0052828;inositol-3,4-bisphosphate 4-phosphatase activity;10;185;GO:0004721
GO:0052825;inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity;0;10;GO:0004721
GO:0052826;inositol hexakisphosphate 2-phosphatase activity;958;7;GO:0004721
GO:0052823;2-hydroxy-6-oxonona-2,4,7-trienedioate hydrolase activity;996;4;GO:0004553
GO:0052821;DNA-7-methyladenine glycosylase activity;4603;6;GO:0004518
GO:0052822;DNA-3-methylguanine glycosylase activity;4603;6;GO:0004553
GO:0052830;inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity;0;9;GO:0004721
GO:0052831;inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity;0;9;GO:0004721
GO:0052838;thiazole metabolic process;8935;5;GO:0006749
GO:0052839;inositol diphosphate tetrakisphosphate kinase activity;4;10;GO:0004721
GO:0052836;inositol 5-diphosphate pentakisphosphate 5-kinase activity;4;10;GO:0004721
GO:0052837;thiazole biosynthetic process;8935;52;GO:0009061
GO:0052834;inositol monophosphate phosphatase activity;195372;165;GO:0004721
GO:0052835;inositol-3,4,6-trisphosphate 1-kinase activity;4;8;GO:0004721
GO:0052832;inositol monophosphate 3-phosphatase activity;33536;117;GO:0004721
GO:0052833;inositol monophosphate 4-phosphatase activity;33592;388;GO:0004721
GO:0052841;inositol bisdiphosphate tetrakisphosphate diphosphatase activity;47;41;GO:0005524
GO:0052842;inositol diphosphate pentakisphosphate diphosphatase activity;183;43;GO:0004721
GO:0052840;inositol diphosphate tetrakisphosphate diphosphatase activity;95;39;GO:0004721
GO:0052849;NADPH-dependent curcumin reductase activity;0;1;GO:0004067
GO:0052847;inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity;12;142;GO:0004723
GO:0052848;inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity;9;35;GO:0005524
GO:0052845;inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity;54;105;GO:0005524
GO:0052846;inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity;26;35;GO:0004721
GO:0052843;inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity;57;37;GO:0004723
GO:0052844;inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity;0;69;GO:0005524
GO:1904452;negative regulation of potassium:proton exchanging ATPase activity;0;1;GO:0010468
GO:1904451;regulation of potassium:proton exchanging ATPase activity;0;0;GO:0045730
GO:1904450;positive regulation of aspartate secretion;10;153;GO:0048193
GO:1904456;negative regulation of neuronal action potential;38;5;GO:0048167
GO:1904453;positive regulation of potassium:proton exchanging ATPase activity;0;0;GO:0048405
GO:0050280;sequoyitol dehydrogenase activity;0;3;GO:0006073
GO:1904459;negative regulation of substance P secretion;0;0;GO:0048608
GO:0050282;serine 2-dehydrogenase activity;0;3;GO:0004067
GO:1904458;regulation of substance P secretion;4;1;GO:0048608
GO:0050281;serine-glyoxylate transaminase activity;678;9;GO:0004073
GO:1904457;positive regulation of neuronal action potential;128;21;GO:0048167
GO:1990374;Kir2 inward rectifier potassium channel complex;0;0;GO:0048169
GO:0050277;sedoheptulokinase activity;1056;9;GO:0004721
GO:0050276;scyllo-inosamine 4-kinase activity;4;4;GO:0004721
GO:0050279;sepiapterin deaminase activity;2;2;GO:0004041
GO:0050278;sedoheptulose-bisphosphatase activity;1176;9;GO:0006096
GO:0050273;S-succinylglutathione hydrolase activity;0;3;GO:0004723
GO:0050272;S-carboxymethylcysteine synthase activity;3;2;GO:0004465
GO:0050275;scopoletin glucosyltransferase activity;3;5;GO:0006073
GO:0050274;salicyl-alcohol beta-D-glucosyltransferase activity;0;3;GO:0004553
GO:1904463;ergosteryl 3-beta-D-glucoside biosynthetic process;0;1;GO:0009813
GO:1904462;ergosteryl 3-beta-D-glucoside catabolic process;60;0;GO:0009813
GO:1904461;ergosteryl 3-beta-D-glucoside metabolic process;60;0;GO:0006073
GO:1904460;positive regulation of substance P secretion;4;2;GO:0048608
GO:1904466;positive regulation of matrix metallopeptidase secretion;117;10;GO:0048608
GO:1904465;negative regulation of matrix metallopeptidase secretion;59;9;GO:0048193
GO:1904464;regulation of matrix metallopeptidase secretion;225;9;GO:0048608
GO:0050291;sphingosine N-acyltransferase activity;21195;224;GO:0004073
GO:0050290;sphingomyelin phosphodiesterase D activity;2820;46;GO:0008030
GO:0050293;steroid-lactonase activity;0;3;GO:0016817
GO:1990380;K48-linked deubiquitinase activity;16112;8;GO:0004867
GO:0050292;steroid 9-alpha-monooxygenase activity;1;3;GO:0004497
GO:1990381;ubiquitin-specific protease binding;1290;244;GO:0005576
GO:1990383;cellular response to biotin starvation;0;0;GO:0009734
GO:1990384;hyaloid vascular plexus regression;292;55;GO:0048661
GO:1990385;meiotic spindle midzone;184;17;GO:0007062
GO:0050288;sorbose dehydrogenase activity;3;2;GO:0004067
GO:1990375;baculum development;1;1;GO:0048706
GO:0050287;sorbose 5-dehydrogenase (NADP+) activity;5;0;GO:0004067
GO:1990377;organomineral extracellular matrix;2;3;GO:0044421
GO:0050289;spermidine dehydrogenase activity;31;3;GO:0009065
GO:1990378;upstream stimulatory factor complex;0;2;GO:0003712
GO:0050284;sinapate 1-glucosyltransferase activity;29;8;GO:0006081
GO:1990379;lipid transport across blood-brain barrier;371;247;GO:0006869
GO:0050283;serine-sulfate ammonia-lyase activity;0;3;GO:0004067
GO:0050286;sorbitol-6-phosphatase activity;29;4;GO:0006066
GO:0050285;sinapine esterase activity;68;3;GO:0004553
GO:1904474;cellular response to L-dopa;1;1;GO:0042592
GO:1904473;response to L-dopa;1;1;GO:0048167
GO:1904472;positive regulation of endothelin production;53;7;GO:0048608
GO:1904471;negative regulation of endothelin production;2;2;GO:0010401
GO:1904478;regulation of intestinal absorption;695;34;GO:0007586
GO:1904477;positive regulation of small GTPase binding;0;1;GO:0048010
GO:1904476;negative regulation of small GTPase binding;0;1;GO:0048193
GO:1904475;regulation of small GTPase binding;0;1;GO:0005524
GO:1990390;protein K33-linked ubiquitination;9;7;GO:0006464
GO:1990391;DNA repair complex;156183;672;GO:0006364
GO:1904479;negative regulation of intestinal absorption;292;5;GO:0048407
GO:1990392;EFF-1 complex;1;0;GO:0005634
GO:1990393;3M complex;270;216;GO:0043161
GO:1990394;cellular response to cell wall damage;0;1;GO:0071363
GO:1990395;meiotic spindle pole body organization;39;1;GO:0000976
GO:1990396;single-strand break repair via homologous recombination;15;1;GO:0006281
GO:0050299;streptomycin 3''-kinase activity;142;0;GO:0004721
GO:1990386;mitotic cleavage furrow ingression;62;4;GO:0007067
GO:0050298;stizolobinate synthase activity;0;2;GO:0004497
GO:1990387;isogloboside biosynthetic process;0;1;GO:0006021
GO:1990388;xylem-to-phloem iron transport;1;1;GO:0006826
GO:1990389;CUE1-UBC7 ubiquitin-conjugating enzyme complex;67;0;GO:0005840
GO:0050295;steryl-beta-glucosidase activity;629;3;GO:0004553
GO:0050294;steroid sulfotransferase activity;160;79;GO:0004730
GO:0050297;stizolobate synthase activity;1818;3;GO:0004497
GO:0050296;stipitatonate decarboxylase activity;0;3;GO:0006073
GO:1904470;regulation of endothelin production;55;1;GO:0048608
GO:1904484;cloacal gland development;1;0;GO:0007530
GO:1904483;synthetic cannabinoid binding;1;0;GO:0008152
GO:1904482;cellular response to tetrahydrofolate;50;217;GO:0009719
GO:1990397;queuosine salvage;41129;184;GO:0009065
GO:1990398;Cus cation efflux complex;0;0;GO:0005576
GO:1990399;epithelium regeneration;443;2;GO:0043407
GO:1904481;response to tetrahydrofolate;50;9;GO:0006790
GO:1904480;positive regulation of intestinal absorption;109;1;GO:0048407
GO:0062223;regulation of somatic muscle development;0;0;GO:0048731
GO:0062224;positive regulation of somatic muscle development;0;1;GO:0048704
GO:0062225;negative regulation of somatic muscle development;0;0;GO:0048704
GO:1904412;regulation of cardiac ventricle development;56;4;GO:0048608
GO:1904411;positive regulation of secretory granule organization;13;2;GO:0048193
GO:1904410;negative regulation of secretory granule organization;0;1;GO:0048193
GO:1904416;negative regulation of xenophagy;0;2;GO:0048193
GO:1904415;regulation of xenophagy;432;7;GO:0048193
GO:1904414;positive regulation of cardiac ventricle development;56;7;GO:0048608
GO:1904413;negative regulation of cardiac ventricle development;0;0;GO:0048704
GO:0062226;regulation of adult somatic muscle development;0;0;GO:0048731
GO:0062227;positive regulation of adult somatic muscle development;0;0;GO:0048704
GO:1904419;negative regulation of telomeric loop formation;0;0;GO:0048285
GO:0062228;negative regulation of adult somatic muscle development;0;0;GO:0048704
GO:1904418;regulation of telomeric loop formation;0;0;GO:0007050
GO:0062229;regulation of larval somatic muscle development;0;0;GO:0048704
GO:1904417;positive regulation of xenophagy;432;100;GO:0048193
GO:0050233;pyranose oxidase activity;349;2;GO:0004601
GO:0052896;spermidine oxidase (propane-1,3-diamine-forming) activity;20;2;GO:0004730
GO:0050232;putrescine oxidase activity;411;7;GO:0004721
GO:0052897;N8-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity;3;2;GO:0004091
GO:0050235;pyridoxal 4-dehydrogenase activity;1067;5;GO:0004073
GO:0052894;norspermine:oxygen oxidoreductase activity;145;21;GO:0004091
GO:0050234;pyrazolylalanine synthase activity;4;4;GO:0006030
GO:0052895;N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity;46;9;GO:0004091
GO:0052892;aromatic (S)-hydroxynitrile lyase activity;2;0;GO:0004073
GO:0052893;N1-acetylspermine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity;20;2;GO:0004091
GO:0050231;putrescine carbamoyltransferase activity;1281;6;GO:0006067
GO:0052890;oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor;262863;20;GO:0004497
GO:0050230;purine imidazole-ring cyclase activity;0;2;GO:0004721
GO:0052891;aliphatic (S)-hydroxynitrile lyase activity;4;0;GO:0004073
GO:0050237;pyridoxine 4-oxidase activity;23;4;GO:0004601
GO:0050236;pyridoxine:NADP 4-dehydrogenase activity;390;4;GO:0004073
GO:0050239;pyrithiamine deaminase activity;0;3;GO:0004721
GO:0050238;pyridoxine 5-dehydrogenase activity;0;3;GO:0004497
GO:0052899;N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity;27;0;GO:0006066
GO:0062211;root regeneration;62;1;GO:0048608
GO:0062212;regulation of mitotic DNA replication initiation from early origin;0;0;GO:0007050
GO:0062213;peroxynitrite isomerase activity;3529;3;GO:0003906
GO:1904423;dehydrodolichyl diphosphate synthase complex;3454;24;GO:0005576
GO:1904422;cellular response to D-galactosamine;0;0;GO:0006954
GO:1904421;response to D-galactosamine;1;1;GO:0002526
GO:0062210;shoot regeneration;1;2;GO:0048316
GO:1904420;positive regulation of telomeric loop formation;0;1;GO:0048285
GO:1904427;positive regulation of calcium ion transmembrane transport;2137;153;GO:0048407
GO:1904426;positive regulation of GTP binding;29;7;GO:0043403
GO:1904425;negative regulation of GTP binding;2;8;GO:0005524
GO:1904424;regulation of GTP binding;56;94;GO:0005524
GO:1904429;regulation of t-circle formation;420;5;GO:0010468
GO:1904428;negative regulation of tubulin deacetylation;264;22;GO:0010467
GO:0050244;pyruvate oxidase (CoA-acetylating) activity;0;3;GO:0004091
GO:0050243;pyruvate dehydrogenase (NADP+) activity;72;0;GO:0006096
GO:0050246;questin monooxygenase activity;2;3;GO:0004497
GO:0050245;quercitrinase activity;0;3;GO:0004553
GO:0050240;pyrogallol 1,2-oxygenase activity;0;3;GO:0004497
GO:0050242;pyruvate, phosphate dikinase activity;76013;251;GO:0006099
GO:0050241;pyrroline-2-carboxylate reductase activity;48;2;GO:0004067
GO:0050248;Renilla-luciferin 2-monooxygenase activity;15;4;GO:0004497
GO:0050247;raucaffricine beta-glucosidase activity;28;3;GO:0004553
GO:0050249;Renilla-luciferin sulfotransferase activity;0;3;GO:0004730
GO:0062244;double membrane vesicle viral factory lumen;0;1;GO:0005741
GO:1904430;negative regulation of t-circle formation;291;100;GO:0010468
GO:0062245;double membrane vesicle viral factory inner membrane;0;0;GO:0016021
GO:0062246;exocytic vesicle lumen;0;1;GO:0005768
GO:0062247;chloroplast vesicle;0;1;GO:0009536
GO:0062240;euchromatin-nuclear membrane anchor activity;0;0;GO:0005576
GO:1904434;positive regulation of ferrous iron binding;2;24;GO:0046395
GO:0062241;double strand break-nuclear membrane anchor activity;0;0;GO:0005576
GO:1904433;negative regulation of ferrous iron binding;0;0;GO:0046395
GO:0062242;double membrane vesicle viral factory membrane;98;1;GO:0016021
GO:1904432;regulation of ferrous iron binding;2;7;GO:0046395
GO:0062243;double membrane vesicle viral factory outer membrane;98;2;GO:0016021
GO:1904431;positive regulation of t-circle formation;129;24;GO:0048285
GO:1904438;regulation of iron ion import across plasma membrane;50;0;GO:0006826
GO:1904437;positive regulation of transferrin receptor binding;2;33;GO:0048193
GO:0050260;ribose-5-phosphate-ammonia ligase activity;0;4;GO:0006094
GO:1904436;negative regulation of transferrin receptor binding;0;0;GO:0048193
GO:1904435;regulation of transferrin receptor binding;2;8;GO:0004872
GO:0062248;cleistothecium formation;0;1;GO:0048305
GO:1904439;negative regulation of iron ion import across plasma membrane;41;3;GO:0006826
GO:0050255;ribitol 2-dehydrogenase activity;446;2;GO:0006032
GO:0050254;rhodopsin kinase activity;669;173;GO:0004713
GO:0050257;riboflavin phosphotransferase activity;0;4;GO:0004723
GO:0050256;ribitol-5-phosphate 2-dehydrogenase activity;1459;3;GO:0006032
GO:0050251;retinol isomerase activity;97;6;GO:0004041
GO:0050253;retinyl-palmitate esterase activity;995;218;GO:0005576
GO:0050252;retinol O-fatty-acyltransferase activity;974;152;GO:0004073
GO:0050259;ribose 1-dehydrogenase (NADP+) activity;1;0;GO:0006066
GO:0050258;riboflavinase activity;0;3;GO:0004067
GO:0062233;F2-isoprostane catabolic process;0;0;GO:0009072
GO:1904441;regulation of thyroid gland epithelial cell proliferation;8;0;GO:0042127
GO:0062234;platelet activating factor catabolic process;95;3;GO:0046395
GO:1904440;positive regulation of iron ion import across plasma membrane;9;6;GO:0006826
GO:0062235;axonemal basal plate assembly;0;1;GO:0048704
GO:0062236;ionocyte differentiation;2;1;GO:0048407
GO:1904445;negative regulation of establishment of Sertoli cell barrier;5;2;GO:0048193
GO:0062230;negative regulation of larval somatic muscle development;0;0;GO:0048704
GO:1904444;regulation of establishment of Sertoli cell barrier;17;4;GO:0048193
GO:0062231;positive regulation of larval somatic muscle development;0;0;GO:0048704
GO:1904443;positive regulation of thyroid gland epithelial cell proliferation;0;1;GO:0048010
GO:0062232;prostanoid catabolic process;264;0;GO:0046274
GO:1904442;negative regulation of thyroid gland epithelial cell proliferation;8;0;GO:0048193
GO:1904449;negative regulation of aspartate secretion;0;1;GO:0048193
GO:1904448;regulation of aspartate secretion;10;5;GO:0048193
GO:0050271;S-alkylcysteine lyase activity;0;2;GO:0004730
GO:1904447;folate import across plasma membrane;415;8;GO:0006874
GO:0050270;S-adenosylhomocysteine deaminase activity;18019;5;GO:0004497
GO:1904446;positive regulation of establishment of Sertoli cell barrier;12;6;GO:0048193
GO:0062237;protein localization to postsynapse;2521;4;GO:0048608
GO:0062238;Smp focus;0;0;GO:0005576
GO:0062239;heterochromatin-nuclear membrane anchor activity;5;3;GO:0005576
GO:0050266;rosmarinate synthase activity;10;4;GO:0004497
GO:0050265;RNA uridylyltransferase activity;1655;172;GO:0003729
GO:0050268;coniferyl-alcohol dehydrogenase activity;120;2;GO:0004073
GO:0050267;rubber cis-polyprenylcistransferase activity;7;3;GO:0004073
GO:0050262;ribosylnicotinamide kinase activity;3120;36;GO:0004721
GO:0050261;ribose isomerase activity;0;3;GO:0003824
GO:0050264;rifamycin-B oxidase activity;0;3;GO:0004497
GO:0050263;ribosylpyrimidine nucleosidase activity;12155;58;GO:0004553
GO:0050269;coniferyl-aldehyde dehydrogenase activity;257;5;GO:0004073
GO:1990300;cellulosome binding;0;1;GO:0005576
GO:1990302;Bre1-Rad6 ubiquitin ligase complex;0;2;GO:0005576
GO:1990303;UBR1-RAD6 ubiquitin ligase complex;77;3;GO:0005829
GO:1990304;MUB1-RAD6-UBR2 ubiquitin ligase complex;96;6;GO:0005829
GO:1990305;RAD6-UBR2 ubiquitin ligase complex;72;3;GO:0005840
GO:1990306;RSP5-BUL ubiquitin ligase complex;61;5;GO:0005576
GO:1990308;type-I dockerin domain binding;0;3;GO:0005515
GO:1990309;type-II dockerin domain binding;0;3;GO:0005515
GO:2000709;regulation of maintenance of meiotic sister chromatid cohesion, centromeric;6;0;GO:0007070
GO:2000705;regulation of dense core granule biogenesis;59;9;GO:0048193
GO:1990310;type-III dockerin domain binding;0;2;GO:0005576
GO:2000706;negative regulation of dense core granule biogenesis;7;1;GO:0048193
GO:1990311;type-I cohesin domain binding;0;2;GO:0005524
GO:2000707;positive regulation of dense core granule biogenesis;52;5;GO:0048193
GO:1990312;type-II cohesin domain binding;0;2;GO:0005524
GO:1990313;type-III cohesin domain binding;0;2;GO:0005524
GO:2000701;glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation;51;0;GO:0048405
GO:1990314;cellular response to insulin-like growth factor stimulus;172;47;GO:0048608
GO:2000702;regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation;51;1;GO:0048608
GO:1990315;Mcs4 RR-MAPKKK complex;80;4;GO:0048285
GO:2000703;negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation;51;7;GO:0048405
GO:1990316;Atg1/ULK1 kinase complex;5475;173;GO:0005764
GO:2000704;positive regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation;0;1;GO:0048608
GO:1990317;Gin4 complex;202;3;GO:0005524
GO:1990318;collagen type XIX trimer;0;2;GO:0005578
GO:1990319;collagen type XX trimer;0;1;GO:0005581
GO:2000700;positive regulation of cardiac muscle cell myoblast differentiation;0;0;GO:0048407
GO:0062189;anandamide 14,15 epoxidase activity;131;6;GO:0004497
GO:1904375;regulation of protein localization to cell periphery;8475;41;GO:0048193
GO:1904374;cellular response to kainic acid;1;1;GO:0048167
GO:1904373;response to kainic acid;17;3;GO:0048167
GO:1904372;positive regulation of protein localization to actin cortical patch;4;1;GO:0048193
GO:0062185;secalciferol 1-monooxygenase activity;60;4;GO:0004497
GO:1904379;protein localization to cytosolic proteasome complex involved in ERAD pathway;43;34;GO:0005765
GO:0062186;anandamide epoxidase activity;293;2;GO:0004497
GO:1904378;maintenance of unfolded protein involved in ERAD pathway;152;31;GO:0006457
GO:0062187;anandamide 8,9 epoxidase activity;81;7;GO:0004497
GO:1904377;positive regulation of protein localization to cell periphery;4858;119;GO:0048193
GO:0062188;anandamide 11,12 epoxidase activity;81;6;GO:0004497
GO:1904376;negative regulation of protein localization to cell periphery;1435;74;GO:0048193
GO:1990330;IscS-IscU complex;2;0;GO:0005737
GO:1990320;collagen type XXI trimer;0;1;GO:0005581
GO:2000716;negative regulation of maintenance of mitotic sister chromatid cohesion, arms;0;0;GO:0048285
GO:0050199;piperidine N-piperoyltransferase activity;0;3;GO:0004730
GO:1990321;collagen type XXII trimer;0;1;GO:0005581
GO:2000717;positive regulation of maintenance of mitotic sister chromatid cohesion, arms;0;0;GO:0048285
GO:1990322;collagen type XXIII trimer;0;1;GO:0005578
GO:2000718;regulation of maintenance of mitotic sister chromatid cohesion, centromeric;103;1;GO:0007070
GO:1990323;collagen type XXIV trimer;0;1;GO:0005581
GO:2000719;negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric;55;2;GO:0048285
GO:0050196;[phosphorylase] phosphatase activity;11;5;GO:0004721
GO:1990324;collagen type XXVI trimer;0;5;GO:0005581
GO:2000712;regulation of maintenance of meiotic sister chromatid cohesion, arms;0;0;GO:0007070
GO:0050195;phosphoribokinase activity;0;4;GO:0004721
GO:1990325;collagen type XXVII trimer;0;2;GO:0005578
GO:2000713;negative regulation of maintenance of meiotic sister chromatid cohesion, arms;0;0;GO:0048285
GO:0050198;pinosylvin synthase activity;15;3;GO:0004497
GO:1990326;collagen type XXVIII trimer;0;4;GO:0005578
GO:2000714;positive regulation of maintenance of meiotic sister chromatid cohesion, arms;0;0;GO:0048285
GO:0050197;phytanate-CoA ligase activity;90;5;GO:0006081
GO:1990327;collagen type XXV trimer;0;1;GO:0005581
GO:2000715;regulation of maintenance of mitotic sister chromatid cohesion, arms;0;0;GO:0007067
GO:0062192;L-rhamnose mutarotase activity;5739;4;GO:0006032
GO:1990328;RPB4-RPB7 complex;66;0;GO:0043161
GO:0062193;D-ribose pyranase activity;18356;2;GO:0004553
GO:1990329;IscS-TusA complex;2;0;GO:0005737
GO:0062194;cytoplasmic microtubule minus-end;0;0;GO:0005819
GO:2000710;negative regulation of maintenance of meiotic sister chromatid cohesion, centromeric;0;0;GO:0048285
GO:0062195;microtubule bundle maintenance;0;1;GO:0048471
GO:2000711;positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric;6;1;GO:0048285
GO:1904371;negative regulation of protein localization to actin cortical patch;0;0;GO:0048193
GO:1904370;regulation of protein localization to actin cortical patch;4;1;GO:0048193
GO:0062191;galactoxylomannan biosynthetic process;0;1;GO:1901363
GO:1904386;response to L-phenylalanine derivative;35;9;GO:0009628
GO:0062179;vitamin D 23-hydroxylase activity;134;0;GO:0004073
GO:1904385;cellular response to angiotensin;8493;77;GO:0002526
GO:1904384;cellular response to sodium phosphate;3;4;GO:0050832
GO:1904383;response to sodium phosphate;324;115;GO:0050832
GO:0062174;brexanolone biosynthetic process;0;1;GO:0046395
GO:0062175;brexanolone catabolic process;45;1;GO:0046395
GO:1904389;rod bipolar cell differentiation;120;6;GO:0048666
GO:0062176;R-loop processing;341;1;GO:0007042
GO:1904388;negative regulation of ncRNA transcription associated with protein coding gene TSS/TES;4;1;GO:0045944
GO:0062177;radial spoke assembly;66;7;GO:0005576
GO:1904387;cellular response to L-phenylalanine derivative;11;9;GO:0009611
GO:1990340;laminin-15 complex;0;0;GO:0048407
GO:1990341;thrombospondin complex;0;2;GO:0005578
GO:1990331;Hpa2 acetyltransferase complex;1;0;GO:0043405
GO:2000727;positive regulation of cardiac muscle cell differentiation;337;325;GO:0048407
GO:1990332;Ire1 complex;7;3;GO:0009536
GO:2000728;regulation of mRNA export from nucleus in response to heat stress;12;3;GO:0045944
GO:0003810;protein-glutamine gamma-glutamyltransferase activity;14898;458;GO:0006468
GO:1990333;mitotic checkpoint complex, CDC20-MAD2 subcomplex;14;0;GO:0007067
GO:2000729;positive regulation of mesenchymal cell proliferation involved in ureter development;99;9;GO:0048608
GO:1990334;Bfa1-Bub2 complex;1305;1;GO:0048193
GO:2000723;negative regulation of cardiac vascular smooth muscle cell differentiation;3;0;GO:0048608
GO:2000724;positive regulation of cardiac vascular smooth muscle cell differentiation;58;8;GO:0048608
GO:2000725;regulation of cardiac muscle cell differentiation;848;44;GO:0048608
GO:1990338;laminin-14 complex;0;0;GO:0005576
GO:2000726;negative regulation of cardiac muscle cell differentiation;475;134;GO:0048407
GO:0062181;1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity;73;3;GO:0004073
GO:1990339;laminin-522 complex;0;0;GO:0005576
GO:0062182;all-trans retinoic acid 4-hydrolase activity;5;1;GO:0004073
GO:2000720;positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric;48;1;GO:0048285
GO:0062183;all-trans retinoic acid 18-hydroxylase activity;75;2;GO:0004073
GO:0062184;testosterone 16-beta-hydroxylase activity;37;1;GO:0004722
GO:2000722;regulation of cardiac vascular smooth muscle cell differentiation;61;4;GO:0048608
GO:1904382;mannose trimming involved in glycoprotein ERAD pathway;17;58;GO:0006486
GO:1904381;Golgi apparatus mannose trimming;0;58;GO:0005764
GO:1904380;endoplasmic reticulum mannose trimming;6;389;GO:0006493
GO:0062180;25-hydroxycholecalciferol-23-hydroxylase activity;61;1;GO:0004073
GO:1904397;negative regulation of neuromuscular junction development;563;6;GO:0048704
GO:1904396;regulation of neuromuscular junction development;1934;5;GO:0048666
GO:1904395;positive regulation of skeletal muscle acetylcholine-gated channel clustering;115;7;GO:0048608
GO:1904394;negative regulation of skeletal muscle acetylcholine-gated channel clustering;45;0;GO:0048608
GO:1904399;heparan sulfate binding;149;103;GO:0005539
GO:1904398;positive regulation of neuromuscular junction development;610;7;GO:0048666
GO:1990350;glucose transporter complex;54;2;GO:0005975
GO:1990351;transporter complex;1603574;707;GO:0005576
GO:1990352;BRE1 E3 ubiquitin ligase complex;0;1;GO:0005576
GO:1990342;heterochromatin island;116;15;GO:0000786
GO:2000738;positive regulation of stem cell differentiation;1281;499;GO:0045766
GO:1990343;heterochromatin domain;1;6;GO:0000786
GO:2000739;regulation of mesenchymal stem cell differentiation;466;52;GO:0045595
GO:1990344;secondary cell septum biogenesis;27;3;GO:0048285
GO:1990346;BID-BCL-xl complex;0;0;GO:0005829
GO:2000734;negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation;51;6;GO:0048405
GO:2000735;positive regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation;0;0;GO:0048704
GO:2000736;regulation of stem cell differentiation;5141;435;GO:0045595
GO:1990349;gap junction-mediated intercellular transport;497;9;GO:0007030
GO:2000737;negative regulation of stem cell differentiation;1591;505;GO:0045766
GO:2000730;regulation of termination of RNA polymerase I transcription;55;3;GO:0045944
GO:2000731;negative regulation of termination of RNA polymerase I transcription;0;0;GO:0045944
GO:2000732;positive regulation of termination of RNA polymerase I transcription;0;0;GO:0045944
GO:2000733;regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation;51;1;GO:0048608
GO:1904393;regulation of skeletal muscle acetylcholine-gated channel clustering;256;4;GO:0048608
GO:1904392;cellular response to ciliary neurotrophic factor;0;0;GO:0048608
GO:1904391;response to ciliary neurotrophic factor;1;0;GO:0048608
GO:1904390;cone retinal bipolar cell differentiation;161;5;GO:0048666
GO:0062196;regulation of lysosome size;18;6;GO:0048193
GO:0062197;cellular response to chemical stress;500247;533;GO:0009628
GO:1990360;PKM2 protein kinase complex;0;0;GO:0043408
GO:1990361;PKM2 pyruvate kinase complex;0;0;GO:0005740
GO:1990362;butanol dehydrogenase activity;15837;5;GO:0006066
GO:1990353;Fused-Smurf ubiquitin ligase complex;0;1;GO:0005576
GO:2000749;positive regulation of rDNA heterochromatin formation;24;1;GO:0045944
GO:1990354;activated SUMO-E1 ligase complex;0;0;GO:0004842
GO:1990355;L-methionine salvage from methionine sulphoxide;9;1;GO:0009064
GO:1990357;terminal web;344;147;GO:0048305
GO:1990358;xylanosome;0;1;GO:0009579
GO:2000746;regulation of defecation rhythm;31;3;GO:0048608
GO:1990359;stress response to zinc ion;292;3;GO:0006950
GO:2000747;negative regulation of defecation rhythm;6;1;GO:0048608
GO:2000748;positive regulation of defecation rhythm;9;2;GO:0048608
GO:2000741;positive regulation of mesenchymal stem cell differentiation;211;45;GO:0045595
GO:2000742;regulation of anterior head development;152;7;GO:0048704
GO:2000743;negative regulation of anterior head development;0;0;GO:0048704
GO:2000744;positive regulation of anterior head development;114;359;GO:0048704
GO:2000740;negative regulation of mesenchymal stem cell differentiation;145;4;GO:0045595
GO:0015830;diaminopimelate transport;0;2;GO:0006836
GO:0003850;2-deoxyglucose-6-phosphatase activity;225;4;GO:0006066
GO:0003851;2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity;34;10;GO:0006022
GO:0003841;1-acylglycerol-3-phosphate O-acyltransferase activity;69905;851;GO:0008610
GO:0003842;1-pyrroline-5-carboxylate dehydrogenase activity;82752;585;GO:0006066
GO:0003843;1,3-beta-D-glucan synthase activity;13041;185;GO:0006030
GO:0003844;1,4-alpha-glucan branching enzyme activity;94949;547;GO:0005976
GO:0003845;11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity;310;0;GO:0004089
GO:2000756;regulation of peptidyl-lysine acetylation;5381;177;GO:0016567
GO:0003846;2-acylglycerol O-acyltransferase activity;433;40;GO:0004734
GO:2000757;negative regulation of peptidyl-lysine acetylation;482;167;GO:0010401
GO:0003847;1-alkyl-2-acetylglycerophosphocholine esterase activity;11063;173;GO:0008610
GO:0015829;valine transport;511;7;GO:0006836
GO:2000758;positive regulation of peptidyl-lysine acetylation;841;73;GO:0045944
GO:0003848;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity;93674;431;GO:0004061
GO:0015828;tyrosine transport;647;7;GO:0006865
GO:2000759;regulation of N-terminal peptidyl-lysine acetylation;43;2;GO:0016567
GO:0003849;3-deoxy-7-phosphoheptulonate synthase activity;160422;644;GO:0006099
GO:0015827;tryptophan transport;724;136;GO:0006865
GO:2000752;regulation of glucosylceramide catabolic process;57;1;GO:0046394
GO:0015826;threonine transport;8236;94;GO:0006865
GO:2000753;positive regulation of glucosylceramide catabolic process;57;6;GO:0046394
GO:0015825;L-serine transport;619;713;GO:0006865
GO:2000754;regulation of sphingomyelin catabolic process;61;1;GO:0046395
GO:0015824;proline transport;30632;2650;GO:0006865
GO:2000755;positive regulation of sphingomyelin catabolic process;61;5;GO:0046395
GO:0015823;phenylalanine transport;747;9;GO:0006865
GO:0015822;ornithine transport;7146;499;GO:0006836
GO:0015821;methionine transport;41390;13;GO:0006865
GO:2000750;negative regulation of establishment or maintenance of bipolar cell polarity regulating cell shape;0;0;GO:0048706
GO:0015820;leucine transport;1340;157;GO:0006810
GO:0015841;chromaffin granule amine transport;0;3;GO:0006836
GO:0015840;urea transport;30722;311;GO:0006873
GO:0003860;3-hydroxyisobutyryl-CoA hydrolase activity;31829;132;GO:0006081
GO:0003861;3-isopropylmalate dehydratase activity;277017;378;GO:0006099
GO:0003862;3-isopropylmalate dehydrogenase activity;125660;364;GO:0004073
GO:0003852;2-isopropylmalate synthase activity;150349;443;GO:0006099
GO:0003853;2-methylacyl-CoA dehydrogenase activity;92;4;GO:0004089
GO:0003854;3-beta-hydroxy-delta5-steroid dehydrogenase activity;20104;759;GO:0004091
GO:0003855;3-dehydroquinate dehydratase activity;172821;813;GO:0006099
GO:0003856;3-dehydroquinate synthase activity;132222;598;GO:0006099
GO:2000767;positive regulation of cytoplasmic translation;1187;196;GO:0010467
GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity;58611;1030;GO:0004089
GO:2000768;positive regulation of nephron tubule epithelial cell differentiation;145;123;GO:0048193
GO:0003858;3-hydroxybutyrate dehydrogenase activity;19272;141;GO:0004089
GO:2000769;regulation of establishment or maintenance of cell polarity regulating cell shape;309;9;GO:0048608
GO:0015839;cadaverine transport;13;5;GO:0006869
GO:0015838;amino-acid betaine transport;30394;511;GO:0006826
GO:0015837;amine transport;14530;1160;GO:0006865
GO:2000764;positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis;50;1;GO:0048608
GO:0015836;lipid-linked peptidoglycan transport;79746;6;GO:0006869
GO:2000765;regulation of cytoplasmic translation;2664;112;GO:0006412
GO:0015835;peptidoglycan transport;80047;8;GO:0006811
GO:2000766;negative regulation of cytoplasmic translation;545;121;GO:0010467
GO:0015834;peptidoglycan-associated peptide transport;2;4;GO:0008544
GO:0015833;peptide transport;518686;2120;GO:0006865
GO:2000760;negative regulation of N-terminal peptidyl-lysine acetylation;0;1;GO:0016567
GO:2000761;positive regulation of N-terminal peptidyl-lysine acetylation;43;3;GO:0016567
GO:2000762;regulation of phenylpropanoid metabolic process;3582;315;GO:0046274
GO:2000780;negative regulation of double-strand break repair;3376;202;GO:0048285
GO:0003823;antigen binding;3771;3380;GO:0044421
GO:0003824;catalytic activity;283473288;60100;GO:0003824
GO:0015808;L-alanine transport;1641;225;GO:0006865
GO:2000779;regulation of double-strand break repair;12909;399;GO:0006281
GO:0003825;alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity;17547;95;GO:0006032
GO:0015807;L-amino acid transport;98177;877;GO:0005215
GO:0015806;S-methylmethionine transport;4;5;GO:0006865
GO:0003827;alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity;3160;59;GO:0006029
GO:0015805;S-adenosyl-L-methionine transport;1092;8;GO:0006849
GO:2000774;positive regulation of cellular senescence;595;263;GO:0045944
GO:0003828;alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity;710;144;GO:0006022
GO:0015804;neutral amino acid transport;85202;925;GO:0006865
GO:0003829;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;113;163;GO:0004553
GO:0015803;branched-chain amino acid transport;329580;463;GO:0006865
GO:0015802;basic amino acid transport;25872;444;GO:0015837
GO:2000777;positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia;114;73;GO:0016567
GO:0015801;aromatic amino acid transport;24106;169;GO:0006865
GO:2000770;negative regulation of establishment or maintenance of cell polarity regulating cell shape;0;0;GO:0048608
GO:0015800;acidic amino acid transport;19056;871;GO:0006865
GO:2000771;positive regulation of establishment or maintenance of cell polarity regulating cell shape;88;18;GO:0048608
GO:2000772;regulation of cellular senescence;2216;488;GO:0010942
GO:2000773;negative regulation of cellular senescence;1046;540;GO:0010942
GO:2000790;regulation of mesenchymal cell proliferation involved in lung development;117;5;GO:0048704
GO:2000791;negative regulation of mesenchymal cell proliferation involved in lung development;117;10;GO:0048704
GO:0052809;acharan sulfate lyase activity;1;0;GO:0004553
GO:0052807;aflatoxin reductase (coenzyme F420) activity;2;1;GO:0009065
GO:0052808;reduced coenzyme F420:NADP+ oxidoreductase activity;86;1;GO:0008021
GO:0003830;beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity;5101;132;GO:0006029
GO:0003831;beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity;260;222;GO:0006029
GO:0003832;beta-alanyl-dopamine hydrolase activity;9;1;GO:0004867
GO:0003833;beta-alanyl amine synthase activity;26;1;GO:0004497
GO:0003834;beta-carotene 15,15'-dioxygenase activity;2965;3;GO:0004497
GO:2000789;positive regulation of venous endothelial cell fate commitment;0;2;GO:0048706
GO:0003835;beta-galactoside alpha-2,6-sialyltransferase activity;232;137;GO:0004553
GO:0015819;lysine transport;293;161;GO:0006865
GO:0003836;beta-galactoside (CMP) alpha-2,3-sialyltransferase activity;579;89;GO:0004553
GO:0015818;isoleucine transport;332;7;GO:0006869
GO:0003837;beta-ureidopropionase activity;536;58;GO:0004479
GO:0015817;histidine transport;431;236;GO:0006865
GO:0003838;sterol 24-C-methyltransferase activity;1569;8;GO:0004714
GO:0015816;glycine transport;10083;1040;GO:0006836
GO:0052805;imidazole-containing compound catabolic process;65;8;GO:0009065
GO:2000785;regulation of autophagosome assembly;2723;415;GO:0048471
GO:0003839;gamma-glutamylcyclotransferase activity;30584;70;GO:0006469
GO:0052806;sulfite reductase (coenzyme F420) activity;0;1;GO:0006749
GO:2000786;positive regulation of autophagosome assembly;1249;240;GO:0048471
GO:0015814;p-aminobenzoyl-glutamate transport;9225;3;GO:0006874
GO:0052803;imidazole-containing compound metabolic process;375;427;GO:0006730
GO:2000787;regulation of venous endothelial cell fate commitment;0;0;GO:0048706
GO:0015813;L-glutamate transmembrane transport;16005;391;GO:0006836
GO:0052804;nitroimidazole catabolic process;1;2;GO:0009065
GO:2000788;negative regulation of venous endothelial cell fate commitment;0;1;GO:0048706
GO:0015812;gamma-aminobutyric acid transport;13609;3500;GO:0006836
GO:0052801;bicyclic nitroimidazole metabolic process;0;0;GO:0046148
GO:2000781;positive regulation of double-strand break repair;4976;382;GO:0045727
GO:0015811;L-cystine transport;1076;424;GO:0006836
GO:0052802;nitroimidazole metabolic process;0;0;GO:0006749
GO:2000782;regulation of establishment of cell polarity regulating cell shape;7;8;GO:0048608
GO:0015810;aspartate transmembrane transport;2072;235;GO:0006836
GO:2000783;negative regulation of establishment of cell polarity regulating cell shape;0;0;GO:0048608
GO:0052800;bicyclic nitroimidazole catabolic process;0;0;GO:0046395
GO:2000784;positive regulation of establishment of cell polarity regulating cell shape;7;22;GO:0048608
GO:0015874;norepinephrine transport;1179;80;GO:0006836
GO:0015872;dopamine transport;4419;773;GO:0006836
GO:0015871;choline transport;16377;529;GO:0006869
GO:0015870;acetylcholine transport;441;15;GO:0006869
GO:0001228;DNA-binding transcription activator activity, RNA polymerase II-specific;47630;2980;GO:0003700
GO:0001227;DNA-binding transcription repressor activity, RNA polymerase II-specific;18996;1180;GO:0003700
GO:0001223;transcription coactivator binding;2386;489;GO:0030528
GO:0003885;D-arabinono-1,4-lactone oxidase activity;20670;229;GO:0004497
GO:0003886;DNA (cytosine-5-)-methyltransferase activity;69187;1;GO:0003729
GO:0003887;DNA-directed DNA polymerase activity;1415687;5050;GO:0003964
GO:2000796;Notch signaling pathway involved in negative regulation of venous endothelial cell fate commitment;0;2;GO:0048010
GO:2000797;regulation of amniotic stem cell differentiation;45;0;GO:0045766
GO:0015869;protein-DNA complex transport;0;6;GO:0006413
GO:2000798;negative regulation of amniotic stem cell differentiation;45;1;GO:0045766
GO:0015868;purine ribonucleotide transport;84984;222;GO:0006873
GO:2000799;positive regulation of amniotic stem cell differentiation;0;0;GO:0045766
GO:0015867;ATP transport;48779;763;GO:0006810
GO:2000792;positive regulation of mesenchymal cell proliferation involved in lung development;0;1;GO:0048704
GO:0015866;ADP transport;45316;267;GO:0006865
GO:2000793;cell proliferation involved in heart valve development;261;5;GO:0048608
GO:0015865;purine nucleotide transport;87531;176;GO:0006865
GO:2000794;regulation of epithelial cell proliferation involved in lung morphogenesis;346;339;GO:0048608
GO:0015864;pyrimidine nucleoside transport;4964;8;GO:0006865
GO:2000795;negative regulation of epithelial cell proliferation involved in lung morphogenesis;62;56;GO:0048608
GO:0015885;5-formyltetrahydrofolate transport;24;3;GO:0006826
GO:0015884;folic acid transport;2256;369;GO:0006865
GO:0015883;FAD transport;844;9;GO:0006869
GO:0015882;L-ascorbic acid transmembrane transport;12102;6;GO:0006826
GO:0015881;creatine transmembrane transport;869;10;GO:0006873
GO:0015880;coenzyme A transport;838;8;GO:0006869
GO:0003896;DNA primase activity;166076;1140;GO:0003676
GO:0003899;DNA-directed 5'-3' RNA polymerase activity;1238803;629;GO:0003899
GO:0015879;carnitine transport;5809;781;GO:0006836
GO:0015878;biotin transport;67925;102;GO:0006865
GO:0015877;biopterin transport;10;4;GO:0006874
GO:0015876;acetyl-CoA transport;14330;4;GO:0006869
GO:0015851;nucleobase transport;265036;581;GO:0006873
GO:0015850;organic hydroxy compound transport;237707;894;GO:0015717
GO:0003870;5-aminolevulinate synthase activity;24843;330;GO:0004497
GO:0003871;5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity;88959;477;GO:0006749
GO:0003872;6-phosphofructokinase activity;174267;799;GO:0006096
GO:0003873;6-phosphofructo-2-kinase activity;22327;441;GO:0006094
GO:0003863;3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity;14679;116;GO:0006066
GO:0003864;3-methyl-2-oxobutanoate hydroxymethyltransferase activity;135829;657;GO:0006081
GO:0003865;3-oxo-5-alpha-steroid 4-dehydrogenase activity;11267;233;GO:0004497
GO:0003866;3-phosphoshikimate 1-carboxyvinyltransferase activity;158839;605;GO:0006099
GO:0003867;4-aminobutyrate transaminase activity;27504;365;GO:0004089
GO:0003868;4-hydroxyphenylpyruvate dioxygenase activity;29771;116;GO:0004497
GO:0015849;organic acid transport;2198241;2300;GO:0006865
GO:0015848;spermidine transport;11475;18;GO:0006826
GO:0015847;putrescine transport;36019;318;GO:0006826
GO:0015846;polyamine transport;253292;339;GO:0006869
GO:0015844;monoamine transport;14300;656;GO:0006836
GO:0015843;methylammonium transport;343;26;GO:0006865
GO:0015842;aminergic neurotransmitter loading into synaptic vesicle;101;41;GO:0007612
GO:0015863;xanthosine transport;2;2;GO:0006836
GO:0015862;uridine transport;4446;50;GO:0006836
GO:0015861;cytidine transport;447;4;GO:0006865
GO:0015860;purine nucleoside transmembrane transport;20305;28;GO:0008528
GO:0001217;DNA-binding transcription repressor activity;19914;197;GO:0003700
GO:0001216;DNA-binding transcription activator activity;82543;562;GO:0003700
GO:0003880;protein C-terminal carboxyl O-methyltransferase activity;27879;10;GO:0003729
GO:0003881;CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity;4868;182;GO:0008610
GO:0003882;CDP-diacylglycerol-serine O-phosphatidyltransferase activity;25403;112;GO:0004722
GO:0003883;CTP synthase activity;184160;1150;GO:0006099
GO:0003884;D-amino-acid oxidase activity;22245;155;GO:0004401
GO:0001222;transcription corepressor binding;2345;461;GO:0003700
GO:0003874;6-pyruvoyltetrahydropterin synthase activity;4130;67;GO:0004497
GO:0001221;transcription coregulator binding;6563;168;GO:0030528
GO:0003875;ADP-ribosylarginine hydrolase activity;1337;26;GO:0004867
GO:0003876;AMP deaminase activity;18576;307;GO:0004553
GO:0003877;ATP adenylyltransferase activity;4163;8;GO:0003964
GO:0003878;ATP citrate synthase activity;11055;197;GO:0006099
GO:0003879;ATP phosphoribosyltransferase activity;149983;633;GO:0003964
GO:0015859;intracellular nucleoside transport;0;2;GO:0006873
GO:0015858;nucleoside transport;190294;263;GO:0006873
GO:0015857;uracil transport;673;10;GO:0006869
GO:0015856;cytosine transport;30751;2;GO:0006865
GO:0015855;pyrimidine nucleobase transport;32250;40;GO:0006865
GO:0015854;guanine transport;745;5;GO:0006865
GO:0015853;adenine transport;589;36;GO:0006873
GO:0036496;regulation of translational initiation by eIF2 alpha dephosphorylation;42;105;GO:0006414
GO:0061452;retrotrapezoid nucleus neuron differentiation;49;4;GO:0048704
GO:0036497;eIF2alpha dephosphorylation in response to endoplasmic reticulum stress;39;2;GO:0006986
GO:0061453;interstitial cell of Cajal differentiation;33;1;GO:0048706
GO:0036498;IRE1-mediated unfolded protein response;1184;563;GO:0006986
GO:0061454;release of sequestered calcium ion into cytosol by Golgi;1;1;GO:0006836
GO:0036499;PERK-mediated unfolded protein response;838;262;GO:0006986
GO:0036492;eiF2alpha phosphorylation in response to endoplasmic reticulum stress;13;6;GO:0006986
GO:1902552;negative regulation of catalase activity;0;1;GO:0046395
GO:0036493;positive regulation of translation in response to endoplasmic reticulum stress;360;26;GO:0010401
GO:1902553;positive regulation of catalase activity;3;2;GO:0046394
GO:0036494;positive regulation of translation initiation in response to endoplasmic reticulum stress;59;5;GO:0010401
GO:0061450;trophoblast cell migration;822;9;GO:0030900
GO:1902550;lymphoid lineage cell migration into thymus involved in thymus epithelium morphogenesis;0;0;GO:0048703
GO:0036495;negative regulation of translation initiation in response to endoplasmic reticulum stress;0;2;GO:0010467
GO:0061451;retrotrapezoid nucleus development;49;0;GO:0048704
GO:1902551;regulation of catalase activity;3;1;GO:0046394
GO:1902556;phosphatidylinositol transporter complex;4;1;GO:0005576
GO:1902557;5'-adenylyl sulfate transmembrane transporter activity;17;1;GO:0005026
GO:0036490;regulation of translation in response to endoplasmic reticulum stress;605;8;GO:0006986
GO:1902554;serine/threonine protein kinase complex;68415;334;GO:0006468
GO:0036491;regulation of translation initiation in response to endoplasmic reticulum stress;111;3;GO:0006986
GO:0048479;style development;84;6;GO:0048608
GO:1902555;endoribonuclease complex;159850;25;GO:0005576
GO:0061456;mesenchymal stem cell migration involved in uteric bud morphogenesis;1;0;GO:0048608
GO:0061457;mesonephric cell migration involved in male gonad development;1;2;GO:0048608
GO:0061458;reproductive system development;94896;1260;GO:0007275
GO:1902558;5'-adenylyl sulfate transmembrane transport;36;2;GO:0006826
GO:0061459;L-arginine transmembrane transporter activity;7035;9;GO:0005215
GO:1902559;3'-phospho-5'-adenylyl sulfate transmembrane transport;722;1;GO:0006826
GO:0048485;sympathetic nervous system development;1248;1140;GO:0007517
GO:0048484;enteric nervous system development;5769;727;GO:0007420
GO:0048483;autonomic nervous system development;8862;176;GO:0007517
GO:0048482;plant ovule morphogenesis;8;2;GO:0009908
GO:0048489;synaptic vesicle transport;2032;1730;GO:0008030
GO:0097401;synaptic vesicle lumen acidification;844;34;GO:0008030
GO:0048488;synaptic vesicle endocytosis;3318;3610;GO:0008026
GO:0097400;interleukin-17-mediated signaling pathway;597;10;GO:0007188
GO:0048487;beta-tubulin binding;12229;1440;GO:0005524
GO:0097403;cellular response to raffinose;57;8;GO:0009739
GO:0048486;parasympathetic nervous system development;1299;123;GO:0007517
GO:0097402;neuroblast migration;363;7;GO:0048608
GO:0097407;Bunina body;0;1;GO:0048706
GO:0036489;neuromelanin biosynthetic process;0;1;GO:0006073
GO:0048481;plant ovule development;724;165;GO:0009908
GO:0097409;glial cytoplasmic inclusion;57;5;GO:0008021
GO:0048480;stigma development;25;7;GO:0048608
GO:0097408;fibrillary inclusion;0;1;GO:0048407
GO:0036485;dorsolateral trunk neural crest cell migration;0;1;GO:0048704
GO:0061441;renal artery morphogenesis;74;9;GO:0048608
GO:0036486;ventral trunk neural crest cell migration;128;185;GO:0048704
GO:0061442;cardiac muscle cell fate determination;0;2;GO:0007507
GO:1902560;GMP reductase complex;8953;90;GO:0005976
GO:0036487;nitric-oxide synthase inhibitor activity;53;21;GO:0004872
GO:0061443;endocardial cushion cell differentiation;136;2;GO:0048608
GO:0036488;CHOP-C/EBP complex;217;27;GO:0048193
GO:0061444;endocardial cushion cell development;76;6;GO:0007530
GO:0036481;intrinsic apoptotic signaling pathway in response to hydrogen peroxide;503;8;GO:0008630
GO:1902563;regulation of neutrophil activation;423;149;GO:0002684
GO:0036482;neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide;145;6;GO:0097190
GO:1902564;negative regulation of neutrophil activation;173;33;GO:0045087
GO:0036483;neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;144;7;GO:0097190
GO:1902561;origin recognition complex assembly;0;1;GO:0000786
GO:0036484;trunk neural crest cell migration;311;7;GO:0048704
GO:0061440;kidney vasculature development;1266;9;GO:0001944
GO:1902562;H4 histone acetyltransferase complex;39949;187;GO:0016569
GO:0061449;olfactory bulb tufted cell development;0;0;GO:0048699
GO:1902567;negative regulation of eosinophil activation;62;7;GO:0050729
GO:1902568;positive regulation of eosinophil activation;111;8;GO:0050729
GO:1902565;positive regulation of neutrophil activation;140;9;GO:0050729
GO:0036480;neuron intrinsic apoptotic signaling pathway in response to oxidative stress;1292;8;GO:0097190
GO:1902566;regulation of eosinophil activation;173;4;GO:0050729
GO:0061445;endocardial cushion cell fate commitment;58;3;GO:0048704
GO:0061446;endocardial cushion cell fate determination;0;1;GO:0007517
GO:0061447;endocardial cushion cell fate specification;0;0;GO:0007517
GO:1902569;negative regulation of activation of Janus kinase activity;1;3;GO:0046330
GO:0061448;connective tissue development;33255;1590;GO:0001501
GO:0048496;maintenance of animal organ identity;308;34;GO:0048731
GO:0048495;Roundabout binding;451;145;GO:0008092
GO:0048494;chromatophore ribulose bisphosphate carboxylase complex;0;1;GO:0009536
GO:0097410;hippocampal interneuron differentiation;0;4;GO:0048608
GO:0048493;plasma membrane-derived thylakoid ribulose bisphosphate carboxylase complex;0;1;GO:0009536
GO:0097412;hyaline inclusion;0;1;GO:0005578
GO:0048499;synaptic vesicle membrane organization;1330;106;GO:0048471
GO:0097411;hypoxia-inducible factor-1alpha signaling pathway;1405;41;GO:0009719
GO:0048498;establishment of petal orientation;4;3;GO:0048316
GO:0097414;classical Lewy body;57;5;GO:0048207
GO:0048497;maintenance of floral organ identity;31;45;GO:0048316
GO:0097413;Lewy body;400;42;GO:0048207
GO:0097416;Lewy body-like hyaline inclusion;0;1;GO:0048169
GO:0097415;cortical Lewy body;0;1;GO:0048167
GO:0097418;neurofibrillary tangle;178;212;GO:0043161
GO:0097417;nematosome;0;1;GO:0048309
GO:0036478;L-dopa decarboxylase activator activity;48;10;GO:0004867
GO:0048492;ribulose bisphosphate carboxylase complex;0;4;GO:0009536
GO:0036479;peroxidase inhibitor activity;58;4;GO:0004601
GO:0048491;retrograde synaptic vesicle transport;22;3;GO:0006929
GO:0097419;Pick body;0;1;GO:0005737
GO:0048490;anterograde synaptic vesicle transport;893;629;GO:0006903
GO:0061474;phagolysosome membrane;72;10;GO:0030168
GO:1902570;protein localization to nucleolus;971;271;GO:0005829
GO:0061475;cytosolic valyl-tRNA aminoacylation;2;0;GO:0006418
GO:1902571;regulation of serine-type peptidase activity;50;7;GO:0010467
GO:0061476;response to anticoagulant;0;4;GO:0007596
GO:0036477;somatodendritic compartment;95884;864;GO:0097458
GO:0061477;response to aromatase inhibitor;4;3;GO:0030518
GO:0036470;tyrosine 3-monooxygenase activator activity;48;16;GO:0004872
GO:0061470;T follicular helper cell differentiation;224;285;GO:0042254
GO:0036471;cellular response to glyoxal;94;10;GO:0046395
GO:0061471;karyomere assembly;0;2;GO:0000976
GO:1902575;protein localization to cell division site involved in cytokinesis, actomyosin contractile ring assembly;28;0;GO:0007067
GO:0061472;karyomere membrane fusion;33;2;GO:0005576
GO:1902572;negative regulation of serine-type peptidase activity;33;43;GO:0010401
GO:0061473;murein tripeptide carboxypeptidase activity;1346;6;GO:0004721
GO:1902573;positive regulation of serine-type peptidase activity;17;6;GO:0048407
GO:1902576;negative regulation of nuclear cell cycle DNA replication;33;2;GO:0045727
GO:1902577;protein localization to medial cortical node;1;0;GO:0005576
GO:0061478;response to platelet aggregation inhibitor;0;1;GO:0048407
GO:0061479;response to reverse transcriptase inhibitor;0;1;GO:009748
GO:0061480;response to asparaginase;0;0;GO:0006958
GO:0036467;5-hydroxy-L-tryptophan decarboxylase activity;90;3;GO:0004465
GO:0036468;L-dopa decarboxylase activity;116;10;GO:0004497
GO:0036469;L-tryptophan decarboxylase activity;60;4;GO:0009065
GO:0036463;TRAIL receptor activity;19;2;GO:0004896
GO:0061463;O-acetyl-ADP-ribose deacetylase activity;121;3;GO:0004721
GO:0036464;cytoplasmic ribonucleoprotein granule;71814;2290;GO:0005740
GO:0036465;synaptic vesicle recycling;3852;136;GO:0008030
GO:0036466;synaptic vesicle recycling via endosome;361;67;GO:0007049
GO:0036460;cellular response to cell envelope stress;25;17;GO:0050829
GO:0036461;BLOC-2 complex binding;102;5;GO:0048193
GO:0036462;TRAIL-activated apoptotic signaling pathway;568;474;GO:0097190
GO:0061462;protein localization to lysosome;4040;43;GO:0005764
GO:1902584;positive regulation of response to water deprivation;509;25;GO:0045727
GO:0061468;karyomere;0;2;GO:0000976
GO:0061469;regulation of type B pancreatic cell proliferation;715;215;GO:0048608
GO:0036456;L-methionine-(S)-S-oxide reductase activity;268;0;GO:0006067
GO:0036457;keratohyalin granule;38;61;GO:0005576
GO:0036458;hepatocyte growth factor binding;62;4;GO:0005178
GO:0120310;amastigogenesis;0;0;GO:0048608
GO:0120311;ciliary pro-basal body maturation;0;0;GO:0005576
GO:0061411;positive regulation of transcription from RNA polymerase II promoter in response to cold;5;2;GO:0045944
GO:0120312;ciliary basal body segregation;0;3;GO:0048471
GO:0120313;regulation of oocyte karyosome formation;0;2;GO:0048608
GO:0120314;negative regulation of oocyte karyosome formation;0;1;GO:0048706
GO:0120315;positive regulation of oocyte karyosome formation;0;1;GO:0048608
GO:0120316;sperm flagellum assembly;2621;9;GO:0005576
GO:0048438;floral whorl development;4502;466;GO:0048316
GO:0120317;sperm mitochondrial sheath assembly;210;3;GO:0005576
GO:1902512;positive regulation of apoptotic DNA fragmentation;105;68;GO:0042981
GO:0048437;floral organ development;6698;447;GO:0009908
GO:0061417;negative regulation of transcription from RNA polymerase II promoter in response to oxidative stress;1;0;GO:0045944
GO:0120318;olfactory sociosexual communication;0;0;GO:0007589
GO:1902513;regulation of organelle transport along microtubule;358;10;GO:0048285
GO:0061418;regulation of transcription from RNA polymerase II promoter in response to hypoxia;511;833;GO:0045944
GO:0120319;long-chain fatty acid omega-1 hydroxylase activity;129;4;GO:0004041
GO:1902510;regulation of apoptotic DNA fragmentation;426;84;GO:0042981
GO:0061419;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia;272;197;GO:0045944
GO:1902511;negative regulation of apoptotic DNA fragmentation;173;8;GO:0043066
GO:1902516;sn-glycerol 3-phosphate binding;1;0;GO:0097159
GO:0061413;regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source;46;1;GO:0006355
GO:1902517;glycerol-3-phosphate-transporting ATPase complex;4;0;GO:0008023
GO:0061414;positive regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source;29;5;GO:0045944
GO:1902514;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;340;43;GO:0006816
GO:0048439;flower morphogenesis;179;47;GO:0048437
GO:0061415;negative regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source;17;2;GO:0045944
GO:1902515;thioredoxin-disulfide reductase complex;1;2;GO:0005737
GO:0048441;petal development;202;43;GO:0009908
GO:1902509;methionine-importing complex;3;0;GO:0009086
GO:0048440;carpel development;1144;464;GO:0009952
GO:1902507;thiazole synthase complex;0;0;GO:0009536
GO:1902508;2-iminoacetate synthase complex;2;0;GO:0005576
GO:0048445;carpel morphogenesis;67;2;GO:0048608
GO:0048444;floral organ morphogenesis;931;185;GO:0048468
GO:0048443;stamen development;2761;330;GO:0009908
GO:0048442;sepal development;93;10;GO:0009908
GO:0120300;peptide lactyltransferase activity;66;1;GO:0004712
GO:0120301;histone lactyltransferase activity;64;3;GO:0004721
GO:0120302;background adaptation;152;0;GO:0009416
GO:0120303;visually-mediated background adaptation;0;1;GO:0009416
GO:1902520;response to doxorubicin;0;2;GO:0042981
GO:0120304;integument-mediated background adaptation;0;0;GO:0009628
GO:0120305;regulation of pigmentation;1505;4;GO:0043473
GO:0048449;floral organ formation;550;250;GO:0048437
GO:0120306;cellular response to actin cytoskeletal stress;0;1;GO:0006950
GO:1902523;positive regulation of protein K63-linked ubiquitination;361;35;GO:0048193
GO:0048448;stamen morphogenesis;231;8;GO:0048468
GO:0061406;positive regulation of transcription from RNA polymerase II promoter in response to glucose starvation;0;3;GO:0045944
GO:0120307;Hechtian strand;0;0;GO:0005576
GO:1902524;positive regulation of protein K48-linked ubiquitination;149;6;GO:0016567
GO:0048447;sepal morphogenesis;34;0;GO:0048316
GO:0061407;positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide;2;3;GO:0045944
GO:0120308;axonemal outer doublet assembly;0;1;GO:0005576
GO:1902521;response to etoposide;0;2;GO:0042981
GO:0048446;petal morphogenesis;63;6;GO:0048437
GO:0061408;positive regulation of transcription from RNA polymerase II promoter in response to heat stress;61;49;GO:0045944
GO:0120309;cilium attachment to cell body;0;3;GO:0005929
GO:1902522;response to 4'-epidoxorubicin;0;2;GO:0010468
GO:1902527;positive regulation of protein monoubiquitination;196;74;GO:0016567
GO:0061402;positive regulation of transcription from RNA polymerase II promoter in response to acidic pH;115;10;GO:0045944
GO:1902528;regulation of protein linear polyubiquitination;142;6;GO:0016567
GO:1902525;regulation of protein monoubiquitination;246;40;GO:0043687
GO:1902526;negative regulation of protein monoubiquitination;0;1;GO:0042787
GO:0048452;petal structural organization;0;1;GO:0048437
GO:0048451;petal formation;8;139;GO:0048316
GO:0048450;floral organ structural organization;41;0;GO:0048468
GO:1902518;response to cyclophosphamide;0;3;GO:0010033
GO:1902519;response to docetaxel trihydrate;0;2;GO:0042127
GO:0048456;stamen structural organization;0;0;GO:0048316
GO:0048455;stamen formation;157;9;GO:0048316
GO:0048454;sepal structural organization;0;1;GO:0048468
GO:0048453;sepal formation;34;10;GO:0048316
GO:0061430;bone trabecula morphogenesis;605;131;GO:0001503
GO:0050365;tryptophanamidase activity;0;2;GO:0004867
GO:0050364;tryptophan dimethylallyltransferase activity;167;5;GO:0004067
GO:0050367;tyrosine-arginine ligase activity;0;3;GO:0004812
GO:0050366;tyramine N-feruloyltransferase activity;17;3;GO:0006073
GO:0050361;tryptophan 2-monooxygenase activity;465;3;GO:0004497
GO:0050360;tryptophan 2'-dioxygenase activity;0;0;GO:0004497
GO:0050363;tryptophan dehydrogenase activity;5;2;GO:0009065
GO:0050362;L-tryptophan:2-oxoglutarate aminotransferase activity;21;5;GO:0009065
GO:0050369;[tyrosine 3-monooxygenase] kinase activity;0;3;GO:0004713
GO:0050368;tyrosine 2,3-aminomutase activity;158;3;GO:0004061
GO:1902130;(+)-lariciresinol metabolic process;11;3;GO:0046356
GO:1904793;regulation of euchromatin binding;0;9;GO:0016569
GO:1902131;(+)-lariciresinol catabolic process;5;1;GO:0046274
GO:1904792;positive regulation of shelterin complex assembly;49;0;GO:0048193
GO:1904791;negative regulation of shelterin complex assembly;57;0;GO:0048193
GO:1904790;regulation of shelterin complex assembly;106;0;GO:0048193
GO:1902134;(+)-secoisolariciresinol catabolic process;0;0;GO:0046274
GO:1904797;negative regulation of core promoter binding;3;3;GO:0045944
GO:1902135;(+)-secoisolariciresinol biosynthetic process;3;1;GO:0046405
GO:1904796;regulation of core promoter binding;16;44;GO:0000122
GO:1902132;(+)-lariciresinol biosynthetic process;6;1;GO:0046405
GO:1904795;positive regulation of euchromatin binding;0;0;GO:0016567
GO:1902133;(+)-secoisolariciresinol metabolic process;3;2;GO:0046356
GO:1904794;negative regulation of euchromatin binding;0;0;GO:0016525
GO:1902138;(-)-secoisolariciresinol biosynthetic process;6;1;GO:0046274
GO:1902136;(-)-secoisolariciresinol metabolic process;6;2;GO:0046356
GO:1904799;regulation of neuron remodeling;177;9;GO:0048666
GO:0050380;undecaprenyl-diphosphatase activity;172614;285;GO:0003906
GO:1902137;(-)-secoisolariciresinol catabolic process;0;0;GO:0046274
GO:1904798;positive regulation of core promoter binding;12;65;GO:0045944
GO:0050376;UDP-glucosamine 4-epimerase activity;0;3;GO:0006029
GO:0050378;UDP-glucuronate 4-epimerase activity;418;8;GO:0006081
GO:0050377;UDP-glucose 4,6-dehydratase activity;105;9;GO:0006066
GO:0050371;tyrosine phenol-lyase activity;3042;5;GO:0004061
GO:0050374;UDP-galacturonate decarboxylase activity;1;3;GO:0006029
GO:0050373;UDP-arabinose 4-epimerase activity;91;5;GO:0006032
GO:0050379;UDP-glucuronate 5'-epimerase activity;1;0;GO:0004497
GO:1902141;cellular response to inositol;1;0;GO:0009719
GO:1902140;response to inositol;1;0;GO:0009719
GO:1902145;regulation of response to cell cycle checkpoint signaling;55;0;GO:0045727
GO:1902146;positive regulation of response to cell cycle checkpoint signaling;0;1;GO:0045727
GO:0050390;valine decarboxylase activity;0;3;GO:0006066
GO:0050392;vicianin beta-glucosidase activity;5;3;GO:0004553
GO:1902147;regulation of response to cytokinesis checkpoint signaling;0;0;GO:0048285
GO:0050391;valine dehydrogenase (NADP) activity;15;3;GO:0009065
GO:1902148;positive regulation of response to cytokinesis checkpoint signaling;0;0;GO:0048285
GO:0050387;urethanase activity;2;3;GO:0004553
GO:0050386;ureidosuccinase activity;0;3;GO:0006067
GO:0050389;uronolactonase activity;0;3;GO:0004730
GO:0050388;uronate dehydrogenase activity;398;4;GO:0004073
GO:0050383;uracil dehydrogenase activity;0;3;GO:0004073
GO:0050382;uracil-5-carboxylate decarboxylase activity;1;3;GO:0006066
GO:0050385;ureidoglycolate lyase activity;31129;10;GO:0004553
GO:0050384;urate-ribonucleotide phosphorylase activity;0;2;GO:0003964
GO:1990640;inositol-2,4,5-triphosphate 5-phosphatase activity;4;2;GO:0004721
GO:1990641;response to iron ion starvation;275;100;GO:0006826
GO:1990643;cellular response to granulocyte colony-stimulating factor;1;3;GO:0002576
GO:1990644;microtubule site clamp;17;0;GO:0005524
GO:1990646;cellular response to prolactin;15;5;GO:0048608
GO:1990647;C/EBP complex;113;2;GO:0030528
GO:1990648;inositol-4,5,6-triphosphate 5-phosphatase activity;4;2;GO:0004721
GO:1990649;inositol-1,2,4,5-tetrakisphosphate 5-phosphatase activity;4;2;GO:0004721
GO:1990660;calprotectin complex;0;3;GO:0005829
GO:1990650;inositol-2,4,5,6-tetrakisphosphate 5-phosphatase activity;4;2;GO:0004721
GO:1990651;inositol-1,2,4,5,6-pentakisphosphate 5-phosphatase activity;4;2;GO:0004721
GO:1990654;sebum secreting cell proliferation;150;8;GO:0042127
GO:1990655;4 iron, 3 sulfur cluster binding;0;2;GO:0005525
GO:1990656;t-SNARE clustering;4;0;GO:0008021
GO:1990657;iNOS-S100A8/A9 complex;0;3;GO:0043161
GO:1990658;transnitrosylase complex;0;1;GO:0005737
GO:1990659;sequestering of manganese ion;0;1;GO:0006836
GO:1990670;vesicle fusion with Golgi cis cisterna membrane;0;0;GO:0005766
GO:1990671;vesicle fusion with Golgi medial cisterna membrane;0;0;GO:0005766
GO:1990661;S100A8 complex;0;1;GO:0043161
GO:1990662;S100A9 complex;0;3;GO:0043161
GO:1990663;dihydroorotate dehydrogenase (fumarate) activity;3785;3;GO:0006066
GO:1990664;Nkx-2.5 complex;61;3;GO:0048704
GO:1990665;AnxA2-p11 complex;80;3;GO:0048193
GO:1990666;PCSK9-LDLR complex;101;102;GO:0048193
GO:1990667;PCSK9-AnxA2 complex;88;25;GO:0043405
GO:1990668;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;0;5;GO:0005764
GO:1990669;endoplasmic reticulum-Golgi intermediate compartment (ERGIC) derived vesicle fusion with endoplasmic reticulum membrane;0;2;GO:0006986
GO:1990680;response to melanocyte-stimulating hormone;126;4;GO:0002504
GO:1990682;CSF1-CSF1R complex;116;71;GO:0002449
GO:1990672;medial-Golgi-derived vesicle fusion with Golgi trans cisterna membrane;0;1;GO:0006906
GO:1990674;Golgi cis cisterna membrane;161;2;GO:0005764
GO:1990675;Golgi medial cisterna membrane;74;2;GO:0005764
GO:1990676;Golgi trans cisterna membrane;79;1;GO:0005764
GO:1990677;mitochondrial inner membrane assembly complex;5;0;GO:0005743
GO:1990678;histone H4-K16 deacetylation;0;2;GO:0016569
GO:1990679;histone H4-K12 deacetylation;0;2;GO:0016569
GO:1902075;cellular response to salt;75290;150;GO:0050832
GO:1902076;regulation of lateral motor column neuron migration;44;0;GO:0048704
GO:1902073;positive regulation of hypoxia-inducible factor-1alpha signaling pathway;1143;3;GO:0010713
GO:1902074;response to salt;109229;425;GO:0006950
GO:1902079;D-valine catabolic process;0;0;GO:0009065
GO:1902077;negative regulation of lateral motor column neuron migration;0;0;GO:0048704
GO:1902078;positive regulation of lateral motor column neuron migration;44;1;GO:0048704
GO:1990690;Golgi medial cisterna-derived vesicle fusion with Golgi cis cisterna membrane;0;1;GO:0005764
GO:1990691;cis-Golgi-derived vesicle fusion with Golgi medial cisterna membrane;0;1;GO:0005764
GO:1990692;trans-Golgi-derived vesicle fusion with Golgi medial cisterna membrane;0;0;GO:0005764
GO:1990683;DNA double-strand break attachment to nuclear envelope;97;7;GO:0007040
GO:1990684;protein-lipid-RNA complex;0;0;GO:0030529
GO:0003920;GMP reductase activity;34835;280;GO:0003824
GO:1990685;HDL-containing protein-lipid-RNA complex;0;1;GO:0005829
GO:0003921;GMP synthase activity;52283;228;GO:0004497
GO:0015909;long-chain fatty acid transport;29364;984;GO:0006869
GO:1990686;LDL-containing protein-lipid-RNA complex;0;0;GO:0005840
GO:0003922;GMP synthase (glutamine-hydrolyzing) activity;218255;645;GO:0006099
GO:0015908;fatty acid transport;35145;1600;GO:0006869
GO:1990687;endoplasmic reticulum-derived vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;0;2;GO:0006986
GO:0003923;GPI-anchor transamidase activity;4221;254;GO:0005576
GO:1990688;Golgi vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;0;1;GO:0006612
GO:0003924;GTPase activity;2732969;15700;GO:0003924
GO:1990689;endoplasmic reticulum-Golgi intermediate compartment (ERGIC) derived vesicle fusion with Golgi cis cisterna membrane;0;1;GO:0005764
GO:0003925;G protein activity;12629;163;GO:0004930
GO:0015905;bicyclomycin transmembrane transport;0;2;GO:0005215
GO:0015904;tetracycline transmembrane transport;6;3;GO:0008565
GO:0015903;fluconazole transport;40;5;GO:0006811
GO:0015901;cycloheximide transport;0;4;GO:0006810
GO:1902071;regulation of hypoxia-inducible factor-1alpha signaling pathway;1188;5;GO:0010721
GO:1902072;negative regulation of hypoxia-inducible factor-1alpha signaling pathway;45;2;GO:0010468
GO:1902070;positive regulation of sphingolipid mediated signaling pathway;30;2;GO:0045765
GO:1902086;fumagillin biosynthetic process;15;1;GO:0006021
GO:1902087;dimethylsulfoniopropionate catabolic process;0;0;GO:0046395
GO:1902084;fumagillin metabolic process;15;1;GO:0006721
GO:1902085;fumagillin catabolic process;0;1;GO:0009065
GO:1902088;plant-type cell wall loosening involved in abscission;0;0;GO:0009813
GO:1902089;cell wall polysaccharide catabolic process involved in lateral root development;0;0;GO:0046274
GO:2000606;regulation of cell proliferation involved in mesonephros development;51;0;GO:0048608
GO:2000607;negative regulation of cell proliferation involved in mesonephros development;51;6;GO:0045766
GO:1990696;USH2 complex;141;9;GO:0048471
GO:2000608;positive regulation of cell proliferation involved in mesonephros development;0;1;GO:0048608
GO:1990697;protein depalmitoleylation;10;8;GO:0006464
GO:2000609;regulation of thyroid hormone generation;314;27;GO:0048193
GO:0003933;GTP cyclohydrolase activity;308376;334;GO:0004721
GO:0015919;peroxisomal membrane transport;38316;43;GO:0006629
GO:1990698;palmitoleoyltransferase activity;149;42;GO:0004734
GO:0003934;GTP cyclohydrolase I activity;168914;512;GO:0004721
GO:0015918;sterol transport;47083;1810;GO:0006869
GO:1990699;palmitoleyl hydrolase activity;149;9;GO:0004721
GO:2000603;regulation of secondary growth;12;1;GO:0010468
GO:0003935;GTP cyclohydrolase II activity;121226;392;GO:0004061
GO:0015917;aminophospholipid transport;2591;57;GO:0006869
GO:2000604;negative regulation of secondary growth;7;3;GO:0010468
GO:0015916;fatty-acyl-CoA transport;14531;6;GO:0006869
GO:2000605;positive regulation of secondary growth;5;1;GO:0045944
GO:0003937;IMP cyclohydrolase activity;152462;1210;GO:0004497
GO:0003938;IMP dehydrogenase activity;166780;821;GO:0004721
GO:0015914;phospholipid transport;126207;2270;GO:0006869
GO:0003939;L-iditol 2-dehydrogenase activity;4400;143;GO:0004497
GO:0015913;short-chain fatty acid transmembrane transport;287;1;GO:0008544
GO:0015912;short-chain fatty acid transport;521;63;GO:0006865
GO:2000601;positive regulation of Arp2/3 complex-mediated actin nucleation;681;83;GO:0048608
GO:0015911;long-chain fatty acid import across plasma membrane;452;6;GO:0006869
GO:1902082;positive regulation of calcium ion import into sarcoplasmic reticulum;9;4;GO:0006836
GO:0015910;long-chain fatty acid import into peroxisome;1548;79;GO:0006635
GO:1902083;negative regulation of peptidyl-cysteine S-nitrosylation;234;72;GO:0046395
GO:1902080;regulation of calcium ion import into sarcoplasmic reticulum;114;9;GO:0006836
GO:1902081;negative regulation of calcium ion import into sarcoplasmic reticulum;105;129;GO:0006836
GO:1902098;calcitriol binding;63;2;GO:0005509
GO:1902099;regulation of metaphase/anaphase transition of cell cycle;22903;1430;GO:0000086
GO:2000617;positive regulation of histone H3-K9 acetylation;80;110;GO:0045944
GO:2000613;negative regulation of thyroid-stimulating hormone secretion;0;0;GO:0048193
GO:2000614;positive regulation of thyroid-stimulating hormone secretion;2;0;GO:0048193
GO:2000615;regulation of histone H3-K9 acetylation;119;30;GO:0045944
GO:2000616;negative regulation of histone H3-K9 acetylation;39;8;GO:0045944
GO:0003904;deoxyribodipyrimidine photo-lyase activity;8395;32;GO:0004730
GO:0003905;alkylbase DNA N-glycosylase activity;89016;43;GO:0004518
GO:1902090;regulation of fumagillin biosynthetic process;2;0;GO:0010401
GO:2000610;negative regulation of thyroid hormone generation;0;3;GO:0048169
GO:0003906;DNA-(apurinic or apyrimidinic site) endonuclease activity;325099;0;GO:0004518
GO:2000611;positive regulation of thyroid hormone generation;209;40;GO:0048193
GO:2000612;regulation of thyroid-stimulating hormone secretion;45;8;GO:0048193
GO:0003908;methylated-DNA-[protein]-cysteine S-methyltransferase activity;167608;0;GO:0003729
GO:1902093;positive regulation of flagellated sperm motility;601;9;GO:0048193
GO:0003909;DNA ligase activity;300106;260;GO:0004518
GO:1902091;negative regulation of fumagillin biosynthetic process;0;0;GO:0010468
GO:1902092;positive regulation of fumagillin biosynthetic process;2;1;GO:0046395
GO:2000628;regulation of miRNA metabolic process;4884;218;GO:0045934
GO:2000629;negative regulation of miRNA metabolic process;1248;3;GO:0045730
GO:0003910;DNA ligase (ATP) activity;115805;697;GO:0004518
GO:0003911;DNA ligase (NAD+) activity;147008;1;GO:0004518
GO:2000624;positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;26;3;GO:0045944
GO:0003912;DNA nucleotidylexotransferase activity;1870;9;GO:0004518
GO:2000625;regulation of miRNA catabolic process;335;7;GO:0010433
GO:0003913;DNA photolyase activity;15102;276;GO:0003677
GO:2000626;negative regulation of miRNA catabolic process;72;2;GO:0045730
GO:0003914;DNA (6-4) photolyase activity;210;9;GO:0003677
GO:2000627;positive regulation of miRNA catabolic process;263;172;GO:0045730
GO:2000620;positive regulation of histone H4-K16 acetylation;50;240;GO:0045944
GO:0003916;DNA topoisomerase activity;1281561;1410;GO:0003676
GO:2000621;regulation of DNA replication termination;21;0;GO:0006281
GO:0003917;DNA topoisomerase type I (single strand cut, ATP-independent) activity;232241;480;GO:0003676
GO:2000622;regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;722;100;GO:0045944
GO:0003918;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity;603147;853;GO:0003676
GO:2000623;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;488;80;GO:0045944
GO:0003919;FMN adenylyltransferase activity;152796;881;GO:0004867
GO:0015951;purine ribonucleotide interconversion;2;2;GO:0006749
GO:0015950;purine nucleotide interconversion;3;8;GO:0006749
GO:0003972;RNA ligase (ATP) activity;9946;49;GO:0004518
GO:0003962;cystathionine gamma-synthase activity;11149;20;GO:0004067
GO:2000639;negative regulation of SREBP signaling pathway;282;9;GO:0045944
GO:0003963;RNA-3'-phosphate cyclase activity;18903;6;GO:0003964
GO:0003964;RNA-directed DNA polymerase activity;966380;2410;GO:0003964
GO:2000635;negative regulation of primary miRNA processing;162;7;GO:0010467
GO:2000636;positive regulation of primary miRNA processing;189;5;GO:0010467
GO:0003968;RNA-dependent RNA polymerase activity;822563;399;GO:0003964
GO:2000637;positive regulation of miRNA-mediated gene silencing;832;27;GO:0045730
GO:0015949;nucleobase-containing small molecule interconversion;1279;2360;GO:0006749
GO:2000638;regulation of SREBP signaling pathway;2477;9;GO:0030514
GO:0015948;methanogenesis;91441;78;GO:0009061
GO:2000631;regulation of pre-miRNA processing;302;5;GO:0010467
GO:0015947;methane metabolic process;91645;6;GO:0006096
GO:2000632;negative regulation of pre-miRNA processing;183;9;GO:0010467
GO:0015946;methanol oxidation;594;5;GO:0032787
GO:2000633;positive regulation of pre-miRNA processing;119;5;GO:0010467
GO:0015945;methanol metabolic process;1762;4;GO:0006091
GO:2000634;regulation of primary miRNA processing;355;3;GO:0010467
GO:0015944;formate oxidation;11536;23;GO:0009062
GO:0015943;formate biosynthetic process;0;4;GO:0006099
GO:0015942;formate metabolic process;100863;433;GO:0006066
GO:0015941;pantothenate catabolic process;39926;8;GO:0009062
GO:2000630;positive regulation of miRNA metabolic process;3401;51;GO:0045730
GO:0015962;diadenosine triphosphate metabolic process;67;2;GO:0006793
GO:0015961;diadenosine polyphosphate catabolic process;480;52;GO:0046395
GO:0015960;diadenosine polyphosphate biosynthetic process;146;6;GO:0009065
GO:0052908;16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase activity;61436;0;GO:0003906
GO:0052909;18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity;2072;0;GO:0003906
GO:0052906;tRNA (guanine(37)-N(1))-methyltransferase activity;115566;0;GO:0003735
GO:0052907;23S rRNA (adenine(1618)-N(6))-methyltransferase activity;8565;0;GO:0003735
GO:0003980;UDP-glucose:glycoprotein glucosyltransferase activity;7076;50;GO:0005581
GO:0003983;UTP:glucose-1-phosphate uridylyltransferase activity;110358;451;GO:0006096
GO:0003973;(S)-2-hydroxy-acid oxidase activity;6963;0;GO:0004091
GO:0003974;UDP-N-acetylglucosamine 4-epimerase activity;2130;50;GO:0006029
GO:0003975;UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity;11322;112;GO:0006029
GO:0003976;UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;233;68;GO:0005929
GO:0003977;UDP-N-acetylglucosamine diphosphorylase activity;113585;385;GO:0006032
GO:2000646;positive regulation of receptor catabolic process;295;52;GO:0048608
GO:0003978;UDP-glucose 4-epimerase activity;169233;1110;GO:0006032
GO:2000647;negative regulation of stem cell proliferation;1183;275;GO:0045766
GO:0003979;UDP-glucose 6-dehydrogenase activity;128733;330;GO:0006096
GO:2000648;positive regulation of stem cell proliferation;2716;496;GO:0045727
GO:2000649;regulation of sodium ion transmembrane transporter activity;232;464;GO:0005215
GO:0015959;diadenosine polyphosphate metabolic process;683;4;GO:0006073
GO:0052904;N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity;57;5;GO:0006096
GO:2000642;negative regulation of early endosome to late endosome transport;100;8;GO:0048193
GO:0015958;bis(5'-nucleosidyl) oligophosphate catabolic process;0;1;GO:0009065
GO:0052905;tRNA (guanine(9)-N(1))-methyltransferase activity;3361;0;GO:0003735
GO:2000643;positive regulation of early endosome to late endosome transport;472;51;GO:0048193
GO:0015957;bis(5'-nucleosidyl) oligophosphate biosynthetic process;0;0;GO:0009065
GO:0052902;spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity;53;5;GO:0004091
GO:2000644;regulation of receptor catabolic process;525;13;GO:0048608
GO:0015956;bis(5'-nucleosidyl) oligophosphate metabolic process;0;0;GO:0006519
GO:0052903;N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity;114;4;GO:0006096
GO:2000645;negative regulation of receptor catabolic process;136;17;GO:0048608
GO:0015955;pyrimidine deoxyribonucleotide interconversion;0;3;GO:0006793
GO:0052900;spermine oxidase (propane-1,3-diamine-forming) activity;20;2;GO:0004730
GO:0015954;pyrimidine ribonucleotide interconversion;0;3;GO:0006793
GO:0052901;spermine:oxygen oxidoreductase (spermidine-forming) activity;206;86;GO:0004091
GO:0015953;pyrimidine nucleotide interconversion;0;5;GO:0006793
GO:2000640;positive regulation of SREBP signaling pathway;2114;4;GO:0030513
GO:0015952;purine deoxyribonucleotide interconversion;0;2;GO:0006796
GO:2000641;regulation of early endosome to late endosome transport;5421;773;GO:0048193
GO:0052919;aliphatic (R)-hydroxynitrile lyase activity;1;0;GO:0004073
GO:0052917;dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase;2530;0;GO:0005524
GO:0052918;dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity;2859;0;GO:0006022
GO:0003950;NAD+ ADP-ribosyltransferase activity;71805;2480;GO:0004867
GO:0003940;L-iduronidase activity;134;63;GO:0004553
GO:0003941;L-serine ammonia-lyase activity;141543;883;GO:0004067
GO:0003942;N-acetyl-gamma-glutamyl-phosphate reductase activity;134770;576;GO:0004067
GO:0003943;N-acetylgalactosamine-4-sulfatase activity;170;242;GO:0006029
GO:0003944;N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity;43;7;GO:0004553
GO:2000657;negative regulation of apolipoprotein binding;1;10;GO:0048193
GO:0003945;N-acetyllactosamine synthase activity;224;172;GO:0006029
GO:0015929;hexosaminidase activity;179335;46;GO:0004553
GO:2000658;positive regulation of apolipoprotein binding;0;2;GO:0048193
GO:0015928;fucosidase activity;51002;35;GO:0004553
GO:2000659;regulation of interleukin-1-mediated signaling pathway;360;148;GO:0050729
GO:0003947;(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity;116;0;GO:0006029
GO:0015927;trehalase activity;49312;99;GO:0006032
GO:0003948;N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity;607;0;GO:0004553
GO:0015926;glucosidase activity;173379;559;GO:0004553
GO:0052915;23S rRNA (guanine(2445)-N(2))-methyltransferase activity;17870;0;GO:0003735
GO:0003949;1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase activity;130165;0;GO:0003954
GO:0015925;galactosidase activity;233426;158;GO:0004553
GO:0052916;23S rRNA (guanine(1835)-N(2))-methyltransferase activity;6660;0;GO:0003735
GO:2000654;regulation of cellular response to testosterone stimulus;116;1;GO:0048545
GO:0015924;mannosyl-oligosaccharide mannosidase activity;32048;48;GO:0006029
GO:0052913;16S rRNA (guanine(966)-N(2))-methyltransferase activity;20052;0;GO:0003735
GO:2000655;negative regulation of cellular response to testosterone stimulus;49;5;GO:0010468
GO:0015923;mannosidase activity;113847;329;GO:0004553
GO:0052914;16S rRNA (guanine(1207)-N(2))-methyltransferase activity;7947;0;GO:0003735
GO:2000656;regulation of apolipoprotein binding;1;7;GO:0048193
GO:0052911;23S rRNA (guanine(745)-N(1))-methyltransferase activity;1881;0;GO:0003735
GO:0052912;23S rRNA (guanine(748)-N(1))-methyltransferase activity;100;0;GO:0003735
GO:2000650;negative regulation of sodium ion transmembrane transporter activity;35;57;GO:0045766
GO:0015920;lipopolysaccharide transport;80237;874;GO:0005553
GO:2000651;positive regulation of sodium ion transmembrane transporter activity;161;304;GO:0050890
GO:0052910;23S rRNA (adenine(2085)-N(6))-dimethyltransferase activity;548;0;GO:0003906
GO:2000652;regulation of secondary cell wall biogenesis;257;105;GO:0046364
GO:0015940;pantothenate biosynthetic process;504202;912;GO:0009061
GO:2000670;positive regulation of dendritic cell apoptotic process;93;51;GO:0043066
GO:0052929;ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity;124;0;GO:0003964
GO:0003960;NADPH:quinone reductase activity;26790;160;GO:0004067
GO:0003961;O-acetylhomoserine aminocarboxypropyltransferase activity;10535;5;GO:0004073
GO:0003951;NAD+ kinase activity;228133;1330;GO:0004721
GO:0003952;NAD+ synthase (glutamine-hydrolyzing) activity;133873;495;GO:0004723
GO:0003953;NAD+ nucleosidase activity;15913;81;GO:0004725
GO:0003954;NADH dehydrogenase activity;1760937;2260;GO:0003954
GO:0003955;NAD(P)H dehydrogenase (quinone) activity;1771846;321;GO:0004746
GO:2000668;regulation of dendritic cell apoptotic process;465;35;GO:0043066
GO:2000669;negative regulation of dendritic cell apoptotic process;372;204;GO:0043066
GO:0003957;NAD(P)+ transhydrogenase (B-specific) activity;11887;0;GO:0006749
GO:0015939;pantothenate metabolic process;544266;1050;GO:0009063
GO:0003958;NADPH-hemoprotein reductase activity;27924;289;GO:0004067
GO:0015938;coenzyme A catabolic process;335;69;GO:0009062
GO:0003959;NADPH dehydrogenase activity;33611;30;GO:0004784
GO:0015937;coenzyme A biosynthetic process;678534;2300;GO:0006022
GO:0052926;dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity;2860;0;GO:0006022
GO:0015936;coenzyme A metabolic process;698887;604;GO:0006732
GO:0052927;CTP:tRNA cytidylyltransferase activity;18;4;GO:0006457
GO:0015935;small ribosomal subunit;453094;3640;GO:0005840
GO:0052924;all-trans-nonaprenyl-diphosphate synthase (geranylgeranyl-diphosphate specific) activity;47;3;GO:0004497
GO:0015934;large ribosomal subunit;492325;3320;GO:0005840
GO:0052925;dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity;3190;0;GO:0006022
GO:0052922;hexaprenyl diphosphate synthase (geranylgeranyl-diphosphate specific) activity;6;6;GO:0004091
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;251;329;GO:0050729
GO:0015932;nucleobase-containing compound transmembrane transporter activity;146869;244;GO:0008528
GO:0052923;all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity;405;9;GO:0006096
GO:2000661;positive regulation of interleukin-1-mediated signaling pathway;44;42;GO:0050729
GO:0015931;nucleobase-containing compound transport;528533;1100;GO:0006865
GO:0015930;glutamate synthase activity;99383;686;GO:0003824
GO:0015995;chlorophyll biosynthetic process;115014;1860;GO:0009579
GO:0015994;chlorophyll metabolic process;120114;705;GO:0019613
GO:0015990;electron transport coupled proton transport;37277;727;GO:009700
GO:2000679;positive regulation of transcription regulatory region DNA binding;117;419;GO:0030528
GO:1990600;single-stranded DNA endodeoxyribonuclease activator activity;0;1;GO:0003676
GO:1990601;5' overhang single-stranded DNA endodeoxyribonuclease activity;6;1;GO:0004518
GO:1990603;dark adaptation;96;1;GO:0009416
GO:2000675;negative regulation of type B pancreatic cell apoptotic process;261;309;GO:0043066
GO:1990604;IRE1-TRAF2-ASK1 complex;532;41;GO:0043161
GO:2000676;positive regulation of type B pancreatic cell apoptotic process;63;43;GO:0010941
GO:1990605;GU repeat RNA binding;43;1;GO:0003723
GO:2000677;regulation of transcription regulatory region DNA binding;230;44;GO:0003700
GO:1990606;membrane scission GTPase motor activity;2;2;GO:0005524
GO:2000678;negative regulation of transcription regulatory region DNA binding;95;807;GO:0010468
GO:0015988;energy coupled proton transmembrane transport, against electrochemical gradient;37280;998;GO:0015986
GO:2000671;regulation of motor neuron apoptotic process;728;26;GO:0048608
GO:0015987;GTP synthesis coupled proton transport;0;1;GO:0009060
GO:1990608;mitotic spindle pole body localization;39;1;GO:0007062
GO:2000672;negative regulation of motor neuron apoptotic process;569;68;GO:0048608
GO:0015986;proton motive force-driven ATP synthesis;1932107;908;GO:0005746
GO:1990609;glutamate-cysteine ligase regulator activity;3;2;GO:0005524
GO:2000673;positive regulation of motor neuron apoptotic process;102;4;GO:0048608
GO:0015985;energy coupled proton transport, down electrochemical gradient;0;1870;GO:0015986
GO:2000674;regulation of type B pancreatic cell apoptotic process;366;6;GO:0043066
GO:2000690;regulation of cardiac muscle cell myoblast differentiation;103;7;GO:0048608
GO:2000691;negative regulation of cardiac muscle cell myoblast differentiation;65;9;GO:0048405
GO:2000692;negative regulation of seed maturation;5;4;GO:0010468
GO:1990610;acetolactate synthase regulator activity;73682;428;GO:0003700
GO:1990611;regulation of cytoplasmic translational initiation in response to stress;254;2;GO:0006412
GO:1990612;Sad1-Kms1 LINC complex;2;3;GO:0048471
GO:1990615;Kelch-containing formin regulatory complex;9;2;GO:0048193
GO:1990616;magnesium ion export from mitochondrion;78;3;GO:0006836
GO:1990617;CHOP-ATF4 complex;133;103;GO:0048193
GO:2000689;actomyosin contractile ring assembly actin filament organization;169;5;GO:0003779
GO:1990619;histone H3-K9 deacetylation;2;25;GO:0016569
GO:2000683;regulation of cellular response to X-ray;154;79;GO:0050817
GO:2000684;negative regulation of cellular response to X-ray;0;1;GO:0010468
GO:0015996;chlorophyll catabolic process;4770;631;GO:0046274
GO:2000685;positive regulation of cellular response to X-ray;74;9;GO:0010468
GO:0015973;guanosine pentaphosphate biosynthetic process;0;3;GO:0009065
GO:0015972;guanosine pentaphosphate metabolic process;4260;2;GO:0006790
GO:0015971;guanosine tetraphosphate catabolic process;12;5;GO:0006559
GO:0015970;guanosine tetraphosphate biosynthetic process;29072;7;GO:0009065
GO:0001326;replication of extrachromosomal circular DNA;0;5;GO:0048285
GO:0003990;acetylcholinesterase activity;3314;173;GO:0004497
GO:0001325;formation of extrachromosomal circular DNA;779;8;GO:0048285
GO:0003991;acetylglutamate kinase activity;120545;457;GO:0004721
GO:0003992;N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity;76823;10;GO:0004073
GO:0003993;acid phosphatase activity;75510;2210;GO:0004723
GO:0003994;aconitate hydratase activity;100973;839;GO:0004067
GO:0003984;acetolactate synthase activity;270634;584;GO:0004474
GO:0003985;acetyl-CoA C-acetyltransferase activity;71744;432;GO:0004497
GO:0003986;acetyl-CoA hydrolase activity;1848;78;GO:0004553
GO:0003987;acetate-CoA ligase activity;118890;572;GO:0004497
GO:1990620;ANPR-A receptor complex;0;2;GO:0005576
GO:0003988;acetyl-CoA C-acyltransferase activity;116976;619;GO:0004497
GO:1990621;ESCRT IV complex;59;3;GO:0005576
GO:0003989;acetyl-CoA carboxylase activity;182202;1370;GO:0004497
GO:1990622;CHOP-ATF3 complex;135;190;GO:0048193
GO:1990623;Herring body;0;3;GO:0005576
GO:1990624;guanyl nucleotide exchange factor inhibitor activity;6;2;GO:0004842
GO:1990625;negative regulation of cytoplasmic translational initiation in response to stress;141;2;GO:0010467
GO:2000697;negative regulation of epithelial cell differentiation involved in kidney development;184;7;GO:0048316
GO:0015969;guanosine tetraphosphate metabolic process;104858;300;GO:0006790
GO:1990626;mitochondrial outer membrane fusion;79;2;GO:0005743
GO:2000698;positive regulation of epithelial cell differentiation involved in kidney development;279;7;GO:0048704
GO:0015968;stringent response;8;10;GO:0009628
GO:1990627;mitochondrial inner membrane fusion;80;4;GO:0005743
GO:2000699;fibroblast growth factor receptor signaling pathway involved in ureteric bud formation;51;1;GO:0048010
GO:0015967;diadenosine tetraphosphate catabolic process;15;5;GO:0009081
GO:0015966;diadenosine tetraphosphate biosynthetic process;146;131;GO:0009065
GO:1990629;phospholamban complex;0;0;GO:0005576
GO:2000693;positive regulation of seed maturation;23;3;GO:0048704
GO:0015965;diadenosine tetraphosphate metabolic process;161;6;GO:0006073
GO:2000694;regulation of phragmoplast microtubule organization;594;1;GO:0048285
GO:0015964;diadenosine triphosphate catabolic process;67;6;GO:0006064
GO:0015963;diadenosine triphosphate biosynthetic process;0;2;GO:0006064
GO:2000696;regulation of epithelial cell differentiation involved in kidney development;876;9;GO:0048316
GO:0015980;energy derivation by oxidation of organic compounds;6917570;2360;GO:0006091
GO:0003995;acyl-CoA dehydrogenase activity;260193;1840;GO:0004049
GO:0003997;acyl-CoA oxidase activity;20524;481;GO:0004049
GO:1990630;IRE1-RACK1-PP2A complex;101;8;GO:0009986
GO:0003998;acylphosphatase activity;89791;310;GO:0004721
GO:1990631;ErbB-4 class receptor binding;4;3;GO:0005515
GO:0003999;adenine phosphoribosyltransferase activity;117723;597;GO:0004073
GO:1990632;branching involved in submandibular gland morphogenesis;0;0;GO:0048608
GO:1990633;mutator focus;22;3;GO:0000786
GO:1990634;protein phosphatase 5 binding;4;1;GO:0048193
GO:1990635;proximal dendrite;164;64;GO:0043005
GO:1990636;reproductive senescence;0;0;GO:0048608
GO:1990637;response to prolactin;21;10;GO:0048608
GO:0015979;photosynthesis;2107806;7800;GO:0015979
GO:1990638;response to granulocyte colony-stimulating factor;2;1;GO:0045766
GO:0015977;carbon fixation;676524;1030;GO:0006096
GO:0015976;carbon utilization;44017;1630;GO:0006091
GO:0015975;energy derivation by oxidation of reduced inorganic compounds;91612;6;GO:0006091
GO:0015974;guanosine pentaphosphate catabolic process;4259;6;GO:0009065
GO:2000480;negative regulation of cAMP-dependent protein kinase activity;26;225;GO:0010468
GO:2000481;positive regulation of cAMP-dependent protein kinase activity;50;45;GO:0043403
GO:1904610;response to 3,3',4,4',5-pentachlorobiphenyl;0;0;GO:0046686
GO:1904614;response to biphenyl;0;0;GO:0046686
GO:1904613;cellular response to 2,3,7,8-tetrachlorodibenzodioxine;971;4;GO:0046686
GO:1904612;response to 2,3,7,8-tetrachlorodibenzodioxine;981;1;GO:0046686
GO:1904611;cellular response to 3,3',4,4',5-pentachlorobiphenyl;0;1;GO:0043407
GO:1904618;positive regulation of actin binding;7;2;GO:0051015
GO:1904617;negative regulation of actin binding;4;10;GO:0048010
GO:1904616;regulation of actin binding;12;7;GO:0051015
GO:1904615;cellular response to biphenyl;0;1;GO:0043407
GO:0050431;transforming growth factor beta binding;1785;1170;GO:0005518
GO:0050433;regulation of catecholamine secretion;2218;137;GO:0048167
GO:0050432;catecholamine secretion;2604;99;GO:0002864
GO:0050439;2-hydroxy-3-oxoadipate synthase activity;514;3;GO:0006081
GO:2000477;regulation of metanephric podocyte development;64;0;GO:0048193
GO:0050438;2-ethylmalate synthase activity;0;2;GO:0006099
GO:2000478;positive regulation of metanephric podocyte development;64;9;GO:0048193
GO:2000479;regulation of cAMP-dependent protein kinase activity;81;449;GO:0008083
GO:0050435;amyloid-beta metabolic process;3455;148;GO:0043603
GO:2000473;positive regulation of hematopoietic stem cell migration;87;86;GO:0045765
GO:0050434;positive regulation of viral transcription;26381;573;GO:0010467
GO:2000474;regulation of opioid receptor signaling pathway;60;146;GO:0007186
GO:0050437;(-)-endo-fenchol synthase activity;6;5;GO:0004474
GO:2000475;negative regulation of opioid receptor signaling pathway;0;1;GO:0048169
GO:0050436;microfibril binding;145;56;GO:0005576
GO:2000476;positive regulation of opioid receptor signaling pathway;4;0;GO:0048165
GO:2000491;positive regulation of hepatic stellate cell activation;90;117;GO:0032989
GO:2000492;regulation of interleukin-18-mediated signaling pathway;145;1;GO:0050727
GO:2000493;negative regulation of interleukin-18-mediated signaling pathway;6;1;GO:0050727
GO:2000494;positive regulation of interleukin-18-mediated signaling pathway;139;6;GO:0050727
GO:1904620;cellular response to dimethyl sulfoxide;2;3;GO:0045727
GO:2000490;negative regulation of hepatic stellate cell activation;63;7;GO:0032989
GO:1904625;negative regulation of glycine secretion, neurotransmission;0;1;GO:0048608
GO:1904624;regulation of glycine secretion, neurotransmission;0;2;GO:0048666
GO:1904629;response to diterpene;66;1;GO:0009611
GO:1904628;cellular response to phorbol 13-acetate 12-myristate;218;39;GO:0046686
GO:1904627;response to phorbol 13-acetate 12-myristate;218;7;GO:0030599
GO:1904626;positive regulation of glycine secretion, neurotransmission;0;1;GO:0048167
GO:0050442;3-propylmalate synthase activity;0;2;GO:0006099
GO:0050441;3-ethylmalate synthase activity;0;3;GO:0006099
GO:1904619;response to dimethyl sulfoxide;2;0;GO:0010033
GO:0050440;2-methylcitrate synthase activity;844;6;GO:0006099
GO:2000488;positive regulation of brassinosteroid biosynthetic process;14;0;GO:0046394
GO:0050449;casbene synthase activity;12;4;GO:0004497
GO:2000489;regulation of hepatic stellate cell activation;155;4;GO:0032989
GO:0050446;azobenzene reductase activity;785;4;GO:0004067
GO:0050445;asparagusate reductase activity;0;2;GO:0004073
GO:2000485;regulation of glutamine transport;18;3;GO:0006865
GO:0050448;beta-cyclopiazonate dehydrogenase activity;6;3;GO:0009081
GO:2000486;negative regulation of glutamine transport;6;7;GO:0006874
GO:0050447;zeatin 9-aminocarboxyethyltransferase activity;0;4;GO:0004725
GO:2000487;positive regulation of glutamine transport;12;7;GO:0045765
GO:1904632;cellular response to glucoside;2;0;GO:0009719
GO:1904631;response to glucoside;5;2;GO:0009737
GO:1904630;cellular response to diterpene;15;2;GO:0071346
GO:1904636;response to ionomycin;117;5;GO:0006955
GO:1904635;positive regulation of podocyte apoptotic process;115;2;GO:0043066
GO:1904634;negative regulation of podocyte apoptotic process;0;1;GO:0043066
GO:1904633;regulation of podocyte apoptotic process;121;2;GO:0043066
GO:1904639;cellular response to resveratrol;5;3;GO:0071456
GO:1904638;response to resveratrol;89;5;GO:0046347
GO:1904637;cellular response to ionomycin;117;39;GO:0006955
GO:0050452;CoA-glutathione reductase (NADP) activity;1;2;GO:0006749
GO:0050455;columbamine oxidase activity;0;3;GO:0004601
GO:0050454;coenzyme F420 hydrogenase activity;1763;7;GO:0009065
GO:0050451;CoA-disulfide reductase (NADP) activity;2387;5;GO:0009065
GO:0050450;citrate (Re)-synthase activity;33;0;GO:0006099
GO:0050457;decylcitrate synthase activity;0;3;GO:0004497
GO:2000495;regulation of cell proliferation involved in compound eye morphogenesis;112;6;GO:0048608
GO:0050456;cystine reductase activity;3;2;GO:0004073
GO:2000496;negative regulation of cell proliferation involved in compound eye morphogenesis;0;1;GO:0048608
GO:0050459;ethanolamine-phosphate phospho-lyase activity;111;5;GO:0006067
GO:2000497;positive regulation of cell proliferation involved in compound eye morphogenesis;21;2;GO:0048608
GO:0050458;decylhomocitrate synthase activity;0;3;GO:0004449
GO:1904643;response to curcumin;44;4;GO:0006950
GO:1904642;cellular response to dinitrophenol;0;2;GO:0006979
GO:1904641;response to dinitrophenol;0;1;GO:0009432
GO:1904640;response to methionine;68;9;GO:0006541
GO:1904647;response to rotenone;37;5;GO:0046274
GO:1904646;cellular response to amyloid-beta;1500;378;GO:0010467
GO:1904645;response to amyloid-beta;1982;114;GO:0042605
GO:1904644;cellular response to curcumin;2;2;GO:0071346
GO:1904649;regulation of fat cell apoptotic process;27;4;GO:0043066
GO:1904648;cellular response to rotenone;2;1;GO:0045727
GO:0050464;nitrate reductase (NADPH) activity;3075;16;GO:0006779
GO:0050463;nitrate reductase [NAD(P)H] activity;3886;3;GO:0006779
GO:0050465;nitroquinoline-N-oxide reductase activity;0;2;GO:0008033
GO:0050460;hydroxylamine reductase (NADH) activity;0;3;GO:0004067
GO:0050462;N-acetylneuraminate synthase activity;1413;7;GO:0004734
GO:0050461;L-mimosine synthase activity;4;4;GO:0004497
GO:0050468;reticuline oxidase activity;46;4;GO:0006067
GO:0050467;pentalenene synthase activity;24;3;GO:0004497
GO:0050469;sabinene-hydrate synthase activity;6;3;GO:0004497
GO:0050409;indolylacetylinositol arabinosyltransferase activity;35;3;GO:0006021
GO:0050400;xylitol kinase activity;0;3;GO:0004721
GO:0050406;[acetyl-CoA carboxylase]-phosphatase activity;6;0;GO:0004721
GO:0050405;[acetyl-CoA carboxylase] kinase activity;1565;58;GO:0004721
GO:0050408;[pyruvate kinase]-phosphatase activity;3;0;GO:0004721
GO:0050407;[glycogen-synthase-D] phosphatase activity;0;2;GO:0004721
GO:0050402;xylono-1,4-lactonase activity;24;2;GO:0005576
GO:0050401;xylonate dehydratase activity;1917;5;GO:0006067
GO:0050404;zeatin O-beta-D-xylosyltransferase activity;4;4;GO:0004553
GO:0050403;trans-zeatin O-beta-D-glucosyltransferase activity;25;9;GO:0006073
GO:0050410;3-oxolaurate decarboxylase activity;25;3;GO:0006081
GO:0050417;glutamin-(asparagin-)ase activity;272;0;GO:0004721
GO:0050416;formimidoylglutamate deiminase activity;2778;4;GO:0004723
GO:0050419;hydroxymandelonitrile lyase activity;2;2;GO:0046395
GO:0050418;hydroxylamine reductase activity;24056;9;GO:0046395
GO:0050413;D-alanine 2-hydroxymethyltransferase activity;148;2;GO:0004067
GO:0050412;cinnamate beta-D-glucosyltransferase activity;12;3;GO:0006073
GO:0050415;formimidoylglutamase activity;18009;20;GO:0004721
GO:0050414;formimidoylaspartate deiminase activity;0;2;GO:0004466
GO:1904603;regulation of advanced glycation end-product receptor activity;1;5;GO:0048193
GO:1904602;serotonin-activated cation-selective channel complex;167;2;GO:0008026
GO:1904601;protein transport to mating projection actin fusion focus;7;2;GO:0006810
GO:1904600;mating projection actin fusion focus assembly;9;3;GO:0005576
GO:1904606;fat cell apoptotic process;84;5;GO:0042981
GO:1904605;positive regulation of advanced glycation end-product receptor activity;0;2;GO:0048193
GO:1904604;negative regulation of advanced glycation end-product receptor activity;1;7;GO:0048193
GO:0050420;maltose synthase activity;0;3;GO:0006099
GO:0050422;strictosidine beta-glucosidase activity;12;3;GO:0004553
GO:0050421;nitrite reductase (NO-forming) activity;20011;74;GO:0004784
GO:0050428;3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;283;2;GO:0006734
GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process;633;10;GO:0006790
GO:0050429;calcium-dependent phospholipase C activity;671;7;GO:0004721
GO:0050423;thiamine oxidase activity;0;2;GO:0004721
GO:1902031;regulation of NADP metabolic process;452;25;GO:0046394
GO:1904694;negative regulation of vascular associated smooth muscle contraction;153;3;GO:0048010
GO:1904693;midbrain morphogenesis;58;22;GO:0048704
GO:1904692;positive regulation of type B pancreatic cell proliferation;153;5;GO:0048608
GO:1904691;negative regulation of type B pancreatic cell proliferation;143;7;GO:0048608
GO:1902035;positive regulation of hematopoietic stem cell proliferation;476;53;GO:0045765
GO:1904698;negative regulation of acinar cell proliferation;3;4;GO:0048608
GO:1902036;regulation of hematopoietic stem cell differentiation;1184;414;GO:0045765
GO:1904697;regulation of acinar cell proliferation;57;0;GO:0048608
GO:1902033;regulation of hematopoietic stem cell proliferation;743;91;GO:0045765
GO:1902034;negative regulation of hematopoietic stem cell proliferation;50;4;GO:0045766
GO:1904695;positive regulation of vascular associated smooth muscle contraction;50;7;GO:0048010
GO:1902039;negative regulation of seed dormancy process;5;6;GO:0010033
GO:1902037;negative regulation of hematopoietic stem cell differentiation;352;39;GO:0045765
GO:1902038;positive regulation of hematopoietic stem cell differentiation;146;5;GO:0045765
GO:1904699;positive regulation of acinar cell proliferation;6;3;GO:0048608
GO:1904690;positive regulation of cytoplasmic translational initiation;274;9;GO:0045944
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;1425;801;GO:0043066
GO:1902043;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;691;465;GO:0043066
GO:1902040;positive regulation of seed dormancy process;1;2;GO:0010033
GO:1902041;regulation of extrinsic apoptotic signaling pathway via death domain receptors;2376;274;GO:0043066
GO:1902046;positive regulation of Fas signaling pathway;2;1;GO:0046649
GO:1902047;polyamine transmembrane transport;149931;27;GO:0006836
GO:1902044;regulation of Fas signaling pathway;231;19;GO:0046649
GO:1902045;negative regulation of Fas signaling pathway;127;7;GO:0046330
GO:1902048;neosartoricin metabolic process;0;1;GO:0006066
GO:1902049;neosartoricin catabolic process;0;1;GO:0046274
GO:1902053;regulation of neosartoricin biosynthetic process;0;0;GO:0046394
GO:1902054;negative regulation of neosartoricin biosynthetic process;0;0;GO:0046274
GO:1902051;(25S)-Delta(4)-dafachronate binding;5;0;GO:0005524
GO:1902052;(25S)-Delta(7)-dafachronate binding;5;0;GO:0005524
GO:1902057;(25S)-Delta(4)-dafachronate metabolic process;0;0;GO:0006749
GO:1902058;regulation of sporocarp development involved in sexual reproduction;9;1;GO:0048285
GO:1902055;positive regulation of neosartoricin biosynthetic process;0;0;GO:0046356
GO:1902056;(25S)-Delta(7)-dafachronate metabolic process;0;0;GO:0006749
GO:1902059;negative regulation of sporocarp development involved in sexual reproduction;2;1;GO:0048285
GO:1902050;neosartoricin biosynthetic process;0;0;GO:0046395
GO:1902065;response to L-glutamate;245;26;GO:0007601
GO:1902062;betaine aldehyde catabolic process;0;0;GO:0046395
GO:1902063;betaine aldehyde biosynthetic process;0;0;GO:0006032
GO:1902068;regulation of sphingolipid mediated signaling pathway;81;2;GO:0030522
GO:1902069;negative regulation of sphingolipid mediated signaling pathway;0;0;GO:0048193
GO:1902066;regulation of cell wall pectin metabolic process;94;10;GO:0010467
GO:1902060;positive regulation of sporocarp development involved in sexual reproduction;6;1;GO:0048285
GO:1902061;betaine aldehyde metabolic process;0;0;GO:0006032
GO:1904650;negative regulation of fat cell apoptotic process;0;3;GO:0043066
GO:1904654;negative regulation of lung alveolus development;0;1;GO:0050727
GO:1904653;regulation of lung alveolus development;1;0;GO:0050730
GO:1904652;protein localization to cell division site involved in cell separation after cytokinesis;0;0;GO:0007067
GO:1904651;positive regulation of fat cell apoptotic process;6;7;GO:0043066
GO:1904658;positive regulation of sensory perception of sweet taste;0;0;GO:0050877
GO:1904657;negative regulation of sensory perception of sweet taste;1;0;GO:0009410
GO:0050480;imidazolonepropionase activity;52101;183;GO:0006029
GO:1904656;regulation of sensory perception of sweet taste;1;0;GO:0007600
GO:1904655;positive regulation of lung alveolus development;1;0;GO:0048661
GO:1904659;glucose transmembrane transport;38587;1020;GO:0006865
GO:0050474;(S)-norcoclaurine synthase activity;32;0;GO:0004497
GO:0050477;acyl-lysine deacylase activity;0;3;GO:0004867
GO:0050476;acetylenedicarboxylate decarboxylase activity;0;3;GO:0006066
GO:0050471;uracilylalanine synthase activity;0;3;GO:0006030
GO:0050470;trimethylamine dehydrogenase activity;132;4;GO:0009065
GO:0050473;arachidonate 15-lipoxygenase activity;336;23;GO:0004722
GO:0050472;zeatin reductase activity;0;3;GO:0009813
GO:0050479;glyceryl-ether monooxygenase activity;177;9;GO:0004497
GO:1904661;negative regulation of sensory perception of bitter taste;1;1;GO:0009593
GO:1904660;regulation of sensory perception of bitter taste;1;1;GO:0009593
GO:1904665;positive regulation of N-terminal peptidyl-methionine acetylation;0;0;GO:0010401
GO:1902003;regulation of amyloid-beta formation;2070;36;GO:0010467
GO:1904664;negative regulation of N-terminal peptidyl-methionine acetylation;0;0;GO:0010401
GO:1902000;homogentisate catabolic process;185;8;GO:0006559
GO:1904663;regulation of N-terminal peptidyl-methionine acetylation;0;0;GO:0016567
GO:1902001;fatty acid transmembrane transport;2307;512;GO:0006869
GO:1904662;positive regulation of sensory perception of bitter taste;0;1;GO:0009593
GO:1902006;negative regulation of proline biosynthetic process;2;1;GO:0045944
GO:1904669;ATP export;479;10;GO:0008544
GO:1902007;regulation of toxin transport;4;0;GO:0006879
GO:1904668;positive regulation of ubiquitin protein ligase activity;797;564;GO:0048193
GO:0050491;sulcatone reductase activity;0;3;GO:0004091
GO:1902004;positive regulation of amyloid-beta formation;1072;48;GO:0010467
GO:1904667;negative regulation of ubiquitin protein ligase activity;59;144;GO:0043161
GO:0050490;1,4-lactonase activity;28;3;GO:0004497
GO:1902005;regulation of proline biosynthetic process;2;1;GO:0045944
GO:1904666;regulation of ubiquitin protein ligase activity;858;107;GO:0004842
GO:1902008;negative regulation of toxin transport;0;0;GO:0048169
GO:1902009;positive regulation of toxin transport;4;0;GO:0048169
GO:0050486;intramolecular transferase activity, transferring hydroxy groups;57124;2;GO:0016740
GO:0050485;oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond, with a disulfide as acceptor;20732;6;GO:0004601
GO:0050488;ecdysteroid UDP-glucosyltransferase activity;0;1;GO:0008021
GO:0050487;sulfoacetaldehyde acetyltransferase activity;4550;6;GO:0004073
GO:0050482;arachidonic acid secretion;23180;740;GO:0006631
GO:0050481;mandelate 4-monooxygenase activity;0;3;GO:0004497
GO:0050484;GMP 5'-nucleotidase activity;91;3;GO:0004721
GO:0050483;IMP 5'-nucleotidase activity;2125;2;GO:0004721
GO:1904672;regulation of somatic stem cell population maintenance;395;50;GO:0045727
GO:1902010;negative regulation of translation in response to endoplasmic reticulum stress;119;4;GO:0010467
GO:1904671;negative regulation of cell differentiation involved in stem cell population maintenance;0;2;GO:0045727
GO:1902013;poly(glycerol phosphate) teichoic acid metabolic process;0;0;GO:0009211
GO:1904676;negative regulation of somatic stem cell division;1;0;GO:0045766
GO:1902014;poly(glycerol phosphate) teichoic acid biosynthetic process;0;0;GO:0009266
GO:1904675;regulation of somatic stem cell division;78;0;GO:0045727
GO:1902011;poly(ribitol phosphate) teichoic acid metabolic process;1187;0;GO:0006021
GO:1904674;positive regulation of somatic stem cell population maintenance;97;20;GO:0045727
GO:1902012;poly(ribitol phosphate) teichoic acid biosynthetic process;1187;2;GO:0009266
GO:1904673;negative regulation of somatic stem cell population maintenance;126;3;GO:0045727
GO:1902017;regulation of cilium assembly;4868;448;GO:0048407
GO:1902018;negative regulation of cilium assembly;1049;176;GO:0048193
GO:1904679;myo-inositol import across plasma membrane;37;1;GO:0006869
GO:1902015;poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid metabolic process;0;0;GO:0006021
GO:1904678;alpha-aminoacyl-tRNA binding;78;2;GO:0003735
GO:1902016;poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid biosynthetic process;0;0;GO:0009063
GO:1904677;positive regulation of somatic stem cell division;77;5;GO:0045766
GO:1902019;regulation of cilium-dependent cell motility;1598;6;GO:0048608
GO:0050497;alkylthioltransferase activity;196011;1;GO:0004734
GO:0050496;peptidyl-L-glutamyl 5-omega-hydroxyceramide ester biosynthetic process from peptidyl-glutamine;0;2;GO:0006066
GO:0050499;oxidoreductase activity, acting on phosphorus or arsenic in donors, with NAD(P)+ as acceptor;85;0;GO:0004784
GO:0050498;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with 2-oxoglutarate as one donor, and the other dehydrogenated;2921;9;GO:0004497
GO:0050493;GPI anchor biosynthetic process via N-threonyl-glycosylphosphatidylinositolethanolamine;0;3;GO:0006631
GO:0050492;glycerol-1-phosphate dehydrogenase [NAD(P)+] activity;8588;0;GO:0004073
GO:0050495;peptidyl-glycyl-phosphatidylethanolamine biosynthetic process from peptidyl-glycine;0;2;GO:0006631
GO:0050494;GSI anchor biosynthetic process via N-glycyl-glycosylsphingolipidinositolethanolamine;0;2;GO:0008610
GO:1902020;negative regulation of cilium-dependent cell motility;182;1;GO:0048193
GO:1904683;regulation of metalloendopeptidase activity;45;4;GO:0048407
GO:1902021;regulation of bacterial-type flagellum-dependent cell motility;6979;5;GO:0030529
GO:1904682;cellular response to 3-methylcholanthrene;7;0;GO:0010468
GO:1904681;response to 3-methylcholanthrene;8;1;GO:0030528
GO:1904680;peptide transmembrane transporter activity;104476;214;GO:0008565
GO:1902024;L-histidine transport;265;5;GO:0006865
GO:1904687;positive regulation of mitotic spindle disassembly;0;0;GO:0048285
GO:1902025;nitrate import;97608;5;GO:0006879
GO:1904686;regulation of mitotic spindle disassembly;0;1;GO:0048285
GO:1902022;L-lysine transport;16499;4;GO:0006865
GO:1904685;positive regulation of metalloendopeptidase activity;24;75;GO:0048169
GO:1904684;negative regulation of metalloendopeptidase activity;21;31;GO:0048169
GO:1902026;regulation of cartilage condensation;4;0;GO:0048608
GO:1904689;negative regulation of cytoplasmic translational initiation;221;1;GO:0006412
GO:1902027;positive regulation of cartilage condensation;1;0;GO:0048608
GO:1904688;regulation of cytoplasmic translational initiation;683;12;GO:0006414
GO:1990520;separase-securin complex;9;1;GO:0007062
GO:1990522;tail spike morphogenesis;8;1;GO:0048706
GO:1990523;bone regeneration;244;62;GO:0048608
GO:1990524;INA complex;8;3;GO:0005840
GO:1990525;BIR domain binding;34;3;GO:0005515
GO:1990526;Ste12p-Dig1p-Dig2p complex;18;4;GO:0005730
GO:1990527;Tec1p-Ste12p-Dig1p complex;18;5;GO:0048285
GO:1990528;Rvs161p-Rvs167p complex;68;4;GO:0043161
GO:1990529;glycosylphosphatidylinositol-mannosyltransferase I complex;128;3;GO:0005576
GO:1990530;Cdc50p-Drs2p complex;11;2;GO:0005576
GO:1990531;phospholipid-translocating ATPase complex;702;5;GO:0005766
GO:1990532;stress response to nickel ion;9;4;GO:0006950
GO:1990533;Dom34-Hbs1 complex;176;4;GO:0005737
GO:1990534;thermospermine oxidase activity;22;1;GO:0004730
GO:1990535;neuron projection maintenance;539;62;GO:0048666
GO:1990536;phosphoenolpyruvate transmembrane import into Golgi lumen;41;1;GO:0006836
GO:1990537;mitotic spindle polar microtubule;36;3;GO:0007088
GO:1990538;xylan O-acetyltransferase activity;4394;5;GO:0006073
GO:1990539;fructose import across plasma membrane;115;10;GO:0006869
GO:1990550;mitochondrial alpha-ketoglutarate transmembrane transport;62;2;GO:0009060
GO:1990540;mitochondrial manganese ion transmembrane transport;65;1;GO:0006836
GO:1990542;mitochondrial transmembrane transport;40386;355;GO:0007049
GO:1990543;mitochondrial S-adenosyl-L-methionine transmembrane transport;62;2;GO:0008544
GO:1990544;mitochondrial ATP transmembrane transport;11312;38;GO:0009060
GO:1990545;mitochondrial thiamine pyrophosphate transmembrane transport;25;3;GO:0006836
GO:1990546;mitochondrial tricarboxylic acid transmembrane transport;217;0;GO:0006890
GO:1990547;mitochondrial phosphate ion transmembrane transport;8673;4;GO:0008047
GO:1990548;mitochondrial FAD transmembrane transport;115;2;GO:0005746
GO:1990549;mitochondrial NAD transmembrane transport;55;3;GO:0006890
GO:1990551;mitochondrial 2-oxoadipate transmembrane transport;1;2;GO:0006836
GO:1990553;mitochondrial 5'-adenylyl sulfate transmembrane transport;1;0;GO:0008023
GO:1990554;mitochondrial 3'-phospho-5'-adenylyl sulfate transmembrane transport;1;0;GO:0008023
GO:1990555;mitochondrial oxaloacetate transmembrane transport;1;1;GO:0006836
GO:1990556;mitochondrial isopropylmalate transmembrane transport;1;1;GO:0009060
GO:1990557;mitochondrial sulfate transmembrane transport;1;1;GO:0006836
GO:1990558;mitochondrial malonate(1-) transmembrane transport;0;0;GO:0006836
GO:1990559;mitochondrial coenzyme A transmembrane transport;218;2;GO:0006836
GO:1990570;GDP-mannose transmembrane transport;350;4;GO:0008544
GO:1990571;meiotic centromere clustering;52;2;GO:0000786
GO:1990572;TERT-RMRP complex;43;5;GO:0005840
GO:1990562;syndecan-syntenin-ALIX complex;0;1;GO:0072335
GO:1990563;extracellular exosome complex;0;3;GO:0070062
GO:1990564;protein polyufmylation;37;45;GO:0006464
GO:1990565;HSP90-CDC37 chaperone complex;150;9;GO:0005833
GO:1990566;I(KACh) inward rectifier potassium channel complex;0;0;GO:0008092
GO:1990567;DPS complex;39;4;GO:0005737
GO:1990569;UDP-N-acetylglucosamine transmembrane transport;519;72;GO:0008565
GO:1990580;regulation of cytoplasmic translational termination;1;2;GO:0006414
GO:1990583;phospholipase D activator activity;3;2;GO:0005525
GO:1990573;potassium ion import across plasma membrane;3803;479;GO:0006836
GO:1990574;meiotic spindle astral microtubule;3;1;GO:0007062
GO:1990575;mitochondrial L-ornithine transmembrane transport;468;8;GO:0006836
GO:1990576;G protein-coupled glucose receptor activity;4;1;GO:0004930
GO:1990577;C-terminal protein demethylation;0;0;GO:0006465
GO:1990578;perinuclear endoplasmic reticulum membrane;237;86;GO:0005789
GO:1990579;peptidyl-serine trans-autophosphorylation;1;2;GO:0006468
GO:1990590;ATF1-ATF4 transcription factor complex;243;54;GO:0045944
GO:1990591;asparagine transmembrane import into vacuole;11;1;GO:0008544
GO:1990592;protein K69-linked ufmylation;37;42;GO:0006469
GO:1990593;nascent polypeptide-associated complex binding;751;1;GO:0003735
GO:1990594;L-altrarate dehydratase activity;1517;1;GO:0004067
GO:1990584;cardiac Troponin complex;174;91;GO:0005576
GO:1990585;hydroxyproline O-arabinosyltransferase activity;44;0;GO:0004073
GO:1990586;divisome complex;24;3;GO:0005840
GO:1990587;FtsQBL complex;5;0;GO:0043161
GO:1990588;FtsBL complex;2;0;GO:0005576
GO:1990589;ATF4-CREB1 transcription factor complex;303;53;GO:0045944
GO:1990595;mast cell secretagogue receptor activity;11;4;GO:0004930
GO:2000508;regulation of dendritic cell chemotaxis;440;9;GO:0050900
GO:1990597;AIP1-IRE1 complex;153;8;GO:0005737
GO:2000509;negative regulation of dendritic cell chemotaxis;3;2;GO:0050900
GO:1990599;3' overhang single-stranded DNA endodeoxyribonuclease activity;171;187;GO:0004518
GO:2000503;positive regulation of natural killer cell chemotaxis;132;78;GO:0050900
GO:2000504;positive regulation of blood vessel remodeling;79;66;GO:0010717
GO:2000501;regulation of natural killer cell chemotaxis;208;52;GO:0050900
GO:2000502;negative regulation of natural killer cell chemotaxis;76;48;GO:0050900
GO:2000518;negative regulation of T-helper 1 cell activation;3;3;GO:0042110
GO:2000519;positive regulation of T-helper 1 cell activation;0;0;GO:0032727
GO:2000514;regulation of CD4-positive, alpha-beta T cell activation;3945;419;GO:0042110
GO:2000515;negative regulation of CD4-positive, alpha-beta T cell activation;1643;1060;GO:0042110
GO:2000516;positive regulation of CD4-positive, alpha-beta T cell activation;1948;230;GO:0050821
GO:2000517;regulation of T-helper 1 cell activation;3;1;GO:0046649
GO:2000510;positive regulation of dendritic cell chemotaxis;430;240;GO:0050900
GO:2000511;regulation of granzyme A production;3;2;GO:0048608
GO:2000512;negative regulation of granzyme A production;0;1;GO:0048193
GO:2000513;positive regulation of granzyme A production;3;3;GO:0048308
GO:2000529;positive regulation of myeloid dendritic cell chemotaxis;101;7;GO:0050900
GO:2000525;positive regulation of T cell costimulation;130;39;GO:0042110
GO:2000526;positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation;61;5;GO:0048193
GO:2000527;regulation of myeloid dendritic cell chemotaxis;101;2;GO:0050900
GO:2000528;negative regulation of myeloid dendritic cell chemotaxis;0;0;GO:0050900
GO:2000521;negative regulation of immunological synapse formation;37;9;GO:0048308
GO:2000522;positive regulation of immunological synapse formation;117;7;GO:0048011
GO:2000523;regulation of T cell costimulation;172;28;GO:0042110
GO:2000524;negative regulation of T cell costimulation;42;5;GO:0042110
GO:2000520;regulation of immunological synapse formation;154;5;GO:0002227
GO:0001409;guanine nucleotide transmembrane transporter activity;443;8;GO:0005026
GO:0001408;guanine nucleotide transport;1205;6;GO:0008528
GO:0001407;glycerophosphodiester transmembrane transport;99;4;GO:0008544
GO:0001406;glycerophosphodiester transmembrane transporter activity;30;5;GO:0008565
GO:0001405;PAM complex, Tim23 associated import motor;3025;19;GO:0005740
GO:0001403;invasive growth in response to glucose limitation;567;164;GO:0048285
GO:0001402;signal transduction involved in filamentous growth;97;280;GO:0007165
GO:0001401;SAM complex;5798;108;GO:0005524
GO:0001400;mating projection base;123;7;GO:0048608
GO:2000536;negative regulation of entry of bacterium into host cell;65;8;GO:0048304
GO:2000537;regulation of B cell chemotaxis;86;10;GO:0050900
GO:2000538;positive regulation of B cell chemotaxis;86;52;GO:0050900
GO:2000539;regulation of protein geranylgeranylation;40;2;GO:0048193
GO:2000532;regulation of renal albumin absorption;149;5;GO:0048193
GO:2000533;negative regulation of renal albumin absorption;13;9;GO:0010468
GO:2000534;positive regulation of renal albumin absorption;136;8;GO:0010468
GO:2000535;regulation of entry of bacterium into host cell;350;44;GO:0048304
GO:0001411;hyphal tip;114;8;GO:0030900
GO:0001410;chlamydospore formation;27;7;GO:0048304
GO:2000547;regulation of dendritic cell dendrite assembly;10;10;GO:0048002
GO:2000548;negative regulation of dendritic cell dendrite assembly;4;4;GO:0048002
GO:2000549;positive regulation of dendritic cell dendrite assembly;4;4;GO:0048002
GO:2000543;positive regulation of gastrulation;286;403;GO:0048704
GO:2000544;regulation of endothelial cell chemotaxis to fibroblast growth factor;432;41;GO:0048010
GO:2000545;negative regulation of endothelial cell chemotaxis to fibroblast growth factor;46;5;GO:0048010
GO:2000546;positive regulation of endothelial cell chemotaxis to fibroblast growth factor;227;40;GO:0048010
GO:2000540;negative regulation of protein geranylgeranylation;0;1;GO:0048193
GO:2000541;positive regulation of protein geranylgeranylation;40;4;GO:0048193
GO:2000542;negative regulation of gastrulation;0;20;GO:0048704
GO:2000560;positive regulation of CD24 production;49;2;GO:0048608
GO:2000558;positive regulation of immunoglobulin production in mucosal tissue;41;3;GO:0050729
GO:2000559;regulation of CD24 production;49;0;GO:0048608
GO:2000554;regulation of T-helper 1 cell cytokine production;375;5;GO:0050727
GO:2000555;negative regulation of T-helper 1 cell cytokine production;0;0;GO:0050727
GO:2000556;positive regulation of T-helper 1 cell cytokine production;375;78;GO:0050729
GO:2000557;regulation of immunoglobulin production in mucosal tissue;41;1;GO:0050729
GO:2000550;negative regulation of B cell chemotaxis;0;0;GO:0050900
GO:2000551;regulation of T-helper 2 cell cytokine production;555;7;GO:0050729
GO:2000552;negative regulation of T-helper 2 cell cytokine production;133;8;GO:0050729
GO:2000553;positive regulation of T-helper 2 cell cytokine production;422;83;GO:0050729
GO:2000570;positive regulation of T-helper 2 cell activation;55;23;GO:0050729
GO:2000571;regulation of interleukin-4-dependent isotype switching to IgE isotypes;5;0;GO:0046649
GO:2000569;regulation of T-helper 2 cell activation;55;4;GO:0050729
GO:2000565;negative regulation of CD8-positive, alpha-beta T cell proliferation;47;6;GO:0045727
GO:2000566;positive regulation of CD8-positive, alpha-beta T cell proliferation;176;10;GO:0045727
GO:2000567;regulation of memory T cell activation;53;84;GO:0046649
GO:2000568;positive regulation of memory T cell activation;53;10;GO:0048011
GO:2000561;regulation of CD4-positive, alpha-beta T cell proliferation;939;18;GO:0046649
GO:2000562;negative regulation of CD4-positive, alpha-beta T cell proliferation;462;40;GO:0045727
GO:2000563;positive regulation of CD4-positive, alpha-beta T cell proliferation;405;46;GO:0048011
GO:2000564;regulation of CD8-positive, alpha-beta T cell proliferation;342;56;GO:0045727
GO:1990500;eif4e-cup complex;0;2;GO:0005829
GO:1990501;exon-exon junction subcomplex mago-y14;146;1;GO:0005576
GO:1990502;dense core granule maturation;219;9;GO:0008021
GO:1990503;dendritic lamellar body;0;0;GO:0008021
GO:1990504;dense core granule exocytosis;7986;19;GO:0008021
GO:1990505;mitotic DNA replication maintenance of fidelity;3075;5;GO:0007067
GO:1990506;mitotic DNA-templated DNA replication;67;1;GO:0006260
GO:1990508;CKM complex;258;4;GO:0005524
GO:2000572;positive regulation of interleukin-4-dependent isotype switching to IgE isotypes;5;2;GO:0046649
GO:1990509;PYM-mago-Y14 complex;0;0;GO:0005524
GO:2000573;positive regulation of DNA biosynthetic process;2158;682;GO:0045944
GO:2000590;negative regulation of metanephric mesenchymal cell migration;64;9;GO:0048706
GO:2000591;positive regulation of metanephric mesenchymal cell migration;172;10;GO:0048608
GO:2000592;regulation of metanephric DCT cell differentiation;27;5;GO:0048608
GO:2000593;negative regulation of metanephric DCT cell differentiation;0;1;GO:0048706
GO:1990512;Cry-Per complex;18;6;GO:0005840
GO:1990513;CLOCK-BMAL transcription complex;373;8;GO:0005819
GO:1990514;5' transitive RNA interference;1;0;GO:0003724
GO:1990515;3' transitive RNA interference;1;0;GO:0006026
GO:2000587;negative regulation of platelet-derived growth factor receptor-beta signaling pathway;94;172;GO:0030518
GO:1990516;ribonucleotide excision repair;21;1;GO:0006281
GO:2000588;positive regulation of platelet-derived growth factor receptor-beta signaling pathway;157;10;GO:0048010
GO:2000589;regulation of metanephric mesenchymal cell migration;236;5;GO:0048608
GO:1990518;single-stranded 3'-5' DNA helicase activity;387;3;GO:0003690
GO:1990519;pyrimidine nucleotide import into mitochondrion;198;3;GO:0009060
GO:2000583;regulation of platelet-derived growth factor receptor-alpha signaling pathway;355;7;GO:0030518
GO:2000584;negative regulation of platelet-derived growth factor receptor-alpha signaling pathway;119;32;GO:0030518
GO:2000585;positive regulation of platelet-derived growth factor receptor-alpha signaling pathway;0;0;GO:0048010
GO:2000586;regulation of platelet-derived growth factor receptor-beta signaling pathway;305;39;GO:0030518
GO:0015797;mannitol transmembrane transport;12780;6;GO:0006826
GO:0015796;galactitol transmembrane transport;13547;3;GO:0008544
GO:0015795;sorbitol transmembrane transport;23;6;GO:0006826
GO:0015794;glycerol-3-phosphate transmembrane transport;14331;7;GO:0006869
GO:0015793;glycerol transmembrane transport;1559;162;GO:0008565
GO:0015792;arabinitol transmembrane transport;0;1;GO:0006826
GO:0015791;polyol transmembrane transport;29294;8;GO:0006826
GO:0015790;UDP-xylose transmembrane transport;709;7;GO:0005576
GO:0001147;transcription termination site sequence-specific DNA binding;190;40;GO:0003677
GO:0001156;TFIIIC-class transcription factor complex binding;241;9;GO:0003700
GO:0052731;phosphocholine phosphatase activity;79;8;GO:0004721
GO:1902792;pyrroline-5-carboxylate reductase complex;0;1;GO:0009065
GO:0034076;cucurbitadienol synthase activity;2;1;GO:0004497
GO:0061693;alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase activity;1426;3;GO:0006032
GO:1900132;positive regulation of lipid binding;0;1;GO:0048193
GO:1902793;glutamate decarboxylase complex;0;0;GO:0005764
GO:1900135;positive regulation of renin secretion into blood stream;113;7;GO:0048193
GO:1902798;positive regulation of snoRNA processing;0;1;GO:0010467
GO:1900134;negative regulation of renin secretion into blood stream;66;3;GO:0048193
GO:1902799;regulation of phosphodiesterase I activity;1;0;GO:0004553
GO:0046059;dAMP catabolic process;264;9;GO:0006559
GO:1900137;negative regulation of chemokine activity;8;4;GO:0050921
GO:1902796;regulation of snoRNA processing;0;1;GO:0010467
GO:1900136;regulation of chemokine activity;8;4;GO:0050921
GO:1902797;negative regulation of snoRNA processing;0;2;GO:0010467
GO:0034071;aminoglycoside phosphotransferase activity;2828;6;GO:0005525
GO:0061698;protein deglutarylation;6;3;GO:0006464
GO:1900139;negative regulation of arachidonic acid secretion;7;6;GO:0010467
GO:0034070;aminoglycoside 1-N-acetyltransferase activity;0;1;GO:0006029
GO:0061699;peptidyl-lysine deglutarylation;0;2;GO:0006464
GO:1900138;negative regulation of phospholipase A2 activity;3;117;GO:0010467
GO:0046064;dCMP biosynthetic process;0;4;GO:0006790
GO:0046065;dCTP metabolic process;1258;2;GO:0006559
GO:0071010;prespliceosome;4896;43;GO:0000786
GO:0046062;dCDP metabolic process;22;2;GO:0006793
GO:0097641;alpha-ketoglutarate-dependent xanthine dioxygenase activity;8;2;GO:0004725
GO:0046063;dCMP metabolic process;280;3;GO:0006796
GO:0097640;L-ornithine import across plasma membrane;49;3;GO:0006836
GO:0046068;cGMP metabolic process;56432;385;GO:0006583
GO:0071013;catalytic step 2 spliceosome;15153;2630;GO:0000976
GO:0097643;amylin receptor activity;215;47;GO:0004930
GO:2001207;regulation of transcription elongation by RNA polymerase I;76;1;GO:0006351
GO:0046069;cGMP catabolic process;272;361;GO:0006555
GO:0071014;post-mRNA release spliceosomal complex;2640;219;GO:0000398
GO:0097642;calcitonin family receptor activity;5123;6;GO:0004872
GO:2001208;negative regulation of transcription elongation by RNA polymerase I;22;3;GO:0045944
GO:0046066;dGDP metabolic process;73;5;GO:0006796
GO:0071011;precatalytic spliceosome;12386;1470;GO:0000976
GO:0097645;amylin binding;2;4;GO:0005576
GO:2001209;positive regulation of transcription elongation by RNA polymerase I;54;5;GO:0045944
GO:0046067;dGDP catabolic process;58;5;GO:0006749
GO:0071012;catalytic step 1 spliceosome;3856;65;GO:0000398
GO:0097644;calcitonin family binding;226;2;GO:0005515
GO:0071017;U12-type catalytic step 1 spliceosome;0;1;GO:0000976
GO:0097647;amylin receptor signaling pathway;278;234;GO:0007267
GO:0071018;U12-type catalytic step 2 spliceosome;0;2;GO:0008033
GO:0097646;calcitonin family receptor signaling pathway;677;10;GO:0007186
GO:2001204;regulation of osteoclast development;581;45;GO:0045595
GO:0071015;U12-type prespliceosome;0;1;GO:0008033
GO:0097649;A axonemal microtubule;7;0;GO:0005525
GO:2001205;negative regulation of osteoclast development;304;32;GO:0045595
GO:0034069;aminoglycoside N-acetyltransferase activity;15662;1;GO:0004067
GO:0071016;U12-type precatalytic spliceosome;0;1;GO:0008033
GO:0097648;G protein-coupled receptor complex;1162;10;GO:0004872
GO:2001206;positive regulation of osteoclast development;161;49;GO:0045595
GO:0046060;dATP metabolic process;222;9;GO:0006796
GO:0046061;dATP catabolic process;163;24;GO:0006796
GO:2001200;positive regulation of dendritic cell differentiation;131;69;GO:0046649
GO:0071019;U12-type post-mRNA release spliceosomal complex;0;1;GO:0008380
GO:0034064;Tor2-Mei2-Ste11 complex;11;6;GO:0005576
GO:0061683;branching involved in seminal vesicle morphogenesis;0;1;GO:0048706
GO:0034063;stress granule assembly;2511;776;GO:0007030
GO:0061684;chaperone-mediated autophagy;639;392;GO:0006914
GO:0034062;5'-3' RNA polymerase activity;2331205;25;GO:0003700
GO:0061685;diphthine methylesterase activity;135;5;GO:0004553
GO:1900140;regulation of seedling development;1596;115;GO:0048731
GO:0034061;DNA polymerase activity;2389068;457;GO:0003964
GO:0061686;hercynylcysteine sulfoxide synthase activity;6;2;GO:0004497
GO:0034068;aminoglycoside nucleotidyltransferase activity;2714;1;GO:0003929
GO:1900142;negative regulation of oligodendrocyte apoptotic process;62;16;GO:0043066
GO:0034067;protein localization to Golgi apparatus;3591;1190;GO:0005764
GO:0061680;Entner-Doudoroff pathway through gluconate to D-glyceraldehyde;0;0;GO:0006099
GO:1900141;regulation of oligodendrocyte apoptotic process;72;3;GO:0043066
GO:0034066;Ric1-Rgp1 guanyl-nucleotide exchange factor complex;4800;8;GO:0005524
GO:0061681;Entner-Doudoroff pathway through gluconate to D-glyceraldehyde-3-phosphate;0;0;GO:0006099
GO:1900144;positive regulation of BMP secretion;52;2;GO:0048704
GO:0061682;seminal vesicle morphogenesis;13;3;GO:0048706
GO:1900143;positive regulation of oligodendrocyte apoptotic process;10;0;GO:0043066
GO:1900148;negative regulation of Schwann cell migration;95;9;GO:0048193
GO:1900147;regulation of Schwann cell migration;162;9;GO:0048706
GO:0034060;cyanelle stroma;1;3;GO:0005576
GO:0061687;detoxification of inorganic compound;79384;354;GO:0009628
GO:0061688;glycolytic process via Entner-Doudoroff Pathway;93;3;GO:0006096
GO:1900149;positive regulation of Schwann cell migration;65;9;GO:0048010
GO:0061689;tricellular tight junction;372;54;GO:0005929
GO:0046075;dTTP metabolic process;80982;6;GO:0006513
GO:0097650;B axonemal microtubule;0;0;GO:0008021
GO:0046076;dTTP catabolic process;29;2;GO:0006559
GO:0046073;dTMP metabolic process;100002;5;GO:0006796
GO:0097652;phosphatidylinositol 3-kinase complex, class II;0;0;GO:0005576
GO:0046074;dTMP catabolic process;118;4;GO:0006559
GO:0097651;phosphatidylinositol 3-kinase complex, class I;3047;5;GO:0005554
GO:0046079;dUMP catabolic process;277;5;GO:0006559
GO:0071002;U4atac/U6atac snRNP;1;1;GO:0008033
GO:0097654;platelet SNARE complex;0;1;GO:0008021
GO:0071003;penta-snRNP complex;0;4;GO:0000976
GO:0097653;unencapsulated part of cell;0;3;GO:0044421
GO:0046077;dUDP metabolic process;234;7;GO:0006096
GO:0071000;response to magnetism;43;15;GO:0005096
GO:0097656;cell-cell self recognition;7;1;GO:0002449
GO:0046078;dUMP metabolic process;101863;10;GO:0006559
GO:0071001;U4/U6 snRNP;177;33;GO:0008033
GO:0097655;serpin family protein binding;40;4;GO:0050840
GO:0071006;U2-type catalytic step 1 spliceosome;3856;79;GO:0000976
GO:0097658;Asi complex;11;1;GO:0005576
GO:2001214;positive regulation of vasculogenesis;483;439;GO:0050727
GO:0071007;U2-type catalytic step 2 spliceosome;2345;352;GO:0000976
GO:0097657;3',5'-nucleotide bisphosphate phosphatase activity;147;1;GO:0004721
GO:0034059;response to anoxia;210;140;GO:0006979
GO:0071004;U2-type prespliceosome;4893;732;GO:0008033
GO:0034058;endosomal vesicle fusion;4919;192;GO:0006906
GO:0071005;U2-type precatalytic spliceosome;3391;167;GO:0008033
GO:0046071;dGTP biosynthetic process;1;2;GO:0009063
GO:2001210;regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway;122;3;GO:0009693
GO:0046072;dTDP metabolic process;49669;7;GO:0006796
GO:2001211;negative regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway;70;1;GO:0010467
GO:0071008;U2-type post-mRNA release spliceosomal complex;367;51;GO:0008380
GO:2001212;regulation of vasculogenesis;701;26900;GO:0001525
GO:0046070;dGTP metabolic process;2261;9;GO:0006561
GO:0071009;U4atac/U6atac x U5 tri-snRNP complex;0;2;GO:0005576
GO:2001213;negative regulation of vasculogenesis;59;6;GO:0050727
GO:0009097;isoleucine biosynthetic process;520083;1290;GO:0006540
GO:0010086;embryonic root morphogenesis;20;7;GO:0048608
GO:0034053;symbiont-mediated perturbation of host defense-related programmed cell death;3813;0;GO:0097194
GO:0010085;polarity specification of proximal/distal axis;171;8;GO:0048608
GO:0034052;positive regulation of plant-type hypersensitive response;118;9;GO:0046274
GO:0009095;aromatic amino acid family biosynthetic process, prephenate pathway;232166;9;GO:0009061
GO:0010088;phloem development;2757;75;GO:0009953
GO:0034051;negative regulation of plant-type hypersensitive response;103;18;GO:0046274
GO:1900151;regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;3698;111;GO:0045944
GO:2001230;positive regulation of response to gamma radiation;8;1;GO:0045727
GO:0009094;L-phenylalanine biosynthetic process;130324;825;GO:0006559
GO:0010087;phloem or xylem histogenesis;6249;290;GO:0048316
GO:0034050;programmed cell death induced by symbiont;1595;87;GO:0012501
GO:1900150;regulation of defense response to fungus;3758;81;GO:0050832
GO:2001231;regulation of protein localization to prospore membrane;0;0;GO:0048285
GO:0010082;regulation of root meristem growth;876;35;GO:0048316
GO:0034057;RNA strand-exchange activity;7547;44;GO:0003676
GO:1900153;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;3092;245;GO:0045944
GO:0010081;regulation of inflorescence meristem growth;53;6;GO:0048316
GO:0034056;estrogen response element binding;475;232;GO:0003700
GO:1900152;negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;541;7;GO:0045944
GO:0009099;valine biosynthetic process;338065;1410;GO:0006536
GO:0010084;specification of animal organ axis polarity;7;1;GO:0048608
GO:0034055;effector-mediated activation of programmed cell death in host;3;0;GO:0043066
GO:1900155;negative regulation of bone trabecula formation;94;10;GO:0048608
GO:0009098;leucine biosynthetic process;709742;1550;GO:0006576
GO:0010083;regulation of vegetative meristem growth;1;4;GO:0048316
GO:0034054;symbiont-mediated suppression of host defense-related programmed cell death;3;0;GO:0048608
GO:1900154;regulation of bone trabecula formation;94;8;GO:0048608
GO:1900157;regulation of bone mineralization involved in bone maturation;299;7;GO:0048609
GO:1900156;positive regulation of bone trabecula formation;0;1;GO:0048608
GO:0010080;regulation of floral meristem growth;94;25;GO:0048316
GO:1900159;positive regulation of bone mineralization involved in bone maturation;139;10;GO:0048609
GO:1900158;negative regulation of bone mineralization involved in bone maturation;160;6;GO:0048193
GO:0046086;adenosine biosynthetic process;57;40;GO:0009065
GO:0071031;nuclear mRNA surveillance of mRNA 3'-end processing;153;1;GO:0008380
GO:0046087;cytidine metabolic process;115047;576;GO:0006749
GO:0071032;nuclear mRNA surveillance of mRNP export;6;2;GO:0007049
GO:0046084;adenine biosynthetic process;66027;22;GO:0009065
GO:0046085;adenosine metabolic process;2839;670;GO:0006548
GO:0071030;nuclear mRNA surveillance of spliceosomal pre-mRNA splicing;11;88;GO:0008380
GO:0071035;nuclear polyadenylation-dependent rRNA catabolic process;1311;129;GO:0022627
GO:0097621;monoamine oxidase activity;1205;14;GO:0004497
GO:2001229;negative regulation of response to gamma radiation;42;5;GO:0010468
GO:0071036;nuclear polyadenylation-dependent snoRNA catabolic process;258;8;GO:0010467
GO:0097620;(R)-mandelate dehydrogenase activity;0;0;GO:0004073
GO:0046088;cytidine biosynthetic process;0;2;GO:0006749
GO:0097623;potassium ion export across plasma membrane;1035;36;GO:0006836
GO:0046089;cytosine biosynthetic process;0;2;GO:0006749
GO:0071034;CUT catabolic process;784;337;GO:0046274
GO:0097622;cytoplasmic translational elongation through polyproline stretches;3;0;GO:0006414
GO:0071039;nuclear polyadenylation-dependent CUT catabolic process;392;6;GO:0045944
GO:0097625;low-affinity basic amino acid transmembrane transporter activity;0;0;GO:0005215
GO:2001225;regulation of chloride transport;227;154;GO:0006811
GO:0097624;UDP-galactose transmembrane import into Golgi lumen;8;1;GO:0005576
GO:2001226;negative regulation of chloride transport;54;9;GO:0050890
GO:0071037;nuclear polyadenylation-dependent snRNA catabolic process;256;8;GO:0010467
GO:0097627;high-affinity L-ornithine transmembrane transporter activity;2;2;GO:0005215
GO:2001227;quercitrin binding;4;5;GO:0005515
GO:0071038;nuclear polyadenylation-dependent tRNA catabolic process;2050;26;GO:0006415
GO:0097626;low-affinity L-arginine transmembrane transporter activity;0;1;GO:0005215
GO:2001228;regulation of response to gamma radiation;50;4;GO:0010468
GO:0009093;cysteine catabolic process;13795;70;GO:0006520
GO:0010079;maintenance of vegetative meristem identity;0;2;GO:0048316
GO:0046082;5-methylcytosine biosynthetic process;0;2;GO:0006725
GO:0097629;extrinsic component of omegasome membrane;143;35;GO:0005737
GO:0009092;homoserine metabolic process;152607;380;GO:0009060
GO:0010078;maintenance of root meristem identity;529;27;GO:0048316
GO:0046083;adenine metabolic process;97483;18;GO:0006569
GO:0097628;distal tip cell migration;153;2;GO:0030900
GO:2001222;regulation of neuron migration;3987;348;GO:0048699
GO:0009091;homoserine catabolic process;0;2;GO:0009062
GO:0046080;dUTP metabolic process;87510;111;GO:0006559
GO:2001223;negative regulation of neuron migration;379;360;GO:0048699
GO:0009090;homoserine biosynthetic process;402;16;GO:0009061
GO:0046081;dUTP catabolic process;48376;603;GO:0006559
GO:2001224;positive regulation of neuron migration;779;226;GO:0048699
GO:0010097;specification of stamen identity;27;7;GO:0048316
GO:0034042;5-formyluracil DNA N-glycosylase activity;26;2;GO:0004553
GO:1900160;plastid chromosome packaging;2;2;GO:0048285
GO:0010096;specification of sepal identity;0;1;GO:0048316
GO:0034041;ABC-type sterol transporter activity;149;4;GO:0005525
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;1287;650;GO:0043066
GO:0010099;regulation of photomorphogenesis;1592;84;GO:0048316
GO:0034040;ATPase-coupled lipid transmembrane transporter activity;10504;471;GO:0008565
GO:1900162;negative regulation of phospholipid scramblase activity;0;1;GO:0048193
GO:2001241;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;417;639;GO:0043407
GO:0010098;suspensor development;164;8;GO:0048707
GO:1900161;regulation of phospholipid scramblase activity;8;2;GO:0008023
GO:2001242;regulation of intrinsic apoptotic signaling pathway;11538;563;GO:0043066
GO:0010093;specification of floral organ identity;303;379;GO:0009908
GO:0034046;poly(G) binding;547;86;GO:0005515
GO:0010092;specification of animal organ identity;1148;59;GO:0048513
GO:0034045;phagophore assembly site membrane;28525;223;GO:0005737
GO:1900163;positive regulation of phospholipid scramblase activity;8;6;GO:0048193
GO:0010095;specification of petal identity;1;1;GO:0048316
GO:0034044;exomer complex;1891;10;GO:0005576
GO:1900166;regulation of glial cell-derived neurotrophic factor production;169;0;GO:0048608
GO:0010094;specification of carpel identity;49;4;GO:0048316
GO:0034043;5-hydroxymethyluracil DNA N-glycosylase activity;26;1;GO:0004553
GO:1900168;positive regulation of glial cell-derived neurotrophic factor production;169;7;GO:0048169
GO:1900167;negative regulation of glial cell-derived neurotrophic factor production;0;0;GO:0048169
GO:0010091;trichome branching;371;135;GO:0048309
GO:0010090;trichome morphogenesis;3794;828;GO:0048608
GO:1900169;regulation of glucocorticoid mediated signaling pathway;8;7;GO:0030528
GO:0046097;deoxyuridine biosynthetic process;0;2;GO:0006520
GO:0071020;post-spliceosomal complex;295;20;GO:0000398
GO:0046098;guanine metabolic process;35581;47;GO:0006541
GO:0071021;U2-type post-spliceosomal complex;178;5;GO:0009986
GO:0046095;deoxyinosine biosynthetic process;0;2;GO:0009065
GO:0046096;deoxyuridine metabolic process;0;2;GO:0006518
GO:0071024;SL snRNP;3;1;GO:0009986
GO:0097632;extrinsic component of phagophore assembly site membrane;111;2;GO:0005783
GO:0071025;RNA surveillance;13471;97;GO:0006364
GO:0046099;guanine biosynthetic process;215;2;GO:0006541
GO:0071022;U12-type post-spliceosomal complex;0;1;GO:0009986
GO:0071023;trans spliceosomal complex;0;4;GO:0000398
GO:0034039;8-oxo-7,8-dihydroguanine DNA N-glycosylase activity;723;8;GO:0004721
GO:0071028;nuclear mRNA surveillance;1355;408;GO:0008340
GO:2001236;regulation of extrinsic apoptotic signaling pathway;8152;399;GO:0043407
GO:0034038;deoxyhypusine synthase activity;5211;322;GO:0004730
GO:0046090;deoxyadenosine metabolic process;239;3;GO:0006556
GO:0071029;nuclear ncRNA surveillance;4483;8;GO:0008380
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;4831;2040;GO:0043066
GO:0034037;purine ribonucleoside bisphosphate catabolic process;4271;1;GO:0009065
GO:0071026;cytoplasmic RNA surveillance;196;1;GO:0006364
GO:0097638;L-arginine import across plasma membrane;335;9;GO:0006865
GO:2001238;positive regulation of extrinsic apoptotic signaling pathway;2809;1580;GO:0046330
GO:0034036;purine ribonucleoside bisphosphate biosynthetic process;29355;8;GO:0006066
GO:0071027;nuclear RNA surveillance;6130;31;GO:0006364
GO:2001239;regulation of extrinsic apoptotic signaling pathway in absence of ligand;1708;332;GO:0043407
GO:0046093;deoxycytidine biosynthetic process;0;2;GO:0006796
GO:2001232;positive regulation of protein localization to prospore membrane;0;1;GO:0048285
GO:0010089;xylem development;1755;307;GO:0048468
GO:0046094;deoxyinosine metabolic process;219;2;GO:0006790
GO:0097639;L-lysine import across plasma membrane;55;2;GO:0006865
GO:2001233;regulation of apoptotic signaling pathway;25470;1220;GO:0042981
GO:0046091;deoxyadenosine biosynthetic process;0;2;GO:0009065
GO:2001234;negative regulation of apoptotic signaling pathway;15598;1110;GO:0043066
GO:0046092;deoxycytidine metabolic process;66;10;GO:0006518
GO:2001235;positive regulation of apoptotic signaling pathway;7944;1040;GO:0042981
GO:0061650;ubiquitin-like protein conjugating enzyme activity;9537;54;GO:0004842
GO:2001250;positive regulation of ammonia assimilation cycle;59;10;GO:0046395
GO:0061651;Atg12 conjugating enzyme activity;53;1;GO:0004842
GO:2001251;negative regulation of chromosome organization;21749;652;GO:0071013
GO:0061652;FAT10 conjugating enzyme activity;0;1;GO:0003735
GO:2001252;positive regulation of chromosome organization;7035;363;GO:0071013
GO:0061653;ISG15 conjugating enzyme activity;0;0;GO:0004867
GO:1902750;negative regulation of cell cycle G2/M phase transition;13037;438;GO:0010942
GO:1902751;positive regulation of cell cycle G2/M phase transition;7358;216;GO:0045786
GO:0061658;URM1 conjugating enzyme activity;0;0;GO:0005524
GO:1902754;positive regulation of renal amino acid absorption;0;0;GO:0010468
GO:0048679;regulation of axon regeneration;1563;604;GO:0048704
GO:0061659;ubiquitin-like protein ligase activity;329697;397;GO:0004842
GO:1902755;sulfurated eukaryotic molybdenum cofactor(2-) metabolic process;0;0;GO:0006732
GO:0046015;regulation of transcription by glucose;763;28;GO:0010468
GO:0048678;response to axon injury;5547;1410;GO:0048771
GO:1902752;regulation of renal amino acid absorption;0;0;GO:0010831
GO:0046016;positive regulation of transcription by glucose;362;40;GO:0045944
GO:0048677;axon extension involved in regeneration;361;76;GO:0048704
GO:1902753;negative regulation of renal amino acid absorption;0;0;GO:0010468
GO:0061654;NEDD8 conjugating enzyme activity;73;3;GO:0004842
GO:1902758;bis(molybdopterin guanine dinucleotide)molybdenum biosynthetic process;13;1;GO:0009061
GO:0061655;Pup conjugating enzyme activity;0;0;GO:0004364
GO:1902759;Mo(VI)-molybdopterin cytosine dinucleotide metabolic process;1;0;GO:0006790
GO:0061656;SUMO conjugating enzyme activity;286;7;GO:0008037
GO:1902756;sulfurated eukaryotic molybdenum cofactor(2-) biosynthetic process;0;0;GO:0006732
GO:0061657;UFM1 conjugating enzyme activity;1748;4;GO:0004842
GO:1902757;bis(molybdopterin guanine dinucleotide)molybdenum metabolic process;13;0;GO:0006790
GO:0048683;regulation of collateral sprouting of intact axon in response to injury;10;5;GO:0048704
GO:0048682;sprouting of injured axon;433;8;GO:0048704
GO:0048681;negative regulation of axon regeneration;661;166;GO:0048704
GO:1902749;regulation of cell cycle G2/M phase transition;21759;601;GO:0000077
GO:0048680;positive regulation of axon regeneration;502;143;GO:0048704
GO:0048687;positive regulation of sprouting of injured axon;88;21;GO:0048704
GO:0046025;precorrin-6Y C5,15-methyltransferase (decarboxylating) activity;1799;10;GO:0006022
GO:0048686;regulation of sprouting of injured axon;237;8;GO:0048704
GO:0048685;negative regulation of collateral sprouting of intact axon in response to injury;6;7;GO:0048704
GO:0097601;retina blood vessel maintenance;99;2;GO:0048407
GO:0048684;positive regulation of collateral sprouting of intact axon in response to injury;0;3;GO:0048704
GO:0097600;exoxylanase activity;0;0;GO:0004553
GO:0097603;temperature-gated ion channel activity;136;34;GO:0005216
GO:2001247;positive regulation of phosphatidylcholine biosynthetic process;88;18;GO:0046394
GO:0097602;cullin family protein binding;8691;442;GO:0005515
GO:2001248;regulation of ammonia assimilation cycle;59;8;GO:0009065
GO:2001249;negative regulation of ammonia assimilation cycle;0;1;GO:0046395
GO:0097604;temperature-gated cation channel activity;77;9;GO:0005216
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;7389;785;GO:0043066
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;3274;1210;GO:0010941
GO:0097609;longitudinal flagellum;0;0;GO:0048446
GO:2001245;regulation of phosphatidylcholine biosynthetic process;191;127;GO:0045944
GO:0097608;transverse flagellum;0;0;GO:0048446
GO:2001246;negative regulation of phosphatidylcholine biosynthetic process;56;5;GO:0046394
GO:2001261;negative regulation of semaphorin-plexin signaling pathway;9;5;GO:0048608
GO:0061640;cytoskeleton-dependent cytokinesis;31557;1030;GO:0007067
GO:2001262;positive regulation of semaphorin-plexin signaling pathway;117;2;GO:0048608
GO:2001263;regulation of C-C chemokine binding;0;1;GO:0050921
GO:0061642;chemoattraction of axon;112;9;GO:0048608
GO:2001264;negative regulation of C-C chemokine binding;0;1;GO:0048247
GO:1902761;positive regulation of chondrocyte development;98;1;GO:0045595
GO:1902762;regulation of embryonic skeletal joint development;2;0;GO:0048704
GO:1900100;positive regulation of plasma cell differentiation;171;229;GO:0045595
GO:1902760;Mo(VI)-molybdopterin cytosine dinucleotide biosynthetic process;1;0;GO:0006790
GO:2001260;regulation of semaphorin-plexin signaling pathway;185;5;GO:0048608
GO:0046028;electron transporter, transferring electrons from cytochrome b6/f complex of photosystem II activity;5;2;GO:0009523
GO:0061647;histone H3-K9 modification;923;321;GO:0016569
GO:1900102;negative regulation of endoplasmic reticulum unfolded protein response;727;110;GO:0010467
GO:0046029;mannitol dehydrogenase activity;126;9;GO:0004067
GO:0061648;tooth replacement;0;3;GO:0048608
GO:1900101;regulation of endoplasmic reticulum unfolded protein response;1621;107;GO:0034976
GO:1902766;skeletal muscle satellite cell migration;458;66;GO:0048771
GO:0046026;precorrin-4 C11-methyltransferase activity;20240;25;GO:0003676
GO:0048689;formation of growth cone in injured axon;7;2;GO:0048706
GO:0061649;ubiquitin modification-dependent histone binding;330;5;GO:0042393
GO:1900104;regulation of hyaluranon cable assembly;172;9;GO:0048608
GO:1902763;negative regulation of embryonic skeletal joint development;0;0;GO:0048704
GO:0046027;phospholipid:diacylglycerol acyltransferase activity;356;9;GO:0008610
GO:0048688;negative regulation of sprouting of injured axon;149;5;GO:0048704
GO:1900103;positive regulation of endoplasmic reticulum unfolded protein response;671;134;GO:0034976
GO:1902764;positive regulation of embryonic skeletal joint development;2;2;GO:0048704
GO:0061643;chemorepulsion of axon;279;83;GO:0048706
GO:1900106;positive regulation of hyaluranon cable assembly;172;30;GO:0048193
GO:1902769;regulation of choline O-acetyltransferase activity;15;5;GO:0010468
GO:0061644;protein localization to CENP-A containing chromatin;46;5;GO:0005819
GO:1900105;negative regulation of hyaluranon cable assembly;0;0;GO:0048193
GO:0061645;endocytic patch;7920;63;GO:0008029
GO:1900108;negative regulation of nodal signaling pathway;177;34;GO:0048704
GO:1902767;isoprenoid biosynthetic process via mevalonate;11639;6;GO:0006633
GO:0061646;positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization;10;1;GO:0048167
GO:1900107;regulation of nodal signaling pathway;339;6;GO:0030522
GO:1902768;isoprenoid biosynthetic process via 1-deoxy-D-xylulose 5-phosphate;0;2;GO:0006022
GO:0046031;ADP metabolic process;7190;958;GO:0006096
GO:0048694;positive regulation of collateral sprouting of injured axon;2;9;GO:0048704
GO:0046032;ADP catabolic process;116;7;GO:0006066
GO:0048693;regulation of collateral sprouting of injured axon;2;3;GO:0048704
GO:0048692;negative regulation of axon extension involved in regeneration;149;7;GO:0048704
GO:0046030;inositol trisphosphate phosphatase activity;15575;379;GO:0004721
GO:0048691;positive regulation of axon extension involved in regeneration;74;92;GO:0048704
GO:0046035;CMP metabolic process;20036;39;GO:0006511
GO:0048698;negative regulation of collateral sprouting in absence of injury;54;10;GO:0048704
GO:0097610;cell surface furrow;0;169;GO:0009986
GO:0046036;CTP metabolic process;250641;9;GO:0006096
GO:0048697;positive regulation of collateral sprouting in absence of injury;101;8;GO:0048608
GO:0046033;AMP metabolic process;215293;310;GO:0006555
GO:0048696;regulation of collateral sprouting in absence of injury;325;6;GO:0048608
GO:0097612;dinoflagellate sulcus;0;1;GO:0005576
GO:0046034;ATP metabolic process;2684841;4450;GO:0006091
GO:0048695;negative regulation of collateral sprouting of injured axon;0;2;GO:0048704
GO:0097611;dinoflagellate cingulum;0;1;GO:0005576
GO:0097614;dinoflagellate hypocone;0;0;GO:0005576
GO:2001258;negative regulation of cation channel activity;194;182;GO:0022836
GO:0097613;dinoflagellate epicone;0;1;GO:0005576
GO:2001259;positive regulation of cation channel activity;193;693;GO:0022836
GO:0097616;positive regulation by host of symbiont type IV pilus-dependent motility;0;0;GO:0048285
GO:0097615;modulation by host of symbiont type IV pilus-dependent motility;0;0;GO:0048285
GO:0048690;regulation of axon extension involved in regeneration;223;6;GO:0048704
GO:0097618;dinoflagellate sulcal notch;0;0;GO:0005576
GO:2001256;regulation of store-operated calcium entry;3109;162;GO:0006873
GO:0097619;PTEX complex;5;3;GO:0005737
GO:2001257;regulation of cation channel activity;510;533;GO:0022836
GO:0034097;response to cytokine;342087;6420;GO:0032496
GO:0061672;glutathione hydrolase complex;103;1;GO:0008021
GO:2001272;positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;47;13;GO:0046330
GO:0034096;positive regulation of maintenance of meiotic sister chromatid cohesion;14;3;GO:0048285
GO:0061673;mitotic spindle astral microtubule;447;15;GO:0007088
GO:0034095;negative regulation of maintenance of meiotic sister chromatid cohesion;0;2;GO:0048285
GO:0061674;gap filling involved in double-strand break repair via nonhomologous end joining;3;5;GO:0000724
GO:0034094;regulation of maintenance of meiotic sister chromatid cohesion;14;1;GO:0007070
GO:0061675;RBL family protein binding;3;0;GO:0042802
GO:1902772;positive regulation of phosphorelay signal transduction system involved in hydrogen peroxide mediated signaling pathway;0;1;GO:0043406
GO:1902773;GTPase activator complex;1788;0;GO:0005524
GO:0034099;luminal surveillance complex;66;9;GO:0005829
GO:0061670;evoked neurotransmitter secretion;76;1;GO:0007611
GO:1900111;positive regulation of histone H3-K9 dimethylation;634;94;GO:0045944
GO:1902770;negative regulation of choline O-acetyltransferase activity;0;0;GO:0010468
GO:2001270;regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;64;18;GO:0046330
GO:0034098;VCP-NPL4-UFD1 AAA ATPase complex;1126;473;GO:0005737
GO:0061671;Cbp3p-Cbp6 complex;974;3;GO:0043405
GO:1900110;negative regulation of histone H3-K9 dimethylation;0;8;GO:0045944
GO:1902771;positive regulation of choline O-acetyltransferase activity;2;21;GO:0010468
GO:2001271;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;17;73;GO:0046330
GO:0046039;GTP metabolic process;88481;1290;GO:0006096
GO:1900113;negative regulation of histone H3-K9 trimethylation;1;187;GO:0045944
GO:1902776;6-sulfoquinovose(1-) metabolic process;5127;0;GO:0006066
GO:1900112;regulation of histone H3-K9 trimethylation;2;133;GO:0045944
GO:1902777;6-sulfoquinovose(1-) catabolic process;5127;0;GO:0006032
GO:0046037;GMP metabolic process;885809;461;GO:0006073
GO:1900115;extracellular regulation of signal transduction;743;8;GO:0007165
GO:1902774;late endosome to lysosome transport;1731;30;GO:0006897
GO:0046038;GMP catabolic process;238;10;GO:0006066
GO:0048699;generation of neurons;264215;2920;GO:0048699
GO:1900114;positive regulation of histone H3-K9 trimethylation;1;28;GO:0045944
GO:1902775;mitochondrial large ribosomal subunit assembly;323;55;GO:0005743
GO:0034093;positive regulation of maintenance of sister chromatid cohesion;314;22;GO:0048285
GO:0061676;importin-alpha family protein binding;541;39;GO:0005515
GO:1900117;regulation of execution phase of apoptosis;865;79;GO:0010941
GO:0034092;negative regulation of maintenance of sister chromatid cohesion;161;5;GO:0007067
GO:0061677;2-dehydro-3-deoxy-D-gluconate aldolase activity;34;3;GO:0006099
GO:1900116;extracellular negative regulation of signal transduction;731;428;GO:0030528
GO:0034091;regulation of maintenance of sister chromatid cohesion;475;9;GO:0007067
GO:0061678;Entner-Doudoroff pathway;30936;3;GO:0006096
GO:1900119;positive regulation of execution phase of apoptosis;472;361;GO:0042981
GO:1902778;response to alkane;0;0;GO:0046686
GO:0034090;maintenance of meiotic sister chromatid cohesion;1184;7;GO:0007070
GO:0061679;Entner-Doudoroff pathway through gluconate;0;0;GO:0006099
GO:1900118;negative regulation of execution phase of apoptosis;384;389;GO:0043066
GO:1902779;cellular response to alkane;0;0;GO:0050727
GO:0046042;ITP biosynthetic process;0;3;GO:0006022
GO:0046043;TDP metabolic process;0;3;GO:0006749
GO:1900109;regulation of histone H3-K9 dimethylation;664;5;GO:0045944
GO:0046040;IMP metabolic process;1193504;1250;GO:0006541
GO:0046041;ITP metabolic process;1950;10;GO:0006796
GO:0046046;TTP metabolic process;29;1;GO:0006511
GO:0046047;TTP catabolic process;27;2;GO:0006559
GO:0046044;TMP metabolic process;2072;4;GO:0006790
GO:0046045;TMP catabolic process;0;2;GO:0006559
GO:2001269;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;34;49;GO:0046330
GO:2001265;positive regulation of C-C chemokine binding;0;1;GO:0050921
GO:2001266;Roundabout signaling pathway involved in axon guidance;3;2;GO:0007409
GO:2001267;regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;42;38;GO:0046330
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;8;148;GO:0046330
GO:0034086;maintenance of sister chromatid cohesion;2095;112;GO:0007067
GO:0061661;FAT10 ligase activity;0;0;GO:0004842
GO:2001283;Roundabout signaling pathway involved in muscle cell chemotaxis toward tendon cell;8;1;GO:0048608
GO:0034085;establishment of sister chromatid cohesion;7232;42;GO:0007059
GO:0061662;ISG15 ligase activity;0;0;GO:0004867
GO:1902780;response to nonane;0;0;GO:0050890
GO:2001284;regulation of BMP secretion;62;1;GO:0048608
GO:0034084;steryl deacetylase activity;5;4;GO:0004723
GO:0061663;NEDD8 ligase activity;160;36;GO:0004842
GO:2001285;negative regulation of BMP secretion;0;58;GO:0048704
GO:0034083;type III polyketide synthase complex;2;3;GO:0009536
GO:0061664;Pup ligase activity;0;0;GO:0004871
GO:2001286;regulation of caveolin-mediated endocytosis;192;24;GO:0048193
GO:1900120;regulation of receptor binding;56;29;GO:0048407
GO:1902783;cellular response to decane;0;0;GO:0050727
GO:0034089;establishment of meiotic sister chromatid cohesion;50;8;GO:0007059
GO:1902784;response to undecane;0;0;GO:0046686
GO:2001280;positive regulation of unsaturated fatty acid biosynthetic process;407;74;GO:0046394
GO:0034088;maintenance of mitotic sister chromatid cohesion;908;68;GO:0007067
GO:1900122;positive regulation of receptor binding;14;60;GO:0048407
GO:1902781;cellular response to nonane;0;0;GO:0071346
GO:2001281;regulation of muscle cell chemotaxis toward tendon cell;8;2;GO:0048608
GO:0034087;establishment of mitotic sister chromatid cohesion;6941;54;GO:0007059
GO:0061660;Atg12 ligase activity;0;0;GO:0004842
GO:1900121;negative regulation of receptor binding;36;74;GO:0048407
GO:1902782;response to decane;0;0;GO:0046686
GO:2001282;negative regulation of muscle cell chemotaxis toward tendon cell;8;2;GO:0048193
GO:0061669;spontaneous neurotransmitter secretion;420;264;GO:0007611
GO:1900124;negative regulation of nodal receptor complex assembly;4;3;GO:0048706
GO:1902787;cellular response to dodecane;0;0;GO:0050727
GO:1900123;regulation of nodal receptor complex assembly;4;0;GO:0048608
GO:1902788;response to isooctane;0;0;GO:0046686
GO:0046048;UDP metabolic process;748;3;GO:0006790
GO:1900126;negative regulation of hyaluronan biosynthetic process;211;226;GO:0010401
GO:1902785;cellular response to undecane;0;0;GO:0050727
GO:0046049;UMP metabolic process;452695;128;GO:0006561
GO:1900125;regulation of hyaluronan biosynthetic process;473;65;GO:0010401
GO:1902786;response to dodecane;0;0;GO:0046686
GO:0034082;type II polyketide synthase complex;0;2;GO:0009536
GO:0061665;SUMO ligase activity;1179;141;GO:0004842
GO:1900128;regulation of G-protein activated inward rectifier potassium channel activity;0;1;GO:0048407
GO:0034081;polyketide synthase complex;22;5;GO:0005576
GO:0061666;UFM1 ligase activity;2823;3;GO:0004842
GO:1900127;positive regulation of hyaluronan biosynthetic process;173;289;GO:0010401
GO:0034080;CENP-A containing chromatin assembly;4213;229;GO:0007067
GO:0061667;URM1 ligase activity;0;0;GO:0004842
GO:1902789;cellular response to isooctane;0;0;GO:0050727
GO:0061668;mitochondrial ribosome assembly;612;30;GO:0005740
GO:1900129;positive regulation of G-protein activated inward rectifier potassium channel activity;0;1;GO:0048407
GO:0046053;dAMP metabolic process;1506;1;GO:0006519
GO:0046054;dGMP metabolic process;334;4;GO:0006561
GO:0046051;UTP metabolic process;85738;386;GO:0006561
GO:0046052;UTP catabolic process;91;2;GO:0006519
GO:0046057;dADP catabolic process;57;6;GO:0006066
GO:0046058;cAMP metabolic process;65123;505;GO:0006096
GO:0046055;dGMP catabolic process;276;6;GO:0006066
GO:0046056;dADP metabolic process;58;5;GO:0006096
GO:2001276;regulation of leucine biosynthetic process;10;0;GO:0006511
GO:0046050;UMP catabolic process;241;5;GO:0006559
GO:2001277;negative regulation of leucine biosynthetic process;0;0;GO:0046394
GO:2001278;positive regulation of leucine biosynthetic process;10;1;GO:0046394
GO:2001279;regulation of unsaturated fatty acid biosynthetic process;589;9;GO:0006631
GO:2001294;malonyl-CoA catabolic process;288;3;GO:0009062
GO:2001295;malonyl-CoA biosynthetic process;98955;61;GO:0006096
GO:2001296;N(omega)-methyl-L-arginine metabolic process;0;0;GO:0006569
GO:2001297;N(omega)-methyl-L-arginine catabolic process;0;0;GO:0006569
GO:2001290;hydroperoxide metabolic process;0;0;GO:0006979
GO:2001291;codeine metabolic process;2;1;GO:0009060
GO:2001292;codeine catabolic process;1;0;GO:0009062
GO:2001293;malonyl-CoA metabolic process;99248;26;GO:0006081
GO:0071097;alphaV-beta3 integrin-paxillin-Pyk2 complex;0;0;GO:0048193
GO:0071098;alpha6-beta4 integrin-Fyn complex;0;1;GO:0005911
GO:0071095;alpha3-beta1 integrin-thrombospondin complex;0;2;GO:0005976
GO:0071096;alphaV-beta3 integrin-gelsolin complex;0;0;GO:0005925
GO:0071099;alphaV-beta6 integrin-TGFbeta-3 complex;0;2;GO:0005916
GO:2001287;negative regulation of caveolin-mediated endocytosis;76;20;GO:0048193
GO:2001288;positive regulation of caveolin-mediated endocytosis;60;74;GO:0048193
GO:2001289;lipid X metabolic process;683;5;GO:0006629
GO:0071090;alphaIIb-beta3 integrin-fibronectin-tissue transglutaminase complex;0;1;GO:0005976
GO:0071093;alpha5-beta1 integrin-fibronectin-tissue transglutaminase complex;0;1;GO:0005925
GO:0071094;alpha6-beta4 integrin-CD9 complex;0;1;GO:0005929
GO:0071091;alpha1-beta1 integrin-tissue transglutaminase complex;0;1;GO:0005911
GO:0071092;alpha3-beta1 integrin-tissue transglutaminase complex;0;1;GO:0005911
GO:0071086;alphaIIb-beta3 integrin-CD9-CD47-platelet glycoprotein Ib complex;0;2;GO:0002576
GO:0071087;alpha11-beta1 integrin-collagen type I complex;0;1;GO:0005911
GO:0071084;alpha2-beta1 integrin-CD47 complex;0;1;GO:0005975
GO:0071085;alphaIIb-beta3 integrin-CD9 complex;0;1;GO:0005929
GO:0071088;alpha5-beta1 integrin-tissue transglutaminase complex;0;1;GO:0005929
GO:0071089;alphaV-beta3 integrin-tissue transglutaminase complex;0;1;GO:0005976
GO:2001298;N(omega),N(omega)-dimethyl-L-arginine metabolic process;0;0;GO:0006569
GO:2001299;N(omega),N(omega)-dimethyl-L-arginine catabolic process;0;0;GO:0009065
GO:1900171;positive regulation of glucocorticoid mediated signaling pathway;0;0;GO:0010828
GO:1900170;negative regulation of glucocorticoid mediated signaling pathway;6;4;GO:0010828
GO:1900177;regulation of aflatoxin biosynthetic process;3;0;GO:0010468
GO:1900179;positive regulation of aflatoxin biosynthetic process;3;0;GO:0046405
GO:1900178;negative regulation of aflatoxin biosynthetic process;0;2;GO:0010468
GO:0071060;alpha7-beta1 integrin-CD151 complex;0;1;GO:0005929
GO:0097690;iron ion transmembrane transporter inhibitor activity;3;1;GO:0046395
GO:0071061;alpha6-beta4 integrin-CD151 complex;0;0;GO:0005929
GO:0097692;histone H3-K4 monomethylation;1;20;GO:0045944
GO:0097691;bacterial extracellular vesicle;20;3;GO:0070062
GO:0071053;alpha9-beta1 integrin-ADAM2 complex;0;0;GO:0005911
GO:0097683;dinoflagellate apex;0;0;GO:0005576
GO:0071054;alpha9-beta1 integrin-ADAM3 complex;0;1;GO:0005911
GO:0097682;intracellular phosphatidylinositol-3,5-bisphosphate-sensitive monatomic cation channel activity;243;1;GO:0008092
GO:0071051;polyadenylation-dependent snoRNA 3'-end processing;920;1;GO:0006461
GO:0097685;dinoflagellate apical groove;0;0;GO:0005576
GO:0071052;alpha9-beta1 integrin-ADAM1 complex;0;1;GO:0005911
GO:0097684;dinoflagellate antapex;0;0;GO:0005576
GO:0071057;alphav-beta3 integrin-ADAM15 complex;0;1;GO:0030199
GO:0097687;dinoflagellate antapical horn;0;0;GO:0005576
GO:0071058;alpha3-beta1 integrin-CD151 complex;0;1;GO:0005929
GO:0097686;dinoflagellate apical horn;0;0;GO:0005576
GO:0071055;alpha9-beta1 integrin-ADAM9 complex;0;1;GO:0005911
GO:0071056;alpha9-beta1 integrin-ADAM15 complex;0;1;GO:0030199
GO:0097688;glutamate receptor clustering;464;27;GO:0048169
GO:0071059;alpha6-beta1 integrin-CD151 complex;0;1;GO:0005929
GO:1900182;positive regulation of protein localization to nucleus;4540;1100;GO:0045944
GO:0000709;meiotic joint molecule formation;170;15;GO:0007049
GO:1900181;negative regulation of protein localization to nucleus;1795;160;GO:0010468
GO:0000708;meiotic strand invasion;171;9;GO:0000910
GO:1900184;negative regulation of xanthone-containing compound biosynthetic process;1;0;GO:0046356
GO:0000707;meiotic DNA recombinase assembly;151;243;GO:0000786
GO:1900183;regulation of xanthone-containing compound biosynthetic process;1;0;GO:0046148
GO:0000706;meiotic DNA double-strand break processing;381;46;GO:0000786
GO:1900186;negative regulation of clathrin-dependent endocytosis;139;9;GO:0048193
GO:0000705;achiasmate meiosis I;46;158;GO:0007067
GO:1900185;positive regulation of xanthone-containing compound biosynthetic process;0;1;GO:0046356
GO:0000704;pyrimidine dimer DNA N-glycosylase activity;1;3;GO:0006096
GO:1900188;negative regulation of cell adhesion involved in single-species biofilm formation;4;0;GO:0022617
GO:0000703;oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity;5752;160;GO:0006073
GO:1900187;regulation of cell adhesion involved in single-species biofilm formation;112;3;GO:0022610
GO:0000702;oxidized base lesion DNA N-glycosylase activity;102781;154;GO:0006066
GO:0000701;purine-specific mismatch base pair DNA N-glycosylase activity;31100;50;GO:0004518
GO:1900189;positive regulation of cell adhesion involved in single-species biofilm formation;108;8;GO:0050921
GO:0000700;mismatch base pair DNA N-glycosylase activity;44708;10;GO:0004518
GO:0071042;nuclear polyadenylation-dependent mRNA catabolic process;479;172;GO:0010467
GO:0097694;establishment of RNA localization to telomere;155;46;GO:0007049
GO:0071043;CUT metabolic process;784;10;GO:0046274
GO:0097693;ocelloid;0;3;GO:0005576
GO:0071040;nuclear polyadenylation-dependent antisense transcript catabolic process;196;4;GO:0010467
GO:0097696;receptor signaling pathway via STAT;12644;121;GO:0007165
GO:0071041;antisense RNA transcript catabolic process;208;2;GO:0010467
GO:0097695;establishment of protein-containing complex localization to telomere;68;91;GO:0048193
GO:0071046;nuclear polyadenylation-dependent ncRNA catabolic process;4479;8;GO:0010467
GO:0097698;telomere maintenance via base-excision repair;53;3;GO:0007049
GO:0071047;polyadenylation-dependent mRNA catabolic process;482;10;GO:0010467
GO:0097697;tRNA 5-carboxymethoxyuridine methyltransferase activity;3693;4;GO:0003729
GO:0071044;histone mRNA catabolic process;794;592;GO:0022613
GO:0071045;nuclear histone mRNA catabolic process;51;4;GO:0022613
GO:0097699;vascular endothelial cell response to fluid shear stress;54;2;GO:0048146
GO:1900180;regulation of protein localization to nucleus;7091;736;GO:0010467
GO:1900193;regulation of oocyte maturation;535;5;GO:0048608
GO:1900192;positive regulation of single-species biofilm formation;134;4;GO:0045734
GO:1900195;positive regulation of oocyte maturation;162;151;GO:0048608
GO:1900194;negative regulation of oocyte maturation;336;87;GO:0048608
GO:1900197;negative regulation of penicillin biosynthetic process;3;0;GO:0046274
GO:1900196;regulation of penicillin biosynthetic process;10;0;GO:0046274
GO:1900199;positive regulation of protein export from nucleus during meiotic anaphase II;0;2;GO:0048285
GO:1900198;positive regulation of penicillin biosynthetic process;7;1;GO:0046405
GO:0071082;alpha9-beta1 integrin-tenascin complex;0;2;GO:0005911
GO:0071083;alphaV-beta3 integrin-CD47-FCER2 complex;0;1;GO:0002576
GO:0071080;alpha3-beta1 integrin-basigin complex;0;1;GO:0005929
GO:0097670;SCF-Ufo1/Pof10 ubiquitin ligase complex;0;0;GO:0005515
GO:0071081;alpha3-beta1 integrin-CD63 complex;0;2;GO:0005929
GO:0071075;CUGBP1-eIF2 complex;0;2;GO:0005840
GO:0097661;SCF-Ctf13 ubiquitin ligase complex;0;0;GO:0005515
GO:0071076;RNA 3' uridylation;1156;8;GO:0005576
GO:0097660;SCF-Cdc4 ubiquitin ligase complex;0;0;GO:0005576
GO:0071073;positive regulation of phospholipid biosynthetic process;578;39;GO:0045944
GO:0097663;SCF-Dia2/Pof3 ubiquitin ligase complex;0;0;GO:0005515
GO:0071074;eukaryotic initiation factor eIF2 binding;270;41;GO:0003735
GO:0097662;SCF-Das1 ubiquitin ligase complex;0;0;GO:0005515
GO:0071079;alpha2-beta1 integrin-chondroadherin complex;0;1;GO:0005911
GO:0097665;SCF-Mdm30 ubiquitin ligase complex;0;0;GO:0005515
GO:0097664;SCF-Grr1/Pof2 ubiquitin ligase complex;0;0;GO:0005515
GO:0071077;adenosine 3',5'-bisphosphate transmembrane transporter activity;7674;1;GO:0008565
GO:0097667;SCF-Rcy1/Pof6 ubiquitin ligase complex;0;0;GO:0005515
GO:0071078;fibronectin-tissue transglutaminase complex;0;1;GO:0005578
GO:0097666;SCF-Met30/Pof1 ubiquitin ligase complex;0;0;GO:0005515
GO:0097669;SCF-Skp2 ubiquitin ligase complex;0;0;GO:0005829
GO:0097668;SCF-Saf1/Pof9 ubiquitin ligase complex;0;0;GO:0005576
GO:1900191;negative regulation of single-species biofilm formation;1204;15;GO:0045734
GO:1900190;regulation of single-species biofilm formation;1413;8;GO:0045734
GO:0071071;regulation of phospholipid biosynthetic process;1214;142;GO:0045944
GO:0071072;negative regulation of phospholipid biosynthetic process;449;189;GO:0045944
GO:0097681;double-strand break repair via alternative nonhomologous end joining;294;10;GO:0006281
GO:0071070;alpha4-beta1 integrin-thrombospondin-2 complex;0;1;GO:0005929
GO:0097680;double-strand break repair via classical nonhomologous end joining;332;150;GO:0006281
GO:0071064;alphaE-beta7 integrin-E-cadherin complex;0;1;GO:0048193
GO:0097672;SCF-Pof5 ubiquitin ligase complex;0;0;GO:0005515
GO:0071065;alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;53;22;GO:0048010
GO:0097671;SCF-YDR131C ubiquitin ligase complex;0;0;GO:0005829
GO:0071062;alphav-beta3 integrin-vitronectin complex;3;30;GO:0005911
GO:0097674;SCF-YLR352W ubiquitin ligase complex;0;0;GO:0005829
GO:0071063;sensory perception of wind;0;1;GO:0007600
GO:0097673;SCF-Ucc1 ubiquitin ligase complex;0;0;GO:0005515
GO:0071068;alpha9-beta1 integrin-ADAM12 complex;0;1;GO:0005911
GO:0097676;histone H3-K36 dimethylation;2;20;GO:0016569
GO:0071069;alpha4-beta1 integrin-thrombospondin-1 complex;0;0;GO:0005929
GO:0097675;SCF-Hrt3/Pof7 ubiquitin ligase complex;0;0;GO:0005515
GO:0071066;detection of mechanical stimulus involved in sensory perception of wind;0;1;GO:0007600
GO:0097678;SOCS family protein binding;14;0;GO:0019901
GO:0071067;alphav-beta3 integrin-ADAM23 complex;0;2;GO:0030199
GO:0097677;STAT family protein binding;460;47;GO:0030528
GO:0009002;serine-type D-Ala-D-Ala carboxypeptidase activity;222412;274;GO:0004867
GO:0009001;serine O-acetyltransferase activity;87653;703;GO:0004073
GO:0009000;selenocysteine lyase activity;3236;57;GO:0004721
GO:0009009;site-specific recombinase activity;88784;196;GO:0003677
GO:0009008;DNA-methyltransferase activity;291455;132;GO:0003729
GO:0009007;site-specific DNA-methyltransferase (adenine-specific) activity;175450;448;GO:0003700
GO:0010020;chloroplast fission;2371;35;GO:0048285
GO:0009030;thiamine-phosphate kinase activity;111050;258;GO:0004721
GO:0010022;meristem determinacy;410;23;GO:0048316
GO:0010021;amylopectin biosynthetic process;390;32;GO:0005976
GO:0009035;type I site-specific deoxyribonuclease activity;51149;28;GO:0004518
GO:0009034;tryptophanase activity;5962;8;GO:0004867
GO:0009033;trimethylamine-N-oxide reductase activity;0;4;GO:0004067
GO:0009032;thymidine phosphorylase activity;40771;31;GO:0004073
GO:0009039;urease activity;156664;579;GO:0004553
GO:0022006;zona limitans intrathalamica formation;20;4;GO:0008030
GO:0048636;positive regulation of muscle organ development;279;68;GO:0048731
GO:0061614;miRNA transcription;4096;185;GO:0006396
GO:1902710;GABA receptor complex;1153;116;GO:0031589
GO:0009038;undecaprenol kinase activity;639;3;GO:0004721
GO:0022007;convergent extension involved in neural plate elongation;115;40;GO:0048704
GO:0048635;negative regulation of muscle organ development;519;132;GO:0048731
GO:0061615;glycolytic process through fructose-6-phosphate;348493;430;GO:0006096
GO:1902711;GABA-A receptor complex;973;518;GO:0005509
GO:0009037;tyrosine-based site-specific recombinase activity;62234;10;GO:0003677
GO:0022008;neurogenesis;315574;6820;GO:0048699
GO:0048634;regulation of muscle organ development;1414;172;GO:0048731
GO:0061616;glycolytic process from fructose through fructose-6-phosphate;0;1;GO:0006096
GO:0009036;type II site-specific deoxyribonuclease activity;19517;37;GO:0004518
GO:0022009;central nervous system vasculogenesis;216;292;GO:0007420
GO:0048633;positive regulation of skeletal muscle tissue growth;177;133;GO:0048193
GO:0061617;MICOS complex;20686;271;GO:0005743
GO:0022002;negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway;1;2;GO:0048704
GO:0061610;glycerol to glycerone phosphate metabolic process;13;8;GO:0006094
GO:0022003;negative regulation of anterior neural cell fate commitment of the neural plate by fibroblast growth factor receptor signaling pathway;0;1;GO:0048704
GO:0048639;positive regulation of developmental growth;9785;959;GO:0048589
GO:0061611;mannose to fructose-6-phosphate metabolic process;51;2;GO:0006096
GO:0022004;midbrain-hindbrain boundary maturation during brain development;62;9;GO:0007430
GO:0048638;regulation of developmental growth;28413;1670;GO:0048731
GO:0061612;galactose to glucose-1-phosphate metabolic process;0;1;GO:0006096
GO:1902712;G protein-coupled GABA receptor complex;115;1;GO:0004890
GO:0022005;midbrain-hindbrain boundary maturation during neural plate development;0;3;GO:0009952
GO:0061613;glycolytic process from glycerol;4;5;GO:0006096
GO:0022010;central nervous system myelination;1258;2090;GO:0048666
GO:1902708;response to plumbagin;0;0;GO:0046686
GO:0022011;myelination in peripheral nervous system;1489;1120;GO:0030428
GO:0022012;subpallium cell proliferation in forebrain;50;1;GO:0048608
GO:0048643;positive regulation of skeletal muscle tissue development;945;313;GO:0048731
GO:0048642;negative regulation of skeletal muscle tissue development;163;368;GO:0048731
GO:0061619;glycolytic process from mannose through fructose-6-phosphate;1;2;GO:0006096
GO:0048641;regulation of skeletal muscle tissue development;1263;322;GO:0048731
GO:1902709;cellular response to plumbagin;0;1;GO:0071456
GO:0048640;negative regulation of developmental growth;7452;410;GO:0048731
GO:0010017;red or far-red light signaling pathway;3014;211;GO:0009765
GO:0010016;shoot system morphogenesis;8778;116;GO:0048731
GO:0010019;chloroplast-nucleus signaling pathway;223;105;GO:0009913
GO:0010018;far-red light signaling pathway;54;7;GO:0009765
GO:0010013;N-1-naphthylphthalamic acid binding;18;5;GO:0043169
GO:0010012;steroid 22-alpha hydroxylase activity;36;4;GO:0004497
GO:0010015;root morphogenesis;6796;376;GO:0048468
GO:0010014;meristem initiation;647;401;GO:0048316
GO:0009042;valine-pyruvate transaminase activity;1978;6;GO:0004089
GO:0010031;circumnutation;119;7;GO:0009908
GO:0009041;UMP/dUMP kinase activity;204148;7;GO:0004721
GO:0010030;positive regulation of seed germination;380;166;GO:0010033
GO:0009040;ureidoglycolate dehydrogenase activity;883;5;GO:0006067
GO:0010033;response to organic substance;1095316;8970;GO:0010033
GO:0010032;meiotic chromosome condensation;1326;212;GO:0007062
GO:0009046;zinc D-Ala-D-Ala carboxypeptidase activity;275;5;GO:0004721
GO:0009045;xylose isomerase activity;58227;122;GO:0005975
GO:0009044;xylan 1,4-beta-xylosidase activity;18762;87;GO:0004553
GO:0048647;polyphenic determination;1;2;GO:0009952
GO:0061603;molybdenum cofactor guanylyltransferase activity;31269;42;GO:0004721
GO:1902721;negative regulation of prolactin secretion;5;2;GO:0048608
GO:0048646;anatomical structure formation involved in morphogenesis;267018;3600;GO:0048513
GO:0061604;molybdopterin-synthase sulfurtransferase activity;2012;6;GO:0004723
GO:1902722;positive regulation of prolactin secretion;18;30;GO:0048608
GO:0009048;dosage compensation by inactivation of X chromosome;1043;689;GO:0007568
GO:0048645;animal organ formation;5658;107;GO:0048513
GO:0061605;molybdopterin-synthase adenylyltransferase activity;3589;8;GO:0004721
GO:0009047;dosage compensation by hyperactivation of X chromosome;342;67;GO:0007568
GO:0048644;muscle organ morphogenesis;5163;799;GO:0048731
GO:0061606;N-terminal protein amino acid propionylation;1;2;GO:0006464
GO:1902725;negative regulation of satellite cell differentiation;390;27;GO:0048704
GO:1902726;positive regulation of skeletal muscle satellite cell differentiation;52;0;GO:0048193
GO:0048649;caste determination, influence by genetic factors;0;0;GO:0009952
GO:1902723;negative regulation of skeletal muscle satellite cell proliferation;343;47;GO:0048771
GO:0048648;caste determination;1;2;GO:0009952
GO:0061602;molybdenum cofactor cytidylyltransferase activity;555;2;GO:0006096
GO:1902724;positive regulation of skeletal muscle satellite cell proliferation;116;7;GO:0048771
GO:0048650;caste determination, influence by environmental factors;1;1;GO:0009952
GO:0022000;forebrain induction by the anterior neural ridge;0;2;GO:0048704
GO:1902716;cell cortex of growing cell tip;111;5;GO:0009987
GO:0022001;negative regulation of anterior neural cell fate commitment of the neural plate;1;2;GO:0048704
GO:0048654;anther morphogenesis;165;5;GO:0048316
GO:0061607;peptide alpha-N-propionyltransferase activity;0;0;GO:0009081
GO:0048653;anther development;2336;384;GO:0009908
GO:0061608;nuclear import signal receptor activity;18165;214;GO:0005524
GO:0048652;polyphenic determination, influence by genetic factors;0;0;GO:0009909
GO:0061609;fructose-1-phosphate aldolase activity;157;10;GO:0004073
GO:0048651;polyphenic determination, influence by environmental factors;1;3;GO:0009909
GO:0010028;xanthophyll cycle;1237;8;GO:0009579
GO:0010027;thylakoid membrane organization;2515;507;GO:0009986
GO:0010029;regulation of seed germination;1424;555;GO:0010033
GO:0010024;phytochromobilin biosynthetic process;2606;14;GO:0006749
GO:0010023;proanthocyanidin biosynthetic process;115;165;GO:0009813
GO:0010026;trichome differentiation;5372;421;GO:0009913
GO:0010025;wax biosynthetic process;625;609;GO:0009865
GO:0061630;ubiquitin protein ligase activity;321054;4410;GO:0004842
GO:0061631;ubiquitin conjugating enzyme activity;7325;1100;GO:0004842
GO:0009013;succinate-semialdehyde dehydrogenase [NAD(P)+] activity;41574;0;GO:0004073
GO:0009012;aminoglycoside 3''-adenylyltransferase activity;2703;0;GO:0003929
GO:0009011;starch synthase activity;42056;119;GO:0005986
GO:0009010;sorbitol-6-phosphate 2-dehydrogenase activity;1424;4;GO:0006066
GO:0009017;succinylglutamate desuccinylase activity;12540;8;GO:0006066
GO:0048658;anther wall tapetum development;1376;118;GO:0048707
GO:1902732;positive regulation of chondrocyte proliferation;456;88;GO:0048608
GO:0009016;succinyldiaminopimelate transaminase activity;14119;10;GO:0004073
GO:0048657;anther wall tapetum cell differentiation;99;6;GO:0048471
GO:1902733;regulation of growth plate cartilage chondrocyte differentiation;3;1;GO:0048608
GO:0009015;N-succinylarginine dihydrolase activity;21097;25;GO:0004721
GO:0048656;anther wall tapetum formation;100;3;GO:0048471
GO:0061638;CENP-A containing chromatin;351;5;GO:0007049
GO:1902730;positive regulation of proteoglycan biosynthetic process;287;242;GO:0045944
GO:0009014;succinyl-diaminopimelate desuccinylase activity;69626;44;GO:0006032
GO:0048655;anther wall tapetum morphogenesis;141;6;GO:0048471
GO:0061639;Cdv-dependent cytokinesis;0;6;GO:0048608
GO:1902731;negative regulation of chondrocyte proliferation;329;19;GO:0048608
GO:0061632;RNA lariat debranching enzyme activator activity;101;3;GO:0003723
GO:1902736;positive regulation of receptor-mediated virion attachment to host cell;0;2;GO:0048193
GO:0061633;transport-coupled glycolytic process through glucose-6-phosphate;0;1;GO:0006096
GO:1902737;dendritic filopodium;79;37;GO:0048608
GO:0009019;tRNA (guanine-N1-)-methyltransferase activity;169417;0;GO:0003735
GO:0061634;alpha-D-xyloside xylohydrolase;3112;4;GO:0004553
GO:1902734;regulation of receptor-mediated virion attachment to host cell;1;3;GO:0048193
GO:0009018;sucrose phosphorylase activity;2381;6;GO:0006094
GO:0048659;smooth muscle cell proliferation;6172;588;GO:0042127
GO:0061635;regulation of protein complex stability;933;58;GO:0010468
GO:1902735;negative regulation of receptor-mediated virion attachment to host cell;1;1;GO:0048193
GO:0048661;positive regulation of smooth muscle cell proliferation;2924;3060;GO:0048010
GO:1902729;negative regulation of proteoglycan biosynthetic process;61;0;GO:0045944
GO:0048660;regulation of smooth muscle cell proliferation;5671;1800;GO:0048608
GO:1902727;negative regulation of growth factor dependent skeletal muscle satellite cell proliferation;4;0;GO:0048771
GO:1902728;positive regulation of growth factor dependent skeletal muscle satellite cell proliferation;8;10;GO:0048608
GO:0046002;positive regulation of preblastoderm mitotic cell cycle;0;2;GO:0048285
GO:0048665;neuron fate specification;7417;546;GO:0048699
GO:0046003;negative regulation of syncytial blastoderm mitotic cell cycle;0;1;GO:0048285
GO:0048664;neuron fate determination;745;813;GO:0030182
GO:0046000;positive regulation of ecdysteroid secretion;2;1;GO:0048608
GO:0048663;neuron fate commitment;11742;1460;GO:0030182
GO:0046001;negative regulation of preblastoderm mitotic cell cycle;0;1;GO:0048285
GO:0048662;negative regulation of smooth muscle cell proliferation;2290;1060;GO:0048010
GO:0009020;tRNA (guanosine-2'-O-)-methyltransferase activity;18156;0;GO:0003735
GO:0010011;auxin binding;858;269;GO:0009734
GO:0061620;glycolytic process through glucose-6-phosphate;741;177;GO:0006096
GO:0009024;tagatose-6-phosphate kinase activity;17587;25;GO:0006096
GO:0009022;tRNA nucleotidyltransferase activity;96788;167;GO:0003729
GO:0009028;tartronate-semialdehyde synthase activity;8029;16;GO:0004091
GO:0046006;regulation of activated T cell proliferation;1706;230;GO:0045727
GO:0048669;collateral sprouting in absence of injury;471;24;GO:0048608
GO:0061625;glycolytic process through fructose-1-phosphate;4;7;GO:0006096
GO:1902743;regulation of lamellipodium organization;2816;27;GO:0048193
GO:0009027;tartrate dehydrogenase activity;3315;98;GO:0004073
GO:0046007;negative regulation of activated T cell proliferation;557;774;GO:0045727
GO:0048668;collateral sprouting;1894;298;GO:0048608
GO:0061626;pharyngeal arch artery morphogenesis;476;89;GO:0048704
GO:1902744;negative regulation of lamellipodium organization;266;4;GO:0048193
GO:0009026;tagaturonate reductase activity;5426;5;GO:0006081
GO:0046004;positive regulation of syncytial blastoderm mitotic cell cycle;0;2;GO:0048285
GO:0048667;cell morphogenesis involved in neuron differentiation;103753;2700;GO:0048667
GO:0061627;S-methylmethionine-homocysteine S-methyltransferase activity;63;6;GO:0004497
GO:0009025;tagatose-bisphosphate aldolase activity;12266;125;GO:0006099
GO:0046005;positive regulation of circadian sleep/wake cycle, REM sleep;11;27;GO:0048405
GO:0048666;neuron development;173939;4650;GO:0048699
GO:0061628;H3K27me3 modified histone binding;274;8;GO:0016569
GO:1902742;apoptotic process involved in development;2751;152;GO:0042981
GO:0061621;canonical glycolysis;622;1060;GO:0006096
GO:1902747;negative regulation of lens fiber cell differentiation;237;6;GO:0048661
GO:0061622;glycolytic process through glucose-1-phosphate;115;5;GO:0006096
GO:1902748;positive regulation of lens fiber cell differentiation;56;38;GO:0048661
GO:0046008;regulation of female receptivity, post-mating;185;10;GO:0030518
GO:0061623;glycolytic process from galactose;64;3;GO:0006096
GO:1902745;positive regulation of lamellipodium organization;1885;268;GO:0048193
GO:0009029;tetraacyldisaccharide 4'-kinase activity;73555;1;GO:0004721
GO:0046009;positive regulation of female receptivity, post-mating;0;5;GO:0048608
GO:0061624;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate;125;62;GO:0006066
GO:1902746;regulation of lens fiber cell differentiation;426;28;GO:0048407
GO:0048672;positive regulation of collateral sprouting;519;220;GO:0048608
GO:0046010;positive regulation of circadian sleep/wake cycle, non-REM sleep;67;37;GO:0048405
GO:0048671;negative regulation of collateral sprouting;304;337;GO:0048704
GO:0048670;regulation of collateral sprouting;1087;594;GO:0048608
GO:1902738;regulation of chondrocyte differentiation involved in endochondral bone morphogenesis;4;1;GO:0048608
GO:0046013;regulation of T cell homeostatic proliferation;125;284;GO:0045727
GO:0061629;RNA polymerase II-specific DNA-binding transcription factor binding;32117;654;GO:0003700
GO:0010009;cytoplasmic side of endosome membrane;476;8;GO:0005768
GO:0046014;negative regulation of T cell homeostatic proliferation;2;5;GO:0045727
GO:0048675;axon extension;7990;1970;GO:0043005
GO:0046011;regulation of oskar mRNA translation;195;20;GO:0010401
GO:0048674;collateral sprouting of injured axon;35;7;GO:0048704
GO:0046012;positive regulation of oskar mRNA translation;8;72;GO:0010401
GO:0048673;collateral sprouting of intact axon in response to injury;10;4;GO:0048704
GO:0010006;Toc complex;42;5;GO:0005765
GO:0010005;cortical microtubule, transverse to long axis;260;5;GO:0043005
GO:0010008;endosome membrane;308933;4030;GO:0005768
GO:0010007;magnesium chelatase complex;5;20;GO:0009516
GO:0010002;cardioblast differentiation;1524;372;GO:0048608
GO:0010001;glial cell differentiation;19058;2600;GO:0048667
GO:0010004;gastrulation involving germ band extension;708;18;GO:0009952
GO:0010064;embryonic shoot morphogenesis;13;6;GO:0048731
GO:0034031;ribonucleoside bisphosphate catabolic process;7524;7;GO:0009065
GO:0009074;aromatic amino acid family catabolic process;327018;2440;GO:0009065
GO:0010063;positive regulation of trichoblast fate specification;5;5;GO:0048704
GO:0034030;ribonucleoside bisphosphate biosynthetic process;971426;55;GO:0006030
GO:0009073;aromatic amino acid family biosynthetic process;2509267;2000;GO:0009061
GO:0010066;ground meristem histogenesis;0;2;GO:0048316
GO:0009072;aromatic amino acid metabolic process;3202659;2180;GO:0009060
GO:0010065;primary meristem tissue development;640;7;GO:0009908
GO:0009079;pyruvate family amino acid biosynthetic process;62644;4;GO:0009061
GO:0010060;negative regulation of atrichoblast fate specification;0;2;GO:0048706
GO:0034035;purine ribonucleoside bisphosphate metabolic process;109751;323;GO:0006749
GO:0009078;pyruvate family amino acid metabolic process;209428;10;GO:0006096
GO:0034034;purine nucleoside bisphosphate catabolic process;7524;8;GO:0009065
GO:0010062;negative regulation of trichoblast fate specification;27;2;GO:0048704
GO:0034033;purine nucleoside bisphosphate biosynthetic process;971426;62;GO:0006730
GO:0010061;regulation of trichoblast fate specification;32;3;GO:0048704
GO:0034032;purine nucleoside bisphosphate metabolic process;1232444;220;GO:0006730
GO:0034028;5-(carboxyamino)imidazole ribonucleotide synthase activity;71331;0;GO:0009065
GO:0034027;(carboxyethyl)arginine beta-lactam-synthase activity;12;3;GO:0006022
GO:0034026;L-amino-acid alpha-ligase activity;238;5;GO:0004867
GO:0034025;D-aspartate ligase activity;146;3;GO:0004867
GO:0009071;serine family amino acid catabolic process;269117;1220;GO:0009062
GO:0010057;trichoblast fate specification;32;2;GO:0009952
GO:0009070;serine family amino acid biosynthetic process;992500;1490;GO:0009061
GO:0010056;atrichoblast fate specification;2;2;GO:0048608
GO:0010059;positive regulation of atrichoblast fate specification;2;6;GO:0048608
GO:0010058;regulation of atrichoblast fate specification;2;4;GO:0048608
GO:0034029;2-oxoglutarate carboxylase activity;666;3;GO:0004089
GO:0009086;methionine biosynthetic process;876554;2920;GO:0006541
GO:0010075;regulation of meristem growth;1398;986;GO:0048316
GO:0034020;neoxanthin synthase activity;14;2;GO:0004730
GO:0009085;lysine biosynthetic process;1213683;266;GO:0006541
GO:0010074;maintenance of meristem identity;1129;66;GO:0048316
GO:0009084;glutamine family amino acid biosynthetic process;2005934;1100;GO:0009065
GO:0010077;maintenance of inflorescence meristem identity;78;99;GO:0048316
GO:0048609;multicellular organismal reproductive process;120974;1330;GO:0032502
GO:0009083;branched-chain amino acid catabolic process;44228;1410;GO:0006544
GO:0010076;maintenance of floral meristem identity;28;44;GO:0009908
GO:0048608;reproductive structure development;94589;2420;GO:0048608
GO:0010071;root meristem specification;219;44;GO:0048316
GO:0034024;glutamate-putrescine ligase activity;1288;4;GO:0004866
GO:0009089;lysine biosynthetic process via diaminopimelate;816400;2690;GO:0006541
GO:0010070;zygote asymmetric cell division;113;8;GO:0048608
GO:0034023;5-(carboxyamino)imidazole ribonucleotide mutase activity;97620;0;GO:0003906
GO:0009088;threonine biosynthetic process;465955;1340;GO:0006565
GO:0010073;meristem maintenance;12416;320;GO:0048316
GO:0034022;3-(hydroxyamino)phenol mutase activity;40;0;GO:0004067
GO:0009087;methionine catabolic process;65;9;GO:0006541
GO:0010072;primary shoot apical meristem specification;80;280;GO:0009953
GO:0034021;response to silicon dioxide;31;8;GO:0046686
GO:0048601;oocyte morphogenesis;33;8;GO:0008544
GO:0048600;oocyte fate commitment;18;6;GO:0032502
GO:0022035;rhombomere cell migration;1;2;GO:0048608
GO:0022036;rhombomere cell differentiation;0;1;GO:0048699
GO:0022037;metencephalon development;8033;255;GO:0007430
GO:0022038;corpus callosum development;1096;167;GO:0007417
GO:0034017;trans-2-decenoyl-acyl-carrier-protein isomerase activity;20216;6;GO:0006066
GO:0034016;polyenoic fatty acid isomerase activity;3;3;GO:0008610
GO:0034015;L-ribulose-5-phosphate 3-epimerase activity;3392;5;GO:0006094
GO:0034014;response to triglyceride;71;9;GO:0006629
GO:0009082;branched-chain amino acid biosynthetic process;2317747;1230;GO:0009060
GO:0010068;protoderm histogenesis;22;6;GO:0048316
GO:0009081;branched-chain amino acid metabolic process;2419702;2240;GO:0009062
GO:0010067;procambium histogenesis;618;35;GO:0048608
GO:0009080;pyruvate family amino acid catabolic process;45450;7;GO:0009064
GO:0010069;zygote asymmetric cytokinesis in embryo sac;25;4;GO:0048608
GO:0034018;ascopyrone tautomerase activity;0;2;GO:0004091
GO:0010042;response to manganese ion;407;793;GO:0006879
GO:0009052;pentose-phosphate shunt, non-oxidative branch;49982;1380;GO:0006066
GO:0010041;response to iron(III) ion;105;38;GO:0006826
GO:0009051;pentose-phosphate shunt, oxidative branch;2676;634;GO:0006066
GO:0010044;response to aluminum ion;1760;384;GO:0009628
GO:0009050;glycopeptide catabolic process;1;4;GO:0009062
GO:0010043;response to zinc ion;2062;1620;GO:0009739
GO:0048619;embryonic hindgut morphogenesis;794;168;GO:0007565
GO:0009057;macromolecule catabolic process;2924634;3940;GO:0043170
GO:0034013;aliphatic aldoxime dehydratase activity;18;3;GO:0004067
GO:0009056;catabolic process;10714981;7550;GO:0006511
GO:0034012;FAD-AMP lyase (cyclizing) activity;928;6;GO:0004746
GO:0009055;electron transfer activity;8799572;4020;GO:0004746
GO:0010040;response to iron(II) ion;145;46;GO:0006826
GO:0034011;L-cysteate sulfo-lyase activity;174;2;GO:0004723
GO:0034010;sulfolactate sulfo-lyase activity;299;4;GO:0004734
GO:0022028;tangential migration from the subventricular zone to the olfactory bulb;351;167;GO:0048666
GO:0048614;post-embryonic ectodermal digestive tract morphogenesis;0;1;GO:0048731
GO:0022029;telencephalon cell migration;3328;577;GO:0048699
GO:0048613;embryonic ectodermal digestive tract morphogenesis;139;4;GO:0007565
GO:0009059;macromolecule biosynthetic process;84633382;3650;GO:0009059
GO:0001155;TFIIIA-class transcription factor binding;2;0;GO:0003700
GO:0052732;phosphoethanolamine phosphatase activity;173;7;GO:0004723
GO:0001154;TFIIIB-class transcription factor complex binding;0;0;GO:0003700
GO:0052730;sarcosine N-methyltransferase activity;910;6;GO:0004730
GO:0052739;phosphatidylserine 1-acylhydrolase activity;8488;200;GO:0004734
GO:0052737;pyruvate dehydrogenase (quinone) activity;12910;17;GO:0004723
GO:0052738;oxidoreductase activity, acting on the aldehyde or oxo group of donors, with a quinone or similar compound as acceptor;12910;2;GO:0004497
GO:0052735;tRNA (cytosine-3-)-methyltransferase activity;2546;0;GO:0003729
GO:0015789;UDP-N-acetylgalactosamine transmembrane transport;196;2;GO:0008544
GO:0052736;beta-glucanase activity;11027;5;GO:0004553
GO:0052733;quinate 3-dehydrogenase (NADP+) activity;1423;0;GO:0006066
GO:0015787;UDP-glucuronic acid transmembrane transport;143;3;GO:0008565
GO:0052734;shikimate 3-dehydrogenase (NAD+) activity;1427;0;GO:0006099
GO:1904504;positive regulation of lipophagy;324;32;GO:0045944
GO:1904503;negative regulation of lipophagy;19;2;GO:0045944
GO:1904502;regulation of lipophagy;343;9;GO:0045944
GO:1904508;regulation of protein localization to basolateral plasma membrane;18;0;GO:0048193
GO:1904507;positive regulation of telomere maintenance in response to DNA damage;651;8;GO:0045727
GO:1904506;negative regulation of telomere maintenance in response to DNA damage;209;1;GO:0045727
GO:1904505;regulation of telomere maintenance in response to DNA damage;860;1;GO:0045727
GO:0052742;phosphatidylinositol kinase activity;85232;71;GO:0004721
GO:0052743;inositol tetrakisphosphate phosphatase activity;4933;7;GO:0004721
GO:0001165;RNA polymerase I cis-regulatory region sequence-specific DNA binding;118;4;GO:0003700
GO:0052740;1-acyl-2-lysophosphatidylserine acylhydrolase activity;8468;327;GO:0008610
GO:0001164;RNA polymerase I core promoter sequence-specific DNA binding;4671;172;GO:0003700
GO:0052741;(R)-limonene 6-monooxygenase activity;4;0;GO:0004497
GO:0001163;RNA polymerase I transcription regulatory region sequence-specific DNA binding;4839;3;GO:0003700
GO:0001162;RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;385;55;GO:0003700
GO:0001161;intronic transcription regulatory region sequence-specific DNA binding;594;210;GO:0003700
GO:0052748;baicalin beta-D-glucuronidase activity;3;2;GO:0004553
GO:0052749;glucose-6-phosphate dehydrogenase (coenzyme F420) activity;3019;2;GO:0006096
GO:0052747;sinapyl alcohol dehydrogenase activity;453;5;GO:0006073
GO:0015799;propanediol transport;0;2;GO:0006869
GO:0052744;phosphatidylinositol monophosphate phosphatase activity;16193;40;GO:0004721
GO:0015798;myo-inositol transport;1266;120;GO:0006869
GO:0052745;inositol phosphate phosphatase activity;221528;262;GO:0004721
GO:0015775;beta-glucan transport;3966;5;GO:0006865
GO:0015774;polysaccharide transport;120207;59;GO:0008565
GO:0015773;raffinose transport;2;3;GO:0006830
GO:0015772;oligosaccharide transport;24521;58;GO:0005985
GO:0015771;trehalose transport;9268;99;GO:0006865
GO:1904511;cytoplasmic microtubule plus-end;74;4;GO:0005922
GO:0015770;sucrose transport;4119;1260;GO:0006869
GO:1904510;positive regulation of protein localization to basolateral plasma membrane;5;1;GO:0048193
GO:1904515;positive regulation of TORC2 signaling;270;3;GO:1901563
GO:1904514;positive regulation of initiation of premeiotic DNA replication;22;2;GO:0045740
GO:1904513;negative regulation of initiation of premeiotic DNA replication;0;0;GO:0045740
GO:1904512;regulation of initiation of premeiotic DNA replication;22;0;GO:0000086
GO:1904519;protein localization to microtubule minus-end;0;0;GO:0005840
GO:1904518;protein localization to cytoplasmic microtubule plus-end;58;4;GO:0005737
GO:0003796;lysozyme activity;85825;1340;GO:0004721
GO:1904516;myofibroblast cell apoptotic process;15;5;GO:0043066
GO:0003786;actin lateral binding;123;7;GO:0003779
GO:0052753;propan-2-ol:coenzyme F420 oxidoreductase activity;0;0;GO:0006096
GO:0052754;GTP:coenzyme F420 guanyltransferase activity;0;0;GO:0003906
GO:0052751;GDP-mannose hydrolase activity;115;3;GO:0006032
GO:0003789;actin filament severing activity;9;3;GO:0003700
GO:0052752;reduced coenzyme F420:heterodisulfide oxidoreductase activity;0;1;GO:0008800
GO:1904509;negative regulation of protein localization to basolateral plasma membrane;0;0;GO:0048193
GO:0052750;reactive-black-5:hydrogen-peroxide oxidoreductase activity;29;3;GO:0004091
GO:0052759;coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity;0;2;GO:0009065
GO:0015769;melibiose transport;4;2;GO:0006830
GO:0015768;maltose transport;7474;28;GO:0006865
GO:0052757;chondroitin hydrolase activity;57;2;GO:0004553
GO:0015767;lactose transport;1705;5;GO:0005929
GO:0052758;coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity;0;2;GO:0009065
GO:0015766;disaccharide transport;22570;35;GO:0005985
GO:0052755;reduced coenzyme F420:quinone oxidoreductase activity;0;0;GO:0008800
GO:0015765;methylgalactoside transport;9;2;GO:0006869
GO:0052756;chitobiose phosphorylase activity;0;2;GO:0006029
GO:0015786;UDP-glucose transmembrane transport;1223;7;GO:0008565
GO:0015783;GDP-fucose transmembrane transport;896;2;GO:0008544
GO:0015782;CMP-N-acetylneuraminate transmembrane transport;173;2;GO:0006826
GO:1904522;positive regulation of myofibroblast cell apoptotic process;0;4;GO:0043066
GO:1904521;negative regulation of myofibroblast cell apoptotic process;0;2;GO:0043066
GO:0015780;nucleotide-sugar transmembrane transport;36978;6;GO:0008529
GO:1904520;regulation of myofibroblast cell apoptotic process;15;3;GO:0043066
GO:1904526;regulation of microtubule binding;18;26;GO:0048608
GO:1904525;positive regulation of DNA amplification;0;1;GO:0045944
GO:1904524;negative regulation of DNA amplification;15;3;GO:0045944
GO:0001139;RNA polymerase II complex recruiting activity;139;9;GO:0003712
GO:1904523;regulation of DNA amplification;15;0;GO:0045944
GO:1904529;regulation of actin filament binding;11;4;GO:0003779
GO:1904528;positive regulation of microtubule binding;6;24;GO:0048285
GO:1904527;negative regulation of microtubule binding;3;7;GO:0048285
GO:0050101;mimosinase activity;0;3;GO:0004553
GO:0052764;exo-oligoalginate lyase activity;23;1;GO:0004553
GO:0050100;methylitaconate delta-isomerase activity;486;3;GO:0004497
GO:0052765;reduced coenzyme F420 oxidase activity;0;0;GO:0008800
GO:0050103;dextrin dextranase activity;3;4;GO:0004553
GO:0052762;gellan lyase activity;41;1;GO:0004733
GO:0050102;cellodextrin phosphorylase activity;18;3;GO:0006029
GO:0052763;ulvan lyase activity;0;0;GO:0004733
GO:0052760;coenzyme F420-dependent 2,4-dinitrophenol reductase activity;0;3;GO:0009065
GO:0052761;exo-1,4-beta-D-glucosaminidase activity;1978;3;GO:0004553
GO:0050109;morphine 6-dehydrogenase activity;188;2;GO:0004497
GO:0050108;monoterpenyl-diphosphatase activity;1;1;GO:0004497
GO:0015779;glucuronoside transport;82;3;GO:0008565
GO:0039724;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IKBKE activity;2211;4;GO:1901169
GO:0050105;L-gulonolactone oxidase activity;1495;8;GO:0004730
GO:0052768;mannosyl-oligosaccharide 1,3-alpha-mannosidase activity;1;1;GO:0006029
GO:0015778;hexuronide transmembrane transport;16;1;GO:0008565
GO:0039723;suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of TBK1 activity;814;4;GO:1901169
GO:0050104;L-gulonate 3-dehydrogenase activity;148;5;GO:0004497
GO:0052769;beta-6-sulfate-N-acetylglucosaminidase activity;0;0;GO:0004553
GO:0015777;teichoic acid transport;1775;4;GO:0006826
GO:0050107;monoterpenol O-acetyltransferase activity;0;3;GO:0004497
GO:0052766;mannoside alpha-1,4-mannosidase activity;0;0;GO:0006032
GO:0015776;capsular polysaccharide transport;8;2;GO:0008544
GO:0050106;monomethyl-sulfatase activity;0;2;GO:0004553
GO:0052767;mannosyl-oligosaccharide 1,6-alpha-mannosidase activity;11;2;GO:0006029
GO:0001195;maintenance of transcriptional fidelity during transcription elongation by RNA polymerase III;4;2;GO:0006091
GO:0001193;maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II;202;4;GO:0006470
GO:0001192;maintenance of transcriptional fidelity during transcription elongation;206;0;GO:0045944
GO:0052708;N-alpha,N-alpha,N-alpha-trimethyl-L-histidine metabolic process;7;0;GO:0006541
GO:0052709;N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthetic process;7;0;GO:0009061
GO:0052706;histidine N-methyltransferase activity;4;0;GO:0004723
GO:0052707;N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine;7;0;GO:0009061
GO:0052704;ergothioneine biosynthesis from histidine via gamma-glutamyl-hercynylcysteine sulfoxide;7517;1;GO:0009065
GO:0052705;methylhistidine N-methyltransferase activity;0;0;GO:0004721
GO:0052702;cellular modified histidine catabolic process;0;0;GO:0046395
GO:0052703;cellular modified histidine biosynthetic process;45095;1;GO:0006730
GO:0052700;ergothioneine catabolic process;0;0;GO:0006559
GO:0052701;cellular modified histidine metabolic process;45095;0;GO:0006730
GO:0052719;apurinic/apyrimidinic endoribonuclease activity;0;1;GO:0004518
GO:0001178;regulation of transcriptional start site selection at RNA polymerase II promoter;197;7;GO:0006366
GO:0001177;regulation of transcription open complex formation at RNA polymerase II promoter;0;0;GO:0006355
GO:0052710;N-alpha,N-alpha,N-alpha-trimethyl-L-histidine catabolic process;0;0;GO:0009065
GO:0001175;transcriptional start site selection at RNA polymerase III promoter;0;1;GO:0000976
GO:0001174;transcriptional start site selection at RNA polymerase II promoter;439;14;GO:0000976
GO:0001173;DNA-templated transcriptional start site selection;449;3;GO:0006366
GO:0001172;RNA-templated transcription;1645103;9;GO:0006351
GO:0001171;reverse transcription;107;266;GO:0006412
GO:0052717;tRNA-specific adenosine-34 deaminase activity;90155;98;GO:0008544
GO:0052718;tRNA-specific adenosine-34 deaminase complex;21;1;GO:0005737
GO:0052715;mannosyl-diinositol phosphorylceramide phospholipase activity;0;0;GO:0005576
GO:0052716;hydroquinone:oxygen oxidoreductase activity;17796;300;GO:0004497
GO:0052713;inositol phosphorylceramide phospholipase activity;39;0;GO:0005576
GO:0052714;mannosyl-inositol phosphorylceramide phospholipase activity;39;0;GO:0005576
GO:0052712;inositol phosphosphingolipid phospholipase activity;109;0;GO:0004650
GO:0001179;RNA polymerase I general transcription initiation factor binding;133;5;GO:0003729
GO:0052720;class II DNA-(apurinic or apyrimidinic site) endonuclease activity;83;0;GO:0004518
GO:0001188;RNA polymerase I preinitiation complex assembly;9428;67;GO:0000786
GO:0001182;RNA polymerase I promoter clearance;0;4;GO:0000976
GO:0001181;RNA polymerase I general transcription initiation factor activity;5478;25;GO:0003700
GO:0052728;capsorubin synthase activity;20;3;GO:0006032
GO:0052729;dimethylglycine N-methyltransferase activity;260;4;GO:0004067
GO:0052726;inositol-1,3,4-trisphosphate 5-kinase activity;9477;64;GO:0004721
GO:0052727;capsanthin synthase activity;20;3;GO:0004497
GO:0052724;inositol hexakisphosphate 3-kinase activity;6420;221;GO:0004721
GO:0052725;inositol-1,3,4-trisphosphate 6-kinase activity;9480;159;GO:0004721
GO:0052722;fatty acid in-chain hydroxylase activity;75;4;GO:0004497
GO:0052723;inositol hexakisphosphate 1-kinase activity;9879;449;GO:0004721
GO:0062145;L-propargylglycine--L-glutamate ligase activity;2;0;GO:0004497
GO:1904573;regulation of selenocysteine insertion sequence binding;0;0;GO:0048285
GO:0062146;4-chloro-allylglycine synthase activity;2;1;GO:0004497
GO:1904572;negative regulation of mRNA binding;0;0;GO:0010467
GO:0062147;L-lysine 4-chlorinase activity;2;1;GO:0004497
GO:1904571;positive regulation of selenocysteine incorporation;5;4;GO:0046395
GO:0062148;L-gamma-glutamyl-L-propargylglycine hydroxylase activity;2;1;GO:0004467
GO:1904570;negative regulation of selenocysteine incorporation;8;5;GO:0046395
GO:0062141;nuclear exosome targeting complex;3;0;GO:0005840
GO:0062142;L-beta-ethynylserine biosynthetic process;5;0;GO:0009061
GO:0062143;L-propargylglycine biosynthetic process;3;0;GO:0009065
GO:1904575;positive regulation of selenocysteine insertion sequence binding;0;0;GO:0048193
GO:0062144;L-propargylglycine synthase activity;2;1;GO:0004497
GO:1904574;negative regulation of selenocysteine insertion sequence binding;0;1;GO:0048193
GO:0050161;succinyl-CoA:oxalate CoA-transferase;0;2;GO:0006081
GO:1990490;archaeal proton-transporting A-type ATPase complex;0;1;GO:0005746
GO:0050160;orsellinate-depside hydrolase activity;0;2;GO:0004553
GO:1990491;methane biosynthetic process from methanol and hydrogen;0;0;GO:0019316
GO:0062149;detection of stimulus involved in sensory perception of pain;1249;7;GO:0007600
GO:0050156;ornithine N-benzoyltransferase activity;0;3;GO:0006081
GO:1990485;anaerobic lactate catabolic process;0;0;GO:0006099
GO:1990486;anaerobic fatty acid catabolic process;0;2;GO:0006631
GO:0050158;dihydroorotate dehydrogenase (NADPH) activity;1;2;GO:0004067
GO:1990487;anaerobic lignin catabolic process;0;2;GO:0046395
GO:0050157;ornithine racemase activity;172;2;GO:0004721
GO:1990488;anaerobic cellulose catabolic process;0;1;GO:0006099
GO:0050152;omega-amidase activity;440;6;GO:0004553
GO:1990489;anaerobic pectin catabolic process;0;1;GO:0006073
GO:0050151;oleate hydratase activity;7872;71;GO:0004497
GO:0050154;opheline kinase activity;0;4;GO:0004721
GO:0050153;omega-hydroxydecanoate dehydrogenase activity;6;2;GO:0009086
GO:0062150;amorpha-4,11-diene 12-monooxygenase activity;6;3;GO:0004497
GO:0062151;catalase complex;57;3;GO:0009579
GO:0050159;orsellinate decarboxylase activity;0;3;GO:0006073
GO:0062134;positive regulation of L-glutamine biosynthetic process;0;0;GO:0046394
GO:1904584;cellular response to polyamine macromolecule;3;1;GO:0006986
GO:1904583;response to polyamine macromolecule;5;1;GO:0005576
GO:0062136;low-density lipoprotein receptor complex;1;0;GO:0005840
GO:1904582;positive regulation of intracellular mRNA localization;191;39;GO:0010467
GO:0062137;cargo receptor complex;60;2;GO:0005840
GO:1904581;negative regulation of intracellular mRNA localization;16;0;GO:0010467
GO:0062130;adhesive extracellular matrix;25;5;GO:0022610
GO:1904588;cellular response to glycoprotein;116;5;GO:0002576
GO:0062131;3-butenylglucosinolate 2-hydroxylase activity;3;2;GO:0004734
GO:1904587;response to glycoprotein;366;5;GO:0002576
GO:0062132;regulation of L-glutamine biosynthetic process;0;0;GO:0006570
GO:1904586;cellular response to putrescine;6;10;GO:0009725
GO:0062133;negative regulation of L-glutamine biosynthetic process;0;0;GO:0046395
GO:1904585;response to putrescine;19;7;GO:0009725
GO:0050170;peptidyl-glutaminase activity;0;3;GO:0008021
GO:0050172;phenylalanine 2-monooxygenase activity;16;3;GO:0004497
GO:0050171;phenol beta-glucosyltransferase activity;2;2;GO:0004553
GO:1904589;regulation of protein import;94;197;GO:0015031
GO:0062139;camera-type eye photoreceptor cell development;105;1;GO:0008544
GO:0050167;pantothenoylcysteine decarboxylase activity;0;3;GO:0009065
GO:0050166;pantoate 4-dehydrogenase activity;0;4;GO:0009065
GO:1990497;regulation of cytoplasmic translation in response to stress;255;3;GO:0010467
GO:1990498;mitotic spindle microtubule;1031;96;GO:0000910
GO:0050168;pentanamidase activity;0;3;GO:0004730
GO:1990499;raps-insc complex;0;1;GO:0005737
GO:0050163;oxaloacetate tautomerase activity;15;2;GO:0004723
GO:0050162;oxalate oxidase activity;60;7;GO:0004601
GO:0050165;pantetheine kinase activity;1;4;GO:0004721
GO:0050164;oxoglutarate dehydrogenase (NADP+) activity;9;0;GO:0004073
GO:0062140;hyphae septin collar;0;0;GO:0008037
GO:1904580;regulation of intracellular mRNA localization;495;9;GO:0034660
GO:0062167;complement component C1q complex;117;12;GO:0005576
GO:1904595;positive regulation of termination of RNA polymerase II transcription;178;3;GO:0045944
GO:0062168;negative regulation of plus-end directed microtubule sliding;4;3;GO:0048285
GO:1904594;regulation of termination of RNA polymerase II transcription;313;0;GO:0006366
GO:0062169;regulation of plus-end directed microtubule sliding;4;0;GO:0048285
GO:1904593;prostaglandin binding;3;3;GO:0042632
GO:1904592;positive regulation of protein refolding;2;5;GO:0016570
GO:0062163;pseudohyphal septin ring assembly;0;0;GO:0048285
GO:1904599;advanced glycation end-product binding;0;7;GO:0030199
GO:0062164;regulation of pseudohyphal septin ring assembly;0;1;GO:0048285
GO:1904598;positive regulation of connective tissue replacement involved in inflammatory response wound healing;2;1;GO:0010717
GO:0062165;positive regulation of pseudohyphal septin ring assembly;0;0;GO:0048285
GO:1904597;negative regulation of connective tissue replacement involved in inflammatory response wound healing;52;10;GO:0050729
GO:0062166;negative regulation of pseudohyphal septin ring assembly;0;0;GO:0048285
GO:1904596;regulation of connective tissue replacement involved in inflammatory response wound healing;54;5;GO:0010717
GO:0050181;phorbol-diester hydrolase activity;0;3;GO:0004722
GO:0050180;phloretin hydrolase activity;23;3;GO:0004553
GO:0050183;phosphatidylcholine 12-monooxygenase activity;4;3;GO:0008610
GO:0050182;phosphate butyryltransferase activity;2155;5;GO:0006081
GO:0050178;phenylpyruvate tautomerase activity;385;70;GO:0004067
GO:0050177;phenylpyruvate decarboxylase activity;76;3;GO:0006099
GO:0050179;phenylserine aldolase activity;5;3;GO:0004073
GO:0050174;phenylalanine decarboxylase activity;3;4;GO:0006073
GO:0050176;phenylalanine N-acetyltransferase activity;2;3;GO:0004073
GO:0050175;phenylalanine dehydrogenase activity;44;3;GO:0009065
GO:0062170;lutein metabolic process;5;0;GO:0009579
GO:0062171;lutein biosynthetic process;0;0;GO:0009579
GO:0062172;lutein catabolic process;5;0;GO:0009062
GO:0062173;brexanolone metabolic process;101;4;GO:0046395
GO:1904591;positive regulation of protein import;93;45;GO:0048193
GO:1904590;negative regulation of protein import;0;43;GO:0015031
GO:0062156;mitochondrial ATP-gated potassium channel activity;107;1;GO:0008092
GO:0086101;endothelin receptor signaling pathway involved in heart process;147;10;GO:0007186
GO:0062157;mitochondrial ATP-gated potassium channel complex;222;1;GO:0008092
GO:0086102;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway involved in negative regulation of heart rate;0;0;GO:0008021
GO:0062158;chloride:proton antiporter activity;2;0;GO:0005215
GO:0062159;contractile vacuole complex;216;1;GO:0005788
GO:0086100;endothelin receptor signaling pathway;6433;232;GO:0007186
GO:0062152;mRNA (cytidine-5-)-methyltransferase activity;114;0;GO:0003729
GO:0062153;C5-methylcytidine-containing RNA reader activity;182;8;GO:0003700
GO:0062154;N6-methyl-AMP deaminase activity;10;2;GO:0004553
GO:0086103;G protein-coupled receptor signaling pathway involved in heart process;601;10;GO:0007186
GO:0062155;curli secretion complex;6;2;GO:0048193
GO:0050192;phosphoglycerate phosphatase activity;2;3;GO:0004721
GO:0050191;phosphoglycerate kinase (GTP) activity;0;5;GO:0003824
GO:0050194;phosphonoacetaldehyde hydrolase activity;16549;18;GO:0046395
GO:0050193;phosphoketolase activity;597;4;GO:0004721
GO:0050190;phosphoglucokinase activity;0;3;GO:0006096
GO:0050189;phosphoenolpyruvate phosphatase activity;5;3;GO:0004723
GO:0050188;phosphoenolpyruvate mutase activity;4465;6;GO:0006099
GO:0050185;phosphatidylinositol deacylase activity;131;5;GO:0005525
GO:0050184;phosphatidylcholine desaturase activity;19;3;GO:0008610
GO:0050187;phosphoamidase activity;68;8;GO:0004721
GO:0050186;phosphoadenylylsulfatase activity;0;3;GO:0004723
GO:0062160;spongiome;4;0;GO:0044419
GO:0062161;regulation of pyocyanine biosynthetic process;1;0;GO:0046395
GO:0062162;positive regulation of pyocyanine biosynthetic process;1;1;GO:0046395
GO:0062101;peptidyl-aspartic acid 3-dioxygenase activity;4139;4;GO:0004867
GO:0062102;female germline stem cell symmetric division;0;0;GO:0048608
GO:0062104;pumilio-response element binding;58;1;GO:0003700
GO:1904533;regulation of telomeric loop disassembly;193;2;GO:0048285
GO:1904531;positive regulation of actin filament binding;7;4;GO:0048010
GO:0062100;positive regulation of programmed necrotic cell death;443;8;GO:0010942
GO:1904530;negative regulation of actin filament binding;4;9;GO:0048010
GO:0062109;regulation of DNA recombinase disassembly;0;0;GO:0048285
GO:1904537;negative regulation of mitotic telomere tethering at nuclear periphery;13;1;GO:0048285
GO:1904536;regulation of mitotic telomere tethering at nuclear periphery;13;0;GO:0048285
GO:1904535;positive regulation of telomeric loop disassembly;41;2;GO:0048285
GO:1904534;negative regulation of telomeric loop disassembly;152;0;GO:0048285
GO:0062105;RNA 2'-O-methyltransferase activity;95934;2;GO:0003729
GO:0062107;regulation of protein localization to non-growing cell tip;0;0;GO:0048285
GO:1904539;negative regulation of glycolytic process through fructose-6-phosphate;180;2;GO:0045727
GO:0062108;negative regulation of protein localization to non-growing cell tip;0;0;GO:0048285
GO:1904538;regulation of glycolytic process through fructose-6-phosphate;182;3;GO:0006096
GO:0050112;inositol 2-dehydrogenase activity;19173;10;GO:0004723
GO:0052775;endo-1,3-alpha-L-rhamnosidase activity;2;2;GO:0004553
GO:0050111;mycocerosate synthase activity;353;83;GO:0006021
GO:0052776;diacetylchitobiose catabolic process to glucosamine and acetate;0;1;GO:0006032
GO:0050114;myo-inosose-2 dehydratase activity;8303;10;GO:0006073
GO:0052773;diacetylchitobiose deacetylase activity;1;0;GO:0006029
GO:0050113;inositol oxygenase activity;14294;225;GO:0004725
GO:0052774;glucosyl-N-acetylglucosamine glucosaminidase activity;0;0;GO:0004553
GO:0052771;coenzyme F390-G hydrolase activity;0;1;GO:0003824
GO:0052772;brefeldin A esterase activity;0;0;GO:0005576
GO:0050110;mucinaminylserine mucinaminidase activity;213;2;GO:0004553
GO:0052770;coenzyme F390-A hydrolase activity;0;1;GO:0005524
GO:0050119;N-acetylglucosamine deacetylase activity;168;26;GO:0004553
GO:0050116;N,N-dimethylformamidase activity;139;3;GO:0004553
GO:0052779;amino disaccharide metabolic process;1567;2;GO:0006032
GO:0050115;myosin-light-chain-phosphatase activity;102;36;GO:0004721
GO:0050118;N-acetyldiaminopimelate deacetylase activity;9010;5;GO:0004721
GO:0052777;diacetylchitobiose catabolic process;1177;2;GO:0006032
GO:0050117;N-acetyl-beta-alanine deacetylase activity;0;2;GO:0004723
GO:0052778;diacetylchitobiose metabolic process;1178;0;GO:0006032
GO:1904540;positive regulation of glycolytic process through fructose-6-phosphate;2;2;GO:0045727
GO:1904544;positive regulation of free ubiquitin chain polymerization;59;2;GO:0016567
GO:1904543;negative regulation of free ubiquitin chain polymerization;0;0;GO:0016567
GO:1904542;regulation of free ubiquitin chain polymerization;59;0;GO:0006464
GO:1904541;fungal-type cell wall disassembly involved in conjugation with cellular fusion;42;4;GO:0048285
GO:0052790;chitooligosaccharide deacetylase activity;0;1;GO:0004553
GO:1904547;regulation of cellular response to glucose starvation;16;3;GO:0045737
GO:0050123;N-acylmannosamine 1-dehydrogenase activity;14;2;GO:0006032
GO:0052786;alpha-linked polysaccharide catabolism to maltotriose;0;2;GO:0005976
GO:0050122;N-acylhexosamine oxidase activity;0;3;GO:0004553
GO:0052787;alpha-linked polysaccharide catabolism to maltopentaose;0;2;GO:0005976
GO:0050125;N-benzyloxycarbonylglycine hydrolase activity;0;2;GO:0004721
GO:0052784;reuteran biosynthetic process;0;0;GO:1901363
GO:0050124;N-acylneuraminate-9-phosphatase activity;123;8;GO:0004721
GO:0052785;cellulose catabolism by endo-processive cellulases;0;1;GO:0005976
GO:0052782;amino disaccharide catabolic process;1375;1;GO:0006032
GO:0052783;reuteran metabolic process;0;0;GO:0006091
GO:0050121;N-acylglucosamine 2-epimerase activity;723;8;GO:0006021
GO:0052780;chitobiose metabolic process;0;0;GO:0006032
GO:0050120;N-acetylhexosamine 1-dehydrogenase activity;0;3;GO:0006032
GO:0052781;chitobiose catabolic process;2;1;GO:0006032
GO:0050127;N-carbamoylsarcosine amidase activity;266;3;GO:0004553
GO:0050126;N-carbamoylputrescine amidase activity;6486;7;GO:0004725
GO:0050129;N-formylglutamate deformylase activity;2050;5;GO:0009081
GO:0052788;d-4,5 unsaturated beta-glucuronyl hydrolase activity;0;0;GO:0004553
GO:0050128;N-feruloylglycine deacylase activity;0;3;GO:0006081
GO:0052789;mannan 1,3-beta-mannosidase activity;0;0;GO:0004553
GO:0062123;regulation of linear element maturation;13;2;GO:0048608
GO:1904551;cellular response to arachidonic acid;0;0;GO:0006954
GO:0062124;4-hydroxybutyrate receptor activity;28;3;GO:0004930
GO:1904550;response to arachidonic acid;6;6;GO:0006954
GO:0062125;regulation of mitochondrial gene expression;2085;16;GO:0045944
GO:0062126;fatty acid primary amide metabolic process;5;2;GO:0006631
GO:1904555;L-proline transmembrane transport;190;0;GO:0006865
GO:0062120;LinE complex assembly;0;1;GO:0005840
GO:1904554;positive regulation of chemotaxis to arachidonic acid;0;0;GO:0050921
GO:0062121;linear element maturation;13;0;GO:0005576
GO:1904553;negative regulation of chemotaxis to arachidonic acid;0;0;GO:0050921
GO:0062122;histone H3K37 methyltransferase activity;1866;0;GO:0016569
GO:1904552;regulation of chemotaxis to arachidonic acid;0;0;GO:0002684
GO:1904559;cellular response to dextromethorphan;0;1;GO:0042493
GO:1904558;response to dextromethorphan;1;2;GO:0042493
GO:1904557;L-alanine transmembrane transport;405;1;GO:0006836
GO:1904556;L-tryptophan transmembrane transport;53;2;GO:0006865
GO:0062127;fatty acid primary amide catabolic process;0;0;GO:0009062
GO:0062128;MutSgamma complex;9;3;GO:0005524
GO:0062129;chitin-based extracellular matrix;831;88;GO:0005576
GO:0050134;N6-methyl-lysine oxidase activity;3;3;GO:0004725
GO:0052797;4-O-methyl-glucuronoyl methylesterase activity;0;1;GO:0004553
GO:0050133;N6-hydroxylysine O-acetyltransferase activity;217;3;GO:0004730
GO:0052798;beta-galactoside alpha-2,3-sialyltransferase activity;13;24;GO:0004553
GO:0050136;NADH dehydrogenase (quinone) activity;1726532;1280;GO:0004746
GO:0052795;exo-alpha-(2->6)-sialidase activity;278051;0;GO:0004553
GO:0050135;NAD(P)+ nucleosidase activity;2628;1;GO:0004725
GO:0052796;exo-alpha-(2->8)-sialidase activity;278243;1;GO:0004553
GO:0050130;N-methyl-2-oxoglutaramate hydrolase activity;0;3;GO:0004723
GO:0052793;pectin acetylesterase activity;334;6;GO:0004553
GO:0052794;exo-alpha-(2->3)-sialidase activity;278295;0;GO:0004553
GO:0050132;N-methylalanine dehydrogenase activity;5;3;GO:0009065
GO:0052791;3-deoxy-D-glycero-D-galacto-2-nonulosonic acid hydrolase activity;0;0;GO:0004553
GO:0050131;N-methyl-L-amino-acid oxidase activity;2345;8;GO:0004449
GO:0052792;endo-xylogalacturonan hydrolase activity;0;0;GO:0004553
GO:0050138;nicotinate dehydrogenase activity;1115;3;GO:0009065
GO:0050137;NADPH peroxidase activity;57;6;GO:0004601
GO:0052799;coenzyme F420-dependent bicyclic nitroimidazole catabolic process;0;0;GO:0046395
GO:0050139;nicotinate-N-glucosyltransferase activity;4;3;GO:0006073
GO:0062112;fatty acid primary amide biosynthetic process;5;1;GO:0006631
GO:1904562;phosphatidylinositol 5-phosphate metabolic process;107;155;GO:0006631
GO:0062113;early phagosome lumen;0;1;GO:0005768
GO:1904561;cellular response to diphenidol;4;2;GO:0006954
GO:1904560;response to diphenidol;5;1;GO:0009615
GO:1904566;cellular response to 1-oleoyl-sn-glycerol 3-phosphate;6;9;GO:0006631
GO:1904565;response to 1-oleoyl-sn-glycerol 3-phosphate;6;62;GO:0006631
GO:0062110;negative regulation of DNA recombinase disassembly;0;0;GO:0048285
GO:1904564;Nbp35-Cfd1 ATPase complex;65;3;GO:0005737
GO:0062111;zinc ion import into organelle;857;7;GO:0006836
GO:1904563;phosphatidylinositol 5-phosphate biosynthetic process;0;1;GO:0006631
GO:1904569;regulation of selenocysteine incorporation;13;5;GO:0006457
GO:0050150;o-pyrocatechuate decarboxylase activity;77;4;GO:0006073
GO:1904568;cellular response to wortmannin;18;2;GO:0006974
GO:1904567;response to wortmannin;18;1;GO:0006974
GO:0062116;phenyloplast;0;1;GO:0009941
GO:0062119;LinE complex;0;0;GO:0005840
GO:0050145;nucleoside monophosphate kinase activity;869712;7;GO:0004721
GO:0050144;nucleoside deoxyribosyltransferase activity;199;6;GO:0004518
GO:0050147;nucleoside ribosyltransferase activity;0;2;GO:0004518
GO:0050146;nucleoside phosphotransferase activity;112;25;GO:0004721
GO:0050141;nitroethane oxidase activity;18;2;GO:0004784
GO:0050140;nitrate reductase (cytochrome) activity;6555;2;GO:0003954
GO:0050143;nocardicin-A epimerase activity;0;3;GO:0004497
GO:0050142;nitrogenase (flavodoxin) activity;1;3;GO:0009579
GO:0050149;o-aminophenol oxidase activity;13;2;GO:0004721
GO:0050148;nucleotide diphosphokinase activity;0;3;GO:0004553
GO:0086079;gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling;1;3;GO:0008021
GO:0086077;gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling;155;10;GO:0008021
GO:0086078;gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling;64;4;GO:0008021
GO:0098061;viral capsid, internal space;0;0;GO:0044427
GO:1990400;mitochondrial ribosomal large subunit rRNA binding;63;2;GO:0003735
GO:1990401;embryonic lung development;66;6;GO:0009952
GO:1990402;embryonic liver development;221;24;GO:0007565
GO:1990403;embryonic brain development;824;243;GO:0007420
GO:1990404;NAD+-protein ADP-ribosyltransferase activity;30153;0;GO:0004812
GO:0086082;cell adhesive protein binding involved in AV node cell-bundle of His cell communication;2;1;GO:0005576
GO:1990405;protein antigen binding;161;57;GO:0042802
GO:0086083;cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication;5;429;GO:0005929
GO:1990406;CGRP receptor complex;106;2;GO:0004872
GO:0086080;protein binding involved in heterotypic cell-cell adhesion;101;87;GO:0048308
GO:1990407;calcitonin gene-related peptide binding;45;1;GO:0004930
GO:0086081;cell adhesive protein binding involved in atrial cardiac muscle cell-AV node cell communication;0;1;GO:0005929
GO:1990408;calcitonin gene-related peptide receptor signaling pathway;159;3;GO:0007186
GO:0086086;voltage-gated potassium channel activity involved in AV node cell action potential repolarization;0;1;GO:0048608
GO:1990409;adrenomedullin binding;113;4;GO:0005576
GO:0086087;voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization;50;1;GO:0048507
GO:0086084;cell adhesive protein binding involved in Purkinje myocyte-ventricular cardiac muscle cell communication;0;0;GO:0005929
GO:0086085;cell adhesive protein binding involved in SA cardiac muscle cell-atrial cardiac muscle cell communication;0;0;GO:0005929
GO:0086088;voltage-gated potassium channel activity involved in Purkinje myocyte action potential repolarization;0;0;GO:0048507
GO:0086089;voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization;177;93;GO:0048407
GO:0062097;chemosynthesis;0;1;GO:0006091
GO:0062098;regulation of programmed necrotic cell death;1727;8;GO:0012501
GO:0062099;negative regulation of programmed necrotic cell death;901;7;GO:0043066
GO:2000808;negative regulation of synaptic vesicle clustering;6;5;GO:0048608
GO:2000809;positive regulation of synaptic vesicle clustering;169;142;GO:0048608
GO:2000804;regulation of termination of RNA polymerase II transcription, poly(A)-coupled;187;0;GO:0045944
GO:2000805;negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled;131;0;GO:0045944
GO:1990410;adrenomedullin receptor signaling pathway;240;13;GO:0007186
GO:2000806;positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled;52;0;GO:0045944
GO:1990411;hercynylcysteine sulfoxide lyase activity (ergothioneine-forming);528;1;GO:0006067
GO:2000807;regulation of synaptic vesicle clustering;217;42;GO:0048608
GO:1990412;hercynylselenocysteine lyase activity (selenoneine-forming);4;1;GO:0004730
GO:2000800;regulation of endocardial cushion to mesenchymal transition involved in heart valve formation;33;1;GO:0048608
GO:0086090;voltage-gated potassium channel activity involved in SA node cell action potential repolarization;51;1;GO:0048507
GO:1990413;eyespot apparatus;0;1;GO:0005576
GO:2000801;negative regulation of endocardial cushion to mesenchymal transition involved in heart valve formation;0;0;GO:0048608
GO:1990414;replication-born double-strand break repair via sister chromatid exchange;610;130;GO:0000724
GO:2000802;positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation;33;3;GO:0048608
GO:0086093;G protein-coupled acetylcholine receptor signaling pathway involved in heart process;0;1;GO:0007186
GO:1990416;cellular response to brain-derived neurotrophic factor stimulus;164;55;GO:0048608
GO:0086094;positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction;1;2;GO:0048010
GO:1990417;snoRNA release from pre-rRNA;51;1;GO:0006661
GO:0086091;regulation of heart rate by cardiac conduction;1870;1920;GO:0002080
GO:1990418;response to insulin-like growth factor stimulus;136;27;GO:0030516
GO:0086092;regulation of the force of heart contraction by cardiac conduction;114;25;GO:0048407
GO:0086097;phospholipase C-activating angiotensin-activated signaling pathway;1787;50;GO:0008021
GO:0086098;angiotensin-activated signaling pathway involved in heart process;156;192;GO:0002026
GO:0086095;positive regulation of IKACh channel activity by G protein-coupled acetylcholine receptor signaling pathway involved in negative regulation of heart rate;0;1;GO:0048608
GO:0086096;adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process;61;1;GO:0008021
GO:0086057;voltage-gated calcium channel activity involved in bundle of His cell action potential;55;9;GO:0008092
GO:0086058;voltage-gated calcium channel activity involved in Purkinje myocyte cell action potential;0;1;GO:0008092
GO:0086055;Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling;2;4;GO:0006936
GO:0086056;voltage-gated calcium channel activity involved in AV node cell action potential;105;63;GO:0008092
GO:0086059;voltage-gated calcium channel activity involved SA node cell action potential;57;7;GO:0008092
GO:2000819;regulation of nucleotide-excision repair;421;224;GO:0006281
GO:0098035;viral DNA genome packaging via site-specific sequence recognition;327;3;GO:0042254
GO:2000815;regulation of mRNA stability involved in response to oxidative stress;8;5;GO:0010467
GO:1990420;establishment of septation initiation network asymmetry;0;0;GO:0048285
GO:2000816;negative regulation of mitotic sister chromatid separation;18539;1860;GO:0048285
GO:0098037;viral DNA genome packaging, 5' extended cos packaging;0;0;GO:0016021
GO:0098036;viral DNA genome packaging, 3' extended cos packaging;0;0;GO:0016021
GO:1990422;glyoxalase (glycolic acid-forming) activity;53;5;GO:0004067
GO:2000818;negative regulation of myoblast proliferation;202;10;GO:0048771
GO:0098039;replicative DNA transposition;0;2;GO:0006313
GO:1990423;RZZ complex;3138;43;GO:0005819
GO:2000811;negative regulation of anoikis;849;990;GO:0010942
GO:0098038;non-replicative DNA transposition;969;3;GO:0006313
GO:1990424;protein arginine kinase activity;0;2;GO:0004721
GO:2000812;regulation of barbed-end actin filament capping;290;80;GO:0048608
GO:1990425;ryanodine receptor complex;13;28;GO:0008092
GO:2000813;negative regulation of barbed-end actin filament capping;165;4;GO:0048193
GO:1990426;mitotic recombination-dependent replication fork processing;3068;90;GO:0007067
GO:2000814;positive regulation of barbed-end actin filament capping;4;9;GO:0048608
GO:0086060;voltage-gated sodium channel activity involved in AV node cell action potential;48;5;GO:0048507
GO:1990427;stereocilia tip-link density;11;1;GO:0005578
GO:0086061;voltage-gated sodium channel activity involved in bundle of His cell action potential;48;5;GO:0048169
GO:1990428;miRNA transport;200;9;GO:0030529
GO:1990429;peroxisomal importomer complex;481;28;GO:0005765
GO:2000810;regulation of bicellular tight junction assembly;941;83;GO:0048316
GO:0086064;cell communication by electrical coupling involved in cardiac conduction;1059;2110;GO:0007154
GO:0086065;cell communication involved in cardiac conduction;5017;800;GO:0007154
GO:0086062;voltage-gated sodium channel activity involved in Purkinje myocyte action potential;94;207;GO:0008092
GO:0086063;voltage-gated sodium channel activity involved in SA node cell action potential;50;4;GO:0008026
GO:0086068;Purkinje myocyte to ventricular cardiac muscle cell communication;317;6;GO:0007517
GO:0086069;bundle of His cell to Purkinje myocyte communication;1115;1200;GO:0048193
GO:0086066;atrial cardiac muscle cell to AV node cell communication;1243;8;GO:0005986
GO:0086067;AV node cell to bundle of His cell communication;1015;26;GO:0007218
GO:1990440;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;713;309;GO:0045944
GO:0098046;type V protein secretion system complex;28;0;GO:0015986
GO:1990430;extracellular matrix protein binding;222;198;GO:0050840
GO:2000826;regulation of heart morphogenesis;473;290;GO:0048608
GO:0098045;virus baseplate assembly;0;2;GO:0043169
GO:1990431;priRNA 3'-end processing;9;1;GO:0008033
GO:2000827;mitochondrial RNA surveillance;192;2;GO:0007042
GO:1990432;siRNA 3'-end processing;8;0;GO:0003723
GO:2000828;regulation of parathyroid hormone secretion;41;10;GO:0048193
GO:1990433;CSL-Notch-Mastermind transcription factor complex;53;2;GO:0005667
GO:2000829;negative regulation of parathyroid hormone secretion;0;0;GO:0048193
GO:1990434;lower tip-link density;0;0;GO:0008544
GO:2000822;regulation of behavioral fear response;223;97;GO:0007610
GO:1990435;upper tip-link density;11;4;GO:0005524
GO:1990437;snRNA 2'-O-methylation;58;0;GO:0045944
GO:2000825;positive regulation of androgen receptor activity;8;168;GO:0030518
GO:0086071;atrial cardiac muscle cell-AV node cell adhesion involved in cell communication;0;2;GO:0045202
GO:1990438;U6 2'-O-snRNA methylation;58;0;GO:0045944
GO:0086072;AV node cell-bundle of His cell adhesion involved in cell communication;9;2;GO:0044421
GO:1990439;MAP kinase serine/threonine phosphatase activity;80;2;GO:0004721
GO:0086070;SA node cell to atrial cardiac muscle cell communication;805;10;GO:0006936
GO:2000821;regulation of grooming behavior;142;56;GO:0050789
GO:0086075;gap junction channel activity involved in cardiac conduction electrical coupling;375;113;GO:0008021
GO:0086076;gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling;87;3;GO:0008021
GO:0086073;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;320;107;GO:0048608
GO:0086074;Purkinje myocyte-ventricular cardiac muscle cell adhesion involved in cell communication;0;2;GO:0048608
GO:0062068;chloroplast photosystem II binding;1;0;GO:0009579
GO:0170013;channel complex;0;2;GO:0048471
GO:1904496;positive regulation of substance P secretion, neurotransmission;2;2;GO:0048608
GO:0062069;GARP complex binding;57;1;GO:0048193
GO:0086036;regulation of cardiac muscle cell membrane potential;417;226;GO:0048407
GO:0170014;ankyrin-1 complex;292;14;GO:0005515
GO:1904495;negative regulation of substance P secretion, neurotransmission;0;0;GO:0048608
GO:0086033;G protein-coupled acetylcholine receptor signaling pathway involved in negative regulation of heart rate;0;0;GO:0008021
GO:0170011;stalled ribosome sensor activity;180;2;GO:0006414
GO:1904494;regulation of substance P secretion, neurotransmission;2;2;GO:0048608
GO:0170012;histone H3K18 decrotonylase activity;0;0;GO:0016567
GO:1904493;tetrahydrofolyl-poly(glutamate) polymer binding;45;5;GO:0005524
GO:0062064;box C/D snoRNP complex binding;120;2;GO:0003735
GO:0086039;P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential;82;4;GO:0008092
GO:0062065;box H/ACA snoRNP complex binding;2;1;GO:0043161
GO:0170010;nonsense-mediated decay complex;0;2;GO:0000786
GO:0062066;PSII associated light-harvesting complex II binding;1;0;GO:0043169
GO:0086037;P-type sodium:potassium-exchanging transporter activity involved in regulation of cardiac muscle cell membrane potential;2;0;GO:0008092
GO:1904498;protein localization to mitotic actomyosin contractile ring;16;4;GO:0007067
GO:0062067;chloroplast photosystem I binding;1;0;GO:0009536
GO:0086038;calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential;51;7;GO:0006836
GO:0050082;maltose phosphorylase activity;469;6;GO:0006032
GO:0050081;maltose-6'-phosphate glucosidase activity;628;0;GO:0006032
GO:0050084;mannitol-1-phosphatase activity;71;3;GO:0006032
GO:0050083;malyl-CoA lyase activity;653;3;GO:0006081
GO:0050080;malonyl-CoA decarboxylase activity;6675;25;GO:0009063
GO:0098022;viral capsid, fiber;2;0;GO:0016021
GO:0170015;carbon dioxide receptor activity;0;0;GO:0009579
GO:1990450;linear polyubiquitin binding;203;11;GO:0005515
GO:0098021;viral capsid, decoration;2189;5;GO:0044436
GO:0170016;endoplasmic reticulum-endosome tether activity;0;0;GO:0005765
GO:1990451;cellular stress response to acidic pH;1122;7;GO:0006950
GO:0050079;acetylenecarboxylate hydratase activity, producing 3-oxopropanoate;0;4;GO:0006081
GO:1990441;negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;234;10;GO:0045944
GO:2000837;regulation of androstenedione secretion;2;0;GO:0048608
GO:0050078;malonate CoA-transferase activity;0;3;GO:0004067
GO:1990442;intrinsic apoptotic signaling pathway in response to nitrosative stress;130;9;GO:0008629
GO:2000838;negative regulation of androstenedione secretion;0;0;GO:0010468
GO:0098015;virus tail;17031;10;GO:0016032
GO:1990443;peptidyl-threonine autophosphorylation;7;7;GO:0004672
GO:2000839;positive regulation of androstenedione secretion;2;1;GO:0048608
GO:1990444;F-box domain binding;180;4;GO:0005515
GO:0050075;maleate hydratase activity;12;4;GO:0004067
GO:0098017;viral capsid, major subunit;4;0;GO:0042803
GO:2000833;positive regulation of steroid hormone secretion;601;6;GO:0030520
GO:0050074;malate-CoA ligase activity;37;2;GO:0006099
GO:1990446;U1 snRNP binding;231;68;GO:0005524
GO:2000834;regulation of androgen secretion;118;1;GO:0030518
GO:0050077;maleylpyruvate isomerase activity;745;2;GO:0006099
GO:1990447;U2 snRNP binding;62;1;GO:0005524
GO:2000835;negative regulation of androgen secretion;30;0;GO:0048608
GO:0050076;maleate isomerase activity;8113;5;GO:0004067
GO:0098018;viral capsid, minor subunit;1;0;GO:0016021
GO:1990448;exon-exon junction complex binding;68;0;GO:0005615
GO:2000836;positive regulation of androgen secretion;88;6;GO:0048608
GO:0062071;Pi Mi complex;2;4;GO:0005576
GO:0062072;H3K9me3 modified histone binding;164;1;GO:0016569
GO:2000830;positive regulation of parathyroid hormone secretion;8;67;GO:0048193
GO:0062073;histone mRNA stem-loop binding complex;110;0;GO:0045944
GO:2000831;regulation of steroid hormone secretion;1105;7;GO:0030518
GO:0062074;pollen aperture;51;1;GO:0009555
GO:2000832;negative regulation of steroid hormone secretion;206;4;GO:0010468
GO:0086042;cardiac muscle cell-cardiac muscle cell adhesion;394;167;GO:0007155
GO:1904492;Ac-Asp-Glu binding;45;5;GO:0005515
GO:0086043;bundle of His cell action potential;563;22;GO:0048407
GO:1904491;protein localization to ciliary transition zone;521;259;GO:0005576
GO:0086040;sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential;1;10;GO:0048407
GO:0062070;SAGA complex binding;3;1;GO:0000976
GO:0086041;voltage-gated potassium channel activity involved in SA node cell action potential depolarization;52;3;GO:0048507
GO:0062057;L-aspartate:fumarate antiporter activity;0;1;GO:0009060
GO:0086046;membrane depolarization during SA node cell action potential;317;104;GO:0048407
GO:0170002;halotropism;0;0;GO:0009813
GO:0062058;transcription factor TFIIH holo complex binding;0;0;GO:0003700
GO:0086047;membrane depolarization during Purkinje myocyte cell action potential;232;35;GO:0048407
GO:0170003;heme B transmembrane transporter activity;0;1;GO:0008565
GO:0062059;FACT complex binding;0;1;GO:0003677
GO:0086044;atrial cardiac muscle cell to AV node cell communication by electrical coupling;176;5;GO:0006936
GO:0086045;membrane depolarization during AV node cell action potential;352;249;GO:0048407
GO:0170001;ergothioneine transmembrane transporter activity;0;0;GO:0005525
GO:0062054;fluoride channel activity;42353;2;GO:0005216
GO:0062055;photosynthetic state transition;42;2;GO:0015979
GO:0086048;membrane depolarization during bundle of His cell action potential;250;34;GO:0048407
GO:0062056;compound eye pigment cell differentiation;0;0;GO:0048608
GO:0086049;membrane repolarization during AV node cell action potential;0;1;GO:0048407
GO:0050093;methanol dehydrogenase activity;559;6;GO:0004089
GO:0050092;meso-tartrate dehydrogenase activity;0;3;GO:0004721
GO:0050095;methionine decarboxylase activity;0;3;GO:0004497
GO:0170008;mRNA phosphatase activator activity;15;0;GO:0004871
GO:0050094;methionine-glyoxylate transaminase activity;59;4;GO:0004497
GO:0170009;endoplasmic reticulum-organelle membrane tether activity;153;0;GO:0005743
GO:0098031;icosahedral viral capsid, collar;0;0;GO:0044427
GO:0170006;lipoate transmembrane transport;0;0;GO:0006826
GO:0098030;icosahedral viral capsid, neck;0;1;GO:0044436
GO:0170007;endoplasmic reticulum-lipid droplet tether activity;0;0;GO:0006631
GO:1990460;leptin receptor binding;219;106;GO:0005125
GO:0050091;melilotate 3-monooxygenase activity;0;3;GO:0004497
GO:0098033;icosahedral viral capsid, neck fiber;0;0;GO:0043169
GO:0170004;lipoate transmembrane transporter activity;0;1;GO:0005525
GO:1990461;detoxification of iron ion;31;2;GO:0006879
GO:0050090;mannuronate reductase activity;951;1;GO:0004067
GO:0098032;icosahedral viral capsid, collar fiber;0;0;GO:0043169
GO:0170005;cyclic nucleotide phosphodiesterase activator activity;3;1;GO:0005524
GO:1990462;omegasome;379;26;GO:0005764
GO:0098024;virus tail, fiber;2743;8;GO:0042803
GO:1990452;Parkin-FBXW7-Cul1 ubiquitin ligase complex;171;101;GO:0008033
GO:2000848;positive regulation of corticosteroid hormone secretion;295;3;GO:0010817
GO:0050089;mannose isomerase activity;34;3;GO:0004553
GO:0098023;virus tail, tip;2;0;GO:0042303
GO:1990453;nucleosome disassembly/reassembly complex;22;1;GO:0000786
GO:2000849;regulation of glucocorticoid secretion;499;6;GO:0048608
GO:0098026;virus tail, tube;30;1;GO:0016021
GO:1990454;L-type voltage-gated calcium channel complex;477;199;GO:0005509
GO:0098025;virus tail, baseplate;5604;6;GO:0042165
GO:1990455;PTEN phosphatase complex;0;4;GO:0005524
GO:0050086;mannitol 2-dehydrogenase activity;870;4;GO:0004067
GO:0098028;virus tail, shaft;0;1;GO:0042303
GO:1990456;mitochondrion-endoplasmic reticulum membrane tethering;3489;16;GO:0005743
GO:2000844;negative regulation of testosterone secretion;18;3;GO:0010468
GO:0050085;mannitol 2-dehydrogenase (NADP+) activity;33;0;GO:0004067
GO:0098027;virus tail, sheath;1286;3;GO:0016021
GO:1990457;pexophagosome;1;1;GO:0005764
GO:2000845;positive regulation of testosterone secretion;74;74;GO:0030520
GO:0050088;mannose-6-phosphate 6-reductase activity;6;3;GO:0006066
GO:1990458;lipooligosaccharide binding;1;0;GO:0008643
GO:2000846;regulation of corticosteroid hormone secretion;644;7;GO:0048608
GO:0050087;mannitol dehydrogenase (cytochrome) activity;3;5;GO:0004067
GO:0098029;icosahedral viral capsid, spike;2;2;GO:0044436
GO:1990459;transferrin receptor binding;595;105;GO:0004872
GO:2000847;negative regulation of corticosteroid hormone secretion;175;4;GO:0010467
GO:0062060;NuA4 histone acetyltransferase complex binding;61;2;GO:0045944
GO:2000840;regulation of dehydroepiandrosterone secretion;0;0;GO:0048608
GO:0062061;TAP complex binding;121;9;GO:0005515
GO:0086050;membrane repolarization during bundle of His cell action potential;100;2;GO:0048407
GO:2000841;negative regulation of dehydroepiandrosterone secretion;0;0;GO:0010467
GO:0062062;oligosaccharyltransferase complex binding;40;1;GO:0005576
GO:2000842;positive regulation of dehydroepiandrosterone secretion;0;0;GO:0048608
GO:0062063;BBSome binding;216;5;GO:0005576
GO:2000843;regulation of testosterone secretion;103;4;GO:0030518
GO:0086053;AV node cell to bundle of His cell communication by electrical coupling;307;23;GO:0008021
GO:0086054;bundle of His cell to Purkinje myocyte communication by electrical coupling;179;7;GO:0048608
GO:0086051;membrane repolarization during Purkinje myocyte action potential;0;1;GO:0048407
GO:0086052;membrane repolarization during SA node cell action potential;102;2;GO:0048407
GO:0086013;membrane repolarization during cardiac muscle cell action potential;2000;524;GO:0048407
GO:0086014;atrial cardiac muscle cell action potential;1058;718;GO:0008629
GO:0086011;membrane repolarization during action potential;2636;258;GO:0048407
GO:0086012;membrane depolarization during cardiac muscle cell action potential;2409;2270;GO:0048407
GO:0062086;regulation of vein smooth muscle contraction;2;2;GO:0048010
GO:0086017;Purkinje myocyte action potential;293;3;GO:0048407
GO:0062087;positive regulation of vein smooth muscle contraction;0;1;GO:0048010
GO:0086018;SA node cell to atrial cardiac muscle cell signaling;746;4;GO:0007186
GO:0062088;negative regulation of vein smooth muscle contraction;0;0;GO:0048010
GO:0086015;SA node cell action potential;742;200;GO:0048608
GO:0062089;regulation of taurine biosynthetic process;0;0;GO:0010468
GO:0086016;AV node cell action potential;631;43;GO:0007631
GO:0086019;cell-cell signaling involved in cardiac conduction;3444;138;GO:0007186
GO:1990470;piRNA cluster binding;12;2;GO:0044822
GO:1990471;piRNA uni-strand cluster binding;0;0;GO:0044822
GO:1990472;piRNA dual-strand cluster binding;1;0;GO:0048305
GO:1990473;ciliary targeting signal binding;1;0;GO:0005576
GO:1990463;lateral cortical node;45;3;GO:0048666
GO:2000859;negative regulation of aldosterone secretion;0;2;GO:0048193
GO:1990464;D-2-hydroxyacid dehydrogenase (quinone) activity;0;1;GO:0004089
GO:1990465;aldehyde oxygenase (deformylating) activity;2255;5;GO:0004497
GO:1990466;protein autosumoylation;12;2;GO:0006470
GO:0050097;methylaspartate mutase activity;7928;6;GO:0006030
GO:1990467;NuA3a histone acetyltransferase complex;28;3;GO:0043161
GO:2000855;regulation of mineralocorticoid secretion;145;2;GO:0048193
GO:0050096;methylaspartate ammonia-lyase activity;3185;5;GO:0004474
GO:1990468;NuA3b histone acetyltransferase complex;23;3;GO:0043161
GO:2000856;negative regulation of mineralocorticoid secretion;0;2;GO:0048193
GO:0050099;methylglutamate dehydrogenase activity;26;4;GO:0004067
GO:1990469;Rhino-Deadlock-Cutoff Complex;3;0;GO:0005576
GO:2000857;positive regulation of mineralocorticoid secretion;75;109;GO:0048193
GO:0050098;methylguanidinase activity;0;2;GO:0016829
GO:2000858;regulation of aldosterone secretion;145;5;GO:0048193
GO:0062093;lysophagy;0;0;GO:0006914
GO:2000851;positive regulation of glucocorticoid secretion;220;3;GO:0010467
GO:0062094;stomach development;287;2;GO:0007586
GO:2000852;regulation of corticosterone secretion;122;325;GO:0010817
GO:0062095;endoplasmic reticulum-peroxisome tethering;0;1;GO:0005743
GO:2000853;negative regulation of corticosterone secretion;6;2;GO:0010817
GO:0062096;kinetochore disassembly;0;0;GO:0000786
GO:2000854;positive regulation of corticosterone secretion;12;7;GO:0010817
GO:0086020;gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling;3;9;GO:0008021
GO:0062090;positive regulation of taurine biosynthetic process;0;0;GO:0046356
GO:0086021;SA node cell to atrial cardiac muscle cell communication by electrical coupling;6;7;GO:0006986
GO:0062091;Ycf2/FtsHi complex;104;2;GO:0005576
GO:0062092;Yae1-Lto1 complex;7;1;GO:0043161
GO:2000850;negative regulation of glucocorticoid secretion;175;17;GO:0010467
GO:0062079;ATG2-ATG18 complex;0;4;GO:0005783
GO:0086024;adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate;2;3;GO:0007623
GO:0086022;SA node cell-atrial cardiac muscle cell adhesion involved in cell communication;0;2;GO:0045202
GO:0086023;adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;192;5;GO:0007218
GO:0062075;pollen aperture formation;60;2;GO:0009555
GO:0086028;bundle of His cell to Purkinje myocyte signaling;563;5;GO:0048407
GO:0062076;acyl-CoA delta5-desaturase activity;72;2;GO:0006631
GO:0086029;Purkinje myocyte to ventricular cardiac muscle cell signaling;315;133;GO:0007186
GO:0062077;phenylacetyl-CoA 1,2-epoxidase complex;4;0;GO:0009536
GO:0086026;atrial cardiac muscle cell to AV node cell signaling;1058;10;GO:0007186
GO:0062078;TSC1-TSC2 complex binding;72;2;GO:0005524
GO:0086027;AV node cell to bundle of His cell signaling;635;22;GO:0007186
GO:1990481;mRNA pseudouridine synthesis;1050;263;GO:0006631
GO:1990482;sphingolipid alpha-glucuronosyltransferase activity;18;0;GO:0006081
GO:1990483;Clr6 histone deacetylase complex I'';72;4;GO:0016570
GO:1990484;aerobic lactate catabolic process;0;0;GO:0006099
GO:0098002;receptor-mediated bacteriophage irreversible attachment to host cell;1;1;GO:0048285
GO:1990474;synaptic vesicle, readily releasable pool;0;2;GO:0005768
GO:0098001;receptor-mediated bacteriophage reversible attachment to host cell;0;0;GO:0048285
GO:1990475;synaptic vesicle, recycling pool;0;1;GO:0008030
GO:0098004;virus tail fiber assembly;396;5;GO:0042803
GO:1990476;synaptic vesicle, resting pool;0;2;GO:0005768
GO:0098003;viral tail assembly;6814;18;GO:0016021
GO:1990477;MTREC complex;23;4;GO:0005737
GO:0098006;viral DNA genome packaging, headful;2;1;GO:0016021
GO:1990478;response to ultrasound;10;5;GO:0009611
GO:2000866;positive regulation of estradiol secretion;171;57;GO:0010468
GO:0098005;viral head-tail joining;1;3;GO:0043405
GO:2000867;regulation of estrone secretion;0;0;GO:0010468
GO:2000868;negative regulation of estrone secretion;0;0;GO:0010468
GO:2000869;positive regulation of estrone secretion;0;0;GO:0010468
GO:0062082;HLA-E specific inhibitory MHC class Ib receptor activity;67;2;GO:0004872
GO:2000862;negative regulation of estrogen secretion;0;0;GO:0010468
GO:0062083;HLA-G specific inhibitory MHC class Ib receptor activity;0;0;GO:0004872
GO:0098009;viral terminase, large subunit;1810;4;GO:0005576
GO:2000863;positive regulation of estrogen secretion;1;8;GO:0010468
GO:0062084;regulation of capsule polysaccharide biosynthetic process;0;2;GO:0046395
GO:2000864;regulation of estradiol secretion;220;9;GO:0010468
GO:0062085;positive regulation of capsule polysaccharide biosynthetic process;0;1;GO:0046395
GO:2000865;negative regulation of estradiol secretion;0;0;GO:0010468
GO:0062080;inhibitory MHC class Ib receptor activity;67;0;GO:0004930
GO:2000860;positive regulation of aldosterone secretion;75;222;GO:0048193
GO:0062081;activating MHC class Ib receptor activity;9;1;GO:0002449
GO:0086030;adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation;22;1;GO:0008021
GO:2000861;regulation of estrogen secretion;1;5;GO:0010468
GO:0003730;mRNA 3'-UTR binding;21907;1800;GO:0003729
GO:0003720;telomerase activity;5159;343;GO:0003964
GO:0003721;telomerase RNA reverse transcriptase activity;4324;25;GO:0003964
GO:0003723;RNA binding;22742486;44100;GO:0003723
GO:0003724;RNA helicase activity;569287;1800;GO:0003797
GO:2000877;negative regulation of oligopeptide transport;1;0;GO:0045765
GO:0003725;double-stranded RNA binding;141383;4140;GO:0003723
GO:0015709;thiosulfate transport;16264;33;GO:0006849
GO:2000878;positive regulation of oligopeptide transport;70;1;GO:0045765
GO:0003726;double-stranded RNA adenosine deaminase activity;2300;68;GO:0004518
GO:0015708;silicic acid import across plasma membrane;573;2;GO:0006830
GO:2000879;negative regulation of dipeptide transport;1;0;GO:0045765
GO:0003727;single-stranded RNA binding;57367;2250;GO:0003723
GO:0015707;nitrite transport;15665;177;GO:0006879
GO:0015706;nitrate transmembrane transport;96289;10;GO:0006865
GO:0003729;mRNA binding;4835261;7540;GO:0003735
GO:0015705;iodide transport;1332;157;GO:0006826
GO:2000874;regulation of glyoxylate cycle;1;1;GO:0006099
GO:0015704;cyanate transport;0;2;GO:0006826
GO:2000875;negative regulation of glyoxylate cycle;0;1;GO:0046394
GO:0015703;chromate transport;87472;61;GO:0006865
GO:2000876;positive regulation of glyoxylate cycle;0;2;GO:0046394
GO:0015702;chlorate transport;0;3;GO:0006826
GO:0015701;bicarbonate transport;6714;2020;GO:0006874
GO:2000870;regulation of progesterone secretion;94;5;GO:0048608
GO:0015700;arsenite transport;61067;242;GO:0006830
GO:2000871;negative regulation of progesterone secretion;1;0;GO:0048608
GO:2000872;positive regulation of progesterone secretion;30;5;GO:0048608
GO:0015720;allantoin transport;223;9;GO:0006873
GO:2000890;cellodextrin catabolic process;0;0;GO:0006029
GO:0003735;structural constituent of ribosome;10354397;18000;GO:0003735
GO:2000888;arabinoxylan-containing compound catabolic process;0;0;GO:0006073
GO:2000889;cellodextrin metabolic process;3;0;GO:0006091
GO:0015719;allantoate transport;65;5;GO:0006869
GO:0015718;monocarboxylic acid transport;378127;1490;GO:0006865
GO:0015717;triose phosphate transport;455;194;GO:0006096
GO:2000884;glucomannan catabolic process;3;2;GO:0006032
GO:0015716;organic phosphonate transport;91085;84;GO:0006865
GO:2000885;galactoglucomannan catabolic process;0;1;GO:0006032
GO:0015715;nucleotide-sulfate transport;0;2;GO:0006865
GO:2000886;glucuronoxylan catabolic process;3;0;GO:0006073
GO:0015714;phosphoenolpyruvate transport;389;212;GO:0006865
GO:2000887;glucuronoarabinoxylan catabolic process;0;0;GO:0006073
GO:0015713;phosphoglycerate transmembrane transport;3436;1;GO:0006869
GO:2000880;positive regulation of dipeptide transport;70;1;GO:0045765
GO:0015712;hexose phosphate transport;5642;134;GO:0006865
GO:2000881;regulation of starch catabolic process;0;1;GO:0045735
GO:0015711;organic anion transport;2309085;2660;GO:0015717
GO:2000882;negative regulation of starch catabolic process;0;1;GO:0045766
GO:0015710;tellurite transport;2;4;GO:0006830
GO:2000883;positive regulation of starch catabolic process;0;1;GO:0045735
GO:0003700;DNA-binding transcription factor activity;6761220;21100;GO:0003700
GO:2000899;xyloglucan catabolic process;23;1;GO:0006073
GO:2000895;hemicellulose catabolic process;81247;3;GO:0006073
GO:0003707;nuclear steroid receptor activity;22882;40;GO:0003700
GO:2000896;amylopectin metabolic process;392;5;GO:0005976
GO:2000897;amylopectin catabolic process;2;4;GO:0006032
GO:2000898;regulation of glucomannan catabolic process;0;1;GO:0046395
GO:2000891;cellobiose metabolic process;65;1;GO:0006094
GO:2000892;cellobiose catabolic process;64;3;GO:0006032
GO:2000893;cellotriose metabolic process;0;0;GO:0006032
GO:2000894;cellotriose catabolic process;0;0;GO:0006032
GO:0170022;ionotropic bitter taste receptor activity;0;0;GO:0004930
GO:0170023;ionotropic sweet taste receptor activity;0;0;GO:0004930
GO:0170020;ionotropic olfactory receptor activity;0;1;GO:0004930
GO:0170021;ionotropic taste receptor activity;11;0;GO:0004930
GO:0170027;SKA complex;0;0;GO:0048316
GO:0003711;transcription elongation factor activity;1666;354;GO:0003729
GO:0003712;transcription coregulator activity;247142;1580;GO:0003712
GO:0003713;transcription coactivator activity;70983;9370;GO:0003712
GO:0003714;transcription corepressor activity;80221;6770;GO:0003700
GO:0015753;D-xylose transmembrane transport;9505;5;GO:0005553
GO:0039720;virogenic stroma;1;0;GO:0048407
GO:0015752;D-ribose transmembrane transport;294;4;GO:0006869
GO:0015751;arabinose transmembrane transport;10511;3;GO:0008544
GO:0039722;suppression by virus of host toll-like receptor signaling pathway;857;6;GO:1902535
GO:0015750;pentose transmembrane transport;20328;4;GO:0008528
GO:0039721;peristromal region viral factory;0;0;GO:0048608
GO:0001109;promoter clearance during DNA-templated transcription;251;3;GO:0045944
GO:0001108;bacterial-type RNA polymerase holo enzyme binding;6;1;GO:0003700
GO:0003774;cytoskeletal motor activity;627725;903;GO:0003774
GO:0001112;DNA-templated transcription open complex formation;324;3;GO:0000976
GO:0001111;RNA polymerase II promoter clearance;251;10;GO:0000976
GO:0001110;RNA polymerase III promoter clearance;0;0;GO:0000976
GO:0039717;spherule viral factory;0;0;GO:0016032
GO:0015749;monosaccharide transmembrane transport;195438;383;GO:0008565
GO:0039716;viroplasm viral factory;0;0;GO:0016032
GO:0015748;organophosphate ester transport;259584;393;GO:0006869
GO:0039719;tube viral factory;0;0;GO:0016021
GO:0015747;urate transport;1275;398;GO:0006836
GO:0039718;double membrane vesicle viral factory;102;1;GO:0016021
GO:0015746;citrate transport;14842;213;GO:0006836
GO:0039713;viral factory;204;10;GO:0016032
GO:0015745;tartrate transmembrane transport;0;1;GO:0006836
GO:0015744;succinate transport;2902;233;GO:0006820
GO:0039715;nuclear viral factory;9;2;GO:0005634
GO:0015743;malate transport;14835;217;GO:0006836
GO:0039714;cytoplasmic viral factory;193;208;GO:0005737
GO:0015764;N-acetylglucosamine transport;19;6;GO:0006865
GO:0015763;N-acetylgalactosamine transport;0;2;GO:0005576
GO:0015762;rhamnose transmembrane transport;12133;5;GO:0005576
GO:0039711;cytoplasmic helical capsid assembly;0;2;GO:0043169
GO:0015761;mannose transmembrane transport;178;6;GO:0008528
GO:0039710;cytoplasmic icosahedral capsid assembly;1;2;GO:0044427
GO:0015760;glucose-6-phosphate transport;5639;150;GO:0006865
GO:0001119;protein-DNA-RNA complex remodeling;0;1;GO:0048193
GO:0001118;transcription ternary complex disassembly;0;1;GO:0003700
GO:0001117;protein-DNA-RNA complex disassembly;0;3;GO:0048193
GO:0001116;protein-DNA-RNA complex assembly;0;2;GO:0043234
GO:0001115;protein-DNA-RNA complex organization;0;1;GO:0043234
GO:0001114;protein-DNA-RNA complex;0;0;GO:0032991
GO:0001113;transcription open complex formation at RNA polymerase II promoter;256;7;GO:0000976
GO:0003785;actin monomer binding;9246;1150;GO:0005516
GO:0003777;microtubule motor activity;182463;7010;GO:0003774
GO:0001120;protein-DNA complex remodeling;324;2;GO:0048285
GO:0003779;actin binding;612411;17200;GO:0003779
GO:0039709;cytoplasmic capsid assembly;4;4;GO:0043161
GO:0039706;co-receptor binding;602;239;GO:0048247
GO:0039705;viral translational readthrough;133;3;GO:0006415
GO:0015759;beta-glucoside transport;78;5;GO:0006865
GO:0039708;nuclear capsid assembly;340;7;GO:0048305
GO:0039707;virus-mediated pore formation in host cell membrane;149564;5;GO:0048304
GO:0015757;galactose transmembrane transport;15758;70;GO:0008528
GO:0039702;viral budding via host ESCRT complex;35073;185;GO:0005740
GO:0015756;fucose transmembrane transport;19580;10;GO:0005576
GO:0039701;microtubule-dependent intracellular transport of viral material towards cell periphery;847;4;GO:0048193
GO:0015755;fructose transmembrane transport;44309;168;GO:0006869
GO:0039704;viral translational shunt;1067;5;GO:0006412
GO:0015754;allose transmembrane transport;5;1;GO:0006869
GO:0039703;RNA replication;2;27;GO:0006260
GO:0015731;3-hydroxyphenyl propanoate transport;0;3;GO:0006869
GO:0015730;propanoate transmembrane transport;206;0;GO:0008544
GO:0039700;fusion of viral membrane with host outer nuclear membrane;223;3;GO:0009986
GO:0086099;phospholipase C-activating angiotensin-activated signaling pathway involved in heart process;0;1;GO:0048010
GO:0003743;translation initiation factor activity;911572;8300;GO:0003735
GO:0003746;translation elongation factor activity;1100993;5050;GO:0003735
GO:0003747;translation release factor activity;328300;1480;GO:0003735
GO:0015729;oxaloacetate transport;1125;125;GO:0015731
GO:0015728;mevalonate transport;2;63;GO:0006890
GO:0015727;lactate transport;97141;53;GO:0006836
GO:0015726;L-idonate transmembrane transport;6;1;GO:0006869
GO:0015724;formate transport;5310;66;GO:0006890
GO:0015723;bilirubin transport;160;10;GO:0006865
GO:0015722;canalicular bile acid transport;287;76;GO:0006865
GO:0015721;bile acid and bile salt transport;2345;1780;GO:0006865
GO:0015742;alpha-ketoglutarate transport;965;275;GO:0006836
GO:0015741;fumarate transport;472;234;GO:0006836
GO:0015740;C4-dicarboxylate transport;48533;956;GO:0006869
GO:0001101;response to acid chemical;29444;1410;GO:0097159
GO:0001100;negative regulation of exit from mitosis;1561;143;GO:0048285
GO:0003755;peptidyl-prolyl cis-trans isomerase activity;1561045;5740;GO:0004867
GO:1904983;glycine import into mitochondrion;4313;10;GO:0006836
GO:0036241;glutamate catabolic process to 4-hydroxybutyrate;0;4;GO:0006541
GO:1904982;sucrose transmembrane transport;6;2;GO:0008565
GO:0036242;glutamate catabolic process to succinate via 2-oxoglutarate-dependent GABA-transaminase activity;0;2;GO:0006541
GO:1902320;nuclear DNA replication DNA duplex unwinding;0;1;GO:0003676
GO:1904981;maltose transmembrane transport;2542;3;GO:0008544
GO:0061207;mesonephric juxtaglomerulus cell differentiation;0;0;GO:0048706
GO:1902325;negative regulation of chlorophyll biosynthetic process;5;1;GO:0010468
GO:1904988;negative regulation of endothelial cell activation;1;2;GO:0050727
GO:0061208;cell differentiation involved in mesonephros development;1;0;GO:0007548
GO:1902326;positive regulation of chlorophyll biosynthetic process;106;2;GO:0010468
GO:1904987;regulation of endothelial cell activation;2;2;GO:0050727
GO:0048249;high-affinity phosphate transmembrane transporter activity;2;1;GO:0008565
GO:0061209;cell proliferation involved in mesonephros development;148;9;GO:0042127
GO:1902323;negative regulation of methyl-branched fatty acid biosynthetic process;0;0;GO:0045944
GO:1904986;positive regulation of quinolinate biosynthetic process;0;2;GO:0046356
GO:0048248;CXCR3 chemokine receptor binding;220;242;GO:0005125
GO:1902324;positive regulation of methyl-branched fatty acid biosynthetic process;0;0;GO:0045944
GO:1904985;negative regulation of quinolinate biosynthetic process;1426;3;GO:0010468
GO:0061203;striated muscle paramyosin thick filament assembly;13;2;GO:0005544
GO:1902329;bacterial-type DNA replication termination;0;0;GO:0006364
GO:0061204;paramyosin filament assembly or disassembly;13;2;GO:0005576
GO:0061205;paramesonephric duct development;261;294;GO:0048704
GO:1902327;bacterial-type DNA replication DNA ligation;0;0;GO:0006213
GO:0061206;mesonephros morphogenesis;45;3;GO:0048608
GO:1902328;bacterial-type DNA replication initiation;2;0;GO:0006260
GO:1904989;positive regulation of endothelial cell activation;1;2;GO:0050727
GO:0048254;snoRNA localization;408;208;GO:0005840
GO:0051895;negative regulation of focal adhesion assembly;738;635;GO:0048010
GO:0051896;regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;9361;6;GO:0007179
GO:0048252;lauric acid metabolic process;58;38;GO:0006073
GO:0051893;regulation of focal adhesion assembly;2775;762;GO:0048010
GO:0048251;elastic fiber assembly;552;1220;GO:0048407
GO:0051894;positive regulation of focal adhesion assembly;1151;579;GO:0048010
GO:0048258;3-ketoglucose-reductase activity;0;6;GO:0006096
GO:0051891;positive regulation of cardioblast differentiation;274;457;GO:0048608
GO:0048257;3'-flap endonuclease activity;182;4;GO:0004518
GO:0051892;negative regulation of cardioblast differentiation;114;8;GO:0045944
GO:0048256;flap endonuclease activity;40592;23;GO:0004518
GO:0048255;mRNA stabilization;7874;2020;GO:0010467
GO:0051890;regulation of cardioblast differentiation;455;1060;GO:0048608
GO:0036236;acyl glucuronidation;0;2;GO:0006725
GO:0048250;iron import into the mitochondrion;338;5;GO:0006826
GO:0051899;membrane depolarization;6152;2630;GO:0048169
GO:0036237;acyl-glucuronidase activity;0;0;GO:0004497
GO:0036238;gallate dioxygenase activity;278;2;GO:0004497
GO:0051897;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;6015;99;GO:0007179
GO:0036239;taxoid 7beta-hydroxylase activity;3;3;GO:0004746
GO:0051898;negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;2511;10;GO:0045944
GO:0061232;mesonephric glomerular epithelium development;0;2;GO:0048608
GO:1904991;negative regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway;0;1;GO:0048167
GO:0061233;mesonephric glomerular basement membrane development;0;0;GO:0048608
GO:1904990;regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway;60;0;GO:0048167
GO:0036234;deglucuronidation;0;1;GO:0009065
GO:0061234;mesonephric glomerulus morphogenesis;0;1;GO:0048608
GO:0036235;acyl deglucuronidation;0;1;GO:0009081
GO:0061235;mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis;45;2;GO:0048608
GO:1902332;bacterial-type DNA replication DNA duplex unwinding;0;0;GO:0003676
GO:1904995;negative regulation of leukocyte adhesion to vascular endothelial cell;218;70;GO:0050729
GO:1902333;nuclear DNA replication DNA ligation;0;0;GO:0006260
GO:1904994;regulation of leukocyte adhesion to vascular endothelial cell;1548;8;GO:0030168
GO:0036230;granulocyte activation;2322;1680;GO:0002688
GO:0061230;mesonephric juxtaglomerulus cell fate commitment;0;0;GO:0048704
GO:1902330;synthesis of RNA primer involved in bacterial-type DNA replication;0;0;GO:0005524
GO:0061231;mesonephric glomerulus vasculature development;0;0;GO:0048193
GO:1904992;positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway;60;1;GO:0048167
GO:1902336;positive regulation of retinal ganglion cell axon guidance;74;27;GO:0048608
GO:1904999;positive regulation of leukocyte adhesion to arterial endothelial cell;102;10;GO:0050900
GO:1902337;regulation of apoptotic process involved in morphogenesis;456;6;GO:0043066
GO:1904998;negative regulation of leukocyte adhesion to arterial endothelial cell;45;5;GO:0050900
GO:1902334;fructose export from vacuole to cytoplasm;3;0;GO:0009410
GO:1904997;regulation of leukocyte adhesion to arterial endothelial cell;210;4;GO:0030168
GO:0048259;regulation of receptor-mediated endocytosis;5449;434;GO:0009986
GO:1904996;positive regulation of leukocyte adhesion to vascular endothelial cell;1099;180;GO:0050900
GO:0061236;mesonephric comma-shaped body morphogenesis;0;0;GO:0048706
GO:0000279;M phase;0;2810;GO:0000278
GO:0061237;convergent extension involved in mesonephric nephron morphogenesis;0;0;GO:0048706
GO:0000278;mitotic cell cycle;241657;13400;GO:0007049
GO:0061238;establishment of planar polarity involved in mesonephric nephron morphogenesis;0;0;GO:0048704
GO:1902338;negative regulation of apoptotic process involved in morphogenesis;195;3;GO:0043066
GO:0000277;[cytochrome c]-lysine N-methyltransferase activity;68;1;GO:0004725
GO:0061239;mesenchymal stem cell differentiation involved in mesonephric nephron morphogenesis;0;0;GO:0048704
GO:1902339;positive regulation of apoptotic process involved in morphogenesis;258;83;GO:0043066
GO:0000287;magnesium ion binding;3480615;11200;GO:0005509
GO:0048265;response to pain;1445;1020;GO:0007600
GO:0000286;alanine dehydrogenase activity;120581;9;GO:0004073
GO:0048264;determination of ventral identity;492;9;GO:0048704
GO:0000285;1-phosphatidylinositol-3-phosphate 5-kinase activity;10801;449;GO:0004721
GO:0048263;determination of dorsal identity;874;172;GO:0031591
GO:0048262;determination of dorsal/ventral asymmetry;1409;37;GO:0048513
GO:0048269;methionine adenosyltransferase complex;238;40;GO:0005737
GO:0000282;cellular bud site selection;295;97;GO:0048285
GO:0048268;clathrin coat assembly;18792;1120;GO:0005929
GO:0000281;mitotic cytokinesis;22759;3480;GO:0007067
GO:0000280;nuclear division;145385;5320;GO:0051301
GO:0048266;behavioral response to pain;812;941;GO:0007610
GO:0036225;cellular response to vitamin B1 starvation;0;2;GO:0009719
GO:0048261;negative regulation of receptor-mediated endocytosis;1115;255;GO:0048193
GO:0048260;positive regulation of receptor-mediated endocytosis;2787;1120;GO:0048193
GO:0036227;mitotic G2 cell cycle arrest in response to glucose starvation;0;4;GO:0007050
GO:0036228;protein localization to nuclear inner membrane;324;5;GO:0005730
GO:0036221;UTP diphosphatase activity;17962;3;GO:0004723
GO:0061221;mesonephric mesenchyme morphogenesis;0;0;GO:0048608
GO:0036222;XTP diphosphatase activity;58983;8;GO:0004721
GO:0061222;mesonephric mesenchymal cell proliferation involved in mesonephros development;0;0;GO:0048608
GO:1902340;negative regulation of chromosome condensation;141;29;GO:0048285
GO:0036223;cellular response to adenine starvation;0;1;GO:0009737
GO:0061223;mesonephric mesenchymal cell differentiation;0;0;GO:0045595
GO:0036224;pairing center;0;1;GO:0005819
GO:0061224;mesonephric glomerulus development;0;4;GO:0048608
GO:1902343;regulation of maltose transport;5;0;GO:0005929
GO:1902344;negative regulation of maltose transport;5;4;GO:0046395
GO:1902341;xylitol transmembrane transport;2;3;GO:0008544
GO:0036220;ITP diphosphatase activity;58983;9;GO:0004723
GO:0061220;mesonephric macula densa development;0;0;GO:0048608
GO:0061229;mesonephric juxtaglomerulus cell development;0;0;GO:0048608
GO:1902347;response to strigolactone;119;9;GO:0009733
GO:1902348;cellular response to strigolactone;22;2;GO:0071347
GO:1902345;positive regulation of maltose transport;0;0;GO:0046356
GO:1902346;meiotic strand displacement involved in double-strand break repair via SDSA;4;0;GO:0000786
GO:0061225;mesonephric extraglomerular mesangial cell proliferation involved in mesonephros development;0;1;GO:0048608
GO:0061226;proximal/distal pattern formation involved in mesonephric nephron development;0;0;GO:0048704
GO:0000289;nuclear-transcribed mRNA poly(A) tail shortening;19273;1480;GO:0006415
GO:0061227;pattern specification involved in mesonephros development;108;4;GO:0048513
GO:1902349;response to chloroquine;109;5;GO:0006936
GO:0000288;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;52934;1060;GO:0010467
GO:0061228;mesonephric nephron morphogenesis;45;5;GO:0048608
GO:0000298;endopolyphosphatase activity;2754;60;GO:0004721
GO:0000297;spermine transmembrane transporter activity;52;7;GO:0008544
GO:0048275;N-terminal peptidyl-arginine acetylation;0;2;GO:0006464
GO:0000296;spermine transport;311;10;GO:0006826
GO:0000295;adenine nucleotide transmembrane transporter activity;41009;46;GO:0008528
GO:0048273;mitogen-activated protein kinase p38 binding;259;494;GO:0043406
GO:0000294;nuclear-transcribed mRNA catabolic process, RNase MRP-dependent;74;4;GO:0006631
GO:0000293;ferric-chelate reductase activity;13506;182;GO:0004073
GO:0048279;vesicle fusion with endoplasmic reticulum;5;7;GO:0008021
GO:0000292;RNA fragment catabolic process;94;10;GO:0010467
GO:0048278;vesicle docking;7346;980;GO:0008092
GO:0000291;nuclear-transcribed mRNA catabolic process, exonucleolytic;7483;1780;GO:0006396
GO:0000290;deadenylation-dependent decapping of nuclear-transcribed mRNA;18934;422;GO:0006414
GO:0036218;dTTP diphosphatase activity;18195;5;GO:0004553
GO:0036219;GTP diphosphatase activity;7;4;GO:0004721
GO:0036214;contractile ring localization;276;2;GO:0007088
GO:0036215;response to stem cell factor;2002;9;GO:0048608
GO:0036216;cellular response to stem cell factor stimulus;2002;29;GO:0048608
GO:0048270;methionine adenosyltransferase regulator activity;98;5;GO:0003723
GO:0036217;dGTP diphosphatase activity;5;3;GO:0004553
GO:0036298;recombinational interstrand cross-link repair;146;2;GO:0007040
GO:0036299;non-recombinational interstrand cross-link repair;0;2;GO:0048285
GO:0036294;cellular response to decreased oxygen levels;7862;497;GO:0006979
GO:0036295;cellular response to increased oxygen levels;651;125;GO:0050832
GO:0036296;response to increased oxygen levels;878;44;GO:0050832
GO:0036297;interstrand cross-link repair;23075;918;GO:0007049
GO:0036290;protein trans-autophosphorylation;17;9;GO:0006468
GO:1904933;regulation of cell proliferation in midbrain;53;6;GO:0042127
GO:0036291;protein cis-autophosphorylation;0;5;GO:0006468
GO:1904932;negative regulation of cartilage condensation;1;0;GO:0048608
GO:0036292;DNA rewinding;136;34;GO:0003673
GO:1904931;MCM complex binding;131;1;GO:0005524
GO:0036293;response to decreased oxygen levels;18481;1070;GO:0006979
GO:1904930;amphisome membrane;1201;7;GO:0005764
GO:1904937;sensory neuron migration;46;3;GO:0048666
GO:1904936;interneuron migration;667;47;GO:0048666
GO:1904935;positive regulation of cell proliferation in midbrain;4;2;GO:0042127
GO:1904934;negative regulation of cell proliferation in midbrain;49;5;GO:0042127
GO:1904927;cellular response to palmitoleic acid;3;0;GO:0046655
GO:0048203;vesicle targeting, trans-Golgi to endosome;1283;145;GO:0006626
GO:0048202;clathrin coating of Golgi vesicle;0;2;GO:0005764
GO:0048201;vesicle targeting, plasma membrane to endosome;0;1;GO:0006626
GO:0048200;Golgi transport vesicle coating;277;9;GO:0005840
GO:0051844;translocation of peptides or proteins into symbiont;1;1;GO:0006936
GO:0036287;response to iloperidone;0;3;GO:0048608
GO:0036288;response to ximelagatran;0;2;GO:0009611
GO:0036289;peptidyl-serine autophosphorylation;36;160;GO:0006468
GO:0036284;tubulobulbar complex;15;5;GO:0048704
GO:0036285;SAGA complex assembly;50;2;GO:0000976
GO:0036286;eisosome filament;40;5;GO:0005576
GO:0048207;vesicle targeting, rough ER to cis-Golgi;9948;305;GO:0005764
GO:1904944;positive regulation of cardiac ventricle formation;0;0;GO:0048608
GO:0036280;cellular response to L-canavanine;0;2;GO:0009611
GO:0048206;vesicle targeting, cis-Golgi to rough endoplasmic reticulum;0;2;GO:0006626
GO:1904943;negative regulation of cardiac ventricle formation;0;0;GO:0048608
GO:0048205;COPI coating of Golgi vesicle;276;2500;GO:0005829
GO:1904942;regulation of cardiac ventricle formation;0;0;GO:0048608
GO:0048204;vesicle targeting, inter-Golgi cisterna;0;2;GO:0005829
GO:1904948;midbrain dopaminergic neuron differentiation;813;112;GO:0048699
GO:1904947;folate import into mitochondrion;239;2;GO:0006836
GO:0048209;regulation of vesicle targeting, to, from or within Golgi;1;7;GO:0006626
GO:0048208;COPII vesicle coating;9948;1630;GO:0008023
GO:0048210;Golgi vesicle fusion to target membrane;292;27;GO:0006974
GO:0051851;modulation by host of symbiont process;4603;43;GO:0045735
GO:0051850;acquisition of nutrients from symbiont;0;3;GO:0009416
GO:1904938;planar cell polarity pathway involved in axon guidance;171;19;GO:0007409
GO:0048214;regulation of Golgi vesicle fusion to target membrane;53;4;GO:0006986
GO:0048213;Golgi vesicle prefusion complex stabilization;36;31;GO:0008029
GO:0048212;Golgi vesicle uncoating;7;3;GO:0005766
GO:0048211;Golgi vesicle docking;127;196;GO:0005813
GO:0036276;response to antidepressant;0;5;GO:0006950
GO:0036277;response to anticonvulsant;0;2;GO:0048167
GO:1990909;Wnt signalosome;531;353;GO:0030198
GO:0036279;positive regulation of protein export from nucleus in response to glucose starvation;0;4;GO:0048285
GO:0036272;response to gemcitabine;0;3;GO:0006974
GO:1904951;positive regulation of establishment of protein localization;19368;582;GO:0050729
GO:0036273;response to statin;0;2;GO:0030518
GO:1904950;negative regulation of establishment of protein localization;13699;62;GO:0010468
GO:0036274;response to lapatinib;0;3;GO:0042127
GO:0036275;response to 5-fluorouracil;0;4;GO:0006915
GO:1904955;planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation;1;6;GO:0007409
GO:0048217;pectic matrix;0;1;GO:0005576
GO:1904954;canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;184;8;GO:0048704
GO:0036270;response to diuretic;0;5;GO:0048608
GO:0048216;negative regulation of Golgi vesicle fusion to target membrane;0;2;GO:0006986
GO:1904953;Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;301;7;GO:0007219
GO:0036271;response to methylphenidate;0;2;GO:0048608
GO:0048215;positive regulation of Golgi vesicle fusion to target membrane;53;4;GO:0048193
GO:1904952;hydroxycinnamic acid transport;0;3;GO:0006869
GO:1904959;regulation of cytochrome-c oxidase activity;29;116;GO:0005746
GO:1904958;positive regulation of midbrain dopaminergic neuron differentiation;22;4;GO:0048608
GO:1904957;negative regulation of midbrain dopaminergic neuron differentiation;0;0;GO:0048608
GO:0048219;inter-Golgi cisterna vesicle-mediated transport;77;5;GO:0006906
GO:1904956;regulation of midbrain dopaminergic neuron differentiation;125;25;GO:0048608
GO:0051862;translocation of molecules into symbiont;1;1;GO:0002223
GO:0051861;glycolipid binding;3917;151;GO:0048193
GO:1904949;ATPase complex;1474643;449;GO:0005737
GO:0048225;suberin network;10;3;GO:0009579
GO:0048224;lignin network;0;1;GO:0005976
GO:0048223;hemicellulose network;0;1;GO:0046364
GO:0048222;glycoprotein network;0;2;GO:0005581
GO:1990900;ciliary pocket collar;14;0;GO:0005576
GO:1990901;old cell pole;0;0;GO:0005819
GO:1990902;new cell pole;0;0;GO:0005829
GO:0036269;swimming behavior;1256;89;GO:0007626
GO:0051866;general adaptation syndrome;220;36;GO:0006950
GO:1990904;ribonucleoprotein complex;6018440;3450;GO:0022627
GO:0051867;general adaptation syndrome, behavioral process;163;23;GO:0007610
GO:1990905;dinoflagellate peduncle;0;0;GO:0005976
GO:0051864;histone H3K36 demethylase activity;3383;8;GO:0016569
GO:1990906;accessory outer segment;0;2;GO:0002599
GO:0051865;protein autoubiquitination;644;1740;GO:0006464
GO:1990907;beta-catenin-TCF complex;1056;307;GO:0003700
GO:0036265;RNA (guanine-N7)-methylation;475725;1;GO:0032555
GO:1990919;proteasome-nuclear membrane anchor activity;0;0;GO:0004840
GO:0036266;Cdc48p-Npl4p-Vms1p AAA ATPase complex;29;8;GO:0005737
GO:0036267;invasive filamentous growth;588;13;GO:0046887
GO:0036268;swimming;297;65;GO:0007623
GO:0036261;7-methylguanosine cap hypermethylation;472;9;GO:0045944
GO:1904962;plastid to vacuole vesicle-mediated transport;3;0;GO:0006897
GO:0036262;granulysin production;0;3;GO:0008544
GO:1902300;galactarate transmembrane transport;0;0;GO:0008544
GO:1904961;quiescent center organization;13;1;GO:0005819
GO:1904960;positive regulation of cytochrome-c oxidase activity;22;6;GO:0045747
GO:0048229;gametophyte development;9573;241;GO:0048316
GO:1904966;positive regulation of vitamin E biosynthetic process;8;1;GO:0046395
GO:1904965;regulation of vitamin E biosynthetic process;8;0;GO:0006749
GO:0048227;plasma membrane to endosome transport;434;75;GO:0006810
GO:1902301;galactarate transmembrane transporter activity;0;0;GO:0005215
GO:1904964;positive regulation of phytol biosynthetic process;6;0;GO:0046394
GO:0036260;RNA capping;447055;624;GO:0003743
GO:0048226;Casparian strip;254;9;GO:0009813
GO:1904963;regulation of phytol biosynthetic process;12;0;GO:0046394
GO:1902307;positive regulation of sodium ion transmembrane transport;374;315;GO:0045735
GO:1902308;regulation of peptidyl-serine dephosphorylation;204;2;GO:0010468
GO:1904969;slow muscle cell migration;35;0;GO:0048608
GO:1902305;regulation of sodium ion transmembrane transport;963;250;GO:0015031
GO:1904968;positive regulation of spindle attachment to meiosis I kinetochore;48;0;GO:0048285
GO:1902306;negative regulation of sodium ion transmembrane transport;184;33;GO:0045766
GO:1904967;regulation of spindle attachment to meiosis I kinetochore;90;1;GO:0007067
GO:0048232;male gamete generation;65117;1460;GO:0007276
GO:0051873;killing by host of symbiont cells;979;260;GO:0048405
GO:0051874;sphinganine-1-phosphate catabolic process;0;0;GO:0006633
GO:0051871;dihydrofolic acid binding;5;2;GO:0043169
GO:0051872;sphingosine catabolic process;6;1;GO:0006633
GO:0048236;plant-type sporogenesis;1032;7;GO:0048316
GO:0048235;pollen sperm cell differentiation;326;294;GO:0048305
GO:0051870;methotrexate binding;1;10;GO:0005509
GO:1990910;response to hypobaric hypoxia;19;10;GO:0006979
GO:1990911;response to psychosocial stress;23;8;GO:0006950
GO:0051879;Hsp90 protein binding;14195;1240;GO:0042803
GO:1990913;sperm head plasma membrane;299;8;GO:0009986
GO:0036258;multivesicular body assembly;1491;135;GO:0005840
GO:0051877;pigment granule aggregation in cell center;201;7;GO:0048285
GO:1990915;structural constituent of ascospore wall;1;0;GO:0030430
GO:0036259;aerobic raffinose catabolic process;0;1;GO:0006032
GO:0051878;lateral element assembly;61;2;GO:0048704
GO:1990916;Isp3 layer of spore wall;2;0;GO:0005576
GO:0051875;pigment granule localization;3201;37;GO:0030163
GO:1990917;ooplasm;106;5;GO:0005667
GO:0051876;pigment granule dispersal;70;1;GO:0048285
GO:1990918;double-strand break repair involved in meiotic recombination;1091;48;GO:0000724
GO:0061298;retina vasculature development in camera-type eye;1591;365;GO:0048608
GO:0120111;neuron projection cytoplasm;9758;7;GO:0043005
GO:1902394;positive regulation of exodeoxyribonuclease activity;11;2;GO:0010468
GO:0061299;retina vasculature morphogenesis in camera-type eye;821;959;GO:0048608
GO:0120112;UDP-glucose transmembrane transport into endoplasmic reticulum;60;0;GO:0008544
GO:1902395;regulation of 1-deoxy-D-xylulose-5-phosphate synthase activity;1;3;GO:0006749
GO:0120113;cytoplasm to vacuole transport by the NVT pathway;153;3;GO:0006810
GO:1902392;regulation of exodeoxyribonuclease activity;11;0;GO:0004518
GO:0120114;Sm-like protein family complex;456431;292;GO:0005515
GO:1902393;negative regulation of exodeoxyribonuclease activity;0;0;GO:0004867
GO:0061294;mesonephric renal vesicle induction;0;0;GO:0048608
GO:0120115;Lsm2-8 complex;401;5;GO:0048193
GO:0061295;regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis;45;4;GO:0010942
GO:0120116;glucagon processing;1;4;GO:0009044
GO:0061296;negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis;45;7;GO:0010942
GO:0120117;T cell meandering migration;43;2;GO:0002521
GO:1902396;protein localization to bicellular tight junction;168;34;GO:0005576
GO:0061297;positive regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis;0;0;GO:0048608
GO:0120118;flagella connector;8;2;GO:0005929
GO:0120119;flagellum attachment zone;81;3;GO:0005576
GO:0097250;mitochondrial respirasome assembly;2093;21;GO:0005743
GO:0097252;oligodendrocyte apoptotic process;224;35;GO:0043066
GO:0097251;leukotriene B4 biosynthetic process;0;2;GO:0006022
GO:0097243;flavonoid binding;119;1;GO:0042546
GO:0097242;amyloid-beta clearance;2142;62;GO:0043161
GO:0097245;flavanol binding;0;1;GO:0097159
GO:0097244;flavonol binding;0;0;GO:0042593
GO:0097247;epigallocatechin 3-gallate binding;0;0;GO:0046983
GO:0097246;catechin binding;0;0;GO:0043169
GO:0097248;maintenance of protein location in cell cortex of cell tip;61;3;GO:0009987
GO:1902390;regulation of N-terminal peptidyl-serine acetylation;0;0;GO:0016525
GO:1902391;positive regulation of N-terminal peptidyl-serine acetylation;0;0;GO:0010401
GO:0120120;bilobe structure;56;1;GO:0048706
GO:0120121;tripartite attachment complex;8;2;GO:0048193
GO:0061287;mesonephric capsule formation;0;1;GO:0048608
GO:0120100;bacterial-type flagellum motor;11;2;GO:0005575
GO:0061288;mesonephric capsule specification;0;0;GO:0048704
GO:0120101;bacterial-type flagellum stator complex;2;3;GO:0005576
GO:0061289;Wnt signaling pathway involved in kidney development;104;10;GO:0009952
GO:0120102;bacterial-type flagellum secretion apparatus;10;3;GO:0044421
GO:0120103;centriolar subdistal appendage;469;5;GO:0005819
GO:0061283;specification of mesonephric distal tubule identity;0;0;GO:0048706
GO:0120104;mitotic actomyosin contractile ring, proximal layer;87;9;GO:0007067
GO:0061284;specification of mesonephric proximal tubule identity;0;0;GO:0048706
GO:0120105;mitotic actomyosin contractile ring, intermediate layer;158;5;GO:0007067
GO:0061285;mesonephric capsule development;0;2;GO:0048608
GO:0120106;mitotic actomyosin contractile ring, distal actin filament layer;78;4;GO:0007088
GO:0061286;mesonephric capsule morphogenesis;0;1;GO:0048608
GO:0120107;bacterial-type flagellum rotor complex;9;2;GO:0005575
GO:0120108;DNA-3'-diphospho-5'-guanosine diphosphatase;696;0;GO:0005524
GO:0120109;mitotic telomere clustering and tethering at nuclear periphery;82;0;GO:0007067
GO:0097261;eoxin C4 synthase activity;0;1;GO:0004497
GO:0097260;eoxin A4 synthase activity;0;2;GO:0004497
GO:0097263;eoxin E4 synthase activity;0;3;GO:0004867
GO:0097262;eoxin D4 synthase activity;0;1;GO:0004497
GO:0097254;renal tubular secretion;1017;36;GO:0002576
GO:0097253;beta-hydroxybutyrate transmembrane transporter activity;0;1;GO:0015075
GO:0097256;phenyllactate dehydrogenase activity;4;2;GO:0004067
GO:0097255;R2TP complex;712;211;GO:0005829
GO:0097258;20-hydroxy-leukotriene B4 omega oxidase activity;14;9;GO:0004067
GO:0097257;leukotriene B4 12-hydroxy dehydrogenase activity;21;3;GO:0004067
GO:0097259;20-aldehyde-leukotriene B4 20-monooxygenase activity;14;32;GO:0004497
GO:0061290;canonical Wnt signaling pathway involved in metanephric kidney development;104;9;GO:0009952
GO:0061291;canonical Wnt signaling pathway involved in ureteric bud branching;0;0;GO:0009952
GO:0061292;canonical Wnt signaling pathway involved in mesonephros development;0;1;GO:0007631
GO:0061293;canonical Wnt signaling pathway involved in mesonephric nephron development;0;0;GO:0007631
GO:0120110;interphase mitotic telomere clustering;42;1;GO:0007067
GO:0120133;negative regulation of actin cortical patch assembly;3;2;GO:0048285
GO:0120134;proximal portion of axoneme;90;2;GO:0005576
GO:0120135;distal portion of axoneme;87;1;GO:0005576
GO:0120136;dUMP kinase activity;0;1;GO:0004721
GO:0120137;positive regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity;0;2;GO:0048646
GO:0120138;regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;0;1;GO:0005524
GO:0120139;positive regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;0;2;GO:0048193
GO:0097230;cell motility in response to potassium ion;3;1;GO:0048870
GO:0097221;M/G1 phase-specific MADS box-forkhead transcription factor complex;6;3;GO:0048285
GO:0097220;simple sieve plate;0;0;GO:0005576
GO:0097222;mitochondrial mRNA polyadenylation;170;4;GO:0006415
GO:0097225;sperm midpiece;2424;496;GO:0009948
GO:0097224;sperm connecting piece;2753;43;GO:0048704
GO:0097227;sperm annulus;308;43;GO:0005576
GO:0097226;sperm mitochondrial sheath;99;108;GO:0005576
GO:0097229;sperm end piece;103;6;GO:0008037
GO:0097228;sperm principal piece;2165;343;GO:0009566
GO:0120140;negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;0;2;GO:0010467
GO:0120141;regulation of ecdysone receptor-mediated signaling pathway;29;0;GO:0030518
GO:0120142;positive regulation of ecdysone receptor-mediated signaling pathway;17;0;GO:0030518
GO:0120143;negative regulation of ecdysone receptor-mediated signaling pathway;12;1;GO:0030501
GO:0120122;prolactin metabolic process;1;0;GO:0006955
GO:0120123;ubiquitin activating enzyme complex;7;0;GO:0005840
GO:0120124;membrane fusion priming complex;3;0;GO:0005743
GO:0120125;PNGase complex;57;1;GO:0005576
GO:0120126;response to copper ion starvation;75;2;GO:0009414
GO:0120127;response to zinc ion starvation;152;2;GO:0009739
GO:0097241;hematopoietic stem cell migration to bone marrow;300;10;GO:0048017
GO:0097240;chromosome attachment to the nuclear envelope;2543;124;GO:0005829
GO:0097232;lamellar body membrane;220;6;GO:0048193
GO:0097231;cell motility in response to calcium ion;2;2;GO:0048870
GO:0097234;epidermal lamellar body membrane;56;1;GO:0005576
GO:0097233;alveolar lamellar body membrane;108;9;GO:0009986
GO:0097238;cellular response to methylglyoxal;118;5;GO:0045727
GO:0097237;cellular response to toxic substance;3654882;498;GO:0046686
GO:0120132;positive regulation of apoptotic process in bone marrow cell;2;1;GO:0042981
GO:0061254;mesonephric glomerular parietal epithelial cell development;0;0;GO:0048608
GO:0120155;MIH complex;23;3;GO:0048706
GO:1902350;cellular response to chloroquine;95;5;GO:0071456
GO:0061255;mesonephric glomerular parietal epithelial cell fate commitment;0;1;GO:0048608
GO:1902351;response to imidacloprid;21;0;GO:0046686
GO:0061256;mesonephric podocyte differentiation;0;1;GO:0048193
GO:0120157;PAR polarity complex;194;2;GO:0000976
GO:0061257;mesonephric podocyte development;0;1;GO:0048193
GO:0120158;positive regulation of collagen catabolic process;42;4;GO:0048407
GO:0061250;mesonephric glomerular epithelial cell differentiation;0;1;GO:0048608
GO:0120159;rRNA pseudouridine synthase activity;121959;4;GO:0003905
GO:1902354;blood vessel endothelial cell delamination involved in blood vessel lumen ensheathment;1;1;GO:0048661
GO:0061251;mesonephric glomerular epithelial cell development;0;0;GO:0048608
GO:1902355;endothelial tube lumen extension involved in blood vessel lumen ensheathment;1;1;GO:0048661
GO:0061252;mesonephric glomerular epithelial cell fate commitment;0;1;GO:0048608
GO:0061253;mesonephric glomerular parietal epithelial cell differentiation;0;0;GO:0048608
GO:1902358;sulfate transmembrane transport;193081;577;GO:0006826
GO:1902359;Notch signaling pathway involved in somitogenesis;126;2;GO:0007219
GO:1902356;oxaloacetate(2-) transmembrane transport;734;0;GO:0006836
GO:1902357;2-isopropylmalate(2-) transmembrane transport;1;0;GO:0008544
GO:0061258;mesonephric podocyte cell fate commitment;0;1;GO:0048405
GO:0061259;mesonephric glomerular mesangial cell differentiation;0;0;GO:0048608
GO:0048286;lung alveolus development;2472;1040;GO:0048513
GO:0048285;organelle fission;179251;4030;GO:0048471
GO:0097201;negative regulation of transcription from RNA polymerase II promoter in response to stress;430;78;GO:0045944
GO:0048284;organelle fusion;38934;794;GO:0005743
GO:0097200;cysteine-type endopeptidase activity involved in execution phase of apoptosis;641;227;GO:0004637
GO:0097203;phagocytic cup lip;24;0;GO:0002541
GO:0097202;activation of cysteine-type endopeptidase activity;48;337;GO:0004867
GO:0048289;isotype switching to IgE isotypes;450;42;GO:0002755
GO:0097205;renal filtration;1772;947;GO:0009096
GO:0048288;nuclear membrane fusion involved in karyogamy;1855;5;GO:0005730
GO:0097204;phagocytic cup base;12;1;GO:0005764
GO:0097207;bud dormancy process;0;2;GO:0048304
GO:0097206;nephrocyte filtration;74;9;GO:0008521
GO:0097209;epidermal lamellar body;241;95;GO:0005576
GO:0120160;intraciliary transport particle A binding;211;3;GO:0005576
GO:0061260;mesonephric mesangial cell differentiation;0;0;GO:0048608
GO:0097208;alveolar lamellar body;351;311;GO:0002504
GO:0120161;regulation of cold-induced thermogenesis;5910;271;GO:0010467
GO:0048283;indeterminate inflorescence morphogenesis;17;4;GO:0048706
GO:0120162;positive regulation of cold-induced thermogenesis;3943;356;GO:0010467
GO:0048282;determinate inflorescence morphogenesis;0;2;GO:0048706
GO:0120163;negative regulation of cold-induced thermogenesis;1907;218;GO:0010467
GO:0048281;inflorescence morphogenesis;75;111;GO:0048468
GO:0120164;conidium germination;1;1;GO:0048305
GO:0048280;vesicle fusion with Golgi apparatus;5048;496;GO:0005766
GO:0120165;perithecium development;0;0;GO:0048305
GO:0061243;mesonephric renal vesicle morphogenesis;0;1;GO:0048706
GO:0061244;mesonephric S-shaped body morphogenesis;0;0;GO:0048608
GO:0120145;protein localization to basal ectoplasmic specialization;0;0;GO:0009986
GO:1902362;melanocyte apoptotic process;113;8;GO:0042981
GO:0061245;establishment or maintenance of bipolar cell polarity;3864;263;GO:0048405
GO:0120146;sulfatide binding;340;9;GO:0005576
GO:0061246;establishment or maintenance of bipolar cell polarity regulating cell shape;300;0;GO:0048608
GO:0120147;formylglycine-generating oxidase activity;123;4;GO:0004746
GO:0120148;host cell centrosome;0;0;GO:0005819
GO:1902365;positive regulation of protein localization to spindle pole body;76;10;GO:0048285
GO:0061240;mesonephric nephron tubule morphogenesis;0;0;GO:0048608
GO:0120149;host cell peroxisome;0;0;GO:0009536
GO:1902366;regulation of Notch signaling pathway involved in somitogenesis;126;1;GO:0048608
GO:0061241;mesonephric nephron epithelium development;1;1;GO:0030216
GO:1902363;regulation of protein localization to spindle pole body;168;10;GO:0048285
GO:0061242;mesonephric nephron tubule development;1;0;GO:0048608
GO:1902364;negative regulation of protein localization to spindle pole body;29;0;GO:0048285
GO:1902369;negative regulation of RNA catabolic process;9963;9;GO:0010467
GO:1902367;negative regulation of Notch signaling pathway involved in somitogenesis;87;6;GO:0048704
GO:0061247;mesonephric glomerular mesangium development;0;0;GO:0048608
GO:0061248;mesonephric glomerulus vasculature morphogenesis;0;1;GO:0048706
GO:0061249;mesonephric glomerular capillary formation;0;0;GO:0048193
GO:0048298;positive regulation of isotype switching to IgA isotypes;308;121;GO:0048193
GO:0097210;response to gonadotropin-releasing hormone;383;109;GO:0009725
GO:0048297;negative regulation of isotype switching to IgA isotypes;54;6;GO:0048193
GO:0048296;regulation of isotype switching to IgA isotypes;362;6;GO:0032989
GO:0097212;lysosomal membrane organization;252;66;GO:0030163
GO:0048295;positive regulation of isotype switching to IgE isotypes;132;163;GO:0046649
GO:0097211;cellular response to gonadotropin-releasing hormone;319;73;GO:0009725
GO:0097214;positive regulation of lysosomal membrane permeability;62;5;GO:0048193
GO:0097213;regulation of lysosomal membrane permeability;110;2;GO:0006986
GO:0097216;guanosine tetraphosphate binding;66487;4;GO:0005524
GO:0048299;regulation of isotype switching to IgD isotypes;0;2;GO:0048193
GO:0097215;negative regulation of lysosomal membrane permeability;0;1;GO:0048193
GO:0048290;isotype switching to IgA isotypes;377;89;GO:0002776
GO:0097218;sieve plate;28;2;GO:0005576
GO:0097217;sieve area;0;0;GO:0005576
GO:0097219;compound sieve plate;0;0;GO:0046274
GO:0120150;regulation of mitotic actomyosin contractile ring disassembly;59;0;GO:0048285
GO:0048294;negative regulation of isotype switching to IgE isotypes;156;86;GO:0048193
GO:0120151;positive regulation of mitotic actomyosin contractile ring disassembly;59;4;GO:0048285
GO:0048293;regulation of isotype switching to IgE isotypes;288;179;GO:0050729
GO:0120152;calcium-dependent outer dynein arm binding;2;1;GO:0005525
GO:0048292;isotype switching to IgD isotypes;0;3;GO:0002729
GO:0120153;calcium-dependent carbohydrate binding;61;6;GO:0008150
GO:0048291;isotype switching to IgG isotypes;743;303;GO:0002729
GO:0120154;negative regulation of ERBB4 signaling pathway;55;0;GO:0030518
GO:0061276;mesonephric proximal tubule morphogenesis;0;0;GO:0048608
GO:0120177;negative regulation of torso signaling pathway;63;1;GO:0048706
GO:1902372;positive regulation of tRNA catabolic process;3;1;GO:0010467
GO:0061277;mesonephric nephron tubule formation;0;0;GO:0048193
GO:0120178;steroid hormone biosynthetic process;5058;23;GO:0046649
GO:1902373;negative regulation of mRNA catabolic process;9125;51;GO:0010467
GO:0061278;epithelial cell migration involved in mesonephric nephron tubule morphogenesis;0;0;GO:0048608
GO:0120179;adherens junction disassembly;4;1;GO:0030199
GO:1902370;regulation of tRNA catabolic process;194;0;GO:0006519
GO:0061279;epithelial cell migration involved in mesonephric distal tubule morphogenesis;0;0;GO:0048608
GO:1902371;negative regulation of tRNA catabolic process;179;0;GO:0010467
GO:0061272;mesonephric connecting tubule development;0;0;GO:0048608
GO:0061273;mesonephric distal tubule morphogenesis;0;0;GO:0048608
GO:0061274;mesonephric distal tubule development;0;0;GO:0048608
GO:1902374;regulation of rRNA catabolic process;59;1;GO:0045944
GO:0061275;mesonephric proximal tubule development;0;0;GO:0048608
GO:1902378;VEGF-activated neuropilin signaling pathway involved in axon guidance;19;203;GO:0048608
GO:1902379;chemoattractant activity involved in axon guidance;53;10;GO:0008092
GO:0120180;cell-substrate junction disassembly;308;1;GO:0048193
GO:0061280;epithelial cell migration involved in mesonephric proximal tubule morphogenesis;0;0;GO:0048608
GO:0120181;focal adhesion disassembly;308;3;GO:0048010
GO:0061281;specification of mesonephric connecting tubule identity;0;0;GO:0048704
GO:0120182;regulation of focal adhesion disassembly;207;3;GO:0048010
GO:0061282;specification of mesonephric nephron tubule identity;0;0;GO:0048704
GO:0120183;positive regulation of focal adhesion disassembly;207;7;GO:0048010
GO:0120184;negative regulation of focal adhesion disassembly;0;0;GO:0048010
GO:0120185;MBF transcription complex assembly;0;0;GO:0048285
GO:0120186;negative regulation of protein localization to chromatin;323;6;GO:0016568
GO:0120187;positive regulation of protein localization to chromatin;132;4;GO:0016570
GO:0061265;mesonephric nephron tubule epithelial cell differentiation;1;0;GO:0048193
GO:0120166;protoperithecium formation;0;0;GO:0048608
GO:1902383;11-oxo-beta-amyrin biosynthetic process;0;0;GO:0046395
GO:0061266;mesonephric interstitial fibroblast differentiation;0;0;GO:0048706
GO:1902384;glycyrrhetinate metabolic process;2;2;GO:0006073
GO:0061267;mesonephric interstitial fibroblast development;0;0;GO:0048608
GO:0120168;detection of hot stimulus involved in thermoception;49;1;GO:0009416
GO:1902381;11-oxo-beta-amyrin metabolic process;2;0;GO:0006081
GO:0061268;mesonephric interstitial fibroblast fate commitment;0;0;GO:0048706
GO:0120169;detection of cold stimulus involved in thermoception;52;2;GO:0009416
GO:1902382;11-oxo-beta-amyrin catabolic process;2;1;GO:0046395
GO:0061261;mesenchymal to epithelial transition involved in mesonephros morphogenesis;0;0;GO:0048704
GO:1902387;ceramide 1-phosphate binding;529;9;GO:0097367
GO:0061262;mesonephric renal vesicle formation;0;0;GO:0048706
GO:1902388;ceramide 1-phosphate transfer activity;561;5;GO:0004872
GO:0061263;mesonephric glomerular mesangial cell development;0;0;GO:0048608
GO:1902385;glycyrrhetinate catabolic process;0;0;GO:0009062
GO:0061264;mesonephric glomerular mesangial cell fate commitment;0;0;GO:0048608
GO:1902386;glycyrrhetinate biosynthetic process;2;1;GO:0006073
GO:1902389;ceramide 1-phosphate transport;1110;7;GO:0006869
GO:0061269;mesonephric glomerular mesangial cell proliferation involved in mesonephros development;0;0;GO:0048608
GO:0120170;intraciliary transport particle B binding;290;5;GO:0005576
GO:0061270;mesonephric intraglomerular mesangial cell proliferation;0;0;GO:0048193
GO:0120171;Cdc24p-Far1p-Gbetagamma complex;25;3;GO:0005524
GO:0061271;mesenchymal to epithelial transition involved in mesonephric renal vesicle formation;0;0;GO:0048704
GO:0120174;stress-induced homeostatically regulated protein degradation pathway;85;4;GO:0006950
GO:1902380;positive regulation of endoribonuclease activity;11;7;GO:0003723
GO:0120175;regulation of torso signaling pathway;65;0;GO:0048608
GO:0120176;positive regulation of torso signaling pathway;2;1;GO:0048608
GO:0120199;cone photoreceptor outer segment;553;8;GO:0005576
GO:1990890;netrin receptor binding;162;1;GO:0005539
GO:1990891;mitotic sister chromatid arm separation;44;0;GO:0000786
GO:1990882;rRNA acetylation;120;3;GO:0010467
GO:1990883;rRNA cytidine N-acetyltransferase activity;128;3;GO:0003954
GO:1990884;RNA acetylation;11994;3;GO:0016570
GO:1990887;2-polyprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol O-methyltransferase activity;0;0;GO:0004091
GO:1990888;2-polyprenyl-6-hydroxyphenol O-methyltransferase activity;0;0;GO:0004089
GO:1990889;H4K20me3 modified histone binding;111;3;GO:0016569
GO:0120188;regulation of bile acid secretion;103;3;GO:0042127
GO:0120189;positive regulation of bile acid secretion;55;5;GO:0010467
GO:1990892;mitotic chromosome arm condensation;0;2;GO:0000786
GO:1990893;mitotic chromosome centromere condensation;16;2;GO:0000786
GO:1990895;regulation of protein localization to cell cortex of cell tip;0;0;GO:0048471
GO:0002800;regulation of antifungal peptide secretion;0;1;GO:0046274
GO:1990896;protein localization to cell cortex of cell tip;16;3;GO:0009987
GO:0002801;negative regulation of antifungal peptide secretion;0;2;GO:0046274
GO:0002802;positive regulation of antifungal peptide secretion;0;2;GO:0046655
GO:0002803;positive regulation of antibacterial peptide production;617;146;GO:0046274
GO:0120190;negative regulation of bile acid secretion;8;5;GO:0010467
GO:0002804;positive regulation of antifungal peptide production;135;7;GO:0046655
GO:0120191;negative regulation of termination of RNA polymerase II transcription;131;1;GO:0045944
GO:0002805;regulation of antimicrobial peptide biosynthetic process;594;113;GO:0046274
GO:0120192;tight junction assembly;5118;166;GO:0005923
GO:0002806;negative regulation of antimicrobial peptide biosynthetic process;50;4;GO:0046274
GO:0120193;tight junction organization;5534;104;GO:0030054
GO:0002807;positive regulation of antimicrobial peptide biosynthetic process;544;19;GO:0046323
GO:0120194;regulation of anther dehiscence;14;0;GO:0048704
GO:0002808;regulation of antibacterial peptide biosynthetic process;479;5;GO:0046274
GO:0120195;positive regulation of anther dehiscence;4;1;GO:0048704
GO:0002809;negative regulation of antibacterial peptide biosynthetic process;50;3;GO:0046274
GO:0120196;negative regulation of anther dehiscence;5;0;GO:0010468
GO:0120197;mucociliary clearance;349;5;GO:0002541
GO:0120198;positive regulation of imaginal disc-derived wing size;0;0;GO:0048608
GO:0097191;extrinsic apoptotic signaling pathway;15026;2670;GO:0008630
GO:0097190;apoptotic signaling pathway;56304;3070;GO:0042981
GO:0097193;intrinsic apoptotic signaling pathway;24085;2330;GO:0008630
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;3401;1640;GO:0008631
GO:0097195;pilomotor reflex;104;10;GO:0007631
GO:0097194;execution phase of apoptosis;6305;1250;GO:0010941
GO:0097197;tetraspanin-enriched microdomain;681;136;GO:0005615
GO:0097196;Shu complex;363;27;GO:0005524
GO:0097188;dentin mineralization;57;4;GO:0008544
GO:0097187;dentinogenesis;191;28;GO:0007586
GO:0097189;apoptotic body;1;5;GO:0008219
GO:0097199;cysteine-type endopeptidase activity involved in apoptotic signaling pathway;838;70;GO:0004637
GO:0097198;histone H3-K36 trimethylation;2;9;GO:0045944
GO:0097171;ADP-L-glycero-beta-D-manno-heptose biosynthetic process;16445;1;GO:0006022
GO:0097170;ADP-L-glycero-beta-D-manno-heptose metabolic process;16445;2;GO:0006032
GO:0097173;N-acetylmuramic acid catabolic process;13249;3;GO:0006032
GO:0097172;N-acetylmuramic acid metabolic process;13255;4;GO:0006032
GO:0097175;1,6-anhydro-N-acetyl-beta-muramic acid catabolic process;18824;1;GO:0006032
GO:0097174;1,6-anhydro-N-acetyl-beta-muramic acid metabolic process;18824;3;GO:0006032
GO:0097166;lens epithelial cell proliferation;91;4;GO:0042127
GO:0002830;positive regulation of type 2 immune response;820;753;GO:0050729
GO:0097165;nuclear stress granule;376;98;GO:0007050
GO:0002831;regulation of response to biotic stimulus;238173;859;GO:0050832
GO:0097168;mesenchymal stem cell proliferation;391;56;GO:0042127
GO:0002832;negative regulation of response to biotic stimulus;160227;227;GO:0050832
GO:0097167;circadian regulation of translation;191;63;GO:0006413
GO:0002833;positive regulation of response to biotic stimulus;62515;526;GO:0050832
GO:0014819;regulation of skeletal muscle contraction;1007;1060;GO:0048407
GO:0002834;regulation of response to tumor cell;1059;80;GO:0010468
GO:0014818;skeletal muscle satellite cell fate determination;0;1;GO:0048193
GO:0097169;AIM2 inflammasome complex;185;157;GO:0005576
GO:0002835;negative regulation of response to tumor cell;200;9;GO:0048523
GO:0014817;skeletal muscle satellite cell fate specification;0;1;GO:0048771
GO:0002836;positive regulation of response to tumor cell;783;8;GO:0045727
GO:0014816;skeletal muscle satellite cell differentiation;399;278;GO:0048667
GO:0002837;regulation of immune response to tumor cell;1005;9;GO:0002684
GO:0002838;negative regulation of immune response to tumor cell;200;6;GO:0002684
GO:0014814;axon regeneration at neuromuscular junction;33;2;GO:0048704
GO:0002839;positive regulation of immune response to tumor cell;783;92;GO:0002684
GO:0014813;skeletal muscle satellite cell commitment;3;4;GO:0048193
GO:0014812;muscle cell migration;4253;672;GO:0030900
GO:0014811;negative regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;0;2;GO:0048407
GO:0014810;positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;1;4;GO:0048407
GO:0097180;serine protease inhibitor complex;718;151;GO:0005578
GO:0097182;protein C inhibitor-coagulation factor Xa complex;46;10;GO:0005576
GO:0097181;protein C inhibitor-coagulation factor V complex;46;7;GO:0005576
GO:0097184;response to azide;66;2;GO:0046686
GO:0097183;protein C inhibitor-coagulation factor XI complex;46;7;GO:0005576
GO:0097186;amelogenesis;1439;60;GO:0008544
GO:0002850;negative regulation of peripheral T cell tolerance induction;0;2;GO:0048308
GO:0097185;cellular response to azide;65;9;GO:0006979
GO:0002840;regulation of T cell mediated immune response to tumor cell;341;234;GO:0002821
GO:0097177;mitochondrial ribosome binding;568;177;GO:0005743
GO:0002841;negative regulation of T cell mediated immune response to tumor cell;121;7;GO:0002821
GO:0097176;epoxide metabolic process;460;5;GO:0006720
GO:0002842;positive regulation of T cell mediated immune response to tumor cell;198;273;GO:0002821
GO:0097179;protease inhibitor complex;744;8;GO:0005578
GO:0002843;regulation of tolerance induction to tumor cell;55;2;GO:0048704
GO:0097178;ruffle assembly;1919;194;GO:0005576
GO:0002844;negative regulation of tolerance induction to tumor cell;0;2;GO:0048706
GO:0002845;positive regulation of tolerance induction to tumor cell;55;5;GO:0048704
GO:0014829;vascular associated smooth muscle contraction;1242;300;GO:0002576
GO:0002846;regulation of T cell tolerance induction to tumor cell;0;1;GO:0002821
GO:0014828;distal stomach smooth muscle contraction;9;2;GO:0008092
GO:0002847;negative regulation of T cell tolerance induction to tumor cell;0;2;GO:0048011
GO:0014827;intestine smooth muscle contraction;209;156;GO:0006936
GO:0002848;positive regulation of T cell tolerance induction to tumor cell;0;2;GO:0048011
GO:0014826;vein smooth muscle contraction;280;38;GO:0006936
GO:0002849;regulation of peripheral T cell tolerance induction;48;4;GO:0002821
GO:0014825;stomach fundus smooth muscle contraction;2;2;GO:0006936
GO:0014824;artery smooth muscle contraction;456;209;GO:0002526
GO:0014823;response to activity;1626;1510;GO:0048511
GO:0014822;detection of wounding;49;6;GO:0009611
GO:0014821;phasic smooth muscle contraction;999;28;GO:0002537
GO:0014820;tonic smooth muscle contraction;480;279;GO:0006936
GO:0097151;positive regulation of inhibitory postsynaptic potential;87;187;GO:0048608
GO:0097150;neuronal stem cell population maintenance;1416;290;GO:0048699
GO:0097153;cysteine-type endopeptidase activity involved in apoptotic process;3112;295;GO:0004637
GO:0097152;mesenchymal cell apoptotic process;1117;47;GO:0043066
GO:0097144;BAX complex;100;4;GO:0005737
GO:0097143;PUMA-BCL-xl complex;3;2;GO:0005615
GO:0097146;NOXA-BCL-xl complex;0;0;GO:0005737
GO:0002810;regulation of antifungal peptide biosynthetic process;44;4;GO:0046274
GO:0097145;BAK complex;144;7;GO:0005840
GO:0002811;negative regulation of antifungal peptide biosynthetic process;0;2;GO:0046274
GO:0097148;BCL-2 complex;0;0;GO:0042981
GO:0002812;biosynthetic process of antibacterial peptides active against Gram-negative bacteria;171;5;GO:0046274
GO:0097147;NOXA-BCL-2 complex;0;0;GO:0005737
GO:0002813;regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria;130;3;GO:0046274
GO:0002814;negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria;38;4;GO:0046274
GO:0097149;centralspindlin complex;217;109;GO:0005815
GO:0002815;biosynthetic process of antibacterial peptides active against Gram-positive bacteria;132;65;GO:0046274
GO:0002816;regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;84;2;GO:0046274
GO:0002817;negative regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;0;1;GO:0046274
GO:0002819;regulation of adaptive immune response;55836;1350;GO:0002684
GO:0097160;polychlorinated biphenyl binding;6;1;GO:0097159
GO:0097162;MADS box domain binding;43;3;GO:0003700
GO:0097161;DH domain binding;71;5;GO:0042802
GO:0097164;ammonium ion metabolic process;55590;275;GO:0006541
GO:0097163;sulfur carrier activity;31116;10;GO:0004746
GO:0097155;fasciculation of sensory neuron axon;118;410;GO:0048666
GO:0097154;GABAergic neuron differentiation;1401;92;GO:0048666
GO:0002820;negative regulation of adaptive immune response;47077;394;GO:0045087
GO:0097157;pre-mRNA intronic binding;939;387;GO:0003729
GO:0002821;positive regulation of adaptive immune response;7009;607;GO:0050821
GO:0014809;regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;95;148;GO:0048407
GO:0097156;fasciculation of motor neuron axon;114;68;GO:0048704
GO:0002822;regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;10222;728;GO:0002757
GO:0014808;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;1615;367;GO:0006836
GO:0097159;organic cyclic compound binding;139134449;6070;GO:0097159
GO:0002823;negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;2507;43;GO:0048002
GO:0014807;regulation of somitogenesis;367;530;GO:0048704
GO:0097158;pre-mRNA intronic pyrimidine-rich binding;106;101;GO:0003723
GO:0002824;positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;6498;177;GO:0048002
GO:0014806;smooth muscle hyperplasia;28;283;GO:0048608
GO:0002825;regulation of T-helper 1 type immune response;1424;146;GO:0046649
GO:0014805;smooth muscle adaptation;36;54;GO:0048608
GO:0002826;negative regulation of T-helper 1 type immune response;165;154;GO:0032727
GO:0014804;terminal cisterna lumen;4;3;GO:0005764
GO:0002827;positive regulation of T-helper 1 type immune response;957;626;GO:0032724
GO:0014803;longitudinal sarcoplasmic reticulum lumen;0;1;GO:0005789
GO:0002828;regulation of type 2 immune response;1671;376;GO:0050729
GO:0014802;terminal cisterna;100;43;GO:0005764
GO:0002829;negative regulation of type 2 immune response;806;853;GO:0050729
GO:0014801;longitudinal sarcoplasmic reticulum;57;8;GO:0005789
GO:0014862;regulation of skeletal muscle contraction by chemo-mechanical energy conversion;184;3;GO:0006936
GO:1990809;endoplasmic reticulum tubular network membrane organization;272;8;GO:0007043
GO:0014861;regulation of skeletal muscle contraction via regulation of action potential;68;8;GO:0048407
GO:0014860;neurotransmitter secretion involved in regulation of skeletal muscle contraction;6;3;GO:0008092
GO:0000217;DNA secondary structure binding;106788;136;GO:0003676
GO:0000215;tRNA 2'-phosphotransferase activity;2440;4;GO:0006418
GO:0000214;tRNA-intron endonuclease complex;8428;532;GO:0005737
GO:0002880;regulation of chronic inflammatory response to non-antigenic stimulus;39;4;GO:0050729
GO:0000213;tRNA-intron endonuclease activity;21405;423;GO:0003729
GO:0002881;negative regulation of chronic inflammatory response to non-antigenic stimulus;1;52;GO:0050729
GO:0000212;meiotic spindle organization;2677;588;GO:0007018
GO:0002882;positive regulation of chronic inflammatory response to non-antigenic stimulus;38;66;GO:0050729
GO:0002883;regulation of hypersensitivity;421;219;GO:0050729
GO:0000221;vacuolar proton-transporting V-type ATPase, V1 domain;8831;515;GO:0005525
GO:0002873;positive regulation of natural killer cell tolerance induction;0;4;GO:1903047
GO:0000220;vacuolar proton-transporting V-type ATPase, V0 domain;10428;580;GO:0008544
GO:0002874;regulation of chronic inflammatory response to antigenic stimulus;185;43;GO:0050729
GO:0002875;negative regulation of chronic inflammatory response to antigenic stimulus;69;8;GO:0050729
GO:0002876;positive regulation of chronic inflammatory response to antigenic stimulus;116;115;GO:0050729
GO:0002877;regulation of acute inflammatory response to non-antigenic stimulus;89;9;GO:0002684
GO:0002878;negative regulation of acute inflammatory response to non-antigenic stimulus;4;4;GO:0002684
GO:0002879;positive regulation of acute inflammatory response to non-antigenic stimulus;85;74;GO:0050729
GO:0014859;negative regulation of skeletal muscle cell proliferation;399;81;GO:0048771
GO:0014858;positive regulation of skeletal muscle cell proliferation;190;66;GO:0048193
GO:0014857;regulation of skeletal muscle cell proliferation;959;10;GO:0048771
GO:0014856;skeletal muscle cell proliferation;1314;9;GO:0042127
GO:0014855;striated muscle cell proliferation;4511;164;GO:0042127
GO:0051800;phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity;1991;275;GO:0004721
GO:1990805;central cylinder;4;0;GO:0048608
GO:0014854;response to inactivity;272;514;GO:0048511
GO:1990806;ligand-gated ion channel signaling pathway;85664;5;GO:0007268
GO:0014853;regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction;47;7;GO:0048608
GO:0014852;regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction;53;3;GO:0048010
GO:1990808;F-bar domain binding;8;3;GO:0005515
GO:0014873;response to muscle activity involved in regulation of muscle adaptation;124;21;GO:0048405
GO:0014872;myoblast division;0;1;GO:0030198
GO:0014871;cross bridge formation involved in regulation of the velocity of shortening in skeletal muscle contraction;0;2;GO:0005524
GO:0014870;response to muscle inactivity;256;30;GO:0048405
GO:0051819;induction by symbiont of tumor or growth in host;98;1;GO:0048405
GO:1904900;negative regulation of myosin II filament organization;0;1;GO:0048608
GO:0000228;nuclear chromosome;135234;3740;GO:0005634
GO:0000227;oxaloacetate secondary active transmembrane transporter activity;0;3;GO:0005215
GO:0000226;microtubule cytoskeleton organization;305442;8520;GO:0007010
GO:0002890;negative regulation of immunoglobulin mediated immune response;577;10;GO:0002729
GO:0000225;N-acetylglucosaminylphosphatidylinositol deacetylase activity;3779;16;GO:0004721
GO:0002891;positive regulation of immunoglobulin mediated immune response;2364;554;GO:0002729
GO:1904904;regulation of endothelial cell-matrix adhesion via fibronectin;290;4;GO:0048010
GO:0000224;peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity;1723;0;GO:0004553
GO:0002892;regulation of type II hypersensitivity;162;20;GO:0046649
GO:1904903;ESCRT III complex disassembly;67;126;GO:0007041
GO:0000223;plasma membrane proton-transporting V-type ATPase, V1 domain;0;2;GO:0005576
GO:0002893;negative regulation of type II hypersensitivity;1;3;GO:0046649
GO:1904902;ESCRT III complex assembly;89;3;GO:0007031
GO:0000222;plasma membrane proton-transporting V-type ATPase, V0 domain;0;4;GO:0005576
GO:0002894;positive regulation of type II hypersensitivity;160;43;GO:0050729
GO:1904901;positive regulation of myosin II filament organization;23;0;GO:0048608
GO:0002884;negative regulation of hypersensitivity;54;10;GO:0050729
GO:0002885;positive regulation of hypersensitivity;319;44;GO:0050821
GO:0002886;regulation of myeloid leukocyte mediated immunity;2328;1100;GO:0002684
GO:0002887;negative regulation of myeloid leukocyte mediated immunity;335;43;GO:0002768
GO:0002888;positive regulation of myeloid leukocyte mediated immunity;862;364;GO:0002684
GO:0002889;regulation of immunoglobulin mediated immune response;3247;317;GO:0002729
GO:1990810;microtubule anchoring at mitotic spindle pole body;32;3;GO:0005524
GO:1990811;MWP complex;94;1;GO:0048285
GO:1990812;growth cone filopodium;20;56;GO:0048608
GO:0014869;detection of muscle inactivity;0;1;GO:0048608
GO:1990813;meiotic centromeric cohesion protection in anaphase I;121;5;GO:0007062
GO:0014868;cross bridge cycling involved in regulation of the velocity of shortening in skeletal muscle contraction;0;2;GO:0002044
GO:1990814;DNA/DNA annealing activity;534;10;GO:0003676
GO:0014866;skeletal myofibril assembly;1027;546;GO:0007517
GO:1990816;vacuole-mitochondrion membrane contact site;196;14;GO:0005743
GO:0014865;detection of activity;0;3;GO:0050789
GO:1990817;poly(A) RNA polymerase activity;81366;24;GO:0003964
GO:0014864;detection of muscle activity;0;2;GO:0048608
GO:1990818;L-arginine transmembrane export from vacuole;52;1;GO:0008544
GO:0014863;detection of inactivity;0;2;GO:0048608
GO:1990819;mating projection actin fusion focus;191;5;GO:0005576
GO:1904911;negative regulation of establishment of RNA localization to telomere;49;1;GO:0010468
GO:1904910;regulation of establishment of RNA localization to telomere;49;1;GO:0048285
GO:1904915;positive regulation of establishment of protein-containing complex localization to telomere;0;1;GO:0048193
GO:1904914;negative regulation of establishment of protein-containing complex localization to telomere;1;0;GO:0048285
GO:0002860;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;371;114;GO:0002273
GO:1904913;regulation of establishment of protein-containing complex localization to telomere;1;0;GO:0048285
GO:0002861;regulation of inflammatory response to antigenic stimulus;1378;242;GO:0002684
GO:1904912;positive regulation of establishment of RNA localization to telomere;0;1;GO:0048285
GO:0002851;positive regulation of peripheral T cell tolerance induction;48;8;GO:0048364
GO:1904908;negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric;103;6;GO:0007067
GO:0002852;regulation of T cell mediated cytotoxicity directed against tumor cell target;87;8;GO:0002821
GO:1904907;regulation of maintenance of mitotic sister chromatid cohesion, telomeric;103;3;GO:0007050
GO:0002853;negative regulation of T cell mediated cytotoxicity directed against tumor cell target;2;2;GO:0002821
GO:1904906;positive regulation of endothelial cell-matrix adhesion via fibronectin;239;9;GO:0048010
GO:0002854;positive regulation of T cell mediated cytotoxicity directed against tumor cell target;85;6;GO:0002687
GO:1904905;negative regulation of endothelial cell-matrix adhesion via fibronectin;51;6;GO:0048010
GO:0002855;regulation of natural killer cell mediated immune response to tumor cell;445;6;GO:0002449
GO:0002856;negative regulation of natural killer cell mediated immune response to tumor cell;45;7;GO:0002449
GO:1990820;response to mitotic DNA integrity checkpoint signaling;13;1;GO:1903561
GO:0002857;positive regulation of natural killer cell mediated immune response to tumor cell;400;84;GO:0002449
GO:0014839;myoblast migration involved in skeletal muscle regeneration;267;54;GO:0048771
GO:0002858;regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;416;10;GO:0002221
GO:0014838;myoblast fate specification involved in skeletal muscle regeneration;0;1;GO:0048771
GO:1904909;positive regulation of maintenance of mitotic sister chromatid cohesion, telomeric;0;0;GO:0048285
GO:1990822;basic amino acid transmembrane transport;25331;58;GO:0015031
GO:0002859;negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;45;15;GO:0002821
GO:0014837;myoblast fate determination involved in skeletal muscle regeneration;0;1;GO:0048771
GO:0051826;negative regulation of synapse structural plasticity;1;0;GO:0048167
GO:1990823;response to leukemia inhibitory factor;5902;76;GO:0048405
GO:0014836;myoblast fate commitment involved in skeletal muscle regeneration;0;1;GO:0048771
GO:0014835;myoblast differentiation involved in skeletal muscle regeneration;60;47;GO:0048667
GO:1990825;sequence-specific mRNA binding;943;94;GO:0003735
GO:0014834;skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration;229;55;GO:0048771
GO:1990826;nucleoplasmic periphery of the nuclear pore complex;4;2;GO:0005730
GO:0014833;skeletal muscle satellite stem cell asymmetric division;0;3;GO:0048193
GO:1990827;deaminase binding;3;1;GO:0043169
GO:0014832;urinary bladder smooth muscle contraction;328;91;GO:0006936
GO:0051823;regulation of synapse structural plasticity;210;2700;GO:0048167
GO:1990828;hepatocyte dedifferentiation;4;7;GO:0042127
GO:0014831;gastro-intestinal system smooth muscle contraction;1364;10;GO:0006936
GO:1990829;C-rich single-stranded DNA binding;81;38;GO:0003677
GO:0014830;arteriole smooth muscle contraction;0;1;GO:0002544
GO:0014850;response to muscle activity;671;863;GO:0048407
GO:0000209;protein polyubiquitination;2836;5650;GO:0006464
GO:1904926;response to palmitoleic acid;3;0;GO:0046655
GO:0002870;T cell anergy;500;31;GO:0002821
GO:1904925;positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization;777;9;GO:0048193
GO:0002871;regulation of natural killer cell tolerance induction;0;4;GO:0048011
GO:1904924;negative regulation of mitophagy in response to mitochondrial depolarization;59;8;GO:0048285
GO:0002872;negative regulation of natural killer cell tolerance induction;0;3;GO:0045087
GO:1904923;regulation of autophagy of mitochondrion in response to mitochondrial depolarization;836;4;GO:0048471
GO:0000210;NAD+ diphosphatase activity;27762;64;GO:0004723
GO:0002862;negative regulation of inflammatory response to antigenic stimulus;640;616;GO:0002684
GO:1904919;transmembrane L-cystine transport from lysosomal lumen to cytosol;0;0;GO:0006836
GO:0002863;positive regulation of inflammatory response to antigenic stimulus;639;315;GO:0002684
GO:1904918;transmembrane L-histidine transport from lysosomal lumen to cytosol;0;0;GO:0006836
GO:0002864;regulation of acute inflammatory response to antigenic stimulus;588;171;GO:0002684
GO:1904917;L-arginine transmembrane transport from lysosomal lumen to cytosol;0;0;GO:0006836
GO:0002865;negative regulation of acute inflammatory response to antigenic stimulus;118;95;GO:0002684
GO:1904916;transmembrane L-lysine transport from lysosomal lumen to cytosol;0;0;GO:0006836
GO:0002866;positive regulation of acute inflammatory response to antigenic stimulus;371;209;GO:0002684
GO:1990830;cellular response to leukemia inhibitory factor;5794;1240;GO:0045727
GO:0002867;regulation of B cell deletion;0;4;GO:0050729
GO:1990831;cellular response to carcinoembryonic antigen;1;0;GO:0002576
GO:0002868;negative regulation of B cell deletion;0;4;GO:0045727
GO:1990832;slow axonal transport;27;3;GO:0006928
GO:0002869;positive regulation of B cell deletion;0;4;GO:0050729
GO:0014849;ureter smooth muscle contraction;102;1;GO:0006936
GO:1990833;clathrin-uncoating ATPase activity;28;3;GO:0005524
GO:0014848;urinary tract smooth muscle contraction;430;229;GO:0006936
GO:1990834;response to odorant;271;32;GO:0009410
GO:0014847;proximal stomach smooth muscle contraction;2;3;GO:0006936
GO:0051838;cytolysis by host of symbiont cells;239;136;GO:0048646
GO:0014846;esophagus smooth muscle contraction;1042;32;GO:0006936
GO:0051835;positive regulation of synapse structural plasticity;97;40;GO:0048167
GO:1990836;lysosomal matrix;7;3;GO:0005764
GO:0014845;stomach body smooth muscle contraction;0;2;GO:0006936
GO:1990837;sequence-specific double-stranded DNA binding;409318;1580;GO:0003677
GO:0014844;myoblast proliferation involved in skeletal muscle regeneration;2;1;GO:0048771
GO:1990838;poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends;1915;0;GO:0004553
GO:0014843;growth factor dependent regulation of skeletal muscle satellite cell proliferation;45;6;GO:0048608
GO:1990839;response to endothelin;32;6;GO:0009719
GO:0014842;regulation of skeletal muscle satellite cell proliferation;787;57;GO:0048771
GO:0014841;skeletal muscle satellite cell proliferation;983;51;GO:0048771
GO:0036210;protein modification process in another organism;2;0;GO:0043687
GO:0036211;protein modification process;3674187;4780;GO:0006464
GO:0036213;contractile ring contraction;609;3;GO:0007088
GO:0000257;nitrilase activity;18416;9;GO:0004725
GO:0000256;allantoin catabolic process;49366;643;GO:0006559
GO:0000255;allantoin metabolic process;58216;503;GO:0006541
GO:0000262;mitochondrial chromosome;1385;133;GO:0005739
GO:1990840;response to lectin;520;1;GO:0048193
GO:1990841;promoter-specific chromatin binding;3711;703;GO:0016570
GO:1990845;adaptive thermogenesis;7226;273;GO:0007566
GO:1990846;ribonucleoside-diphosphate reductase inhibitor activity;21;3;GO:0003676
GO:0036209;9beta-pimara-7,15-diene oxidase activity;10;3;GO:0004497
GO:0014899;cardiac muscle atrophy;26;6;GO:0048407
GO:0036203;taxoid 14-beta-hydroxylase activity;4;4;GO:0004497
GO:1990849;vacuolar localization;5655;1;GO:0005737
GO:0014898;cardiac muscle hypertrophy in response to stress;1043;749;GO:0048407
GO:0036204;abieta-7,13-dien-18-ol hydroxylase activity;67;2;GO:0004497
GO:0014897;striated muscle hypertrophy;3570;390;GO:0048407
GO:0036205;histone catabolic process;42;7;GO:0016567
GO:0014896;muscle hypertrophy;3731;481;GO:0048193
GO:0036200;3-ketosteroid 9-alpha-monooxygenase activity;258;3;GO:0004497
GO:0061808;negative regulation of DNA recombination at centromere;0;1;GO:0007067
GO:1902919;poly(5-hydroxyvalerate) biosynthetic process;0;0;GO:0009405
GO:0034258;nicotinamide riboside transport;42390;8;GO:0046356
GO:0034257;nicotinamide riboside transmembrane transporter activity;21197;8;GO:0008544
GO:0034256;chlorophyll(ide) b reductase activity;282;3;GO:0009579
GO:0009295;nucleoid;183460;1120;GO:0005829
GO:0010284;lariciresinol reductase activity;21;5;GO:0004497
GO:0034251;regulation of amide catabolic process;26;2;GO:0046394
GO:0009294;DNA-mediated transformation;92631;1250;GO:0032259
GO:0010283;pinoresinol reductase activity;30;5;GO:0004073
GO:0034250;positive regulation of amide metabolic process;94568;5;GO:0045944
GO:0009293;transduction;0;49;GO:0032496
GO:0010286;heat acclimation;984;594;GO:0006974
GO:0009292;horizontal gene transfer;92635;7;GO:0015979
GO:0010285;L,L-diaminopimelate aminotransferase activity;14971;10;GO:0004449
GO:0009299;mRNA transcription;3387;553;GO:0006351
GO:0010280;UDP-L-rhamnose synthase activity;82;6;GO:0006032
GO:0034255;regulation of urea metabolic process;67;23;GO:0046356
GO:0009298;GDP-mannose biosynthetic process;47973;294;GO:0006022
GO:0034254;regulation of urea catabolic process;8;2;GO:0046278
GO:0009297;pilus assembly;76789;260;GO:0043169
GO:0010282;senescence-associated vacuole;8;6;GO:0007049
GO:0034253;positive regulation of amide catabolic process;20;1;GO:0046394
GO:0034252;negative regulation of amide catabolic process;1;0;GO:0046274
GO:0048856;anatomical structure development;3998997;8470;GO:0048513
GO:0061834;actin filament branch point;2;1;GO:0005934
GO:1902930;regulation of alcohol biosynthetic process;3339;85;GO:0046395
GO:0048855;adenohypophysis morphogenesis;92;6;GO:0048608
GO:0061835;ventral surface of cell;2;2;GO:0009952
GO:1902931;negative regulation of alcohol biosynthetic process;788;7;GO:0010468
GO:0048854;brain morphogenesis;2148;1060;GO:0048856
GO:0061836;intranuclear rod;20;5;GO:0005634
GO:0048853;forebrain morphogenesis;679;300;GO:0007420
GO:0061837;neuropeptide processing;83;4;GO:0006953
GO:0061830;concave side of sperm head;6;2;GO:0005576
GO:1902934;isopentenol biosynthetic process;0;1;GO:0006098
GO:0048859;formation of anatomical boundary;1150;36;GO:0009987
GO:0061831;apical ectoplasmic specialization;4;5;GO:0009986
GO:1902935;protein localization to septin ring;7;0;GO:0005737
GO:0048858;cell projection morphogenesis;110857;1940;GO:0042995
GO:0061832;basal ectoplasmic specialization;5;4;GO:0005615
GO:1902932;positive regulation of alcohol biosynthetic process;1123;186;GO:0046395
GO:0048857;neural nucleus development;1870;132;GO:0048666
GO:0061833;protein localization to tricellular tight junction;146;4;GO:0005925
GO:1902933;isopentenol metabolic process;0;3;GO:0006081
GO:1902927;inulin catabolic process;5;0;GO:0006032
GO:1902928;inulin biosynthetic process;0;0;GO:0005976
GO:1902925;poly(hydroxyalkanoate) biosynthetic process from fatty acid;0;0;GO:0009405
GO:1902926;inulin metabolic process;5;0;GO:0005985
GO:0048863;stem cell differentiation;21759;2710;GO:0030154
GO:0061838;CENP-T-W-S-X complex;4;3;GO:0005524
GO:0046201;cyanate biosynthetic process;0;2;GO:0006067
GO:0048861;leukemia inhibitory factor signaling pathway;365;60;GO:0007179
GO:1902929;plasma membrane of growing cell tip;17;2;GO:0009986
GO:0048860;glioblast division;0;0;GO:0048285
GO:0034248;regulation of amide metabolic process;3204972;6;GO:0050789
GO:0034247;snoRNA splicing;182;8;GO:0008319
GO:0034246;mitochondrial transcription factor activity;279;6;GO:0003700
GO:0034245;mitochondrial DNA-directed RNA polymerase complex;238;9;GO:0005740
GO:0009291;unidirectional conjugation;4;27;GO:0046148
GO:0010277;chlorophyllide a oxygenase [overall] activity;3293;51;GO:0009579
GO:0009290;DNA import into cell involved in transformation;7;190;GO:0006810
GO:0010276;phytol kinase activity;124;6;GO:0004721
GO:0010279;indole-3-acetic acid amido synthetase activity;153;76;GO:0004497
GO:0010278;chloroplast outer membrane translocon;0;1;GO:0009536
GO:0034249;negative regulation of amide metabolic process;226235;5;GO:0046394
GO:0010295;(+)-abscisic acid 8'-hydroxylase activity;207;1;GO:0004497
GO:0034240;negative regulation of macrophage fusion;7;10;GO:0048661
GO:0010294;abscisic acid glucosyltransferase activity;29;259;GO:0006073
GO:0010297;heteropolysaccharide binding;22;5;GO:0005576
GO:0010296;prenylcysteine methylesterase activity;105;3;GO:0004730
GO:0010291;carotene beta-ring hydroxylase activity;140;3;GO:0004497
GO:0034244;negative regulation of transcription elongation by RNA polymerase II;1155;10;GO:0000981
GO:0010290;chlorophyll catabolite transmembrane transporter activity;4;2;GO:0008565
GO:0034243;regulation of transcription elongation by RNA polymerase II;28266;49;GO:0006357
GO:0010293;abscisic aldehyde oxidase activity;12;6;GO:0004497
GO:0034242;negative regulation of syncytium formation by plasma membrane fusion;167;48;GO:0048193
GO:0010292;GTP:GDP antiporter activity;0;4;GO:0008565
GO:0034241;positive regulation of macrophage fusion;255;23;GO:0048661
GO:0046204;nor-spermidine metabolic process;8829;5;GO:0009065
GO:0048867;stem cell fate determination;74;34;GO:0030182
GO:0061823;ring centriole;22;1;GO:0005819
GO:1902941;regulation of voltage-gated chloride channel activity;1;6;GO:0048169
GO:0046205;nor-spermidine catabolic process;0;1;GO:0046395
GO:0048866;stem cell fate specification;424;10;GO:0030182
GO:0061824;cytosolic ciliogenesis;71;5;GO:0009986
GO:1902942;negative regulation of voltage-gated chloride channel activity;0;0;GO:0048704
GO:0046202;cyanide biosynthetic process;1;2;GO:0006066
GO:0048865;stem cell fate commitment;737;197;GO:0030182
GO:0061825;podosome core;6;3;GO:0030198
GO:0046203;spermidine catabolic process;105;9;GO:0009062
GO:0048864;stem cell development;9161;703;GO:0030154
GO:0061826;podosome ring;58;5;GO:0030198
GO:1902940;positive regulation of intracellular calcium activated chloride channel activity;0;0;GO:0048407
GO:0046208;spermine catabolic process;493;144;GO:0006559
GO:1902945;metalloendopeptidase activity involved in amyloid precursor protein catabolic process;192;7;GO:0004867
GO:0046209;nitric oxide metabolic process;11796;563;GO:0006569
GO:0061820;telomeric D-loop disassembly;540;165;GO:0007060
GO:1902946;protein localization to early endosome;575;6;GO:0007049
GO:0046206;trypanothione metabolic process;8;2;GO:0006749
GO:0048869;cellular developmental process;1060950;4200;GO:0032502
GO:0061821;telomeric D-loop binding;201;60;GO:0003677
GO:1902943;positive regulation of voltage-gated chloride channel activity;1;28;GO:0048169
GO:0046207;trypanothione catabolic process;0;2;GO:0006559
GO:0048868;pollen tube development;3464;159;GO:0048316
GO:0061822;ciliary cap;46;2;GO:0005929
GO:1902944;aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;31;1;GO:0004867
GO:0048870;cell motility;750525;4850;GO:0006928
GO:1902938;regulation of intracellular calcium activated chloride channel activity;4;9;GO:0008026
GO:1902939;negative regulation of intracellular calcium activated chloride channel activity;1;0;GO:0048407
GO:1902936;phosphatidylinositol bisphosphate binding;24782;74;GO:0097367
GO:1902937;inward rectifier potassium channel complex;103;119;GO:0048169
GO:0046211;(+)-camphor biosynthetic process;4;1;GO:0009065
GO:0048874;host-mediated regulation of intestinal microbiota composition;376;13;GO:0045765
GO:0061827;sperm head;774;154;GO:0005576
GO:0048873;homeostasis of number of cells within a tissue;2070;1510;GO:0048731
GO:0061828;apical tubulobulbar complex;6;2;GO:0048704
GO:0048872;homeostasis of number of cells;26063;1220;GO:0045737
GO:0061829;basal tubulobulbar complex;4;0;GO:0048704
GO:0046210;nitric oxide catabolic process;48;14;GO:0006569
GO:0048871;multicellular organismal-level homeostasis;58812;3;GO:0048519
GO:0034237;protein kinase A regulatory subunit binding;2035;373;GO:0043402
GO:0034236;protein kinase A catalytic subunit binding;887;441;GO:0043402
GO:0034235;GPI anchor binding;2681;179;GO:0005576
GO:0034234;regulation of ascospore wall chitin catabolic process;0;2;GO:0046395
GO:0010288;response to lead ion;310;570;GO:0046686
GO:0010287;plastoglobule;1187;839;GO:0009986
GO:0034239;regulation of macrophage fusion;262;5;GO:0048661
GO:0010289;homogalacturonan biosynthetic process;54;6;GO:0005976
GO:0034238;macrophage fusion;358;16;GO:0002576
GO:0071380;cellular response to prostaglandin E stimulus;626;311;GO:0006954
GO:1900259;regulation of RNA-dependent RNA polymerase activity;4;1;GO:0010467
GO:0071372;cellular response to follicle-stimulating hormone stimulus;322;317;GO:0009952
GO:0071373;cellular response to luteinizing hormone stimulus;197;42;GO:0009952
GO:0071370;cellular response to gibberellin stimulus;11137;93;GO:0009743
GO:0071371;cellular response to gonadotropin stimulus;956;607;GO:0009725
GO:0071376;cellular response to corticotropin-releasing hormone stimulus;443;72;GO:0006955
GO:0071377;cellular response to glucagon stimulus;3511;615;GO:0009725
GO:0071374;cellular response to parathyroid hormone stimulus;263;155;GO:0009719
GO:0071375;cellular response to peptide hormone stimulus;32599;782;GO:0009719
GO:0071378;cellular response to growth hormone stimulus;976;445;GO:0048193
GO:0071379;cellular response to prostaglandin stimulus;856;503;GO:0006954
GO:1900261;positive regulation of RNA-dependent RNA polymerase activity;3;1;GO:0010467
GO:1900260;negative regulation of RNA-dependent RNA polymerase activity;1;1;GO:0010467
GO:1900263;negative regulation of DNA-directed DNA polymerase activity;0;1;GO:0003964
GO:1900262;regulation of DNA-directed DNA polymerase activity;45;64;GO:0003964
GO:1900265;regulation of substance P receptor binding;0;0;GO:0048608
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;45;309;GO:0045944
GO:1900267;positive regulation of substance P receptor binding;0;0;GO:0048608
GO:1900266;negative regulation of substance P receptor binding;0;0;GO:0048608
GO:1900269;negative regulation of reverse transcription;0;1;GO:0010467
GO:1900268;regulation of reverse transcription;105;1;GO:0010467
GO:0071361;cellular response to ethanol;471;1200;GO:0050877
GO:0071362;cellular response to ether;251;6;GO:0050829
GO:0071360;cellular response to exogenous dsRNA;807;755;GO:0032496
GO:0071365;cellular response to auxin stimulus;62503;272;GO:0009734
GO:0071366;cellular response to indolebutyric acid stimulus;11;8;GO:0009719
GO:0071363;cellular response to growth factor stimulus;104388;2710;GO:0048608
GO:0071364;cellular response to epidermal growth factor stimulus;1772;1470;GO:0097190
GO:0071369;cellular response to ethylene stimulus;25354;102;GO:0009723
GO:0071367;cellular response to brassinosteroid stimulus;14662;80;GO:0009739
GO:0071368;cellular response to cytokinin stimulus;28994;18;GO:0009737
GO:1900270;positive regulation of reverse transcription;0;2;GO:0010467
GO:1900272;negative regulation of long-term synaptic potentiation;479;60;GO:0048167
GO:1900271;regulation of long-term synaptic potentiation;1602;199;GO:0048167
GO:1900274;regulation of phospholipase C activity;115;164;GO:0008021
GO:1900273;positive regulation of long-term synaptic potentiation;643;225;GO:0048167
GO:1900276;regulation of proteinase activated receptor activity;2;10;GO:0048608
GO:1900275;negative regulation of phospholipase C activity;3;7;GO:0048010
GO:1900278;positive regulation of proteinase activated receptor activity;0;1;GO:0048608
GO:1900277;negative regulation of proteinase activated receptor activity;0;2;GO:0048608
GO:1900279;regulation of CD4-positive, alpha-beta T cell costimulation;36;1;GO:0042110
GO:0071394;cellular response to testosterone stimulus;385;130;GO:0009725
GO:0071395;cellular response to jasmonic acid stimulus;14169;232;GO:0009723
GO:0071392;cellular response to estradiol stimulus;2766;1080;GO:0010468
GO:0071393;cellular response to progesterone stimulus;87;103;GO:0006954
GO:0071398;cellular response to fatty acid;15419;929;GO:0006631
GO:0071399;cellular response to linoleic acid;3;3;GO:0046649
GO:0071396;cellular response to lipid;137252;2280;GO:0006629
GO:0071397;cellular response to cholesterol;644;428;GO:0032496
GO:1900281;positive regulation of CD4-positive, alpha-beta T cell costimulation;5;2;GO:0042110
GO:1900280;negative regulation of CD4-positive, alpha-beta T cell costimulation;31;1;GO:0042110
GO:1900283;negative regulation of cellobiose catabolic process;0;0;GO:0046395
GO:1900282;regulation of cellobiose catabolic process;0;0;GO:0046395
GO:1900285;regulation of cellotriose transport;0;0;GO:0006869
GO:1900284;positive regulation of cellobiose catabolic process;0;0;GO:0046356
GO:1900287;positive regulation of cellotriose transport;0;0;GO:0046356
GO:1900286;negative regulation of cellotriose transport;0;0;GO:0006869
GO:1900289;negative regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process;0;1;GO:0046395
GO:1900288;regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process;0;0;GO:0046395
GO:0071390;cellular response to ecdysone;1128;7;GO:0048608
GO:0071391;cellular response to estrogen stimulus;1487;564;GO:0030518
GO:0071383;cellular response to steroid hormone stimulus;69187;2670;GO:0048545
GO:0071384;cellular response to corticosteroid stimulus;4811;100;GO:0006950
GO:0071381;cellular response to prostaglandin F stimulus;0;1;GO:0006954
GO:0071382;cellular response to prostaglandin I stimulus;0;1;GO:0006954
GO:0071387;cellular response to cortisol stimulus;143;6;GO:0009628
GO:0071388;cellular response to cortisone stimulus;0;2;GO:0006954
GO:0071385;cellular response to glucocorticoid stimulus;4552;576;GO:0032496
GO:0071386;cellular response to corticosterone stimulus;61;85;GO:0009611
GO:0071389;cellular response to mineralocorticoid stimulus;289;150;GO:0048193
GO:0034399;nuclear periphery;15300;1070;GO:0005634
GO:1902871;positive regulation of amacrine cell differentiation;173;93;GO:0048608
GO:1902872;regulation of horizontal cell localization;1;0;GO:0048608
GO:1900210;positive regulation of cardiolipin metabolic process;10;204;GO:0046395
GO:1902870;negative regulation of amacrine cell differentiation;163;6;GO:0048608
GO:1900212;negative regulation of mesenchymal cell apoptotic process involved in metanephros development;109;49;GO:0010942
GO:1902875;regulation of embryonic pattern specification;2;1;GO:0048704
GO:1900211;regulation of mesenchymal cell apoptotic process involved in metanephros development;109;4;GO:0010942
GO:1902876;negative regulation of embryonic pattern specification;1;1;GO:0048704
GO:0046378;enterobacterial common antigen metabolic process;49389;6;GO:0006021
GO:1900214;regulation of apoptotic process involved in metanephric collecting duct development;27;5;GO:0043066
GO:1902873;negative regulation of horizontal cell localization;1;1;GO:0048608
GO:0046379;extracellular polysaccharide metabolic process;88310;111;GO:0005976
GO:1900213;positive regulation of mesenchymal cell apoptotic process involved in metanephros development;0;0;GO:0010942
GO:1902874;positive regulation of horizontal cell localization;0;0;GO:0048608
GO:1900216;positive regulation of apoptotic process involved in metanephric collecting duct development;0;0;GO:0010941
GO:1900215;negative regulation of apoptotic process involved in metanephric collecting duct development;27;8;GO:0043066
GO:1900218;negative regulation of apoptotic process involved in metanephric nephron tubule development;29;8;GO:0043066
GO:1902877;positive regulation of embryonic pattern specification;0;2;GO:0048704
GO:1900217;regulation of apoptotic process involved in metanephric nephron tubule development;29;5;GO:0043066
GO:0046383;dTDP-rhamnose metabolic process;89329;3;GO:0006032
GO:1900209;negative regulation of cardiolipin metabolic process;0;0;GO:0046395
GO:0046384;2-deoxyribose 1-phosphate metabolic process;0;2;GO:0006066
GO:1900208;regulation of cardiolipin metabolic process;117;8;GO:0045927
GO:0046381;CMP-N-acetylneuraminate metabolic process;66;6;GO:0006022
GO:0046382;GDP-D-rhamnose metabolic process;2;3;GO:0006073
GO:0046387;deoxyribose 1,5-bisphosphate metabolic process;0;2;GO:0006096
GO:0071332;cellular response to fructose stimulus;127;10;GO:0009719
GO:0071333;cellular response to glucose stimulus;6554;1390;GO:0045727
GO:0046385;deoxyribose phosphate biosynthetic process;372156;447;GO:0006073
GO:0071330;cellular response to trehalose-6-phosphate stimulus;0;2;GO:0009719
GO:0046386;deoxyribose phosphate catabolic process;73576;9;GO:0006073
GO:0071331;cellular response to hexose stimulus;6699;30;GO:0009725
GO:0071336;regulation of hair follicle cell proliferation;69;5;GO:0042127
GO:0071337;negative regulation of hair follicle cell proliferation;0;2;GO:0048608
GO:0071334;cellular response to rhamnose stimulus;0;1;GO:0046395
GO:0071335;hair follicle cell proliferation;128;9;GO:0042127
GO:0046380;N-acetylneuraminate biosynthetic process;84;10;GO:0006022
GO:0071338;positive regulation of hair follicle cell proliferation;67;10;GO:0045944
GO:0071339;MLL1 complex;5436;1030;GO:0042981
GO:1902882;regulation of response to oxidative stress;7342;144;GO:0046686
GO:1902883;negative regulation of response to oxidative stress;341;80;GO:0042542
GO:1900221;regulation of amyloid-beta clearance;752;130;GO:0048216
GO:1900220;semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;92;45;GO:0048608
GO:1900223;positive regulation of amyloid-beta clearance;262;22;GO:0048216
GO:1900222;negative regulation of amyloid-beta clearance;361;19;GO:0048216
GO:0046389;deoxyribose 5-phosphate metabolic process;0;2;GO:0006066
GO:1900225;regulation of NLRP3 inflammasome complex assembly;1759;34;GO:1903047
GO:1902884;positive regulation of response to oxidative stress;1125;39;GO:0046686
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;1196;40;GO:1903047
GO:1900226;negative regulation of NLRP3 inflammasome complex assembly;514;86;GO:1903047
GO:1900229;negative regulation of single-species biofilm formation in or on host organism;129;96;GO:0045734
GO:1902888;protein localization to astral microtubule;58;0;GO:0005840
GO:1900228;regulation of single-species biofilm formation in or on host organism;130;5;GO:0045734
GO:1902889;protein localization to spindle microtubule;131;9;GO:0051726
GO:0046394;carboxylic acid biosynthetic process;19664630;2900;GO:0006094
GO:0046395;carboxylic acid catabolic process;2050482;2590;GO:0006541
GO:1900219;positive regulation of apoptotic process involved in metanephric nephron tubule development;0;0;GO:0010941
GO:0046392;galactarate catabolic process;10610;9;GO:0006073
GO:0046398;UDP-glucuronate metabolic process;44628;141;GO:0006096
GO:0071321;cellular response to cGMP;294;37;GO:0009719
GO:0046399;glucuronate biosynthetic process;0;2;GO:0006073
GO:0071322;cellular response to carbohydrate stimulus;8166;187;GO:0009719
GO:0046396;D-galacturonate metabolic process;121;5;GO:0006073
GO:0046397;galacturonate catabolic process;86;1;GO:0006073
GO:0071320;cellular response to cAMP;2111;1040;GO:0009719
GO:0071325;cellular response to mannitol stimulus;1;2;GO:0009628
GO:0071326;cellular response to monosaccharide stimulus;6719;222;GO:0009719
GO:0071323;cellular response to chitin;49;5;GO:0045087
GO:0071324;cellular response to disaccharide stimulus;375;5;GO:0009719
GO:0046390;ribose phosphate biosynthetic process;6684331;946;GO:0006073
GO:0071329;cellular response to sucrose stimulus;344;39;GO:0009719
GO:0046391;5-phosphoribose 1-diphosphate metabolic process;62808;153;GO:0006064
GO:0071327;cellular response to trehalose stimulus;31;3;GO:0009628
GO:0071328;cellular response to maltose stimulus;0;1;GO:0046395
GO:1902890;regulation of root hair elongation;17;1;GO:0048316
GO:1900230;positive regulation of single-species biofilm formation in or on host organism;0;0;GO:0045734
GO:1902893;regulation of miRNA transcription;4060;34;GO:0045944
GO:1902894;negative regulation of miRNA transcription;1171;10;GO:0045944
GO:1900232;negative regulation of single-species biofilm formation on inanimate substrate;14;3;GO:0046284
GO:1902891;negative regulation of root hair elongation;0;4;GO:0046658
GO:1900231;regulation of single-species biofilm formation on inanimate substrate;97;3;GO:0045734
GO:1902892;positive regulation of root hair elongation;3;2;GO:0048706
GO:1900234;regulation of Kit signaling pathway;90;0;GO:0042127
GO:1902897;regulation of postsynaptic density protein 95 clustering;94;28;GO:0048608
GO:1900233;positive regulation of single-species biofilm formation on inanimate substrate;30;2;GO:0045734
GO:1902898;fatty acid methyl ester metabolic process;0;1;GO:0006631
GO:1900236;positive regulation of Kit signaling pathway;0;0;GO:0048193
GO:1902895;positive regulation of miRNA transcription;2877;159;GO:0045944
GO:1900235;negative regulation of Kit signaling pathway;90;2;GO:0048193
GO:1902896;terminal web assembly;158;165;GO:0043005
GO:1900238;regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway;109;4;GO:0048706
GO:1900237;positive regulation of induction of conjugation with cellular fusion;121;7;GO:0048285
GO:1902899;fatty acid methyl ester biosynthetic process;0;1;GO:0006633
GO:1900239;regulation of phenotypic switching;144;40;GO:0010468
GO:0071350;cellular response to interleukin-15;2347;810;GO:0071346
GO:0071351;cellular response to interleukin-18;847;23;GO:0071346
GO:0071354;cellular response to interleukin-6;1893;937;GO:0071346
GO:0071355;cellular response to interleukin-9;425;9;GO:0071346
GO:0071352;cellular response to interleukin-2;1910;44;GO:0006955
GO:0071353;cellular response to interleukin-4;1638;855;GO:0071346
GO:0071358;cellular response to type III interferon;178;2;GO:0032496
GO:0071359;cellular response to dsRNA;1038;115;GO:0032496
GO:0071356;cellular response to tumor necrosis factor;18090;3350;GO:0006954
GO:0071357;cellular response to type I interferon;153772;2220;GO:0032496
GO:1900241;positive regulation of phenotypic switching;20;58;GO:0010468
GO:1900240;negative regulation of phenotypic switching;51;2;GO:0010468
GO:1900243;negative regulation of synaptic vesicle endocytosis;2;2;GO:0048608
GO:1900242;regulation of synaptic vesicle endocytosis;967;194;GO:0048608
GO:1900245;positive regulation of MDA-5 signaling pathway;174;129;GO:0046649
GO:1900244;positive regulation of synaptic vesicle endocytosis;196;168;GO:0048608
GO:1900247;regulation of cytoplasmic translational elongation;94;27;GO:0006414
GO:1900246;positive regulation of RIG-I signaling pathway;477;101;GO:0043408
GO:1900249;positive regulation of cytoplasmic translational elongation;2;0;GO:0045944
GO:1900248;negative regulation of cytoplasmic translational elongation;13;167;GO:0045944
GO:0071340;skeletal muscle acetylcholine-gated channel clustering;516;145;GO:0008092
GO:0071344;diphosphate metabolic process;163;9;GO:0006796
GO:0071341;medial cortical node;185;9;GO:0043005
GO:0071347;cellular response to interleukin-1;6067;2200;GO:0032496
GO:0071348;cellular response to interleukin-11;47;201;GO:0071346
GO:0071345;cellular response to cytokine stimulus;332635;3210;GO:0071346
GO:0071346;cellular response to type II interferon;5618;193;GO:0032496
GO:0071349;cellular response to interleukin-12;520;75;GO:0071346
GO:1900292;negative regulation of galactotriose transport;0;0;GO:0006874
GO:1900291;regulation of galactotriose transport;0;0;GO:0006869
GO:1900294;regulation of heptasaccharide transport;0;0;GO:0005929
GO:1900293;positive regulation of galactotriose transport;0;0;GO:0006836
GO:1900296;positive regulation of heptasaccharide transport;0;0;GO:0008544
GO:1900295;negative regulation of heptasaccharide transport;0;0;GO:0008544
GO:1900298;negative regulation of hexasaccharide transport;0;0;GO:0008029
GO:1900297;regulation of hexasaccharide transport;0;0;GO:0005985
GO:1900299;positive regulation of hexasaccharide transport;0;0;GO:0008544
GO:1900290;positive regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process;0;1;GO:0046395
GO:0009401;phosphoenolpyruvate-dependent sugar phosphotransferase system;516093;1250;GO:0005975
GO:0009404;toxin metabolic process;76864;1220;GO:0006032
GO:0009403;toxin biosynthetic process;57066;112;GO:0006032
GO:0048919;posterior lateral line neuromast development;1157;5;GO:0048405
GO:0048918;posterior lateral line nerve development;246;2;GO:0048704
GO:0048917;posterior lateral line ganglion development;43;0;GO:0048704
GO:0048916;posterior lateral line development;2080;4;GO:0008544
GO:0009310;amine catabolic process;48976;1630;GO:0006541
GO:0000979;RNA polymerase II core promoter sequence-specific DNA binding;1134;1380;GO:0003700
GO:0000978;RNA polymerase II cis-regulatory region sequence-specific DNA binding;111560;5510;GO:0003700
GO:0000977;RNA polymerase II transcription regulatory region sequence-specific DNA binding;177484;3360;GO:0003700
GO:0009314;response to radiation;210978;4880;GO:0009628
GO:0048911;efferent axon development in anterior lateral line nerve;0;0;GO:0048704
GO:0000976;transcription cis-regulatory region binding;269689;1890;GO:0030528
GO:0009313;oligosaccharide catabolic process;46315;728;GO:0005975
GO:0048910;afferent axon development in anterior lateral line nerve;0;1;GO:0048704
GO:0009312;oligosaccharide biosynthetic process;181253;1000;GO:0005976
GO:0000974;Prp19 complex;15174;368;GO:0005737
GO:0009311;oligosaccharide metabolic process;407928;1330;GO:0005975
GO:0000973;post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery;435;9;GO:0048285
GO:0009318;exodeoxyribonuclease VII complex;82794;395;GO:0005576
GO:0048915;posterior lateral line system development;2371;2;GO:0048405
GO:0000972;transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery;868;337;GO:0045944
GO:0009317;acetyl-CoA carboxylase complex;125044;718;GO:0006099
GO:0048914;myelination of anterior lateral line nerve axons;36;1;GO:0048704
GO:0000971;tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate;67;3;GO:0006412
GO:0009316;3-isopropylmalate dehydratase complex;34075;321;GO:0006099
GO:0048913;anterior lateral line nerve glial cell differentiation;36;1;GO:0048704
GO:0000970;tRNA exon ligation utilizing GTP as source of linkage phosphate;0;2;GO:0009081
GO:0048912;glial cell migration in anterior lateral line nerve;0;0;GO:0048666
GO:0009309;amine biosynthetic process;1600014;1460;GO:0006520
GO:0009308;amine metabolic process;2332509;3590;GO:0006541
GO:0048929;efferent axon development in posterior lateral line nerve;35;0;GO:0048704
GO:0048928;posterior lateral line ganglion neuron differentiation;0;1;GO:0048704
GO:0048927;posterior lateral line neuromast support cell differentiation;0;1;GO:0048608
GO:0009321;alkyl hydroperoxide reductase complex;4;1;GO:0008023
GO:0009320;phosphoribosylaminoimidazole carboxylase complex;0;10;GO:0005524
GO:0009325;nitrate reductase complex;29092;195;GO:0009536
GO:0048922;posterior lateral line neuromast deposition;311;2;GO:0048407
GO:0000987;cis-regulatory region sequence-specific DNA binding;129801;385;GO:0003700
GO:0009324;D-amino-acid dehydrogenase complex;0;1;GO:0005737
GO:0048921;posterior lateral line neuromast cupula development;0;1;GO:0048405
GO:0048920;posterior lateral line neuromast primordium migration;519;3;GO:0048405
GO:0009322;trimethylamine-N-oxide reductase complex;0;3;GO:0009086
GO:0009329;acetate CoA-transferase complex;2;7;GO:0005737
GO:0048926;electrosensory lateral line system development;0;1;GO:0048407
GO:0009328;phenylalanine-tRNA ligase complex;511;915;GO:0005737
GO:0048925;lateral line system development;4084;3;GO:0008544
GO:0048924;posterior lateral line neuromast mantle cell differentiation;35;3;GO:0048405
GO:0000981;DNA-binding transcription factor activity, RNA polymerase II-specific;588893;5300;GO:0003700
GO:0009326;formate dehydrogenase complex;8508;427;GO:0009065
GO:0048923;posterior lateral line neuromast hair cell differentiation;538;6;GO:0048405
GO:0009319;cytochrome o ubiquinol oxidase complex;36;6;GO:0005739
GO:0010307;acetylglutamate kinase regulator activity;35;2;GO:0010468
GO:0010306;rhamnogalacturonan II biosynthetic process;69;5;GO:0005976
GO:0010309;acireductone dioxygenase [iron(II)-requiring] activity;32056;0;GO:0004497
GO:0010308;acireductone dioxygenase (Ni2+-requiring) activity;23284;0;GO:0004497
GO:0010303;limit dextrinase activity;71;5;GO:0004553
GO:0010305;leaf vascular tissue pattern formation;702;234;GO:0048468
GO:0010304;PSII associated light-harvesting complex II catabolic process;216;27;GO:0015979
GO:0010301;xanthoxin dehydrogenase activity;134;10;GO:0004721
GO:0048939;anterior lateral line nerve glial cell development;36;0;GO:0048704
GO:0048938;lateral line nerve glial cell morphogenesis involved in differentiation;133;3;GO:0048704
GO:0000959;mitochondrial RNA metabolic process;12471;691;GO:0006364
GO:0000958;mitochondrial mRNA catabolic process;401;10;GO:0006613
GO:0000957;mitochondrial RNA catabolic process;1021;182;GO:0006631
GO:0000956;nuclear-transcribed mRNA catabolic process;151666;2760;GO:0006396
GO:0000955;amino acid catabolic process via Ehrlich pathway;389;5;GO:0009062
GO:0048933;afferent axon development in posterior lateral line nerve;35;0;GO:0048704
GO:0061911;amphisome-lysosome fusion;5;1;GO:0006979
GO:0000954;methionine catabolic process to 3-methylthiopropanoate;0;4;GO:0009062
GO:0048932;myelination of posterior lateral line nerve axons;97;5;GO:0048704
GO:0061912;selective autophagy;11106;76;GO:0006914
GO:0000953;branched-chain amino acid catabolic process to carboxylic acid via Ehrlich pathway;0;2;GO:0009062
GO:0048931;posterior lateral line nerve glial cell differentiation;97;1;GO:0048704
GO:0061913;positive regulation of growth plate cartilage chondrocyte proliferation;0;2;GO:0048608
GO:0000952;aromatic amino acid family catabolic process to carboxylic acid via Ehrlich pathway;0;2;GO:0009065
GO:0048930;glial cell migration in posterior lateral line nerve;0;0;GO:0048666
GO:0061914;negative regulation of growth plate cartilage chondrocyte proliferation;2;2;GO:0048608
GO:0000951;methionine catabolic process to 3-methylthiopropanol;4;4;GO:0009062
GO:0048937;lateral line nerve glial cell development;177;7;GO:0048704
GO:0000950;branched-chain amino acid catabolic process to alcohol via Ehrlich pathway;4;2;GO:0009065
GO:0048936;peripheral nervous system neuron axonogenesis;313;33;GO:0048666
GO:0048935;peripheral nervous system neuron development;913;914;GO:0048699
GO:0048934;peripheral nervous system neuron differentiation;951;122;GO:0048666
GO:0061910;autophagosome-endosome fusion;63;3;GO:0006914
GO:0061919;process utilizing autophagic mechanism;307164;402;GO:0006914
GO:0048940;anterior lateral line nerve glial cell morphogenesis involved in differentiation;36;1;GO:0048704
GO:0061916;leading edge of axonal growth cone;0;0;GO:0048666
GO:0061917;leading edge of dendritic growth cone;4;1;GO:0048608
GO:0000969;tRNA exon ligation utilizing ATP as source of linkage phosphate;0;3;GO:0009081
GO:0000968;tRNA exon ligation;67;6;GO:0006415
GO:0000967;rRNA 5'-end processing;42093;7;GO:0006364
GO:0000966;RNA 5'-end processing;139214;8;GO:0006364
GO:0009303;rRNA transcription;5008;1730;GO:0006364
GO:0061900;glial cell activation;2618;121;GO:0050877
GO:0000965;mitochondrial RNA 3'-end processing;688;7;GO:0008033
GO:0009302;sno(s)RNA transcription;87;0;GO:0006396
GO:0000964;mitochondrial RNA 5'-end processing;386;6;GO:0008033
GO:0009301;snRNA transcription;2459;342;GO:0006397
GO:0048942;posterior lateral line nerve glial cell morphogenesis involved in differentiation;97;2;GO:0048704
GO:0000963;mitochondrial RNA processing;3031;355;GO:0006364
GO:0009300;antisense RNA transcription;71;2;GO:0006418
GO:0048941;posterior lateral line nerve glial cell development;97;2;GO:0048704
GO:0000962;positive regulation of mitochondrial RNA catabolic process;185;10;GO:0010467
GO:0009307;DNA restriction-modification system;274550;631;GO:0045727
GO:0000961;negative regulation of mitochondrial RNA catabolic process;74;70;GO:0010467
GO:0009306;protein secretion;715709;3740;GO:0006986
GO:0000960;regulation of mitochondrial RNA catabolic process;259;23;GO:0010467
GO:0009304;tRNA transcription;1245;157;GO:0006364
GO:0061908;phagophore;220;7;GO:0048308
GO:0061909;autophagosome-lysosome fusion;724;8;GO:0006914
GO:0061906;autophagosome localization;0;0;GO:0006914
GO:0061907;negative regulation of AMPA receptor activity;1;3;GO:0048167
GO:0009350;ethanolamine ammonia-lyase complex;15093;4;GO:0005576
GO:0010341;gibberellin carboxyl-O-methyltransferase activity;7;0;GO:0004714
GO:0010340;carboxyl-O-methyltransferase activity;194635;31;GO:0004028
GO:0034310;primary alcohol catabolic process;32675;524;GO:0006066
GO:0009353;mitochondrial oxoglutarate dehydrogenase complex;2455;87;GO:0005739
GO:0009358;polyphosphate kinase complex;38681;63;GO:0005524
GO:0009357;protein-N(PI)-phosphohistidine-sugar phosphotransferase complex;0;0;GO:0005524
GO:0009356;aminodeoxychorismate synthase complex;4;0;GO:0009536
GO:0009355;DNA polymerase V complex;6;2;GO:0005730
GO:0009359;type II site-specific deoxyribonuclease complex;0;3;GO:0005576
GO:0034309;primary alcohol biosynthetic process;693090;10;GO:0006022
GO:0034308;primary alcohol metabolic process;791117;572;GO:0006066
GO:0010339;external side of cell wall;17;5;GO:0009505
GO:0010336;gibberellic acid homeostasis;159;29;GO:0009734
GO:0034303;myxospore formation;0;2;GO:0048285
GO:0010335;response to non-ionic osmotic stress;58;4;GO:0006970
GO:0034302;akinete formation;0;3;GO:0007049
GO:0010338;leaf formation;109;218;GO:0048316
GO:0034301;endospore formation;2;2;GO:0048304
GO:0010337;regulation of salicylic acid metabolic process;599;236;GO:0046274
GO:0034300;sporangiospore formation;0;2;GO:0048304
GO:0010332;response to gamma radiation;3802;2480;GO:0009611
GO:0034307;regulation of ascospore formation;99;4;GO:0048285
GO:0010331;gibberellin binding;139;7;GO:0005524
GO:0034306;regulation of sexual sporulation;127;2;GO:0048304
GO:0010334;sesquiterpene synthase activity;1818;132;GO:0004497
GO:0034305;regulation of asexual sporulation;85;2;GO:0048304
GO:0010333;terpene synthase activity;22261;1130;GO:0004497
GO:0034304;actinomycete-type spore formation;0;2;GO:0048285
GO:0009361;succinate-CoA ligase complex (ADP-forming);225;10;GO:0005740
GO:0010350;cellular response to magnesium starvation;8;7;GO:0009416
GO:0009360;DNA polymerase III complex;148191;1570;GO:0005730
GO:0010352;lithium ion export across the plasma membrane;5;0;GO:0006810
GO:0010351;lithium ion transport;67;29;GO:0006811
GO:0009365;protein histidine kinase complex;9;5;GO:0000976
GO:0009368;endopeptidase Clp complex;1021;773;GO:0005840
GO:0009366;enterobactin synthetase complex;9212;7;GO:0005576
GO:0010347;L-galactose-1-phosphate phosphatase activity;40;2;GO:0004734
GO:0010346;shoot axis formation;998;4;GO:0048706
GO:0010349;L-galactose dehydrogenase activity;1980;5;GO:0006066
GO:0010348;lithium:proton antiporter activity;58;5;GO:0005215
GO:0010343;singlet oxygen-mediated programmed cell death;1344;34;GO:0097190
GO:0010342;endosperm cellularization;65;3;GO:0009952
GO:0010345;suberin biosynthetic process;477;169;GO:0009579
GO:0010344;seed oilbody biogenesis;205;104;GO:0009579
GO:0009332;glutamate-tRNA ligase complex;0;296;GO:0005737
GO:0009331;glycerol-3-phosphate dehydrogenase complex;132136;1550;GO:0009536
GO:0009330;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex;1422;857;GO:0003676
GO:0009336;sulfate adenylyltransferase complex (ATP);5;5;GO:0005525
GO:0009334;3-phenylpropionate dioxygenase complex;4;2;GO:0009536
GO:0009333;cysteine synthase complex;5;4;GO:0006457
GO:0000995;RNA polymerase III general transcription initiation factor activity;973;203;GO:0003700
GO:0000994;RNA polymerase III core binding;125;16;GO:0000976
GO:0009339;glycolate oxidase complex;3010;5;GO:0009536
GO:0000993;RNA polymerase II complex binding;13772;304;GO:0000976
GO:0009338;exodeoxyribonuclease V complex;20487;34;GO:0005737
GO:0000992;RNA polymerase III cis-regulatory region sequence-specific DNA binding;1281;1;GO:0003700
GO:0009337;sulfite reductase complex (NADPH);5869;159;GO:0008021
GO:0010318;pyrophosphate-dependent phosphofructokinase complex, beta-subunit complex;0;3;GO:0005524
GO:0010317;pyrophosphate-dependent phosphofructokinase complex, alpha-subunit complex;0;3;GO:0005524
GO:0010319;stromule;544;425;GO:0005976
GO:0010314;phosphatidylinositol-5-phosphate binding;1155;455;GO:0005524
GO:0010313;phytochrome binding;16;9;GO:0003677
GO:0010316;pyrophosphate-dependent phosphofructokinase complex;0;3;GO:0005975
GO:0010315;auxin export across the plasma membrane;1331;1;GO:0009834
GO:0010310;regulation of hydrogen peroxide metabolic process;617;588;GO:0046395
GO:0010312;detoxification of zinc ion;277;68;GO:0006836
GO:0010311;lateral root formation;675;315;GO:0048316
GO:0048908;anterior lateral line ganglion neuron differentiation;0;1;GO:0048704
GO:0048907;anterior lateral line ganglion development;0;0;GO:0048704
GO:0010330;cellulose synthase complex;1323;9;GO:0009536
GO:0048906;anterior lateral line neuromast support cell differentiation;0;1;GO:0048407
GO:0048905;anterior lateral line neuromast mantle cell differentiation;0;1;GO:0048405
GO:0009342;glutamate synthase complex (NADPH);2;5;GO:0009536
GO:0009341;beta-galactosidase complex;45237;391;GO:0005840
GO:0009340;DNA topoisomerase IV complex;2;7;GO:0005819
GO:0048909;anterior lateral line nerve development;72;4;GO:0048704
GO:0009347;aspartate carbamoyltransferase complex;8467;8;GO:0005737
GO:0048900;anterior lateral line neuromast primordium migration;0;1;GO:0048405
GO:0009346;ATP-independent citrate lyase complex;11681;131;GO:0005737
GO:0009345;glycine-tRNA ligase complex;5;217;GO:0005737
GO:0009344;nitrite reductase complex [NAD(P)H];33;4;GO:0008061
GO:0048904;anterior lateral line neuromast cupula development;0;1;GO:0048405
GO:0048903;anterior lateral line neuromast hair cell differentiation;114;2;GO:0048407
GO:0009349;riboflavin synthase complex;46885;740;GO:0005737
GO:0048902;anterior lateral line neuromast deposition;0;1;GO:0008544
GO:0048901;anterior lateral line neuromast development;154;0;GO:0048405
GO:0010329;auxin efflux transmembrane transporter activity;598;92;GO:0005525
GO:0010328;auxin influx transmembrane transporter activity;90;9;GO:0008544
GO:0010325;raffinose family oligosaccharide biosynthetic process;107;8;GO:0005976
GO:0010324;membrane invagination;3826;1480;GO:0006936
GO:0010327;acetyl CoA:(Z)-3-hexen-1-ol acetyltransferase activity;4;0;GO:0004089
GO:0010326;methionine-oxo-acid transaminase activity;66;1;GO:0004497
GO:0010321;regulation of vegetative phase change;53;31;GO:0048285
GO:0010323;negative regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway;18;3;GO:0046394
GO:0010322;regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway;32;5;GO:0006749
GO:0009394;2'-deoxyribonucleotide metabolic process;433539;7;GO:0006520
GO:0010383;cell wall polysaccharide metabolic process;103963;258;GO:0005976
GO:0034350;regulation of glial cell apoptotic process;479;38;GO:0010941
GO:0061970;maintenance of right sidedness;0;0;GO:0048706
GO:0009392;N-acetyl-anhydromuramoyl-L-alanine amidase activity;2;2;GO:0004553
GO:0010385;double-stranded methylated DNA binding;1026;198;GO:0003676
GO:0061971;replacement bone morphogenesis;0;0;GO:0048608
GO:0010384;cell wall proteoglycan metabolic process;233;5;GO:0005976
GO:0061972;dermal bone morphogenesis;36;0;GO:0048704
GO:0009398;FMN biosynthetic process;83179;367;GO:0009061
GO:0034354;'de novo' NAD biosynthetic process from tryptophan;25330;80;GO:0009065
GO:0009397;folic acid-containing compound catabolic process;127;7;GO:0046395
GO:0034353;mRNA 5'-diphosphatase activity;1556;3;GO:0006032
GO:0009396;folic acid-containing compound biosynthetic process;975673;3680;GO:0009405
GO:0010381;peroxisome-chloroplast membrane tethering;41;0;GO:0009986
GO:0034352;positive regulation of glial cell apoptotic process;27;7;GO:0010941
GO:0009395;phospholipid catabolic process;39535;944;GO:0006631
GO:0010380;regulation of chlorophyll biosynthetic process;197;54;GO:0010468
GO:0034351;negative regulation of glial cell apoptotic process;450;846;GO:0043066
GO:0046336;ethanolamine catabolic process;31928;7;GO:0009065
GO:0061977;hip joint articular cartilage development;0;0;GO:0007517
GO:1902831;positive regulation of spinal cord association neuron differentiation;0;1;GO:0048704
GO:0046337;phosphatidylethanolamine metabolic process;48255;397;GO:0006631
GO:0061978;mandibular condyle articular cartilage development;3;1;GO:0007599
GO:1902832;negative regulation of cell proliferation in dorsal spinal cord;1;0;GO:0042127
GO:0046334;octopamine catabolic process;1;6;GO:0006569
GO:0061979;femoral head articular cartilage development;0;0;GO:0007599
GO:0009399;nitrogen fixation;112140;572;GO:0046395
GO:0046335;ethanolamine biosynthetic process;5;4;GO:0006561
GO:1902830;negative regulation of spinal cord association neuron differentiation;0;1;GO:0048704
GO:0061973;membrane bone morphogenesis;87;0;GO:0043588
GO:1902835;negative regulation of proline import across plasma membrane;0;2;GO:0046395
GO:0061974;perichondral bone morphogenesis;51;3;GO:0048609
GO:1902836;positive regulation of proline import across plasma membrane;116;1;GO:0046395
GO:0046338;phosphatidylethanolamine catabolic process;135;28;GO:0006631
GO:0061975;articular cartilage development;262;10;GO:0007599
GO:1902833;positive regulation of cell proliferation in dorsal spinal cord;0;0;GO:0045727
GO:0046339;diacylglycerol metabolic process;1719;644;GO:0006633
GO:0061976;temporomandibular joint articular cartilage development;3;0;GO:0007518
GO:1902834;regulation of proline import across plasma membrane;116;0;GO:0009913
GO:0046340;diacylglycerol catabolic process;200;217;GO:0006631
GO:1902829;regulation of spinal cord association neuron differentiation;2;1;GO:0048704
GO:0046343;streptomycin metabolic process;33;2;GO:0009060
GO:0046344;ecdysteroid catabolic process;12;6;GO:0046274
GO:0046341;CDP-diacylglycerol metabolic process;65289;109;GO:0006633
GO:0046342;CDP-diacylglycerol catabolic process;3328;4;GO:0006631
GO:0034347;type III interferon binding;0;0;GO:0035020
GO:0010379;phaseic acid biosynthetic process;0;2;GO:0006021
GO:0034346;positive regulation of type III interferon production;61;8;GO:0046649
GO:0034345;negative regulation of type III interferon production;21;5;GO:0046649
GO:0034344;regulation of type III interferon production;84;163;GO:0046649
GO:0009390;dimethyl sulfoxide reductase complex;17;2;GO:0005737
GO:0010376;stomatal complex formation;22;8;GO:0009913
GO:0010375;stomatal complex patterning;129;9;GO:0048309
GO:0010378;temperature compensation of the circadian clock;113;81;GO:0008544
GO:0034349;glial cell apoptotic process;787;250;GO:0010941
GO:0010377;guard cell fate commitment;18;7;GO:0009913
GO:0034348;type III interferon receptor activity;4;1;GO:0002768
GO:0010394;homogalacturonan metabolic process;57;2;GO:0005976
GO:0010393;galacturonan metabolic process;90517;110;GO:0005976
GO:0010396;rhamnogalacturonan II metabolic process;69;2;GO:0005976
GO:0061960;regulation of heme oxygenase activity;0;2;GO:0046289
GO:0010395;rhamnogalacturonan I metabolic process;73;3;GO:0005976
GO:0061961;positive regulation of heme oxygenase activity;0;2;GO:0010401
GO:0010390;histone monoubiquitination;2;425;GO:0043687
GO:0034343;type III interferon production;145;136;GO:0046649
GO:0034342;response to type III interferon;237;10;GO:0032496
GO:0010392;galactoglucomannan metabolic process;4;3;GO:0006073
GO:0034341;response to type II interferon;7164;288;GO:0046649
GO:0010391;glucomannan metabolic process;5;2;GO:0006073
GO:0034340;response to type I interferon;154233;3150;GO:0032496
GO:0046347;mannosamine biosynthetic process;0;2;GO:0006032
GO:0061966;establishment of left/right asymmetry;474;9;GO:0002040
GO:1902842;negative regulation of netrin-activated signaling pathway;4;2;GO:0048608
GO:0046348;amino sugar catabolic process;85545;591;GO:0006032
GO:0061967;establishment of left sidedness;0;0;GO:0048704
GO:1902843;positive regulation of netrin-activated signaling pathway;1;0;GO:0048608
GO:0046345;abscisic acid catabolic process;67;27;GO:0009628
GO:0061968;maintenance of left/right asymmetry;0;1;GO:0048704
GO:1902840;positive regulation of nuclear migration along microtubule;4;0;GO:0048285
GO:0046346;mannosamine catabolic process;13;3;GO:0006032
GO:0061969;maintenance of left sidedness;0;0;GO:0048704
GO:1902841;regulation of netrin-activated signaling pathway;5;2;GO:0048608
GO:0061962;negative regulation of heme oxygenase activity;0;1;GO:0010401
GO:1902846;positive regulation of mitotic spindle elongation;111;20;GO:0048285
GO:0061963;regulation of entry into reproductive diapause;59;0;GO:0048405
GO:1902847;regulation of neuronal signal transduction;71;284;GO:0007268
GO:0046349;amino sugar biosynthetic process;145103;91;GO:0005976
GO:0061964;negative regulation of entry into reproductive diapause;46;1;GO:0048405
GO:1902844;positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway;2;4;GO:0048704
GO:0061965;positive regulation of entry into reproductive diapause;13;0;GO:0048405
GO:1902845;negative regulation of mitotic spindle elongation;16;1;GO:0048285
GO:0046350;galactosaminoglycan metabolic process;0;4;GO:0006030
GO:1902839;negative regulation of nuclear migration along microtubule;0;1;GO:0048285
GO:0046351;disaccharide biosynthetic process;99419;74;GO:0005976
GO:1902838;regulation of nuclear migration along microtubule;16;1;GO:0048285
GO:0046354;mannan biosynthetic process;321;5;GO:0006021
GO:0046355;mannan catabolic process;2214;10;GO:0006032
GO:0046352;disaccharide catabolic process;29731;33;GO:0005975
GO:0046353;aminoglycoside 3-N-acetyltransferase activity;12777;7;GO:0006029
GO:0034336;misfolded RNA binding;39;6;GO:0003723
GO:0034335;DNA negative supercoiling activity;59598;5;GO:0003676
GO:0034334;adherens junction maintenance;562;57;GO:0030199
GO:0034333;adherens junction assembly;853;1320;GO:0030054
GO:0010387;COP9 signalosome assembly;4545;63;GO:0008031
GO:0010389;regulation of G2/M transition of mitotic cell cycle;15693;1420;GO:0000086
GO:0034338;short-chain carboxylesterase activity;21596;139;GO:0004730
GO:0034337;RNA folding;243;87;GO:0003674
GO:0009372;quorum sensing;64056;244;GO:0009528
GO:0010361;regulation of anion channel activity by blue light;2;3;GO:0048405
GO:0010360;negative regulation of anion channel activity;8;29;GO:0048407
GO:0010363;regulation of plant-type hypersensitive response;248;358;GO:0009626
GO:0061993;calcium:proton antiporter complex;2;1;GO:0008047
GO:0010362;negative regulation of anion channel activity by blue light;2;8;GO:0048405
GO:0009376;HslUV protease complex;82784;18;GO:0005737
GO:0034332;adherens junction organization;2875;2140;GO:0030054
GO:0009375;ferredoxin hydrogenase complex;12036;6;GO:0009536
GO:0034331;cell junction maintenance;3207;174;GO:0007067
GO:1902850;microtubule cytoskeleton organization involved in mitosis;31097;629;GO:0007018
GO:0009374;biotin binding;3193;363;GO:0097194
GO:0034330;cell junction organization;71357;1450;GO:0030054
GO:0061990;beta-ketodecanoyl-[acyl-carrier-protein] synthase activity;5;0;GO:0004497
GO:0046358;butyrate biosynthetic process;558;6;GO:0006066
GO:0061999;regulation of cardiac endothelial to mesenchymal transition;49;1;GO:0010717
GO:1902853;negative regulation of nuclear migration during mitotic telophase;0;0;GO:0048285
GO:0009379;Holliday junction helicase complex;42018;10;GO:0005524
GO:0046359;butyrate catabolic process;44;6;GO:0006066
GO:1902854;positive regulation of nuclear migration during mitotic telophase;4;0;GO:0048285
GO:0009378;four-way junction helicase activity;101933;898;GO:0003690
GO:0046356;acetyl-CoA catabolic process;1992;329;GO:0006066
GO:0046357;galactarate biosynthetic process;0;2;GO:0006073
GO:1902852;regulation of nuclear migration during mitotic telophase;4;0;GO:0007067
GO:0061995;ATP-dependent protein-DNA complex displacement activity;37;2;GO:0003682
GO:1902857;positive regulation of non-motile cilium assembly;370;86;GO:0048193
GO:1902858;propionyl-CoA metabolic process;229;1;GO:0006066
GO:1902855;regulation of non-motile cilium assembly;508;7;GO:0048193
GO:1902856;negative regulation of non-motile cilium assembly;64;5;GO:0048193
GO:0046361;2-oxobutyrate metabolic process;78;1;GO:0006066
GO:0046362;ribitol biosynthetic process;0;2;GO:0006032
GO:1902848;negative regulation of neuronal signal transduction;6;0;GO:0050890
GO:0046360;2-oxobutyrate biosynthetic process;73;3;GO:0006099
GO:1902849;positive regulation of neuronal signal transduction;0;0;GO:0050890
GO:0046365;monosaccharide catabolic process;292985;1160;GO:0006032
GO:0071310;cellular response to organic substance;785958;3960;GO:0050727
GO:0046366;allose biosynthetic process;0;2;GO:0006032
GO:0071311;cellular response to acetate;29;33;GO:0045734
GO:0046363;ribitol catabolic process;0;2;GO:0006032
GO:0046364;monosaccharide biosynthetic process;769710;1180;GO:0005975
GO:0010358;leaf shaping;88;38;GO:0048316
GO:0034325;O-decanoyltransferase activity;0;0;GO:0004722
GO:0071314;cellular response to cocaine;355;28;GO:0071456
GO:0010357;homogentisate solanesyltransferase activity;16;2;GO:0004073
GO:0034324;O-hexanoyltransferase activity;0;1;GO:0004734
GO:0071315;cellular response to morphine;278;52;GO:0042493
GO:0034323;O-butanoyltransferase activity;3;1;GO:0006081
GO:0071312;cellular response to alkaloid;1736;471;GO:0048608
GO:0010359;regulation of anion channel activity;21;151;GO:0005216
GO:0034322;alcohol O-decanoyltransferase activity;0;1;GO:0006081
GO:0071313;cellular response to caffeine;370;183;GO:0071456
GO:0010354;homogentisate prenyltransferase activity;57;3;GO:0004067
GO:0034329;cell junction assembly;39250;2630;GO:0030054
GO:0071318;cellular response to ATP;603;856;GO:0006955
GO:0010353;response to trehalose;90;95;GO:0009628
GO:0034328;decanoyltransferase activity;0;0;GO:0004730
GO:0071319;cellular response to benzoic acid;0;3;GO:0046686
GO:0010356;homogentisate geranylgeranyltransferase activity;16;2;GO:0004073
GO:0034327;hexanoyltransferase activity;0;1;GO:0004089
GO:0071316;cellular response to nicotine;304;308;GO:0042493
GO:0010355;homogentisate farnesyltransferase activity;16;1;GO:0004067
GO:0034326;butanoyltransferase activity;3;0;GO:0006081
GO:0071317;cellular response to isoquinoline alkaloid;284;15;GO:0009615
GO:0009383;rRNA (cytosine-C5-)-methyltransferase activity;336;0;GO:0003729
GO:0010372;positive regulation of gibberellin biosynthetic process;23;8;GO:0010468
GO:0061980;regulatory RNA binding;13587;46;GO:0003723
GO:0009382;imidazoleglycerol-phosphate synthase complex;4;3;GO:0009536
GO:0010371;regulation of gibberellin biosynthetic process;67;28;GO:0010468
GO:0061981;3-hydroxykynureninase activity;9909;3;GO:0006066
GO:0009381;excinuclease ABC activity;162847;1070;GO:0005524
GO:0010374;stomatal complex development;13020;254;GO:0048316
GO:0061982;meiosis I cell cycle process;58723;218;GO:0000724
GO:0071309;cellular response to phylloquinone;0;0;GO:0009913
GO:0009380;excinuclease repair complex;154252;825;GO:0005737
GO:0010373;negative regulation of gibberellin biosynthetic process;18;299;GO:0010468
GO:0061983;meiosis II cell cycle process;3210;2;GO:0051321
GO:0034321;alcohol O-octanoyltransferase activity;1;3;GO:0006081
GO:1902860;propionyl-CoA biosynthetic process;59;7;GO:0006099
GO:0009386;translational attenuation;52;697;GO:0006414
GO:0034320;alcohol O-hexanoyltransferase activity;0;1;GO:0006081
GO:0009385;N-acylmannosamine-6-phosphate 2-epimerase activity;6867;5;GO:0006022
GO:0010370;perinucleolar chromocenter;102;21;GO:0005819
GO:0009384;N-acylmannosamine kinase activity;4187;51;GO:0005524
GO:0046369;galactose biosynthetic process;1;4;GO:0005976
GO:0061988;karyosome formation;344;3;GO:0007062
GO:1902864;negative regulation of embryonic camera-type eye development;1;0;GO:0048706
GO:0061989;sperm karyosome formation;0;1;GO:0007049
GO:1900200;mesenchymal cell apoptotic process involved in metanephros development;158;7;GO:0042127
GO:1902865;positive regulation of embryonic camera-type eye development;0;2;GO:0048608
GO:0009389;dimethyl sulfoxide reductase activity;6999;56;GO:0004091
GO:0046367;allose catabolic process;1911;2;GO:0006032
GO:0046368;GDP-L-fucose metabolic process;82746;23;GO:0006032
GO:1902863;regulation of embryonic camera-type eye development;1;0;GO:0009952
GO:0061984;catabolite repression;991;1;GO:0009432
GO:1900205;apoptotic process involved in metanephric nephron tubule development;29;5;GO:0042127
GO:1902868;positive regulation of retina development in camera-type eye;82;18;GO:0048608
GO:0061985;carbon catabolite repression;980;0;GO:0006096
GO:1900204;apoptotic process involved in metanephric collecting duct development;27;5;GO:0048608
GO:1902869;regulation of amacrine cell differentiation;371;4;GO:0048608
GO:0061986;negative regulation of transcription by glucose;210;0;GO:0045944
GO:1900207;negative regulation of pronephric nephron tubule development;1;2;GO:0048405
GO:1902866;regulation of retina development in camera-type eye;162;9;GO:0048608
GO:0061987;negative regulation of transcription from RNA polymerase II promoter by glucose;208;3;GO:0045944
GO:1900206;regulation of pronephric nephron tubule development;1;1;GO:0048608
GO:1902867;negative regulation of retina development in camera-type eye;1;3;GO:0048706
GO:0046372;D-arabinose metabolic process;15;2;GO:0006073
GO:0046373;L-arabinose metabolic process;69737;379;GO:0006066
GO:0046370;fructose biosynthetic process;142;136;GO:0006094
GO:1902859;propionyl-CoA catabolic process;73;0;GO:0009062
GO:0034319;alcohol O-butanoyltransferase activity;3;3;GO:0006081
GO:0046371;dTDP-mannose metabolic process;0;3;GO:0006032
GO:0046376;GDP-alpha-D-mannosylchitobiosyldiphosphodolichol metabolic process;0;6;GO:0006021
GO:0046377;colanic acid metabolic process;36;3;GO:0006073
GO:0071300;cellular response to retinoic acid;2726;1710;GO:0045730
GO:0046374;teichoic acid metabolic process;61161;4;GO:0006032
GO:0046375;K antigen metabolic process;0;3;GO:0006066
GO:0010369;chromocenter;1113;679;GO:0000786
GO:0034314;Arp2/3 complex-mediated actin nucleation;35743;1530;GO:0005524
GO:0071303;cellular response to vitamin B3;1;0;GO:0009719
GO:0010368;chloroplast isoamylase complex;39;3;GO:0005929
GO:0034313;diol catabolic process;6585;3;GO:0006073
GO:0071304;cellular response to vitamin B6;0;1;GO:0009719
GO:0034312;diol biosynthetic process;49468;128;GO:0006022
GO:0071301;cellular response to vitamin B1;6;33;GO:0009719
GO:0034311;diol metabolic process;59264;1030;GO:0006066
GO:0071302;cellular response to vitamin B2;0;2;GO:0009719
GO:0010365;positive regulation of ethylene biosynthetic process;15;5;GO:0010468
GO:0034318;alcohol O-acyltransferase activity;89;1;GO:0004746
GO:0071307;cellular response to vitamin K;227;82;GO:0009725
GO:0010364;regulation of ethylene biosynthetic process;217;7;GO:0010468
GO:0034317;nicotinic acid riboside kinase activity;0;0;GO:0004721
GO:0071308;cellular response to menaquinone;0;3;GO:0009719
GO:0010367;extracellular isoamylase complex;0;4;GO:0005578
GO:0034316;negative regulation of Arp2/3 complex-mediated actin nucleation;540;43;GO:0048193
GO:0071305;cellular response to vitamin D;837;1510;GO:0009725
GO:0010366;negative regulation of ethylene biosynthetic process;122;3;GO:0010468
GO:0034315;regulation of Arp2/3 complex-mediated actin nucleation;2723;285;GO:0048608
GO:0071306;cellular response to vitamin E;8;43;GO:0006979
GO:0034394;protein localization to cell surface;4796;884;GO:0005576
GO:0034393;positive regulation of smooth muscle cell apoptotic process;527;37;GO:0043066
GO:0034392;negative regulation of smooth muscle cell apoptotic process;511;405;GO:0043066
GO:0034391;regulation of smooth muscle cell apoptotic process;1142;431;GO:0043066
GO:0034398;telomere tethering at nuclear periphery;2595;92;GO:0007030
GO:0034397;telomere localization;3742;22;GO:0007050
GO:0034396;negative regulation of transcription from RNA polymerase II promoter in response to iron;0;6;GO:0045944
GO:0034395;regulation of transcription from RNA polymerase II promoter in response to iron;73;94;GO:0006355
GO:0061934;regulation of adenine biosynthetic process;0;0;GO:0045944
GO:0061935;fusion of sperm to egg plasma membrane involved in double fertilization forming two zygotes;0;0;GO:0009986
GO:0061936;fusion of sperm to egg plasma membrane involved in double fertilization forming a zygote and endosperm;42;2;GO:0009952
GO:0034390;smooth muscle cell apoptotic process;1226;7;GO:0043066
GO:0061930;regulation of erythrocyte enucleation;12;1;GO:0048193
GO:0061931;positive regulation of erythrocyte enucleation;12;2;GO:0048193
GO:0061932;negative regulation of erythrocyte enucleation;0;0;GO:0048193
GO:0046300;2,4-dichlorophenoxyacetic acid catabolic process;7;4;GO:0046274
GO:0061938;protein localization to somatodendritic compartment;60;1;GO:0005764
GO:0061939;c-di-GMP signaling;115;5;GO:0030528
GO:0034389;lipid droplet organization;9700;181;GO:0005811
GO:0034388;Pwp2p-containing subcomplex of 90S preribosome;748;69;GO:0043161
GO:0034383;low-density lipoprotein particle clearance;1199;1780;GO:0032963
GO:0034382;chylomicron remnant clearance;210;665;GO:0048193
GO:0034381;plasma lipoprotein particle clearance;2776;2370;GO:0032963
GO:0034380;high-density lipoprotein particle assembly;525;826;GO:0043169
GO:0034387;4-aminobutyrate:pyruvate transaminase activity;123;4;GO:0004073
GO:0034386;4-aminobutyrate:2-oxoglutarate transaminase activity;10169;7;GO:0004089
GO:0034385;triglyceride-rich plasma lipoprotein particle;3138;41;GO:0048193
GO:0034384;high-density lipoprotein particle clearance;481;517;GO:0032869
GO:0061922;histone propionyltransferase activity;0;0;GO:0003700
GO:0046304;2-nitropropane catabolic process;0;2;GO:0009065
GO:0061923;(2S,3R,6S,9S)-(-)-protoillud-7-ene synthase activity;1;0;GO:0004497
GO:0061924;regulation of formation of radial glial scaffolds;0;2;GO:0048666
GO:0046302;2-chloro-N-isopropylacetanilide catabolic process;0;3;GO:0046148
GO:0061925;negative regulation of formation of radial glial scaffolds;0;1;GO:0048704
GO:0046307;Z-phenylacetaldoxime biosynthetic process;0;2;GO:0046395
GO:1902802;regulation of siRNA-dependent facultative heterochromatin formation;14;2;GO:0045944
GO:0046308;Z-phenylacetaldoxime catabolic process;0;2;GO:0046395
GO:1902803;regulation of synaptic vesicle transport;137;1550;GO:0048608
GO:0046305;alkanesulfonate biosynthetic process;3195;2;GO:0006032
GO:0061920;protein propionyltransferase activity;66;5;GO:0009061
GO:1902800;positive regulation of phosphodiesterase I activity;1;0;GO:0010468
GO:0046306;alkanesulfonate catabolic process;6840;9;GO:0009062
GO:0061921;peptidyl-lysine propionylation;2;3;GO:0006468
GO:1902801;regulation of siRNA-independent facultative heterochromatin formation;75;5;GO:0045944
GO:0061926;positive regulation of formation of radial glial scaffolds;0;3;GO:0048666
GO:0046311;prenylcysteine biosynthetic process;0;3;GO:0009061
GO:0061927;TOC-TIC supercomplex I;135;1;GO:0005740
GO:0061928;glutathione specific gamma-glutamylcyclotransferase activity;33565;10;GO:0006081
GO:0061929;gamma-glutamylaminecyclotransferase activity;6923;5;GO:0004073
GO:0034379;very-low-density lipoprotein particle assembly;444;916;GO:0006631
GO:0034378;chylomicron assembly;123;153;GO:0006629
GO:0034377;plasma lipoprotein particle assembly;1163;1720;GO:0006629
GO:0034372;very-low-density lipoprotein particle remodeling;1078;416;GO:0048193
GO:0034371;chylomicron remodeling;74;131;GO:0048608
GO:0034370;triglyceride-rich lipoprotein particle remodeling;1262;1270;GO:0048193
GO:0061950;negative regulation of premature acrosome loss;0;0;GO:0048706
GO:0034376;conversion of discoidal high-density lipoprotein particle to spherical high-density lipoprotein particle;0;1;GO:0043169
GO:0034375;high-density lipoprotein particle remodeling;1196;2460;GO:0043169
GO:0034374;low-density lipoprotein particle remodeling;596;1330;GO:0048193
GO:0034373;intermediate-density lipoprotein particle remodeling;1;2;GO:0043169
GO:0046314;phosphocreatine biosynthetic process;24306;181;GO:0006094
GO:0046315;phosphocreatine catabolic process;0;2;GO:0006066
GO:0061956;penetration of cumulus oophorus;51;5;GO:0048407
GO:1902810;negative regulation of skeletal muscle fiber differentiation;0;2;GO:0048193
GO:0046312;phosphoarginine biosynthetic process;0;3;GO:0006569
GO:0061957;NVT complex;109;2;GO:0005829
GO:0046313;phosphoarginine catabolic process;0;4;GO:0006559
GO:0046318;negative regulation of glucosylceramide biosynthetic process;1;7;GO:0010467
GO:0061951;establishment of protein localization to plasma membrane;6415;29;GO:0005576
GO:0046319;positive regulation of glucosylceramide biosynthetic process;0;1;GO:0046394
GO:0061952;midbody abscission;1597;270;GO:0007080
GO:0046316;gluconokinase activity;29730;84;GO:0004721
GO:0061953;mRNA (adenine-N1-)-methyltransferase activity;155;0;GO:0003729
GO:1902811;positive regulation of skeletal muscle fiber differentiation;110;34;GO:0048193
GO:0046317;regulation of glucosylceramide biosynthetic process;1;3;GO:0010467
GO:1902806;regulation of cell cycle G1/S phase transition;8778;558;GO:0045786
GO:1902807;negative regulation of cell cycle G1/S phase transition;3936;366;GO:0045727
GO:1902804;negative regulation of synaptic vesicle transport;8;1;GO:0048608
GO:1902805;positive regulation of synaptic vesicle transport;49;5;GO:0048608
GO:0046321;positive regulation of fatty acid oxidation;768;1230;GO:0045944
GO:0061959;response to (R)-carnitine;141;0;GO:0006836
GO:0046322;negative regulation of fatty acid oxidation;844;75;GO:0045944
GO:1902808;positive regulation of cell cycle G1/S phase transition;2797;81;GO:0045786
GO:0046320;regulation of fatty acid oxidation;2113;645;GO:0006631
GO:1902809;regulation of skeletal muscle fiber differentiation;220;9;GO:0048608
GO:0034369;plasma lipoprotein particle remodeling;3285;1610;GO:0048193
GO:0034368;protein-lipid complex remodeling;3289;1220;GO:0048193
GO:0034367;protein-containing complex remodeling;3734;117;GO:0048193
GO:0034366;spherical high-density lipoprotein particle;384;739;GO:0043169
GO:0010398;xylogalacturonan metabolic process;5;2;GO:0005976
GO:0010397;apiogalacturonan metabolic process;0;3;GO:0005975
GO:0010399;rhamnogalacturonan I backbone metabolic process;0;1;GO:0005976
GO:0034361;very-low-density lipoprotein particle;2870;1040;GO:0042803
GO:0034360;chylomicron remnant;48;6;GO:0048608
GO:0034365;discoidal high-density lipoprotein particle;98;111;GO:0043169
GO:0034364;high-density lipoprotein particle;7258;1230;GO:0015918
GO:0034363;intermediate-density lipoprotein particle;268;144;GO:0043169
GO:0034362;low-density lipoprotein particle;1132;517;GO:0042803
GO:0046325;negative regulation of glucose import;818;414;GO:0010467
GO:0061944;negative regulation of protein K48-linked ubiquitination;81;5;GO:0016567
GO:1902820;1-undecene metabolic process;0;0;GO:0006631
GO:0046326;positive regulation of glucose import;2010;1200;GO:0010468
GO:0061945;regulation of protein K48-linked ubiquitination;292;4;GO:0016567
GO:1902821;1-undecene biosynthetic process;0;0;GO:0009081
GO:0046323;glucose import;4090;690;GO:0009432
GO:0046324;regulation of glucose import;3093;369;GO:0006096
GO:0046329;negative regulation of JNK cascade;1595;988;GO:0043406
GO:0061940;regulation of c-di-GMP signaling;0;1;GO:0010468
GO:1902824;positive regulation of late endosome to lysosome transport;3;7;GO:0048193
GO:0061941;positive regulation of c-di-GMP signaling;0;0;GO:0010468
GO:0046327;glycerol biosynthetic process from pyruvate;145;14;GO:0006094
GO:0061942;negative regulation of c-di-GMP signaling;0;0;GO:0010468
GO:1902822;regulation of late endosome to lysosome transport;96;6;GO:0048193
GO:0046328;regulation of JNK cascade;13272;947;GO:0043406
GO:1902823;negative regulation of late endosome to lysosome transport;57;8;GO:0048193
GO:1902817;negative regulation of protein localization to microtubule;153;5;GO:0048193
GO:1902818;ethyl acetate metabolic process;0;0;GO:0046274
GO:1902815;N,N'-diacetylchitobiose import;15;0;GO:0005576
GO:1902816;regulation of protein localization to microtubule;153;1;GO:0048193
GO:0046332;SMAD binding;12941;2500;GO:0030528
GO:0061948;premature acrosome loss;0;1;GO:0008042
GO:0046333;octopamine metabolic process;141;7;GO:0006749
GO:0061949;regulation of premature acrosome loss;0;0;GO:0048608
GO:0046330;positive regulation of JNK cascade;8063;2370;GO:0043406
GO:1902819;ethyl acetate biosynthetic process;0;0;GO:0046274
GO:0046331;lateral inhibition;252;107;GO:0048608
GO:0034358;plasma lipoprotein particle;14939;475;GO:0048193
GO:0034357;photosynthetic membrane;2170134;809;GO:0009579
GO:0034356;NAD biosynthesis via nicotinamide riboside salvage pathway;117;61;GO:0009065
GO:0034355;NAD salvage;162;7;GO:0006749
GO:0034359;mature chylomicron;68;5;GO:0006629
GO:0034075;arabidiol synthase activity;3;3;GO:0004497
GO:0061694;alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase complex;10;1;GO:0005524
GO:1902790;undecan-2-one metabolic process;0;0;GO:0006081
GO:0034074;marneral synthase activity;3;4;GO:0004497
GO:0061695;transferase complex, transferring phosphorus-containing groups;1102971;231;GO:0006461
GO:1902791;undecan-2-one biosynthetic process;0;0;GO:1901363
GO:0034073;tetrahymanol cyclase activity;0;1;GO:0004073
GO:0061696;pituitary gonadotropin complex;289;24;GO:0005520
GO:0034072;squalene cyclase activity;2357;1;GO:0004730
GO:0061697;protein-glutaryllysine deglutarylase activity;752;3;GO:0006067
GO:0034079;butanediol biosynthetic process;28;6;GO:0006066
GO:0061690;lipoamidase activity;61;0;GO:0008610
GO:1900131;negative regulation of lipid binding;4;7;GO:0048169
GO:1902794;siRNA-independent facultative heterochromatin formation;93;4;GO:0016570
GO:0034078;butanediol catabolic process;2;3;GO:0046395
GO:0061691;detoxification of hydrogen peroxide;225;4;GO:0006979
GO:1900130;regulation of lipid binding;4;2;GO:0048316
GO:1902795;siRNA-mediated facultative heterochromatin formation;14;0;GO:0016570
GO:0034077;butanediol metabolic process;2604;10;GO:0006066
GO:0061692;cellular detoxification of hydrogen peroxide;130;7;GO:0006979
GO:1900133;regulation of renin secretion into blood stream;181;10;GO:0048193
GO:0048612;post-embryonic ectodermal digestive tract development;0;1;GO:0007517
GO:0009058;biosynthetic process;137440074;15700;GO:0009058
GO:0048611;embryonic ectodermal digestive tract development;186;8;GO:0007565
GO:0048618;post-embryonic foregut morphogenesis;80;2;GO:0048704
GO:0022025;leukemia inhibitory factor signaling pathway involved in forebrain neuron fate commitment;0;3;GO:0048608
GO:0048617;embryonic foregut morphogenesis;450;692;GO:0007565
GO:0022026;epidermal growth factor signaling pathway involved in forebrain neuron fate commitment;0;4;GO:0007179
GO:0048616;post-embryonic anterior midgut (ectodermal) morphogenesis;0;1;GO:0048608
GO:0022027;interkinetic nuclear migration;251;926;GO:0007067
GO:0048615;embryonic anterior midgut (ectodermal) morphogenesis;54;6;GO:0007565
GO:0022031;telencephalon astrocyte cell migration;0;3;GO:0048699
GO:0022032;telencephalon oligodendrocyte cell migration;0;1;GO:0048699
GO:0022033;telencephalon microglial cell migration;0;2;GO:0048169
GO:0022034;rhombomere cell proliferation;0;2;GO:0048608
GO:0048621;post-embryonic digestive tract morphogenesis;74;3;GO:0048608
GO:2001306;lipoxin B4 biosynthetic process;51;1;GO:0046395
GO:0048620;post-embryonic hindgut morphogenesis;9;0;GO:0048608
GO:2001307;xanthone-containing compound biosynthetic process;5;1;GO:0046148
GO:2001308;gliotoxin metabolic process;19;1;GO:0006032
GO:0022030;telencephalon glial cell migration;1413;8;GO:0048666
GO:2001309;gliotoxin catabolic process;0;2;GO:0046274
GO:0010039;response to iron ion;2633;1620;GO:0006826
GO:0034006;amorpha-4,11-diene synthase activity;7;2;GO:0004497
GO:2001302;lipoxin A4 metabolic process;139;10;GO:0006631
GO:0010038;response to metal ion;144467;3150;GO:0006810
GO:0034005;germacrene-A synthase activity;45;5;GO:0004497
GO:2001303;lipoxin A4 biosynthetic process;121;31;GO:0046649
GO:0034004;germacradienol synthase activity;60;4;GO:0006021
GO:2001304;lipoxin B4 metabolic process;62;3;GO:0046649
GO:0034003;vetispiradiene synthase activity;15;3;GO:0004497
GO:2001305;xanthone-containing compound metabolic process;5;1;GO:0046148
GO:0010035;response to inorganic substance;650240;5130;GO:009743
GO:0010034;response to acetate;58;289;GO:0046394
GO:0034009;isoprene synthase activity;25;3;GO:0004497
GO:0010037;response to carbon dioxide;299;60;GO:0045735
GO:0034008;R-linalool synthase activity;28;6;GO:0004497
GO:2001300;lipoxin metabolic process;258;63;GO:0006631
GO:0010036;response to boron-containing substance;62;3;GO:0046686
GO:0034007;S-linalool synthase activity;70;6;GO:0004497
GO:2001301;lipoxin biosynthetic process;229;143;GO:0009044
GO:0009064;glutamine family amino acid metabolic process;3830876;1010;GO:0006541
GO:0010053;root epidermal cell differentiation;2268;89;GO:0009908
GO:0009063;amino acid catabolic process;1490766;2830;GO:0006520
GO:0010052;guard cell differentiation;5325;88;GO:0009913
GO:0009062;fatty acid catabolic process;176233;2070;GO:0006631
GO:0010055;atrichoblast differentiation;7;2;GO:0048699
GO:0009061;anaerobic respiration;117569;1430;GO:0009060
GO:0010054;trichoblast differentiation;2153;99;GO:0009913
GO:0009068;aspartate family amino acid catabolic process;138251;1020;GO:0006544
GO:0034002;(R)-limonene synthase activity;27;0;GO:0004497
GO:0009067;aspartate family amino acid biosynthetic process;2728605;639;GO:0009060
GO:0034001;chondroitin-sulfate-ABC exolyase activity;20;1;GO:0005576
GO:0009066;aspartate family amino acid metabolic process;2975105;1050;GO:0006544
GO:0010051;xylem and phloem pattern formation;1295;462;GO:0048468
GO:0034000;chondroitin-sulfate-ABC endolyase activity;846;2;GO:0005576
GO:0009065;glutamine family amino acid catabolic process;292106;513;GO:0006541
GO:0010050;vegetative phase change;131;301;GO:0048304
GO:0022017;neuroblast division in pallium;0;1;GO:0048666
GO:0048625;myoblast fate commitment;300;239;GO:0048193
GO:0022018;lateral ganglionic eminence cell proliferation;50;5;GO:0048608
GO:0048624;plantlet formation on parent plant;0;1;GO:0048608
GO:1902700;pentose catabolic process to butan-1-ol;0;0;GO:0006066
GO:0022019;dorsal lateral ganglionic eminence cell proliferation;0;2;GO:0048699
GO:0048623;seed germination on parent plant;0;2;GO:0048366
GO:0009069;serine family amino acid metabolic process;1538613;1800;GO:0006519
GO:0022013;pallium cell proliferation in forebrain;60;4;GO:0048666
GO:0048629;trichome patterning;53;8;GO:0048608
GO:0048628;myoblast maturation;37;4;GO:0048193
GO:0022015;radial glial cell division in pallium;0;2;GO:0048666
GO:0048627;myoblast development;269;88;GO:0048667
GO:1902701;pentose catabolic process to propan-2-ol;0;1;GO:0006066
GO:0022016;pallium glioblast division;0;1;GO:0048666
GO:0048626;myoblast fate specification;67;5;GO:0048667
GO:0022020;medial ganglionic eminence cell proliferation;0;2;GO:0048608
GO:0022021;caudal ganglionic eminence cell proliferation;0;2;GO:0048608
GO:0022022;septal cell proliferation;0;2;GO:0042127
GO:0022023;radial glial cell fate commitment in forebrain;0;2;GO:0048667
GO:0048632;negative regulation of skeletal muscle tissue growth;195;9;GO:0048193
GO:2001317;kojic acid biosynthetic process;5;1;GO:0009813
GO:0048631;regulation of skeletal muscle tissue growth;416;103;GO:0048608
GO:0048630;skeletal muscle tissue growth;665;76;GO:0048731
GO:2001313;UDP-4-deoxy-4-formamido-beta-L-arabinopyranose metabolic process;1;3;GO:0006032
GO:0010049;acquisition of plant reproductive competence;0;2;GO:0048608
GO:2001314;UDP-4-deoxy-4-formamido-beta-L-arabinopyranose catabolic process;0;0;GO:0006032
GO:2001315;UDP-4-deoxy-4-formamido-beta-L-arabinopyranose biosynthetic process;1;0;GO:0006022
GO:2001316;kojic acid metabolic process;5;3;GO:0006073
GO:0009060;aerobic respiration;5635977;5040;GO:0015979
GO:0010046;response to mycotoxin;124;66;GO:0046686
GO:0010045;response to nickel cation;7295;45;GO:0046686
GO:2001310;gliotoxin biosynthetic process;19;6;GO:0046405
GO:0010048;vernalization response;1969;194;GO:0009628
GO:2001311;lysobisphosphatidic acid metabolic process;144;4;GO:0006631
GO:0010047;fruit dehiscence;246;177;GO:0009813
GO:2001312;lysobisphosphatidic acid biosynthetic process;0;3;GO:0006631
GO:0034196;acylglycerol transport;1468;33;GO:0006869
GO:0034195;L-galactonate catabolic process;1;2;GO:0006073
GO:1902670;carbon dioxide binding;36;2;GO:0097159
GO:0034194;D-galactonate catabolic process;15909;21;GO:0006073
GO:0034193;L-galactonate metabolic process;1;1;GO:0006073
GO:1900010;regulation of corticotropin-releasing hormone receptor activity;4;2;GO:0004872
GO:1902673;left posteriolateral basal body;0;1;GO:0005576
GO:0034199;activation of protein kinase A activity;7;1250;GO:0043406
GO:1902674;right posteriolateral basal body;0;2;GO:0005576
GO:0034198;cellular response to amino acid starvation;56842;832;GO:0009063
GO:1900012;positive regulation of corticotropin-releasing hormone receptor activity;0;3;GO:0048167
GO:1902671;left anterior basal body;0;1;GO:0005576
GO:0034197;triglyceride transport;653;38;GO:0006869
GO:1900011;negative regulation of corticotropin-releasing hormone receptor activity;4;1;GO:0048608
GO:1902672;right anterior basal body;0;1;GO:0005986
GO:1902677;left caudal basal body;0;1;GO:0005576
GO:1902678;right caudal basal body;0;1;GO:0005576
GO:1900016;negative regulation of cytokine production involved in inflammatory response;1026;217;GO:0050729
GO:1902675;left ventral basal body;0;1;GO:0005576
GO:1900015;regulation of cytokine production involved in inflammatory response;3078;199;GO:0050729
GO:1902676;right ventral basal body;0;1;GO:0005576
GO:0034192;D-galactonate metabolic process;15909;2;GO:0006066
GO:0034191;apolipoprotein A-I receptor binding;215;262;GO:0004872
GO:1900017;positive regulation of cytokine production involved in inflammatory response;1607;369;GO:0050729
GO:0034190;apolipoprotein receptor binding;379;209;GO:0005509
GO:1902679;negative regulation of RNA biosynthetic process;1018608;1340;GO:0010467
GO:1900019;regulation of protein kinase C activity;12;5;GO:0043403
GO:0046185;aldehyde catabolic process;59240;918;GO:0006066
GO:0071130;alpha5-beta1 integrin-LPP3 complex;0;0;GO:0030199
GO:0046186;acetaldehyde biosynthetic process;4;4;GO:0006066
GO:0071131;alphaV-beta3 integrin-laminin alpha-4 complex;0;0;GO:0005925
GO:0046183;L-idonate catabolic process;9;6;GO:0006066
GO:0046184;aldehyde biosynthetic process;358049;54;GO:0006066
GO:0046189;phenol-containing compound biosynthetic process;69585;212;GO:0009405
GO:0071134;alpha9-beta1 integrin-thrombospondin-1 complex;0;2;GO:0005911
GO:0071135;alpha7-beta1 integrin-focal adhesion kinase complex;0;1;GO:0005911
GO:0046187;acetaldehyde catabolic process;18;5;GO:0006066
GO:0071132;alphaX-beta2 integrin-ICAM-4 complex;0;1;GO:0005929
GO:0046188;methane catabolic process;122;2;GO:0006096
GO:0071133;alpha9-beta1 integrin-ADAM8 complex;91;8;GO:0030199
GO:0071138;alpha5-beta5-fibronectin-SFRP2 complex;0;1;GO:0048407
GO:0071139;resolution of recombination intermediates;543;21;GO:0000746
GO:0071136;alpha7-beta1 integrin-laminin alpha-2 complex;0;1;GO:0005925
GO:0071137;alphaV-beta3 integrin-CD98 complex;0;1;GO:0005929
GO:0046181;ketogluconate catabolic process;1;3;GO:0006067
GO:0046182;L-idonate biosynthetic process;0;3;GO:0006066
GO:0046180;ketogluconate biosynthetic process;0;1;GO:0006073
GO:0034185;apolipoprotein binding;932;703;GO:0048193
GO:1902680;positive regulation of RNA biosynthetic process;775027;2200;GO:0010467
GO:0034184;positive regulation of maintenance of mitotic sister chromatid cohesion;299;49;GO:0048285
GO:1902681;regulation of replication fork arrest at rDNA repeats;7;0;GO:0007050
GO:0034183;negative regulation of maintenance of mitotic sister chromatid cohesion;161;6;GO:0048285
GO:0034182;regulation of maintenance of mitotic sister chromatid cohesion;460;10;GO:0007067
GO:0034189;very-low-density lipoprotein particle binding;219;179;GO:0005576
GO:1902684;negative regulation of receptor localization to synapse;11;1;GO:0048169
GO:0034188;apolipoprotein A-I receptor activity;106;50;GO:0004872
GO:1900020;positive regulation of protein kinase C activity;9;50;GO:0043403
GO:1902685;positive regulation of receptor localization to synapse;137;6;GO:0048169
GO:1900023;positive regulation of D-erythro-sphingosine kinase activity;0;0;GO:0046395
GO:1902682;protein localization to pericentric heterochromatin;46;0;GO:0005819
GO:0034186;apolipoprotein A-I binding;262;279;GO:0005576
GO:1900022;regulation of D-erythro-sphingosine kinase activity;10;4;GO:0010468
GO:1902683;regulation of receptor localization to synapse;902;124;GO:0048169
GO:1900025;negative regulation of substrate adhesion-dependent cell spreading;1913;221;GO:0048661
GO:1902688;regulation of NAD metabolic process;63;5;GO:0046394
GO:1900024;regulation of substrate adhesion-dependent cell spreading;3920;122;GO:0048407
GO:1902689;negative regulation of NAD metabolic process;0;0;GO:0046394
GO:1900027;regulation of ruffle assembly;1236;211;GO:0048193
GO:1902686;mitochondrial outer membrane permeabilization involved in programmed cell death;2289;222;GO:0006915
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;1861;1060;GO:0048661
GO:1902687;glucosidase complex;1;5;GO:0005975
GO:0034181;positive regulation of toll-like receptor 13 signaling pathway;2;2;GO:0046649
GO:1900029;positive regulation of ruffle assembly;541;162;GO:0048193
GO:0034180;negative regulation of toll-like receptor 13 signaling pathway;0;2;GO:0046330
GO:1900028;negative regulation of ruffle assembly;269;281;GO:0048193
GO:0046196;4-nitrophenol catabolic process;6;1;GO:0009065
GO:0046197;orcinol biosynthetic process;1;2;GO:0006021
GO:0071120;alpha4-beta1 integrin-CD47 complex;0;1;GO:0005975
GO:0071123;alpha9-beta1 integrin-VEGF-C complex;0;1;GO:0005929
GO:0071124;alpha1-beta1 integrin-tyrosine-protein phosphatase non-receptor type 2 complex;0;1;GO:0005911
GO:0071121;alpha9-beta1 integrin-VEGF-D complex;0;0;GO:0005911
GO:0046199;cresol catabolic process;1;1;GO:0006066
GO:0071122;alpha9-beta1 integrin-VEGF-A complex;0;1;GO:0005911
GO:0071127;alpha9-beta1 integrin-osteopontin complex;0;1;GO:0005911
GO:0071128;alpha5-beta1 integrin-osteopontin complex;0;1;GO:0005911
GO:0071125;alphaV-beta3 integrin-EGFR complex;0;0;GO:0005911
GO:0034179;regulation of toll-like receptor 13 signaling pathway;2;2;GO:0046649
GO:0071126;alphaV-beta6 integrin-osteopontin complex;0;2;GO:0005976
GO:0046192;anaerobic phenol-containing compound biosynthetic process;0;1;GO:0046271
GO:0046193;anaerobic phenol-containing compound catabolic process;1;1;GO:0046395
GO:0046190;aerobic phenol-containing compound biosynthetic process;0;1;GO:0009405
GO:0071129;alphaV-beta3 integrin-LPP3 complex;0;0;GO:0005929
GO:0046191;aerobic phenol-containing compound catabolic process;4;1;GO:0046274
GO:0034174;toll-like receptor 12 signaling pathway;0;3;GO:0007165
GO:1902691;respiratory basal cell differentiation;42;4;GO:0045595
GO:0034173;positive regulation of toll-like receptor 11 signaling pathway;0;1;GO:0046649
GO:1902692;regulation of neuroblast proliferation;2758;84;GO:0048666
GO:0034172;negative regulation of toll-like receptor 11 signaling pathway;0;2;GO:1901362
GO:1900030;regulation of pectin biosynthetic process;17;1;GO:0010401
GO:0034171;regulation of toll-like receptor 11 signaling pathway;0;2;GO:1901362
GO:1902690;positive regulation of NAD metabolic process;0;0;GO:0046394
GO:2001110;negative regulation of lens epithelial cell proliferation;0;1;GO:0048608
GO:0034178;toll-like receptor 13 signaling pathway;4;2;GO:0007165
GO:1900032;regulation of trichome patterning;24;2;GO:0048704
GO:1902695;metallochaperone complex;0;0;GO:0005737
GO:0034177;positive regulation of toll-like receptor 12 signaling pathway;0;1;GO:0046649
GO:1902696;glycine catabolic process to isobutanol;0;0;GO:0009062
GO:0034176;negative regulation of toll-like receptor 12 signaling pathway;0;2;GO:0046649
GO:1900034;regulation of cellular response to heat;1138;1090;GO:0010467
GO:1902693;superoxide dismutase complex;67;1;GO:0009539
GO:0034175;regulation of toll-like receptor 12 signaling pathway;0;2;GO:1901362
GO:1900033;negative regulation of trichome patterning;21;3;GO:0048704
GO:1902694;superoxide dismutase copper chaperone complex;0;0;GO:0005737
GO:1900036;positive regulation of cellular response to heat;63;10;GO:0010427
GO:1902699;pentose catabolic process to acetate;0;1;GO:0006066
GO:1900035;negative regulation of cellular response to heat;29;6;GO:0043473
GO:1900038;negative regulation of cellular response to hypoxia;417;47;GO:0010721
GO:1902697;valine catabolic process to isobutanol;0;1;GO:0009062
GO:1900037;regulation of cellular response to hypoxia;670;45;GO:0010721
GO:1902698;pentose catabolic process to butyrate;0;0;GO:0006066
GO:0034170;toll-like receptor 11 signaling pathway;0;4;GO:0007165
GO:0071160;cyanophycin synthetase activity (L-aspartate-adding);5619;2;GO:0005524
GO:1900039;positive regulation of cellular response to hypoxia;33;250;GO:0010721
GO:0071152;G-protein alpha(q)-synembrin complex;0;0;GO:0005515
GO:0071153;G-protein alpha(o)-synembrin complex;0;0;GO:0005576
GO:0097740;paraflagellar rod;59;3;GO:0005576
GO:0097742;de novo centriole assembly;282;2;GO:0007049
GO:2001108;positive regulation of Rho guanyl-nucleotide exchange factor activity;13;6;GO:0048285
GO:0097741;mastigoneme;0;2;GO:0005576
GO:2001109;regulation of lens epithelial cell proliferation;91;0;GO:0048608
GO:0071154;G-protein alpha(i)1-synembrin complex;0;0;GO:0005515
GO:0097744;renal urate salt excretion;77;8;GO:0006836
GO:0071155;G-protein alpha(13)-synembrin complex;0;0;GO:0005515
GO:0097743;de novo centriole assembly via blepharoplast;0;0;GO:0048471
GO:0097746;blood vessel diameter maintenance;39398;119;GO:0048608
GO:2001104;heptasaccharide transport;0;0;GO:0008544
GO:0097745;mitochondrial tRNA 5'-end processing;248;1;GO:0008033
GO:2001105;maltoheptaose transport;0;0;GO:0006869
GO:0034169;positive regulation of toll-like receptor 10 signaling pathway;0;2;GO:0046649
GO:0097748;3'-5' RNA polymerase activity;4;0;GO:0003700
GO:2001106;regulation of Rho guanyl-nucleotide exchange factor activity;0;44;GO:0005085
GO:0034168;negative regulation of toll-like receptor 10 signaling pathway;0;2;GO:1901362
GO:0071159;NF-kappaB complex;168;211;GO:0005634
GO:0097747;RNA polymerase activity;2331212;159;GO:0003964
GO:2001107;negative regulation of Rho guanyl-nucleotide exchange factor activity;18;2;GO:0048285
GO:2001100;pentasaccharide transport;0;0;GO:0006869
GO:0010199;organ boundary specification between lateral organs and the meristem;46;25;GO:0048316
GO:0097749;membrane tubulation;278;10;GO:0070062
GO:2001101;maltopentaose transport;0;0;GO:0006869
GO:2001102;hexasaccharide transport;0;0;GO:0008565
GO:2001103;maltohexaose transport;0;0;GO:0006869
GO:0034163;regulation of toll-like receptor 9 signaling pathway;606;89;GO:1901362
GO:0034162;toll-like receptor 9 signaling pathway;987;581;GO:0032496
GO:0034161;positive regulation of toll-like receptor 8 signaling pathway;169;7;GO:0032727
GO:2001120;methanofuran biosynthetic process;1327;2;GO:0006099
GO:0034160;negative regulation of toll-like receptor 8 signaling pathway;0;2;GO:1901362
GO:2001121;coenzyme gamma-F420-2 biosynthetic process;3;3;GO:0006749
GO:0034167;regulation of toll-like receptor 10 signaling pathway;0;2;GO:1903047
GO:0034166;toll-like receptor 10 signaling pathway;0;67;GO:0007165
GO:0034165;positive regulation of toll-like receptor 9 signaling pathway;329;45;GO:0046649
GO:1900045;negative regulation of protein K63-linked ubiquitination;191;34;GO:0016567
GO:0034164;negative regulation of toll-like receptor 9 signaling pathway;196;37;GO:1901362
GO:1900044;regulation of protein K63-linked ubiquitination;606;9;GO:0042981
GO:1900047;negative regulation of hemostasis;5394;429;GO:0050817
GO:1900046;regulation of hemostasis;7345;365;GO:0007596
GO:1900048;positive regulation of hemostasis;1992;425;GO:0050817
GO:0071141;SMAD protein complex;805;584;GO:0030528
GO:0071142;homomeric SMAD protein complex;129;3;GO:0048407
GO:0097751;spore-bearing structure formation;0;0;GO:0048305
GO:0071140;resolution of mitotic recombination intermediates;184;10;GO:0000746
GO:0097750;endosome membrane tubulation;153;5;GO:0007043
GO:0097753;membrane bending;121;3;GO:0048471
GO:2001119;methanofuran metabolic process;1327;2;GO:0006096
GO:0097752;regulation of DNA stability;208;9;GO:0006281
GO:0071144;heteromeric SMAD protein complex;432;27;GO:0048407
GO:0097754;clathrin-mediated membrane bending;0;0;GO:0008029
GO:2001115;methanopterin-containing compound metabolic process;1249;1;GO:0006790
GO:0034159;regulation of toll-like receptor 8 signaling pathway;169;3;GO:1902535
GO:2001116;methanopterin-containing compound biosynthetic process;1249;1;GO:0009061
GO:0034158;toll-like receptor 8 signaling pathway;299;15;GO:0007165
GO:2001117;tetrahydromethanopterin metabolic process;1248;0;GO:0006790
GO:0034157;positive regulation of toll-like receptor 7 signaling pathway;359;43;GO:0046649
GO:2001118;tetrahydromethanopterin biosynthetic process;1248;3;GO:0006790
GO:2001111;positive regulation of lens epithelial cell proliferation;91;6;GO:0048010
GO:2001112;regulation of cellular response to hepatocyte growth factor stimulus;46;5;GO:0048193
GO:2001113;negative regulation of cellular response to hepatocyte growth factor stimulus;45;10;GO:0048193
GO:2001114;positive regulation of cellular response to hepatocyte growth factor stimulus;1;3;GO:0048010
GO:0061771;response to caloric restriction;229;46;GO:0006958
GO:0061772;xenobiotic transport across blood-nerve barrier;6;1;GO:0008565
GO:2001130;methane biosynthetic process from trimethylamine;0;1;GO:0009061
GO:0061773;eNoSc complex;155;8;GO:0005576
GO:2001131;methane biosynthetic process from dimethyl sulfide;0;0;GO:0019438
GO:0061774;cohesin unloading;14;3;GO:0007062
GO:2001132;methane biosynthetic process from 3-(methylthio)propionic acid;0;0;GO:0009061
GO:1902630;regulation of membrane hyperpolarization;75;128;GO:0048608
GO:0061770;translation elongation factor binding;187;4;GO:0003735
GO:0061779;Tapasin-ERp57 complex;110;4;GO:0005576
GO:1902633;1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process;214;1;GO:0006631
GO:1902634;1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process;1;0;GO:0006631
GO:0046136;positive regulation of vitamin metabolic process;219;9;GO:0046394
GO:0048799;animal organ maturation;1511;7;GO:0007565
GO:1902631;negative regulation of membrane hyperpolarization;56;1;GO:0048608
GO:0046137;negative regulation of vitamin metabolic process;204;6;GO:0046394
GO:0048798;swim bladder inflation;147;4;GO:0048407
GO:1902632;positive regulation of membrane hyperpolarization;9;6;GO:0048608
GO:0061775;cohesin loader activity;305;8;GO:0005524
GO:1902637;neural crest cell differentiation involved in thymus development;0;2;GO:0007517
GO:0061776;topological DNA co-entrapment activity;25;6;GO:0003677
GO:1902638;neural crest cell differentiation involved in parathyroid gland development;0;1;GO:0048704
GO:1902635;1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process;213;2;GO:0006631
GO:0061778;intracellular chloride channel activity;3178;5;GO:0005216
GO:1902636;kinociliary basal body;197;25;GO:0005576
GO:0046141;corrin catabolic process;0;3;GO:0009062
GO:1902628;positive regulation of assembly of large subunit precursor of preribosome;0;1;GO:0045944
GO:0046140;corrin biosynthetic process;10922;6;GO:0006021
GO:1902629;regulation of mRNA stability involved in cellular response to UV;22;5;GO:0010467
GO:0097720;calcineurin-mediated signaling;13928;382;GO:0009968
GO:0046146;tetrahydrobiopterin metabolic process;45030;119;GO:0006765
GO:0097722;sperm motility;10830;192;GO:0006928
GO:0097721;ciliary vesicle;0;0;GO:0005576
GO:2001126;positive regulation of translational frameshifting;120;1;GO:0006414
GO:0097723;amoeboid sperm motility;22;0;GO:0007530
GO:2001127;methane biosynthetic process from formic acid;0;1;GO:0006096
GO:0097726;LEM domain binding;0;4;GO:0005515
GO:2001128;methane biosynthetic process from methylamine;0;0;GO:0006091
GO:2001129;methane biosynthetic process from dimethylamine;90;2;GO:0046394
GO:0097728;9+0 motile cilium;243;0;GO:0005929
GO:2001122;maltoheptaose metabolic process;0;0;GO:0006073
GO:0097727;blepharoplast;0;0;GO:0005576
GO:2001123;maltoheptaose catabolic process;0;0;GO:0006032
GO:2001124;regulation of translational frameshifting;251;0;GO:0006414
GO:0097729;9+2 motile cilium;14407;0;GO:0005576
GO:2001125;negative regulation of translational frameshifting;131;6;GO:0006414
GO:0061760;antifungal innate immune response;1002;45;GO:0045087
GO:2001140;positive regulation of phospholipid transport;702;25;GO:0048193
GO:0061761;alpha-latrotoxin receptor binding;0;0;GO:0005509
GO:2001141;regulation of RNA biosynthetic process;23241263;2020;GO:0010467
GO:0061762;CAMKK-AMPK signaling cascade;473;117;GO:0007186
GO:2001142;nicotinate transport;260;3;GO:0006826
GO:0061763;multivesicular body-lysosome fusion;75;7;GO:0006906
GO:2001143;N-methylnicotinate transport;42;3;GO:0006869
GO:1902640;propan-2-ol biosynthetic process;0;2;GO:0046323
GO:1902641;regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process;0;0;GO:0046395
GO:0046149;pigment catabolic process;6543;115;GO:0046148
GO:0061768;magnesium:sodium antiporter activity;114;3;GO:0006811
GO:1902644;tertiary alcohol metabolic process;3764;254;GO:0046323
GO:0061769;ribosylnicotinate kinase activity;8;5;GO:0004721
GO:1902645;tertiary alcohol biosynthetic process;3071;1;GO:0046395
GO:0046147;tetrahydrobiopterin catabolic process;0;1;GO:0006559
GO:1902642;negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process;0;2;GO:0046395
GO:0046148;pigment biosynthetic process;1096569;1060;GO:0046148
GO:1902643;positive regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process;0;0;GO:0046395
GO:0061764;late endosome to lysosome transport via multivesicular body sorting pathway;60;1;GO:0006906
GO:1902648;positive regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process;4;0;GO:0046394
GO:0061765;perturbation by virus of host non-canonical NF-kappaB signal transduction;1;0;GO:0046330
GO:0061766;positive regulation of lung blood pressure;5;1;GO:0050727
GO:1902646;regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process;28;0;GO:0006631
GO:0061767;negative regulation of lung blood pressure;5;6;GO:0050727
GO:1902647;negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process;24;1;GO:0046394
GO:0046152;ommochrome metabolic process;383;4;GO:0006725
GO:0046153;ommochrome catabolic process;0;2;GO:0006032
GO:0046150;melanin catabolic process;0;2;GO:0009611
GO:1902639;propan-2-ol metabolic process;0;1;GO:0006066
GO:0046151;eye pigment catabolic process;0;2;GO:0006066
GO:0046156;siroheme metabolic process;100627;5;GO:0006749
GO:0097731;9+0 non-motile cilium;12985;0;GO:0005929
GO:0046157;siroheme catabolic process;0;2;GO:0009065
GO:0097730;non-motile cilium;17461;202;GO:0005929
GO:0046154;rhodopsin metabolic process;264;8;GO:0006836
GO:0097733;photoreceptor cell cilium;12373;123;GO:0005929
GO:0046155;rhodopsin catabolic process;0;2;GO:0006836
GO:0097732;9+2 non-motile cilium;556;0;GO:0005929
GO:0097735;DIM/DIP cell wall layer;0;0;GO:0005618
GO:2001137;positive regulation of endocytic recycling;478;42;GO:0048193
GO:0097734;extracellular exosome biogenesis;1676;18;GO:0070062
GO:2001138;regulation of phospholipid transport;727;7;GO:0006869
GO:0097737;acquisition of mycelium reproductive competence;0;1;GO:0048285
GO:2001139;negative regulation of phospholipid transport;8;3;GO:0048193
GO:0097736;aerial mycelium formation;1;0;GO:0048285
GO:0097739;negative regulation of ferrichrome biosynthetic process in response to iron;0;1;GO:0046395
GO:2001133;methane biosynthetic process from methanethiol;0;0;GO:0006096
GO:0097738;substrate mycelium formation;0;0;GO:0048285
GO:2001134;methane biosynthetic process from carbon monoxide;0;1;GO:0019216
GO:2001135;regulation of endocytic recycling;1269;347;GO:0030163
GO:2001136;negative regulation of endocytic recycling;132;6;GO:0048193
GO:0061793;chromatin lock complex;96;1;GO:0005829
GO:2001151;regulation of renal water transport;71;7;GO:0050900
GO:0061794;conidium development;9319;2;GO:0048305
GO:0097709;connective tissue replacement;489;9;GO:0048407
GO:2001152;negative regulation of renal water transport;0;0;GO:0010467
GO:0061795;Golgi lumen acidification;126;1;GO:0005737
GO:2001153;positive regulation of renal water transport;59;20;GO:0010401
GO:0061796;membrane addition at site of mitotic cytokinesis;7;2;GO:0007067
GO:2001154;regulation of glycolytic fermentation to ethanol;7;0;GO:0046394
GO:0061790;dense core granule docking;4;0;GO:0005829
GO:1902652;secondary alcohol metabolic process;131076;391;GO:0046323
GO:0061791;GTPase motor activity;3;2;GO:0003924
GO:0061792;secretory granule maturation;222;2;GO:0008021
GO:2001150;positive regulation of dipeptide transmembrane transport;70;180;GO:0048193
GO:1902655;aromatic primary alcohol biosynthetic process;0;1;GO:0006022
GO:1902656;calcium ion import into cytosol;116;26;GO:0006836
GO:0046158;ocellus pigment metabolic process;403;2;GO:0006865
GO:1902653;secondary alcohol biosynthetic process;38862;334;GO:0046356
GO:0046159;ocellus pigment catabolic process;0;2;GO:0009062
GO:1902654;aromatic primary alcohol metabolic process;0;1;GO:0006066
GO:0061797;pH-gated chloride channel activity;198;6;GO:0005216
GO:1902659;regulation of glucose mediated signaling pathway;546;8;GO:0010468
GO:0061798;GTP 3',8'-cyclase activity;76680;1;GO:0003954
GO:0061799;cyclic pyranopterin monophosphate synthase activity;70778;6;GO:0006749
GO:1902657;protein localization to prospore membrane;11;1;GO:0005737
GO:0046163;heme C catabolic process;0;2;GO:0006796
GO:0046164;alcohol catabolic process;163940;866;GO:0006066
GO:0046161;heme a catabolic process;0;3;GO:0006796
GO:0046162;heme C metabolic process;0;3;GO:0006796
GO:0046167;glycerol-3-phosphate biosynthetic process;36211;126;GO:0006066
GO:0071112;alpha4-beta4 integrin-EMILIN-1 complex;0;1;GO:0030199
GO:0046168;glycerol-3-phosphate catabolic process;62642;697;GO:0006066
GO:0071113;alphaIIb-beta3 integrin-ICAM-4 complex;0;1;GO:0002576
GO:0046165;alcohol biosynthetic process;844898;1420;GO:0006066
GO:0097700;vascular endothelial cell response to laminar fluid shear stress;0;0;GO:0050727
GO:0046166;glyceraldehyde-3-phosphate biosynthetic process;438;52;GO:0006096
GO:0071111;cyclic-guanylate-specific phosphodiesterase activity;18166;139;GO:0004553
GO:0071116;alpha6-beta1 integrin-CYR61 complex;0;0;GO:0030199
GO:0097702;response to oscillatory fluid shear stress;38;0;GO:0002074
GO:2001148;regulation of dipeptide transmembrane transport;70;2;GO:0006865
GO:0071117;alpha5-beta1 integrin-fibronectin-NOV complex;0;1;GO:0005925
GO:0097701;response to pulsatile fluid shear stress;0;0;GO:0006936
GO:2001149;negative regulation of dipeptide transmembrane transport;0;2;GO:0048193
GO:0071114;alphaV-beta3 integrin-tumstatin complex;0;1;GO:0005929
GO:0097704;cellular response to oscillatory fluid shear stress;38;2;GO:0048407
GO:0071115;alpha5-beta1 integrin-endostatin complex;0;1;GO:0005911
GO:0097703;cellular response to pulsatile fluid shear stress;0;2;GO:0006954
GO:0097706;vascular endothelial cell response to oscillatory fluid shear stress;0;0;GO:0048146
GO:2001144;regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity;2;0;GO:0004721
GO:0046160;heme a metabolic process;45432;2;GO:0006796
GO:0097705;vascular endothelial cell response to pulsatile fluid shear stress;0;0;GO:0050727
GO:2001145;negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity;2;6;GO:0005524
GO:0071118;alphaV-beta3 integrin-NOV complex;0;1;GO:0005929
GO:0097708;intracellular vesicle;1354435;510;GO:0005768
GO:2001146;positive regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity;0;1;GO:0048193
GO:0071119;alpha7-beta1 integrin-nicotinamide riboside kinase complex;0;1;GO:0030199
GO:0097707;ferroptosis;290;4;GO:0006979
GO:2001147;camalexin binding;4;4;GO:0042546
GO:0061782;vesicle fusion with vesicle;3;0;GO:0008026
GO:0061783;peptidoglycan muralytic activity;426114;77;GO:0005576
GO:0061784;peptidoglycan N-acetylglucosaminidase activity;6;1;GO:0004553
GO:0061785;peptidoglycan endopeptidase activity;7;1;GO:0004721
GO:1902662;regulation of peptidyl-L-cysteine S-palmitoylation;0;3;GO:0048193
GO:1902663;negative regulation of peptidyl-L-cysteine S-palmitoylation;0;2;GO:0048193
GO:0061780;mitotic cohesin loading;6592;4;GO:0007062
GO:1900001;negative regulation of anthocyanin catabolic process;0;0;GO:0046274
GO:1902660;negative regulation of glucose mediated signaling pathway;283;4;GO:0010468
GO:0061781;mitotic cohesin unloading;14;2;GO:0007067
GO:1900000;regulation of anthocyanin catabolic process;5;0;GO:0046274
GO:1902661;positive regulation of glucose mediated signaling pathway;206;107;GO:0010468
GO:1900003;regulation of serine-type endopeptidase activity;48;172;GO:0010401
GO:1900002;positive regulation of anthocyanin catabolic process;0;0;GO:0046274
GO:1902667;regulation of axon guidance;1136;481;GO:0048608
GO:0046169;methanol biosynthetic process;0;3;GO:0009405
GO:1900005;positive regulation of serine-type endopeptidase activity;16;22;GO:0048407
GO:1902664;positive regulation of peptidyl-L-cysteine S-palmitoylation;0;2;GO:0048193
GO:1900004;negative regulation of serine-type endopeptidase activity;32;72;GO:0010401
GO:1902665;response to isobutanol;0;0;GO:0046395
GO:0061786;peptidoglycan stem peptide endopeptidase activity;4;0;GO:0004721
GO:0061787;peptidoglycan cross-bridge peptide endopeptidase activity;1;0;GO:0004871
GO:1900006;positive regulation of dendrite development;488;560;GO:0048667
GO:0061788;EGF repeat binding;0;0;GO:0030198
GO:1902668;negative regulation of axon guidance;67;364;GO:0048608
GO:0061789;dense core granule priming;77;6;GO:0008021
GO:1902669;positive regulation of axon guidance;365;28;GO:0048608
GO:0046174;polyol catabolic process;104517;380;GO:0006066
GO:0046175;aldonic acid biosynthetic process;1;2;GO:0006073
GO:0046172;octanol catabolic process;0;3;GO:0009062
GO:0046173;polyol biosynthetic process;98939;217;GO:0006066
GO:0046178;D-gluconate biosynthetic process;1;2;GO:0006066
GO:0071101;alpha4-beta1 integrin-JAM2 complex;0;1;GO:0005929
GO:0046179;keto-D-gluconate biosynthetic process;0;1;GO:0006099
GO:0071102;alpha4-beta1 integrin-paxillin complex;0;0;GO:0048193
GO:0046176;aldonic acid catabolic process;29851;7;GO:0006066
GO:0097711;ciliary basal body-plasma membrane docking;40;71;GO:0005576
GO:0046177;D-gluconate catabolic process;13926;29;GO:0006066
GO:0071100;alphaV-beta8 integrin-MMP14-TGFbeta-1 complex;0;1;GO:0048407
GO:0097710;viral terminase, small subunit;2;0;GO:0005576
GO:0071105;response to interleukin-11;87;33;GO:0030530
GO:0097713;dolichol-phosphate-mannose synthase regulator activity;0;0;GO:0005524
GO:2001159;regulation of protein localization by the Cvt pathway;10;4;GO:0006464
GO:0071106;adenosine 3',5'-bisphosphate transmembrane transport;8142;0;GO:0006826
GO:0097712;vesicle targeting, trans-Golgi to periciliary membrane compartment;92;4;GO:0005764
GO:0071103;DNA conformation change;2271151;2770;GO:0097194
GO:0097715;cellular response to viscosity;0;0;GO:0042592
GO:0071104;response to interleukin-9;467;29;GO:0046649
GO:0097714;response to viscosity;0;1;GO:0030529
GO:0046170;methanol catabolic process;324;2;GO:0006091
GO:0071109;superior temporal gyrus development;89;47;GO:0048666
GO:0097717;copper ion transport across blood-cerebrospinal fluid barrier;0;1;GO:0006811
GO:2001155;negative regulation of glycolytic fermentation to ethanol;0;1;GO:0046395
GO:0046171;octanol biosynthetic process;0;2;GO:0006720
GO:0097716;copper ion transport across blood-brain barrier;0;1;GO:0006836
GO:2001156;regulation of proline catabolic process to glutamate;13;0;GO:0046395
GO:0071107;response to parathyroid hormone;599;134;GO:0009719
GO:0097719;neural tissue regeneration;174;5;GO:0048704
GO:2001157;negative regulation of proline catabolic process to glutamate;1;0;GO:0046395
GO:0071108;protein K48-linked deubiquitination;342;771;GO:0042788
GO:0097718;disordered domain specific binding;1564;441;GO:0042802
GO:2001158;positive regulation of proline catabolic process to glutamate;12;1;GO:0046356
GO:2001173;regulation of histone H2B conserved C-terminal lysine ubiquitination;0;2;GO:0016567
GO:1900093;positive regulation of raffinose biosynthetic process;0;2;GO:0046271
GO:2001176;regulation of mediator complex assembly;49;17;GO:0048193
GO:1900098;regulation of plasma cell differentiation;228;5;GO:0045595
GO:2001170;negative regulation of ATP biosynthetic process;195;29;GO:0015986
GO:2001171;positive regulation of ATP biosynthetic process;414;246;GO:0015986
GO:1900099;negative regulation of plasma cell differentiation;57;8;GO:0045595
GO:2001172;positive regulation of glycolytic fermentation to ethanol;7;1;GO:0046394
GO:1900090;positive regulation of inositol biosynthetic process;0;0;GO:0045765
GO:2001166;regulation of histone H2B ubiquitination;0;55;GO:0016567
GO:1900092;negative regulation of raffinose biosynthetic process;0;0;GO:0046395
GO:2001168;positive regulation of histone H2B ubiquitination;0;100;GO:0045944
GO:1900091;regulation of raffinose biosynthetic process;5;1;GO:0009913
GO:2001169;regulation of ATP biosynthetic process;877;50;GO:0015986
GO:2001185;regulation of CD8-positive, alpha-beta T cell activation;914;41;GO:0042110
GO:2001186;negative regulation of CD8-positive, alpha-beta T cell activation;302;142;GO:0042110
GO:2001187;positive regulation of CD8-positive, alpha-beta T cell activation;392;62;GO:0042110
GO:2001177;negative regulation of mediator complex assembly;0;0;GO:0048193
GO:2001178;positive regulation of mediator complex assembly;49;8;GO:0048193
GO:2001195;negative regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine;0;0;GO:0046395
GO:2001196;positive regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine;4;1;GO:0046395
GO:2001197;basement membrane assembly involved in embryonic body morphogenesis;200;7;GO:0048771
GO:2001198;regulation of dendritic cell differentiation;304;84;GO:0045595
GO:2001191;regulation of gamma-delta T cell activation involved in immune response;5;5;GO:0046649
GO:2001192;negative regulation of gamma-delta T cell activation involved in immune response;0;0;GO:0046649
GO:2001193;positive regulation of gamma-delta T cell activation involved in immune response;5;66;GO:0046649
GO:2001194;regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine;4;0;GO:0046395
GO:2001190;positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;176;169;GO:0002821
GO:2001188;regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;226;8;GO:0002821
GO:2001189;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;50;25;GO:0002821
GO:2001199;negative regulation of dendritic cell differentiation;132;77;GO:0045595
GO:0000819;sister chromatid segregation;70371;3700;GO:0007059
GO:1900052;regulation of retinoic acid biosynthetic process;256;3;GO:0045944
GO:0000817;COMA complex;15;17;GO:0005840
GO:1900054;positive regulation of retinoic acid biosynthetic process;19;2;GO:0045944
GO:0000815;ESCRT III complex;1557;758;GO:0005576
GO:1900053;negative regulation of retinoic acid biosynthetic process;86;3;GO:0010468
GO:0000814;ESCRT II complex;16699;96;GO:0005737
GO:1900056;negative regulation of leaf senescence;116;122;GO:0010468
GO:0000813;ESCRT I complex;19127;375;GO:0005737
GO:1900055;regulation of leaf senescence;498;14;GO:0048608
GO:0000812;Swr1 complex;3796;645;GO:0048285
GO:1900058;regulation of sulfate assimilation;42;2;GO:0006732
GO:0000811;GINS complex;9328;137;GO:0000786
GO:1900057;positive regulation of leaf senescence;158;8;GO:0048193
GO:0000810;diacylglycerol diphosphate phosphatase activity;225;16;GO:0004722
GO:1900059;positive regulation of sulfate assimilation;0;1;GO:0046394
GO:0071181;MAML3-RBP-Jkappa-ICN3 complex;0;1;GO:0048608
GO:0071182;MAML3-RBP-Jkappa-ICN4 complex;0;1;GO:0048608
GO:0071180;MAML3-RBP-Jkappa-ICN2 complex;0;1;GO:0048608
GO:0071174;mitotic spindle checkpoint signaling;18399;45;GO:0000819
GO:0071175;MAML2-RBP-Jkappa-ICN1 complex;0;1;GO:0048704
GO:0071172;dihydromonapterin reductase activity;1;2;GO:0004067
GO:0071173;spindle assembly checkpoint signaling;18511;49;GO:0000737
GO:0071178;MAML2-RBP-Jkappa-ICN4 complex;0;1;GO:0048608
GO:0071179;MAML3-RBP-Jkappa-ICN1 complex;0;1;GO:0048704
GO:0071176;MAML2-RBP-Jkappa-ICN2 complex;0;1;GO:0048608
GO:0071177;MAML2-RBP-Jkappa-ICN3 complex;0;1;GO:0048608
GO:1900060;negative regulation of ceramide biosynthetic process;320;143;GO:0010467
GO:0000829;inositol heptakisphosphate kinase activity;10078;158;GO:0004721
GO:1900063;regulation of peroxisome organization;273;32;GO:0048646
GO:0000828;inositol hexakisphosphate kinase activity;32697;54;GO:0004721
GO:0000827;inositol-1,3,4,5,6-pentakisphosphate kinase activity;6424;46;GO:0004721
GO:1900065;regulation of ethanol catabolic process;2;0;GO:0046395
GO:1900064;positive regulation of peroxisome organization;11;1;GO:0048285
GO:0000825;inositol tetrakisphosphate 6-kinase activity;125;8;GO:0004721
GO:1900067;regulation of cellular response to alkaline pH;4;3;GO:0043407
GO:0000824;inositol tetrakisphosphate 3-kinase activity;40;10;GO:0004721
GO:1900066;positive regulation of ethanol catabolic process;0;0;GO:0046356
GO:0000823;inositol-1,4,5-trisphosphate 6-kinase activity;507;7;GO:0004721
GO:1900069;regulation of cellular hyperosmotic salinity response;215;5;GO:0046686
GO:0000822;inositol hexakisphosphate binding;835;117;GO:0097367
GO:1900068;negative regulation of cellular response to alkaline pH;0;1;GO:0010468
GO:0000821;regulation of arginine metabolic process;201;195;GO:0006569
GO:0000820;regulation of glutamine family amino acid metabolic process;14941;9;GO:0006541
GO:0071170;site-specific DNA replication termination;41;2;GO:0007050
GO:0071171;site-specific DNA replication termination at RTS1 barrier;33;1;GO:0007067
GO:0071163;DNA replication preinitiation complex assembly;2956;39;GO:0006260
GO:0071164;RNA trimethylguanosine synthase activity;229;7;GO:0003729
GO:0071161;cyanophycin synthetase activity (L-arginine-adding);5311;3;GO:0004730
GO:0071162;CMG complex;2616;73;GO:0005829
GO:0071168;protein localization to chromatin;9305;417;GO:0006325
GO:0071165;GINS complex assembly;1;2;GO:0005819
GO:0071166;ribonucleoprotein complex localization;656;219;GO:0022627
GO:0071169;establishment of protein localization to chromatin;512;536;GO:0016570
GO:1900072;positive regulation of sulfite transport;0;0;GO:0046356
GO:1900071;regulation of sulfite transport;1;1;GO:0006826
GO:1900074;negative regulation of neuromuscular synaptic transmission;150;30;GO:0048666
GO:1900073;regulation of neuromuscular synaptic transmission;444;96;GO:0007268
GO:1900076;regulation of cellular response to insulin stimulus;5538;179;GO:0010766
GO:1900075;positive regulation of neuromuscular synaptic transmission;145;59;GO:0048666
GO:1900078;positive regulation of cellular response to insulin stimulus;1419;104;GO:0010766
GO:1900077;negative regulation of cellular response to insulin stimulus;2923;48;GO:0010766
GO:1900079;regulation of arginine biosynthetic process;56;6;GO:0006569
GO:0071196;Kv4.3-KChIP1 channel complex;0;2;GO:0048471
GO:0071197;Kv4.2-Kv4.3 channel complex;0;1;GO:0048408
GO:0071194;Kv4.2-KChIP3 channel complex;0;0;GO:0048471
GO:0071195;Kv4.2-KChIP4 channel complex;0;1;GO:0048471
GO:0071198;Kv4.1-DPP6 channel complex;0;2;GO:0048608
GO:0071199;Kv4.1-DPP10 channel complex;0;2;GO:0048608
GO:1900070;negative regulation of cellular hyperosmotic salinity response;3;1;GO:0046686
GO:0000809;cytoplasmic origin of replication recognition complex;0;3;GO:0005840
GO:0000808;origin recognition complex;22139;5160;GO:0000786
GO:1900082;negative regulation of arginine catabolic process;54;10;GO:0046395
GO:0000807;Z chromosome;0;1;GO:0000003
GO:1900085;negative regulation of peptidyl-tyrosine autophosphorylation;110;9;GO:0043406
GO:0000806;Y chromosome;102;143;GO:0044427
GO:1900084;regulation of peptidyl-tyrosine autophosphorylation;271;4;GO:0043406
GO:0000805;X chromosome;678;150;GO:0000786
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;2230;784;GO:0051726
GO:0000804;W chromosome;0;2;GO:0048608
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;161;123;GO:0043406
GO:0000803;sex chromosome;1974;65;GO:0007548
GO:1900089;negative regulation of inositol biosynthetic process;2;0;GO:0045765
GO:0000802;transverse filament;124;19;GO:0048608
GO:1900088;regulation of inositol biosynthetic process;7;0;GO:0045765
GO:0000801;central element;967;260;GO:0005576
GO:0000800;lateral element;826;615;GO:0048706
GO:0071192;Kv4.2-KChIP1 channel complex;0;1;GO:0048471
GO:0071193;Kv4.2-KChIP2 channel complex;104;3;GO:0048471
GO:0071190;protocadherin-alpha-v7-protocadherin-gamma-b2 complex;0;0;GO:0048608
GO:0071191;protocadherin-alpha-v7-protocadherin-gamma-b4 complex;0;1;GO:0048608
GO:0071185;protocadherin-alpha-v4-protocadherin-gamma-a3 complex;0;1;GO:0048608
GO:0071186;protocadherin-alpha-v4-protocadherin-gamma-b2 complex;0;0;GO:0048608
GO:0071183;protocadherin-alpha-protocadherin-gamma complex;0;1;GO:0048608
GO:0071184;protocadherin-alpha-v4-protocadherin-gamma-a1 complex;0;0;GO:0048608
GO:0071189;protocadherin-alpha-v7-protocadherin-gamma-a3 complex;0;0;GO:0048608
GO:0071187;protocadherin-alpha-v4-protocadherin-gamma-b4 complex;0;1;GO:0048608
GO:0071188;protocadherin-alpha-v7-protocadherin-gamma-a1 complex;0;0;GO:0048608
GO:1900081;regulation of arginine catabolic process;61;10;GO:0006569
GO:1900080;positive regulation of arginine biosynthetic process;0;1;GO:0045944
GO:0000736;double-strand break repair via single-strand annealing, removal of nonhomologous ends;153;7;GO:0006281
GO:0000735;removal of nonhomologous ends;198;10;GO:0043161
GO:0000732;strand displacement;59;152;GO:0003677
GO:0000731;DNA synthesis involved in DNA repair;21430;1310;GO:0006281
GO:0000730;DNA recombinase assembly;2343;288;GO:0006310
GO:0000749;response to pheromone triggering conjugation with cellular fusion;2196;5;GO:0048285
GO:0000748;conjugation with mutual genetic exchange;1;6;GO:0048285
GO:0000747;conjugation with cellular fusion;5528;518;GO:0048285
GO:0000745;nuclear migration involved in conjugation with mutual genetic exchange;0;4;GO:0007049
GO:0000744;karyogamy involved in conjugation with mutual genetic exchange;0;5;GO:0000965
GO:0000743;nuclear migration involved in conjugation with cellular fusion;91;7;GO:0007049
GO:0000742;karyogamy involved in conjugation with cellular fusion;2109;92;GO:0008544
GO:0000741;karyogamy;5895;110;GO:0000965
GO:0000740;nuclear membrane fusion;1888;6;GO:0007050
GO:0000719;photoreactive repair;285;116;GO:0046686
GO:0000718;nucleotide-excision repair, DNA damage removal;0;205;GO:0006281
GO:0000717;nucleotide-excision repair, DNA duplex unwinding;64;217;GO:0006281
GO:0000716;transcription-coupled nucleotide-excision repair, DNA damage recognition;39986;10;GO:0006974
GO:0000715;nucleotide-excision repair, DNA damage recognition;40099;272;GO:0006281
GO:0000714;meiotic strand displacement;4;3;GO:0000922
GO:0000713;meiotic heteroduplex formation;7;6;GO:0000786
GO:0000712;resolution of meiotic recombination intermediates;2925;1260;GO:0000786
GO:0000711;meiotic DNA repair synthesis;1024;34;GO:0006281
GO:0000710;meiotic mismatch repair;296;455;GO:0007050
GO:0048709;oligodendrocyte differentiation;8119;1800;GO:0048666
GO:0048708;astrocyte differentiation;4149;1340;GO:0048667
GO:0000729;DNA double-strand break processing;1497;1840;GO:0000082
GO:0048707;instar larval or pupal morphogenesis;8316;59;GO:0048608
GO:0000727;double-strand break repair via break-induced replication;6489;726;GO:0006281
GO:0000725;recombinational repair;139530;1930;GO:0000724
GO:0000724;double-strand break repair via homologous recombination;100119;5000;GO:0006281
GO:0048702;embryonic neurocranium morphogenesis;841;130;GO:0048704
GO:0000723;telomere maintenance;86741;4250;GO:0007050
GO:0048701;embryonic cranial skeleton morphogenesis;6125;1470;GO:0048704
GO:0000722;telomere maintenance via recombination;1374;4670;GO:0000723
GO:0048700;acquisition of desiccation tolerance in seed;40;3;GO:0009631
GO:0000721;(R,R)-butanediol dehydrogenase activity;490;0;GO:0004067
GO:0000720;pyrimidine dimer repair by nucleotide-excision repair;250;62;GO:0006281
GO:0048706;embryonic skeletal system development;13431;1820;GO:0001501
GO:0048705;skeletal system morphogenesis;20219;3040;GO:0048608
GO:0048704;embryonic skeletal system morphogenesis;9553;2540;GO:0009952
GO:0048703;embryonic viscerocranium morphogenesis;2382;584;GO:0007565
GO:0009112;nucleobase metabolic process;669214;582;GO:0006793
GO:0009111;vitamin catabolic process;45624;9;GO:0006541
GO:0009110;vitamin biosynthetic process;4210104;1110;GO:0006767
GO:0000779;condensed chromosome, centromeric region;127863;1330;GO:0000786
GO:0009116;nucleoside metabolic process;1162587;4880;GO:0006796
GO:0009115;xanthine catabolic process;220;51;GO:0006569
GO:0009114;hypoxanthine catabolic process;190;6;GO:0006559
GO:0000776;kinetochore;122804;6320;GO:0000776
GO:0009113;purine nucleobase biosynthetic process;175213;1790;GO:0006796
GO:0000775;chromosome, centromeric region;236440;3850;GO:0000786
GO:0000774;adenyl-nucleotide exchange factor activity;61603;1570;GO:0005085
GO:0009119;ribonucleoside metabolic process;879476;1310;GO:0009063
GO:0000773;phosphatidyl-N-methylethanolamine N-methyltransferase activity;5307;152;GO:0004734
GO:0009118;regulation of nucleoside metabolic process;0;87;GO:0009063
GO:0000772;mating pheromone activity;427;8;GO:0009410
GO:0009117;nucleotide metabolic process;14888960;3580;GO:0006561
GO:0000782;telomere cap complex;7752;223;GO:0000786
GO:0000781;chromosome, telomeric region;101958;2380;GO:0000786
GO:0010110;regulation of photosynthesis, dark reaction;141;9;GO:0015979
GO:0009123;nucleoside monophosphate metabolic process;4907843;1660;GO:0006796
GO:0009120;deoxyribonucleoside metabolic process;8798;4;GO:0009063
GO:0009127;purine nucleoside monophosphate biosynthetic process;2026864;493;GO:0006749
GO:0009126;purine nucleoside monophosphate metabolic process;2366891;1450;GO:0006796
GO:0009125;nucleoside monophosphate catabolic process;5407;584;GO:0009064
GO:0009124;nucleoside monophosphate biosynthetic process;3116987;840;GO:0006793
GO:0000786;nucleosome;222691;5930;GO:0000786
GO:0000785;chromatin;1376583;10800;GO:0005634
GO:0009129;pyrimidine nucleoside monophosphate metabolic process;676949;43;GO:0006793
GO:0000783;nuclear telomere cap complex;7632;316;GO:0005819
GO:0009128;purine nucleoside monophosphate catabolic process;3121;349;GO:0009065
GO:0000793;condensed chromosome;176319;2810;GO:0048706
GO:0000792;heterochromatin;12797;1800;GO:0000786
GO:0000791;euchromatin;3792;1240;GO:0007021
GO:0010109;regulation of photosynthesis;19172;245;GO:0015979
GO:0010105;negative regulation of ethylene-activated signaling pathway;3262;96;GO:0010468
GO:0010104;regulation of ethylene-activated signaling pathway;3612;49;GO:0010631
GO:0010106;cellular response to iron ion starvation;524;318;GO:0006826
GO:0010101;post-embryonic root morphogenesis;827;10;GO:0048608
GO:0010100;negative regulation of photomorphogenesis;600;31;GO:0048367
GO:0010103;stomatal complex morphogenesis;5466;206;GO:0048309
GO:0010102;lateral root morphogenesis;804;85;GO:0048316
GO:0000758;agglutination involved in conjugation with mutual genetic exchange;0;4;GO:0005976
GO:0000756;response to pheromone regulating conjugation with mutual genetic exchange;1;2;GO:0048305
GO:0000755;cytogamy;221;43;GO:0009699
GO:0000754;adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion;151;10;GO:0009913
GO:0000753;cell morphogenesis involved in conjugation with cellular fusion;93;7;GO:0048285
GO:0000752;agglutination involved in conjugation with cellular fusion;59;7;GO:0005929
GO:0000751;mitotic cell cycle G1 arrest in response to pheromone;8;4;GO:0007049
GO:0000750;pheromone-dependent signal transduction involved in conjugation with cellular fusion;1954;87;GO:0009611
GO:0000760;adaptation to pheromone regulating conjugation with mutual genetic exchange;1;1;GO:0048285
GO:0009101;glycoprotein biosynthetic process;113742;1700;GO:0006418
GO:0009100;glycoprotein metabolic process;135993;1390;GO:0005975
GO:0000769;syncytium formation by mitosis without cytokinesis;1;3;GO:0048285
GO:0000768;syncytium formation by plasma membrane fusion;4738;283;GO:0006979
GO:0009104;lipopolysaccharide catabolic process;74;7;GO:0046274
GO:0000766;negative adaptation of signaling pathway by response to pheromone involved in pheromone-induced unidirectional conjugation;0;3;GO:0048285
GO:0009103;lipopolysaccharide biosynthetic process;421856;1970;GO:0009405
GO:0000765;response to pheromone regulating pheromone-induced unidirectional conjugation;0;0;GO:0009410
GO:0009102;biotin biosynthetic process;415714;879;GO:0006730
GO:0000762;pheromone-induced unidirectional conjugation;0;4;GO:0009611
GO:0009107;lipoate biosynthetic process;226911;779;GO:0006631
GO:0000761;conjugant formation;0;2;GO:0000976
GO:0009106;lipoate metabolic process;226914;263;GO:0006631
GO:0000770;peptide pheromone export;11;10;GO:0008544
GO:0009152;purine ribonucleotide biosynthetic process;5726754;3350;GO:0006749
GO:0009151;purine deoxyribonucleotide metabolic process;4515;10;GO:0006796
GO:0009150;purine ribonucleotide metabolic process;6675254;2440;GO:0006793
GO:0010143;cutin biosynthetic process;695;286;GO:0009813
GO:0010142;farnesyl diphosphate biosynthetic process, mevalonate pathway;11639;18;GO:0006661
GO:0061730;C-rich strand telomeric DNA binding;2;2;GO:0003677
GO:0009156;ribonucleoside monophosphate biosynthetic process;2659498;1460;GO:0009063
GO:0034112;positive regulation of homotypic cell-cell adhesion;571;56;GO:0048608
GO:0009155;purine deoxyribonucleotide catabolic process;3037;10;GO:0009060
GO:0034111;negative regulation of homotypic cell-cell adhesion;599;322;GO:0022610
GO:0009154;purine ribonucleotide catabolic process;26635;938;GO:0009060
GO:0034110;regulation of homotypic cell-cell adhesion;1487;199;GO:0007156
GO:0009153;purine deoxyribonucleotide biosynthetic process;1306;65;GO:0006796
GO:0048757;pigment granule maturation;696;118;GO:0008544
GO:0061735;DNM1L-mediated stimulation of mitophagy in response to mitochondrial depolarization;0;1;GO:0048471
GO:0009159;deoxyribonucleoside monophosphate catabolic process;2363;19;GO:0009065
GO:0048756;sieve cell differentiation;7;1;GO:0048638
GO:0061736;engulfment of target by autophagosome;61;3;GO:0006986
GO:0009158;ribonucleoside monophosphate catabolic process;2990;262;GO:0009060
GO:0048755;branching morphogenesis of a nerve;504;186;GO:0048608
GO:0061737;leukotriene signaling pathway;5915;166;GO:0007186
GO:0009157;deoxyribonucleoside monophosphate biosynthetic process;457447;249;GO:0006796
GO:0048754;branching morphogenesis of an epithelial tube;11461;1120;GO:0030900
GO:0061738;late endosomal microautophagy;167;149;GO:0006986
GO:0061731;ribonucleoside-diphosphate reductase activity;203539;38;GO:0003954
GO:0048759;xylem vessel member cell differentiation;89;2;GO:0048468
GO:0061733;peptide-lysine-N-acetyltransferase activity;123980;70;GO:0004867
GO:0048758;companion cell differentiation;0;1;GO:0048608
GO:0061734;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;310;8;GO:0048471
GO:0048760;plant parenchymal cell differentiation;0;1;GO:0048468
GO:0046101;hypoxanthine biosynthetic process;9738;32;GO:0006725
GO:0048764;trichoblast maturation;2118;109;GO:0009913
GO:0061739;protein lipidation involved in autophagosome assembly;2;50;GO:0006626
GO:0046102;inosine metabolic process;1973;9;GO:0006749
GO:0048763;calcium-induced calcium release activity;6593;117;GO:0008092
GO:0048762;mesenchymal cell differentiation;21766;2370;GO:0030183
GO:0046100;hypoxanthine metabolic process;10245;22;GO:0006555
GO:0048761;collenchyma cell differentiation;0;0;GO:0048468
GO:0010138;pyrimidine ribonucleotide salvage;66059;6;GO:0009063
GO:0034105;positive regulation of tissue remodeling;226;155;GO:0010717
GO:0010137;ureide biosynthetic process;0;6;GO:0006066
GO:0034104;negative regulation of tissue remodeling;878;156;GO:0010717
GO:0034103;regulation of tissue remodeling;3069;301;GO:0010717
GO:0010139;pyrimidine deoxyribonucleotide salvage;4;2;GO:0009063
GO:0034102;erythrocyte clearance;4;3;GO:0007599
GO:0010134;sulfate assimilation via adenylyl sulfate reduction;45;7;GO:0009065
GO:0034109;homotypic cell-cell adhesion;4008;758;GO:0007155
GO:0010133;proline catabolic process to glutamate;85288;441;GO:0006559
GO:0034108;positive regulation of erythrocyte clearance;0;2;GO:0050729
GO:0010136;ureide catabolic process;186;41;GO:0009062
GO:0034107;negative regulation of erythrocyte clearance;4;4;GO:0002576
GO:0010135;ureide metabolic process;186;5;GO:0006066
GO:0034106;regulation of erythrocyte clearance;4;3;GO:0002576
GO:0009163;nucleoside biosynthetic process;760570;800;GO:0009063
GO:0010152;pollen maturation;302;64;GO:0009555
GO:0009162;deoxyribonucleoside monophosphate metabolic process;459867;1080;GO:0006796
GO:0010151;chloroplast elongation;6;1;GO:0009536
GO:0009161;ribonucleoside monophosphate metabolic process;3001816;1500;GO:0006790
GO:0010154;fruit development;18353;1010;GO:0009908
GO:0009167;purine ribonucleoside monophosphate metabolic process;2364996;1220;GO:0006790
GO:0034101;erythrocyte homeostasis;13067;876;GO:0007596
GO:0009166;nucleotide catabolic process;235901;1600;GO:0006139
GO:0009165;nucleotide biosynthetic process;12799999;2740;GO:0009059
GO:0010150;leaf senescence;7213;1330;GO:0048608
GO:0009164;nucleoside catabolic process;155003;922;GO:0009061
GO:0046105;thymidine biosynthetic process;116;3;GO:0006520
GO:0048768;root hair cell tip growth;170;29;GO:0048707
GO:0061724;lipophagy;482;101;GO:0006914
GO:1902600;proton transmembrane transport;13974871;2410;GO:0015075
GO:0046106;thymine biosynthetic process;0;2;GO:0006559
GO:0048767;root hair elongation;739;575;GO:0048707
GO:0061725;cytosolic lipolysis;7;3;GO:0006629
GO:1902601;silver ion transmembrane transport;239;1;GO:0006810
GO:0009169;purine ribonucleoside monophosphate catabolic process;2527;272;GO:0009065
GO:0046103;inosine biosynthetic process;1670;147;GO:0006749
GO:0048766;root hair initiation;85;18;GO:0009913
GO:0061726;mitochondrion disassembly;19243;170;GO:0005740
GO:0009168;purine ribonucleoside monophosphate biosynthetic process;2025620;1510;GO:0006749
GO:0046104;thymidine metabolic process;5378;61;GO:0006559
GO:0048765;root hair cell differentiation;2118;462;GO:0048316
GO:0061727;methylglyoxal catabolic process to lactate;22861;9;GO:0046395
GO:0046109;uridine biosynthetic process;24;6;GO:0006561
GO:0061720;6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde;10;0;GO:0006066
GO:1902604;p-aminobenzoyl-glutamate transmembrane transport;9213;6;GO:0048169
GO:0061721;6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-);0;0;GO:0006066
GO:1902605;heterotrimeric G-protein complex assembly;68;8;GO:0005737
GO:0046107;uracil biosynthetic process;27503;2;GO:0006555
GO:0061722;sulphoglycolysis;0;5;GO:0006096
GO:1902602;aluminum ion transmembrane transport;44;1;GO:0006826
GO:0046108;uridine metabolic process;347;204;GO:0006561
GO:0048769;sarcomerogenesis;192;59;GO:0048407
GO:0061723;glycophagy;349;9;GO:0006979
GO:1902603;carnitine transmembrane transport;4219;489;GO:0006836
GO:0048771;tissue remodeling;11796;1160;GO:0043062
GO:0048770;pigment granule;23907;680;GO:0030165
GO:0046112;nucleobase biosynthetic process;449572;1470;GO:0009063
GO:0048775;regulation of leucophore differentiation;0;2;GO:0048405
GO:0061728;GDP-mannose biosynthetic process from mannose;0;0;GO:0006022
GO:0046113;nucleobase catabolic process;92066;1400;GO:0006518
GO:0048774;cyanophore differentiation;0;0;GO:0048608
GO:0061729;GDP-mannose biosynthetic process from fructose-6-phosphate;0;2;GO:0006022
GO:0046110;xanthine metabolic process;9439;135;GO:0006569
GO:0048773;erythrophore differentiation;9;3;GO:0002576
GO:0046111;xanthine biosynthetic process;58;9;GO:0009065
GO:0048772;leucophore differentiation;0;1;GO:0009952
GO:0010148;transpiration;50;71;GO:0009987
GO:0010145;fructan metabolic process;10;3;GO:0005976
GO:0010144;pyridoxal phosphate biosynthetic process from pyridoxamine;1;2;GO:0009065
GO:0010147;fructan catabolic process;10;3;GO:0005986
GO:0010146;fructan biosynthetic process;0;2;GO:0005976
GO:0009130;pyrimidine nucleoside monophosphate biosynthetic process;675821;142;GO:0006793
GO:0061750;acid sphingomyelin phosphodiesterase activity;166;2;GO:0003954
GO:0010121;arginine catabolic process to proline via ornithine;160;4;GO:0006559
GO:0061751;neutral sphingomyelin phosphodiesterase activity;56;2;GO:0004553
GO:0010120;camalexin biosynthetic process;124;58;GO:0046274
GO:0061752;telomeric repeat-containing RNA binding;86;36;GO:0003729
GO:0009134;nucleoside diphosphate catabolic process;1170;133;GO:0009061
GO:0009133;nucleoside diphosphate biosynthetic process;57889;416;GO:0006793
GO:0009132;nucleoside diphosphate metabolic process;351677;1230;GO:0006793
GO:0009131;pyrimidine nucleoside monophosphate catabolic process;1126;3;GO:0009065
GO:0009138;pyrimidine nucleoside diphosphate metabolic process;50917;332;GO:0006793
GO:0046116;queuosine metabolic process;581476;114;GO:0006790
GO:0048779;negative regulation of erythrophore differentiation;0;1;GO:0045595
GO:0061757;leukocyte adhesion to arterial endothelial cell;268;2;GO:0030200
GO:1902611;cellular response to N-phenylthiourea;0;0;GO:0046686
GO:0009137;purine nucleoside diphosphate catabolic process;463;9;GO:0009065
GO:0046117;queuosine catabolic process;0;2;GO:0006559
GO:0048778;regulation of erythrophore differentiation;0;1;GO:0045595
GO:0061758;2-hydroxyglutarate dehydrogenase activity, forward reaction;0;1;GO:0006066
GO:1902612;regulation of anti-Mullerian hormone signaling pathway;2;9;GO:0030518
GO:0009136;purine nucleoside diphosphate biosynthetic process;7066;5;GO:0006749
GO:0046114;guanosine biosynthetic process;2;2;GO:0009063
GO:0048777;positive regulation of leucophore differentiation;0;2;GO:0048405
GO:0061759;alpha-ketoglutarate reductase activity;6;2;GO:0004067
GO:0009135;purine nucleoside diphosphate metabolic process;295178;300;GO:0006796
GO:0046115;guanosine catabolic process;42;7;GO:0006559
GO:0048776;negative regulation of leucophore differentiation;0;2;GO:0048405
GO:1902610;response to N-phenylthiourea;7;1;GO:0046148
GO:0061753;substrate localization to autophagosome;156;4;GO:0006914
GO:1902615;immune response involved in response to exogenous dsRNA;34;2;GO:0032496
GO:0000796;condensin complex;11472;1160;GO:0000786
GO:0061754;negative regulation of circulating fibrinogen levels;16;5;GO:0048168
GO:1902616;acyl carnitine transmembrane transport;319;21;GO:0006836
GO:0000795;synaptonemal complex;7955;1430;GO:0000786
GO:0046118;7-methylguanosine biosynthetic process;0;85;GO:0006032
GO:0061755;positive regulation of circulating fibrinogen levels;0;0;GO:0048407
GO:1902613;negative regulation of anti-Mullerian hormone signaling pathway;2;6;GO:0030518
GO:0000794;condensed nuclear chromosome;22329;2790;GO:0005634
GO:0009139;pyrimidine nucleoside diphosphate biosynthetic process;50763;9;GO:0006793
GO:0046119;7-methylguanosine catabolic process;0;2;GO:0006519
GO:0061756;leukocyte adhesion to vascular endothelial cell;2807;67;GO:0030200
GO:1902614;positive regulation of anti-Mullerian hormone signaling pathway;0;0;GO:0030520
GO:0048782;negative regulation of cyanophore differentiation;0;1;GO:0048405
GO:1902608;positive regulation of large conductance calcium-activated potassium channel activity;2;9;GO:0048167
GO:0046120;deoxyribonucleoside biosynthetic process;120;2;GO:0009063
GO:0048781;regulation of cyanophore differentiation;0;1;GO:0050731
GO:1902609;(R)-2-hydroxy-alpha-linolenic acid biosynthetic process;35;0;GO:0006633
GO:0048780;positive regulation of erythrophore differentiation;0;2;GO:0045595
GO:1902606;regulation of large conductance calcium-activated potassium channel activity;3;4;GO:0048167
GO:1902607;negative regulation of large conductance calcium-activated potassium channel activity;1;1;GO:0048167
GO:0046123;purine deoxyribonucleoside biosynthetic process;3;2;GO:0009060
GO:0048786;presynaptic active zone;5444;1610;GO:0005730
GO:0010119;regulation of stomatal movement;3607;462;GO:0010468
GO:0046124;purine deoxyribonucleoside catabolic process;1987;6;GO:0009065
GO:0048785;hatching gland development;72;4;GO:0008544
GO:0046121;deoxyribonucleoside catabolic process;2160;8;GO:0009063
GO:0048784;pigment biosynthetic process involved in pigment granule maturation;0;1;GO:0046148
GO:0046122;purine deoxyribonucleoside metabolic process;2051;6;GO:0006796
GO:0048783;positive regulation of cyanophore differentiation;0;2;GO:0048608
GO:0010116;positive regulation of abscisic acid biosynthetic process;74;6;GO:0046274
GO:0010115;regulation of abscisic acid biosynthetic process;670;62;GO:0046274
GO:0010118;stomatal movement;4430;694;GO:0009579
GO:0010117;photoprotection;106;203;GO:0009416
GO:0010112;regulation of systemic acquired resistance;1775;416;GO:0046274
GO:0010111;glyoxysome organization;3;4;GO:0009536
GO:0010114;response to red light;1025;1460;GO:0009416
GO:0010113;negative regulation of systemic acquired resistance;76;5;GO:0046274
GO:0009141;nucleoside triphosphate metabolic process;3396773;2030;GO:0006793
GO:0010130;anaerobic ethylbenzene catabolic process;1;2;GO:0006066
GO:0009140;pyrimidine nucleoside diphosphate catabolic process;132;1;GO:0009065
GO:0010132;dhurrin biosynthetic process;3;4;GO:0006021
GO:0061740;protein targeting to lysosome involved in chaperone-mediated autophagy;243;41;GO:0005764
GO:0009145;purine nucleoside triphosphate biosynthetic process;2588069;1310;GO:0006793
GO:0009144;purine nucleoside triphosphate metabolic process;2818817;1940;GO:0006793
GO:0009143;nucleoside triphosphate catabolic process;163988;1010;GO:0009063
GO:0009142;nucleoside triphosphate biosynthetic process;3044409;1250;GO:0006793
GO:0009149;pyrimidine nucleoside triphosphate catabolic process;49862;9;GO:0009060
GO:0046127;pyrimidine deoxyribonucleoside catabolic process;116;2;GO:0009065
GO:1990712;HFE-transferrin receptor complex;416;191;GO:0005576
GO:0051958;methotrexate transport;813;26;GO:0006816
GO:1990713;survivin complex;4;1;GO:0005829
GO:0051959;dynein light intermediate chain binding;49032;310;GO:0005525
GO:1990714;hydroxyproline O-galactosyltransferase activity;128;1;GO:0004553
GO:0051956;negative regulation of amino acid transport;417;174;GO:0006865
GO:1990715;mRNA CDS binding;206;10;GO:0003735
GO:0051957;positive regulation of amino acid transport;709;215;GO:0045735
GO:1990716;axonemal central apparatus;264;30;GO:0005576
GO:0051954;positive regulation of amine transport;1170;104;GO:0048169
GO:1990717;axonemal central bridge;0;0;GO:0005576
GO:0051955;regulation of amino acid transport;5172;69;GO:0006865
GO:1990718;axonemal central pair projection;42;3;GO:0048316
GO:0051952;regulation of amine transport;7890;431;GO:0007218
GO:1990719;C1 axonemal microtubule;0;0;GO:0005525
GO:0051953;negative regulation of amine transport;784;33;GO:0048169
GO:0036331;avascular cornea development in camera-type eye;65;1;GO:0048405
GO:0036332;placental growth factor receptor activity;55;2;GO:0004872
GO:0036333;hepatocyte homeostasis;92;53;GO:0048193
GO:0036334;epidermal stem cell homeostasis;14;3;GO:0045727
GO:0000379;tRNA-type intron splice site recognition and cleavage;4494;403;GO:0003700
GO:0000378;RNA exon ligation;75;6;GO:0006461
GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;712632;2110;GO:0000398
GO:0000376;RNA splicing, via transesterification reactions with guanosine as nucleophile;11559;2;GO:0000398
GO:0000386;second spliceosomal transesterification activity;223;60;GO:0008340
GO:0000384;first spliceosomal transesterification activity;70;192;GO:0000398
GO:1990720;C2 axonemal microtubule;0;0;GO:0005525
GO:0000381;regulation of alternative mRNA splicing, via spliceosome;20195;1620;GO:0000398
GO:0000380;alternative mRNA splicing, via spliceosome;23004;882;GO:0000398
GO:1990722;DAPK1-calmodulin complex;52;1;GO:0005524
GO:1990723;cytoplasmic periphery of the nuclear pore complex;15;7;GO:0005730
GO:1990724;galectin complex;98;5;GO:0005829
GO:1990725;cord factor receptor activity;0;1;GO:0004872
GO:1990726;Lsm1-7-Pat1 complex;872;134;GO:0048193
GO:1990727;tubulin folding cofactor complex;3;0;GO:0005515
GO:0036324;vascular endothelial growth factor receptor-2 signaling pathway;318;46;GO:0007179
GO:1990728;mitotic spindle assembly checkpoint MAD1-MAD2 complex;177;1;GO:0007067
GO:0036325;vascular endothelial growth factor receptor-3 signaling pathway;66;4;GO:0048010
GO:0036320;mating-type P-factor pheromone receptor activity;4;0;GO:0004930
GO:0036321;ghrelin secretion;59;4;GO:0007596
GO:0036322;pancreatic polypeptide secretion;0;1;GO:0007596
GO:0036323;vascular endothelial growth factor receptor-1 signaling pathway;110;10;GO:0048010
GO:0000389;mRNA 3'-splice site recognition;286;10;GO:0003723
GO:0000388;spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);181;10;GO:0008380
GO:0000387;spliceosomal snRNP assembly;194299;2810;GO:0000976
GO:0000395;mRNA 5'-splice site recognition;35700;173;GO:0003700
GO:0000394;RNA splicing, via endonucleolytic cleavage and ligation;33752;1910;GO:0000398
GO:1990730;VCP-NSFL1C complex;87;49;GO:0005576
GO:0000393;spliceosomal conformational changes to generate catalytic conformation;7628;31;GO:0008340
GO:1990732;pyrenoid;0;3;GO:0009579
GO:1990733;titin-telethonin complex;15;7;GO:0005576
GO:0000390;spliceosomal complex disassembly;5060;184;GO:0000976
GO:1990734;astral microtubule anchoring at mitotic spindle pole body;43;2;GO:0005576
GO:0036317;tyrosyl-RNA phosphodiesterase activity;50;8;GO:0003723
GO:1990735;gamma-tubulin complex localization to mitotic spindle pole body;5;0;GO:0005819
GO:0036318;peptide pheromone receptor activity;1455;1;GO:0004930
GO:1990736;regulation of vascular associated smooth muscle cell membrane depolarization;0;1;GO:0048010
GO:0036319;mating-type M-factor pheromone receptor activity;0;1;GO:0004930
GO:1990737;response to manganese-induced endoplasmic reticulum stress;10;35;GO:0006986
GO:1990738;pseudouridine 5'-phosphatase activity;42;0;GO:0004721
GO:0036313;phosphatidylinositol 3-kinase catalytic subunit binding;306;186;GO:0048193
GO:1990739;granulosa cell proliferation;92;1;GO:0042127
GO:0036314;response to sterol;2931;207;GO:0009725
GO:0036315;cellular response to sterol;2097;452;GO:0032496
GO:0036316;SREBP-SCAP complex retention in endoplasmic reticulum;156;4;GO:0006631
GO:0036310;ATP-dependent DNA/DNA annealing activity;276;7;GO:0003676
GO:0036311;chitin disaccharide deacetylase activity;1172;3;GO:0004553
GO:0051909;acetylenecarboxylate hydratase activity, producing 3-hydroxypropenoate;0;3;GO:0006081
GO:0036312;phosphatidylinositol 3-kinase regulatory subunit binding;497;339;GO:0048193
GO:0051907;S-(hydroxymethyl)glutathione synthase activity;7441;0;GO:0006066
GO:0051908;double-stranded DNA 5'-3' exodeoxyribonuclease activity;2489;0;GO:0004518
GO:0051905;establishment of pigment granule localization;2738;9;GO:0048285
GO:0051906;maintenance of pigment granule location;0;1;GO:0048285
GO:0000354;cis assembly of pre-catalytic spliceosome;21;32;GO:0000976
GO:1990742;microvesicle;89;25;GO:0070062
GO:1990743;protein sialylation;12;10;GO:0006469
GO:1990745;EARP complex;4874;64;GO:0005829
GO:0036306;embryonic heart tube elongation;105;5;GO:0048704
GO:0051903;S-(hydroxymethyl)glutathione dehydrogenase activity;80278;0;GO:0009065
GO:0036307;23S rRNA (adenine(2030)-N(6))-methyltransferase activity;28019;0;GO:0003735
GO:0051904;pigment granule transport;2414;304;GO:0008021
GO:1990747;pancreatic trypsinogen secretion;2;2;GO:0007596
GO:0036308;16S rRNA (guanine(1516)-N(2))-methyltransferase activity;1;0;GO:0003735
GO:0051901;positive regulation of mitochondrial depolarization;359;120;GO:0048285
GO:1990748;cellular detoxification;3654516;718;GO:0006979
GO:0036309;protein localization to M-band;23;156;GO:0005525
GO:0051902;negative regulation of mitochondrial depolarization;188;168;GO:0048285
GO:1990749;polynucleotide adenylyltransferase activator activity;9;1;GO:0005524
GO:0036302;atrioventricular canal development;1068;56;GO:0007530
GO:0036303;lymph vessel morphogenesis;2307;52;GO:0001944
GO:0051900;regulation of mitochondrial depolarization;842;132;GO:0048285
GO:0036304;umbilical cord morphogenesis;55;3;GO:0048513
GO:0036305;ameloblast differentiation;260;15;GO:0048638
GO:0036300;B cell receptor internalization;0;3;GO:0002474
GO:0036301;macrophage colony-stimulating factor production;305;5;GO:0048608
GO:0051918;negative regulation of fibrinolysis;1010;2770;GO:0050840
GO:0051919;positive regulation of fibrinolysis;185;215;GO:0050817
GO:0051916;granulocyte colony-stimulating factor binding;82;10;GO:0004974
GO:0051917;regulation of fibrinolysis;1257;1420;GO:0007596
GO:0000366;intergenic mRNA trans splicing;12;3;GO:0006415
GO:0000365;mRNA trans splicing, via spliceosome;139652;28;GO:0000398
GO:0000375;RNA splicing, via transesterification reactions;727145;2910;GO:0000398
GO:0000374;Group III intron splicing;18;8;GO:0008033
GO:0000373;Group II intron splicing;22797;297;GO:0008033
GO:1990751;Schwann cell chemotaxis;7;2;GO:0050921
GO:0000372;Group I intron splicing;11558;25;GO:0008033
GO:1990752;microtubule end;2772;209;GO:0005930
GO:1990753;equatorial cell cortex;11;4;GO:0009986
GO:1990755;mitotic spindle microtubule depolymerization;44;1;GO:0007088
GO:1990756;ubiquitin ligase-substrate adaptor activity;3577;55;GO:0004842
GO:0051914;positive regulation of synaptic plasticity by chemical substance;3;1;GO:0048167
GO:1990757;ubiquitin ligase activator activity;754;27;GO:0004842
GO:0051915;induction of synaptic plasticity by chemical substance;3;4;GO:0048167
GO:1990758;mitotic sister chromatid biorientation;199;10;GO:0000910
GO:0051912;CoB--CoM heterodisulfide reductase activity;3124;3;GO:0008061
GO:0051913;regulation of synaptic plasticity by chemical substance;3;2;GO:0048167
GO:0051911;Methanosarcina-phenazine hydrogenase activity;823;3;GO:0009065
GO:1900371;regulation of purine nucleotide biosynthetic process;1542;44;GO:0009065
GO:1900370;positive regulation of post-transcriptional gene silencing by RNA;895;1;GO:0010468
GO:1900373;positive regulation of purine nucleotide biosynthetic process;449;9;GO:0045944
GO:1900372;negative regulation of purine nucleotide biosynthetic process;199;5;GO:0045944
GO:1900377;negative regulation of secondary metabolite biosynthetic process;262;26;GO:0046274
GO:1900376;regulation of secondary metabolite biosynthetic process;1481;8;GO:0046394
GO:1900379;regulation of asperthecin biosynthetic process;4;0;GO:0010468
GO:1900378;positive regulation of secondary metabolite biosynthetic process;662;116;GO:0046394
GO:0071251;cellular response to silicon dioxide;0;3;GO:0046686
GO:0071252;cellular response to sulfur dioxide;0;0;GO:0046395
GO:0071250;cellular response to nitrite;5;5;GO:0006979
GO:0071255;Cvt vesicle assembly;17;8;GO:0005764
GO:0071256;translocon complex;5702;10;GO:0005737
GO:0071253;connexin binding;1637;92;GO:0005515
GO:0071254;cytoplasmic U snRNP body;138;4;GO:0005840
GO:0071259;cellular response to magnetism;6;4;GO:0009628
GO:0071257;cellular response to electrical stimulus;384;258;GO:0009719
GO:0071258;cellular response to gravity;8;22;GO:0072358
GO:1900380;negative regulation of asperthecin biosynthetic process;1;0;GO:0010468
GO:1900381;positive regulation of asperthecin biosynthetic process;3;0;GO:0046356
GO:1900384;regulation of flavonol biosynthetic process;21;4;GO:0046322
GO:1900383;regulation of synaptic plasticity by receptor localization to synapse;2;6;GO:0048666
GO:1900386;positive regulation of flavonol biosynthetic process;12;2;GO:0046316
GO:1900385;negative regulation of flavonol biosynthetic process;0;0;GO:0046274
GO:0071240;cellular response to food;1;1;GO:0007599
GO:0071241;cellular response to inorganic substance;12488;684;GO:0050829
GO:0071244;cellular response to carbon dioxide;148;7;GO:0045735
GO:0071245;cellular response to carbon monoxide;4;5;GO:0045727
GO:0071242;cellular response to ammonium ion;261;185;GO:0045735
GO:0071243;cellular response to arsenic-containing substance;930;988;GO:0043407
GO:0071248;cellular response to metal ion;10943;631;GO:0009628
GO:0071249;cellular response to nitrate;201;151;GO:0046332
GO:0071246;cellular response to chlorate;0;1;GO:0046686
GO:0071247;cellular response to chromate;4;8;GO:0043407
GO:0034295;basidiospore formation;0;4;GO:0048304
GO:0034294;sexual spore wall assembly;0;2;GO:0048305
GO:0034293;sexual sporulation;3170;231;GO:0048304
GO:0034299;reproductive blastospore formation;0;3;GO:0048285
GO:1900395;negative regulation of kojic acid biosynthetic process;1;1;GO:0046274
GO:0034298;arthrospore formation;0;4;GO:0048305
GO:1900394;regulation of kojic acid biosynthetic process;2;1;GO:0046394
GO:0034297;oidium formation;0;2;GO:0048608
GO:1900397;regulation of pyrimidine nucleotide biosynthetic process;3;0;GO:0006559
GO:0034296;zygospore formation;0;3;GO:0048304
GO:1900396;positive regulation of kojic acid biosynthetic process;1;2;GO:0046394
GO:1900399;positive regulation of pyrimidine nucleotide biosynthetic process;3;2;GO:0045944
GO:1900398;negative regulation of pyrimidine nucleotide biosynthetic process;0;0;GO:0045944
GO:0071280;cellular response to copper ion;679;453;GO:0006811
GO:0071281;cellular response to iron ion;572;432;GO:0006826
GO:0071273;morphine catabolic process;1;2;GO:0046274
GO:0071274;isoquinoline alkaloid catabolic process;2;3;GO:0046148
GO:0071271;1-butanol biosynthetic process;7;2;GO:0046323
GO:0071272;morphine metabolic process;7;3;GO:0043161
GO:0071277;cellular response to calcium ion;5388;2770;GO:0009719
GO:0071278;cellular response to cesium ion;1;1;GO:0043407
GO:0071275;cellular response to aluminum ion;10;6;GO:0009611
GO:0071276;cellular response to cadmium ion;1645;1140;GO:0043207
GO:0071279;cellular response to cobalt ion;109;268;GO:0006979
GO:0034289;detection of maltose stimulus;18;7;GO:0009410
GO:0034284;response to monosaccharide;13881;700;GO:0005975
GO:0034283;syn-stemod-13(17)-ene synthase activity;2;0;GO:0004497
GO:0034282;ent-pimara-8(14),15-diene synthase activity;2;2;GO:0004497
GO:0034281;ent-isokaurene synthase activity;0;3;GO:0004497
GO:2001000;regulation of xylan catabolic process;3;0;GO:0046274
GO:0034288;detection of disaccharide stimulus;38;3;GO:0009410
GO:0034287;detection of monosaccharide stimulus;28;9;GO:0009410
GO:0034286;response to maltose;40;5;GO:0046395
GO:0034285;response to disaccharide;3620;57;GO:0005976
GO:0034280;ent-sandaracopimaradiene synthase activity;2;3;GO:0004497
GO:0071270;1-butanol metabolic process;7;0;GO:0046323
GO:0071262;regulation of translational initiation in response to starvation;168;5;GO:0006414
GO:0071263;negative regulation of translational initiation in response to starvation;0;3;GO:0045944
GO:0071260;cellular response to mechanical stimulus;2797;2010;GO:0050896
GO:0071261;Ssh1 translocon complex;210;7;GO:0005737
GO:0071266;'de novo' L-methionine biosynthetic process;80379;175;GO:0009065
GO:0071267;L-methionine salvage;163054;728;GO:0009064
GO:0071264;positive regulation of translational initiation in response to starvation;168;6;GO:0006414
GO:0071265;L-methionine biosynthetic process;243433;468;GO:0009064
GO:0034279;syn-pimara-7,15-diene synthase activity;4;3;GO:0004497
GO:0071268;homocysteine biosynthetic process;11767;7;GO:0009065
GO:0034278;stemar-13-ene synthase activity;2;4;GO:0004497
GO:0071269;L-homocysteine biosynthetic process;20;1;GO:0006541
GO:2001010;negative regulation of plant-type cell wall cellulose biosynthetic process;0;0;GO:0046274
GO:2001011;positive regulation of plant-type cell wall cellulose biosynthetic process;71;2;GO:0046394
GO:1902992;negative regulation of amyloid precursor protein catabolic process;1097;732;GO:0010467
GO:1902993;positive regulation of amyloid precursor protein catabolic process;1215;59;GO:0010467
GO:0061890;positive regulation of astrocyte activation;5;6;GO:0050890
GO:1900331;negative regulation of methane biosynthetic process from trimethylamine;0;0;GO:0045944
GO:1902990;mitotic telomere maintenance via semi-conservative replication;135;87;GO:0007050
GO:0061891;calcium ion sensor activity;245;5;GO:0008083
GO:1900330;regulation of methane biosynthetic process from trimethylamine;0;1;GO:0045944
GO:1902991;regulation of amyloid precursor protein catabolic process;2518;597;GO:0010467
GO:1900333;regulation of methane biosynthetic process from 3-(methylthio)propionic acid;0;0;GO:0045944
GO:1902996;regulation of neurofibrillary tangle assembly;107;8;GO:0048167
GO:1900332;positive regulation of methane biosynthetic process from trimethylamine;0;0;GO:0045944
GO:1902997;negative regulation of neurofibrillary tangle assembly;51;153;GO:0048167
GO:1900335;positive regulation of methane biosynthetic process from 3-(methylthio)propionic acid;0;0;GO:0045944
GO:1902994;regulation of phospholipid efflux;202;7;GO:0048193
GO:0046258;anaerobic 2,4,6-trinitrotoluene catabolic process;0;1;GO:0009065
GO:1900334;negative regulation of methane biosynthetic process from 3-(methylthio)propionic acid;0;0;GO:0046394
GO:1902995;positive regulation of phospholipid efflux;200;56;GO:0048193
GO:0061896;all-trans retinol 3,4-desaturase activity;17;1;GO:0006631
GO:1900337;negative regulation of methane biosynthetic process from carbon monoxide;0;0;GO:0045730
GO:0061897;all-trans retinal 3,4-desaturase activity;13;0;GO:0006631
GO:1900336;regulation of methane biosynthetic process from carbon monoxide;0;0;GO:0045944
GO:0061898;all-trans retinoic acid 3,4-desaturase activity;13;0;GO:0004497
GO:1900339;regulation of methane biosynthetic process from formic acid;0;0;GO:0045944
GO:1902998;positive regulation of neurofibrillary tangle assembly;56;66;GO:0048167
GO:0061899;11-cis-retinal 3,4-desaturase activity;1;0;GO:0006631
GO:1900338;positive regulation of methane biosynthetic process from carbon monoxide;0;0;GO:0045735
GO:0046263;nitrotoluene catabolic process;21;3;GO:0009065
GO:1900329;positive regulation of mannotriose transport;0;0;GO:0006865
GO:0046260;trinitrotoluene catabolic process;21;3;GO:0046274
GO:0071211;protein targeting to vacuole involved in autophagy;398;130;GO:0005764
GO:2001009;regulation of plant-type cell wall cellulose biosynthetic process;170;4;GO:0009753
GO:0071212;subsynaptic reticulum;146;98;GO:0005789
GO:0046265;thiocyanate catabolic process;4;4;GO:0006559
GO:0071210;protein insertion into membrane raft;0;1;GO:0016021
GO:0071215;cellular response to abscisic acid stimulus;20720;377;GO:0009737
GO:2001005;positive regulation of pectin catabolic process;0;1;GO:0046274
GO:0071216;cellular response to biotic stimulus;16031;1480;GO:0009607
GO:2001006;regulation of cellulose biosynthetic process;1535;4;GO:0030216
GO:0071213;cellular response to 1-aminocyclopropane-1-carboxylic acid;0;2;GO:0009734
GO:2001007;negative regulation of cellulose biosynthetic process;33;0;GO:0046274
GO:0071214;cellular response to abiotic stimulus;82436;1360;GO:0009628
GO:2001008;positive regulation of cellulose biosynthetic process;73;3;GO:0046394
GO:0071219;cellular response to molecule of bacterial origin;12128;1070;GO:0002237
GO:2001001;negative regulation of xylan catabolic process;0;0;GO:0046274
GO:2001002;positive regulation of xylan catabolic process;3;0;GO:0046274
GO:0071217;cellular response to external biotic stimulus;20;37;GO:0009607
GO:2001003;regulation of pectin catabolic process;0;0;GO:0046274
GO:0071218;cellular response to misfolded protein;5633;155;GO:0006986
GO:2001004;negative regulation of pectin catabolic process;0;1;GO:0046274
GO:0061881;positive regulation of anterograde axonal transport of mitochondrion;4;1;GO:0048193
GO:0061882;negative regulation of anterograde axonal transport of mitochondrion;0;1;GO:0048193
GO:0061883;clathrin-dependent endocytosis involved in vitellogenesis;52;4;GO:0006897
GO:0061884;regulation of mini excitatory postsynaptic potential;65;0;GO:0048608
GO:1900340;negative regulation of methane biosynthetic process from formic acid;0;0;GO:0045730
GO:1900342;regulation of methane biosynthetic process from dimethyl sulfide;0;0;GO:0045944
GO:0061880;regulation of anterograde axonal transport of mitochondrion;4;0;GO:0048193
GO:1900341;positive regulation of methane biosynthetic process from formic acid;0;0;GO:0045944
GO:0061889;negative regulation of astrocyte activation;153;10;GO:0050890
GO:1900344;positive regulation of methane biosynthetic process from dimethyl sulfide;0;0;GO:0045944
GO:1900343;negative regulation of methane biosynthetic process from dimethyl sulfide;0;0;GO:0046395
GO:1900346;negative regulation of methane biosynthetic process from methanethiol;0;0;GO:0046395
GO:0046269;toluene-4-sulfonate catabolic process;0;3;GO:0046395
GO:1900345;regulation of methane biosynthetic process from methanethiol;0;0;GO:0045944
GO:0061885;positive regulation of mini excitatory postsynaptic potential;55;4;GO:0048167
GO:1900348;regulation of methane biosynthetic process from methylamine;0;1;GO:0045944
GO:0061886;negative regulation of mini excitatory postsynaptic potential;10;1;GO:0048666
GO:1900347;positive regulation of methane biosynthetic process from methanethiol;0;0;GO:0045944
GO:0061888;regulation of astrocyte activation;159;10;GO:0050890
GO:1900349;negative regulation of methane biosynthetic process from methylamine;0;0;GO:0045944
GO:0046273;lignan catabolic process;31;3;GO:0046274
GO:0046274;lignin catabolic process;14762;660;GO:0009405
GO:0046271;phenylpropanoid catabolic process;15556;108;GO:0046274
GO:0046272;stilbene catabolic process;54;2;GO:0046274
GO:0046277;methylgallate biosynthetic process;0;2;GO:1901363
GO:0071200;Kv4.2-DPP6 channel complex;0;2;GO:0048608
GO:0046278;3,4-dihydroxybenzoate metabolic process;51081;9;GO:0006066
GO:0071201;Kv4.3-DPP6 channel complex;0;2;GO:0048608
GO:0046275;flavonoid catabolic process;63;3;GO:0009813
GO:0046276;methylgallate catabolic process;0;2;GO:0046395
GO:0071204;histone pre-mRNA 3'end processing complex;266;257;GO:0008314
GO:2001016;positive regulation of skeletal muscle cell differentiation;277;16;GO:0045595
GO:0071205;protein localization to juxtaparanode region of axon;195;36;GO:0048471
GO:2001017;regulation of retrograde axon cargo transport;21;1;GO:0048193
GO:0071202;Kv4.3-DPP10 channel complex;8;1;GO:0048608
GO:2001018;negative regulation of retrograde axon cargo transport;0;1;GO:0048193
GO:0071203;WASH complex;10349;332;GO:0005576
GO:2001019;positive regulation of retrograde axon cargo transport;21;8;GO:0048193
GO:0071208;histone pre-mRNA DCP binding;166;73;GO:0003729
GO:2001012;mesenchymal cell differentiation involved in renal system development;235;520;GO:0030509
GO:0071209;U7 snRNA binding;1500;33;GO:0003723
GO:2001013;epithelial cell proliferation involved in renal tubule morphogenesis;255;30;GO:0042127
GO:0071206;establishment of protein localization to juxtaparanode region of axon;53;3;GO:0048471
GO:2001014;regulation of skeletal muscle cell differentiation;1171;303;GO:0045595
GO:0071207;histone pre-mRNA stem-loop binding;147;83;GO:0045944
GO:2001015;negative regulation of skeletal muscle cell differentiation;451;235;GO:0045595
GO:2001030;negative regulation of cellular glucuronidation;10;56;GO:0010468
GO:2001031;positive regulation of cellular glucuronidation;47;6;GO:0010401
GO:2001032;regulation of double-strand break repair via nonhomologous end joining;2359;223;GO:0006281
GO:2001033;negative regulation of double-strand break repair via nonhomologous end joining;658;226;GO:0043161
GO:1900351;regulation of methanofuran biosynthetic process;0;1;GO:0010468
GO:1900350;positive regulation of methane biosynthetic process from methylamine;0;0;GO:0045944
GO:1900353;positive regulation of methanofuran biosynthetic process;0;0;GO:0046395
GO:1900352;negative regulation of methanofuran biosynthetic process;0;0;GO:0010468
GO:1900355;negative regulation of methanofuran metabolic process;0;1;GO:0046395
GO:1900354;regulation of methanofuran metabolic process;0;1;GO:0045944
GO:0046279;3,4-dihydroxybenzoate biosynthetic process;18220;4;GO:0006022
GO:1900357;regulation of nigerotriose transport;0;0;GO:0006869
GO:1900356;positive regulation of methanofuran metabolic process;0;1;GO:0045944
GO:1900359;positive regulation of nigerotriose transport;0;0;GO:0048193
GO:1900358;negative regulation of nigerotriose transport;0;0;GO:0046356
GO:0046284;anthocyanin-containing compound catabolic process;5;2;GO:0046274
GO:0046285;flavonoid phytoalexin metabolic process;0;2;GO:0009813
GO:0071230;cellular response to amino acid stimulus;11050;2590;GO:0009064
GO:0046282;cinnamic acid ester catabolic process;0;1;GO:0046274
GO:0046283;anthocyanin-containing compound metabolic process;1944;50;GO:0009536
GO:0046288;isoflavonoid catabolic process;0;2;GO:0046274
GO:0071233;cellular response to leucine;670;206;GO:0006919
GO:0046289;isoflavonoid phytoalexin metabolic process;2;1;GO:0009617
GO:0071234;cellular response to phenylalanine;40;4;GO:0006979
GO:0046286;flavonoid phytoalexin catabolic process;0;2;GO:0046274
GO:0071231;cellular response to folic acid;169;10;GO:0009719
GO:0046287;isoflavonoid metabolic process;10;4;GO:0009813
GO:0071232;cellular response to histidine;61;2;GO:0006952
GO:0071237;cellular response to bacteriocin;3;1;GO:0046686
GO:2001027;negative regulation of endothelial cell chemotaxis;209;38;GO:0050727
GO:0071238;cellular response to brefeldin A;0;2;GO:0071345
GO:2001028;positive regulation of endothelial cell chemotaxis;990;75;GO:0050727
GO:0071235;cellular response to proline;4;1;GO:0071346
GO:2001029;regulation of cellular glucuronidation;57;6;GO:0006725
GO:0071236;cellular response to antibiotic;521;1100;GO:0010033
GO:0046280;chalcone catabolic process;0;2;GO:0009699
GO:2001023;regulation of response to drug;137;236;GO:0048519
GO:0046281;cinnamic acid catabolic process;751;4;GO:0006073
GO:2001024;negative regulation of response to drug;16;8;GO:0048519
GO:0071239;cellular response to streptomycin;3;0;GO:0010033
GO:2001025;positive regulation of response to drug;40;81;GO:0048522
GO:2001026;regulation of endothelial cell chemotaxis;1358;164;GO:0050921
GO:2001042;negative regulation of septum digestion after cytokinesis;5;2;GO:0048285
GO:1900360;regulation of pentasaccharide transport;0;0;GO:0005929
GO:2001043;positive regulation of septum digestion after cytokinesis;6;3;GO:0048285
GO:2001044;regulation of integrin-mediated signaling pathway;2421;587;GO:0007155
GO:1900362;positive regulation of pentasaccharide transport;0;0;GO:0006874
GO:1900361;negative regulation of pentasaccharide transport;0;0;GO:0006874
GO:1900364;negative regulation of mRNA polyadenylation;4603;131;GO:0010467
GO:2001040;positive regulation of cellular response to drug;27;8;GO:0048522
GO:1900366;negative regulation of defense response to insect;24;4;GO:0050832
GO:1900368;regulation of post-transcriptional gene silencing by regulatory ncRNA;3297;0;GO:0010431
GO:1900367;positive regulation of defense response to insect;103;6;GO:0050832
GO:1900369;negative regulation of post-transcriptional gene silencing by regulatory ncRNA;923;2;GO:0010468
GO:0046295;glycolate biosynthetic process;10584;9;GO:0006096
GO:0046296;glycolate catabolic process;75;9;GO:0006067
GO:0046293;formaldehyde biosynthetic process;56;6;GO:0006066
GO:0046294;formaldehyde catabolic process;26699;537;GO:0006559
GO:0071222;cellular response to lipopolysaccharide;10524;6900;GO:0032496
GO:0071223;cellular response to lipoteichoic acid;452;308;GO:0002237
GO:0071220;cellular response to bacterial lipoprotein;496;5;GO:0046649
GO:0046298;2,4-dichlorobenzoate catabolic process;0;3;GO:0009065
GO:0071221;cellular response to bacterial lipopeptide;494;42;GO:0071346
GO:0071226;cellular response to molecule of fungal origin;1048;68;GO:0009617
GO:2001038;regulation of cellular response to drug;34;71;GO:0048568
GO:0071227;cellular response to molecule of oomycetes origin;0;3;GO:0009620
GO:2001039;negative regulation of cellular response to drug;1;4;GO:0048523
GO:0071224;cellular response to peptidoglycan;247;170;GO:0071345
GO:0071225;cellular response to muramyl dipeptide;545;78;GO:0071346
GO:2001034;positive regulation of double-strand break repair via nonhomologous end joining;804;43;GO:0043207
GO:0046292;formaldehyde metabolic process;28311;275;GO:0006066
GO:2001035;regulation of tongue muscle cell differentiation;56;8;GO:0048704
GO:0071228;cellular response to tumor cell;1007;9;GO:0009963
GO:2001036;negative regulation of tongue muscle cell differentiation;0;0;GO:0048704
GO:0046290;isoflavonoid phytoalexin catabolic process;0;2;GO:0046274
GO:0071229;cellular response to acid chemical;11751;1230;GO:0050877
GO:2001037;positive regulation of tongue muscle cell differentiation;56;23;GO:0048704
GO:2001053;regulation of mesenchymal cell apoptotic process;579;182;GO:0010941
GO:2001054;negative regulation of mesenchymal cell apoptotic process;477;261;GO:0043066
GO:2001055;positive regulation of mesenchymal cell apoptotic process;102;48;GO:0010941
GO:2001050;negative regulation of tendon cell differentiation;0;0;GO:0048661
GO:2001051;positive regulation of tendon cell differentiation;45;4;GO:0048608
GO:2001049;regulation of tendon cell differentiation;45;1;GO:0045595
GO:2001045;negative regulation of integrin-mediated signaling pathway;1818;94;GO:0048010
GO:2001046;positive regulation of integrin-mediated signaling pathway;478;247;GO:0048010
GO:0000908;taurine dioxygenase activity;2542;5;GO:0004497
GO:2001063;glucomannan binding;0;1;GO:0005576
GO:0000907;sulfonate dioxygenase activity;10;10;GO:0004497
GO:2001064;cellooligosaccharide binding;0;0;GO:0005576
GO:0000906;6,7-dimethyl-8-ribityllumazine synthase activity;145253;9;GO:0006033
GO:2001065;mannan binding;90;5;GO:0005576
GO:0000905;sporocarp development involved in asexual reproduction;10;4;GO:0048608
GO:2001066;amylopectin binding;40;4;GO:0005576
GO:2001060;D-glycero-D-manno-heptose 7-phosphate metabolic process;11773;3;GO:0006032
GO:0000902;cell morphogenesis;1564456;9940;GO:0042127
GO:2001061;D-glycero-D-manno-heptose 7-phosphate biosynthetic process;11772;2;GO:0006022
GO:0000901;translation repressor activity, non-nucleic acid binding;1;3;GO:0003735
GO:2001062;xylan binding;1;2;GO:0005576
GO:0000900;mRNA regulatory element binding translation repressor activity;2543;34;GO:0045944
GO:2001056;positive regulation of cysteine-type endopeptidase activity;704;343;GO:0048407
GO:2001057;reactive nitrogen species metabolic process;190708;309;GO:0046395
GO:2001058;D-tagatose 6-phosphate metabolic process;15354;1;GO:0006066
GO:0000909;sporocarp development involved in sexual reproduction;58;7;GO:0048608
GO:2001059;D-tagatose 6-phosphate catabolic process;15354;1;GO:0006066
GO:2001074;regulation of metanephric ureteric bud development;14;5;GO:0048608
GO:2001075;negative regulation of metanephric ureteric bud development;0;1;GO:0048706
GO:2001076;positive regulation of metanephric ureteric bud development;14;266;GO:0048608
GO:2001077;(1->3),(1->4)-beta-glucan binding;0;0;GO:0008061
GO:2001070;starch binding;23711;542;GO:0005976
GO:2001071;maltoheptaose binding;21;2;GO:0005576
GO:2001072;galactomannan binding;0;1;GO:0042379
GO:2001073;cyclodextrin binding;0;1;GO:0043169
GO:2001067;pullulan binding;1;1;GO:0005576
GO:2001068;arabinoxylan binding;0;1;GO:0005576
GO:2001069;glycogen binding;937;25;GO:0005529
GO:2001085;arabinogalactan binding;0;1;GO:0005576
GO:2001087;sophorose transport;0;1;GO:0009400
GO:2001088;trisaccharide transport;2;0;GO:0005985
GO:2001081;(1->4)-beta-D-galactan binding;0;0;GO:0005576
GO:2001082;inulin binding;0;1;GO:0005576
GO:2001083;alpha-D-glucan binding;0;1;GO:0005125
GO:2001084;L-arabinofuranose binding;0;1;GO:0005996
GO:2001080;chitosan binding;6;2;GO:0005576
GO:2001078;(1->6)-beta-D-glucan binding;0;0;GO:0005125
GO:2001079;beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc binding;0;0;GO:0005529
GO:2001096;cellotriose transport;0;0;GO:0006869
GO:2001097;laminaritriose transport;0;0;GO:0006836
GO:0000939;inner kinetochore;1876;196;GO:0005819
GO:2001098;tetrasaccharide transport;0;0;GO:0005576
GO:0000938;GARP complex;13677;79;GO:0005829
GO:2001099;maltotetraose transport;0;0;GO:0006869
GO:0000937;dolipore septum;0;3;GO:0008544
GO:2001092;arabinotriose transport;0;0;GO:0006869
GO:0000936;primary cell septum;58;6;GO:0005618
GO:2001093;galactotriose transport;0;1;GO:0006836
GO:0000935;division septum;431;53;GO:0048285
GO:2001094;xylotriose transport;0;0;GO:0006869
GO:0000934;porous cell septum;3;2;GO:0048471
GO:2001095;mannotriose transport;0;0;GO:0006826
GO:0000933;adventitious septum;0;2;GO:0048706
GO:0000932;P-body;43781;1570;GO:0005840
GO:0000931;gamma-tubulin ring complex;2910;182;GO:0005819
GO:2001090;maltotriulose transport;0;0;GO:0006869
GO:0000930;gamma-tubulin complex;14158;830;GO:0005819
GO:2001091;nigerotriose transport;0;0;GO:0006869
GO:0071295;cellular response to vitamin;1259;710;GO:0009719
GO:0071296;cellular response to biotin;0;1;GO:0009719
GO:0071293;cellular response to tellurium ion;0;1;GO:0046686
GO:0071294;cellular response to zinc ion;646;1640;GO:0006879
GO:0071299;cellular response to vitamin A;2;9;GO:0009725
GO:0071297;cellular response to cobalamin;0;4;GO:0009765
GO:0071298;cellular response to L-ascorbic acid;6;5;GO:0009719
GO:2001089;maltotriose transport;0;0;GO:0006869
GO:0000949;aromatic amino acid family catabolic process to alcohol via Ehrlich pathway;240;8;GO:0009065
GO:0000948;amino acid catabolic process to carboxylic acid via Ehrlich pathway;0;3;GO:0009062
GO:0000947;amino acid catabolic process to alcohol via Ehrlich pathway;306;103;GO:0009062
GO:0000943;retrotransposon nucleocapsid;93;103;GO:0005730
GO:0000940;outer kinetochore;33840;637;GO:0005819
GO:0071291;cellular response to selenium ion;5;2;GO:0046686
GO:0071292;cellular response to silver ion;8;2;GO:0043407
GO:0071290;cellular response to platinum ion;0;1;GO:0097194
GO:0071284;cellular response to lead ion;51;66;GO:0043207
GO:0071285;cellular response to lithium ion;660;730;GO:0043407
GO:0071282;cellular response to iron(II) ion;3;2;GO:0006826
GO:0071283;cellular response to iron(III) ion;45;39;GO:0006826
GO:0071288;cellular response to mercury ion;181;141;GO:0043407
GO:0071289;cellular response to nickel ion;6;2;GO:0006979
GO:0071286;cellular response to magnesium ion;313;69;GO:0006874
GO:0071287;cellular response to manganese ion;207;506;GO:0006836
GO:0000919;cell plate assembly;314;8;GO:0005840
GO:0000918;division septum site selection;24;157;GO:0007067
GO:0000917;division septum assembly;177085;140;GO:0048285
GO:0000916;actomyosin contractile ring contraction;608;53;GO:0007049
GO:0000915;actomyosin contractile ring assembly;4020;218;GO:0007088
GO:0000914;phragmoplast assembly;665;9;GO:0048285
GO:0000913;preprophase band assembly;76;4;GO:0000976
GO:0000912;assembly of actomyosin apparatus involved in cytokinesis;4698;44;GO:0007067
GO:0000911;cytokinesis by cell plate formation;3970;503;GO:0007067
GO:0000910;cytokinesis;607513;6430;GO:0007067
GO:0000923;equatorial microtubule organizing center;623;41;GO:0005813
GO:0000922;spindle pole;44316;3540;GO:0005819
GO:0000921;septin ring assembly;3886;133;GO:0048193
GO:0000920;septum digestion after cytokinesis;545;120;GO:0006936
GO:0048809;analia morphogenesis;0;1;GO:0048608
GO:0048808;male genitalia morphogenesis;522;34;GO:0009952
GO:0048807;female genitalia morphogenesis;153;48;GO:0007565
GO:0048806;genitalia development;3166;781;GO:0009952
GO:0009200;deoxyribonucleoside triphosphate metabolic process;5542;195;GO:0006796
GO:0009204;deoxyribonucleoside triphosphate catabolic process;5212;163;GO:0009063
GO:0048801;antennal joint morphogenesis;19;1;GO:0048608
GO:0009203;ribonucleoside triphosphate catabolic process;230;657;GO:0009063
GO:0048800;antennal morphogenesis;211;10;GO:0008544
GO:0009202;deoxyribonucleoside triphosphate biosynthetic process;201;10;GO:0006793
GO:0009201;ribonucleoside triphosphate biosynthetic process;2924138;1030;GO:0006793
GO:0009208;pyrimidine ribonucleoside triphosphate metabolic process;336408;6;GO:0006793
GO:0048805;imaginal disc-derived genitalia morphogenesis;219;0;GO:0048608
GO:0009207;purine ribonucleoside triphosphate catabolic process;47;769;GO:0009060
GO:0048804;imaginal disc-derived female genitalia morphogenesis;39;2;GO:0008544
GO:0009206;purine ribonucleoside triphosphate biosynthetic process;2588021;1540;GO:0006793
GO:0048803;imaginal disc-derived male genitalia morphogenesis;180;10;GO:0048608
GO:0009205;purine ribonucleoside triphosphate metabolic process;2775272;3020;GO:0006793
GO:0048802;notum morphogenesis;48;7;GO:0048608
GO:0048819;regulation of hair follicle maturation;497;3;GO:0048608
GO:0048818;positive regulation of hair follicle maturation;279;3;GO:0048608
GO:0000839;Hrd1p ubiquitin ligase ERAD-L complex;536;62;GO:0005783
GO:0048817;negative regulation of hair follicle maturation;95;3;GO:0048608
GO:0000838;Hrd1p ubiquitin ligase ERAD-M complex;6;6;GO:0005783
GO:0000837;Doa10p ubiquitin ligase complex;109;9;GO:0005576
GO:0000836;Hrd1p ubiquitin ligase complex;635;45;GO:0005783
GO:0000835;ER ubiquitin ligase complex;812;489;GO:0005634
GO:0000834;inositol heptakisphosphate 6-kinase activity;0;1;GO:0004721
GO:0048812;neuron projection morphogenesis;109554;3690;GO:0043005
GO:0000833;inositol heptakisphosphate 4-kinase activity;0;2;GO:0004721
GO:0048811;male analia morphogenesis;0;0;GO:0007565
GO:0000832;inositol hexakisphosphate 5-kinase activity;6477;126;GO:0004721
GO:0048810;female analia morphogenesis;0;1;GO:0007565
GO:0000831;inositol hexakisphosphate 6-kinase activity;94;5;GO:0004721
GO:0000830;inositol hexakisphosphate 4-kinase activity;31;3;GO:0004721
GO:0048816;ocellus morphogenesis;1;5;GO:0048608
GO:0048814;regulation of dendrite morphogenesis;2971;1310;GO:0048699
GO:0048813;dendrite morphogenesis;8068;3450;GO:0048608
GO:0048829;root cap development;208;159;GO:0048316
GO:0048823;nucleate erythrocyte development;162;4;GO:0008544
GO:0048822;enucleate erythrocyte development;114;9;GO:0007049
GO:0048821;erythrocyte development;3855;1480;GO:0007599
GO:0048820;hair follicle maturation;754;206;GO:0008544
GO:0048827;phyllome development;16641;210;GO:0048707
GO:0048826;cotyledon morphogenesis;252;10;GO:0048706
GO:1902902;negative regulation of autophagosome assembly;777;298;GO:0048193
GO:0048825;cotyledon development;564;169;GO:0009865
GO:0048824;pigment cell precursor differentiation;0;0;GO:0048608
GO:1902900;gut granule assembly;9;2;GO:0008021
GO:0048830;adventitious root development;717;27;GO:0048608
GO:0010220;positive regulation of vernalization response;20;5;GO:0046274
GO:0009233;menaquinone metabolic process;493579;10;GO:0006790
GO:0009232;riboflavin catabolic process;0;3;GO:0009065
GO:0009231;riboflavin biosynthetic process;648968;740;GO:0009065
GO:0009230;thiamine catabolic process;2;6;GO:0006559
GO:0009237;siderophore metabolic process;60084;8;GO:0006749
GO:0009236;cobalamin biosynthetic process;911395;1280;GO:0009065
GO:0009235;cobalamin metabolic process;914203;735;GO:0006790
GO:0009234;menaquinone biosynthetic process;493542;530;GO:0006790
GO:0009239;enterobactin biosynthetic process;21559;31;GO:0009405
GO:0009238;enterobactin metabolic process;21560;5;GO:0009065
GO:0010219;regulation of vernalization response;72;8;GO:0045746
GO:0010218;response to far red light;581;605;GO:0009765
GO:0010215;cellulose microfibril organization;4177;424;GO:0032989
GO:0010214;seed coat development;588;225;GO:0009908
GO:0010211;IAA-Leu conjugate hydrolase activity;8;2;GO:0004553
GO:0010210;IAA-Phe conjugate hydrolase activity;8;1;GO:0046274
GO:0010213;non-photoreactive DNA repair;52;7;GO:0006281
GO:0010212;response to ionizing radiation;15680;2750;GO:0009628
GO:0009240;isopentenyl diphosphate biosynthetic process;288665;471;GO:0006725
GO:0010231;maintenance of seed dormancy;168;22;GO:0009832
GO:0010230;alternative respiration;370;8;GO:0009060
GO:0009244;lipopolysaccharide core region biosynthetic process;73212;428;GO:0009405
GO:0009243;O antigen biosynthetic process;19741;594;GO:0006021
GO:0009242;colanic acid biosynthetic process;33;9;GO:0009405
GO:0009248;K antigen biosynthetic process;0;2;GO:0006021
GO:0009247;glycolipid biosynthetic process;669006;851;GO:0006631
GO:0009246;enterobacterial common antigen biosynthetic process;49389;38;GO:0009405
GO:0009245;lipid A biosynthetic process;542571;885;GO:0009405
GO:0009249;protein lipoylation;36;1870;GO:0006464
GO:0010229;inflorescence development;452;315;GO:0048316
GO:0010226;response to lithium ion;776;586;GO:0097159
GO:0010225;response to UV-C;840;574;GO:0009416
GO:0010228;vegetative to reproductive phase transition of meristem;8063;1250;GO:0048316
GO:0010227;floral organ abscission;1613;222;GO:0009908
GO:0010222;stem vascular tissue pattern formation;125;40;GO:0048731
GO:0010221;negative regulation of vernalization response;2;3;GO:0010468
GO:0010224;response to UV-B;3019;1140;GO:0009628
GO:0010223;secondary shoot formation;998;307;GO:0048707
GO:0009211;pyrimidine deoxyribonucleoside triphosphate metabolic process;169768;6;GO:0006793
GO:0009210;pyrimidine ribonucleoside triphosphate catabolic process;182;3;GO:0009060
GO:0009215;purine deoxyribonucleoside triphosphate metabolic process;2549;19;GO:0006796
GO:0009214;cyclic nucleotide catabolic process;17423;348;GO:0006561
GO:0009213;pyrimidine deoxyribonucleoside triphosphate catabolic process;49680;93;GO:0009063
GO:0009212;pyrimidine deoxyribonucleoside triphosphate biosynthetic process;119175;171;GO:0006793
GO:0009219;pyrimidine deoxyribonucleotide metabolic process;421923;508;GO:0006793
GO:0009218;pyrimidine ribonucleotide metabolic process;812369;90;GO:0006518
GO:0009217;purine deoxyribonucleoside triphosphate catabolic process;2427;8;GO:0009065
GO:0009216;purine deoxyribonucleoside triphosphate biosynthetic process;48;3;GO:0006796
GO:0009209;pyrimidine ribonucleoside triphosphate biosynthetic process;336117;8;GO:0006793
GO:0009222;pyrimidine ribonucleotide catabolic process;766;3;GO:0009063
GO:0009221;pyrimidine deoxyribonucleotide biosynthetic process;370571;23;GO:0006793
GO:0009220;pyrimidine ribonucleotide biosynthetic process;811472;1240;GO:0006520
GO:0009226;nucleotide-sugar biosynthetic process;491749;991;GO:0006032
GO:0009225;nucleotide-sugar metabolic process;662114;1010;GO:0005976
GO:0009224;CMP biosynthetic process;19826;137;GO:0006796
GO:0009223;pyrimidine deoxyribonucleotide catabolic process;50438;9;GO:0009063
GO:0009229;thiamine diphosphate biosynthetic process;234964;184;GO:0006749
GO:0009228;thiamine biosynthetic process;681508;2340;GO:0006749
GO:0009227;nucleotide-sugar catabolic process;28;10;GO:0006073
GO:0010208;pollen wall assembly;1218;295;GO:0009913
GO:0010207;photosystem II assembly;6317;799;GO:0009579
GO:0010209;vacuolar sorting signal binding;7;2;GO:0008037
GO:0010203;response to very low fluence red light stimulus;1;3;GO:0009416
GO:0010206;photosystem II repair;3180;231;GO:0046274
GO:0010205;photoinhibition;76;396;GO:0009416
GO:0010200;response to chitin;317;3710;GO:0045087
GO:0010202;response to low fluence red light stimulus;10;5;GO:0009416
GO:0010201;response to continuous far red light stimulus by the high-irradiance response system;4;6;GO:0009416
GO:0009273;peptidoglycan-based cell wall biogenesis;2282742;160;GO:0009277
GO:0010262;somatic embryogenesis;88;126;GO:0048608
GO:0009272;fungal-type cell wall biogenesis;2646;266;GO:0042546
GO:0009271;phage shock;3422;63;GO:0043169
GO:0010264;myo-inositol hexakisphosphate biosynthetic process;250;26;GO:0006030
GO:0061850;growth cone leading edge;9;2;GO:0048608
GO:0009270;response to humidity;87;8;GO:0009415
GO:0010263;tricyclic triterpenoid biosynthetic process;3;5;GO:0046274
GO:0061851;leading edge of lamellipodium;142;6;GO:0002504
GO:0009277;fungal-type cell wall;7284;535;GO:0031224
GO:0034233;regulation of cell wall chitin catabolic process;0;3;GO:0046274
GO:0009276;Gram-negative-bacterium-type cell wall;27101;20;GO:0022617
GO:0034232;ascospore wall chitin catabolic process;6;4;GO:0006032
GO:0009275;Gram-positive-bacterium-type cell wall;14;1;GO:0022617
GO:0034231;islet amyloid polypeptide processing;6;5;GO:0006486
GO:0009274;peptidoglycan-based cell wall;59662;1270;GO:0009277
GO:0034230;enkephalin processing;63;8;GO:0009060
GO:0046215;siderophore catabolic process;2;2;GO:0009065
GO:0048878;chemical homeostasis;736122;3210;GO:0042592
GO:0061856;Golgi calcium ion transmembrane transport;2;1;GO:0006836
GO:1902952;positive regulation of dendritic spine maintenance;180;45;GO:0048608
GO:0046216;indole phytoalexin catabolic process;0;2;GO:0046274
GO:0048877;homeostasis of number of retina cells;101;5;GO:0050789
GO:0061857;endoplasmic reticulum stress-induced pre-emptive quality control;117;9;GO:0006986
GO:1902953;positive regulation of ER to Golgi vesicle-mediated transport;314;100;GO:0006986
GO:0009279;cell outer membrane;2191252;2120;GO:0005576
GO:0046213;methyl ethyl ketone catabolic process;0;2;GO:0046274
GO:1902950;regulation of dendritic spine maintenance;441;123;GO:0048608
GO:0046214;enterobactin catabolic process;1;3;GO:0009065
GO:1902951;negative regulation of dendritic spine maintenance;139;10;GO:0048608
GO:0046219;indolalkylamine biosynthetic process;1206955;39;GO:0009065
GO:0061852;retrograde transporter complex, Golgi to ER;190;3;GO:0005764
GO:1902956;regulation of mitochondrial electron transport, NADH to ubiquinone;250;7;GO:0005747
GO:0061853;regulation of neuroblast migration;19;1;GO:0048699
GO:1902957;negative regulation of mitochondrial electron transport, NADH to ubiquinone;50;112;GO:0045944
GO:0046217;indole phytoalexin metabolic process;143;8;GO:0009629
GO:0061854;positive regulation of neuroblast migration;0;1;GO:0048608
GO:1902954;regulation of early endosome to recycling endosome transport;137;10;GO:0048193
GO:0061855;negative regulation of neuroblast migration;13;5;GO:0048704
GO:1902955;positive regulation of early endosome to recycling endosome transport;56;22;GO:0048193
GO:0048881;mechanosensory lateral line system development;2665;1;GO:0048405
GO:1902949;positive regulation of tau-protein kinase activity;17;67;GO:0043406
GO:0048880;sensory system development;56337;244;GO:0007608
GO:1902947;regulation of tau-protein kinase activity;26;36;GO:0043406
GO:1902948;negative regulation of tau-protein kinase activity;6;98;GO:0043406
GO:0046222;aflatoxin metabolic process;1589;105;GO:0009065
GO:0048885;neuromast deposition;426;3;GO:0048608
GO:0046223;aflatoxin catabolic process;12;38;GO:0009065
GO:0048884;neuromast development;2503;10;GO:0007517
GO:0046220;pyridine biosynthetic process;0;4;GO:0006021
GO:0048883;neuromast primordium migration;520;3;GO:0048704
GO:0046221;pyridine catabolic process;0;4;GO:0009065
GO:0048882;lateral line development;3567;2;GO:0008544
GO:0010258;NADH dehydrogenase complex (plastoquinone) assembly;1258;34;GO:0005746
GO:0034224;cellular response to zinc ion starvation;151;10;GO:0009739
GO:0034223;regulation of ascospore wall chitin biosynthetic process;0;2;GO:0010401
GO:0010255;glucose mediated signaling pathway;873;141;GO:0007186
GO:0010254;nectary development;32;9;GO:0009953
GO:0034229;ethanolamine transport;5776;9;GO:0006869
GO:0010257;NADH dehydrogenase complex assembly;23391;1730;GO:0005743
GO:0034228;ethanolamine transmembrane transporter activity;2888;9;GO:0005576
GO:0010256;endomembrane system organization;215821;1140;GO:0005789
GO:0034227;tRNA thio-modification;77048;313;GO:0006519
GO:0010273;detoxification of copper ion;399;418;GO:0006836
GO:0010272;response to silver ion;108;18;GO:0046686
GO:0010275;NAD(P)H dehydrogenase complex assembly;1383;9;GO:0005743
GO:0010274;hydrotropism;3472;17;GO:0009414
GO:0061840;high-affinity ferrous iron transmembrane transporter activity;24;0;GO:0008544
GO:0009288;bacterial-type flagellum;1371977;592;GO:0044421
GO:0034222;regulation of cell wall chitin metabolic process;0;2;GO:0046274
GO:0034221;fungal-type cell wall chitin biosynthetic process;266;195;GO:0006032
GO:1902960;negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;6;10;GO:0048608
GO:0010271;regulation of chlorophyll catabolic process;97;8;GO:0046274
GO:0034220;monoatomic ion transmembrane transport;21472630;921;GO:0015075
GO:0010270;photosystem II oxygen evolving complex assembly;114;6;GO:0009579
GO:0046226;coumarin catabolic process;9;25;GO:0009065
GO:0048889;neuromast support cell differentiation;0;1;GO:0048608
GO:0061845;neuron projection branch point;19;1;GO:0043005
GO:1902963;negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process;6;9;GO:0048405
GO:0048888;neuromast mantle cell differentiation;35;3;GO:0048703
GO:0061846;dendritic spine cytoplasm;4;2;GO:0097458
GO:1902964;positive regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process;0;0;GO:0048405
GO:0046224;bacteriocin metabolic process;79;5;GO:0046275
GO:0048887;cupula development;0;1;GO:0048608
GO:0061847;response to cholecystokinin;16;5;GO:0009967
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;12;53;GO:0048608
GO:0009289;pilus;136244;355;GO:0073455
GO:0046225;bacteriocin catabolic process;0;3;GO:0046274
GO:0048886;neuromast hair cell differentiation;1018;3;GO:0048608
GO:0061848;cellular response to cholecystokinin;0;2;GO:0006954
GO:1902962;regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process;6;7;GO:0048407
GO:0061841;high-affinity iron exporter complex;12;1;GO:0008565
GO:1900304;negative regulation of laminaritriose transport;0;0;GO:0048193
GO:1902967;protein localization to mitotic spindle midzone;0;0;GO:0007062
GO:0061842;microtubule organizing center localization;2036;6;GO:0005819
GO:1900303;regulation of laminaritriose transport;0;0;GO:0006869
GO:0046228;2,4,5-trichlorophenoxyacetic acid catabolic process;2;4;GO:0046148
GO:0061843;Sertoli cell barrier remodeling;3;3;GO:0048193
GO:1900306;regulation of maltoheptaose transport;0;0;GO:0006869
GO:1902965;regulation of protein localization to early endosome;487;8;GO:0048193
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;3554;698;GO:0002526
GO:1900305;positive regulation of laminaritriose transport;0;0;GO:0048193
GO:1902966;positive regulation of protein localization to early endosome;487;339;GO:0048193
GO:0048892;lateral line nerve development;412;2;GO:0048704
GO:0046230;2-aminobenzenesulfonate catabolic process;0;4;GO:0009065
GO:0048891;lateral line ganglion neuron differentiation;0;2;GO:0048704
GO:0048890;lateral line ganglion development;67;2;GO:0048704
GO:1902958;positive regulation of mitochondrial electron transport, NADH to ubiquinone;182;223;GO:0045935
GO:1902959;regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;21;10;GO:0048608
GO:0048896;lateral line nerve glial cell migration;0;1;GO:0048704
GO:0061849;telomeric G-quadruplex DNA binding;110;9;GO:0003677
GO:0048895;lateral line nerve glial cell differentiation;177;4;GO:0048704
GO:0048894;efferent axon development in a lateral line nerve;84;5;GO:0048704
GO:0046232;carbazole catabolic process;9;2;GO:0009062
GO:0048893;afferent axon development in lateral line nerve;35;1;GO:0048704
GO:0034215;thiamine:proton symporter activity;4;0;GO:0005215
GO:0010269;response to selenium ion;201;208;GO:0046395
GO:0034214;protein hexamerization;1562;600;GO:0008083
GO:0034213;quinolinate catabolic process;169;6;GO:0009065
GO:0034212;peptide N-acetyltransferase activity;156033;148;GO:0009065
GO:0010266;response to vitamin B1;58;61;GO:0009719
GO:0034219;carbohydrate transmembrane transport;1160113;759;GO:0008544
GO:0010265;SCF complex assembly;6750;265;GO:0005840
GO:0034218;ascospore wall chitin metabolic process;60;3;GO:0006030
GO:0010268;brassinosteroid homeostasis;1140;79;GO:0009725
GO:0034217;ascospore wall chitin biosynthetic process;54;3;GO:0006030
GO:0010267;ta-siRNA processing;317;3;GO:0008033
GO:0034216;high-affinity thiamine:proton symporter activity;4;0;GO:0005215
GO:0009251;glucan catabolic process;152884;475;GO:0006073
GO:0010240;plastid pyruvate dehydrogenase complex;1;3;GO:0005737
GO:0061870;positive regulation of hepatic stellate cell migration;10;2;GO:0048010
GO:0009250;glucan biosynthetic process;421161;1050;GO:0006073
GO:0061871;negative regulation of hepatic stellate cell migration;5;1;GO:0048010
GO:0010242;oxygen evolving activity;34529;34;GO:0009579
GO:0061872;hepatic stellate cell contraction;7;1;GO:0048407
GO:0010241;ent-kaurene oxidation to kaurenoic acid;792;6;GO:0009813
GO:0061873;regulation of hepatic stellate cell contraction;7;1;GO:0048010
GO:0009255;Entner-Doudoroff pathway through 6-phosphogluconate;30936;211;GO:0006096
GO:0034211;GTP-dependent protein kinase activity;68;8;GO:0004721
GO:1902970;premeiotic DNA replication DNA duplex unwinding;0;0;GO:0007050
GO:0009254;peptidoglycan turnover;128490;307;GO:0009063
GO:1902971;mitotic DNA replication DNA duplex unwinding;0;1;GO:0007067
GO:0009253;peptidoglycan catabolic process;196917;1180;GO:0006032
GO:0009252;peptidoglycan biosynthetic process;2217827;2270;GO:0009405
GO:0009259;ribonucleotide metabolic process;7573359;2390;GO:0006364
GO:1900311;positive regulation of maltoheptaose metabolic process;0;0;GO:0046395
GO:1902974;meiotic DNA replication initiation;30;3;GO:0000786
GO:0009258;10-formyltetrahydrofolate catabolic process;5555;87;GO:0009065
GO:0048899;anterior lateral line development;221;0;GO:0008544
GO:1900310;negative regulation of maltoheptaose metabolic process;0;0;GO:0046395
GO:1902975;mitotic DNA replication initiation;4522;70;GO:0000786
GO:0009257;10-formyltetrahydrofolate biosynthetic process;151;77;GO:0006790
GO:0048898;anterior lateral line system development;293;1;GO:0008544
GO:1900313;negative regulation of maltohexaose transport;0;0;GO:0006869
GO:1902972;premeiotic DNA replication DNA ligation;0;1;GO:0006260
GO:0009256;10-formyltetrahydrofolate metabolic process;5710;49;GO:0006790
GO:0046236;mandelate biosynthetic process;0;2;GO:0006073
GO:0048897;myelination of lateral line nerve axons;133;3;GO:0048704
GO:1900312;regulation of maltohexaose transport;0;0;GO:0006869
GO:1902973;mitotic DNA replication DNA ligation;0;1;GO:0007049
GO:0061874;positive regulation of hepatic stellate cell contraction;5;2;GO:0048010
GO:1900315;regulation of maltopentaose transport;0;0;GO:0006869
GO:1902978;premeiotic DNA replication termination;0;1;GO:0000786
GO:0061875;negative regulation of hepatic stellate cell contraction;2;2;GO:0048010
GO:1900314;positive regulation of maltohexaose transport;0;0;GO:0006869
GO:1902979;mitotic DNA replication termination;3580;6;GO:0000786
GO:0046239;phthalate catabolic process;6;7;GO:0046356
GO:1900317;positive regulation of maltopentaose transport;0;0;GO:0046395
GO:1902976;premeiotic DNA replication preinitiation complex assembly;0;1;GO:0000786
GO:1900316;negative regulation of maltopentaose transport;0;0;GO:0006874
GO:1902977;mitotic DNA replication preinitiation complex assembly;219;8;GO:0000786
GO:1900308;positive regulation of maltoheptaose transport;0;0;GO:0006869
GO:1900307;negative regulation of maltoheptaose transport;0;0;GO:0006874
GO:1902969;mitotic DNA replication;12429;168;GO:0007049
GO:1900309;regulation of maltoheptaose metabolic process;0;0;GO:0046394
GO:0046244;salicylic acid catabolic process;22;34;GO:0046274
GO:0034204;lipid translocation;159774;906;GO:0006629
GO:0010236;plastoquinone biosynthetic process;990;105;GO:0006767
GO:0034203;glycolipid translocation;123;6;GO:0006629
GO:0010239;chloroplast mRNA processing;808;9;GO:0006364
GO:0034202;glycolipid floppase activity;3;4;GO:0005576
GO:0010238;response to proline;6;2;GO:0006950
GO:0034201;response to oleic acid;81;64;GO:0006979
GO:0010233;phloem transport;126;20;GO:0006810
GO:0010232;vascular transport;1065;224;GO:0006811
GO:0010235;guard mother cell cytokinesis;85;8;GO:0007067
GO:0034206;enhanceosome;0;3;GO:0048285
GO:0010234;anther wall tapetum cell fate specification;16;4;GO:0048707
GO:0034205;amyloid-beta formation;2797;44;GO:0007568
GO:0009262;deoxyribonucleotide metabolic process;606419;500;GO:0006259
GO:0009261;ribonucleotide catabolic process;27401;774;GO:0009063
GO:0010250;S-methylmethionine biosynthetic process;0;5;GO:0009065
GO:0061860;DNA clamp unloader activity;164;5;GO:0005524
GO:0009260;ribonucleotide biosynthetic process;6621408;1360;GO:0006520
GO:0010253;UDP-rhamnose biosynthetic process;158;17;GO:0006022
GO:0061862;cellular response to differentiation-inducing factor 2;0;1;GO:0045766
GO:0009266;response to temperature stimulus;248555;4310;GO:0009266
GO:0034200;D,D-heptose 1,7-bisphosphate phosphatase activity;421;2;GO:0006066
GO:1902981;synthesis of RNA primer involved in mitotic DNA replication;12;2;GO:0007049
GO:0009265;2'-deoxyribonucleotide biosynthetic process;372156;7;GO:0009063
GO:1902982;DNA strand elongation involved in premeiotic DNA replication;0;2;GO:0007050
GO:0009264;deoxyribonucleotide catabolic process;112466;798;GO:0006271
GO:1900320;positive regulation of methane biosynthetic process from dimethylamine;0;0;GO:0045944
GO:0009263;deoxyribonucleotide biosynthetic process;486026;1160;GO:0009059
GO:1902980;synthesis of RNA primer involved in premeiotic DNA replication;0;1;GO:0005524
GO:0046248;alpha-pinene biosynthetic process;18;5;GO:1901363
GO:0061867;establishment of mitotic spindle asymmetry;18;3;GO:0048285
GO:1900322;negative regulation of maltotetraose transport;0;0;GO:0006874
GO:1902985;mitotic pre-replicative complex assembly;6;2;GO:0000786
GO:0009269;response to desiccation;6968;574;GO:0006950
GO:0046249;alpha-pinene catabolic process;0;2;GO:0046274
GO:0061868;hepatic stellate cell migration;15;1;GO:0048010
GO:1900321;regulation of maltotetraose transport;0;0;GO:0006869
GO:1902986;regulation of lysine biosynthetic process via aminoadipic acid;4;0;GO:0046395
GO:0009268;response to pH;10893;672;GO:0045735
GO:0046246;terpene biosynthetic process;13596;287;GO:0016114
GO:0061869;regulation of hepatic stellate cell migration;15;1;GO:0048010
GO:1900324;regulation of maltotriulose transport;0;0;GO:0006869
GO:1902983;DNA strand elongation involved in mitotic DNA replication;358;6;GO:0007067
GO:0009267;cellular response to starvation;107636;3920;GO:0006950
GO:0046247;terpene catabolic process;2764;5;GO:0046274
GO:1900323;positive regulation of maltotetraose transport;0;0;GO:0046395
GO:1902984;pre-replicative complex assembly involved in premeiotic DNA replication;0;1;GO:0000786
GO:0061863;microtubule plus end polymerase;6400;4;GO:0005524
GO:1900326;positive regulation of maltotriulose transport;0;0;GO:0010401
GO:1902989;meiotic telomere maintenance via semi-conservative replication;0;0;GO:0007040
GO:0061864;basement membrane constituent secretion;122;2;GO:0005578
GO:1900325;negative regulation of maltotriulose transport;0;0;GO:0010468
GO:0061865;polarized secretion of basement membrane proteins in epithelium;80;1;GO:0008021
GO:1900328;negative regulation of mannotriose transport;0;0;GO:0006874
GO:1902987;negative regulation of lysine biosynthetic process via aminoadipic acid;0;0;GO:0046395
GO:1900327;regulation of mannotriose transport;0;0;GO:0006865
GO:1902988;neurofibrillary tangle assembly;108;9;GO:0048167
GO:0046251;limonene catabolic process;1;3;GO:0009062
GO:1900319;negative regulation of methane biosynthetic process from dimethylamine;0;0;GO:0045944
GO:0046252;toluene biosynthetic process;0;2;GO:0006721
GO:1900318;regulation of methane biosynthetic process from dimethylamine;0;1;GO:0045944
GO:0046250;limonene biosynthetic process;9;4;GO:0009813
GO:0046256;2,4,6-trinitrotoluene catabolic process;21;5;GO:0046148
GO:0046253;anaerobic toluene biosynthetic process;0;1;GO:0009061
GO:0046254;anaerobic toluene catabolic process;0;2;GO:0009065
GO:0010248;establishment or maintenance of transmembrane electrochemical gradient;1614;452;GO:0048471
GO:0010247;detection of phosphate ion;7;5;GO:0006874
GO:0010249;auxin conjugate metabolic process;6;2;GO:0006749
GO:0010244;response to low fluence blue light stimulus by blue low-fluence system;188;9;GO:0009416
GO:0010243;response to organonitrogen compound;189608;2020;GO:0019748
GO:0010246;rhamnogalacturonan I biosynthetic process;31;7;GO:0005976
GO:0010245;radial microtubular system formation;8;2;GO:0048285
GO:0034272;phosphatidylinositol 3-kinase complex, class III, type II;753;182;GO:0005576
GO:0034271;phosphatidylinositol 3-kinase complex, class III, type I;563;67;GO:0005520
GO:0034270;Cvt complex;28;7;GO:0005764
GO:0048839;inner ear development;22465;2110;GO:0007586
GO:0034277;ent-cassa-12,15-diene synthase activity;4;4;GO:0004497
GO:0034276;kynurenic acid biosynthetic process;85;4;GO:0009065
GO:0034275;kynurenic acid metabolic process;85;4;GO:0006583
GO:0034274;Atg12-Atg5-Atg16 complex;766;37;GO:0005764
GO:0048834;specification of petal number;9;3;GO:0048316
GO:0061812;cyclic ADP-ribose hydrolase;55;2;GO:0004867
GO:0048833;specification of floral organ number;142;99;GO:0048316
GO:0048832;specification of plant organ number;142;1;GO:0048468
GO:0048831;regulation of shoot system development;12097;327;GO:0048731
GO:0061815;Met1-linked polyubiquitin deubiquitinase activity;96;3;GO:0004867
GO:0048838;release of seed from dormancy;63;126;GO:0048471
GO:1902912;pyruvate kinase complex;6;35;GO:0005975
GO:0048837;sorocarp sorus development;136;2;GO:0048608
GO:1902913;positive regulation of neuroepithelial cell differentiation;142;5;GO:0048666
GO:0048836;specification of increased petal number;0;0;GO:0048706
GO:0061810;NAD glycohydrolase activity;6978;5;GO:0004553
GO:1902910;positive regulation of melanosome transport;47;8;GO:0048193
GO:0048835;specification of decreased petal number;0;1;GO:0048706
GO:0061811;ADP-ribosyl cyclase activity;55;2;GO:0004721
GO:1902911;protein kinase complex;74252;512;GO:0006468
GO:1902905;positive regulation of supramolecular fiber organization;11637;103;GO:0048608
GO:1902906;proteasome storage granule assembly;75;4;GO:0005840
GO:1902903;regulation of supramolecular fiber organization;118223;480;GO:0048608
GO:1902904;negative regulation of supramolecular fiber organization;82058;89;GO:0048608
GO:0048841;regulation of axon extension involved in axon guidance;1482;945;GO:0048608
GO:0061816;proteaphagy;0;0;GO:0006914
GO:1902909;negative regulation of melanosome transport;0;2;GO:0048193
GO:0048840;otolith development;1702;140;GO:0048608
GO:0061817;endoplasmic reticulum-plasma membrane tethering;9021;16;GO:0005929
GO:0061818;tRNA folding;7;0;GO:0006413
GO:1902907;proteasome storage granule disassembly;0;0;GO:0005740
GO:0061819;telomeric DNA-containing double minutes formation;168;6;GO:0007030
GO:1902908;regulation of melanosome transport;126;7;GO:0048193
GO:0034269;discadenine catabolic process;0;2;GO:0009065
GO:0034268;discadenine biosynthetic process;0;2;GO:0009065
GO:0034267;discadenine metabolic process;0;5;GO:0006749
GO:0010299;detoxification of cobalt ion;0;4;GO:0006836
GO:0010298;dihydrocamalexic acid decarboxylase activity;4;4;GO:0009065
GO:0034260;negative regulation of GTPase activity;72;664;GO:0005085
GO:0034266;isopentenyl adenine catabolic process;0;1;GO:0009065
GO:0034265;isopentenyl adenine biosynthetic process;1;1;GO:0006725
GO:0034264;isopentenyl adenine metabolic process;1;4;GO:0006725
GO:0034263;positive regulation of autophagy in response to ER overload;13;9;GO:0046164
GO:0048845;venous blood vessel morphogenesis;576;798;GO:0048514
GO:0061801;laminin-5B complex;0;0;GO:0005576
GO:0048844;artery morphogenesis;4591;1330;GO:0001944
GO:0061802;anterior cell cortex;33;3;GO:0009952
GO:1902920;poly(hydroxyvalerate) metabolic process;0;0;GO:0006081
GO:0048843;negative regulation of axon extension involved in axon guidance;826;918;GO:0048608
GO:0061803;posterior cell cortex;90;3;GO:0048471
GO:0048842;positive regulation of axon extension involved in axon guidance;298;489;GO:0048608
GO:0061804;mitotic spindle formation (spindle phase one);203;5;GO:0000910
GO:0048849;neurohypophysis formation;0;2;GO:0048608
GO:1902923;poly(3-hydroxyvalerate) biosynthetic process;0;0;GO:0009405
GO:0048848;neurohypophysis morphogenesis;35;3;GO:0048608
GO:1902924;poly(hydroxyalkanoate) biosynthetic process from glucose;0;3;GO:0009405
GO:0048847;adenohypophysis formation;0;1;GO:0007548
GO:1902921;poly(hydroxyvalerate) biosynthetic process;0;0;GO:0009405
GO:0048846;axon extension involved in axon guidance;2178;1260;GO:0048608
GO:0061800;fibronectin fibril;0;2;GO:0005578
GO:1902922;poly(3-hydroxyvalerate) metabolic process;0;0;GO:0006081
GO:0061809;NAD+ nucleotidase, cyclic ADP-ribose generating;2680;25;GO:0004721
GO:1902916;positive regulation of protein polyubiquitination;969;30;GO:0016567
GO:1902917;positive regulation of mating projection assembly;11;4;GO:0048608
GO:1902914;regulation of protein polyubiquitination;1465;7;GO:0016567
GO:1902915;negative regulation of protein polyubiquitination;337;36;GO:0042787
GO:0048852;diencephalon morphogenesis;246;111;GO:0048704
GO:0061805;mitotic spindle elongation (spindle phase three);36;5;GO:0000910
GO:0048851;hypophysis formation;0;2;GO:0007548
GO:0061806;regulation of DNA recombination at centromere;67;2;GO:0007076
GO:0048850;hypophysis morphogenesis;186;30;GO:0048608
GO:0061807;positive regulation of DNA recombination at centromere;0;0;GO:0007050
GO:1902918;poly(5-hydroxyvalerate) metabolic process;0;0;GO:0006081
GO:0036201;ent-isokaurene C2-hydroxylase activity;4;3;GO:0006096
GO:0036202;ent-cassa-12,15-diene 11-hydroxylase activity;12;3;GO:0004497
GO:0000269;toxin export channel activity;0;3;GO:0008544
GO:0000268;peroxisome targeting sequence binding;4002;56;GO:0008037
GO:0000266;mitochondrial fission;18905;1520;GO:0007041
GO:0000276;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);48703;1570;GO:0005746
GO:0000275;mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1);4408;314;GO:0005746
GO:0000274;mitochondrial proton-transporting ATP synthase, stator stalk;442;27;GO:0005746
GO:1990850;H-gal-GP complex;0;2;GO:0005576
GO:1990851;Wnt-Frizzled-LRP5/6 complex;132;7;GO:0009986
GO:0000272;polysaccharide catabolic process;617830;2490;GO:0005976
GO:1990852;protein transport along microtubule to spindle pole body;3;0;GO:0006986
GO:0000271;polysaccharide biosynthetic process;1246104;2190;GO:0009405
GO:0000270;peptidoglycan metabolic process;2680592;661;GO:0006064
GO:1990854;vacuole-ER tethering;5;2;GO:0005743
GO:1990856;methionyl-initiator methionine tRNA binding;154;4;GO:0003735
GO:1990858;cellular response to lectin;520;10;GO:0006952
GO:1990859;cellular response to endothelin;26;19;GO:0002576
GO:0014884;detection of muscle inactivity involved in regulation of muscle adaptation;0;1;GO:0048405
GO:0014883;transition between fast and slow fiber;400;258;GO:0048608
GO:0014882;regulation of myofibril number;0;3;GO:0048608
GO:0014881;regulation of myofibril size;66;7;GO:0048608
GO:0014880;regulation of muscle filament sliding involved in regulation of the velocity of shortening in skeletal muscle contraction;0;2;GO:0006936
GO:0000239;pachytene;0;71;GO:0007049
GO:0000238;zygotene;0;6;GO:0007049
GO:0000237;leptotene;0;17;GO:0009566
GO:0000236;mitotic prometaphase;0;154;GO:0000278
GO:0000235;astral microtubule;914;580;GO:0007088
GO:0000234;phosphoethanolamine N-methyltransferase activity;757;34;GO:0004734
GO:0000243;commitment complex;3377;357;GO:0005634
GO:0002895;regulation of central B cell tolerance induction;59;3;GO:0002704
GO:0000242;pericentriolar material;1254;631;GO:0005829
GO:0002896;negative regulation of central B cell tolerance induction;0;2;GO:0002729
GO:1990860;Pho85-Pho80 CDK-cyclin complex;66;5;GO:0005524
GO:0000241;diakinesis;0;5;GO:0009566
GO:0002897;positive regulation of central B cell tolerance induction;59;8;GO:0048364
GO:1990861;Ubp3-Bre5 deubiquitination complex;27;1;GO:0048193
GO:0000240;diplotene;0;3;GO:0009566
GO:0002898;regulation of central B cell deletion;0;3;GO:0050729
GO:1990862;nuclear membrane complex Bqt3-Bqt4;1092;2;GO:0005634
GO:0002899;negative regulation of central B cell deletion;0;1;GO:0050729
GO:1990863;acinar cell proliferation;62;4;GO:0042127
GO:1990864;response to growth hormone-releasing hormone;3;1;GO:0009719
GO:1990867;response to gastrin;6;2;GO:0002768
GO:1990868;response to chemokine;47355;155;GO:0006935
GO:0014879;detection of electrical stimulus involved in regulation of muscle adaptation;0;1;GO:0008092
GO:1990869;cellular response to chemokine;47355;426;GO:0071346
GO:0014878;response to electrical stimulus involved in regulation of muscle adaptation;21;210;GO:0006936
GO:0014877;response to muscle inactivity involved in regulation of muscle adaptation;249;10;GO:0048405
GO:0014876;response to injury involved in regulation of muscle adaptation;39;9;GO:0048407
GO:0014875;detection of muscle activity involved in regulation of muscle adaptation;0;2;GO:0048608
GO:0014874;response to stimulus involved in regulation of muscle adaptation;433;266;GO:0048407
GO:0014895;smooth muscle hypertrophy;7;145;GO:0048608
GO:0014894;response to denervation involved in regulation of muscle adaptation;249;213;GO:0048405
GO:0014893;response to rest involved in regulation of muscle adaptation;0;2;GO:0048405
GO:0014891;striated muscle atrophy;241;216;GO:0048407
GO:0014890;smooth muscle atrophy;0;2;GO:0048608
GO:0000249;C-22 sterol desaturase activity;39;7;GO:0004497
GO:0000248;C-5 sterol desaturase activity;192;28;GO:0004497
GO:0000247;C-8 sterol isomerase activity;197;23;GO:0004497
GO:0000246;delta24(24-1) sterol reductase activity;244;17;GO:0004497
GO:0000245;spliceosomal complex assembly;81443;1340;GO:0000398
GO:0000244;spliceosomal tri-snRNP complex assembly;151114;1900;GO:0008033
GO:1990880;cellular detoxification of copper ion;0;3;GO:0006836
GO:0000254;C-4 methylsterol oxidase activity;502;273;GO:0004497
GO:0000253;3-keto sterol reductase activity;825;229;GO:0004067
GO:1990871;Vma12-Vma22 assembly complex;23;1;GO:0005737
GO:0000252;C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity;105;106;GO:0004497
GO:0000250;lanosterol synthase activity;176;86;GO:0004497
GO:1990874;vascular associated smooth muscle cell proliferation;2733;9;GO:0048608
GO:1990875;nucleoplasmic side of nuclear pore;11;3;GO:0005730
GO:1990876;cytoplasmic side of nuclear pore;54;27;GO:0005730
GO:1990877;FNIP-folliculin RagC/D GAP;482;5;GO:0005576
GO:1990878;cellular response to gastrin;3;2;GO:0009725
GO:1990879;CST complex;3454;252;GO:0005819
GO:0014889;muscle atrophy;518;180;GO:0048608
GO:0014888;striated muscle adaptation;2151;217;GO:0048407
GO:0014887;cardiac muscle adaptation;1072;264;GO:0048407
GO:0014886;transition between slow and fast fiber;55;6;GO:0048608
GO:0014885;detection of injury involved in regulation of muscle adaptation;0;2;GO:0048407
GO:0036375;Kibra-Ex-Mer complex;35;7;GO:0048608
GO:0061331;epithelial cell proliferation involved in Malpighian tubule morphogenesis;124;15;GO:0042127
GO:0036376;sodium ion export across plasma membrane;18285;70;GO:0006836
GO:0061332;Malpighian tubule bud morphogenesis;40;145;GO:0048706
GO:0036377;arbuscular mycorrhizal association;497;5;GO:0045734
GO:0061333;renal tubule morphogenesis;6429;682;GO:0042127
GO:0036378;calcitriol biosynthetic process from calciol;655;40;GO:0006767
GO:0061334;cell rearrangement involved in Malpighian tubule morphogenesis;19;2;GO:0048285
GO:0036371;protein localization to T-tubule;35;47;GO:0005743
GO:1904852;trimethylamine-N-oxide reductase (cytochrome c) complex;2;1;GO:0008030
GO:0036372;opsin transport;265;5;GO:0006836
GO:1904851;positive regulation of establishment of protein localization to telomere;523;343;GO:0048285
GO:0036373;L-fucose mutarotase activity;1325;5;GO:0004553
GO:1904850;negative regulation of establishment of protein localization to telomere;49;3;GO:0048285
GO:0036374;glutathione hydrolase activity;113795;386;GO:0004364
GO:0061330;Malpighian tubule stellate cell differentiation;39;8;GO:0048608
GO:0061339;establishment or maintenance of monopolar cell polarity;1518;332;GO:0048471
GO:1904856;cytolytic granule lumen;0;2;GO:0005737
GO:1904855;proteasome regulatory particle binding;121;1;GO:0005840
GO:0048359;mucilage metabolic process involved in seed coat development;252;8;GO:0010468
GO:1904854;proteasome core complex binding;5;6;GO:0005840
GO:0036370;D-alanyl carrier activity;3969;35;GO:0005525
GO:0048358;mucilage pectin biosynthetic process;84;4;GO:0005976
GO:1904853;protein localization to ascospore wall;0;0;GO:0005737
GO:0061335;cell growth involved in Malpighian tubule morphogenesis;0;2;GO:0048608
GO:0061336;cell morphogenesis involved in Malpighian tubule morphogenesis;1;3;GO:0048608
GO:1904859;positive regulation of endothelial cell chemotaxis to vascular endothelial growth factor;0;2;GO:0050727
GO:0061337;cardiac conduction;8104;1820;GO:0004872
GO:1904858;negative regulation of endothelial cell chemotaxis to vascular endothelial growth factor;3;4;GO:0030599
GO:1904857;regulation of endothelial cell chemotaxis to vascular endothelial growth factor;3;1;GO:0030599
GO:0048364;root development;21024;2200;GO:0048316
GO:0048363;mucilage pectin metabolic process;96;5;GO:0005976
GO:0048362;pedicel mucilage metabolic process;0;1;GO:0005976
GO:0048361;root epithelial mucilage metabolic process;0;2;GO:0046274
GO:0048368;lateral mesoderm development;927;229;GO:0009952
GO:0048367;shoot system development;59338;1060;GO:0048731
GO:0048366;leaf development;12340;1270;GO:0048316
GO:0036368;cone photoresponse recovery;283;4;GO:0009579
GO:0048360;root cap mucilage metabolic process;0;2;GO:0005976
GO:0036364;transforming growth factor beta1 activation;128;1;GO:0030516
GO:0061320;pericardial nephrocyte differentiation;137;67;GO:0048193
GO:0036365;transforming growth factor beta2 activation;1;1;GO:0030516
GO:0061321;garland nephrocyte differentiation;27;10;GO:0048608
GO:0036366;transforming growth factor beta3 activation;53;1;GO:0030516
GO:0061322;disseminated nephrocyte differentiation;0;0;GO:0048193
GO:0036367;light adaption;345;6;GO:0009416
GO:0061323;cell proliferation involved in heart morphogenesis;1154;8;GO:0042127
GO:0036360;sorocarp stalk morphogenesis;20;4;GO:0048706
GO:1902200;3-methylbut-2-enoyl-CoA(4-) biosynthetic process;0;0;GO:0006631
GO:1904863;regulation of beta-catenin-TCF complex assembly;128;0;GO:0048316
GO:0036361;racemase activity, acting on amino acids and derivatives;590943;173;GO:0009065
GO:1902201;negative regulation of bacterial-type flagellum-dependent cell motility;982;9;GO:0048308
GO:1904862;inhibitory synapse assembly;1140;85;GO:0048608
GO:0036362;ascus membrane;8;6;GO:0005576
GO:1904861;excitatory synapse assembly;1452;343;GO:0048608
GO:0036363;transforming growth factor beta activation;672;22;GO:0030516
GO:1904860;DNA synthesis involved in mitotic DNA replication;57;0;GO:0007050
GO:0061328;posterior Malpighian tubule development;53;8;GO:0048608
GO:1902204;positive regulation of hepatocyte growth factor receptor signaling pathway;76;2;GO:0048010
GO:1904867;protein localization to Cajal body;188;24;GO:0005840
GO:0061329;Malpighian tubule principal cell differentiation;0;2;GO:0048608
GO:1902205;regulation of interleukin-2-mediated signaling pathway;93;0;GO:0050727
GO:1904866;ventral tegmental area development;0;0;GO:0048608
GO:1902202;regulation of hepatocyte growth factor receptor signaling pathway;224;10;GO:0048010
GO:1904865;positive regulation of beta-catenin-TCF complex assembly;0;0;GO:0048364
GO:0048369;lateral mesoderm morphogenesis;147;8;GO:0009952
GO:1902203;negative regulation of hepatocyte growth factor receptor signaling pathway;45;7;GO:0048010
GO:1904864;negative regulation of beta-catenin-TCF complex assembly;128;3;GO:0048316
GO:0061324;canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation;54;48;GO:0048704
GO:1902208;regulation of bacterial-type flagellum assembly;25882;9;GO:0048446
GO:0061325;cell proliferation involved in outflow tract morphogenesis;119;6;GO:0048608
GO:1902209;negative regulation of bacterial-type flagellum assembly;5346;6;GO:0048193
GO:0061326;renal tubule development;9769;591;GO:0007566
GO:1902206;negative regulation of interleukin-2-mediated signaling pathway;93;3;GO:0050727
GO:1904869;regulation of protein localization to Cajal body;119;261;GO:0048193
GO:0061327;anterior Malpighian tubule development;211;16;GO:0009952
GO:1902207;positive regulation of interleukin-2-mediated signaling pathway;0;0;GO:0050727
GO:1904868;telomerase catalytic core complex assembly;359;7;GO:0005737
GO:0048375;negative regulation of lateral mesodermal cell fate determination;0;0;GO:0048704
GO:0048374;regulation of lateral mesodermal cell fate determination;0;1;GO:0048704
GO:0048373;lateral mesodermal cell fate determination;0;0;GO:0009952
GO:0048372;lateral mesodermal cell fate commitment;55;10;GO:0009952
GO:0048379;positive regulation of lateral mesodermal cell fate specification;0;2;GO:0048704
GO:0048378;regulation of lateral mesodermal cell fate specification;55;90;GO:0048704
GO:0048377;lateral mesodermal cell fate specification;55;5;GO:0009952
GO:0048376;positive regulation of lateral mesodermal cell fate determination;0;0;GO:0048704
GO:0036357;2-phosphoglycerate kinase activity;0;1;GO:0003824
GO:0048371;lateral mesodermal cell differentiation;145;9;GO:0048608
GO:0036358;lipoteichoic acid D-alanylation;0;1;GO:0002538
GO:0048370;lateral mesoderm formation;147;7;GO:0009952
GO:0036359;renal potassium excretion;110;8;GO:0006811
GO:0036353;histone H2A-K119 monoubiquitination;0;291;GO:0042379
GO:1904870;negative regulation of protein localization to Cajal body;0;0;GO:0048193
GO:0036354;2-desacetyl-2-hydroxyethyl bacteriochlorophyllide a dehydrogenase activity;1071;2;GO:0006089
GO:0061354;planar cell polarity pathway involved in pericardium morphogenesis;52;5;GO:0048608
GO:0036355;2-iminoacetate synthase activity;1848;4;GO:0006032
GO:0061355;Wnt protein secretion;596;54;GO:0008021
GO:0036356;cyclic 2,3-diphosphoglycerate synthetase activity;255;0;GO:0006096
GO:0061356;regulation of Wnt protein secretion;345;6;GO:0048407
GO:1902211;regulation of prolactin signaling pathway;3;0;GO:0030518
GO:1904874;positive regulation of telomerase RNA localization to Cajal body;220;340;GO:0048285
GO:0036350;mannose-specific flocculation;0;1;GO:0005929
GO:0061350;planar cell polarity pathway involved in cardiac muscle tissue morphogenesis;61;9;GO:0048608
GO:1902212;negative regulation of prolactin signaling pathway;0;0;GO:0048608
GO:1904873;negative regulation of telomerase RNA localization to Cajal body;0;1;GO:0048285
GO:0036351;histone H2A-K13 ubiquitination;0;6;GO:0016567
GO:0061351;neural precursor cell proliferation;13250;571;GO:0048699
GO:1904872;regulation of telomerase RNA localization to Cajal body;436;56;GO:0048285
GO:0036352;histone H2A-K15 ubiquitination;0;5;GO:0016567
GO:0061352;cell chemotaxis involved in Malpighian tubule morphogenesis;19;3;GO:0048285
GO:1902210;positive regulation of bacterial-type flagellum assembly;6;2;GO:0048446
GO:1904871;positive regulation of protein localization to Cajal body;119;347;GO:0048193
GO:1902215;negative regulation of interleukin-4-mediated signaling pathway;47;2;GO:0050729
GO:1904878;negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;164;5;GO:0048407
GO:1902216;positive regulation of interleukin-4-mediated signaling pathway;100;5;GO:0050729
GO:1904877;positive regulation of DNA ligase activity;3;4;GO:0004812
GO:1902213;positive regulation of prolactin signaling pathway;3;2;GO:0030516
GO:1904876;negative regulation of DNA ligase activity;2;2;GO:0006360
GO:1902214;regulation of interleukin-4-mediated signaling pathway;147;3;GO:0050729
GO:1904875;regulation of DNA ligase activity;5;3;GO:0006313
GO:0061357;positive regulation of Wnt protein secretion;284;38;GO:0048407
GO:1902219;negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress;251;188;GO:0043066
GO:0061358;negative regulation of Wnt protein secretion;61;10;GO:0048407
GO:0000399;cellular bud neck septin structure;602;4;GO:0005912
GO:0061359;regulation of Wnt signaling pathway by Wnt protein secretion;2;1;GO:0048407
GO:1902217;erythrocyte apoptotic process;100;0;GO:0008219
GO:0000398;mRNA splicing, via spliceosome;689817;9230;GO:0000398
GO:1902218;regulation of intrinsic apoptotic signaling pathway in response to osmotic stress;377;8;GO:0043066
GO:1904879;positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;14;45;GO:0048407
GO:0048386;positive regulation of retinoic acid receptor signaling pathway;273;148;GO:0030528
GO:0048385;regulation of retinoic acid receptor signaling pathway;1010;277;GO:0030528
GO:0048384;retinoic acid receptor signaling pathway;6745;677;GO:0030528
GO:0048383;mesectoderm development;53;3;GO:0009952
GO:0048389;intermediate mesoderm development;157;8;GO:0008544
GO:0048388;endosomal lumen acidification;198;204;GO:0008026
GO:0048387;negative regulation of retinoic acid receptor signaling pathway;426;879;GO:0030528
GO:0036346;cellular response to L-cysteine;0;2;GO:0006979
GO:0048382;mesendoderm development;741;149;GO:0007530
GO:0048381;lateral mesoderm structural organization;0;1;GO:0048704
GO:0036348;hydantoin racemase activity;247;2;GO:0006081
GO:0048380;negative regulation of lateral mesodermal cell fate specification;0;2;GO:0048704
GO:0036349;galactose-specific flocculation;6;3;GO:0005976
GO:0036342;post-anal tail morphogenesis;1523;630;GO:0048704
GO:0061342;regulation of cell adhesion involved in heart morphogenesis by non-canonical Wnt signaling pathway;0;0;GO:0048608
GO:1904881;cellular response to hydrogen sulfide;66;4;GO:0050890
GO:0036343;psychomotor behavior;236;36;GO:0007610
GO:0061343;cell adhesion involved in heart morphogenesis;436;142;GO:0007517
GO:1904880;response to hydrogen sulfide;113;2;GO:0050890
GO:0036344;platelet morphogenesis;1181;143;GO:0048514
GO:0061344;regulation of cell adhesion involved in heart morphogenesis;4;5;GO:0022610
GO:0036345;platelet maturation;47;6;GO:0002576
GO:0061345;planar cell polarity pathway involved in cardiac muscle cell fate commitment;0;1;GO:0048608
GO:1902222;erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process;109448;1380;GO:0009065
GO:1904885;beta-catenin destruction complex assembly;0;70;GO:0004842
GO:1902223;erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process;130324;2;GO:0006099
GO:1904884;positive regulation of telomerase catalytic core complex assembly;106;33;GO:0048285
GO:0036340;chitin-based cuticle sclerotization by biomineralization;0;2;GO:0048305
GO:0061340;establishment or maintenance of monopolar cell polarity regulating cell shape;0;1;GO:0048608
GO:1902220;positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress;47;4;GO:0043066
GO:1904883;negative regulation of telomerase catalytic core complex assembly;0;0;GO:0048285
GO:0036341;chitin-based cuticle sclerotization by protein cross-linking;0;1;GO:0005576
GO:0061341;non-canonical Wnt signaling pathway involved in heart development;273;7;GO:0009952
GO:1902221;erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process;239837;1750;GO:0006096
GO:1904882;regulation of telomerase catalytic core complex assembly;106;8;GO:0007049
GO:1902226;regulation of macrophage colony-stimulating factor signaling pathway;189;8;GO:0030530
GO:1904889;regulation of excitatory synapse assembly;674;4;GO:0048167
GO:1902227;negative regulation of macrophage colony-stimulating factor signaling pathway;144;151;GO:0050727
GO:1904888;cranial skeletal system development;8947;607;GO:0007518
GO:1902224;ketone body metabolic process;10947;1440;GO:0006081
GO:1904887;Wnt signalosome assembly;60;6;GO:0005634
GO:1902225;negative regulation of acrosome reaction;5;2;GO:0048193
GO:1904886;beta-catenin destruction complex disassembly;100;145;GO:0007050
GO:0061346;planar cell polarity pathway involved in heart morphogenesis;271;8;GO:0009952
GO:0061347;planar cell polarity pathway involved in outflow tract morphogenesis;52;8;GO:0048608
GO:0061348;planar cell polarity pathway involved in ventricular septum morphogenesis;52;8;GO:0009952
GO:1902228;positive regulation of macrophage colony-stimulating factor signaling pathway;45;26;GO:0050727
GO:0061349;planar cell polarity pathway involved in cardiac right atrium morphogenesis;52;5;GO:0048608
GO:1902229;regulation of intrinsic apoptotic signaling pathway in response to DNA damage;2863;51;GO:0042981
GO:0048397;positive regulation of intermediate mesodermal cell fate determination;0;0;GO:0048704
GO:0048396;negative regulation of intermediate mesodermal cell fate determination;0;1;GO:0048704
GO:0048395;regulation of intermediate mesodermal cell fate determination;0;1;GO:0048704
GO:0048394;intermediate mesodermal cell fate determination;0;1;GO:0009952
GO:0048399;regulation of intermediate mesodermal cell fate specification;0;1;GO:0048704
GO:0048398;intermediate mesodermal cell fate specification;0;3;GO:0009952
GO:0036339;lymphocyte adhesion to endothelial cell of high endothelial venule;51;3;GO:0030155
GO:0036335;intestinal stem cell homeostasis;632;96;GO:0045765
GO:0048393;intermediate mesodermal cell fate commitment;0;3;GO:0009952
GO:0036336;dendritic cell migration;1114;553;GO:0030924
GO:0048392;intermediate mesodermal cell differentiation;68;17;GO:0045595
GO:0036337;Fas signaling pathway;291;28;GO:0006915
GO:0048391;intermediate mesoderm formation;68;7;GO:0008544
GO:0036338;viral membrane;1365575;52;GO:0016021
GO:0048390;intermediate mesoderm morphogenesis;68;7;GO:0048704
GO:0048317;seed morphogenesis;94;16;GO:0048316
GO:1904812;rRNA acetylation involved in maturation of SSU-rRNA;118;3;GO:0006470
GO:0048316;seed development;14580;1220;GO:0009813
GO:1904811;positive regulation of dense core granule transport;72;3;GO:0048193
GO:0048315;conidium formation;9319;157;GO:0048304
GO:1904810;negative regulation of dense core granule transport;39;1;GO:0048193
GO:0048314;embryo sac morphogenesis;7;4;GO:0048608
GO:1904816;positive regulation of protein localization to chromosome, telomeric region;633;46;GO:0048285
GO:1904815;negative regulation of protein localization to chromosome, telomeric region;108;133;GO:0048285
GO:0048319;axial mesoderm morphogenesis;236;8;GO:0048704
GO:1904814;regulation of protein localization to chromosome, telomeric region;741;46;GO:0048285
GO:0048318;axial mesoderm development;600;27;GO:0009952
GO:1904813;ficolin-1-rich granule lumen;124;1400;GO:0005576
GO:0048320;axial mesoderm formation;158;200;GO:0007530
GO:0051961;negative regulation of nervous system development;7577;604;GO:0050789
GO:1904809;regulation of dense core granule transport;121;2;GO:0048193
GO:0051962;positive regulation of nervous system development;16885;884;GO:0048699
GO:1904808;positive regulation of protein oxidation;57;10;GO:0046395
GO:1904807;negative regulation of protein oxidation;10;3;GO:0046395
GO:0051960;regulation of nervous system development;29712;2630;GO:0048699
GO:1904806;regulation of protein oxidation;67;8;GO:0006979
GO:0048324;regulation of axial mesodermal cell fate determination;0;2;GO:0048704
GO:0048323;axial mesodermal cell fate determination;0;2;GO:0048704
GO:0048322;axial mesodermal cell fate commitment;53;4;GO:0048704
GO:0048321;axial mesodermal cell differentiation;53;3;GO:0045595
GO:0051969;regulation of transmission of nerve impulse;663;664;GO:0048666
GO:0051967;negative regulation of synaptic transmission, glutamatergic;240;1350;GO:0048167
GO:0051968;positive regulation of synaptic transmission, glutamatergic;706;1570;GO:0048167
GO:0051965;positive regulation of synapse assembly;3776;2030;GO:0048167
GO:0051966;regulation of synaptic transmission, glutamatergic;2054;2390;GO:0048167
GO:0051963;regulation of synapse assembly;13236;1030;GO:0048167
GO:0051964;negative regulation of synapse assembly;795;60;GO:0048167
GO:0048328;regulation of axial mesodermal cell fate specification;1;2;GO:0048704
GO:1904823;purine nucleobase transmembrane transport;56911;9;GO:0008528
GO:0048327;axial mesodermal cell fate specification;53;7;GO:0048704
GO:0048326;positive regulation of axial mesodermal cell fate determination;0;2;GO:0048704
GO:1904821;chloroplast disassembly;134;1;GO:0048285
GO:0048325;negative regulation of axial mesodermal cell fate determination;0;1;GO:0048704
GO:1904820;peritoneum development;0;0;GO:0001944
GO:1904827;negative regulation of hydrogen sulfide biosynthetic process;1;1;GO:0046323
GO:1904826;regulation of hydrogen sulfide biosynthetic process;88;0;GO:0046323
GO:1904825;protein localization to microtubule plus-end;158;6;GO:0007049
GO:0048329;negative regulation of axial mesodermal cell fate specification;1;3;GO:0048704
GO:1904824;anaphase-promoting complex assembly;1;1;GO:0000724
GO:0048331;axial mesoderm structural organization;2;2;GO:0048704
GO:0051972;regulation of telomerase activity;87;238;GO:0007050
GO:0048330;positive regulation of axial mesodermal cell fate specification;0;2;GO:0048704
GO:0051973;positive regulation of telomerase activity;62;1260;GO:0045944
GO:1904819;parietal peritoneum development;0;1;GO:0007517
GO:0051970;negative regulation of transmission of nerve impulse;120;259;GO:0048666
GO:1904818;visceral peritoneum development;0;0;GO:0007596
GO:0051971;positive regulation of transmission of nerve impulse;308;326;GO:0048666
GO:1904817;serous membrane development;0;0;GO:0001944
GO:0048335;negative regulation of mesodermal cell fate determination;2;3;GO:0048704
GO:0048334;regulation of mesodermal cell fate determination;2;3;GO:0048704
GO:0048333;mesodermal cell differentiation;2701;1150;GO:0030182
GO:0048332;mesoderm morphogenesis;5759;324;GO:0048513
GO:0051978;lysophospholipid:sodium symporter activity;1410;4;GO:0005515
GO:0051979;alginic acid acetylation;6;2;GO:0008037
GO:0051976;lysine biosynthetic process via alpha-aminoadipate and N2-acetyl-alpha-aminoadipate;0;1;GO:0006541
GO:0051977;lysophospholipid transport;2979;7;GO:0006869
GO:0051974;negative regulation of telomerase activity;15;455;GO:0045944
GO:0051975;lysine biosynthetic process via alpha-aminoadipate and saccharopine;4;1;GO:0006541
GO:0036397;formate dehydrogenase (quinone) activity;1149;5;GO:0003954
GO:0036398;TCR signalosome;65;49;GO:0002757
GO:0061310;canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development;2;1;GO:0048704
GO:0036399;TCR signalosome assembly;6;7;GO:0007219
GO:0061311;cell surface receptor signaling pathway involved in heart development;1567;152;GO:0007186
GO:0036393;thiocyanate peroxidase activity;70;4;GO:0004601
GO:1904830;negative regulation of aortic smooth muscle cell differentiation;1;1;GO:0048608
GO:0036394;amylase secretion;6;3;GO:0005976
GO:0036395;pancreatic amylase secretion;4;2;GO:0007596
GO:0036396;RNA N6-methyladenosine methyltransferase complex;2468;149;GO:0043405
GO:0048339;paraxial mesoderm development;1260;1850;GO:0009952
GO:0061317;canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment;168;8;GO:0048704
GO:0036390;pre-replicative complex assembly involved in bacterial-type DNA replication;0;1;GO:0006260
GO:0048338;mesoderm structural organization;55;4;GO:0048513
GO:0061318;renal filtration cell differentiation;1669;123;GO:0048193
GO:1904833;positive regulation of removal of superoxide radicals;0;4;GO:0046395
GO:0036391;medial cortex septin ring;64;4;GO:0005829
GO:0048337;positive regulation of mesodermal cell fate specification;119;4;GO:0048704
GO:0061319;nephrocyte differentiation;164;1;GO:0048193
GO:1904832;negative regulation of removal of superoxide radicals;12;2;GO:0046395
GO:0036392;chemokine (C-C motif) ligand 20 production;52;2;GO:0050921
GO:0048336;positive regulation of mesodermal cell fate determination;0;2;GO:0048704
GO:1904831;positive regulation of aortic smooth muscle cell differentiation;64;3;GO:0048608
GO:0061313;fibroblast growth factor receptor signaling pathway involved in heart development;0;0;GO:0048010
GO:1904838;regulation of male germ-line stem cell asymmetric division;1;0;GO:0048608
GO:0061314;Notch signaling involved in heart development;442;411;GO:0007517
GO:1904837;beta-catenin-TCF complex assembly;129;343;GO:0048316
GO:0061315;canonical Wnt signaling pathway involved in positive regulation of cardiac muscle cell proliferation;0;0;GO:0048010
GO:1904836;facioacoustic ganglion morphogenesis;0;0;GO:0048704
GO:0061316;canonical Wnt signaling pathway involved in heart development;396;5;GO:0007631
GO:1904835;dorsal root ganglion morphogenesis;70;29;GO:0048704
GO:0048342;paraxial mesodermal cell differentiation;126;3;GO:0045595
GO:0051983;regulation of chromosome segregation;27593;1820;GO:0051301
GO:0048341;paraxial mesoderm formation;449;391;GO:0007530
GO:0051984;positive regulation of chromosome segregation;1943;1460;GO:0051321
GO:0048340;paraxial mesoderm morphogenesis;616;175;GO:0048704
GO:0051981;copper chelate transmembrane transporter activity;0;0;GO:0005215
GO:1904829;regulation of aortic smooth muscle cell differentiation;66;0;GO:0048608
GO:0051982;copper-nicotianamine transmembrane transporter activity;0;1;GO:0008544
GO:1904828;positive regulation of hydrogen sulfide biosynthetic process;87;3;GO:0046323
GO:0048346;positive regulation of paraxial mesodermal cell fate determination;0;2;GO:0048704
GO:0048345;regulation of paraxial mesodermal cell fate determination;0;2;GO:0048704
GO:0051980;iron-nicotianamine transmembrane transporter activity;133;3;GO:0008565
GO:0048344;paraxial mesodermal cell fate determination;0;2;GO:0009952
GO:0048343;paraxial mesodermal cell fate commitment;96;8;GO:0009952
GO:0051989;coproporphyrinogen dehydrogenase activity;46019;316;GO:0006073
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;774;223;GO:0048285
GO:0051988;regulation of attachment of spindle microtubules to kinetochore;3234;1910;GO:0007018
GO:0051985;negative regulation of chromosome segregation;18990;972;GO:0051321
GO:0051986;negative regulation of attachment of spindle microtubules to kinetochore;15;2;GO:0048285
GO:0036386;bacterial nucleoid packaging;278;0;GO:0030529
GO:0036387;pre-replicative complex;12613;37;GO:0000786
GO:0036388;pre-replicative complex assembly;1342;132;GO:0000786
GO:0061300;cerebellum vasculature development;382;77;GO:0048598
GO:0036389;bacterial pre-replicative complex;0;0;GO:0005737
GO:0061301;cerebellum vasculature morphogenesis;53;5;GO:0048856
GO:0036382;flavin reductase (NADH) activity;1860;2;GO:0004067
GO:1904841;TORC2 complex binding;144;4;GO:0005515
GO:0036383;3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione monooxygenase activity;740;0;GO:0004497
GO:1904840;positive regulation of male germ-line stem cell asymmetric division;1;2;GO:0048608
GO:0036384;CDP phosphatase activity;181;2;GO:0004723
GO:1904845;cellular response to L-glutamine;20;34;GO:0006974
GO:0048349;regulation of paraxial mesodermal cell fate specification;0;2;GO:0048704
GO:0061307;cardiac neural crest cell differentiation involved in heart development;847;7;GO:0007517
GO:1904844;response to L-glutamine;25;27;GO:0009065
GO:0036380;UDP-N-acetylglucosamine-undecaprenyl-phosphate N-acetylglucosaminephosphotransferase activity;10235;5;GO:0006029
GO:0048348;paraxial mesodermal cell fate specification;1;4;GO:0009952
GO:0061308;cardiac neural crest cell development involved in heart development;845;25;GO:0007517
GO:1904843;cellular response to nitroglycerin;7;5;GO:0071346
GO:0036381;pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity;66463;3;GO:0004073
GO:0048347;negative regulation of paraxial mesodermal cell fate determination;0;1;GO:0048704
GO:0061309;cardiac neural crest cell development involved in outflow tract morphogenesis;633;16;GO:0048704
GO:1904842;response to nitroglycerin;11;3;GO:0042592
GO:0061302;smooth muscle cell-matrix adhesion;403;55;GO:0007155
GO:1904849;positive regulation of cell chemotaxis to fibroblast growth factor;227;24;GO:0048608
GO:0061303;cornea development in camera-type eye;589;640;GO:0048407
GO:1904848;negative regulation of cell chemotaxis to fibroblast growth factor;48;4;GO:0048608
GO:0061304;retinal blood vessel morphogenesis;406;122;GO:0048513
GO:1904847;regulation of cell chemotaxis to fibroblast growth factor;434;8;GO:0048608
GO:0061305;maintenance of bipolar cell polarity regulating cell shape;0;0;GO:0048608
GO:1904846;negative regulation of establishment of bipolar cell polarity;4;1;GO:0048704
GO:0048353;primary endosperm nucleus;4;4;GO:0005634
GO:0051994;P-methyltransferase activity;0;0;GO:0016567
GO:0048352;paraxial mesoderm structural organization;53;9;GO:0048704
GO:0051995;Se-methyltransferase activity;6;1;GO:0003729
GO:0048351;negative regulation of paraxial mesodermal cell fate specification;0;2;GO:0048704
GO:0051992;UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine:undecaprenyl-phosphate transferase activity;58596;5;GO:0003824
GO:0048350;positive regulation of paraxial mesodermal cell fate specification;0;1;GO:0048704
GO:0051993;abscisic acid glucose ester beta-glucosidase activity;6;3;GO:0004553
GO:1904839;negative regulation of male germ-line stem cell asymmetric division;0;0;GO:0048608
GO:0048357;pedicel mucilage biosynthetic process;0;3;GO:0005976
GO:0051990;(R)-2-hydroxyglutarate dehydrogenase activity;138;0;GO:0004067
GO:0048356;root epithelial mucilage biosynthetic process;0;3;GO:0046395
GO:0051991;UDP-N-acetyl-D-glucosamine:N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine-diphosphoundecaprenol 4-beta-N-acetylglucosaminlytransferase activity;62142;5;GO:0006029
GO:0048355;root cap mucilage biosynthetic process;0;2;GO:0046395
GO:0048354;mucilage biosynthetic process involved in seed coat development;222;148;GO:0048471
GO:0036379;myofilament;15189;227;GO:0005524
GO:0051998;protein carboxyl O-methyltransferase activity;176301;24;GO:0003729
GO:0051999;mannosyl-inositol phosphorylceramide biosynthetic process;66;3;GO:0006631
GO:0051996;squalene synthase activity;7784;37;GO:0004497
GO:0051997;2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity;9317;7;GO:0004725
GO:1902273;negative regulation of (R)-carnitine transmembrane transport;0;0;GO:0048193
GO:1902274;positive regulation of (R)-carnitine transmembrane transport;38;0;GO:0048193
GO:1902271;D3 vitamins binding;176;6;GO:0097367
GO:1902272;regulation of (R)-carnitine transmembrane transport;38;0;GO:0006836
GO:1902277;negative regulation of pancreatic amylase secretion;2;2;GO:0048193
GO:1902278;positive regulation of pancreatic amylase secretion;2;1;GO:0048193
GO:1902275;regulation of chromatin organization;2689;822;GO:0045727
GO:1902276;regulation of pancreatic amylase secretion;4;0;GO:0048193
GO:1902279;positive regulation of pancreatic amylase secretion by cholecystokinin signaling pathway;0;0;GO:0048193
GO:0097371;MDM2/MDM4 family protein binding;486;215;GO:0005515
GO:0097370;protein O-GlcNAcylation via threonine;54;1;GO:0006493
GO:0097373;MCM core complex;294;9;GO:0005840
GO:0097372;NAD-dependent histone H3K18 deacetylase activity;198;2;GO:0016569
GO:0097364;stretch-activated, monoatomic cation-selective, calcium channel activity involved in regulation of action potential;0;1;GO:0008092
GO:0097363;protein O-acetylglucosaminyltransferase activity;4239;6;GO:0006029
GO:0097366;response to bronchodilator;0;57;GO:0042440
GO:0097365;stretch-activated, monoatomic cation-selective, calcium channel activity involved in regulation of cardiac muscle cell action potential;0;0;GO:0008092
GO:0097368;establishment of Sertoli cell barrier;103;328;GO:0048513
GO:0097367;carbohydrate derivative binding;43513866;3280;GO:0097159
GO:1902270;(R)-carnitine transmembrane transport;2941;0;GO:0006836
GO:1902284;neuron projection extension involved in neuron projection guidance;2178;1180;GO:0048666
GO:1902285;semaphorin-plexin signaling pathway involved in neuron projection guidance;684;166;GO:0007409
GO:1902282;voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;455;360;GO:0048407
GO:1902283;negative regulation of primary amine oxidase activity;3;7;GO:0010467
GO:1902288;regulation of defense response to oomycetes;135;1;GO:0050832
GO:1902289;negative regulation of defense response to oomycetes;29;3;GO:0050832
GO:1902286;semaphorin-plexin signaling pathway involved in dendrite guidance;0;0;GO:0048608
GO:1902287;semaphorin-plexin signaling pathway involved in axon guidance;552;357;GO:0007268
GO:0097380;dorsal spinal cord interneuron anterior axon guidance;9;1;GO:0048704
GO:0097381;photoreceptor disc membrane;619;361;GO:0005576
GO:0097384;cellular lipid biosynthetic process;7050;67;GO:0006629
GO:0097383;dIDP phosphatase activity;14;2;GO:0004723
GO:0097375;spinal sensory neuron axon guidance;0;0;GO:0048704
GO:0097374;sensory neuron axon guidance;398;43;GO:0048666
GO:0097377;spinal cord interneuron axon guidance;71;2;GO:0048666
GO:0097376;interneuron axon guidance;175;2;GO:0048666
GO:0097379;dorsal spinal cord interneuron posterior axon guidance;10;2;GO:0048704
GO:0097378;dorsal spinal cord interneuron axon guidance;19;0;GO:0048704
GO:1902280;regulation of RNA helicase activity;1;4;GO:0003723
GO:1902281;negative regulation of RNA helicase activity;0;2;GO:0010401
GO:0120012;intermembrane sphingolipid transfer;60;1;GO:0009986
GO:1902295;synthesis of RNA primer involved in cell cycle DNA replication;12;1;GO:0006260
GO:0120013;lipid transfer activity;22156;48;GO:0003754
GO:1902296;DNA strand elongation involved in cell cycle DNA replication;358;3;GO:0007050
GO:0120014;phospholipid transfer activity;6109;9;GO:0005576
GO:0120015;sterol transfer activity;4687;30;GO:0003676
GO:1902294;cell cycle DNA replication termination;3580;0;GO:0007049
GO:0120016;sphingolipid transfer activity;892;1;GO:0004867
GO:1902299;pre-replicative complex assembly involved in cell cycle DNA replication;1342;10;GO:0007049
GO:0120017;ceramide transfer activity;717;2;GO:0004867
GO:1902297;cell cycle DNA replication DNA unwinding;0;1;GO:0007049
GO:0120019;phosphatidylcholine transfer activity;358;7;GO:0005576
GO:1902298;cell cycle DNA replication maintenance of fidelity;3075;5;GO:0007049
GO:0097351;toxin sequestering activity;8238;9;GO:0048169
GO:0097350;neutrophil clearance;369;78;GO:0006979
GO:0097342;ripoptosome;361;241;GO:0005737
GO:0097341;zymogen inhibition;44;7;GO:0004872
GO:0097344;Rix1 complex;2480;9;GO:0048285
GO:0097343;ripoptosome assembly;167;67;GO:0008033
GO:0097346;INO80-type complex;28474;26;GO:0005831
GO:0097345;mitochondrial outer membrane permeabilization;1959;95;GO:0006979
GO:0097348;host cell endocytic vesicle membrane;0;0;GO:0005768
GO:0097347;TAM protein secretion complex;20;1;GO:0005737
GO:1902291;cell cycle DNA replication DNA ligation;0;0;GO:0007049
GO:0120020;cholesterol transfer activity;4271;51;GO:0003676
GO:1902292;cell cycle DNA replication initiation;4622;8;GO:0000086
GO:0120021;oxysterol transfer activity;0;0;GO:0003676
GO:0120022;glucagon family peptide binding;47;1;GO:0005549
GO:1902290;positive regulation of defense response to oomycetes;105;3;GO:0050832
GO:0120001;apical plasma membrane urothelial plaque;164;4;GO:0009986
GO:0120002;fusiform vesicle;0;1;GO:0008037
GO:0120003;hinge region between urothelial plaques of apical plasma membrane;32;2;GO:0009986
GO:0120006;regulation of glutamatergic neuron differentiation;58;1;GO:0048666
GO:0120007;negative regulation of glutamatergic neuron differentiation;53;1;GO:0048666
GO:0120008;positive regulation of glutamatergic neuron differentiation;5;1;GO:0048666
GO:0120009;intermembrane lipid transfer;42659;158;GO:0006629
GO:0097360;chorionic trophoblast cell proliferation;210;7;GO:0048608
GO:0097362;MCM8-MCM9 complex;217;9;GO:0005819
GO:0097361;CIA complex;10707;55;GO:0005634
GO:0097353;centrolateral pattern formation;7;0;GO:0048608
GO:0097352;autophagosome maturation;4816;762;GO:0006914
GO:0097355;protein localization to heterochromatin;256;3;GO:0016569
GO:0097354;prenylation;182;10;GO:0006639
GO:0097356;perinucleolar compartment;139;5;GO:0005819
GO:0097359;UDP-glucosylation;14152;90;GO:0006096
GO:0097358;D-leucyl-tRNA(Leu) deacylase activity;10;3;GO:0004867
GO:0120010;intermembrane phospholipid transfer;39;5;GO:0006633
GO:0120011;intermembrane sterol transfer;1;1;GO:0006869
GO:0061375;mammillotectal axonal tract development;0;0;GO:0048704
GO:0120034;positive regulation of plasma membrane bounded cell projection assembly;5634;191;GO:0048193
GO:1904892;regulation of receptor signaling pathway via STAT;5132;28;GO:0007186
GO:0061376;mammillotegmental axonal tract development;0;0;GO:0048704
GO:0120035;regulation of plasma membrane bounded cell projection organization;36539;432;GO:0048471
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;2357;351;GO:0043066
GO:1904891;positive regulation of excitatory synapse assembly;178;8;GO:0048167
GO:0061377;mammary gland lobule development;915;89;GO:0007517
GO:0120036;plasma membrane bounded cell projection organization;292772;398;GO:0048471
GO:1904890;negative regulation of excitatory synapse assembly;14;0;GO:0048167
GO:0061378;corpora quadrigemina development;132;1;GO:0048608
GO:0061371;determination of heart left/right asymmetry;7712;103;GO:0002044
GO:1902233;negative regulation of positive thymic T cell selection;45;3;GO:0045087
GO:1904896;ESCRT complex disassembly;68;152;GO:0007040
GO:0120039;plasma membrane bounded cell projection morphogenesis;110612;342;GO:0048471
GO:1902234;positive regulation of positive thymic T cell selection;0;1;GO:0050821
GO:1904895;ESCRT complex assembly;89;4;GO:0007031
GO:0061373;mammillary axonal complex development;70;8;GO:0048704
GO:1902231;positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage;417;67;GO:0042981
GO:1904894;positive regulation of receptor signaling pathway via STAT;2162;71;GO:0048010
GO:0061374;mammillothalamic axonal tract development;62;3;GO:0048704
GO:1902232;regulation of positive thymic T cell selection;153;42;GO:0042430
GO:1904893;negative regulation of receptor signaling pathway via STAT;1775;69;GO:0030528
GO:1902237;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;458;286;GO:0030968
GO:1902238;regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator;130;0;GO:0043407
GO:1904899;positive regulation of hepatic stellate cell proliferation;19;10;GO:0048010
GO:1902235;regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;1728;227;GO:0030968
GO:1904898;negative regulation of hepatic stellate cell proliferation;1;2;GO:0048010
GO:1902236;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;1113;474;GO:0030968
GO:1904897;regulation of hepatic stellate cell proliferation;20;5;GO:0048010
GO:0061379;inferior colliculus development;114;5;GO:0048704
GO:1902239;negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator;51;1;GO:0043407
GO:0097320;plasma membrane tubulation;3203;713;GO:0007043
GO:0097322;7SK snRNA binding;578;154;GO:0005524
GO:0097321;cell growth mode switching, filamentous to budding;0;1;GO:0048285
GO:0097324;melanocyte migration;376;255;GO:0048452
GO:0097323;B cell adhesion;25;5;GO:0007155
GO:0097326;melanocyte adhesion;59;88;GO:0007155
GO:0097325;melanocyte proliferation;291;92;GO:0048452
GO:0097328;response to carboplatin;5;6;GO:0097194
GO:0097327;response to antineoplastic agent;20;68;GO:0097159
GO:0061380;superior colliculus development;18;1;GO:0048704
GO:0061381;cell migration in diencephalon;61;4;GO:0030900
GO:0097329;response to antimetabolite;0;6;GO:0007049
GO:0120040;regulation of macrophage proliferation;243;2;GO:0050729
GO:0120041;positive regulation of macrophage proliferation;216;10;GO:0050729
GO:0120042;negative regulation of macrophage proliferation;27;3;GO:0050729
GO:0120043;stereocilium shaft;117;3;GO:0005576
GO:0120044;stereocilium base;261;7;GO:0005576
GO:0061364;apoptotic process involved in luteolysis;109;144;GO:0042981
GO:0120023;somatostatin binding;0;1;GO:0005509
GO:1902240;positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator;0;1;GO:0043409
GO:0061365;positive regulation of triglyceride lipase activity;25;785;GO:0010467
GO:1902241;copal-8-ol diphosphate(3-) metabolic process;2;0;GO:0006081
GO:0061366;behavioral response to chemical pain;157;10;GO:0007610
GO:0120025;plasma membrane bounded cell projection;670279;428;GO:0042995
GO:0061367;behavioral response to acetic acid induced pain;50;5;GO:0007610
GO:0120026;host cell uropod;1;0;GO:0048193
GO:0061360;optic chiasma development;7;8;GO:0048608
GO:0120027;regulation of osmosensory signaling pathway;0;1;GO:0009416
GO:1902244;cis-abienol metabolic process;1;1;GO:0006749
GO:0061361;positive regulation of maintenance of bipolar cell polarity regulating cell shape;0;0;GO:0048704
GO:0120028;negative regulation of osmosensory signaling pathway;0;3;GO:0045730
GO:1902245;cis-abienol catabolic process;0;0;GO:0009065
GO:0061362;negative regulation of maintenance of bipolar cell polarity regulating cell shape;0;0;GO:0048706
GO:0120029;proton export across plasma membrane;18346;130;GO:0006830
GO:1902242;copal-8-ol diphosphate(3-) catabolic process;1;0;GO:0046395
GO:0061363;negative regulation of progesterone biosynthesis involved in luteolysis;0;0;GO:0048608
GO:1902243;copal-8-ol diphosphate(3-) biosynthetic process;1;0;GO:0046395
GO:1902248;5-O-phosphono-alpha-D-ribofuranosyl diphosphate binding;0;0;GO:0005524
GO:1902249;IMP binding;0;1;GO:0005524
GO:1902246;cis-abienol biosynthetic process;1;0;GO:0006021
GO:1902247;geranylgeranyl diphosphate catabolic process;50;2;GO:0006631
GO:0061368;behavioral response to formalin induced pain;107;186;GO:0007610
GO:0061369;negative regulation of testicular blood vessel morphogenesis;47;2;GO:0048706
GO:0097340;inhibition of cysteine-type endopeptidase activity;41;83;GO:0004867
GO:0097331;response to cytarabine;0;1;GO:0097159
GO:0097330;response to 5-fluoro-2'-deoxyuridine;0;0;GO:0007049
GO:0097333;response to olanzapine;0;1;GO:0045765
GO:0097332;response to antipsychotic drug;6;6;GO:0045765
GO:0097335;response to quetiapine;0;1;GO:0050867
GO:0097334;response to perphenazine;0;2;GO:0048608
GO:0097337;response to ziprasidone;0;1;GO:0048608
GO:0097336;response to risperidone;0;2;GO:0048608
GO:0097339;glycolate transmembrane transport;2744;4;GO:0006890
GO:0097338;response to clozapine;0;8;GO:0050890
GO:0061370;testosterone biosynthetic process;461;136;GO:0009065
GO:0120030;positive regulation of cilium beat frequency involved in ciliary motility;1;0;GO:0048407
GO:0120031;plasma membrane bounded cell projection assembly;121719;219;GO:0042995
GO:0120032;regulation of plasma membrane bounded cell projection assembly;11751;110;GO:0048193
GO:0120033;negative regulation of plasma membrane bounded cell projection assembly;1697;93;GO:0048193
GO:0120056;large intestinal transit;56;1;GO:0007599
GO:1902251;negative regulation of erythrocyte apoptotic process;51;2;GO:0042981
GO:0120057;regulation of small intestinal transit;11;1;GO:0048207
GO:1902252;positive regulation of erythrocyte apoptotic process;0;0;GO:0042981
GO:0120058;positive regulation of small intestinal transit;11;5;GO:0048207
GO:0120059;negative regulation of small intestinal transit;0;0;GO:0048207
GO:1902250;regulation of erythrocyte apoptotic process;51;0;GO:0042981
GO:1902255;positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator;293;49;GO:0043409
GO:1902256;regulation of apoptotic process involved in outflow tract morphogenesis;71;7;GO:0043066
GO:1902253;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;1556;38;GO:0010941
GO:1902254;negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator;1031;51;GO:0043066
GO:1902259;regulation of delayed rectifier potassium channel activity;78;29;GO:0048407
GO:1902257;negative regulation of apoptotic process involved in outflow tract morphogenesis;68;5;GO:0043066
GO:1902258;positive regulation of apoptotic process involved in outflow tract morphogenesis;0;0;GO:0043066
GO:0097300;programmed necrotic cell death;4545;314;GO:0010942
GO:0097302;lipoprotein biosynthetic process via diacylglyceryl transfer;0;0;GO:0006631
GO:0097304;lipoprotein biosynthetic process via signal peptide cleavage;3;0;GO:0006631
GO:0097303;lipoprotein biosynthetic process via N-acyl transfer;0;0;GO:0006631
GO:0097306;cellular response to alcohol;25800;367;GO:0006950
GO:0097305;response to alcohol;39482;912;GO:0048167
GO:0120060;regulation of gastric emptying;2;1;GO:0048608
GO:0097308;cellular response to farnesol;45;2;GO:0009611
GO:0120061;negative regulation of gastric emptying;2;1;GO:0048608
GO:0097307;response to farnesol;45;0;GO:0009813
GO:0120062;positive regulation of gastric emptying;0;0;GO:0048608
GO:0120063;stomach smooth muscle contraction;11;1;GO:0006936
GO:0097309;cap1 mRNA methylation;2452;8;GO:0045944
GO:0120064;stomach pylorus smooth muscle contraction;9;0;GO:0006936
GO:0120065;pyloric antrum smooth muscle contraction;9;0;GO:0006936
GO:0120066;pyloric canal smooth muscle contraction;0;0;GO:0006936
GO:0061386;closure of optic fissure;2272;160;GO:0007565
GO:0120045;stereocilium maintenance;172;5;GO:0048407
GO:1902262;apoptotic process involved in blood vessel morphogenesis;273;6;GO:0043066
GO:0061387;regulation of extent of cell growth;5359;261;GO:0045944
GO:0120046;regulation of protein localization to medial cortical node;1;0;GO:0048193
GO:1902263;apoptotic process involved in embryonic digit morphogenesis;137;119;GO:0042127
GO:0061388;regulation of rate of cell growth;17;2;GO:0042127
GO:0120047;positive regulation of protein localization to medial cortical node;1;1;GO:0048193
GO:1902260;negative regulation of delayed rectifier potassium channel activity;35;56;GO:0048407
GO:0061389;regulation of direction of cell growth;31;3;GO:0045944
GO:0120048;U6 snRNA (adenine-(43)-N(6))-methyltransferase activity;613;0;GO:0003729
GO:1902261;positive regulation of delayed rectifier potassium channel activity;8;77;GO:0048169
GO:0061382;Malpighian tubule tip cell differentiation;147;10;GO:0048608
GO:0120049;snRNA (adenine-N6)-methylation;121;0;GO:0045944
GO:1902266;intracellular abscisic acid homeostasis;0;0;GO:0009737
GO:0061383;trabecula morphogenesis;2338;141;GO:0048608
GO:1902267;regulation of polyamine transmembrane transport;384;5;GO:0006873
GO:0061384;heart trabecula morphogenesis;1676;186;GO:0048608
GO:0061385;fibroblast proliferation involved in heart morphogenesis;0;1;GO:0048608
GO:1902265;abscisic acid homeostasis;26;3;GO:0009737
GO:1902268;negative regulation of polyamine transmembrane transport;138;114;GO:0048193
GO:1902269;positive regulation of polyamine transmembrane transport;245;17;GO:0048193
GO:0097311;bacterial biofilm matrix;322;1;GO:0072332
GO:0097310;cap2 mRNA methylation;69;2;GO:0045944
GO:0097313;bacterial biofilm matrix surface;0;0;GO:0046364
GO:0097315;response to N-acetyl-D-glucosamine;10;1;GO:0009617
GO:0097314;apoptosome assembly;52;3;GO:0007049
GO:0097317;invasive growth in response to biotic stimulus;0;1;GO:0048608
GO:0061390;positive regulation of direction of cell growth;0;1;GO:0045944
GO:0097316;cellular response to N-acetyl-D-glucosamine;10;5;GO:0009611
GO:0061391;negative regulation of direction of cell growth;0;3;GO:0045944
GO:0097318;invasive growth in response to abiotic stimulus;0;0;GO:0048316
GO:0120053;ribitol beta-1,4-xylosyltransferase activity;91;1;GO:0006022
GO:0120054;intestinal motility;106;196;GO:0007586
GO:0120055;small intestinal transit;11;0;GO:0007599
GO:0120078;cell adhesion involved in sprouting angiogenesis;66;5;GO:0022610
GO:1990770;small intestine smooth muscle contraction;75;9;GO:0006936
GO:1990760;osmolarity-sensing monoatomic cation channel activity;158;7;GO:0005216
GO:1990761;growth cone lamellipodium;36;95;GO:0048608
GO:1990762;cytoplasmic alanyl-tRNA aminoacylation;1;2;GO:0006418
GO:1990763;arrestin family protein binding;423;149;GO:0005515
GO:0002910;positive regulation of peripheral B cell deletion;0;2;GO:0050729
GO:1990764;myofibroblast contraction;84;9;GO:0048010
GO:0002911;regulation of lymphocyte anergy;314;9;GO:0042110
GO:1990765;colon smooth muscle contraction;11;3;GO:0002029
GO:0002912;negative regulation of lymphocyte anergy;3;2;GO:0042430
GO:0002913;positive regulation of lymphocyte anergy;196;91;GO:0042430
GO:1990767;prostaglandin receptor internalization;2;1;GO:0004930
GO:0002914;regulation of central B cell anergy;0;2;GO:0042430
GO:1990768;gastric mucosal blood circulation;11;7;GO:0007596
GO:0002915;negative regulation of central B cell anergy;0;2;GO:0042430
GO:0120082;smooth endoplasmic reticulum cisterna;36;3;GO:0005783
GO:1990769;proximal neuron projection;109;10;GO:0043005
GO:0002916;positive regulation of central B cell anergy;0;3;GO:0042430
GO:0120083;rough endoplasmic reticulum cisterna;0;0;GO:0005783
GO:0002917;regulation of peripheral B cell anergy;0;1;GO:0042430
GO:0120084;endothelial tip cell filopodium assembly;10;1;GO:0048193
GO:0002918;negative regulation of peripheral B cell anergy;0;1;GO:0042430
GO:0002919;positive regulation of peripheral B cell anergy;0;2;GO:0042430
GO:0120086;(3S)-(+)-asterisca-2(9),6-diene synthase activity;1;0;GO:0004497
GO:0120067;pyloric sphincter smooth muscle contraction;0;0;GO:0008092
GO:0120068;regulation of stomach fundus smooth muscle contraction;2;0;GO:0048608
GO:0120069;positive regulation of stomach fundus smooth muscle contraction;2;1;GO:0048608
GO:1990780;cytoplasmic side of dendritic spine plasma membrane;4;4;GO:0009986
GO:1990781;response to immobilization stress combined with electrical stimulus;0;1;GO:0006950
GO:1990771;clathrin-dependent extracellular exosome endocytosis;5;7;GO:0006897
GO:1990772;substance P secretion;4;1;GO:0004930
GO:0014909;smooth muscle cell migration;3146;557;GO:0030509
GO:1990773;matrix metallopeptidase secretion;225;7;GO:0042623
GO:0002920;regulation of humoral immune response;9603;896;GO:0002757
GO:0014908;myotube differentiation involved in skeletal muscle regeneration;563;175;GO:0048667
GO:0002921;negative regulation of humoral immune response;995;410;GO:0002757
GO:1990775;endothelin production;55;1;GO:0008544
GO:0002922;positive regulation of humoral immune response;1814;605;GO:0050729
GO:0014906;myotube cell development involved in skeletal muscle regeneration;53;6;GO:0048667
GO:1990776;response to angiotensin;8597;40;GO:0002676
GO:0002923;regulation of humoral immune response mediated by circulating immunoglobulin;690;910;GO:0002757
GO:0014905;myoblast fusion involved in skeletal muscle regeneration;291;10;GO:0048771
GO:1990777;lipoprotein particle;14992;191;GO:0042803
GO:0002924;negative regulation of humoral immune response mediated by circulating immunoglobulin;308;178;GO:0002757
GO:0014904;myotube cell development;3776;337;GO:0048667
GO:1990778;protein localization to cell periphery;27608;322;GO:0009986
GO:0002925;positive regulation of humoral immune response mediated by circulating immunoglobulin;336;311;GO:0002757
GO:0120070;negative regulation of stomach fundus smooth muscle contraction;0;0;GO:0048608
GO:1990779;glycoprotein Ib-IX-V complex;159;10;GO:0002576
GO:0002926;tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation;344;8;GO:0008544
GO:0014902;myotube differentiation;9945;1170;GO:0048667
GO:0120071;regulation of pyloric antrum smooth muscle contraction;9;0;GO:0048608
GO:0002927;archaeosine-tRNA biosynthetic process;3;5;GO:0009061
GO:0014901;satellite cell activation involved in skeletal muscle regeneration;230;190;GO:0048667
GO:0120072;positive regulation of pyloric antrum smooth muscle contraction;9;6;GO:0048608
GO:0014900;muscle hyperplasia;96;7;GO:0048771
GO:0120073;negative regulation of pyloric antrum smooth muscle contraction;0;0;GO:0048608
GO:0002929;MECO complex;0;0;GO:0005737
GO:0120074;regulation of endocardial cushion cell differentiation;2;1;GO:0048608
GO:0120075;positive regulation of endocardial cushion cell differentiation;0;0;GO:0048608
GO:0120076;negative regulation of endocardial cushion cell differentiation;2;0;GO:0048608
GO:0120077;angiogenic sprout fusion;67;2;GO:0048706
GO:1990790;response to glial cell derived neurotrophic factor;12;1;GO:0048608
GO:1990791;dorsal root ganglion development;330;253;GO:0048704
GO:1990792;cellular response to glial cell derived neurotrophic factor;12;3;GO:0048608
GO:1990782;protein tyrosine kinase binding;9335;299;GO:0019901
GO:1990783;periphagosomal region of cytoplasm;0;0;GO:0005768
GO:1990784;response to dsDNA;116;0;GO:0009615
GO:1990785;response to water-immersion restraint stress;28;24;GO:0006950
GO:1990786;cellular response to dsDNA;116;4;GO:0071346
GO:1990787;negative regulation of hh target transcription factor activity;3;2;GO:0030528
GO:1990788;GLI-SUFU complex;174;1;GO:0005634
GO:1990789;thyroid gland epithelial cell proliferation;8;1;GO:0042127
GO:1990793;substance P secretion, neurotransmission;2;2;GO:0007218
GO:1990794;basolateral part of cell;111;5;GO:0044421
GO:1990795;rod bipolar cell terminal bouton;2;3;GO:0048666
GO:1990796;photoreceptor cell terminal bouton;8;188;GO:0005929
GO:0002900;positive regulation of central B cell deletion;0;3;GO:0050729
GO:1990798;pancreas regeneration;149;1;GO:0042127
GO:0002901;mature B cell apoptotic process;233;74;GO:0042981
GO:1990799;mitochondrial tRNA wobble position uridine thiolation;17;2;GO:0006519
GO:0002902;regulation of B cell apoptotic process;1074;299;GO:0042981
GO:0120091;jasmonic acid hydrolase;83;2;GO:0046274
GO:0002903;negative regulation of B cell apoptotic process;797;534;GO:0042981
GO:0120092;crotonyl-CoA hydratase activity;57;2;GO:0006067
GO:0002904;positive regulation of B cell apoptotic process;205;149;GO:0042981
GO:0120093;regulation of peptidyl-lysine crotonylation;90;1;GO:0010468
GO:0002905;regulation of mature B cell apoptotic process;185;37;GO:0042981
GO:0120094;negative regulation of peptidyl-lysine crotonylation;90;1;GO:0046395
GO:0002906;negative regulation of mature B cell apoptotic process;185;136;GO:0042981
GO:0120095;vacuole-isolation membrane contact site;130;5;GO:0005737
GO:0002907;positive regulation of mature B cell apoptotic process;0;1;GO:0042981
GO:0002908;regulation of peripheral B cell deletion;0;3;GO:0050729
GO:0120097;glycosylphosphatidylinositol-mannosyltransferase II complex;9;2;GO:0005576
GO:0002909;negative regulation of peripheral B cell deletion;0;1;GO:0050729
GO:0120098;procentriole;174;0;GO:0000976
GO:0120099;procentriole replication complex;337;5;GO:0000976
GO:1902196;isovaleryl-CoA(4-) catabolic process;1;0;GO:0009062
GO:1902197;isovaleryl-CoA(4-) biosynthetic process;0;0;GO:0006081
GO:1902194;2-methylbut-2-enoyl-CoA(4-) biosynthetic process;0;0;GO:0006081
GO:1902195;isovaleryl-CoA(4-) metabolic process;1;0;GO:0006081
GO:1902198;3-methylbut-2-enoyl-CoA(4-) metabolic process;1;0;GO:0006631
GO:1902199;3-methylbut-2-enoyl-CoA(4-) catabolic process;0;0;GO:0009062
GO:0097290;alpha-ribazole biosynthetic process;0;2;GO:0009065
GO:0097292;XMP metabolic process;12705;0;GO:0006091
GO:0097291;renal phosphate ion absorption;63;3;GO:0006836
GO:0097294;'de novo' XMP biosynthetic process;470;10;GO:0009405
GO:0097293;XMP biosynthetic process;12705;1;GO:0009405
GO:0097296;activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;2;122;GO:0046330
GO:0097295;morphine biosynthetic process;5;1;GO:0009891
GO:0002950;ceramide phosphoethanolamine synthase activity;230;7;GO:0004721
GO:0097287;7-cyano-7-deazaguanine metabolic process;0;1;GO:0009065
GO:0002951;leukotriene-C(4) hydrolase;139;6;GO:0010401
GO:0002952;(4S)-4-hydroxy-5-phosphonooxypentane-2,3-dione isomerase activity;1;0;GO:0004467
GO:0097289;alpha-ribazole metabolic process;0;1;GO:0006749
GO:0002953;5'-deoxynucleotidase activity;18865;2;GO:0004553
GO:0097288;7-cyano-7-deazaguanine biosynthetic process;0;1;GO:0046395
GO:1902192;2-methylbut-2-enoyl-CoA(4-) metabolic process;1;0;GO:0006081
GO:1902193;2-methylbut-2-enoyl-CoA(4-) catabolic process;0;0;GO:0009062
GO:1902190;2-methylbutanoyl-CoA(4-) catabolic process;1;0;GO:0009062
GO:1902191;2-methylbutanoyl-CoA(4-) biosynthetic process;0;0;GO:0006081
GO:0000309;nicotinamide-nucleotide adenylyltransferase activity;21769;355;GO:0004061
GO:0000308;cytoplasmic cyclin-dependent protein kinase holoenzyme complex;132;117;GO:0005819
GO:0000307;cyclin-dependent protein kinase holoenzyme complex;11662;2190;GO:0005524
GO:0000305;response to oxygen radical;418800;389;GO:0006979
GO:0000304;response to singlet oxygen;1533;42;GO:0009432
GO:0000303;response to superoxide;418793;877;GO:0006979
GO:0000302;response to reactive oxygen species;449894;5390;GO:0006979
GO:0000301;retrograde transport, vesicle recycling within Golgi;572;814;GO:0006986
GO:0097298;regulation of nucleus size;122;7;GO:0045944
GO:0097270;dishabituation;0;5;GO:0007612
GO:0097272;ammonium homeostasis;522;7;GO:0006874
GO:0097271;protein localization to bud neck;132;9;GO:0009987
GO:0097265;5(S)-hydroxyeicosatetraenoic acid dehydrogenase activity;0;0;GO:0004073
GO:0097264;self proteolysis;604;141;GO:0006414
GO:0002930;trabecular meshwork development;86;10;GO:0043588
GO:0097267;omega-hydroxylase P450 pathway;116;865;GO:0006721
GO:0002931;response to ischemia;1508;724;GO:0006979
GO:0097266;phenylacetyl-CoA 1,2-epoxidase activity;12668;8;GO:0004091
GO:0002932;tendon sheath development;2;1;GO:0007518
GO:0097269;all-trans-decaprenyl-diphosphate synthase activity;181;6;GO:0004061
GO:0002933;lipid hydroxylation;224;104;GO:0046148
GO:0097268;cytoophidium;185;6;GO:0005976
GO:0002934;desmosome organization;676;1690;GO:0030199
GO:0014916;regulation of lung blood pressure;178;19;GO:0050727
GO:0002935;tRNA (adenine-C2-)-methyltransferase activity;37984;0;GO:0003735
GO:0014915;regulation of muscle filament sliding speed involved in regulation of the velocity of shortening in skeletal muscle contraction;0;1;GO:0048407
GO:0002936;bradykinin biosynthetic process;1;0;GO:0009065
GO:0014914;myoblast maturation involved in muscle regeneration;0;1;GO:0048771
GO:0002937;tRNA 4-thiouridine biosynthesis;27;0;GO:0009064
GO:0002938;tRNA guanine ribose methylation;6172;2;GO:0008544
GO:0014912;negative regulation of smooth muscle cell migration;1039;804;GO:0010717
GO:0002939;tRNA N1-guanine methylation;447;5;GO:0006461
GO:0014911;positive regulation of smooth muscle cell migration;1139;871;GO:0048010
GO:0014910;regulation of smooth muscle cell migration;2377;806;GO:0016477
GO:0097281;immune complex formation;30;5;GO:0002429
GO:0097280;histamine secretion mediated by immunoglobulin;35;2;GO:0002768
GO:0097283;keratinocyte apoptotic process;432;9;GO:0010941
GO:0097282;immunoglobulin-mediated neutralization;0;2;GO:0002449
GO:0097284;hepatocyte apoptotic process;957;890;GO:0042981
GO:0002940;tRNA N2-guanine methylation;307;10;GO:0006461
GO:0097275;intracellular ammonium homeostasis;25;0;GO:0006873
GO:0002941;synoviocyte proliferation;141;4;GO:0042127
GO:0097278;complement-dependent cytotoxicity;333;53;GO:0006915
GO:0002942;tRNA m2,2-guanine biosynthesis;0;1;GO:0006413
GO:0002943;tRNA dihydrouridine synthesis;306736;372;GO:0006418
GO:0002944;cyclin K-CDK12 complex;121;10;GO:0048285
GO:0097279;histamine secretion mediated by IgE immunoglobulin;35;2;GO:0002768
GO:0002945;cyclin K-CDK13 complex;108;90;GO:0048285
GO:0002946;tRNA C5-cytosine methylation;174;6;GO:0006470
GO:0002947;tumor necrosis factor receptor superfamily complex;131;30;GO:0005975
GO:0002948;archaeosine synthase activity;86;4;GO:0006033
GO:0002949;tRNA threonylcarbamoyladenosine modification;203953;155;GO:0008544
GO:0051928;positive regulation of calcium ion transport;3512;893;GO:0010467
GO:0000339;RNA cap binding;25371;480;GO:0003723
GO:0000338;protein deneddylation;160;1720;GO:0006457
GO:0000334;3-hydroxyanthranilate 3,4-dioxygenase activity;21917;40;GO:0004497
GO:0000333;telomerase catalytic core complex;452;71;GO:0005737
GO:0000332;template for synthesis of G-rich strand of telomere DNA activity;8;3;GO:0003676
GO:0000342;RNA cap 4 binding;6;1;GO:0003723
GO:0000341;RNA trimethylguanosine cap binding;9;1;GO:0003723
GO:0000340;RNA 7-methylguanosine cap binding;6587;287;GO:0003723
GO:0051926;negative regulation of calcium ion transport;1568;899;GO:0010467
GO:0051923;sulfation;1930;1330;GO:0004734
GO:0051924;regulation of calcium ion transport;12652;2320;GO:0006873
GO:0051921;adenosylcobyric acid synthase (glutamine-hydrolyzing) activity;313;5;GO:0004497
GO:0051922;cholesterol sulfotransferase activity;3;1;GO:0004784
GO:0051920;peroxiredoxin activity;286400;1250;GO:0004601
GO:0051938;L-glutamate import;16687;359;GO:0006836
GO:0051939;gamma-aminobutyric acid import;185;8;GO:0006836
GO:0000349;generation of catalytic spliceosome for first transesterification step;3009;32;GO:0000976
GO:0000348;mRNA branch site recognition;23484;130;GO:0003729
GO:0000347;THO complex;14835;314;GO:0005840
GO:0000346;transcription export complex;4652;651;GO:0005840
GO:0000345;cytosolic DNA-directed RNA polymerase complex;24;771;GO:0009536
GO:0000344;plastid-encoded plastid RNA polymerase complex B;0;1;GO:0009536
GO:0000343;plastid-encoded plastid RNA polymerase complex A;0;1;GO:0009536
GO:0000353;formation of quadruple SL/U4/U5/U6 snRNP;139351;289;GO:0008033
GO:0000352;trans assembly of SL-containing precatalytic spliceosome;0;3;GO:0008033
GO:0000350;generation of catalytic spliceosome for second transesterification step;4352;283;GO:0000976
GO:0051936;gamma-aminobutyric acid reuptake;4;1;GO:0006836
GO:0051937;catecholamine transport;6507;138;GO:0006836
GO:0051934;catecholamine uptake involved in synaptic transmission;561;7;GO:0006836
GO:0051935;glutamate reuptake;178;10;GO:0006890
GO:0051932;synaptic transmission, GABAergic;2422;507;GO:0007268
GO:0051933;amino acid neurotransmitter reuptake;182;7;GO:0006836
GO:0051930;regulation of sensory perception of pain;798;684;GO:0007600
GO:0051931;regulation of sensory perception;889;28;GO:0007600
GO:0000319;sulfite transmembrane transporter activity;28;3;GO:0005525
GO:0051949;negative regulation of gamma-aminobutyric acid uptake involved in transmission of nerve impulse;0;0;GO:0048167
GO:0000316;sulfite transport;64;7;GO:0006826
GO:0000315;organellar large ribosomal subunit;17497;1310;GO:0005840
GO:0000314;organellar small ribosomal subunit;11375;1150;GO:0005840
GO:0000313;organellar ribosome;38736;485;GO:0005840
GO:0000312;plastid small ribosomal subunit;65;641;GO:0005840
GO:0000311;plastid large ribosomal subunit;10;9;GO:0005840
GO:0000310;xanthine phosphoribosyltransferase activity;40199;10;GO:0004073
GO:0000320;re-entry into mitotic cell cycle;178;56;GO:0048285
GO:0051940;regulation of catecholamine uptake involved in synaptic transmission;356;6;GO:0006836
GO:0048302;regulation of isotype switching to IgG isotypes;699;375;GO:0032989
GO:0048301;positive regulation of isotype switching to IgD isotypes;0;0;GO:0048193
GO:0048300;negative regulation of isotype switching to IgD isotypes;0;1;GO:0048193
GO:1990700;nucleolar chromatin organization;2301;6;GO:0006364
GO:0051947;regulation of gamma-aminobutyric acid uptake involved in transmission of nerve impulse;0;1;GO:0048167
GO:0051948;negative regulation of glutamate uptake involved in transmission of nerve impulse;0;1;GO:0048169
GO:0051945;negative regulation of catecholamine uptake involved in synaptic transmission;48;5;GO:0048167
GO:0051946;regulation of glutamate uptake involved in transmission of nerve impulse;94;24;GO:0048169
GO:1990705;cholangiocyte proliferation;230;6;GO:0042127
GO:0051943;positive regulation of amino acid uptake involved in synaptic transmission;88;2;GO:0048169
GO:1990706;MAD1 complex;99;1;GO:0005524
GO:0051944;positive regulation of catecholamine uptake involved in synaptic transmission;120;5;GO:0048167
GO:0051941;regulation of amino acid uptake involved in synaptic transmission;94;17;GO:0006836
GO:1990708;conditioned place preference;95;81;GO:0007611
GO:0051942;negative regulation of amino acid uptake involved in synaptic transmission;0;1;GO:0048169
GO:1990709;presynaptic active zone organization;972;112;GO:0008026
GO:0000329;fungal-type vacuole membrane;7797;566;GO:0005737
GO:0000328;fungal-type vacuole lumen;278;23;GO:0005737
GO:0048306;calcium-dependent protein binding;4064;2120;GO:0005509
GO:1904801;positive regulation of neuron remodeling;106;3;GO:0048666
GO:0000327;lytic vacuole within protein storage vacuole;4;36;GO:0005764
GO:1904800;negative regulation of neuron remodeling;10;9;GO:0048666
GO:0000326;protein storage vacuole;619;86;GO:0005764
GO:0048304;positive regulation of isotype switching to IgG isotypes;515;291;GO:0048308
GO:0000325;plant-type vacuole;5110;366;GO:0005737
GO:0048303;negative regulation of isotype switching to IgG isotypes;0;2;GO:0048308
GO:0000324;fungal-type vacuole;10065;637;GO:0005764
GO:0000323;lytic vacuole;260501;2260;GO:0005737
GO:0048309;endoplasmic reticulum inheritance;409;16;GO:0007046
GO:0000322;storage vacuole;10818;132;GO:0005764
GO:0048308;organelle inheritance;5835;292;GO:0048308
GO:1904803;regulation of translation involved in cellular response to UV;39;2;GO:0010467
GO:0000321;re-entry into mitotic cell cycle after pheromone arrest;28;68;GO:0048285
GO:0048307;ferredoxin-nitrite reductase activity;817;10;GO:0008033
GO:1904802;RITS complex assembly;16;1;GO:0048608
GO:0000331;contractile vacuole;212;8;GO:0005789
GO:0051950;positive regulation of gamma-aminobutyric acid uptake involved in transmission of nerve impulse;0;1;GO:0048167
GO:0000330;plant-type vacuole lumen;1;2;GO:0005737
GO:0051951;positive regulation of glutamate uptake involved in transmission of nerve impulse;88;4;GO:0048169
GO:0048313;Golgi inheritance;1074;20;GO:0005764
GO:0048312;intracellular distribution of mitochondria;411;286;GO:0005739
GO:1990710;MutS complex;1;4;GO:0000723
GO:0048311;mitochondrion distribution;3023;498;GO:0005739
GO:1990711;beta-catenin-ICAT complex;95;6;GO:0048407
GO:0120331;endothelial tube formation;0;0;GO:0001525
GO:0061431;cellular response to methionine;56;3;GO:0006979
GO:0120332;host-mediated regulation of oral microbiota composition;0;1;GO:0045765
GO:0120333;radial spoke 1;116;0;GO:0005576
GO:0061433;cellular response to caloric restriction;54;9;GO:0006958
GO:0120334;radial spoke 2;8;0;GO:0005525
GO:0120335;radial spoke 3;116;0;GO:0005576
GO:1902530;positive regulation of protein linear polyubiquitination;142;25;GO:0016567
GO:0120336;radial spoke head 1;116;2;GO:0005576
GO:1902531;regulation of intracellular signal transduction;280711;1740;GO:0007165
GO:0120337;radial spoke head 2;8;0;GO:0005576
GO:0120338;radial spoke head 3;116;1;GO:0005576
GO:0061438;renal system vasculature morphogenesis;300;5;GO:0048514
GO:0120339;radial spoke base;0;0;GO:0005576
GO:0048459;floral whorl structural organization;25;2;GO:0048316
GO:0061439;kidney vasculature morphogenesis;300;4;GO:0048582
GO:0048458;floral whorl formation;0;1;GO:0048608
GO:1902532;negative regulation of intracellular signal transduction;58454;1110;GO:0010468
GO:0048457;floral whorl morphogenesis;56;5;GO:0048316
GO:1902533;positive regulation of intracellular signal transduction;117239;1490;GO:0007165
GO:0061435;positive regulation of transcription from a mobile element promoter;4;3;GO:0045944
GO:0061436;establishment of skin barrier;1671;1700;GO:0009913
GO:0061437;renal system vasculature development;1266;90;GO:0001944
GO:0048463;carpel structural organization;0;1;GO:0009952
GO:0048462;carpel formation;59;5;GO:0048608
GO:0048461;flower structural organization;71;1;GO:0048468
GO:1902529;negative regulation of protein linear polyubiquitination;0;0;GO:0016567
GO:0048460;flower formation;0;2;GO:0009908
GO:0048467;gynoecium development;1372;292;GO:0009908
GO:0048466;androecium development;2761;9;GO:0048316
GO:0048465;corolla development;211;5;GO:0009908
GO:0048464;flower calyx development;93;4;GO:0009908
GO:0120340;radial spoke base 1;0;0;GO:0005576
GO:0120341;radial spoke base 2;0;0;GO:0005576
GO:0120320;lateral pseudopodium retraction;33;4;GO:0008047
GO:0120321;nuclear envelope adjacent to nuclear pore complex;1;2;GO:0005615
GO:0120322;lipid modification by small protein conjugation;9;0;GO:0016567
GO:0120323;lipid ubiquitination;9;0;GO:0006511
GO:0120324;procyclogenesis;0;3;GO:0009908
GO:0120325;NuRD complex binding;199;3;GO:0048471
GO:1902542;regulation of protein localization to mitotic spindle pole body;92;2;GO:0007062
GO:0120326;appressorium-mediated entry into host;2;0;GO:0048285
GO:0120327;telopode;0;0;GO:0048608
GO:0120328;ATP-dependent DNA (cytosine-5-)-methyltransferase activity;2;0;GO:0003729
GO:0061428;negative regulation of transcription from RNA polymerase II promoter in response to hypoxia;130;192;GO:0045944
GO:0120329;protein localization to centriolar satellite;0;0;GO:0005730
GO:0048469;cell maturation;18691;2090;GO:0007517
GO:0061429;positive regulation of transcription from RNA polymerase II promoter by oleic acid;13;2;GO:0045944
GO:1902543;negative regulation of protein localization to mitotic spindle pole body;29;2;GO:0048285
GO:0048468;cell development;552067;5100;GO:0048513
GO:1902549;protein localization to Mei2 nuclear dot;0;0;GO:0005730
GO:0061425;positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter;0;2;GO:0045944
GO:1902547;regulation of cellular response to vascular endothelial growth factor stimulus;1491;8;GO:0050727
GO:1902548;negative regulation of cellular response to vascular endothelial growth factor stimulus;812;16;GO:0050727
GO:0048473;D-methionine transport;41099;29;GO:0006865
GO:0048472;threonine-phosphate decarboxylase activity;34466;31;GO:0009065
GO:0048471;perinuclear region of cytoplasm;68367;12000;GO:0005737
GO:0048477;oogenesis;26582;3510;GO:0007530
GO:0048476;Holliday junction resolvase complex;127901;277;GO:0005576
GO:0048475;coated membrane;253127;469;GO:0016021
GO:0120330;rixosome complex;0;2;GO:0005737
GO:0097490;sympathetic neuron projection extension;167;166;GO:0043005
GO:0097492;sympathetic neuron axon guidance;224;7;GO:0007611
GO:0097491;sympathetic neuron projection guidance;132;27;GO:0048608
GO:0097494;regulation of vesicle size;672;28;GO:0048193
GO:0097493;structural molecule activity conferring elasticity;194;172;GO:0008092
GO:0097485;neuron projection guidance;67213;900;GO:0048666
GO:0097484;dendrite extension;1504;184;GO:0048666
GO:0097487;multivesicular body, internal vesicle;405;176;GO:0005768
GO:0097486;multivesicular body lumen;17;46;GO:0005768
GO:0097489;multivesicular body, internal vesicle lumen;63;180;GO:0005768
GO:0097488;multivesicular body, internal vesicle membrane;0;2;GO:0005768
GO:0120342;radial spoke base 3;0;0;GO:0005576
GO:0120343;radial spoke neck;0;0;GO:0005576
GO:0097496;blood vessel lumen ensheathment;2;1;GO:0005576
GO:0097495;H-NS-Hha complex;2;0;GO:0048304
GO:0097498;endothelial tube lumen extension;110;281;GO:0048407
GO:0097497;blood vessel endothelial cell delamination;61;1;GO:0048407
GO:0097499;protein localization to non-motile cilium;808;15;GO:0005929
GO:0097470;ribbon synapse;822;51;GO:0008092
GO:0097472;cyclin-dependent protein kinase activity;67910;358;GO:0004721
GO:0097471;mossy fiber rosette;47;2;GO:0048608
GO:0097463;gemmule;0;2;GO:0005576
GO:0097462;Lewy neurite;57;5;GO:0048167
GO:0097465;somatic spine;0;1;GO:0008092
GO:0097464;thorny excrescence;0;2;GO:0048305
GO:0097467;type III terminal bouton;10;1;GO:0048608
GO:0097466;ubiquitin-dependent glycoprotein ERAD pathway;246;8;GO:0006486
GO:0097468;programmed cell death in response to reactive oxygen species;2142;10;GO:0010941
GO:0097480;establishment of synaptic vesicle localization;0;511;GO:0048471
GO:0097482;muscle cell postsynaptic specialization;178;2;GO:0008092
GO:0097474;retinal cone cell apoptotic process;63;3;GO:0043407
GO:0097473;retinal rod cell apoptotic process;102;9;GO:0048608
GO:0097476;spinal cord motor neuron migration;252;8;GO:0048704
GO:0097475;motor neuron migration;1037;238;GO:0048704
GO:0097478;leaflet of membrane bilayer;0;9;GO:0016020
GO:0097477;lateral motor column neuron migration;211;10;GO:0048704
GO:0097479;synaptic vesicle localization;2813;422;GO:0008030
GO:0061496;half bridge of mitotic spindle pole body;141;6;GO:0005515
GO:0061497;inner plaque of mitotic spindle pole body;135;6;GO:0005819
GO:0061498;intermediate layer of mitotic spindle pole body;0;0;GO:0005819
GO:0061499;outer plaque of mitotic spindle pole body;50;6;GO:0005819
GO:0061492;asymmetric protein localization to old or new spindle pole body;107;1;GO:0048285
GO:1902596;negative regulation of DNA replication origin binding;5;5;GO:0045727
GO:0061493;central plaque of mitotic spindle pole body;9;6;GO:0005813
GO:1902597;positive regulation of DNA replication origin binding;1;3;GO:0007050
GO:1902595;regulation of DNA replication origin binding;8;212;GO:0003677
GO:1902599;sulfathiazole transmembrane transport;2;4;GO:0008544
GO:0097450;astrocyte end-foot;198;116;GO:0009986
GO:0097441;basal dendrite;75;10;GO:0097458
GO:0097440;apical dendrite;337;802;GO:0043005
GO:0097443;sorting endosome;276;262;GO:0006906
GO:0097442;CA3 pyramidal cell dendrite;100;125;GO:0030425
GO:0097445;presynaptic active zone dense projection;7;2;GO:0005730
GO:0097444;spine apparatus;72;21;GO:0005615
GO:0097447;dendritic tree;62098;323;GO:0030425
GO:0097446;protein localization to eisosome filament;8;3;GO:0005576
GO:0097449;astrocyte projection;624;444;GO:0043005
GO:0097448;spine mat;0;1;GO:0005615
GO:0061485;memory T cell proliferation;55;7;GO:0042127
GO:0061486;high-affinity fructose transmembrane transporter activity;0;0;GO:0008565
GO:0061481;response to TNF agonist;45;2;GO:0046330
GO:0061482;response to irinotecan;0;0;GO:0048589
GO:0061483;sulfinylpropanyl adenylate synthase;43;3;GO:0004721
GO:0061484;hematopoietic stem cell homeostasis;1270;186;GO:0045765
GO:0097452;GAIT complex;251;321;GO:0008092
GO:0097451;glial limiting end-foot;68;19;GO:0009986
GO:0097454;Schwann cell microvillus;6;235;GO:0005576
GO:0097453;mesaxon;6;6;GO:0005576
GO:0097456;terminal loop;2;1;GO:0003700
GO:0097455;spiny bracelet of Nageotte;0;1;GO:0005576
GO:0097457;hippocampal mossy fiber;210;9;GO:0048608
GO:0097421;liver regeneration;519;852;GO:0042127
GO:0097420;skein-like inclusion;0;2;GO:0005576
GO:0097423;mitochondrion-associated adherens complex;0;4;GO:0005737
GO:0097422;tubular endosome;311;163;GO:0005764
GO:0097424;nucleolus-associated heterochromatin;0;3;GO:0000786
GO:0097427;microtubule bundle;356;70;GO:0015629
GO:0097426;glial filament;2;3;GO:0043005
GO:0097429;amino acid ligation activity by nonribosomal peptide synthase;0;0;GO:0004871
GO:0097428;protein maturation by iron-sulfur cluster transfer;17493;407;GO:0008544
GO:0097430;copper ion import across prospore membrane;1;0;GO:0006826
GO:0097432;hippocampal pyramidal neuron differentiation;2;2;GO:0048667
GO:0097431;mitotic spindle pole;2226;387;GO:0005819
GO:0097434;succinate:proton symporter activity;4;1;GO:0005215
GO:0097433;dense body;597;328;GO:0005829
GO:0097436;entry into dormancy;1;0;GO:0048304
GO:0097435;supramolecular fiber organization;319576;976;GO:0043005
GO:0097438;exit from dormancy;63;1;GO:0048308
GO:0097437;maintenance of dormancy;168;2;GO:0048471
GO:0097439;acquisition of desiccation tolerance;40;2;GO:0009628
GO:0000419;RNA polymerase V complex;174;6;GO:0005840
GO:0000418;RNA polymerase IV complex;92;4;GO:0000976
GO:0000417;HIR complex;214;70;GO:0005840
GO:0000413;protein peptidyl-prolyl isomerization;131;3630;GO:0006457
GO:0000412;histone peptidyl-prolyl isomerization;0;36;GO:0006457
GO:0000411;positive regulation of transcription by galactose;192;7;GO:0045944
GO:0000410;carbon catabolite repression of transcription by galactose;0;1;GO:0009410
GO:0000429;carbon catabolite regulation of transcription from RNA polymerase II promoter;843;10;GO:0045944
GO:0000428;DNA-directed RNA polymerase complex;788015;478;GO:0009536
GO:0000427;plastid-encoded plastid RNA polymerase complex;1555;6;GO:0009536
GO:0000426;micropexophagy;2;3;GO:0006914
GO:0000425;pexophagy;444;18;GO:0006914
GO:0000424;micromitophagy;0;2;GO:0042592
GO:0000423;mitophagy;4046;490;GO:0006979
GO:0000422;autophagy of mitochondrion;19243;1150;GO:0006914
GO:0000421;autophagosome membrane;8336;695;GO:0005764
GO:0000430;regulation of transcription from RNA polymerase II promoter by glucose;568;63;GO:0006355
GO:0097391;chemokine (C-X-C motif) ligand 13 production;0;1;GO:0046649
GO:0097390;chemokine (C-X-C motif) ligand 12 production;0;1;GO:0050921
GO:0097393;telomeric repeat-containing RNA transcription;0;3;GO:0010467
GO:0097392;chemokine (C-X-C motif) ligand 16 production;0;1;GO:0050921
GO:0097395;response to interleukin-32;0;1;GO:0032496
GO:0097386;glial cell projection;1230;351;GO:0043005
GO:0097385;programmed necrotic cell death in response to starvation;0;2;GO:0012501
GO:0097388;chemokine (C-C motif) ligand 19 production;0;1;GO:0046649
GO:0097387;capitate projection;0;0;GO:0048706
GO:0097389;chemokine (C-C motif) ligand 21 production;0;1;GO:0050921
GO:0000409;regulation of transcription by galactose;201;1;GO:0006355
GO:0000408;EKC/KEOPS complex;6344;110;GO:0005737
GO:0000407;phagophore assembly site;40649;230;GO:0070097
GO:0000406;double-strand/single-strand DNA junction binding;44;33;GO:0003677
GO:0000405;bubble DNA binding;366;293;GO:0003677
GO:0000404;heteroduplex DNA loop binding;61;33;GO:0003677
GO:0000403;Y-form DNA binding;1285;166;GO:0003677
GO:0000402;crossed form four-way junction DNA binding;20;5;GO:0003677
GO:0000401;open form four-way junction DNA binding;2;5;GO:0003677
GO:0000400;four-way junction DNA binding;85809;730;GO:0003677
GO:0097397;cellular response to interleukin-32;0;2;GO:0071346
GO:0097396;response to interleukin-17;958;10;GO:0046649
GO:0097399;interleukin-32-mediated signaling pathway;0;1;GO:0007165
GO:0097398;cellular response to interleukin-17;928;38;GO:0071346
GO:0036410;Mst2 histone acetyltransferase complex;4;2;GO:0016569
GO:0036411;H-NS-Cnu complex;2;3;GO:0048304
GO:0000458;endonucleolytic cleavage between LSU-rRNA and 5S rRNA of tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 5S);0;1;GO:0006414
GO:0000457;endonucleolytic cleavage between SSU-rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 5S);0;1;GO:0006364
GO:0000455;enzyme-directed rRNA pseudouridine synthesis;121211;24;GO:0006091
GO:0000454;snoRNA guided rRNA pseudouridine synthesis;216;77;GO:0006418
GO:0000463;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);21580;560;GO:0006412
GO:0000462;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);19571;1100;GO:0006364
GO:0000461;endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);201;3;GO:0006364
GO:0000460;maturation of 5.8S rRNA;20805;1350;GO:0009063
GO:0036409;histone H3-K14 acetyltransferase complex;162;1;GO:0016569
GO:0048401;negative regulation of intermediate mesodermal cell fate specification;0;2;GO:0048704
GO:0048400;positive regulation of intermediate mesodermal cell fate specification;0;2;GO:0048704
GO:0036407;mycolate outer membrane;0;6;GO:0005576
GO:0036408;histone H3K14 acetyltransferase activity;529;10;GO:0016569
GO:0036401;pyrokinin receptor activity;80;4;GO:0004930
GO:0036402;proteasome-activating activity;19741;59;GO:0004867
GO:0036403;arachidonate 8(S)-lipoxygenase activity;49;0;GO:0004497
GO:0036400;short neuropeptide F receptor activity;11;2;GO:0004930
GO:0048403;brain-derived neurotrophic factor binding;131;46;GO:0048408
GO:0000468;generation of mature 3'-end of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);0;2;GO:0006412
GO:0048402;intermediate mesoderm structural organization;0;1;GO:0048513
GO:0000467;exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);7953;6;GO:0005929
GO:0000466;maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);19259;235;GO:0006470
GO:0048408;epidermal growth factor binding;147;653;GO:0005549
GO:0000465;exonucleolytic trimming to generate mature 5'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);75;1;GO:0005929
GO:0048407;platelet-derived growth factor binding;661;1540;GO:0005125
GO:0000464;endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);131;9;GO:0006032
GO:0048406;nerve growth factor binding;332;163;GO:0030198
GO:0000474;maturation of SSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);0;2;GO:0006364
GO:0000473;maturation of LSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);0;1;GO:0006470
GO:0000472;endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);1676;10;GO:0006364
GO:0000471;endonucleolytic cleavage in 3'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);0;1;GO:0003735
GO:0000470;maturation of LSU-rRNA;27390;697;GO:0008544
GO:0000439;transcription factor TFIIH core complex;25015;243;GO:0000976
GO:0000438;core TFIIH complex portion of holo TFIIH complex;124;36;GO:0005524
GO:0000437;carbon catabolite repression of transcription from RNA polymerase II promoter;17;7;GO:0003729
GO:0000436;carbon catabolite activation of transcription from RNA polymerase II promoter;608;27;GO:0003729
GO:0000435;positive regulation of transcription from RNA polymerase II promoter by galactose;174;10;GO:0045944
GO:0000434;carbon catabolite repression of transcription from RNA polymerase II promoter by galactose;0;0;GO:0003729
GO:0000433;carbon catabolite repression of transcription from RNA polymerase II promoter by glucose;197;9;GO:0003729
GO:0000432;positive regulation of transcription from RNA polymerase II promoter by glucose;357;111;GO:0045944
GO:0000431;regulation of transcription from RNA polymerase II promoter by galactose;177;2;GO:0006355
GO:0000440;core TFIIH complex portion of NEF3 complex;0;6;GO:0005524
GO:0000449;endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 5S);0;0;GO:0006364
GO:1902501;lysosomal HOPS complex;124;2;GO:0005764
GO:0000448;cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);271;165;GO:0006032
GO:1902502;multivesicular body HOPS complex;0;0;GO:0005766
GO:0000447;endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);1970;594;GO:0006091
GO:0000446;nucleoplasmic THO complex;68;8;GO:0005840
GO:1902500;vacuolar HOPS complex;130;2;GO:0005740
GO:0000445;THO complex part of transcription export complex;3986;298;GO:0005840
GO:0000444;MIS12/MIND type complex;5234;53;GO:0005524
GO:1902503;adenylyltransferase complex;39;1;GO:0005524
GO:0000452;snoRNA guided rRNA 2'-O-methylation;178;1;GO:0006418
GO:0000451;rRNA 2'-O-methylation;16574;5;GO:0006412
GO:0000450;cleavage of bicistronic rRNA transcript (SSU-rRNA, LSU-rRNA);0;1;GO:0006412
GO:0036452;ESCRT complex;37714;288;GO:0005737
GO:0036453;transitive RNA interference;5;1;GO:0003724
GO:0036454;growth factor complex;416;10;GO:0005615
GO:0036455;iron-sulfur transferase activity;6;4;GO:0004091
GO:0036450;polyuridylation-dependent decapping of nuclear-transcribed mRNA;6;2;GO:0006414
GO:0036451;cap mRNA methylation;2521;5;GO:0045944
GO:0000497;DNA template activity;8;1;GO:0003676
GO:0036449;microtubule minus-end;495;54;GO:0005819
GO:0036445;neuronal stem cell division;49;8;GO:0048608
GO:0036446;myofibroblast differentiation;481;71;GO:0048010
GO:0036447;cellular response to sugar-phosphate stress;6;1;GO:0006974
GO:0036448;cellular response to glucose-phosphate stress;6;1;GO:0046395
GO:0036441;2-dehydropantolactone reductase activity;8;1;GO:0004497
GO:0036443;dermatan 6-sulfotransferase activity;0;0;GO:0004730
GO:0036444;calcium import into the mitochondrion;3338;131;GO:0006836
GO:0036440;citrate synthase activity;103803;10;GO:0004073
GO:0036438;maintenance of lens transparency;371;270;GO:0048407
GO:0036434;nitronate monooxygenase (FMN-linked) activity;0;1;GO:0004497
GO:0036435;K48-linked polyubiquitin modification-dependent protein binding;2793;19;GO:0043161
GO:0036436;Isw1a complex;12;2;GO:0048608
GO:0036437;Isw1b complex;17;5;GO:0048285
GO:0036430;CMP kinase activity;27644;1;GO:0004721
GO:0036431;dCMP kinase activity;27642;2;GO:0004721
GO:0036432;all-trans undecaprenol kinase activity;0;2;GO:0004721
GO:0036433;di-trans, poly-cis-undecaprenol kinase activity;2;1;GO:0004721
GO:0000479;endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);6373;89;GO:0006364
GO:0000477;generation of mature 5'-end of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);0;2;GO:0006364
GO:0000476;maturation of 4.5S rRNA;6;3;GO:0009060
GO:0000475;maturation of 2S rRNA;0;1;GO:0006091
GO:0000485;cleavage between 2S rRNA and LSU-rRNA of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);0;1;GO:0006412
GO:0000484;cleavage between SSU-rRNA and 5.8S rRNA of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);0;1;GO:0006412
GO:0000483;endonucleolytic cleavage of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);1;1;GO:0006364
GO:0000482;maturation of 5S rRNA from tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);0;1;GO:0006470
GO:0000481;maturation of 5S rRNA;156;7;GO:0009063
GO:0000480;endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);1713;8;GO:0005576
GO:0036427;all-trans-undecaprenyl-phosphate mannosyltransferase activity;1;1;GO:0006021
GO:0036428;adenosylcobinamide kinase (GTP-specific) activity;8033;2;GO:0005524
GO:0036429;adenosylcobinamide kinase (ATP-specific) activity;8033;2;GO:0004721
GO:0036423;hexaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) activity;81;0;GO:0006096
GO:0036424;L-phosphoserine phosphatase activity;59196;71;GO:0004721
GO:0036426;ditrans, polycis-undecaprenyl-phosphate mannosyltransferase activity;0;0;GO:0006021
GO:0036420;extrinsic component of mycolate outer membrane;0;0;GO:0005576
GO:0036421;extrinsic component of external side of mycolate outer membrane;0;0;GO:0005576
GO:0000489;maturation of SSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA);36;4;GO:0006470
GO:0000488;maturation of LSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA);36;2;GO:0006470
GO:0000487;maturation of 5.8S rRNA from tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);0;2;GO:0006470
GO:0000486;cleavage between 5.8S rRNA and 2S rRNA of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA);0;3;GO:0006412
GO:0000495;box H/ACA RNA 3'-end processing;207;9;GO:0008033
GO:0000494;box C/D RNA 3'-end processing;426;4;GO:0003743
GO:0000493;box H/ACA snoRNP assembly;5652;304;GO:0007030
GO:0000492;box C/D snoRNP assembly;2980;135;GO:0007030
GO:0000491;small nucleolar ribonucleoprotein complex assembly;8636;8;GO:0000786
GO:0036416;tRNA stabilization;179;2;GO:0006413
GO:0036417;tRNA destabilization;3;1;GO:0006413
GO:0036412;acetyl-CoA:oxalate CoA-transferase;3;1;GO:0006081
GO:0036415;regulation of tRNA stability;194;0;GO:0006413
GO:0061573;actin filament bundle retrograde transport;21;1;GO:0007049
GO:0061574;ASAP complex;279;196;GO:0005840
GO:0061575;cyclin-dependent protein serine/threonine kinase activator activity;6378;87;GO:0005524
GO:0061576;acyl-CoA ceramide synthase complex;9;4;GO:0005737
GO:1902432;protein localization to division septum;0;0;GO:0007067
GO:0061572;actin filament bundle organization;19760;603;GO:0030054
GO:1902430;negative regulation of amyloid-beta formation;930;47;GO:0010467
GO:1902435;regulation of male mating behavior;108;1;GO:0030518
GO:1902436;negative regulation of male mating behavior;51;0;GO:0048608
GO:1902433;positive regulation of water channel activity involved in maintenance of lens transparency;0;0;GO:0048407
GO:1902434;sulfate import across plasma membrane;1;0;GO:0006835
GO:0061577;calcium ion transmembrane transport via high voltage-gated calcium channel;412;24;GO:0006811
GO:1902439;cellular response to vanadate(3-);0;0;GO:0009631
GO:0061578;K63-linked deubiquitinase activity;5367;7;GO:0004842
GO:0061579;N-acyl homoserine lactone synthase activity;15130;6;GO:0004734
GO:1902437;positive regulation of male mating behavior;33;2;GO:0048608
GO:1902438;response to vanadate(3-);4;2;GO:0009739
GO:0097520;nucleotide-excision repair, preincision complex;0;1;GO:0000724
GO:0097522;protein-DNA ISRE complex;0;1;GO:0030528
GO:0097524;sperm plasma membrane;799;220;GO:0005886
GO:0097523;transcription ternary complex;0;0;GO:0003700
GO:0097526;spliceosomal tri-snRNP complex;178015;58;GO:0008033
GO:0097525;spliceosomal snRNP complex;434044;195;GO:0000976
GO:0097528;execution phase of necroptosis;117;6;GO:0097190
GO:0097527;necroptotic signaling pathway;992;68;GO:1903047
GO:0097529;myeloid leukocyte migration;14644;1860;GO:0002684
GO:0061562;cranial ganglion structural organization;4;1;GO:0048666
GO:0061563;trigeminal ganglion structural organization;4;2;GO:0043005
GO:0061564;axon development;98845;1810;GO:0043005
GO:0061565;dAMP phosphorylation;0;5;GO:0006468
GO:1902442;regulation of ripoptosome assembly involved in necroptotic process;42;0;GO:1903047
GO:1902443;negative regulation of ripoptosome assembly involved in necroptotic process;42;2;GO:1901041
GO:0061560;cranial ganglion formation;14;0;GO:0048704
GO:1902440;protein localization to mitotic spindle pole body;258;5;GO:0005813
GO:0061561;trigeminal ganglion formation;5;4;GO:0048704
GO:1902441;protein localization to meiotic spindle pole body;39;3;GO:0007062
GO:1902446;regulation of shade avoidance;20;1;GO:0048608
GO:1902447;negative regulation of shade avoidance;0;1;GO:0048405
GO:1902444;riboflavin binding;47;8;GO:0043169
GO:1902445;regulation of mitochondrial membrane permeability involved in programmed necrotic cell death;220;29;GO:0048193
GO:0061566;CMP phosphorylation;0;5;GO:0006468
GO:0061567;dCMP phosphorylation;0;5;GO:0006468
GO:1902448;positive regulation of shade avoidance;18;9;GO:0048405
GO:0097531;mast cell migration;627;10;GO:0050900
GO:0097530;granulocyte migration;7909;602;GO:0050900
GO:0097533;cellular stress response to acid chemical;85;8;GO:0006950
GO:0097532;stress response to acid chemical;86;5;GO:0006950
GO:0097535;lymphoid lineage cell migration into thymus;398;60;GO:0030900
GO:0097534;lymphoid lineage cell migration;408;6;GO:0030900
GO:0097537;Y-shaped link;1;1;GO:0048608
GO:0097536;thymus epithelium morphogenesis;114;7;GO:0030216
GO:0097539;ciliary transition fiber;2214;66;GO:0005576
GO:0097538;ciliary necklace;0;2;GO:0048608
GO:0061595;6-deoxy-6-sulfofructose-1-phosphate aldolase activity;1723;1;GO:0006099
GO:0061596;3-sulfolactaldehyde reductase activity;2813;3;GO:0004067
GO:0061598;molybdopterin adenylyltransferase activity;13587;115;GO:0004721
GO:0061591;calcium activated galactosylceramide scrambling;181;21;GO:0008029
GO:0061592;phosphatidylserine exposure on osteoblast involved in bone mineralization;0;4;GO:0048193
GO:0061593;sulfoquinovose isomerase activity;1533;2;GO:0006032
GO:0061594;6-deoxy-6-sulfofructose kinase activity;2935;4;GO:0006098
GO:1902457;negative regulation of stomatal opening;35;1;GO:0010468
GO:1902458;positive regulation of stomatal opening;31;1;GO:0010468
GO:1902455;negative regulation of stem cell population maintenance;306;55;GO:0045727
GO:1902456;regulation of stomatal opening;274;31;GO:0010468
GO:0061599;molybdopterin molybdotransferase activity;140532;28;GO:0004723
GO:1902459;positive regulation of stem cell population maintenance;555;53;GO:0045727
GO:0097500;receptor localization to non-motile cilium;221;10;GO:0005929
GO:0097502;mannosylation;33155;997;GO:0006486
GO:0097501;stress response to metal ion;1484;347;GO:0006950
GO:0097504;Gemini of coiled bodies;2563;67;GO:0005829
GO:0097503;sialylation;307;519;GO:0005929
GO:0097506;deaminated base DNA N-glycosylase activity;217158;8;GO:0004518
GO:0097505;Rad6-Rad18 complex;121;4;GO:0007031
GO:0097508;xanthine DNA N-glycosylase activity;3;0;GO:0004553
GO:0097507;hypoxanthine DNA N-glycosylase activity;5;0;GO:0006096
GO:0097509;oxanine DNA N-glycosylase activity;3;0;GO:0006066
GO:0061584;orexin secretion;0;0;GO:0005576
GO:1902460;regulation of mesenchymal stem cell proliferation;274;9;GO:0045737
GO:0061585;orexin secretion, neurotransmission;0;0;GO:0005764
GO:1902461;negative regulation of mesenchymal stem cell proliferation;4;2;GO:0045766
GO:0061586;positive regulation of transcription by transcription factor localization;118;4;GO:0045944
GO:0061580;colon epithelial cell migration;55;8;GO:0030334
GO:1902464;regulation of histone H3-K27 trimethylation;43;2;GO:0045944
GO:0061581;corneal epithelial cell migration;0;0;GO:0030900
GO:1902465;negative regulation of histone H3-K27 trimethylation;43;6;GO:0045944
GO:0061582;intestinal epithelial cell migration;93;12;GO:0030900
GO:1902462;positive regulation of mesenchymal stem cell proliferation;270;10;GO:0045766
GO:0061583;colon epithelial cell chemotaxis;0;2;GO:0050921
GO:1902463;protein localization to cell leading edge;249;108;GO:0009987
GO:1902466;positive regulation of histone H3-K27 trimethylation;0;2;GO:0045944
GO:0061588;calcium activated phospholipid scrambling;576;159;GO:0006979
GO:0061589;calcium activated phosphatidylserine scrambling;167;21;GO:0006979
GO:0097511;dendritic cell dendrite;0;1;GO:0030424
GO:0097510;base-excision repair, AP site formation via deaminated base removal;256;3;GO:0006281
GO:0097513;myosin II filament;148;179;GO:0005524
GO:0097512;cardiac myofibril;313;123;GO:0005576
GO:0097515;asexual spore wall;0;0;GO:0048305
GO:0097514;sexual spore wall;0;0;GO:0048305
GO:0097517;contractile actin filament bundle;3584;325;GO:0003779
GO:0061590;calcium activated phosphatidylcholine scrambling;204;10;GO:0006629
GO:0097516;microvillar actin bundle;4;0;GO:0005576
GO:0097519;DNA recombinase complex;43;5;GO:0003677
GO:0097518;parallel actin filament bundle;64;0;GO:0005576
GO:0061530;aspartate secretion, neurotransmission;0;1;GO:0007411
GO:0061531;primary amine secretion;0;0;GO:0042165
GO:0061532;primary amine secretion, neurotransmission;0;1;GO:0007218
GO:0048559;establishment of floral organ orientation;4;1;GO:0048316
GO:0061537;glycine secretion, neurotransmission;2;121;GO:0007218
GO:0061538;histamine secretion, neurotransmission;0;0;GO:0004930
GO:0048557;embryonic digestive tract morphogenesis;1089;481;GO:0007565
GO:0061539;octopamine secretion;0;2;GO:0008021
GO:0048556;microsporocyte nucleus;1;6;GO:0005730
GO:0061533;norepinephrine secretion, neurotransmission;0;0;GO:0007218
GO:0061534;gamma-aminobutyric acid secretion, neurotransmission;32;9;GO:0008030
GO:0061535;glutamate secretion, neurotransmission;222;10;GO:0007611
GO:0061536;glycine secretion;2;10;GO:0008544
GO:0048562;embryonic organ morphogenesis;33625;1350;GO:0009952
GO:0048561;establishment of animal organ orientation;52;3;GO:0048608
GO:0048560;establishment of anatomical structure orientation;153;6;GO:0048608
GO:0048566;embryonic digestive tract development;2189;662;GO:0007565
GO:0048565;digestive tract development;12013;1210;GO:0007596
GO:0048564;photosystem I assembly;1802;86;GO:0009579
GO:0061520;Langerhans cell differentiation;203;6;GO:0002504
GO:0061521;hepatic stellate cell differentiation;0;2;GO:0060537
GO:0061526;acetylcholine secretion;147;5;GO:0008021
GO:0061527;dopamine secretion, neurotransmission;0;1;GO:0007601
GO:0048568;embryonic organ development;54668;2230;GO:0008544
GO:0061528;aspartate secretion;10;6;GO:0007586
GO:0048567;ectodermal digestive tract morphogenesis;180;10;GO:0007517
GO:0061529;epinephrine secretion, neurotransmission;0;1;GO:0007601
GO:0061522;1,4-dihydroxy-2-naphthoyl-CoA thioesterase activity;1138;0;GO:0004497
GO:1902406;mitotic actomyosin contractile ring maturation;90;1;GO:0007067
GO:0061523;cilium disassembly;266;2;GO:0048193
GO:1902407;assembly of actomyosin apparatus involved in mitotic cytokinesis;1480;2;GO:0007067
GO:0061524;central canal development;32;0;GO:0008544
GO:1902404;mitotic actomyosin contractile ring contraction;384;7;GO:0007088
GO:0061525;hindgut development;1285;10;GO:0007565
GO:0048573;photoperiodism, flowering;6237;567;GO:0009723
GO:0048572;short-day photoperiodism;510;7;GO:0009628
GO:0048571;long-day photoperiodism;2508;8;GO:0009628
GO:0048570;notochord morphogenesis;1110;38;GO:0002041
GO:0048577;negative regulation of short-day photoperiodism, flowering;103;142;GO:0048704
GO:0048576;positive regulation of short-day photoperiodism, flowering;140;5;GO:0048704
GO:0048575;short-day photoperiodism, flowering;388;9;GO:0009723
GO:0048574;long-day photoperiodism, flowering;2305;200;GO:0009723
GO:0061551;trigeminal ganglion development;197;66;GO:0008544
GO:0120210;rod telodendria;0;0;GO:0048706
GO:0061552;ganglion morphogenesis;88;10;GO:0048608
GO:0120211;proacrosomal vesicle fusion;62;4;GO:0006979
GO:0061553;ganglion maturation;0;0;GO:0048666
GO:0120212;sperm head-tail coupling apparatus;46;0;GO:0048704
GO:0061554;ganglion formation;14;1;GO:0048666
GO:0120213;regulation of histidine biosynthetic process;5;2;GO:0046395
GO:0120214;negative regulation of histidine biosynthetic process;0;1;GO:0046395
GO:0120215;positive regulation of histidine biosynthetic process;0;1;GO:0046356
GO:1902410;mitotic cytokinetic process;4259;157;GO:0000910
GO:0120216;matrilin complex;65;8;GO:0005576
GO:0061550;cranial ganglion development;466;7;GO:0048704
GO:0120217;DNA gyrase complex;0;0;GO:0005737
GO:0061559;cranial ganglion morphogenesis;18;0;GO:0048704
GO:0120218;host interaction involved in quorum sensing;1;0;GO:0009628
GO:1902413;negative regulation of mitotic cytokinesis;118;6;GO:0048285
GO:0120219;subapical part of cell;168;3;GO:0044464
GO:1902414;protein localization to cell junction;5567;64;GO:0005911
GO:0048579;negative regulation of long-day photoperiodism, flowering;316;127;GO:0048704
GO:0048578;positive regulation of long-day photoperiodism, flowering;1271;5;GO:0048704
GO:1902412;regulation of mitotic cytokinesis;3114;167;GO:0048285
GO:0061555;ganglion structural organization;4;0;GO:0048666
GO:1902417;(+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity;7;0;GO:0008544
GO:0061556;trigeminal ganglion morphogenesis;9;1;GO:0048704
GO:1902418;(+)-abscisic acid D-glucopyranosyl ester transmembrane transport;14;2;GO:0046356
GO:0061557;trigeminal ganglion maturation;0;0;GO:0007517
GO:1902415;regulation of mRNA binding;16;7;GO:0030528
GO:0061558;cranial ganglion maturation;0;0;GO:0007565
GO:1902416;positive regulation of mRNA binding;16;65;GO:0010467
GO:0048584;positive regulation of response to stimulus;336224;2310;GO:0048583
GO:0048583;regulation of response to stimulus;1618207;3970;GO:0050896
GO:0048582;positive regulation of post-embryonic development;3127;6;GO:0048731
GO:1902408;mitotic cytokinesis, division site positioning;87;5;GO:0007067
GO:0048581;negative regulation of post-embryonic development;3399;10;GO:0048731
GO:0048588;developmental cell growth;16947;730;GO:0042127
GO:0048587;regulation of short-day photoperiodism, flowering;327;6;GO:0048704
GO:0048586;regulation of long-day photoperiodism, flowering;1895;28;GO:0048316
GO:0048585;negative regulation of response to stimulus;812999;1770;GO:0048583
GO:0048580;regulation of post-embryonic development;19243;66;GO:0048731
GO:0120220;basal body patch;41;1;GO:0048471
GO:0061540;octopamine secretion, neurotransmission;0;1;GO:0008021
GO:0061541;rhabdomere morphogenesis;38;10;GO:0048285
GO:0120200;rod photoreceptor outer segment;319;7;GO:0005576
GO:0061542;3-demethylubiquinol-n 3-O-methyltransferase activity;31208;3;GO:0004497
GO:0120201;cone photoreceptor disc membrane;0;1;GO:0005576
GO:0061543;3-demethylubiquinol-6 3-O-methyltransferase activity;171;2;GO:0004497
GO:0120202;rod photoreceptor disc membrane;4;1;GO:0005576
GO:0120203;rod photoreceptor disc lumen;0;1;GO:0005576
GO:0120204;methylcytosine to 5-glyceryl-methylcytosine dioxygenase activity;1;1;GO:0006066
GO:1902421;hydrogen metabolic process;6;2;GO:0019318
GO:0120205;photoreceptor proximal connecting cilium;4;2;GO:0005929
GO:0120206;photoreceptor distal connecting cilium;168;4;GO:0005929
GO:0061548;ganglion development;1305;324;GO:0048704
GO:0120207;endocytosis, site selection;4;1;GO:0006897
GO:1902424;negative regulation of attachment of mitotic spindle microtubules to kinetochore;15;2;GO:0048285
GO:0061549;sympathetic ganglion development;455;182;GO:0007517
GO:0120208;telodendria;0;1;GO:0005576
GO:1902425;positive regulation of attachment of mitotic spindle microtubules to kinetochore;521;21;GO:0048285
GO:0120209;cone telodendria;0;0;GO:0005576
GO:1902422;hydrogen biosynthetic process;0;1;GO:0046394
GO:0048589;developmental growth;72292;3480;GO:0048856
GO:1902423;regulation of attachment of mitotic spindle microtubules to kinetochore;539;3;GO:0048285
GO:0061544;peptide secretion, neurotransmission;1;1;GO:0007399
GO:1902428;negative regulation of water channel activity;0;2;GO:0010467
GO:0061545;tyramine secretion;0;1;GO:0008544
GO:1902429;positive regulation of water channel activity;0;0;GO:0048407
GO:0061546;tyramine secretion, neurotransmission;0;0;GO:0007601
GO:1902426;deactivation of mitotic spindle assembly checkpoint;254;13;GO:0007067
GO:0061547;glycogen synthase activity, transferring glucose-1-phosphate;56;8;GO:0005976
GO:1902427;regulation of water channel activity;0;2;GO:0005215
GO:0048593;camera-type eye morphogenesis;15051;1340;GO:0007586
GO:0048592;eye morphogenesis;24641;920;GO:0007530
GO:0048599;oocyte development;6563;1400;GO:0009790
GO:0048598;embryonic morphogenesis;87483;3770;GO:0009952
GO:0048597;post-embryonic camera-type eye morphogenesis;153;279;GO:0007565
GO:0048596;embryonic camera-type eye morphogenesis;3967;651;GO:0007565
GO:0120232;prenyl-FMNH2 biosynthetic process;1;0;GO:0006021
GO:0120233;prenyl-FMNH2 binding;1;1;GO:0042803
GO:0120234;stereocilium coat;47;2;GO:0005576
GO:0120235;regulation of post-translational protein targeting to membrane, translocation;20;0;GO:0010467
GO:0120236;negative regulation of post-translational protein targeting to membrane, translocation;20;1;GO:0010468
GO:0120237;terminal acetylenic compound biosynthetic process;8;0;GO:0046395
GO:0120238;sperm glycocalyx;2;0;GO:0008021
GO:0120239;vascular endothelial glycocalyx;0;0;GO:0009986
GO:0120240;platelet glycocalyx;0;0;GO:0009986
GO:0120241;2-iminobutanoate/2-iminopropanoate deaminase;1883;1;GO:0006081
GO:0120242;2-iminobutanoate deaminase activity;61;5;GO:0006081
GO:0120221;maintenance of ciliary planar beating movement pattern;12;1;GO:0048407
GO:0120222;regulation of blastocyst development;182;3;GO:0048589
GO:0120223;larynx morphogenesis;104;2;GO:0009952
GO:0120224;larynx development;104;0;GO:0007517
GO:0120225;coenzyme A binding;70;23;GO:0097159
GO:0120226;succinyl-CoA binding;1;0;GO:0005525
GO:0120227;acyl-CoA binding;27715;5;GO:0097367
GO:0120228;outer dynein arm docking complex;65;2;GO:0005525
GO:0120229;protein localization to motile cilium;225;5;GO:0005929
GO:0120230;recombinase activator activity;106;4;GO:0004872
GO:0120231;DNA recombinase auxiliary factor complex;106;4;GO:0005576
GO:0120254;olefinic compound metabolic process;28859;56;GO:0006066
GO:0120255;olefinic compound biosynthetic process;10490;2;GO:0009694
GO:0120256;olefinic compound catabolic process;890;0;GO:0006081
GO:0120257;peptidyl-threonine acetylation;2;2;GO:0016525
GO:0120258;peptidyl-threonine O-acetylation;2;2;GO:0009066
GO:0120259;7SK snRNP;186;4;GO:0005831
GO:0097591;ventral disc lateral crest;0;0;GO:0002076
GO:0097590;archaeal-type flagellum-dependent cell motility;1;1;GO:0005929
GO:0097593;ventral disc microtubule array;0;1;GO:0048285
GO:0097592;ventral disc overlap zone;0;0;GO:0005634
GO:0097584;dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt2p dimer complex;8;3;GO:0005524
GO:0097583;dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt3p dimer complex;6;3;GO:0005524
GO:0097586;dolichyl-phosphate-mannose-protein mannosyltransferase Pmt4p homodimer complex;19;1;GO:0005524
GO:0097585;dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt3p dimer complex;6;3;GO:0005524
GO:0097588;archaeal or bacterial-type flagellum-dependent cell motility;494935;170;GO:0005929
GO:0097587;MutLgamma complex;13;2;GO:0005524
GO:0097589;archaeal-type flagellum;4034;3;GO:0005575
GO:0120260;ciliary microtubule quartet;3;4;GO:0005929
GO:0120261;regulation of heterochromatin organization;1951;2;GO:0016570
GO:0120262;negative regulation of heterochromatin organization;556;0;GO:0016570
GO:0120263;positive regulation of heterochromatin organization;1016;1;GO:0045730
GO:0120264;regulation of chromosome attachment to the nuclear envelope;0;1;GO:0048285
GO:0120243;2-iminopropanoate deaminase activity;13;2;GO:0006081
GO:0120244;terminal acetylenic compound metabolic process;8;0;GO:0006022
GO:0120245;terminal acetylenic compound catabolic process;0;0;GO:0046395
GO:0120246;acetylenic compound metabolic process;8;1;GO:0006725
GO:0120247;acetylenic compound biosynthetic process;8;0;GO:0046395
GO:0120248;acetylenic compound catabolic process;0;0;GO:0046395
GO:0120249;lateral wall of outer hair cell;62;0;GO:0048771
GO:0097595;ventral disc crossbridge;0;0;GO:0005544
GO:0097594;ventral disc dorsal microribbon;0;0;GO:0005576
GO:0097597;ventral disc;2;0;GO:0005634
GO:0097596;ventral disc supernumerary microtubule array;0;1;GO:0048285
GO:0097599;xylanase activity;53177;8;GO:0004553
GO:0097598;sperm cytoplasmic droplet;177;21;GO:0009986
GO:0120250;fatty acid omega-hydroxylase activity;190;3;GO:0004076
GO:0120251;hydrocarbon biosynthetic process;109319;2;GO:0009809
GO:0120252;hydrocarbon metabolic process;126553;2;GO:0006066
GO:0120253;hydrocarbon catabolic process;15149;1;GO:0006066
GO:0120276;regulation of cerebral blood circulation;2;2;GO:0050877
GO:0120277;positive regulation of cerebral blood circulation;2;2;GO:0050877
GO:1902472;regulation of mitotic cytokinesis, division site positioning;24;3;GO:0048285
GO:0120278;negative regulation of cerebral blood circulation;0;1;GO:0050877
GO:0120279;Z granule;0;1;GO:0008021
GO:1902475;L-alpha-amino acid transmembrane transport;94903;920;GO:0008565
GO:1902476;chloride transmembrane transport;465961;1880;GO:0006836
GO:1902473;regulation of protein localization to synapse;940;10;GO:0048169
GO:1902474;positive regulation of protein localization to synapse;136;37;GO:0048169
GO:0097571;left nucleus;0;1;GO:0005634
GO:0097570;cyst wall;1;1;GO:0048471
GO:0097562;left lateral basal body pair;0;1;GO:0005929
GO:0097561;right caudal flagellum;0;0;GO:0048193
GO:0097564;right lateral basal body pair;0;1;GO:0005576
GO:0097563;left middle basal body pair;0;2;GO:0048471
GO:0097566;left tetrad;0;0;GO:0009954
GO:0097565;right middle basal body pair;0;1;GO:0048471
GO:0097568;median body;2;1;GO:0005576
GO:0097567;right tetrad;0;0;GO:0009952
GO:0097569;lateral shield;0;1;GO:0048285
GO:0120280;ciliary pro-basal body;0;0;GO:0005576
GO:0120281;autolysosome membrane;13;3;GO:0005764
GO:0120282;autolysosome lumen;48;1;GO:0033279
GO:0120283;protein serine/threonine kinase binding;262;3;GO:0019901
GO:0120284;tryptophan binding;64;2;GO:0005515
GO:0120285;tyrosine sensor activity;0;0;GO:0004872
GO:0120286;tryptophan sensor activity;0;1;GO:0009416
GO:0120265;negative regulation of chromosome attachment to the nuclear envelope;0;0;GO:0048285
GO:1902482;regulatory T cell apoptotic process;9;2;GO:0042981
GO:0120266;positive regulation of chromosome attachment to the nuclear envelope;0;0;GO:0048285
GO:1902483;cytotoxic T cell pyroptotic process;67;3;GO:1903047
GO:0120267;pellicular membrane;0;0;GO:0016021
GO:1902480;protein localization to mitotic spindle;64;4;GO:0007062
GO:0120268;paraflagellar rod assembly;0;0;GO:0005576
GO:1902481;gamma-tubulin complex assembly;0;1;GO:0005819
GO:0120269;ciliary centrin arm;1;3;GO:0005576
GO:1902486;protein localization to growing cell tip;0;0;GO:0009987
GO:1902487;protein localization to non-growing cell tip;0;0;GO:0009987
GO:1902484;Sertoli cell apoptotic process;0;2;GO:0042981
GO:1902485;L-cysteine binding;6;2;GO:0043169
GO:1902488;cholangiocyte apoptotic process;32;0;GO:0043066
GO:1902489;hepatoblast apoptotic process;0;4;GO:0010941
GO:0097580;intracellular sequestering of copper ion;0;1;GO:0006836
GO:0097582;dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex;12;4;GO:0005524
GO:0097581;lamellipodium organization;5195;52;GO:0030198
GO:0097572;right nucleus;0;2;GO:0005634
GO:0097575;lateral cell cortex;288;5;GO:0048471
GO:0097574;lateral part of cell;465;4;GO:0044464
GO:0097577;sequestering of iron ion;1040;146;GO:0006826
GO:0097576;vacuole fusion;1665;9;GO:0005766
GO:0097579;extracellular sequestering of copper ion;0;2;GO:0005576
GO:0097578;sequestering of copper ion;1;2;GO:0006836
GO:0120270;regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts;9;0;GO:0022613
GO:0120271;negative regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts;5;2;GO:0010467
GO:0120272;positive regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts;4;1;GO:0010467
GO:0120273;ciliary centrin arm assembly;2;1;GO:0005576
GO:0120274;virus coreceptor activity;48;5;GO:0003779
GO:0120275;cerebral blood circulation;2;3;GO:0007599
GO:0120298;peptide noradrenalinyltransferase activity;7;1;GO:0004867
GO:1902493;acetyltransferase complex;128955;53;GO:0005529
GO:0120299;peptide histaminyltransferase activity;70;4;GO:0004867
GO:1902494;catalytic complex;5986735;1670;GO:0005840
GO:1902491;negative regulation of sperm capacitation;14;1;GO:0048308
GO:1902492;positive regulation of sperm capacitation;3;0;GO:0048308
GO:1902497;iron-sulfur cluster transmembrane transport;82;1;GO:0006826
GO:1902498;regulation of protein autoubiquitination;296;32;GO:0006464
GO:1902495;transmembrane transporter complex;1583820;873;GO:0015075
GO:1902499;positive regulation of protein autoubiquitination;165;97;GO:0016567
GO:0097540;axonemal central pair;1;1;GO:0005576
GO:0097542;ciliary tip;846;416;GO:0005929
GO:0097541;axonemal basal plate;78;5;GO:0048316
GO:0097544;ciliary shaft;0;4;GO:0048407
GO:0097543;ciliary inversin compartment;490;24;GO:0005576
GO:0097546;ciliary base;3278;533;GO:0005929
GO:0097545;axonemal outer doublet;16;3;GO:0005576
GO:0097548;seed abscission;26;2;GO:0009813
GO:0097547;synaptic vesicle protein transport vesicle;0;2;GO:0008030
GO:1902490;regulation of sperm capacitation;51;9;GO:0048407
GO:0097560;left caudal flagellum;0;0;GO:0048193
GO:0097551;mitochondrial double-strand break repair;176;2;GO:0007050
GO:0097550;transcription preinitiation complex;1205;15;GO:0000786
GO:0097553;calcium ion transmembrane import into cytosol;43033;368;GO:0006836
GO:0097552;mitochondrial double-strand break repair via homologous recombination;176;8;GO:0007040
GO:0097555;right anterior flagellum;0;1;GO:0048308
GO:0097554;left anterior flagellum;0;1;GO:0005575
GO:0097557;right posteriolateral flagellum;0;1;GO:0048308
GO:0097556;left posteriolateral flagellum;0;1;GO:0005575
GO:0097559;right ventral flagellum;0;0;GO:0048308
GO:0120290;stalled replication fork localization to nuclear periphery;147;8;GO:0007050
GO:0097558;left ventral flagellum;0;0;GO:0048308
GO:0120291;negative regulation of mitotic recombination-dependent replication fork processing;0;0;GO:0048285
GO:0120292;positive regulation of mitotic recombination-dependent replication fork processing;0;0;GO:0048285
GO:0120293;dynein axonemal particle;4752;17;GO:0005856
GO:0120294;peptide serotonyltransferase activity;72;1;GO:0004872
GO:0120295;histone serotonyltransferase activity;63;2;GO:0003676
GO:0120296;peptide dopaminyltransferase activity;70;1;GO:0004867
GO:0120297;histone dopaminyltransferase activity;63;2;GO:0004723
GO:0000506;glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex;6168;269;GO:0005581
GO:0000502;proteasome complex;578175;6190;GO:0000502
GO:0000500;RNA polymerase I upstream activating factor complex;1209;10;GO:0000976
GO:0012511;monolayer-surrounded lipid storage body;2694;204;GO:0006631
GO:0012510;trans-Golgi network transport vesicle membrane;25665;305;GO:0005764
GO:0000515;aspartate:glutamate, proton antiporter activity;114;3;GO:0005215
GO:0000514;3-sulfino-L-alanine: proton, glutamate antiporter activity;113;5;GO:0005215
GO:0000513;actin severing activator activity;0;1;GO:0003700
GO:0000512;lncRNA-mediated post-transcriptional gene silencing;17;9;GO:0034470
GO:0000511;H2A-H2B histone complex chaperone activity;9;3;GO:0003774
GO:0000510;H3-H4 histone complex chaperone activity;24;3;GO:0003774
GO:0012508;Golgi to ER transport vesicle membrane;5;1;GO:0005764
GO:0012509;inter-Golgi transport vesicle membrane;0;1;GO:0005764
GO:0012506;vesicle membrane;630579;1390;GO:0030141
GO:0012507;ER to Golgi transport vesicle membrane;61784;1190;GO:0005764
GO:0012505;endomembrane system;4857202;5190;GO:0005764
GO:0012502;induction of programmed cell death;209;773;GO:0010941
GO:0012501;programmed cell death;416606;7010;GO:0010941
GO:0036530;protein deglycation, methylglyoxal removal;11;7;GO:0009066
GO:0036531;glutathione deglycation;47;8;GO:0006979
GO:0048515;spermatid differentiation;15480;855;GO:0007283
GO:0048514;blood vessel morphogenesis;74614;5360;GO:0001944
GO:0048513;animal organ development;685808;2650;GO:0048513
GO:0000578;embryonic axis specification;4467;638;GO:0009952
GO:0048512;circadian behavior;6947;739;GO:0007623
GO:0048519;negative regulation of biological process;4196895;4260;GO:0048523
GO:0048518;positive regulation of biological process;2591850;5030;GO:0050789
GO:0048522;positive regulation of cellular process;2228430;4730;GO:0050789
GO:0048521;negative regulation of behavior;705;182;GO:0048519
GO:0048520;positive regulation of behavior;1468;302;GO:0048519
GO:0036526;peptidyl-cysteine deglycation;1;8;GO:0006464
GO:1990922;hepatic stellate cell proliferation;20;4;GO:0048010
GO:0036527;peptidyl-arginine deglycation;7;7;GO:0006464
GO:1990923;PET complex;150;46;GO:0005737
GO:0036528;peptidyl-lysine deglycation;1;8;GO:0006464
GO:0036529;protein deglycation, glyoxal removal;1;8;GO:0006457
GO:0036522;negative regulation by symbiont of host protein localization to phagocytic vesicle;1;1;GO:0048193
GO:1990926;short-term synaptic potentiation;155;10;GO:0008092
GO:1990927;calcium ion regulated lysosome exocytosis;129;10;GO:0006916
GO:0036524;protein deglycase activity;1707;23;GO:0006066
GO:1990928;response to amino acid starvation;57004;50;GO:0009063
GO:0036525;protein deglycation;25;6;GO:0006457
GO:1990929;sulfoquinovosidase activity;1;3;GO:0004733
GO:0036520;astrocyte-dopaminergic neuron signaling;133;7;GO:0050877
GO:0036521;modulation by symbiont of host protein localization to phagocytic vesicle;1;1;GO:0048193
GO:0048526;imaginal disc-derived wing expansion;80;12;GO:0009952
GO:0048525;negative regulation of viral process;4959;594;GO:0016032
GO:0048524;positive regulation of viral process;29660;261;GO:0016032
GO:0048523;negative regulation of cellular process;3655865;5190;GO:0048523
GO:0048529;magnesium-protoporphyrin IX monomethyl ester (oxidative) cyclase activity;10740;182;GO:0004730
GO:0048528;post-embryonic root development;2429;42;GO:0048608
GO:0048527;lateral root development;2253;401;GO:0048316
GO:0036519;chemorepulsion of serotonergic neuron axon;0;3;GO:0048608
GO:0048533;sporocyte differentiation;7;2;GO:0009952
GO:0048532;anatomical structure arrangement;3482;182;GO:0050829
GO:1990930;mRNA N1-methyladenosine dioxygenase activity;69;2;GO:0006066
GO:0048531;beta-1,3-galactosyltransferase activity;3003;89;GO:0004553
GO:1990931;mRNA N6-methyladenosine dioxygenase activity;549;2;GO:0006066
GO:0048530;fruit morphogenesis;137;9;GO:0048468
GO:1990932;5.8S rRNA binding;13;42;GO:0003735
GO:0036515;serotonergic neuron axon guidance;167;31;GO:0048608
GO:1990933;microtubule cytoskeleton attachment to nuclear envelope;0;0;GO:0048471
GO:0036516;chemoattraction of dopaminergic neuron axon;3;1;GO:0048608
GO:1990934;nucleolus-like body;0;1;GO:0005730
GO:0036517;chemoattraction of serotonergic neuron axon;48;9;GO:0007610
GO:1990935;splicing factor binding;342;7;GO:0003723
GO:0036518;chemorepulsion of dopaminergic neuron axon;96;10;GO:0048608
GO:1990936;vascular associated smooth muscle cell dedifferentiation;69;0;GO:0048608
GO:0036511;trimming of first mannose on A branch;0;10;GO:0005976
GO:1990937;xylan acetylation;4531;8;GO:0046395
GO:0036512;trimming of second mannose on A branch;0;8;GO:0005929
GO:1990938;peptidyl-aspartic acid autophosphorylation;1;5;GO:0006468
GO:0036513;Derlin-1 retrotranslocation complex;522;68;GO:0005737
GO:0036514;dopaminergic neuron axon guidance;170;26;GO:0048608
GO:0036510;trimming of terminal mannose on C branch;1;7;GO:0006021
GO:0061510;asymmetric protein localization to new mitotic spindle pole body;4;1;GO:0007062
GO:0048537;mucosa-associated lymphoid tissue development;433;5;GO:0002526
GO:0061515;myeloid cell development;6574;306;GO:0030097
GO:0048536;spleen development;1915;1160;GO:0007517
GO:0061516;monocyte proliferation;23;2;GO:0042113
GO:0048535;lymph node development;1339;900;GO:0002526
GO:0061517;macrophage proliferation;636;6;GO:0042113
GO:0048534;hematopoietic or lymphoid organ development;8623;562;GO:0002520
GO:0061518;microglial cell proliferation;390;52;GO:0042127
GO:0061511;centriole elongation;640;32;GO:0007088
GO:0061512;protein localization to cilium;4613;2380;GO:0005929
GO:0048539;bone marrow development;465;510;GO:0030097
GO:0061513;glucose 6-phosphate:inorganic phosphate antiporter activity;2787;41;GO:0009432
GO:0048538;thymus development;2860;2530;GO:0007517
GO:0061514;interleukin-34-mediated signaling pathway;45;1;GO:0007186
GO:0048540;bursa of Fabricius development;1;3;GO:0002520
GO:0036508;protein alpha-1,2-demannosylation;28;18;GO:0006468
GO:0048544;recognition of pollen;30344;1020;GO:0009555
GO:0061519;macrophage homeostasis;138;5;GO:0048646
GO:0036509;trimming of terminal mannose on B branch;3;10;GO:0006021
GO:0048543;phytochrome chromophore biosynthetic process;1;1;GO:0009579
GO:1990941;mitotic spindle kinetochore microtubule;5;0;GO:0007088
GO:0048542;lymph gland development;1199;213;GO:0002520
GO:1990942;mitotic metaphase chromosome recapture;28;3;GO:0000786
GO:0048541;Peyer's patch development;377;526;GO:0002576
GO:1990943;mating type region replication fork barrier binding;3;0;GO:0003677
GO:0036504;Golgi membrane fusion;0;0;GO:0006986
GO:0036505;prosaposin receptor activity;141;6;GO:0004872
GO:0036506;maintenance of unfolded protein;158;8;GO:0006457
GO:1990946;meiosis I/meiosis II transition;3;0;GO:0007126
GO:0036507;protein demannosylation;28;9;GO:0006464
GO:1990947;exit from meiosis;8;0;GO:0007126
GO:0036500;ATF6-mediated unfolded protein response;179;124;GO:0006986
GO:1990948;ubiquitin ligase inhibitor activity;297;65;GO:0004842
GO:0036501;UFD1-NPL4 complex;150;4;GO:0005840
GO:1990949;metaphase/anaphase transition of meiosis I;165;2;GO:0000910
GO:0036502;Derlin-1-VIMP complex;131;22;GO:0005576
GO:0036503;ERAD pathway;46831;635;GO:0006986
GO:0048548;regulation of pinocytosis;661;8;GO:0009913
GO:0061504;cyclic threonylcarbamoyladenosine biosynthetic process;105;2;GO:0006033
GO:0048546;digestive tract morphogenesis;4705;978;GO:0048513
GO:0048545;response to steroid hormone;72547;3290;GO:0048545
GO:0061507;2',3'-cyclic GMP-AMP binding;462;4;GO:0005524
GO:0061501;2',3'-cyclic GMP-AMP synthase activity;195;4;GO:0004061
GO:0061502;early endosome to recycling endosome transport;189;28;GO:0006897
GO:0048549;positive regulation of pinocytosis;393;150;GO:0048193
GO:0061503;tRNA threonylcarbamoyladenosine dehydratase;104;3;GO:0006091
GO:0048550;negative regulation of pinocytosis;235;146;GO:0048193
GO:1990950;metaphase/anaphase transition of meiosis II;12;1;GO:0000910
GO:0048555;generative cell nucleus;11;7;GO:0005634
GO:0061509;asymmetric protein localization to old mitotic spindle pole body;103;2;GO:0007049
GO:1990953;intramanchette transport;90;2;GO:0006810
GO:1990955;G-rich single-stranded DNA binding;59;3;GO:0003677
GO:1990956;fibroblast chemotaxis;0;1;GO:0050900
GO:1990957;NPHP complex;0;2;GO:0048407
GO:1990959;eosinophil homeostasis;63;9;GO:0045765
GO:1990960;basophil homeostasis;6;3;GO:0045730
GO:1990961;xenobiotic detoxification by transmembrane export across the plasma membrane;75107;196;GO:0006836
GO:1990962;xenobiotic transport across blood-brain barrier;124;5;GO:0015509
GO:1990963;establishment of blood-retinal barrier;201;8;GO:0009986
GO:1990964;actin cytoskeleton-regulatory complex;27;5;GO:0030529
GO:1990965;cytosylglucuronate decarboxylase activity;0;0;GO:0006029
GO:1990966;ATP generation from poly-ADP-D-ribose;360;207;GO:0006096
GO:1990968;modulation by host of RNA binding by virus;1;1;GO:0030529
GO:1990969;modulation by host of viral RNA-binding transcription factor activity;45;0;GO:0045944
GO:1990970;trans-activation response element binding;8875;2;GO:0003700
GO:1990971;EMILIN complex;59;5;GO:0045202
GO:1990972;multimerin complex;59;4;GO:0048608
GO:1990973;transmembrane actin-associated (TAN) line;0;0;GO:0005576
GO:1990974;actin-dependent nuclear migration;0;1;GO:0007050
GO:1990976;protein transport along microtubule to mitotic spindle pole body;3;2;GO:0007049
GO:1990983;tRNA demethylation;118;1;GO:0006519
GO:0048500;signal recognition particle;234434;806;GO:0005840
GO:1990984;tRNA demethylase activity;120;3;GO:0003729
GO:1990986;DNA recombinase disassembly;6;0;GO:0006364
GO:0048509;regulation of meristem development;1050;205;GO:0048316
GO:0048504;regulation of timing of animal organ formation;0;0;GO:0048608
GO:0048502;ABC-type thiamine transporter activity;3126;87;GO:0005525
GO:0048501;signal recognition particle, plasma membrane targeting;53108;5;GO:0006613
GO:0048508;embryonic meristem development;951;8;GO:0009953
GO:0048507;meristem development;25972;221;GO:0048316
GO:0048506;regulation of timing of meristematic phase transition;611;34;GO:0048316
GO:0048505;regulation of timing of cell differentiation;711;625;GO:0045595
GO:0048511;rhythmic process;105202;5400;GO:0048511
GO:0048510;regulation of timing of transition from vegetative to reproductive phase;611;139;GO:0048608
GO:0061210;cell-cell signaling involved in mesonephros development;0;1;GO:0007267
GO:0036255;response to methylamine;4;5;GO:0046395
GO:0061211;mesonephric collecting duct development;0;2;GO:0048608
GO:0036256;cellular response to methylamine;0;1;GO:0045735
GO:0061212;mesonephric juxtaglomerular apparatus development;0;2;GO:0048608
GO:0036257;multivesicular body organization;1640;186;GO:0005840
GO:0061213;positive regulation of mesonephros development;0;10;GO:0048608
GO:0036250;peroxisome transport along microtubule;56;1;GO:0006836
GO:1902310;positive regulation of peptidyl-serine dephosphorylation;42;59;GO:0010468
GO:1904973;positive regulation of viral translation;172;10;GO:0010467
GO:1902311;regulation of copper ion transmembrane transport;43;1;GO:0006826
GO:1904972;negative regulation of viral translation;19;3;GO:0010467
GO:1904971;regulation of viral translation;191;1;GO:0010467
GO:1904970;brush border assembly;835;77;GO:0048308
GO:0061218;negative regulation of mesonephros development;45;150;GO:0048704
GO:1902314;hydroquinone binding;0;0;GO:0097159
GO:1904977;lymphatic endothelial cell migration;143;10;GO:0030900
GO:0048239;negative regulation of DNA recombination at telomere;196;19;GO:0045944
GO:0061219;mesonephric mesenchyme development;1;1;GO:0048513
GO:1902315;nuclear cell cycle DNA replication initiation;4620;7;GO:0007049
GO:1904976;cellular response to bleomycin;93;9;GO:0071456
GO:0048238;smooth endoplasmic reticulum lumen;0;5;GO:0005783
GO:1902312;negative regulation of copper ion transmembrane transport;0;0;GO:0046395
GO:1904975;response to bleomycin;159;7;GO:0050829
GO:0048237;rough endoplasmic reticulum lumen;97;317;GO:0005783
GO:1902313;positive regulation of copper ion transmembrane transport;0;0;GO:0045730
GO:1904974;heparanase complex;4;1;GO:0005578
GO:0061214;mesonephric smooth muscle tissue development;0;1;GO:0001944
GO:1902318;synthesis of RNA primer involved in nuclear cell cycle DNA replication;12;2;GO:0006260
GO:0061215;mesonephric nephron development;46;3;GO:0048608
GO:1902319;DNA strand elongation involved in nuclear cell cycle DNA replication;358;3;GO:0007050
GO:1904979;negative regulation of endosome organization;46;0;GO:0048193
GO:0061217;regulation of mesonephros development;271;10;GO:0048704
GO:1902317;nuclear DNA replication termination;3580;1;GO:0006260
GO:1904978;regulation of endosome organization;156;5;GO:0048193
GO:0048243;norepinephrine secretion;111;22;GO:0007601
GO:0051884;regulation of timing of anagen;203;17;GO:0048608
GO:0048242;epinephrine secretion;157;60;GO:0002768
GO:0051885;positive regulation of timing of anagen;103;3;GO:0048608
GO:0048241;epinephrine transport;535;241;GO:0006869
GO:0051882;mitochondrial depolarization;992;375;GO:0007049
GO:1902309;negative regulation of peptidyl-serine dephosphorylation;162;44;GO:0010468
GO:0048240;sperm capacitation;2056;998;GO:0007596
GO:0048247;lymphocyte chemotaxis;2799;1530;GO:0002687
GO:0051880;G-quadruplex DNA binding;1186;393;GO:0003677
GO:0048246;macrophage chemotaxis;1795;784;GO:0002548
GO:0051881;regulation of mitochondrial membrane potential;4404;1100;GO:0048285
GO:0048245;eosinophil chemotaxis;602;842;GO:0050900
GO:0048244;phytanoyl-CoA dioxygenase activity;4400;31;GO:0004497
GO:0036247;phytochelatin 3 import into vacuole;0;1;GO:0005986
GO:0051888;positive regulation of timing of exogen;0;0;GO:0048608
GO:0036248;phytochelatin 4 import into vacuole;0;1;GO:0005986
GO:0051889;negative regulation of timing of exogen;0;0;GO:0048608
GO:0036249;cadmium ion import into vacuole;30;2;GO:0006836
GO:0051886;negative regulation of timing of anagen;48;2;GO:0048608
GO:0051887;regulation of timing of exogen;0;0;GO:0050789
GO:0036243;succinate-semialdehyde dehydrogenase (NADP+) activity;4695;0;GO:0004073
GO:1904980;positive regulation of endosome organization;50;6;GO:0048193
GO:0036244;cellular response to neutral pH;56;7;GO:0006950
GO:0061200;clathrin-sculpted gamma-aminobutyric acid transport vesicle;22;22;GO:0008029
GO:0036245;cellular response to menadione;42;7;GO:0006950
GO:0061201;clathrin-sculpted gamma-aminobutyric acid transport vesicle lumen;0;1;GO:0008029
GO:0036246;phytochelatin 2 import into vacuole;35;4;GO:0005986
GO:0061202;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane;22;62;GO:0008029
GO:1902321;methyl-branched fatty acid biosynthetic process;12;1;GO:0006633
GO:1904984;regulation of quinolinate biosynthetic process;1426;1;GO:0010468
GO:0036240;septal periplasm;0;3;GO:0005737
GO:1902322;regulation of methyl-branched fatty acid biosynthetic process;0;0;GO:0045944
GO:1902622;regulation of neutrophil migration;2554;239;GO:0050921
GO:0009148;pyrimidine nucleoside triphosphate biosynthetic process;455292;10;GO:0006793
GO:0046128;purine ribonucleoside metabolic process;182391;1180;GO:0006749
GO:0048789;cytoskeletal matrix organization at active zone;147;18;GO:0030199
GO:1902623;negative regulation of neutrophil migration;259;8;GO:0050921
GO:0009147;pyrimidine nucleoside triphosphate metabolic process;506176;627;GO:0006793
GO:0046125;pyrimidine deoxyribonucleoside metabolic process;6690;8;GO:0006796
GO:0048788;cytoskeleton of presynaptic active zone;314;194;GO:0008092
GO:1902620;positive regulation of microtubule minus-end binding;0;0;GO:0048285
GO:0009146;purine nucleoside triphosphate catabolic process;43470;892;GO:0009060
GO:0046126;pyrimidine deoxyribonucleoside biosynthetic process;117;2;GO:0006793
GO:0048787;presynaptic active zone membrane;909;139;GO:0005730
GO:0061749;forked DNA-dependent helicase activity;115;10;GO:0003690
GO:1902621;actomyosin contractile ring disassembly;76;1;GO:0048285
GO:0061742;chaperone-mediated autophagy translocation complex;4;2;GO:0005764
GO:1902626;assembly of large subunit precursor of preribosome;558;455;GO:0005840
GO:0061743;motor learning;286;77;GO:0007612
GO:1902627;regulation of assembly of large subunit precursor of preribosome;0;0;GO:0006470
GO:0046129;purine ribonucleoside biosynthetic process;178778;558;GO:0009060
GO:0061744;motor behavior;1330;437;GO:0007626
GO:1902624;positive regulation of neutrophil migration;1727;384;GO:0050921
GO:0046130;purine ribonucleoside catabolic process;2994;970;GO:0009065
GO:0048793;pronephros development;3580;148;GO:0008544
GO:1902619;regulation of microtubule minus-end binding;0;0;GO:0048285
GO:0046131;pyrimidine ribonucleoside metabolic process;115608;108;GO:0006793
GO:0048792;spontaneous exocytosis of neurotransmitter;7;3;GO:0007611
GO:0048791;calcium ion-regulated exocytosis of neurotransmitter;1013;446;GO:0007416
GO:1902617;response to fluoride;42806;33;GO:0046686
GO:0048790;maintenance of presynaptic active zone structure;795;98;GO:0048608
GO:1902618;cellular response to fluoride;42306;8;GO:0009628
GO:0046134;pyrimidine nucleoside biosynthetic process;178;216;GO:0006793
GO:0048797;swim bladder formation;12;2;GO:0048407
GO:0046135;pyrimidine nucleoside catabolic process;115679;153;GO:0009065
GO:0048796;swim bladder maturation;147;3;GO:0048407
GO:0046132;pyrimidine ribonucleoside biosynthetic process;55;28;GO:0009060
GO:0048795;swim bladder morphogenesis;131;4;GO:0048407
GO:0046133;pyrimidine ribonucleoside catabolic process;115484;9;GO:0009065
GO:0048794;swim bladder development;616;4;GO:0048407
GO:0010127;mycothiol-dependent detoxification;4328;9;GO:0009072
GO:0010126;mycothiol metabolic process;32176;8;GO:0006032
GO:0010129;anaerobic cyclohexane-1-carboxylate catabolic process;0;3;GO:0006066
GO:0010128;benzoate catabolic process via CoA ligation;3;5;GO:0009065
GO:0010122;arginine catabolic process to alanine via ornithine;0;2;GO:0006559
GO:0010125;mycothiol biosynthetic process;23122;10;GO:0006032
GO:0010124;phenylacetate catabolic process;77705;54;GO:0046395
GO:0009196;pyrimidine deoxyribonucleoside diphosphate metabolic process;49925;10;GO:0006796
GO:0010185;regulation of cellular defense response;5396;10;GO:0009620
GO:0034152;negative regulation of toll-like receptor 6 signaling pathway;0;3;GO:1901362
GO:0009195;pyrimidine ribonucleoside diphosphate catabolic process;132;3;GO:0006066
GO:0010184;cytokinin transport;48;5;GO:0006869
GO:0034151;regulation of toll-like receptor 6 signaling pathway;39;38;GO:1903047
GO:0009194;pyrimidine ribonucleoside diphosphate biosynthetic process;839;4;GO:0006793
GO:0010187;negative regulation of seed germination;353;244;GO:0010033
GO:0034150;toll-like receptor 6 signaling pathway;39;9;GO:0007165
GO:0048719;epistomal sclerite morphogenesis;0;0;GO:0048706
GO:0009193;pyrimidine ribonucleoside diphosphate metabolic process;992;7;GO:0006793
GO:0010186;positive regulation of cellular defense response;32;7;GO:0045087
GO:0048718;cibarial fish-trap bristle morphogenesis;0;0;GO:0048706
GO:0010181;FMN binding;785336;3920;GO:0005525
GO:0034156;negative regulation of toll-like receptor 7 signaling pathway;18;8;GO:1901362
GO:0009199;ribonucleoside triphosphate metabolic process;3111681;1560;GO:0006793
GO:0010180;thioglucosidase binding;1;3;GO:0043161
GO:0034155;regulation of toll-like receptor 7 signaling pathway;377;6;GO:1902535
GO:0009198;pyrimidine deoxyribonucleoside diphosphate catabolic process;0;2;GO:0006066
GO:0010183;pollen tube guidance;890;242;GO:0007165
GO:0034154;toll-like receptor 7 signaling pathway;686;282;GO:0007165
GO:0009197;pyrimidine deoxyribonucleoside diphosphate biosynthetic process;49924;8;GO:0006793
GO:0010182;sugar mediated signaling pathway;1784;301;GO:0009813
GO:0034153;positive regulation of toll-like receptor 6 signaling pathway;0;2;GO:0046649
GO:0048713;regulation of oligodendrocyte differentiation;1751;318;GO:0048666
GO:0048712;negative regulation of astrocyte differentiation;521;611;GO:0048666
GO:0048711;positive regulation of astrocyte differentiation;468;443;GO:0048666
GO:0048710;regulation of astrocyte differentiation;1098;219;GO:0048667
GO:0048717;anterior cibarial plate morphogenesis;0;1;GO:0008544
GO:0048716;labrum morphogenesis;0;0;GO:0048608
GO:0048715;negative regulation of oligodendrocyte differentiation;583;743;GO:0048193
GO:0048714;positive regulation of oligodendrocyte differentiation;929;840;GO:0048666
GO:0048720;posterior cibarial plate morphogenesis;0;1;GO:0048608
GO:0034149;positive regulation of toll-like receptor 5 signaling pathway;0;3;GO:0046649
GO:0034148;negative regulation of toll-like receptor 5 signaling pathway;55;28;GO:0046649
GO:0034147;regulation of toll-like receptor 5 signaling pathway;55;7;GO:1902535
GO:0034146;toll-like receptor 5 signaling pathway;63;135;GO:0007165
GO:0009192;deoxyribonucleoside diphosphate catabolic process;115;1;GO:0009063
GO:0010178;IAA-amino acid conjugate hydrolase activity;334;6;GO:0005524
GO:0009191;ribonucleoside diphosphate catabolic process;540;10;GO:0009060
GO:0010177;2-(2'-methylthio)ethylmalate synthase activity;10;0;GO:0006099
GO:0009190;cyclic nucleotide biosynthetic process;264185;1270;GO:0009791
GO:0010179;IAA-Ala conjugate hydrolase activity;315;5;GO:0004872
GO:0010196;nonphotochemical quenching;394;102;GO:0009416
GO:0034141;positive regulation of toll-like receptor 3 signaling pathway;494;68;GO:0032724
GO:0034140;negative regulation of toll-like receptor 3 signaling pathway;154;58;GO:0046332
GO:0010198;synergid death;43;6;GO:0048706
GO:0010197;polar nucleus fusion;529;58;GO:0009952
GO:0048729;tissue morphogenesis;89810;2200;GO:0009887
GO:0010192;mucilage biosynthetic process;390;18;GO:0005976
GO:0034145;positive regulation of toll-like receptor 4 signaling pathway;739;80;GO:0032724
GO:0010191;mucilage metabolic process;432;8;GO:0005976
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;387;698;GO:0046649
GO:0034143;regulation of toll-like receptor 4 signaling pathway;1296;104;GO:0032496
GO:0010193;response to ozone;483;676;GO:0050829
GO:0034142;toll-like receptor 4 signaling pathway;2921;1160;GO:0007165
GO:0048724;epistomal sclerite development;0;1;GO:0048608
GO:0048723;clypeus development;0;0;GO:0008544
GO:0010190;cytochrome b6f complex assembly;734;33;GO:0005746
GO:0048722;anterior cibarial plate development;0;2;GO:0008544
GO:0048721;clypeus morphogenesis;0;1;GO:0009952
GO:0048728;proboscis development;70;135;GO:0009952
GO:0048727;posterior cibarial plate development;0;0;GO:0048608
GO:0048726;labrum development;0;1;GO:0009952
GO:0048725;cibarial fish-trap bristle development;0;0;GO:0009913
GO:0048731;system development;1305370;5390;GO:0007275
GO:0048730;epidermis morphogenesis;1666;948;GO:0008544
GO:0034138;toll-like receptor 3 signaling pathway;1205;1020;GO:0007165
GO:0034137;positive regulation of toll-like receptor 2 signaling pathway;357;55;GO:0032724
GO:0034136;negative regulation of toll-like receptor 2 signaling pathway;284;57;GO:0046649
GO:0034135;regulation of toll-like receptor 2 signaling pathway;641;10;GO:0032496
GO:0010189;vitamin E biosynthetic process;470;202;GO:0006749
GO:0010188;response to microbial phytotoxin;132;157;GO:0046686
GO:0034139;regulation of toll-like receptor 3 signaling pathway;705;136;GO:0032496
GO:0009174;pyrimidine ribonucleoside monophosphate biosynthetic process;474351;31;GO:0006793
GO:0034130;toll-like receptor 1 signaling pathway;0;111;GO:0032496
GO:0009173;pyrimidine ribonucleoside monophosphate metabolic process;474804;114;GO:0006793
GO:0010162;seed dormancy process;885;460;GO:0009664
GO:0009172;purine deoxyribonucleoside monophosphate catabolic process;540;3;GO:0009065
GO:0010165;response to X-ray;1483;1420;GO:0009628
GO:0009171;purine deoxyribonucleoside monophosphate biosynthetic process;1244;3;GO:0006749
GO:0010164;response to cesium ion;8;6;GO:0046686
GO:0009178;pyrimidine deoxyribonucleoside monophosphate catabolic process;675;3;GO:0009065
GO:0034134;toll-like receptor 2 signaling pathway;952;1480;GO:0002237
GO:0009177;pyrimidine deoxyribonucleoside monophosphate biosynthetic process;201470;7;GO:0006730
GO:0034133;positive regulation of toll-like receptor 1 signaling pathway;0;3;GO:0032724
GO:0009176;pyrimidine deoxyribonucleoside monophosphate metabolic process;202145;5;GO:0006796
GO:0010161;red light signaling pathway;57;35;GO:0009765
GO:0034132;negative regulation of toll-like receptor 1 signaling pathway;0;5;GO:0032727
GO:0009175;pyrimidine ribonucleoside monophosphate catabolic process;451;2;GO:0009065
GO:0010160;formation of animal organ boundary;512;4;GO:0048513
GO:0034131;regulation of toll-like receptor 1 signaling pathway;0;2;GO:0032496
GO:0048735;haltere morphogenesis;15;5;GO:0048608
GO:0061713;anterior neural tube closure;126;176;GO:0007530
GO:0048734;proboscis morphogenesis;16;3;GO:0009952
GO:0061714;folic acid receptor activity;86;10;GO:0004872
GO:0048733;sebaceous gland development;549;80;GO:0008544
GO:0009179;purine ribonucleoside diphosphate metabolic process;295047;466;GO:0006793
GO:0048732;gland development;42272;2260;GO:0008544
GO:0061716;miRNA export from nucleus;2;1;GO:0022627
GO:0048738;cardiac muscle tissue development;17149;1530;GO:0043530
GO:0061710;L-threonylcarbamoyladenylate synthase;37729;5;GO:0006081
GO:0048737;imaginal disc-derived appendage development;6182;10;GO:0009952
GO:0061711;N(6)-L-threonylcarbamoyladenine synthase activity;80529;0;GO:0006029
GO:0048736;appendage development;25048;1290;GO:0009952
GO:0061712;tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase;7371;0;GO:0003735
GO:0048742;regulation of skeletal muscle fiber development;714;177;GO:0048608
GO:0048741;skeletal muscle fiber development;3492;1530;GO:0048608
GO:0061718;glucose catabolic process to pyruvate;622;269;GO:0006096
GO:0061719;glucose catabolic process to pyruvate utilizing ADP;0;6;GO:0006096
GO:0034127;regulation of MyD88-independent toll-like receptor signaling pathway;2379;20;GO:0046649
GO:0010159;specification of animal organ position;199;4;GO:0048704
GO:0034126;positive regulation of MyD88-dependent toll-like receptor signaling pathway;0;5;GO:0046649
GO:0034125;negative regulation of MyD88-dependent toll-like receptor signaling pathway;57;131;GO:0046649
GO:0034124;regulation of MyD88-dependent toll-like receptor signaling pathway;156;42;GO:0032496
GO:0009170;purine deoxyribonucleoside monophosphate metabolic process;1841;4;GO:0006796
GO:0010155;regulation of proton transport;266;624;GO:0045735
GO:0010158;abaxial cell fate specification;2707;281;GO:0009953
GO:0034129;positive regulation of MyD88-independent toll-like receptor signaling pathway;0;2;GO:0046649
GO:0010157;response to chlorate;93;153;GO:0046686
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;2338;43;GO:0046649
GO:0009185;ribonucleoside diphosphate metabolic process;296360;376;GO:0006793
GO:0010174;nucleoside transmembrane transporter activity, against a concentration gradient;2;2;GO:0005215
GO:0009184;purine deoxyribonucleoside diphosphate catabolic process;115;2;GO:0009065
GO:0009183;purine deoxyribonucleoside diphosphate biosynthetic process;15;6;GO:0009063
GO:0010176;homogentisate phytyltransferase activity;9;2;GO:0004073
GO:0009182;purine deoxyribonucleoside diphosphate metabolic process;131;5;GO:0006796
GO:0009189;deoxyribonucleoside diphosphate biosynthetic process;49939;9;GO:0009063
GO:0010170;glucose-1-phosphate adenylyltransferase complex;29;5;GO:0005524
GO:0034123;positive regulation of toll-like receptor signaling pathway;50;592;GO:0032724
GO:0009188;ribonucleoside diphosphate biosynthetic process;7908;9;GO:0009063
GO:0034122;negative regulation of toll-like receptor signaling pathway;3208;511;GO:0032724
GO:0009187;cyclic nucleotide metabolic process;282015;578;GO:0006749
GO:0010172;embryonic body morphogenesis;697;1040;GO:0048513
GO:0034121;regulation of toll-like receptor signaling pathway;4339;536;GO:0032496
GO:0009186;deoxyribonucleoside diphosphate metabolic process;50280;475;GO:0006796
GO:0010171;body morphogenesis;3192;718;GO:0048513
GO:0034120;positive regulation of erythrocyte aggregation;16;8;GO:0050877
GO:0061702;canonical inflammasome complex;3706;8;GO:0005829
GO:0048745;smooth muscle tissue development;1660;1720;GO:0001944
GO:0061703;pyroptosome complex;0;0;GO:0043161
GO:0048744;negative regulation of skeletal muscle fiber development;0;2;GO:0048608
GO:0061704;glycolytic process from sucrose;0;2;GO:0006096
GO:0048743;positive regulation of skeletal muscle fiber development;344;167;GO:0048608
GO:0061705;sucrose catabolic process to fructose-6-phosphate through glucose and fructose;0;3;GO:0005975
GO:0048749;compound eye development;7049;744;GO:0007600
GO:0061700;GATOR2 complex;734;105;GO:0005524
GO:0061701;bacterial outer membrane vesicle;0;1;GO:0016021
GO:0048753;pigment granule organization;1936;371;GO:0030163
GO:0061706;glycolytic process from sucrose through glucose and fructose;0;1;GO:0006096
GO:0048752;semicircular canal morphogenesis;668;283;GO:0048704
GO:0061707;extracellular exosome macropinocytosis;0;1;GO:0006986
GO:0061708;tRNA-5-taurinomethyluridine 2-sulfurtransferase;1743;5;GO:0008544
GO:0048750;compound eye corneal lens morphogenesis;9;4;GO:0007530
GO:0061709;reticulophagy;3426;83;GO:0006909
GO:0034116;positive regulation of heterotypic cell-cell adhesion;678;956;GO:0048193
GO:0034115;negative regulation of heterotypic cell-cell adhesion;500;254;GO:0048193
GO:0034114;regulation of heterotypic cell-cell adhesion;1180;86;GO:0022610
GO:0034113;heterotypic cell-cell adhesion;2653;1150;GO:0007156
GO:0009181;purine ribonucleoside diphosphate catabolic process;348;17;GO:0009065
GO:0010167;response to nitrate;1701;539;GO:0046395
GO:0009180;purine ribonucleoside diphosphate biosynthetic process;7051;7;GO:0009060
GO:0010166;wax metabolic process;629;80;GO:0009631
GO:0034119;negative regulation of erythrocyte aggregation;2;4;GO:0050877
GO:0010169;thioglucosidase complex;1;2;GO:0005975
GO:0034118;regulation of erythrocyte aggregation;18;4;GO:0002576
GO:0010168;ER body;136;21;GO:0005783
GO:0034117;erythrocyte aggregation;94;6;GO:0007599
GO:0044079;modulation by symbiont of host neurotransmitter secretion;2;5;GO:0048608
GO:0093002;response to nematicide;32;5;GO:0046274
GO:0093001;glycolysis from storage polysaccharide through glucose-1-phosphate;51;16;GO:0006096
GO:0044083;perturbation of host Rho protein signal transduction;2;0;GO:0006936
GO:0071691;cardiac muscle thin filament assembly;146;7;GO:0003743
GO:0044082;perturbation of host small GTPase mediated signal transduction;3;2;GO:0007264
GO:0071692;protein localization to extracellular region;716321;186;GO:0005576
GO:0044085;cellular component biogenesis;10561010;3230;GO:0044062
GO:0044084;host cell membrane pore complex;0;2;GO:0009986
GO:0071690;cardiac muscle myosin thick filament assembly;33;2;GO:0005524
GO:0044087;regulation of cellular component biogenesis;278510;1450;GO:0044057
GO:0071695;anatomical structure maturation;25292;716;GO:0048513
GO:0071696;ectodermal placode development;2007;100;GO:0009952
GO:0044089;positive regulation of cellular component biogenesis;34863;792;GO:0043687
GO:0071693;protein transport within extracellular region;59;2;GO:0019900
GO:0044088;regulation of vacuole organization;3619;125;GO:0048471
GO:0071694;maintenance of protein location in extracellular region;499;8;GO:0048471
GO:0071699;olfactory placode morphogenesis;249;17;GO:0048704
GO:0071697;ectodermal placode morphogenesis;1542;6;GO:0009952
GO:0071698;olfactory placode development;410;10;GO:0007576
GO:0044081;symbiont-mediated suppression of host nitric oxide-mediated signaling;4;2;GO:0046649
GO:0044080;perturbation of host cGMP-mediated signal transduction;0;0;GO:0007218
GO:0044094;host cell nuclear part;87853;7;GO:0044428
GO:0071680;response to indole-3-methanol;269;9;GO:0046365
GO:0044093;positive regulation of molecular function;7039;2490;GO:0050789
GO:0071681;cellular response to indole-3-methanol;265;326;GO:0046686
GO:0044096;type IV pilus;30;7;GO:0008643
GO:0044095;host cell nucleoplasm;663;3;GO:0005634
GO:0044098;DNA secretion by the type IV secretion system;0;2;GO:0015935
GO:0071684;organism emergence from protective structure;1448;10;GO:0044421
GO:0044097;secretion by the type IV secretion system;21602;6;GO:0055085
GO:0071685;NADH dehydrogenase complex (plastoquinone);0;2;GO:0005747
GO:0071682;endocytic vesicle lumen;48;869;GO:0005768
GO:0044099;polar tube;15;3;GO:0005576
GO:0071683;sensory dendrite;213;27;GO:0048666
GO:0071688;striated muscle myosin thick filament assembly;297;135;GO:0005524
GO:0071689;muscle thin filament assembly;114;6;GO:0008544
GO:0044090;positive regulation of vacuole organization;1615;130;GO:0048193
GO:0044092;negative regulation of molecular function;3294;1230;GO:0050789
GO:0044091;membrane biogenesis;172476;260;GO:0016021
GO:0009710;tropane alkaloid biosynthetic process;5;3;GO:0046148
GO:0009714;chalcone metabolic process;5;4;GO:0009813
GO:0009713;catechol-containing compound biosynthetic process;47397;36;GO:0009809
GO:0009712;catechol-containing compound metabolic process;99613;449;GO:0006725
GO:0009711;purine alkaloid biosynthetic process;0;2;GO:0009065
GO:0009707;chloroplast outer membrane;7537;389;GO:0009536
GO:0009706;chloroplast inner membrane;41331;338;GO:0009536
GO:0009705;plant-type vacuole membrane;3214;423;GO:0005737
GO:0009704;de-etiolation;1200;44;GO:0009628
GO:0009709;terpenoid indole alkaloid biosynthetic process;110;2;GO:0046394
GO:0009708;benzyl isoquinoline alkaloid biosynthetic process;6;3;GO:0046148
GO:0009721;detection of auxin stimulus;0;3;GO:0009734
GO:0009720;detection of hormone stimulus;126;8;GO:0009719
GO:0009725;response to hormone;358055;9690;GO:0009725
GO:0009724;detection of abscisic acid stimulus;0;3;GO:0009737
GO:0009723;response to ethylene;28909;1760;GO:0009723
GO:0009722;detection of cytokinin stimulus;5;7;GO:0009725
GO:0009718;anthocyanin-containing compound biosynthetic process;1629;436;GO:0009813
GO:0010707;globoside biosynthetic process via lactosylceramide;61;3;GO:0008610
GO:0009717;isoflavonoid biosynthetic process;8;4;GO:0009813
GO:0010706;ganglioside biosynthetic process via lactosylceramide;460;7;GO:0006631
GO:0009716;flavonoid phytoalexin biosynthetic process;0;3;GO:0009813
GO:0010709;heteroduplex formation involved in double-strand break repair via synthesis-dependent strand annealing;8;1;GO:0000724
GO:0009715;chalcone biosynthetic process;5;138;GO:0009813
GO:0010705;meiotic DNA double-strand break processing involved in reciprocal meiotic recombination;94;34;GO:0000786
GO:0009719;response to endogenous stimulus;553070;4940;GO:0009719
GO:0010704;meiotic DNA double-strand break processing involved in meiotic gene conversion;0;1;GO:0000786
GO:0010701;positive regulation of norepinephrine secretion;27;102;GO:0048608
GO:0010700;negative regulation of norepinephrine secretion;31;750;GO:0048608
GO:0009703;nitrate reductase (NADH) activity;787;48;GO:0006779
GO:0009702;L-arabinokinase activity;100;9;GO:0004721
GO:0009701;isoflavonoid phytoalexin biosynthetic process;2;3;GO:0009640
GO:0009700;indole phytoalexin biosynthetic process;143;10;GO:1901363
GO:0009750;response to fructose;3660;907;GO:0009719
GO:0009754;detection of jasmonic acid stimulus;0;3;GO:0009723
GO:0009753;response to jasmonic acid;16072;2590;GO:0009753
GO:0009752;detection of salicylic acid stimulus;0;4;GO:0009627
GO:0009751;response to salicylic acid;9701;2580;GO:0009751
GO:0009758;carbohydrate utilization;2432;97;GO:0005975
GO:0009757;hexose mediated signaling;891;12;GO:0009410
GO:0009756;carbohydrate mediated signaling;1787;31;GO:0009913
GO:0009755;hormone-mediated signaling pathway;245638;2380;GO:0007218
GO:0034707;chloride channel complex;50224;1300;GO:0003779
GO:0010739;positive regulation of protein kinase A signaling;1659;242;GO:0043406
GO:0034706;sodium channel complex;33075;308;GO:0048169
GO:0009749;response to glucose;10046;2550;GO:0045735
GO:0034705;potassium channel complex;41493;553;GO:0048169
GO:0009748;hexokinase-independent signaling;0;1;GO:0007218
GO:0034704;calcium channel complex;45419;1170;GO:0005509
GO:0010736;serum response element binding;136;23;GO:0003700
GO:0010738;regulation of protein kinase A signaling;2051;538;GO:0007186
GO:0034709;methylosome;2369;221;GO:0048285
GO:0010737;protein kinase A signaling;2914;691;GO:0007186
GO:0034708;methyltransferase complex;69326;252;GO:0005524
GO:0010732;regulation of protein glutathionylation;59;8;GO:0016579
GO:0010731;protein glutathionylation;73;250;GO:0006464
GO:0010734;negative regulation of protein glutathionylation;59;165;GO:0046395
GO:0010733;positive regulation of protein glutathionylation;0;0;GO:0046395
GO:0034703;cation channel complex;123532;976;GO:0048471
GO:0034702;monoatomic ion channel complex;181409;5;GO:0048471
GO:0010730;negative regulation of hydrogen peroxide biosynthetic process;54;35;GO:0046323
GO:0034701;tripeptidase activity;34749;5;GO:0004721
GO:0034700;allulose 6-phosphate 3-epimerase activity;1470;4;GO:0006073
GO:0009761;CAM photosynthesis;0;6;GO:0009579
GO:0009760;C4 photosynthesis;1;5;GO:0009579
GO:0009765;photosynthesis, light harvesting;17386;1730;GO:0009579
GO:0009764;PEP carboxykinase C4 photosynthesis;0;2;GO:0009579
GO:0007100;mitotic centrosome separation;1342;296;GO:0000922
GO:0009763;NAD-malic enzyme C4 photosynthesis;0;4;GO:0009536
GO:0009762;NADP-malic enzyme C4 photosynthesis;0;4;GO:0009579
GO:0009769;photosynthesis, light harvesting in photosystem II;14;45;GO:0009579
GO:0007107;membrane addition at site of cytokinesis;42;3;GO:0007067
GO:0009768;photosynthesis, light harvesting in photosystem I;1127;368;GO:0009579
GO:0009767;photosynthetic electron transport chain;179234;594;GO:0009579
GO:0007105;cytokinesis, division site positioning;274;1;GO:0007067
GO:0009759;indole glucosinolate biosynthetic process;37;34;GO:0009813
GO:0010747;positive regulation of long-chain fatty acid import across plasma membrane;25;3;GO:0046394
GO:0010746;regulation of long-chain fatty acid import across plasma membrane;231;0;GO:0006631
GO:0010749;regulation of nitric oxide mediated signal transduction;467;48;GO:0007165
GO:0010748;negative regulation of long-chain fatty acid import across plasma membrane;206;9;GO:0046395
GO:0010743;regulation of macrophage derived foam cell differentiation;1146;279;GO:0045595
GO:0010742;macrophage derived foam cell differentiation;1429;208;GO:0002576
GO:0010745;negative regulation of macrophage derived foam cell differentiation;411;1350;GO:0045595
GO:0010744;positive regulation of macrophage derived foam cell differentiation;734;681;GO:0045595
GO:0009732;detection of hexose stimulus;28;9;GO:0009725
GO:0009731;detection of sucrose stimulus;20;8;GO:0009410
GO:0009730;detection of carbohydrate stimulus;66;19;GO:0009410
GO:0009736;cytokinin-activated signaling pathway;28958;439;GO:0007165
GO:0009735;response to cytokinin;29600;1920;GO:0009737
GO:0009734;auxin-activated signaling pathway;62381;2050;GO:0009734
GO:0009733;response to auxin;88815;4580;GO:0009733
GO:0009729;detection of brassinosteroid stimulus;101;154;GO:0009723
GO:0010718;positive regulation of epithelial to mesenchymal transition;2989;1670;GO:0048704
GO:0009728;detection of gibberellic acid stimulus;0;6;GO:0009723
GO:0010717;regulation of epithelial to mesenchymal transition;5145;715;GO:0010717
GO:0009727;detection of ethylene stimulus;20;15;GO:0009723
GO:0009726;detection of endogenous stimulus;200;8;GO:0009719
GO:0010719;negative regulation of epithelial to mesenchymal transition;1585;1230;GO:0010717
GO:0010714;positive regulation of collagen metabolic process;1093;98;GO:0048407
GO:0010713;negative regulation of collagen metabolic process;192;10;GO:0048407
GO:0010716;negative regulation of extracellular matrix disassembly;166;127;GO:0032989
GO:0010715;regulation of extracellular matrix disassembly;644;911;GO:0032989
GO:0010710;regulation of collagen catabolic process;201;174;GO:0032963
GO:0010712;regulation of collagen metabolic process;1508;228;GO:0032963
GO:0010711;negative regulation of collagen catabolic process;33;9;GO:0032963
GO:0009743;response to carbohydrate;19281;1830;GO:0005975
GO:0009742;brassinosteroid mediated signaling pathway;14625;333;GO:0007165
GO:0009741;response to brassinosteroid;15477;954;GO:0009737
GO:0009740;gibberellic acid mediated signaling pathway;10836;515;GO:0009734
GO:0009747;hexokinase-dependent signaling;4;4;GO:0007218
GO:0009746;response to hexose;13758;403;GO:0005975
GO:0009745;sucrose mediated signaling;55;9;GO:0009813
GO:0009744;response to sucrose;3437;1480;GO:0009734
GO:0010729;positive regulation of hydrogen peroxide biosynthetic process;199;29;GO:0046394
GO:0009739;response to gibberellin;13123;1110;GO:0009737
GO:0010728;regulation of hydrogen peroxide biosynthetic process;262;121;GO:0046395
GO:0009738;abscisic acid-activated signaling pathway;20353;952;GO:0009737
GO:0009737;response to abscisic acid;29772;3870;GO:0009737
GO:0010725;regulation of primitive erythrocyte differentiation;224;80;GO:0050877
GO:0010724;regulation of definitive erythrocyte differentiation;187;67;GO:0050877
GO:0010727;negative regulation of hydrogen peroxide metabolic process;67;242;GO:0046395
GO:0010726;positive regulation of hydrogen peroxide metabolic process;256;35;GO:0046394
GO:0010721;negative regulation of cell development;14076;975;GO:0045595
GO:0010720;positive regulation of cell development;25320;1050;GO:0045595
GO:0010723;positive regulation of transcription from RNA polymerase II promoter in response to iron;0;5;GO:0045944
GO:0010722;regulation of ferrochelatase activity;1;7;GO:0006879
GO:0046619;lens placode formation involved in camera-type eye formation;196;3;GO:0048704
GO:0010660;regulation of muscle cell apoptotic process;2625;68;GO:0010941
GO:0046618;xenobiotic export from cell;75278;13;GO:0006820
GO:0007010;cytoskeleton organization;946988;14600;GO:0007010
GO:0009673;low-affinity phosphate transmembrane transporter activity;2;4;GO:0008565
GO:0009672;auxin:proton symporter activity;0;2;GO:0005215
GO:0009671;nitrate:proton symporter activity;59;1;GO:0005215
GO:0009670;triose-phosphate:phosphate antiporter activity;34;3;GO:0005215
GO:0007014;actin ubiquitination;0;6;GO:0042775
GO:0009677;double fertilization forming two zygotes;0;1;GO:0009566
GO:0046611;lysosomal proton-transporting V-type ATPase complex;24;4;GO:0005764
GO:0007015;actin filament organization;235269;5200;GO:0030036
GO:0009676;low-affinity sulfate:proton symporter activity;0;0;GO:0008544
GO:0046612;lysosomal proton-transporting V-type ATPase, V1 domain;0;3;GO:0005764
GO:0009675;high-affinity sulfate:proton symporter activity;10;0;GO:0008544
GO:0009674;potassium:sodium symporter activity;270;6;GO:0005215
GO:0046610;lysosomal proton-transporting V-type ATPase, V0 domain;0;4;GO:0005764
GO:0007018;microtubule-based movement;277924;9490;GO:0006936
GO:0007019;microtubule depolymerization;4257;1870;GO:0007049
GO:0009679;hexose:proton symporter activity;6726;5;GO:0005215
GO:0007017;microtubule-based process;694508;7180;GO:0007017
GO:0009678;diphosphate hydrolysis-driven proton transmembrane transporter activity;76168;10;GO:0015986
GO:0007009;plasma membrane organization;113996;1460;GO:0031093
GO:0034628;'de novo' NAD biosynthetic process from aspartate;118;29;GO:0009061
GO:0034627;'de novo' NAD biosynthetic process;25496;10;GO:0006749
GO:0010659;cardiac muscle cell apoptotic process;1622;126;GO:0043066
GO:0010658;striated muscle cell apoptotic process;1834;8;GO:0010941
GO:0019001;guanyl nucleotide binding;4826753;2210;GO:0005524
GO:0019003;GDP binding;3861;1890;GO:0043565
GO:0010654;apical cell fate commitment;6;2;GO:0048608
GO:0019002;GMP binding;123;176;GO:0046983
GO:0010657;muscle cell apoptotic process;3253;206;GO:0010941
GO:0019005;SCF ubiquitin ligase complex;20491;2430;GO:0005829
GO:0034620;cellular response to unfolded protein;24154;1970;GO:0006986
GO:0010656;negative regulation of muscle cell apoptotic process;1701;460;GO:0043066
GO:0010651;negative regulation of cell communication by electrical coupling;28;1;GO:0050877
GO:0034626;fatty acid elongation, polyunsaturated fatty acid;2745;499;GO:0006633
GO:0010650;positive regulation of cell communication by electrical coupling;8;23;GO:0050877
GO:0034625;fatty acid elongation, monounsaturated fatty acid;2939;186;GO:0006633
GO:0010653;negative regulation of cell communication by chemical coupling;0;1;GO:0050877
GO:0010652;positive regulation of cell communication by chemical coupling;9;26;GO:0050877
GO:0019008;molybdopterin synthase complex;46553;184;GO:0005524
GO:0046628;positive regulation of insulin receptor signaling pathway;1266;581;GO:0030516
GO:0046629;gamma-delta T cell activation;933;314;GO:0046649
GO:0007021;tubulin complex assembly;14673;517;GO:0005840
GO:0009684;indoleacetic acid biosynthetic process;106;205;GO:0006749
GO:0009683;indoleacetic acid metabolic process;159;6;GO:0006554
GO:0009682;induced systemic resistance;454;117;GO:0046686
GO:0007020;microtubule nucleation;33793;2140;GO:0000226
GO:0009688;abscisic acid biosynthetic process;2577;199;GO:0009697
GO:0046622;positive regulation of organ growth;2683;732;GO:0048608
GO:0007026;negative regulation of microtubule depolymerization;1396;1070;GO:0048285
GO:0009687;abscisic acid metabolic process;2772;452;GO:0009737
GO:0046623;sphingolipid floppase activity;136;4;GO:0005525
GO:0007023;post-chaperonin tubulin folding pathway;17225;273;GO:0006091
GO:0009686;gibberellin biosynthetic process;1646;234;GO:0009813
GO:0046620;regulation of organ growth;6728;658;GO:0048731
GO:0009685;gibberellin metabolic process;2170;92;GO:0009813
GO:0046621;negative regulation of organ growth;2942;392;GO:0048608
GO:0007029;endoplasmic reticulum organization;49095;1690;GO:0007030
GO:0046626;regulation of insulin receptor signaling pathway;4546;811;GO:0007179
GO:1900700;positive regulation of o-orsellinic acid biosynthetic process;0;0;GO:0046395
GO:0046627;negative regulation of insulin receptor signaling pathway;2858;1330;GO:0030513
GO:0007027;negative regulation of axonemal microtubule depolymerization;0;2;GO:0048285
GO:0046624;sphingolipid transporter activity;1389;46;GO:0005576
GO:1900702;negative regulation of orcinol biosynthetic process;0;0;GO:0046395
GO:0007028;cytoplasm organization;2012;357;GO:0007049
GO:0009689;induction of phytoalexin biosynthetic process;3;5;GO:0046274
GO:0046625;sphingolipid binding;1821;56;GO:0030198
GO:1900701;regulation of orcinol biosynthetic process;0;0;GO:0010468
GO:0034618;arginine binding;19867;99;GO:0005515
GO:0034617;tetrahydrobiopterin binding;109;216;GO:0097367
GO:0034616;response to laminar fluid shear stress;427;1470;GO:0048407
GO:0010669;epithelial structure maintenance;2669;738;GO:0030574
GO:0046630;gamma-delta T cell proliferation;0;1;GO:0042127
GO:0010666;positive regulation of cardiac muscle cell apoptotic process;275;182;GO:0043066
GO:0034611;oligoribonucleotidase activity;3;2;GO:0004867
GO:0010665;regulation of cardiac muscle cell apoptotic process;1174;37;GO:0043066
GO:0034610;oligodeoxyribonucleotidase activity;0;0;GO:0004518
GO:0010668;ectodermal cell differentiation;429;37;GO:0009952
GO:0010667;negative regulation of cardiac muscle cell apoptotic process;888;603;GO:0043066
GO:0010662;regulation of striated muscle cell apoptotic process;1337;9;GO:0043066
GO:0034615;GCH1 complex;0;0;GO:0043161
GO:0010661;positive regulation of muscle cell apoptotic process;806;8;GO:0010941
GO:0034614;cellular response to reactive oxygen species;425877;1800;GO:0006979
GO:0010664;negative regulation of striated muscle cell apoptotic process;1049;264;GO:0043066
GO:0010663;positive regulation of striated muscle cell apoptotic process;277;8;GO:0010941
GO:0034612;response to tumor necrosis factor;19799;1590;GO:0006954
GO:0046639;negative regulation of alpha-beta T cell differentiation;1337;57;GO:0045595
GO:0009651;response to salt stress;11318;5090;GO:0006950
GO:0022626;cytosolic ribosome;78277;4100;GO:0005840
GO:0009650;UV protection;806;844;GO:0009628
GO:0022627;cytosolic small ribosomal subunit;17370;5480;GO:0005840
GO:0022628;chloroplast large ribosomal subunit;0;2;GO:0005840
GO:0022629;chloroplast small ribosomal subunit;0;1;GO:0005840
GO:0009655;PSII associated light-harvesting complex II, core complex;0;2;GO:0009565
GO:0022622;root system development;21048;141;GO:0048316
GO:0046633;alpha-beta T cell proliferation;2735;289;GO:0042127
GO:0009654;photosystem II oxygen evolving complex;13998;494;GO:0009579
GO:0022623;proteasome-activating nucleotidase complex;1804;3;GO:0004867
GO:0046634;regulation of alpha-beta T cell activation;6761;409;GO:0046649
GO:0009653;anatomical structure morphogenesis;2150645;9920;GO:0009653
GO:0022624;proteasome accessory complex;46875;1230;GO:0005840
GO:0046631;alpha-beta T cell activation;13484;863;GO:0002449
GO:0009652;thigmotropism;133;169;GO:0007626
GO:0022625;cytosolic large ribosomal subunit;51409;6150;GO:0005840
GO:0046632;alpha-beta T cell differentiation;9147;1370;GO:0002449
GO:0009659;leucoplast organization;0;1;GO:0009986
GO:0046637;regulation of alpha-beta T cell differentiation;3786;116;GO:0045595
GO:1900711;negative regulation of tensidol B biosynthetic process;0;0;GO:0010468
GO:0009658;chloroplast organization;11917;931;GO:0009536
GO:0046638;positive regulation of alpha-beta T cell differentiation;2101;639;GO:0045595
GO:1900710;regulation of tensidol B biosynthetic process;0;1;GO:0010401
GO:0009657;plastid organization;15952;665;GO:0009536
GO:0022620;microgametophyte vegetative cell differentiation;0;2;GO:0048316
GO:0046635;positive regulation of alpha-beta T cell activation;3778;262;GO:0046649
GO:1900713;regulation of violaceol I biosynthetic process;0;0;GO:0046274
GO:0009656;PSII associated light-harvesting complex II, peripheral complex;0;3;GO:0009565
GO:0046636;negative regulation of alpha-beta T cell activation;2343;229;GO:0042110
GO:1900712;positive regulation of tensidol B biosynthetic process;0;0;GO:0046356
GO:0034608;vulval location;42;2;GO:0005576
GO:1900704;regulation of siderophore biosynthetic process;39;0;GO:0046395
GO:0034607;turning behavior involved in mating;65;6;GO:0007586
GO:1900703;positive regulation of orcinol biosynthetic process;0;0;GO:0046356
GO:0034606;response to hermaphrodite contact;69;6;GO:0009583
GO:1900706;positive regulation of siderophore biosynthetic process;21;1;GO:0046395
GO:0009649;entrainment of circadian clock;2369;369;GO:0007623
GO:0034605;cellular response to heat;59403;2800;GO:0006950
GO:1900705;negative regulation of siderophore biosynthetic process;18;0;GO:0046365
GO:0010637;negative regulation of mitochondrial fusion;496;233;GO:0048471
GO:0046640;regulation of alpha-beta T cell proliferation;2006;989;GO:0042127
GO:1900708;negative regulation of tensidol A biosynthetic process;0;0;GO:0010468
GO:0010636;positive regulation of mitochondrial fusion;324;52;GO:0048471
GO:0046641;positive regulation of alpha-beta T cell proliferation;1141;1030;GO:0048011
GO:1900707;regulation of tensidol A biosynthetic process;0;0;GO:0010468
GO:0010639;negative regulation of organelle organization;119869;1340;GO:0050789
GO:0010638;positive regulation of organelle organization;44847;2080;GO:0050789
GO:0034609;spicule insertion;23;2;GO:0048706
GO:1900709;positive regulation of tensidol A biosynthetic process;0;0;GO:0046356
GO:0010633;negative regulation of epithelial cell migration;3983;375;GO:0030574
GO:0010632;regulation of epithelial cell migration;15468;731;GO:0030334
GO:0010635;regulation of mitochondrial fusion;855;197;GO:0007049
GO:0010634;positive regulation of epithelial cell migration;10150;1930;GO:0030574
GO:0034604;pyruvate dehydrogenase (NAD+) activity;284;0;GO:0006096
GO:0034603;pyruvate dehydrogenase [NAD(P)+] activity;356;0;GO:0006099
GO:0010631;epithelial cell migration;23562;827;GO:0030334
GO:0034602;oxoglutarate dehydrogenase (NAD+) activity;50;0;GO:0004097
GO:0010630;regulation of transcription, start site selection;0;1;GO:0006355
GO:0034601;oxoglutarate dehydrogenase [NAD(P)+] activity;68;0;GO:0004073
GO:0022619;generative cell differentiation;16;12;GO:0030154
GO:0009662;etioplast organization;118;22;GO:0007049
GO:0022615;protein to membrane docking;279;30;GO:0048193
GO:0007000;nucleolus organization;2793;243;GO:0005730
GO:0009661;chromoplast organization;1;3;GO:0009908
GO:0022616;DNA strand elongation;39343;2090;GO:0003676
GO:0009660;amyloplast organization;277;9;GO:0009913
GO:0022617;extracellular matrix disassembly;1832;3060;GO:0043062
GO:0022618;protein-RNA complex assembly;615297;34;GO:0003774
GO:0009666;plastid outer membrane organization;28;2;GO:0009536
GO:0022611;dormancy process;1785;232;GO:0048308
GO:0046644;negative regulation of gamma-delta T cell activation;0;2;GO:0048002
GO:0007004;telomere maintenance via telomerase;6692;1040;GO:0007049
GO:0009665;plastid inheritance;1;2;GO:0048316
GO:0022612;gland morphogenesis;10139;1040;GO:0009952
GO:0046645;positive regulation of gamma-delta T cell activation;339;10;GO:0048011
GO:0009664;plant-type cell wall organization;16228;956;GO:0072555
GO:0022613;ribonucleoprotein complex biogenesis;5174543;5150;GO:0022613
GO:0046642;negative regulation of alpha-beta T cell proliferation;674;60;GO:0045727
GO:1900720;negative regulation of uterine smooth muscle relaxation;0;0;GO:0048608
GO:0009663;plasmodesma organization;110;6;GO:0032559
GO:0022614;membrane to membrane docking;232;170;GO:0048193
GO:0046643;regulation of gamma-delta T cell activation;456;2030;GO:0046649
GO:0007007;inner mitochondrial membrane organization;16843;1040;GO:0005743
GO:0046648;positive regulation of gamma-delta T cell proliferation;0;2;GO:0048011
GO:1900722;regulation of protein adenylylation;3691;2;GO:0010468
GO:0007008;outer mitochondrial membrane organization;9103;28;GO:0005743
GO:0009669;sucrose:monoatomic cation symporter activity;587;0;GO:0005215
GO:0046649;lymphocyte activation;216043;2540;GO:0046649
GO:1900721;positive regulation of uterine smooth muscle relaxation;17;4;GO:0048608
GO:0007005;mitochondrion organization;238800;5620;GO:0005739
GO:0009668;plastid membrane organization;2667;214;GO:0009941
GO:0046646;regulation of gamma-delta T cell proliferation;0;2;GO:0046649
GO:1900724;positive regulation of protein adenylylation;0;1;GO:0010468
GO:0007006;mitochondrial membrane organization;31179;1240;GO:0005743
GO:0009667;plastid inner membrane organization;32;2;GO:0009536
GO:0046647;negative regulation of gamma-delta T cell proliferation;0;0;GO:0048364
GO:1900723;negative regulation of protein adenylylation;3691;2;GO:0010468
GO:1900715;positive regulation of violaceol I biosynthetic process;0;0;GO:0046274
GO:1900714;negative regulation of violaceol I biosynthetic process;0;0;GO:0046274
GO:1900717;negative regulation of violaceol II biosynthetic process;0;0;GO:0046274
GO:1900716;regulation of violaceol II biosynthetic process;0;0;GO:0046274
GO:0010648;negative regulation of cell communication;348065;1260;GO:0050877
GO:0046651;lymphocyte proliferation;24224;1930;GO:0042127
GO:1900719;regulation of uterine smooth muscle relaxation;17;1;GO:0048010
GO:0010647;positive regulation of cell communication;189721;1570;GO:0050877
GO:1900718;positive regulation of violaceol II biosynthetic process;0;0;GO:0046274
GO:0010649;regulation of cell communication by electrical coupling;329;730;GO:0007154
GO:0010644;cell communication by electrical coupling;1732;1260;GO:0007154
GO:0010643;cell communication by chemical coupling;75;35;GO:0007154
GO:0010646;regulation of cell communication;797916;2970;GO:0007154
GO:0010645;regulation of cell communication by chemical coupling;9;7;GO:0007154
GO:0010640;regulation of platelet-derived growth factor receptor signaling pathway;1388;354;GO:0048010
GO:0010642;negative regulation of platelet-derived growth factor receptor signaling pathway;718;251;GO:0048010
GO:0010641;positive regulation of platelet-derived growth factor receptor signaling pathway;278;124;GO:0048010
GO:0007051;spindle organization;52976;2670;GO:0007052
GO:0007054;spindle assembly involved in male meiosis I;39;2;GO:0007018
GO:0032010;phagolysosome;243;251;GO:0005764
GO:0034673;inhibin-betaglycan-ActRII complex;175;80;GO:0005576
GO:0007055;spindle assembly involved in male meiosis II;0;0;GO:0007018
GO:0032011;ARF protein signal transduction;42752;61;GO:0009733
GO:0034672;anterior/posterior pattern specification involved in pronephros development;89;2;GO:0009952
GO:0007052;mitotic spindle organization;23957;4310;GO:0007059
GO:0034671;retinoic acid receptor signaling pathway involved in pronephros anterior/posterior pattern specification;0;1;GO:0030501
GO:0007053;spindle assembly involved in male meiosis;90;8;GO:0007018
GO:0034670;chemotaxis to arachidonic acid;4;38;GO:0007626
GO:0007058;spindle assembly involved in female meiosis II;81;8;GO:0007018
GO:0020025;subpellicular microtubule;2;6;GO:0005576
GO:0007059;chromosome segregation;534274;9470;GO:0007059
GO:0007056;spindle assembly involved in female meiosis;563;53;GO:0007018
GO:0020023;kinetoplast;360;9;GO:0005737
GO:0007057;spindle assembly involved in female meiosis I;207;50;GO:0007018
GO:0020022;acidocalcisome;61;9;GO:0005829
GO:0020028;endocytic hemoglobin import into cell;6;3;GO:0006897
GO:0020027;hemoglobin metabolic process;1478;639;GO:0006096
GO:0020026;merozoite dense granule;3;3;GO:0005576
GO:0032009;early phagosome;694;193;GO:0005764
GO:0019043;establishment of viral latency;357999;903;GO:009743
GO:0020032;basal ring of apical complex;0;3;GO:0009986
GO:0019042;viral latency;358805;17;GO:0010467
GO:0020031;polar ring of apical complex;0;4;GO:0005576
GO:0019045;latent virus replication;180;2;GO:0016032
GO:0020030;infected host cell surface knob;54;9;GO:0048304
GO:0019044;maintenance of viral latency;41;2;GO:009743
GO:0032003;interleukin-28 receptor binding;25;3;GO:0005126
GO:0034666;integrin alpha2-beta1 complex;116;162;GO:0005911
GO:0010698;acetyltransferase activator activity;358;47;GO:0016567
GO:0019046;release from viral latency;180;31;GO:009743
GO:0034665;integrin alpha1-beta1 complex;109;113;GO:0005911
GO:0019049;mitigation of host antiviral defense response;1168943;22;GO:0046649
GO:0032001;1,4-alpha-glucan 6-alpha-glucosyltransferase activity;2;2;GO:0006073
GO:0034664;Ig heavy chain-bound endoplasmic reticulum chaperone complex;0;3;GO:0005783
GO:0019048;modulation by virus of host process;2331131;36;GO:0043407
GO:0032002;interleukin-28 receptor complex;68;38;GO:0005125
GO:0034663;endoplasmic reticulum chaperone complex;890;459;GO:0005829
GO:0010695;regulation of mitotic spindle pole body separation;129;1;GO:0048285
GO:0032007;negative regulation of TOR signaling;19142;826;GO:0045944
GO:0010694;positive regulation of alkaline phosphatase activity;25;49;GO:0010468
GO:0032008;positive regulation of TOR signaling;19639;779;GO:0045944
GO:0034669;integrin alpha4-beta7 complex;119;43;GO:0002576
GO:0010697;negative regulation of mitotic spindle pole body separation;60;3;GO:0048285
GO:0032005;signal transduction involved in positive regulation of conjugation with cellular fusion;1976;3;GO:0048285
GO:0034668;integrin alpha4-beta1 complex;57;5;GO:0005911
GO:0010696;positive regulation of mitotic spindle pole body separation;69;5;GO:0048285
GO:0032006;regulation of TOR signaling;42488;917;GO:0007049
GO:0034667;integrin alpha3-beta1 complex;124;130;GO:0005911
GO:0007062;sister chromatid cohesion;85321;4380;GO:0007059
GO:0007060;male meiosis chromosome segregation;345;271;GO:0007059
GO:0007065;male meiosis sister chromatid cohesion;114;6;GO:0007070
GO:0034662;CFTR-NHERF-ezrin complex;0;1;GO:0005576
GO:0007066;female meiosis sister chromatid cohesion;108;96;GO:0007070
GO:0032000;positive regulation of fatty acid beta-oxidation;513;1040;GO:0045944
GO:0034661;ncRNA catabolic process;37149;417;GO:0010467
GO:0007063;regulation of sister chromatid cohesion;1205;928;GO:0007070
GO:0034660;ncRNA metabolic process;14359241;3460;GO:0034660
GO:0007064;mitotic sister chromatid cohesion;30294;3540;GO:0007030
GO:0020014;schizogony;1;5;GO:0048608
GO:0020013;modulation by symbiont of host erythrocyte aggregation;73;7;GO:0048193
GO:0020011;apicoplast;2502;35;GO:0005737
GO:0020018;ciliary pocket membrane;192;5;GO:0005576
GO:0020016;ciliary pocket;348;78;GO:0005829
GO:0020015;glycosome;490;35;GO:0005764
GO:0019030;icosahedral viral capsid;192883;7;GO:0043234
GO:0019031;viral envelope;1365517;460;GO:0016021
GO:0020020;food vacuole;48;10;GO:0005737
GO:0019034;viral replication complex;10;34;GO:0030529
GO:0019033;viral tegument;17916;87;GO:0016021
GO:0019036;viral transcriptional complex;0;1;GO:0030528
GO:0034655;nucleobase-containing compound catabolic process;1429765;1840;GO:0009062
GO:0019035;viral integration complex;0;7;GO:0043405
GO:0034654;nucleobase-containing compound biosynthetic process;51466128;2000;GO:0009405
GO:0034653;retinoic acid catabolic process;240;96;GO:0009062
GO:0034659;isopropylmalate transport;110;3;GO:0009060
GO:0034658;isopropylmalate transmembrane transporter activity;55;3;GO:0008544
GO:0034657;GID complex;534;90;GO:0005840
GO:0034656;nucleobase-containing small molecule catabolic process;155151;62;GO:0046395
GO:0009691;cytokinin biosynthetic process;138406;202;GO:0009791
GO:0009690;cytokinin metabolic process;144200;515;GO:0006725
GO:0020009;microneme;45;25;GO:0048305
GO:0020008;rhoptry;55;27;GO:0005576
GO:0007032;endosome organization;11406;1150;GO:0007041
GO:0009695;jasmonic acid biosynthetic process;2916;765;GO:0009697
GO:0034651;cortisol biosynthetic process;456;82;GO:0009060
GO:0007033;vacuole organization;48763;1870;GO:0007049
GO:0009694;jasmonic acid metabolic process;3590;556;GO:0009813
GO:0034650;cortisol metabolic process;595;27;GO:0007555
GO:0007030;Golgi organization;27923;4360;GO:0005840
GO:0009693;ethylene biosynthetic process;3665;492;GO:0009873
GO:0007031;peroxisome organization;84755;2480;GO:0005742
GO:0009692;ethylene metabolic process;3666;86;GO:0006725
GO:0007036;vacuolar calcium ion homeostasis;56;4;GO:0006874
GO:0009699;phenylpropanoid biosynthetic process;20527;1070;GO:0009698
GO:0020003;symbiont-containing vacuole;203;67;GO:0005764
GO:0009698;phenylpropanoid metabolic process;48675;2430;GO:0009813
GO:0020002;host cell plasma membrane;1626852;97;GO:0005886
GO:0007034;vacuolar transport;109397;2300;GO:0006897
GO:0009697;salicylic acid biosynthetic process;2586;349;GO:0009697
GO:0007035;vacuolar acidification;2274;1030;GO:0008037
GO:0009696;salicylic acid metabolic process;3282;84;GO:0009813
GO:0020007;apical complex;112;162;GO:0048471
GO:0020006;symbiont-containing vacuolar membrane network;0;2;GO:0005737
GO:0007038;endocytosed protein transport to vacuole;1;2;GO:0006897
GO:0020005;symbiont-containing vacuole membrane;69;78;GO:0005737
GO:0007039;protein catabolic process in the vacuole;1225;92;GO:0006914
GO:0020004;symbiont-containing vacuolar space;9;4;GO:0005737
GO:0020010;conoid;0;4;GO:0005576
GO:0034644;cellular response to UV;6866;2780;GO:0009628
GO:0034643;establishment of mitochondrion localization, microtubule-mediated;1286;710;GO:0005740
GO:0034642;mitochondrion migration along actin filament;55;2;GO:0006935
GO:0034641;cellular nitrogen compound metabolic process;126943368;6870;GO:0034641
GO:0010673;positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle;15;5;GO:0006355
GO:0019029;helical viral capsid;159921;14;GO:0042303
GO:0010672;regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle;42;3;GO:0006355
GO:0019028;viral capsid;1357217;634;GO:0042303
GO:0034647;histone H3K4me/H3K4me2/H3K4me3 demethylase activity;3929;7;GO:0016569
GO:0034646;organelle-enclosing lipid monolayer;247;1;GO:0005737
GO:0010674;negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle;11;8;GO:0000976
GO:0010691;negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter in response to nutrient levels;0;3;GO:0045944
GO:0046608;carotenoid isomerase activity;1125;10;GO:0004091
GO:0007040;lysosome organization;8401;1570;GO:0005764
GO:0010690;negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter in response to stress;0;1;GO:0045944
GO:0010693;negative regulation of alkaline phosphatase activity;64;131;GO:0010468
GO:0046606;negative regulation of centrosome cycle;2792;7;GO:0048193
GO:0010692;regulation of alkaline phosphatase activity;90;75;GO:0010468
GO:0046607;positive regulation of centrosome cycle;0;8;GO:0048193
GO:0007043;cell-cell junction assembly;9474;1740;GO:0005911
GO:0034640;establishment of mitochondrion localization by microtubule attachment;11;2;GO:0005740
GO:0007044;cell-substrate junction assembly;4942;2120;GO:0005911
GO:0007041;lysosomal transport;11766;1030;GO:0006897
GO:0007042;lysosomal lumen acidification;705;176;GO:0005764
GO:0046600;negative regulation of centriole replication;2486;448;GO:0048193
GO:0046601;positive regulation of centriole replication;594;33;GO:0048193
GO:0046604;positive regulation of mitotic centrosome separation;185;108;GO:0048285
GO:0046605;regulation of centrosome cycle;7041;1160;GO:0048608
GO:0007049;cell cycle;3127106;29200;GO:0007049
GO:0046602;regulation of mitotic centrosome separation;508;63;GO:0048285
GO:0046603;negative regulation of mitotic centrosome separation;21;10;GO:0048285
GO:0034639;L-amino acid efflux transmembrane transporter activity;10916;7;GO:0005215
GO:0034638;phosphatidylcholine catabolic process;845;266;GO:0006631
GO:0019010;farnesoic acid O-methyltransferase activity;17;8;GO:0004722
GO:0010688;negative regulation of ribosomal protein gene transcription by RNA polymerase II;14;6;GO:0045944
GO:0034633;retinol transport;10154;9;GO:0006865
GO:0019013;viral nucleocapsid;373129;528;GO:0016021
GO:0034632;retinol transmembrane transporter activity;5102;60;GO:0005515
GO:0034631;microtubule anchoring at spindle pole body;75;3;GO:0005524
GO:0010689;negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter in response to chemical stimulus;0;1;GO:0045944
GO:0034630;RITS complex localization;0;3;GO:0005576
GO:0010684;tricyclic triterpenoid catabolic process;0;1;GO:0046274
GO:0010683;tricyclic triterpenoid metabolic process;9;5;GO:0006032
GO:0010686;tetracyclic triterpenoid biosynthetic process;9;3;GO:0009061
GO:0034635;glutathione transport;12809;202;GO:0006879
GO:0010685;tetracyclic triterpenoid metabolic process;9;2;GO:0006032
GO:0034634;glutathione transmembrane transporter activity;219;48;GO:0008529
GO:0007094;mitotic spindle assembly checkpoint signaling;18258;294;GO:0000922
GO:0032050;clathrin heavy chain binding;1335;189;GO:0005515
GO:0007095;mitotic G2 DNA damage checkpoint signaling;7554;173;GO:0007050
GO:0032051;clathrin light chain binding;8596;352;GO:0005515
GO:0007093;mitotic cell cycle checkpoint signaling;33325;137;GO:0000077
GO:0007098;centrosome cycle;26790;1580;GO:0007088
GO:0007099;centriole replication;9430;1690;GO:0007067
GO:0032055;negative regulation of translation in response to stress;454;45;GO:0010468
GO:0007096;regulation of exit from mitosis;4142;875;GO:0048285
GO:0032052;bile acid binding;1674;399;GO:0097159
GO:0007097;nuclear migration;2522;765;GO:0007050
GO:0032053;ciliary basal body organization;404;260;GO:0048471
GO:0044036;cell wall macromolecule metabolic process;181200;1510;GO:0005976
GO:1900772;fumitremorgin B biosynthetic process;3;0;GO:0046395
GO:0044038;cell wall macromolecule biosynthetic process;2298892;202;GO:0009405
GO:0046697;decidualization;917;867;GO:0007596
GO:0019081;viral translation;2382;44;GO:0006412
GO:0019080;viral gene expression;564921;597;GO:0010467
GO:0019083;viral transcription;485109;3630;GO:0010467
GO:0019082;viral protein processing;77423;528;GO:0016567
GO:1900769;fonsecin biosynthetic process;0;1;GO:0009061
GO:0019085;early viral transcription;117;54;GO:0010467
GO:0019084;middle viral transcription;0;4;GO:0045944
GO:0019087;transformation of host cell by virus;37869;34;GO:0016032
GO:0071651;positive regulation of chemokine (C-C motif) ligand 5 production;227;28;GO:0050729
GO:0019086;late viral transcription;1239;48;GO:0010467
GO:0044042;glucan metabolic process;721449;1280;GO:0006073
GO:0071652;regulation of chemokine (C-C motif) ligand 1 production;23;2;GO:0050921
GO:0071650;negative regulation of chemokine (C-C motif) ligand 5 production;163;9;GO:0050727
GO:0032047;mitosome;18;25;GO:0005739
GO:0071655;regulation of granulocyte colony-stimulating factor production;189;7;GO:0046330
GO:0032048;cardiolipin metabolic process;43198;80;GO:0006633
GO:0071656;negative regulation of granulocyte colony-stimulating factor production;42;5;GO:0048193
GO:0032045;guanyl-nucleotide exchange factor complex;10896;429;GO:0005524
GO:0071653;negative regulation of chemokine (C-C motif) ligand 1 production;0;1;GO:0050729
GO:0032046;micropexophagy-specific membrane apparatus;0;1;GO:0005764
GO:0071654;positive regulation of chemokine (C-C motif) ligand 1 production;23;6;GO:0050729
GO:0071659;negative regulation of IP-10 production;100;12;GO:0050727
GO:0007091;metaphase/anaphase transition of mitotic cell cycle;22980;498;GO:0000278
GO:0032049;cardiolipin biosynthetic process;42510;839;GO:0006633
GO:0071657;positive regulation of granulocyte colony-stimulating factor production;147;34;GO:0046649
GO:0071658;regulation of IP-10 production;138;2;GO:0050727
GO:0032040;small-subunit processome;49443;1450;GO:0005840
GO:0032043;mitochondrial DNA catabolic process;105;2;GO:0006512
GO:0032044;DSIF complex;516;43;GO:0005829
GO:0032041;NAD-dependent histone H3K14 deacetylase activity;52;2;GO:0016569
GO:0032042;mitochondrial DNA metabolic process;5112;306;GO:0006259
GO:1900781;fumiquinazoline C biosynthetic process;10;0;GO:0046395
GO:1900786;naphtho-gamma-pyrone catabolic process;0;0;GO:0046274
GO:1900785;naphtho-gamma-pyrone metabolic process;2;0;GO:0046148
GO:1900788;pseurotin A metabolic process;3;0;GO:0006032
GO:1900787;naphtho-gamma-pyrone biosynthetic process;2;1;GO:0046148
GO:0019070;viral genome maturation;1;6;GO:0016032
GO:1900789;pseurotin A catabolic process;0;0;GO:0046274
GO:0019072;viral genome packaging;9405;171;GO:0016032
GO:0019071;viral DNA cleavage involved in viral genome maturation;1;2;GO:0048706
GO:0019074;viral RNA genome packaging;1195;148;GO:0016021
GO:0019073;viral DNA genome packaging;6234;81;GO:0016021
GO:0019076;viral release from host cell;375271;450;GO:0016032
GO:0071640;regulation of macrophage inflammatory protein 1 alpha production;248;7;GO:0050729
GO:0019075;virus maturation;2827;39;GO:0016032
GO:0044053;translocation of peptides or proteins into host cell cytoplasm;5;7;GO:0006936
GO:0071641;negative regulation of macrophage inflammatory protein 1 alpha production;97;6;GO:0050729
GO:0032036;myosin heavy chain binding;5400;543;GO:0005524
GO:0034699;response to luteinizing hormone;322;8;GO:0009725
GO:0071644;negative regulation of chemokine (C-C motif) ligand 4 production;60;8;GO:0050727
GO:0019079;viral genome replication;518706;1110;GO:0016032
GO:0032037;myosin I heavy chain binding;6;2;GO:0005524
GO:0034698;response to gonadotropin;1225;156;GO:0009725
GO:0071645;positive regulation of chemokine (C-C motif) ligand 4 production;0;3;GO:0050729
GO:0032034;myosin II head/neck binding;44;3;GO:0005524
GO:0034697;response to prostaglandin I;0;1;GO:0006954
GO:0071642;positive regulation of macrophage inflammatory protein 1 alpha production;112;8;GO:0050729
GO:0032035;myosin II tail binding;5;1;GO:0005524
GO:0034696;response to prostaglandin F;14;10;GO:0006954
GO:0071643;regulation of chemokine (C-C motif) ligand 4 production;60;1;GO:0050921
GO:0071648;positive regulation of macrophage inflammatory protein-1 gamma production;0;2;GO:0050729
GO:0071649;regulation of chemokine (C-C motif) ligand 5 production;390;9;GO:0050921
GO:0032038;myosin II heavy chain binding;86;23;GO:0005524
GO:0071646;regulation of macrophage inflammatory protein-1 gamma production;0;1;GO:0050729
GO:0032039;integrator complex;15810;1140;GO:0005840
GO:0071647;negative regulation of macrophage inflammatory protein-1 gamma production;0;2;GO:0050729
GO:0007072;positive regulation of transcription involved in exit from mitosis;58;3;GO:0048285
GO:0034691;integrin alphaE-beta7 complex;0;1;GO:0005929
GO:0007073;positive regulation of transcription involved in exit from mitosis, from RNA polymerase I promoter;0;0;GO:0045944
GO:0034690;integrin alphaD-beta2 complex;0;1;GO:0005911
GO:0007076;mitotic chromosome condensation;18246;3250;GO:0007067
GO:0032032;myosin I tail binding;0;1;GO:0005524
GO:0034695;response to prostaglandin E;855;248;GO:0006954
GO:1900791;shamixanthone metabolic process;4;1;GO:0006725
GO:0007077;mitotic nuclear membrane disassembly;35;171;GO:0007067
GO:0032033;myosin II light chain binding;29;7;GO:0005524
GO:0034694;response to prostaglandin;1135;48;GO:0006954
GO:1900790;pseurotin A biosynthetic process;3;0;GO:0046395
GO:0007074;positive regulation of transcription involved in exit from mitosis, from RNA polymerase II promoter;4;2;GO:0045944
GO:0032030;myosin I light chain binding;0;1;GO:0005524
GO:0034693;U11/U12 snRNP;98;5;GO:0008033
GO:1900793;shamixanthone biosynthetic process;4;2;GO:0046395
GO:0007075;positive regulation of transcription involved in exit from mitosis, from RNA polymerase III promoter;0;2;GO:0045944
GO:0032031;myosin I head/neck binding;0;0;GO:0005524
GO:0034692;E.F.G complex;0;1;GO:0005576
GO:1900792;shamixanthone catabolic process;0;1;GO:0046274
GO:0044058;regulation of digestive system process;1763;64;GO:0050896
GO:0044057;regulation of system process;64356;3150;GO:0048519
GO:0007078;lamin depolymerization;5;5;GO:0005576
GO:1900797;cordyol C metabolic process;1;1;GO:0006021
GO:0007079;mitotic chromosome movement towards spindle pole;455;73;GO:0000922
GO:1900796;terrequinone A biosynthetic process;11;4;GO:0046274
GO:1900799;cordyol C biosynthetic process;0;1;GO:0006021
GO:1900798;cordyol C catabolic process;0;0;GO:0006032
GO:0019061;uncoating of virus;2;82;GO:0016032
GO:0019060;intracellular transport of viral protein in host cell;558;36;GO:0048193
GO:0044060;regulation of endocrine process;2223;51;GO:0048608
GO:0071670;smooth muscle cell chemotaxis;351;14;GO:0050921
GO:0019062;virion attachment to host cell;710578;1070;GO:0043169
GO:0044062;regulation of excretion;430;78;GO:0050789
GO:0019065;receptor-mediated endocytosis of virus by host cell;584349;88;GO:0006897
GO:0044065;regulation of respiratory system process;647;553;GO:0050789
GO:0071673;positive regulation of smooth muscle cell chemotaxis;126;21;GO:0048608
GO:0019064;fusion of virus membrane with host plasma membrane;293388;180;GO:0048193
GO:0071674;mononuclear cell migration;13783;378;GO:0050900
GO:0044067;symbiont-mediated perturbation of host cell-cell junction;2;0;GO:0048316
GO:0071671;regulation of smooth muscle cell chemotaxis;299;3;GO:0050900
GO:0044066;symbiont-mediated disruption of host cell nucleus;0;0;GO:0048285
GO:0071672;negative regulation of smooth muscle cell chemotaxis;172;9;GO:0048608
GO:0019069;viral capsid assembly;31298;39;GO:0042803
GO:0032025;response to cobalt ion;168;113;GO:0046395
GO:0034688;integrin alphaM-beta2 complex;14;34;GO:0005911
GO:0071677;positive regulation of mononuclear cell migration;5456;471;GO:0050900
GO:0103003;oleate peroxygenase activity;0;0;GO:0004601
GO:0019068;virion assembly;442433;1010;GO:0016032
GO:0032026;response to magnesium ion;674;447;GO:0006874
GO:0034687;integrin alphaL-beta2 complex;59;82;GO:0005911
GO:0071678;olfactory bulb axon guidance;143;25;GO:0007411
GO:0103002;16-hydroxypalmitate dehydrogenase activity;9;3;GO:0004073
GO:0032023;trypsinogen activation;38;11;GO:0007586
GO:0034686;integrin alphav-beta8 complex;171;118;GO:0005911
GO:0071675;regulation of mononuclear cell migration;8692;801;GO:0050900
GO:0103005;9,10-epoxystearate hydrolase activity;0;0;GO:0004449
GO:0032024;positive regulation of insulin secretion;4025;1450;GO:0010467
GO:0034685;integrin alphav-beta6 complex;245;27;GO:0005911
GO:0071676;negative regulation of mononuclear cell migration;918;30;GO:0050900
GO:0103004;9,10-epoxystearate hydroxylase activity;0;0;GO:0046395
GO:0032029;myosin tail binding;4909;3;GO:0005524
GO:0032027;myosin light chain binding;2648;242;GO:0005524
GO:0071679;commissural neuron axon guidance;747;513;GO:0048608
GO:0103001;dimethylsulfoxide oxygenase activity;0;1;GO:0004497
GO:0032028;myosin head/neck binding;56;4;GO:0005524
GO:0034689;integrin alphaX-beta2 complex;2;0;GO:0005911
GO:0103000;UDP-glucose:4-hydroxylamino-2,6-dinitrotoluene-O-glucosyltransferase activity;0;0;GO:0006022
GO:0034680;integrin alpha10-beta1 complex;108;156;GO:0005911
GO:0007084;mitotic nuclear membrane reassembly;397;122;GO:0007067
GO:0007087;mitotic nuclear pore complex reassembly;0;3;GO:0005730
GO:0032021;NELF complex;1549;51;GO:0000976
GO:0034684;integrin alphav-beta5 complex;174;37;GO:0005911
GO:0103007;indole-3-acetate carboxyl methyltransferase activity;12;3;GO:0004734
GO:0007088;regulation of mitotic nuclear division;24516;1550;GO:0048285
GO:0034683;integrin alphav-beta3 complex;126;17;GO:0005911
GO:0103006;9,10-dihydroxystearate hydroxylase activity;0;0;GO:0004067
GO:0034682;integrin alphav-beta1 complex;0;1;GO:0005911
GO:0103009;3-chlorotoluene monooxygenase activity;0;0;GO:0004497
GO:0007086;vesicle fusion with nuclear membrane involved in mitotic nuclear envelope reassembly;0;3;GO:0007067
GO:0032020;ISG15-protein conjugation;504;400;GO:0043161
GO:0034681;integrin alpha11-beta1 complex;109;21;GO:0005911
GO:0103008;4-chloro-2-methylphenoxyacetate oxygenase activity;0;0;GO:0004497
GO:0020036;Maurer's cleft;102;6;GO:0005615
GO:0044069;modulation by symbiont of host anion transport;0;3;GO:0045730
GO:0020035;adhesion of symbiont to microvasculature;654;4;GO:0048407
GO:0044068;modulation by symbiont of host cellular process;2352551;636;GO:0050727
GO:0007089;traversing start control point of mitotic cell cycle;313;462;GO:0007067
GO:0020033;antigenic variation;279;179;GO:0042302
GO:0020039;pellicle;28;115;GO:0048407
GO:0020038;subpellicular network;2;3;GO:0048446
GO:0020037;heme binding;3486868;18400;GO:0020037
GO:0019050;suppression by virus of host apoptotic process;1601;51;GO:0043066
GO:0044072;suppression of host cell cycle progression;1;0;GO:0010941
GO:0044071;perturbation of host cell cycle progression;74069;1;GO:0010941
GO:0044074;negative regulation by symbiont of host translation;3;4;GO:0010401
GO:0019051;induction by virus of host apoptotic process;11686;8;GO:0008629
GO:0044073;modulation by symbiont of host translation;77690;3;GO:0010467
GO:0019054;modulation by virus of host cellular process;2321928;408;GO:0043407
GO:0044076;positive regulation by symbiont of host vacuole organization;0;2;GO:0048193
GO:0071662;negative regulation of granzyme B production;0;1;GO:0048308
GO:0044075;modulation by symbiont of host vacuole organization;1;1;GO:0048193
GO:0071663;positive regulation of granzyme B production;101;8;GO:0048308
GO:0019056;modulation by virus of host transcription;376364;10;GO:0010467
GO:0044078;positive regulation by symbiont of host receptor-mediated endocytosis;1;4;GO:0048193
GO:0071660;positive regulation of IP-10 production;38;7;GO:0050727
GO:0019055;perturbation by virus of host cell cycle regulation;74059;1;GO:0010942
GO:0044077;modulation by symbiont of host receptor-mediated endocytosis;1;2;GO:0008021
GO:0071661;regulation of granzyme B production;101;2;GO:0048308
GO:0019058;viral life cycle;4519508;3460;GO:0016032
GO:0032014;positive regulation of ARF protein signal transduction;80;9;GO:0010468
GO:0034677;integrin alpha7-beta1 complex;35;9;GO:0005911
GO:0071666;Slit-Robo signaling complex;16;7;GO:0008076
GO:0019057;modulation by virus of host translation;77686;1;GO:0010467
GO:0032015;regulation of Ran protein signal transduction;0;4;GO:0007264
GO:0034676;integrin alpha6-beta4 complex;9;10;GO:0005911
GO:0071667;DNA/RNA hybrid binding;80;6;GO:0003676
GO:0032012;regulation of ARF protein signal transduction;42744;2580;GO:0009725
GO:0034675;integrin alpha6-beta1 complex;0;1;GO:0005911
GO:0071664;catenin-TCF7L2 complex;262;7;GO:0005665
GO:0103016;tRNA-specific 2-thiouridylase activity;4;0;GO:0003729
GO:0032013;negative regulation of ARF protein signal transduction;2;6;GO:0010468
GO:0034674;integrin alpha5-beta1 complex;110;7;GO:0005911
GO:0071665;gamma-catenin-TCF7L2 complex;53;7;GO:0048193
GO:0103015;4-amino-4-deoxy-L-arabinose transferase activity;3364;3;GO:0006029
GO:0032018;2-methylbutanol:NADP oxidoreductase activity;0;0;GO:0004067
GO:0103010;gibberellin A53,2-oxoglutarate:oxygen oxidoreductase activity (GA97-forming);0;1;GO:0004497
GO:0007080;mitotic metaphase chromosome alignment;12598;32;GO:0000922
GO:0032019;mitochondrial cloud;43;6;GO:0005739
GO:0032016;negative regulation of Ran protein signal transduction;0;2;GO:0048285
GO:0034679;integrin alpha9-beta1 complex;8;7;GO:0005911
GO:0044070;regulation of monoatomic anion transport;902;6;GO:0045730
GO:0071668;plant-type cell wall assembly;4194;30;GO:0009664
GO:0103012;ferredoxin-thioredoxin reductase activity;1548;2;GO:0004746
GO:0032017;positive regulation of Ran protein signal transduction;0;2;GO:0045944
GO:0034678;integrin alpha8-beta1 complex;2;32;GO:0005911
GO:0071669;plant-type cell wall organization or biogenesis;26329;489;GO:0071555
GO:0103011;mannosylfructose-phosphate synthase activity;684;3;GO:0006030
GO:0032094;response to food;3697;614;GO:0009408
GO:0032095;regulation of response to food;2833;337;GO:0045737
GO:0032092;positive regulation of protein binding;118;2100;GO:0045944
GO:0071617;lysophospholipid acyltransferase activity;71183;121;GO:0004497
GO:0032093;SAM domain binding;38;178;GO:0005524
GO:0071618;lysophosphatidylethanolamine acyltransferase activity;84;2;GO:0008610
GO:0032098;regulation of appetite;4199;274;GO:0045727
GO:0032099;negative regulation of appetite;2152;736;GO:0045727
GO:0032096;negative regulation of response to food;2155;115;GO:0048518
GO:0032097;positive regulation of response to food;177;22;GO:0045735
GO:0046655;folic acid metabolic process;158347;1430;GO:0006796
GO:0046656;folic acid biosynthetic process;157474;270;GO:0006796
GO:0046653;tetrahydrofolate metabolic process;556749;1210;GO:0006790
GO:1900731;positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway;4;1;GO:0048165
GO:0046654;tetrahydrofolate biosynthetic process;292725;1040;GO:0006790
GO:1900730;negative regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway;0;0;GO:0048608
GO:0032090;Pyrin domain binding;86;88;GO:0043161
GO:0046659;digestive hormone activity;14;3;GO:0007596
GO:1900733;negative regulation of polyketide biosynthetic process;0;0;GO:0046274
GO:0032091;negative regulation of protein binding;197;2260;GO:0019901
GO:1900732;regulation of polyketide biosynthetic process;2;0;GO:0009405
GO:0046657;folic acid catabolic process;127;9;GO:0006559
GO:1900735;positive regulation of flocculation;4;2;GO:0048285
GO:1900734;positive regulation of polyketide biosynthetic process;2;1;GO:0046394
GO:1900726;osmoregulated periplasmic glucan catabolic process;0;0;GO:0006064
GO:1900725;osmoregulated periplasmic glucan metabolic process;5;0;GO:0006064
GO:1900728;cardiac neural crest cell delamination involved in outflow tract morphogenesis;0;1;GO:0048704
GO:1900727;osmoregulated periplasmic glucan biosynthetic process;5;2;GO:0006021
GO:0046662;regulation of egg-laying behavior;481;6;GO:0048608
GO:0046663;dorsal closure, leading edge cell differentiation;21;6;GO:0009913
GO:1900729;regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway;4;0;GO:0007218
GO:0044001;migration in host;15167;2;GO:0048608
GO:0046660;female sex differentiation;9304;431;GO:0007548
GO:0044000;movement in host;2627278;6;GO:0042330
GO:0046661;male sex differentiation;10505;656;GO:0007548
GO:0071611;granulocyte colony-stimulating factor production;189;5;GO:0046649
GO:0071612;IP-10 production;138;2;GO:0030528
GO:0032089;NACHT domain binding;66;173;GO:0043169
GO:0103027;FMN phosphatase activity;0;0;GO:0004723
GO:0071610;chemokine (C-C motif) ligand 1 production;23;2;GO:0050921
GO:0103026;fructose-1-phosphatase activity;2009;4;GO:0004553
GO:0071616;acyl-CoA biosynthetic process;263215;793;GO:0006631
GO:0103020;1-deoxy-D-xylulose kinase activity;1;1;GO:0004721
GO:0071613;granzyme B production;101;4;GO:0002687
GO:0103023;ITPase activity;5286;3;GO:0003906
GO:0071614;linoleic acid epoxygenase activity;107;37;GO:0004497
GO:0032083;negative regulation of type IV site-specific deoxyribonuclease activity;0;3;GO:0004867
GO:0071608;macrophage inflammatory protein-1 alpha production;248;6;GO:0046649
GO:0032084;regulation of type I site-specific deoxyribonuclease activity;0;3;GO:0004518
GO:0071609;chemokine (C-C motif) ligand 5 production;390;8;GO:0050921
GO:0032081;negative regulation of type II site-specific deoxyribonuclease activity;0;3;GO:0004867
GO:0071606;chemokine (C-C motif) ligand 4 production;60;1;GO:0050921
GO:0032082;negative regulation of type III site-specific deoxyribonuclease activity;0;3;GO:0010401
GO:0071607;macrophage inflammatory protein-1 gamma production;0;2;GO:0046649
GO:0032087;regulation of type IV site-specific deoxyribonuclease activity;0;2;GO:0004518
GO:0032088;negative regulation of NF-kappaB transcription factor activity;251;1500;GO:0045944
GO:0103028;murein hydrolase activity;0;0;GO:0015941
GO:0032085;regulation of type II site-specific deoxyribonuclease activity;0;4;GO:0004518
GO:0032086;regulation of type III site-specific deoxyribonuclease activity;0;3;GO:0004518
GO:0044003;modulation by symbiont of host process;2369975;226;GO:0045734
GO:0046666;retinal cell programmed cell death;737;168;GO:0010941
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;63;763;GO:0048193
GO:0044002;acquisition of nutrients from host;23;6;GO:0009615
GO:0046667;compound eye retinal cell programmed cell death;273;17;GO:0010941
GO:0046664;dorsal closure, amnioserosa morphology change;94;103;GO:0007565
GO:1900742;negative regulation of filamentous growth of a population of unicellular organisms in response to pH;2;0;GO:0046364
GO:0046665;amnioserosa maintenance;61;6;GO:0048608
GO:1900741;regulation of filamentous growth of a population of unicellular organisms in response to pH;25;4;GO:0046332
GO:1900744;regulation of p38MAPK cascade;3910;561;GO:0043406
GO:0032080;negative regulation of type I site-specific deoxyribonuclease activity;0;4;GO:0004867
GO:1900743;positive regulation of filamentous growth of a population of unicellular organisms in response to pH;23;0;GO:0046364
GO:0046668;regulation of retinal cell programmed cell death;485;53;GO:0010941
GO:1900746;regulation of vascular endothelial growth factor signaling pathway;1391;784;GO:0030518
GO:0046669;regulation of compound eye retinal cell programmed cell death;228;7;GO:0010941
GO:1900745;positive regulation of p38MAPK cascade;3007;864;GO:0043409
GO:1900737;negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway;53;17;GO:0048010
GO:0046670;positive regulation of retinal cell programmed cell death;135;7;GO:0010941
GO:1900736;regulation of phospholipase C-activating G protein-coupled receptor signaling pathway;223;5;GO:0007186
GO:1900739;regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;63;61;GO:0006915
GO:1900738;positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway;170;35;GO:0048010
GO:0044010;single-species biofilm formation;10752;43;GO:0048565
GO:0046673;negative regulation of compound eye retinal cell programmed cell death;75;8;GO:0010941
GO:0044012;histone H2AK9 acetyltransferase activity;0;0;GO:0016569
GO:0046671;negative regulation of retinal cell programmed cell death;243;194;GO:0010941
GO:0044011;single-species biofilm formation on inanimate substrate;264;16;GO:0044765
GO:0046672;positive regulation of compound eye retinal cell programmed cell death;132;9;GO:0010941
GO:0071600;otic vesicle morphogenesis;1432;29;GO:0008544
GO:0103036;NADH:menaquinone oxidoreductase activity;0;1;GO:0003954
GO:0071601;sphere organelle;1;4;GO:0005730
GO:0103035;NAD(P)H:methyl-1,4-benzoquinone oxidoreductase activity;0;1;GO:0004091
GO:0032078;negative regulation of endodeoxyribonuclease activity;3;8;GO:0004867
GO:0032079;positive regulation of endodeoxyribonuclease activity;5;27;GO:0010401
GO:0103037;L-glyceraldehyde 3-phosphate reductase activity;0;0;GO:0004067
GO:0071604;transforming growth factor beta production;2276;63;GO:0048010
GO:0071605;monocyte chemotactic protein-1 production;949;6;GO:0046649
GO:0103031;L-Ala-D/L-Glu epimerase activity;6;1;GO:0006066
GO:0071602;phytosphingosine biosynthetic process;78;5;GO:0008610
GO:0071603;endothelial cell-cell adhesion;210;47;GO:0022610
GO:0103033;beta-galactosidase activity (lactose isomerization);0;0;GO:0006066
GO:0032072;regulation of restriction endodeoxyribonuclease activity;1;28;GO:0004518
GO:0032073;negative regulation of restriction endodeoxyribonuclease activity;0;3;GO:0045727
GO:0032070;regulation of deoxyribonuclease activity;42;44;GO:0004518
GO:0071639;positive regulation of monocyte chemotactic protein-1 production;628;60;GO:0050729
GO:0032071;regulation of endodeoxyribonuclease activity;17;38;GO:0004518
GO:0032076;negative regulation of deoxyribonuclease activity;4;5;GO:0010401
GO:0032077;positive regulation of deoxyribonuclease activity;29;18;GO:0010401
GO:0103039;protein methylthiotransferase activity;40089;6;GO:0003723
GO:0032074;negative regulation of nuclease activity;27;28;GO:0004518
GO:0032075;positive regulation of nuclease activity;42;434;GO:0004518
GO:0044014;histone H2BK5 acetyltransferase activity;0;0;GO:0016569
GO:0046677;response to antibiotic;430011;4050;GO:0046686
GO:1900751;4-(trimethylammonio)butanoate transport;644;0;GO:0006810
GO:0044013;histone H2B acetyltransferase activity;123;6;GO:0003723
GO:0046678;response to bacteriocin;3;4;GO:0048285
GO:1900750;oligopeptide binding;49;40;GO:0005515
GO:0044016;histone H3K4 acetyltransferase activity;89;0;GO:0016569
GO:1900753;doxorubicin transport;24334;6;GO:0006817
GO:0044015;histone H2BK12 acetyltransferase activity;0;0;GO:0016569
GO:0046676;negative regulation of insulin secretion;1907;820;GO:0010467
GO:1900752;malonic acid transport;4370;2;GO:0006836
GO:0044018;histone H3K36 acetyltransferase activity;0;0;GO:0016569
GO:0044017;histone H3K27 acetyltransferase activity;27;1;GO:0016570
GO:1900754;4-hydroxyphenylacetate transport;1058;9;GO:0006869
GO:0046679;response to streptomycin;3;2;GO:0010033
GO:1900757;regulation of D-amino-acid oxidase activity;1;0;GO:0004866
GO:0044019;histone H3K72 acetyltransferase activity;0;1;GO:0016569
GO:1900756;protein processing in phagocytic vesicle;121;9;GO:0006909
GO:0046680;response to DDT;45;112;GO:0046686
GO:1900748;positive regulation of vascular endothelial growth factor signaling pathway;393;78;GO:0030518
GO:0046681;response to carbamate;1;3;GO:0046686
GO:1900747;negative regulation of vascular endothelial growth factor signaling pathway;712;148;GO:0030518
GO:0103041;thiosulfate-thioredoxin sulfurtransferase activity;0;0;GO:0004723
GO:0103040;aldose sugar dehydrogenase activity;0;1;GO:0006066
GO:1900749;(R)-carnitine transport;3649;0;GO:0006836
GO:0046684;response to pyrethroid;14;234;GO:0009631
GO:0044020;histone H4R3 methyltransferase activity;1059;7;GO:0003677
GO:0046685;response to arsenic-containing substance;31681;958;GO:0046686
GO:0071630;nuclear protein quality control by the ubiquitin-proteasome system;3056;9;GO:0007049
GO:0044023;histone H4S1 kinase activity;0;1;GO:0004721
GO:0046682;response to cyclodiene;0;1;GO:0046686
GO:0044022;histone H3S28 kinase activity;187;3;GO:0043406
GO:0046683;response to organophosphorus;11935;462;GO:0046686
GO:0032069;regulation of nuclease activity;114;714;GO:0004518
GO:0071633;dihydroceramidase activity;330;16;GO:0004723
GO:0103047;methyl beta-D-glucoside 6-phosphate glucohydrolase activity;7875;1;GO:0004553
GO:0071634;regulation of transforming growth factor beta production;1969;69;GO:0010468
GO:0103046;alanylglutamate dipeptidase activity;1716;3;GO:0004723
GO:0032067;type IV site-specific deoxyribonuclease activity;5;2;GO:0004518
GO:0071631;mating pheromone secretion involved in positive regulation of conjugation with cellular fusion;1;0;GO:0048305
GO:0032068;type IV site-specific deoxyribonuclease complex;0;0;GO:0005737
GO:0071632;optomotor response;198;8;GO:0007623
GO:0103048;tRNA m2A37 methyltransferase activity;0;1;GO:0003729
GO:0071637;regulation of monocyte chemotactic protein-1 production;949;19;GO:0050900
GO:0103043;5-phospho-alpha-D-ribosyl 1,2-cyclic phosphate phosphodiesterase activity;784;3;GO:0004553
GO:0071638;negative regulation of monocyte chemotactic protein-1 production;319;35;GO:0050729
GO:0103042;4-hydroxy-L-threonine aldolase activity;0;1;GO:0006066
GO:0071635;negative regulation of transforming growth factor beta production;504;80;GO:0010468
GO:0103045;methione N-acyltransferase activity;34937;3;GO:0004733
GO:0071636;positive regulation of transforming growth factor beta production;763;228;GO:0048010
GO:0103044;ribosomal protein S6 glutamate-glutamate ligase activity;0;0;GO:0003735
GO:0032061;negative regulation of translation in response to osmotic stress;0;2;GO:0010467
GO:0032062;positive regulation of translation in response to osmotic stress;0;3;GO:0010401
GO:0032060;bleb assembly;781;284;GO:0048706
GO:0071629;cytoplasm protein quality control by the ubiquitin-proteasome system;305;9;GO:0005737
GO:0032065;maintenance of protein location in cell cortex;2453;4;GO:0007049
GO:0032063;negative regulation of translational initiation in response to osmotic stress;0;3;GO:0010401
GO:1900760;negative regulation of sterigmatocystin biosynthetic process;3;0;GO:0046395
GO:0032064;positive regulation of translational initiation in response to osmotic stress;0;3;GO:0010401
GO:0044025;histone H2BS14 kinase activity;37;2;GO:0004721
GO:0046688;response to copper ion;28460;1410;GO:0046395
GO:1900762;averantin catabolic process;0;0;GO:0009062
GO:0044024;histone H2AS1 kinase activity;61;2;GO:0043406
GO:0046689;response to mercury ion;58633;633;GO:0046686
GO:1900761;averantin metabolic process;0;0;GO:0006725
GO:0044027;negative regulation of gene expression via CpG island methylation;552;4;GO:0045944
GO:0046686;response to cadmium ion;3293;4320;GO:0046686
GO:1900764;emericellin metabolic process;2;0;GO:0006032
GO:0046687;response to chromate;17;8;GO:0046686
GO:1900763;averantin biosynthetic process;0;0;GO:0046395
GO:0019090;mitochondrial rRNA export from mitochondrion;0;3;GO:0005740
GO:0044029;positive regulation of gene expression via CpG island demethylation;115;4;GO:0045944
GO:1900766;emericellin biosynthetic process;2;1;GO:0046395
GO:1900765;emericellin catabolic process;0;0;GO:0046395
GO:0019092;mitochondrial srRNA export from mitochondrion;0;2;GO:0005740
GO:1900768;fonsecin catabolic process;0;1;GO:0006541
GO:0019091;mitochondrial lrRNA export from mitochondrion;0;1;GO:0005743
GO:1900767;fonsecin metabolic process;0;1;GO:0006091
GO:0019094;pole plasm mRNA localization;702;37;GO:0003700
GO:0046691;intracellular canaliculus;120;76;GO:0009986
GO:1900759;positive regulation of D-amino-acid oxidase activity;0;0;GO:0010468
GO:0019093;mitochondrial RNA localization;0;1;GO:0005743
GO:0046692;sperm competition;307;110;GO:0007548
GO:1900758;negative regulation of D-amino-acid oxidase activity;1;2;GO:0010468
GO:0019096;pole plasm mitochondrial lrRNA localization;0;1;GO:0005740
GO:0044030;regulation of DNA methylation;1679;684;GO:0032259
GO:0019095;pole plasm mitochondrial rRNA localization;0;2;GO:0005740
GO:0046690;response to tellurium ion;9419;56;GO:0046686
GO:0019098;reproductive behavior;5813;575;GO:0000003
GO:0044032;modulation by symbiont of indole acetic acid levels in host;0;2;GO:0046686
GO:0046695;SLIK (SAGA-like) complex;10569;33;GO:0005819
GO:0019097;pole plasm mitochondrial srRNA localization;0;2;GO:0005740
GO:0046696;lipopolysaccharide receptor complex;358;463;GO:0042623
GO:0046693;sperm storage;136;29;GO:0006909
GO:0019099;female germ-line sex determination;10;10;GO:0007548
GO:0046694;sperm incapacitation;0;3;GO:0007599
GO:0032058;positive regulation of translational initiation in response to stress;228;29;GO:0006414
GO:0071622;regulation of granulocyte chemotaxis;2857;165;GO:0050900
GO:0103058;kaempferol 3-glucoside 7-O-rhamnosyltransferase activity;0;0;GO:0006073
GO:0032059;bleb;236;351;GO:0005576
GO:0071623;negative regulation of granulocyte chemotaxis;256;7;GO:0050900
GO:0103057;gibberellin A19, 2-oxoglutarate:oxygen oxidoreductase activity;0;1;GO:0004091
GO:0032056;positive regulation of translation in response to stress;543;87;GO:0010401
GO:0032057;negative regulation of translational initiation in response to stress;505;170;GO:0010401
GO:0071621;granulocyte chemotaxis;6155;921;GO:0002675
GO:0103059;UDP-L-rhamnose:kaempferol 3-O-rhamnosyltransferase activity;1;1;GO:0006022
GO:0071626;mastication;96;6;GO:0007586
GO:0103054;gibberellin A12, 2-oxoglutarate:oxygen oxidoreductase activity (gibberellin A15-forming);2;1;GO:0004497
GO:0071624;positive regulation of granulocyte chemotaxis;1317;171;GO:0050900
GO:0103056;gibberellin A53, 2-oxoglutarate:oxygen oxidoreductase activity;2;1;GO:0004091
GO:0071625;vocalization behavior;786;3040;GO:0007586
GO:0103055;gibberelli A15, 2-oxoglutarate:oxygen oxidoreductase activity;2;2;GO:0004091
GO:1900690;negative regulation of gliotoxin biosynthetic process;0;0;GO:0046395
GO:1900692;regulation of (+)-kotanin biosynthetic process;0;0;GO:0010468
GO:1900691;positive regulation of gliotoxin biosynthetic process;6;0;GO:0046405
GO:1900694;positive regulation of (+)-kotanin biosynthetic process;0;0;GO:0046356
GO:1900693;negative regulation of (+)-kotanin biosynthetic process;0;0;GO:0010468
GO:1900696;negative regulation of N',N'',N'''-triacetylfusarinine C biosynthetic process;0;1;GO:0046274
GO:1900695;regulation of N',N'',N'''-triacetylfusarinine C biosynthetic process;0;0;GO:0046394
GO:1900698;regulation of o-orsellinic acid biosynthetic process;1;0;GO:0046395
GO:1900697;positive regulation of N',N'',N'''-triacetylfusarinine C biosynthetic process;0;0;GO:0046274
GO:1900699;negative regulation of o-orsellinic acid biosynthetic process;1;1;GO:0046395
GO:0009802;cinnamic acid ester biosynthetic process;4;3;GO:0009813
GO:0009801;cinnamic acid ester metabolic process;10;4;GO:0006073
GO:0009800;cinnamic acid biosynthetic process;2547;190;GO:0009813
GO:0022809;mobile ion carrier activity;0;2;GO:0005215
GO:0022803;passive transmembrane transporter activity;3351299;2050;GO:0005215
GO:0022804;active transmembrane transporter activity;11473805;1440;GO:0005215
GO:0009831;plant-type cell wall modification involved in multidimensional cell growth;61;6;GO:0046364
GO:0009830;cell wall modification involved in abscission;3;118;GO:0009813
GO:0009835;fruit ripening;3039;452;GO:0009813
GO:0009834;plant-type secondary cell wall biogenesis;2740;443;GO:0009813
GO:0009833;plant-type primary cell wall biogenesis;1215;313;GO:0009813
GO:0009832;plant-type cell wall biogenesis;10794;465;GO:0042546
GO:0009828;plant-type cell wall loosening;51;88;GO:0009664
GO:0010817;regulation of hormone levels;225478;2290;GO:0048608
GO:0009827;plant-type cell wall modification;255;418;GO:0009664
GO:0010816;calcitonin catabolic process;55;33;GO:0006599
GO:0009826;unidimensional cell growth;6576;1080;GO:0042127
GO:0010819;regulation of T cell chemotaxis;707;160;GO:0050900
GO:0009825;multidimensional cell growth;624;921;GO:0048608
GO:0010818;T cell chemotaxis;1130;699;GO:0006935
GO:0010813;neuropeptide catabolic process;245;9;GO:0006511
GO:0010812;negative regulation of cell-substrate adhesion;4368;1060;GO:0022610
GO:0010815;bradykinin catabolic process;370;174;GO:0006559
GO:0009829;cell wall modification involved in fruit ripening;0;3;GO:0009813
GO:0010814;substance P catabolic process;180;68;GO:0006559
GO:0010811;positive regulation of cell-substrate adhesion;6564;1990;GO:0022610
GO:0010810;regulation of cell-substrate adhesion;12890;1030;GO:0007155
GO:0009842;cyanelle;432;29;GO:0005576
GO:0009841;mitochondrial endopeptidase Clp complex;51;7;GO:0005743
GO:0009840;chloroplastic endopeptidase Clp complex;186;77;GO:0005788
GO:0009846;pollen germination;1501;229;GO:0048305
GO:0009845;seed germination;2695;1280;GO:0048366
GO:0009843;cyanelle thylakoid;109;2;GO:0009579
GO:0010828;positive regulation of glucose transmembrane transport;2503;96;GO:0010468
GO:0009838;abscission;2081;314;GO:0009699
GO:0010827;regulation of glucose transmembrane transport;4162;151;GO:0005929
GO:0009837;fruit ripening, non-climacteric;0;1;GO:0009813
GO:0009836;fruit ripening, climacteric;2722;7;GO:0009813
GO:0010829;negative regulation of glucose transmembrane transport;997;292;GO:0010468
GO:0010824;regulation of centrosome duplication;6880;1050;GO:0048608
GO:0010823;negative regulation of mitochondrion organization;2927;107;GO:0050789
GO:0010826;negative regulation of centrosome duplication;2792;410;GO:0048193
GO:0010825;positive regulation of centrosome duplication;1947;49;GO:0048193
GO:0010820;positive regulation of T cell chemotaxis;653;375;GO:0050900
GO:0010822;positive regulation of mitochondrion organization;7492;244;GO:0050789
GO:0010821;regulation of mitochondrion organization;13363;725;GO:0050789
GO:0009813;flavonoid biosynthetic process;14129;2300;GO:0009813
GO:0009812;flavonoid metabolic process;14700;1850;GO:0009813
GO:0009811;stilbene biosynthetic process;0;9;GO:0046274
GO:0009810;stilbene metabolic process;54;4;GO:0046274
GO:0009806;lignan metabolic process;1596;6;GO:0046148
GO:0009805;coumarin biosynthetic process;3097;241;GO:0009813
GO:0009804;coumarin metabolic process;3184;234;GO:0006725
GO:0009803;cinnamic acid metabolic process;3304;80;GO:0006073
GO:0009809;lignin biosynthetic process;2362;1080;GO:0009809
GO:0009808;lignin metabolic process;17266;867;GO:0009809
GO:0009807;lignan biosynthetic process;1564;63;GO:0046274
GO:0046806;viral scaffold;4;2;GO:0042803
GO:0046807;viral scaffold assembly and maintenance;1;2;GO:0048193
GO:0046804;peptide cross-linking via (2S,3S,4Xi,6R)-3-methyl-lanthionine sulfoxide;0;0;GO:0009065
GO:0046805;protein-heme linkage via 1'-L-histidine;0;2;GO:0046395
GO:0046809;replication compartment;1;7;GO:0005840
GO:0009820;alkaloid metabolic process;8993;1160;GO:0004429
GO:0009824;AMP dimethylallyltransferase activity;3660;5;GO:0004723
GO:0046802;exit of virus from host cell nucleus by nuclear egress;1039;4;GO:0009986
GO:0009823;cytokinin catabolic process;44;11;GO:0006569
GO:0010809;negative regulation of synaptic vesicle priming;0;2;GO:0048608
GO:0009822;alkaloid catabolic process;80;45;GO:0046274
GO:0009821;alkaloid biosynthetic process;1552;389;GO:0046148
GO:0009815;1-aminocyclopropane-1-carboxylate oxidase activity;222;35;GO:0004497
GO:0010808;positive regulation of synaptic vesicle priming;7;6;GO:0048608
GO:0010807;regulation of synaptic vesicle priming;406;225;GO:0048608
GO:0010801;negative regulation of peptidyl-threonine phosphorylation;9716;641;GO:0043406
GO:0009819;drought recovery;92;25;GO:0006977
GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway;1048;484;GO:0050727
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;2358;553;GO:0050727
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;1274;1110;GO:0043406
GO:0009871;jasmonic acid and ethylene-dependent systemic resistance, ethylene mediated signaling pathway;4;7;GO:0009723
GO:0022848;acetylcholine-gated monoatomic cation-selective channel activity;26982;61;GO:0005216
GO:0022849;glutamate-gated calcium ion channel activity;358;22;GO:0022836
GO:0007212;dopamine receptor signaling pathway;14247;1610;GO:0007186
GO:0009875;pollen-pistil interaction;978;280;GO:0009909
GO:0022842;narrow pore channel activity;1254;8;GO:0005215
GO:0007213;G protein-coupled acetylcholine receptor signaling pathway;23044;1150;GO:0007186
GO:0022843;voltage-gated monoatomic cation channel activity;164707;9;GO:0005244
GO:0007210;serotonin receptor signaling pathway;27037;847;GO:0007186
GO:0009873;ethylene-activated signaling pathway;25250;1080;GO:0009723
GO:0007211;octopamine or tyramine signaling pathway;89;4;GO:0007218
GO:0007216;G protein-coupled glutamate receptor signaling pathway;7550;2230;GO:0007268
GO:0009879;determination of radial symmetry;0;2;GO:0048608
GO:0007217;tachykinin receptor signaling pathway;10919;752;GO:0007186
GO:0007214;gamma-aminobutyric acid signaling pathway;8706;2560;GO:0007214
GO:0009877;nodulation;469;191;GO:0046274
GO:0022840;leak channel activity;1254;180;GO:0006811
GO:0007215;glutamate receptor signaling pathway;95022;3230;GO:0007268
GO:0009876;pollen adhesion;0;4;GO:0007155
GO:0022841;potassium ion leak channel activity;1126;378;GO:0048169
GO:0007209;phospholipase C-activating tachykinin receptor signaling pathway;0;2;GO:0007186
GO:0034828;4-(2-oxocyclohexyl)-2-hydroxy-buta-2,4-dienoate hydrolase activity;0;0;GO:0004467
GO:0034827;1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity;0;4;GO:0004497
GO:0007207;phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;230;73;GO:0007186
GO:0034826;1,2-dihydroxy-1,2,5,6,7,8-hexyhadronaphthalene dehydrogenase activity;0;1;GO:0004091
GO:0007208;phospholipase C-activating serotonin receptor signaling pathway;175;42;GO:0007186
GO:0034825;tetralin ring-hydroxylating dioxygenase activity;0;2;GO:0046395
GO:0010857;calcium-dependent protein kinase activity;18726;213;GO:0004721
GO:0010856;adenylate cyclase activator activity;211;19;GO:0005524
GO:0010859;calcium-dependent cysteine-type endopeptidase inhibitor activity;68;173;GO:0004867
GO:0010858;calcium-dependent protein kinase regulator activity;150;6;GO:0005524
GO:0034829;2-hydroxydec-2,4-diene-1,10-dioate hydratase activity;0;2;GO:0004067
GO:0010853;cyclase activator activity;1637;26;GO:0004872
GO:0034820;4,9-DSHA hydrolase activity;2;2;GO:0004553
GO:0010852;cyclase inhibitor activity;236;2;GO:0004872
GO:0019200;carbohydrate kinase activity;837039;830;GO:0004721
GO:0010855;adenylate cyclase inhibitor activity;185;3;GO:0004866
GO:0019203;carbohydrate phosphatase activity;219973;224;GO:0004730
GO:0010854;adenylate cyclase regulator activity;433;5;GO:0005524
GO:0019202;amino acid kinase activity;492313;19;GO:0004721
GO:0019205;nucleobase-containing compound kinase activity;1299322;1020;GO:0004721
GO:0034824;citronellyl-CoA dehydrogenase activity;3;1;GO:0004091
GO:0034823;citronellyl-CoA ligase activity;0;1;GO:0006081
GO:0010851;cyclase regulator activity;2021;20;GO:0004872
GO:0019207;kinase regulator activity;188497;913;GO:0030528
GO:0034822;citronellal dehydrogenase activity;0;1;GO:0004497
GO:0010850;regulation of blood pressure by chemoreceptor signaling pathway;0;3;GO:0007218
GO:0019206;nucleoside kinase activity;198876;382;GO:0004721
GO:0034821;citronellol dehydrogenase activity;0;4;GO:0004067
GO:0022839;monoatomic ion gated channel activity;893509;7;GO:0022836
GO:0009882;blue light photoreceptor activity;15479;197;GO:0009579
GO:0022835;transmitter-gated channel activity;76993;204;GO:0005216
GO:0007220;Notch receptor processing;897;1410;GO:0007548
GO:0009881;photoreceptor activity;82473;663;GO:0009521
GO:0022836;gated channel activity;897893;1340;GO:0005216
GO:0009880;embryonic pattern specification;8984;1500;GO:0007398
GO:0007223;Wnt signaling pathway, calcium modulating pathway;404;330;GO:0007219
GO:0009886;post-embryonic animal morphogenesis;9022;28;GO:0032502
GO:0022831;narrow pore, gated channel activity;0;0;GO:0005216
GO:0007224;smoothened signaling pathway;15915;2200;GO:0007398
GO:0009885;transmembrane histidine kinase cytokinin receptor activity;7;2;GO:0004723
GO:0022832;voltage-gated channel activity;391092;720;GO:0005244
GO:0007221;positive regulation of transcription of Notch receptor target;3074;241;GO:0045944
GO:0009884;cytokinin receptor activity;16;4;GO:0004930
GO:0009883;red or far-red light photoreceptor activity;25;7;GO:0009579
GO:0022834;ligand-gated channel activity;338000;744;GO:0005244
GO:0007227;signal transduction downstream of smoothened;47;10;GO:0007186
GO:0007228;positive regulation of hh target transcription factor activity;9;42;GO:0030528
GO:0009889;regulation of biosynthetic process;28294387;2740;GO:0009891
GO:0007225;patched ligand maturation;68;10;GO:0004872
GO:0009888;tissue development;375177;7750;GO:0009887
GO:0009887;animal organ morphogenesis;161694;2270;GO:0048513
GO:0034817;cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity;0;3;GO:0004073
GO:0034816;anthracene 9,10-dioxygenase activity;0;2;GO:0004497
GO:0007218;neuropeptide signaling pathway;94929;3170;GO:0007218
GO:0034815;cis-4-(8-hydroxypyren-7-yl)-2-oxobut-3-enoate lyase activity;0;0;GO:0046395
GO:0007219;Notch signaling pathway;68310;4710;GO:0007165
GO:0034814;7,8-dihydroxy benzo(a)pyrene dioxygenase activity;0;3;GO:0004497
GO:0010868;negative regulation of triglyceride biosynthetic process;139;83;GO:0045944
GO:0010867;positive regulation of triglyceride biosynthetic process;694;490;GO:0045944
GO:0034819;3-HSA hydroxylase activity;0;3;GO:0046395
GO:0034818;ADD 9alpha-hydroxylase activity;0;2;GO:0004041
GO:0010864;positive regulation of protein histidine kinase activity;0;2;GO:0043406
GO:0010863;positive regulation of phospholipase C activity;111;571;GO:0048010
GO:0010866;regulation of triglyceride biosynthetic process;1010;279;GO:0045944
GO:0010865;stipule development;11;3;GO:0048771
GO:0034813;benzo(a)pyrene 7,8-dioxygenase activity;2;4;GO:0004497
GO:0034812;9,10-dihydroxybenzo(a)pyrene dioxygenase activity;0;4;GO:0004497
GO:0034811;benzo(a)pyrene 9,10-dioxygenase activity;2;4;GO:0004497
GO:0034810;4,5-dihydroxybenzo(a)pyrene dioxygenase activity;0;4;GO:0004497
GO:0022828;phosphorylation-gated channel activity;0;0;GO:0022836
GO:0022829;wide pore channel activity;222688;109;GO:0005215
GO:0022824;transmitter-gated monoatomic ion channel activity;76993;1;GO:0005216
GO:0009853;photorespiration;152062;1080;GO:0006099
GO:0009852;auxin catabolic process;15;9;GO:0006569
GO:0022821;solute:potassium antiporter activity;10669;2;GO:0005215
GO:0009851;auxin biosynthetic process;2801;277;GO:0009697
GO:0009850;auxin metabolic process;5188;137;GO:0006725
GO:0009856;pollination;6022;510;GO:0009631
GO:0009855;determination of bilateral symmetry;19482;623;GO:0048513
GO:0009854;oxidative photosynthetic carbon pathway;57;97;GO:0006096
GO:0010839;negative regulation of keratinocyte proliferation;1172;1380;GO:0042127
GO:0034806;benzo(a)pyrene 11,12-dioxygenase activity;0;4;GO:0004497
GO:0009849;tryptophan-independent indoleacetic acid biosynthetic process;0;1;GO:0009065
GO:0010838;positive regulation of keratinocyte proliferation;648;50;GO:0045727
GO:0034805;benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity;0;2;GO:0004073
GO:0009848;indoleacetic acid biosynthetic process via tryptophan;53;2;GO:1901363
GO:0034804;benzo(a)pyrene 11,12-epoxidase activity;0;3;GO:0004073
GO:0009847;spore germination;66500;182;GO:0048305
GO:0034803;3-hydroxy-2-naphthoate 2,3-dioxygenase activity;0;4;GO:0004497
GO:0010835;regulation of protein ADP-ribosylation;23;50;GO:0010468
GO:0034809;benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity;0;2;GO:0004073
GO:0010837;regulation of keratinocyte proliferation;2232;1120;GO:0042127
GO:0034808;benzo(a)pyrene 4,5-dioxygenase activity;0;4;GO:0004497
GO:0010836;negative regulation of protein ADP-ribosylation;15;36;GO:0010425
GO:0034807;4,5-dihydroxybenzo(a)pyrene methyltransferase activity;0;2;GO:0004497
GO:0010831;positive regulation of myotube differentiation;841;805;GO:0048608
GO:0010830;regulation of myotube differentiation;2481;704;GO:0048608
GO:0010833;telomere maintenance via telomere lengthening;10354;1470;GO:0007050
GO:0010832;negative regulation of myotube differentiation;573;544;GO:0048608
GO:0034802;branched-chain dodecylbenzene sulfonate monooxygenase activity;0;3;GO:0004497
GO:0034801;2,4-dinitrocyclohexanone hydrolase activity;0;1;GO:0004553
GO:0034800;trinitrophenol dihydride denitratase activity;0;2;GO:0004730
GO:0022818;sodium ion uniporter activity;0;1;GO:0006836
GO:0022819;potassium ion uniporter activity;0;1;GO:0006836
GO:0009860;pollen tube growth;2059;516;GO:0048316
GO:0009864;induced systemic resistance, jasmonic acid mediated signaling pathway;175;134;GO:0009723
GO:0007202;activation of phospholipase C activity;85;1230;GO:0008021
GO:0009863;salicylic acid mediated signaling pathway;7263;587;GO:0009734
GO:0022810;membrane potential driven uniporter activity;421;1;GO:0048471
GO:0009862;systemic acquired resistance, salicylic acid mediated signaling pathway;1816;266;GO:0009734
GO:0007200;phospholipase C-activating G protein-coupled receptor signaling pathway;10596;1560;GO:0007186
GO:0009861;jasmonic acid and ethylene-dependent systemic resistance;48;37;GO:0009723
GO:0007205;protein kinase C-activating G protein-coupled receptor signaling pathway;23007;1440;GO:0007186
GO:0009868;jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway;1;5;GO:0009723
GO:0007206;phospholipase C-activating G protein-coupled glutamate receptor signaling pathway;13;54;GO:0007186
GO:0009867;jasmonic acid mediated signaling pathway;13975;1400;GO:0009723
GO:0009866;induced systemic resistance, ethylene mediated signaling pathway;31;7;GO:0009723
GO:0007204;positive regulation of cytosolic calcium ion concentration;6154;3940;GO:0048407
GO:0009865;pollen tube adhesion;87;6;GO:0007155
GO:0010849;regulation of proton-transporting ATPase activity, rotational mechanism;5;9;GO:0015986
GO:0009859;pollen hydration;45;5;GO:0009555
GO:0010846;activation of reciprocal meiotic recombination;4;5;GO:0000976
GO:0010845;positive regulation of reciprocal meiotic recombination;173;26;GO:0048285
GO:0010842;retina layer formation;1981;970;GO:0030216
GO:0010841;positive regulation of circadian sleep/wake cycle, wakefulness;78;29;GO:0048405
GO:0010844;recombination hotspot binding;39;64;GO:0003677
GO:0010840;regulation of circadian sleep/wake cycle, wakefulness;89;8;GO:0048405
GO:0009790;embryo development;184347;5590;GO:0009790
GO:0010781;meiotic DNA double-strand break formation involved in meiotic gene conversion;0;1;GO:0000786
GO:0010780;meiotic DNA double-strand break formation involved in reciprocal meiotic recombination;152;5;GO:0000786
GO:0046739;transport of virus in multicellular host;15155;5;GO:0016021
GO:0007131;reciprocal meiotic recombination;24180;2620;GO:0000786
GO:0009794;regulation of mitotic cell cycle, embryonic;597;10;GO:0048285
GO:0034750;Scrib-APC-beta-catenin complex;97;68;GO:0005576
GO:0007132;meiotic metaphase I;0;7;GO:0000910
GO:0009793;embryo development ending in seed dormancy;8370;1650;GO:0009631
GO:0009792;embryo development ending in birth or egg hatching;66845;1850;GO:0007565
GO:0007130;synaptonemal complex assembly;6307;1250;GO:0000922
GO:0009791;post-embryonic development;111876;4760;GO:0009792
GO:0007135;meiosis II;3067;42;GO:0007126
GO:0009798;axis specification;12297;531;GO:0043565
GO:0007136;meiotic prophase II;0;4;GO:0000910
GO:0007133;meiotic anaphase I;0;3;GO:0000910
GO:0007134;meiotic telophase I;0;8;GO:0000965
GO:0007139;meiotic telophase II;0;1;GO:0000965
GO:0007137;meiotic metaphase II;0;2;GO:0000910
GO:0007138;meiotic anaphase II;0;1;GO:0000910
GO:0009799;specification of symmetry;19491;332;GO:0048608
GO:0034749;Scrib-APC complex;0;1;GO:0005819
GO:0034748;Par3-APC-KIF3A complex;0;1;GO:0048471
GO:0019120;hydrolase activity, acting on acid halide bonds, in C-halide compounds;40237;9;GO:0016829
GO:0010779;meiotic DNA repair synthesis involved in meiotic gene conversion;0;1;GO:0007040
GO:0046740;transport of virus in host, cell to cell;14900;5;GO:0016021
GO:0019122;peptidyl-D-alanine racemization;0;2;GO:0006457
GO:0019121;peptidoglycan-protein cross-linking via N6-mureinyl-L-lysine;0;1;GO:0008061
GO:0010776;meiotic mismatch repair involved in meiotic gene conversion;0;1;GO:0007040
GO:0019124;peptidyl-isoleucine racemization;0;3;GO:0006412
GO:0034743;APC-IQGAP complex;0;1;GO:0005576
GO:0010775;meiotic strand invasion involved in meiotic gene conversion;0;0;GO:0000922
GO:0019123;peptidyl-methionine racemization;0;3;GO:0006457
GO:0010778;meiotic DNA repair synthesis involved in reciprocal meiotic recombination;19;3;GO:0007040
GO:0019126;peptidyl-serine racemization;0;3;GO:0006464
GO:0034741;APC-tubulin-IQGAP1 complex;0;0;GO:0005515
GO:0010777;meiotic mismatch repair involved in reciprocal meiotic recombination;95;3;GO:0000786
GO:0019125;peptidyl-phenylalanine racemization;0;3;GO:0006468
GO:0034740;TFIIIC-TOP1-SUB1 complex;0;1;GO:0003700
GO:0010772;meiotic DNA recombinase assembly involved in reciprocal meiotic recombination;19;3;GO:0000976
GO:0019128;peptidyl-tryptophan racemization;0;3;GO:0006468
GO:0010771;negative regulation of cell morphogenesis;123;467;GO:0048468
GO:0034746;APC-IQGAP1-CLIP-170 complex;0;2;GO:0048471
GO:0010774;meiotic strand invasion involved in reciprocal meiotic recombination;110;5;GO:0000922
GO:0034745;APC-IQGAP1-Rac1 complex;0;1;GO:0005515
GO:0010773;meiotic DNA recombinase assembly involved in meiotic gene conversion;0;1;GO:0000976
GO:0019129;peptidyl-leucine racemization;0;3;GO:0006457
GO:0034744;APC-IQGAP1-Cdc42 complex;0;2;GO:0048285
GO:0010790;meiotic sister chromatid cohesion involved in meiosis II;0;1;GO:0007070
GO:0010792;DNA double-strand break processing involved in repair via single-strand annealing;416;160;GO:0006281
GO:0010791;DNA double-strand break processing involved in repair via synthesis-dependent strand annealing;57;6;GO:0006281
GO:0007142;male meiosis II;1719;8;GO:0007126
GO:0007143;female meiotic nuclear division;4265;308;GO:0007067
GO:0007140;male meiotic nuclear division;9118;328;GO:0007067
GO:0007141;male meiosis I;1492;2530;GO:0007067
GO:0007146;meiotic recombination nodule assembly;36;1;GO:0007067
GO:0007147;female meiosis II;196;108;GO:0007126
GO:0007144;female meiosis I;613;276;GO:0007067
GO:0046741;transport of virus in host, tissue to tissue;62;1;GO:0048193
GO:0046745;viral capsid secondary envelopment;60;6;GO:0016021
GO:0034739;histone H4K16 deacetylase activity;278;2;GO:0016569
GO:0034738;lanosterol O-acyltransferase activity;4;2;GO:0004714
GO:0034737;ergosterol O-acyltransferase activity;28;5;GO:0004714
GO:0019111;phenanthrol sulfotransferase activity;0;0;GO:0004730
GO:0010787;COPI coating of Golgi vesicle, inter-Golgi cisterna;0;1;GO:0005829
GO:0019113;limonene monooxygenase activity;5692;4;GO:0004497
GO:0034732;transcription factor TFIIIB-alpha complex;0;2;GO:0003700
GO:0010786;clathrin coating of Golgi vesicle, trans-Golgi to endosome targeting;0;1;GO:0006626
GO:0019112;phenanthrol glycosyltransferase activity;0;3;GO:0004553
GO:0034731;Lsm-containing SMN-Sm protein complex;0;1;GO:0005576
GO:0010789;meiotic sister chromatid cohesion involved in meiosis I;47;7;GO:0007070
GO:0019115;benzaldehyde dehydrogenase [NAD(P)+] activity;659;0;GO:0004067
GO:0034730;SmD-containing SMN-Sm protein complex;23;3;GO:0048193
GO:0010788;COPI coating of Golgi vesicle, cis-Golgi to rough ER;0;2;GO:0005764
GO:0019114;catechol dioxygenase activity;22266;3;GO:0004497
GO:0010783;proboscis morphogenesis, eye-antennal disc-derived;0;3;GO:0008544
GO:0019117;dihydroxyfluorene dioxygenase activity;0;3;GO:0004497
GO:0034736;cholesterol O-acyltransferase activity;978;295;GO:0004746
GO:0010782;proboscis morphogenesis, labial disc-derived;0;2;GO:0048608
GO:0019116;hydroxy-nicotine oxidase activity;546;2;GO:0004601
GO:0034735;transcription factor TFIIIC2 complex;0;3;GO:0003700
GO:0010785;clathrin coating of Golgi vesicle, plasma membrane to endosome targeting;0;0;GO:0006626
GO:0019119;phenanthrene-9,10-epoxide hydrolase activity;21;1;GO:0004497
GO:0034734;transcription factor TFIIIC1 complex;0;3;GO:0003700
GO:0010784;proboscis morphogenesis, clypeo-labral disc-derived;0;2;GO:0048608
GO:0019118;phenanthrene-epoxide hydrolase activity;21;4;GO:0004497
GO:0034733;transcription factor TFIIIB-beta complex;0;2;GO:0003700
GO:0071718;sodium-independent icosanoid transport;5;3;GO:0006869
GO:0071719;sodium-independent leukotriene transport;0;1;GO:0006869
GO:0071716;leukotriene transport;305;8;GO:0006869
GO:0071717;thromboxane transport;0;2;GO:0006869
GO:0009772;photosynthetic electron transport in photosystem II;82361;279;GO:0009579
GO:0007110;meiosis I cytokinesis;197;19;GO:0007067
GO:0007113;endomitotic cell cycle;221;66;GO:0007067
GO:0046754;viral exocytosis;96;3;GO:0006903
GO:0007114;cell budding;792;140;GO:0048193
GO:0046755;viral budding;377240;66;GO:0016032
GO:0007111;meiosis II cytokinesis;131;79;GO:0007067
GO:0007112;male meiosis cytokinesis;522;195;GO:0007067
GO:0009773;photosynthetic electron transport in photosystem I;17189;238;GO:0009579
GO:0046753;non-lytic viral release;306352;1;GO:0048193
GO:0007117;budding cell bud growth;367;21;GO:0048285
GO:0007118;budding cell apical bud growth;243;100;GO:0048285
GO:0009779;noncyclic photosynthetic phosphorylation;0;2;GO:0006468
GO:0009778;cyclic photosynthetic phosphorylation;0;1;GO:0006457
GO:0007116;regulation of cell budding;36;3;GO:0048193
GO:0009777;photosynthetic phosphorylation;0;6;GO:0006468
GO:0034729;histone H3-K79 methylation;2;25;GO:0016569
GO:0034728;nucleosome organization;50748;1600;GO:0031497
GO:0034727;piecemeal microautophagy of the nucleus;2155;86;GO:0006941
GO:0010758;regulation of macrophage chemotaxis;1258;508;GO:0050900
GO:0046761;viral budding from plasma membrane;306225;8;GO:0048193
GO:0010757;negative regulation of plasminogen activation;417;267;GO:0048168
GO:0046762;viral budding from endoplasmic reticulum membrane;6;0;GO:0005764
GO:0019100;male germ-line sex determination;151;65;GO:0007548
GO:0044100;sporoplasm;0;1;GO:0005737
GO:0010759;positive regulation of macrophage chemotaxis;869;487;GO:0050921
GO:0046760;viral budding from Golgi membrane;2716;9;GO:0005766
GO:0010754;negative regulation of cGMP-mediated signaling;236;37;GO:0010468
GO:0019102;male somatic sex determination;56;265;GO:0007548
GO:0034721;histone H3-K4 demethylation, trimethyl-H3-K4-specific;0;21;GO:0045944
GO:0071710;membrane macromolecule biosynthetic process;0;2;GO:0009059
GO:0010753;positive regulation of cGMP-mediated signaling;115;7;GO:0010468
GO:0019101;female somatic sex determination;53;8;GO:0007548
GO:0034720;histone H3-K4 demethylation;1;162;GO:0045944
GO:0071711;basement membrane organization;2352;1310;GO:0030198
GO:0010756;positive regulation of plasminogen activation;1491;137;GO:0048168
GO:0019104;DNA N-glycosylase activity;609742;706;GO:0004518
GO:0010755;regulation of plasminogen activation;1949;728;GO:0048168
GO:0019103;pyrimidine nucleotide binding;991;27;GO:0046955
GO:0010750;positive regulation of nitric oxide mediated signal transduction;197;48;GO:0030528
GO:0071714;icosanoid transmembrane transporter activity;622;1;GO:0005085
GO:0071715;icosanoid transport;25403;54;GO:0006869
GO:0010752;regulation of cGMP-mediated signaling;397;31;GO:0030518
GO:0019108;aryl-aldehyde dehydrogenase (NAD) activity;0;4;GO:0004073
GO:0071712;ER-associated misfolded protein catabolic process;1587;200;GO:0006457
GO:0010751;negative regulation of nitric oxide mediated signal transduction;156;41;GO:0030518
GO:0019107;myristoyltransferase activity;15072;30;GO:0004721
GO:0034722;gamma-glutamyl-peptidase activity;5881;100;GO:0004553
GO:0071713;para-aminobenzoyl-glutamate hydrolase activity;82;2;GO:0004721
GO:0071707;immunoglobulin heavy chain V-D-J recombination;122;5;GO:0002440
GO:0071708;immunoglobulin light chain V-J recombination;0;1;GO:0002776
GO:0010770;positive regulation of cell morphogenesis;1522;385;GO:0048468
GO:0071705;nitrogen compound transport;10909782;2700;GO:0006810
GO:0071706;tumor necrosis factor superfamily cytokine production;8862;131;GO:0046330
GO:0007120;axial cellular bud site selection;101;26;GO:0048285
GO:0009783;photosystem II antenna complex;14;18;GO:0009579
GO:0007121;bipolar cellular bud site selection;137;144;GO:0048285
GO:0009782;photosystem I antenna complex;33;17;GO:0009579
GO:0071709;membrane assembly;172089;699;GO:0022627
GO:0009780;photosynthetic NADP+ reduction;35;6;GO:0006749
GO:0007124;pseudohyphal growth;641;407;GO:0048316
GO:0009787;regulation of abscisic acid-activated signaling pathway;4900;154;GO:0009737
GO:0044102;purine deoxyribosyltransferase activity;0;1;GO:0004073
GO:0046765;viral budding from nuclear membrane;410;3;GO:0048193
GO:0009786;regulation of asymmetric cell division;1596;212;GO:0048608
GO:0044101;(3R)-citramalyl-CoA lyase activity;28;0;GO:0006081
GO:0009785;blue light signaling pathway;31845;113;GO:0048405
GO:0044104;2,5-dioxovalerate dehydrogenase (NAD+) activity;0;0;GO:0009065
GO:0009784;transmembrane receptor histidine kinase activity;9;2;GO:0004721
GO:0044103;L-arabinose 1-dehydrogenase (NADP+) activity;90;0;GO:0006066
GO:0007128;meiotic prophase I;0;28;GO:0000910
GO:1900601;endocrocin catabolic process;0;0;GO:0006032
GO:0007129;homologous chromosome pairing at meiosis;10938;69;GO:0000965
GO:0044105;L-xylulose reductase (NAD+) activity;1;0;GO:0004073
GO:1900600;endocrocin metabolic process;4;1;GO:0006073
GO:0009789;positive regulation of abscisic acid-activated signaling pathway;400;45;GO:0046274
GO:1900603;tensidol A metabolic process;1;3;GO:0006066
GO:0007127;meiosis I;42305;2730;GO:0007126
GO:0009788;negative regulation of abscisic acid-activated signaling pathway;3719;187;GO:0010468
GO:1900602;endocrocin biosynthetic process;4;2;GO:0006033
GO:0034718;SMN-Gemin2 complex;83;6;GO:0005524
GO:0034717;Gemin6-Gemin7-unrip complex;0;1;GO:0005576
GO:0007119;budding cell isotropic bud growth;12;5;GO:0048285
GO:0034716;Gemin3-Gemin4-Gemin5 complex;0;2;GO:0005524
GO:0034715;pICln-Sm protein complex;2804;59;GO:0005576
GO:0046772;viral budding from outer nuclear membrane;0;1;GO:0005741
GO:0046773;suppression by virus of host translation termination;0;0;GO:0006414
GO:0044111;formation of structure involved in a symbiotic process;124;4;GO:0043160
GO:0034719;SMN-Sm protein complex;6120;249;GO:0005576
GO:0046771;viral budding from inner nuclear membrane;0;0;GO:0005740
GO:0010765;positive regulation of sodium ion transport;1104;698;GO:0050890
GO:0034710;inhibin complex binding;0;1;GO:0048608
GO:0010764;negative regulation of fibroblast migration;391;52;GO:0016477
GO:0071700;olfactory placode maturation;0;1;GO:0007565
GO:0010766;negative regulation of sodium ion transport;435;593;GO:0050890
GO:0010761;fibroblast migration;2535;753;GO:0030900
GO:0034714;type III transforming growth factor beta receptor binding;460;245;GO:0048407
GO:0071703;detection of organic substance;0;0;GO:0043603
GO:0010760;negative regulation of macrophage chemotaxis;265;87;GO:0050900
GO:0034713;type I transforming growth factor beta receptor binding;647;482;GO:0048407
GO:0071704;organic substance metabolic process;199476113;6600;GO:0005975
GO:0010763;positive regulation of fibroblast migration;613;683;GO:0016477
GO:0071701;regulation of MAPK export from nucleus;65;3;GO:0048285
GO:0010762;regulation of fibroblast migration;1660;156;GO:0030509
GO:0034711;inhibin binding;151;133;GO:0005530
GO:0071702;organic substance transport;13858785;1950;GO:0006810
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;11;448;GO:0048010
GO:0034790;3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity;0;2;GO:0004497
GO:0007172;signal complex assembly;5451;779;GO:0005667
GO:0007175;negative regulation of epidermal growth factor-activated receptor activity;61;541;GO:0030518
GO:0032131;alkylated DNA binding;136;5;GO:0003676
GO:0034794;cyclopropanecarboxyl-CoA decyclase activity;0;3;GO:0006081
GO:0007176;regulation of epidermal growth factor-activated receptor activity;82;258;GO:0048407
GO:0032132;O6-alkylguanine-DNA binding;11;1;GO:0003676
GO:0034793;cyclopropanecarboxylate-CoA ligase activity;0;2;GO:0006081
GO:0007173;epidermal growth factor receptor signaling pathway;10219;3910;GO:0007179
GO:0034792;hypophosphite dioxygenase activity;0;5;GO:0004723
GO:0007174;epidermal growth factor catabolic process;55;19;GO:0006953
GO:0032130;medial membrane band assembly;0;1;GO:0048471
GO:0034791;isobutylamine N-hydroxylase activity;0;3;GO:0004067
GO:0007179;transforming growth factor beta receptor signaling pathway;24438;3830;GO:0007179
GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway;112643;2270;GO:0007186
GO:0019160;NMN nucleosidase activity;1;3;GO:0004725
GO:0019162;pyridoxamine-oxaloacetate transaminase activity;0;2;GO:0004073
GO:0019161;diamine transaminase activity;1488;3;GO:0004497
GO:0019164;pyruvate synthase activity;8500;9;GO:0006099
GO:0019163;pyridoxamine-phosphate transaminase activity;33;2;GO:0004467
GO:0019166;trans-2-enoyl-CoA reductase (NADPH) activity;437;91;GO:0004089
GO:0019165;thiamine kinase activity;5290;9;GO:0004721
GO:0019168;2-octaprenylphenol hydroxylase activity;9;3;GO:0004497
GO:0032124;macronucleus organization;0;3;GO:0048305
GO:0034787;1-hydro-1,1a-dihydroxy-9-fluorenone dehydrogenase activity;0;3;GO:0003954
GO:0032125;micronucleus organization;0;4;GO:0007067
GO:0034786;9-fluorenone-3,4-dioxygenase activity;0;3;GO:0004497
GO:0032122;oral apparatus organization;0;0;GO:0050877
GO:0034785;salicylate 5-hydroxylase activity;211;4;GO:0004073
GO:0032123;deep fiber;0;2;GO:0005576
GO:0034784;pivalyl-CoA mutase activity;5798;4;GO:0006067
GO:0032129;histone H3K9 deacetylase activity;306;2;GO:0016569
GO:0032126;eisosome;156;98;GO:0005576
GO:0034789;2-hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate hydrolase activity;0;0;GO:0004466
GO:0032127;dense core granule membrane;264;66;GO:0005829
GO:0034788;2,3-dihydroxy-2'-carboxybiphenyl 1,2-dioxygenase activity;0;0;GO:0004497
GO:0046707;IDP metabolic process;54;8;GO:0006091
GO:0046708;IDP biosynthetic process;0;2;GO:0009405
GO:0046705;CDP biosynthetic process;228;2;GO:0006061
GO:0007181;transforming growth factor beta receptor complex assembly;40;259;GO:0005665
GO:0046706;CDP catabolic process;0;1;GO:0006066
GO:0007186;G protein-coupled receptor signaling pathway;2820413;19900;GO:0007186
GO:0032120;ascospore-type prospore membrane formation;920;31;GO:0009986
GO:0034783;pivalate-CoA ligase activity;0;1;GO:0006081
GO:0007187;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;1256;957;GO:0007186
GO:0032121;meiotic attachment of telomeric heterochromatin to spindle pole body;17;2;GO:0007062
GO:0034782;dimethylmalonate decarboxylase activity;0;3;GO:0006066
GO:0034781;N-cyclohexylformamide amidohydrolase activity;0;2;GO:0004721
GO:0046709;IDP catabolic process;54;8;GO:0006541
GO:0007185;transmembrane receptor protein tyrosine phosphatase signaling pathway;70;177;GO:0007169
GO:0034780;glyphosate dehydrogenase activity;0;2;GO:0004497
GO:0046700;heterocycle catabolic process;1848667;1900;GO:0046274
GO:0007188;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;35084;1390;GO:0007186
GO:0007189;adenylate cyclase-activating G protein-coupled receptor signaling pathway;13894;1860;GO:0007186
GO:0046703;natural killer cell lectin-like receptor binding;345;128;GO:0042379
GO:0046704;CDP metabolic process;244;4;GO:0006091
GO:0046701;insecticide catabolic process;25;9;GO:0006559
GO:0046702;galactoside 6-L-fucosyltransferase activity;6;1;GO:0004553
GO:0019151;galactose 1-dehydrogenase activity;297;2;GO:0006066
GO:0032119;sequestering of zinc ion;122;209;GO:0008047
GO:0019150;D-ribulokinase activity;2845;8;GO:0004721
GO:0019153;protein-disulfide reductase (glutathione) activity;697;12;GO:0004746
GO:0019152;acetoin dehydrogenase activity;11682;146;GO:0009065
GO:0019155;3-(imidazol-5-yl)lactate dehydrogenase activity;0;0;GO:0004746
GO:0019154;glycolate dehydrogenase activity;4157;5;GO:0004067
GO:0032113;regulation of carbohydrate phosphatase activity;2;3;GO:0006066
GO:0034776;response to histamine;446;1790;GO:0002544
GO:0019156;isoamylase activity;2106;8;GO:0004553
GO:0032114;regulation of glucose-6-phosphatase activity;0;2;GO:0006066
GO:0034775;glutathione transmembrane transport;12655;134;GO:0006826
GO:0019159;nicotinamide-nucleotide amidase activity;2115;4;GO:0004553
GO:0034774;secretory granule lumen;1546;2800;GO:0005737
GO:0019158;mannokinase activity;153;107;GO:0004721
GO:0032112;negative regulation of protein histidine kinase activity;0;2;GO:0043169
GO:0034773;histone H4-K20 trimethylation;1;59;GO:0045944
GO:0032117;horsetail-astral microtubule array;5;3;GO:0007030
GO:0032118;horsetail-astral microtubule organization;10;1;GO:0007049
GO:0034779;4-isopropenyl-2-ketocyclohexane-1-carboxyl-CoA hydrolase activity;0;1;GO:0006081
GO:0032115;sorbose reductase activity;32;4;GO:0004067
GO:0034778;2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity;0;4;GO:0006066
GO:0032116;SMC loading complex;468;60;GO:0005819
GO:0034777;recycling endosome lumen;8;4;GO:0005768
GO:0046718;viral entry into host cell;2117639;2160;GO:0016032
GO:0046719;regulation by virus of viral protein levels in host cell;854;32;GO:0010431
GO:0046716;muscle cell cellular homeostasis;3426;1260;GO:0007049
GO:0046717;acid secretion;2298;362;GO:0007586
GO:0034772;histone H4-K20 dimethylation;0;6;GO:0016569
GO:0007154;cell communication;16641316;10100;GO:0007154
GO:0032110;regulation of protein histidine kinase activity;1;6;GO:0043169
GO:0034770;histone H4-K20 methylation;1;26;GO:0016569
GO:0007157;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;3965;1750;GO:0007155
GO:0046710;GDP metabolic process;287750;40;GO:0006549
GO:0007158;neuron cell-cell adhesion;541;3870;GO:0007155
GO:0046711;GDP biosynthetic process;29;2;GO:0009809
GO:0007155;cell adhesion;999027;38600;GO:0007155
GO:0007156;homophilic cell adhesion via plasma membrane adhesion molecules;135559;5350;GO:0007156
GO:0046714;borate binding;0;1;GO:0097194
GO:0046715;active borate transmembrane transporter activity;106;5;GO:0008544
GO:0007159;leukocyte cell-cell adhesion;90180;3180;GO:0007155
GO:0046712;GDP catabolic process;125;7;GO:0006549
GO:0046713;borate transport;382;24;GO:0006826
GO:0019140;inositol 3-kinase activity;15;4;GO:0004721
GO:0032108;negative regulation of response to nutrient levels;2177;10;GO:0042592
GO:0032109;positive regulation of response to nutrient levels;736;120;GO:0045735
GO:0019142;2-hydroxyglutarate synthase activity;0;4;GO:0006099
GO:0019141;2-dehydropantolactone reductase (B-specific) activity;0;2;GO:0006067
GO:0019144;ADP-sugar diphosphatase activity;284;21;GO:0004553
GO:0019143;3-deoxy-manno-octulosonate-8-phosphatase activity;21074;7;GO:0008800
GO:0010798;regulation of multivesicular body size involved in ubiquitin-dependent protein catabolism;0;5;GO:0048193
GO:0019146;arabinose-5-phosphate isomerase activity;13972;6;GO:0006066
GO:0032102;negative regulation of response to external stimulus;181391;1020;GO:0048583
GO:0034765;regulation of monoatomic ion transmembrane transport;132211;260;GO:0015031
GO:0010797;regulation of multivesicular body size involved in endosome transport;0;7;GO:0048193
GO:0019145;aminobutyraldehyde dehydrogenase activity;6398;10;GO:0004067
GO:0032103;positive regulation of response to external stimulus;83310;1720;GO:0048583
GO:0034764;positive regulation of transmembrane transport;9584;457;GO:0048169
GO:0019148;D-cysteine desulfhydrase activity;5372;9;GO:0004705
GO:0032100;positive regulation of appetite;164;116;GO:0045727
GO:0034763;negative regulation of transmembrane transport;3596;80;GO:0048169
GO:0010799;regulation of peptidyl-threonine phosphorylation;10990;166;GO:0043406
GO:0019147;(R)-aminopropanol dehydrogenase activity;62;0;GO:0004073
GO:0032101;regulation of response to external stimulus;399420;1820;GO:0048583
GO:0034762;regulation of transmembrane transport;142136;691;GO:0055085
GO:0010794;regulation of dolichol biosynthetic process;56;4;GO:0010468
GO:0032106;positive regulation of response to extracellular stimulus;742;10;GO:0048583
GO:0034769;basement membrane disassembly;243;84;GO:0048771
GO:0010793;regulation of mRNA export from nucleus;420;150;GO:0022627
GO:0019149;3-chloro-D-alanine dehydrochlorinase activity;1;3;GO:0006067
GO:0032107;regulation of response to nutrient levels;91321;43;GO:0045735
GO:0034768;(E)-beta-ocimene synthase activity;30;0;GO:0004497
GO:0010796;regulation of multivesicular body size;150;215;GO:0048193
GO:0032104;regulation of response to extracellular stimulus;92675;205;GO:0042221
GO:0034767;positive regulation of monoatomic ion transmembrane transport;6238;10;GO:0015031
GO:0010795;regulation of ubiquinone biosynthetic process;6341;8;GO:0010468
GO:0032105;negative regulation of response to extracellular stimulus;3525;8;GO:0048523
GO:0034766;negative regulation of monoatomic ion transmembrane transport;1905;6;GO:0045730
GO:0007160;cell-matrix adhesion;27223;4590;GO:0007155
GO:0046729;viral procapsid;363;5;GO:0016021
GO:0007161;calcium-independent cell-matrix adhesion;171;254;GO:0007155
GO:0046727;capsomere;7;3;GO:0005576
GO:0007164;establishment of tissue polarity;10008;1100;GO:0031589
GO:0034761;positive regulation of iron ion transmembrane transport;22;6;GO:0006826
GO:0007165;signal transduction;15520562;61200;GO:0007165
GO:0034760;negative regulation of iron ion transmembrane transport;104;6;GO:0006826
GO:0007162;negative regulation of cell adhesion;19916;2570;GO:0022610
GO:0007163;establishment or maintenance of cell polarity;101343;2400;GO:0051604
GO:0007168;receptor guanylyl cyclase signaling pathway;915;749;GO:0007218
GO:0046721;formic acid secretion;0;2;GO:0006099
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;200829;6640;GO:0007169
GO:0046722;lactic acid secretion;2;7;GO:0006096
GO:0007166;cell surface receptor signaling pathway;1551257;12500;GO:0007186
GO:0007167;enzyme-linked receptor protein signaling pathway;315040;4910;GO:0007186
GO:0046720;citric acid secretion;49;9;GO:0006099
GO:0046725;negative regulation by virus of viral protein levels in host cell;61;52;GO:0010431
GO:0046726;positive regulation by virus of viral protein levels in host cell;231;189;GO:0010431
GO:0046723;malic acid secretion;0;2;GO:0009813
GO:0046724;oxalic acid secretion;82;9;GO:0007565
GO:0034759;regulation of iron ion transmembrane transport;126;6;GO:0006826
GO:0019133;choline monooxygenase activity;1725;3;GO:0004497
GO:0019135;deoxyhypusine monooxygenase activity;9897;19;GO:0004073
GO:0019134;glucosamine-1-phosphate N-acetyltransferase activity;113093;481;GO:0006073
GO:0034753;nuclear aryl hydrocarbon receptor complex;128;12;GO:0005615
GO:0019137;thioglucosidase activity;745;16;GO:0004553
GO:0034752;cytosolic aryl hydrocarbon receptor complex;2;5;GO:0005737
GO:0019136;deoxynucleoside kinase activity;128300;27;GO:0004721
GO:0034751;aryl hydrocarbon receptor complex;432;76;GO:0005615
GO:0019139;cytokinin dehydrogenase activity;10005;874;GO:0004497
GO:0034758;positive regulation of iron ion transport;27;19;GO:0006826
GO:0034757;negative regulation of iron ion transport;192;26;GO:0006826
GO:0034756;regulation of iron ion transport;412;367;GO:0006826
GO:0034755;iron ion transmembrane transport;402228;845;GO:0006826
GO:0032171;germ tube septin cap;0;1;GO:0008037
GO:0032172;germ tube septin ring;0;0;GO:0008037
GO:0032170;pseudohyphal septin ring;0;1;GO:0008042
GO:0032175;mating projection septin ring;27;2;GO:0008037
GO:0032176;split septin rings;21;4;GO:0008061
GO:0032173;septin collar;163;9;GO:0005819
GO:1900650;negative regulation of dehydroaustinol biosynthetic process;0;0;GO:0010468
GO:0032174;cellular bud neck septin collar;112;8;GO:0005929
GO:0044157;host cell projection;3185;3;GO:0042995
GO:1900652;regulation of demethylkotanin biosynthetic process;0;0;GO:0010468
GO:0044156;host cell junction;8408;9;GO:0005911
GO:1900651;positive regulation of dehydroaustinol biosynthetic process;0;0;GO:0046356
GO:0044159;host thylakoid;8;2;GO:0009579
GO:1900654;positive regulation of demethylkotanin biosynthetic process;0;0;GO:0046395
GO:0044158;host cell wall;4;4;GO:0009505
GO:1900653;negative regulation of demethylkotanin biosynthetic process;0;1;GO:0010468
GO:1900656;negative regulation of diorcinol biosynthetic process;0;0;GO:0010468
GO:1900655;regulation of diorcinol biosynthetic process;0;0;GO:0010468
GO:1900658;regulation of emericellamide biosynthetic process;0;1;GO:0010468
GO:1900657;positive regulation of diorcinol biosynthetic process;0;0;GO:0046356
GO:0044160;host thylakoid membrane;4;2;GO:0009536
GO:1900649;regulation of dehydroaustinol biosynthetic process;0;0;GO:0010468
GO:1900648;positive regulation of chanoclavine-I aldehyde biosynthetic process;0;1;GO:0046395
GO:0044162;host cell cytoplasmic vesicle membrane;11376;3;GO:0005789
GO:0044161;host cell cytoplasmic vesicle;31414;8;GO:0005789
GO:0044164;host cell cytosol;54047;9;GO:0005829
GO:0071772;response to BMP;17501;429;GO:0048608
GO:0044163;host cytoskeleton;19511;9;GO:0005815
GO:0071773;cellular response to BMP stimulus;17500;1370;GO:0048704
GO:0044166;host cell endoplasmic reticulum lumen;24201;4;GO:0005783
GO:0071770;DIM/DIP cell wall layer assembly;49;4;GO:0042546
GO:0044165;host cell endoplasmic reticulum;457908;98;GO:0005783
GO:0071771;aldehyde decarbonylase activity;3611;3;GO:0004497
GO:0032168;hyphal septin ring;5;2;GO:0008037
GO:0032169;prospore septin ring;26;2;GO:0008037
GO:0032166;chlamydospore septin filament array;0;1;GO:0005576
GO:0071774;response to fibroblast growth factor;24686;596;GO:0048407
GO:0032160;septin filament array;139;9;GO:0048608
GO:0032161;cleavage apparatus septin structure;756;3;GO:0005819
GO:0032164;hyphal septin cap;0;1;GO:0008037
GO:0032165;prospore septin filament array;1;2;GO:0008037
GO:0032162;mating projection septin band;0;1;GO:0048285
GO:1900661;regulation of emericellamide A biosynthetic process;0;0;GO:0010468
GO:0032163;hyphal septin band;3;2;GO:0008037
GO:1900660;positive regulation of emericellamide biosynthetic process;0;1;GO:0046395
GO:0044168;host cell rough endoplasmic reticulum;9819;3;GO:0005783
GO:1900663;positive regulation of emericellamide A biosynthetic process;0;0;GO:0046405
GO:0044167;host cell endoplasmic reticulum membrane;151203;13;GO:0005783
GO:1900662;negative regulation of emericellamide A biosynthetic process;0;0;GO:0046274
GO:1900665;negative regulation of emodin biosynthetic process;0;0;GO:0010468
GO:0044169;host cell rough endoplasmic reticulum membrane;4553;4;GO:0005783
GO:1900664;regulation of emodin biosynthetic process;0;0;GO:0010468
GO:1900667;regulation of endocrocin biosynthetic process;0;0;GO:0010401
GO:1900666;positive regulation of emodin biosynthetic process;0;0;GO:0046356
GO:0019191;cellobiose transmembrane transporter activity;0;5;GO:0008565
GO:1900669;positive regulation of endocrocin biosynthetic process;0;1;GO:0046395
GO:1900668;negative regulation of endocrocin biosynthetic process;0;0;GO:0010468
GO:0044171;host cell smooth endoplasmic reticulum membrane;11;2;GO:0005789
GO:0044170;host cell smooth endoplasmic reticulum;11;3;GO:0005783
GO:1900659;negative regulation of emericellamide biosynthetic process;0;1;GO:0046395
GO:0044173;host cell endoplasmic reticulum-Golgi intermediate compartment membrane;9579;8;GO:0005764
GO:0019194;sorbose transmembrane transporter activity;46;1;GO:0005215
GO:0044172;host cell endoplasmic reticulum-Golgi intermediate compartment;21467;8;GO:0005783
GO:0019197;phosphoenolpyruvate-dependent sugar phosphotransferase complex;0;5;GO:0005975
GO:0044175;host cell endosome membrane;161721;9;GO:0005768
GO:0071761;IgZ immunoglobulin complex;0;1;GO:0002376
GO:0019196;galactosamine transmembrane transporter activity;0;0;GO:0005215
GO:0044174;host cell endosome;268718;7;GO:0005768
GO:0071762;heavy chain immunoglobulin complex;0;1;GO:0002504
GO:0019199;transmembrane receptor protein kinase activity;164139;1300;GO:0004713
GO:0044177;host cell Golgi apparatus;148615;64;GO:0005829
GO:0019198;transmembrane receptor protein phosphatase activity;223;121;GO:0004713
GO:0044176;host cell filopodium;1592;3;GO:0048193
GO:0071760;IgY immunoglobulin complex;0;1;GO:0002376
GO:0032157;prospore contractile ring;0;1;GO:0005576
GO:0071765;nuclear inner membrane organization;1179;9;GO:0005789
GO:0032158;septin band;3;2;GO:0048608
GO:0071766;Actinobacterium-type cell wall biogenesis;3694;16;GO:0022617
GO:0071763;nuclear membrane organization;6207;74;GO:0048471
GO:0032156;septin cytoskeleton;15191;33;GO:0005912
GO:0071764;nuclear outer membrane organization;0;0;GO:0005789
GO:0071769;mycolate cell wall layer assembly;11;4;GO:0010467
GO:0032159;septin cap;0;2;GO:0005576
GO:0071767;mycolic acid metabolic process;36;2;GO:0006073
GO:0071768;mycolic acid biosynthetic process;36;9;GO:0009405
GO:0007193;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;8510;2040;GO:0007186
GO:0007194;negative regulation of adenylate cyclase activity;21;654;GO:0010468
GO:0032150;ubiquinone biosynthetic process from chorismate;9034;3;GO:0006749
GO:0007191;adenylate cyclase-activating dopamine receptor signaling pathway;474;1410;GO:0007610
GO:0007192;adenylate cyclase-activating serotonin receptor signaling pathway;3;8;GO:0007186
GO:0007197;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;242;338;GO:0007218
GO:0032153;cell division site;153782;1540;GO:0000910
GO:1900670;regulation of F-9775A biosynthetic process;0;1;GO:0010468
GO:0007198;adenylate cyclase-inhibiting serotonin receptor signaling pathway;453;365;GO:0007218
GO:0032154;cleavage furrow;12674;1260;GO:0007067
GO:0007195;adenylate cyclase-inhibiting dopamine receptor signaling pathway;3173;320;GO:0007623
GO:0032151;mitotic septin complex;33;4;GO:0007067
GO:1900672;positive regulation of F-9775A biosynthetic process;0;1;GO:0046356
GO:0007196;adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway;1073;134;GO:0007218
GO:0032152;meiotic septin complex;27;3;GO:0007067
GO:1900671;negative regulation of F-9775A biosynthetic process;0;0;GO:0010468
GO:0044179;hemolysis in another organism;621;6;GO:0008544
GO:1900674;olefin biosynthetic process;3677;5;GO:0006661
GO:0044178;host cell Golgi membrane;65041;10;GO:0005764
GO:1900673;olefin metabolic process;3686;5;GO:0006631
GO:0007199;G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger;38;643;GO:0007186
GO:1900676;negative regulation of F-9775B biosynthetic process;0;0;GO:0010468
GO:1900675;regulation of F-9775B biosynthetic process;0;0;GO:0010468
GO:1900678;regulation of ferricrocin biosynthetic process;0;0;GO:0046395
GO:1900677;positive regulation of F-9775B biosynthetic process;0;0;GO:0046356
GO:0019180;dTDP-4-amino-4,6-dideoxygalactose transaminase activity;5581;6;GO:0006029
GO:1900679;negative regulation of ferricrocin biosynthetic process;0;0;GO:0046395
GO:0019182;histamine-gated chloride channel activity;75;5;GO:0004930
GO:0044182;filamentous growth of a population of unicellular organisms;2882;482;GO:0048285
GO:0019181;halohydrin hydrogen-halide-lyase activity;0;1;GO:0004497
GO:0044181;filamentous growth of a multicellular organism;0;4;GO:0030430
GO:0071791;chemokine (C-C motif) ligand 5 binding;118;4;GO:0005125
GO:0019184;nonribosomal peptide biosynthetic process;354938;153;GO:0009405
GO:0044184;host cell late endosome;2305;2;GO:0005768
GO:0019183;histamine-gated chloride channel complex;71;7;GO:0004930
GO:0044183;protein folding chaperone;480592;629;GO:0006457
GO:0019186;acyl-CoA N-acyltransferase activity;9;1;GO:0004089
GO:0044186;host cell lipid droplet;160487;7;GO:0005811
GO:0071794;CAP-Gly domain binding;0;1;GO:0005515
GO:0019185;snRNA-activating protein complex;346;114;GO:0008033
GO:0044185;host cell late endosome membrane;366;5;GO:0005768
GO:0071795;K11-linked polyubiquitin modification-dependent protein binding;64;0;GO:0043161
GO:0044188;host cell lysosomal membrane;0;2;GO:0005764
GO:0071792;bacillithiol metabolic process;12005;3;GO:0006749
GO:0019187;beta-1,4-mannosyltransferase activity;3788;8;GO:0004553
GO:0044187;host cell lysosome;2;3;GO:0005764
GO:0071793;bacillithiol biosynthetic process;12005;170;GO:0006066
GO:0071798;response to prostaglandin D;114;10;GO:0006954
GO:0032147;activation of protein kinase activity;374;3050;GO:0016310
GO:0071799;cellular response to prostaglandin D stimulus;114;173;GO:0006954
GO:0032144;4-aminobutyrate transaminase complex;62;67;GO:0005737
GO:0071796;K6-linked polyubiquitin modification-dependent protein binding;115;0;GO:0048193
GO:0032145;succinate-semialdehyde dehydrogenase binding;4;78;GO:0005525
GO:0071797;LUBAC complex;2271;44;GO:0005576
GO:0007190;activation of adenylate cyclase activity;60;1900;GO:0004725
GO:0032148;activation of protein kinase B activity;82;1180;GO:0043406
GO:0044180;filamentous growth of a unicellular organism;0;4;GO:0048308
GO:0032149;response to rhamnose;1;2;GO:0009813
GO:0032142;single guanine insertion binding;166;175;GO:0003676
GO:1900681;octadecene metabolic process;0;0;GO:0006633
GO:0032143;single thymine insertion binding;116;54;GO:0003677
GO:1900680;positive regulation of ferricrocin biosynthetic process;0;0;GO:0046395
GO:0032140;single adenine insertion binding;0;1;GO:0048285
GO:1900683;regulation of fumonisin biosynthetic process;1;0;GO:0010468
GO:0032141;single cytosine insertion binding;1;1;GO:0048285
GO:1900682;octadecene biosynthetic process;0;0;GO:0006685
GO:1900685;positive regulation of fumonisin biosynthetic process;1;0;GO:0010468
GO:1900684;negative regulation of fumonisin biosynthetic process;0;0;GO:0010468
GO:1900687;negative regulation of gerfelin biosynthetic process;0;0;GO:0010468
GO:1900686;regulation of gerfelin biosynthetic process;0;0;GO:0010401
GO:1900689;regulation of gliotoxin biosynthetic process;7;0;GO:0046148
GO:1900688;positive regulation of gerfelin biosynthetic process;0;1;GO:0046395
GO:0019171;(3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity;85843;0;GO:0006066
GO:0044193;host cell mitochondrial outer membrane;628;6;GO:0005739
GO:0019170;methylglyoxal reductase (NADH-dependent) activity;4;5;GO:0004067
GO:0044192;host cell mitochondrial inner membrane;118;4;GO:0005739
GO:0044195;nucleoplasmic reticulum;2;2;GO:0005739
GO:0019172;glyoxalase III activity;709;25;GO:0006067
GO:0044194;cytolytic granule;551;68;GO:0006958
GO:0044197;Rel homology domain binding;0;2;GO:0042802
GO:0071783;endoplasmic reticulum cisternal network organization;9;1;GO:0005789
GO:0019174;tetrahydrothiophene 1-oxide reductase activity;0;0;GO:0004091
GO:0044196;host cell nucleolus;82671;5;GO:0005730
GO:0071784;endoplasmic reticulum cisternal network assembly;9;3;GO:0005789
GO:0019177;dihydroneopterin triphosphate pyrophosphohydrolase activity;5108;25;GO:0005525
GO:0044199;host cell nuclear envelope;3294;2;GO:0005634
GO:0071781;endoplasmic reticulum cisternal network;48;0;GO:0005789
GO:0019176;dihydroneopterin monophosphate phosphatase activity;0;5;GO:0004723
GO:0044198;zf-TRAF domain binding;3;2;GO:0005515
GO:0071782;endoplasmic reticulum tubular network;11985;290;GO:0005789
GO:0019179;dTDP-4-amino-4,6-dideoxy-D-glucose transaminase activity;242;2;GO:0006099
GO:0032135;DNA insertion or deletion binding;818;35;GO:0044822
GO:0034798;fosfomycin 2-L-cysteine ligase activity;0;2;GO:0004725
GO:0071787;endoplasmic reticulum tubular network formation;1853;9;GO:0007043
GO:0019178;NADP phosphatase activity;63;7;GO:0004723
GO:0032136;adenine/cytosine mispair binding;2;2;GO:0003676
GO:0034797;fosfomycin 2-glutathione ligase activity;0;1;GO:0005524
GO:0071788;endoplasmic reticulum tubular network maintenance;3154;4;GO:0007049
GO:0032133;chromosome passenger complex;795;350;GO:0000786
GO:0034796;adipate-CoA ligase activity;0;1;GO:0006081
GO:0071785;endoplasmic reticulum cisternal network maintenance;0;1;GO:0007046
GO:0034795;cyclohexane monooxygenase activity;0;2;GO:0004497
GO:0071786;endoplasmic reticulum tubular network organization;16646;488;GO:0007043
GO:0032139;dinucleotide insertion or deletion binding;290;182;GO:0043169
GO:0032137;guanine/thymine mispair binding;369;252;GO:0003676
GO:0044191;host cell mitochondrial membrane;11979;3;GO:0005739
GO:0032138;single base insertion or deletion binding;427;58;GO:0043169
GO:0034799;dihydride TNP tautomerase activity;0;2;GO:0004721
GO:0044190;host cell mitochondrial envelope;11979;3;GO:0005739
GO:0071738;IgD immunoglobulin complex;6;5;GO:0002376
GO:0071739;IgD immunoglobulin complex, circulating;0;3;GO:0002504
GO:0046776;suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I;44676;6;GO:0002449
GO:0046777;protein autophosphorylation;3233;6740;GO:0006468
GO:0046774;suppression by virus of host intracellular interferon activity;6;2;GO:0048704
GO:1900610;F-9775A catabolic process;0;0;GO:0006541
GO:0044114;development of symbiont in host;39;10;GO:0044421
GO:0046775;suppression by virus of host cytokine production;28;3;GO:0046649
GO:1900612;F-9775B metabolic process;3;0;GO:0006091
GO:1900611;F-9775A biosynthetic process;3;3;GO:0009405
GO:0046778;modification by virus of host mRNA processing;115515;6;GO:0008565
GO:1900614;F-9775B biosynthetic process;3;2;GO:0009405
GO:1900613;F-9775B catabolic process;0;0;GO:0006541
GO:1900605;tensidol A biosynthetic process;1;3;GO:0046274
GO:0046780;suppression by virus of host mRNA splicing;1;2;GO:0008033
GO:1900604;tensidol A catabolic process;0;1;GO:0009062
GO:1900607;tensidol B catabolic process;0;0;GO:0046274
GO:1900606;tensidol B metabolic process;0;3;GO:0006066
GO:0046783;modification by virus of host polysomes;0;1;GO:0010467
GO:1900609;F-9775A metabolic process;3;0;GO:0006091
GO:0046784;viral mRNA export from host cell nucleus;374;969;GO:0006412
GO:1900608;tensidol B biosynthetic process;0;2;GO:0046271
GO:0046782;regulation of viral transcription;30538;178;GO:0010467
GO:0071732;cellular response to nitric oxide;292;616;GO:0006979
GO:0071730;beak formation;3;1;GO:0048706
GO:0071731;response to nitric oxide;538;165;GO:0008629
GO:0071736;IgG immunoglobulin complex, circulating;0;2;GO:0002576
GO:0071737;IgG B cell receptor complex;0;1;GO:0002729
GO:0071734;biotin-[pyruvate-carboxylase] ligase activity;50;0;GO:0006099
GO:0071735;IgG immunoglobulin complex;83;30;GO:0002379
GO:0071729;beak morphogenesis;6;0;GO:0048608
GO:0071727;cellular response to triacyl bacterial lipopeptide;172;45;GO:0071346
GO:0071728;beak development;6;1;GO:0048704
GO:0046787;viral DNA repair;1;8;GO:0006364
GO:0046785;microtubule polymerization;47337;1040;GO:0000226
GO:0046786;viral replication complex formation and maintenance;36;9;GO:0043169
GO:1900620;acetate ester biosynthetic process;306;4;GO:0006066
GO:1900623;regulation of monocyte aggregation;160;35;GO:0048661
GO:0044127;regulation of development of symbiont in host;5;2;GO:0050731
GO:0046789;host cell surface receptor binding;295366;110;GO:0048407
GO:1900625;positive regulation of monocyte aggregation;160;56;GO:0048661
GO:0044129;positive regulation of development of symbiont in host;3;3;GO:0050731
GO:1900624;negative regulation of monocyte aggregation;0;0;GO:0048661
GO:0046790;virion binding;307;338;GO:0042803
GO:1900616;emericellamide A catabolic process;0;0;GO:0046395
GO:1900615;emericellamide A metabolic process;3;0;GO:0006032
GO:1900618;regulation of shoot system morphogenesis;419;6;GO:0048731
GO:1900617;emericellamide A biosynthetic process;3;2;GO:0046148
GO:0044131;negative regulation of development of symbiont in host;2;2;GO:0050731
GO:0046794;transport of virus;1179571;168;GO:0006810
GO:1900619;acetate ester metabolic process;1007;7;GO:0006066
GO:0046792;suppression by virus of host cell cycle arrest;1;1;GO:0010942
GO:0071721;sodium-independent thromboxane transport;0;1;GO:0006869
GO:0071722;detoxification of arsenic-containing substance;11493;9;GO:0046686
GO:0071720;sodium-independent prostaglandin transport;3;1;GO:0006869
GO:0071725;response to triacyl bacterial lipopeptide;264;7;GO:0046655
GO:0071726;cellular response to diacyl bacterial lipopeptide;244;82;GO:0071346
GO:0071723;lipopeptide binding;270;183;GO:0005576
GO:0071724;response to diacyl bacterial lipopeptide;334;8;GO:0009617
GO:0032193;ubiquinone biosynthetic process via 2-polyprenylphenol;0;2;GO:0006749
GO:0032194;ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate;157;3;GO:0006749
GO:0032197;retrotransposition;1831;55;GO:0006313
GO:0032195;post-lysosomal vacuole;13;4;GO:0005764
GO:0032196;transposition;647506;612;GO:0032259
GO:0046798;viral portal complex;756;9;GO:0005831
GO:1900630;methanophenazine biosynthetic process;0;0;GO:0046395
GO:0046799;recruitment of helicase-primase complex to DNA lesions;0;2;GO:0007049
GO:1900632;tridecane biosynthetic process;0;0;GO:0046395
GO:0046797;viral procapsid maturation;2684;26;GO:0042303
GO:1900631;tridecane metabolic process;0;0;GO:0006081
GO:1900634;pentadecane biosynthetic process;0;0;GO:0006021
GO:0032190;acrosin binding;272;244;GO:0005576
GO:1900633;pentadecane metabolic process;0;1;GO:0006081
GO:1900636;heptadecane biosynthetic process;0;2;GO:0046395
GO:1900635;heptadecane metabolic process;0;0;GO:0006081
GO:1900627;negative regulation of arugosin biosynthetic process;0;0;GO:0010468
GO:1900626;regulation of arugosin biosynthetic process;0;0;GO:0010468
GO:1900629;methanophenazine metabolic process;0;1;GO:0009064
GO:1900628;positive regulation of arugosin biosynthetic process;0;0;GO:0046356
GO:0071750;dimeric IgA immunoglobulin complex;180;6;GO:0002729
GO:0071751;secretory IgA immunoglobulin complex;204;50;GO:0002737
GO:0071754;IgM immunoglobulin complex, circulating;133;2;GO:0002376
GO:0071755;IgM B cell receptor complex;0;0;GO:0002474
GO:0071752;secretory dimeric IgA immunoglobulin complex;64;7;GO:0002737
GO:0071753;IgM immunoglobulin complex;140;3;GO:0002374
GO:0071758;IgW immunoglobulin complex;0;1;GO:0002376
GO:0071759;IgX immunoglobulin complex;0;1;GO:0002504
GO:0071756;pentameric IgM immunoglobulin complex;110;7;GO:0002504
GO:0071757;hexameric IgM immunoglobulin complex;23;6;GO:0002504
GO:0032182;ubiquitin-like protein binding;83973;424;GO:0005515
GO:0032183;SUMO binding;2223;572;GO:0005515
GO:0032180;ubiquinone biosynthetic process from tyrosine;4;3;GO:0006749
GO:0071749;polymeric IgA immunoglobulin complex;320;7;GO:0002576
GO:0032181;dinucleotide repeat insertion binding;109;10;GO:0003677
GO:0032186;cellular bud neck septin ring organization;158;9;GO:0007067
GO:0032184;SUMO polymer binding;252;63;GO:0005515
GO:0032185;septin cytoskeleton organization;4431;87;GO:0048471
GO:1900641;negative regulation of austinol biosynthetic process;0;0;GO:0010468
GO:0044145;modulation of formation of structure involved in a symbiotic process;43;3;GO:0045734
GO:1900640;regulation of austinol biosynthetic process;0;2;GO:0010468
GO:0044147;negative regulation of formation of structure involved in a symbiotic process;2;2;GO:0045734
GO:1900642;positive regulation of austinol biosynthetic process;0;0;GO:0046356
GO:0044149;positive regulation of formation of structure involved in a symbiotic process;3;1;GO:0045734
GO:1900647;negative regulation of chanoclavine-I aldehyde biosynthetic process;0;0;GO:0046395
GO:1900646;regulation of chanoclavine-I aldehyde biosynthetic process;0;0;GO:0046395
GO:1900638;negative regulation of asperfuranone biosynthetic process;0;0;GO:0046274
GO:1900637;regulation of asperfuranone biosynthetic process;0;0;GO:0010468
GO:1900639;positive regulation of asperfuranone biosynthetic process;0;0;GO:0046405
GO:0071740;IgD B cell receptor complex;0;1;GO:0002474
GO:0044155;host caveola;4386;4;GO:0005766
GO:0044154;histone H3-K14 acetylation;3;140;GO:0016569
GO:0032179;germ tube;0;1;GO:0048305
GO:0071743;IgE immunoglobulin complex, circulating;0;2;GO:0002504
GO:0071744;IgE B cell receptor complex;4;1;GO:0002713
GO:0032177;cellular bud neck split septin rings;13;6;GO:0005986
GO:0071741;IgD immunoglobulin complex, GPI-anchored;0;2;GO:0002504
GO:0032178;medial membrane band;11;7;GO:0048471
GO:0071742;IgE immunoglobulin complex;11;2;GO:0002376
GO:0071747;IgA B cell receptor complex;0;1;GO:0002729
GO:0071748;monomeric IgA immunoglobulin complex;78;59;GO:0002504
GO:0071745;IgA immunoglobulin complex;405;10;GO:0002376
GO:0071746;IgA immunoglobulin complex, circulating;398;9;GO:0002576
GO:0071493;cellular response to UV-B;1582;288;GO:0009628
GO:0071494;cellular response to UV-C;212;44;GO:0009611
GO:0071491;cellular response to red light;69;7;GO:0046365
GO:0071492;cellular response to UV-A;669;242;GO:0009611
GO:0071497;cellular response to freezing;36;9;GO:0006950
GO:0071498;cellular response to fluid shear stress;912;516;GO:0002576
GO:0071495;cellular response to endogenous stimulus;480938;1450;GO:0009719
GO:0071496;cellular response to external stimulus;789629;1790;GO:0009628
GO:0071499;cellular response to laminar fluid shear stress;244;101;GO:0048407
GO:0071490;cellular response to far red light;60;7;GO:0046365
GO:0071482;cellular response to light stimulus;46961;991;GO:0009416
GO:0071483;cellular response to blue light;31939;320;GO:0046365
GO:0071480;cellular response to gamma radiation;2405;1430;GO:0006974
GO:0071481;cellular response to X-ray;522;232;GO:0009628
GO:0071486;cellular response to high light intensity;806;203;GO:0009416
GO:0071487;cellular response to low light intensity stimulus;0;0;GO:0009416
GO:0071484;cellular response to light intensity;1053;35;GO:0046365
GO:0071485;cellular response to absence of light;110;4;GO:0050832
GO:0071488;cellular response to very low light intensity stimulus;0;0;GO:0009416
GO:0071489;cellular response to red or far red light;3032;35;GO:0046365
GO:1900571;diorcinol catabolic process;0;0;GO:0046274
GO:1900570;diorcinol metabolic process;1;0;GO:0006725
GO:1900573;emodin metabolic process;1;0;GO:0006725
GO:1900572;diorcinol biosynthetic process;0;0;GO:0046395
GO:1900575;emodin biosynthetic process;1;2;GO:0046148
GO:1900574;emodin catabolic process;0;0;GO:0046274
GO:0046499;S-adenosylmethioninamine metabolic process;6;87;GO:0006725
GO:1900577;gerfelin catabolic process;0;1;GO:0006041
GO:1900576;gerfelin metabolic process;0;2;GO:0006081
GO:1900579;(17Z)-protosta-17(20),24-dien-3beta-ol metabolic process;2;0;GO:0006629
GO:1900578;gerfelin biosynthetic process;0;0;GO:0006021
GO:0071450;cellular response to oxygen radical;418438;62;GO:0006979
GO:0071453;cellular response to oxygen levels;8729;554;GO:0045735
GO:0071454;cellular response to anoxia;124;18;GO:0006979
GO:0071451;cellular response to superoxide;418438;112;GO:0006979
GO:0071452;cellular response to singlet oxygen;1383;1;GO:0009611
GO:0071457;cellular response to ozone;70;6;GO:0071456
GO:0071455;cellular response to hyperoxia;256;62;GO:0050890
GO:0071456;cellular response to hypoxia;7539;6110;GO:0006979
GO:0071459;protein localization to chromosome, centromeric region;6702;2210;GO:0000786
GO:1900580;(17Z)-protosta-17(20),24-dien-3beta-ol catabolic process;0;0;GO:0006631
GO:1900582;o-orsellinic acid metabolic process;5;1;GO:0006073
GO:1900581;(17Z)-protosta-17(20),24-dien-3beta-ol biosynthetic process;2;0;GO:1901363
GO:1900584;o-orsellinic acid biosynthetic process;5;3;GO:0046395
GO:1900583;o-orsellinic acid catabolic process;0;0;GO:0046395
GO:1900586;arugosin catabolic process;0;1;GO:0009062
GO:1900585;arugosin metabolic process;1;1;GO:0006081
GO:1900588;violaceol I metabolic process;2;0;GO:0009579
GO:1900587;arugosin biosynthetic process;1;2;GO:1901363
GO:1900589;violaceol I catabolic process;0;0;GO:0009065
GO:0071443;tDNA binding;4;3;GO:0003677
GO:0071446;cellular response to salicylic acid stimulus;7413;111;GO:0009739
GO:0071447;cellular response to hydroperoxide;422;84;GO:0006979
GO:0071444;cellular response to pheromone;2278;126;GO:0009628
GO:0071448;cellular response to alkyl hydroperoxide;1;2;GO:0006979
GO:0071449;cellular response to lipid hydroperoxide;52;38;GO:0046686
GO:1900591;violaceol II metabolic process;2;0;GO:0046274
GO:1900590;violaceol I biosynthetic process;1;2;GO:0046274
GO:1900593;violaceol II biosynthetic process;1;3;GO:0046274
GO:1900592;violaceol II catabolic process;0;0;GO:0046274
GO:1900595;(+)-kotanin catabolic process;0;0;GO:0046274
GO:1900594;(+)-kotanin metabolic process;5;0;GO:0006081
GO:1900597;demethylkotanin metabolic process;1;0;GO:0006066
GO:1900596;(+)-kotanin biosynthetic process;5;3;GO:0046395
GO:1900599;demethylkotanin biosynthetic process;1;2;GO:0046395
GO:1900598;demethylkotanin catabolic process;0;1;GO:0046395
GO:0071471;cellular response to non-ionic osmotic stress;47;6;GO:0006970
GO:0071472;cellular response to salt stress;2428;227;GO:0006950
GO:0071470;cellular response to osmotic stress;19516;1060;GO:0006970
GO:0071475;cellular hyperosmotic salinity response;374;54;GO:0006970
GO:0071476;cellular hypotonic response;576;132;GO:0006970
GO:0071473;cellular response to cation stress;5;6;GO:0006979
GO:0071474;cellular hyperosmotic response;3661;287;GO:0006970
GO:0071479;cellular response to ionizing radiation;5915;1160;GO:0009628
GO:0071477;cellular hypotonic salinity response;123;131;GO:0009416
GO:0071478;cellular response to radiation;52917;809;GO:0009628
GO:0071460;cellular response to cell-matrix adhesion;11;203;GO:0022610
GO:0071461;cellular response to redox state;137;100;GO:0042542
GO:0071464;cellular response to hydrostatic pressure;159;113;GO:0050877
GO:0071465;cellular response to desiccation;38;10;GO:0006950
GO:0071462;cellular response to water stimulus;616;46;GO:0009414
GO:0071463;cellular response to humidity;0;1;GO:0009415
GO:0071468;cellular response to acidic pH;4233;293;GO:0043407
GO:0071469;cellular response to alkaline pH;161;22;GO:0043407
GO:0071466;cellular response to xenobiotic stimulus;99601;906;GO:0042221
GO:0071467;cellular response to pH;6192;554;GO:0050832
GO:0009512;cytochrome b6f complex;42596;90;GO:0009565
GO:0009511;plasmodesmatal endoplasmic reticulum;19;3;GO:0005783
GO:0009510;plasmodesmatal desmotubule;27;5;GO:0005576
GO:0009516;leucoplast;10;4;GO:0005576
GO:0009515;granal stacked thylakoid;46;1;GO:0009579
GO:0009514;glyoxysome;3939;51;GO:0009536
GO:0009513;etioplast;1198;6;GO:0005576
GO:0009509;chromoplast;2603;26;GO:0009579
GO:0009508;plastid chromosome;0;336;GO:0005975
GO:0009507;chloroplast;3817895;9290;GO:0009536
GO:0009506;plasmodesma;10174;1610;GO:0005618
GO:0009523;photosystem II;588517;1580;GO:0009579
GO:0009522;photosystem I;186393;2300;GO:0009579
GO:0009521;photosystem;810333;1530;GO:0009579
GO:0009527;plastid outer membrane;12304;33;GO:0009536
GO:0009526;plastid envelope;1171424;580;GO:0009536
GO:0009525;phragmosome;0;0;GO:0048305
GO:0009524;phragmoplast;1480;364;GO:0048285
GO:0010509;intracellular polyamine homeostasis;34;0;GO:0006749
GO:0009519;middle lamella;7;5;GO:0046364
GO:0010508;positive regulation of autophagy;34846;2030;GO:0045926
GO:0009518;PSI associated light-harvesting complex I;0;1;GO:0009565
GO:0009517;PSII associated light-harvesting complex II;31;74;GO:0009565
GO:0010507;negative regulation of autophagy;5495;1150;GO:0048471
GO:0010506;regulation of autophagy;65338;2380;GO:0048471
GO:0010501;RNA secondary structure unwinding;3204;968;GO:0003676
GO:0010500;transmitting tissue development;18;6;GO:0009952
GO:0009501;amyloplast;9084;74;GO:0009579
GO:0009505;plant-type cell wall;3773;1210;GO:0005618
GO:0009504;cell plate;362;27;GO:0005618
GO:0009503;thylakoid light-harvesting complex;38;17;GO:0009579
GO:0009431;bacterial-type flagellum basal body, MS ring;21032;40;GO:0005576
GO:0022406;membrane docking;23855;347;GO:0005576
GO:0022407;regulation of cell-cell adhesion;96813;1670;GO:0007156
GO:0022408;negative regulation of cell-cell adhesion;12890;1450;GO:0022610
GO:0022409;positive regulation of cell-cell adhesion;81107;1650;GO:0022610
GO:0009435;NAD biosynthetic process;824981;3510;GO:0006749
GO:0022402;cell cycle process;1570891;7110;GO:0007049
GO:0022403;cell cycle phase;0;3610;GO:0007049
GO:0009433;bacterial-type flagellum basal body, C ring;9;174;GO:0005575
GO:0022404;molting cycle process;6525;345;GO:0007530
GO:0009432;SOS response;622158;1150;GO:0009432
GO:0022405;hair cycle process;5317;447;GO:0008544
GO:0009439;cyanate metabolic process;14460;37;GO:0006066
GO:0009438;methylglyoxal metabolic process;56309;101;GO:0006066
GO:0009437;carnitine metabolic process;31855;778;GO:0006631
GO:0022400;regulation of rhodopsin mediated signaling pathway;570;820;GO:0007186
GO:0009436;glyoxylate catabolic process;5299;123;GO:0006066
GO:0022401;negative adaptation of signaling pathway;1020;128;GO:0043406
GO:0009429;bacterial-type flagellum basal body, proximal rod;1;378;GO:0005576
GO:0010417;glucuronoxylan biosynthetic process;523;59;GO:0009813
GO:0010416;arabinoxylan-containing compound metabolic process;0;1;GO:0006073
GO:0010419;rhamnogalacturonan II side chain metabolic process;0;0;GO:0005976
GO:0010418;rhamnogalacturonan II backbone metabolic process;0;2;GO:0005976
GO:0010413;glucuronoxylan metabolic process;559;77;GO:0006073
GO:0010412;mannan metabolic process;2549;3;GO:0006073
GO:0010415;unsubstituted mannan metabolic process;0;2;GO:0006073
GO:0010414;glucuronoarabinoxylan metabolic process;0;1;GO:0006073
GO:0010411;xyloglucan metabolic process;9787;531;GO:0005975
GO:0010410;hemicellulose metabolic process;99961;462;GO:0005976
GO:0009442;allantoin assimilation pathway;975;107;GO:0006073
GO:0009441;glycolate metabolic process;10662;350;GO:0006096
GO:0009440;cyanate catabolic process;52;33;GO:0006067
GO:0009446;putrescine biosynthetic process;34870;460;GO:0009065
GO:0009445;putrescine metabolic process;43925;147;GO:0009065
GO:0009444;pyruvate oxidation;4;10;GO:0006096
GO:0009443;pyridoxal 5'-phosphate salvage;22462;2;GO:0009065
GO:0009449;gamma-aminobutyric acid biosynthetic process;303;194;GO:0009060
GO:0009448;gamma-aminobutyric acid metabolic process;41751;162;GO:0006541
GO:0009447;putrescine catabolic process;8944;139;GO:0009065
GO:0010428;methyl-CpNpG binding;63;9;GO:0048285
GO:0010427;abscisic acid binding;6029;134;GO:0009536
GO:0010429;methyl-CpNpN binding;16;7;GO:0097367
GO:0010424;DNA methylation on cytosine within a CG sequence;365;127;GO:0005578
GO:0010423;negative regulation of brassinosteroid biosynthetic process;6;4;GO:0010468
GO:0010426;DNA methylation on cytosine within a CHH sequence;13;4;GO:0045944
GO:0010425;DNA methylation on cytosine within a CNG sequence;51;3;GO:0005578
GO:0010420;3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity;7911;3;GO:0004497
GO:0010422;regulation of brassinosteroid biosynthetic process;39;5;GO:0010468
GO:0010421;hydrogen peroxide-mediated programmed cell death;726;150;GO:0097190
GO:0009413;response to flooding;135;37;GO:0006950
GO:0009411;response to UV;21134;3700;GO:0009416
GO:0009410;response to xenobiotic stimulus;105687;4310;GO:0042221
GO:0009416;response to light stimulus;194444;6540;GO:0009416
GO:0009415;response to water;16982;3280;GO:0009414
GO:0009414;response to water deprivation;13742;4900;GO:0009414
GO:0009409;response to cold;28744;7590;GO:0009409
GO:0009408;response to heat;215814;8960;GO:0009408
GO:0009407;toxin catabolic process;2368;896;GO:0046274
GO:0046408;chlorophyll synthetase activity;1574;8;GO:0003824
GO:0046409;p-coumarate 3-hydroxylase activity;8;5;GO:0004073
GO:0009420;bacterial-type flagellum filament;19440;9;GO:0043169
GO:0009424;bacterial-type flagellum hook;84803;293;GO:0005576
GO:0046402;O antigen metabolic process;19741;3;GO:0006032
GO:0009423;chorismate biosynthetic process;259454;2330;GO:0009405
GO:0046403;polynucleotide 3'-phosphatase activity;1101;1;GO:0004553
GO:0009422;bacterial-type flagellum hook-filament junction;1;2;GO:0005576
GO:0046400;keto-3-deoxy-D-manno-octulosonic acid metabolic process;18078;7;GO:0006073
GO:0009421;bacterial-type flagellum filament cap;19440;13;GO:0043169
GO:0046401;lipopolysaccharide core region metabolic process;73212;5;GO:0046274
GO:0009428;bacterial-type flagellum basal body, distal rod, P ring;17958;246;GO:0005575
GO:0046406;magnesium protoporphyrin IX methyltransferase activity;3261;74;GO:0004721
GO:0009427;bacterial-type flagellum basal body, distal rod, L ring;16846;69;GO:0005575
GO:0009426;bacterial-type flagellum basal body, distal rod;62184;149;GO:0005576
GO:0046404;ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity;1349;2;GO:0004721
GO:0009425;bacterial-type flagellum basal body;559617;346;GO:0005576
GO:0046405;glycerol dehydratase activity;379;3;GO:0006067
GO:0010409;extensin metabolic process;36;3;GO:0009908
GO:0009419;pilus tip;5;2;GO:0045202
GO:0009418;pilus shaft;1285;3;GO:0043403
GO:0010406;classical arabinogalactan protein metabolic process;4;2;GO:0005975
GO:0010405;arabinogalactan protein metabolic process;197;5;GO:0005975
GO:0010408;fasciclin-like arabinogalactan protein metabolic process;0;2;GO:0009987
GO:0010407;non-classical arabinogalactan protein metabolic process;15;4;GO:0009987
GO:0010402;pectic arabinan metabolic process;0;2;GO:0006021
GO:0010401;pectic galactan metabolic process;17;4;GO:0006021
GO:0010404;cell wall hydroxyproline-rich glycoprotein metabolic process;233;2;GO:0005576
GO:0010403;pectic arabinogalactan I metabolic process;0;2;GO:0006073
GO:0010400;rhamnogalacturonan I side chain metabolic process;38;6;GO:0005976
GO:0010460;positive regulation of heart rate;931;575;GO:0048407
GO:0010462;regulation of light-activated voltage-gated calcium channel activity;0;3;GO:0008092
GO:0010461;light-activated monoatomic ion channel activity;1353;2;GO:0005216
GO:0034431;bis(5'-adenosyl)-hexaphosphatase activity;219;0;GO:0005524
GO:0034430;monolayer-surrounded lipid storage body outer lipid monolayer;0;2;GO:0005811
GO:0034429;tectobulbar tract morphogenesis;0;2;GO:0048704
GO:0010457;centriole-centriole cohesion;793;283;GO:0005524
GO:0034424;Vps55/Vps68 complex;161;7;GO:0005576
GO:0010456;cell proliferation in dorsal spinal cord;20;3;GO:0042127
GO:0034423;autophagosome lumen;3;4;GO:0033279
GO:0010459;negative regulation of heart rate;477;647;GO:0048407
GO:0034422;aleurone grain lumen;0;3;GO:0009566
GO:0010458;exit from mitosis;5046;448;GO:0000278
GO:0034421;post-translational protein acetylation;7;56;GO:0016525
GO:0010453;regulation of cell fate commitment;2901;447;GO:0030154
GO:0034428;nuclear-transcribed mRNA catabolic process, exonucleolytic, 5'-3';37;2;GO:0006396
GO:0010452;histone H3-K36 methylation;18;121;GO:0016569
GO:0034427;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';4270;9;GO:0006396
GO:0010455;positive regulation of cell fate commitment;376;382;GO:0045595
GO:0034426;etioplast membrane;1098;5;GO:0009986
GO:0010454;negative regulation of cell fate commitment;1155;228;GO:0045595
GO:0034425;etioplast envelope;1098;2;GO:0009986
GO:0010471;GDP-galactose:mannose-1-phosphate guanylyltransferase activity;42;3;GO:0006022
GO:0010470;regulation of gastrulation;834;687;GO:0048316
GO:0010473;GDP-galactose:myoinositol-1-phosphate guanylyltransferase activity;4;1;GO:0006030
GO:0010472;GDP-galactose:glucose-1-phosphate guanylyltransferase activity;42;3;GO:0006096
GO:0009486;cytochrome bo3 ubiquinol oxidase activity;29658;43;GO:0008865
GO:0034420;co-translational protein acetylation;0;3;GO:0006464
GO:0034418;urate biosynthetic process;69;21;GO:0006099
GO:0010468;regulation of gene expression;28150110;14800;GO:0010468
GO:0034413;ascospore wall (1->3)-beta-D-glucan biosynthetic process;13;0;GO:0005976
GO:0010467;gene expression;74199442;11400;GO:0010467
GO:0034412;ascospore wall beta-glucan biosynthetic process;21;4;GO:0006021
GO:0034411;cell wall (1->3)-beta-D-glucan biosynthetic process;168;0;GO:0005976
GO:0010469;regulation of signaling receptor activity;486;1010;GO:0007186
GO:0034410;cell wall beta-glucan biosynthetic process;840;4;GO:0009405
GO:0010464;regulation of mesenchymal cell proliferation;1670;855;GO:0045595
GO:0034417;bisphosphoglycerate 3-phosphatase activity;1025;5;GO:0006066
GO:0010463;mesenchymal cell proliferation;3185;878;GO:0042127
GO:0010466;negative regulation of peptidase activity;439;4150;GO:0010467
GO:0010465;nerve growth factor receptor activity;113;48;GO:0004872
GO:0010440;stomatal lineage progression;199;19;GO:0048316
GO:0009453;energy taxis;276;9;GO:0006950
GO:0009452;7-methylguanosine RNA capping;307504;1100;GO:0006631
GO:0009451;RNA modification;6913378;5030;GO:0043687
GO:0009450;gamma-aminobutyric acid catabolic process;24356;226;GO:0006541
GO:0009455;redox taxis;0;5;GO:0006979
GO:0009454;aerotaxis;27;7;GO:0007623
GO:0034409;ascospore wall (1->3)-beta-D-glucan metabolic process;13;0;GO:0006073
GO:0034408;ascospore wall beta-glucan metabolic process;21;3;GO:0006021
GO:0034407;cell wall (1->3)-beta-D-glucan metabolic process;180;0;GO:0006073
GO:0010439;regulation of glucosinolate biosynthetic process;80;81;GO:0010468
GO:0010438;cellular response to sulfur starvation;73;82;GO:0009719
GO:0010435;3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity;0;0;GO:0006081
GO:0034402;recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex;254;1;GO:0000976
GO:0010434;bract formation;13;7;GO:0048608
GO:0010437;9,10 (9', 10')-carotenoid-cleaving dioxygenase activity;7;1;GO:0004497
GO:0034400;gerontoplast;0;4;GO:0005576
GO:0010436;carotenoid dioxygenase activity;2551;23;GO:0004497
GO:0010431;seed maturation;1798;341;GO:0009813
GO:0034406;cell wall beta-glucan metabolic process;893;3;GO:0006073
GO:0010430;fatty acid omega-oxidation;243;61;GO:0006631
GO:0034405;response to fluid shear stress;1424;865;GO:0002576
GO:0010433;bract morphogenesis;13;4;GO:0048608
GO:0034404;nucleobase-containing small molecule biosynthetic process;760570;77;GO:0009405
GO:0010432;bract development;19;5;GO:0048608
GO:0034403;alignment of 3' and 5' splice sites of mRNA;2;3;GO:0003676
GO:0010451;floral meristem growth;99;6;GO:0048316
GO:0010450;inflorescence meristem growth;62;7;GO:0048316
GO:0022417;protein maturation by protein folding;371;1820;GO:0006457
GO:0022413;reproductive process in single-celled organism;2686;7;GO:0048608
GO:0022414;reproductive process;595856;4770;GO:0000003
GO:0022416;chaeta development;1005;359;GO:0009952
GO:0022410;circadian sleep/wake cycle process;4368;134;GO:0007623
GO:0022411;cellular component disassembly;1129461;1960;GO:0042612
GO:0022412;cellular process involved in reproduction in multicellular organism;75475;1190;GO:0032502
GO:0010449;root meristem growth;1048;28;GO:0048316
GO:0010446;response to alkaline pH;282;45;GO:0043407
GO:0010445;nuclear dicing body;71;103;GO:0005819
GO:0010448;vegetative meristem growth;20;4;GO:0048316
GO:0010447;response to acidic pH;7708;685;GO:0043407
GO:0010442;guard cell morphogenesis;48;5;GO:0048471
GO:0010441;guard cell development;76;2;GO:0009913
GO:0010444;guard mother cell differentiation;56;161;GO:0048608
GO:0010443;meristemoid mother cell division;0;2;GO:0048316
GO:0034471;ncRNA 5'-end processing;139068;2;GO:0000976
GO:0034470;ncRNA processing;9469325;3110;GO:0000398
GO:0071419;cellular response to amphetamine;15;1;GO:0042330
GO:0034475;U4 snRNA 3'-end processing;1134;5;GO:0008033
GO:0034474;U2 snRNA 3'-end processing;2129;1;GO:0008033
GO:0034473;U1 snRNA 3'-end processing;482;1;GO:0008033
GO:0034472;snRNA 3'-end processing;12412;295;GO:0006364
GO:0046457;prostanoid biosynthetic process;9591;303;GO:0009791
GO:0046458;hexadecanal metabolic process;55;3;GO:0006629
GO:0046455;organosilicon catabolic process;0;3;GO:0009062
GO:1900533;palmitic acid metabolic process;97;4;GO:0006631
GO:0046456;icosanoid biosynthetic process;13599;341;GO:0006631
GO:1900535;palmitic acid biosynthetic process;97;212;GO:0006631
GO:1900534;palmitic acid catabolic process;0;0;GO:0006631
GO:0046459;short-chain fatty acid metabolic process;57038;979;GO:0006082
GO:0046460;neutral lipid biosynthetic process;27530;519;GO:0008610
GO:0046461;neutral lipid catabolic process;6178;510;GO:0006631
GO:0046464;acylglycerol catabolic process;6139;540;GO:0006631
GO:0046465;dolichyl diphosphate metabolic process;125;17;GO:0006064
GO:0071410;cellular response to cyclopentenone;0;2;GO:0010468
GO:0046462;monoacylglycerol metabolic process;818;125;GO:0006661
GO:0046463;acylglycerol biosynthetic process;27506;312;GO:0006633
GO:0034468;glycosome lumen;1;1;GO:0005764
GO:0071413;cellular response to hydroxyisoflavone;22;1;GO:0009611
GO:0034467;esterosome lumen;0;2;GO:0005766
GO:0071414;cellular response to methotrexate;3;2;GO:0048568
GO:0034466;chromaffin granule lumen;851;8;GO:0005768
GO:0071411;cellular response to fluoxetine;0;3;GO:0006954
GO:0034465;response to carbon monoxide;68;371;GO:0045735
GO:0071412;cellular response to genistein;22;3;GO:0006954
GO:0010497;plasmodesmata-mediated intercellular transport;1180;54;GO:0009913
GO:0071417;cellular response to organonitrogen compound;119180;878;GO:0043407
GO:0010496;intercellular transport;1802;37;GO:0006909
GO:0071418;cellular response to amine stimulus;64;46;GO:0042221
GO:0010499;proteasomal ubiquitin-independent protein catabolic process;3080;596;GO:0006511
GO:0071415;cellular response to purine-containing compound;554;73;GO:0009725
GO:0010498;proteasomal protein catabolic process;317717;2640;GO:0006511
GO:0034469;Golgi stack lumen;0;4;GO:0005764
GO:0071416;cellular response to tropane;0;3;GO:0048608
GO:0034460;uropod assembly;0;1;GO:0009986
GO:0071408;cellular response to cycloalkane;0;1;GO:0050727
GO:0071409;cellular response to cycloheximide;16;140;GO:0006950
GO:0034464;BBSome;14813;370;GO:0008026
GO:0034463;90S preribosome assembly;35;8;GO:0005840
GO:0034462;small-subunit processome assembly;294;9;GO:0005819
GO:1900540;fumonisin catabolic process;1;0;GO:0046395
GO:0034461;uropod retraction;7;5;GO:0007565
GO:0046468;phosphatidyl-N-monomethylethanolamine metabolic process;0;2;GO:0006631
GO:1900542;regulation of purine nucleotide metabolic process;2489;791;GO:0009072
GO:0046469;platelet activating factor metabolic process;337;118;GO:0006631
GO:1900541;fumonisin biosynthetic process;12;0;GO:0046395
GO:0046466;membrane lipid catabolic process;25339;333;GO:0006631
GO:1900544;positive regulation of purine nucleotide metabolic process;618;254;GO:0045944
GO:0046467;membrane lipid biosynthetic process;714980;751;GO:0006629
GO:1900543;negative regulation of purine nucleotide metabolic process;487;89;GO:0045944
GO:1900548;heme B catabolic process;0;1;GO:0046395
GO:0046471;phosphatidylglycerol metabolic process;65824;59;GO:0006631
GO:1900539;fumonisin metabolic process;13;1;GO:0006066
GO:0046470;phosphatidylcholine metabolic process;45185;1350;GO:0006629
GO:0046475;glycerophospholipid catabolic process;5526;886;GO:0006631
GO:0046476;glycosylceramide biosynthetic process;705;111;GO:0006029
GO:0046473;phosphatidic acid metabolic process;19764;209;GO:0006661
GO:0046474;glycerophospholipid biosynthetic process;437635;1570;GO:0006631
GO:0034457;Mpp10 complex;6956;38;GO:0043161
GO:0071402;cellular response to lipoprotein particle stimulus;1461;123;GO:0002576
GO:0034456;UTP-C complex;287;72;GO:0005819
GO:0071403;cellular response to high density lipoprotein particle stimulus;158;8;GO:0071363
GO:0034455;t-UTP complex;365;111;GO:0005819
GO:0071400;cellular response to oleic acid;69;178;GO:0045737
GO:0034454;microtubule anchoring at centrosome;3663;135;GO:0005524
GO:0071401;cellular response to triglyceride;61;4;GO:0006629
GO:0071406;cellular response to methylmercury;17;9;GO:0045727
GO:0071407;cellular response to organic cyclic compound;135248;3770;GO:0010033
GO:0071404;cellular response to low-density lipoprotein particle stimulus;1251;483;GO:0071363
GO:0034458;3'-5' RNA helicase activity;3238;3;GO:0003797
GO:0071405;cellular response to methanol;36;2;GO:0045737
GO:0010482;regulation of epidermal cell division;240;192;GO:0048608
GO:0010481;epidermal cell division;302;46;GO:0051301
GO:0010484;histone H3 acetyltransferase activity;3070;9;GO:0016570
GO:0010483;pollen tube reception;87;28;GO:0009555
GO:0034453;microtubule anchoring;9879;1090;GO:0005524
GO:0009496;plastoquinol--plastocyanin reductase activity;2325;5;GO:0003824
GO:0034452;dynactin binding;608;473;GO:0005525
GO:0010480;microsporocyte differentiation;0;6;GO:0048608
GO:0034451;centriolar satellite;7789;708;GO:0005788
GO:1900551;N',N'',N'''-triacetylfusarinine C biosynthetic process;8;0;GO:1901363
GO:0034450;ubiquitin-ubiquitin ligase activity;8436;679;GO:0004842
GO:1900550;N',N'',N'''-triacetylfusarinine C catabolic process;0;0;GO:0046395
GO:0046479;glycosphingolipid catabolic process;9276;465;GO:0006631
GO:1900553;asperfuranone catabolic process;0;1;GO:0046274
GO:1900552;asperfuranone metabolic process;4;0;GO:0046274
GO:0046477;glycosylceramide catabolic process;6633;33;GO:0009044
GO:1900555;emericellamide metabolic process;9;3;GO:0006032
GO:0046478;lactosylceramide metabolic process;119;3;GO:0006631
GO:1900554;asperfuranone biosynthetic process;4;3;GO:0046271
GO:1900557;emericellamide biosynthetic process;9;6;GO:0046395
GO:1900556;emericellamide catabolic process;0;1;GO:0046395
GO:1900559;austinol catabolic process;0;0;GO:0006081
GO:1900558;austinol metabolic process;11;2;GO:0006066
GO:0046482;para-aminobenzoic acid metabolic process;143;44;GO:0009065
GO:0046483;heterocycle metabolic process;104138693;4090;GO:0006725
GO:1900549;N',N'',N'''-triacetylfusarinine C metabolic process;8;0;GO:0006032
GO:0046480;galactolipid galactosyltransferase activity;8;6;GO:0008610
GO:0046481;digalactosyldiacylglycerol synthase activity;2197;4;GO:0004734
GO:0046486;glycerolipid metabolic process;675352;2720;GO:0006629
GO:0046487;glyoxylate metabolic process;154232;2980;GO:0006066
GO:0071432;peptide mating pheromone maturation involved in positive regulation of conjugation with cellular fusion;59;4;GO:0048285
GO:0046484;oxazole or thiazole metabolic process;8969;8;GO:0006790
GO:0046485;ether lipid metabolic process;4574;144;GO:0006633
GO:0010479;stele development;13;3;GO:0048608
GO:0034446;substrate adhesion-dependent cell spreading;6490;1590;GO:0022610
GO:0010478;chlororespiration;100;6;GO:0009065
GO:0034445;negative regulation of plasma lipoprotein oxidation;151;9;GO:0048146
GO:0034444;regulation of plasma lipoprotein oxidation;151;8;GO:0032963
GO:0071433;cell wall repair;21;2;GO:0046274
GO:0034443;negative regulation of lipoprotein oxidation;108;9;GO:0048146
GO:0071434;cell chemotaxis to angiotensin;0;3;GO:0006935
GO:0071439;clathrin complex;6477;140;GO:0048193
GO:0010477;response to sulfur dioxide;14;10;GO:0046395
GO:0010476;gibberellin mediated signaling pathway;10996;61;GO:0009734
GO:0034447;very-low-density lipoprotein particle clearance;392;413;GO:0048193
GO:0010493;Lewis a epitope biosynthetic process;19;8;GO:0006021
GO:0010492;maintenance of shoot apical meristem identity;330;152;GO:0048316
GO:0010495;siRNA-mediated long-distance post-transcriptional gene silencing;62;0;GO:0070972
GO:0010494;cytoplasmic stress granule;11309;1790;GO:0006986
GO:0034442;regulation of lipoprotein oxidation;114;9;GO:0045595
GO:1900560;austinol biosynthetic process;11;5;GO:1901363
GO:0034441;plasma lipoprotein particle oxidation;206;37;GO:0006979
GO:0010491;UTP:arabinose-1-phosphate uridylyltransferase activity;61;2;GO:0006067
GO:0034440;lipid oxidation;149808;1840;GO:0006979
GO:1900562;dehydroaustinol catabolic process;0;1;GO:0046274
GO:0010490;UDP-4-keto-rhamnose-4-keto-reductase activity;2;5;GO:0006099
GO:1900561;dehydroaustinol metabolic process;14;2;GO:0046274
GO:1900564;chanoclavine-I metabolic process;0;0;GO:0006749
GO:1900563;dehydroaustinol biosynthetic process;14;5;GO:1901363
GO:0046488;phosphatidylinositol metabolic process;258528;1950;GO:0006631
GO:1900567;chanoclavine-I aldehyde metabolic process;0;2;GO:0006032
GO:1900569;chanoclavine-I aldehyde biosynthetic process;0;1;GO:0046395
GO:0046493;lipid A metabolic process;546790;9;GO:0006631
GO:0046494;rhizobactin 1021 metabolic process;6;3;GO:0009405
GO:0046491;L-methylmalonyl-CoA metabolic process;130;4;GO:0006066
GO:0046492;heme B metabolic process;4529;2;GO:0006796
GO:0046497;nicotinate nucleotide metabolic process;103;3;GO:0006749
GO:0071420;cellular response to histamine;241;217;GO:0002544
GO:0046498;S-adenosylhomocysteine metabolic process;280;58;GO:0006749
GO:0071421;manganese ion transmembrane transport;84762;132;GO:0006826
GO:0046495;nicotinamide riboside metabolic process;94;7;GO:0046395
GO:0046496;nicotinamide nucleotide metabolic process;1592955;1210;GO:0006749
GO:0071424;rRNA (cytosine-N4-)-methyltransferase activity;45041;0;GO:0003729
GO:0010489;UDP-4-keto-6-deoxy-glucose-3,5-epimerase activity;2;3;GO:0006032
GO:0071425;hematopoietic stem cell proliferation;2160;269;GO:0019827
GO:0071422;succinate transmembrane transport;1612;35;GO:0006836
GO:0034432;bis(5'-adenosyl)-pentaphosphatase activity;325;0;GO:0004723
GO:0071423;malate transmembrane transport;9672;86;GO:0006836
GO:0010486;manganese:proton antiporter activity;66;1;GO:0005215
GO:0034439;lipoprotein lipid oxidation;132;4;GO:0006629
GO:0010485;histone H4 acetyltransferase activity;6709;10;GO:0016570
GO:0034438;lipoprotein amino acid oxidation;0;3;GO:0006635
GO:0046490;isopentenyl diphosphate metabolic process;288683;48;GO:0006725
GO:0010488;UDP-galactose:N-glycan beta-1,3-galactosyltransferase activity;38;3;GO:0008878
GO:0010487;thermospermine synthase activity;134;5;GO:0006030
GO:0034436;glycoprotein transport;172;122;GO:0006869
GO:0046419;octopine metabolic process;6;2;GO:0006073
GO:0046413;organomercury catabolic process;2744;6;GO:0046148
GO:0046414;organomercury biosynthetic process;0;3;GO:0009065
GO:0046411;2-keto-3-deoxygluconate transmembrane transport;11233;6;GO:0006810
GO:0046412;phenylmercury acetate metabolic process;0;3;GO:0006725
GO:0046417;chorismate metabolic process;329891;509;GO:0006073
GO:0046418;nopaline metabolic process;0;3;GO:0009405
GO:0046415;urate metabolic process;18141;993;GO:0006066
GO:0046416;D-amino acid metabolic process;121677;59;GO:0006520
GO:0046421;methylisocitrate lyase activity;36047;41;GO:0006099
GO:0046424;ferulate 5-hydroxylase activity;0;2;GO:0004497
GO:0046425;regulation of receptor signaling pathway via JAK-STAT;4722;48;GO:0007165
GO:0046422;violaxanthin de-epoxidase activity;1336;127;GO:0009523
GO:1900500;regulation of butyryl-CoA catabolic process to butyrate;0;1;GO:0046394
GO:0046423;allene-oxide cyclase activity;2218;21;GO:0004722
GO:0046428;1,4-dihydroxy-2-naphthoate octaprenyltransferase activity;41406;28;GO:0004073
GO:1900502;positive regulation of butyryl-CoA catabolic process to butyrate;0;0;GO:0046394
GO:0046429;4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase activity;79548;564;GO:0004497
GO:1900501;negative regulation of butyryl-CoA catabolic process to butyrate;0;2;GO:0046395
GO:0046426;negative regulation of receptor signaling pathway via JAK-STAT;1629;28;GO:0030528
GO:1900504;negative regulation of cellulosome assembly;0;0;GO:0048193
GO:0046427;positive regulation of receptor signaling pathway via JAK-STAT;1898;140;GO:0007165
GO:1900503;regulation of cellulosome assembly;0;1;GO:0048193
GO:0046431;(R)-4-hydroxymandelate metabolic process;0;0;GO:0006073
GO:0046432;2'-(5''-triphosphoribosyl)-3'-dephospho-CoA metabolic process;0;0;GO:0006066
GO:0046430;non-phosphorylated glucose metabolic process;1108;6;GO:0005975
GO:0034499;late endosome to Golgi transport;252;106;GO:0006897
GO:0034498;early endosome to Golgi transport;636;227;GO:0006897
GO:0034493;melanosome lumen;1;4;GO:0005576
GO:0034492;hydrogenosome lumen;3;3;GO:0005746
GO:0034491;neutral amino acid transmembrane import into vacuole;57;1;GO:0006836
GO:0034490;basic amino acid transmembrane import into vacuole;234;4;GO:0008565
GO:0034497;protein localization to phagophore assembly site;1354;121;GO:0005783
GO:0034496;multivesicular body membrane disassembly;37;2;GO:0007088
GO:0034495;protein storage vacuole lumen;1;2;GO:0005764
GO:0034494;microneme lumen;4;2;GO:0005576
GO:0046435;3-(3-hydroxy)phenylpropionate metabolic process;1834;0;GO:0009062
GO:0046436;D-alanine metabolic process;40517;10;GO:0006559
GO:0046433;2-aminoethylphosphonate metabolic process;0;3;GO:0006559
GO:1900511;positive regulation of pentose catabolic process to ethanol;0;1;GO:0046395
GO:0046434;organophosphate catabolic process;521552;2010;GO:0006569
GO:1900510;negative regulation of pentose catabolic process to ethanol;0;1;GO:0046395
GO:0046439;L-cysteine metabolic process;13765;42;GO:0006520
GO:1900513;negative regulation of starch utilization system complex assembly;0;0;GO:0046395
GO:1900512;regulation of starch utilization system complex assembly;0;0;GO:0046395
GO:0046437;D-amino acid biosynthetic process;39554;5;GO:0009061
GO:1900515;regulation of xylose catabolic process to ethanol;0;1;GO:0046395
GO:0046438;D-cysteine metabolic process;25;3;GO:0006520
GO:1900514;positive regulation of starch utilization system complex assembly;0;1;GO:0046395
GO:1900506;regulation of iron-sulfur-molybdenum cofactor assembly;0;0;GO:0009065
GO:1900505;positive regulation of cellulosome assembly;0;0;GO:0048193
GO:1900508;positive regulation of iron-sulfur-molybdenum cofactor assembly;0;0;GO:0046395
GO:1900507;negative regulation of iron-sulfur-molybdenum cofactor assembly;0;0;GO:0046395
GO:0046442;aerobactin metabolic process;10;1;GO:0009063
GO:0046443;FAD metabolic process;83743;6;GO:0006749
GO:1900509;regulation of pentose catabolic process to ethanol;0;1;GO:0046395
GO:0046440;L-lysine metabolic process;46554;21;GO:0006541
GO:0046441;D-lysine metabolic process;0;3;GO:0006541
GO:0034489;neutral amino acid transmembrane export from vacuole;0;1;GO:0008544
GO:0034488;basic amino acid transmembrane export from vacuole;22;7;GO:0008544
GO:0034487;vacuolar amino acid transmembrane transport;22;2;GO:0006865
GO:0034482;chondroitin 2-O-sulfotransferase activity;0;1;GO:0004719
GO:0034481;chondroitin sulfotransferase activity;1373;8;GO:0004719
GO:0034480;phosphatidylcholine phospholipase C activity;16731;9;GO:0005576
GO:0034486;vacuolar transmembrane transport;3046;35;GO:0006897
GO:0034485;phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity;2485;29;GO:0004721
GO:0034484;raffinose catabolic process;14;9;GO:0006032
GO:0034483;heparan sulfate sulfotransferase activity;9394;130;GO:0004332
GO:0046446;purine alkaloid metabolic process;0;5;GO:0006725
GO:1900520;positive regulation of response to pullulan;0;0;GO:0043547
GO:0046447;terpenoid indole alkaloid metabolic process;110;2;GO:0046394
GO:0046444;FMN metabolic process;85656;7;GO:0006749
GO:1900522;negative regulation of response to amylopectin;0;0;GO:0010468
GO:0046445;benzyl isoquinoline alkaloid metabolic process;6;4;GO:0046148
GO:1900521;regulation of response to amylopectin;0;2;GO:0010468
GO:1900523;positive regulation of response to amylopectin;0;0;GO:0010468
GO:0046448;tropane alkaloid metabolic process;9;4;GO:0008610
GO:0046449;creatinine metabolic process;1079;149;GO:0007567
GO:1900517;positive regulation of xylose catabolic process to ethanol;0;0;GO:0046395
GO:0046450;dethiobiotin metabolic process;0;3;GO:0009065
GO:1900516;negative regulation of xylose catabolic process to ethanol;0;0;GO:0046395
GO:1900519;negative regulation of response to pullulan;0;0;GO:0043565
GO:1900518;regulation of response to pullulan;0;3;GO:0010468
GO:0046453;dipyrrin metabolic process;0;3;GO:0046395
GO:0046454;dimethylsilanediol metabolic process;0;2;GO:0046395
GO:0046451;diaminopimelate metabolic process;1158405;6;GO:0009065
GO:0046452;dihydrofolate metabolic process;33660;109;GO:0006790
GO:0034479;phosphatidylglycerol phospholipase C activity;14;4;GO:0008033
GO:0034478;phosphatidylglycerol catabolic process;79;8;GO:0006631
GO:0034477;U6 snRNA 3'-end processing;5429;6;GO:0008033
GO:0034476;U5 snRNA 3'-end processing;531;1;GO:0008033
GO:1900492;negative regulation of [4Fe-4S] cluster assembly;0;1;GO:0008631
GO:1900491;regulation of [4Fe-4S] cluster assembly;0;1;GO:0008033
GO:1900494;regulation of butyryl-CoA biosynthetic process from acetyl-CoA;0;0;GO:0045944
GO:1900493;positive regulation of [4Fe-4S] cluster assembly;0;0;GO:0046395
GO:1900496;positive regulation of butyryl-CoA biosynthetic process from acetyl-CoA;0;1;GO:0045944
GO:1900495;negative regulation of butyryl-CoA biosynthetic process from acetyl-CoA;0;0;GO:0046394
GO:1900498;negative regulation of butyryl-CoA catabolic process to butanol;0;3;GO:0046395
GO:1900497;regulation of butyryl-CoA catabolic process to butanol;0;2;GO:0046394
GO:1900499;positive regulation of butyryl-CoA catabolic process to butanol;0;0;GO:0046394
GO:1900450;negative regulation of glutamate receptor signaling pathway;5;4;GO:0048169
GO:1900452;regulation of long-term synaptic depression;553;26;GO:0048167
GO:1900451;positive regulation of glutamate receptor signaling pathway;74;97;GO:0048169
GO:1900454;positive regulation of long-term synaptic depression;273;131;GO:0048167
GO:1900453;negative regulation of long-term synaptic depression;113;7;GO:0048167
GO:1900458;negative regulation of brassinosteroid mediated signaling pathway;146;6;GO:0046686
GO:1900457;regulation of brassinosteroid mediated signaling pathway;513;9;GO:0030521
GO:1900459;positive regulation of brassinosteroid mediated signaling pathway;125;0;GO:0046354
GO:0071570;cement gland development;5;2;GO:0009913
GO:0071574;protein localization to medial cortex;58;4;GO:0005576
GO:0071572;histone H3-K56 deacetylation;0;2;GO:0016569
GO:0071573;shelterin complex assembly;106;2;GO:0005840
GO:0071578;zinc ion import across plasma membrane;765;67;GO:0006826
GO:0071579;regulation of zinc ion transport;122;10;GO:0006836
GO:0071576;tetrahydrodictyopterin binding;0;1;GO:0043169
GO:0071577;zinc ion transmembrane transport;72605;797;GO:0006836
GO:1900461;positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter;131;5;GO:0010467
GO:1900469;negative regulation of phosphatidylserine biosynthetic process;0;1;GO:0048193
GO:1900468;regulation of phosphatidylserine biosynthetic process;0;0;GO:0045944
GO:0071560;cellular response to transforming growth factor beta stimulus;27191;1680;GO:0048010
GO:0071563;Myo2p-Vac17p-Vac8p transport complex;81;4;GO:0005737
GO:0071564;npBAF complex;1732;536;GO:0000976
GO:0071561;nucleus-vacuole junction;317;169;GO:0005737
GO:0071562;nucleus-vacuole junction assembly;2850;2;GO:0005737
GO:0071567;deUFMylase activity;140;3;GO:0004553
GO:0071568;UFM1 transferase activity;4733;9;GO:0004842
GO:0071565;nBAF complex;671;543;GO:0000786
GO:0071566;UFM1 activating enzyme activity;217;9;GO:0004842
GO:0071569;protein ufmylation;6793;197;GO:0006464
GO:1900470;positive regulation of phosphatidylserine biosynthetic process;0;0;GO:0048193
GO:1900477;negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter;73;9;GO:0045944
GO:0071592;nicotinic acid riboside biosynthetic process;35;2;GO:0009065
GO:0071593;lymphocyte aggregation;212;58;GO:0002526
GO:0071590;nicotinamide riboside biosynthetic process;35;2;GO:0046395
GO:0071591;nicotinic acid riboside metabolic process;35;1;GO:0009064
GO:0071596;ubiquitin-dependent protein catabolic process via the N-end rule pathway;31966;81;GO:0006511
GO:0071597;cellular birth scar;3;4;GO:0002040
GO:0071594;thymocyte aggregation;2;7;GO:0002576
GO:0071595;Nem1-Spo7 phosphatase complex;1995;182;GO:0048193
GO:0071598;neuronal ribonucleoprotein granule;440;67;GO:0008021
GO:0071599;otic vesicle development;2371;123;GO:0008544
GO:1900481;negative regulation of diacylglycerol biosynthetic process;0;1;GO:0010467
GO:1900480;regulation of diacylglycerol biosynthetic process;66;0;GO:0010467
GO:1900483;regulation of protein targeting to vacuolar membrane;2;3;GO:0006626
GO:1900482;positive regulation of diacylglycerol biosynthetic process;9;0;GO:0010467
GO:1900485;positive regulation of protein targeting to vacuolar membrane;0;0;GO:0048193
GO:1900484;negative regulation of protein targeting to vacuolar membrane;0;1;GO:0006626
GO:1900487;regulation of [2Fe-2S] cluster assembly;0;0;GO:0008033
GO:1900486;positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway;38;4;GO:0045944
GO:1900489;positive regulation of [2Fe-2S] cluster assembly;0;0;GO:0046395
GO:1900488;negative regulation of [2Fe-2S] cluster assembly;0;0;GO:0046395
GO:0071581;regulation of zinc ion transmembrane import;56;0;GO:0006836
GO:0071582;negative regulation of zinc ion transport;58;2;GO:0006836
GO:0071580;regulation of zinc ion transmembrane transport;58;1;GO:0006836
GO:0071585;detoxification of cadmium ion;498;21;GO:0006829
GO:0071586;CAAX-box protein processing;132629;465;GO:0006464
GO:0071583;negative regulation of zinc ion transmembrane transport;58;2;GO:0045730
GO:0071584;negative regulation of zinc ion transmembrane import;56;5;GO:0048193
GO:0071589;pyridine nucleoside biosynthetic process;70;1;GO:0009061
GO:0071587;CAAX-box protein modification;0;4;GO:0006464
GO:0071588;hydrogen peroxide mediated signaling pathway;130;3;GO:0006979
GO:0009600;detection of nematode;0;2;GO:0050829
GO:0009604;detection of symbiotic bacterium;0;1;GO:0044421
GO:0009603;detection of symbiotic fungus;1;2;GO:0043161
GO:0009602;detection of symbiont;1;4;GO:0044419
GO:0009601;detection of insect;0;3;GO:0009536
GO:0022608;multicellular organism adhesion;29;4;GO:0007155
GO:0022609;multicellular organism adhesion to substrate;27;4;GO:0007155
GO:0022604;regulation of cell morphogenesis;1298425;2500;GO:0048468
GO:0022605;mammalian oogenesis stage;468;5;GO:0008544
GO:0022606;establishment of proximal/distal cell polarity;25;4;GO:0031589
GO:0022607;cellular component assembly;3727738;2570;GO:0043234
GO:0022600;digestive system process;7923;539;GO:0046907
GO:0022601;menstrual cycle phase;0;5;GO:0007548
GO:0009631;cold acclimation;1558;711;GO:0009409
GO:0022602;ovulation cycle process;4115;1310;GO:0048545
GO:0009630;gravitropism;7033;371;GO:0048407
GO:0022603;regulation of anatomical structure morphogenesis;1356537;1790;GO:0048731
GO:0009637;response to blue light;37059;829;GO:0009416
GO:0009636;response to toxic substance;3843251;4180;GO:0046686
GO:0009635;response to herbicide;22298;651;GO:0046356
GO:0010619;adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway;128;8;GO:0007186
GO:0009629;response to gravity;7605;701;GO:0048073
GO:0010618;aerenchyma formation;50;8;GO:0046395
GO:0009628;response to abiotic stimulus;573596;8490;GO:0009628
GO:0009627;systemic acquired resistance;7943;1070;GO:0009627
GO:0010615;positive regulation of cardiac muscle adaptation;131;27;GO:0048407
GO:0010614;negative regulation of cardiac muscle hypertrophy;920;320;GO:0048407
GO:0010617;circadian regulation of calcium ion oscillation;75;20;GO:0048407
GO:0010616;negative regulation of cardiac muscle adaptation;190;7;GO:0048407
GO:0010611;regulation of cardiac muscle hypertrophy;2235;286;GO:0048407
GO:0010610;regulation of mRNA stability involved in response to stress;73;10;GO:0010467
GO:0010613;positive regulation of cardiac muscle hypertrophy;1109;1150;GO:0048407
GO:0010612;regulation of cardiac muscle adaptation;386;5;GO:0048407
GO:0009640;photomorphogenesis;5400;775;GO:0009644
GO:0009644;response to high light intensity;2478;1320;GO:0046365
GO:0009643;photosynthetic acclimation;201;71;GO:0009416
GO:0009642;response to light intensity;4977;728;GO:0009416
GO:0009641;shade avoidance;208;62;GO:0009952
GO:0009648;photoperiodism;8534;664;GO:0009628
GO:0009647;skotomorphogenesis;126;146;GO:0048316
GO:0009646;response to absence of light;858;241;GO:0009416
GO:0009645;response to low light intensity stimulus;294;31;GO:0009416
GO:0010629;negative regulation of gene expression;1623320;7680;GO:0010468
GO:0009639;response to red or far red light;13973;611;GO:0009765
GO:0009638;phototropism;1475;254;GO:0009865
GO:0010626;negative regulation of Schwann cell proliferation;171;184;GO:0048010
GO:0010625;positive regulation of Schwann cell proliferation;58;23;GO:0048010
GO:0010628;positive regulation of gene expression;482190;14200;GO:0010468
GO:0010622;specification of ovule identity;2;3;GO:0048316
GO:0010621;negative regulation of transcription by transcription factor localization;81;23;GO:0045944
GO:0010624;regulation of Schwann cell proliferation;231;21;GO:0048010
GO:0010623;programmed cell death involved in cell development;2928;196;GO:0012501
GO:0010620;negative regulation of transcription by transcription factor catabolism;0;6;GO:0045944
GO:0009611;response to wounding;85963;14900;GO:0009611
GO:0009610;response to symbiotic fungus;2951;84;GO:0045734
GO:0009615;response to virus;261033;7260;GO:0043169
GO:0009612;response to mechanical stimulus;10874;7250;GO:0050921
GO:0009608;response to symbiont;3201;32;GO:0045734
GO:0009607;response to biotic stimulus;2244712;6900;GO:0009607
GO:0009606;tropism;12138;158;GO:0002526
GO:0009605;response to external stimulus;4276900;6510;GO:0009605
GO:0009609;response to symbiotic bacterium;206;37;GO:0045734
GO:0009620;response to fungus;46263;3130;GO:0050832
GO:0009626;plant-type hypersensitive response;1532;767;GO:0009626
GO:0009625;response to insect;277;241;GO:0009628
GO:0009624;response to nematode;562;890;GO:0046508
GO:0010608;post-transcriptional regulation of gene expression;3348587;422;GO:0010467
GO:0010607;negative regulation of cytoplasmic mRNA processing body assembly;112;8;GO:0010467
GO:0009617;response to bacterium;129933;5480;GO:0044765
GO:0009616;RNAi-mediated antiviral immune response;143;4;GO:1902535
GO:0010609;mRNA localization resulting in post-transcriptional regulation of gene expression;132;6;GO:0010467
GO:0010604;positive regulation of macromolecule metabolic process;1486024;3540;GO:0045944
GO:0010603;regulation of cytoplasmic mRNA processing body assembly;2959;41;GO:0010467
GO:0010606;positive regulation of cytoplasmic mRNA processing body assembly;2766;440;GO:0010467
GO:0010605;negative regulation of macromolecule metabolic process;2740340;3330;GO:0045944
GO:0010600;regulation of auxin biosynthetic process;116;28;GO:0010468
GO:0010602;regulation of 1-aminocyclopropane-1-carboxylate metabolic process;14;4;GO:0009735
GO:0010601;positive regulation of auxin biosynthetic process;22;6;GO:0045735
GO:0009551;secondary plasmodesma;26;4;GO:0009986
GO:0009550;primary plasmodesma;0;1;GO:0009986
GO:0009556;microsporogenesis;304;99;GO:0048316
GO:0009555;pollen development;6648;1400;GO:0009555
GO:0009554;megasporogenesis;170;34;GO:0048285
GO:0009553;embryo sac development;2511;588;GO:0009952
GO:0009559;embryo sac central cell differentiation;592;2;GO:0048608
GO:0009558;embryo sac cellularization;79;10;GO:0008544
GO:0009557;antipodal cell differentiation;6;1;GO:0048608
GO:0034508;centromere complex assembly;19614;768;GO:0000786
GO:0034506;chromosome, centromeric core domain;494;51;GO:0000786
GO:0034501;protein localization to kinetochore;6263;2990;GO:0000776
GO:0010533;regulation of activation of Janus kinase activity;19;136;GO:0046330
GO:0010536;positive regulation of activation of Janus kinase activity;18;42;GO:0046330
GO:0034505;tooth mineralization;1498;1100;GO:0007596
GO:0034504;protein localization to nucleus;72919;1800;GO:0005634
GO:0034503;protein localization to nucleolar rDNA repeats;29;75;GO:0005840
GO:0034502;protein localization to chromosome;18436;1030;GO:0051301
GO:0046509;1,2-diacylglycerol 3-beta-galactosyltransferase activity;800;4;GO:0008610
GO:0010550;regulation of PSII associated light-harvesting complex II catabolic process;0;3;GO:0046274
GO:0046507;UDPsulfoquinovose synthase activity;395;5;GO:0006032
GO:0046508;hydrolase activity, acting on carbon-sulfur bonds;50235;4;GO:0004553
GO:0009563;synergid differentiation;8;2;GO:0048608
GO:0009562;embryo sac nuclear migration;0;2;GO:0007049
GO:0009561;megagametogenesis;1122;43;GO:0007276
GO:0009560;embryo sac egg cell differentiation;31;28;GO:0008544
GO:0009567;double fertilization forming a zygote and endosperm;3870;129;GO:0009555
GO:0046501;protoporphyrinogen IX metabolic process;280141;348;GO:0006784
GO:0009566;fertilization;31571;2350;GO:0007276
GO:0046502;uroporphyrinogen III metabolic process;54226;9;GO:0006749
GO:0046500;S-adenosylmethionine metabolic process;166274;1070;GO:0006725
GO:0046505;sulfolipid metabolic process;187;6;GO:0006631
GO:0046506;sulfolipid biosynthetic process;182;124;GO:0006631
GO:0009569;chloroplast starch grain;192;8;GO:0009536
GO:0046503;glycerolipid catabolic process;11682;218;GO:0006631
GO:0009568;amyloplast starch grain;0;5;GO:0048471
GO:0046504;glycerol ether biosynthetic process;4160;59;GO:0046395
GO:0010549;regulation of membrane disassembly;8;0;GO:0048193
GO:0010548;regulation of thylakoid membrane disassembly;0;0;GO:0048285
GO:0010544;negative regulation of platelet activation;846;598;GO:0042592
GO:0010547;thylakoid membrane disassembly;0;2;GO:0009986
GO:0010541;acropetal auxin transport;26;21;GO:0009734
GO:0010540;basipetal auxin transport;145;67;GO:0009734
GO:0010543;regulation of platelet activation;2180;623;GO:0042330
GO:0010542;nitrate efflux transmembrane transporter activity;1;5;GO:0005215
GO:0046518;octamethylcyclotetrasiloxane metabolic process;0;1;GO:0006730
GO:0046519;sphingoid metabolic process;9771;338;GO:0008610
GO:0009530;primary cell wall;9;10;GO:0009505
GO:0009534;chloroplast thylakoid;1054963;1710;GO:0009579
GO:0046512;sphingosine biosynthetic process;4278;197;GO:0006633
GO:0009533;chloroplast stromal thylakoid;88;51;GO:0009579
GO:0046513;ceramide biosynthetic process;30261;1040;GO:0006631
GO:0009532;plastid stroma;91961;644;GO:0009579
GO:0046510;UDP-sulfoquinovose:DAG sulfoquinovosyltransferase activity;87;7;GO:0004721
GO:0009531;secondary cell wall;321;29;GO:0009531
GO:0046511;sphinganine biosynthetic process;76;4;GO:0006639
GO:0009538;photosystem I reaction center;11859;429;GO:0009579
GO:0046516;hypusine metabolic process;2;4;GO:0006749
GO:0009537;proplastid;94;3;GO:0009536
GO:0046517;octamethylcyclotetrasiloxane catabolic process;0;0;GO:0046395
GO:0009536;plastid;5694757;4920;GO:0009536
GO:0046514;ceramide catabolic process;17804;863;GO:0006631
GO:0009535;chloroplast thylakoid membrane;1050935;2640;GO:0009579
GO:0010519;negative regulation of phospholipase activity;10;42;GO:0010468
GO:0009529;plastid intermembrane space;54;7;GO:0009536
GO:0009528;plastid inner membrane;72033;48;GO:0009536
GO:0010516;negative regulation of cellular response to nitrogen starvation;0;2;GO:0045735
GO:0010515;negative regulation of induction of conjugation with cellular fusion;253;9;GO:0048285
GO:0046520;sphingoid biosynthetic process;4499;303;GO:0008610
GO:0010518;positive regulation of phospholipase activity;169;650;GO:0048407
GO:0010517;regulation of phospholipase activity;183;229;GO:0010468
GO:0010512;negative regulation of phosphatidylinositol biosynthetic process;133;95;GO:0045944
GO:0010511;regulation of phosphatidylinositol biosynthetic process;355;8;GO:0045944
GO:0010514;induction of conjugation with cellular fusion;35;8;GO:0048285
GO:0010513;positive regulation of phosphatidylinositol biosynthetic process;216;121;GO:0045944
GO:0010510;regulation of acetyl-CoA biosynthetic process from pyruvate;301;826;GO:0045944
GO:0046529;imaginal disc fusion, thorax closure;243;8;GO:0007530
GO:0009541;etioplast prolamellar body;0;3;GO:0009986
GO:0009545;elaioplast;0;1;GO:0009579
GO:0046523;S-methyl-5-thioribose-1-phosphate isomerase activity;50944;224;GO:0006032
GO:0009544;chloroplast ATP synthase complex;3;6;GO:0005737
GO:0046524;sucrose-phosphate synthase activity;5623;192;GO:0006094
GO:0009543;chloroplast thylakoid lumen;2220;281;GO:0009536
GO:0046521;sphingoid catabolic process;133;48;GO:0009986
GO:0009542;granum;46;6;GO:0048608
GO:0046522;S-methyl-5-thioribose kinase activity;10927;25;GO:0006030
GO:0009549;cellulose microfibril;0;9;GO:0005578
GO:0046527;glucosyltransferase activity;252209;694;GO:0004553
GO:0009548;plasmodesmatal plasma membrane;0;3;GO:0005886
GO:0046528;imaginal disc fusion;269;6;GO:0002041
GO:0009547;plastid ribosome;165;19;GO:0005840
GO:0046525;xylosylprotein 4-beta-galactosyltransferase activity;181;12;GO:0004553
GO:0009546;plasmodesmatal cytoplasmic sleeve;0;3;GO:0005576
GO:0046526;D-xylulose reductase activity;424;8;GO:0004073
GO:0009539;photosystem II reaction center;113837;194;GO:0009579
GO:0046530;photoreceptor cell differentiation;11154;975;GO:0048666
GO:0010526;retrotransposon silencing;1735;138;GO:0010467
GO:0010523;negative regulation of calcium ion transport into cytosol;154;125;GO:0048407
GO:0010522;regulation of calcium ion transport into cytosol;571;211;GO:0006873
GO:0010524;positive regulation of calcium ion transport into cytosol;340;683;GO:0010467
GO:0010521;telomerase inhibitor activity;694;109;GO:0003690
GO:0010520;regulation of reciprocal meiotic recombination;407;76;GO:0000922
GO:0010581;regulation of starch biosynthetic process;202;8;GO:0010467
GO:0009590;detection of gravity;184;10;GO:0007623
GO:0010583;response to cyclopentenone;37;247;GO:0009611
GO:0010582;floral meristem determinacy;328;70;GO:0009908
GO:0034552;respiratory chain complex II assembly;6660;9;GO:0005746
GO:0009595;detection of biotic stimulus;66285;1750;GO:0009595
GO:0034551;mitochondrial respiratory chain complex III assembly;9399;297;GO:0005746
GO:0009594;detection of nutrient;2;8;GO:0009065
GO:0034550;dimethylarsinate reductase activity;0;4;GO:0009081
GO:0009593;detection of chemical stimulus;390711;874;GO:0009583
GO:0009597;detection of virus;508;410;GO:0043169
GO:0010578;regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway;10;9;GO:0007218
GO:0034545;fumarylpyruvate hydrolase activity;545;6;GO:0004553
GO:0034544;trans-ACOHDA hydrolase activity;0;0;GO:0005524
GO:0034543;5-aminosalicylate dioxygenase activity;0;3;GO:0004497
GO:0034542;trimethylarsine oxidase activity;0;3;GO:0004497
GO:0010574;regulation of vascular endothelial growth factor production;1637;512;GO:0030518
GO:0034549;N-cyclopropylammelide alkylamino hydrolase activity;0;2;GO:0004721
GO:0010573;vascular endothelial growth factor production;2442;406;GO:0048010
GO:0034548;N-cyclopropylammeline deaminase activity;0;3;GO:0004730
GO:0034547;N-cyclopropylmelamine deaminase activity;0;3;GO:0009081
GO:0010575;positive regulation of vascular endothelial growth factor production;1366;1040;GO:0050727
GO:0034546;2,4-dichloroaniline reductive dehalogenase activity;0;4;GO:0004497
GO:0010592;positive regulation of lamellipodium assembly;1397;855;GO:0048193
GO:0010591;regulation of lamellipodium assembly;2058;507;GO:0048193
GO:0010594;regulation of endothelial cell migration;11537;678;GO:0030574
GO:0010593;negative regulation of lamellipodium assembly;166;247;GO:0048193
GO:0034541;dimethylarsinite methyltransferase activity;0;3;GO:0004730
GO:0034540;3-monobromobisphenol A reductive dehalogenase activity;0;3;GO:0004497
GO:0010590;regulation of septum digestion after cytokinesis;131;1;GO:0048285
GO:0034539;3,3',5,5'-tetrabromobisphenol A reductive dehalogenase activity;0;0;GO:0004497
GO:0010589;leaf proximal/distal pattern formation;27;5;GO:0048316
GO:0034534;1-methylnaphthalene hydroxylase activity;0;3;GO:0046395
GO:0010588;cotyledon vascular tissue pattern formation;173;40;GO:0048731
GO:0034533;1,2-dihydroxy-7-hydroxymethylnaphthalene dioxygenase activity;0;2;GO:0004497
GO:0034532;2-hydroxy-7-hydroxymethylchromene-2-carboxylate isomerase activity;0;3;GO:0006073
GO:0034531;2-hydroxy-4-hydroxymethylbenzalpyruvate hydratase-aldolase activity;0;2;GO:0006066
GO:0010585;glutamine secretion;72;65;GO:0008544
GO:0034538;3-methylsalicylaldehyde dehydrogenase activity;0;2;GO:0004073
GO:0010584;pollen exine formation;886;493;GO:0009555
GO:0034537;2-hydroxy-3-methylbenzalpyruvate hydratase-aldolase activity;0;1;GO:0006067
GO:0010587;miRNA catabolic process;1738;160;GO:0010467
GO:0034536;2-hydroxy-8-methylchromene-2-carboxylate isomerase activity;0;3;GO:0006099
GO:0010586;miRNA metabolic process;6718;308;GO:0034660
GO:0034535;1,2-dihydroxy-8-methylnaphthalene dioxygenase activity;0;2;GO:0004497
GO:0009570;chloroplast stroma;80150;2550;GO:0009579
GO:0010561;negative regulation of glycoprotein biosynthetic process;449;140;GO:0010467
GO:0010560;positive regulation of glycoprotein biosynthetic process;952;591;GO:0010467
GO:0009574;preprophase band;217;10;GO:0000976
GO:0034530;4-hydroxymethylsalicyaldehyde dehydrogenase activity;0;3;GO:0004073
GO:0009573;chloroplast ribulose bisphosphate carboxylase complex;0;135;GO:0009536
GO:0009571;proplastid stroma;0;4;GO:0009579
GO:0009578;etioplast stroma;1;2;GO:0009579
GO:0009577;elaioplast stroma;0;0;GO:0009579
GO:0009576;leucoplast stroma;0;2;GO:0005576
GO:0009575;chromoplast stroma;19;8;GO:0009579
GO:0009579;thylakoid;2967870;2720;GO:0009579
GO:0034529;2-hydroxy-3-carboxy-benzalpyruvate hydratase-aldolase activity;0;2;GO:0006067
GO:0034528;2-carboxy-2-hydroxy-8-carboxychromene isomerase activity;0;3;GO:0006073
GO:0010559;regulation of glycoprotein biosynthetic process;1887;135;GO:0010467
GO:0010556;regulation of macromolecule biosynthetic process;28214994;2560;GO:0009891
GO:0034523;3-formylsalicylate oxidase activity;0;2;GO:0004091
GO:0010555;response to mannitol;152;91;GO:0009416
GO:0034522;cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity;0;4;GO:0004073
GO:0010558;negative regulation of macromolecule biosynthetic process;2645664;1930;GO:0045944
GO:0034521;1-naphthoic acid dioxygenase activity;0;3;GO:0004497
GO:0010557;positive regulation of macromolecule biosynthetic process;1262812;3040;GO:0045944
GO:0034520;2-naphthaldehyde dehydrogenase activity;0;4;GO:0004073
GO:0034527;1,2-dihydroxy-8-carboxynaphthalene dioxygenase activity;0;1;GO:0004497
GO:0034526;2-methylnaphthalene hydroxylase activity;0;2;GO:0046395
GO:0034525;1-naphthaldehyde dehydrogenase activity;0;1;GO:0004073
GO:0034524;2-hydroxyisophthalate decarboxylase activity;0;3;GO:0006067
GO:0009581;detection of external stimulus;102590;584;GO:0007600
GO:0010570;regulation of filamentous growth;1209;150;GO:0032989
GO:0010572;positive regulation of platelet activation;427;237;GO:0050817
GO:0010571;positive regulation of nuclear cell cycle DNA replication;369;106;GO:0000086
GO:0009585;red, far-red light phototransduction;2004;224;GO:0009579
GO:0009584;detection of visible light;26750;928;GO:0009579
GO:0009583;detection of light stimulus;98046;1020;GO:0009583
GO:0009582;detection of abiotic stimulus;102546;483;GO:0009628
GO:0009589;detection of UV;296;22;GO:0009579
GO:0009588;UV-A, blue light phototransduction;3;8;GO:0009579
GO:0034518;RNA cap binding complex;12929;308;GO:0003723
GO:0034517;ribophagy;157;17;GO:0006914
GO:0010567;regulation of ketone catabolic process;0;1;GO:0046395
GO:0034512;box C/D RNA binding;108;4;GO:0003735
GO:0010566;regulation of ketone biosynthetic process;7589;41;GO:0046395
GO:0034511;U3 snoRNA binding;5127;63;GO:0005840
GO:0010569;regulation of double-strand break repair via homologous recombination;7573;1290;GO:0006281
GO:0034510;centromere separation;0;3;GO:0000786
GO:0010568;regulation of budding cell apical bud growth;20;5;GO:0048285
GO:0010563;negative regulation of phosphorus metabolic process;69227;523;GO:0045735
GO:0034516;response to vitamin B6;114;8;GO:0009765
GO:0010562;positive regulation of phosphorus metabolic process;34395;1020;GO:0045735
GO:0034515;proteasome storage granule;2095;49;GO:0005840
GO:0010565;regulation of cellular ketone metabolic process;41905;1190;GO:0045735
GO:0034514;mitochondrial unfolded protein response;263;45;GO:0006986
GO:0010564;regulation of cell cycle process;183896;3680;GO:0051726
GO:0034513;box H/ACA snoRNA binding;513;319;GO:0003723
GO:0034592;synaptic vesicle lumen;6;5;GO:0005768
GO:0034591;rhoptry lumen;2;4;GO:0005764
GO:0034590;L-hydroxyproline transmembrane transporter activity;56;8;GO:0005525
GO:0034596;phosphatidylinositol phosphate 4-phosphatase activity;13693;22;GO:0004721
GO:0034595;phosphatidylinositol phosphate 5-phosphatase activity;16021;367;GO:0004721
GO:0034594;phosphatidylinositol trisphosphate phosphatase activity;6939;271;GO:0004721
GO:0034593;phosphatidylinositol bisphosphate phosphatase activity;33290;10;GO:0004721
GO:0046578;regulation of Ras protein signal transduction;61888;1690;GO:0007165
GO:0046579;positive regulation of Ras protein signal transduction;5216;930;GO:0007165
GO:0046576;rhamnogalacturonan alpha-L-rhamnopyranosyl-(1->4)-alpha-D-galactopyranosyluronide lyase activity;15;0;GO:0004553
GO:0046577;long-chain-alcohol oxidase activity;6181;20;GO:0004601
GO:0046581;intercellular canaliculus;261;275;GO:0009986
GO:1900407;regulation of cellular response to oxidative stress;1066;166;GO:0034599
GO:1900409;positive regulation of cellular response to oxidative stress;18;7;GO:0046686
GO:0046580;negative regulation of Ras protein signal transduction;6167;939;GO:0030528
GO:1900408;negative regulation of cellular response to oxidative stress;240;54;GO:0042542
GO:0046585;enniatin biosynthetic process;3;2;GO:0046395
GO:0046586;regulation of calcium-dependent cell-cell adhesion;95;77;GO:0007156
GO:0046583;monoatomic cation efflux transmembrane transporter activity;154;4;GO:0008565
GO:0046584;enniatin metabolic process;3;3;GO:0006749
GO:0095500;acetylcholine receptor signaling pathway;23661;436;GO:0007186
GO:0034589;hydroxyproline transport;116;6;GO:0006865
GO:0071535;RING-like zinc finger domain binding;153;98;GO:0005515
GO:0034587;piRNA processing;1392;10;GO:0000786
GO:0071532;ankyrin repeat binding;345;356;GO:0005515
GO:0034586;21U-RNA catabolic process;0;0;GO:0010467
GO:0071539;protein localization to centrosome;6804;465;GO:0005813
GO:0034581;4-methyloct-2-enoyl-CoA hydratase activity;0;2;GO:0004467
GO:0034580;4-methyloctanoyl-CoA dehydrogenase activity;0;3;GO:0004073
GO:0071529;cementum mineralization;136;34;GO:0008544
GO:0034585;21U-RNA metabolic process;9;3;GO:0010467
GO:0034584;piRNA binding;516;168;GO:0003729
GO:0034583;21U-RNA binding;4;4;GO:0003735
GO:0034582;3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity;0;4;GO:0004091
GO:0046589;ribonuclease T1 activity;381;3;GO:0004518
GO:1900421;positive regulation of cellular alcohol catabolic process;0;1;GO:0046356
GO:1900420;negative regulation of cellular alcohol catabolic process;0;1;GO:0046395
GO:0046587;positive regulation of calcium-dependent cell-cell adhesion;52;5;GO:0048608
GO:0046588;negative regulation of calcium-dependent cell-cell adhesion;43;6;GO:0048608
GO:1900425;negative regulation of defense response to bacterium;770;129;GO:0050832
GO:1900424;regulation of defense response to bacterium;2430;133;GO:0050832
GO:1900426;positive regulation of defense response to bacterium;1429;141;GO:0042742
GO:0046592;polyamine oxidase activity;1640;48;GO:0004723
GO:0046593;mandelonitrile lyase activity;465;7;GO:0004553
GO:1900419;regulation of cellular alcohol catabolic process;2;1;GO:0046395
GO:0046596;regulation of viral entry into host cell;2011;316;GO:0016032
GO:0046597;negative regulation of viral entry into host cell;1007;579;GO:0016032
GO:0071520;actomyosin contractile ring assembly actin filament bundle convergence;39;3;GO:0005912
GO:0046594;maintenance of pole plasm mRNA location;2;7;GO:0048706
GO:0046595;establishment of pole plasm mRNA localization;1;3;GO:0048305
GO:0034578;limonene 8-hydratase activity;0;3;GO:0004497
GO:0034577;N-isopropylacetaniline monooxygenase activity;0;3;GO:0004497
GO:0071524;pyrrolysine biosynthetic process;579;6;GO:0009065
GO:0034576;N-isopropylacetanilide amidohydrolase activity;0;1;GO:0004730
GO:0071521;Cdc42 GTPase complex;51;6;GO:0005925
GO:0034575;4-isopropylaniline dehydrogenase activity;0;3;GO:0004073
GO:0071522;ureidoglycine aminohydrolase activity;7382;6;GO:0004721
GO:0071527;semaphorin-plexin signaling pathway involved in outflow tract morphogenesis;0;3;GO:0048608
GO:0071528;tRNA re-export from nucleus;7740;25;GO:0006413
GO:0071525;pyrrolysine metabolic process;579;2;GO:0009065
GO:0034579;(1-methylpentyl)succinate synthase activity;0;1;GO:0006081
GO:0071526;semaphorin-plexin signaling pathway;47611;1740;GO:0007186
GO:0034570;hydroxymonomethylisoproturon dimethylaminedehydrogenase activity;0;3;GO:0004497
GO:0034574;didemethylisoproturon dehydrogenase activity;0;3;GO:0004497
GO:0034573;didemethylisoproturon amidohydrolase activity;0;2;GO:0004497
GO:0034572;monodemethylisoproturon dimethylaminedehydrogenase activity;0;3;GO:0004497
GO:1900430;positive regulation of filamentous growth of a population of unicellular organisms;748;3;GO:0048285
GO:0034571;4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity;0;0;GO:0004497
GO:1900432;negative regulation of filamentous growth of a population of unicellular organisms in response to heat;3;2;GO:0048285
GO:1900431;regulation of filamentous growth of a population of unicellular organisms in response to heat;9;1;GO:0048285
GO:0046598;positive regulation of viral entry into host cell;647;218;GO:0016032
GO:1900434;regulation of filamentous growth of a population of unicellular organisms in response to starvation;100;2;GO:0046395
GO:0046599;regulation of centriole replication;3561;1430;GO:0048285
GO:1900433;positive regulation of filamentous growth of a population of unicellular organisms in response to heat;6;3;GO:0046364
GO:1900436;positive regulation of filamentous growth of a population of unicellular organisms in response to starvation;99;7;GO:0046395
GO:1900438;negative regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus;3;0;GO:0046364
GO:1900437;regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus;22;2;GO:0048285
GO:1900429;negative regulation of filamentous growth of a population of unicellular organisms;95;1;GO:0048285
GO:1900428;regulation of filamentous growth of a population of unicellular organisms;1073;2;GO:0048285
GO:0071553;G protein-coupled pyrimidinergic nucleotide receptor activity;282;7;GO:0004930
GO:0071550;death-inducing signaling complex assembly;104;103;GO:0008313
GO:0071551;RIP homotypic interaction motif binding;0;1;GO:0048285
GO:0034567;chromate reductase activity;3;4;GO:0004067
GO:0010599;lsiRNA processing;20;2;GO:0006364
GO:0071557;histone H3-K27 demethylation;14;136;GO:0045944
GO:0034565;1-nitro-1,2-dihydro-1,3,5-triazine hydrolase activity;0;4;GO:0004721
GO:0071554;cell wall organization or biogenesis;3743966;2650;GO:0071555
GO:0034564;4,4'-dihydroxy-alpha-methylstilbene dioxygenase activity;0;1;GO:0004497
GO:0071555;cell wall organization;1227392;4690;GO:0071555
GO:0010596;negative regulation of endothelial cell migration;3234;709;GO:0050727
GO:0010595;positive regulation of endothelial cell migration;7328;2060;GO:0016477
GO:0010598;NAD(P)H dehydrogenase complex (plastoquinone);1714;37;GO:0005746
GO:0034569;monodemethylisoproturon dehydrogenase activity;0;3;GO:0004497
GO:0071558;histone H3K27me2/H3K27me3 demethylase activity;621;9;GO:0016569
GO:0010597;green leaf volatile biosynthetic process;4101;10;GO:0046274
GO:0034568;isoproturon dimethylaminedehydrogenase activity;0;2;GO:0004497
GO:0071559;response to transforming growth factor beta;27585;929;GO:0030518
GO:0034563;2,3-bis(4-hydroxyphenyl)-1,2-propanediol dioxygenase activity;0;0;GO:0004497
GO:0034562;2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity;0;0;GO:0046395
GO:0034561;1,2-bis(4-hydroxyphenyl)-2-proponol dehydratase activity;0;0;GO:0004091
GO:1900441;negative regulation of filamentous growth of a population of unicellular organisms in response to neutral pH;1;0;GO:0046364
GO:0034560;bisphenol A hydroxylase A activity;0;4;GO:0004497
GO:1900440;regulation of filamentous growth of a population of unicellular organisms in response to neutral pH;22;0;GO:0046332
GO:1900443;regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus;295;3;GO:0046332
GO:1900442;positive regulation of filamentous growth of a population of unicellular organisms in response to neutral pH;21;4;GO:0046332
GO:1900445;positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus;279;7;GO:0046332
GO:1900444;negative regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus;3;0;GO:0046274
GO:1900447;regulation of cell morphogenesis involved in phenotypic switching;0;0;GO:0010789
GO:1900449;regulation of glutamate receptor signaling pathway;1588;2480;GO:0048169
GO:1900439;positive regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus;18;7;GO:0046332
GO:0071541;eukaryotic translation initiation factor 3 complex, eIF3m;3678;94;GO:0005840
GO:0071542;dopaminergic neuron differentiation;2527;1020;GO:0048699
GO:0071540;eukaryotic translation initiation factor 3 complex, eIF3e;3825;7;GO:0005840
GO:0034556;nitrobenzoate nitroreductase activity;1;2;GO:0004746
GO:0071545;inositol phosphate catabolic process;133;393;GO:0006559
GO:0034555;3,3'-dibromobisphenol A reductive dehalogenase activity;0;0;GO:0004497
GO:0071546;pi-body;365;271;GO:0022627
GO:0034554;3,3',5-tribromobisphenol A reductive dehalogenase activity;0;3;GO:0004497
GO:0071543;diphosphoinositol polyphosphate metabolic process;144;50;GO:0006631
GO:0034553;mitochondrial respiratory chain complex II assembly;6657;45;GO:0005746
GO:0071544;diphosphoinositol polyphosphate catabolic process;58;7;GO:0006631
GO:0071549;cellular response to dexamethasone stimulus;812;746;GO:0045727
GO:0034559;bisphenol A hydroxylase B activity;0;2;GO:0046395
GO:0034558;technetium (VII) reductase activity;0;2;GO:0008033
GO:0071547;piP-body;188;29;GO:0005829
GO:0034557;2-hydroxylaminobenzoate reductase activity;0;3;GO:0004067
GO:0071548;response to dexamethasone;1012;214;GO:0032496
GO:0046534;positive regulation of photoreceptor cell differentiation;70;24;GO:0048661
GO:0046535;detection of chemical stimulus involved in sensory perception of umami taste;0;1;GO:0009991
GO:0046532;regulation of photoreceptor cell differentiation;1429;8;GO:0048661
GO:0046533;negative regulation of photoreceptor cell differentiation;540;318;GO:0048661
GO:0046538;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity;42805;53;GO:0006099
GO:0046539;histamine N-methyltransferase activity;302;10;GO:0010468
GO:0046536;dosage compensation complex;110;9;GO:0005840
GO:0046537;2,3-bisphosphoglycerate-independent phosphoglycerate mutase activity;67582;75;GO:0006099
GO:0046541;saliva secretion;1294;87;GO:0007599
GO:0046540;U4/U6 x U5 tri-snRNP complex;177236;1000;GO:0005576
GO:0046545;development of primary female sexual characteristics;8010;295;GO:0007548
GO:0046546;development of primary male sexual characteristics;7664;266;GO:0030534
GO:0046543;development of secondary female sexual characteristics;281;97;GO:0048608
GO:0046544;development of secondary male sexual characteristics;104;14;GO:0030534
GO:0046549;retinal cone cell development;741;1050;GO:0048699
GO:0046547;trans-aconitate 3-methyltransferase activity;14;5;GO:0006081
GO:0046548;retinal rod cell development;532;539;GO:0048699
GO:0046552;photoreceptor cell fate commitment;1495;98;GO:0048608
GO:0046553;D-malate dehydrogenase (decarboxylating) activity;10755;4;GO:0003824
GO:0046551;retinal cone cell fate commitment;120;2;GO:0048608
GO:0071518;autoinducer-2 kinase activity;2946;5;GO:0004725
GO:0071519;actomyosin contractile ring actin filament bundle assembly;0;1;GO:0005930
GO:0046556;alpha-L-arabinofuranosidase activity;43217;521;GO:0004553
GO:0046557;glucan endo-1,6-beta-glucosidase activity;134;3;GO:0004553
GO:0046554;malate dehydrogenase (NADP+) activity;963;0;GO:0004073
GO:0046555;acetylxylan esterase activity;893;5;GO:0004553
GO:0046558;arabinan endo-1,5-alpha-L-arabinosidase activity;6272;9;GO:0004553
GO:0046559;alpha-glucuronidase activity;7515;8;GO:0004553
GO:0046563;methanol oxidase activity;0;1;GO:0004497
GO:0046564;oxalate decarboxylase activity;453;19;GO:0006067
GO:0046562;glucose oxidase activity;42;4;GO:0004601
GO:0071513;phosphopantothenoylcysteine decarboxylase complex;216;6;GO:0005737
GO:0071514;genomic imprinting;644;67;GO:0002034
GO:0071515;mating-type locus imprinting;42;2;GO:0007049
GO:0071507;pheromone response MAPK cascade;119;8;GO:0007165
GO:0046567;aphidicolan-16 beta-ol synthase activity;4;2;GO:0004497
GO:0046568;3-methylbutanol:NAD(P) oxidoreductase activity;2;4;GO:0004089
GO:0046565;3-dehydroshikimate dehydratase activity;12582;5;GO:0006099
GO:0046566;DOPA dioxygenase activity;3;4;GO:0004497
GO:0046569;glyoxal oxidase activity;0;1;GO:0004067
GO:0046570;methylthioribulose 1-phosphate dehydratase activity;19196;10;GO:0006067
GO:0046571;aspartate-2-keto-4-methylthiobutyrate transaminase activity;0;1;GO:0004089
GO:0046574;glycuronidase activity;0;0;GO:0004553
GO:0046575;rhamnogalacturonan acetylesterase activity;4;1;GO:0004553
GO:0046572;versicolorin B synthase activity;7;3;GO:0004497
GO:0046573;lactonohydrolase activity;1351;18;GO:0016829
GO:0071501;cellular response to sterol depletion;8100;149;GO:0006629
GO:0034599;cellular response to oxidative stress;477885;7150;GO:0006979
GO:0071502;cellular response to temperature stimulus;255;27;GO:0009628
GO:0034598;phosphothreonine lyase activity;0;2;GO:0004721
GO:0034597;phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;4840;34;GO:0004721
GO:0071500;cellular response to nitrosative stress;382;72;GO:0006979
GO:0071505;response to mycophenolic acid;13;7;GO:0046686
GO:0071506;cellular response to mycophenolic acid;13;23;GO:0046686
GO:0071503;response to heparin;251;102;GO:0002879
GO:0071504;cellular response to heparin;170;318;GO:0002576
GO:0140360;cyclic-GMP-AMP transmembrane transporter activity;231;6;GO:0005026
GO:0140361;cyclic-GMP-AMP transmembrane import across plasma membrane;418;3;GO:0008565
GO:0140359;ABC-type transporter activity;1499983;1080;GO:0005215
GO:0140355;cargo receptor ligand activity;104;4;GO:0004872
GO:0140357;heme export from vacuole to cytoplasm;1;1;GO:0006835
GO:0140358;P-type transmembrane transporter activity;316281;9;GO:0005215
GO:0140351;glycosylceramide flippase activity;176;3;GO:0005576
GO:0140352;export from cell;1041437;141;GO:0009986
GO:0140353;lipid export from cell;2153;8;GO:0006629
GO:0140354;lipid import into cell;1507;19;GO:0006869
GO:0140348;lysophosphatidylcholine flippase activity;55;2;GO:0005525
GO:0140344;triglyceride transfer activity;135;1;GO:0003676
GO:0140345;phosphatidylcholine flippase activity;300;6;GO:0005525
GO:0140346;phosphatidylserine flippase activity;914;8;GO:0005525
GO:0140347;N-retinylidene-phosphatidylethanolamine flippase activity;52;2;GO:0003676
GO:0140340;cerebroside transfer activity;59;2;GO:0004867
GO:0140341;phosphatidylethanolamine floppase activity;4;1;GO:0005525
GO:0140343;phosphatidylserine transfer activity;109;0;GO:0008033
GO:0140380;psilocybin biosynthetic process;8;2;GO:0046356
GO:0140381;4-hydroxytryptamine 4-phosphate methyltransferase activity;3;2;GO:0004725
GO:0140382;tryptamine 4-monooxygenase activity;5;3;GO:0004497
GO:0140383;4-hydroxytryptamine kinase activity;5;2;GO:0004713
GO:0140374;antiviral innate immune response;2458;408;GO:0009615
GO:0140375;immune receptor activity;61968;147;GO:0004872
GO:0140376;innate immune receptor activity;2;1;GO:0004872
GO:0140366;galectin lattice;0;0;GO:0005576
GO:0140367;antibacterial innate immune response;213;5;GO:0002237
GO:0140368;decoy receptor complex;0;2;GO:0030198
GO:0140363;TIS granule;0;1;GO:0005829
GO:0140364;GW body;0;1;GO:0005829
GO:0140365;RNP body;0;1;GO:0005840
GO:0140399;aflatoxin B synthase activity;8;2;GO:0004497
GO:0140395;averantin hydroxylase activity;5;2;GO:0046395
GO:0140396;5'-hydroxyaverantin dehydrogenase activity;7;0;GO:0004091
GO:0140397;versiconal hemiacetal acetate esterase activity;5;3;GO:0004445
GO:0140398;versicolorin B desaturase activity;4;1;GO:0004734
GO:0140393;norsolorinic acid ketoreductase activity;6;2;GO:0006073
GO:0140394;ABC-type azole transporter activity;3127;2;GO:0005215
GO:0007502;digestive tract mesoderm development;111;10;GO:0007530
GO:0007503;fat body development;110;10;GO:0009952
GO:0007500;mesodermal cell fate determination;81;319;GO:0009952
GO:0007501;mesodermal cell fate specification;1071;129;GO:0009952
GO:0140384;metacyclogenesis;0;1;GO:0048608
GO:0019517;L-threonine catabolic process to D-lactate;0;3;GO:0009065
GO:0019516;lactate oxidation;29039;242;GO:0006096
GO:0019519;pentitol metabolic process;120;2;GO:0006096
GO:0019518;L-threonine catabolic process to glycine;30946;263;GO:0009065
GO:0007531;mating type determination;3593;9;GO:0007165
GO:0007532;regulation of mating-type specific transcription, DNA-templated;1601;4;GO:0010468
GO:0007530;sex determination;6463;1100;GO:0007548
GO:0007535;donor selection;41;7;GO:0008629
GO:0007536;activation of recombination (HML);0;2;GO:0000976
GO:0007533;mating type switching;399;62;GO:0048285
GO:0007534;gene conversion at mating-type locus;137;54;GO:0007049
GO:0007528;neuromuscular junction development;5792;2210;GO:0007517
GO:0007529;establishment of synaptic specificity at neuromuscular junction;84;123;GO:0008092
GO:0007526;larval somatic muscle development;495;87;GO:0007517
GO:0007527;adult somatic muscle development;147;22;GO:0007517
GO:0019520;aldonic acid metabolic process;95878;26;GO:0006066
GO:0019522;ketogluconate metabolic process;1;1;GO:0006073
GO:0019521;D-gluconate metabolic process;70572;208;GO:0006066
GO:0019524;keto-D-gluconate catabolic process;0;1;GO:0006067
GO:0019523;L-idonate metabolic process;9;4;GO:0006066
GO:0019526;pentitol biosynthetic process;0;2;GO:0006021
GO:0019525;keto-D-gluconate metabolic process;0;1;GO:0006096
GO:0019506;phenylmercury acetate catabolic process;0;2;GO:0046274
GO:0019505;resorcinol metabolic process;5;2;GO:0006725
GO:0019508;2,5-dihydroxypyridine catabolic process to fumarate;0;3;GO:0009062
GO:0019507;pyridine metabolic process;0;3;GO:0006749
GO:0019509;L-methionine salvage from methylthioadenosine;110634;871;GO:0009065
GO:0007542;primary sex determination, germ-line;161;5;GO:0007548
GO:0007543;sex determination, somatic-gonadal interaction;0;2;GO:0007548
GO:0007540;sex determination, establishment of X:A ratio;20;9;GO:0007548
GO:0007541;sex determination, primary response to X:A ratio;4;4;GO:0009952
GO:0007546;somatic processes downstream of sex determination signal;0;2;GO:0009952
GO:0007547;germ-line processes downstream of sex determination signal;0;3;GO:0007049
GO:0007545;processes downstream of sex determination signal;0;1;GO:0048608
GO:0007539;primary sex determination, soma;36;2;GO:0007548
GO:0007537;inactivation of recombination (HML);0;2;GO:0007067
GO:0007538;primary sex determination;277;176;GO:0007548
GO:0019511;peptidyl-proline hydroxylation;58;942;GO:0006457
GO:0019510;S-adenosylhomocysteine catabolic process;94;73;GO:0006519
GO:0019513;lactose catabolic process, using glucoside 3-dehydrogenase;0;7;GO:0006066
GO:0019512;lactose catabolic process via tagatose-6-phosphate;9305;102;GO:0006066
GO:0019515;lactose catabolic process via UDP-galactose;0;9;GO:0006066
GO:0007510;cardioblast cell fate determination;24;9;GO:0048699
GO:0007512;adult heart development;844;759;GO:0007517
GO:0007506;gonadal mesoderm development;758;674;GO:0007530
GO:0007507;heart development;91099;9890;GO:0007507
GO:0007504;larval fat body development;58;2;GO:0007566
GO:0007505;adult fat body development;28;1;GO:0007565
GO:0007508;larval heart development;104;8;GO:0007565
GO:0007509;mesoderm migration involved in gastrulation;228;36;GO:0007533
GO:0019500;cyanide catabolic process;852;7;GO:0006066
GO:0019502;L-proline betaine metabolic process;1;2;GO:0006570
GO:0019501;arsonoacetate catabolic process;0;2;GO:0009062
GO:0019504;L-proline betaine catabolic process;1;0;GO:0006559
GO:0019503;L-proline betaine biosynthetic process;0;0;GO:0009065
GO:0044506;modulation of glucagon-like peptide receptor 1 activity in another organism;0;0;GO:0004930
GO:0044505;positive regulation of G protein-coupled receptor activity in another organism;1;3;GO:0004930
GO:0044508;glucagon-like peptide 1 receptor activity;66;3;GO:0004930
GO:0044507;positive regulation of receptor activity in another organism;1;1;GO:0048407
GO:0044509;envenomation resulting in modulation of signal transduction in another organism;0;0;GO:0009967
GO:0007520;myoblast fusion;3365;1070;GO:0048471
GO:0007521;muscle cell fate determination;148;129;GO:0048667
GO:0044500;envenomation resulting in negative regulation of blood pressure in another organism;1;0;GO:0048608
GO:0007524;adult visceral muscle development;0;2;GO:0007517
GO:0007525;somatic muscle development;1157;295;GO:0007517
GO:0044501;perturbation of signal transduction in another organism;178026;2;GO:0007165
GO:0007522;visceral muscle development;229;39;GO:0048731
GO:0044504;modulation of receptor activity in another organism;13;2;GO:0004872
GO:0007523;larval visceral muscle development;124;25;GO:0007530
GO:0044503;modulation of G protein-coupled receptor activity in another organism;2;0;GO:0004930
GO:0007517;muscle organ development;41711;4210;GO:0007517
GO:0007518;myoblast fate determination;69;23;GO:0048667
GO:0007516;hemocyte development;54;9;GO:0002541
GO:0007519;skeletal muscle tissue development;13031;2810;GO:0001501
GO:0032528;microvillus organization;1271;28;GO:0032559
GO:0032529;follicle cell microvillus organization;54;4;GO:0030198
GO:0032526;response to retinoic acid;4416;1560;GO:0030522
GO:0032527;protein exit from endoplasmic reticulum;3992;144;GO:0006464
GO:0019560;histidine catabolic process to hydantoin-5-propionate;0;3;GO:0009065
GO:0019561;anaerobic phenylalanine oxidation;0;3;GO:0009065
GO:0019564;aerobic glycerol catabolic process;4;2;GO:0006099
GO:0019563;glycerol catabolic process;49162;145;GO:0006073
GO:0019566;arabinose metabolic process;90871;69;GO:0006073
GO:0019568;arabinose catabolic process;56804;76;GO:0006073
GO:0019567;arabinose biosynthetic process;9;5;GO:0006073
GO:0032525;somite rostral/caudal axis specification;498;1050;GO:0002041
GO:0019569;L-arabinose catabolic process to xylulose 5-phosphate;34578;43;GO:0006066
GO:0032523;silicon efflux transmembrane transporter activity;0;2;GO:0008565
GO:0019549;glutamate catabolic process to succinate via succinate semialdehyde;0;3;GO:0009062
GO:0007586;digestion;12371;3220;GO:0007586
GO:0007584;response to nutrient;6802;3840;GO:0009719
GO:0007585;respiratory gaseous exchange by respiratory system;4676;33;GO:0009072
GO:0007588;excretion;1818;1460;GO:0007586
GO:0007589;body fluid secretion;5535;766;GO:0007596
GO:0032517;SOD1-calcineurin complex;0;1;GO:0005576
GO:0032515;negative regulation of phosphoprotein phosphatase activity;83;582;GO:0010468
GO:0032516;positive regulation of phosphoprotein phosphatase activity;46;886;GO:0010468
GO:0019551;glutamate catabolic process to 2-oxoglutarate;18410;46;GO:0006541
GO:0019550;glutamate catabolic process to aspartate;92;25;GO:0006541
GO:0019553;glutamate catabolic process via L-citramalate;3299;3;GO:0006569
GO:0019552;glutamate catabolic process via 2-hydroxyglutarate;11;2;GO:0006541
GO:0032510;endosome to lysosome transport via multivesicular body sorting pathway;445;177;GO:0006906
GO:0019555;glutamate catabolic process to ornithine;0;5;GO:0006541
GO:0019554;glutamate catabolic process to oxaloacetate;0;5;GO:0006541
GO:0019557;histidine catabolic process to glutamate and formate;69670;86;GO:0006559
GO:0019556;histidine catabolic process to glutamate and formamide;100080;118;GO:0006559
GO:0019559;histidine catabolic process to imidazol-5-yl-lactate;0;1;GO:0009065
GO:0032511;late endosome to vacuole transport via multivesicular body sorting pathway;16788;90;GO:0006897
GO:0019558;histidine catabolic process to 2-oxoglutarate;2;3;GO:0006559
GO:0019539;hydroxymate-containing siderophore biosynthetic process;42;0;GO:0046395
GO:0019538;protein metabolic process;42914114;7380;GO:0006412
GO:0007553;regulation of ecdysteroid metabolic process;73;3;GO:0010468
GO:0007554;regulation of ecdysteroid biosynthetic process;60;2;GO:0010468
GO:0007552;metamorphosis;8684;244;GO:0048608
GO:0007557;regulation of juvenile hormone biosynthetic process;10;2;GO:0030518
GO:0007558;regulation of juvenile hormone secretion;0;2;GO:0048608
GO:0007555;regulation of ecdysteroid secretion;14;2;GO:0048608
GO:0007556;regulation of juvenile hormone metabolic process;22;3;GO:0010468
GO:0032506;cytokinetic process;387783;837;GO:0042592
GO:0032507;maintenance of protein location in cell;16774;687;GO:0048471
GO:0007548;sex differentiation;27820;2040;GO:0007548
GO:0032504;multicellular organism reproduction;134045;2950;GO:0007275
GO:0007549;sex-chromosome dosage compensation;1766;6;GO:0007049
GO:0032505;reproduction of a single-celled organism;186581;502;GO:0044770
GO:0019540;catechol-containing siderophore biosynthetic process;21569;0;GO:0046395
GO:0032508;DNA duplex unwinding;1727237;3680;GO:0003674
GO:0032509;endosome transport via multivesicular body sorting pathway;25269;407;GO:0006897
GO:0019542;propionate biosynthetic process;13;10;GO:0006091
GO:0019541;propionate metabolic process;45899;201;GO:0006091
GO:0019544;arginine catabolic process to glutamate;23057;23;GO:0006541
GO:0019543;propionate catabolic process;28897;9;GO:0006066
GO:0019546;arginine deiminase pathway;239;99;GO:0006066
GO:0032502;developmental process;4453665;20100;GO:0032502
GO:0019545;arginine catabolic process to succinate;22427;8;GO:0009062
GO:0019548;arginine catabolic process to spermine;0;2;GO:0009062
GO:0032500;muramyl dipeptide binding;129;27;GO:0005576
GO:0019547;arginine catabolic process to ornithine;9260;171;GO:0006542
GO:0032501;multicellular organismal process;3336259;15700;GO:0032501
GO:0019528;D-arabitol catabolic process to xylulose 5-phosphate;1;2;GO:0006067
GO:0019527;pentitol catabolic process;59;2;GO:0006032
GO:0019529;taurine catabolic process;2450;5;GO:0006559
GO:0007560;imaginal disc morphogenesis;7414;36;GO:0048608
GO:0007561;imaginal disc eversion;67;9;GO:0002076
GO:0007564;regulation of chitin-based cuticle tanning;36;2;GO:0048305
GO:0007565;female pregnancy;5804;3570;GO:0007565
GO:0007562;eclosion;173;15;GO:0007548
GO:0007563;regulation of eclosion;51;6;GO:0050789
GO:0007566;embryo implantation;2143;1570;GO:0007565
GO:0007567;parturition;369;537;GO:0048609
GO:0019531;oxalate transmembrane transporter activity;2755;222;GO:0005215
GO:0019530;taurine metabolic process;5791;226;GO:0006541
GO:0019533;cellobiose transport;0;4;GO:0006865
GO:0019532;oxalate transport;5626;511;GO:0006836
GO:0019535;ferric-vibriobactin transmembrane transporter activity;0;1;GO:0005525
GO:0019534;toxin transmembrane transporter activity;12100;56;GO:0005215
GO:0019537;vibriobactin biosynthetic process;5;4;GO:0046395
GO:0019536;vibriobactin metabolic process;8;5;GO:0009065
GO:0007490;tergite morphogenesis;11;7;GO:0048608
GO:0007491;sternite morphogenesis;9;2;GO:0048706
GO:0007494;midgut development;678;879;GO:0007576
GO:0032450;maltose alpha-glucosidase activity;6046;360;GO:0005975
GO:0007495;visceral mesoderm-endoderm interaction involved in midgut development;75;7;GO:0007565
GO:0032451;demethylase activity;47139;598;GO:0016567
GO:0007492;endoderm development;7091;1140;GO:0002221
GO:0007493;endodermal cell fate determination;97;30;GO:0030154
GO:0007498;mesoderm development;11775;1690;GO:0007533
GO:0007499;ectoderm and mesoderm interaction;59;67;GO:0009952
GO:0007496;anterior midgut development;30;5;GO:0007576
GO:0007497;posterior midgut development;64;144;GO:0007565
GO:0019481;L-alanine catabolic process, by transamination;146;6;GO:0006559
GO:0032449;CBM complex;329;100;GO:0044436
GO:0019480;L-alanine oxidation to pyruvate via D-alanine;3;7;GO:0006559
GO:0019483;beta-alanine biosynthetic process;2315;49;GO:0009065
GO:0019482;beta-alanine metabolic process;2383;70;GO:0006559
GO:0019485;beta-alanine catabolic process to L-alanine;0;2;GO:0009065
GO:0019484;beta-alanine catabolic process;3;4;GO:0009062
GO:0019487;anaerobic acetylene catabolic process;0;2;GO:0009062
GO:0032443;regulation of ergosterol biosynthetic process;117;9;GO:0010467
GO:0019486;beta-alanine catabolic process to mevalonate semialdehyde, by transamination;0;2;GO:0009065
GO:0032444;activin responsive factor complex;250;137;GO:0030501
GO:0019489;methylgallate metabolic process;312;5;GO:0006021
GO:0032441;pheophorbide a oxygenase activity;136;7;GO:0004497
GO:0019488;ribitol catabolic process to xylulose 5-phosphate;0;1;GO:0006032
GO:0032442;phenylcoumaran benzylic ether reductase activity;1;7;GO:0004067
GO:0032447;protein urmylation;7570;215;GO:0006469
GO:0032448;DNA hairpin binding;67;4;GO:0003676
GO:0032446;protein modification by small protein conjugation;615529;2730;GO:0016567
GO:0032440;2-alkenal reductase [NAD(P)+] activity;5030;0;GO:0004067
GO:0019470;4-hydroxyproline catabolic process;50;22;GO:0006559
GO:0032438;melanosome organization;1569;511;GO:0030198
GO:0019472;4-hydroxyproline biosynthetic process;0;4;GO:0009044
GO:0019471;4-hydroxyproline metabolic process;50;422;GO:0009044
GO:0019474;L-lysine catabolic process to acetyl-CoA;41838;19;GO:0006559
GO:0019473;L-lysine catabolic process to glutarate, by acetylation;1;2;GO:0006569
GO:0019476;D-lysine catabolic process;0;2;GO:0006559
GO:0032432;actin filament bundle;4445;906;GO:0003779
GO:0019475;L-lysine catabolic process to acetate;15;3;GO:0009062
GO:0032433;filopodium tip;2178;500;GO:0048608
GO:0019478;D-amino acid catabolic process;55770;325;GO:0009065
GO:0032430;positive regulation of phospholipase A2 activity;27;143;GO:0010467
GO:0019477;L-lysine catabolic process;46554;260;GO:0006559
GO:0032431;activation of phospholipase A2 activity;21;10;GO:0046323
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;7493;2680;GO:0016567
GO:0019479;L-alanine oxidation to D-lactate and ammonia;0;2;GO:0009066
GO:0032437;cuticular plate;330;60;GO:0009913
GO:0032434;regulation of proteasomal ubiquitin-dependent protein catabolic process;12906;1150;GO:0016567
GO:0032435;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;2005;679;GO:0016567
GO:0007472;wing disc morphogenesis;4923;42;GO:0009952
GO:0007473;wing disc proximal/distal pattern formation;19;9;GO:0048608
GO:0007470;prothoracic disc morphogenesis;0;1;GO:0048608
GO:0007476;imaginal disc-derived wing morphogenesis;4633;322;GO:0009952
GO:0007477;notum development;103;10;GO:0009952
GO:0007474;imaginal disc-derived wing vein specification;708;10;GO:0008544
GO:0007475;apposition of dorsal and ventral imaginal disc-derived wing surfaces;181;223;GO:0048608
GO:0044458;motile cilium assembly;4220;1250;GO:0007049
GO:0007478;leg disc morphogenesis;1031;7;GO:0048608
GO:0007479;leg disc proximal/distal pattern formation;147;36;GO:0009952
GO:0032429;regulation of phospholipase A2 activity;32;287;GO:0010467
GO:0032427;GBD domain binding;83;40;GO:0005515
GO:0032428;beta-N-acetylgalactosaminidase activity;30;4;GO:0004553
GO:0019461;glutamine catabolic process to fumarate, using glutamate synthase (NADPH);0;2;GO:0009065
GO:0019460;glutamine catabolic process to fumarate;0;4;GO:0006559
GO:0019463;glycine catabolic process to creatine;0;2;GO:0009065
GO:0019462;glutamine catabolic process to fumarate, using glutaminase;0;2;GO:0006541
GO:0019465;aspartate transamidation;0;4;GO:0006464
GO:0032421;stereocilium bundle;7018;186;GO:0005576
GO:0019464;glycine decarboxylation via glycine cleavage system;155927;1210;GO:0009065
GO:0032422;purine-rich negative regulatory element binding;7215;243;GO:0030528
GO:0019467;ornithine catabolic process, by decarboxylation;0;2;GO:0006569
GO:0019466;ornithine catabolic process via proline;0;2;GO:0006541
GO:0032420;stereocilium;5535;681;GO:0005576
GO:0019469;octopine catabolic process;6;1;GO:0009062
GO:0032425;positive regulation of mismatch repair;119;214;GO:0045727
GO:0019468;nopaline catabolic process;0;2;GO:0009405
GO:0032426;stereocilium tip;882;122;GO:0005576
GO:0032423;regulation of mismatch repair;175;19;GO:0006281
GO:0032424;negative regulation of mismatch repair;0;4;GO:0045727
GO:0007480;imaginal disc-derived leg morphogenesis;993;247;GO:0048608
GO:0007483;genital disc morphogenesis;257;41;GO:0048608
GO:0007484;imaginal disc-derived genitalia development;310;4;GO:0008544
GO:0007481;haltere disc morphogenesis;29;3;GO:0048706
GO:0007482;haltere development;134;8;GO:0009952
GO:0007487;analia development;38;9;GO:0007565
GO:0044465;modulation of sensory perception of pain in another organism;2;3;GO:0007600
GO:0007488;histoblast morphogenesis;188;77;GO:0048608
GO:0007485;imaginal disc-derived male genitalia development;248;195;GO:0008544
GO:0044467;glial cell-derived neurotrophic factor production;169;2;GO:0048608
GO:0007486;imaginal disc-derived female genitalia development;62;103;GO:0008544
GO:0044466;glutaryl-CoA hydrolase activity;5;3;GO:0004721
GO:0044469;envenomation resulting in positive regulation of blood coagulation in another organism;174;0;GO:0007596
GO:0044468;envenomation resulting in modulation of blood coagulation in another organism;196;0;GO:0007596
GO:0007489;maintenance of imaginal histoblast diploidy;13;4;GO:0048285
GO:0032418;lysosome localization;5648;1030;GO:0005764
GO:0032416;negative regulation of sodium:proton antiporter activity;0;10;GO:0045730
GO:0044470;envenomation resulting in negative regulation of blood coagulation in another organism;3;0;GO:0007596
GO:0032417;positive regulation of sodium:proton antiporter activity;21;31;GO:0045735
GO:0019450;L-cysteine catabolic process to pyruvate;13585;5;GO:0006559
GO:0044472;envenomation resulting in modulation of calcium channel activity in another organism;2;0;GO:0008092
GO:0044471;envenomation resulting in pore formation in membrane of another organism;0;0;GO:0048706
GO:0019452;L-cysteine catabolic process to taurine;6;4;GO:0009065
GO:0044474;envenomation resulting in negative regulation of voltage-gated calcium channel activity in another organism;2;0;GO:0008092
GO:0019451;L-cysteine catabolic process to pyruvate, using cysteine dioxygenase;1;4;GO:0009065
GO:0044473;envenomation resulting in negative regulation of calcium channel activity in another organism;2;0;GO:0008092
GO:0019454;L-cysteine catabolic process via cystine, using glutathione-cystine transhydrogenase;0;1;GO:0009065
GO:0032410;negative regulation of transporter activity;336;169;GO:0015031
GO:0019453;L-cysteine catabolic process via cystine;0;2;GO:0009065
GO:0032411;positive regulation of transporter activity;489;417;GO:0015031
GO:0019456;L-cysteine catabolic process via cystine, using cysteine transaminase;0;1;GO:0009065
GO:0019455;L-cysteine catabolic process via cystine, using cystine reductase;0;1;GO:0009065
GO:0019458;methionine catabolic process via 2-oxobutanoate;1;2;GO:0006541
GO:0032414;positive regulation of ion transmembrane transporter activity;447;223;GO:0015031
GO:0019457;methionine catabolic process to succinyl-CoA;0;3;GO:0009062
GO:0032415;regulation of sodium:proton antiporter activity;21;7;GO:0045730
GO:0032412;regulation of monoatomic ion transmembrane transporter activity;1106;6;GO:0005215
GO:0032413;negative regulation of ion transmembrane transporter activity;298;43;GO:0045730
GO:0032490;detection of molecule of bacterial origin;936;1760;GO:0009065
GO:0032491;detection of molecule of fungal origin;93;11;GO:0009617
GO:0032494;response to peptidoglycan;757;2200;GO:0009617
GO:0032495;response to muramyl dipeptide;1323;2150;GO:0045087
GO:0032492;detection of molecule of oomycetes origin;0;2;GO:0009986
GO:0032493;response to bacterial lipoprotein;739;23;GO:0046686
GO:0032487;regulation of Rap protein signal transduction;130;237;GO:0007186
GO:0032488;Cdc42 protein signal transduction;668;106;GO:0007165
GO:0032485;regulation of Ral protein signal transduction;105;64;GO:0007264
GO:0032486;Rap protein signal transduction;4633;354;GO:0007165
GO:0032489;regulation of Cdc42 protein signal transduction;400;303;GO:0007165
GO:0044407;single-species biofilm formation in or on host organism;144;8;GO:0044765
GO:0032480;negative regulation of type I interferon production;3091;933;GO:0032724
GO:0044406;adhesion of symbiont to host;1032502;1450;GO:0022610
GO:0044409;entry into host;2118123;1240;GO:0048407
GO:0032483;regulation of Rab protein signal transduction;440;342;GO:0045944
GO:0032484;Ral protein signal transduction;266;34;GO:0007224
GO:0032481;positive regulation of type I interferon production;7204;1740;GO:0032724
GO:0032482;Rab protein signal transduction;10238;729;GO:0007264
GO:0044403;biological process involved in symbiotic interaction;6061051;286;GO:0044419
GO:0032476;decaprenyl diphosphate synthase complex;13;4;GO:0009536
GO:0032477;homodimeric decaprenyl diphosphate synthase complex;0;1;GO:0009536
GO:0032474;otolith morphogenesis;634;103;GO:0048706
GO:0032475;otolith formation;143;5;GO:0008544
GO:0032478;heterotetrameric decaprenyl diphosphate synthase complex;0;1;GO:0009536
GO:0032479;regulation of type I interferon production;10656;939;GO:0032724
GO:0044418;translocation of DNA into host;1;4;GO:0006281
GO:0044417;translocation of molecules into host;392;22;GO:0006986
GO:0044419;biological process involved in interspecies interaction between organisms;7506053;1060;GO:0044419
GO:0032472;Golgi calcium ion transport;383;282;GO:0006836
GO:0032473;cytoplasmic side of mitochondrial outer membrane;150;124;GO:0005743
GO:0032470;positive regulation of endoplasmic reticulum calcium ion concentration;218;65;GO:0010467
GO:0032471;negative regulation of endoplasmic reticulum calcium ion concentration;483;1450;GO:0010467
GO:0044414;suppression of host defenses by symbiont;536361;2;GO:0050832
GO:0044416;induction by symbiont of host defense response;29;97;GO:0046686
GO:0032465;regulation of cytokinesis;16854;1200;GO:0048285
GO:0032466;negative regulation of cytokinesis;3935;359;GO:0048285
GO:0032463;negative regulation of protein homooligomerization;66;243;GO:0010468
GO:0032464;positive regulation of protein homooligomerization;73;525;GO:0042802
GO:0032469;endoplasmic reticulum calcium ion homeostasis;8579;638;GO:0006873
GO:0032467;positive regulation of cytokinesis;4434;1610;GO:0048285
GO:0032468;Golgi calcium ion homeostasis;343;145;GO:0006836
GO:0032461;positive regulation of protein oligomerization;206;427;GO:0042802
GO:0032462;regulation of protein homooligomerization;139;146;GO:0042802
GO:0032460;negative regulation of protein oligomerization;66;117;GO:0042802
GO:0044423;virion component;5612733;374;GO:0044427
GO:0019490;2-aminobenzenesulfonate desulfonation;0;0;GO:0046395
GO:0019492;proline salvage;1;2;GO:0006565
GO:0019491;ectoine biosynthetic process;36063;16;GO:0006099
GO:0019493;arginine catabolic process to proline;160;3;GO:0006569
GO:0019496;serine-isocitrate lyase pathway;3;4;GO:0006099
GO:0019495;proline catabolic process to 2-oxoglutarate;0;3;GO:0006569
GO:0019498;n-octane oxidation;0;2;GO:0046395
GO:0032454;histone H3K9 demethylase activity;18016;10;GO:0016539
GO:0019497;hexachlorocyclohexane metabolic process;1;3;GO:0046148
GO:0032455;nerve growth factor processing;0;54;GO:0008544
GO:0032452;histone demethylase activity;33666;568;GO:0016570
GO:0019499;cyanide metabolic process;863;12;GO:0006066
GO:0032453;histone H3K4 demethylase activity;8935;5;GO:0016569
GO:0032458;slow endocytic recycling;103;2;GO:0006953
GO:0032459;regulation of protein oligomerization;272;148;GO:0042802
GO:0032456;endocytic recycling;14698;1370;GO:0006897
GO:0032457;fast endocytic recycling;0;1;GO:0006914
GO:0140418;effector-mediated modulation of host process by symbiont;47;4;GO:0048646
GO:0140414;phosphopantetheine-dependent carrier activity;54327;1;GO:0004867
GO:0140415;effector-mediated modulation of host defenses by symbiont;40;1;GO:0046649
GO:0140416;transcription regulator inhibitor activity;1025;9;GO:0030528
GO:0140417;ATP-sensitive calcium-release channel activity;9;0;GO:0008092
GO:0140410;monoatomic cation:bicarbonate symporter activity;1022;9;GO:0005215
GO:0140412;zinc:bicarbonate symporter activity;62;1;GO:0006836
GO:0140413;zinc:bicarbonate:selenite symporter activity;0;0;GO:0006826
GO:0140407;L-alanine:proton antiporter activity;0;0;GO:0005215
GO:0140408;regulation of mRNA alternative polyadenylation;0;0;GO:0010467
GO:0140409;positive regulation of mRNA alternative polyadenylation;0;0;GO:0010467
GO:0140403;effector-mediated suppression of host innate immune response;24;1;GO:0045087
GO:0140404;effector-mediated perturbation of host innate immune response by symbiont;39;1;GO:0046649
GO:0140405;spindle pole body-led chromosome movement during mitotic interphase;1;2;GO:0007062
GO:0140406;L-alanine export across the plasma membrane;0;0;GO:0006836
GO:0032498;detection of muramyl dipeptide;55;134;GO:0002376
GO:0032499;detection of peptidoglycan;115;23;GO:0005576
GO:0032496;response to lipopolysaccharide;16237;7050;GO:0032496
GO:0032497;detection of lipopolysaccharide;377;42;GO:0002237
GO:0044476;envenomation resulting in negative regulation of low voltage-gated calcium channel activity in another organism;1;1;GO:0008092
GO:0044475;envenomation resulting in negative regulation of high voltage-gated calcium channel activity in another organism;1;1;GO:0008092
GO:0044478;envenomation resulting in positive regulation of platelet aggregation in another organism;8;1;GO:0048407
GO:0044477;envenomation resulting in negative regulation of platelet aggregation in another organism;13;0;GO:0048168
GO:0044479;envenomation resulting in modulation of mast cell degranulation in another organism;0;1;GO:0002541
GO:0044480;envenomation resulting in positive regulation of mast cell degranulation in another organism;0;1;GO:0002526
GO:0044483;envenomation resulting in impairment of hemostasis in another organism;192;0;GO:0007596
GO:0044482;envenomation resulting in blood vessel extracellular matrix damage, causing hemorrhagic damage in another organism;2;0;GO:0048407
GO:0044485;envenomation resulting in fibrinogenolysis in another organism;12;0;GO:0007596
GO:0140438;protein stearoylation;4;3;GO:0042302
GO:0044484;envenomation resulting in fibrinolysis in another organism;3;1;GO:0007596
GO:0140439;protein-cysteine S-stearoyltransferase activity;366;3;GO:0004073
GO:0140432;5'-hydroxyl dinucleotide hydrolase activity;29;0;GO:0004553
GO:0140433;regulation of protein localization to meiotic spindle pole body;16;0;GO:0048285
GO:0140434;positive regulation of protein localization to meiotic spindle pole body;16;2;GO:0048285
GO:0140435;negative regulation of protein localization to meiotic spindle pole body;0;0;GO:0048285
GO:0140430;positive regulation of chromosome passenger complex localization to kinetochore;0;0;GO:0048285
GO:0140431;DNA-(abasic site) binding;64;0;GO:0003676
GO:0044487;envenomation resulting in modulation of transmission of nerve impulse in another organism;2;1;GO:0008092
GO:0044486;modulation of transmission of nerve impulse in another organism;0;1;GO:0007399
GO:0044489;negative regulation of voltage-gated sodium channel activity in another organism;9;2;GO:0048169
GO:0044488;modulation of voltage-gated sodium channel activity in another organism;14;0;GO:0008092
GO:0044490;positive regulation of voltage-gated sodium channel activity in another organism;1;1;GO:0048169
GO:0140429;positive regulation of mitotic sister chromatid biorientation;181;5;GO:0048285
GO:0044492;envenomation resulting in modulation of voltage-gated sodium channel activity in another organism;15;0;GO:0008092
GO:0044491;positive regulation of molecular function in another organism;2;2;GO:0050789
GO:0044494;envenomation resulting in positive regulation of voltage-gated sodium channel activity in another organism;0;0;GO:0008092
GO:0140425;galactose import across plasma membrane;1;0;GO:0005576
GO:0044493;envenomation resulting in negative regulation of voltage-gated sodium channel activity in another organism;14;3;GO:0008092
GO:0140426;pathogen-associated molecular pattern receptor signaling pathway;20;3;GO:0002224
GO:0044496;negative regulation of blood pressure in another organism;3;0;GO:0050727
GO:0044495;modulation of blood pressure in another organism;3;0;GO:0048608
GO:0140421;endocytic heme import into cell;0;1;GO:0006865
GO:0140423;effector-mediated suppression of host pattern-triggered immunity signaling;3;0;GO:0046686
GO:0140420;heme import into cell;13;1;GO:0006865
GO:0140460;response to Gram-negative bacterium;13;1;GO:0046686
GO:0044498;envenomation resulting in modulation of blood pressure in another organism;3;0;GO:0048608
GO:0044497;positive regulation of blood pressure in another organism;0;0;GO:0050731
GO:0044499;envenomation resulting in positive regulation of blood pressure in another organism;1;0;GO:0048608
GO:0140459;response to Gram-positive bacterium;135;4;GO:0048304
GO:0140454;protein aggregate center assembly;88;1;GO:0043161
GO:0140455;cytoplasm protein quality control;353;2;GO:0007049
GO:0140456;initial meiotic spindle pole body separation;5;0;GO:0007062
GO:0140457;protein demethylase activity;33804;2;GO:0016567
GO:0140450;protein targeting to Golgi apparatus;71;2;GO:0005764
GO:0140451;counting factor complex;0;0;GO:0005737
GO:0140453;protein aggregate center;212;5;GO:0005840
GO:0140447;cytokine precursor processing;171;8;GO:0002576
GO:0140448;signaling receptor ligand precursor processing;3102;5;GO:0004872
GO:0140449;centromere-nuclear envelope anchor activity;2;4;GO:0005576
GO:0140443;mitochondrion-plasma membrane adaptor activity;1;0;GO:0005743
GO:0140444;cytoskeleton-nuclear membrane anchor activity;267;13;GO:0005576
GO:0140445;chromosome, telomeric repeat region;8348;87;GO:0000786
GO:0140446;fumigermin biosynthetic process;0;0;GO:0046395
GO:0140440;protein-cysteine S-oleoyltransferase activity;0;1;GO:0004364
GO:0140441;protein-cysteine S-arachidonoyltransferase activity;0;1;GO:0004722
GO:0140442;peroxide sensor activity;1;1;GO:0004601
GO:0140240;perforant pathway to dendrate granule cell synapse;12;1;GO:0048666
GO:0140238;presynaptic endocytosis;3380;27;GO:0006897
GO:0140239;postsynaptic endocytosis;961;9;GO:0008026
GO:0140235;RNA polyadenylation at postsynapse;4;3;GO:0008021
GO:0140236;translation at presynapse;102;6;GO:0006412
GO:0140237;translation at presynapse, modulating chemical synaptic transmission;0;1;GO:0007613
GO:0140231;anterograde axonal transport of neurotransmitter receptor complex;47;1;GO:0007411
GO:0140232;intracellular cAMP-activated cation channel activity involved in regulation of presynaptic membrane potential;42;2;GO:0008026
GO:0140233;intracellular cAMP-activated cation channel activity involved in regulation of postsynaptic membrane potential;0;2;GO:0008026
GO:0140227;serotonin-gated cation-selective signaling pathway;0;0;GO:0007218
GO:0140223;general transcription initiation factor activity;17768;54;GO:0003700
GO:0140224;SLAC complex;28;2;GO:0005576
GO:0140225;DNA topoisomerase III-beta-TDRD3 complex;63;4;GO:0042773
GO:0140226;RNA topoisomerase activity;0;1;GO:0003676
GO:0140220;pathogen-containing vacuole;977;5;GO:0005764
GO:0140221;pathogen-containing vacuole membrane;28;2;GO:0005764
GO:0140222;pathogen-containing vacuole lumen;0;2;GO:0005764
GO:0140260;mitochondrial proton-transporting ATP synthase complex binding;99;4;GO:0005739
GO:0140261;BCOR complex;52;1;GO:0005831
GO:0140262;mRNA cap binding complex binding;215;5;GO:0003723
GO:0140256;negative regulation of cellular response to phosphate starvation;0;2;GO:0045735
GO:0140259;PRC1 complex binding;10;0;GO:0048608
GO:0140252;regulation protein catabolic process at postsynapse;184;5;GO:0048608
GO:0140253;cell-cell fusion;4810;31;GO:0048193
GO:0140255;regulation of cellular response to phosphate starvation;96;2;GO:0045735
GO:0140250;regulation protein catabolic process at synapse;296;0;GO:0048608
GO:0140251;regulation protein catabolic process at presynapse;112;1;GO:0048608
GO:0140249;protein catabolic process at postsynapse;130;9;GO:0048608
GO:0140245;regulation of translation at postsynapse;157;4;GO:0045944
GO:0140246;protein catabolic process at synapse;136;1;GO:0048167
GO:0140247;protein catabolic process at presynapse;0;0;GO:0048608
GO:0140241;translation at synapse;171;5;GO:0007613
GO:0140242;translation at postsynapse;69;7;GO:0006412
GO:0140243;regulation of translation at synapse;205;3;GO:0045935
GO:0140244;regulation of translation at presynapse;20;1;GO:0045944
GO:0140281;positive regulation of mitotic division septum assembly;112;4;GO:0048285
GO:0140282;carbon-nitrogen ligase activity on lipid II;31300;4;GO:0006086
GO:0140284;endoplasmic reticulum-endosome membrane contact site;324;3;GO:0005743
GO:0140280;negative regulation of mitotic division septum assembly;13;0;GO:0048285
GO:0007612;learning;7648;4050;GO:0007612
GO:0007613;memory;6579;3070;GO:0007611
GO:0007610;behavior;77620;5820;GO:0007610
GO:0007611;learning or memory;16668;2860;GO:0007611
GO:0007605;sensory perception of sound;20659;3630;GO:0007600
GO:0007606;sensory perception of chemical stimulus;580319;1760;GO:0009410
GO:0007603;phototransduction, visible light;1540;972;GO:0009579
GO:0007604;phototransduction, UV;223;123;GO:0009579
GO:0007608;sensory perception of smell;532304;3510;GO:0007600
GO:0140278;mitotic division septum assembly;218;5;GO:0007067
GO:0140279;regulation of mitotic division septum assembly;138;1;GO:0048285
GO:0019601;toluene oxidation via 2-hydroxytoluene;0;2;GO:0046148
GO:0140274;repair of kinetochore microtubule attachment defect;272;0;GO:0007067
GO:0019600;toluene oxidation;0;0;GO:0046148
GO:0140275;MIB complex;14;6;GO:0005829
GO:0019603;toluene oxidation via 4-hydroxytoluene;0;1;GO:0046148
GO:0019602;toluene oxidation via 3-hydroxytoluene;0;2;GO:0046148
GO:0140270;gluconate import across plasma membrane;0;2;GO:0006836
GO:0140271;hexose import across plasma membrane;369;4;GO:0005975
GO:0140272;exogenous protein binding;1600;116;GO:0005515
GO:0140273;repair of mitotic kinetochore microtubule attachment defect;182;3;GO:0007067
GO:0007620;copulation;924;519;GO:0007186
GO:0007623;circadian rhythm;47436;6260;GO:0007623
GO:0007624;ultradian rhythm;3138;26;GO:0007623
GO:0007621;negative regulation of female receptivity;216;123;GO:0048608
GO:0007622;rhythmic behavior;7092;314;GO:0007623
GO:0007616;long-term memory;2350;3170;GO:0007613
GO:0007617;mating behavior;3806;1550;GO:0007626
GO:0007614;short-term memory;844;942;GO:0007611
GO:0007615;anesthesia-resistant memory;126;114;GO:0007611
GO:0007618;mating;343;549;GO:0000003
GO:0007619;courtship behavior;1208;248;GO:0007610
GO:0140267;viral entry via permeabilization of host membrane;22343;1;GO:0016032
GO:0140268;endoplasmic reticulum-plasma membrane contact site;646;5;GO:0005929
GO:0140266;Woronin body;5;1;GO:0005730
GO:0140296;general transcription initiation factor binding;40693;48;GO:0003700
GO:0140297;DNA-binding transcription factor binding;50036;909;GO:0003700
GO:0140298;endocytic iron import into cell;65;2;GO:0006897
GO:0140299;small molecule sensor activity;1936432;95;GO:0004930
GO:0140292;ADP-ribosylserine hydrolase activity;113;2;GO:0006032
GO:0140293;ADP-ribosylglutamate hydrolase activity;177;5;GO:0008033
GO:0140294;NAD DNA ADP-ribosyltransferase activity;169;2;GO:0004812
GO:0140295;pathogen-derived receptor ligand activity;2;2;GO:0004872
GO:0140290;peptidyl-serine ADP-deribosylation;9;2;GO:0006464
GO:0140291;peptidyl-glutamate ADP-deribosylation;12;6;GO:0006464
GO:0007601;visual perception;65856;5990;GO:0007600
GO:0007602;phototransduction;65985;1750;GO:0007600
GO:0007600;sensory perception;680621;2580;GO:0007600
GO:0140285;endosome fission;191;5;GO:0007036
GO:0140288;GBAF complex;28;10;GO:0005829
GO:0019638;6-hydroxycineole metabolic process;0;2;GO:0046148
GO:0019637;organophosphate metabolic process;19910959;3740;GO:0006725
GO:0019639;6-hydroxycineole catabolic process;0;2;GO:0046274
GO:0032605;hepatocyte growth factor production;62;6;GO:0048608
GO:0032606;type I interferon production;10659;433;GO:0032724
GO:0032603;fractalkine production;36;4;GO:0002504
GO:0032604;granulocyte macrophage colony-stimulating factor production;697;10;GO:0046649
GO:0032609;type II interferon production;5543;4;GO:0046649
GO:0032607;interferon-alpha production;1535;42;GO:0032724
GO:0032608;interferon-beta production;3047;329;GO:0032724
GO:0019640;glucuronate catabolic process to xylulose 5-phosphate;201;27;GO:0006073
GO:0019643;reductive tricarboxylic acid cycle;2;6;GO:0006096
GO:0019645;anaerobic electron transport chain;10153;130;GO:0009060
GO:0032601;connective tissue growth factor production;68;3;GO:0048608
GO:0032602;chemokine production;5683;316;GO:0002687
GO:0019647;formaldehyde assimilation via ribulose monophosphate cycle;1539;3;GO:0006099
GO:0019646;aerobic electron transport chain;285974;690;GO:0005746
GO:0032600;chemokine receptor transport out of membrane raft;5;8;GO:0006876
GO:0019627;urea metabolic process;132879;1580;GO:0006541
GO:0044605;phosphocholine transferase activity;2;1;GO:0004725
GO:0019626;short-chain fatty acid catabolic process;28963;131;GO:0009062
GO:0044604;ABC-type phytochelatin transporter activity;38;1;GO:0005525
GO:0019629;propionate catabolic process, 2-methylcitrate cycle;28150;44;GO:0006066
GO:0019628;urate catabolic process;17642;143;GO:0006096
GO:0044606;phosphocholine hydrolase activity;1;1;GO:0046395
GO:0044609;DBIRD complex;139;10;GO:0005840
GO:0005000;vasopressin receptor activity;6852;177;GO:0004872
GO:0005001;transmembrane receptor protein tyrosine phosphatase activity;223;1270;GO:0004872
GO:0005004;GPI-linked ephrin receptor activity;229;92;GO:0004872
GO:0044601;protein denucleotidylation;20;3;GO:0006464
GO:0005003;ephrin receptor activity;18599;1090;GO:0004872
GO:0044600;protein guanylyltransferase activity;3;3;GO:0004721
GO:0005006;epidermal growth factor receptor activity;360;595;GO:0004872
GO:0044603;protein adenylylhydrolase activity;20;2;GO:0004723
GO:0005005;transmembrane-ephrin receptor activity;426;455;GO:0004872
GO:0044602;protein deadenylylation;20;5;GO:0006470
GO:0019630;quinate metabolic process;1630;7;GO:0006073
GO:0019632;shikimate metabolic process;31059;212;GO:0006096
GO:0019631;quinate catabolic process;42;5;GO:0006073
GO:0019634;organic phosphonate metabolic process;53255;65;GO:0006073
GO:0019633;shikimate catabolic process;2;2;GO:0006099
GO:0019636;phosphonoacetate metabolic process;3;6;GO:0006081
GO:0019635;2-aminoethylphosphonate catabolic process;0;2;GO:0009081
GO:0019616;catechol catabolic process, meta-cleavage;0;2;GO:0006559
GO:0044616;modulation of relaxation of muscle in another organism;9;2;GO:0048407
GO:0019615;catechol catabolic process, ortho-cleavage;1;7;GO:0006559
GO:0044615;nuclear pore nuclear basket;875;106;GO:0005634
GO:0019618;protocatechuate catabolic process, ortho-cleavage;0;4;GO:0009061
GO:0044618;modulation of relaxation of uterine smooth muscle in another organism;1;1;GO:0048608
GO:0019617;protocatechuate catabolic process, meta-cleavage;1;3;GO:0009065
GO:0044617;modulation of relaxation of smooth muscle in another organism;1;1;GO:0048608
GO:0019619;3,4-dihydroxybenzoate catabolic process;25530;10;GO:0006066
GO:0044619;positive regulation of relaxation of uterine smooth muscle in another organism;1;1;GO:0048608
GO:0007630;jump response;68;18;GO:0048589
GO:0007631;feeding behavior;9076;3030;GO:0007586
GO:0044610;FMN transmembrane transporter activity;112;1;GO:0005215
GO:0007634;optokinetic behavior;650;40;GO:0007623
GO:0044612;nuclear pore linkers;12;4;GO:0005829
GO:0007635;chemosensory behavior;3316;963;GO:0007600
GO:0044611;nuclear pore inner ring;276;114;GO:0005829
GO:0007632;visual behavior;3158;470;GO:0007610
GO:0044614;nuclear pore cytoplasmic filaments;438;40;GO:0005929
GO:0007633;pattern orientation;7;5;GO:0003700
GO:0044613;nuclear pore central transport channel;1228;42;GO:0008511
GO:0007628;adult walking behavior;1599;2350;GO:0007626
GO:0007625;grooming behavior;760;950;GO:0007626
GO:0007626;locomotory behavior;15959;4240;GO:0007626
GO:0007629;flight behavior;204;47;GO:0007626
GO:0019621;creatinine catabolic process to formate;0;4;GO:0009065
GO:0019620;aerobic benzoate metabolic process;0;1;GO:0006099
GO:0019623;atrazine catabolic process to urea;0;2;GO:0006569
GO:0019622;3-(3-hydroxy)phenylpropionate catabolic process;1834;0;GO:0046395
GO:0019625;atrazine catabolic process to cyanuric acid;0;1;GO:0046356
GO:0019624;atrazine catabolic process to isopropylamine;1;3;GO:0009065
GO:0019605;butyrate metabolic process;10792;238;GO:0006082
GO:0044627;modulation of complement activation, classical pathway in another organism;0;0;GO:0006958
GO:0019604;toluene oxidation to catechol;0;3;GO:0046148
GO:0019607;phenylethylamine catabolic process;3;2;GO:0009065
GO:0044629;negative regulation of complement activation, classical pathway in another organism;0;0;GO:0006958
GO:0019606;2-oxobutyrate catabolic process;5;4;GO:0009065
GO:0044628;positive regulation of complement activation, classical pathway in another organism;0;0;GO:0006958
GO:0019609;3-hydroxyphenylacetate metabolic process;0;3;GO:0006081
GO:0019608;nicotine catabolic process;23;6;GO:0009062
GO:0044621;modulation of cell migration in another organism;1;1;GO:0016477
GO:0044620;ACP phosphopantetheine attachment site binding;50358;6;GO:0005525
GO:0044623;positive regulation of cell migration in another organism;0;1;GO:0016477
GO:0044622;negative regulation of cell migration in another organism;1;1;GO:0045727
GO:0007638;mechanosensory behavior;1087;2010;GO:0007626
GO:0007639;homeostasis of number of meristem cells;79;1;GO:0048608
GO:0007636;chemosensory jump behavior;17;5;GO:0007626
GO:0007637;proboscis extension reflex;83;25;GO:0007610
GO:0019610;3-hydroxyphenylacetate catabolic process;0;3;GO:0046395
GO:0019612;4-toluenecarboxylate catabolic process;0;1;GO:0009062
GO:0019611;4-toluenecarboxylate metabolic process;0;3;GO:0006099
GO:0019614;catechol-containing compound catabolic process;28958;9;GO:0006559
GO:0005031;tumor necrosis factor receptor activity;2747;808;GO:0004872
GO:0005030;neurotrophin receptor activity;3133;310;GO:0004872
GO:0005035;death receptor activity;2907;277;GO:0006915
GO:0005034;osmosensor activity;1710;17;GO:0009593
GO:0032649;regulation of type II interferon production;5536;9;GO:0046649
GO:0032647;regulation of interferon-alpha production;1535;891;GO:0032724
GO:0032648;regulation of interferon-beta production;3047;295;GO:0032724
GO:0019681;acetyl-CoA assimilation pathway;0;2;GO:0006099
GO:0019680;L-methylmalonyl-CoA biosynthetic process;0;2;GO:0006066
GO:0017020;myosin phosphatase regulator activity;111;9;GO:0005524
GO:0019683;glyceraldehyde-3-phosphate catabolic process;0;5;GO:0006066
GO:0019682;glyceraldehyde-3-phosphate metabolic process;258570;1170;GO:0006096
GO:0017022;myosin binding;17500;2070;GO:0005524
GO:0019685;photosynthesis, dark reaction;219996;105;GO:0015979
GO:0032641;lymphotoxin A production;44;14;GO:0046649
GO:0017023;myosin phosphatase complex;0;2;GO:0048608
GO:0019684;photosynthesis, light reaction;473395;2230;GO:0015979
GO:0032642;regulation of chemokine production;5677;507;GO:0050921
GO:0017024;myosin I binding;79;9;GO:0005524
GO:0019687;pyruvate biosynthetic process from acetate;0;3;GO:0006099
GO:0017025;TBP-class protein binding;32716;955;GO:0003677
GO:0019686;purine nucleoside interconversion;1;3;GO:0006749
GO:0032640;tumor necrosis factor production;8512;327;GO:0032724
GO:0019689;pyrimidine nucleoside interconversion;0;3;GO:0006793
GO:0032645;regulation of granulocyte macrophage colony-stimulating factor production;697;175;GO:0046649
GO:0019688;purine deoxyribonucleoside interconversion;0;2;GO:0006749
GO:0032646;regulation of hepatocyte growth factor production;62;6;GO:0048608
GO:0032643;regulation of connective tissue growth factor production;68;2;GO:0048608
GO:0032644;regulation of fractalkine production;36;3;GO:0050921
GO:0017008;protein-phycobiliviolin linkage;0;2;GO:0005576
GO:0017009;protein-phycocyanobilin linkage;6;8;GO:0046395
GO:0005042;netrin receptor activity;14617;70;GO:0005021
GO:0005041;low-density lipoprotein particle receptor activity;849;303;GO:0004872
GO:0005044;scavenger receptor activity;16751;2320;GO:0004896
GO:0005043;netrin receptor activity involved in chemorepulsion;52;5;GO:0008021
GO:0005046;KDEL sequence binding;177;256;GO:0005576
GO:0005048;signal sequence binding;36041;1340;GO:0003735
GO:0005047;signal recognition particle binding;8585;1190;GO:0003735
GO:0005049;nuclear export signal receptor activity;20879;759;GO:0003711
GO:0032638;interleukin-9 production;0;3;GO:0046649
GO:0032639;TRAIL production;135;7;GO:0008621
GO:0032636;interleukin-7 production;2;3;GO:0046649
GO:0032637;interleukin-8 production;3884;534;GO:0050921
GO:0019670;anaerobic glutamate catabolic process;5810;9;GO:0006067
GO:0019672;ethanol-acetate fermentation to butyrate and caproate;0;2;GO:0046394
GO:0017010;protein-phycourobilin linkage;0;3;GO:0005576
GO:0019671;glutamate catabolic process via mesaconate and citramalate;0;2;GO:0006569
GO:0017011;protein-phycoerythrobilin linkage;0;2;GO:0005576
GO:0019674;NAD metabolic process;888486;1190;GO:0006749
GO:0032630;interleukin-26 production;0;3;GO:0046649
GO:0017012;protein-phytochromobilin linkage;3;4;GO:0005576
GO:0019673;GDP-mannose metabolic process;79769;1110;GO:0006032
GO:0032631;interleukin-27 production;1;3;GO:0046503
GO:0017013;protein flavinylation;2;95;GO:0006469
GO:0019676;ammonia assimilation cycle;368;297;GO:0009064
GO:0017014;protein nitrosylation;372;8;GO:0006464
GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;9732;868;GO:0030518
GO:0019678;propionate metabolic process, methylmalonyl pathway;44;3;GO:0006091
GO:0032634;interleukin-5 production;828;9;GO:0046649
GO:0019677;NAD catabolic process;1969;14;GO:0006749
GO:0032635;interleukin-6 production;7628;650;GO:0046649
GO:0017017;MAP kinase tyrosine/serine/threonine phosphatase activity;10283;1040;GO:0004722
GO:0032632;interleukin-3 production;93;14;GO:0046649
GO:0017018;myosin phosphatase activity;99228;220;GO:0004721
GO:0019679;propionate metabolic process, methylcitrate cycle;11405;36;GO:0006091
GO:0032633;interleukin-4 production;1549;581;GO:0046649
GO:0019659;glucose catabolic process to lactate;266;7;GO:0006096
GO:0005011;macrophage colony-stimulating factor receptor activity;137;92;GO:0004872
GO:0005010;insulin-like growth factor receptor activity;69;209;GO:0004870
GO:0005017;platelet-derived growth factor receptor activity;1127;5;GO:0048407
GO:0005008;hepatocyte growth factor receptor activity;22;8;GO:0048010
GO:0032627;interleukin-23 production;470;9;GO:0046649
GO:0005007;fibroblast growth factor receptor activity;7709;728;GO:0008083
GO:0032628;interleukin-24 production;0;4;GO:0048608
GO:0032625;interleukin-21 production;14;9;GO:0046649
GO:0005009;insulin receptor activity;157;10;GO:0004872
GO:0032626;interleukin-22 production;0;4;GO:0046649
GO:0019661;glucose catabolic process to lactate via pyruvate;266;71;GO:0006096
GO:0032629;interleukin-25 production;0;3;GO:0046649
GO:0019660;glycolytic fermentation;336;8;GO:0006096
GO:0017000;antibiotic biosynthetic process;155407;396;GO:0009405
GO:0017001;antibiotic catabolic process;118274;251;GO:0046274
GO:0019662;non-glycolytic fermentation;3662;6;GO:0006091
GO:0032620;interleukin-17 production;1902;86;GO:0046649
GO:0017002;activin receptor activity;656;530;GO:0004870
GO:0019665;anaerobic amino acid catabolic process;5826;2;GO:0009062
GO:0017003;protein-heme linkage;9;28;GO:0097194
GO:0019664;mixed acid fermentation;6;4;GO:0006091
GO:0017004;cytochrome complex assembly;513683;2110;GO:0005739
GO:0019667;anaerobic L-alanine catabolic process;0;1;GO:0009065
GO:0032623;interleukin-2 production;4160;224;GO:0046649
GO:0017005;3'-tyrosyl-DNA phosphodiesterase activity;266;0;GO:0004518
GO:0019666;nitrogenous compound fermentation;5831;1;GO:0046394
GO:0032624;interleukin-20 production;0;2;GO:0046649
GO:0017006;protein-tetrapyrrole linkage;18;220;GO:0009536
GO:0019669;anaerobic glycine catabolic process;0;1;GO:0009062
GO:0032621;interleukin-18 production;248;10;GO:0046330
GO:0017007;protein-bilin linkage;9;3;GO:0009536
GO:0019668;anaerobic catabolism of pairs of amino acids;0;0;GO:0009061
GO:0032622;interleukin-19 production;0;3;GO:0046649
GO:0019649;formaldehyde assimilation;1540;2;GO:0006099
GO:0019648;formaldehyde assimilation via xylulose monophosphate cycle;0;2;GO:0006099
GO:0005020;stem cell factor receptor activity;52;27;GO:0004872
GO:0005021;vascular endothelial growth factor receptor activity;7015;1060;GO:0048010
GO:0005024;transforming growth factor beta receptor activity;3413;401;GO:0005088
GO:0005026;transforming growth factor beta receptor activity, type II;2383;50;GO:0005024
GO:0005025;transforming growth factor beta receptor activity, type I;476;438;GO:0005024
GO:0005019;platelet-derived growth factor beta-receptor activity;348;10;GO:0004813
GO:0032616;interleukin-13 production;927;40;GO:0046649
GO:0005018;platelet-derived growth factor alpha-receptor activity;772;10;GO:0004813
GO:0032614;interleukin-11 production;3;2;GO:0048608
GO:0032615;interleukin-12 production;2854;192;GO:0046649
GO:0019650;glycolytic fermentation to butanediol;0;2;GO:0006096
GO:0032618;interleukin-15 production;56;6;GO:0046330
GO:0032619;interleukin-16 production;58;1;GO:0046649
GO:0019652;lactate fermentation to propionate and acetate;1428;4;GO:0006096
GO:0019651;citrate catabolic process to diacetyl;0;2;GO:0006066
GO:0019654;acetate fermentation;5;8;GO:0006099
GO:0019653;anaerobic purine nucleobase catabolic process;0;0;GO:0009065
GO:0019656;glucose catabolic process to D-lactate and ethanol;0;3;GO:0006096
GO:0032612;interleukin-1 production;8801;186;GO:0002687
GO:0019655;glycolytic fermentation to ethanol;26;44;GO:0006096
GO:0032613;interleukin-10 production;2652;219;GO:0050727
GO:0019658;glucose fermentation to lactate and acetate;0;2;GO:0006096
GO:0032610;interleukin-1 alpha production;365;7;GO:0046653
GO:0019657;glycolytic fermentation to propionate;0;1;GO:0006096
GO:0032611;interleukin-1 beta production;4309;355;GO:0046653
GO:0032571;response to vitamin K;1259;38;GO:0009765
GO:0032572;response to menaquinone;1;1;GO:0009416
GO:0032570;response to progesterone;1009;1200;GO:0006954
GO:0044553;modulation of biological quality in another organism;8;1;GO:0042221
GO:0044552;vasodilation in another organism;3;0;GO:0007596
GO:0044555;negative regulation of heart rate in another organism;1;0;GO:0048608
GO:0044554;modulation of heart rate in another organism;2;1;GO:0007596
GO:0044557;relaxation of smooth muscle;395;150;GO:0048608
GO:0044556;envenomation resulting in negative regulation of heart rate in another organism;0;0;GO:0002072
GO:0044559;envenomation resulting in modulation of voltage-gated potassium channel activity in another organism;3297;0;GO:0008092
GO:0044558;uterine smooth muscle relaxation;17;1;GO:0048507
GO:0044560;envenomation resulting in modulation of ion channel activity in another organism;3314;0;GO:0008092
GO:0044562;envenomation resulting in negative regulation of voltage-gated potassium channel activity in another organism;3296;4;GO:0048608
GO:0044561;modulation of ion channel activity in another organism;33;0;GO:0048407
GO:0032564;dATP binding;16;73;GO:0003676
GO:0032565;dGMP binding;0;0;GO:0043531
GO:0032562;dAMP binding;0;0;GO:0005524
GO:0032563;dADP binding;0;1;GO:0005524
GO:0032566;dGDP binding;0;1;GO:0043565
GO:0032567;dGTP binding;69;9;GO:0005524
GO:0032560;guanyl deoxyribonucleotide binding;69;3;GO:0005524
GO:0032561;guanyl ribonucleotide binding;4793159;1350;GO:0005524
GO:0044564;envenomation resulting in occlusion of the pore of voltage-gated potassium channel in another organism;50;4;GO:0008092
GO:0044563;envenomation resulting in slowing of activation kinetics of voltage-gated potassium channel in another organism;0;0;GO:0008092
GO:0044566;chondrocyte activation;36;1;GO:0032989
GO:0044565;dendritic cell proliferation;160;72;GO:0045727
GO:0044568;secondary cell wall cellulose synthase complex;7;1;GO:0009536
GO:0044567;primary cell wall cellulose synthase complex;0;0;GO:0009536
GO:0044569;[Ni-Fe] hydrogenase complex;38;5;GO:0009536
GO:0032559;adenyl ribonucleotide binding;37148638;3500;GO:0005524
GO:0019590;L-arabitol catabolic process to xylulose 5-phosphate;0;1;GO:0006067
GO:0019593;mannitol biosynthetic process;2;4;GO:0006032
GO:0044571;[2Fe-2S] cluster assembly;42000;82;GO:0008032
GO:0019592;mannitol catabolic process;19;2;GO:0006032
GO:0044570;starch utilization system complex;0;1;GO:0009536
GO:0019595;non-phosphorylated glucose catabolic process;1108;4;GO:0006096
GO:0044573;nitrogenase P cluster assembly;0;2;GO:0046395
GO:0019594;mannitol metabolic process;17590;87;GO:0006032
GO:0044572;[4Fe-4S] cluster assembly;307;9;GO:0005739
GO:0019597;(R)-mandelate catabolic process to benzoate;0;0;GO:0046395
GO:0032553;ribonucleotide binding;42727683;3120;GO:0005524
GO:0019596;mandelate catabolic process;7;2;GO:0006081
GO:0032554;purine deoxyribonucleotide binding;115;8;GO:0003676
GO:0019599;(R)-4-hydroxymandelate catabolic process;0;0;GO:0046395
GO:0032551;pyrimidine ribonucleoside binding;0;23;GO:0005524
GO:0019598;(R)-mandelate catabolic process to catechol;0;0;GO:0006081
GO:0032552;deoxyribonucleotide binding;164;5;GO:0003676
GO:0032557;pyrimidine ribonucleotide binding;888;8;GO:0005524
GO:0032558;adenyl deoxyribonucleotide binding;46;143;GO:0003676
GO:0032555;purine ribonucleotide binding;41941394;3730;GO:0005524
GO:0032556;pyrimidine deoxyribonucleotide binding;49;6;GO:0003676
GO:0007593;chitin-based cuticle sclerotization;352;5;GO:0005576
GO:0007594;puparial adhesion;27;27;GO:0006936
GO:0032550;purine ribonucleoside binding;4;1080;GO:0005524
GO:0007591;molting cycle, chitin-based cuticle;1633;31;GO:0009579
GO:0007597;blood coagulation, intrinsic pathway;251;897;GO:0007596
GO:0044575;cellulosome assembly;0;1;GO:0005975
GO:0007598;blood coagulation, extrinsic pathway;6;70;GO:0007596
GO:0044574;starch utilization system complex assembly;0;1;GO:0005975
GO:0007595;lactation;1400;1880;GO:0007586
GO:0044577;xylose catabolic process to ethanol;3;0;GO:0006099
GO:0007596;blood coagulation;51867;7480;GO:0007596
GO:0044576;pentose catabolic process to ethanol;3;1;GO:0006066
GO:0044579;butyryl-CoA biosynthetic process from acetyl-CoA;2;1;GO:0006066
GO:0044578;butyryl-CoA biosynthetic process;2;0;GO:0006066
GO:0007599;hemostasis;64341;4070;GO:0007596
GO:0019580;galactarate metabolic process;10615;5;GO:0006073
GO:0032548;pyrimidine deoxyribonucleoside binding;3;2;GO:0003676
GO:0044580;butyryl-CoA catabolic process;121;5;GO:0006066
GO:0032549;ribonucleoside binding;145783;2350;GO:0005524
GO:0044582;butyryl-CoA catabolic process to butanol;0;0;GO:0006099
GO:0044581;butyryl-CoA catabolic process to butyrate;1;1;GO:0006066
GO:0019584;galactonate catabolic process;15911;1;GO:0006073
GO:0044584;cellodextrin binding;0;0;GO:0005576
GO:0019583;galactonate metabolic process;15912;2;GO:0006073
GO:0044583;cellotriose binding;0;0;GO:0005576
GO:0019586;galacturonate metabolic process;140;1;GO:0005976
GO:0032542;sulfiredoxin activity;4068;70;GO:0004723
GO:0019585;glucuronate metabolic process;30071;793;GO:0006081
GO:0032543;mitochondrial translation;37861;3670;GO:0006412
GO:0019588;anaerobic glycerol catabolic process;2233;2;GO:0006099
GO:0032540;positive regulation of host-seeking behavior;0;1;GO:0050729
GO:0032541;cortical endoplasmic reticulum;4325;222;GO:0005783
GO:0032546;deoxyribonucleoside binding;7;4;GO:0003676
GO:0019589;anaerobic glycerol catabolic process to propane-1,3-diol;0;1;GO:0006099
GO:0032547;purine deoxyribonucleoside binding;0;1;GO:0003676
GO:0032544;plastid translation;535;49;GO:0006412
GO:0032545;CURI complex;255;66;GO:0005829
GO:0044586;cellotetraose binding;0;0;GO:0005576
GO:0044585;cellobiose binding;0;0;GO:0005125
GO:0044588;laminaribiose binding;0;0;GO:0005576
GO:0044587;cellopentaose binding;0;0;GO:0005576
GO:0044589;pectin binding;0;0;GO:0005576
GO:0032539;negative regulation of host-seeking behavior;1;1;GO:0048608
GO:0032537;host-seeking behavior;1;6;GO:0007626
GO:0044591;response to amylopectin;0;0;GO:0045737
GO:0032538;regulation of host-seeking behavior;1;2;GO:0050729
GO:0044590;iron-sulfur-molybdenum cofactor binding;0;1;GO:0005525
GO:0019571;D-arabinose catabolic process;15;5;GO:0006073
GO:0044593;iron-sulfur-molybdenum cofactor assembly;0;2;GO:0005737
GO:0019570;L-arabinose catabolic process to 2-oxoglutarate;7;2;GO:0006066
GO:0044592;response to pullulan;0;1;GO:0009611
GO:0019573;D-arabinose catabolic process to xylulose 5-phosphate;0;2;GO:0006073
GO:0044595;decaprenyldihydroxybenzoate methyltransferase activity;11;3;GO:0004497
GO:0019572;L-arabinose catabolic process;37861;5;GO:0006073
GO:0044594;17-beta-hydroxysteroid dehydrogenase (NAD+) activity;160;0;GO:0004089
GO:0032531;regulation of follicle cell microvillus organization;8;1;GO:0048608
GO:0019574;sucrose catabolic process via 3'-ketosucrose;0;2;GO:0006066
GO:0032532;regulation of microvillus length;262;104;GO:0048193
GO:0019577;aldaric acid metabolic process;31360;1;GO:0006073
GO:0019576;aerobic fructose catabolic process;0;0;GO:0006099
GO:0032530;regulation of microvillus organization;587;15;GO:0048193
GO:0019579;aldaric acid catabolic process;31351;1;GO:0009062
GO:0032535;regulation of cellular component size;117679;1480;GO:0048471
GO:0019578;aldaric acid biosynthetic process;0;1;GO:0006073
GO:0032536;regulation of cell projection size;487;6;GO:0048608
GO:0032533;regulation of follicle cell microvillus length;8;2;GO:0048706
GO:0032534;regulation of microvillus assembly;325;55;GO:0048193
GO:0044517;modulation of vasoactive intestinal polypeptide receptor activity in another organism;0;0;GO:0048608
GO:0044516;positive regulation of glucagon-like peptide receptor 1 activity in another organism;0;1;GO:0048608
GO:0044519;envenomation resulting in modulation of vasoactive intestinal polypeptide receptor activity in another organism;0;0;GO:0004930
GO:0044518;positive regulation of vasoactive intestinal polypeptide receptor activity in another organism;0;1;GO:0048608
GO:0044511;envenomation resulting in modulation of receptor activity in another organism;2;0;GO:0004872
GO:0044510;envenomation resulting in positive regulation of signal transduction in another organism;0;0;GO:0009913
GO:0044513;envenomation resulting in modulation of G protein-coupled receptor activity in another organism;1;0;GO:0004930
GO:0044512;envenomation resulting in modulation of glucagon-like peptide receptor 1 activity in another organism;0;0;GO:0004930
GO:0044515;envenomation resulting in positive regulation of glucagon-like peptide receptor 1 activity in another organism;0;0;GO:0048608
GO:0044514;envenomation resulting in positive regulation of G protein-coupled receptor activity in another organism;1;0;GO:0004930
GO:0044528;regulation of mitochondrial mRNA stability;6296;15;GO:0010467
GO:0044527;formation of peptidyl-cystine persulfide by sulphur transfer from H2S;0;1;GO:0009065
GO:0044529;regulation of mitochondrial rRNA stability;0;0;GO:0006613
GO:0044520;envenomation resulting in positive regulation of vasoactive intestinal polypeptide receptor activity in another organism;0;0;GO:0048608
GO:0044522;envenomation resulting in myocyte killing in another organism;1;1;GO:0048608
GO:0044521;envenomation resulting in muscle damage in another organism;9;3;GO:0007596
GO:0044524;protein sulfhydration;7;6;GO:0006464
GO:0044523;envenomation resulting in damage of muscle extracellular matrix in another organism;0;1;GO:0048608
GO:0044526;formation of peptidyl-cystine persulfide by sulphur transfer from free cysteine;0;2;GO:0006457
GO:0044525;peptidyl-cystine sulfhydration;0;2;GO:0006464
GO:0032597;B cell receptor transport into membrane raft;18;7;GO:0006974
GO:0032598;B cell receptor transport into immunological synapse;0;2;GO:0002213
GO:0032595;B cell receptor transport within lipid bilayer;18;1;GO:0006874
GO:0032596;protein transport into membrane raft;145;25;GO:0006613
GO:0032599;protein transport out of membrane raft;5;3;GO:0006810
GO:0044539;long-chain fatty acid import into cell;1333;99;GO:0006869
GO:0032590;dendrite membrane;2661;870;GO:0043005
GO:0044538;host cell periphery;10;2;GO:0005615
GO:0032593;insulin-responsive compartment;378;86;GO:0005737
GO:0032594;protein transport within lipid bilayer;274;35;GO:0006810
GO:0032591;dendritic spine membrane;1733;219;GO:0097403
GO:0044530;supraspliceosomal complex;150;64;GO:0000786
GO:0044533;positive regulation of apoptotic process in another organism;7;4;GO:0042981
GO:0044532;modulation of apoptotic process in another organism;10;2;GO:0042981
GO:0044535;very-long-chain fatty acyl-CoA oxidase activity;0;0;GO:0008629
GO:0044534;envenomation resulting in modulation of apoptotic process in another organism;6;1;GO:0008631
GO:0044537;regulation of circulating fibrinogen levels;32;33;GO:0050727
GO:0044536;envenomation resulting in depletion of circulating fibrinogen in another organism;12;0;GO:0007596
GO:0044540;L-cystine L-cysteine-lyase (deaminating);4164;5;GO:0009065
GO:0032586;protein storage vacuole membrane;57;4;GO:0005764
GO:0032587;ruffle membrane;12170;2230;GO:0005615
GO:0032584;growth cone membrane;3575;119;GO:0048471
GO:0032585;multivesicular body membrane;7835;160;GO:0005764
GO:0032588;trans-Golgi network membrane;5020;1370;GO:0005764
GO:0032589;neuron projection membrane;3300;294;GO:0043005
GO:0044549;GTP cyclohydrolase binding;25;23;GO:0005525
GO:0032580;Golgi cisterna membrane;46807;1350;GO:0005764
GO:0032581;ER-dependent peroxisome organization;121;10;GO:0009536
GO:0044542;plasminogen activation in another organism;0;1;GO:0007596
GO:0044541;zymogen activation in another organism;0;1;GO:0008544
GO:0044544;envenomation resulting in plasminogen activation in another organism;0;1;GO:0007596
GO:0044546;NLRP3 inflammasome complex assembly;2015;131;GO:0008313
GO:0044545;NSL complex;953;18;GO:0048471
GO:0044548;S100 protein binding;2710;562;GO:0043169
GO:0044547;DNA topoisomerase binding;182;43;GO:0003676
GO:0044551;envenomation resulting in vasodilation in another organism;1;0;GO:0002687
GO:0044550;secondary metabolite biosynthetic process;241320;1380;GO:0009405
GO:0032576;O-linoleoyltransferase activity;14;1;GO:0004734
GO:0032573;response to phylloquinone;0;1;GO:0009765
GO:0032574;5'-3' RNA helicase activity;3058;4;GO:0003797
GO:0032579;apical lamina of hyaline layer;1;8;GO:0048771
GO:0032577;phosphatidylcholine:cardiolipin O-linoleoyltransferase activity;14;0;GO:0004714
GO:0032578;aleurone grain membrane;39;5;GO:0005576
GO:0044597;daunorubicin metabolic process;337;1340;GO:0009060
GO:0044596;3-demethylubiquinol-10 3-O-methyltransferase activity;11;3;GO:0004497
GO:0044599;AP-5 adaptor complex;1678;4;GO:0005737
GO:0044598;doxorubicin metabolic process;359;1060;GO:0009063
GO:0140319;receptor decoy activity;15;0;GO:0004872
GO:0140315;iron ion sequestering activity;49;3;GO:0005525
GO:0140317;export across cell outer membrane;25;0;GO:0008610
GO:0140318;protein transporter activity;378031;358;GO:0008565
GO:0140311;protein sequestering activity;1218;34;GO:0005515
GO:0140312;cargo adaptor activity;14208;9;GO:0004842
GO:0140313;molecular sequestering activity;10203;66;GO:0048193
GO:0140314;calcium ion sequestering activity;65;3;GO:0008037
GO:0140306;lipoprotein releasing activity;6;0;GO:0006629
GO:0140300;serine import into mitochondrion;286;4;GO:0006836
GO:0140301;pollen-stigma interaction;14;0;GO:0009909
GO:0140302;pollen-style interaction;0;0;GO:0009908
GO:0140303;intramembrane lipid transporter activity;82214;5;GO:0008565
GO:0140337;diacylglyceride transfer activity;59;2;GO:0005576
GO:0140338;sphingomyelin transfer activity;175;2;GO:0008030
GO:0140339;phosphatidylglycerol transfer activity;59;2;GO:0005576
GO:0140333;glycerophospholipid flippase activity;6088;5;GO:0005525
GO:0140334;lipopolysaccharide localization to cell outer membrane;0;1;GO:0005576
GO:0140330;xenobiotic detoxification by transmembrane export across the cell outer membrane;25;4;GO:0006836
GO:0140331;aminophospholipid translocation;2336;3;GO:0006869
GO:0140332;lipopolysaccharide transfer activity;0;0;GO:0002821
GO:0140326;ATPase-coupled intramembrane lipid transporter activity;72137;137;GO:0008544
GO:0140327;flippase activity;6582;8;GO:0003900
GO:0140328;floppase activity;833;4;GO:0005576
GO:0140329;lysophospholipid translocation;57;4;GO:0006631
GO:0140325;negative regulation of protein localization to medial cortex;1;0;GO:0048193
GO:0140320;PAMP receptor decoy activity;7;0;GO:0004896
GO:0140321;symbiont-mediated suppression of host autophagy;14;3;GO:0048193
GO:0140113;extracellular microvesicle biogenesis;0;2;GO:0070062
GO:0140114;cellular detoxification of fluoride;42298;3;GO:0006879
GO:0140115;export across plasma membrane;120536;40;GO:0009986
GO:0140116;fluoride export across plasma membrane;2;0;GO:0006836
GO:0140110;transcription regulator activity;7086260;2410;GO:0030528
GO:0140111;[choline trimethylamine-lyase]-activating enzyme activity;0;0;GO:0004497
GO:0140112;extracellular vesicle biogenesis;1772;45;GO:0070062
GO:0140107;high-affinity potassium ion transmembrane transporter activity;38;2;GO:0005215
GO:0140108;high-affinity glucose transmembrane transporter activity;1;1;GO:0005215
GO:0140102;catalytic activity, acting on a rRNA;843881;7;GO:0003735
GO:0140103;catalytic activity, acting on a glycoprotein;37719;10;GO:0005515
GO:0140104;molecular carrier activity;325275;254;GO:0005515
GO:0140105;interleukin-10-mediated signaling pathway;9;3;GO:0043023
GO:0140101;catalytic activity, acting on a tRNA;9547073;196;GO:0003735
GO:0140140;mitochondrial guanine nucleotide transmembrane transport;1;1;GO:0008544
GO:0140141;mitochondrial potassium ion transmembrane transport;264;6;GO:0048471
GO:0140135;mechanosensitive monoatomic cation channel activity;214;5;GO:0005216
GO:0140131;positive regulation of lymphocyte chemotaxis;926;25;GO:0050900
GO:0140132;iron-sulfur cluster carrier activity;11;1;GO:0005739
GO:0140133;suppression by symbiont of host cytokine production;0;0;GO:0046649
GO:0140124;positive regulation of Lewy body formation;0;1;GO:0048167
GO:0140125;thiamine import across plasma membrane;4;2;GO:0006836
GO:0140121;Lewy body formation;9;0;GO:0048207
GO:0140122;regulation of Lewy body formation;9;1;GO:0048167
GO:0140123;negative regulation of Lewy body formation;9;1;GO:0048167
GO:0140161;monocarboxylate:sodium symporter activity;3963;7;GO:0005215
GO:0009912;auditory receptor cell fate commitment;336;237;GO:0008544
GO:0009911;positive regulation of flower development;512;386;GO:0048316
GO:0009910;negative regulation of flower development;1267;327;GO:0048316
GO:0009905;ent-copalyl diphosphate synthase activity;115;9;GO:0004497
GO:0009904;chloroplast accumulation movement;608;172;GO:0009908
GO:0009903;chloroplast avoidance movement;659;48;GO:0009909
GO:0009902;chloroplast relocation;1351;385;GO:0009986
GO:0009909;regulation of flower development;11850;1240;GO:0009908
GO:0009908;flower development;26675;1940;GO:0009908
GO:0009907;response to photoperiod, red light;0;2;GO:0046316
GO:0009906;response to photoperiod, blue light;10;2;GO:0046316
GO:0140157;ammonium import across plasma membrane;155;4;GO:0006865
GO:0140159;borate export across plasma membrane;1;1;GO:0006830
GO:0009923;fatty acid elongase complex;120;8;GO:0005737
GO:0010909;positive regulation of heparan sulfate proteoglycan biosynthetic process;182;173;GO:0048407
GO:0009922;fatty acid elongase activity;54574;492;GO:0004089
GO:0010908;regulation of heparan sulfate proteoglycan biosynthetic process;244;10;GO:0048407
GO:0009921;auxin efflux carrier complex;87;4;GO:0005576
GO:0009920;cell plate formation involved in plant-type cell wall biogenesis;83;10;GO:0046394
GO:0009916;alternative oxidase activity;9370;65;GO:0009524
GO:0010905;negative regulation of UDP-glucose catabolic process;1;4;GO:0046395
GO:0009915;phloem sucrose loading;37;10;GO:0009909
GO:0010904;regulation of UDP-glucose catabolic process;1;5;GO:0046394
GO:0009914;hormone transport;33768;757;GO:0006811
GO:0010907;positive regulation of glucose metabolic process;2144;532;GO:0045944
GO:0009913;epidermal cell differentiation;16291;1690;GO:0008544
GO:0010906;regulation of glucose metabolic process;10315;1220;GO:0045735
GO:0010901;regulation of very-low-density lipoprotein particle remodeling;318;35;GO:0048193
GO:0010900;negative regulation of phosphatidylcholine catabolic process;22;215;GO:0046395
GO:0009918;sterol delta7 reductase activity;125;6;GO:0004639
GO:0010903;negative regulation of very-low-density lipoprotein particle remodeling;268;265;GO:0048193
GO:0009917;sterol 5-alpha reductase activity;76;5;GO:0004639
GO:0010902;positive regulation of very-low-density lipoprotein particle remodeling;50;24;GO:0048193
GO:0140146;calcium ion import into vacuole;3;1;GO:0006836
GO:0140147;zinc ion export from vacuole;1;2;GO:0006836
GO:0140142;nucleocytoplasmic carrier activity;39044;10;GO:0003735
GO:0140145;copper ion export from vacuole;1;1;GO:0006826
GO:0009901;anther dehiscence;392;190;GO:0009908
GO:0009900;dehiscence;653;27;GO:0009699
GO:0140164;Golgi transport complex binding;14;1;GO:0005840
GO:0009952;anterior/posterior pattern specification;21786;4370;GO:0009952
GO:0009951;polarity specification of dorsal/ventral axis;111;7;GO:0048608
GO:0009950;dorsal/ventral axis specification;1931;1160;GO:0009952
GO:0009956;radial pattern formation;492;397;GO:0048608
GO:0009955;adaxial/abaxial pattern specification;646;60;GO:0048316
GO:0009954;proximal/distal pattern formation;2372;1800;GO:0048608
GO:0009953;dorsal/ventral pattern formation;11764;1870;GO:0009952
GO:0009949;polarity specification of anterior/posterior axis;274;9;GO:0009952
GO:0010938;cytoplasmic microtubule depolymerization;52;5;GO:0007050
GO:0034905;5-chloro-4-hydroxy-2-oxopentanate aldolase activity;0;3;GO:0006099
GO:0009948;anterior/posterior axis specification;5662;1040;GO:0009952
GO:0010937;regulation of cytoplasmic microtubule depolymerization;0;2;GO:0048285
GO:0034904;5-chloro-2-oxopent-4-enoate hydratase activity;0;1;GO:0004467
GO:0009947;centrolateral axis specification;7;1;GO:0048704
GO:0034903;endosulfan ether monooxygenase activity;0;2;GO:0004497
GO:0009946;proximal/distal axis specification;276;95;GO:0048704
GO:0034902;endosulfan sulfate hydrolase activity;0;3;GO:0004553
GO:0010934;macrophage cytokine production;1944;234;GO:0002687
GO:0034909;6-hydroxypseudooxynicotine dehydrogenase activity;247;4;GO:0009081
GO:0010933;positive regulation of macrophage tolerance induction;47;6;GO:0048646
GO:0034908;2-chloro-N-isopropylacetanilide 1,2-dioxygenase activity;0;2;GO:0004497
GO:0010936;negative regulation of macrophage cytokine production;741;376;GO:0050729
GO:0034907;acetanilide 1,2-dioxygenase activity;0;2;GO:0004497
GO:0010935;regulation of macrophage cytokine production;1944;349;GO:0050729
GO:0034906;N-isopropylaniline 1,2-dixoxygenase activity;0;2;GO:0004497
GO:0010930;negative regulation of auxin mediated signaling pathway;83;2;GO:0010468
GO:0010932;regulation of macrophage tolerance induction;47;3;GO:1902547
GO:0010931;macrophage tolerance induction;47;1;GO:0002576
GO:0034901;endosulfan hydroxyether dehydrogenase activity;0;4;GO:0004091
GO:0034900;3-(N-formyl)-formiminopyruvate hydrolase activity;0;0;GO:0009065
GO:0140199;negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;106;3;GO:0048010
GO:0046905;15-cis-phytoene synthase activity;1483;3;GO:0004497
GO:0140193;regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process;61;2;GO:0007218
GO:0046906;tetrapyrrole binding;4118545;3150;GO:0046906
GO:0140194;negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process;59;2;GO:0048608
GO:0046903;secretion;956321;4880;GO:0006935
GO:0140195;positive regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process;0;0;GO:0048010
GO:0046904;calcium oxalate binding;2;5;GO:0005509
GO:0140196;positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;2;1;GO:0048010
GO:0046907;intracellular transport;2451290;4430;GO:0006810
GO:0140192;regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;109;1;GO:0007218
GO:0007300;ovarian nurse cell to oocyte transport;327;62;GO:0008023
GO:0009963;positive regulation of flavonoid biosynthetic process;123;94;GO:0046364
GO:0007301;female germline ring canal formation;85;81;GO:0008544
GO:0009962;regulation of flavonoid biosynthetic process;304;56;GO:0046322
GO:0009961;response to 1-aminocyclopropane-1-carboxylic acid;34;10;GO:0009734
GO:0009960;endosperm development;1495;185;GO:0009813
GO:0007304;chorion-containing eggshell formation;1509;108;GO:0008544
GO:0009967;positive regulation of signal transduction;173910;3110;GO:0007165
GO:0046901;tetrahydrofolylpolyglutamate biosynthetic process;203904;109;GO:0006066
GO:0007305;vitelline membrane formation involved in chorion-containing eggshell formation;175;36;GO:0048706
GO:0009966;regulation of signal transduction;738657;6500;GO:0007165
GO:0046902;regulation of mitochondrial membrane permeability;3625;629;GO:0008629
GO:0007302;nurse cell nucleus anchoring;21;4;GO:0005634
GO:0009965;leaf morphogenesis;1735;969;GO:0048468
GO:0007303;cytoplasmic transport, nurse cell to oocyte;120;153;GO:0006936
GO:0009964;negative regulation of flavonoid biosynthetic process;7;5;GO:0046274
GO:0046900;tetrahydrofolylpolyglutamate metabolic process;204052;53;GO:0006541
GO:0010949;negative regulation of intestinal phytosterol absorption;114;77;GO:0010467
GO:0009959;negative gravitropism;3493;354;GO:0048706
GO:0010948;negative regulation of cell cycle process;82826;1670;GO:0051726
GO:0009958;positive gravitropism;438;103;GO:0048407
GO:0009957;epidermal cell fate specification;273;270;GO:0009913
GO:0010945;CoA pyrophosphatase activity;35594;33;GO:0004792
GO:0010944;negative regulation of transcription by competitive promoter binding;430;394;GO:0045944
GO:0010947;negative regulation of meiotic joint molecule formation;7;4;GO:0048285
GO:0010946;regulation of meiotic joint molecule formation;7;2;GO:0008037
GO:0010943;NADPH pyrophosphatase activity;0;2;GO:0004725
GO:0046917;triphosphoribosyl-dephospho-CoA synthase activity;29691;10;GO:0006066
GO:0046914;transition metal ion binding;8286786;4740;GO:0046872
GO:0046915;transition metal ion transmembrane transporter activity;322085;479;GO:0008565
GO:0046918;N-terminal peptidyl-glycine N-palmitoylation;0;3;GO:0006469
GO:0022904;respiratory electron transport chain;1390488;7070;GO:0005746
GO:0046919;pyruvyltransferase activity;4;8;GO:0004497
GO:0009930;longitudinal side of cell surface;4;7;GO:0009986
GO:0022900;electron transport chain;17206134;8530;GO:0005746
GO:0009934;regulation of meristem structural organization;458;152;GO:0010468
GO:0046912;acyltransferase activity, acyl groups converted into alkyl on transfer;569696;113;GO:0008610
GO:0009933;meristem structural organization;2149;212;GO:0048316
GO:0010919;regulation of inositol phosphate biosynthetic process;640;250;GO:0046394
GO:0009932;cell tip growth;2386;149;GO:0048608
GO:0046910;pectinesterase inhibitor activity;3245;122;GO:0004553
GO:0009931;calcium-dependent protein serine/threonine kinase activity;18465;259;GO:0004721
GO:0046911;metal chelating activity;54;212;GO:0004630
GO:0009927;histidine phosphotransfer kinase activity;10355;33;GO:0004721
GO:0010916;negative regulation of very-low-density lipoprotein particle clearance;207;28;GO:0010467
GO:0009926;auxin polar transport;2754;643;GO:0009734
GO:0010915;regulation of very-low-density lipoprotein particle clearance;209;5;GO:0032963
GO:0009925;basal plasma membrane;36837;1610;GO:0005886
GO:0010918;positive regulation of mitochondrial membrane potential;490;360;GO:0048285
GO:0009924;octadecanal decarbonylase activity;2514;6;GO:0004497
GO:0010917;negative regulation of mitochondrial membrane potential;306;50;GO:0048285
GO:0010912;positive regulation of isomerase activity;32;22;GO:0010468
GO:0010911;regulation of isomerase activity;33;7;GO:0010468
GO:0010914;positive regulation of sterigmatocystin biosynthetic process;22;6;GO:0046405
GO:0010913;regulation of sterigmatocystin biosynthetic process;33;7;GO:0046405
GO:0010910;positive regulation of heparan sulfate proteoglycan biosynthesis by positive regulation of epimerase activity;0;2;GO:0048407
GO:0046927;peptidyl-threonine racemization;0;3;GO:0006468
GO:0046928;regulation of neurotransmitter secretion;3688;1860;GO:0048167
GO:0046925;peptide cross-linking via 2-(S-L-cysteinyl)-D-phenylalanine;0;0;GO:0008021
GO:0046926;peptide cross-linking via 2-(S-L-cysteinyl)-D-allo-threonine;0;0;GO:0009065
GO:0046929;negative regulation of neurotransmitter secretion;277;751;GO:0048167
GO:0009941;chloroplast envelope;71992;2070;GO:0009536
GO:0009940;amino-terminal vacuolar sorting propeptide binding;6;3;GO:0005515
GO:0046920;alpha-(1->3)-fucosyltransferase activity;4964;4;GO:0004553
GO:0009945;radial axis specification;13;3;GO:0048608
GO:0046923;ER retention sequence binding;9042;370;GO:0003712
GO:0009944;polarity specification of adaxial/abaxial axis;338;610;GO:0048367
GO:0046924;peptide cross-linking via 2-(S-L-cysteinyl)-L-phenylalanine;0;0;GO:0008021
GO:0009943;adaxial/abaxial axis specification;383;28;GO:0048316
GO:0046921;alpha-(1->6)-fucosyltransferase activity;2296;0;GO:0004553
GO:0009942;longitudinal axis specification;109;18;GO:0048704
GO:0046922;peptide-O-fucosyltransferase activity;7291;10;GO:0004553
GO:0009938;negative regulation of gibberellic acid mediated signaling pathway;280;257;GO:0010468
GO:0010927;cellular component assembly involved in morphogenesis;13367;1120;GO:0048856
GO:0009937;regulation of gibberellic acid mediated signaling pathway;1364;143;GO:0030534
GO:0010929;positive regulation of auxin mediated signaling pathway;158;6;GO:0045734
GO:0010928;regulation of auxin mediated signaling pathway;1874;182;GO:0009733
GO:0010923;negative regulation of phosphatase activity;185;757;GO:0010468
GO:0010922;positive regulation of phosphatase activity;103;357;GO:0010468
GO:0010925;positive regulation of inositol-polyphosphate 5-phosphatase activity;1;4;GO:0048193
GO:0009939;positive regulation of gibberellic acid mediated signaling pathway;280;9;GO:0046274
GO:0010924;regulation of inositol-polyphosphate 5-phosphatase activity;1;4;GO:0005524
GO:0010921;regulation of phosphatase activity;324;572;GO:0010468
GO:0010920;negative regulation of inositol phosphate biosynthetic process;69;25;GO:0046394
GO:0019319;hexose biosynthetic process;739920;1040;GO:0005975
GO:0019318;hexose metabolic process;1538381;2430;GO:0005975
GO:0009992;intracellular water homeostasis;439;4;GO:0006874
GO:0009991;response to extracellular stimulus;943626;4310;GO:0009611
GO:0009990;contact guidance;0;2;GO:0048608
GO:0009996;negative regulation of cell fate specification;708;507;GO:0045595
GO:0009995;soluble molecule recognition;1;2;GO:0005515
GO:0009994;oocyte differentiation;7186;790;GO:0032502
GO:0007338;single fertilization;25212;2600;GO:0009566
GO:0009999;negative regulation of auditory receptor cell fate specification;0;2;GO:0048704
GO:0009998;negative regulation of retinal cone cell fate specification;0;1;GO:0048706
GO:0009997;negative regulation of cardioblast cell fate specification;47;9;GO:0048706
GO:0034949;1,1-dichloroethane reductive dehalogenase activity;0;2;GO:0004497
GO:0034948;2,6-dihydroxypseudooxynicotine hydrolase activity;0;3;GO:0004479
GO:0034947;terephthalate decarboxylase activity;0;3;GO:0006099
GO:0034946;3-isopropylbut-3-enoyl-CoA thioesterase activity;0;3;GO:0004497
GO:0010977;negative regulation of neuron projection development;5842;2480;GO:0048666
GO:0019320;hexose catabolic process;97428;1420;GO:0006066
GO:0010979;regulation of vitamin D 24-hydroxylase activity;3;9;GO:0046395
GO:0010974;negative regulation of division septum assembly;3423;8;GO:0048285
GO:0019322;pentose biosynthetic process;111;228;GO:0006096
GO:0034941;pyrrole-2-carboxylate decarboxylase activity;0;4;GO:0006073
GO:0010973;positive regulation of division septum assembly;264;2;GO:0048285
GO:0019321;pentose metabolic process;382122;482;GO:0006096
GO:0034940;5-oxo-4,5-dihydropyrrole-2-carboxylate amidase activity;0;2;GO:0004721
GO:0010976;positive regulation of neuron projection development;5795;3020;GO:0048666
GO:0019324;L-lyxose metabolic process;17;3;GO:0006066
GO:0010975;regulation of neuron projection development;23146;2240;GO:0048699
GO:0019323;pentose catabolic process;190361;33;GO:0006073
GO:0010970;transport along microtubule;32248;333;GO:0006810
GO:0019326;nitrotoluene metabolic process;21;3;GO:0006749
GO:0034945;2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity;0;2;GO:0004497
GO:0019325;anaerobic fructose catabolic process;0;2;GO:0006099
GO:0034944;3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity;0;4;GO:0006066
GO:0010972;negative regulation of G2/M transition of mitotic cell cycle;12801;936;GO:0051726
GO:0019328;anaerobic gallate catabolic process;0;2;GO:0009062
GO:0034943;trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity;0;2;GO:0006081
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;1872;702;GO:0051726
GO:0019327;lead sulfide oxidation;0;2;GO:0046395
GO:0034942;cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity;0;1;GO:0006081
GO:0019308;dTDP-mannose biosynthetic process;0;2;GO:0006022
GO:0019307;mannose biosynthetic process;5;182;GO:0006032
GO:0019309;mannose catabolic process;21;6;GO:0006032
GO:0007340;acrosome reaction;4887;1700;GO:0008092
GO:0007341;penetration of zona pellucida;367;168;GO:0008037
GO:0007344;pronuclear fusion;117;20;GO:0008360
GO:0007342;fusion of sperm to egg plasma membrane involved in single fertilization;3811;67;GO:0009986
GO:0007343;egg activation;870;115;GO:0008340
GO:0007348;regulation of syncytial blastoderm mitotic cell cycle;107;10;GO:0000278
GO:0007349;cellularization;1722;451;GO:0009987
GO:0007346;regulation of mitotic cell cycle;71774;5820;GO:0000278
GO:0007347;regulation of preblastoderm mitotic cell cycle;24;3;GO:0048285
GO:0034938;pyrrole-2-carboxylate monooxygenase activity;0;3;GO:0004497
GO:0034937;perchlorate reductase activity;0;3;GO:0009065
GO:0007339;binding of sperm to zona pellucida;6162;2320;GO:0008033
GO:0034936;4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity;0;3;GO:0004497
GO:0034935;tetrachlorobenzene dioxygenase activity;0;4;GO:0004497
GO:0010989;negative regulation of low-density lipoprotein particle clearance;288;145;GO:0032963
GO:0010988;regulation of low-density lipoprotein particle clearance;610;78;GO:0032963
GO:0034939;5-hydroxypyrrole-2-carboxylate tautomerase activity;0;1;GO:0004497
GO:0010985;negative regulation of lipoprotein particle clearance;556;10;GO:0032963
GO:0019311;sorbose metabolic process;4;3;GO:0006066
GO:0034930;1-hydroxypyrene sulfotransferase activity;1;3;GO:0004073
GO:0010984;regulation of lipoprotein particle clearance;1002;8;GO:0032963
GO:0019310;inositol catabolic process;43147;486;GO:0006559
GO:0010987;negative regulation of high-density lipoprotein particle clearance;57;15;GO:0010467
GO:0019313;allose metabolic process;1911;3;GO:0006066
GO:0010986;positive regulation of lipoprotein particle clearance;289;38;GO:0032963
GO:0019312;L-sorbose metabolic process;4;2;GO:0006066
GO:0010981;regulation of cell wall macromolecule metabolic process;288;5;GO:0042546
GO:0019315;D-allose biosynthetic process;0;2;GO:0006073
GO:0034934;phenanthrene-4-carboxylate dioxygenase activity;0;3;GO:0004497
GO:0010980;positive regulation of vitamin D 24-hydroxylase activity;3;216;GO:0046356
GO:0019314;D-allose metabolic process;1911;2;GO:0006066
GO:0034933;1-hydroxy-6-methoxypyrene methyltransferase activity;0;2;GO:0004497
GO:0010983;positive regulation of high-density lipoprotein particle clearance;116;133;GO:0032963
GO:0019317;fucose catabolic process;17491;1140;GO:0006032
GO:0034932;1-methoxypyrene 6,7-monooxygenase activity;0;2;GO:0004497
GO:0010982;regulation of high-density lipoprotein particle clearance;173;141;GO:0032963
GO:0019316;D-allose catabolic process;1911;5;GO:0006073
GO:0034931;1-hydroxypyrene methyltransferase activity;0;1;GO:0004497
GO:0009970;cellular response to sulfate starvation;128;25;GO:0009733
GO:0007311;maternal specification of dorsal/ventral axis, oocyte, germ-line encoded;13;14;GO:0007548
GO:0009974;zeinoxanthin epsilon hydroxylase activity;100;3;GO:0004730
GO:0007312;oocyte nucleus migration involved in oocyte dorsal/ventral axis specification;33;147;GO:0048704
GO:0009973;adenylyl-sulfate reductase activity;1836;61;GO:0004723
GO:0009972;cytidine deamination;114966;1410;GO:0006519
GO:0007310;oocyte dorsal/ventral axis specification;315;10;GO:0009952
GO:0009971;anastral spindle assembly involved in male meiosis;4;4;GO:0007067
GO:0007315;pole plasm assembly;1413;26;GO:0002376
GO:0009978;allene oxide synthase activity;105;7;GO:0004497
GO:0007316;pole plasm RNA localization;743;17;GO:0006464
GO:0009977;proton motive force dependent protein transmembrane transporter activity;149;4;GO:0015075
GO:0007313;maternal specification of dorsal/ventral axis, oocyte, soma encoded;48;9;GO:0008544
GO:0009976;tocopherol cyclase activity;3247;21;GO:0004073
GO:0007314;oocyte anterior/posterior axis specification;2063;55;GO:0009952
GO:0009975;cyclase activity;277421;925;GO:0003824
GO:0007308;oocyte construction;2912;43;GO:0008544
GO:0034927;pyrene 1,2-monooxygenase activity;0;2;GO:0004497
GO:0007309;oocyte axis specification;2751;93;GO:0048608
GO:0010959;regulation of metal ion transport;25829;950;GO:0006865
GO:0034926;pyrene-4,5-epoxide hydrolase activity;0;2;GO:0004497
GO:0007306;egg chorion assembly;903;5;GO:0005576
GO:0009969;xyloglucan biosynthetic process;660;114;GO:0009813
GO:0034925;pyrene 4,5-monooxygenase activity;0;3;GO:0004497
GO:0007307;eggshell chorion gene amplification;131;71;GO:0048706
GO:0009968;negative regulation of signal transduction;341345;3370;GO:0030528
GO:0034924;cis-3,4-phenanthrenedihydrodiol-4-carboxylate dehydrogenase activity;0;2;GO:0004497
GO:0010956;negative regulation of calcidiol 1-monooxygenase activity;3;165;GO:0010468
GO:0010955;negative regulation of protein processing;897;994;GO:0010467
GO:0010958;regulation of amino acid import across plasma membrane;583;6;GO:0006865
GO:0034929;1-hydroxypyrene 7,8-monooxygenase activity;0;2;GO:0004497
GO:0010957;negative regulation of vitamin D biosynthetic process;117;241;GO:0045944
GO:0034928;1-hydroxypyrene 6,7-monooxygenase activity;0;2;GO:0004497
GO:0010952;positive regulation of peptidase activity;867;1400;GO:0048608
GO:0019300;rhamnose biosynthetic process;1;3;GO:0009405
GO:0010951;negative regulation of endopeptidase activity;395;3870;GO:0010401
GO:0010954;positive regulation of protein processing;2290;169;GO:0010467
GO:0019302;D-ribose biosynthetic process;0;2;GO:0006066
GO:0019301;rhamnose catabolic process;19386;50;GO:0006073
GO:0019304;anaerobic rhamnose catabolic process;0;1;GO:0006067
GO:0034923;phenanthrene-4,5-dicarboxylate decarboxylase activity;0;3;GO:0006073
GO:0019303;D-ribose catabolic process;74179;106;GO:0006066
GO:0034922;4,5-dihydroxypyrene dioxygenase activity;0;4;GO:0004497
GO:0010950;positive regulation of endopeptidase activity;795;974;GO:0048608
GO:0019306;GDP-D-rhamnose biosynthetic process;2;2;GO:0009405
GO:0034921;cis-4,5-dihydroxy-4,5-dihydropyrene dehydrogenase activity;0;2;GO:0004073
GO:0019305;dTDP-rhamnose biosynthetic process;89329;9;GO:0006032
GO:0034920;pyrene dioxygenase activity;0;4;GO:0004497
GO:0007323;peptide pheromone maturation;122;4;GO:0008544
GO:0007320;insemination;584;310;GO:0007548
GO:0007321;sperm displacement;1;6;GO:0048308
GO:0009982;pseudouridine synthase activity;948676;2130;GO:0003906
GO:0009989;cell-matrix recognition;0;4;GO:0005615
GO:0009988;cell-cell recognition;7638;892;GO:0007156
GO:0009987;cellular process;298082032;21900;GO:0009987
GO:0009986;cell surface;211484;15200;GO:0005615
GO:0007319;negative regulation of oskar mRNA translation;124;10;GO:0010467
GO:0034916;2-methylhexanoyl-CoA dehydrogenase activity;0;3;GO:0006081
GO:0034915;2-methylhexanoyl-CoA C-acetyltransferase activity;0;2;GO:0006081
GO:0007317;regulation of pole plasm oskar mRNA localization;297;195;GO:0048704
GO:0034914;trinitrophenol hydride denitratase activity;0;2;GO:0004730
GO:0007318;pole plasm protein localization;125;18;GO:0005576
GO:0009979;16:0 monogalactosyldiacylglycerol desaturase activity;153;2;GO:0008610
GO:0010967;regulation of polyamine biosynthetic process;55;7;GO:0045944
GO:0010966;regulation of phosphate transport;484;130;GO:0006874
GO:0034919;butyryl-CoA 2-C-propionyltransferase activity;0;2;GO:0006081
GO:0010969;regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion;32;2;GO:0009913
GO:0034918;3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity;0;3;GO:0006066
GO:0010968;regulation of microtubule nucleation;1163;51;GO:0048285
GO:0034917;2-methylhex-2-enoyl-CoA hydratase activity;0;1;GO:0006081
GO:0010962;regulation of glucan biosynthetic process;3349;37;GO:0010467
GO:0010965;regulation of mitotic sister chromatid separation;19975;850;GO:0007067
GO:0010964;regulation of regulatory ncRNA-mediated heterochromatin formation;28;1;GO:0045944
GO:0034912;phthalate 3,4-cis-dihydrodiol dehydrogenase activity;0;1;GO:0009065
GO:0034911;phthalate 3,4-dioxygenase activity;0;3;GO:0004497
GO:0010961;intracellular magnesium ion homeostasis;215;7;GO:0006836
GO:0034910;6-hydroxy-3-succinoylpyridine hydrolase activity;0;2;GO:0004730
GO:0010960;magnesium ion homeostasis;12636;350;GO:0006873
GO:0071817;MMXD complex;466;96;GO:0005524
GO:0071818;BAT3 complex;384;139;GO:0048285
GO:0046859;hydrogenosomal membrane;1;2;GO:0005746
GO:0071815;intermediate-density lipoprotein particle binding;0;0;GO:0048193
GO:0071816;tail-anchored membrane protein insertion into ER membrane;4338;174;GO:0006612
GO:0007252;I-kappaB phosphorylation;3901;903;GO:0043406
GO:0034871;1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity;0;4;GO:0004091
GO:0007253;cytoplasmic sequestering of NF-kappaB;30;190;GO:0005615
GO:0034870;pinacolone 5-monooxygenase activity;0;2;GO:0004497
GO:0007250;activation of NF-kappaB-inducing kinase activity;46;879;GO:0043406
GO:0071819;DUBm complex;3378;24;GO:0005515
GO:0022886;channel-forming ionophore activity;0;1;GO:0048407
GO:0046854;phosphatidylinositol phosphate biosynthetic process;157128;530;GO:0006631
GO:0007254;JNK cascade;17749;2140;GO:0019458
GO:0046851;negative regulation of bone remodeling;740;310;GO:0048609
GO:0022889;serine transmembrane transporter activity;1439;386;GO:0005215
GO:0046852;positive regulation of bone remodeling;0;98;GO:0048609
GO:0022882;protein-N(PI)-phosphohistidine-beta-glucoside phosphotransferase system transporter activity;0;0;GO:0008565
GO:0046857;oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor;196560;10;GO:0004497
GO:1900931;positive regulation of L-tyrosine import across plasma membrane;0;0;GO:0048193
GO:0022883;zinc efflux transmembrane transporter activity;123;1;GO:0008544
GO:0046858;chlorosome;393;7;GO:0009579
GO:1900930;negative regulation of L-tyrosine import across plasma membrane;0;1;GO:0048193
GO:0007258;JUN phosphorylation;11;202;GO:0043406
GO:0022884;macromolecule transmembrane transporter activity;502922;57;GO:0005215
GO:1900933;negative regulation of nonadec-1-ene metabolic process;0;1;GO:0010468
GO:0007259;receptor signaling pathway via JAK-STAT;12070;217;GO:0007165
GO:0022885;bacteriocin transmembrane transporter activity;2030;3;GO:0005553
GO:0046856;phosphatidylinositol dephosphorylation;48217;1360;GO:0006631
GO:1900932;regulation of nonadec-1-ene metabolic process;0;0;GO:0010467
GO:0032209;positive regulation of telomere maintenance via recombination;0;3;GO:0045944
GO:1900924;negative regulation of glycine import across plasma membrane;10;3;GO:0046395
GO:0022890;inorganic cation transmembrane transporter activity;9000335;1560;GO:0005215
GO:1900923;regulation of glycine import across plasma membrane;12;0;GO:0006836
GO:0032207;regulation of telomere maintenance via recombination;139;9;GO:0045944
GO:1900926;regulation of L-threonine import across plasma membrane;0;0;GO:0006865
GO:0032208;negative regulation of telomere maintenance via recombination;139;16;GO:0045944
GO:0034869;2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity;0;3;GO:0006081
GO:1900925;positive regulation of glycine import across plasma membrane;2;1;GO:0046395
GO:0019241;citrulline catabolic process;0;2;GO:0006552
GO:0046860;glycosome membrane;16;3;GO:0005764
GO:1900928;positive regulation of L-threonine import across plasma membrane;0;0;GO:0046395
GO:0019240;citrulline biosynthetic process;406;516;GO:0006576
GO:0046861;glyoxysomal membrane;15;6;GO:0005764
GO:1900927;negative regulation of L-threonine import across plasma membrane;0;1;GO:0046395
GO:0019243;methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione;21506;373;GO:0046395
GO:0019242;methylglyoxal biosynthetic process;30384;112;GO:0006066
GO:1900929;regulation of L-tyrosine import across plasma membrane;0;0;GO:0006836
GO:0010897;negative regulation of triglyceride catabolic process;210;43;GO:0045944
GO:0019245;D(-)-lactate biosynthetic process from pyruvate;0;1;GO:0006099
GO:0032201;telomere maintenance via semi-conservative replication;252;2320;GO:0007050
GO:0034864;2,4,4-trimethylpentanal dehydrogenase activity;0;3;GO:0004091
GO:0010896;regulation of triglyceride catabolic process;1992;1190;GO:0045944
GO:0019244;lactate biosynthetic process from pyruvate;46;63;GO:0006096
GO:0032202;telomere assembly;204;149;GO:0000723
GO:0034863;2,4,4-trimethyl-1-pentanol dehydrogenase activity;0;3;GO:0004089
GO:0071810;regulation of fever generation by regulation of prostaglandin secretion;0;6;GO:0048608
GO:0010899;regulation of phosphatidylcholine catabolic process;124;44;GO:0046394
GO:0019247;lactate racemization;0;2;GO:0006099
GO:0034862;2,6-dihydroxybenzothiazole monooxygenase activity;0;2;GO:0004497
GO:0010898;positive regulation of triglyceride catabolic process;1758;248;GO:0045944
GO:0019246;L(+)-lactate biosynthetic process from pyruvate;1;0;GO:0006096
GO:0032200;telomere organization;93189;1950;GO:0007050
GO:0034861;benzothiazole-2-sulfonate hydrolase activity;0;5;GO:0004721
GO:0010893;positive regulation of steroid biosynthetic process;1188;149;GO:0045944
GO:0019249;lactate biosynthetic process;1533;43;GO:0006096
GO:0032205;negative regulation of telomere maintenance;2661;804;GO:0045944
GO:0034868;2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity;0;6;GO:0009086
GO:0071813;lipoprotein particle binding;2102;837;GO:0048193
GO:0010892;positive regulation of mitochondrial translation in response to stress;0;3;GO:0045944
GO:0019248;D-lactate biosynthetic process from methylglyoxal via (R)-lactaldehyde;0;0;GO:0046395
GO:0032206;positive regulation of telomere maintenance;4350;232;GO:0045944
GO:0034867;2,4,4-trimethylpent-2-enoyl-CoA hydratase activity;0;2;GO:0006081
GO:0071814;protein-lipid complex binding;2102;144;GO:0097159
GO:0010895;negative regulation of ergosterol biosynthetic process;5;5;GO:0010467
GO:0032203;telomere formation via telomerase;59;349;GO:0007049
GO:0034866;2,4,4-trimethylpentanoyl-CoA dehydrogenase activity;0;2;GO:0009086
GO:0071811;positive regulation of fever generation by positive regulation of prostaglandin biosynthesis;0;2;GO:0048608
GO:0010894;negative regulation of steroid biosynthetic process;1629;391;GO:0010468
GO:0032204;regulation of telomere maintenance;8335;870;GO:0007050
GO:0034865;2,4,4-trimethylpentanoate-CoA ligase activity;0;2;GO:0006081
GO:0071812;positive regulation of fever generation by positive regulation of prostaglandin secretion;102;9;GO:0048608
GO:0044209;AMP salvage;90595;362;GO:0009063
GO:0071806;protein transmembrane transport;1301110;576;GO:0015031
GO:0007260;tyrosine phosphorylation of STAT protein;3659;671;GO:0043406
GO:0044208;'de novo' AMP biosynthetic process;86963;305;GO:0009405
GO:0071807;replication fork arrest involved in DNA replication termination;13;2;GO:0007050
GO:0071805;potassium ion transmembrane transport;958368;3500;GO:0015075
GO:0007263;nitric oxide mediated signal transduction;1332;952;GO:0007165
GO:0022879;protein-N(PI)-phosphohistidine-trehalose phosphotransferase system transporter activity;0;0;GO:0005525
GO:0034860;2-mercaptobenzothiazole desulfurase activity;0;3;GO:0004723
GO:0007264;small GTPase mediated signal transduction;292564;9000;GO:0007264
GO:0071808;satellite fibril;0;1;GO:0048608
GO:0071809;regulation of fever generation by regulation of prostaglandin biosynthesis;0;0;GO:0048608
GO:0007267;cell-cell signaling;631590;10700;GO:0007267
GO:0022875;protein-N(PI)-phosphohistidine-galactitol phosphotransferase system transmembrane transporter activity;0;0;GO:0005525
GO:0044201;host cell nuclear inner membrane;2710;4;GO:0005634
GO:0046864;isoprenoid transport;10419;6;GO:0006869
GO:0007268;chemical synaptic transmission;219346;4710;GO:0007268
GO:0022876;protein-N(PI)-phosphohistidine-galactosamine phosphotransferase system transporter activity;0;0;GO:0008565
GO:0044200;host cell nuclear membrane;3057;5;GO:0005634
GO:0046865;terpenoid transport;10419;162;GO:0006810
GO:0007265;Ras protein signal transduction;105350;4350;GO:0007165
GO:0022877;protein-N(PI)-phosphohistidine-fructose phosphotransferase system transporter activity;21394;0;GO:0008565
GO:0044203;host cell nuclear lamina;233;2;GO:0005618
GO:0046862;chromoplast membrane;2;6;GO:0009908
GO:1900940;positive regulation of (Z)-nonadeca-1,14-diene metabolic process;0;0;GO:0046356
GO:0007266;Rho protein signal transduction;35142;2760;GO:0007165
GO:0022878;protein-N(PI)-phosphohistidine-sucrose phosphotransferase system transporter activity;0;0;GO:0008565
GO:0044202;host cell nuclear outer membrane;1;1;GO:0005634
GO:0046863;ribulose-1,5-bisphosphate carboxylase/oxygenase activator activity;1639;6;GO:0003754
GO:0022871;protein-N(PI)-phosphohistidine-sorbose phosphotransferase system transporter activity;46;0;GO:0005525
GO:0044205;'de novo' UMP biosynthetic process;314236;1160;GO:0009061
GO:0046868;mesosome;0;2;GO:0005764
GO:1900942;negative regulation of (Z)-nonadeca-1,14-diene biosynthetic process;0;0;GO:0010468
GO:0022872;protein-N(PI)-phosphohistidine-mannitol phosphotransferase system transmembrane transporter activity;6352;0;GO:0005525
GO:0044204;host cell nuclear matrix;1212;4;GO:0005634
GO:0046869;iron incorporation into iron-sulfur cluster via tris-L-cysteinyl-L-aspartato diiron disulfide;0;1;GO:0009086
GO:1900941;regulation of (Z)-nonadeca-1,14-diene biosynthetic process;0;0;GO:0010468
GO:0007269;neurotransmitter secretion;23118;4750;GO:0007611
GO:0022873;protein-N(PI)-phosphohistidine-maltose phosphotransferase system transporter activity;0;0;GO:0005525
GO:0044207;translation initiation ternary complex;5;7;GO:0006413
GO:0046866;tetraterpenoid transport;94;1;GO:0006810
GO:1900944;regulation of isoprene metabolic process;0;0;GO:0010468
GO:0022874;protein-N(PI)-phosphohistidine-cellobiose phosphotransferase system transporter activity;0;0;GO:0005525
GO:0044206;UMP salvage;48718;242;GO:0009063
GO:0046867;carotenoid transport;94;3;GO:0006869
GO:1900943;positive regulation of (Z)-nonadeca-1,14-diene biosynthetic process;0;0;GO:0046356
GO:1900935;regulation of nonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:1900934;positive regulation of nonadec-1-ene metabolic process;0;0;GO:0010468
GO:0022880;protein-N(PI)-phosphohistidine-N-acetylglucosamine phosphotransferase system transporter activity;0;0;GO:0008565
GO:0034859;benzothiazole monooxygenase activity;0;2;GO:0004497
GO:1900937;positive regulation of nonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:0022881;protein-N(PI)-phosphohistidine-N-acetylgalactosamine phosphotransferase system transporter activity;0;0;GO:0008565
GO:0034858;2-hydroxybenzothiazole monooxygenase activity;0;1;GO:0004497
GO:1900936;negative regulation of nonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:0019230;proprioception;246;96;GO:0007600
GO:0046871;N-acetylgalactosamine binding;48;1;GO:0042379
GO:1900939;negative regulation of (Z)-nonadeca-1,14-diene metabolic process;0;0;GO:0010468
GO:0046872;metal ion binding;37933098;54200;GO:0046872
GO:1900938;regulation of (Z)-nonadeca-1,14-diene metabolic process;0;0;GO:0010467
GO:0019232;perception of rate of movement;8;2;GO:0007600
GO:0044210;'de novo' CTP biosynthetic process;95371;319;GO:0006030
GO:0019231;perception of static position;0;3;GO:0007600
GO:0046870;cadmium ion binding;250;495;GO:0043167
GO:0019234;sensory perception of fast pain;0;5;GO:0007600
GO:0034853;2,4,4-trimethyl-3-oxopentanoate decarboxylase activity;0;3;GO:0006099
GO:0019233;sensory perception of pain;3641;2880;GO:0007600
GO:0034852;4,4-dimethyl-3-oxopentanal dehydrogenase activity;0;3;GO:0004467
GO:0019236;response to pheromone;15017;2970;GO:0009614
GO:0034851;2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity;0;2;GO:0006081
GO:0019235;sensory perception of slow pain;0;5;GO:0007600
GO:0034850;isooctane monooxygenase activity;0;3;GO:0004497
GO:0019238;cyclohydrolase activity;726678;122;GO:0004721
GO:0034857;2-(methylthio)benzothiazole monooxygenase activity;0;0;GO:0004497
GO:0071802;negative regulation of podosome assembly;2;49;GO:0048193
GO:0019237;centromeric DNA binding;3202;379;GO:0003677
GO:0034856;2-hydroxyhexa-2,4-dienoate hydratase activity;270;3;GO:0004467
GO:0071803;positive regulation of podosome assembly;499;491;GO:0048193
GO:0034855;4-AD 9alpha-hydroxylase activity;0;3;GO:0004041
GO:0071800;podosome assembly;895;162;GO:0030199
GO:0019239;deaminase activity;905577;1450;GO:0004553
GO:0034854;4,4-dimethyl-3-oxopentanoate decarboxylase activity;0;2;GO:0009065
GO:0071801;regulation of podosome assembly;664;305;GO:0030198
GO:0071839;apoptotic process in bone marrow cell;254;5;GO:0010941
GO:0019219;regulation of nucleobase-containing compound metabolic process;23841365;2250;GO:0045944
GO:0044219;host cell plasmodesma;3127;3;GO:0009986
GO:0010880;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;1265;1250;GO:0048407
GO:0071837;HMG box domain binding;599;856;GO:0030528
GO:0071838;cell proliferation in bone marrow;368;6;GO:0042127
GO:0009893;positive regulation of metabolic process;1594123;2830;GO:0050789
GO:0007231;osmosensory signaling pathway;1880;89;GO:0007608
GO:0009892;negative regulation of metabolic process;2826894;2350;GO:0050789
GO:0022869;protein-N(PI)-phosphohistidine-lactose phosphotransferase system transporter activity;831;0;GO:0005525
GO:0009891;positive regulation of biosynthetic process;1275143;3010;GO:0010468
GO:0009890;negative regulation of biosynthetic process;2664792;2670;GO:0010468
GO:0007234;osmosensory signaling via phosphorelay pathway;140;176;GO:0009416
GO:0009897;external side of plasma membrane;20051;12600;GO:0009986
GO:0046875;ephrin receptor binding;6841;925;GO:0005576
GO:0009896;positive regulation of catabolic process;186340;1790;GO:0050789
GO:0044211;CTP salvage;17341;43;GO:0006749
GO:0046876;3,4-didehydroretinal binding;0;1;GO:0043169
GO:0007232;osmosensory signaling pathway via Sho1 osmosensor;1360;9;GO:0009416
GO:0009895;negative regulation of catabolic process;24677;660;GO:0042346
GO:0046873;metal ion transmembrane transporter activity;1839318;2750;GO:0008565
GO:1900951;negative regulation of 18-methylnonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:0009894;regulation of catabolic process;294572;1620;GO:0042330
GO:0046874;quinolinate metabolic process;178275;68;GO:0009065
GO:1900950;regulation of 18-methylnonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:0046879;hormone secretion;21956;898;GO:0007548
GO:1900953;regulation of 18-methylnonadec-1-ene metabolic process;0;0;GO:0010468
GO:1900952;positive regulation of 18-methylnonadec-1-ene biosynthetic process;0;0;GO:0046356
GO:0009899;ent-kaurene synthase activity;112;9;GO:0004497
GO:0044218;other organism cell membrane;6888;89;GO:0016021
GO:0046877;regulation of saliva secretion;286;21;GO:0007599
GO:1900955;positive regulation of 18-methylnonadec-1-ene metabolic process;0;0;GO:0046356
GO:0009898;cytoplasmic side of plasma membrane;78265;2980;GO:0009986
GO:0044217;other organism part;6977;133;GO:0044421
GO:0046878;positive regulation of saliva secretion;117;44;GO:0050877
GO:1900954;negative regulation of 18-methylnonadec-1-ene metabolic process;0;1;GO:0010468
GO:1900946;positive regulation of isoprene metabolic process;0;0;GO:0010468
GO:0034849;2-naphthoate CoA-transferase activity;0;2;GO:0004073
GO:1900945;negative regulation of isoprene metabolic process;0;0;GO:0010468
GO:0007229;integrin-mediated signaling pathway;61365;6360;GO:0007229
GO:0034848;naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity;0;2;GO:0006081
GO:1900948;negative regulation of isoprene biosynthetic process;0;1;GO:0010468
GO:0022870;protein-N(PI)-phosphohistidine-mannose phosphotransferase system transporter activity;4;0;GO:0005525
GO:0034847;naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity;0;5;GO:0009065
GO:1900947;regulation of isoprene biosynthetic process;0;0;GO:0010468
GO:0010879;cholesterol transport involved in cholesterol storage;76;5;GO:0006869
GO:0046882;negative regulation of follicle-stimulating hormone secretion;74;56;GO:0048193
GO:0010878;cholesterol storage;1159;103;GO:0006836
GO:0046883;regulation of hormone secretion;14853;1110;GO:0048608
GO:1900949;positive regulation of isoprene biosynthetic process;0;0;GO:0010468
GO:0019221;cytokine-mediated signaling pathway;307399;13000;GO:0007186
GO:0044221;host cell synapse;5207;3;GO:0048608
GO:0046880;regulation of follicle-stimulating hormone secretion;293;95;GO:0048193
GO:0019220;regulation of phosphate metabolic process;125289;3140;GO:0045735
GO:0044220;host cell perinuclear region of cytoplasm;19212;10;GO:0005737
GO:0046881;positive regulation of follicle-stimulating hormone secretion;142;52;GO:0048193
GO:0010875;positive regulation of cholesterol efflux;1414;996;GO:0045727
GO:0034842;thiophene-2-carboxylate-CoA ligase activity;0;2;GO:0006081
GO:0071831;intermediate-density lipoprotein particle clearance;88;6;GO:0043169
GO:0010874;regulation of cholesterol efflux;2104;342;GO:0045727
GO:0019222;regulation of metabolic process;29231351;5700;GO:0050789
GO:0034841;mentha-1,3-dione-CoA ligase activity;0;1;GO:0004497
GO:0010877;lipid transport involved in lipid storage;189;125;GO:0006629
GO:0034840;3-hydroxymenthone dehydrogenase activity;0;3;GO:0004091
GO:0010876;lipid localization;665745;2070;GO:0006631
GO:0071830;triglyceride-rich lipoprotein particle clearance;475;33;GO:0048193
GO:0019227;neuronal action potential propagation;494;3860;GO:0048666
GO:0034846;naphthyl-2-methylene-succinyl-CoA lyase activity;0;1;GO:0006081
GO:0071835;mating pheromone secretion involved in regulation of conjugation with cellular fusion;0;0;GO:0048305
GO:0019226;transmission of nerve impulse;3755;5040;GO:0048666
GO:0034845;naphthyl-2-methyl-succinyl-CoA dehydrogenase activity;0;3;GO:0004073
GO:0071836;nectar secretion;84;3;GO:0005975
GO:0019229;regulation of vasoconstriction;11024;955;GO:0002026
GO:0034844;naphthyl-2-methyl-succinate CoA-transferase activity;0;2;GO:0004073
GO:0019228;neuronal action potential;1761;2760;GO:0007631
GO:0034843;2-oxoglutaryl-CoA thioesterase activity;0;3;GO:0006081
GO:0071834;mating pheromone secretion;13;0;GO:0009414
GO:0019209;kinase activator activity;26371;1120;GO:0030528
GO:0071828;apolipoprotein E recycling;0;3;GO:0006836
GO:0019208;phosphatase regulator activity;115728;701;GO:0010468
GO:0071829;plasma lipoprotein particle disassembly;0;0;GO:0048193
GO:0010891;negative regulation of sequestering of triglyceride;431;117;GO:0010467
GO:0071826;protein-RNA complex organization;620790;3;GO:0003735
GO:0010890;positive regulation of sequestering of triglyceride;456;339;GO:0010467
GO:0071827;plasma lipoprotein particle organization;4448;495;GO:0006629
GO:0022857;transmembrane transporter activity;23745542;11300;GO:0005215
GO:0022858;alanine transmembrane transporter activity;1121;32;GO:0005215
GO:0022859;dephosphorylation-gated channel activity;0;0;GO:0048169
GO:0022853;active monoatomic ion transmembrane transporter activity;6407406;22;GO:0008565
GO:0044223;pirellulosome;0;2;GO:0016021
GO:0046886;positive regulation of hormone biosynthetic process;438;886;GO:0030518
GO:1900960;negative regulation of 17-methylnonadec-1-ene metabolic process;0;0;GO:0010468
GO:0044222;anammoxosome;11;2;GO:0042726
GO:0046887;positive regulation of hormone secretion;6849;956;GO:0030518
GO:0022855;protein-N(PI)-phosphohistidine-glucose phosphotransferase system transporter activity;1;0;GO:0008565
GO:0044225;apical pole of neuron;42;4;GO:0043005
GO:0046884;follicle-stimulating hormone secretion;362;189;GO:0007548
GO:1900962;regulation of methanophenazine biosynthetic process;0;0;GO:0046395
GO:0022856;protein-N(PI)-phosphohistidine-sorbitol phosphotransferase system transporter activity;0;0;GO:0005525
GO:0044224;juxtaparanode region of axon;606;548;GO:0043005
GO:0046885;regulation of hormone biosynthetic process;1703;70;GO:0030522
GO:1900961;positive regulation of 17-methylnonadec-1-ene metabolic process;0;1;GO:0010468
GO:0007249;canonical NF-kappaB signal transduction;38574;317;GO:0043409
GO:0044227;methane-oxidizing organelle;0;1;GO:0009536
GO:1900964;positive regulation of methanophenazine biosynthetic process;0;0;GO:0046395
GO:0022850;serotonin-gated monoatomic cation-selective channel activity;283;2;GO:0005216
GO:0044226;basal pole of neuron;0;3;GO:0097458
GO:1900963;negative regulation of methanophenazine biosynthetic process;0;0;GO:0046395
GO:0022851;GABA-gated chloride ion channel activity;874;124;GO:0022836
GO:0044229;host cell periplasmic space;1328;2;GO:0005615
GO:0046888;negative regulation of hormone secretion;3053;405;GO:0048608
GO:1900966;negative regulation of methanophenazine metabolic process;0;2;GO:0046395
GO:0022852;glycine-gated chloride ion channel activity;124;3;GO:0005216
GO:0044228;host cell surface;13010;139;GO:0005615
GO:0046889;positive regulation of lipid biosynthetic process;5343;1180;GO:0045944
GO:1900965;regulation of methanophenazine metabolic process;0;1;GO:0046395
GO:0034839;menth-2-enone hydratase activity;0;2;GO:0004497
GO:1900957;negative regulation of 17-methylnonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:0034838;menthone dehydrogenase activity;0;2;GO:0004497
GO:0046890;regulation of lipid biosynthetic process;27773;1130;GO:0045944
GO:1900956;regulation of 17-methylnonadec-1-ene biosynthetic process;0;0;GO:0010468
GO:0034837;2-mercaptobenzothiazole-cis-6,7-dihydrodiol dehydrogenase activity;0;3;GO:0004067
GO:1900959;regulation of 17-methylnonadec-1-ene metabolic process;0;0;GO:0010467
GO:0034836;6-hydroxy-2-mercaptobenzothiazole monooxygenase activity;0;3;GO:0004497
GO:1900958;positive regulation of 17-methylnonadec-1-ene biosynthetic process;0;0;GO:0046356
GO:0044230;host cell envelope;1;2;GO:0009277
GO:0046893;iron incorporation into hydrogenase diiron subcluster via L-cysteine ligation;0;3;GO:0009086
GO:0010889;regulation of sequestering of triglyceride;901;578;GO:0010467
GO:0019210;kinase inhibitor activity;97127;730;GO:0030521
GO:0044232;organelle membrane contact site;20647;42;GO:0005737
GO:0046891;peptidyl-cysteine S-carbamoylation;0;2;GO:0006483
GO:0044231;host cell presynaptic membrane;5196;5;GO:0048471
GO:0046892;peptidyl-S-carbamoyl-L-cysteine dehydration;0;3;GO:0006457
GO:0010886;positive regulation of cholesterol storage;390;256;GO:0010467
GO:0019212;phosphatase inhibitor activity;49325;204;GO:0004721
GO:0034831;(R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity;0;2;GO:0004073
GO:0071820;N-box binding;72;8;GO:0005515
GO:0010885;regulation of cholesterol storage;833;666;GO:0032963
GO:0019211;phosphatase activator activity;8478;329;GO:0004723
GO:0034830;(2Z)-2,4-dihydroxydec-2-enedioate aldolase activity;0;0;GO:0006099
GO:0071821;FANCM-MHF complex;2734;130;GO:0005524
GO:0010888;negative regulation of lipid storage;1265;1860;GO:0045944
GO:0010887;negative regulation of cholesterol storage;443;546;GO:0010467
GO:0019213;deacetylase activity;373682;655;GO:0016525
GO:0010882;regulation of cardiac muscle contraction by calcium ion signaling;950;1110;GO:0048407
GO:0019216;regulation of lipid metabolic process;46802;3740;GO:0019216
GO:0034835;2-mercaptobenzothiazole monooxygenase activity;0;3;GO:0004497
GO:0071824;protein-DNA complex organization;1657813;6;GO:0043234
GO:0010881;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;442;471;GO:0048407
GO:0019215;intermediate filament binding;1267;385;GO:0048471
GO:0034834;2-mercaptobenzothiazole dioxygenase activity;0;4;GO:0004497
GO:0071825;protein-lipid complex organization;4694;1;GO:0043231
GO:0010884;positive regulation of lipid storage;1583;596;GO:0045944
GO:0019218;regulation of steroid metabolic process;5806;1150;GO:0010468
GO:0034833;geranylate CoA-transferase activity;0;1;GO:0004067
GO:0010883;regulation of lipid storage;3402;986;GO:0006631
GO:0019217;regulation of fatty acid metabolic process;16307;942;GO:0006631
GO:0034832;geranial dehydrogenase activity;1;2;GO:0004497
GO:0071823;protein-carbohydrate complex subunit organization;0;1;GO:0005576
GO:0007292;female gamete generation;32578;1290;GO:0007276
GO:0046817;chemokine receptor antagonist activity;4;10;GO:0004872
GO:0007293;germarium-derived egg chamber formation;1540;100;GO:0008544
GO:0046818;dense nuclear body;0;1;GO:0005829
GO:0007290;spermatid nucleus elongation;210;31;GO:0048704
GO:0007291;sperm individualization;741;380;GO:0006940
GO:0046816;virion transport vesicle;0;2;GO:0005740
GO:0007296;vitellogenesis;366;173;GO:0008544
GO:0032252;secretory granule localization;395;413;GO:0005829
GO:0007297;follicle cell of egg chamber migration;2002;3;GO:0048608
GO:0032253;dense core granule localization;252;6;GO:0005829
GO:0007294;germarium-derived oocyte fate determination;378;93;GO:0007492
GO:0032250;negative regulation of adenosine transport;0;2;GO:0006874
GO:0046819;protein secretion by the type V secretion system;31;159;GO:0055085
GO:0007295;growth of a germarium-derived egg chamber;149;145;GO:0048608
GO:0032251;positive regulation of adenosine transport;0;1;GO:0006874
GO:0046810;host cell extracellular matrix binding;7;3;GO:0044421
GO:0007298;border follicle cell migration;1736;179;GO:0048608
GO:0007299;follicle cell of egg chamber-cell adhesion;71;4;GO:0005916
GO:0046813;receptor-mediated virion attachment to host cell;17634;380;GO:0048193
GO:0046814;coreceptor-mediated virion attachment to host cell;57;7;GO:0042803
GO:0046811;histone deacetylase inhibitor activity;15;3;GO:0016564
GO:0046812;host cell surface binding;295744;74;GO:0048193
GO:0019281;L-methionine biosynthetic process from homoserine via O-succinyl-L-homoserine and cystathionine;10851;5;GO:0009065
GO:0019280;L-methionine biosynthetic process from homoserine via O-acetyl-L-homoserine and cystathionine;69;3;GO:0009065
GO:0019283;L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine;0;1;GO:0009065
GO:0019285;glycine betaine biosynthetic process from choline;47452;394;GO:0009065
GO:0019284;L-methionine salvage from S-adenosylmethionine;51237;8;GO:0009065
GO:0019287;isopentenyl diphosphate biosynthetic process, mevalonate pathway;30541;476;GO:0006096
GO:0019286;glycine betaine biosynthetic process from glycine;14;4;GO:0009065
GO:0019289;rhizobactin 1021 biosynthetic process;6;6;GO:0009405
GO:0032245;regulation of purine nucleoside transport;0;2;GO:0006873
GO:0019288;isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway;257965;1450;GO:0006096
GO:0032246;regulation of pyrimidine nucleoside transport;0;1;GO:0008529
GO:0032243;negative regulation of nucleoside transport;21;3;GO:0008529
GO:0032244;positive regulation of nucleoside transport;4;5;GO:0048285
GO:0032249;regulation of adenosine transport;0;2;GO:0006873
GO:0032247;negative regulation of purine nucleoside transport;0;1;GO:0010425
GO:0032248;positive regulation of purine nucleoside transport;0;2;GO:0048285
GO:0046828;regulation of RNA import into nucleus;19;2;GO:0010467
GO:0046829;negative regulation of RNA import into nucleus;0;2;GO:0010467
GO:0046826;negative regulation of protein export from nucleus;293;271;GO:0022627
GO:0046827;positive regulation of protein export from nucleus;1137;850;GO:0022627
GO:0032241;positive regulation of nucleobase-containing compound transport;310;10;GO:0045765
GO:0032242;regulation of nucleoside transport;25;7;GO:0006873
GO:0032240;negative regulation of nucleobase-containing compound transport;145;7;GO:0045765
GO:0046820;4-amino-4-deoxychorismate synthase activity;17287;103;GO:0006099
GO:0046821;extrachromosomal DNA;1619;3;GO:0005629
GO:0046824;positive regulation of nucleocytoplasmic transport;3707;590;GO:0010467
GO:0046825;regulation of protein export from nucleus;1925;464;GO:0006887
GO:0046822;regulation of nucleocytoplasmic transport;6735;1110;GO:0010467
GO:1900900;negative regulation of heptadecane metabolic process;0;0;GO:0046356
GO:0046823;negative regulation of nucleocytoplasmic transport;1067;44;GO:0010467
GO:0019270;aerobactin biosynthetic process;10;4;GO:0009405
GO:0019272;L-alanine biosynthetic process from pyruvate;2;3;GO:0006066
GO:0019271;aerobactin transport;3;3;GO:0008544
GO:0019273;L-alanine biosynthetic process via ornithine;0;3;GO:0006559
GO:0019276;UDP-N-acetylgalactosamine metabolic process;50143;51;GO:0006032
GO:0019278;UDP-N-acetylgalactosamine catabolic process;0;4;GO:0006032
GO:0034897;4-(1-ethyl-1,4-dimethyl-pentyl)phenol monooxygenase activity;0;0;GO:0004497
GO:0019277;UDP-N-acetylgalactosamine biosynthetic process;49894;8;GO:0006029
GO:0034896;3-formiminopyruvate hydrolase activity;0;3;GO:0006066
GO:0032232;negative regulation of actin filament bundle assembly;1523;119;GO:0048010
GO:0034895;pyridine-3,4-diol dioxygenase activity;0;3;GO:0004497
GO:0019279;L-methionine biosynthetic process from L-homoserine via cystathionine;10923;3;GO:0009065
GO:0032233;positive regulation of actin filament bundle assembly;3037;495;GO:0048010
GO:0034894;4-hydroxypyridine-3-hydroxylase activity;0;3;GO:0004073
GO:0032238;adenosine transport;482;8;GO:0006873
GO:0032239;regulation of nucleobase-containing compound transport;985;7;GO:0006865
GO:0034899;trimethylamine monooxygenase activity;522;9;GO:0004497
GO:0032237;activation of store-operated calcium channel activity;23;62;GO:0008092
GO:0034898;hexadecyltrimethylammonium chloride monooxygenase activity;0;2;GO:0004497
GO:0007270;neuron-neuron synaptic transmission;223;1960;GO:0007268
GO:0046839;phospholipid dephosphorylation;49213;535;GO:0006631
GO:0007271;synaptic transmission, cholinergic;24437;1360;GO:0007268
GO:0007274;neuromuscular synaptic transmission;2235;2060;GO:0007268
GO:0032230;positive regulation of synaptic transmission, GABAergic;488;1200;GO:0048167
GO:0034893;N-nitrodimethylamine hydroxylase activity;0;2;GO:0004497
GO:0007275;multicellular organism development;1598635;11300;GO:0007275
GO:0032231;regulation of actin filament bundle assembly;5428;144;GO:0050921
GO:0034892;endosulfan lactone lactonase activity;0;2;GO:0046274
GO:0007272;ensheathment of neurons;9727;1410;GO:0048666
GO:0034891;endosulfan diol dehydrogenase activity;0;4;GO:0004073
GO:0034890;endosulfan diol hydrolyase (cyclizing) activity;0;2;GO:0008037
GO:0007278;pole cell fate determination;55;5;GO:0048608
GO:0046831;regulation of RNA export from nucleus;939;1790;GO:0022627
GO:0007279;pole cell formation;201;404;GO:0048285
GO:0046832;negative regulation of RNA export from nucleus;123;19;GO:0010467
GO:0007276;gamete generation;110421;2470;GO:0007283
GO:0007277;pole cell development;389;18;GO:0048608
GO:0046830;positive regulation of RNA import into nucleus;19;2;GO:0010467
GO:0046835;carbohydrate phosphorylation;1289750;1380;GO:0006470
GO:0046836;glycolipid transport;533;125;GO:0006869
GO:0046833;positive regulation of RNA export from nucleus;287;164;GO:0010467
GO:1900911;regulation of olefin biosynthetic process;217;2;GO:1901363
GO:0046834;lipid phosphorylation;754;1220;GO:0006631
GO:1900910;positive regulation of olefin metabolic process;15;0;GO:0046394
GO:1900902;regulation of hexadecanal biosynthetic process;0;0;GO:0046395
GO:1900901;positive regulation of heptadecane metabolic process;0;1;GO:0046356
GO:0019261;1,4-dichlorobenzene catabolic process;0;3;GO:0006559
GO:0032229;negative regulation of synaptic transmission, GABAergic;90;1970;GO:0048167
GO:1900904;positive regulation of hexadecanal biosynthetic process;0;0;GO:0046395
GO:0019260;1,2-dichloroethane catabolic process;2;5;GO:0006559
GO:1900903;negative regulation of hexadecanal biosynthetic process;0;2;GO:0046655
GO:0019263;adamantanone catabolic process;0;3;GO:0009065
GO:1900906;negative regulation of hexadecanal metabolic process;0;0;GO:0046655
GO:0019262;N-acetylneuraminate catabolic process;24753;36;GO:0009065
GO:1900905;regulation of hexadecanal metabolic process;0;1;GO:0046655
GO:0019265;glycine biosynthetic process, by transamination of glyoxylate;278;109;GO:0006569
GO:1900908;regulation of olefin metabolic process;217;2;GO:0046394
GO:0019264;glycine biosynthetic process from serine;120232;311;GO:0006541
GO:1900907;positive regulation of hexadecanal metabolic process;0;1;GO:0046356
GO:0019267;asparagine biosynthetic process from cysteine;0;3;GO:0006559
GO:0032223;negative regulation of synaptic transmission, cholinergic;52;183;GO:0048666
GO:0034886;gamma-aminovinylacetate deaminase activity;0;4;GO:0004497
GO:0019266;asparagine biosynthetic process from oxaloacetate;1;4;GO:0006559
GO:0032224;positive regulation of synaptic transmission, cholinergic;250;413;GO:0048167
GO:0034885;gamma-N-formylaminovinylacetate hydrolase activity;0;2;GO:0004479
GO:1900909;negative regulation of olefin metabolic process;122;0;GO:0046274
GO:0032221;Rpd3S complex;180;6;GO:0048309
GO:0032222;regulation of synaptic transmission, cholinergic;7200;26;GO:0007268
GO:0032227;negative regulation of synaptic transmission, dopaminergic;12;31;GO:0048167
GO:0032228;regulation of synaptic transmission, GABAergic;1603;1340;GO:0048167
GO:0034889;endosulfan hemisulfate sulfatase activity;0;3;GO:0004730
GO:0032225;regulation of synaptic transmission, dopaminergic;273;268;GO:0007268
GO:0034888;endosulfan monooxygenase I activity;0;1;GO:0004497
GO:0032226;positive regulation of synaptic transmission, dopaminergic;167;949;GO:0048167
GO:0007281;germ cell development;47388;2990;GO:0007283
GO:0007282;cystoblast division;185;24;GO:0048285
GO:0046848;hydroxyapatite binding;74;33;GO:0005576
GO:0007280;pole cell migration;161;169;GO:0048608
GO:0046849;bone remodeling;6069;1090;GO:0048608
GO:0007285;primary spermatocyte growth;49;53;GO:0048608
GO:0034882;cis-aconitamide amidase activity;0;2;GO:0006032
GO:0007286;spermatid development;14413;2890;GO:0007283
GO:0032220;plasma membrane fusion involved in cytogamy;88;7;GO:0009986
GO:0034881;citrazinate hydrolase activity;0;2;GO:0004553
GO:0007283;spermatogenesis;55429;9710;GO:0007283
GO:0034880;citrazinate dehydrogenase activity;0;1;GO:0009065
GO:0007284;spermatogonial cell division;193;53;GO:0051327
GO:0007289;spermatid nucleus differentiation;1949;1340;GO:0048704
GO:0022897;proton-dependent peptide secondary active transmembrane transporter activity;0;9;GO:0008544
GO:0046842;trisporic acid biosynthetic process;2;2;GO:1901363
GO:0022898;regulation of transmembrane transporter activity;1136;514;GO:0005215
GO:0046843;dorsal appendage formation;556;157;GO:0048608
GO:0007287;Nebenkern assembly;30;6;GO:0043161
GO:0007288;sperm axoneme assembly;1934;584;GO:0005576
GO:0046841;trisporic acid metabolic process;2;4;GO:0006073
GO:0022893;low-affinity tryptophan transmembrane transporter activity;2;2;GO:0005215
GO:0022894;Intermediate conductance calcium-activated potassium channel activity;19;3;GO:0008092
GO:0046847;filopodium assembly;3866;1090;GO:0048608
GO:0046844;chorion micropyle formation;43;1;GO:0008544
GO:0046845;branched duct epithelial cell fate determination, open tracheal system;0;30;GO:0048704
GO:1900913;positive regulation of olefin biosynthetic process;15;0;GO:0046394
GO:1900912;negative regulation of olefin biosynthetic process;122;0;GO:0046274
GO:0019250;aerobic cobalamin biosynthetic process;1;4;GO:0009065
GO:0032218;riboflavin transport;38325;71;GO:0006869
GO:1900915;negative regulation of octadecene biosynthetic process;0;0;GO:0010468
GO:0032219;cell wall macromolecule catabolic process involved in cytogamy;0;3;GO:0046274
GO:1900914;regulation of octadecene biosynthetic process;0;0;GO:0046395
GO:0019252;starch biosynthetic process;25784;1020;GO:0005976
GO:1900917;regulation of octadecene metabolic process;0;0;GO:0010467
GO:0019251;anaerobic cobalamin biosynthetic process;6379;5;GO:0009061
GO:0046850;regulation of bone remodeling;2320;332;GO:0048609
GO:1900916;positive regulation of octadecene biosynthetic process;0;0;GO:0046395
GO:0019254;carnitine metabolic process, CoA-linked;215;119;GO:0006631
GO:1900919;positive regulation of octadecene metabolic process;0;0;GO:0046356
GO:0019253;reductive pentose-phosphate cycle;209152;285;GO:0006096
GO:1900918;negative regulation of octadecene metabolic process;0;0;GO:0046274
GO:0019256;acrylonitrile catabolic process;0;1;GO:0009065
GO:0032212;positive regulation of telomere maintenance via telomerase;1614;702;GO:0045944
GO:0034875;caffeine oxidase activity;595;318;GO:0004497
GO:0019255;glucose 1-phosphate metabolic process;22;108;GO:0006094
GO:0032213;regulation of telomere maintenance via semi-conservative replication;60;6;GO:0045944
GO:0034874;thioacetamide S-oxide S-oxygenase activity;0;2;GO:0004746
GO:0019258;4-nitrotoluene catabolic process;0;2;GO:0009065
GO:0032210;regulation of telomere maintenance via telomerase;3301;614;GO:0007050
GO:0034873;thioacetamide S-oxygenase activity;0;1;GO:0004784
GO:0019257;4-nitrotoluene metabolic process;0;2;GO:0006749
GO:0032211;negative regulation of telomere maintenance via telomerase;1366;337;GO:0045944
GO:0034872;trans-geranyl-CoA isomerase activity;0;3;GO:0004497
GO:0032216;glucosaminyl-phosphatidylinositol O-acyltransferase activity;111;1;GO:0004866
GO:0034879;2,3,6-trihydroxyisonicotinate decarboxylase activity;0;3;GO:0006073
GO:0032217;riboflavin transmembrane transporter activity;19213;18;GO:0005525
GO:0034878;2-hydroxyisonicotinate dehydrogenase activity;0;2;GO:0004067
GO:0032214;negative regulation of telomere maintenance via semi-conservative replication;2;8;GO:0045944
GO:0034877;isonicotinate dehydrogenase activity;0;2;GO:0004073
GO:0032215;positive regulation of telomere maintenance via semi-conservative replication;58;2;GO:0045944
GO:0034876;isonicotinic acid hydrazide hydrolase activity;0;1;GO:0004553
GO:0032292;peripheral nervous system axon ensheathment;1489;482;GO:0048666
GO:0032293;non-myelinated axon ensheathment in central nervous system;0;1;GO:0048666
GO:0032290;peripheral nervous system myelin formation;71;80;GO:0048666
GO:0032291;axon ensheathment in central nervous system;1288;1300;GO:0048666
GO:0032296;double-stranded RNA-specific ribonuclease activity;157066;37;GO:0004518
GO:0032297;negative regulation of DNA-templated DNA replication initiation;12763;52;GO:0045727
GO:0032294;peripheral nervous system non-myelinated axon ensheathment;0;1;GO:0043005
GO:0032295;ensheathment of neuronal cell bodies;0;2;GO:0048666
GO:0044277;cell wall disassembly;52;21;GO:0042546
GO:0044281;small molecule metabolic process;59978104;7770;GO:0044281
GO:0044280;subplasmalemmal coating;2;3;GO:0009986
GO:0071890;bicarbonate binding;56;3;GO:0043169
GO:0044283;small molecule biosynthetic process;25640401;3270;GO:0009058
GO:0044282;small molecule catabolic process;2943601;2570;GO:0046274
GO:0044284;mitochondrial crista junction;1077;18;GO:0005743
GO:0071894;histone H2B conserved C-terminal lysine ubiquitination;0;28;GO:0016567
GO:0071891;N-terminal peptidyl-proline dimethylation involved in translation;0;2;GO:0006464
GO:0044286;peg and socket contact;0;2;GO:0005576
GO:0071892;thrombocyte activation;0;3;GO:0002576
GO:0032289;central nervous system myelin formation;315;42;GO:0048666
GO:0071897;DNA biosynthetic process;4561028;1740;GO:0009059
GO:0032287;peripheral nervous system myelin maintenance;466;584;GO:0048704
GO:0071895;odontoblast differentiation;429;172;GO:0030900
GO:0032288;myelin assembly;910;335;GO:0048193
GO:0071896;protein localization to adherens junction;367;175;GO:0005912
GO:0032281;AMPA glutamate receptor complex;1198;560;GO:0008066
GO:0032282;plastid acetyl-CoA carboxylase complex;0;4;GO:0009536
GO:0032280;symmetric synapse;73;98;GO:0045202
GO:0032285;non-myelinated axon ensheathment;1;1;GO:0048666
GO:0032286;central nervous system myelin maintenance;173;109;GO:0048666
GO:0032283;plastid acetate CoA-transferase complex;0;2;GO:0009536
GO:0044289;mitochondrial inner-outer membrane contact site;2;3;GO:0005743
GO:0044288;puncta adhaerentia;0;3;GO:0005923
GO:0044292;dendrite terminus;527;31;GO:0097403
GO:0044291;cell-cell contact zone;3771;883;GO:0005911
GO:0044294;dendritic growth cone;190;110;GO:0048608
GO:0044293;dendriole;0;1;GO:0048608
GO:0044296;dendritic tuft;0;2;GO:0030425
GO:0071882;phospholipase C-activating adrenergic receptor signaling pathway;46;5;GO:0007186
GO:0044295;axonal growth cone;1113;816;GO:0048666
GO:0071883;MAPK-activating adrenergic receptor signaling pathway;0;1;GO:0007186
GO:0044298;cell body membrane;1035;60;GO:0048471
GO:0071880;adenylate cyclase-activating adrenergic receptor signaling pathway;905;950;GO:0007218
GO:0044297;cell body;36129;2140;GO:0097458
GO:0071881;adenylate cyclase-inhibiting adrenergic receptor signaling pathway;151;4;GO:0007218
GO:0032278;positive regulation of gonadotropin secretion;258;8;GO:0048608
GO:0071886;1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding;115;0;GO:0043169
GO:0032279;asymmetric synapse;26792;883;GO:0008076
GO:0071887;leukocyte apoptotic process;7417;715;GO:0006915
GO:0032276;regulation of gonadotropin secretion;562;24;GO:0048608
GO:0032277;negative regulation of gonadotropin secretion;225;96;GO:0048608
GO:0071885;N-terminal protein N-methyltransferase activity;1230;77;GO:0004725
GO:0044290;mitochondrial intracristal space;0;2;GO:0005740
GO:0071888;macrophage apoptotic process;269;21;GO:0043066
GO:0071889;14-3-3 protein binding;1342;641;GO:0005515
GO:0032271;regulation of protein polymerization;101696;491;GO:0010467
GO:0032274;gonadotropin secretion;850;382;GO:0007596
GO:0032275;luteinizing hormone secretion;307;204;GO:0007548
GO:0032272;negative regulation of protein polymerization;76691;231;GO:0010467
GO:0032273;positive regulation of protein polymerization;5341;743;GO:0010467
GO:0044299;C-fiber;54;8;GO:0002376
GO:0032267;tRNA(Ile)-lysidine synthase activity;1;0;GO:0006413
GO:0032265;XMP salvage;12234;3;GO:0009060
GO:0032266;phosphatidylinositol-3-phosphate binding;17393;978;GO:0097367
GO:0032260;response to jasmonic acid stimulus involved in jasmonic acid and ethylene-dependent systemic resistance;9;3;GO:0009737
GO:0032263;GMP salvage;11154;7;GO:0009063
GO:0032264;IMP salvage;50930;324;GO:0009063
GO:0032261;purine nucleotide salvage;165287;241;GO:0009063
GO:0032262;pyrimidine nucleotide salvage;66063;7;GO:0006793
GO:0019290;siderophore biosynthetic process;60060;234;GO:0009405
GO:0019292;tyrosine biosynthetic process from chorismate via 4-hydroxyphenylpyruvate;1;2;GO:0006559
GO:0019294;keto-3-deoxy-D-manno-octulosonic acid biosynthetic process;18078;17;GO:0009405
GO:0019293;tyrosine biosynthetic process, by oxidation of phenylalanine;34575;8;GO:0006559
GO:0019296;coenzyme M metabolic process;1398;3;GO:0006790
GO:0019295;coenzyme M biosynthetic process;1398;9;GO:0009061
GO:0019298;coenzyme B biosynthetic process;275;5;GO:0006749
GO:0019297;coenzyme B metabolic process;275;3;GO:0006749
GO:0032256;establishment of dense core granule localization;0;2;GO:0048471
GO:0019299;rhamnose metabolic process;70799;16;GO:0006073
GO:0032257;maintenance of dense core granule location;0;2;GO:0048471
GO:0032254;establishment of secretory granule localization;7;3;GO:0005764
GO:0032255;maintenance of secretory granule location;0;2;GO:0006979
GO:0032258;cytoplasm to vacuole transport by the Cvt pathway;395;30;GO:0006836
GO:0032259;methylation;8227526;6330;GO:0045840
GO:0071859;neuropeptide F receptor binding;14;4;GO:0005509
GO:0046897;N-terminal peptidyl-tyrosine methylation;0;2;GO:0016567
GO:1900971;regulation of sarcinapterin biosynthetic process;0;0;GO:0010468
GO:0044233;mitochondria-associated endoplasmic reticulum membrane;12959;144;GO:0005743
GO:0046898;response to cycloheximide;118;140;GO:0009628
GO:1900970;positive regulation of sarcinapterin metabolic process;0;0;GO:0045944
GO:0046895;N-terminal peptidyl-isoleucine methylation;0;3;GO:0046395
GO:1900973;positive regulation of sarcinapterin biosynthetic process;0;0;GO:0046395
GO:0046896;N-terminal peptidyl-leucine methylation;0;2;GO:0006468
GO:1900972;negative regulation of sarcinapterin biosynthetic process;0;0;GO:0010468
GO:0044238;primary metabolic process;178528819;14900;GO:0044237
GO:1900975;negative regulation of tatiopterin biosynthetic process;0;0;GO:0010468
GO:0044237;cellular metabolic process;208730459;11200;GO:0044237
GO:1900974;regulation of tatiopterin biosynthetic process;0;0;GO:0010468
GO:0046899;nucleoside triphosphate adenylate kinase activity;5173;98;GO:0005524
GO:1900977;regulation of tatiopterin metabolic process;0;1;GO:0010468
GO:1900976;positive regulation of tatiopterin biosynthetic process;0;0;GO:0010468
GO:1900968;regulation of sarcinapterin metabolic process;0;1;GO:0010468
GO:1900967;positive regulation of methanophenazine metabolic process;0;1;GO:0046356
GO:1900969;negative regulation of sarcinapterin metabolic process;0;1;GO:0046395
GO:0044241;lipid digestion;918;299;GO:0007586
GO:0044242;cellular lipid catabolic process;248024;1750;GO:0006631
GO:0071853;fungal-type cell wall disassembly;48;3;GO:0046395
GO:0071854;cell wall macromolecule catabolic process involved in fungal-type cell wall disassembly;6;1;GO:0046274
GO:0071852;fungal-type cell wall organization or biogenesis;12012;255;GO:0071555
GO:0071857;beta-endorphin receptor binding;0;0;GO:0005126
GO:0071858;corazonin receptor binding;220;2;GO:0005509
GO:0071855;neuropeptide receptor binding;5780;525;GO:0005509
GO:0071848;positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling;106;8;GO:0043406
GO:1900980;regulation of phenazine biosynthetic process;0;0;GO:0046274
GO:0044245;polysaccharide digestion;4;511;GO:0005985
GO:1900982;positive regulation of phenazine biosynthetic process;0;0;GO:0046274
GO:1900981;negative regulation of phenazine biosynthetic process;0;1;GO:0046274
GO:1900983;vindoline metabolic process;2;0;GO:0006073
GO:0044249;cellular biosynthetic process;131570712;4460;GO:0009058
GO:0044248;cellular catabolic process;4814207;3450;GO:0044237
GO:1900985;vindoline biosynthetic process;2;1;GO:0046395
GO:1900988;ajmaline biosynthetic process;0;0;GO:0046395
GO:1900979;positive regulation of tatiopterin metabolic process;0;1;GO:0045944
GO:1900978;negative regulation of tatiopterin metabolic process;0;1;GO:0010468
GO:0044250;negative regulation of metabolic activity involved in hibernation;0;4;GO:0045735
GO:0071840;cellular component organization or biogenesis;20020374;4340;GO:0044057
GO:0071846;actin filament debranching;3145;10;GO:0008544
GO:0071847;TNFSF11-mediated signaling pathway;438;9;GO:0007186
GO:1900991;scopolamine biosynthetic process;0;0;GO:0046395
GO:0044256;protein digestion;2;95;GO:0007586
GO:1900993;(-)-secologanin catabolic process;0;2;GO:0046274
GO:0044255;cellular lipid metabolic process;7401872;5300;GO:0006629
GO:1900992;(-)-secologanin metabolic process;3;4;GO:0006749
GO:0044258;intestinal lipid catabolic process;52;6;GO:0006631
GO:1900995;ubiquinone-6 binding;0;0;GO:0097159
GO:1900994;(-)-secologanin biosynthetic process;3;5;GO:0046271
GO:1900997;benzene biosynthetic process;0;0;GO:1901363
GO:1900996;benzene catabolic process;0;0;GO:0046395
GO:1900999;nitrobenzene biosynthetic process;0;1;GO:0009405
GO:1900998;nitrobenzene catabolic process;0;0;GO:0009065
GO:0071871;response to epinephrine;406;276;GO:0002976
GO:0140216;negative regulation of D-aspartate import across plasma membrane;0;0;GO:0048193
GO:0071872;cellular response to epinephrine stimulus;307;723;GO:0006974
GO:0140217;positive regulation of D-aspartate import across plasma membrane;0;0;GO:0048193
GO:0071870;cellular response to catecholamine stimulus;42005;318;GO:0006954
GO:0071875;adrenergic receptor signaling pathway;29964;504;GO:0007186
GO:0140212;regulation of long-chain fatty acid import into cell;391;3;GO:0006631
GO:0140213;negative regulation of long-chain fatty acid import into cell;206;0;GO:0010467
GO:0071873;response to norepinephrine;72;126;GO:0007601
GO:0140214;positive regulation of long-chain fatty acid import into cell;74;0;GO:0045735
GO:0071874;cellular response to norepinephrine stimulus;61;133;GO:0002237
GO:0140215;regulation of D-aspartate import across plasma membrane;0;0;GO:0006836
GO:0071879;positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway;52;1;GO:0007218
GO:0071877;regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway;63;1;GO:0007218
GO:0140210;protein transport along microtubule to kinetochore;16;3;GO:0007049
GO:0071878;negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway;244;2;GO:0048010
GO:0140211;folic acid:proton symporter activity;128;1;GO:0005215
GO:0044269;glycerol ether catabolic process;95;10;GO:0046395
GO:0044270;cellular nitrogen compound catabolic process;1747123;2400;GO:0009064
GO:0140209;zinc ion import into endoplasmic reticulum;6;1;GO:0006836
GO:0044272;sulfur compound biosynthetic process;3611491;1300;GO:0006732
GO:0044271;cellular nitrogen compound biosynthetic process;88373922;2470;GO:0009059
GO:0071860;proctolin receptor binding;13;1;GO:0004930
GO:0140205;oligopeptide import across plasma membrane;559;3;GO:0005543
GO:0044273;sulfur compound catabolic process;30292;185;GO:0009062
GO:0071861;tachykinin receptor binding;2;2;GO:0005509
GO:0140206;dipeptide import across plasma membrane;508;5;GO:0006865
GO:0140207;tripeptide import across plasma membrane;15;3;GO:0006810
GO:0140208;apoptotic process in response to mitochondrial fragmentation;54;3;GO:0006915
GO:0071864;positive regulation of cell proliferation in bone marrow;217;136;GO:0045727
GO:0140201;urea import across plasma membrane;0;0;GO:0006810
GO:0071865;regulation of apoptotic process in bone marrow cell;199;2;GO:0042981
GO:0140202;polyamine import across plasma membrane;0;0;GO:0006836
GO:0032298;positive regulation of DNA-templated DNA replication initiation;248;8;GO:0006281
GO:0140203;spermidine import across plasma membrane;0;0;GO:0006836
GO:0032299;ribonuclease H2 complex;6946;593;GO:0005524
GO:0071863;regulation of cell proliferation in bone marrow;270;7;GO:0042127
GO:0140204;pyridoxal import across plasma membrane;0;1;GO:0006836
GO:0071868;cellular response to monoamine stimulus;42070;10;GO:0007601
GO:0071869;response to catecholamine;42127;252;GO:0007629
GO:0071866;negative regulation of apoptotic process in bone marrow cell;197;5;GO:0043066
GO:0071867;response to monoamine;42229;137;GO:0007601
GO:0140200;adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate;3;1;GO:0007623
GO:0103061;trans-methoxy-C60-meroacyl-AMP ligase activity;0;0;GO:0005524
GO:0103060;kaempferol 3-rhamnoside 7-O-rhamnosyltransferase activity;0;0;GO:0006073
GO:0103063;trans-keto-C61-meroacyl-AMP ligase activity;0;0;GO:0004867
GO:0103062;cis-keto-C60-meroacyl-AMP ligase activity;0;0;GO:0004867
GO:0103069;17-hydroxyprogesterone 21-hydroxylase activity;15;1;GO:0004721
GO:0103068;leukotriene C4 gamma-glutamyl transferase activity;31955;7;GO:0004449
GO:0103064;inositol phosphorylceramide mannosyltransferase activity;9;6;GO:0006030
GO:0103067;4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity;71;0;GO:0004467
GO:0103066;4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity;65;0;GO:0006066
GO:0103072;straight chain (R)-2-hydroxy fatty acyl-CoA lyase activity;0;0;GO:0004444
GO:0103074;glucose-6-phosphate 3-dehydrogenase activity;213;2;GO:0006096
GO:0103079;2-(3'-methylthio)propylmalate synthase activity;0;0;GO:0006099
GO:0103075;indole-3-pyruvate monooxygenase activity;112;6;GO:0004497
GO:0103078;quercetin 3-rhamnoside 7-O-rhamnosyltransferase activity;1;1;GO:0006073
GO:0103077;quercetin 3-glucoside 7-O-rhamnosyltransferase activity;1;1;GO:0006073
GO:0140020;DNA methyltransferase complex;0;2;GO:0005634
GO:0103083;methylthiobutylmalate isomerase activity;0;0;GO:0006099
GO:0103082;2-(4'-methylthio)butylmalate synthase activity;0;0;GO:0006099
GO:0103085;2-(5'-methylthio)pentylmalate synthase activity;0;0;GO:0006081
GO:0140018;regulation of cytoplasmic translational fidelity;79;3;GO:0006412
GO:0103080;methylthiopropylmalate isomerase activity;0;1;GO:0006099
GO:0140014;mitotic nuclear division;77363;1900;GO:0007067
GO:0140010;D-aspartate transmembrane transporter activity;58;3;GO:0005215
GO:0103086;methylthiopentylmalate isomerase activity;0;0;GO:0006099
GO:0103089;methylthiohexylmalate isomerase activity;0;0;GO:0006099
GO:0103088;2-(6'-methylthio)hexylmalate synthase activity;0;0;GO:0006033
GO:0140013;meiotic nuclear division;63986;427;GO:0051327
GO:0103096;CYP79F1 dihomomethionine monooxygenase activity;1;1;GO:0004497
GO:0140007;KICSTOR complex;283;6;GO:0005840
GO:0103092;methylthioalkylmalate isomerase activity;0;0;GO:0006099
GO:0140009;L-aspartate import across plasma membrane;357;7;GO:0006865
GO:0103091;2-(7'-methylthio)heptylmalate synthase activity;0;0;GO:0006081
GO:0103098;CYP79F1 tetrahomomethionine monooxygenase activity;0;0;GO:0004497
GO:0103097;CYP79F1 trihomomethionine monooxygenase activity;1;1;GO:0004497
GO:0103099;UDP-glucose:5-methylthiopentylhydroximate S-glucosyltransferase activity;7;3;GO:0006029
GO:0140040;mitochondrial polycistronic RNA processing;13;1;GO:0006415
GO:0140041;cellular detoxification of methylglyoxal;110;1;GO:0006569
GO:0140042;lipid droplet formation;6282;54;GO:0006631
GO:0140036;ubiquitin-dependent protein binding;996;10;GO:0005515
GO:0140037;sumo-dependent protein binding;101;4;GO:0005515
GO:0140039;cell-cell adhesion in response to extracellular stimulus;113;8;GO:0007155
GO:0140032;glycosylation-dependent protein binding;5;0;GO:0005576
GO:0140033;acetylation-dependent protein binding;8111;7;GO:0019901
GO:0140034;methylation-dependent protein binding;9884;155;GO:0019901
GO:0140035;ubiquitination-like modification-dependent protein binding;1101;2;GO:0043161
GO:0140030;modification-dependent protein binding;40924;55;GO:0043169
GO:0140031;phosphorylation-dependent protein binding;323;7;GO:0043169
GO:0140029;exocytic process;28567;55;GO:0006986
GO:0140025;contractile vacuole tethering involved in discharge;3;0;GO:0008033
GO:0140026;contractile vacuole dissociation from plasma membrane;2;0;GO:0006936
GO:0140027;contractile vacuole localization;2;2;GO:0005737
GO:0140028;pore formation during contractile vacuole discharge;6;1;GO:0009986
GO:0140021;mitochondrial ADP transmembrane transport;11198;5;GO:0009060
GO:0140022;cnida;0;0;GO:0005576
GO:0140023;tRNA adenosine deamination to inosine;0;1;GO:0006519
GO:0140024;plus-end-directed endosome transport along mitotic spindle midzone microtubule;9;0;GO:0007049
GO:0140061;5-hydroxymethylcytosine dioxygenase activity;0;1;GO:0004725
GO:0140062;5-formylcytosine dioxygenase activity;0;0;GO:0004497
GO:0140064;peptide crotonyltransferase activity;1323;5;GO:0006081
GO:0140060;axon arborization;133;1;GO:0030424
GO:0140058;neuron projection arborization;1090;9;GO:0043005
GO:0140059;dendrite arborization;346;10;GO:0030425
GO:0140056;organelle localization by membrane tethering;23336;104;GO:0005765
GO:0140057;vacuole-mitochondria membrane tethering;2;0;GO:0005743
GO:0140050;negative regulation of endocardial cushion to mesenchymal transition;2;0;GO:0048704
GO:0140051;positive regulation of endocardial cushion to mesenchymal transition;33;1;GO:0048704
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;542;24;GO:0097169
GO:0140053;mitochondrial gene expression;45593;619;GO:0005743
GO:0140048;manganese ion export across plasma membrane;57;1;GO:0006826
GO:0140049;regulation of endocardial cushion to mesenchymal transition;35;0;GO:0048704
GO:0140043;lipid droplet localization to prospore membrane leading edge;3;2;GO:0006631
GO:0140083;ATP-dependent protein-DNA unloader activity;95;3;GO:0003676
GO:0140084;sexual macrocyst formation;4;0;GO:0048608
GO:0140080;class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity;1;0;GO:0004518
GO:0140081;glycosylated region protein binding;8;3;GO:0042803
GO:0140082;SUMO-ubiquitin ligase activity;25;1;GO:0004842
GO:0007411;axon guidance;66435;8550;GO:0007409
GO:0007414;axonal defasciculation;131;9;GO:0048666
GO:0007415;defasciculation of motor neuron axon;97;24;GO:0048704
GO:0007412;axon target recognition;393;528;GO:0008076
GO:0007413;axonal fasciculation;1133;2440;GO:0043005
GO:0007407;neuroblast activation;0;4;GO:0048666
GO:0007405;neuroblast proliferation;6659;1050;GO:0048666
GO:0007406;negative regulation of neuroblast proliferation;719;405;GO:0048608
GO:0007409;axonogenesis;93261;7410;GO:0048608
GO:0019401;alditol biosynthetic process;1351;74;GO:0006022
GO:0019400;alditol metabolic process;224877;295;GO:0006066
GO:0019403;galactitol biosynthetic process;0;2;GO:0006032
GO:0140076;negative regulation of lipoprotein transport;2;0;GO:0032963
GO:0019402;galactitol metabolic process;4406;23;GO:0006073
GO:0140077;positive regulation of lipoprotein transport;2;1;GO:0048193
GO:0019405;alditol catabolic process;51687;173;GO:0006032
GO:0140078;class I DNA-(apurinic or apyrimidinic site) endonuclease activity;137709;0;GO:0004518
GO:0019404;galactitol catabolic process;2054;6;GO:0006032
GO:0140074;cardiac endothelial to mesenchymal transition;100;4;GO:0010717
GO:0140075;regulation of lipoprotein transport;4;0;GO:0006869
GO:0140070;hydrogen peroxide channel activity;0;2;GO:0006890
GO:0007421;stomatogastric nervous system development;20;7;GO:0007420
GO:0007422;peripheral nervous system development;5542;1810;GO:0007517
GO:0007420;brain development;82071;8850;GO:0007420
GO:0007425;epithelial cell fate determination, open tracheal system;33;17;GO:0030216
GO:0007426;tracheal outgrowth, open tracheal system;204;26;GO:0048704
GO:0007423;sensory organ development;84526;2500;GO:0009952
GO:0007424;open tracheal system development;5238;255;GO:0048704
GO:0007418;ventral midline development;614;71;GO:0009952
GO:0007419;ventral cord development;510;45;GO:0007428
GO:0007416;synapse assembly;23761;3140;GO:0048167
GO:0007417;central nervous system development;119652;6960;GO:0007420
GO:0140069;histone butyryltransferase activity;60;3;GO:0004073
GO:0140065;peptide butyryltransferase activity;211;6;GO:0006081
GO:0140066;peptidyl-lysine crotonylation;92;3;GO:0006468
GO:0140067;peptidyl-lysine butyrylation;3;3;GO:0046405
GO:0140068;histone crotonyltransferase activity;139;6;GO:0004089
GO:0140098;catalytic activity, acting on RNA;15678743;701;GO:0003729
GO:0140096;catalytic activity, acting on a protein;29373222;1060;GO:0003824
GO:0140097;catalytic activity, acting on DNA;8328270;685;GO:0003824
GO:0140090;membrane curvature sensor activity;169;1;GO:0008026
GO:0140091;mBAF complex;0;4;GO:0048471
GO:0140092;bBAF complex;20;111;GO:0048471
GO:0140093;esBAF complex;0;2;GO:0005829
GO:0007400;neuroblast fate determination;321;86;GO:0048704
GO:0007403;glial cell fate determination;106;264;GO:0048667
GO:0007402;ganglion mother cell fate determination;65;258;GO:0048699
GO:0019439;aromatic compound catabolic process;2195824;2640;GO:0006559
GO:0007450;dorsal/ventral pattern formation, imaginal disc;669;115;GO:0009952
GO:0007451;dorsal/ventral lineage restriction, imaginal disc;9;6;GO:0009952
GO:0007454;labial disc morphogenesis;0;3;GO:0048608
GO:0007455;eye-antennal disc morphogenesis;505;10;GO:0008544
GO:0007453;clypeo-labral disc morphogenesis;0;2;GO:0048706
GO:0007458;progression of morphogenetic furrow involved in compound eye morphogenesis;70;9;GO:0048608
GO:0032407;MutSalpha complex binding;351;557;GO:0005524
GO:0032408;MutSbeta complex binding;105;216;GO:0043169
GO:0007449;proximal/distal pattern formation, imaginal disc;180;8;GO:0009952
GO:0032405;MutLalpha complex binding;315;191;GO:0005525
GO:0032406;MutLbeta complex binding;105;124;GO:0005525
GO:0019441;tryptophan catabolic process to kynurenine;86990;746;GO:0006575
GO:0032409;regulation of transporter activity;1206;1060;GO:0005215
GO:0019440;tryptophan catabolic process to indole-3-acetate;49;4;GO:0006559
GO:0019442;tryptophan catabolic process to acetyl-CoA;50;36;GO:0006559
GO:0032400;melanosome localization;2689;128;GO:0005576
GO:0019445;tyrosine catabolic process to fumarate;0;5;GO:0006559
GO:0019444;tryptophan catabolic process to catechol;0;3;GO:0006559
GO:0019447;D-cysteine catabolic process;25;5;GO:0006559
GO:0032404;mismatch repair complex binding;876;167;GO:0005515
GO:0019449;L-cysteine catabolic process to hypotaurine;4;2;GO:0009065
GO:0032401;establishment of melanosome localization;2364;46;GO:0048193
GO:0019448;L-cysteine catabolic process;13764;189;GO:0006559
GO:0032402;melanosome transport;2311;447;GO:0006897
GO:0019429;fluorene catabolic process;1;3;GO:0046395
GO:0019428;allantoin biosynthetic process;65;13;GO:0006073
GO:0007462;R1/R6 cell fate commitment;15;5;GO:0030182
GO:0007460;R8 cell fate commitment;266;9;GO:0030182
GO:0007465;R7 cell fate commitment;608;33;GO:0030182
GO:0007463;R2/R5 cell fate commitment;11;3;GO:0030182
GO:0007464;R3/R4 cell fate commitment;121;38;GO:0030182
GO:0007469;antennal development;401;13;GO:0008544
GO:0019430;removal of superoxide radicals;418325;1600;GO:0006879
GO:0019432;triglyceride biosynthetic process;26561;1670;GO:0006633
GO:0019431;acetyl-CoA biosynthetic process from ethanol;0;3;GO:0006094
GO:0019434;sophorosyloxydocosanoate metabolic process;0;4;GO:0006021
GO:0019433;triglyceride catabolic process;5097;1150;GO:0006631
GO:0019436;sophorosyloxydocosanoate catabolic process;0;2;GO:0009062
GO:0019435;sophorosyloxydocosanoate biosynthetic process;0;4;GO:0046271
GO:0019438;aromatic compound biosynthetic process;59707257;2250;GO:0009698
GO:0019418;sulfide oxidation;457;23;GO:0006890
GO:0019417;sulfur oxidation;8211;38;GO:0006732
GO:0019419;sulfate reduction;71552;602;GO:0009067
GO:0007432;salivary gland boundary specification;134;10;GO:0009952
GO:0007433;larval salivary gland boundary specification;0;2;GO:0008544
GO:0007430;terminal branching, open tracheal system;247;70;GO:0048646
GO:0007431;salivary gland development;3871;573;GO:0007517
GO:0007436;larval salivary gland morphogenesis;147;13;GO:0008544
GO:0007437;adult salivary gland morphogenesis;0;2;GO:0009952
GO:0007434;adult salivary gland boundary specification;0;2;GO:0009952
GO:0007435;salivary gland morphogenesis;3299;1040;GO:0007517
GO:0007429;secondary branching, open tracheal system;37;8;GO:0048646
GO:0007427;epithelial cell migration, open tracheal system;528;102;GO:0030900
GO:0007428;primary branching, open tracheal system;63;30;GO:0048646
GO:0019420;dissimilatory sulfate reduction;6;7;GO:0009067
GO:0019423;sulfur oxidation, ferric ion-dependent;0;2;GO:0006890
GO:0019422;disproportionation of elemental sulfur;0;2;GO:0008629
GO:0019424;sulfide oxidation, using siroheme sulfite reductase;6;5;GO:0006836
GO:0019427;acetyl-CoA biosynthetic process from acetate;39664;337;GO:0006099
GO:0019426;bisulfite reduction;0;4;GO:0006749
GO:0019407;hexitol catabolic process;2466;5;GO:0006032
GO:0019406;hexitol biosynthetic process;7;4;GO:0006032
GO:0019409;aerobic respiration, using ammonia as electron donor;0;3;GO:0009060
GO:0019408;dolichol biosynthetic process;6448;382;GO:0006030
GO:0007440;foregut morphogenesis;667;43;GO:0048704
GO:0007443;Malpighian tubule morphogenesis;681;35;GO:0048608
GO:0007444;imaginal disc development;12211;551;GO:0007530
GO:0007441;anterior midgut (ectodermal) morphogenesis;54;2;GO:0007576
GO:0007442;hindgut morphogenesis;1202;222;GO:0048608
GO:0007447;imaginal disc pattern formation;1507;37;GO:0009952
GO:0007448;anterior/posterior pattern specification, imaginal disc;315;10;GO:0009952
GO:0007445;determination of imaginal disc primordium;153;3;GO:0048608
GO:0007446;imaginal disc growth;671;94;GO:0048608
GO:0007438;oenocyte development;87;16;GO:0009913
GO:0007439;ectodermal digestive tract development;227;17;GO:0007517
GO:0019410;aerobic respiration, using carbon monoxide as electron donor;1;4;GO:0015979
GO:0019412;aerobic respiration, using hydrogen as electron donor;0;5;GO:0015979
GO:0019411;aerobic respiration, using ferrous ions as electron donor;1;5;GO:0009060
GO:0019414;aerobic respiration, using sulfur or sulfate as electron donor;0;3;GO:0009060
GO:0019413;acetate biosynthetic process;40;83;GO:0006066
GO:0019416;polythionate oxidation;0;2;GO:0046395
GO:0019415;acetate biosynthetic process from carbon monoxide;0;2;GO:0032787
GO:0044319;wound healing, spreading of cells;2105;1280;GO:0042127
GO:0071938;vitamin A transport;96;11;GO:0006865
GO:0007370;ventral furrow formation;265;23;GO:0009952
GO:0044318;L-aspartate:fumarate oxidoreductase activity;51465;7;GO:0004073
GO:0071939;vitamin A import into cell;81;1;GO:0006865
GO:0034992;microtubule organizing center attachment site;1732;57;GO:0005815
GO:0007374;posterior midgut invagination;35;8;GO:0048608
GO:0032330;regulation of chondrocyte differentiation;4433;694;GO:0045595
GO:0007371;ventral midline determination;50;5;GO:0009952
GO:0007377;germ-band extension;149;151;GO:0009952
GO:0044311;exoneme;2;3;GO:0005576
GO:0046974;histone H3K9 methyltransferase activity;7142;9;GO:0016569
GO:0007378;amnioserosa formation;91;68;GO:0008544
GO:0044310;osmiophilic body;2;1;GO:0005576
GO:0046975;histone H3K36 methyltransferase activity;9140;5;GO:0016569
GO:0007375;anterior midgut invagination;13;4;GO:0007576
GO:0044313;protein K6-linked deubiquitination;10;37;GO:0006464
GO:0046972;histone H4K16 acetyltransferase activity;480;4;GO:0016569
GO:0007376;cephalic furrow formation;22;5;GO:0008544
GO:0044312;crystalloid;0;2;GO:0005576
GO:0044315;protein secretion by the type VII secretion system;17;4;GO:0055085
GO:0046978;TAP1 binding;224;570;GO:0003723
GO:1900810;helvolic acid metabolic process;9;3;GO:0006790
GO:0044314;protein K27-linked ubiquitination;26;52;GO:0006464
GO:0046979;TAP2 binding;173;81;GO:0005515
GO:0007379;segment specification;1434;675;GO:0009952
GO:0044317;rod spherule;6;5;GO:0048646
GO:0046976;histone H3K27 methyltransferase activity;11170;11;GO:0016569
GO:1900812;helvolic acid biosynthetic process;9;1;GO:0046395
GO:0044316;cone cell pedicle;104;8;GO:0048661
GO:0046977;TAP binding;448;242;GO:0005515
GO:1900811;helvolic acid catabolic process;0;1;GO:0046395
GO:1900802;cspyrone B1 biosynthetic process;0;1;GO:0046274
GO:0019360;nicotinamide nucleotide biosynthetic process from niacinamide;0;2;GO:0009063
GO:0032328;alanine transport;2463;826;GO:0006836
GO:1900805;brevianamide F biosynthetic process;1;2;GO:0046271
GO:0032329;serine transport;9466;380;GO:0006865
GO:0019362;pyridine nucleotide metabolic process;1827796;1390;GO:0006749
GO:0046981;beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity;13;1;GO:0006029
GO:0019361;2'-(5''-triphosphoribosyl)-3'-dephospho-CoA biosynthetic process;0;0;GO:0006066
GO:0046982;protein heterodimerization activity;210445;13500;GO:0043169
GO:0019364;pyridine nucleotide catabolic process;2198;110;GO:0009062
GO:0044320;cellular response to leptin stimulus;1202;427;GO:0048608
GO:1900809;fumigaclavine C biosynthetic process;15;2;GO:0046395
GO:0019363;pyridine nucleotide biosynthetic process;1213265;1290;GO:0009061
GO:0046980;tapasin binding;18;9;GO:0005576
GO:0032322;ubiquinone catabolic process;0;1;GO:0006631
GO:0034985;Ecsit-NDUFAF1 complex;0;1;GO:0043161
GO:0071930;negative regulation of transcription involved in G1/S transition of mitotic cell cycle;918;172;GO:0045944
GO:0019365;pyridine nucleotide salvage;1838;5;GO:0009063
GO:0032323;lipoate catabolic process;0;3;GO:0009062
GO:0071931;positive regulation of transcription involved in G1/S transition of mitotic cell cycle;207;182;GO:0045944
GO:0019368;fatty acid elongation, unsaturated fatty acid;5737;77;GO:0006633
GO:0034983;peptidyl-lysine deacetylation;33;184;GO:0016525
GO:0019367;fatty acid elongation, saturated fatty acid;6974;743;GO:0006633
GO:0034982;mitochondrial protein processing;4653;113;GO:0006986
GO:0032326;Mo-molybdopterin cofactor catabolic process;0;1;GO:0006066
GO:0071934;thiamine transmembrane transport;18283;320;GO:0006836
GO:0019369;arachidonic acid metabolic process;2498;1590;GO:0006631
GO:0032327;W-molybdopterin cofactor catabolic process;0;3;GO:0006066
GO:0034988;Fc-gamma receptor I complex binding;117;106;GO:0004872
GO:0071935;octopamine signaling pathway involved in response to food;0;1;GO:0007610
GO:0032324;molybdopterin cofactor biosynthetic process;764463;367;GO:0009061
GO:0034987;immunoglobulin receptor binding;626;1160;GO:0004872
GO:0071932;replication fork reversal;286;5;GO:0007067
GO:0032325;molybdopterin cofactor catabolic process;0;2;GO:0006066
GO:0034986;iron chaperone activity;235;217;GO:0005739
GO:0071933;Arp2/3 complex binding;3874;281;GO:0005515
GO:0007380;specification of segmental identity, head;117;10;GO:0007389
GO:0071927;octopamine signaling pathway;43;4;GO:0007218
GO:0007381;specification of segmental identity, labial segment;15;5;GO:0009952
GO:0044329;canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion;0;4;GO:0022610
GO:0071928;tyramine signaling pathway;23;1;GO:0007186
GO:0071925;thymic stromal lymphopoietin production;0;1;GO:0046649
GO:0071926;endocannabinoid signaling pathway;171;5;GO:0007186
GO:0007384;specification of segmental identity, thorax;28;8;GO:0002034
GO:0034981;FHL3-CREB complex;0;1;GO:0048608
GO:0007385;specification of segmental identity, abdomen;53;5;GO:0002034
GO:0034980;FHL2-CREB complex;0;0;GO:0048193
GO:0007382;specification of segmental identity, maxillary segment;13;2;GO:0002034
GO:0071929;alpha-tubulin acetylation;21;10;GO:0007049
GO:0007383;specification of segmental identity, antennal segment;16;8;GO:0009952
GO:0007388;posterior compartment specification;2;119;GO:0009952
GO:0044322;endoplasmic reticulum quality control compartment;657;148;GO:0005765
GO:0046985;positive regulation of hemoglobin biosynthetic process;222;37;GO:0050829
GO:0007389;pattern specification process;79329;4150;GO:0048858
GO:0044321;response to leptin;1806;321;GO:0048608
GO:0046986;negative regulation of hemoglobin biosynthetic process;59;19;GO:0050829
GO:0007386;compartment pattern specification;289;366;GO:0043234
GO:0046983;protein dimerization activity;1280453;12300;GO:0046983
GO:0007387;anterior compartment pattern formation;1;9;GO:0048513
GO:0044323;retinoic acid-responsive element binding;242;193;GO:0003700
GO:0046984;regulation of hemoglobin biosynthetic process;417;22;GO:0050829
GO:0044326;dendritic spine neck;90;199;GO:0097403
GO:0046989;galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity;11;4;GO:0008528
GO:1900821;orlandin biosynthetic process;1;3;GO:0009813
GO:0044325;transmembrane transporter binding;7124;231;GO:0015075
GO:1900820;orlandin catabolic process;0;0;GO:0006725
GO:0044328;canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration;0;7;GO:0016477
GO:0046987;N-acetyllactosamine beta-1,3-glucuronosyltransferase activity;11;6;GO:0004553
GO:1900823;negative regulation of ergot alkaloid biosynthetic process;0;2;GO:0046356
GO:0044327;dendritic spine head;60;466;GO:0097403
GO:0046988;asioloorosomucoid beta-1,3-glucuronosyltransferase activity;11;6;GO:0004553
GO:1900822;regulation of ergot alkaloid biosynthetic process;0;0;GO:0046356
GO:1900814;monodictyphenone catabolic process;0;0;GO:0046274
GO:1900813;monodictyphenone metabolic process;10;1;GO:0046148
GO:1900816;ochratoxin A metabolic process;21;2;GO:0009065
GO:0034979;NAD-dependent protein deacetylase activity;38842;332;GO:0004721
GO:1900815;monodictyphenone biosynthetic process;9;4;GO:0046395
GO:0019351;dethiobiotin biosynthetic process;0;3;GO:0009065
GO:0046992;oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond;29124;4;GO:0016616
GO:1900818;ochratoxin A biosynthetic process;20;3;GO:0046148
GO:0019350;teichoic acid biosynthetic process;61161;248;GO:0009266
GO:0046993;oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor;135;2;GO:0016616
GO:1900817;ochratoxin A catabolic process;1;0;GO:0046274
GO:0019353;protoporphyrinogen IX biosynthetic process from glutamate;36;3;GO:0009065
GO:0044331;cell-cell adhesion mediated by cadherin;1797;191;GO:0007156
GO:0046990;N-hydroxyarylamine O-acetyltransferase activity;1250;3;GO:0004073
GO:0019352;protoporphyrinogen IX biosynthetic process from glycine;0;3;GO:0009065
GO:0044330;canonical Wnt signaling pathway involved in positive regulation of wound healing;0;7;GO:0048407
GO:1900819;orlandin metabolic process;1;1;GO:0006725
GO:0032311;angiogenin-PRI complex;113;44;GO:0048193
GO:0034974;Swi5-Swi2 complex;35;7;GO:0048285
GO:0019354;siroheme biosynthetic process;100627;359;GO:0009065
GO:0034973;Sid2-Mob1 complex;113;2;GO:0048285
GO:0071920;cleavage body;125;9;GO:0005576
GO:0019357;nicotinate nucleotide biosynthetic process;103;7;GO:0009063
GO:0034972;histone H3-R26 methylation;2;6;GO:0016569
GO:0019356;nicotinate nucleotide biosynthetic process from tryptophan;0;3;GO:0009065
GO:0032310;prostaglandin secretion;648;201;GO:0007596
GO:0034971;histone H3-R17 methylation;2;10;GO:0016569
GO:0019359;nicotinamide nucleotide biosynthetic process;978424;449;GO:0009063
GO:0034978;PDX1-PBX1b-MRG1 complex;0;1;GO:0048608
GO:0071923;negative regulation of cohesin loading;9;1;GO:0048285
GO:0019358;nicotinate nucleotide salvage;103;111;GO:0009063
GO:0034977;ABIN2-NFKB1-MAP3K8 complex;0;1;GO:0043603
GO:0071924;chemokine (C-C motif) ligand 22 production;0;1;GO:0050921
GO:0034976;response to endoplasmic reticulum stress;89230;4510;GO:0006986
GO:0071921;cohesin loading;6681;98;GO:0007030
GO:0034975;protein folding in endoplasmic reticulum;6900;574;GO:0006457
GO:0071922;regulation of cohesin loading;98;63;GO:0048316
GO:0071958;new mitotic spindle pole body;229;6;GO:0005819
GO:0071959;maintenance of mitotic sister chromatid cohesion, arms;0;0;GO:0007067
GO:0007351;tripartite regional subdivision;3069;35;GO:0030962
GO:0034970;histone H3-R2 methylation;2;9;GO:0016569
GO:0007352;zygotic specification of dorsal/ventral axis;145;276;GO:0009952
GO:0007350;blastoderm segmentation;5246;179;GO:0008544
GO:0007355;anterior region determination;31;9;GO:0009952
GO:0044333;Wnt signaling pathway involved in digestive tract morphogenesis;58;8;GO:0007626
GO:0007356;thorax and anterior abdomen determination;110;172;GO:0009952
GO:0044332;Wnt signaling pathway involved in dorsal/ventral axis specification;314;22;GO:0007631
GO:0046997;oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor;641;9;GO:0004497
GO:0044335;canonical Wnt signaling pathway involved in neural crest cell differentiation;4;6;GO:0048704
GO:0046994;oxidoreductase activity, acting on hydrogen as donor, with a quinone or similar compound as acceptor;463;1;GO:0004497
GO:0007354;zygotic determination of anterior/posterior axis, embryo;407;31;GO:0009790
GO:0044334;canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition;123;132;GO:0048010
GO:0046995;oxidoreductase activity, acting on hydrogen as donor, with other known acceptors;2980;3;GO:0016616
GO:0007359;posterior abdomen determination;12;5;GO:0009952
GO:0044337;canonical Wnt signaling pathway involved in positive regulation of apoptotic process;2;8;GO:0043066
GO:1900832;D-leucine catabolic process;10;3;GO:0006559
GO:0044336;canonical Wnt signaling pathway involved in negative regulation of apoptotic process;15;187;GO:0043066
GO:1900831;D-leucine metabolic process;10;0;GO:0006565
GO:0044339;canonical Wnt signaling pathway involved in osteoblast differentiation;266;200;GO:0048407
GO:0046998;(S)-usnate reductase activity;0;0;GO:0004091
GO:1900834;regulation of emericellin biosynthetic process;1;0;GO:0046394
GO:0044338;canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation;145;6;GO:0048704
GO:1900833;D-leucine biosynthetic process;0;0;GO:0006520
GO:0032308;positive regulation of prostaglandin secretion;369;358;GO:0050731
GO:1900825;regulation of membrane depolarization during cardiac muscle cell action potential;212;22;GO:0048407
GO:0032309;icosanoid secretion;23859;91;GO:0002679
GO:1900824;positive regulation of ergot alkaloid biosynthetic process;0;0;GO:0046356
GO:0032306;regulation of prostaglandin secretion;375;10;GO:0050731
GO:0034969;histone arginine methylation;27;671;GO:0016569
GO:1900827;positive regulation of membrane depolarization during cardiac muscle cell action potential;4;7;GO:0048407
GO:0032307;negative regulation of prostaglandin secretion;5;5;GO:0050731
GO:0034968;histone lysine methylation;1639;2160;GO:0016569
GO:1900826;negative regulation of membrane depolarization during cardiac muscle cell action potential;56;5;GO:0048407
GO:0019340;dibenzofuran catabolic process;3;2;GO:0046274
GO:0044340;canonical Wnt signaling pathway involved in regulation of cell proliferation;271;106;GO:0048407
GO:1900829;D-tyrosine catabolic process;10;4;GO:0006559
GO:0010999;regulation of eIF2 alpha phosphorylation by heme;117;29;GO:0010401
GO:1900828;D-tyrosine metabolic process;10;0;GO:0006559
GO:0019342;trypanothione biosynthetic process;7;2;GO:0006749
GO:0044342;type B pancreatic cell proliferation;1451;833;GO:0042127
GO:0019341;dibenzo-p-dioxin catabolic process;7;6;GO:0046395
GO:0044341;sodium-dependent phosphate transport;29290;151;GO:0006865
GO:0010996;response to auditory stimulus;1333;1890;GO:0007631
GO:0019344;cysteine biosynthetic process;527583;1130;GO:0006520
GO:0032300;mismatch repair complex;58218;741;GO:0000724
GO:0034963;box C/D RNA processing;510;1;GO:0006364
GO:0071952;conversion of O-phosphoseryl-tRNA to cysteinyl-tRNA;4192;1;GO:0006412
GO:0010995;free ubiquitin chain depolymerization;24;8;GO:0006464
GO:0019343;cysteine biosynthetic process via cystathionine;11209;77;GO:0006520
GO:0032301;MutSalpha complex;1520;208;GO:0005524
GO:0071953;elastic fiber;248;273;GO:0005576
GO:0010998;regulation of translational initiation by eIF2 alpha phosphorylation;3374;186;GO:0006414
GO:0019346;transsulfuration;141151;542;GO:0006749
GO:0071950;FADH2 binding;1;2;GO:0097367
GO:0010997;anaphase-promoting complex binding;13357;513;GO:0005524
GO:0019345;cysteine biosynthetic process via S-sulfo-L-cysteine;4;1;GO:0006520
GO:0071951;conversion of methionyl-tRNA to N-formyl-methionyl-tRNA;215345;6;GO:0006412
GO:0010992;ubiquitin recycling;750;25;GO:0006511
GO:0019348;dolichol metabolic process;44257;433;GO:0006032
GO:0032304;negative regulation of icosanoid secretion;28;43;GO:0010467
GO:0034967;Set3 complex;231;9;GO:0005576
GO:0019347;GDP-alpha-D-mannosylchitobiosyldiphosphodolichol biosynthetic process;0;5;GO:0006021
GO:0032305;positive regulation of icosanoid secretion;571;51;GO:0030518
GO:0034966;intronic box H/ACA snoRNA processing;0;2;GO:0006460
GO:0071957;old mitotic spindle pole body;302;8;GO:0005819
GO:0010994;free ubiquitin chain polymerization;456;38;GO:0006464
GO:0032302;MutSbeta complex;149;39;GO:0005524
GO:0034965;intronic box C/D RNA processing;76;4;GO:0003743
GO:0071954;chemokine (C-C motif) ligand 11 production;0;3;GO:0046649
GO:0019349;ribitol metabolic process;0;2;GO:0006073
GO:0032303;regulation of icosanoid secretion;651;24;GO:0030518
GO:0034964;box H/ACA RNA processing;209;1;GO:0006613
GO:0071955;recycling endosome to Golgi transport;102;7;GO:0006897
GO:0071949;FAD binding;652145;2650;GO:0005524
GO:0019329;ammonia oxidation;169;5;GO:0009065
GO:0071947;protein deubiquitination involved in ubiquitin-dependent protein catabolic process;14;47;GO:0006511
GO:0071948;activation-induced B cell apoptotic process;0;1;GO:0042981
GO:0007362;terminal region determination;180;9;GO:0009952
GO:0007366;periodic partitioning by pair rule gene;536;226;GO:0048608
GO:0044344;cellular response to fibroblast growth factor stimulus;24538;1030;GO:0048407
GO:0007367;segment polarity determination;900;76;GO:0009952
GO:0044343;canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation;104;3;GO:0048407
GO:0044346;fibroblast apoptotic process;1474;36;GO:0010941
GO:1900841;negative regulation of helvolic acid biosynthetic process;0;0;GO:0010468
GO:0007365;periodic partitioning;1450;9;GO:0048608
GO:0044345;stromal-epithelial cell signaling involved in prostate gland development;43;5;GO:0048608
GO:1900840;regulation of helvolic acid biosynthetic process;0;0;GO:0010401
GO:0044348;plant-type cell wall cellulose catabolic process;0;1;GO:0009664
GO:1900843;regulation of monodictyphenone biosynthetic process;0;0;GO:0046395
GO:0044347;cell wall polysaccharide catabolic process;83480;7;GO:0009405
GO:1900842;positive regulation of helvolic acid biosynthetic process;0;0;GO:0046395
GO:0007368;determination of left/right symmetry;17864;1960;GO:0048589
GO:1900845;positive regulation of monodictyphenone biosynthetic process;0;0;GO:0046356
GO:0007369;gastrulation;22102;2630;GO:0007398
GO:0044349;DNA excision;1;7;GO:0006281
GO:1900844;negative regulation of monodictyphenone biosynthetic process;0;0;GO:0010468
GO:1900836;positive regulation of emericellin biosynthetic process;0;0;GO:0046395
GO:0034959;endothelin maturation;55;166;GO:0008544
GO:1900835;negative regulation of emericellin biosynthetic process;1;0;GO:0046274
GO:0034958;aminohydroquinone monooxygenase activity;0;4;GO:0004497
GO:1900838;negative regulation of fumigaclavine C biosynthetic process;0;0;GO:0046395
GO:0034957;3-nitrophenol nitroreductase activity;0;2;GO:0004746
GO:1900837;regulation of fumigaclavine C biosynthetic process;0;0;GO:0046395
GO:0044351;macropinocytosis;569;256;GO:0006897
GO:0044350;micropinocytosis;0;3;GO:0006897
GO:1900839;positive regulation of fumigaclavine C biosynthetic process;0;0;GO:0046395
GO:0019331;anaerobic respiration, using ammonium as electron donor;169;3;GO:0009060
GO:0044353;micropinosome;0;0;GO:0072562
GO:0019330;aldoxime metabolic process;0;3;GO:0006066
GO:0044352;pinosome;428;10;GO:0005764
GO:0019333;denitrification pathway;8637;16;GO:0009065
GO:0034952;malonate semialdehyde decarboxylase activity;0;3;GO:0009065
GO:0071941;nitrogen cycle metabolic process;412702;1490;GO:0019538
GO:0019332;aerobic respiration, using nitrite as electron donor;0;4;GO:0009060
GO:0034951;o-hydroxylaminobenzoate mutase activity;0;4;GO:0006067
GO:0071942;XPC complex;251;69;GO:0000724
GO:0019335;3-methylquinoline catabolic process;0;2;GO:0046395
GO:0034950;phenylboronic acid monooxygenase activity;0;2;GO:0046395
GO:0019334;p-cymene catabolic process;0;2;GO:0046356
GO:0071940;fungal-type cell wall assembly;404;7;GO:0010467
GO:0019337;tetrachloroethylene catabolic process;0;2;GO:0009065
GO:0034956;diphenyl ether 1,2-dioxygenase activity;0;4;GO:0004497
GO:0071945;regulation of bacterial-type flagellum-dependent cell motility by regulation of motor speed;5972;3;GO:0048285
GO:0019336;phenol-containing compound catabolic process;36453;9;GO:0046274
GO:0034955;2,3-dihydroxydiphenyl ether dioxygenase activity;0;4;GO:0004497
GO:0071946;cis-acting DNA replication termination;4;2;GO:0006364
GO:0019339;parathion catabolic process;0;4;GO:0009065
GO:0034954;diphenyl ether 2,3-dioxygenase activity;0;2;GO:0046395
GO:0071943;Myc-Max complex;147;4;GO:0048608
GO:0019338;pentachlorophenol catabolic process;3;3;GO:0046274
GO:0034953;perillyl-CoA hydratase activity;0;2;GO:0006081
GO:0071944;cell periphery;32638412;6580;GO:0005615
GO:0046938;phytochelatin biosynthetic process;3482;44;GO:0006732
GO:0032370;positive regulation of lipid transport;4522;357;GO:0006629
GO:0046936;2'-deoxyadenosine deaminase activity;45625;5;GO:0004553
GO:0046937;phytochelatin metabolic process;3486;6;GO:0006732
GO:0032373;positive regulation of sterol transport;2034;184;GO:0010468
GO:0032374;regulation of cholesterol transport;3883;827;GO:0055085
GO:0032371;regulation of sterol transport;3883;90;GO:0006869
GO:0032372;negative regulation of sterol transport;674;1010;GO:0010468
GO:0046930;pore complex;100139;1080;GO:0005576
GO:0046931;pore complex assembly;2650;1430;GO:0009986
GO:0046934;1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity;3533;8;GO:0004721
GO:0046935;1-phosphatidylinositol-3-kinase regulator activity;2991;573;GO:0005524
GO:0046932;sodium-transporting ATP synthase activity, rotational mechanism;10;3;GO:0008528
GO:0046933;proton-transporting ATP synthase activity, rotational mechanism;918907;2750;GO:0005761
GO:0032366;intracellular sterol transport;16615;72;GO:0006869
GO:0032367;intracellular cholesterol transport;7774;540;GO:0006869
GO:0032364;intracellular oxygen homeostasis;331;7;GO:0006816
GO:0032365;intracellular lipid transport;19612;186;GO:0006869
GO:0032368;regulation of lipid transport;8008;329;GO:0006869
GO:0032369;negative regulation of lipid transport;1547;382;GO:0006869
GO:0046949;fatty-acyl-CoA biosynthetic process;2993;885;GO:0006631
GO:0046947;hydroxylysine biosynthetic process;103;32;GO:0009065
GO:0046948;hydroxylysine catabolic process;0;2;GO:0009065
GO:0032363;FMN catabolic process;0;10;GO:0009062
GO:0032361;pyridoxal phosphate catabolic process;91;5;GO:0009065
GO:0046941;azetidine-2-carboxylic acid acetyltransferase activity;10;3;GO:0004497
GO:0046942;carboxylic acid transport;2115236;1710;GO:0006865
GO:0046940;nucleoside monophosphate phosphorylation;1589254;334;GO:0006464
GO:0046945;N-terminal peptidyl-alanine N-carbamoylation;0;3;GO:0006469
GO:0046946;hydroxylysine metabolic process;103;8;GO:0009065
GO:0046943;carboxylic acid transmembrane transporter activity;690385;945;GO:0008544
GO:0046944;protein carbamoylation;0;6;GO:0046395
GO:0019391;glucuronoside catabolic process;130;132;GO:0006081
GO:0019390;glucuronoside biosynthetic process;0;2;GO:0006073
GO:0019393;glucarate biosynthetic process;0;2;GO:0006073
GO:0019392;glucarate metabolic process;20744;1;GO:0006073
GO:0019395;fatty acid oxidation;133873;2860;GO:0006631
GO:0019394;glucarate catabolic process;20740;9;GO:0006073
GO:0019397;gallate catabolic process via 2-pyrone-4,6-dicarboxylate;0;2;GO:0006081
GO:0019396;gallate catabolic process;4;1;GO:0006081
GO:0019399;cyclohexanol oxidation;0;1;GO:0046148
GO:0032355;response to estradiol;3909;3190;GO:0009725
GO:0019398;gallate catabolic process via gallate dioxygenase activity;0;1;GO:0009062
GO:0032356;oxidized DNA binding;630;10;GO:0003677
GO:0032353;negative regulation of hormone biosynthetic process;692;265;GO:0030518
GO:0032354;response to follicle-stimulating hormone;405;379;GO:0002526
GO:0032359;provirus excision;24;2;GO:0048305
GO:0032357;oxidized purine DNA binding;534;104;GO:0003677
GO:0032358;oxidized pyrimidine DNA binding;45;2;GO:0003677
GO:0007391;dorsal closure;1418;271;GO:0007530
GO:0071916;dipeptide transmembrane transporter activity;15596;9;GO:0008565
GO:0007392;initiation of dorsal closure;111;3;GO:0009913
GO:0071917;triose-phosphate transmembrane transporter activity;230;7;GO:0008565
GO:0046958;nonassociative learning;541;189;GO:0007612
GO:0071914;prominosome;113;6;GO:0000786
GO:0007390;germ-band shortening;258;10;GO:0048285
GO:0046959;habituation;418;42;GO:0007612
GO:0071915;protein-lysine lysylation;0;3;GO:0006468
GO:0007395;dorsal closure, spreading of leading edge cells;71;21;GO:0002041
GO:0032351;negative regulation of hormone metabolic process;807;111;GO:0010468
GO:0007396;suture of dorsal opening;8;7;GO:0007517
GO:0032352;positive regulation of hormone metabolic process;685;172;GO:0010468
GO:0007393;dorsal closure, leading edge cell fate determination;0;5;GO:0009913
GO:0071918;urea transmembrane transport;30359;322;GO:0006811
GO:0007394;dorsal closure, elongation of leading edge cells;90;28;GO:0048608
GO:0032350;regulation of hormone metabolic process;2632;621;GO:0042446
GO:0071919;G-quadruplex DNA formation;56;8;GO:0000786
GO:0007399;nervous system development;547396;15200;GO:0007399
GO:0046952;ketone body catabolic process;10479;590;GO:0006066
GO:0046950;cellular ketone body metabolic process;11046;1620;GO:0006094
GO:0007398;ectoderm development;1080;1750;GO:0009952
GO:0046951;ketone body biosynthetic process;424;272;GO:0006094
GO:0046956;positive phototaxis;73;14;GO:0007600
GO:0046957;negative phototaxis;41;10;GO:0007600
GO:0019380;3-phenylpropionate catabolic process;4846;2;GO:0046395
GO:0019382;carbon tetrachloride catabolic process;0;3;GO:0006559
GO:0019381;atrazine catabolic process;1129;2;GO:0006569
GO:0019384;caprolactam catabolic process;0;1;GO:0006081
GO:0019383;(+)-camphor catabolic process;9;1;GO:0046274
GO:0046960;sensitization;67;211;GO:0002237
GO:0019386;methanogenesis, from carbon dioxide;5454;6;GO:0009061
GO:0019385;methanogenesis, from acetate;2670;9;GO:0009061
GO:0019388;galactose catabolic process;23744;728;GO:0006032
GO:0032344;regulation of aldosterone metabolic process;399;20;GO:0010468
GO:0019387;methanogenesis, from methanol;0;2;GO:0009060
GO:0032345;negative regulation of aldosterone metabolic process;226;6;GO:0010468
GO:0032342;aldosterone biosynthetic process;489;60;GO:0009060
GO:0019389;glucuronoside metabolic process;133;10;GO:0006073
GO:0032343;aldosterone catabolic process;0;4;GO:0009062
GO:0032348;negative regulation of aldosterone biosynthetic process;226;27;GO:0010468
GO:0071912;asynchronous neurotransmitter secretion;32;0;GO:0007613
GO:0032349;positive regulation of aldosterone biosynthetic process;109;9;GO:0010468
GO:0071913;citrate secondary active transmembrane transporter activity;124;2;GO:0005215
GO:0032346;positive regulation of aldosterone metabolic process;109;5;GO:0010468
GO:0071910;determination of liver left/right asymmetry;710;52;GO:0007517
GO:0032347;regulation of aldosterone biosynthetic process;395;14;GO:0010468
GO:0071911;synchronous neurotransmitter secretion;51;0;GO:0008021
GO:0044308;axonal spine;135;103;GO:0097403
GO:0071905;protein N-linked glucosylation via asparagine;0;1;GO:0006486
GO:0044307;dendritic branch;28;22;GO:0030425
GO:0071906;CRD domain binding;10;4;GO:0005515
GO:0046969;NAD-dependent histone H3K9 deacetylase activity;247;5;GO:0016569
GO:0071903;protein N-linked N-acetylglucosaminylation via asparagine;0;1;GO:0006486
GO:0044309;neuron spine;15178;423;GO:0097458
GO:0071904;protein N-linked N-acetylgalactosaminylation via asparagine;0;1;GO:0006486
GO:0032340;positive regulation of inhibin secretion;0;2;GO:0048608
GO:0071909;determination of stomach left/right asymmetry;50;5;GO:0007517
GO:0032341;aldosterone metabolic process;604;103;GO:0006767
GO:0071907;determination of digestive tract left/right asymmetry;699;49;GO:0007517
GO:0071908;determination of intestine left/right asymmetry;88;5;GO:0007517
GO:0044300;cerebellar mossy fiber;228;316;GO:0048666
GO:0046963;3'-phosphoadenosine 5'-phosphosulfate transport;819;1;GO:0006874
GO:0046964;3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity;361;4;GO:0005525
GO:0044302;dentate gyrus mossy fiber;50;3;GO:0048666
GO:0046961;proton-transporting ATPase activity, rotational mechanism;259033;2380;GO:0008528
GO:0044301;climbing fiber;94;18;GO:0048608
GO:0046962;sodium-transporting ATPase activity, rotational mechanism;10;3;GO:0008528
GO:0044304;main axon;3763;307;GO:0043005
GO:0046967;cytosol to endoplasmic reticulum transport;356;7;GO:0006986
GO:0044303;axon collateral;2;6;GO:0030430
GO:0046968;peptide antigen transport;51;82;GO:0006874
GO:0044306;neuron projection terminus;5274;515;GO:0043005
GO:0046965;nuclear retinoid X receptor binding;553;8;GO:0030528
GO:1900801;cspyrone B1 catabolic process;0;1;GO:0046274
GO:0044305;calyx of Held;546;65;GO:0005576
GO:0046966;nuclear thyroid hormone receptor binding;1097;24;GO:0003700
GO:1900800;cspyrone B1 metabolic process;0;2;GO:0046274
GO:0019371;cyclooxygenase pathway;247;694;GO:0006096
GO:0032339;negative regulation of inhibin secretion;0;2;GO:0048608
GO:0019370;leukotriene biosynthetic process;3896;759;GO:0006022
GO:0019373;epoxygenase P450 pathway;359;2090;GO:0006874
GO:0046970;NAD-dependent histone H4K16 deacetylase activity;169;2;GO:0016569
GO:0019372;lipoxygenase pathway;4717;942;GO:0009611
GO:0019375;galactolipid biosynthetic process;622;249;GO:0008610
GO:0019374;galactolipid metabolic process;4017;37;GO:0006631
GO:0019377;glycolipid catabolic process;9354;448;GO:0006631
GO:0032333;activin secretion;0;1;GO:0002504
GO:0034996;RasGAP-Fyn-Lyn-Yes complex;0;2;GO:0005525
GO:0019376;galactolipid catabolic process;3309;5;GO:0006631
GO:0032334;inhibin secretion;0;2;GO:0007548
GO:0034995;SC5b-7 complex;0;1;GO:0005823
GO:0019379;sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin);47580;76;GO:0006732
GO:0032331;negative regulation of chondrocyte differentiation;1238;1240;GO:0045595
GO:0034994;microtubule organizing center attachment site organization;1;2;GO:0007049
GO:0032332;positive regulation of chondrocyte differentiation;1108;566;GO:0045595
GO:0034993;meiotic nuclear membrane microtubule tethering complex;1717;20;GO:0005576
GO:0032337;positive regulation of activin secretion;0;2;GO:0048608
GO:0071901;negative regulation of protein serine/threonine kinase activity;293;954;GO:0043406
GO:0032338;regulation of inhibin secretion;0;0;GO:0048608
GO:0034999;oligosaccharyltransferase II complex;1;3;GO:0008029
GO:0071902;positive regulation of protein serine/threonine kinase activity;548;1870;GO:0045944
GO:0032335;regulation of activin secretion;0;2;GO:0048608
GO:0034998;oligosaccharyltransferase I complex;4728;3;GO:0008029
GO:0032336;negative regulation of activin secretion;0;2;GO:0048608
GO:0034997;alphav-beta5 integrin-vitronectin complex;0;1;GO:0005916
GO:0071900;regulation of protein serine/threonine kinase activity;991;1500;GO:0043406
GO:1900890;regulation of pentadecane metabolic process;0;1;GO:0046395
GO:1900892;positive regulation of pentadecane metabolic process;0;1;GO:0046356
GO:1900891;negative regulation of pentadecane metabolic process;0;0;GO:0046395
GO:0044399;multi-species biofilm formation;17;6;GO:0048565
GO:1900894;negative regulation of tridecane metabolic process;0;0;GO:0046356
GO:0044398;envenomation resulting in induction of edema in another organism;12;1;GO:0048407
GO:1900893;regulation of tridecane metabolic process;0;0;GO:0010468
GO:1900896;regulation of heptadecane biosynthetic process;0;0;GO:0046395
GO:1900895;positive regulation of tridecane metabolic process;0;0;GO:0046356
GO:1900898;positive regulation of heptadecane biosynthetic process;0;0;GO:0046395
GO:1900897;negative regulation of heptadecane biosynthetic process;0;0;GO:0046395
GO:1900899;regulation of heptadecane metabolic process;0;0;GO:0046356
GO:0103102;UDP-glucose:8-methylthiooctylhydroximate S-glucosyltransferase activity;7;3;GO:0006029
GO:0103101;UDP-glucose:7-methylthioheptylhydroximate S-glucosyltransferase activity;7;2;GO:0006029
GO:0103104;6-methylthiohexyldesulfoglucosinolate sulfotransferase activity;0;0;GO:0004734
GO:0103103;UDP-glucose: 9-methylthiononylhydroximate S-glucosyltransferase activity;7;2;GO:0006022
GO:0103100;UDP-glucose: 6-methylthiohexylhydroximate S-glucosyltransferase activity;7;2;GO:0006029
GO:0103106;brassinolide 23-O-glucosyltransferase activity;0;0;GO:0006073
GO:0103105;2-oxo-6-methylthiohexanoate aminotransferase activity;0;0;GO:0004073
GO:0103107;castasterone 23-O-glucosyltransferase activity;0;0;GO:0006081
GO:0032399;HECT domain binding;1;4;GO:0043169
GO:0032397;activating MHC class I receptor activity;101;1;GO:0002449
GO:0032398;MHC class Ib protein complex;174;37;GO:0042612
GO:0103111;D-glucosamine PTS permease activity;11397;5;GO:0005975
GO:0032391;photoreceptor connecting cilium;2329;541;GO:0005929
GO:0032392;DNA geometric change;1731284;2430;GO:0006364
GO:0032390;MutLbeta complex;12;7;GO:0005524
GO:0032395;MHC class II receptor activity;38;832;GO:0004872
GO:0103117;UDP-3-O-acyl-N-acetylglucosamine deacetylase activity;20842;3;GO:0004721
GO:0032396;inhibitory MHC class I receptor activity;141;57;GO:0004872
GO:0103116;ABC-type D-galactofuranose transporter;4;3;GO:0005576
GO:0032393;MHC class I receptor activity;297;243;GO:0004872
GO:0032394;MHC class Ib receptor activity;165;10;GO:0004930
GO:0103118;UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase activity;4496;0;GO:0006030
GO:0032388;positive regulation of intracellular transport;12473;952;GO:0051603
GO:0032389;MutLalpha complex;348;266;GO:0005524
GO:0032386;regulation of intracellular transport;25438;1490;GO:0051603
GO:0032387;negative regulation of intracellular transport;3062;327;GO:0010467
GO:0032380;regulation of intracellular sterol transport;522;29;GO:0010468
GO:0032381;negative regulation of intracellular sterol transport;107;0;GO:0010468
GO:0032384;negative regulation of intracellular cholesterol transport;107;4;GO:0010467
GO:0032385;positive regulation of intracellular cholesterol transport;187;9;GO:0010467
GO:0032382;positive regulation of intracellular sterol transport;187;4;GO:0010468
GO:0032383;regulation of intracellular cholesterol transport;522;125;GO:0019900
GO:0032377;regulation of intracellular lipid transport;576;10;GO:0006629
GO:0032378;negative regulation of intracellular lipid transport;107;2;GO:0045765
GO:0032375;negative regulation of cholesterol transport;674;893;GO:0010467
GO:0032376;positive regulation of cholesterol transport;2034;307;GO:0010467
GO:0032379;positive regulation of intracellular lipid transport;237;9;GO:0045765
GO:0044355;clearance of foreign intracellular DNA;274592;6;GO:0048285
GO:1900850;negative regulation of pseurotin A biosynthetic process;0;0;GO:0046274
GO:0044354;macropinosome;428;124;GO:0072593
GO:0044357;regulation of rRNA stability;59;2;GO:0006364
GO:1900851;positive regulation of pseurotin A biosynthetic process;1;1;GO:0046405
GO:0044359;modulation of molecular function in another organism;47;1;GO:0043565
GO:1900854;positive regulation of terrequinone A biosynthetic process;1;2;GO:0046356
GO:0044358;envenomation resulting in hemorrhagic damage in another organism;13;0;GO:0048405
GO:1900847;negative regulation of naphtho-gamma-pyrone biosynthetic process;0;0;GO:0046274
GO:1900846;regulation of naphtho-gamma-pyrone biosynthetic process;0;0;GO:0046274
GO:0044360;modulation of voltage-gated potassium channel activity in another organism;17;0;GO:0048169
GO:1900849;regulation of pseurotin A biosynthetic process;1;0;GO:0046274
GO:1900848;positive regulation of naphtho-gamma-pyrone biosynthetic process;0;0;GO:0046274
GO:0044362;negative regulation of molecular function in another organism;25;1;GO:0050789
GO:0071970;fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process;120;0;GO:0005976
GO:0044361;negative regulation of voltage-gated potassium channel activity in another organism;16;3;GO:0048608
GO:0071971;extracellular exosome assembly;390;22;GO:0070062
GO:0044363;modulation of potassium channel activity in another organism;17;0;GO:0048169
GO:0071975;cell swimming;21;1;GO:0006928
GO:0071972;peptidoglycan L,D-transpeptidase activity;933;10;GO:0005576
GO:0071973;bacterial-type flagellum-dependent cell motility;337848;856;GO:0003700
GO:0071978;bacterial-type flagellum-dependent swarming motility;29230;21;GO:0005575
GO:0071979;cytoskeleton-mediated cell swimming;0;0;GO:0006928
GO:0071976;cell gliding;48;7;GO:0006936
GO:0071977;bacterial-type flagellum-dependent swimming motility;20;4;GO:0002537
GO:0071969;fungal-type cell wall (1->3)-beta-D-glucan metabolic process;120;0;GO:0006073
GO:1900861;regulation of cordyol C biosynthetic process;0;1;GO:0010401
GO:0044365;envenomation resulting in modulation of platelet aggregation in another organism;21;0;GO:0046330
GO:1900863;positive regulation of cordyol C biosynthetic process;0;1;GO:0046356
GO:1900862;negative regulation of cordyol C biosynthetic process;0;1;GO:0010468
GO:1900865;chloroplast RNA modification;404;72;GO:0006519
GO:1900864;mitochondrial RNA modification;1718;178;GO:0006519
GO:1900867;sarcinapterin metabolic process;0;0;GO:0006749
GO:1900866;glycolate transport;2744;2;GO:0006836
GO:0044373;cytokinin binding;13;1;GO:0005524
GO:0071960;maintenance of mitotic sister chromatid cohesion, centromeric;103;3;GO:0007070
GO:0044375;regulation of peroxisome size;1824;91;GO:0045944
GO:0044374;sequence-specific DNA binding, bending;31;5;GO:0003677
GO:0071963;establishment or maintenance of cell polarity regulating cell shape;676;31;GO:0048471
GO:0071964;establishment of cell polarity regulating cell shape;11;18;GO:0048608
GO:0071961;mitotic sister chromatid cohesion, arms;0;2;GO:0007030
GO:0071962;mitotic sister chromatid cohesion, centromeric;230;6;GO:0007030
GO:0071967;lipopolysaccharide core heptosyltransferase activity;1;1;GO:0004867
GO:0071968;lipid A-core heptosyltransferase activity;3;1;GO:0004364
GO:0071965;multicellular organismal locomotion;55;2;GO:0040011
GO:0071966;fungal-type cell wall polysaccharide metabolic process;521;7;GO:0006073
GO:1900870;tatiopterin biosynthetic process;0;0;GO:0006030
GO:0044377;RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending;15;3;GO:0003700
GO:1900872;pentadec-1-ene metabolic process;0;0;GO:0006081
GO:1900871;chloroplast mRNA modification;44;2;GO:0006470
GO:0044379;protein localization to actin cortical patch;17;3;GO:0005911
GO:1900874;heptadec-1-ene metabolic process;0;0;GO:0006749
GO:0044378;non-sequence-specific DNA binding, bending;213;22;GO:0003677
GO:1900873;pentadec-1-ene biosynthetic process;0;0;GO:0046395
GO:1900876;nonadec-1-ene metabolic process;0;0;GO:0046274
GO:1900875;heptadec-1-ene biosynthetic process;0;0;GO:0046274
GO:1900878;(Z)-nonadeca-1,14-diene metabolic process;0;0;GO:0006631
GO:1900877;nonadec-1-ene biosynthetic process;0;0;GO:1901363
GO:0044380;protein localization to cytoskeleton;8832;39;GO:0005829
GO:1900869;tatiopterin metabolic process;0;3;GO:0006790
GO:1900868;sarcinapterin biosynthetic process;0;0;GO:0009061
GO:0044382;CLRC complex localization to heterochromatin;0;0;GO:0007031
GO:0044381;glucose import in response to insulin stimulus;358;50;GO:0009410
GO:0044384;host outer membrane;8291;8;GO:0016021
GO:0044383;host chromosome;1;1;GO:0005634
GO:0071993;phytochelatin transport;109;3;GO:0006826
GO:0071990;maintenance of protein location to spindle pole body;0;0;GO:0048471
GO:0071996;glutathione transmembrane import into vacuole;35;3;GO:0006826
GO:0071994;phytochelatin transmembrane transport;109;3;GO:0008544
GO:0071995;phytochelatin import into vacuole;65;3;GO:0005986
GO:0071998;ascospore release from ascus;15;2;GO:0048305
GO:0071999;extracellular polysaccharide catabolic process;16;2;GO:0005976
GO:1900881;18-methylnonadec-1-ene biosynthetic process;0;0;GO:1901363
GO:1900880;18-methylnonadec-1-ene metabolic process;0;0;GO:0046274
GO:0044388;small protein activating enzyme binding;287;66;GO:0043169
GO:1900883;17-methylnonadec-1-ene biosynthetic process;0;0;GO:0046274
GO:0044387;negative regulation of protein kinase activity by regulation of protein phosphorylation;32;282;GO:0043406
GO:1900882;17-methylnonadec-1-ene metabolic process;0;0;GO:0046274
GO:1900885;negative regulation of tridecane biosynthetic process;0;0;GO:0010468
GO:0044389;ubiquitin-like protein ligase binding;54190;1470;GO:0005515
GO:1900884;regulation of tridecane biosynthetic process;0;0;GO:0010468
GO:1900887;regulation of pentadecane biosynthetic process;0;0;GO:0046395
GO:1900886;positive regulation of tridecane biosynthetic process;0;0;GO:0046395
GO:1900889;positive regulation of pentadecane biosynthetic process;0;1;GO:0046395
GO:1900888;negative regulation of pentadecane biosynthetic process;0;0;GO:0046395
GO:0044391;ribosomal subunit;952109;1490;GO:0005840
GO:0044390;ubiquitin-like protein conjugating enzyme binding;7461;55;GO:0005515
GO:1900879;(Z)-nonadeca-1,14-diene biosynthetic process;0;0;GO:0046148
GO:0044393;microspike;109;209;GO:0048706
GO:0044392;peptidyl-lysine malonylation;0;3;GO:0006468
GO:0044395;protein targeting to vacuolar membrane;61;5;GO:0005764
GO:0071981;exit from diapause;39;1;GO:0007548
GO:0044394;protein malonylation;0;1;GO:0006464
GO:0071982;maintenance of diapause;20;0;GO:0007548
GO:0044396;actin cortical patch organization;1027;24;GO:0050921
GO:0071980;cell surface adhesin-mediated gliding motility;0;0;GO:0002541
GO:0071985;multivesicular body sorting pathway;35839;265;GO:0006626
GO:0071986;Ragulator complex;5239;174;GO:0005524
GO:0071983;exit from reproductive diapause;0;0;GO:0007548
GO:0071984;maintenance of reproductive diapause;0;1;GO:0007548
GO:0071989;establishment of protein localization to spindle pole body;3;1;GO:0005813
GO:0071987;WD40-repeat domain binding;250;48;GO:0043169
GO:0071988;protein localization to spindle pole body;441;2;GO:0005840
